data_2kml_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2kml _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.4 ptp180 . . . . . 0 C--O 1.237 0.396 0 N-CA-C 103.749 -2.686 . . . . 0.0 103.749 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 20.8 mt -129.64 141.61 46.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 -166.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -115.83 146.86 41.62 Favored 'General case' 0 CA--C 1.513 -0.479 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 163.496 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 57.7 t -126.83 106.63 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.715 0 N-CA-C 103.945 -2.613 . . . . 0.0 103.945 170.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -113.37 119.13 36.58 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 -163.235 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -93.87 134.61 12.16 Favored Glycine 0 N--CA 1.451 -0.361 0 N-CA-C 107.909 -2.076 . . . . 0.0 107.909 175.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.7 m -140.96 167.08 17.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 C-N-CA 124.537 1.135 . . . . 0.0 109.457 -178.056 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 127.52 177.44 14.87 Favored Glycine 0 CA--C 1.527 0.821 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 -177.162 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.404 ' HB2' ' CE1' ' A' ' 93' ' ' HIS . 61.2 t-20 -91.76 117.88 30.17 Favored 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 178.332 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 41.3 pt -75.39 24.76 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.793 0 C-N-CA 124.483 1.113 . . . . 0.0 112.125 176.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 38.8 mt -137.45 -3.95 1.88 Allowed 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.594 1.557 . . . . 0.0 112.349 -177.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.5 tp -121.85 52.22 1.28 Allowed 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 120.158 1.345 . . . . 0.0 109.799 -163.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.408 ' HB ' ' H ' ' A' ' 15' ' ' ASP . 0.2 OUTLIER 42.25 -114.5 0.27 Allowed 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 126.502 1.921 . . . . 0.0 110.395 -169.591 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.408 ' H ' ' HB ' ' A' ' 14' ' ' THR . 36.5 m-20 -53.68 -26.21 21.63 Favored 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 126.54 1.936 . . . . 0.0 111.982 -171.514 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -60.04 -20.79 59.73 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 120.172 1.351 . . . . 0.0 111.752 -177.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.09 -11.51 40.5 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 117.773 -1.108 . . . . 0.0 113.415 172.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 7.1 tp -56.33 -44.41 79.73 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-N 120.32 1.418 . . . . 0.0 112.137 -171.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -59.16 -42.19 97.02 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 110.605 -0.998 . . . . 0.0 110.605 -178.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 60.3 t -67.57 -46.7 82.51 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 CA-C-O 118.978 -0.534 . . . . 0.0 110.14 175.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 9.8 mmt180 -58.37 -33.35 69.49 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 119.823 1.192 . . . . 0.0 112.823 -179.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 41.7 mt -57.98 -51.06 75.37 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 177.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 18.0 m -73.49 -35.75 46.16 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 CA-C-N 119.19 0.905 . . . . 0.0 111.717 -173.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -58.56 -47.13 85.27 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 118.811 0.732 . . . . 0.0 110.225 171.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -71.33 -22.13 61.96 Favored 'General case' 0 CA--C 1.531 0.234 0 O-C-N 121.689 -0.632 . . . . 0.0 112.462 -178.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 27.4 tp -73.79 -49.6 24.55 Favored 'General case' 0 C--N 1.339 0.137 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 175.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -52.65 -43.47 65.49 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.068 1.347 . . . . 0.0 111.172 178.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 66.5 mt-30 -85.06 -0.09 53.31 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.702 0.801 . . . . 0.0 113.033 -173.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 85.5 mtt180 -127.66 -23.14 3.48 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-O 116.695 -1.622 . . . . 0.0 112.931 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -134.74 128.75 33.51 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-N 120.823 1.647 . . . . 0.0 109.313 -172.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 48.7 mm -79.77 142.87 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 N-CA-C 105.605 -1.998 . . . . 0.0 105.605 163.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -114.93 154.9 47.0 Favored Pre-proline 0 N--CA 1.453 -0.311 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 178.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -54.81 152.51 28.31 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 121.169 1.246 . . . . 0.0 110.224 158.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -41.41 -46.72 3.45 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 127.575 2.35 . . . . 0.0 113.624 -178.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -78.57 19.9 0.46 Allowed 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 114.149 1.166 . . . . 0.0 114.149 -168.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 10.7 t -126.04 89.08 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 C-N-CA 125.489 1.516 . . . . 0.0 109.023 179.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -71.23 130.16 40.73 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 171.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -93.68 137.19 23.3 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 N-CA-C 105.682 -1.97 . . . . 0.0 105.682 157.213 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 60.5 tp -143.63 129.72 19.65 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 -175.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 30.7 t0 -84.8 133.21 34.35 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 166.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -115.02 31.5 6.24 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 126.351 1.929 . . . . 0.0 111.271 175.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -21.33 110.55 0.01 OUTLIER Glycine 0 CA--C 1.527 0.789 0 C-N-CA 129.026 3.203 . . . . 0.0 114.911 177.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER 59.68 -2.02 0.14 Allowed 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 116.542 2.053 . . . . 0.0 116.542 177.699 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.93 -63.04 1.38 Allowed 'General case' 0 C--N 1.34 0.156 0 CA-C-N 120.211 1.368 . . . . 0.0 112.909 -169.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 57.68 -94.24 0.04 OUTLIER Glycine 0 CA--C 1.533 1.177 0 N-CA-C 110.141 -1.184 . . . . 0.0 110.141 -163.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 7.8 tpt -57.63 -37.69 73.72 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 125.257 1.423 . . . . 0.0 113.147 -169.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -58.2 -26.56 62.94 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.708 0.766 . . . . 0.0 112.108 -173.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 83.1 mt -73.45 2.46 7.73 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 124.721 1.208 . . . . 0.0 112.489 -174.34 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 5.0 tt -43.98 -46.25 8.19 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 125.676 1.591 . . . . 0.0 111.594 174.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -84.05 -31.44 25.96 Favored Glycine 0 CA--C 1.525 0.674 0 CA-C-O 118.827 -0.985 . . . . 0.0 112.323 -178.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -75.6 -44.23 44.01 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 118.739 1.269 . . . . 0.0 110.904 -172.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 37.3 mtp -69.08 -11.32 60.68 Favored 'General case' 0 CA--C 1.54 0.574 0 O-C-N 121.974 -0.454 . . . . 0.0 111.675 -177.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -75.4 153.9 37.46 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 124.818 1.247 . . . . 0.0 110.446 -176.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 62.15 -5.67 0.16 Allowed 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 127.229 2.211 . . . . 0.0 114.107 167.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 8.6 mmt180 -66.29 148.4 51.9 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 175.084 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -80.05 -44.76 19.52 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 -175.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 4.0 t-160 -139.18 131.09 27.72 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 103.118 -2.919 . . . . 0.0 103.118 -177.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 30.1 tp -129.29 122.49 29.71 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 -178.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 52.3 mt -103.07 109.36 26.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 105.318 -2.105 . . . . 0.0 105.318 171.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 21.4 mt -83.39 148.33 5.17 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 168.021 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -131.05 128.8 41.0 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 164.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -153.25 168.37 26.22 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.324 1.05 . . . . 0.0 110.426 -163.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -92.1 129.9 37.95 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 163.122 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 34.9 mt -76.56 -24.71 15.89 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 C-N-CA 123.668 0.787 . . . . 0.0 110.503 175.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . 0.255 26.1 t 64.52 -35.03 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 C-N-CA 128.202 2.601 . . . . 0.0 113.687 -179.701 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -153.68 133.75 13.27 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 121.925 2.148 . . . . 0.0 113.883 -174.324 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.43 ' HG3' ' H ' ' A' ' 68' ' ' LYS . 3.6 tppt? -156.87 -175.73 5.59 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 105.557 -2.016 . . . . 0.0 105.557 147.236 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.43 ' H ' ' HG3' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -85.37 67.01 9.98 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 166.225 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 52.3 t30 -150.36 155.72 40.15 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 119.052 0.842 . . . . 0.0 109.0 178.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 8.1 m -60.02 140.41 90.53 Favored Pre-proline 0 CA--C 1.543 0.699 0 C-N-CA 126.674 1.99 . . . . 0.0 112.124 -165.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_exo -43.97 149.79 0.73 Allowed 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 124.22 3.28 . . . . 0.0 113.492 168.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 66.39 -7.91 1.21 Allowed Glycine 0 CA--C 1.532 1.101 0 C-N-CA 124.86 1.219 . . . . 0.0 115.554 178.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 30.4 m -64.88 149.83 48.85 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 120.202 2.001 . . . . 0.0 109.421 -178.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 28.9 ttp -94.43 147.36 23.32 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 174.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 42.0 mtt -129.23 146.15 51.2 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 106.095 -1.817 . . . . 0.0 106.095 162.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 33.2 mm -117.81 130.17 73.09 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 N-CA-C 103.266 -2.864 . . . . 0.0 103.266 171.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -123.74 143.55 50.22 Favored 'General case' 0 C--O 1.242 0.684 0 N-CA-C 105.013 -2.217 . . . . 0.0 105.013 176.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 79.9 mtm180 -114.73 165.88 12.34 Favored 'General case' 0 C--O 1.222 -0.36 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 177.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -22.29 -66.43 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 127.866 2.466 . . . . 0.0 116.072 -159.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -62.16 -33.52 74.67 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.879 1.672 . . . . 0.0 113.804 -176.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -76.35 -26.87 56.16 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.122 1.369 . . . . 0.0 110.741 -175.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 26.4 t -69.1 -50.89 19.47 Favored Pre-proline 0 CA--C 1.544 0.742 0 CA-C-O 117.69 -1.148 . . . . 0.0 112.394 -169.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -57.25 -39.89 86.68 Favored 'Trans proline' 0 C--N 1.353 0.802 0 CA-C-N 121.602 1.608 . . . . 0.0 111.374 174.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -62.84 -45.4 92.77 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 123.053 0.541 . . . . 0.0 110.59 -179.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -58.03 -47.52 82.85 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 123.817 0.847 . . . . 0.0 110.027 176.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 -75.88 1.36 15.3 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 -175.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 70.9 p -63.7 -13.36 42.41 Favored 'General case' 0 CA--C 1.543 0.685 0 O-C-N 120.198 -1.564 . . . . 0.0 112.315 166.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 41.1 t30 -58.72 109.89 0.89 Allowed 'General case' 0 C--N 1.346 0.454 0 C-N-CA 125.357 1.463 . . . . 0.0 111.712 -178.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 32.4 mmtp -67.87 -16.13 63.94 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 113.298 0.851 . . . . 0.0 113.298 -175.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 41.1 mt -75.03 -21.02 16.54 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 C-N-CA 123.358 0.663 . . . . 0.0 109.536 -179.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 14.6 m -100.56 104.71 32.52 Favored Pre-proline 0 CA--C 1.546 0.819 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 -172.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -72.4 -54.51 0.13 Allowed 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.295 1.996 . . . . 0.0 113.622 -160.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . 0.404 ' CE1' ' HB2' ' A' ' 10' ' ' ASN . 20.3 m80 -65.3 -36.1 83.04 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 177.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 23.1 mp0 -64.66 -30.03 71.04 Favored 'General case' 0 N--CA 1.441 -0.901 0 C-N-CA 125.02 1.328 . . . . 0.0 110.378 -176.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -64.94 -33.63 76.49 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 119.103 0.865 . . . . 0.0 111.535 171.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -78.72 -30.38 48.51 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 110.759 -0.937 . . . . 0.0 110.759 172.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.8 -37.62 88.06 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 118.339 1.07 . . . . 0.0 108.466 171.398 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -60.95 -43.42 98.72 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 117.929 -1.034 . . . . 0.0 109.924 175.007 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -74.15 -24.03 59.35 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 119.638 1.108 . . . . 0.0 113.158 177.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 38.1 t -62.48 -44.91 99.75 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 O-C-N 119.742 -1.848 . . . . 0.0 109.366 164.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 72.9 mt -67.94 -29.74 68.88 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 119.352 0.978 . . . . 0.0 110.811 178.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 44.5 m -62.19 -57.61 10.83 Favored 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 167.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.31 -35.4 78.93 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.795 1.238 . . . . 0.0 113.112 -174.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 13.8 mt -65.1 -42.37 94.09 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-N 118.929 0.786 . . . . 0.0 109.709 173.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 76.5 ttt180 -64.89 -34.65 78.9 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-O 117.677 -1.154 . . . . 0.0 110.649 172.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 13.0 m-30 -66.22 -39.22 89.43 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 120.069 1.304 . . . . 0.0 110.715 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 40.8 p -78.37 -28.05 46.98 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 119.119 0.872 . . . . 0.0 110.828 177.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 83.65 1.56 90.03 Favored Glycine 0 CA--C 1.531 1.056 0 CA-C-O 118.158 -1.357 . . . . 0.0 112.443 -166.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -87.08 21.01 2.47 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 120.479 2.139 . . . . 0.0 111.545 -179.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -61.19 139.01 94.55 Favored Pre-proline 0 CA--C 1.549 0.927 0 C-N-CA 126.274 1.83 . . . . 0.0 109.93 170.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -55.42 167.98 1.7 Allowed 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 123.923 3.082 . . . . 0.0 115.866 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -74.67 -23.12 58.6 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 123.461 0.704 . . . . 0.0 111.686 169.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 52.2 tttm -158.93 84.29 0.81 Allowed 'General case' 0 C--O 1.241 0.632 0 N-CA-C 106.522 -1.659 . . . . 0.0 106.522 -169.109 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.7 tt -79.21 141.88 36.75 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 119.186 -1.006 . . . . 0.0 108.914 165.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -138.9 146.76 41.5 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.88 1.672 . . . . 0.0 107.369 177.458 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -133.11 113.98 13.36 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 -179.274 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 45.1 t -93.35 86.66 2.15 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 173.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.55 150.36 16.94 Favored Glycine 0 C--N 1.338 0.671 0 N-CA-C 111.001 -0.84 . . . . 0.0 111.001 -166.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 22.7 t -129.11 135.84 61.03 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 -169.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 25.0 mt -78.3 135.93 61.23 Favored Pre-proline 0 CA--C 1.549 0.919 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 170.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -75.92 -161.53 0.13 Allowed 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 124.288 3.325 . . . . 0.0 111.522 178.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -138.75 -62.03 0.56 Allowed 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.83 1.652 . . . . 0.0 108.518 173.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 57.6 m -99.24 -48.19 4.91 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 119.104 0.865 . . . . 0.0 111.737 -177.106 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 51.58 45.91 27.34 Favored 'General case' 0 CA--C 1.549 0.911 0 N-CA-C 114.336 1.235 . . . . 0.0 114.336 -177.494 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -110.18 161.84 22.86 Favored Pre-proline 0 CA--C 1.542 0.642 0 C-N-CA 124.195 0.998 . . . . 0.0 110.989 -177.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -72.31 68.94 3.37 Favored 'Trans proline' 0 CA--C 1.543 0.954 0 C-N-CA 124.485 3.457 . . . . 0.0 113.982 -177.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 5.7 p-80 -148.16 173.18 13.24 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 126.874 2.07 . . . . 0.0 106.938 162.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -118.32 144.82 25.39 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.158 0 O-C-N 121.069 -1.019 . . . . 0.0 110.151 -171.185 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 142.09 176.25 16.14 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 105.997 -2.841 . . . . 0.0 105.997 -172.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -98.57 161.76 13.5 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 104.676 -2.342 . . . . 0.0 104.676 150.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 65.7 p -62.12 158.34 46.22 Favored Pre-proline 0 CA--C 1.543 0.71 0 C-N-CA 119.176 -1.01 . . . . 0.0 108.608 155.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -51.85 -38.49 67.97 Favored 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 122.046 1.83 . . . . 0.0 112.03 171.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 6.3 m -53.01 -30.98 38.51 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 126.12 1.768 . . . . 0.0 112.278 176.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 63.9 t -115.51 -18.88 6.96 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 CA-C-N 118.719 0.691 . . . . 0.0 111.014 -170.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -59.52 -43.25 93.49 Favored 'General case' 0 CA--C 1.534 0.338 0 O-C-N 121.325 -0.859 . . . . 0.0 108.73 165.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -59.45 -30.47 68.53 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.154 -0.476 . . . . 0.0 112.096 173.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 15.1 mmm -73.18 -8.47 55.94 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 117.458 -1.258 . . . . 0.0 113.789 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 96.7 mt -58.18 -50.05 79.62 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-N 120.438 1.472 . . . . 0.0 108.458 177.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -78.07 -40.37 1.92 Allowed Pre-proline 0 CA--C 1.535 0.376 0 CA-C-O 117.163 -1.398 . . . . 0.0 114.588 -168.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -54.34 -35.96 85.58 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 CA-C-N 122.38 1.886 . . . . 0.0 112.224 167.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -75.88 -32.85 59.88 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-O 117.981 -1.009 . . . . 0.0 111.313 175.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 53.5 mt -59.18 -48.59 81.03 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 120.579 1.536 . . . . 0.0 108.229 169.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -60.15 -29.53 68.72 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 119.375 0.989 . . . . 0.0 111.565 -179.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 32.6 mm-40 -86.39 -31.86 21.24 Favored 'General case' 0 CA--C 1.529 0.145 0 O-C-N 120.999 -1.063 . . . . 0.0 113.57 176.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 72.2 t -63.83 -40.97 90.97 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 CA-C-N 120.99 1.723 . . . . 0.0 108.736 166.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 83.6 mt -66.39 -39.8 89.28 Favored 'General case' 0 N--CA 1.463 0.179 0 C-N-CA 123.653 0.781 . . . . 0.0 110.722 176.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -64.01 -46.15 85.78 Favored 'General case' 0 C--O 1.227 -0.126 0 CA-C-N 118.748 0.704 . . . . 0.0 110.598 174.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -59.05 -42.88 91.37 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 118.847 -0.597 . . . . 0.0 110.776 178.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 31.1 mt -58.0 -45.23 87.15 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 119.174 0.897 . . . . 0.0 110.27 173.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 64.8 mtt180 -66.38 -18.88 65.62 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 117.096 -1.43 . . . . 0.0 112.791 178.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -60.9 -27.0 67.85 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 121.328 1.877 . . . . 0.0 110.807 171.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 16.7 m -101.89 13.91 33.47 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.107 0.963 . . . . 0.0 111.642 175.01 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 71.85 10.39 72.27 Favored Glycine 0 CA--C 1.53 1.0 0 CA-C-O 118.777 -1.013 . . . . 0.0 113.542 -179.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 61.0 t -79.69 102.92 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 CA-C-N 119.31 1.555 . . . . 0.0 107.301 178.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -72.93 152.87 41.22 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 164.038 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -131.57 150.91 51.98 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 125.351 1.46 . . . . 0.0 107.243 174.269 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 7.7 mm -114.31 122.72 33.77 Favored Pre-proline 0 CA--C 1.53 0.203 0 N-CA-C 107.58 -1.266 . . . . 0.0 107.58 -163.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -62.41 116.66 3.65 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 122.162 1.908 . . . . 0.0 108.031 176.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 59.7 mtm180 40.09 8.16 0.0 OUTLIER 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 129.573 3.149 . . . . 0.0 117.576 -172.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 70.7 m . . . . . 0 N--CA 1.468 0.439 0 CA-C-N 121.231 1.832 . . . . 0.0 110.381 -158.246 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 39.1 mmt180 . . . . . 0 N--CA 1.479 0.977 0 CA-C-O 118.336 -0.84 . . . . 0.0 108.813 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 3.9 mt -123.39 121.67 63.31 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 -176.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -106.81 139.28 41.49 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 168.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 58.0 t -126.87 101.43 7.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 105.467 -2.049 . . . . 0.0 105.467 -177.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.3 mt -98.76 109.36 22.13 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.475 1.11 . . . . 0.0 109.581 -169.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -87.15 127.13 8.29 Favored Glycine 0 C--O 1.237 0.324 0 N-CA-C 106.958 -2.457 . . . . 0.0 106.958 169.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 15.3 m -138.69 172.69 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 CA-C-N 117.588 0.694 . . . . 0.0 111.202 -169.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 101.16 163.45 27.59 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 127.189 2.328 . . . . 0.0 111.731 179.202 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.43 HD22 ' HB2' ' A' ' 12' ' ' LEU . 6.9 t30 -77.32 102.13 6.61 Favored 'General case' 0 C--N 1.332 -0.167 0 O-C-N 121.88 -0.777 . . . . 0.0 111.043 -169.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -56.52 7.51 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.935 0 N-CA-C 117.742 2.497 . . . . 0.0 117.742 179.164 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.43 ' HB2' HD22 ' A' ' 10' ' ' ASN . 67.7 mt -109.54 1.3 19.65 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 122.127 2.24 . . . . 0.0 109.743 -177.438 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.4 mp -111.84 63.02 0.62 Allowed 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 123.895 0.878 . . . . 0.0 111.4 -169.039 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 52.83 -100.15 0.09 Allowed 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.664 0.786 . . . . 0.0 111.152 176.59 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 -83.69 -9.1 59.08 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 124.262 1.025 . . . . 0.0 111.881 -174.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -71.79 -8.41 54.12 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 120.485 1.493 . . . . 0.0 112.454 -175.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -75.37 -14.35 60.46 Favored 'General case' 0 N--CA 1.434 -1.252 0 CA-C-O 115.724 -2.084 . . . . 0.0 109.349 170.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 7.9 tp -52.48 -39.2 28.33 Favored 'Isoleucine or valine' 0 C--N 1.344 0.358 0 CA-C-N 122.588 2.449 . . . . 0.0 112.878 -169.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -61.46 -45.52 96.21 Favored Glycine 0 CA--C 1.525 0.718 0 CA-C-N 119.422 1.01 . . . . 0.0 111.148 177.018 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 69.9 t -64.2 -48.53 85.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-O 118.845 -0.598 . . . . 0.0 110.039 172.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 78.4 mmt-85 -59.07 -33.88 71.32 Favored 'General case' 0 C--O 1.223 -0.336 0 CA-C-O 117.755 -1.116 . . . . 0.0 112.263 -179.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 28.6 mt -63.64 -45.07 98.51 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 CA-C-N 120.679 1.581 . . . . 0.0 109.656 177.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 14.5 m -75.81 -26.0 17.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-N 119.67 1.123 . . . . 0.0 111.071 -176.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 -70.75 -44.92 65.78 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 173.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.69 -42.37 97.02 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 122.885 0.474 . . . . 0.0 109.809 176.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 8.2 tp -65.45 -42.91 91.85 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 118.16 -0.924 . . . . 0.0 110.48 178.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -58.22 -43.98 87.98 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 119.042 0.837 . . . . 0.0 110.73 178.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -72.64 -39.7 66.98 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.715 0.806 . . . . 0.0 111.27 -177.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -95.82 -40.56 9.27 Favored 'General case' 0 C--N 1.34 0.172 0 CA-C-O 117.044 -1.455 . . . . 0.0 113.704 -169.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -109.64 124.14 50.67 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 121.735 2.062 . . . . 0.0 112.151 -169.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 47.2 mm -76.78 137.43 22.54 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 N-CA-C 105.739 -1.948 . . . . 0.0 105.739 169.13 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 29.5 mt -135.25 156.28 78.18 Favored Pre-proline 0 CA--C 1.535 0.4 0 C-N-CA 124.665 1.186 . . . . 0.0 110.83 -169.267 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -60.06 155.86 42.58 Favored 'Trans proline' 0 CA--C 1.535 0.569 0 C-N-CA 123.344 2.696 . . . . 0.0 111.775 169.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -62.26 -30.49 71.16 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -173.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 11.5 p90 -73.54 -6.42 46.42 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 118.207 -0.901 . . . . 0.0 112.752 -179.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 19.7 t -99.28 127.26 52.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 CA-C-N 119.861 1.21 . . . . 0.0 108.264 175.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -127.19 137.27 52.89 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 173.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -102.36 104.15 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 N-CA-C 105.862 -1.903 . . . . 0.0 105.862 176.664 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 56.7 tp -95.88 121.39 37.56 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -79.92 109.46 14.38 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 106.254 -1.758 . . . . 0.0 106.254 169.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -103.86 -27.92 6.12 Favored Glycine 0 CA--C 1.534 1.233 0 CA-C-O 119.248 -0.751 . . . . 0.0 112.373 173.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 40.17 -111.99 0.27 Allowed Glycine 0 C--N 1.34 0.775 0 C-N-CA 125.327 1.442 . . . . 0.0 113.122 -177.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 12.1 p -65.01 -3.49 3.6 Favored 'General case' 0 C--N 1.316 -0.869 0 C-N-CA 128.756 2.823 . . . . 0.0 113.806 -172.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -50.3 -66.3 0.41 Allowed 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 114.974 1.472 . . . . 0.0 114.974 -179.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 64.15 -94.62 0.15 Allowed Glycine 0 CA--C 1.531 1.065 0 N-CA-C 109.416 -1.473 . . . . 0.0 109.416 -169.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 10.4 tpt -69.33 -26.99 64.98 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 126.776 2.03 . . . . 0.0 112.255 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -70.17 -4.68 22.65 Favored 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -169.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 66.2 mt -87.79 -6.01 58.36 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 124.636 1.175 . . . . 0.0 114.063 -171.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 5.2 tt -43.39 -59.74 2.0 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 114.19 1.182 . . . . 0.0 114.19 -169.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -72.25 -36.4 59.93 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 111.723 -0.551 . . . . 0.0 111.723 -170.193 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -68.01 -37.77 81.81 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 117.932 0.866 . . . . 0.0 110.214 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 36.2 mtp -74.13 -18.13 60.83 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 120.664 -0.414 . . . . 0.0 111.782 -174.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -75.73 151.04 37.7 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 121.635 0.731 . . . . 0.0 111.129 -177.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 55.62 44.16 27.02 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 126.373 1.869 . . . . 0.0 114.201 168.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 27.2 mmt180 -108.01 156.98 18.64 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 174.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -78.62 -41.9 30.32 Favored 'General case' 0 N--CA 1.467 0.385 0 O-C-N 121.438 -0.789 . . . . 0.0 109.771 171.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -134.23 133.14 40.52 Favored 'General case' 0 C--O 1.232 0.168 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 -175.171 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 26.1 tp -135.42 131.77 36.65 Favored 'General case' 0 CA--C 1.512 -0.482 0 O-C-N 121.486 -0.759 . . . . 0.0 109.242 169.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 10.6 mt -114.07 123.44 69.73 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 N-CA-C 106.006 -1.85 . . . . 0.0 106.006 178.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 15.5 mt -101.49 127.53 54.75 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 N-CA-C 104.803 -2.295 . . . . 0.0 104.803 177.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -115.64 121.48 42.69 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 105.749 -1.945 . . . . 0.0 105.749 176.079 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -155.41 149.29 25.46 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 118.561 0.619 . . . . 0.0 112.437 -169.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -76.82 116.92 17.92 Favored 'General case' 0 CA--C 1.529 0.136 0 N-CA-C 105.53 -2.026 . . . . 0.0 105.53 168.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.7 tt -68.79 -25.46 30.48 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.772 0 CA-C-O 117.684 -1.151 . . . . 0.0 113.102 -169.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . 0.281 92.9 t 55.28 17.03 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.556 1.202 0 C-N-CA 125.278 1.431 . . . . 0.0 112.806 172.212 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 48.7 m -126.86 164.05 22.26 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 125.057 1.343 . . . . 0.0 111.3 -170.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.487 ' HG3' ' H ' ' A' ' 68' ' ' LYS . 4.6 tppt? 59.72 -172.06 0.12 Allowed 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.12 1.768 . . . . 0.0 111.738 177.417 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.487 ' H ' ' HG3' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -128.66 20.48 6.07 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.223 1.409 . . . . 0.0 112.401 -175.809 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 51.0 t30 -71.48 163.85 26.93 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 108.096 -1.075 . . . . 0.0 108.096 172.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 12.6 m -58.14 142.67 80.17 Favored Pre-proline 0 CA--C 1.546 0.801 0 C-N-CA 123.964 0.906 . . . . 0.0 112.18 -169.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -57.38 152.38 47.03 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.554 2.169 . . . . 0.0 111.453 170.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 67.7 16.48 67.94 Favored Glycine 0 CA--C 1.533 1.169 0 CA-C-O 119.128 -0.818 . . . . 0.0 113.756 177.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 48.7 m -96.32 153.89 17.56 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 118.955 1.377 . . . . 0.0 108.784 175.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 9.6 ttp -97.97 141.77 30.52 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 123.589 0.756 . . . . 0.0 110.222 -179.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 13.6 mtp -126.48 119.31 26.88 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 176.053 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 46.0 mm -103.07 123.81 56.75 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 177.086 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 48.2 mt -125.0 129.28 50.0 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 107.548 -1.278 . . . . 0.0 107.548 -177.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 65.7 mtm180 -104.99 131.49 52.44 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 -169.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 6.9 t70 36.32 -98.11 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 116.168 1.914 . . . . 0.0 116.168 169.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -62.74 -27.57 69.36 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.966 0.906 . . . . 0.0 112.932 -176.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -73.49 -15.47 61.32 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.385 0.674 . . . . 0.0 111.005 -177.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 81.4 t -79.52 -60.84 0.5 Allowed Pre-proline 0 N--CA 1.442 -0.832 0 CA-C-O 117.963 -1.018 . . . . 0.0 110.466 -169.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -59.85 -31.69 94.25 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 CA-C-N 120.846 1.338 . . . . 0.0 111.65 175.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.14 -13.69 62.41 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -177.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -98.14 -38.38 9.35 Favored 'General case' 0 C--N 1.344 0.332 0 CA-C-N 118.713 0.688 . . . . 0.0 109.267 169.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -59.34 -12.79 6.34 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 113.101 0.778 . . . . 0.0 113.101 177.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 70.7 p -52.86 -27.78 19.99 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 113.857 1.058 . . . . 0.0 113.857 169.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -60.23 146.25 44.34 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 122.948 0.499 . . . . 0.0 111.66 -169.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 46.6 mmtm -99.51 -0.16 41.19 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.7 0.8 . . . . 0.0 111.981 177.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 74.8 mt -66.95 -41.13 87.07 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 178.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 5.8 m -96.81 109.43 48.61 Favored Pre-proline 0 CA--C 1.543 0.68 0 C-N-CA 125.737 1.615 . . . . 0.0 109.223 -172.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -68.3 -47.22 1.69 Allowed 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.002 1.802 . . . . 0.0 112.937 -169.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 15.7 m80 -73.94 -22.47 59.65 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 122.729 0.411 . . . . 0.0 111.328 -171.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -68.9 -24.75 64.34 Favored 'General case' 0 C--O 1.222 -0.343 0 CA-C-O 117.72 -1.134 . . . . 0.0 111.847 177.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 2.8 tt -60.77 -43.42 98.08 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 120.387 1.449 . . . . 0.0 109.652 -174.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -59.99 -41.6 97.98 Favored Glycine 0 CA--C 1.529 0.94 0 O-C-N 121.628 -0.67 . . . . 0.0 111.52 176.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -71.62 -32.6 68.14 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 118.526 1.163 . . . . 0.0 110.717 179.083 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -60.3 -45.2 94.18 Favored 'General case' 0 N--CA 1.454 -0.254 0 O-C-N 120.943 -1.098 . . . . 0.0 109.067 171.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -69.9 -23.85 63.3 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 118.979 -0.534 . . . . 0.0 112.104 177.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 20.9 t -66.5 -45.05 89.9 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.697 0 CA-C-N 119.223 0.92 . . . . 0.0 108.552 169.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 93.8 mt -64.44 -34.22 77.68 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 119.377 0.99 . . . . 0.0 110.245 179.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 20.3 m -64.91 -41.41 95.6 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 118.88 0.763 . . . . 0.0 110.318 169.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.451 ' HA ' ' CD2' ' A' ' 106' ' ' PHE . . . -64.39 -36.8 85.33 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 119.121 0.873 . . . . 0.0 111.527 178.296 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.6 mt -66.8 -35.6 80.44 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 118.412 0.551 . . . . 0.0 110.272 176.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 77.7 ttt-85 -65.92 -38.79 89.62 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 118.459 -0.781 . . . . 0.0 109.909 171.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.451 ' CD2' ' HA ' ' A' ' 103' ' ' ALA . 15.6 m-30 -64.09 -44.05 93.53 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 119.372 0.987 . . . . 0.0 110.586 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 42.3 p -75.71 -22.8 56.28 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 118.325 0.511 . . . . 0.0 111.403 178.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 74.47 12.59 82.21 Favored Glycine 0 CA--C 1.531 1.09 0 N-CA-C 111.118 -0.793 . . . . 0.0 111.118 -169.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -98.79 25.29 6.7 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 118.644 1.222 . . . . 0.0 110.97 -178.006 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -57.56 135.58 82.26 Favored Pre-proline 0 CA--C 1.544 0.724 0 C-N-CA 124.111 0.964 . . . . 0.0 109.209 170.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -54.55 151.71 29.87 Favored 'Trans proline' 0 C--N 1.35 0.658 0 C-N-CA 123.643 2.895 . . . . 0.0 114.108 -179.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -60.09 -29.81 68.83 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 119.012 -0.518 . . . . 0.0 110.44 177.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 23.1 ttpp -146.54 125.84 13.07 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 169.161 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.4 tt -105.92 147.38 28.83 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 169.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -143.42 138.9 29.67 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 -177.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.7 tp -125.09 129.39 50.14 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 120.429 1.468 . . . . 0.0 108.828 175.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 53.5 t -102.5 98.95 7.45 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 N-CA-C 104.759 -2.311 . . . . 0.0 104.759 168.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -84.77 140.27 18.59 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 109.981 -1.248 . . . . 0.0 109.981 174.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 40.9 t -119.95 138.25 51.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 173.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 5.4 mt -86.92 126.92 61.65 Favored Pre-proline 0 CA--C 1.54 0.591 0 CA-C-N 119.395 0.998 . . . . 0.0 108.389 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -77.0 167.28 25.39 Favored 'Trans proline' 0 CA--C 1.542 0.884 0 C-N-CA 123.657 2.904 . . . . 0.0 112.25 -178.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -107.38 -58.89 1.9 Allowed 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.673 0.789 . . . . 0.0 109.924 -178.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 4.0 m -105.28 -58.06 1.95 Allowed 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 122.934 0.494 . . . . 0.0 112.04 -170.27 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER 56.46 52.37 10.03 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 126.176 1.79 . . . . 0.0 115.334 171.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -121.71 165.21 20.76 Favored Pre-proline 0 N--CA 1.475 0.796 0 CA-C-O 117.826 -1.083 . . . . 0.0 108.87 172.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -67.47 84.09 0.38 Allowed 'Trans proline' 0 CA--C 1.546 1.084 0 C-N-CA 123.345 2.697 . . . . 0.0 112.551 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -168.85 152.4 5.35 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 104.501 -2.407 . . . . 0.0 104.501 174.241 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -120.27 152.87 23.22 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-O 121.999 0.904 . . . . 0.0 113.286 -169.654 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 120.8 130.73 3.92 Favored Glycine 0 CA--C 1.527 0.814 0 N-CA-C 105.98 -2.848 . . . . 0.0 105.98 -169.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 7.0 mp -77.8 149.39 34.43 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 177.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 54.6 p -67.22 163.19 48.21 Favored Pre-proline 0 CA--C 1.534 0.349 0 CA-C-O 119.148 -0.453 . . . . 0.0 109.942 169.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -58.71 -34.67 99.08 Favored 'Trans proline' 0 CA--C 1.537 0.65 0 C-N-CA 121.099 1.199 . . . . 0.0 109.574 169.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 4.5 m -63.34 -39.06 93.51 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.187 0.995 . . . . 0.0 111.18 -176.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 21.8 t -102.48 -25.89 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 CA-C-N 119.319 0.963 . . . . 0.0 112.146 -176.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -54.1 -43.01 70.02 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 120.825 1.648 . . . . 0.0 109.986 169.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -73.04 -2.43 21.18 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-O 118.332 -0.842 . . . . 0.0 113.107 -176.033 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 16.4 mmm -89.58 -7.09 55.56 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-O 116.953 -1.499 . . . . 0.0 111.022 170.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 91.6 mt -58.9 -47.64 88.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 CA-C-N 121.631 2.014 . . . . 0.0 109.301 -179.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 61.6 mt-10 -73.21 -51.14 6.08 Favored Pre-proline 0 CA--C 1.536 0.425 0 CA-C-O 117.39 -1.29 . . . . 0.0 110.809 -178.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -40.49 -51.99 3.23 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 124.447 3.431 . . . . 0.0 113.672 169.041 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -74.16 -45.33 49.31 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 114.538 -1.21 . . . . 0.0 111.451 -174.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -62.37 -36.02 80.96 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 119.594 1.088 . . . . 0.0 109.984 178.28 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -62.86 -33.04 74.45 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 118.744 -0.645 . . . . 0.0 111.085 176.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 42.9 mm-40 -78.47 -29.97 47.12 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 119.502 1.046 . . . . 0.0 111.892 174.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 67.7 t -61.41 -43.43 96.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 169.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 71.4 mt -69.65 -33.41 72.57 Favored 'General case' 0 N--CA 1.463 0.179 0 O-C-N 120.752 -1.217 . . . . 0.0 111.622 176.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -58.86 -33.6 70.65 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 118.923 0.783 . . . . 0.0 111.455 176.151 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -62.42 -46.79 86.95 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 118.531 0.605 . . . . 0.0 111.292 174.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 7.1 mp -58.44 -43.4 88.76 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.021 0.529 . . . . 0.0 109.866 174.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 84.7 mtt180 -65.38 -17.56 64.63 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 117.418 -1.277 . . . . 0.0 111.896 -177.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -58.16 -34.38 70.24 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 120.616 1.553 . . . . 0.0 111.33 175.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 8.1 m -107.39 28.57 7.98 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.598 1.159 . . . . 0.0 110.956 -179.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 64.22 23.8 68.39 Favored Glycine 0 CA--C 1.53 1.003 0 CA-C-O 118.725 -1.042 . . . . 0.0 113.917 176.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 59.4 t -93.77 134.47 31.31 Favored 'Isoleucine or valine' 0 C--N 1.341 0.213 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 174.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -122.6 145.05 48.7 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 178.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -107.46 143.09 36.32 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 124.06 0.944 . . . . 0.0 109.351 174.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 23.3 mm -105.62 125.97 31.97 Favored Pre-proline 0 C--O 1.234 0.253 0 CA-C-O 117.879 -1.058 . . . . 0.0 108.649 -173.193 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -57.61 110.42 0.62 Allowed 'Trans proline' 0 N--CA 1.461 -0.383 0 C-N-CA 122.608 2.206 . . . . 0.0 108.919 169.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 82.7 mtm180 51.51 30.68 6.63 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.179 0.992 . . . . 0.0 112.715 171.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 17.4 p . . . . . 0 CA--C 1.542 0.64 0 C-N-CA 126.714 2.006 . . . . 0.0 114.872 -171.954 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.475 0.795 0 CA-C-O 119.46 -0.305 . . . . 0.0 110.633 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 5.7 mt -125.52 129.55 72.82 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -120.36 141.11 50.38 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 106.105 -1.813 . . . . 0.0 106.105 168.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 91.6 t -121.42 127.41 75.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 106.722 -1.584 . . . . 0.0 106.722 -176.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.2 tp -109.03 111.61 23.36 Favored 'General case' 0 CA--C 1.515 -0.4 0 C-N-CA 123.468 0.707 . . . . 0.0 111.02 -169.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -94.07 118.24 5.7 Favored Glycine 0 N--CA 1.446 -0.67 0 N-CA-C 104.394 -3.482 . . . . 0.0 104.394 168.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.4 m -141.32 163.74 20.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 -171.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 121.73 160.47 11.01 Favored Glycine 0 C--N 1.338 0.661 0 C-N-CA 124.818 1.199 . . . . 0.0 110.495 176.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.485 ' ND2' ' H ' ' A' ' 12' ' ' LEU . 12.4 t30 -79.22 101.52 8.03 Favored 'General case' 0 C--N 1.333 -0.122 0 O-C-N 121.351 -1.088 . . . . 0.0 109.988 -179.366 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 27.3 pt -53.41 -15.07 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 N-CA-C 116.13 1.9 . . . . 0.0 116.13 -176.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.485 ' H ' ' ND2' ' A' ' 10' ' ' ASN . 5.2 mp -90.17 -3.79 57.66 Favored 'General case' 0 C--O 1.219 -0.536 0 CA-C-N 121.024 1.738 . . . . 0.0 107.558 -170.506 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.3 mp -101.78 55.42 0.81 Allowed 'General case' 0 N--CA 1.439 -0.987 0 C-N-CA 123.477 0.711 . . . . 0.0 109.727 -174.334 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.254 0.1 OUTLIER 49.6 -102.11 0.1 Allowed 'General case' 0 C--O 1.236 0.345 0 CA-C-N 114.348 -1.296 . . . . 0.0 111.331 177.052 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -72.21 -12.34 61.13 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 123.891 0.876 . . . . 0.0 111.319 -172.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -73.07 -2.5 21.56 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-N 119.377 0.99 . . . . 0.0 112.338 176.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.82 -11.85 59.8 Favored 'General case' 0 N--CA 1.439 -1.014 0 CA-C-O 116.436 -1.745 . . . . 0.0 108.564 169.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 7.3 tp -53.47 -41.1 43.84 Favored 'Isoleucine or valine' 0 C--N 1.344 0.345 0 CA-C-N 122.094 2.225 . . . . 0.0 112.44 -169.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -62.03 -49.06 78.91 Favored Glycine 0 CA--C 1.523 0.555 0 CA-C-N 119.257 0.935 . . . . 0.0 111.707 177.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 58.3 t -65.16 -47.27 88.24 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 178.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 71.4 mmt-85 -59.64 -35.02 73.57 Favored 'General case' 0 C--N 1.343 0.292 0 CA-C-O 117.041 -1.457 . . . . 0.0 113.146 177.326 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 27.8 mt -62.74 -45.6 98.43 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 CA-C-N 121.925 2.148 . . . . 0.0 109.995 177.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 22.2 m -74.47 -27.82 21.71 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-N 119.995 1.27 . . . . 0.0 111.632 -175.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -68.63 -44.44 74.22 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 174.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -66.09 -40.11 90.54 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 122.559 0.344 . . . . 0.0 110.28 -179.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 7.8 tp -62.33 -42.59 99.5 Favored 'General case' 0 CA--C 1.527 0.096 0 CA-C-O 118.733 -0.651 . . . . 0.0 109.933 178.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -61.36 -38.62 87.64 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 118.506 0.594 . . . . 0.0 110.835 -178.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 -74.01 -43.21 58.76 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.38 0.672 . . . . 0.0 111.036 177.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 87.9 mtt180 -86.31 -31.13 21.75 Favored 'General case' 0 C--N 1.339 0.124 0 CA-C-O 116.87 -1.538 . . . . 0.0 114.221 -169.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -125.96 138.25 53.75 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 121.369 1.895 . . . . 0.0 112.836 -173.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 49.5 mm -91.71 149.84 3.99 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 N-CA-C 106.366 -1.716 . . . . 0.0 106.366 168.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 51.2 mt -137.44 151.34 71.03 Favored Pre-proline 0 C--O 1.237 0.412 0 C-N-CA 124.218 1.007 . . . . 0.0 110.775 -169.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -67.76 159.97 50.38 Favored 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 122.483 2.122 . . . . 0.0 110.111 169.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -57.71 -32.55 67.5 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 114.51 1.3 . . . . 0.0 114.51 -169.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 31.5 p90 -75.89 -5.61 46.91 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 117.8 -1.095 . . . . 0.0 112.676 -176.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 26.0 t -108.61 129.9 62.3 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 CA-C-N 120.087 1.312 . . . . 0.0 107.888 175.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -136.95 150.98 48.51 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 121.491 0.662 . . . . 0.0 110.113 174.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -103.21 131.01 52.52 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 170.555 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 10.5 tt -123.77 127.68 48.47 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 175.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -91.2 115.15 27.79 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 172.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -71.58 -23.92 77.43 Favored Glycine 0 CA--C 1.533 1.186 0 CA-C-O 118.373 -1.237 . . . . 0.0 112.795 179.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 62.85 77.09 0.22 Allowed Glycine 0 CA--C 1.529 0.949 0 CA-C-N 118.424 1.112 . . . . 0.0 112.886 173.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . 0.28 14.9 p 55.75 32.84 20.24 Favored 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 125.075 1.35 . . . . 0.0 112.761 173.181 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -75.14 -69.26 0.48 Allowed 'General case' 0 C--N 1.345 0.385 0 N-CA-C 114.722 1.378 . . . . 0.0 114.722 -169.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 70.06 -99.1 0.67 Allowed Glycine 0 C--N 1.337 0.584 0 N-CA-C 108.436 -1.866 . . . . 0.0 108.436 -171.038 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 10.1 tpt -67.51 -27.76 67.26 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 125.057 1.343 . . . . 0.0 111.38 -178.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -70.2 -4.65 22.64 Favored 'General case' 0 CA--C 1.548 0.881 0 CA-C-O 121.234 0.54 . . . . 0.0 110.685 -173.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 81.9 mt -81.76 2.13 31.35 Favored 'General case' 0 CA--C 1.535 0.382 0 O-C-N 120.316 -1.49 . . . . 0.0 113.62 -179.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 6.5 tt -50.16 -53.99 23.87 Favored 'General case' 0 C--N 1.339 0.151 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 -170.129 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -87.68 -31.91 14.5 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 -177.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -52.87 -49.3 66.12 Favored 'General case' 0 C--N 1.34 0.164 0 C-N-CA 123.03 0.532 . . . . 0.0 110.257 178.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 28.1 mtp -78.13 -8.71 58.61 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 114.306 1.224 . . . . 0.0 114.306 -169.052 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.79 146.65 54.2 Favored 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 113.78 1.03 . . . . 0.0 113.78 -169.131 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . 0.25 14.7 p30 53.08 13.81 0.42 Allowed 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 128.86 2.864 . . . . 0.0 117.975 169.114 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 89.8 mtt180 -68.08 151.93 46.29 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 121.333 -0.855 . . . . 0.0 109.835 173.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -81.68 -61.75 1.84 Allowed 'General case' 0 C--O 1.222 -0.363 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 176.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 2.3 t-160 -114.85 124.22 51.19 Favored 'General case' 0 C--O 1.231 0.103 0 N-CA-C 105.609 -1.997 . . . . 0.0 105.609 -177.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 54.0 tp -133.24 119.96 20.5 Favored 'General case' 0 CA--C 1.506 -0.713 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 178.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 4.4 mp -103.04 120.09 52.4 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 N-CA-C 105.445 -2.057 . . . . 0.0 105.445 175.194 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 8.1 mt -96.92 132.94 40.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 104.392 -2.447 . . . . 0.0 104.392 176.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -121.55 126.4 49.08 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 172.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -162.46 162.6 27.64 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 122.602 0.361 . . . . 0.0 110.056 177.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -74.06 136.44 43.07 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 104.923 -2.251 . . . . 0.0 104.923 168.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -87.47 -22.03 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 N-CA-C 113.182 0.808 . . . . 0.0 113.182 -168.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.7 t 51.73 31.95 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.221 0 C-N-CA 126.115 1.766 . . . . 0.0 112.569 174.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 19.8 m -137.54 159.75 41.08 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 124.313 1.045 . . . . 0.0 111.711 -172.245 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 22.6 ttmt 63.55 173.93 0.17 Allowed 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 126.732 2.013 . . . . 0.0 112.685 170.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.32 7.98 35.87 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.543 1.137 . . . . 0.0 112.027 -170.02 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 41.4 t-20 -73.66 165.55 24.9 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.368 0.667 . . . . 0.0 109.489 -174.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 10.7 m -58.75 141.59 84.82 Favored Pre-proline 0 CA--C 1.55 0.947 0 C-N-CA 124.199 1.0 . . . . 0.0 112.578 -169.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -55.25 150.16 41.87 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 123.503 2.802 . . . . 0.0 112.132 169.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 68.18 15.2 67.33 Favored Glycine 0 CA--C 1.531 1.032 0 CA-C-O 119.091 -0.839 . . . . 0.0 113.825 176.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 20.9 m -90.92 149.92 21.7 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 118.973 1.386 . . . . 0.0 108.895 175.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 16.7 ttp -95.41 139.12 32.15 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 176.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 3.4 ttt -135.44 115.04 12.72 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 107.275 -1.379 . . . . 0.0 107.275 -170.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 24.0 mm -100.78 122.04 52.32 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 -169.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -117.48 125.24 50.56 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 179.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -90.7 170.53 10.06 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 178.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -28.97 -61.69 0.12 Allowed 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 117.02 2.23 . . . . 0.0 117.02 -170.12 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -78.51 -17.25 56.49 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 119.302 0.955 . . . . 0.0 113.307 -174.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -87.96 -30.69 19.84 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 123.555 0.742 . . . . 0.0 110.417 -170.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . 0.256 0.5 OUTLIER -67.46 -47.31 47.76 Favored Pre-proline 0 N--CA 1.453 -0.289 0 CA-C-O 116.624 -1.655 . . . . 0.0 112.023 -171.351 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -65.63 -35.63 36.72 Favored 'Trans proline' 0 N--CA 1.453 -0.883 0 CA-C-N 122.176 1.813 . . . . 0.0 109.988 179.792 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.2 -26.36 67.36 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.033 0.533 . . . . 0.0 111.199 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -78.39 -52.96 7.81 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 169.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -58.2 -23.06 54.3 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 -174.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -66.86 -6.79 17.75 Favored 'General case' 0 CA--C 1.551 1.009 0 CA-C-N 119.103 0.865 . . . . 0.0 112.26 176.638 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 32.6 t30 -50.2 127.68 17.56 Favored 'General case' 0 C--N 1.344 0.346 0 O-C-N 121.27 -0.894 . . . . 0.0 110.912 173.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 30.5 mmmt -66.91 -26.73 67.01 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 118.541 -0.742 . . . . 0.0 111.994 -178.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 62.1 mt -65.62 -49.6 76.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 -177.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.4 m -65.02 114.41 14.89 Favored Pre-proline 0 CA--C 1.545 0.774 0 C-N-CA 124.609 1.164 . . . . 0.0 109.854 -176.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -70.92 -75.85 0.01 OUTLIER 'Trans proline' 0 CA--C 1.539 0.76 0 C-N-CA 122.761 2.307 . . . . 0.0 112.896 -169.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 13.1 m80 -69.33 -26.66 64.82 Favored 'General case' 0 N--CA 1.47 0.562 0 O-C-N 121.093 -1.004 . . . . 0.0 110.784 -174.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 25.8 mp0 -63.78 -28.87 70.17 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 124.432 1.093 . . . . 0.0 110.659 179.013 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 52.6 tp -64.18 -35.49 80.97 Favored 'General case' 0 C--N 1.342 0.246 0 CA-C-N 119.722 1.146 . . . . 0.0 110.54 174.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -64.64 -40.12 97.27 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 110.552 -1.019 . . . . 0.0 110.552 172.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 19.1 tp -66.2 -32.44 73.88 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 117.976 0.888 . . . . 0.0 110.907 175.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -64.1 -45.19 89.75 Favored 'General case' 0 N--CA 1.466 0.36 0 O-C-N 120.952 -1.092 . . . . 0.0 110.791 171.202 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -70.35 -24.2 62.94 Favored 'General case' 0 CA--C 1.52 -0.18 0 O-C-N 121.602 -0.686 . . . . 0.0 111.574 178.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 7.0 t -68.14 -44.97 83.98 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 CA-C-N 118.722 0.692 . . . . 0.0 110.397 169.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 59.8 mt -62.26 -36.89 83.45 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 119.25 0.932 . . . . 0.0 109.697 176.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 44.5 m -65.03 -40.18 94.44 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 118.005 0.366 . . . . 0.0 110.299 172.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -64.52 -40.34 95.44 Favored 'General case' 0 N--CA 1.454 -0.237 0 O-C-N 121.112 -0.992 . . . . 0.0 110.729 178.231 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 12.6 mt -64.0 -37.61 88.05 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-O 120.98 0.419 . . . . 0.0 110.58 175.155 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 21.1 tpp180 -63.89 -37.82 88.8 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 118.652 -0.689 . . . . 0.0 109.982 173.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 14.6 m-30 -66.18 -42.61 88.65 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 119.124 0.875 . . . . 0.0 110.798 179.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 41.7 p -76.13 -18.72 59.02 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 118.819 0.736 . . . . 0.0 111.722 178.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 76.42 9.72 85.83 Favored Glycine 0 CA--C 1.532 1.127 0 CA-C-O 119.073 -0.848 . . . . 0.0 111.229 -169.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -93.5 31.04 1.6 Allowed 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 118.991 1.395 . . . . 0.0 110.675 178.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -62.24 140.22 96.24 Favored Pre-proline 0 CA--C 1.542 0.647 0 C-N-CA 123.793 0.837 . . . . 0.0 109.724 174.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -66.66 142.9 65.97 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.382 2.055 . . . . 0.0 110.35 -177.364 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -64.48 -29.4 70.44 Favored 'General case' 0 CA--C 1.538 0.504 0 O-C-N 122.141 -0.349 . . . . 0.0 111.483 -174.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 23.9 tptp -143.41 82.78 1.75 Allowed 'General case' 0 C--O 1.234 0.277 0 N-CA-C 106.172 -1.788 . . . . 0.0 106.172 -176.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 24.5 tp -77.02 136.52 38.69 Favored 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 169.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -138.39 144.24 40.15 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 170.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 11.2 tp -128.83 129.83 46.12 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 119.606 1.094 . . . . 0.0 109.464 176.031 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 21.7 t -98.34 101.21 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 N-CA-C 104.215 -2.513 . . . . 0.0 104.215 168.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -82.93 146.7 24.33 Favored Glycine 0 CA--C 1.521 0.454 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 171.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 47.9 t -127.42 143.5 40.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 170.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 13.2 mt -94.14 130.13 35.2 Favored Pre-proline 0 CA--C 1.537 0.458 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 -176.139 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -79.33 166.6 22.26 Favored 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 122.967 2.445 . . . . 0.0 113.026 -174.154 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -111.05 -53.71 2.68 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.371 1.068 . . . . 0.0 110.331 -178.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 73.6 m -111.84 -53.55 2.7 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 118.73 0.695 . . . . 0.0 112.248 -173.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER 56.11 44.71 24.79 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 125.215 1.406 . . . . 0.0 114.609 177.07 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -119.43 171.38 5.51 Favored Pre-proline 0 N--CA 1.477 0.892 0 O-C-N 121.205 -0.934 . . . . 0.0 109.924 175.091 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -65.85 91.0 0.24 Allowed 'Trans proline' 0 CA--C 1.549 1.267 0 C-N-CA 123.447 2.765 . . . . 0.0 114.145 -177.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -167.62 131.64 1.78 Allowed 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 105.102 -2.185 . . . . 0.0 105.102 169.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -80.28 152.91 4.48 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 123.612 0.765 . . . . 0.0 110.293 -171.452 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 80.37 160.79 23.22 Favored Glycine 0 CA--C 1.53 1.0 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.916 179.334 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -76.45 163.17 27.21 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-O 121.188 0.518 . . . . 0.0 112.218 -169.194 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 40.7 p -69.81 169.93 11.3 Favored Pre-proline 0 CA--C 1.541 0.597 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 167.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -55.88 -31.76 82.55 Favored 'Trans proline' 0 CA--C 1.542 0.925 0 C-N-CA 121.315 1.344 . . . . 0.0 111.041 169.097 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 25.3 m -68.18 -45.27 73.91 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 118.976 -0.535 . . . . 0.0 111.505 179.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 5.8 t -99.19 -12.16 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 CA-C-N 119.451 1.023 . . . . 0.0 111.652 -169.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -57.6 -45.55 85.15 Favored 'General case' 0 N--CA 1.465 0.292 0 O-C-N 119.898 -1.751 . . . . 0.0 108.102 169.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -68.19 -2.02 7.25 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-O 118.382 -0.818 . . . . 0.0 112.741 178.021 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 12.9 mmm -92.84 -6.94 47.7 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 119.356 0.98 . . . . 0.0 111.266 175.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 86.6 mt -59.42 -45.26 93.71 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 CA-C-N 119.421 1.01 . . . . 0.0 108.921 175.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -76.07 -47.02 3.71 Favored Pre-proline 0 CA--C 1.543 0.677 0 CA-C-O 117.252 -1.356 . . . . 0.0 113.129 -170.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -55.0 -41.76 75.79 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 122.07 1.847 . . . . 0.0 111.399 170.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -68.36 -41.48 80.6 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 118.162 -0.923 . . . . 0.0 110.718 -177.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 27.1 mt -55.83 -47.48 77.16 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 119.713 1.142 . . . . 0.0 109.223 172.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -62.31 -33.97 75.71 Favored 'General case' 0 N--CA 1.443 -0.817 0 C-N-CA 122.768 0.427 . . . . 0.0 109.849 -177.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 38.9 tp60 -80.29 -34.14 37.13 Favored 'General case' 0 N--CA 1.431 -1.375 0 C-N-CA 123.409 0.684 . . . . 0.0 111.307 -178.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 49.0 t -60.45 -48.77 87.01 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 170.176 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 30.2 mt -62.81 -30.53 71.55 Favored 'General case' 0 C--N 1.331 -0.203 0 O-C-N 121.995 -0.441 . . . . 0.0 110.406 178.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -67.22 -39.37 86.23 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 121.036 -1.04 . . . . 0.0 111.129 176.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -62.06 -47.48 84.52 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 118.608 0.64 . . . . 0.0 110.76 177.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 6.0 mp -58.01 -41.97 84.23 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 174.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 85.0 mtm180 -70.12 -13.83 62.38 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 117.319 -1.324 . . . . 0.0 113.327 -179.051 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -57.29 -33.25 67.48 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 120.959 1.709 . . . . 0.0 110.208 172.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 4.6 m -103.01 22.22 14.34 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.113 1.365 . . . . 0.0 111.502 179.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 68.75 23.26 75.65 Favored Glycine 0 CA--C 1.532 1.155 0 CA-C-O 118.402 -1.221 . . . . 0.0 114.355 178.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 60.9 t -102.41 97.84 6.12 Favored 'Isoleucine or valine' 0 C--N 1.342 0.261 0 CA-C-N 119.52 1.66 . . . . 0.0 107.607 177.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -97.96 136.58 38.04 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 169.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -77.18 161.18 28.4 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.273 0.629 . . . . 0.0 110.619 178.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 5.2 mt -83.57 121.55 76.47 Favored Pre-proline 0 CA--C 1.54 0.565 0 N-CA-C 105.307 -2.109 . . . . 0.0 105.307 175.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -65.94 107.86 1.19 Allowed 'Trans proline' 0 C--N 1.35 0.656 0 N-CA-C 105.781 -2.43 . . . . 0.0 105.781 169.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 22.5 tpt180 47.86 -121.64 1.37 Allowed 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 104.965 -2.235 . . . . 0.0 104.965 -168.049 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 8.1 p . . . . . 0 C--O 1.238 0.467 0 CA-C-N 121.521 1.964 . . . . 0.0 109.958 169.757 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 31.6 ptt-85 . . . . . 0 N--CA 1.476 0.848 0 CA-C-O 119.442 -0.313 . . . . 0.0 110.252 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 4.4 mt -122.19 128.74 75.61 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 -176.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 15.3 tp -115.21 140.77 48.81 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 105.686 -1.968 . . . . 0.0 105.686 168.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 74.9 t -120.01 113.24 39.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 106.152 -1.795 . . . . 0.0 106.152 177.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -93.26 120.84 34.0 Favored 'General case' 0 CA--C 1.516 -0.338 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 -177.534 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -100.03 120.27 6.81 Favored Glycine 0 CA--C 1.499 -0.92 0 N-CA-C 105.679 -2.968 . . . . 0.0 105.679 170.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 11.4 m -148.94 162.47 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.971 0 CA-C-O 121.174 0.511 . . . . 0.0 110.579 -168.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 119.77 146.67 7.81 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 126.382 1.944 . . . . 0.0 108.996 177.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.451 HD22 ' HB2' ' A' ' 12' ' ' LEU . 2.0 t30 -62.57 116.14 4.88 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 123.781 1.753 . . . . 0.0 114.675 -168.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.3 pt -67.84 40.71 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.812 0 CA-C-N 112.264 -2.244 . . . . 0.0 114.981 170.037 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.451 ' HB2' HD22 ' A' ' 10' ' ' ASN . 75.0 mt -132.62 -12.65 3.01 Favored 'General case' 0 C--N 1.343 0.325 0 CA-C-N 121.563 1.983 . . . . 0.0 111.416 170.622 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.7 mp -115.32 62.77 0.69 Allowed 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 -167.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 56.9 -97.63 0.08 Allowed 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 123.51 0.724 . . . . 0.0 111.246 170.387 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -84.18 -9.47 58.52 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 124.39 1.076 . . . . 0.0 110.906 -175.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -70.68 -14.98 62.67 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 119.859 1.208 . . . . 0.0 112.56 -176.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.2 -6.04 55.67 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-O 115.697 -2.097 . . . . 0.0 110.024 172.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 6.4 tp -49.88 -44.37 20.9 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-N 122.062 2.21 . . . . 0.0 111.94 -171.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -62.78 -42.24 99.72 Favored Glycine 0 N--CA 1.446 -0.634 0 CA-C-N 118.88 0.764 . . . . 0.0 111.629 178.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 73.6 t -63.86 -52.92 50.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 173.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 1.4 mmp_? -60.74 -31.89 71.2 Favored 'General case' 0 CA--C 1.531 0.245 0 O-C-N 120.949 -1.094 . . . . 0.0 112.73 -175.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 25.0 mt -60.54 -44.94 97.68 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 CA-C-N 120.145 1.339 . . . . 0.0 110.287 176.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 17.9 m -75.35 -25.44 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-N 120.203 1.365 . . . . 0.0 111.323 -176.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -68.03 -42.92 79.87 Favored 'General case' 0 C--N 1.341 0.2 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 173.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.81 -41.95 91.24 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-O 119.363 -0.351 . . . . 0.0 110.277 179.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 10.4 tp -61.12 -45.11 96.02 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 118.453 -0.784 . . . . 0.0 109.816 176.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -59.89 -39.91 86.97 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 118.467 0.576 . . . . 0.0 111.216 -178.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 50.6 mm-40 -73.58 -40.73 63.66 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 122.938 0.495 . . . . 0.0 111.355 178.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 91.0 mtt180 -90.24 -38.03 13.71 Favored 'General case' 0 C--N 1.342 0.259 0 CA-C-O 117.343 -1.313 . . . . 0.0 114.288 -169.293 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 66.2 m-85 -115.33 136.23 53.31 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 120.991 1.723 . . . . 0.0 113.348 -169.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 39.8 mm -86.48 134.29 27.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 N-CA-C 105.805 -1.924 . . . . 0.0 105.805 168.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 7.3 mp -119.91 150.32 50.54 Favored Pre-proline 0 CA--C 1.539 0.523 0 C-N-CA 125.305 1.442 . . . . 0.0 110.691 -169.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -62.34 153.86 67.6 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 122.888 2.392 . . . . 0.0 109.785 168.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -61.21 -33.6 73.74 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 -169.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 18.0 p90 -74.21 -8.04 54.78 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 118.016 -0.992 . . . . 0.0 112.453 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 12.4 t -101.11 128.03 53.74 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 CA-C-N 119.926 1.239 . . . . 0.0 108.079 174.205 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -133.45 147.66 51.7 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.063 0.545 . . . . 0.0 110.155 175.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -100.17 136.78 30.04 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 N-CA-C 107.459 -1.312 . . . . 0.0 107.459 169.556 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -128.11 144.79 51.13 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 173.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -118.11 114.43 23.08 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 124.131 0.972 . . . . 0.0 108.483 -175.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -93.31 -4.54 64.29 Favored Glycine 0 CA--C 1.533 1.207 0 CA-C-O 119.032 -0.871 . . . . 0.0 113.277 176.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 60.57 -125.82 39.49 Favored Glycine 0 N--CA 1.431 -1.665 0 N-CA-C 108.22 -1.952 . . . . 0.0 108.22 -171.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 12.1 p -54.55 -37.41 65.41 Favored 'General case' 0 C--N 1.313 -0.985 0 C-N-CA 127.501 2.32 . . . . 0.0 111.271 176.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 50.07 -131.32 1.94 Allowed 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 169.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 79.73 -104.92 2.24 Favored Glycine 0 N--CA 1.443 -0.847 0 N-CA-C 106.899 -2.481 . . . . 0.0 106.899 -169.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 66.4 mmm -72.23 -19.55 61.7 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 112.535 0.568 . . . . 0.0 112.535 -175.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -60.67 -18.48 54.06 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 120.871 0.367 . . . . 0.0 111.941 -174.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 28.4 mt -88.71 -2.68 58.72 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 124.929 1.291 . . . . 0.0 114.136 -169.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 5.0 tt -46.9 -53.97 11.01 Favored 'General case' 0 C--N 1.344 0.354 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 -169.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -86.93 -31.24 18.29 Favored Glycine 0 CA--C 1.522 0.493 0 N-CA-C 111.011 -0.836 . . . . 0.0 111.011 -179.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -72.24 -27.75 62.71 Favored 'General case' 0 C--O 1.233 0.199 0 O-C-N 121.735 -0.862 . . . . 0.0 111.217 -170.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 28.8 mtp -81.9 -6.81 59.42 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 176.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -68.61 145.2 54.15 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 118.997 0.817 . . . . 0.0 111.474 -170.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 55.79 21.85 5.06 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 116.741 2.126 . . . . 0.0 116.741 168.577 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 26.2 mmt180 -77.79 148.95 34.52 Favored 'General case' 0 N--CA 1.473 0.681 0 O-C-N 120.593 -1.317 . . . . 0.0 108.867 178.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -83.4 -30.64 27.19 Favored 'General case' 0 N--CA 1.47 0.572 0 O-C-N 121.7 -0.625 . . . . 0.0 109.607 179.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 4.0 t60 -141.33 129.53 22.22 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 105.523 -2.028 . . . . 0.0 105.523 177.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -130.84 127.95 39.64 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-N 118.671 0.669 . . . . 0.0 109.327 171.095 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 29.7 mt -109.69 116.91 53.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 N-CA-C 104.904 -2.258 . . . . 0.0 104.904 174.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 38.8 mt -93.36 127.47 45.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 105.517 -2.031 . . . . 0.0 105.517 177.077 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -110.4 114.97 28.83 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 103.868 -2.641 . . . . 0.0 103.868 169.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -150.48 161.46 42.48 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.813 0.845 . . . . 0.0 110.154 -178.427 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -76.02 151.79 37.08 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 169.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 9.7 mm -84.05 -49.49 16.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-O 118.817 -0.611 . . . . 0.0 110.925 -177.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . 0.252 2.7 t 52.64 28.6 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.164 0 C-N-CA 125.954 1.702 . . . . 0.0 112.907 177.595 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 16.3 m -132.46 157.62 44.13 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 124.481 1.112 . . . . 0.0 111.934 -171.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.403 ' HG2' ' H ' ' A' ' 68' ' ' LYS . 19.7 ttmt 57.87 -167.48 0.14 Allowed 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 126.265 1.826 . . . . 0.0 112.447 171.093 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.403 ' H ' ' HG2' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -114.37 17.98 17.17 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.86 1.264 . . . . 0.0 110.995 -175.177 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -70.84 158.45 36.35 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.529 0.732 . . . . 0.0 109.144 -177.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 8.5 m -59.74 138.71 90.07 Favored Pre-proline 0 CA--C 1.545 0.779 0 C-N-CA 124.078 0.951 . . . . 0.0 111.991 -169.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_exo -55.2 149.01 46.84 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.998 2.465 . . . . 0.0 111.709 170.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 68.95 16.43 70.49 Favored Glycine 0 CA--C 1.533 1.157 0 CA-C-O 119.721 -0.488 . . . . 0.0 113.684 174.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 18.3 m -91.6 141.24 28.92 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 173.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 26.3 ttp -96.12 141.14 29.85 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 175.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 25.9 ttm -129.5 100.61 5.61 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 -173.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 38.4 mm -92.81 119.18 40.03 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 -178.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 44.0 mt -125.46 141.29 52.14 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 -173.281 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 88.2 mtt-85 -113.28 142.89 45.29 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 123.113 0.565 . . . . 0.0 110.425 -178.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 33.6 t70 38.05 -102.11 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 125.6 1.56 . . . . 0.0 114.228 169.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -59.91 -31.06 69.47 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.851 1.26 . . . . 0.0 113.725 -173.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -75.56 -19.52 59.24 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 118.388 0.54 . . . . 0.0 111.173 -176.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 78.9 t -73.96 -60.84 1.42 Allowed Pre-proline 0 N--CA 1.443 -0.781 0 CA-C-O 117.822 -1.085 . . . . 0.0 111.196 -169.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -63.8 -30.98 68.73 Favored 'Trans proline' 0 N--CA 1.447 -1.222 0 CA-C-N 121.315 1.506 . . . . 0.0 110.591 177.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.6 -26.45 67.1 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 122.631 0.372 . . . . 0.0 111.074 -178.028 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -77.98 -54.86 5.81 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 169.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -59.05 -24.56 62.97 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 114.033 1.123 . . . . 0.0 114.033 -170.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.9 t -67.3 -7.93 28.3 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-N 118.948 0.794 . . . . 0.0 112.546 178.021 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . 0.454 HD22 ' HB ' ' A' ' 90' ' ' ILE . 10.1 t30 -51.69 126.54 18.0 Favored 'General case' 0 C--N 1.344 0.347 0 O-C-N 121.409 -0.807 . . . . 0.0 109.754 172.075 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 37.0 mtmt -73.12 -23.51 60.5 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 118.718 -0.658 . . . . 0.0 112.45 -174.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.454 ' HB ' HD22 ' A' ' 88' ' ' ASN . 70.9 mt -67.23 -44.83 87.36 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 -178.054 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.9 m -62.39 113.37 8.6 Favored Pre-proline 0 CA--C 1.544 0.724 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 170.404 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -77.15 -63.68 0.03 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.623 0 CA-C-N 121.215 1.47 . . . . 0.0 113.041 -169.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 6.4 p-80 -78.62 -25.23 45.06 Favored 'General case' 0 N--CA 1.468 0.445 0 O-C-N 121.127 -0.983 . . . . 0.0 110.754 -178.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 22.0 mp0 -59.36 -33.51 71.25 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 119.739 1.154 . . . . 0.0 110.084 171.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -60.63 -41.83 95.65 Favored 'General case' 0 C--O 1.224 -0.248 0 CA-C-N 119.249 0.932 . . . . 0.0 109.14 173.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -61.29 -38.01 94.98 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 110.781 -0.927 . . . . 0.0 110.781 174.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 10.4 tp -69.23 -33.52 73.42 Favored 'General case' 0 CA--C 1.538 0.483 0 O-C-N 120.676 -1.484 . . . . 0.0 110.624 176.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -63.41 -41.3 98.72 Favored 'General case' 0 C--N 1.333 -0.132 0 O-C-N 121.037 -1.039 . . . . 0.0 109.822 171.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -71.2 -22.27 62.04 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 118.877 -0.583 . . . . 0.0 111.775 176.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 6.3 t -73.54 -44.16 54.02 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 CA-C-N 119.526 1.057 . . . . 0.0 109.839 169.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 64.4 mt -58.97 -37.42 76.76 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 119.093 0.86 . . . . 0.0 108.735 174.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 35.8 m -68.33 -39.17 82.01 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 118.708 -0.663 . . . . 0.0 110.554 172.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.413 ' HA ' ' CD2' ' A' ' 106' ' ' PHE . . . -63.77 -39.76 95.03 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 119.879 1.218 . . . . 0.0 110.459 179.583 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 18.8 mt -65.88 -38.84 89.85 Favored 'General case' 0 CA--C 1.519 -0.244 0 C-N-CA 123.119 0.567 . . . . 0.0 110.596 174.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 80.2 ttt180 -62.17 -37.83 86.76 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 118.552 -0.737 . . . . 0.0 109.985 173.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.413 ' CD2' ' HA ' ' A' ' 103' ' ' ALA . 14.1 m-30 -65.73 -42.51 90.94 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 119.346 0.975 . . . . 0.0 110.489 -179.791 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 42.6 p -78.55 -19.77 52.13 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 118.345 0.521 . . . . 0.0 111.624 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 78.56 10.33 86.29 Favored Glycine 0 CA--C 1.532 1.143 0 CA-C-O 119.034 -0.87 . . . . 0.0 111.036 -169.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 30.4 mm-40 -88.9 21.68 3.0 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 119.078 1.439 . . . . 0.0 111.931 -179.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -61.8 140.95 95.41 Favored Pre-proline 0 CA--C 1.543 0.684 0 C-N-CA 123.95 0.9 . . . . 0.0 110.509 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -64.72 148.16 90.08 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 122.493 2.128 . . . . 0.0 111.675 -176.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -64.75 -26.08 68.21 Favored 'General case' 0 CA--C 1.537 0.476 0 O-C-N 122.13 -0.357 . . . . 0.0 111.137 -178.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -140.45 133.29 29.1 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 169.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -124.96 123.22 39.42 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 177.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.2 m -131.62 142.6 49.91 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 -172.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -131.58 123.81 28.68 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 119.681 1.128 . . . . 0.0 109.525 -179.545 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 23.4 t -96.4 78.7 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 105.489 -2.041 . . . . 0.0 105.489 174.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -77.01 145.09 30.61 Favored Glycine 0 N--CA 1.449 -0.471 0 N-CA-C 109.905 -1.278 . . . . 0.0 109.905 -176.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 63.3 t -129.03 137.57 56.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 174.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 18.8 mt -88.56 131.65 41.32 Favored Pre-proline 0 CA--C 1.542 0.656 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 175.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -70.74 171.49 15.43 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 124.147 3.231 . . . . 0.0 113.534 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -113.08 -60.74 1.84 Allowed 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.033 0.933 . . . . 0.0 110.454 176.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 67.8 m -104.56 -52.32 2.92 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 118.791 0.723 . . . . 0.0 112.756 -171.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER 58.48 46.98 14.22 Favored 'General case' 0 CA--C 1.548 0.887 0 N-CA-C 114.706 1.372 . . . . 0.0 114.706 170.429 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -115.8 165.03 15.56 Favored Pre-proline 0 N--CA 1.475 0.81 0 CA-C-O 117.923 -1.037 . . . . 0.0 110.407 175.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -63.94 87.58 0.15 Allowed 'Trans proline' 0 CA--C 1.547 1.136 0 C-N-CA 123.706 2.937 . . . . 0.0 113.736 -179.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -176.76 145.8 0.53 Allowed 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 104.067 -2.568 . . . . 0.0 104.067 174.574 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -108.94 161.72 7.12 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 CA-C-N 119.014 0.825 . . . . 0.0 111.346 -176.463 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 105.21 135.21 8.22 Favored Glycine 0 CA--C 1.528 0.865 0 N-CA-C 105.316 -3.114 . . . . 0.0 105.316 -168.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 5.8 mp -81.43 157.94 24.76 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-N 117.915 0.857 . . . . 0.0 109.332 -175.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 63.4 p -64.22 162.7 30.0 Favored Pre-proline 0 CA--C 1.537 0.462 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 168.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -59.15 -28.56 88.12 Favored 'Trans proline' 0 CA--C 1.541 0.853 0 C-N-CA 120.635 0.89 . . . . 0.0 110.628 169.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 28.7 m -64.14 -50.09 69.57 Favored 'General case' 0 C--N 1.344 0.368 0 CA-C-O 118.785 -0.626 . . . . 0.0 110.999 178.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 5.0 t -96.3 -22.68 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 CA-C-N 119.286 0.948 . . . . 0.0 111.343 -169.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -52.59 -45.53 66.53 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 120.241 1.382 . . . . 0.0 108.674 168.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -75.15 8.81 2.36 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 113.978 1.103 . . . . 0.0 113.978 -179.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 85.3 mtp -103.48 -6.75 21.5 Favored 'General case' 0 N--CA 1.432 -1.367 0 CA-C-O 117.563 -1.208 . . . . 0.0 110.077 169.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 95.1 mt -58.92 -44.55 91.12 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.326 0 CA-C-N 120.342 1.428 . . . . 0.0 107.278 174.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 58.1 mt-10 -72.33 -51.87 7.37 Favored Pre-proline 0 CA--C 1.541 0.625 0 CA-C-O 117.595 -1.193 . . . . 0.0 110.786 -177.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -41.39 -50.47 4.55 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 124.867 3.711 . . . . 0.0 113.499 168.758 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -71.22 -42.68 68.6 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 113.725 -1.579 . . . . 0.0 110.497 -176.088 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 26.1 mt -56.4 -42.64 78.27 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 118.656 0.662 . . . . 0.0 109.354 173.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -62.18 -33.49 74.63 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 118.944 0.793 . . . . 0.0 110.426 -179.042 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 43.7 mm-40 -79.43 -31.48 42.6 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 119.059 0.845 . . . . 0.0 112.255 176.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 71.0 t -60.82 -47.81 91.63 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 169.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 29.0 mt -65.75 -35.06 79.64 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.103 0.561 . . . . 0.0 110.319 -179.076 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -62.15 -40.12 94.89 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-O 118.347 -0.835 . . . . 0.0 110.781 178.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -60.9 -47.99 83.87 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 119.154 0.888 . . . . 0.0 111.417 -179.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 10.4 mp -49.86 -52.47 32.47 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 123.379 0.672 . . . . 0.0 109.808 169.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -67.14 -18.37 65.26 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 117.492 -1.242 . . . . 0.0 111.984 -173.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -63.03 -29.49 70.86 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 120.788 1.631 . . . . 0.0 110.349 177.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 5.2 m -110.27 25.26 11.98 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.99 1.316 . . . . 0.0 110.808 179.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 66.54 18.61 68.06 Favored Glycine 0 CA--C 1.531 1.071 0 CA-C-O 118.295 -1.281 . . . . 0.0 114.047 177.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 63.9 t -84.72 137.05 21.52 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 N-CA-C 106.266 -1.753 . . . . 0.0 106.266 173.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -121.1 148.75 43.75 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 178.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -126.12 135.85 52.19 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 169.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . 0.403 ' CG2' ' HA ' ' A' ' 160' ' ' SER . 33.7 mm -101.63 130.27 24.97 Favored Pre-proline 0 C--O 1.23 0.069 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 -171.463 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -57.73 110.64 0.65 Allowed 'Trans proline' 0 CA--C 1.536 0.599 0 C-N-CA 122.022 1.814 . . . . 0.0 108.533 169.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 4.5 tmm_? 49.96 32.28 5.48 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.154 1.381 . . . . 0.0 113.151 173.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' SER . . . . . 0.403 ' HA ' ' CG2' ' A' ' 157' ' ' ILE . 27.5 p . . . . . 0 CA--C 1.544 0.746 0 C-N-CA 125.997 1.719 . . . . 0.0 113.951 -171.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 6.1 ptp180 . . . . . 0 N--CA 1.479 0.986 0 CA-C-O 118.035 -0.983 . . . . 0.0 108.93 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 57.2 mt -140.75 135.79 34.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 CA-C-N 119.685 1.13 . . . . 0.0 111.143 -169.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -116.94 130.31 56.62 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 105.593 -2.003 . . . . 0.0 105.593 168.244 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 33.2 t -107.36 103.97 16.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 103.258 -2.867 . . . . 0.0 103.258 169.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.2 mt -101.65 110.34 22.31 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 124.003 0.921 . . . . 0.0 109.795 -169.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -92.23 116.76 5.13 Favored Glycine 0 N--CA 1.45 -0.409 0 N-CA-C 107.773 -2.131 . . . . 0.0 107.773 172.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 12.4 m -133.78 -166.63 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.084 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 -177.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 95.15 131.0 6.3 Favored Glycine 0 N--CA 1.441 -0.976 0 N-CA-C 107.369 -2.293 . . . . 0.0 107.369 -170.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.413 HD22 ' HB2' ' A' ' 12' ' ' LEU . 1.6 t30 -66.16 108.41 2.26 Favored 'General case' 0 N--CA 1.441 -0.915 0 C-N-CA 124.004 0.922 . . . . 0.0 110.937 -169.114 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.1 pt -73.21 40.29 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 C-N-CA 124.675 1.19 . . . . 0.0 113.193 179.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.413 ' HB2' HD22 ' A' ' 10' ' ' ASN . 15.2 mt -125.59 -2.76 7.33 Favored 'General case' 0 CA--C 1.536 0.407 0 O-C-N 121.023 -1.048 . . . . 0.0 108.6 169.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -129.24 65.45 1.46 Allowed 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.589 1.156 . . . . 0.0 108.418 -169.602 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 12.7 m 45.44 -109.6 0.2 Allowed 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 114.325 -1.307 . . . . 0.0 112.445 169.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -56.89 -24.59 53.13 Favored 'General case' 0 N--CA 1.443 -0.815 0 C-N-CA 125.617 1.567 . . . . 0.0 112.501 -172.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -64.73 -21.92 66.86 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 120.288 1.404 . . . . 0.0 111.443 -177.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.99 -9.4 15.57 Favored 'General case' 0 N--CA 1.437 -1.118 0 CA-C-O 116.433 -1.746 . . . . 0.0 111.456 173.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 5.6 tp -52.88 -40.44 36.05 Favored 'Isoleucine or valine' 0 C--N 1.343 0.306 0 CA-C-N 122.172 2.26 . . . . 0.0 111.421 -175.321 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -63.17 -45.23 95.79 Favored Glycine 0 C--N 1.336 0.559 0 CA-C-N 119.245 0.93 . . . . 0.0 111.027 178.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 96.9 t -62.62 -47.6 92.17 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 175.423 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 18.5 mmt180 -61.13 -33.61 73.66 Favored 'General case' 0 C--N 1.34 0.163 0 CA-C-O 117.092 -1.432 . . . . 0.0 112.5 179.062 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 21.9 mt -62.5 -47.04 94.87 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 CA-C-N 121.431 1.923 . . . . 0.0 109.847 177.46 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 26.7 m -74.97 -34.08 31.46 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-N 119.327 0.967 . . . . 0.0 111.157 -175.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 61.0 mt-10 -62.45 -44.14 97.12 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 122.863 0.465 . . . . 0.0 110.33 172.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -67.08 -38.15 85.24 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 119.438 1.017 . . . . 0.0 110.18 177.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 5.9 tp -64.73 -38.72 91.95 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 119.369 0.986 . . . . 0.0 109.652 -177.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -61.89 -25.56 67.63 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 112.573 0.583 . . . . 0.0 112.573 -179.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -94.91 -42.63 8.57 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 126.014 1.726 . . . . 0.0 111.076 -178.111 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 75.2 mtt180 -82.95 -25.96 31.84 Favored 'General case' 0 N--CA 1.456 -0.144 0 CA-C-O 118.343 -0.836 . . . . 0.0 111.799 -176.243 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 69.5 m-85 -127.06 147.97 50.14 Favored 'General case' 0 CA--C 1.521 -0.161 0 CA-C-N 119.628 1.104 . . . . 0.0 113.346 -177.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 37.7 mm -99.51 135.63 34.07 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 N-CA-C 104.384 -2.45 . . . . 0.0 104.384 168.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -118.51 147.38 41.82 Favored Pre-proline 0 CA--C 1.536 0.413 0 C-N-CA 123.795 0.838 . . . . 0.0 109.878 -169.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -65.93 157.2 60.47 Favored 'Trans proline' 0 CA--C 1.535 0.545 0 C-N-CA 122.637 2.225 . . . . 0.0 110.007 169.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -58.07 -32.56 68.16 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 114.314 1.227 . . . . 0.0 114.314 -169.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 10.6 p90 -77.06 -13.4 59.96 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 118.688 -0.672 . . . . 0.0 112.686 -177.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 75.5 t -88.73 125.54 41.89 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 170.05 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -120.77 128.17 52.65 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 169.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -88.38 124.33 41.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 105.074 -2.195 . . . . 0.0 105.074 168.664 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 52.2 tp -122.93 133.94 54.37 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 118.234 0.47 . . . . 0.0 110.359 174.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -89.81 123.38 33.74 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 169.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -112.92 -24.37 4.92 Favored Glycine 0 CA--C 1.536 1.401 0 CA-C-O 118.235 -1.314 . . . . 0.0 113.466 171.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 57.0 -111.7 3.0 Favored Glycine 0 C--N 1.342 0.907 0 CA-C-N 119.802 1.801 . . . . 0.0 111.714 171.282 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 67.4 p -75.62 7.28 3.86 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.545 1.538 . . . . 0.0 113.522 -174.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.82 -67.2 0.44 Allowed 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 114.397 1.258 . . . . 0.0 114.397 -169.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 60.87 -102.2 0.38 Allowed Glycine 0 CA--C 1.534 1.272 0 N-CA-C 109.125 -1.59 . . . . 0.0 109.125 -169.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.97 -26.59 67.63 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.939 0.896 . . . . 0.0 112.812 -175.037 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -60.22 -15.68 26.69 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 113.799 1.037 . . . . 0.0 113.799 -170.142 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 7.9 mt -96.39 13.99 25.91 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -169.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 4.2 tt -46.75 -60.9 2.1 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 118.539 0.609 . . . . 0.0 111.736 -176.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -64.68 -32.14 83.24 Favored Glycine 0 CA--C 1.531 1.075 0 CA-C-O 119.527 -0.596 . . . . 0.0 112.552 -178.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -78.79 -33.21 46.49 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 118.629 1.214 . . . . 0.0 112.515 -174.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 39.3 mtp -75.62 -21.44 57.75 Favored 'General case' 0 N--CA 1.449 -0.505 0 O-C-N 121.936 -0.478 . . . . 0.0 110.421 178.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.58 153.93 42.38 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-O 121.755 0.788 . . . . 0.0 111.452 -175.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 62.87 9.64 3.81 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 126.959 2.103 . . . . 0.0 115.592 169.248 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 25.1 mmt180 -79.38 160.29 26.75 Favored 'General case' 0 N--CA 1.473 0.709 0 O-C-N 121.017 -1.052 . . . . 0.0 108.565 178.286 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -87.33 -53.16 4.98 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 175.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . 0.259 0.0 OUTLIER -125.4 146.08 49.76 Favored 'General case' 0 CA--C 1.517 -0.295 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 169.206 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 12.6 tp -138.2 116.69 12.05 Favored 'General case' 0 CA--C 1.513 -0.449 0 N-CA-C 104.067 -2.568 . . . . 0.0 104.067 -176.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 10.8 mt -98.08 113.23 32.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 105.562 -2.014 . . . . 0.0 105.562 175.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 48.6 mt -91.4 138.48 19.62 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.558 0 N-CA-C 106.561 -1.644 . . . . 0.0 106.561 173.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -123.4 121.04 34.74 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 105.397 -2.075 . . . . 0.0 105.397 168.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -157.23 161.37 39.23 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.999 1.32 . . . . 0.0 108.979 -173.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -95.06 141.18 29.0 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 121.42 0.629 . . . . 0.0 110.666 176.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 25.7 mt -89.95 -18.55 7.64 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 C-N-CA 124.434 1.093 . . . . 0.0 110.611 -179.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . 0.308 47.2 t 70.54 -48.21 0.19 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.21 0 C-N-CA 128.323 2.649 . . . . 0.0 113.659 174.283 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 11.9 m -147.07 138.72 24.22 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 -176.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 12.0 tppt? -164.56 174.85 10.41 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 127.166 2.186 . . . . 0.0 105.961 168.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.56 -26.98 65.68 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 121.799 -0.563 . . . . 0.0 111.505 175.016 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -70.58 165.45 22.75 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.345 0.658 . . . . 0.0 110.761 -175.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 3.1 m -60.64 153.13 63.98 Favored Pre-proline 0 CA--C 1.547 0.854 0 C-N-CA 124.709 1.204 . . . . 0.0 112.489 -169.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_exo -57.7 158.39 20.3 Favored 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 123.867 3.045 . . . . 0.0 112.422 169.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 65.62 11.21 52.81 Favored Glycine 0 CA--C 1.536 1.38 0 CA-C-O 119.144 -0.809 . . . . 0.0 114.358 172.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 5.6 m -90.32 146.51 24.14 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 118.875 1.337 . . . . 0.0 111.484 -169.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 26.4 ttp -84.63 139.3 32.16 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 173.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 40.6 mtp -128.75 123.62 33.45 Favored 'General case' 0 CA--C 1.519 -0.214 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 176.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 23.3 mm -99.88 116.62 43.56 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 N-CA-C 107.243 -1.391 . . . . 0.0 107.243 177.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -107.85 130.02 55.03 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 106.857 -1.534 . . . . 0.0 106.857 174.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 21.3 mmt180 -85.66 167.13 15.6 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 122.706 0.402 . . . . 0.0 110.857 176.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -32.74 -54.84 0.36 Allowed 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 116.575 2.065 . . . . 0.0 116.575 -174.169 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -88.99 -10.23 48.41 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 113.461 0.911 . . . . 0.0 113.461 -177.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -93.28 -33.23 14.02 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 123.189 0.596 . . . . 0.0 110.436 -176.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.0 m -53.79 -50.35 84.17 Favored Pre-proline 0 CA--C 1.538 0.484 0 CA-C-O 117.987 -1.006 . . . . 0.0 110.997 175.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -64.8 -40.82 20.34 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 121.82 1.68 . . . . 0.0 110.434 -177.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.14 -15.35 59.58 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 173.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -91.25 -36.79 13.7 Favored 'General case' 0 C--N 1.342 0.273 0 CA-C-N 119.755 1.161 . . . . 0.0 110.953 177.068 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -70.73 9.44 0.66 Allowed 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 113.677 0.992 . . . . 0.0 113.677 -177.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 57.2 p -61.14 -24.4 66.25 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.224 1.01 . . . . 0.0 109.443 168.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 56.0 t-20 -50.34 114.76 1.2 Allowed 'General case' 0 C--N 1.348 0.509 0 C-N-CA 124.578 1.151 . . . . 0.0 110.464 170.253 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 34.7 tttm -97.31 1.04 49.04 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.461 1.104 . . . . 0.0 112.356 -174.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 60.0 mt -64.45 -48.26 85.9 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-N 118.724 0.693 . . . . 0.0 109.469 -170.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -100.49 135.64 20.14 Favored Pre-proline 0 CA--C 1.543 0.686 0 CA-C-O 118.968 -0.539 . . . . 0.0 110.545 -171.648 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -70.98 -36.23 7.88 Favored 'Trans proline' 0 CA--C 1.534 0.507 0 C-N-CA 122.794 2.329 . . . . 0.0 111.576 -177.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 47.9 t-80 -59.51 -50.25 74.63 Favored 'General case' 0 C--N 1.343 0.286 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 175.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -58.96 -43.16 91.26 Favored 'General case' 0 C--O 1.224 -0.264 0 CA-C-O 118.437 -0.792 . . . . 0.0 110.224 179.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 39.3 tp -66.06 -39.11 89.83 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 119.3 0.955 . . . . 0.0 111.123 -178.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -65.17 -44.26 94.24 Favored Glycine 0 CA--C 1.528 0.898 0 N-CA-C 110.615 -0.994 . . . . 0.0 110.615 176.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -62.32 -38.79 90.79 Favored 'General case' 0 CA--C 1.537 0.457 0 O-C-N 122.357 -0.496 . . . . 0.0 110.152 175.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -57.72 -46.14 84.8 Favored 'General case' 0 N--CA 1.455 -0.198 0 O-C-N 121.612 -0.68 . . . . 0.0 110.183 175.039 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 17.7 t0 -72.79 -20.88 61.08 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 119.706 -0.187 . . . . 0.0 111.078 -176.286 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 16.8 t -73.17 -44.59 55.64 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.686 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 169.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 74.5 mt -62.42 -36.31 81.97 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 119.119 0.872 . . . . 0.0 109.348 178.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 39.9 m -64.51 -44.21 91.63 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-O 118.469 -0.776 . . . . 0.0 109.952 172.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.44 ' HA ' ' CD2' ' A' ' 106' ' ' PHE . . . -60.48 -40.82 92.69 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 119.896 1.226 . . . . 0.0 111.641 175.311 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.5 mt -64.4 -33.58 76.19 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 123.621 0.768 . . . . 0.0 110.042 176.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 56.0 ttt85 -72.79 -32.58 65.68 Favored 'General case' 0 CA--C 1.534 0.335 0 O-C-N 121.553 -0.717 . . . . 0.0 110.071 174.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.44 ' CD2' ' HA ' ' A' ' 103' ' ' ALA . 14.3 m-30 -68.98 -47.05 66.52 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 119.058 0.844 . . . . 0.0 110.535 178.489 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 39.7 p -73.98 -25.27 59.84 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 123.4 0.68 . . . . 0.0 111.732 -178.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 74.6 8.08 80.54 Favored Glycine 0 CA--C 1.534 1.27 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -168.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -83.94 19.38 1.76 Allowed 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 119.84 1.82 . . . . 0.0 111.049 174.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -59.98 135.81 90.45 Favored Pre-proline 0 CA--C 1.547 0.833 0 C-N-CA 124.591 1.156 . . . . 0.0 109.33 169.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_exo -59.96 163.8 13.27 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 123.553 2.835 . . . . 0.0 115.713 -177.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 36.3 mmtt -64.85 -41.91 95.31 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 113.156 0.798 . . . . 0.0 113.156 172.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 24.1 ttpp -140.93 68.7 1.34 Allowed 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 -173.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.4 tt -68.6 136.84 53.65 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 174.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -131.79 134.49 45.88 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 177.518 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -123.23 117.47 25.38 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 120.469 1.486 . . . . 0.0 108.721 -179.064 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 18.9 t -92.55 91.84 3.55 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 N-CA-C 105.589 -2.004 . . . . 0.0 105.589 172.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -81.67 150.49 29.71 Favored Glycine 0 CA--C 1.522 0.522 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 178.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 40.4 t -129.04 130.56 68.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 178.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 47.6 mt -83.6 131.67 51.68 Favored Pre-proline 0 CA--C 1.534 0.355 0 N-CA-C 103.519 -2.771 . . . . 0.0 103.519 169.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -78.77 178.55 7.42 Favored 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 122.589 2.193 . . . . 0.0 111.164 -177.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -97.84 -56.47 2.49 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 124.001 0.92 . . . . 0.0 108.558 168.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 63.0 m -110.27 -59.31 1.96 Allowed 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 113.72 1.007 . . . . 0.0 113.72 -169.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.2 tp 53.81 33.11 16.25 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 127.37 2.268 . . . . 0.0 114.08 -173.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -82.33 161.32 60.06 Favored Pre-proline 0 CA--C 1.541 0.624 0 O-C-N 121.443 -0.786 . . . . 0.0 109.643 175.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -81.44 89.39 1.26 Allowed 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 122.142 1.895 . . . . 0.0 112.593 -169.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -174.82 179.55 1.63 Allowed 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 103.42 -2.807 . . . . 0.0 103.42 179.612 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -132.44 162.35 39.93 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 CA-C-N 120.558 1.526 . . . . 0.0 114.952 -176.383 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 110.72 143.5 9.59 Favored Glycine 0 CA--C 1.531 1.092 0 N-CA-C 104.73 -3.348 . . . . 0.0 104.73 -168.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 88.6 mt -76.02 156.48 33.97 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 119.308 1.554 . . . . 0.0 109.642 175.141 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 34.9 p -71.67 165.04 53.03 Favored Pre-proline 0 CA--C 1.539 0.526 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 169.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -57.76 -39.94 83.21 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 C-N-CA 121.821 1.681 . . . . 0.0 111.427 173.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 4.1 m -64.61 -40.02 94.75 Favored 'General case' 0 N--CA 1.442 -0.866 0 C-N-CA 124.117 0.967 . . . . 0.0 110.79 -177.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 74.7 t -90.5 -30.99 5.0 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 O-C-N 121.585 -0.697 . . . . 0.0 110.597 -173.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -53.96 -46.46 71.62 Favored 'General case' 0 CA--C 1.533 0.302 0 O-C-N 121.182 -0.948 . . . . 0.0 109.341 169.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -68.05 -14.86 63.3 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 113.69 0.996 . . . . 0.0 113.69 -178.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 5.3 mmm -82.27 -12.41 58.05 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.776 1.63 . . . . 0.0 111.871 174.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 54.1 mt -54.56 -54.12 25.26 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.357 0 CA-C-N 120.576 1.535 . . . . 0.0 108.897 173.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -67.15 -47.75 50.27 Favored Pre-proline 0 CA--C 1.542 0.671 0 CA-C-O 117.556 -1.212 . . . . 0.0 110.827 -173.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 0.3 OUTLIER -43.3 -54.29 3.62 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 125.293 3.995 . . . . 0.0 112.819 168.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -67.97 -37.2 81.24 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.106 -0.952 . . . . 0.0 112.102 179.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 36.1 mt -61.27 -45.35 94.87 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 121.039 1.745 . . . . 0.0 109.108 175.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -58.69 -33.78 70.55 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 118.686 0.676 . . . . 0.0 110.206 177.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 68.0 tp60 -76.6 -36.69 57.35 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 121.392 -0.818 . . . . 0.0 111.914 178.216 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 46.9 t -60.86 -44.93 98.77 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 171.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 71.1 mt -61.59 -36.25 80.15 Favored 'General case' 0 C--O 1.226 -0.176 0 CA-C-O 118.9 -0.571 . . . . 0.0 110.132 176.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -67.21 -44.49 79.43 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 119.241 0.928 . . . . 0.0 111.025 176.009 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -66.77 -27.89 67.96 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 119.161 0.891 . . . . 0.0 111.708 178.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 33.2 mt -69.14 -49.89 52.83 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 170.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 16.8 mmm-85 -63.8 -21.86 66.63 Favored 'General case' 0 CA--C 1.522 -0.126 0 CA-C-O 118.058 -0.972 . . . . 0.0 112.396 -177.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -63.99 -34.29 77.65 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 119.973 1.261 . . . . 0.0 110.947 174.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 26.0 m -91.45 18.29 7.45 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 122.854 0.462 . . . . 0.0 111.573 170.109 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 70.98 16.87 75.07 Favored Glycine 0 C--N 1.337 0.623 0 CA-C-O 117.607 -1.663 . . . . 0.0 112.578 -178.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 39.0 t -90.76 118.75 36.64 Favored 'Isoleucine or valine' 0 C--N 1.347 0.459 0 CA-C-N 120.648 2.224 . . . . 0.0 106.627 -176.244 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -111.0 85.68 2.16 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 106.198 -1.779 . . . . 0.0 106.198 177.042 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -49.12 139.49 10.68 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 114.627 -1.169 . . . . 0.0 110.005 169.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 24.9 mt -91.05 125.71 57.76 Favored Pre-proline 0 CA--C 1.53 0.202 0 CA-C-O 117.331 -1.318 . . . . 0.0 108.296 -169.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -66.54 98.07 0.39 Allowed 'Trans proline' 0 CA--C 1.534 0.52 0 C-N-CA 122.673 2.249 . . . . 0.0 109.236 175.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 60.5 mtm180 49.9 14.88 0.14 Allowed 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 127.218 2.207 . . . . 0.0 115.519 -178.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 58.6 m . . . . . 0 CA--C 1.539 0.54 0 C-N-CA 123.843 0.857 . . . . 0.0 111.538 -169.252 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 7.9 ptp180 . . . . . 0 N--CA 1.48 1.066 0 CA-C-O 119.435 -0.317 . . . . 0.0 111.521 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 27.0 mt -136.41 135.22 49.52 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 C-N-CA 123.171 0.588 . . . . 0.0 110.732 -172.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 8.3 mt -112.28 138.58 48.79 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 105.711 -1.959 . . . . 0.0 105.711 167.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 49.1 t -116.21 104.38 16.59 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.644 0 N-CA-C 103.387 -2.819 . . . . 0.0 103.387 169.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 14.5 tp -101.73 111.28 23.47 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 -168.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -88.28 127.29 8.5 Favored Glycine 0 C--N 1.331 0.304 0 N-CA-C 107.706 -2.158 . . . . 0.0 107.706 176.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -141.14 165.6 19.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 117.434 0.617 . . . . 0.0 110.958 -170.488 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 119.25 174.54 15.82 Favored Glycine 0 CA--C 1.527 0.827 0 C-N-CA 125.986 1.755 . . . . 0.0 111.259 178.111 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.455 HD22 ' HB2' ' A' ' 12' ' ' LEU . 4.6 t30 -82.88 97.6 8.75 Favored 'General case' 0 C--O 1.235 0.338 0 O-C-N 121.409 -1.053 . . . . 0.0 110.41 -175.188 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.2 pt -62.64 35.67 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 N-CA-C 116.476 2.028 . . . . 0.0 116.476 172.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.455 ' HB2' HD22 ' A' ' 10' ' ' ASN . 33.8 mt -128.67 -7.16 5.11 Favored 'General case' 0 C--O 1.223 -0.304 0 CA-C-N 120.304 1.411 . . . . 0.0 108.749 169.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.6 mp -111.4 60.19 0.61 Allowed 'General case' 0 N--CA 1.442 -0.836 0 C-N-CA 124.174 0.989 . . . . 0.0 113.407 -168.106 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 52.72 -102.19 0.13 Allowed 'General case' 0 C--O 1.236 0.362 0 C-N-CA 124.168 0.987 . . . . 0.0 111.265 171.393 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -78.81 -11.87 60.01 Favored 'General case' 0 N--CA 1.441 -0.881 0 C-N-CA 123.715 0.806 . . . . 0.0 111.018 -173.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -74.35 -8.82 57.57 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 120.444 1.474 . . . . 0.0 112.232 177.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -77.34 -10.49 59.47 Favored 'General case' 0 N--CA 1.432 -1.327 0 CA-C-O 116.0 -1.952 . . . . 0.0 108.878 170.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.8 tp -54.48 -37.92 39.68 Favored 'Isoleucine or valine' 0 C--N 1.345 0.385 0 CA-C-N 122.212 2.278 . . . . 0.0 112.25 -169.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -60.1 -45.0 96.76 Favored Glycine 0 CA--C 1.524 0.602 0 CA-C-N 119.55 1.068 . . . . 0.0 111.599 175.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 55.3 t -69.72 -44.41 79.28 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-O 118.528 -0.749 . . . . 0.0 109.911 175.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 23.1 mmm180 -61.47 -33.66 74.14 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 120.469 1.486 . . . . 0.0 111.778 179.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 30.3 mt -62.25 -46.4 96.52 Favored 'Isoleucine or valine' 0 C--N 1.342 0.256 0 CA-C-N 120.459 1.482 . . . . 0.0 109.464 176.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 30.2 m -73.73 -27.15 22.49 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 CA-C-N 119.748 1.158 . . . . 0.0 111.522 -175.186 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 64.1 mt-10 -72.91 -44.06 61.7 Favored 'General case' 0 CA--C 1.528 0.099 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 175.078 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.57 -42.39 96.56 Favored 'General case' 0 N--CA 1.452 -0.356 0 O-C-N 121.978 -0.451 . . . . 0.0 110.586 176.124 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 5.5 tp -65.85 -40.96 92.22 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-O 118.828 -0.606 . . . . 0.0 109.913 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -61.76 -40.34 94.79 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 118.413 0.551 . . . . 0.0 111.081 177.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -71.99 -34.71 69.13 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.633 0.773 . . . . 0.0 112.068 178.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 36.5 mtp180 -100.17 -34.06 10.19 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 117.204 -1.379 . . . . 0.0 114.054 -169.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -121.34 138.23 54.35 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 121.464 1.938 . . . . 0.0 113.153 -170.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 39.9 mm -99.87 141.16 17.49 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 105.542 -2.021 . . . . 0.0 105.542 169.019 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.8 mt -143.49 161.35 47.52 Favored Pre-proline 0 CA--C 1.539 0.549 0 C-N-CA 126.717 2.007 . . . . 0.0 107.407 -174.065 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -55.77 156.76 17.89 Favored 'Trans proline' 0 CA--C 1.536 0.605 0 C-N-CA 123.21 2.606 . . . . 0.0 112.661 177.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -62.46 -27.29 69.02 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 -170.069 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 10.9 p90 -76.36 -2.23 30.77 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 179.109 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 22.0 t -104.26 130.27 55.26 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 175.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -131.85 135.57 46.8 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 174.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -94.84 106.19 17.86 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 N-CA-C 105.744 -1.947 . . . . 0.0 105.744 171.089 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 53.2 tp -105.74 126.14 51.81 Favored 'General case' 0 C--N 1.343 0.307 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 -174.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -80.17 117.92 21.4 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 122.989 0.515 . . . . 0.0 109.754 171.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -77.86 -83.54 0.56 Allowed Glycine 0 CA--C 1.528 0.872 0 N-CA-C 107.408 -2.277 . . . . 0.0 107.408 169.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 79.84 110.96 0.26 Allowed Glycine 0 C--N 1.343 0.94 0 N-CA-C 111.05 -0.82 . . . . 0.0 111.05 178.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.3 p 52.59 61.05 3.39 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.839 1.256 . . . . 0.0 109.085 175.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -120.18 -84.78 0.66 Allowed 'General case' 0 C--N 1.344 0.344 0 CA-C-N 114.43 -1.259 . . . . 0.0 111.026 -169.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 71.09 -93.25 0.5 Allowed Glycine 0 C--N 1.338 0.668 0 N-CA-C 108.491 -1.843 . . . . 0.0 108.491 -170.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 27.7 tpp -78.61 -22.5 46.91 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 124.125 0.97 . . . . 0.0 112.322 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -63.02 -14.23 45.41 Favored 'General case' 0 CA--C 1.547 0.833 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 -169.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 28.8 mt -101.87 13.43 34.83 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.882 0.873 . . . . 0.0 112.843 -174.02 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 4.3 tt -41.6 -61.44 1.08 Allowed 'General case' 0 C--N 1.344 0.338 0 C-N-CA 124.177 0.991 . . . . 0.0 113.152 -175.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -75.82 -34.67 47.66 Favored Glycine 0 CA--C 1.524 0.608 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.15 -173.189 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -64.35 -34.08 77.33 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 117.549 0.675 . . . . 0.0 111.353 179.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 51.7 mtp -72.7 -13.3 61.31 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 111.911 0.337 . . . . 0.0 111.911 179.442 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -85.32 160.63 19.77 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 123.341 0.656 . . . . 0.0 110.414 -176.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 29.2 m120 59.26 19.44 7.56 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.642 1.577 . . . . 0.0 113.845 172.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 20.4 mmt180 -94.37 151.54 19.32 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 106.388 -1.708 . . . . 0.0 106.388 169.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -89.2 -35.83 15.99 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 -179.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 12.6 t-160 -142.14 128.78 20.34 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 105.849 -1.908 . . . . 0.0 105.849 179.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 6.5 tp -134.86 128.56 32.9 Favored 'General case' 0 CA--C 1.508 -0.669 0 N-CA-C 108.984 -0.746 . . . . 0.0 108.984 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 44.6 mt -106.98 108.98 26.51 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 N-CA-C 105.199 -2.148 . . . . 0.0 105.199 -179.212 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.6 mm -78.32 128.91 38.12 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 N-CA-C 105.25 -2.13 . . . . 0.0 105.25 175.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -112.33 116.66 30.72 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 104.703 -2.332 . . . . 0.0 104.703 169.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -155.35 169.6 23.83 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 118.174 0.443 . . . . 0.0 110.19 -177.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -88.31 156.99 18.88 Favored 'General case' 0 CA--C 1.534 0.351 0 O-C-N 121.921 -0.487 . . . . 0.0 109.858 169.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 87.6 mt -115.05 113.94 45.05 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.104 1 N-CA-C 99.939 -4.097 . . . . 0.0 99.939 168.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 67.1 t -65.36 -37.86 81.13 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 N-CA-C 113.442 0.904 . . . . 0.0 113.442 -168.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 15.2 m -151.43 152.42 33.02 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 119.238 0.926 . . . . 0.0 111.483 173.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.401 ' HG3' ' H ' ' A' ' 68' ' ' LYS . 26.7 tptt -158.68 -177.44 6.53 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.593 1.957 . . . . 0.0 106.512 169.25 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.401 ' H ' ' HG3' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -86.2 42.13 0.97 Allowed 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.742 0.817 . . . . 0.0 110.472 -178.931 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 33.6 t-20 -143.83 160.88 39.98 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.826 1.25 . . . . 0.0 109.215 -170.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.6 m -64.59 146.66 98.18 Favored Pre-proline 0 CA--C 1.548 0.871 0 C-N-CA 124.344 1.058 . . . . 0.0 111.847 -169.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -58.6 153.54 48.23 Favored 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 122.713 2.275 . . . . 0.0 111.426 169.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 68.33 16.0 68.66 Favored Glycine 0 CA--C 1.532 1.114 0 CA-C-O 118.711 -1.049 . . . . 0.0 114.345 177.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 25.9 m -96.36 152.34 18.68 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 119.0 1.4 . . . . 0.0 109.627 179.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 18.8 ttp -95.78 145.07 25.62 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 123.614 0.766 . . . . 0.0 110.372 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 10.3 ttm -136.51 121.95 19.45 Favored 'General case' 0 CA--C 1.528 0.127 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 44.6 mm -109.15 122.47 63.86 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 -177.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -121.1 131.66 54.4 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 -171.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 74.5 mtm180 -100.78 176.14 5.4 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.496 0.718 . . . . 0.0 110.551 -176.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -46.74 -47.19 20.68 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 115.99 1.848 . . . . 0.0 115.99 -169.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -78.91 -18.23 54.21 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 119.242 0.928 . . . . 0.0 112.248 -178.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -90.59 -33.12 16.0 Favored 'General case' 0 N--CA 1.457 -0.119 0 C-N-CA 123.606 0.762 . . . . 0.0 110.754 -169.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -70.36 -37.6 7.27 Favored Pre-proline 0 CA--C 1.539 0.525 0 CA-C-O 117.233 -1.365 . . . . 0.0 113.242 -177.036 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_exo -56.26 -25.93 58.75 Favored 'Trans proline' 0 CA--C 1.54 0.781 0 CA-C-N 121.768 1.667 . . . . 0.0 112.21 169.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -92.4 7.62 42.13 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 124.492 1.117 . . . . 0.0 112.68 177.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -126.53 -42.39 1.81 Allowed 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.512 0.725 . . . . 0.0 112.509 -172.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 -61.85 -11.1 11.09 Favored 'General case' 0 CA--C 1.551 1.017 0 CA-C-N 119.47 1.032 . . . . 0.0 111.39 175.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 64.3 p -59.54 -27.55 66.3 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.946 1.698 . . . . 0.0 113.857 -177.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -63.75 139.83 58.81 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 121.347 0.594 . . . . 0.0 110.78 -170.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -76.13 -21.66 56.35 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 122.658 0.383 . . . . 0.0 111.861 -176.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 97.3 mt -72.42 -26.72 24.76 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 C-N-CA 124.28 1.032 . . . . 0.0 110.318 -170.174 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 9.9 m -102.85 84.47 0.66 Allowed Pre-proline 0 CA--C 1.55 0.962 0 C-N-CA 126.084 1.753 . . . . 0.0 108.63 174.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -70.61 -38.27 6.15 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 123.003 2.469 . . . . 0.0 114.364 -169.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 11.1 m80 -68.71 -39.75 80.32 Favored 'General case' 0 N--CA 1.468 0.441 0 O-C-N 121.055 -1.028 . . . . 0.0 108.81 179.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 16.9 mp0 -66.09 -36.55 83.48 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 125.169 1.388 . . . . 0.0 109.253 177.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 59.0 tp -62.01 -35.27 78.04 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 119.431 1.014 . . . . 0.0 110.969 171.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -60.51 -39.27 96.15 Favored Glycine 0 CA--C 1.532 1.116 0 O-C-N 121.392 -0.817 . . . . 0.0 111.069 171.087 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 8.8 tt -75.21 -23.97 57.68 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 117.549 0.675 . . . . 0.0 110.704 175.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -61.02 -43.72 98.47 Favored 'General case' 0 C--O 1.226 -0.17 0 CA-C-N 119.443 1.02 . . . . 0.0 108.666 169.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -69.77 -21.32 63.44 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 119.03 -0.509 . . . . 0.0 110.747 176.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 73.1 t -69.77 -40.89 79.65 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 168.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 5.3 mp -60.98 -36.64 79.97 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 120.973 1.715 . . . . 0.0 110.492 175.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 17.0 m -63.46 -45.26 91.64 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 118.286 0.494 . . . . 0.0 109.873 172.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -65.39 -38.77 90.99 Favored 'General case' 0 N--CA 1.452 -0.366 0 O-C-N 121.563 -0.711 . . . . 0.0 111.505 -179.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 21.7 mt -59.97 -39.59 86.17 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 125.143 1.377 . . . . 0.0 109.832 173.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 52.6 tpt85 -70.64 -33.35 70.89 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 118.037 -0.982 . . . . 0.0 110.484 175.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 15.5 m-30 -68.38 -42.11 79.57 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 119.646 1.112 . . . . 0.0 110.402 178.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 63.9 p -73.25 -26.78 61.25 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 118.561 0.619 . . . . 0.0 110.515 177.247 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 76.91 6.55 85.76 Favored Glycine 0 CA--C 1.532 1.138 0 CA-C-O 119.182 -0.788 . . . . 0.0 111.599 -169.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -96.06 19.73 11.22 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 118.603 1.202 . . . . 0.0 110.809 -175.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -55.82 135.37 72.62 Favored Pre-proline 0 CA--C 1.543 0.694 0 C-N-CA 126.624 1.969 . . . . 0.0 109.752 174.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_exo -56.04 152.74 35.57 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 123.259 2.639 . . . . 0.0 114.796 179.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 8.7 tttt -64.36 -33.27 75.45 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 119.001 -0.523 . . . . 0.0 110.302 177.033 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 63.1 tttm -139.82 97.46 3.26 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 -178.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -83.62 132.58 34.89 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 106.495 -1.669 . . . . 0.0 106.495 169.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -134.22 148.78 50.92 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 176.779 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.8 tt -135.05 133.87 39.8 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 120.177 1.353 . . . . 0.0 110.504 174.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 60.8 t -103.01 103.43 15.08 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 N-CA-C 103.665 -2.717 . . . . 0.0 103.665 169.095 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -92.85 151.91 20.74 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 111.121 -0.792 . . . . 0.0 111.121 177.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 47.1 t -138.95 136.35 42.73 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 N-CA-C 107.705 -1.221 . . . . 0.0 107.705 178.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 32.1 mt -88.73 131.64 41.01 Favored Pre-proline 0 CA--C 1.546 0.802 0 CA-C-N 119.812 1.187 . . . . 0.0 108.961 177.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -75.16 173.55 14.32 Favored 'Trans proline' 0 CA--C 1.543 0.932 0 C-N-CA 124.978 3.785 . . . . 0.0 113.228 -177.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -116.15 -57.35 2.22 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.836 0.855 . . . . 0.0 110.718 179.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 63.4 m -107.07 -51.89 2.85 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 118.54 0.609 . . . . 0.0 112.609 -172.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 57.25 46.71 18.18 Favored 'General case' 0 CA--C 1.552 1.044 0 N-CA-C 114.776 1.399 . . . . 0.0 114.776 172.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -116.38 165.22 15.53 Favored Pre-proline 0 N--CA 1.478 0.962 0 O-C-N 121.155 -0.966 . . . . 0.0 109.618 177.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -66.09 90.89 0.26 Allowed 'Trans proline' 0 CA--C 1.547 1.125 0 C-N-CA 122.868 2.378 . . . . 0.0 112.931 -179.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -176.98 145.24 0.47 Allowed 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 103.91 -2.626 . . . . 0.0 103.91 173.491 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -107.42 165.79 4.3 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 CA-C-N 119.376 0.989 . . . . 0.0 113.319 -169.539 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 85.3 153.81 21.29 Favored Glycine 0 C--N 1.341 0.845 0 N-CA-C 108.11 -1.996 . . . . 0.0 108.11 -169.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -81.74 163.32 22.51 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-O 121.585 0.707 . . . . 0.0 109.108 -172.529 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 39.5 p -69.19 169.32 12.06 Favored Pre-proline 0 C--O 1.238 0.467 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 168.104 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_exo -55.1 -32.2 78.63 Favored 'Trans proline' 0 CA--C 1.541 0.84 0 C-N-CA 121.469 1.446 . . . . 0.0 110.693 169.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 26.5 m -67.09 -44.73 79.26 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 118.992 -0.528 . . . . 0.0 111.419 179.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 4.6 t -101.06 -11.41 8.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 CA-C-N 119.645 1.111 . . . . 0.0 111.624 -169.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -59.04 -45.69 90.12 Favored 'General case' 0 CA--C 1.518 -0.27 0 O-C-N 119.938 -1.726 . . . . 0.0 107.322 169.016 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -71.24 4.63 2.69 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-O 118.482 -0.771 . . . . 0.0 112.406 178.104 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 26.2 mmm -95.57 -10.54 29.3 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 118.127 -0.94 . . . . 0.0 111.282 170.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 57.0 mt -59.9 -46.99 93.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-N 119.31 0.959 . . . . 0.0 108.554 178.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -72.15 -53.05 6.81 Favored Pre-proline 0 CA--C 1.536 0.422 0 CA-C-O 117.286 -1.34 . . . . 0.0 113.05 -171.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -60.02 -35.26 93.62 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 CA-C-N 122.244 1.837 . . . . 0.0 111.256 176.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.28 -43.01 71.31 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 118.84 0.745 . . . . 0.0 110.538 -179.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.05 -37.21 86.6 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 119.695 1.134 . . . . 0.0 109.782 176.34 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -62.36 -35.94 80.69 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 119.05 -0.5 . . . . 0.0 110.783 175.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 35.1 mm-40 -76.31 -29.5 57.34 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 119.152 0.887 . . . . 0.0 111.627 175.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 38.2 t -61.55 -45.42 98.68 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 CA-C-N 120.065 1.302 . . . . 0.0 108.478 169.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 72.8 mt -63.75 -39.03 93.28 Favored 'General case' 0 C--N 1.341 0.206 0 CA-C-N 118.05 0.386 . . . . 0.0 110.207 176.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -60.4 -41.28 93.53 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 118.906 0.776 . . . . 0.0 111.39 177.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -62.35 -47.38 84.46 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 119.233 0.924 . . . . 0.0 111.038 178.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . 0.297 4.2 pp -67.78 -22.23 65.21 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 118.576 0.626 . . . . 0.0 112.48 177.426 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 61.8 mtt180 -71.22 -26.31 62.87 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 117.822 -1.085 . . . . 0.0 111.821 169.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -59.85 -38.0 80.84 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 120.625 1.557 . . . . 0.0 109.42 174.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 11.3 p -87.39 14.81 7.36 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.549 1.14 . . . . 0.0 112.946 178.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 75.52 19.76 79.05 Favored Glycine 0 CA--C 1.534 1.268 0 CA-C-O 118.704 -1.054 . . . . 0.0 114.597 175.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 15.1 t -102.47 146.32 10.67 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 CA-C-N 118.97 1.385 . . . . 0.0 107.805 178.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -134.54 143.78 47.61 Favored 'General case' 0 C--O 1.236 0.392 0 O-C-N 121.096 -1.002 . . . . 0.0 108.929 176.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -94.74 160.52 14.57 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 124.991 1.316 . . . . 0.0 111.518 178.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . 0.415 ' CG2' ' HA ' ' A' ' 160' ' ' SER . 46.1 mt -124.07 130.76 24.27 Favored Pre-proline 0 CA--C 1.533 0.307 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 171.599 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -57.48 110.2 0.58 Allowed 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.561 2.174 . . . . 0.0 109.03 170.053 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 50.05 21.6 0.77 Allowed 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.628 1.571 . . . . 0.0 114.447 177.188 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' SER . . . . . 0.415 ' HA ' ' CG2' ' A' ' 157' ' ' ILE . 1.1 m . . . . . 0 CA--C 1.544 0.718 0 C-N-CA 124.424 1.09 . . . . 0.0 112.575 -169.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 8.3 ptp180 . . . . . 0 N--CA 1.483 1.187 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 72.7 mt -138.9 133.21 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 CA-C-N 119.332 0.969 . . . . 0.0 111.169 -169.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -115.2 129.74 56.73 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 105.951 -1.87 . . . . 0.0 105.951 168.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.8 t -104.43 105.49 18.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 101.905 -3.369 . . . . 0.0 101.905 169.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 13.0 tp -109.45 104.26 13.31 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 124.533 1.133 . . . . 0.0 110.033 -167.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -91.26 129.85 10.0 Favored Glycine 0 N--CA 1.452 -0.297 0 N-CA-C 106.603 -2.599 . . . . 0.0 106.603 175.083 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 1.4 m -135.32 -28.34 0.48 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.208 0 N-CA-C 117.819 2.525 . . . . 0.0 117.819 -168.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -52.25 151.41 7.65 Favored Glycine 0 CA--C 1.527 0.783 0 CA-C-O 122.22 0.9 . . . . 0.0 114.715 -169.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -61.76 102.39 0.26 Allowed 'General case' 0 N--CA 1.455 -0.225 0 C-N-CA 125.334 1.453 . . . . 0.0 112.372 -169.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.2 pt -76.76 40.97 0.02 OUTLIER 'Isoleucine or valine' 0 C--O 1.222 -0.38 0 C-N-CA 123.93 0.892 . . . . 0.0 113.311 -177.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 19.9 mt -128.11 -7.83 5.4 Favored 'General case' 0 CA--C 1.536 0.429 0 O-C-N 121.177 -0.952 . . . . 0.0 109.018 170.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.3 mp -124.51 67.24 1.08 Allowed 'General case' 0 C--N 1.346 0.417 0 C-N-CA 124.167 0.987 . . . . 0.0 109.235 -168.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.4 m 46.91 -103.16 0.08 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 114.378 -1.283 . . . . 0.0 112.891 171.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -62.95 -26.33 68.77 Favored 'General case' 0 N--CA 1.438 -1.056 0 C-N-CA 125.998 1.719 . . . . 0.0 111.598 -171.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -72.0 -18.79 61.95 Favored 'General case' 0 C--O 1.231 0.101 0 CA-C-N 120.019 1.281 . . . . 0.0 112.003 -174.022 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.86 -15.49 42.73 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-O 117.022 -1.466 . . . . 0.0 111.152 170.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.7 tp -54.2 -37.98 37.61 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 CA-C-N 120.831 1.65 . . . . 0.0 111.136 -174.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -59.54 -43.99 97.14 Favored Glycine 0 CA--C 1.527 0.834 0 N-CA-C 111.244 -0.743 . . . . 0.0 111.244 178.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 74.0 t -70.82 -45.78 71.81 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 176.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 20.0 mmt180 -61.43 -31.71 71.66 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 117.093 -1.432 . . . . 0.0 112.21 -178.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 19.9 mt -58.89 -49.49 82.87 Favored 'Isoleucine or valine' 0 C--N 1.34 0.157 0 CA-C-N 121.286 1.857 . . . . 0.0 109.299 174.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 30.4 m -73.32 -34.13 42.83 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 CA-C-N 119.762 1.164 . . . . 0.0 111.111 -173.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 59.4 mt-10 -64.88 -42.15 95.05 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 118.403 0.547 . . . . 0.0 110.322 173.041 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -68.24 -36.53 79.61 Favored 'General case' 0 C--N 1.34 0.184 0 CA-C-N 118.981 0.809 . . . . 0.0 110.014 179.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.3 tp -65.46 -36.16 83.07 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 118.64 0.654 . . . . 0.0 109.887 -177.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -61.57 -24.16 66.47 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.353 0.661 . . . . 0.0 112.72 179.18 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 -98.85 -39.77 8.43 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 126.45 1.9 . . . . 0.0 110.771 -176.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 21.8 mmt85 -85.02 -32.18 23.06 Favored 'General case' 0 C--N 1.338 0.085 0 CA-C-O 119.449 -0.31 . . . . 0.0 110.242 -173.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 71.5 m-85 -122.02 151.01 41.29 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-O 122.33 1.062 . . . . 0.0 111.826 -176.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 37.0 mt -107.06 134.45 48.7 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 N-CA-C 104.223 -2.51 . . . . 0.0 104.223 169.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -120.13 150.03 50.45 Favored Pre-proline 0 C--O 1.236 0.357 0 C-N-CA 124.005 0.922 . . . . 0.0 110.366 -169.114 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_endo -67.52 156.77 64.73 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 121.977 1.785 . . . . 0.0 108.726 168.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -55.75 -33.25 64.12 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 114.491 1.293 . . . . 0.0 114.491 -169.386 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 17.0 p90 -78.75 -13.2 59.94 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 118.474 -0.774 . . . . 0.0 112.743 -175.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 95.5 t -89.82 121.71 40.34 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 169.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -122.62 125.22 45.2 Favored 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 173.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -81.33 126.63 39.85 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 N-CA-C 106.067 -1.827 . . . . 0.0 106.067 167.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 64.4 tp -125.53 132.94 52.51 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 171.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -88.85 116.92 27.48 Favored 'General case' 0 C--O 1.236 0.395 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 169.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -76.17 -74.37 0.94 Allowed Glycine 0 CA--C 1.529 0.916 0 N-CA-C 108.335 -1.906 . . . . 0.0 108.335 169.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 85.76 98.0 0.75 Allowed Glycine 0 C--N 1.343 0.925 0 N-CA-C 109.729 -1.348 . . . . 0.0 109.729 176.048 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 16.8 p 62.97 16.65 9.42 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.24 1.416 . . . . 0.0 113.378 179.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -70.18 -59.96 2.57 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 114.298 1.222 . . . . 0.0 114.298 -168.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 60.07 -117.09 10.2 Favored Glycine 0 CA--C 1.529 0.91 0 N-CA-C 108.691 -1.764 . . . . 0.0 108.691 -170.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 9.4 tpt -62.22 -21.86 65.48 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.512 1.125 . . . . 0.0 113.68 -173.273 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -60.19 -19.28 53.39 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 -171.087 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 10.0 mt -98.18 20.67 12.03 Favored 'General case' 0 C--N 1.345 0.392 0 CA-C-N 119.522 1.055 . . . . 0.0 113.663 -169.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 6.4 tt -50.5 -57.71 7.45 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 118.988 0.813 . . . . 0.0 110.988 -178.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -64.98 -30.08 77.08 Favored Glycine 0 CA--C 1.53 0.975 0 CA-C-O 119.296 -0.725 . . . . 0.0 112.584 -177.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -79.72 -36.38 37.5 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 118.413 1.107 . . . . 0.0 112.33 -178.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 55.4 mtp -76.25 -28.79 57.26 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 179.219 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.46 157.55 31.76 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 121.96 0.886 . . . . 0.0 110.803 175.079 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 62.14 16.49 8.35 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.377 1.471 . . . . 0.0 114.307 169.6 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 24.6 mmt180 -93.89 154.73 17.55 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 172.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -83.95 -34.91 24.33 Favored 'General case' 0 C--O 1.217 -0.642 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 169.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 4.5 t-160 -144.41 129.06 18.17 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 105.512 -2.033 . . . . 0.0 105.512 -169.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 22.8 tp -134.13 117.87 17.04 Favored 'General case' 0 CA--C 1.499 -1.003 0 N-CA-C 103.434 -2.802 . . . . 0.0 103.434 -173.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 65.7 mt -100.58 107.86 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 N-CA-C 103.907 -2.627 . . . . 0.0 103.907 171.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 63.8 mt -81.2 140.6 16.35 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 N-CA-C 105.885 -1.894 . . . . 0.0 105.885 172.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -120.72 113.18 19.83 Favored 'General case' 0 N--CA 1.446 -0.625 0 N-CA-C 103.635 -2.728 . . . . 0.0 103.635 168.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.419 ' CG ' HE21 ' A' ' 94' ' ' GLN . 38.6 t0 -155.93 157.64 36.62 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 123.574 0.75 . . . . 0.0 109.587 -176.22 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -83.68 149.92 26.19 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 174.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 8.1 mt -76.67 -32.59 20.95 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 C-N-CA 123.731 0.812 . . . . 0.0 110.109 174.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . 0.354 3.3 t 58.49 46.92 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.943 0 C-N-CA 126.148 1.779 . . . . 0.0 112.188 -173.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 8.1 m 63.46 145.28 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 128.327 2.651 . . . . 0.0 118.124 168.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -139.35 -88.34 0.21 Allowed 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 169.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -140.05 31.08 1.99 Allowed 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.56 1.144 . . . . 0.0 111.02 -176.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -134.31 165.22 25.64 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.095 0.958 . . . . 0.0 110.69 -174.289 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 2.8 m -64.87 148.5 97.4 Favored Pre-proline 0 CA--C 1.548 0.867 0 C-N-CA 124.439 1.096 . . . . 0.0 113.071 -169.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_exo -57.05 154.74 31.75 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 124.607 3.538 . . . . 0.0 112.425 169.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 67.04 11.46 58.58 Favored Glycine 0 CA--C 1.532 1.124 0 CA-C-O 119.065 -0.853 . . . . 0.0 113.943 173.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 10.6 m -90.22 140.68 29.45 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 119.146 1.473 . . . . 0.0 109.476 -175.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 28.8 ttp -86.07 142.95 28.35 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 169.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 7.0 ttm -131.53 134.23 45.89 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 169.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 4.9 mm -95.75 121.91 46.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 105.573 -2.01 . . . . 0.0 105.573 176.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.7 mp -116.37 128.86 55.89 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 173.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 22.2 mtp85 -88.53 177.72 6.72 Favored 'General case' 0 CA--C 1.528 0.103 0 O-C-N 123.824 0.703 . . . . 0.0 110.602 178.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -42.24 -50.97 4.88 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 115.336 1.606 . . . . 0.0 115.336 -169.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -86.27 -14.76 42.78 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -175.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -82.18 -36.64 27.13 Favored 'General case' 0 CA--C 1.523 -0.078 0 O-C-N 121.597 -0.69 . . . . 0.0 110.424 -169.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -65.09 -47.86 71.77 Favored Pre-proline 0 CA--C 1.539 0.534 0 CA-C-O 117.397 -1.287 . . . . 0.0 113.454 -175.27 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -53.35 -44.36 49.65 Favored 'Trans proline' 0 C--N 1.352 0.739 0 C-N-CA 121.935 1.757 . . . . 0.0 110.697 174.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -70.22 -13.23 62.09 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 114.142 1.164 . . . . 0.0 114.142 178.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -95.27 -42.64 8.44 Favored 'General case' 0 C--N 1.343 0.323 0 CA-C-N 120.181 1.355 . . . . 0.0 110.558 -177.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 26.5 m-85 -69.01 0.98 3.84 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 -172.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 61.6 p -58.65 -27.85 65.15 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.137 0.975 . . . . 0.0 110.346 169.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 56.8 t-20 -51.52 117.19 2.48 Favored 'General case' 0 C--N 1.345 0.406 0 C-N-CA 124.137 0.975 . . . . 0.0 111.311 -179.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -77.22 -17.0 58.81 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 118.717 -0.659 . . . . 0.0 112.439 -174.289 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 40.2 mt -61.66 -41.13 89.19 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 178.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.5 m -83.18 105.11 4.6 Favored Pre-proline 0 CA--C 1.545 0.777 0 C-N-CA 126.683 1.993 . . . . 0.0 110.523 -169.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -71.95 -61.72 0.05 OUTLIER 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 122.186 1.924 . . . . 0.0 113.181 -169.118 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . 0.403 ' HD1' ' NE2' ' A' ' 94' ' ' GLN . 10.4 t-80 -56.73 -41.66 77.88 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 121.75 0.786 . . . . 0.0 110.46 178.652 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.419 HE21 ' CG ' ' A' ' 62' ' ' ASP . 20.8 mp0 -61.36 -33.13 73.13 Favored 'General case' 0 N--CA 1.433 -1.287 0 CA-C-N 115.08 -0.964 . . . . 0.0 108.939 -175.074 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 1.5 tt -63.13 -46.3 87.94 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 119.457 1.026 . . . . 0.0 108.804 177.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -61.69 -37.32 94.05 Favored Glycine 0 CA--C 1.532 1.14 0 O-C-N 121.089 -1.007 . . . . 0.0 111.014 175.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 54.6 tp -67.96 -30.92 70.33 Favored 'General case' 0 CA--C 1.535 0.382 0 O-C-N 121.755 -0.85 . . . . 0.0 110.353 175.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -60.26 -45.64 92.59 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 172.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 34.0 t0 -63.59 -28.97 70.29 Favored 'General case' 0 C--O 1.238 0.497 0 O-C-N 123.633 0.583 . . . . 0.0 110.592 -178.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 41.8 t -65.49 -50.2 73.69 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 CA-C-N 118.866 0.757 . . . . 0.0 110.126 169.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 33.6 mt -67.26 -31.52 71.92 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 119.202 0.91 . . . . 0.0 110.844 -174.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 48.8 m -64.52 -44.34 91.17 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 119.391 0.996 . . . . 0.0 109.838 169.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.442 ' HA ' ' CD2' ' A' ' 106' ' ' PHE . . . -62.54 -39.51 93.84 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 119.723 1.147 . . . . 0.0 111.276 177.095 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -63.23 -35.25 79.72 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 123.325 0.65 . . . . 0.0 109.819 175.476 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 73.6 ttt-85 -71.66 -31.42 66.79 Favored 'General case' 0 CA--C 1.535 0.39 0 O-C-N 121.554 -0.716 . . . . 0.0 109.937 176.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.442 ' CD2' ' HA ' ' A' ' 103' ' ' ALA . 12.3 m-30 -69.99 -46.47 65.08 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 119.143 0.883 . . . . 0.0 110.702 176.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 35.6 p -74.04 -27.19 60.81 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 122.993 0.517 . . . . 0.0 111.874 -176.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 75.11 7.37 81.81 Favored Glycine 0 CA--C 1.533 1.211 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 -168.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -84.57 16.27 3.29 Favored 'General case' 0 C--N 1.349 0.557 0 CA-C-N 119.734 1.767 . . . . 0.0 111.302 174.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -56.18 137.9 73.94 Favored Pre-proline 0 CA--C 1.542 0.668 0 C-N-CA 125.676 1.59 . . . . 0.0 109.895 170.108 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -62.72 160.24 33.64 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 122.475 2.117 . . . . 0.0 115.695 -176.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 23.7 mmtm -61.01 -40.99 95.67 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 169.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 23.6 ttpp -142.46 73.18 1.4 Allowed 'General case' 0 C--O 1.236 0.356 0 C-N-CA 123.825 0.85 . . . . 0.0 108.972 -172.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 15.2 tp -68.25 137.53 54.82 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 169.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.11 142.75 47.62 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 106.098 -1.815 . . . . 0.0 106.098 174.209 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -130.08 121.62 26.75 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 120.503 1.502 . . . . 0.0 109.055 176.03 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 13.1 t -85.97 87.86 2.63 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 N-CA-C 106.401 -1.703 . . . . 0.0 106.401 173.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -80.96 143.86 24.52 Favored Glycine 0 C--N 1.336 0.56 0 N-CA-C 110.005 -1.238 . . . . 0.0 110.005 -176.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 22.0 t -130.91 134.94 61.04 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.15 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 177.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 36.7 mt -93.63 133.22 28.41 Favored Pre-proline 0 CA--C 1.539 0.552 0 CA-C-N 119.595 1.089 . . . . 0.0 108.106 178.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -78.39 166.54 24.1 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 122.779 2.32 . . . . 0.0 112.372 -174.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -99.77 -50.42 4.04 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.93 0.892 . . . . 0.0 109.644 169.056 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 72.2 m -114.58 -55.16 2.52 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 113.82 1.044 . . . . 0.0 113.82 -169.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER 52.96 42.41 32.18 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 126.564 1.946 . . . . 0.0 112.93 -175.584 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -105.03 165.71 12.74 Favored Pre-proline 0 CA--C 1.542 0.653 0 C-N-CA 123.615 0.766 . . . . 0.0 109.917 178.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -80.94 85.72 1.76 Allowed 'Trans proline' 0 CA--C 1.538 0.722 0 C-N-CA 121.948 1.765 . . . . 0.0 112.977 -169.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -176.05 148.88 0.85 Allowed 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 103.609 -2.738 . . . . 0.0 103.609 178.466 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -110.84 168.63 4.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 CA-C-N 119.718 1.145 . . . . 0.0 113.973 -169.003 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 95.4 145.85 19.68 Favored Glycine 0 C--N 1.34 0.78 0 N-CA-C 106.022 -2.831 . . . . 0.0 106.022 -168.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -73.66 163.54 27.86 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 119.339 1.569 . . . . 0.0 110.379 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 43.0 p -73.06 168.39 25.23 Favored Pre-proline 0 CA--C 1.539 0.54 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 168.391 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -57.13 -35.65 98.96 Favored 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 121.532 1.488 . . . . 0.0 111.185 172.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 99.0 m -66.93 -33.27 75.22 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 124.401 1.081 . . . . 0.0 111.293 -178.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 84.4 t -103.82 -27.55 3.17 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 CA-C-N 118.329 0.513 . . . . 0.0 111.608 -172.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -52.78 -49.28 65.87 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 119.346 0.975 . . . . 0.0 109.27 169.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -62.02 -19.59 63.02 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 4.0 mmm -80.63 -7.4 59.27 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-O 118.436 -0.792 . . . . 0.0 112.4 -179.121 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 71.4 mt -55.69 -51.99 52.97 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.235 0 CA-C-N 119.147 0.885 . . . . 0.0 109.072 172.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -71.36 -43.63 12.57 Favored Pre-proline 0 CA--C 1.535 0.38 0 CA-C-O 116.794 -1.574 . . . . 0.0 113.531 -169.052 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -55.95 -42.82 62.92 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 CA-C-N 121.994 1.748 . . . . 0.0 111.199 169.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.07 -40.09 94.18 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-O 119.004 -0.522 . . . . 0.0 111.959 178.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 74.1 mt -60.32 -45.91 91.74 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 119.589 1.086 . . . . 0.0 108.82 174.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -57.73 -35.28 70.48 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 118.74 0.7 . . . . 0.0 110.687 175.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.62 -44.42 93.98 Favored 'General case' 0 N--CA 1.446 -0.635 0 O-C-N 121.589 -0.695 . . . . 0.0 111.522 173.529 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 63.8 t -57.87 -46.04 87.41 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 N-CA-C 108.245 -1.021 . . . . 0.0 108.245 175.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 13.9 mt -57.9 -42.63 85.12 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 119.439 1.018 . . . . 0.0 110.072 178.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -68.72 -44.44 73.88 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 118.481 -0.771 . . . . 0.0 111.216 -178.014 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -64.62 -32.5 74.19 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 119.702 1.137 . . . . 0.0 110.811 178.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 80.2 mt -64.11 -47.94 78.04 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 170.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 70.9 mtp85 -62.92 -20.91 65.64 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 117.943 -1.027 . . . . 0.0 112.598 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 91.5 mt-10 -63.07 -36.39 83.41 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 120.475 1.489 . . . . 0.0 110.423 173.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 46.4 m -88.87 13.68 12.12 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.511 0.724 . . . . 0.0 111.668 170.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 70.4 21.82 77.53 Favored Glycine 0 CA--C 1.524 0.629 0 CA-C-O 117.877 -1.513 . . . . 0.0 112.434 -177.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 61.4 t -97.05 123.0 49.16 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 CA-C-N 120.089 1.944 . . . . 0.0 105.957 -175.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -105.18 97.15 7.04 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 177.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -58.95 137.12 58.02 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 168.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . 0.412 ' CG2' ' HA ' ' A' ' 160' ' ' SER . 35.4 mm -98.67 122.72 52.31 Favored Pre-proline 0 N--CA 1.461 0.095 0 CA-C-O 117.641 -1.171 . . . . 0.0 108.874 -170.515 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -63.27 105.99 0.53 Allowed 'Trans proline' 0 CA--C 1.534 0.484 0 C-N-CA 122.018 1.812 . . . . 0.0 109.024 171.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 55.8 mtm180 38.94 50.02 1.66 Allowed 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 126.452 1.901 . . . . 0.0 113.509 178.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' SER . . . . . 0.412 ' HA ' ' CG2' ' A' ' 157' ' ' ILE . 35.1 p . . . . . 0 CA--C 1.546 0.793 0 C-N-CA 127.068 2.147 . . . . 0.0 115.633 -179.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 29.4 ptt-85 . . . . . 0 N--CA 1.477 0.89 0 CA-C-O 119.186 -0.435 . . . . 0.0 109.96 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 3.6 mt -130.86 139.24 51.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 C-N-CA 123.412 0.685 . . . . 0.0 110.068 -169.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.7 mt -112.44 143.18 44.0 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 104.805 -2.294 . . . . 0.0 104.805 167.064 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 67.1 t -123.45 97.89 5.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 102.276 -3.231 . . . . 0.0 102.276 171.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.3 tt -106.53 109.7 21.7 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 -167.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -91.86 138.59 14.32 Favored Glycine 0 N--CA 1.443 -0.865 0 N-CA-C 108.206 -1.958 . . . . 0.0 108.206 176.234 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -148.05 167.26 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.612 0 C-N-CA 123.16 0.584 . . . . 0.0 109.429 -179.548 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 130.95 156.51 8.57 Favored Glycine 0 C--N 1.335 0.496 0 N-CA-C 108.723 -1.751 . . . . 0.0 108.723 170.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.554 ' ND2' ' H ' ' A' ' 12' ' ' LEU . 6.6 t30 -75.45 103.75 5.72 Favored 'General case' 0 N--CA 1.454 -0.265 0 O-C-N 121.042 -1.27 . . . . 0.0 109.473 -174.629 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 26.1 pt -58.06 -15.59 5.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 N-CA-C 115.032 1.493 . . . . 0.0 115.032 -173.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.554 ' H ' ' ND2' ' A' ' 10' ' ' ASN . 5.2 mp -89.01 -6.11 57.44 Favored 'General case' 0 C--O 1.216 -0.683 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 -171.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.5 mp -102.45 53.2 0.79 Allowed 'General case' 0 N--CA 1.434 -1.251 0 C-N-CA 124.143 0.977 . . . . 0.0 109.147 -172.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.258 0.1 OUTLIER 49.91 -107.37 0.26 Allowed 'General case' 0 N--CA 1.44 -0.952 0 CA-C-N 113.901 -1.5 . . . . 0.0 110.677 174.896 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -76.51 -6.27 51.12 Favored 'General case' 0 N--CA 1.439 -0.997 0 O-C-N 122.075 -0.391 . . . . 0.0 111.544 -171.023 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -71.94 -4.67 29.71 Favored 'General case' 0 CA--C 1.546 0.809 0 O-C-N 121.131 -0.98 . . . . 0.0 111.874 169.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -80.14 -15.18 57.64 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-O 116.187 -1.863 . . . . 0.0 109.748 169.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 7.0 tp -53.92 -42.02 51.72 Favored 'Isoleucine or valine' 0 C--N 1.342 0.252 0 CA-C-N 121.561 1.982 . . . . 0.0 112.655 -169.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -63.81 -43.45 97.66 Favored Glycine 0 C--N 1.334 0.435 0 CA-C-N 119.295 0.952 . . . . 0.0 111.716 178.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 97.7 t -64.56 -48.95 82.78 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 173.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 27.4 mmm180 -63.51 -31.41 72.56 Favored 'General case' 0 N--CA 1.467 0.404 0 O-C-N 120.433 -1.417 . . . . 0.0 112.678 -177.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 30.0 mt -60.52 -43.92 95.4 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 CA-C-N 120.446 1.476 . . . . 0.0 109.754 173.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.2 m -76.74 -27.79 17.01 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 CA-C-N 120.179 1.354 . . . . 0.0 111.806 -177.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 60.3 mt-10 -70.19 -41.27 73.95 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 175.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -69.03 -40.67 78.49 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-O 119.163 -0.446 . . . . 0.0 110.795 -179.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 5.7 tp -65.35 -42.2 93.07 Favored 'General case' 0 C--O 1.224 -0.283 0 CA-C-N 119.118 0.872 . . . . 0.0 110.233 178.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -62.6 -40.43 96.88 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 119.003 0.82 . . . . 0.0 110.669 179.211 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -71.15 -38.81 72.19 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 122.601 0.36 . . . . 0.0 111.686 177.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 31.4 mtp180 -92.67 -40.41 10.75 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 117.509 -1.234 . . . . 0.0 113.663 -169.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -117.18 123.82 47.61 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 121.074 1.761 . . . . 0.0 111.73 -170.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 50.0 mm -83.32 141.19 15.2 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 N-CA-C 106.372 -1.714 . . . . 0.0 106.372 169.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 17.8 mt -135.8 155.77 77.78 Favored Pre-proline 0 CA--C 1.539 0.523 0 C-N-CA 124.711 1.204 . . . . 0.0 110.153 -169.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_exo -57.88 157.72 23.31 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 123.612 2.875 . . . . 0.0 112.727 171.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -63.82 -30.21 71.33 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -169.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 11.7 p90 -73.13 -5.27 38.04 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 118.706 -0.664 . . . . 0.0 112.346 178.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 12.0 t -101.32 130.06 51.42 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 174.199 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -119.3 132.04 55.83 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 172.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -99.28 123.69 52.12 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 N-CA-C 104.759 -2.311 . . . . 0.0 104.759 169.059 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 5.8 tt -127.56 138.25 52.84 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 119.302 0.955 . . . . 0.0 110.816 -178.122 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -100.58 119.01 37.9 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 169.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -72.4 -24.28 76.56 Favored Glycine 0 CA--C 1.535 1.336 0 CA-C-O 118.683 -1.065 . . . . 0.0 112.752 177.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 66.91 75.54 0.45 Allowed Glycine 0 CA--C 1.529 0.92 0 CA-C-N 118.409 1.105 . . . . 0.0 112.063 173.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . 0.272 17.7 p 55.05 30.79 14.89 Favored 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 125.359 1.464 . . . . 0.0 112.862 176.26 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -76.91 -68.39 0.61 Allowed 'General case' 0 C--N 1.344 0.367 0 N-CA-C 114.701 1.371 . . . . 0.0 114.701 -169.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 74.91 -89.36 0.77 Allowed Glycine 0 CA--C 1.527 0.784 0 N-CA-C 108.463 -1.855 . . . . 0.0 108.463 -168.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 9.9 tpt -76.51 -22.42 54.46 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 125.051 1.34 . . . . 0.0 112.915 -173.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -66.19 -7.49 18.43 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 113.372 0.879 . . . . 0.0 113.372 -168.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 14.6 mt -84.12 4.09 31.92 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 121.622 -0.674 . . . . 0.0 112.76 -170.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -73.92 80.4 1.66 Allowed 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 125.078 2.371 . . . . 0.0 110.856 -177.605 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 141.54 -35.59 1.79 Allowed Glycine 0 C--N 1.309 -0.931 0 CA-C-N 109.676 -3.42 . . . . 0.0 111.073 169.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -69.17 -41.86 76.67 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-N 117.534 0.667 . . . . 0.0 109.87 -175.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 2.6 ptt? -88.84 1.88 54.56 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 115.449 -0.796 . . . . 0.0 112.176 -172.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -79.09 164.33 24.38 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 123.917 0.887 . . . . 0.0 111.257 -177.093 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 58.01 39.08 26.76 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.773 1.629 . . . . 0.0 113.883 168.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 9.5 mmt180 -109.22 153.45 23.79 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -81.25 -24.87 37.04 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 175.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -145.31 143.12 30.0 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 177.68 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 14.1 tp -140.56 126.23 19.14 Favored 'General case' 0 CA--C 1.505 -0.784 0 N-CA-C 106.016 -1.846 . . . . 0.0 106.016 168.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 36.1 mt -104.12 103.78 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 N-CA-C 103.753 -2.684 . . . . 0.0 103.753 172.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 12.9 mt -77.43 135.25 26.82 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 N-CA-C 105.053 -2.203 . . . . 0.0 105.053 171.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -118.56 120.55 37.83 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 105.604 -1.999 . . . . 0.0 105.604 169.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -156.25 167.14 31.36 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 122.875 0.47 . . . . 0.0 110.017 176.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -78.14 154.41 31.24 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 169.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 13.1 mm -78.8 -48.11 22.33 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.46 0 CA-C-O 118.754 -0.641 . . . . 0.0 110.595 -177.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.1 t 49.17 31.15 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.094 0 C-N-CA 126.7 2.0 . . . . 0.0 113.43 177.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 50.8 m -122.14 -25.81 4.83 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 116.291 1.96 . . . . 0.0 116.291 -169.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -149.21 156.98 42.97 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 120.564 1.529 . . . . 0.0 110.803 -172.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.18 33.41 0.13 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.906 1.683 . . . . 0.0 113.791 177.12 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 46.5 t30 -65.74 164.59 14.29 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 108.523 -0.918 . . . . 0.0 108.523 170.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 5.5 m -58.33 132.74 84.81 Favored Pre-proline 0 CA--C 1.545 0.77 0 CA-C-O 118.951 -0.547 . . . . 0.0 109.612 -178.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -61.42 156.19 47.96 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 122.742 2.294 . . . . 0.0 111.755 175.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 67.92 19.17 71.41 Favored Glycine 0 CA--C 1.535 1.324 0 CA-C-O 119.348 -0.696 . . . . 0.0 113.506 176.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 5.0 m -95.65 143.49 26.88 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 125.431 1.492 . . . . 0.0 108.505 178.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 14.7 ttp -91.64 135.48 33.84 Favored 'General case' 0 C--N 1.339 0.151 0 C-N-CA 123.178 0.591 . . . . 0.0 109.809 178.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 74.5 mmm -128.0 93.18 3.61 Favored 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 -169.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 44.2 mm -89.54 114.68 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 -177.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.8 mp -117.18 135.26 53.91 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 -177.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 40.4 ttm180 -102.92 135.87 43.79 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 123.276 0.63 . . . . 0.0 109.689 -176.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 17.4 t70 33.38 -97.91 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 115.734 1.753 . . . . 0.0 115.734 169.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -60.74 -26.72 67.41 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.514 1.125 . . . . 0.0 113.592 -174.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 -73.79 -25.17 60.0 Favored 'General case' 0 CA--C 1.533 0.311 0 O-C-N 122.023 -0.423 . . . . 0.0 110.483 -177.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 94.7 t -68.11 -62.38 3.25 Favored Pre-proline 0 N--CA 1.443 -0.823 0 CA-C-O 117.835 -1.079 . . . . 0.0 111.155 -168.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -63.69 -33.81 64.93 Favored 'Trans proline' 0 N--CA 1.448 -1.194 0 CA-C-N 121.266 1.488 . . . . 0.0 110.797 178.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.18 -21.22 65.8 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.189 0.596 . . . . 0.0 111.656 -175.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -82.71 -49.56 9.65 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 169.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -60.63 -11.51 7.49 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 113.659 0.985 . . . . 0.0 113.659 -172.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 19.3 p -55.45 -23.92 28.05 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 119.488 1.04 . . . . 0.0 112.81 170.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . 0.522 ' ND2' ' H ' ' A' ' 91' ' ' SER . 5.6 t30 -59.53 128.23 36.01 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 122.943 0.497 . . . . 0.0 110.47 -174.472 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 66.2 mttt -81.28 -16.01 53.8 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 118.516 -0.754 . . . . 0.0 112.719 -175.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.505 ' HB ' HD22 ' A' ' 88' ' ' ASN . 83.6 mt -64.85 -40.44 89.08 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 178.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.522 ' H ' ' ND2' ' A' ' 88' ' ' ASN . 1.5 m -66.43 110.36 4.7 Favored Pre-proline 0 CA--C 1.544 0.743 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 169.48 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_exo -72.82 -47.92 0.32 Allowed 'Trans proline' 0 C--N 1.349 0.585 0 CA-C-N 121.358 1.521 . . . . 0.0 113.155 -169.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 21.5 m80 -91.95 -30.16 16.26 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 123.725 0.81 . . . . 0.0 110.072 -169.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 19.9 mp0 -63.68 -28.18 69.72 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 125.926 1.69 . . . . 0.0 110.192 179.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 60.7 tp -60.4 -36.35 77.91 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 118.986 0.812 . . . . 0.0 111.092 172.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -65.61 -40.96 96.26 Favored Glycine 0 CA--C 1.529 0.954 0 N-CA-C 110.891 -0.884 . . . . 0.0 110.891 173.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -66.42 -35.17 79.64 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 118.157 0.979 . . . . 0.0 110.534 176.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -56.57 -44.39 80.95 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 119.827 1.194 . . . . 0.0 109.912 171.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -71.08 -23.59 62.15 Favored 'General case' 0 N--CA 1.457 -0.111 0 CA-C-O 118.599 -0.715 . . . . 0.0 112.443 176.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 91.2 t -65.45 -46.66 89.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 CA-C-N 120.223 1.374 . . . . 0.0 107.566 169.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 65.9 mt -61.68 -38.78 89.05 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 118.73 0.696 . . . . 0.0 110.058 -179.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 21.3 m -61.93 -42.58 99.27 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 118.654 0.661 . . . . 0.0 110.749 171.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.405 ' HA ' ' CD2' ' A' ' 106' ' ' PHE . . . -64.77 -39.36 93.48 Favored 'General case' 0 N--CA 1.449 -0.516 0 O-C-N 121.442 -0.786 . . . . 0.0 111.442 -179.582 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 17.4 mt -70.03 -31.85 69.69 Favored 'General case' 0 CA--C 1.521 -0.135 0 O-C-N 121.727 -0.608 . . . . 0.0 111.039 176.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 29.0 tpt180 -65.14 -37.09 86.32 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 118.56 -0.733 . . . . 0.0 109.645 171.213 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.405 ' CD2' ' HA ' ' A' ' 103' ' ' ALA . 12.9 m-30 -65.69 -42.64 90.97 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 119.403 1.002 . . . . 0.0 110.759 177.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 49.0 p -76.19 -22.01 55.8 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 118.875 0.761 . . . . 0.0 111.781 179.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 77.73 11.56 85.32 Favored Glycine 0 CA--C 1.533 1.19 0 CA-C-O 118.815 -0.992 . . . . 0.0 111.172 -169.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -97.08 23.95 6.8 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 119.104 1.452 . . . . 0.0 111.39 177.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 12.7 t80 -58.43 136.97 85.6 Favored Pre-proline 0 CA--C 1.546 0.791 0 C-N-CA 125.393 1.477 . . . . 0.0 109.319 172.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -56.92 136.72 78.26 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 122.724 2.283 . . . . 0.0 111.866 179.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -66.53 -24.34 66.36 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 111.827 0.306 . . . . 0.0 111.827 -173.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -135.53 95.34 3.24 Favored 'General case' 0 N--CA 1.464 0.225 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 169.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 38.4 tp -81.25 131.87 35.31 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 169.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -132.94 146.09 51.48 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 106.571 -1.64 . . . . 0.0 106.571 171.607 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -131.81 124.27 29.29 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 120.043 1.292 . . . . 0.0 108.374 175.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 44.7 t -92.22 94.8 4.99 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 N-CA-C 105.683 -1.969 . . . . 0.0 105.683 169.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -84.99 156.18 30.87 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.201 -1.159 . . . . 0.0 110.201 175.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 58.1 t -137.44 143.69 33.53 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 174.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 18.1 mm -85.69 129.06 56.25 Favored Pre-proline 0 CA--C 1.541 0.621 0 CA-C-O 118.007 -0.997 . . . . 0.0 108.484 174.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -75.01 154.89 42.75 Favored 'Trans proline' 0 CA--C 1.536 0.611 0 C-N-CA 122.848 2.365 . . . . 0.0 112.389 177.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -100.36 -42.49 6.6 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 169.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 68.6 m -132.65 152.73 51.59 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 123.695 0.798 . . . . 0.0 110.652 175.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.5 tp -148.47 43.64 1.02 Allowed 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.567 0.747 . . . . 0.0 111.178 -172.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -121.57 170.4 7.62 Favored Pre-proline 0 N--CA 1.472 0.67 0 CA-C-O 118.105 -0.95 . . . . 0.0 109.352 -175.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -66.14 89.44 0.25 Allowed 'Trans proline' 0 CA--C 1.546 1.114 0 C-N-CA 123.199 2.599 . . . . 0.0 114.261 -174.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -166.25 128.74 1.93 Allowed 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 105.059 -2.2 . . . . 0.0 105.059 169.718 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -79.91 154.06 4.58 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 C-N-CA 123.626 0.77 . . . . 0.0 109.78 -171.852 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 78.21 166.68 29.41 Favored Glycine 0 CA--C 1.527 0.823 0 N-CA-C 111.326 -0.71 . . . . 0.0 111.326 -179.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -82.64 165.18 20.24 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-O 121.937 0.875 . . . . 0.0 112.459 -169.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 40.7 p -70.48 168.67 17.8 Favored Pre-proline 0 C--O 1.239 0.544 0 CA-C-N 114.123 -1.399 . . . . 0.0 108.813 167.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -56.93 -32.97 94.25 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 121.348 1.365 . . . . 0.0 110.831 169.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 26.2 m -68.12 -41.38 81.82 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 119.213 -0.423 . . . . 0.0 111.47 -179.006 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 16.7 t -105.3 -10.4 9.89 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-N 118.951 0.796 . . . . 0.0 112.105 -169.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -58.95 -45.45 90.42 Favored 'General case' 0 N--CA 1.466 0.346 0 O-C-N 119.929 -1.732 . . . . 0.0 107.768 168.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -70.67 1.47 5.27 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 115.172 -0.922 . . . . 0.0 112.721 176.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 18.0 mmm -92.03 -8.95 44.53 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 119.587 1.085 . . . . 0.0 111.112 172.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 86.8 mt -59.64 -48.31 87.88 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 CA-C-N 119.404 1.002 . . . . 0.0 108.446 176.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -70.5 -50.69 13.83 Favored Pre-proline 0 CA--C 1.535 0.393 0 CA-C-O 117.266 -1.35 . . . . 0.0 113.655 -170.023 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -58.31 -32.73 96.68 Favored 'Trans proline' 0 N--CA 1.459 -0.53 0 CA-C-N 122.214 1.827 . . . . 0.0 112.092 173.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -69.95 -39.53 75.98 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 119.147 0.885 . . . . 0.0 110.749 176.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 71.3 mt -58.04 -44.72 87.55 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 119.897 1.226 . . . . 0.0 109.099 171.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -60.38 -37.22 80.08 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 118.87 -0.586 . . . . 0.0 110.918 -179.37 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 36.1 mm-40 -77.97 -33.1 51.65 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 119.758 1.163 . . . . 0.0 112.921 177.147 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 52.0 t -59.22 -48.67 86.11 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-N 120.107 1.322 . . . . 0.0 108.362 169.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 32.6 mt -64.44 -37.35 87.23 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.028 0.531 . . . . 0.0 110.203 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -62.81 -40.68 98.13 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 118.938 0.79 . . . . 0.0 111.313 177.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -62.85 -41.57 99.41 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 118.87 0.759 . . . . 0.0 110.689 177.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 4.9 mt -63.01 -39.0 93.44 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 123.081 0.553 . . . . 0.0 111.055 174.213 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 72.1 mtp85 -68.34 -14.35 62.93 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 117.081 -1.438 . . . . 0.0 112.27 177.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -58.77 -30.63 67.7 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 120.978 1.717 . . . . 0.0 111.402 178.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 18.3 m -118.4 34.05 5.36 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.568 0.747 . . . . 0.0 111.005 174.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 65.61 27.02 72.2 Favored Glycine 0 C--N 1.342 0.873 0 CA-C-O 118.561 -1.133 . . . . 0.0 114.215 171.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 24.4 t -87.59 83.05 2.15 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 176.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -76.88 117.88 18.92 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 176.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -81.04 157.67 25.36 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 123.264 0.626 . . . . 0.0 109.728 173.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 12.6 mm -109.97 128.08 25.99 Favored Pre-proline 0 CA--C 1.531 0.238 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 179.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -59.36 110.48 0.71 Allowed 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.168 1.912 . . . . 0.0 108.469 169.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 43.1 mtm105 53.65 13.0 0.44 Allowed 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.664 1.586 . . . . 0.0 114.272 174.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 2.6 m . . . . . 0 CA--C 1.543 0.698 0 C-N-CA 124.495 1.118 . . . . 0.0 110.636 -168.287 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 28.2 ptt-85 . . . . . 0 N--CA 1.475 0.787 0 CA-C-O 119.089 -0.482 . . . . 0.0 112.08 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 73.0 mt -133.11 144.61 35.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 C-N-CA 123.553 0.741 . . . . 0.0 109.956 -175.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 9.7 mt -123.29 145.88 48.34 Favored 'General case' 0 CA--C 1.521 -0.139 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 168.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 57.4 t -126.87 95.69 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.797 0 N-CA-C 105.629 -1.989 . . . . 0.0 105.629 172.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.6 mt -87.88 116.71 26.23 Favored 'General case' 0 CA--C 1.517 -0.303 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 -171.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -93.82 127.21 8.96 Favored Glycine 0 C--N 1.332 0.312 0 N-CA-C 106.141 -2.784 . . . . 0.0 106.141 169.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.2 m -142.71 164.61 16.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 117.92 0.86 . . . . 0.0 111.481 -169.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 123.0 173.45 14.08 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 126.014 1.769 . . . . 0.0 111.687 172.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.443 HD21 ' HB2' ' A' ' 13' ' ' LEU . 1.5 t30 -81.83 93.46 6.87 Favored 'General case' 0 N--CA 1.462 0.14 0 O-C-N 121.229 -1.16 . . . . 0.0 110.694 -176.312 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -59.13 5.5 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 N-CA-C 117.262 2.319 . . . . 0.0 117.262 -178.372 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.416 ' H ' ' ND2' ' A' ' 10' ' ' ASN . 80.7 mt -108.67 -0.03 20.35 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 121.518 1.963 . . . . 0.0 109.135 -179.019 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.443 ' HB2' HD21 ' A' ' 10' ' ' ASN . 1.9 mp -110.27 62.77 0.6 Allowed 'General case' 0 N--CA 1.44 -0.948 0 C-N-CA 124.465 1.106 . . . . 0.0 110.122 -169.533 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 53.08 -103.89 0.18 Allowed 'General case' 0 CA--C 1.537 0.446 0 O-C-N 123.766 0.667 . . . . 0.0 111.064 175.166 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -82.71 -8.39 59.6 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 118.513 -0.756 . . . . 0.0 112.462 -175.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -71.75 2.72 4.94 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-N 121.327 1.876 . . . . 0.0 113.015 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -85.01 -13.29 51.03 Favored 'General case' 0 N--CA 1.435 -1.189 0 CA-C-O 116.076 -1.916 . . . . 0.0 108.683 169.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 7.7 tp -50.88 -42.1 22.86 Favored 'Isoleucine or valine' 0 C--N 1.344 0.339 0 CA-C-N 121.671 2.032 . . . . 0.0 113.134 -169.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -61.81 -43.45 99.2 Favored Glycine 0 CA--C 1.527 0.834 0 CA-C-N 119.238 0.926 . . . . 0.0 111.995 177.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 55.6 t -65.38 -48.07 84.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-O 118.649 -0.691 . . . . 0.0 109.855 172.041 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 28.7 mmm180 -57.69 -37.39 73.38 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 120.231 1.378 . . . . 0.0 111.719 -178.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 27.0 mt -63.48 -45.54 97.59 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 CA-C-N 119.987 1.267 . . . . 0.0 110.195 -179.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.9 m -74.29 -27.09 21.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-N 119.985 1.266 . . . . 0.0 111.743 -176.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 19.5 mm-40 -70.41 -41.61 72.73 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 173.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.04 -38.37 90.65 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-O 119.025 -0.512 . . . . 0.0 110.045 177.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.8 tp -62.11 -42.98 99.77 Favored 'General case' 0 C--N 1.343 0.313 0 CA-C-O 118.131 -0.938 . . . . 0.0 109.727 175.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -60.5 -43.74 96.74 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 119.266 0.939 . . . . 0.0 110.678 178.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -66.53 -42.34 87.4 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.017 0.527 . . . . 0.0 110.91 179.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 87.1 mtt180 -88.84 -36.63 15.91 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 117.393 -1.289 . . . . 0.0 113.458 -170.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 72.3 m-85 -125.77 133.29 52.1 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-N 121.076 1.762 . . . . 0.0 112.607 -169.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 45.7 mm -85.66 129.81 37.38 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 N-CA-C 104.213 -2.514 . . . . 0.0 104.213 168.088 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -119.22 157.58 50.7 Favored Pre-proline 0 CA--C 1.537 0.444 0 C-N-CA 124.883 1.273 . . . . 0.0 108.902 -179.107 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_exo -57.97 155.46 33.35 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 123.259 2.639 . . . . 0.0 112.064 172.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -62.23 -28.21 69.53 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 112.937 0.717 . . . . 0.0 112.937 -170.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 8.3 p90 -73.98 -6.35 46.88 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 113.097 0.777 . . . . 0.0 113.097 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 38.2 t -102.96 133.51 46.56 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 174.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -132.45 136.34 46.65 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 169.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -88.67 101.55 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.035 0 N-CA-C 105.107 -2.182 . . . . 0.0 105.107 169.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.5 tt -85.57 112.44 20.95 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 106.784 -1.562 . . . . 0.0 106.784 -178.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -77.78 106.42 9.6 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 169.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -69.92 -80.62 0.27 Allowed Glycine 0 CA--C 1.528 0.875 0 N-CA-C 108.231 -1.948 . . . . 0.0 108.231 171.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 77.21 107.61 0.15 Allowed Glycine 0 C--N 1.341 0.848 0 N-CA-C 110.165 -1.174 . . . . 0.0 110.165 -178.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 5.2 p 52.39 57.98 5.87 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.416 1.086 . . . . 0.0 109.333 175.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -113.14 -88.31 0.55 Allowed 'General case' 0 C--N 1.345 0.411 0 CA-C-N 114.685 -1.143 . . . . 0.0 110.735 -169.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 75.09 -93.1 0.85 Allowed Glycine 0 C--N 1.34 0.778 0 N-CA-C 107.596 -2.202 . . . . 0.0 107.596 -169.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.68 -23.27 60.86 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.585 1.154 . . . . 0.0 113.498 -173.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -67.66 -7.24 25.14 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -169.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 26.0 mt -93.76 -12.91 28.09 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 115.475 1.657 . . . . 0.0 115.475 -168.151 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 5.1 tt -45.31 -61.03 1.83 Allowed 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 113.941 1.089 . . . . 0.0 113.941 -169.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -70.21 -35.42 70.25 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 111.255 -0.738 . . . . 0.0 111.255 -170.091 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -77.54 -29.84 52.49 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 118.068 0.934 . . . . 0.0 110.271 -175.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 69.6 mtp -67.34 -16.63 64.36 Favored 'General case' 0 N--CA 1.454 -0.254 0 O-C-N 121.822 -0.549 . . . . 0.0 111.683 175.13 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -63.14 140.97 58.93 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-O 121.926 0.87 . . . . 0.0 112.873 -169.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 53.53 20.39 2.07 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 117.261 2.319 . . . . 0.0 117.261 168.729 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 23.5 mmt180 -71.55 150.36 44.84 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 121.003 1.729 . . . . 0.0 108.5 176.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -79.96 -29.26 39.6 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 121.677 -0.639 . . . . 0.0 109.37 -178.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -147.81 137.25 22.42 Favored 'General case' 0 C--O 1.232 0.161 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 167.372 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.8 tp -126.59 130.73 51.07 Favored 'General case' 0 CA--C 1.515 -0.374 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 175.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 50.0 mt -105.66 120.1 55.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 105.803 -1.925 . . . . 0.0 105.803 173.004 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 7.9 mt -95.98 128.94 46.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 105.15 -2.167 . . . . 0.0 105.15 175.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -113.19 113.5 25.43 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 105.297 -2.112 . . . . 0.0 105.297 169.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.5 t0 -147.78 157.85 43.74 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.422 0.689 . . . . 0.0 110.217 -174.043 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -75.41 158.06 33.25 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 168.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 27.2 mm -95.4 -85.13 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.639 179.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . 0.385 0.3 OUTLIER 55.47 11.56 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 126.388 1.875 . . . . 0.0 114.549 -169.471 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 5.3 m -74.07 -23.61 59.39 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 124.469 1.108 . . . . 0.0 113.684 -178.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 34.1 ttpt -150.23 161.16 42.96 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.149 0.98 . . . . 0.0 108.781 -171.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 14.5 ptpt -65.55 4.49 0.55 Allowed 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 127.347 2.259 . . . . 0.0 115.177 176.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 54.1 t30 -62.9 155.22 27.82 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 119.114 0.87 . . . . 0.0 109.539 -177.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 4.3 m -56.05 137.67 73.23 Favored Pre-proline 0 CA--C 1.545 0.762 0 C-N-CA 124.34 1.056 . . . . 0.0 113.532 -169.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -58.28 155.54 34.6 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 123.668 2.912 . . . . 0.0 111.708 169.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 64.88 24.76 70.23 Favored Glycine 0 CA--C 1.533 1.214 0 O-C-N 121.852 -0.53 . . . . 0.0 112.684 176.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 20.0 m -102.58 137.11 41.25 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 125.816 1.646 . . . . 0.0 106.706 173.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 28.3 ttp -91.8 136.74 32.92 Favored 'General case' 0 C--O 1.232 0.159 0 N-CA-C 107.629 -1.248 . . . . 0.0 107.629 175.079 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 6.4 ttm -124.95 87.01 2.64 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 -169.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 40.4 mm -83.13 117.64 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 57.1 mt -128.55 141.28 51.42 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 123.197 0.599 . . . . 0.0 109.544 -174.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.8 mtt85 -113.88 138.67 50.0 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 123.329 0.652 . . . . 0.0 109.873 -172.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 38.2 t70 38.91 -106.69 0.05 Allowed 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.833 1.253 . . . . 0.0 113.867 169.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -56.8 -29.82 63.1 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.071 1.349 . . . . 0.0 113.923 -175.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -71.25 -25.55 62.52 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 122.881 0.472 . . . . 0.0 110.238 -176.111 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 84.7 t -70.8 -61.92 2.22 Favored Pre-proline 0 N--CA 1.443 -0.812 0 CA-C-O 117.548 -1.215 . . . . 0.0 111.368 -168.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -65.55 -35.57 37.74 Favored 'Trans proline' 0 N--CA 1.452 -0.957 0 CA-C-N 121.384 1.53 . . . . 0.0 111.155 -178.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.1 -36.22 79.42 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 122.572 0.349 . . . . 0.0 110.634 -173.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -71.91 -44.05 64.31 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 118.867 -0.587 . . . . 0.0 109.698 169.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -55.71 -21.37 18.2 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 -174.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.465 HG21 ' H ' ' A' ' 88' ' ' ASN . 1.7 t -83.95 -76.34 0.3 Allowed 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 119.315 0.961 . . . . 0.0 109.895 168.664 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . 0.465 ' H ' HG21 ' A' ' 87' ' ' THR . 46.6 t30 49.45 17.49 0.22 Allowed 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.042 1.337 . . . . 0.0 114.082 -168.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt 50.4 23.92 1.4 Allowed 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.433 1.493 . . . . 0.0 113.421 -171.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 42.9 mt -134.67 -42.99 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 123.879 0.871 . . . . 0.0 110.96 -171.126 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.3 m -64.2 147.05 97.3 Favored Pre-proline 0 CA--C 1.545 0.765 0 CA-C-N 118.893 0.769 . . . . 0.0 112.52 -169.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -79.97 -110.33 0.01 OUTLIER 'Trans proline' 0 CA--C 1.54 0.823 0 C-N-CA 124.218 3.279 . . . . 0.0 109.979 175.088 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 11.7 m80 -59.13 -28.35 66.47 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.773 1.229 . . . . 0.0 112.675 -169.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 22.3 mp0 -57.57 -31.63 66.34 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 126.003 1.721 . . . . 0.0 111.208 175.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 65.9 tp -62.2 -33.86 75.35 Favored 'General case' 0 C--N 1.342 0.253 0 CA-C-N 119.123 0.874 . . . . 0.0 110.54 175.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -64.14 -39.41 97.11 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.616 -0.993 . . . . 0.0 110.616 175.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 19.0 tp -72.88 -33.88 66.34 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 118.332 1.066 . . . . 0.0 110.439 176.022 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -58.09 -46.85 84.81 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 119.752 1.16 . . . . 0.0 109.95 170.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -69.49 -29.25 66.86 Favored 'General case' 0 CA--C 1.522 -0.126 0 C-N-CA 122.618 0.367 . . . . 0.0 111.527 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 10.9 t -64.29 -44.19 97.28 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.785 0 CA-C-O 118.882 -0.58 . . . . 0.0 110.098 170.093 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 52.1 mt -63.07 -39.05 93.56 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 119.274 0.943 . . . . 0.0 110.036 178.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 23.8 m -61.05 -39.49 90.01 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 118.753 0.706 . . . . 0.0 110.19 169.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.512 ' HA ' ' CD2' ' A' ' 106' ' ' PHE . . . -67.44 -38.62 84.8 Favored 'General case' 0 N--CA 1.448 -0.545 0 O-C-N 121.308 -0.87 . . . . 0.0 111.793 -179.048 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -59.47 -41.75 90.45 Favored 'General case' 0 CA--C 1.524 -0.03 0 CA-C-N 118.835 0.743 . . . . 0.0 109.331 172.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 78.3 ttt180 -65.18 -36.2 83.45 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 118.229 -0.891 . . . . 0.0 110.852 177.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.512 ' CD2' ' HA ' ' A' ' 103' ' ' ALA . 15.1 m-30 -61.21 -45.46 94.47 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 119.506 1.048 . . . . 0.0 110.593 178.597 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 14.9 t -82.51 -13.58 56.42 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 122.298 0.239 . . . . 0.0 111.438 -178.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 78.08 27.93 57.22 Favored Glycine 0 CA--C 1.531 1.059 0 N-CA-C 111.623 -0.591 . . . . 0.0 111.623 179.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -110.98 19.36 18.57 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.628 1.171 . . . . 0.0 110.833 -176.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -59.99 137.11 90.83 Favored Pre-proline 0 CA--C 1.544 0.712 0 C-N-CA 123.952 0.901 . . . . 0.0 109.857 -178.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_exo -51.74 144.98 32.55 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 123.069 2.513 . . . . 0.0 112.96 176.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -63.77 -30.71 71.78 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 119.252 -0.404 . . . . 0.0 110.47 -178.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 30.5 mtmm -136.37 138.3 41.45 Favored 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 105.99 -1.856 . . . . 0.0 105.99 169.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 13.9 tp -120.14 134.06 55.35 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 171.007 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -133.41 139.28 46.66 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 177.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 6.2 tp -125.68 128.62 48.09 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 177.229 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 46.4 t -100.18 85.35 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 N-CA-C 104.092 -2.558 . . . . 0.0 104.092 169.214 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -76.86 147.43 33.6 Favored Glycine 0 C--N 1.332 0.327 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 177.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 85.2 t -130.58 138.2 54.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 170.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 2.8 mt -92.44 125.05 57.49 Favored Pre-proline 0 CA--C 1.537 0.447 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -178.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -72.96 158.1 50.28 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 123.835 3.023 . . . . 0.0 112.424 -176.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -99.78 -41.64 7.18 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 171.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 70.5 m -129.78 149.51 51.49 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 123.487 0.715 . . . . 0.0 110.886 178.178 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -155.59 42.79 0.43 Allowed 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 112.951 0.723 . . . . 0.0 112.951 -169.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 81.7 mm-40 -111.19 164.2 15.52 Favored Pre-proline 0 N--CA 1.474 0.726 0 CA-C-O 117.607 -1.187 . . . . 0.0 108.737 179.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -68.25 87.21 0.4 Allowed 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 122.951 2.434 . . . . 0.0 111.919 -179.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -172.7 153.65 2.81 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 104.489 -2.412 . . . . 0.0 104.489 175.47 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -126.34 153.31 34.71 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 CA-C-O 121.956 0.884 . . . . 0.0 112.376 -170.06 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 121.73 127.68 3.4 Favored Glycine 0 CA--C 1.529 0.939 0 N-CA-C 105.497 -3.041 . . . . 0.0 105.497 -169.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 7.0 mp -79.63 151.73 30.4 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 117.67 0.735 . . . . 0.0 109.657 -177.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 62.0 p -69.76 159.07 85.4 Favored Pre-proline 0 C--O 1.237 0.401 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.565 173.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -62.01 -28.9 80.95 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 120.827 1.018 . . . . 0.0 110.014 169.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 24.7 m -63.53 -42.31 98.45 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 118.73 -0.652 . . . . 0.0 111.485 177.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 46.8 t -105.29 -26.61 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-O 118.072 -0.966 . . . . 0.0 112.896 -169.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -52.89 -42.12 65.01 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 120.754 1.615 . . . . 0.0 110.194 169.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -74.43 2.75 8.76 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 113.696 0.999 . . . . 0.0 113.696 -176.134 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 97.7 mmm -87.84 -10.3 51.23 Favored 'General case' 0 N--CA 1.439 -0.996 0 CA-C-O 117.435 -1.269 . . . . 0.0 110.152 169.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 93.6 mt -60.43 -46.18 95.63 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.406 0 CA-C-N 120.955 1.707 . . . . 0.0 109.022 -178.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -71.29 -49.99 11.58 Favored Pre-proline 0 CA--C 1.543 0.71 0 CA-C-N 120.239 1.382 . . . . 0.0 110.959 -179.13 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -41.37 -50.33 4.58 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 125.056 3.837 . . . . 0.0 112.732 168.802 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -73.11 -44.05 60.86 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 114.022 -1.445 . . . . 0.0 110.778 -175.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 34.3 mt -56.01 -41.45 74.9 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-N 118.833 0.742 . . . . 0.0 109.536 175.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -62.13 -35.91 80.17 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 118.853 0.752 . . . . 0.0 110.456 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 19.2 mm100 -78.7 -32.28 46.89 Favored 'General case' 0 N--CA 1.456 -0.127 0 CA-C-O 118.248 -0.882 . . . . 0.0 112.816 175.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 76.3 t -60.21 -47.56 91.63 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-N 119.976 1.262 . . . . 0.0 108.061 170.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 26.6 mt -65.14 -41.02 95.17 Favored 'General case' 0 CA--C 1.528 0.122 0 C-N-CA 122.99 0.516 . . . . 0.0 110.92 -179.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -63.19 -43.59 97.77 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 118.527 0.603 . . . . 0.0 111.163 177.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -64.7 -44.6 89.74 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 122.656 0.383 . . . . 0.0 110.061 179.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 38.9 mt -55.09 -45.2 75.42 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 174.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 73.7 mtp180 -64.97 -18.97 65.73 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 117.711 -1.138 . . . . 0.0 112.965 -177.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -62.15 -32.48 73.09 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 120.767 1.621 . . . . 0.0 110.957 178.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 22.5 m -97.1 28.59 3.5 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.905 0.882 . . . . 0.0 111.458 176.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 70.49 16.64 73.91 Favored Glycine 0 CA--C 1.533 1.185 0 CA-C-O 119.093 -0.837 . . . . 0.0 113.969 173.065 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 39.3 t -79.39 126.01 38.88 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 CA-C-N 118.746 1.273 . . . . 0.0 108.276 -177.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -96.27 128.69 43.42 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 169.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -97.14 147.47 24.03 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 169.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 2.7 mt -115.41 120.66 36.01 Favored Pre-proline 0 N--CA 1.462 0.153 0 N-CA-C 106.636 -1.616 . . . . 0.0 106.636 178.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -61.66 108.03 0.58 Allowed 'Trans proline' 0 N--CA 1.46 -0.472 0 C-N-CA 121.979 1.786 . . . . 0.0 107.625 172.157 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 14.2 ptp180 47.47 7.31 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 129.26 3.024 . . . . 0.0 117.785 -177.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 2.9 t . . . . . 0 CA--C 1.544 0.747 0 C-N-CA 126.114 1.765 . . . . 0.0 112.405 -169.976 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 5.5 ptp85 . . . . . 0 N--CA 1.477 0.918 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 55.1 mt -141.67 145.01 24.98 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 CA-C-N 119.46 1.027 . . . . 0.0 112.037 -169.058 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.1 mt -128.17 123.42 34.3 Favored 'General case' 0 CA--C 1.519 -0.216 0 N-CA-C 106.489 -1.671 . . . . 0.0 106.489 167.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 43.6 t -101.85 98.71 7.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 100.69 -3.819 . . . . 0.0 100.69 169.153 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -104.24 109.24 20.98 Favored 'General case' 0 N--CA 1.442 -0.864 0 C-N-CA 123.873 0.869 . . . . 0.0 109.35 -168.152 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -91.42 126.3 8.39 Favored Glycine 0 N--CA 1.444 -0.831 0 N-CA-C 107.743 -2.143 . . . . 0.0 107.743 174.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -142.38 179.73 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.812 0 C-N-CA 124.133 0.973 . . . . 0.0 108.517 -175.011 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 124.5 157.04 9.61 Favored Glycine 0 N--CA 1.447 -0.589 0 N-CA-C 108.471 -1.852 . . . . 0.0 108.471 -169.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -73.6 96.96 2.54 Favored 'General case' 0 N--CA 1.442 -0.85 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 169.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 4.2 pt -56.7 -30.62 32.82 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.241 0 O-C-N 121.438 -0.789 . . . . 0.0 112.068 -179.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 22.2 mt -77.55 13.93 1.14 Allowed 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 119.036 0.834 . . . . 0.0 110.902 -172.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -136.41 82.07 1.92 Allowed 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 123.284 0.634 . . . . 0.0 111.494 171.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 25.6 m 35.41 -105.94 0.03 OUTLIER 'General case' 0 N--CA 1.437 -1.121 0 O-C-N 126.46 2.35 . . . . 0.0 111.772 167.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -59.46 -28.02 66.61 Favored 'General case' 0 N--CA 1.442 -0.842 0 C-N-CA 124.201 1.0 . . . . 0.0 111.961 -169.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -67.09 -18.05 65.15 Favored 'General case' 0 C--N 1.341 0.212 0 CA-C-N 120.423 1.465 . . . . 0.0 111.786 179.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.58 -10.56 56.66 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-O 116.33 -1.795 . . . . 0.0 110.888 173.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 6.6 tp -55.6 -39.94 57.07 Favored 'Isoleucine or valine' 0 C--N 1.342 0.243 0 CA-C-N 121.976 2.171 . . . . 0.0 111.814 -174.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -59.17 -43.52 97.07 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 111.4 -0.68 . . . . 0.0 111.4 178.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 74.0 t -68.76 -48.32 71.74 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 CA-C-O 118.134 -0.936 . . . . 0.0 109.874 174.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 20.9 mmt180 -60.14 -31.56 70.21 Favored 'General case' 0 C--N 1.346 0.431 0 CA-C-N 120.498 1.499 . . . . 0.0 111.787 -177.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 23.2 mt -60.68 -51.35 74.11 Favored 'Isoleucine or valine' 0 C--N 1.343 0.285 0 CA-C-N 120.86 1.663 . . . . 0.0 109.789 174.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 24.6 m -72.38 -33.97 47.38 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 CA-C-N 119.461 1.028 . . . . 0.0 111.221 -174.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 58.1 mt-10 -59.88 -48.29 82.3 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 171.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.56 -36.8 84.83 Favored 'General case' 0 C--N 1.342 0.263 0 CA-C-N 119.151 0.887 . . . . 0.0 111.08 179.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 5.9 tp -63.19 -40.04 96.36 Favored 'General case' 0 C--O 1.224 -0.253 0 CA-C-N 118.471 0.578 . . . . 0.0 109.566 -178.231 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -60.52 -26.5 66.9 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.595 0.758 . . . . 0.0 112.771 179.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -90.67 -44.35 9.56 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 125.495 1.518 . . . . 0.0 110.886 -178.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 75.4 mtt180 -84.45 -26.61 28.1 Favored 'General case' 0 C--O 1.231 0.086 0 CA-C-O 118.792 -0.623 . . . . 0.0 111.529 -172.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 64.4 m-85 -125.97 146.21 49.96 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-O 121.694 0.759 . . . . 0.0 112.364 -177.318 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 34.0 mm -101.7 135.66 37.3 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 N-CA-C 104.909 -2.256 . . . . 0.0 104.909 169.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -119.0 150.93 49.66 Favored Pre-proline 0 CA--C 1.535 0.371 0 C-N-CA 124.287 1.035 . . . . 0.0 109.988 -169.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -65.76 157.16 60.31 Favored 'Trans proline' 0 CA--C 1.539 0.748 0 C-N-CA 122.43 2.087 . . . . 0.0 110.189 169.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -58.08 -33.2 68.81 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 114.557 1.317 . . . . 0.0 114.557 -169.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -74.72 -11.45 60.17 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -177.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 73.1 t -90.02 123.01 42.01 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 171.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -112.36 127.01 55.89 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 169.234 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -91.77 116.07 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 N-CA-C 104.422 -2.436 . . . . 0.0 104.422 168.294 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 59.6 tp -117.57 128.25 54.76 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 118.207 0.458 . . . . 0.0 110.675 -178.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -87.73 117.25 26.43 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 168.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -71.59 -65.31 2.45 Favored Glycine 0 CA--C 1.528 0.871 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 176.292 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 84.33 84.61 0.94 Allowed Glycine 0 C--N 1.343 0.937 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 177.137 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 27.6 p 61.38 20.11 10.82 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 125.118 1.367 . . . . 0.0 113.471 -179.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -76.73 -65.78 0.9 Allowed 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 114.875 1.435 . . . . 0.0 114.875 -168.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 56.78 -108.61 1.28 Allowed Glycine 0 CA--C 1.536 1.349 0 N-CA-C 111.416 -0.674 . . . . 0.0 111.416 -176.167 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 13.2 tpt -59.67 -23.58 63.2 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.968 1.307 . . . . 0.0 112.43 -178.239 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 21.3 mm-40 -60.33 -18.79 52.29 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 113.539 0.941 . . . . 0.0 113.539 -178.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 13.3 mt -99.52 22.25 11.05 Favored 'General case' 0 C--N 1.344 0.35 0 N-CA-C 114.728 1.381 . . . . 0.0 114.728 -168.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 6.7 tt -52.19 -58.17 7.43 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 118.856 0.753 . . . . 0.0 111.15 -178.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -68.76 -33.24 75.28 Favored Glycine 0 CA--C 1.529 0.959 0 N-CA-C 111.338 -0.705 . . . . 0.0 111.338 -178.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -74.73 -38.53 62.26 Favored 'General case' 0 CA--C 1.533 0.299 0 O-C-N 122.081 -0.658 . . . . 0.0 112.058 -173.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 12.9 mtp -76.65 -17.76 58.96 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.568 0.747 . . . . 0.0 111.553 -179.037 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.64 151.97 45.27 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 123.533 0.733 . . . . 0.0 112.433 -169.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 16.7 p30 50.23 13.93 0.13 Allowed 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 128.379 2.671 . . . . 0.0 117.507 169.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 35.8 mmt-85 -70.31 157.24 38.09 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 119.499 1.045 . . . . 0.0 108.474 171.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.01 -46.34 18.37 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 178.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -128.26 149.27 50.55 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-N 120.116 1.325 . . . . 0.0 108.66 169.125 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 16.1 tp -135.46 112.38 10.24 Favored 'General case' 0 CA--C 1.506 -0.719 0 N-CA-C 103.723 -2.695 . . . . 0.0 103.723 177.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 46.6 mt -91.94 110.1 22.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 104.811 -2.292 . . . . 0.0 104.811 172.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 7.3 mt -81.79 135.22 25.43 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 N-CA-C 107.0 -1.482 . . . . 0.0 107.0 170.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -122.66 118.24 27.67 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 102.733 -3.062 . . . . 0.0 102.733 167.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 51.5 t0 -158.51 155.75 29.0 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 125.149 1.38 . . . . 0.0 107.399 -179.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -88.45 143.09 27.2 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 169.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 65.2 mt -80.41 -19.66 11.91 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 C-N-CA 125.016 1.326 . . . . 0.0 110.307 -177.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . 0.317 31.3 t 71.29 -38.38 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 C-N-CA 129.818 3.247 . . . . 0.0 114.543 177.713 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 2.7 p -162.42 147.96 12.63 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 120.021 1.282 . . . . 0.0 112.568 169.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 13.8 tppt? -165.51 174.32 10.06 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 128.252 2.621 . . . . 0.0 104.872 169.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 13.2 ptpt -61.24 -26.18 67.58 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 176.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 36.0 t-20 -74.99 165.73 24.79 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.475 0.71 . . . . 0.0 110.522 -173.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 2.4 m -61.27 151.23 77.02 Favored Pre-proline 0 CA--C 1.548 0.876 0 C-N-CA 124.588 1.155 . . . . 0.0 112.704 -169.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -56.94 158.13 18.14 Favored 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 124.21 3.273 . . . . 0.0 113.556 170.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 65.83 7.7 37.24 Favored Glycine 0 CA--C 1.538 1.485 0 CA-C-O 119.59 -0.561 . . . . 0.0 114.272 170.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 5.0 m -87.31 149.92 24.21 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 125.769 1.627 . . . . 0.0 111.513 -169.181 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 31.0 ttp -93.63 140.93 29.05 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 169.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 56.5 mtm -134.88 125.38 26.64 Favored 'General case' 0 C--O 1.232 0.165 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 169.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 37.6 mm -107.44 123.12 62.51 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 -176.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.9 mp -128.74 143.33 50.9 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.875 -171.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 79.4 mtm180 -91.65 175.82 6.76 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 114.867 -1.06 . . . . 0.0 110.431 -175.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -41.07 -53.61 3.0 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 115.861 1.8 . . . . 0.0 115.861 -169.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -87.78 -14.83 38.6 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 113.199 0.815 . . . . 0.0 113.199 -175.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -78.98 -35.4 43.08 Favored 'General case' 0 N--CA 1.456 -0.128 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 -174.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 94.5 t -60.79 -49.34 89.92 Favored Pre-proline 0 CA--C 1.541 0.618 0 CA-C-O 117.397 -1.287 . . . . 0.0 112.267 -176.081 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_exo -55.41 -39.91 88.46 Favored 'Trans proline' 0 CA--C 1.543 0.943 0 C-N-CA 122.091 1.861 . . . . 0.0 112.146 174.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -76.05 -5.37 46.14 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 177.021 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -87.65 -41.4 13.41 Favored 'General case' 0 C--N 1.341 0.213 0 CA-C-N 119.751 1.159 . . . . 0.0 111.34 -178.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -80.22 22.98 0.5 Allowed 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -169.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 24.5 p -58.65 -26.25 63.57 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.237 1.015 . . . . 0.0 111.964 175.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 36.3 t30 -68.32 115.84 8.21 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.142 0.577 . . . . 0.0 109.652 176.062 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 39.3 mttp -88.81 -6.23 57.51 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 113.051 0.76 . . . . 0.0 113.051 -177.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 97.4 mt -58.45 -48.01 86.5 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 177.133 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 3.9 m -67.21 107.61 1.86 Allowed Pre-proline 0 CA--C 1.542 0.669 0 C-N-CA 127.181 2.192 . . . . 0.0 109.397 -173.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -72.47 -56.65 0.09 OUTLIER 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 122.392 2.061 . . . . 0.0 113.015 -168.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 7.2 t-80 -59.88 -43.85 94.53 Favored 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.449 ' CD ' ' H ' ' A' ' 94' ' ' GLN . 16.9 mp0 -61.29 -39.61 91.09 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 125.587 1.555 . . . . 0.0 108.934 -174.255 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 55.2 tp -64.49 -37.49 87.71 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 118.93 0.786 . . . . 0.0 110.704 175.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -65.38 -46.68 85.13 Favored Glycine 0 CA--C 1.529 0.916 0 N-CA-C 110.986 -0.846 . . . . 0.0 110.986 174.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -58.14 -38.6 76.88 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 117.711 0.755 . . . . 0.0 110.115 173.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -66.06 -45.41 81.43 Favored 'General case' 0 C--N 1.333 -0.142 0 O-C-N 120.838 -1.164 . . . . 0.0 111.254 177.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -69.51 -24.75 63.8 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 118.512 0.596 . . . . 0.0 110.574 -179.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -73.91 -37.88 48.8 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.863 0 O-C-N 121.873 -0.517 . . . . 0.0 110.92 172.0 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 29.6 mt -66.1 -36.32 82.86 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 173.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 46.3 m -65.21 -36.38 83.99 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-O 118.344 -0.836 . . . . 0.0 110.319 171.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.97 -41.53 97.51 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 120.476 1.489 . . . . 0.0 110.686 174.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 11.8 mt -64.24 -32.18 73.66 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 118.79 0.723 . . . . 0.0 111.499 173.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 67.1 ttp85 -71.62 -30.74 66.12 Favored 'General case' 0 CA--C 1.532 0.284 0 O-C-N 121.581 -0.699 . . . . 0.0 109.613 176.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 14.8 m-30 -72.09 -46.32 57.22 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 118.877 0.762 . . . . 0.0 110.368 176.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 35.2 p -73.35 -24.14 60.31 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 118.338 0.517 . . . . 0.0 112.009 -177.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 75.93 8.03 84.46 Favored Glycine 0 CA--C 1.534 1.268 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -168.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -84.84 23.25 1.21 Allowed 'General case' 0 C--N 1.349 0.558 0 CA-C-N 119.812 1.806 . . . . 0.0 111.28 171.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -62.18 138.56 96.05 Favored Pre-proline 0 CA--C 1.547 0.844 0 C-N-CA 124.328 1.051 . . . . 0.0 108.933 169.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -61.42 161.53 23.55 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 123.13 2.553 . . . . 0.0 114.683 -176.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -66.21 -35.87 81.57 Favored 'General case' 0 N--CA 1.471 0.58 0 O-C-N 121.803 -0.561 . . . . 0.0 111.664 174.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 17.9 ttmm -138.53 77.59 1.63 Allowed 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 -176.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -69.79 129.18 38.87 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 106.471 -1.678 . . . . 0.0 106.471 170.132 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -130.41 138.89 50.57 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 175.521 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 17.4 tp -119.78 130.09 54.78 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 119.556 1.071 . . . . 0.0 109.115 176.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 13.3 t -102.59 74.88 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 105.44 -2.059 . . . . 0.0 105.44 169.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -78.55 144.74 28.31 Favored Glycine 0 C--N 1.336 0.539 0 N-CA-C 110.547 -1.021 . . . . 0.0 110.547 -174.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 61.5 t -124.57 134.77 65.88 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.275 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 -178.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 40.1 mt -91.01 135.37 28.68 Favored Pre-proline 0 C--N 1.326 -0.449 0 N-CA-C 104.976 -2.231 . . . . 0.0 104.976 169.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -73.28 170.26 20.3 Favored 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 122.008 1.805 . . . . 0.0 111.202 -177.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -89.71 -48.87 6.98 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 168.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 25.1 m -137.31 -34.23 0.72 Allowed 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 116.205 1.928 . . . . 0.0 116.205 -170.002 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 4.3 tp 50.76 50.1 19.65 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.362 1.465 . . . . 0.0 110.495 -168.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -58.84 151.25 55.14 Favored Pre-proline 0 CA--C 1.54 0.577 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 173.152 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -76.37 76.39 3.94 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 122.427 2.085 . . . . 0.0 108.055 169.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . 0.564 ' CD2' ' H ' ' A' ' 128' ' ' ILE . 7.4 t60 -151.47 -167.79 2.9 Favored 'General case' 0 CA--C 1.552 1.028 0 N-CA-C 104.113 -2.551 . . . . 0.0 104.113 175.139 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.564 ' H ' ' CD2' ' A' ' 127' ' ' HIS . 17.5 mt -125.45 -50.2 1.88 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 CA-C-N 123.688 2.949 . . . . 0.0 110.646 -171.145 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -55.73 148.63 26.69 Favored Glycine 0 CA--C 1.53 0.993 0 N-CA-C 111.223 -0.751 . . . . 0.0 111.223 170.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 76.3 mt -70.2 162.64 28.01 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.11 0.964 . . . . 0.0 112.906 -175.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 18.3 p -74.11 164.35 61.83 Favored Pre-proline 0 CA--C 1.543 0.68 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 168.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -62.29 -35.42 73.77 Favored 'Trans proline' 0 CA--C 1.536 0.625 0 C-N-CA 121.259 1.306 . . . . 0.0 112.133 177.037 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 90.7 m -69.16 -37.02 77.99 Favored 'General case' 0 N--CA 1.443 -0.814 0 O-C-N 121.553 -0.717 . . . . 0.0 110.079 -178.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 75.0 t -85.07 -32.16 7.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 O-C-N 121.583 -0.698 . . . . 0.0 109.985 -177.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -54.22 -46.87 72.62 Favored 'General case' 0 CA--C 1.535 0.386 0 O-C-N 121.273 -0.892 . . . . 0.0 109.512 169.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -68.07 -16.51 64.05 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 -179.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 8.9 mmm -79.25 -11.58 59.95 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 125.57 1.548 . . . . 0.0 112.678 173.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 68.2 mt -55.22 -56.37 11.76 Favored 'Isoleucine or valine' 0 C--N 1.346 0.451 0 CA-C-N 120.902 1.683 . . . . 0.0 109.287 174.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -66.42 -46.28 59.42 Favored Pre-proline 0 CA--C 1.548 0.901 0 CA-C-N 119.629 1.104 . . . . 0.0 110.728 -172.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 0.3 OUTLIER -44.11 -52.09 5.99 Favored 'Trans proline' 0 C--N 1.352 0.732 1 C-N-CA 125.606 4.204 . . . . 0.0 112.881 168.665 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -72.75 -35.73 67.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 118.329 -0.843 . . . . 0.0 112.616 -178.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 39.7 mt -60.55 -45.97 91.91 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 120.23 1.377 . . . . 0.0 109.384 174.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 31.8 mm-40 -54.37 -36.07 63.48 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 118.493 0.588 . . . . 0.0 110.371 173.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 1.5 mm100 -78.16 -34.1 49.89 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 179.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 50.7 t -60.33 -46.48 94.91 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 CA-C-N 119.665 1.121 . . . . 0.0 108.025 170.137 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 55.2 mt -61.35 -35.57 77.79 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 119.211 -0.423 . . . . 0.0 110.509 177.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -71.06 -42.46 69.39 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 119.117 0.872 . . . . 0.0 111.45 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -67.96 -30.66 70.0 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 120.068 1.304 . . . . 0.0 111.132 177.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 21.4 mt -63.09 -51.64 65.83 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 169.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 75.6 mtt180 -63.28 -28.62 70.15 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 119.524 1.056 . . . . 0.0 112.288 -178.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -70.52 -18.46 62.95 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 119.056 0.844 . . . . 0.0 111.023 176.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 9.8 m -94.01 8.26 42.08 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.976 1.31 . . . . 0.0 111.04 169.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 72.31 15.1 76.96 Favored Glycine 0 CA--C 1.529 0.908 0 CA-C-O 116.995 -2.003 . . . . 0.0 112.951 -172.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 61.9 t -96.47 119.77 44.95 Favored 'Isoleucine or valine' 0 C--N 1.348 0.536 0 CA-C-N 121.368 2.584 . . . . 0.0 107.482 -176.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -107.49 91.93 3.86 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 107.065 -1.458 . . . . 0.0 107.065 173.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -52.32 144.32 13.14 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.079 169.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 27.1 mm -89.28 124.64 64.17 Favored Pre-proline 0 C--O 1.232 0.16 0 CA-C-O 117.669 -1.158 . . . . 0.0 108.559 -175.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -63.27 103.78 0.38 Allowed 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 122.369 2.046 . . . . 0.0 108.495 170.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 29.0 ttp180 37.46 50.68 1.12 Allowed 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 127.201 2.2 . . . . 0.0 114.157 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . 0.269 3.4 p . . . . . 0 CA--C 1.544 0.744 0 C-N-CA 126.803 2.041 . . . . 0.0 115.657 -179.337 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 23.6 ptt180 . . . . . 0 N--CA 1.475 0.81 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 13.5 mt -140.53 141.01 33.33 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -169.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 17.0 tp -123.05 149.57 44.23 Favored 'General case' 0 N--CA 1.462 0.168 0 N-CA-C 107.216 -1.401 . . . . 0.0 107.216 168.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 66.3 t -123.13 122.87 66.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 105.424 -2.065 . . . . 0.0 105.424 169.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -98.18 130.38 44.93 Favored 'General case' 0 CA--C 1.511 -0.536 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 178.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -105.16 115.9 5.08 Favored Glycine 0 CA--C 1.501 -0.819 0 N-CA-C 104.481 -3.448 . . . . 0.0 104.481 169.487 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 6.8 m -138.46 157.83 30.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 118.933 1.366 . . . . 0.0 111.902 -168.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 130.52 -172.76 20.3 Favored Glycine 0 C--N 1.337 0.591 0 O-C-N 124.454 1.096 . . . . 0.0 111.698 169.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -87.07 85.86 7.26 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 123.54 0.736 . . . . 0.0 111.723 -169.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.3 pt -58.16 29.88 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.555 1.138 0 N-CA-C 116.421 2.008 . . . . 0.0 116.421 171.007 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 72.1 mt -125.96 -3.29 7.05 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 120.979 1.718 . . . . 0.0 108.927 169.371 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.6 mp -119.59 64.15 0.8 Allowed 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 124.212 1.005 . . . . 0.0 110.44 -169.095 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER 51.96 -104.01 0.17 Allowed 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.377 170.74 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -71.21 -16.34 62.5 Favored 'General case' 0 N--CA 1.442 -0.874 0 C-N-CA 124.209 1.004 . . . . 0.0 112.722 -175.47 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -73.76 7.93 2.23 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 120.924 1.693 . . . . 0.0 113.096 -179.757 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -89.66 -15.36 32.81 Favored 'General case' 0 N--CA 1.429 -1.508 0 CA-C-O 115.817 -2.04 . . . . 0.0 107.537 169.374 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 7.1 tp -54.96 -38.65 46.12 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.359 0 CA-C-N 122.329 2.331 . . . . 0.0 112.998 -169.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -59.56 -45.83 94.96 Favored Glycine 0 C--N 1.334 0.464 0 N-CA-C 109.934 -1.266 . . . . 0.0 109.934 176.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 34.3 t -65.85 -46.26 89.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 CA-C-O 118.505 -0.759 . . . . 0.0 110.05 173.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 25.5 mmt180 -62.32 -34.85 77.42 Favored 'General case' 0 C--N 1.346 0.422 0 CA-C-N 120.547 1.522 . . . . 0.0 111.963 -176.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 26.2 mt -61.85 -46.46 96.47 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-N 120.03 1.286 . . . . 0.0 110.137 178.373 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 18.7 m -73.77 -28.59 24.65 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 CA-C-N 119.153 0.888 . . . . 0.0 111.247 -174.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 58.1 mt-10 -70.18 -45.56 66.41 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 174.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.55 -44.59 95.95 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 123.002 0.521 . . . . 0.0 110.108 178.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 7.4 tp -63.45 -40.52 97.35 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 118.438 -0.791 . . . . 0.0 110.982 178.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.7 tm-20 -61.76 -42.38 98.91 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 118.7 0.682 . . . . 0.0 110.489 179.149 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 48.7 mm-40 -71.63 -42.8 67.16 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 122.784 0.434 . . . . 0.0 111.536 179.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 40.4 mmt180 -88.05 -35.44 17.54 Favored 'General case' 0 C--N 1.342 0.264 0 CA-C-O 117.37 -1.3 . . . . 0.0 113.441 -169.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 75.9 m-85 -120.12 137.06 54.37 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-N 121.127 1.785 . . . . 0.0 112.056 -173.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 31.6 mm -89.29 134.12 29.48 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 N-CA-C 105.536 -2.024 . . . . 0.0 105.536 168.269 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -119.5 154.85 54.55 Favored Pre-proline 0 CA--C 1.538 0.494 0 C-N-CA 125.563 1.545 . . . . 0.0 108.858 -172.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -63.87 157.9 49.93 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 122.358 2.039 . . . . 0.0 109.991 169.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -58.6 -31.99 68.57 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 113.619 0.97 . . . . 0.0 113.619 -169.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 53.4 p90 -75.38 -1.26 22.99 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 113.931 1.086 . . . . 0.0 113.931 -177.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 59.5 t -111.1 128.2 67.71 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 176.324 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -129.36 143.84 51.0 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 173.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -110.89 108.36 25.26 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 106.282 -1.748 . . . . 0.0 106.282 176.622 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 8.2 tt -106.88 127.06 53.09 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 -172.433 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -81.76 115.95 21.23 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 124.196 0.998 . . . . 0.0 109.824 176.649 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -77.29 -87.66 0.37 Allowed Glycine 0 CA--C 1.531 1.033 0 N-CA-C 108.762 -1.735 . . . . 0.0 108.762 169.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 77.93 106.88 0.18 Allowed Glycine 0 CA--C 1.53 0.976 0 N-CA-C 110.712 -0.955 . . . . 0.0 110.712 -177.145 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 5.3 p 50.99 57.48 6.61 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.017 1.327 . . . . 0.0 109.489 178.126 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -107.9 -87.75 0.48 Allowed 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 114.88 -1.054 . . . . 0.0 110.222 -169.566 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 73.08 -102.04 1.2 Allowed Glycine 0 C--N 1.339 0.709 0 N-CA-C 107.906 -2.077 . . . . 0.0 107.906 -174.399 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 70.8 mmm -68.24 -23.02 64.75 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 122.914 0.486 . . . . 0.0 112.222 -174.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -64.36 -14.91 59.09 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-O 120.793 0.33 . . . . 0.0 111.014 -177.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 59.4 mt -83.34 -10.0 58.73 Favored 'General case' 0 C--N 1.343 0.32 0 N-CA-C 113.912 1.079 . . . . 0.0 113.912 -172.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.5 tt -47.66 -67.91 0.23 Allowed 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 119.367 0.985 . . . . 0.0 113.577 -169.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -71.4 -26.41 73.41 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 111.339 -0.704 . . . . 0.0 111.339 -171.212 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -78.87 -29.67 44.6 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 122.516 0.326 . . . . 0.0 111.457 -178.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 22.3 mtp -83.7 -28.81 28.03 Favored 'General case' 0 CA--C 1.53 0.176 0 O-C-N 121.936 -0.477 . . . . 0.0 111.352 174.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -59.31 153.67 18.29 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-O 121.707 0.765 . . . . 0.0 110.307 175.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 64.45 -8.45 0.2 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 126.673 1.989 . . . . 0.0 115.314 169.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 24.7 mmt180 -68.41 153.33 43.96 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 170.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 83.8 m-20 -90.19 -34.82 15.67 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 118.991 -0.528 . . . . 0.0 109.952 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 2.0 t-160 -140.24 122.18 15.57 Favored 'General case' 0 CA--C 1.514 -0.414 0 N-CA-C 104.262 -2.495 . . . . 0.0 104.262 -172.138 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 50.0 tp -128.46 131.57 48.4 Favored 'General case' 0 CA--C 1.509 -0.624 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 179.072 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 39.6 mt -109.57 121.94 63.38 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 N-CA-C 105.012 -2.218 . . . . 0.0 105.012 169.665 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 22.1 mt -98.26 125.16 51.63 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 177.501 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -104.21 119.45 38.97 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 171.022 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -147.6 151.46 36.27 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 124.692 1.197 . . . . 0.0 110.736 -172.405 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -88.19 121.31 30.44 Favored 'General case' 0 C--N 1.343 0.298 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 168.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 7.9 mm -54.2 -39.19 41.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 C-N-CA 124.362 1.065 . . . . 0.0 111.797 -173.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . 0.319 6.7 p 43.06 43.03 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.974 0 C-N-CA 126.316 1.846 . . . . 0.0 113.145 175.549 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 4.4 t -157.48 -175.33 5.33 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.946 1.698 . . . . 0.0 109.614 -174.476 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 16.1 tptt 63.29 176.16 0.16 Allowed 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 127.327 2.251 . . . . 0.0 113.433 171.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 9.3 ptpt -103.2 0.44 31.69 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 125.404 1.481 . . . . 0.0 112.978 -178.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 49.5 t30 -73.55 162.35 29.34 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.905 0.882 . . . . 0.0 109.08 -177.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.8 m -58.97 142.86 84.73 Favored Pre-proline 0 CA--C 1.545 0.783 0 C-N-CA 124.068 0.947 . . . . 0.0 111.816 -169.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -55.15 155.17 20.1 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 122.775 2.316 . . . . 0.0 112.167 170.169 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 70.6 4.62 53.44 Favored Glycine 0 CA--C 1.531 1.062 0 CA-C-O 118.655 -1.081 . . . . 0.0 114.859 174.421 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 20.8 m -86.04 147.97 25.95 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 119.849 1.825 . . . . 0.0 110.458 -172.161 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 15.7 ttp -87.88 137.66 32.14 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 123.435 0.694 . . . . 0.0 110.414 175.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 47.0 mtp -129.03 111.46 13.01 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 178.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 42.3 mm -99.03 115.62 40.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 177.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.9 mp -116.43 134.92 54.32 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 -174.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 20.5 mmm180 -104.66 138.86 40.35 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 123.084 0.553 . . . . 0.0 109.931 -177.464 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 38.8 t70 33.95 -100.27 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 115.463 1.653 . . . . 0.0 115.463 169.011 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -61.0 -24.13 65.93 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.789 1.236 . . . . 0.0 113.733 -174.219 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -73.68 -26.54 60.78 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 122.66 0.384 . . . . 0.0 110.568 178.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 49.2 t -72.2 -53.17 6.62 Favored Pre-proline 0 N--CA 1.445 -0.715 0 CA-C-O 116.888 -1.53 . . . . 0.0 110.756 -169.195 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -61.92 -40.15 45.99 Favored 'Trans proline' 0 N--CA 1.448 -1.2 0 CA-C-N 121.992 1.747 . . . . 0.0 110.094 174.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -62.12 -30.35 70.97 Favored 'General case' 0 C--N 1.346 0.414 0 C-N-CA 123.364 0.666 . . . . 0.0 112.38 -174.271 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -68.65 -47.08 67.47 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 171.14 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -64.19 -19.23 65.19 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 -169.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 2.2 p -71.17 -17.79 62.52 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 -177.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 3.4 p30 -59.5 148.93 31.28 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -169.239 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -85.59 -13.54 48.48 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 118.816 -0.611 . . . . 0.0 112.618 -173.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 61.9 mt -70.29 -46.65 70.68 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 -178.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 5.0 m -78.1 119.1 76.04 Favored Pre-proline 0 CA--C 1.54 0.558 0 C-N-CA 124.263 1.025 . . . . 0.0 110.642 -174.285 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -81.96 -39.26 0.18 Allowed 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 121.573 1.515 . . . . 0.0 112.267 -177.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 24.3 m-70 -74.33 -29.67 61.71 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.358 0.663 . . . . 0.0 111.552 -171.194 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 90.6 mt-30 -74.53 -17.5 60.73 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 118.387 -0.816 . . . . 0.0 113.116 -169.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 47.5 tp -59.85 -35.04 73.93 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 119.692 1.133 . . . . 0.0 111.618 -172.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -65.66 -42.43 95.41 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 111.482 -0.647 . . . . 0.0 111.482 175.467 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 27.6 tp -70.29 -33.65 71.81 Favored 'General case' 0 CA--C 1.531 0.223 0 O-C-N 120.91 -1.347 . . . . 0.0 109.945 178.328 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -59.34 -50.33 74.41 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 118.908 0.776 . . . . 0.0 109.724 173.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -70.2 -24.74 63.17 Favored 'General case' 0 N--CA 1.457 -0.101 0 CA-C-O 118.682 -0.675 . . . . 0.0 112.02 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 2.5 t -65.09 -45.35 94.53 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 CA-C-N 119.451 1.023 . . . . 0.0 109.973 169.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 59.7 mt -64.91 -37.87 89.08 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 119.659 1.118 . . . . 0.0 109.705 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 18.6 m -61.92 -40.74 96.54 Favored 'General case' 0 C--O 1.224 -0.238 0 CA-C-N 118.605 0.638 . . . . 0.0 110.107 170.018 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.452 ' HA ' ' CD2' ' A' ' 106' ' ' PHE . . . -66.31 -33.88 76.73 Favored 'General case' 0 N--CA 1.448 -0.553 0 O-C-N 121.168 -0.957 . . . . 0.0 111.067 -179.759 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 6.4 mt -67.86 -34.25 76.32 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-N 118.929 0.786 . . . . 0.0 109.629 175.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 80.0 ttt180 -68.38 -36.43 79.16 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 118.846 -0.597 . . . . 0.0 110.06 172.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.452 ' CD2' ' HA ' ' A' ' 103' ' ' ALA . 15.4 m-30 -65.43 -43.38 90.68 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 119.305 0.957 . . . . 0.0 110.572 178.559 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 41.6 p -74.53 -23.25 58.79 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 118.571 0.623 . . . . 0.0 111.303 177.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 75.18 12.55 83.41 Favored Glycine 0 CA--C 1.531 1.086 0 N-CA-C 110.832 -0.907 . . . . 0.0 110.832 -169.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -96.84 22.16 8.63 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 118.766 1.283 . . . . 0.0 111.235 178.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -58.1 132.87 84.03 Favored Pre-proline 0 CA--C 1.544 0.727 0 C-N-CA 124.964 1.306 . . . . 0.0 109.656 171.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_exo -56.58 150.71 50.62 Favored 'Trans proline' 0 N--CA 1.46 -0.479 0 C-N-CA 123.351 2.701 . . . . 0.0 114.932 -178.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -59.88 -34.57 73.34 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.059 177.193 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 59.2 mttp -134.39 130.4 36.81 Favored 'General case' 0 C--O 1.232 0.16 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 173.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 18.2 tp -118.19 139.15 51.72 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 105.19 -2.152 . . . . 0.0 105.19 168.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -141.39 146.34 36.48 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 105.656 -1.979 . . . . 0.0 105.656 -177.669 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -135.37 136.1 41.22 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 119.729 1.15 . . . . 0.0 109.841 172.815 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 47.6 t -103.61 99.63 8.8 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 N-CA-C 103.61 -2.737 . . . . 0.0 103.61 169.278 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -87.24 145.43 19.74 Favored Glycine 0 N--CA 1.444 -0.825 0 N-CA-C 110.317 -1.113 . . . . 0.0 110.317 176.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 53.2 t -127.35 121.19 56.79 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.497 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 175.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 6.5 mt -71.88 132.48 84.87 Favored Pre-proline 0 CA--C 1.539 0.55 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 173.153 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -73.67 179.35 5.7 Favored 'Trans proline' 0 CA--C 1.541 0.848 0 C-N-CA 122.995 2.463 . . . . 0.0 111.91 179.146 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -115.47 -53.71 2.58 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.488 1.115 . . . . 0.0 110.032 177.446 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 56.1 p -110.25 -65.6 1.14 Allowed 'General case' 0 CA--C 1.535 0.365 0 CA-C-N 119.058 0.845 . . . . 0.0 111.954 -172.632 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 56.29 70.34 0.65 Allowed 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.674 1.99 . . . . 0.0 113.702 176.187 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -128.79 169.83 12.05 Favored Pre-proline 0 CA--C 1.542 0.658 0 CA-C-O 118.331 -0.843 . . . . 0.0 109.421 169.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_exo -65.92 85.21 0.24 Allowed 'Trans proline' 0 CA--C 1.547 1.126 0 C-N-CA 123.617 2.878 . . . . 0.0 113.34 -178.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -175.83 151.18 1.1 Allowed 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 104.404 -2.443 . . . . 0.0 104.404 176.368 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -114.3 161.84 12.83 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 -169.654 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 107.42 141.74 10.11 Favored Glycine 0 CA--C 1.528 0.878 0 N-CA-C 106.85 -2.5 . . . . 0.0 106.85 -169.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 68.7 mt -78.54 158.17 28.62 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 118.645 1.223 . . . . 0.0 108.971 175.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 36.3 p -68.19 164.92 38.05 Favored Pre-proline 0 C--O 1.238 0.462 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 168.304 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -56.69 -33.64 94.17 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 121.477 1.451 . . . . 0.0 110.76 169.334 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 5.9 m -66.48 -43.68 84.73 Favored 'General case' 0 CA--C 1.535 0.37 0 O-C-N 122.201 -0.312 . . . . 0.0 110.183 -178.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 94.4 t -88.48 -28.43 5.37 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 CA-C-N 118.683 0.674 . . . . 0.0 110.075 -172.224 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -55.12 -45.85 75.57 Favored 'General case' 0 CA--C 1.533 0.31 0 O-C-N 120.667 -1.27 . . . . 0.0 107.774 167.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -75.48 18.5 0.22 Allowed 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 114.152 1.167 . . . . 0.0 114.152 176.148 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 25.8 mmm -115.03 -8.44 12.46 Favored 'General case' 0 N--CA 1.437 -1.084 0 C-N-CA 125.743 1.617 . . . . 0.0 107.965 169.215 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 96.3 mt -59.5 -49.65 82.85 Favored 'Isoleucine or valine' 0 C--N 1.346 0.423 0 CA-C-N 120.379 1.445 . . . . 0.0 107.859 174.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -70.71 -53.73 8.97 Favored Pre-proline 0 CA--C 1.536 0.408 0 CA-C-O 117.121 -1.418 . . . . 0.0 109.584 -175.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -38.75 -52.63 2.07 Favored 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 123.876 3.051 . . . . 0.0 113.822 169.113 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -74.19 -45.85 45.78 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.085 -1.416 . . . . 0.0 110.808 -172.137 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -62.28 -36.38 81.89 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-N 118.982 0.81 . . . . 0.0 109.722 179.453 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -64.2 -36.0 82.65 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 177.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 11.9 mm100 -74.56 -31.09 61.98 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-O 117.869 -1.063 . . . . 0.0 112.266 172.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 86.7 t -59.83 -46.25 93.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-N 120.446 1.475 . . . . 0.0 108.154 169.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 74.4 mt -62.68 -41.17 98.95 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 118.714 0.688 . . . . 0.0 110.42 177.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -62.78 -41.04 99.08 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 118.813 0.733 . . . . 0.0 111.0 179.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -66.55 -46.37 76.3 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 177.366 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 78.0 mt -57.76 -37.17 73.16 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 122.514 0.326 . . . . 0.0 110.228 177.391 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 67.6 mtp180 -64.07 -19.09 64.98 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 118.019 -0.991 . . . . 0.0 112.284 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -61.89 -30.12 70.67 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 120.182 1.355 . . . . 0.0 110.546 174.17 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 49.1 m -101.16 31.11 3.79 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.021 1.328 . . . . 0.0 111.447 174.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 66.48 21.5 70.66 Favored Glycine 0 CA--C 1.53 0.974 0 CA-C-O 119.251 -0.749 . . . . 0.0 114.248 169.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 81.6 t -72.74 120.03 20.61 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 CA-C-N 118.572 1.186 . . . . 0.0 107.934 178.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -103.45 94.35 5.43 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 105.744 -1.947 . . . . 0.0 105.744 169.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -74.21 144.14 44.85 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 175.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 9.2 mm -112.04 127.88 26.24 Favored Pre-proline 0 CA--C 1.53 0.191 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -62.6 109.58 0.91 Allowed 'Trans proline' 0 N--CA 1.458 -0.599 0 N-CA-C 107.425 -1.798 . . . . 0.0 107.425 170.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 70.2 ttt-85 56.0 -9.43 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 127.799 2.44 . . . . 0.0 116.809 179.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 4.3 m . . . . . 0 CA--C 1.545 0.764 0 C-N-CA 126.524 1.93 . . . . 0.0 114.742 -169.564 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 28.5 tpt85 . . . . . 0 N--CA 1.469 0.486 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.8 mt -120.21 127.39 75.9 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 -172.01 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 19.4 tp -121.23 138.36 54.26 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 105.256 -2.128 . . . . 0.0 105.256 168.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 92.6 t -124.01 110.58 25.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 -177.178 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -93.73 125.37 38.31 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 -174.367 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -99.58 127.7 9.33 Favored Glycine 0 CA--C 1.508 -0.405 0 N-CA-C 106.17 -2.772 . . . . 0.0 106.17 170.435 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.1 m -138.79 167.15 21.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 117.595 0.697 . . . . 0.0 111.272 -169.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 109.59 169.79 20.27 Favored Glycine 0 CA--C 1.525 0.709 0 C-N-CA 125.973 1.749 . . . . 0.0 110.403 179.099 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.489 HD22 ' HB2' ' A' ' 12' ' ' LEU . 8.7 t30 -87.02 104.95 16.79 Favored 'General case' 0 N--CA 1.452 -0.336 0 O-C-N 121.865 -0.785 . . . . 0.0 110.794 -172.45 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.2 pt -63.67 32.99 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.892 0 N-CA-C 115.501 1.667 . . . . 0.0 115.501 175.036 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.489 ' HB2' HD22 ' A' ' 10' ' ' ASN . 42.4 mt -127.39 0.82 6.32 Favored 'General case' 0 C--O 1.222 -0.386 0 CA-C-N 120.504 1.502 . . . . 0.0 108.14 168.785 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.48 ' HB2' HD21 ' A' ' 10' ' ' ASN . 1.3 mp -118.06 52.28 1.02 Allowed 'General case' 0 N--CA 1.441 -0.916 0 C-N-CA 124.002 0.921 . . . . 0.0 112.074 -168.633 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER 53.8 -108.16 0.41 Allowed 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 122.862 0.465 . . . . 0.0 111.498 171.239 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -57.13 -25.18 58.42 Favored 'General case' 0 C--O 1.224 -0.287 0 CA-C-O 118.209 -0.901 . . . . 0.0 113.009 176.357 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -70.53 -0.03 7.7 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 121.535 1.971 . . . . 0.0 113.542 -177.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -89.0 -16.08 32.57 Favored 'General case' 0 N--CA 1.431 -1.39 0 CA-C-O 115.92 -1.99 . . . . 0.0 108.957 169.389 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 5.9 tp -58.34 -38.0 66.71 Favored 'Isoleucine or valine' 0 C--N 1.342 0.278 0 CA-C-N 122.829 2.559 . . . . 0.0 111.798 -169.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -59.71 -38.83 94.42 Favored Glycine 0 C--N 1.338 0.679 0 N-CA-C 110.572 -1.011 . . . . 0.0 110.572 176.304 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 79.0 t -73.29 -48.44 42.6 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.652 0 CA-C-O 118.641 -0.695 . . . . 0.0 109.452 174.374 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 15.6 mmm180 -59.48 -36.14 75.45 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 120.367 1.439 . . . . 0.0 112.621 -176.421 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 33.6 mt -62.18 -46.7 95.86 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 CA-C-N 120.418 1.463 . . . . 0.0 109.983 179.236 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 10.3 m -72.65 -29.33 30.03 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 O-C-N 121.298 -0.876 . . . . 0.0 110.887 -174.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -70.44 -41.72 72.47 Favored 'General case' 0 CA--C 1.528 0.102 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 175.022 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.41 -37.21 82.65 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-O 118.735 -0.65 . . . . 0.0 110.444 178.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 11.9 tp -62.45 -42.59 99.57 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 118.867 0.758 . . . . 0.0 109.939 174.297 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -62.78 -41.19 99.15 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 118.461 0.573 . . . . 0.0 110.815 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -67.42 -42.69 82.79 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.193 0.997 . . . . 0.0 110.635 179.08 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 88.3 mtt180 -94.43 -38.89 10.72 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 114.837 1.421 . . . . 0.0 114.837 -169.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 63.3 m-85 -113.84 137.68 51.32 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 121.391 1.905 . . . . 0.0 114.207 -169.293 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 47.0 mm -85.68 141.84 13.97 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 N-CA-C 104.382 -2.451 . . . . 0.0 104.382 167.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 46.5 mt -135.98 152.87 76.42 Favored Pre-proline 0 CA--C 1.539 0.55 0 C-N-CA 123.496 0.718 . . . . 0.0 110.518 -169.474 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_exo -59.27 155.2 41.75 Favored 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 123.336 2.691 . . . . 0.0 111.829 169.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -63.01 -31.09 72.14 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -171.232 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 26.1 p90 -70.63 -13.96 62.29 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 118.358 -0.83 . . . . 0.0 112.547 179.149 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 42.7 t -94.91 129.25 45.33 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 C-N-CA 124.114 0.966 . . . . 0.0 108.639 178.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -136.13 146.06 46.53 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-O 121.252 0.548 . . . . 0.0 110.607 170.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -105.28 130.35 56.65 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 N-CA-C 105.648 -1.982 . . . . 0.0 105.648 169.024 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 64.5 tp -121.61 126.41 49.02 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-O 121.311 0.577 . . . . 0.0 109.732 175.088 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -77.87 115.69 17.81 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 169.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -64.58 -64.25 3.71 Favored Glycine 0 CA--C 1.531 1.074 0 N-CA-C 108.225 -1.95 . . . . 0.0 108.225 169.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 79.2 106.0 0.23 Allowed Glycine 0 C--N 1.34 0.793 0 N-CA-C 110.765 -0.934 . . . . 0.0 110.765 171.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . 0.254 40.2 p 50.18 61.18 3.33 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 -173.434 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -89.01 -140.36 0.13 Allowed 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 113.608 -1.633 . . . . 0.0 110.925 -169.304 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 75.93 118.85 0.13 Allowed Glycine 0 CA--C 1.537 1.417 0 N-CA-C 109.031 -1.628 . . . . 0.0 109.031 -168.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 1.6 mmt 61.59 -29.37 0.06 Allowed 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 127.521 2.328 . . . . 0.0 116.411 -173.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -59.47 -21.42 60.06 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 118.998 0.817 . . . . 0.0 112.769 -175.03 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 95.8 mt -91.79 9.63 31.88 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 -171.339 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.5 tt -73.15 79.94 1.26 Allowed 'General case' 0 C--O 1.233 0.213 0 CA-C-O 124.843 2.258 . . . . 0.0 110.827 -179.035 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 145.13 -33.64 1.59 Allowed Glycine 0 C--N 1.308 -0.989 0 CA-C-N 110.142 -3.208 . . . . 0.0 111.028 172.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -68.24 -35.3 77.72 Favored 'General case' 0 N--CA 1.466 0.345 0 O-C-N 121.933 -0.745 . . . . 0.0 111.525 -176.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 38.1 mtp -72.38 0.56 9.79 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.891 1.277 . . . . 0.0 113.151 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -75.63 149.13 38.28 Favored 'General case' 0 N--CA 1.457 -0.087 0 N-CA-C 113.777 1.029 . . . . 0.0 113.777 -169.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 55.26 18.15 2.37 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 128.317 2.647 . . . . 0.0 116.412 168.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 27.1 mmt180 -77.91 149.33 34.24 Favored 'General case' 0 N--CA 1.473 0.698 0 O-C-N 120.798 -1.189 . . . . 0.0 109.416 -178.312 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -80.97 -39.55 25.84 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 177.071 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 1.8 m170 -128.07 136.28 50.99 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 169.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 29.2 tp -130.92 123.72 29.53 Favored 'General case' 0 CA--C 1.505 -0.78 0 N-CA-C 105.851 -1.907 . . . . 0.0 105.851 168.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 18.5 mt -111.35 122.41 65.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 104.657 -2.349 . . . . 0.0 104.657 178.038 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 21.0 mt -102.94 126.56 57.18 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 N-CA-C 105.881 -1.896 . . . . 0.0 105.881 -179.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -111.32 119.09 37.72 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 105.261 -2.126 . . . . 0.0 105.261 171.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -149.1 149.93 31.88 Favored 'General case' 0 C--O 1.24 0.557 0 O-C-N 123.4 0.438 . . . . 0.0 110.202 -175.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -68.64 132.01 46.17 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 104.536 -2.394 . . . . 0.0 104.536 168.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.6 tt -74.95 -38.07 42.58 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.778 0 O-C-N 121.582 -0.699 . . . . 0.0 110.797 -169.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.2 t 45.62 44.43 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.822 0 C-N-CA 125.919 1.688 . . . . 0.0 111.144 176.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 67.2 m -138.75 -73.31 0.39 Allowed 'General case' 0 N--CA 1.471 0.577 0 O-C-N 121.54 -0.725 . . . . 0.0 112.552 -169.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 29.3 ttmt -83.02 154.68 24.33 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 122.758 0.423 . . . . 0.0 109.871 -169.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.32 42.8 1.11 Allowed 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 125.283 1.433 . . . . 0.0 109.033 -172.158 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 40.7 t-20 -89.74 172.47 8.9 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 124.26 1.024 . . . . 0.0 108.915 -171.358 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 10.7 m -60.25 133.95 90.7 Favored Pre-proline 0 CA--C 1.544 0.726 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 179.066 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -57.82 153.66 42.41 Favored 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 122.392 2.061 . . . . 0.0 111.615 174.127 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 71.53 9.38 68.88 Favored Glycine 0 CA--C 1.533 1.163 0 CA-C-O 119.703 -0.498 . . . . 0.0 113.803 176.111 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 29.3 m -89.03 146.56 24.78 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 124.971 1.309 . . . . 0.0 107.545 174.244 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 30.0 ttp -101.78 143.13 32.08 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 175.328 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 17.9 ttm -126.5 126.65 44.08 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 179.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 44.0 mm -107.57 121.19 60.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 -179.108 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -115.71 129.37 56.44 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 -174.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 81.0 mtm180 -90.9 173.45 7.97 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 118.293 0.497 . . . . 0.0 110.288 179.159 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -33.39 -66.15 0.16 Allowed 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 116.215 1.931 . . . . 0.0 116.215 -169.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -77.08 -12.34 59.93 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -172.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 21.6 mm-40 -91.78 -21.95 20.42 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 118.558 -0.734 . . . . 0.0 110.664 -178.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 63.0 t -62.97 -51.13 73.25 Favored Pre-proline 0 C--N 1.344 0.331 0 CA-C-N 120.168 1.349 . . . . 0.0 110.967 -179.111 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -66.65 -37.8 20.52 Favored 'Trans proline' 0 N--CA 1.444 -1.393 0 CA-C-N 121.423 1.544 . . . . 0.0 109.708 -179.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.97 -29.04 69.37 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.298 0.639 . . . . 0.0 111.812 -176.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -68.31 -47.65 67.01 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 169.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -64.63 -11.2 32.71 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 114.041 1.126 . . . . 0.0 114.041 -169.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 24.9 p -66.76 -13.65 61.66 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 113.784 1.031 . . . . 0.0 113.784 -175.281 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -59.29 135.03 57.52 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.362 0.665 . . . . 0.0 110.652 -172.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -87.04 -12.48 47.22 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 -170.394 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 76.2 mt -67.82 -43.55 86.11 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 N-CA-C 107.421 -1.325 . . . . 0.0 107.421 174.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -65.78 130.84 94.57 Favored Pre-proline 0 N--CA 1.445 -0.722 0 C-N-CA 125.802 1.641 . . . . 0.0 110.768 -173.132 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -80.78 -87.55 0.0 OUTLIER 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 123.059 2.506 . . . . 0.0 111.416 177.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 19.4 m80 -66.98 -32.15 73.2 Favored 'General case' 0 N--CA 1.469 0.477 0 O-C-N 120.645 -1.285 . . . . 0.0 110.976 -170.312 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 26.2 mp0 -53.86 -42.65 68.8 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 126.365 1.866 . . . . 0.0 109.93 173.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -70.7 -37.1 73.56 Favored 'General case' 0 N--CA 1.457 -0.117 0 O-C-N 121.571 -0.705 . . . . 0.0 109.671 179.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -59.69 -38.87 94.45 Favored Glycine 0 CA--C 1.53 0.983 0 O-C-N 121.254 -0.904 . . . . 0.0 111.44 171.52 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 24.3 tp -70.19 -28.13 65.06 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 118.37 1.085 . . . . 0.0 110.461 174.423 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -56.23 -46.87 79.38 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 120.141 1.337 . . . . 0.0 109.089 169.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -72.56 -24.21 61.08 Favored 'General case' 0 C--O 1.231 0.08 0 CA-C-O 119.193 -0.432 . . . . 0.0 111.952 -179.163 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 74.2 t -65.45 -46.16 90.82 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 169.19 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 76.1 mt -64.03 -35.28 80.19 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 118.961 0.801 . . . . 0.0 110.433 -179.053 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 19.7 m -63.97 -43.29 96.19 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 118.796 0.725 . . . . 0.0 110.197 170.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -64.9 -41.5 95.54 Favored 'General case' 0 N--CA 1.452 -0.367 0 O-C-N 120.972 -1.08 . . . . 0.0 111.387 -178.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -65.33 -31.58 72.79 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 124.486 1.114 . . . . 0.0 110.318 176.148 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 19.1 tpp180 -70.91 -37.85 72.96 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 118.839 -0.6 . . . . 0.0 109.897 173.58 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 15.2 m-30 -65.44 -42.46 92.4 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 118.773 0.715 . . . . 0.0 110.405 -179.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 31.2 p -74.96 -21.5 59.13 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 118.304 0.502 . . . . 0.0 111.603 178.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 74.34 11.19 82.31 Favored Glycine 0 CA--C 1.534 1.262 0 N-CA-C 111.066 -0.814 . . . . 0.0 111.066 -169.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -83.74 2.27 38.72 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 118.77 1.285 . . . . 0.0 111.944 177.041 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -48.67 134.63 13.69 Favored Pre-proline 0 CA--C 1.549 0.92 0 C-N-CA 125.745 1.618 . . . . 0.0 110.989 177.009 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -52.0 150.02 19.49 Favored 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 124.082 3.188 . . . . 0.0 114.258 179.65 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 31.7 mmmt -63.26 -28.92 70.35 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 118.955 -0.545 . . . . 0.0 111.183 177.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 36.0 ttmt -146.69 110.95 5.1 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 171.226 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 26.2 tp -90.1 144.58 25.76 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 169.119 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -141.45 146.46 36.53 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 171.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -131.4 138.99 49.34 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 120.408 1.458 . . . . 0.0 110.436 172.78 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 43.6 t -105.17 105.93 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 N-CA-C 104.808 -2.293 . . . . 0.0 104.808 168.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -90.07 146.05 18.5 Favored Glycine 0 CA--C 1.522 0.516 0 N-CA-C 110.484 -1.046 . . . . 0.0 110.484 174.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 71.0 t -119.31 138.64 49.32 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 175.575 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 14.4 mm -84.94 128.23 61.3 Favored Pre-proline 0 CA--C 1.543 0.679 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 169.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -70.12 152.3 67.41 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 122.786 2.324 . . . . 0.0 113.365 -176.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -99.58 -42.41 6.92 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 169.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 20.2 m -142.66 151.06 41.02 Favored 'General case' 0 C--N 1.344 0.348 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 176.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.5 tp -153.77 49.61 0.67 Allowed 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 118.719 0.691 . . . . 0.0 111.779 -172.275 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -120.32 168.93 9.45 Favored Pre-proline 0 N--CA 1.477 0.919 0 CA-C-O 117.638 -1.172 . . . . 0.0 110.072 -175.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -62.89 84.3 0.11 Allowed 'Trans proline' 0 CA--C 1.547 1.167 0 C-N-CA 124.138 3.225 . . . . 0.0 113.915 -178.219 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -176.52 156.53 1.52 Allowed 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 105.212 -2.144 . . . . 0.0 105.212 174.527 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -130.54 162.17 39.03 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 CA-C-O 121.772 0.796 . . . . 0.0 110.844 174.817 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 122.36 121.96 2.76 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 103.387 -3.885 . . . . 0.0 103.387 -168.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 74.8 mt -78.86 152.21 31.38 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 -171.108 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 68.6 p -69.8 166.04 35.96 Favored Pre-proline 0 C--O 1.241 0.632 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 169.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -60.21 -27.86 85.73 Favored 'Trans proline' 0 CA--C 1.539 0.727 0 CA-C-N 119.677 0.92 . . . . 0.0 110.466 169.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 5.1 m -69.85 -42.11 73.98 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 118.505 0.593 . . . . 0.0 110.35 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 72.7 t -88.46 -36.6 9.33 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 CA-C-O 119.175 -0.44 . . . . 0.0 110.346 -169.348 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -50.7 -44.59 58.01 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 119.204 0.911 . . . . 0.0 109.938 169.428 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -77.76 5.2 9.92 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 113.789 1.033 . . . . 0.0 113.789 -175.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 75.3 mtp -98.18 -7.28 29.68 Favored 'General case' 0 N--CA 1.439 -1.015 0 CA-C-O 117.387 -1.292 . . . . 0.0 110.59 169.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 94.7 mt -57.67 -47.25 86.06 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 CA-C-N 120.225 1.375 . . . . 0.0 108.391 174.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 58.3 mt-10 -73.56 -48.65 6.83 Favored Pre-proline 0 CA--C 1.542 0.667 0 CA-C-O 117.534 -1.222 . . . . 0.0 110.637 -175.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -43.38 -54.38 3.6 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 124.611 3.541 . . . . 0.0 112.645 168.686 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.35 -42.52 71.73 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 114.788 -1.096 . . . . 0.0 110.755 -174.283 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 33.1 mt -54.69 -44.12 73.09 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-N 118.961 0.8 . . . . 0.0 109.45 173.367 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -64.44 -34.65 78.68 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 119.075 0.852 . . . . 0.0 110.887 -176.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -78.43 -32.8 48.74 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 119.231 0.923 . . . . 0.0 112.021 176.52 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 54.0 t -59.59 -47.99 88.97 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 169.355 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 44.7 mt -64.47 -36.97 85.91 Favored 'General case' 0 CA--C 1.519 -0.244 0 C-N-CA 123.061 0.544 . . . . 0.0 110.67 -178.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -58.18 -36.38 72.98 Favored 'General case' 0 N--CA 1.457 -0.118 0 CA-C-N 118.419 0.554 . . . . 0.0 111.21 179.216 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -63.0 -44.84 94.9 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 117.985 0.357 . . . . 0.0 110.91 177.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 6.2 mp -63.21 -40.26 96.99 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 176.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 87.0 mtt180 -64.81 -18.87 65.5 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 117.411 -1.281 . . . . 0.0 111.759 -179.081 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 69.8 mt-10 -56.26 -30.15 62.05 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 120.53 1.514 . . . . 0.0 112.138 176.359 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 19.4 m -113.38 31.53 6.41 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.294 1.038 . . . . 0.0 111.311 179.211 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 65.42 29.98 76.5 Favored Glycine 0 CA--C 1.531 1.05 0 CA-C-O 118.73 -1.039 . . . . 0.0 113.583 175.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 47.1 t -111.14 103.32 15.29 Favored 'Isoleucine or valine' 0 C--N 1.34 0.175 0 N-CA-C 106.684 -1.599 . . . . 0.0 106.684 176.299 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -100.8 144.87 29.24 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 169.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -78.68 157.5 28.59 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.388 0.675 . . . . 0.0 111.357 177.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 11.7 mt -99.14 112.43 63.09 Favored Pre-proline 0 CA--C 1.532 0.263 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -66.98 104.63 0.86 Allowed 'Trans proline' 0 N--CA 1.458 -0.591 0 N-CA-C 107.942 -1.599 . . . . 0.0 107.942 175.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 69.5 ttt180 57.29 -14.08 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 128.344 2.658 . . . . 0.0 116.98 -178.06 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 2.9 t . . . . . 0 CA--C 1.542 0.667 0 C-N-CA 125.447 1.499 . . . . 0.0 111.047 -169.648 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 7.0 ptp180 . . . . . 0 N--CA 1.48 1.043 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 38.5 mt -142.69 143.8 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-N 119.612 1.096 . . . . 0.0 110.85 -169.104 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 19.7 tp -131.88 109.86 10.39 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 104.168 -2.531 . . . . 0.0 104.168 167.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 39.2 t -85.84 118.72 32.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 102.441 -3.17 . . . . 0.0 102.441 171.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -119.9 105.52 11.17 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-O 121.114 0.483 . . . . 0.0 110.411 -168.673 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -87.46 115.62 4.36 Favored Glycine 0 N--CA 1.447 -0.614 0 N-CA-C 107.651 -2.18 . . . . 0.0 107.651 174.298 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 14.8 m -123.46 -176.38 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.633 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 174.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 111.49 124.71 4.54 Favored Glycine 0 N--CA 1.441 -1.031 0 N-CA-C 106.75 -2.54 . . . . 0.0 106.75 -175.002 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -64.03 109.46 1.82 Allowed 'General case' 0 N--CA 1.442 -0.85 0 C-N-CA 124.284 1.034 . . . . 0.0 109.917 -169.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.3 pt -75.65 37.77 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 C-N-CA 124.642 1.177 . . . . 0.0 113.463 -178.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 20.8 mt -124.24 0.18 8.35 Favored 'General case' 0 CA--C 1.535 0.398 0 O-C-N 121.118 -0.989 . . . . 0.0 108.502 169.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.2 mp -132.56 72.66 1.5 Allowed 'General case' 0 C--N 1.346 0.446 0 N-CA-C 104.895 -2.261 . . . . 0.0 104.895 -173.454 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.583 ' HG1' ' CE1' ' A' ' 127' ' ' HIS . 98.9 m 17.85 -92.84 0.0 OUTLIER 'General case' 0 CA--C 1.522 -0.115 0 C-N-CA 127.091 2.156 . . . . 0.0 115.364 175.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -53.73 -30.74 45.4 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 125.028 1.331 . . . . 0.0 113.003 -169.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -64.61 -31.54 72.81 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 119.592 1.087 . . . . 0.0 111.901 179.513 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.14 -12.55 8.79 Favored 'General case' 0 N--CA 1.437 -1.091 0 CA-C-O 116.187 -1.863 . . . . 0.0 111.277 176.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 5.4 tp -49.55 -42.13 16.68 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.507 0 CA-C-N 121.813 2.097 . . . . 0.0 110.539 179.157 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -66.65 -36.2 90.97 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 111.256 -0.738 . . . . 0.0 111.256 -176.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 69.8 t -67.81 -45.55 84.08 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 172.313 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 20.7 mmt180 -61.53 -29.14 69.81 Favored 'General case' 0 C--O 1.225 -0.201 0 CA-C-O 117.282 -1.342 . . . . 0.0 112.055 178.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 6.3 mm -60.93 -53.11 53.62 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-N 120.682 1.583 . . . . 0.0 108.736 176.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 34.1 m -71.36 -32.24 46.09 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-N 119.199 0.909 . . . . 0.0 111.505 -173.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 63.4 mt-10 -64.89 -49.57 69.95 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 118.49 0.586 . . . . 0.0 109.883 173.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.1 -36.5 83.8 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 119.198 -0.43 . . . . 0.0 110.231 179.031 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 8.2 tp -62.4 -40.42 96.45 Favored 'General case' 0 C--O 1.225 -0.227 0 CA-C-N 119.49 1.041 . . . . 0.0 109.36 -179.217 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -67.83 -25.47 65.58 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 121.339 0.59 . . . . 0.0 112.303 -178.309 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -81.86 -39.29 24.13 Favored 'General case' 0 N--CA 1.436 -1.128 0 C-N-CA 126.219 1.808 . . . . 0.0 109.685 175.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 23.4 mmt85 -89.63 -32.55 17.03 Favored 'General case' 0 C--O 1.231 0.099 0 CA-C-O 118.662 -0.685 . . . . 0.0 112.1 -169.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -128.22 147.73 50.59 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 118.944 0.793 . . . . 0.0 111.334 -176.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 51.6 mm -97.11 138.97 20.64 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 103.834 -2.654 . . . . 0.0 103.834 168.014 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -117.57 153.38 50.44 Favored Pre-proline 0 CA--C 1.539 0.542 0 C-N-CA 123.277 0.631 . . . . 0.0 111.469 -169.362 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -61.03 161.0 23.76 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 123.711 2.941 . . . . 0.0 112.144 169.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -63.42 -32.94 74.51 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -175.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 7.5 p90 -75.17 -10.25 59.29 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 -179.207 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 96.7 t -92.31 122.93 44.21 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 173.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -114.66 127.34 55.71 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 106.703 -1.591 . . . . 0.0 106.703 169.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -93.98 118.33 39.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 105.076 -2.194 . . . . 0.0 105.076 168.559 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 54.1 tp -118.86 132.21 56.1 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 122.902 0.481 . . . . 0.0 110.352 178.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -91.29 120.99 32.65 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 169.154 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -106.7 -22.5 7.65 Favored Glycine 0 CA--C 1.536 1.361 0 CA-C-O 118.437 -1.202 . . . . 0.0 113.6 171.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 56.05 -110.84 2.16 Favored Glycine 0 C--N 1.342 0.897 0 CA-C-N 119.878 1.839 . . . . 0.0 112.329 172.071 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 75.7 p -79.99 7.21 9.46 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 125.365 1.466 . . . . 0.0 112.557 -172.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -57.82 -59.3 5.44 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 114.291 1.219 . . . . 0.0 114.291 -170.033 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 56.72 -112.33 3.37 Favored Glycine 0 CA--C 1.532 1.144 0 N-CA-C 109.846 -1.302 . . . . 0.0 109.846 -170.269 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 8.2 tpt -64.19 -21.41 66.55 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.319 1.048 . . . . 0.0 113.449 -176.506 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -56.33 -17.67 8.47 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 114.545 1.313 . . . . 0.0 114.545 -170.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 8.8 mt -98.24 17.71 18.01 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 119.499 1.045 . . . . 0.0 112.991 -169.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 10.2 tt -48.04 -50.74 26.88 Favored 'General case' 0 C--N 1.343 0.314 0 N-CA-C 112.764 0.654 . . . . 0.0 112.764 -174.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -80.31 -29.67 44.19 Favored Glycine 0 CA--C 1.528 0.848 0 CA-C-O 119.659 -0.523 . . . . 0.0 111.952 -178.035 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -86.94 -22.7 25.47 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 114.267 1.21 . . . . 0.0 114.267 -169.053 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 47.6 mtp -78.14 -15.64 58.67 Favored 'General case' 0 CA--C 1.535 0.394 0 O-C-N 121.537 -0.727 . . . . 0.0 111.108 173.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.09 150.37 45.56 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 123.708 0.803 . . . . 0.0 112.026 -169.324 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . 0.282 14.4 p30 55.34 17.24 2.03 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 127.923 2.489 . . . . 0.0 117.324 170.048 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.5 159.02 35.04 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 169.155 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -80.61 -52.18 7.88 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 173.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -117.22 147.11 42.79 Favored 'General case' 0 CA--C 1.513 -0.478 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 168.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -134.97 122.56 22.05 Favored 'General case' 0 CA--C 1.508 -0.661 0 N-CA-C 104.698 -2.334 . . . . 0.0 104.698 175.293 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 3.0 mt -104.42 106.07 19.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 106.45 -1.685 . . . . 0.0 106.45 176.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 27.4 mt -79.99 124.76 38.45 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 N-CA-C 105.074 -2.195 . . . . 0.0 105.074 169.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -113.28 121.07 43.3 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 104.121 -2.548 . . . . 0.0 104.121 168.542 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 41.7 t0 -163.67 156.37 18.05 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 123.592 0.757 . . . . 0.0 110.23 -175.237 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -83.25 142.67 30.96 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 169.008 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 72.1 mt -77.07 -44.29 31.42 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 -175.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 14.6 t 53.93 43.46 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.151 0 C-N-CA 124.367 1.067 . . . . 0.0 109.66 -172.059 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 2.4 m -153.76 178.81 9.48 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.212 1.405 . . . . 0.0 109.639 175.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . 0.288 30.6 ttmt 67.61 154.69 0.1 Allowed 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 127.968 2.507 . . . . 0.0 113.345 175.557 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 10.3 ptpt -85.14 -5.65 59.33 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 127.205 2.202 . . . . 0.0 114.774 -169.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 33.9 t-20 -74.38 169.61 17.32 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.221 0.608 . . . . 0.0 109.619 -173.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 4.1 m -57.65 146.31 66.1 Favored Pre-proline 0 CA--C 1.548 0.903 0 C-N-CA 124.111 0.964 . . . . 0.0 112.234 -169.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_exo -53.09 148.13 31.84 Favored 'Trans proline' 0 CA--C 1.535 0.573 0 C-N-CA 124.176 3.251 . . . . 0.0 113.178 171.366 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 74.2 0.01 55.29 Favored Glycine 0 CA--C 1.532 1.096 0 CA-C-O 119.221 -0.766 . . . . 0.0 114.684 174.315 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 27.3 m -73.28 143.39 47.03 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 119.026 1.413 . . . . 0.0 111.155 -169.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 11.0 ttp -85.22 132.5 34.27 Favored 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 169.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 65.5 mtm -133.45 127.59 33.63 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 170.071 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 18.6 mm -108.03 124.86 64.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 -173.308 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.5 mp -121.33 134.59 55.14 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 -174.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 53.1 mtt85 -86.23 174.02 9.38 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.789 0.835 . . . . 0.0 110.016 -177.399 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -40.59 -52.52 2.85 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 115.068 1.507 . . . . 0.0 115.068 -172.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -90.34 -13.81 34.4 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 113.056 0.762 . . . . 0.0 113.056 -175.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -77.61 -37.17 50.84 Favored 'General case' 0 C--N 1.339 0.118 0 CA-C-N 118.551 0.614 . . . . 0.0 109.956 -173.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -64.29 -49.52 72.2 Favored Pre-proline 0 CA--C 1.534 0.33 0 CA-C-O 117.605 -1.188 . . . . 0.0 112.822 -175.345 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_exo -54.96 -39.6 89.91 Favored 'Trans proline' 0 CA--C 1.539 0.757 0 CA-C-N 120.997 1.392 . . . . 0.0 111.557 176.339 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -76.16 -7.98 56.0 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 176.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -92.45 -38.16 12.14 Favored 'General case' 0 C--N 1.342 0.274 0 CA-C-N 120.114 1.325 . . . . 0.0 109.622 174.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -77.84 28.83 0.17 Allowed 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -178.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 32.1 p -74.02 -24.62 59.59 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 121.463 -0.773 . . . . 0.0 110.282 173.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -75.38 152.18 38.1 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 171.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 3.1 mppt? -120.88 28.45 7.92 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.895 0.878 . . . . 0.0 111.033 179.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 25.9 mt -69.99 -44.73 78.22 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 -178.304 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 2.6 p -97.57 116.61 65.84 Favored Pre-proline 0 CA--C 1.545 0.765 0 C-N-CA 124.962 1.305 . . . . 0.0 110.084 -170.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -70.55 -50.09 0.4 Allowed 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 122.535 2.156 . . . . 0.0 114.042 -169.238 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . 0.633 ' HD1' ' NE2' ' A' ' 94' ' ' GLN . 10.7 t-80 -60.99 -45.64 93.97 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 178.364 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.633 ' NE2' ' HD1' ' A' ' 93' ' ' HIS . 23.9 mp0 -64.82 -35.88 82.53 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 118.199 -0.905 . . . . 0.0 110.447 -176.287 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -65.28 -41.21 94.4 Favored 'General case' 0 C--O 1.227 -0.128 0 CA-C-N 119.676 1.125 . . . . 0.0 110.028 173.282 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -61.16 -46.28 94.82 Favored Glycine 0 CA--C 1.534 1.237 0 CA-C-N 119.455 1.025 . . . . 0.0 111.232 175.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -58.07 -41.49 83.49 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.261 0.625 . . . . 0.0 110.007 174.103 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -65.33 -36.21 83.36 Favored 'General case' 0 N--CA 1.444 -0.772 0 O-C-N 121.049 -1.032 . . . . 0.0 110.919 178.311 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -67.15 -22.41 65.77 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 118.616 0.643 . . . . 0.0 110.466 178.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 77.7 t -68.87 -42.08 82.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 168.442 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 42.6 mt -64.65 -35.83 82.3 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-N 119.748 1.158 . . . . 0.0 110.2 179.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 17.0 m -63.79 -45.04 91.49 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 119.229 0.922 . . . . 0.0 110.228 172.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.19 -44.13 97.79 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 119.093 0.861 . . . . 0.0 111.275 176.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.7 mt -60.61 -33.81 73.3 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.238 1.015 . . . . 0.0 109.996 175.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 73.9 ttt-85 -73.68 -34.62 64.97 Favored 'General case' 0 CA--C 1.531 0.238 0 O-C-N 121.141 -0.974 . . . . 0.0 109.792 176.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 14.1 m-30 -69.3 -44.14 72.36 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 123.594 0.758 . . . . 0.0 110.665 179.274 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 36.1 p -73.05 -23.95 60.64 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 118.462 0.573 . . . . 0.0 111.701 179.232 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 73.57 7.57 74.21 Favored Glycine 0 CA--C 1.532 1.148 0 N-CA-C 109.394 -1.482 . . . . 0.0 109.394 -168.383 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -86.04 25.58 1.12 Allowed 'General case' 0 C--N 1.348 0.505 0 CA-C-N 119.851 1.826 . . . . 0.0 110.733 174.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -61.78 139.12 95.49 Favored Pre-proline 0 CA--C 1.546 0.82 0 C-N-CA 124.006 0.922 . . . . 0.0 108.705 169.516 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo -59.71 162.41 15.65 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.963 2.442 . . . . 0.0 114.03 -177.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp -65.07 -37.63 88.16 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 119.061 -0.495 . . . . 0.0 111.475 174.459 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 4.5 pttm -143.5 85.46 1.84 Allowed 'General case' 0 C--O 1.234 0.252 0 C-N-CA 124.031 0.933 . . . . 0.0 108.585 177.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 5.9 tt -75.39 144.8 42.07 Favored 'General case' 0 CA--C 1.537 0.468 0 O-C-N 120.835 -1.165 . . . . 0.0 108.502 169.657 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -137.97 139.64 39.81 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.65 1.18 . . . . 0.0 108.02 177.349 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -118.91 121.12 39.23 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 119.901 1.228 . . . . 0.0 108.658 175.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 3.1 t -89.1 89.98 3.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 N-CA-C 105.855 -1.906 . . . . 0.0 105.855 169.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -81.15 138.78 19.71 Favored Glycine 0 C--N 1.335 0.517 0 N-CA-C 110.273 -1.131 . . . . 0.0 110.273 -178.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 38.9 t -122.15 133.39 68.61 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 174.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 13.4 mt -85.41 135.32 38.87 Favored Pre-proline 0 CA--C 1.535 0.369 0 N-CA-C 105.561 -2.015 . . . . 0.0 105.561 169.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -73.21 167.16 28.05 Favored 'Trans proline' 0 CA--C 1.54 0.786 0 C-N-CA 121.815 1.677 . . . . 0.0 111.732 -179.161 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -94.38 -56.85 2.67 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 168.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 49.0 m -118.73 -55.14 2.21 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -169.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.8 tp 52.21 39.29 26.63 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 126.823 2.049 . . . . 0.0 113.581 -174.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -79.61 163.85 56.64 Favored Pre-proline 0 CA--C 1.544 0.721 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 171.025 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -82.39 94.61 0.88 Allowed 'Trans proline' 0 CA--C 1.542 0.896 0 C-N-CA 121.848 1.699 . . . . 0.0 111.863 -176.132 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . 0.583 ' CE1' ' HG1' ' A' ' 14' ' ' THR . 0.8 OUTLIER -173.48 -176.24 1.27 Allowed 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 104.48 -2.415 . . . . 0.0 104.48 -178.178 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -144.24 154.33 15.27 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 CA-C-N 119.42 1.009 . . . . 0.0 112.325 174.738 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 118.6 85.41 1.01 Allowed Glycine 0 CA--C 1.531 1.035 0 N-CA-C 107.93 -2.068 . . . . 0.0 107.93 -174.245 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 81.9 mt -36.55 139.41 0.18 Allowed 'General case' 0 C--N 1.352 0.711 0 N-CA-C 115.192 1.553 . . . . 0.0 115.192 -169.688 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 4.4 p -58.96 151.89 52.98 Favored Pre-proline 0 CA--C 1.535 0.4 0 CA-C-N 113.97 -1.468 . . . . 0.0 108.74 169.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -60.49 -35.24 91.25 Favored 'Trans proline' 0 CA--C 1.537 0.63 0 C-N-CA 121.726 1.618 . . . . 0.0 111.74 -176.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -60.57 -36.21 77.93 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 123.704 0.802 . . . . 0.0 110.834 177.123 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 61.4 t -94.2 -32.49 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 C-N-CA 122.628 0.371 . . . . 0.0 110.004 -172.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -53.91 -46.45 71.47 Favored 'General case' 0 C--N 1.33 -0.24 0 O-C-N 121.347 -0.846 . . . . 0.0 109.311 169.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -69.06 -16.77 63.77 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 -177.38 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 24.4 mmm -77.94 -8.03 57.57 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 125.47 1.508 . . . . 0.0 113.039 172.135 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 53.5 mt -56.86 -56.06 16.58 Favored 'Isoleucine or valine' 0 C--N 1.344 0.353 0 CA-C-N 120.835 1.652 . . . . 0.0 109.157 176.222 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -67.52 -45.59 47.16 Favored Pre-proline 0 CA--C 1.544 0.714 0 CA-C-O 117.822 -1.085 . . . . 0.0 111.033 -174.227 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -42.94 -58.5 1.3 Allowed 'Trans proline' 0 C--N 1.349 0.578 1 C-N-CA 125.478 4.118 . . . . 0.0 112.979 168.66 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -69.2 -35.91 76.72 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.363 -0.835 . . . . 0.0 112.148 -177.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 25.8 mt -57.07 -41.14 78.26 Favored 'General case' 0 CA--C 1.521 -0.146 0 CA-C-N 119.546 1.066 . . . . 0.0 109.068 171.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -62.25 -35.05 77.78 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 118.862 0.755 . . . . 0.0 110.165 178.376 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -64.24 -46.35 84.18 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 119.623 1.102 . . . . 0.0 111.217 173.064 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 36.2 t -56.65 -48.67 80.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 178.181 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 37.7 mt -62.89 -34.46 77.46 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 118.487 -0.768 . . . . 0.0 110.946 178.104 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -67.2 -46.43 73.89 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 119.81 1.186 . . . . 0.0 110.83 178.125 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -64.46 -32.26 73.82 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 119.679 1.127 . . . . 0.0 111.12 177.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 14.1 mt -63.11 -54.75 32.95 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 171.272 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 78.4 mtm-85 -61.21 -32.05 71.82 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 120.336 1.426 . . . . 0.0 111.765 -178.125 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -70.52 -27.65 64.34 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 118.677 0.671 . . . . 0.0 110.332 179.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 23.5 m -81.12 5.47 16.66 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.601 1.16 . . . . 0.0 111.77 169.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 70.89 13.7 72.5 Favored Glycine 0 CA--C 1.53 0.997 0 CA-C-O 117.641 -1.644 . . . . 0.0 112.497 -171.238 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 58.3 t -90.62 118.05 35.1 Favored 'Isoleucine or valine' 0 C--N 1.347 0.463 0 CA-C-N 120.603 2.202 . . . . 0.0 107.787 -177.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -93.86 96.06 9.5 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 171.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -59.63 139.93 56.8 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 169.004 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 11.1 mm -85.41 123.61 72.71 Favored Pre-proline 0 CA--C 1.534 0.342 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 -174.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -64.2 103.23 0.42 Allowed 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 122.913 2.409 . . . . 0.0 105.928 171.184 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 20.4 tpp85 45.3 -110.28 0.22 Allowed 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 104.954 -2.239 . . . . 0.0 104.954 -166.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 3.7 p . . . . . 0 C--N 1.324 -0.54 0 CA-C-N 119.766 1.166 . . . . 0.0 109.576 169.947 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 8.5 ptp180 . . . . . 0 N--CA 1.48 1.059 0 CA-C-O 118.036 -0.983 . . . . 0.0 108.662 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 52.0 mt -140.31 144.16 28.19 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-N 120.033 1.288 . . . . 0.0 110.873 -169.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 3.1 mt -127.8 122.18 32.07 Favored 'General case' 0 CA--C 1.519 -0.248 0 N-CA-C 107.046 -1.465 . . . . 0.0 107.046 168.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 11.5 t -97.46 111.86 28.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 1 N-CA-C 100.125 -4.028 . . . . 0.0 100.125 168.688 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -117.35 107.32 14.23 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 123.112 0.565 . . . . 0.0 109.497 -168.048 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -89.74 123.82 7.12 Favored Glycine 0 N--CA 1.448 -0.511 0 N-CA-C 108.722 -1.751 . . . . 0.0 108.722 179.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.6 m -132.52 -177.91 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.805 0 C-N-CA 124.053 0.941 . . . . 0.0 109.532 -179.314 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 98.07 131.22 7.07 Favored Glycine 0 N--CA 1.437 -1.281 0 N-CA-C 107.158 -2.377 . . . . 0.0 107.158 -169.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -69.16 131.52 45.08 Favored 'General case' 0 N--CA 1.451 -0.379 0 O-C-N 121.846 -0.797 . . . . 0.0 111.947 -168.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.4 pt -79.06 41.39 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 123.605 0.762 . . . . 0.0 112.961 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 19.4 mt -129.7 -12.09 4.35 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 120.129 1.331 . . . . 0.0 109.833 171.22 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.1 mp -117.1 62.7 0.73 Allowed 'General case' 0 C--N 1.346 0.434 0 CA-C-O 122.116 0.96 . . . . 0.0 109.766 -169.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.9 m 51.71 -119.59 1.48 Allowed 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 114.322 -1.308 . . . . 0.0 112.059 169.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 61.3 m-20 -50.92 -23.07 2.58 Favored 'General case' 0 N--CA 1.44 -0.929 0 C-N-CA 127.866 2.466 . . . . 0.0 114.282 179.083 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -63.28 -26.34 68.73 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 119.643 1.11 . . . . 0.0 110.456 -179.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.74 -8.7 45.34 Favored 'General case' 0 N--CA 1.438 -1.059 0 CA-C-O 116.819 -1.562 . . . . 0.0 111.215 176.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.1 tp -51.67 -45.43 36.93 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.414 0 CA-C-N 121.341 1.882 . . . . 0.0 111.132 -173.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -63.51 -34.63 90.45 Favored Glycine 0 CA--C 1.526 0.771 0 CA-C-N 119.131 0.878 . . . . 0.0 111.324 -177.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 97.8 t -68.18 -48.43 73.9 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 CA-C-N 117.518 0.659 . . . . 0.0 109.32 172.304 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 24.1 mmt180 -57.52 -29.65 64.5 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 117.429 -1.272 . . . . 0.0 112.147 177.287 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 5.7 mm -62.42 -53.98 40.12 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-N 120.818 1.645 . . . . 0.0 109.046 176.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 26.5 m -70.61 -34.7 58.14 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 CA-C-N 118.833 0.742 . . . . 0.0 111.312 -176.206 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 58.3 mt-10 -65.36 -45.03 85.72 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 118.954 0.797 . . . . 0.0 110.015 176.209 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.67 -39.88 95.43 Favored 'General case' 0 N--CA 1.452 -0.342 0 O-C-N 121.808 -0.557 . . . . 0.0 109.982 176.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 5.7 tp -64.55 -39.2 93.32 Favored 'General case' 0 C--O 1.221 -0.4 0 CA-C-N 118.858 0.754 . . . . 0.0 110.169 -178.368 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -61.95 -26.23 68.07 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 121.501 0.667 . . . . 0.0 112.493 -178.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -93.33 -40.86 10.17 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 125.994 1.718 . . . . 0.0 111.125 -178.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 37.3 mmm-85 -83.29 -31.17 27.04 Favored 'General case' 0 C--N 1.333 -0.112 0 C-N-CA 123.021 0.528 . . . . 0.0 110.833 -174.393 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -123.89 146.92 48.09 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-O 122.313 1.054 . . . . 0.0 112.728 -177.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 39.3 mm -98.92 135.29 34.52 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 N-CA-C 104.887 -2.264 . . . . 0.0 104.887 169.404 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -120.24 148.6 47.62 Favored Pre-proline 0 CA--C 1.537 0.447 0 C-N-CA 124.025 0.93 . . . . 0.0 109.943 -169.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -67.4 158.62 56.2 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 123.05 2.5 . . . . 0.0 110.253 170.12 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -57.69 -33.79 68.76 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 114.48 1.289 . . . . 0.0 114.48 -169.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 10.8 p90 -74.37 -12.82 60.63 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 112.786 0.661 . . . . 0.0 112.786 -176.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 74.0 t -89.67 125.61 42.62 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 172.319 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 52.1 mm-40 -113.18 130.6 56.16 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 169.01 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -95.78 116.28 37.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 104.877 -2.268 . . . . 0.0 104.877 168.766 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 65.3 tp -118.19 129.02 55.26 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 118.073 0.397 . . . . 0.0 110.373 -179.149 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -88.7 107.04 18.73 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 106.312 -1.736 . . . . 0.0 106.312 168.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -92.32 -40.33 5.14 Favored Glycine 0 CA--C 1.535 1.308 0 N-CA-C 110.432 -1.067 . . . . 0.0 110.432 169.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 57.3 -103.69 0.33 Allowed Glycine 0 C--N 1.341 0.807 0 CA-C-N 117.773 0.787 . . . . 0.0 112.683 171.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 19.8 p -67.9 -5.82 18.76 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 126.521 1.929 . . . . 0.0 113.237 -179.518 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.48 -63.16 1.39 Allowed 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 -172.16 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 53.69 -110.06 1.31 Allowed Glycine 0 CA--C 1.535 1.283 0 N-CA-C 110.62 -0.992 . . . . 0.0 110.62 -170.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.06 -30.42 66.18 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.553 1.141 . . . . 0.0 111.268 -177.382 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -56.82 -19.74 18.86 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 -174.092 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 20.5 mt -85.12 12.99 6.76 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 113.551 0.945 . . . . 0.0 113.551 -177.437 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 6.3 tt -42.04 -61.0 1.24 Allowed 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.27 1.028 . . . . 0.0 112.63 -172.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -79.73 -30.42 43.96 Favored Glycine 0 CA--C 1.527 0.819 0 N-CA-C 111.392 -0.683 . . . . 0.0 111.392 -179.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -67.43 -36.06 80.5 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 118.428 1.114 . . . . 0.0 112.112 -169.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 36.2 mtp -75.4 -9.93 59.0 Favored 'General case' 0 N--CA 1.451 -0.399 0 O-C-N 122.037 -0.414 . . . . 0.0 111.765 -178.264 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.63 151.62 40.77 Favored 'General case' 0 N--CA 1.445 -0.723 0 C-N-CA 123.149 0.58 . . . . 0.0 112.474 -169.271 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . 0.281 15.5 p30 53.51 21.21 2.38 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 128.749 2.82 . . . . 0.0 116.211 170.041 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 17.4 mmt180 -75.5 160.0 30.67 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 169.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -86.57 -52.39 5.58 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 176.734 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . 0.25 0.0 OUTLIER -124.53 143.31 50.74 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 119.952 1.251 . . . . 0.0 107.713 169.37 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 4.5 tt -139.97 120.8 14.45 Favored 'General case' 0 CA--C 1.501 -0.911 0 N-CA-C 105.476 -2.046 . . . . 0.0 105.476 -178.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 25.8 mt -100.21 106.09 18.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 106.104 -1.813 . . . . 0.0 106.104 179.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 16.9 mt -75.13 133.63 31.04 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 N-CA-C 105.135 -2.172 . . . . 0.0 105.135 169.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -120.16 121.49 38.89 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 104.915 -2.254 . . . . 0.0 104.915 168.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 36.8 t0 -156.75 162.19 39.77 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 118.529 0.604 . . . . 0.0 110.287 -171.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -103.74 157.23 17.21 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 121.927 0.87 . . . . 0.0 109.994 172.227 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 5.1 mp -134.64 88.09 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 N-CA-C 106.892 -1.521 . . . . 0.0 106.892 -176.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 31.5 m -52.48 -21.1 2.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 C-N-CA 125.89 1.676 . . . . 0.0 112.217 168.568 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.6 m -78.01 174.08 11.49 Favored 'General case' 0 N--CA 1.442 -0.845 0 C-N-CA 124.249 1.02 . . . . 0.0 111.852 -169.289 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 18.2 ttmm 67.25 163.12 0.19 Allowed 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 126.108 1.763 . . . . 0.0 111.907 -179.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 23.1 mtmt -77.38 -7.83 56.72 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 125.301 1.44 . . . . 0.0 112.134 179.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 43.5 t-20 -68.16 156.94 36.46 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.232 1.013 . . . . 0.0 110.234 -169.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 2.2 m -62.3 149.18 88.08 Favored Pre-proline 0 CA--C 1.546 0.795 0 C-N-CA 124.663 1.185 . . . . 0.0 113.446 -169.004 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_exo -58.9 159.81 20.14 Favored 'Trans proline' 0 CA--C 1.533 0.465 0 C-N-CA 124.029 3.153 . . . . 0.0 111.625 168.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 65.64 19.15 66.79 Favored Glycine 0 CA--C 1.53 0.986 0 CA-C-O 119.753 -0.471 . . . . 0.0 112.952 172.299 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 2.7 m -99.24 142.46 30.7 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 124.495 1.118 . . . . 0.0 109.448 -172.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 13.4 ttp -91.1 134.88 34.16 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 172.607 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 69.6 mtm -122.28 115.73 22.86 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 170.539 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 28.1 mm -102.87 120.81 53.22 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 -177.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.6 mp -128.09 137.18 52.04 Favored 'General case' 0 C--O 1.236 0.376 0 O-C-N 123.97 0.793 . . . . 0.0 109.812 -173.09 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 53.6 mtt85 -89.16 176.31 7.02 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.237 1.015 . . . . 0.0 110.042 -177.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -38.01 -58.94 0.89 Allowed 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.466 1.507 . . . . 0.0 113.762 -173.119 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -86.61 -15.9 38.36 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -171.447 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -75.13 -36.83 61.57 Favored 'General case' 0 N--CA 1.457 -0.11 0 O-C-N 121.876 -0.515 . . . . 0.0 109.902 -175.336 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -66.37 -49.23 54.39 Favored Pre-proline 0 CA--C 1.535 0.383 0 CA-C-O 117.653 -1.165 . . . . 0.0 112.585 -174.619 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -55.32 -37.78 94.3 Favored 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 121.758 1.639 . . . . 0.0 111.594 174.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.11 -2.37 37.08 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 114.234 1.198 . . . . 0.0 114.234 176.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -102.48 -38.46 7.56 Favored 'General case' 0 C--N 1.344 0.33 0 CA-C-N 119.805 1.184 . . . . 0.0 111.376 179.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 43.9 m-85 -70.41 0.94 5.62 Favored 'General case' 0 CA--C 1.544 0.746 0 O-C-N 121.641 -0.662 . . . . 0.0 112.5 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 64.5 p -57.84 -21.0 40.23 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.577 1.551 . . . . 0.0 112.687 174.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 11.1 p30 -60.82 -30.51 70.12 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 118.66 -0.686 . . . . 0.0 112.489 175.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 30.3 mtmm 50.82 27.34 3.05 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 125.152 1.381 . . . . 0.0 114.32 177.205 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 13.5 mt -72.35 -43.15 65.01 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 O-C-N 121.252 -0.905 . . . . 0.0 109.523 -174.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 3.1 p -113.25 143.2 28.79 Favored Pre-proline 0 CA--C 1.544 0.716 0 C-N-CA 123.675 0.79 . . . . 0.0 112.54 -169.541 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -75.31 -42.26 0.5 Allowed 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 122.76 2.307 . . . . 0.0 113.704 -169.147 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 10.2 t-80 -61.81 -45.42 93.91 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 119.399 1.0 . . . . 0.0 108.885 178.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 21.5 mp0 -62.15 -41.94 98.77 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 125.27 1.428 . . . . 0.0 108.634 -177.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 50.7 tp -64.14 -38.19 90.16 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 119.145 0.884 . . . . 0.0 110.995 174.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -63.1 -51.11 57.69 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 110.556 -1.018 . . . . 0.0 110.556 176.599 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -56.94 -43.05 81.12 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.207 0.603 . . . . 0.0 109.963 175.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -62.77 -37.81 88.13 Favored 'General case' 0 N--CA 1.452 -0.36 0 O-C-N 121.306 -0.871 . . . . 0.0 111.413 177.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -69.3 -22.36 63.8 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 118.851 0.75 . . . . 0.0 110.83 178.327 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 97.6 t -68.04 -42.72 85.47 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 168.631 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 92.1 mt -63.73 -36.75 84.88 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 119.348 0.977 . . . . 0.0 109.934 178.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 70.3 m -64.59 -41.68 96.08 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 119.249 0.931 . . . . 0.0 110.726 171.178 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.49 -44.07 97.74 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 120.254 1.388 . . . . 0.0 110.611 176.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.9 mt -63.37 -33.04 74.67 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.669 1.188 . . . . 0.0 110.765 176.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 65.7 ttp85 -73.65 -31.79 63.68 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.008 0.923 . . . . 0.0 110.001 176.057 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 14.9 m-30 -71.34 -46.04 61.5 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 119.185 0.902 . . . . 0.0 110.473 177.095 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 34.0 p -73.84 -24.33 59.76 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 123.128 0.571 . . . . 0.0 112.132 -178.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 74.63 8.0 80.55 Favored Glycine 0 CA--C 1.536 1.351 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -168.329 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -85.04 22.0 1.51 Allowed 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 119.851 1.826 . . . . 0.0 111.438 174.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -60.48 137.63 92.38 Favored Pre-proline 0 CA--C 1.545 0.771 0 C-N-CA 124.175 0.99 . . . . 0.0 108.737 169.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -61.25 163.36 17.4 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.779 2.319 . . . . 0.0 114.543 -176.192 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 68.3 mmtt -67.96 -35.57 78.61 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 118.941 -0.552 . . . . 0.0 112.37 175.117 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 8.2 ttmm -142.08 66.63 1.34 Allowed 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 -175.382 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 7.8 tt -70.83 138.38 50.26 Favored 'General case' 0 C--O 1.234 0.238 0 O-C-N 120.063 -1.648 . . . . 0.0 108.476 172.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -134.61 136.59 43.02 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 179.487 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -114.06 122.46 46.96 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 119.956 1.253 . . . . 0.0 107.874 175.639 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 21.3 t -95.87 85.52 1.63 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 N-CA-C 106.316 -1.735 . . . . 0.0 106.316 169.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -77.25 148.63 34.57 Favored Glycine 0 N--CA 1.445 -0.741 0 N-CA-C 110.706 -0.958 . . . . 0.0 110.706 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 46.9 t -124.54 165.72 21.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 171.716 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 15.5 mt -117.55 120.21 33.39 Favored Pre-proline 0 N--CA 1.468 0.428 0 CA-C-N 121.232 1.833 . . . . 0.0 108.605 171.069 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -55.16 158.93 10.84 Favored 'Trans proline' 0 N--CA 1.455 -0.775 1 C-N-CA 126.142 4.561 . . . . 0.0 116.093 175.614 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -107.75 -64.24 1.23 Allowed 'General case' 0 C--O 1.236 0.344 0 C-N-CA 124.348 1.059 . . . . 0.0 109.628 178.28 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 70.5 m -106.03 -50.13 3.23 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 119.093 -0.479 . . . . 0.0 110.154 -171.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.2 tp 51.97 32.51 10.19 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 124.126 0.971 . . . . 0.0 112.812 178.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -83.49 164.6 44.5 Favored Pre-proline 0 CA--C 1.544 0.734 0 O-C-N 121.525 -0.734 . . . . 0.0 109.417 176.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -78.65 82.96 2.34 Favored 'Trans proline' 0 CA--C 1.544 1.012 0 C-N-CA 121.869 1.713 . . . . 0.0 111.953 -173.142 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -175.67 153.22 1.4 Allowed 'General case' 0 C--O 1.234 0.269 0 N-CA-C 104.276 -2.491 . . . . 0.0 104.276 -177.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -110.38 160.71 9.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.552 0.692 . . . . 0.0 111.861 -170.234 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 108.11 141.37 9.69 Favored Glycine 0 CA--C 1.529 0.929 0 N-CA-C 106.457 -2.657 . . . . 0.0 106.457 -169.286 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 74.8 mt -80.7 154.03 27.52 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 118.065 0.932 . . . . 0.0 109.667 179.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 68.2 p -70.82 168.47 20.15 Favored Pre-proline 0 CA--C 1.541 0.619 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 169.394 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_exo -59.76 -40.21 66.08 Favored 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 121.717 1.611 . . . . 0.0 111.165 173.447 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 85.3 m -59.67 -37.45 78.8 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 124.619 1.168 . . . . 0.0 111.751 -179.358 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 58.4 t -98.51 -29.32 3.53 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 O-C-N 121.776 -0.578 . . . . 0.0 110.638 -174.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -52.37 -45.37 65.74 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 119.518 1.054 . . . . 0.0 108.793 169.193 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -65.68 -15.97 63.31 Favored 'General case' 0 N--CA 1.447 -0.575 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 -177.589 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 14.1 mmm -83.45 -8.41 59.38 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 125.321 1.448 . . . . 0.0 112.425 175.475 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 54.8 mt -56.75 -56.51 13.84 Favored 'Isoleucine or valine' 0 C--N 1.343 0.293 0 CA-C-N 120.192 1.36 . . . . 0.0 108.788 172.071 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 64.3 mm-40 -63.48 -49.7 76.95 Favored Pre-proline 0 CA--C 1.541 0.618 0 CA-C-O 117.468 -1.253 . . . . 0.0 109.99 -172.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -39.96 -56.58 1.38 Allowed 'Trans proline' 0 C--N 1.35 0.613 1 C-N-CA 125.798 4.332 . . . . 0.0 113.353 168.904 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -69.93 -35.5 74.58 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.649 -178.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 37.3 mt -64.06 -45.99 86.35 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 120.806 1.639 . . . . 0.0 109.345 176.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -54.61 -36.43 64.46 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 118.52 0.6 . . . . 0.0 110.226 174.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 70.8 tp60 -75.86 -38.99 57.4 Favored 'General case' 0 N--CA 1.423 -1.809 0 O-C-N 121.465 -0.772 . . . . 0.0 110.913 -179.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 37.2 t -58.68 -45.18 90.99 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 CA-C-N 119.276 0.943 . . . . 0.0 108.93 173.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 56.8 mt -60.85 -36.82 80.12 Favored 'General case' 0 C--O 1.226 -0.176 0 CA-C-O 119.09 -0.481 . . . . 0.0 110.218 175.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -68.68 -46.11 69.94 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 119.523 1.056 . . . . 0.0 111.29 179.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -66.88 -28.81 68.63 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 119.76 1.164 . . . . 0.0 111.068 178.424 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 23.9 mt -63.39 -51.22 66.71 Favored 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 169.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 96.8 mtt-85 -66.69 -16.06 63.95 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 117.845 -1.074 . . . . 0.0 112.543 179.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 33.1 mm-40 -65.97 -24.38 66.78 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 120.769 1.622 . . . . 0.0 110.899 172.176 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 65.3 m -100.53 18.98 17.72 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 119.436 1.016 . . . . 0.0 110.087 168.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 69.43 20.03 74.99 Favored Glycine 0 C--N 1.337 0.595 0 CA-C-O 117.838 -1.535 . . . . 0.0 112.276 -178.073 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 18.0 t -88.05 117.3 31.53 Favored 'Isoleucine or valine' 0 C--N 1.344 0.358 0 CA-C-N 120.23 2.015 . . . . 0.0 107.393 -172.331 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -101.87 88.14 3.3 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 177.16 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -58.06 141.7 49.2 Favored 'General case' 0 CA--C 1.539 0.558 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 169.223 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 30.9 mm -98.82 122.56 52.52 Favored Pre-proline 0 N--CA 1.463 0.176 0 CA-C-O 117.396 -1.287 . . . . 0.0 108.976 -172.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -63.12 106.53 0.56 Allowed 'Trans proline' 0 N--CA 1.459 -0.529 0 C-N-CA 122.17 1.913 . . . . 0.0 109.017 173.237 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 56.7 mtm180 39.9 48.02 1.98 Allowed 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 125.974 1.71 . . . . 0.0 113.604 179.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . 0.272 2.4 p . . . . . 0 CA--C 1.545 0.764 0 C-N-CA 126.698 1.999 . . . . 0.0 115.137 179.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 6.4 ptm85 . . . . . 0 N--CA 1.482 1.128 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 33.9 mt -137.72 148.77 25.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 CA-C-N 121.06 1.755 . . . . 0.0 111.922 -169.023 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 16.4 tp -134.55 111.07 9.77 Favored 'General case' 0 C--N 1.341 0.199 0 N-CA-C 105.484 -2.043 . . . . 0.0 105.484 168.081 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 24.9 t -90.68 115.36 29.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 102.927 -2.99 . . . . 0.0 102.927 170.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -115.37 113.03 23.23 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 123.173 0.589 . . . . 0.0 110.927 -168.376 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -94.13 121.65 6.78 Favored Glycine 0 N--CA 1.445 -0.712 0 N-CA-C 108.055 -2.018 . . . . 0.0 108.055 173.625 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.4 m -131.95 -167.68 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 C-N-CA 124.012 0.925 . . . . 0.0 108.625 -177.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 105.49 158.1 22.75 Favored Glycine 0 C--N 1.333 0.38 0 N-CA-C 110.505 -1.038 . . . . 0.0 110.505 -175.556 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -81.65 94.81 7.02 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 124.572 1.149 . . . . 0.0 108.915 -174.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.3 pt -69.82 27.58 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 N-CA-C 114.659 1.355 . . . . 0.0 114.659 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 38.3 mt -114.31 -9.66 12.78 Favored 'General case' 0 C--O 1.224 -0.245 0 O-C-N 121.138 -0.976 . . . . 0.0 108.581 171.34 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.1 mp -120.75 74.35 1.06 Allowed 'General case' 0 CA--C 1.502 -0.879 0 N-CA-C 105.475 -2.046 . . . . 0.0 105.475 -169.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.464 ' HG1' ' CE1' ' A' ' 127' ' ' HIS . 20.1 m 36.08 -106.53 0.04 OUTLIER 'General case' 0 N--CA 1.447 -0.585 0 O-C-N 126.215 2.197 . . . . 0.0 113.012 169.118 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -68.2 -13.67 62.41 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 114.628 1.344 . . . . 0.0 114.628 -170.165 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -65.84 -19.57 65.93 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 121.457 1.935 . . . . 0.0 111.769 173.258 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.58 -10.81 49.19 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 116.165 -1.874 . . . . 0.0 111.162 172.552 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 6.6 tp -54.96 -38.79 46.65 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 CA-C-N 121.753 2.069 . . . . 0.0 110.977 -178.155 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -60.0 -46.04 94.85 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 110.764 -0.935 . . . . 0.0 110.764 178.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 61.7 t -65.11 -47.4 87.91 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 O-C-N 122.175 -0.603 . . . . 0.0 109.68 174.559 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 20.3 mmt180 -60.21 -32.01 70.7 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 117.374 -1.298 . . . . 0.0 112.922 -178.181 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 20.3 mt -62.97 -44.13 99.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-N 121.151 1.796 . . . . 0.0 110.158 179.257 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 28.4 m -73.74 -34.59 41.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 CA-C-N 120.128 1.331 . . . . 0.0 111.542 -178.185 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 57.8 mt-10 -62.22 -42.37 99.25 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 117.957 0.344 . . . . 0.0 110.458 171.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -67.79 -38.29 83.15 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 119.051 0.842 . . . . 0.0 111.23 176.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 7.1 tp -63.51 -39.52 94.64 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 119.418 1.008 . . . . 0.0 109.844 -177.463 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -61.93 -18.83 61.66 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.88 0.872 . . . . 0.0 113.117 -179.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -102.57 -43.61 5.57 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 126.622 1.969 . . . . 0.0 110.992 -178.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 53.5 mmt-85 -74.69 -34.11 62.57 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.259 0.623 . . . . 0.0 110.547 -176.184 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 -124.89 154.03 41.71 Favored 'General case' 0 CA--C 1.521 -0.163 0 CA-C-O 121.417 0.627 . . . . 0.0 111.944 -178.201 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 47.7 mm -106.26 135.27 45.22 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 N-CA-C 103.418 -2.808 . . . . 0.0 103.418 168.047 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -119.07 149.78 47.6 Favored Pre-proline 0 C--O 1.237 0.438 0 CA-C-O 118.661 -0.685 . . . . 0.0 109.953 -169.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -65.95 162.08 36.79 Favored 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 122.992 2.461 . . . . 0.0 111.562 173.167 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -58.25 -33.69 69.65 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 115.046 1.498 . . . . 0.0 115.046 -169.196 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 8.6 p90 -73.06 -8.73 57.05 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 -178.016 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 76.1 t -88.99 128.16 41.27 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 174.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -116.08 124.35 50.19 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 105.913 -1.884 . . . . 0.0 105.913 169.063 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -93.53 112.9 27.33 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 N-CA-C 104.402 -2.444 . . . . 0.0 104.402 168.61 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 61.4 tp -112.36 128.94 56.43 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 -178.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -89.31 118.96 29.37 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 169.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -78.66 -79.98 0.76 Allowed Glycine 0 CA--C 1.526 0.764 0 N-CA-C 107.234 -2.346 . . . . 0.0 107.234 169.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 78.54 104.65 0.2 Allowed Glycine 0 C--N 1.344 0.974 0 N-CA-C 108.675 -1.77 . . . . 0.0 108.675 -177.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 12.9 p 52.74 50.72 17.48 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 123.535 0.734 . . . . 0.0 109.286 -178.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -104.4 -79.66 0.55 Allowed 'General case' 0 C--N 1.348 0.528 0 CA-C-N 115.312 -0.858 . . . . 0.0 112.105 -169.239 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 59.81 -110.55 2.88 Favored Glycine 0 CA--C 1.533 1.164 0 N-CA-C 110.075 -1.21 . . . . 0.0 110.075 -174.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 12.1 tpt -62.52 -21.57 65.63 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.844 1.258 . . . . 0.0 113.442 -173.366 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -63.91 -18.81 64.58 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 114.193 1.183 . . . . 0.0 114.193 -174.23 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 10.3 mt -100.52 14.37 31.53 Favored 'General case' 0 C--N 1.34 0.173 0 N-CA-C 115.643 1.719 . . . . 0.0 115.643 -168.087 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 6.1 tt -49.1 -55.63 11.63 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 118.968 0.804 . . . . 0.0 110.9 -176.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -67.67 -32.64 78.74 Favored Glycine 0 CA--C 1.527 0.809 0 CA-C-O 119.224 -0.764 . . . . 0.0 112.419 -176.491 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -80.76 -35.36 33.38 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 119.049 1.424 . . . . 0.0 110.763 -171.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 79.8 mtp -69.28 -14.07 62.74 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.134 0.973 . . . . 0.0 111.088 176.084 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -68.07 140.11 56.26 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 123.572 0.749 . . . . 0.0 112.199 -169.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 15.7 p30 50.56 22.17 1.02 Allowed 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 127.776 2.43 . . . . 0.0 115.09 172.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 17.9 mmt180 -71.23 150.15 45.56 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 170.315 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 46.1 m-20 -79.85 -53.68 6.55 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -116.22 145.16 43.34 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-N 120.422 1.464 . . . . 0.0 107.474 168.802 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 22.7 tp -132.19 105.83 7.59 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 103.516 -2.772 . . . . 0.0 103.516 176.044 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 28.0 mt -93.69 112.73 27.15 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 N-CA-C 104.205 -2.517 . . . . 0.0 104.205 173.138 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 24.1 mt -93.49 130.72 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 N-CA-C 105.572 -2.01 . . . . 0.0 105.572 176.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -111.83 124.13 51.71 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 105.414 -2.069 . . . . 0.0 105.414 169.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.416 ' CG ' HE21 ' A' ' 94' ' ' GLN . 42.9 t0 -158.59 159.12 35.1 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 124.285 1.034 . . . . 0.0 108.265 -177.031 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -89.25 144.7 25.91 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 170.099 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 31.9 mt -88.27 -25.56 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 C-N-CA 123.917 0.887 . . . . 0.0 110.453 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . 0.461 12.5 m 58.51 -15.08 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 N-CA-C 119.449 3.129 . . . . 0.0 119.449 176.296 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 5.9 p -157.99 131.26 7.59 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 121.101 1.773 . . . . 0.0 113.778 169.037 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 12.7 tppt? -166.39 175.35 8.24 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 128.236 2.614 . . . . 0.0 105.485 169.063 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.0 -23.8 63.2 Favored 'General case' 0 N--CA 1.474 0.741 0 O-C-N 121.662 -0.648 . . . . 0.0 111.62 174.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 -69.14 162.37 27.15 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.078 0.951 . . . . 0.0 110.994 -173.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 3.1 m -61.63 154.22 66.76 Favored Pre-proline 0 CA--C 1.548 0.873 0 C-N-CA 124.922 1.289 . . . . 0.0 112.697 -169.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_exo -57.32 159.34 16.11 Favored 'Trans proline' 0 N--CA 1.462 -0.375 0 C-N-CA 123.878 3.052 . . . . 0.0 112.591 169.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 64.99 10.18 44.91 Favored Glycine 0 CA--C 1.538 1.514 0 CA-C-O 119.314 -0.714 . . . . 0.0 114.508 171.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 3.3 m -90.98 151.93 20.88 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 125.932 1.693 . . . . 0.0 111.305 -169.408 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 29.0 ttp -96.3 139.5 32.35 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 169.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 70.0 mtm -131.14 131.17 43.91 Favored 'General case' 0 N--CA 1.462 0.129 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 169.412 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 9.5 mm -89.25 123.17 41.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 177.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -113.86 123.97 51.09 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 171.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 85.0 mtm180 -87.67 174.36 8.47 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 123.537 0.735 . . . . 0.0 110.515 -178.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -41.37 -53.87 3.19 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 115.884 1.809 . . . . 0.0 115.884 -169.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -84.03 -16.68 43.01 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -177.002 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -82.4 -37.01 26.14 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 -171.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -64.57 -45.51 76.58 Favored Pre-proline 0 CA--C 1.531 0.242 0 CA-C-O 117.221 -1.371 . . . . 0.0 113.862 -176.732 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -53.61 -42.34 66.73 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 121.981 1.787 . . . . 0.0 110.262 174.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -75.54 4.34 7.74 Favored 'General case' 0 CA--C 1.55 0.943 0 N-CA-C 114.466 1.284 . . . . 0.0 114.466 175.28 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -116.18 -41.77 3.12 Favored 'General case' 0 C--N 1.343 0.316 0 CA-C-N 120.09 1.313 . . . . 0.0 111.155 -177.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -62.75 -8.92 7.65 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 178.167 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 63.2 p -51.65 -28.88 15.84 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.928 1.291 . . . . 0.0 112.955 173.216 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 53.8 t-20 -52.46 117.4 2.83 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.279 0.632 . . . . 0.0 111.17 -175.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -74.95 -19.36 60.14 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.733 0.813 . . . . 0.0 112.329 -173.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 52.7 mt -65.47 -48.89 81.27 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 -178.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 6.6 m -76.08 111.49 15.34 Favored Pre-proline 0 CA--C 1.55 0.955 0 C-N-CA 125.406 1.482 . . . . 0.0 110.444 -169.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -70.56 -60.12 0.07 OUTLIER 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 122.931 2.421 . . . . 0.0 113.847 -168.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 6.7 t-80 -62.32 -40.06 95.09 Favored 'General case' 0 N--CA 1.463 0.2 0 O-C-N 121.463 -0.773 . . . . 0.0 109.319 -178.272 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.416 HE21 ' CG ' ' A' ' 62' ' ' ASP . 18.3 mp0 -62.38 -36.65 82.96 Favored 'General case' 0 N--CA 1.44 -0.961 0 C-N-CA 125.241 1.416 . . . . 0.0 108.943 -176.027 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 57.9 tp -66.72 -36.97 83.73 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 119.43 1.014 . . . . 0.0 110.901 174.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -66.89 -40.51 93.58 Favored Glycine 0 CA--C 1.53 1.027 0 O-C-N 120.962 -1.086 . . . . 0.0 110.931 173.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -61.67 -36.38 80.7 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 172.543 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -56.7 -53.54 56.55 Favored 'General case' 0 CA--C 1.52 -0.21 0 O-C-N 121.145 -0.972 . . . . 0.0 109.672 173.037 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -68.0 -28.4 67.38 Favored 'General case' 0 C--O 1.236 0.362 0 O-C-N 122.961 0.163 . . . . 0.0 110.934 -172.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -70.67 -44.47 76.52 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.951 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 174.311 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 20.2 mt -65.89 -33.08 75.02 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 119.04 0.837 . . . . 0.0 111.079 178.254 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 51.5 m -61.4 -41.73 97.6 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 118.769 0.713 . . . . 0.0 109.204 170.306 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.439 ' HA ' ' CD2' ' A' ' 106' ' ' PHE . . . -64.81 -40.35 95.08 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 119.748 1.158 . . . . 0.0 112.219 177.196 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -61.17 -33.28 73.19 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 119.095 0.861 . . . . 0.0 110.63 171.071 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 22.3 ttm-85 -75.5 -29.61 59.58 Favored 'General case' 0 CA--C 1.534 0.346 0 O-C-N 121.125 -0.984 . . . . 0.0 110.582 178.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.439 ' CD2' ' HA ' ' A' ' 103' ' ' ALA . 15.4 m-30 -69.88 -45.23 68.11 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.552 0.741 . . . . 0.0 110.277 177.208 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 32.8 p -74.46 -24.94 59.12 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 122.925 0.49 . . . . 0.0 111.831 -177.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 78.02 8.78 87.3 Favored Glycine 0 CA--C 1.538 1.499 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 -168.399 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -77.11 10.35 2.43 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 119.776 1.788 . . . . 0.0 111.612 171.382 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -57.32 140.09 79.43 Favored Pre-proline 0 CA--C 1.552 1.045 0 C-N-CA 125.346 1.459 . . . . 0.0 110.65 177.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -63.92 160.36 37.76 Favored 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 123.259 2.639 . . . . 0.0 115.402 -175.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -68.27 -35.42 77.85 Favored 'General case' 0 N--CA 1.473 0.675 0 O-C-N 121.663 -0.648 . . . . 0.0 112.163 171.514 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 61.7 mttm -134.52 92.66 2.94 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 124.253 1.021 . . . . 0.0 108.459 176.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 18.3 tp -78.57 131.58 36.81 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 105.072 -2.195 . . . . 0.0 105.072 168.055 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -132.72 139.45 47.64 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 172.004 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -124.72 123.15 39.39 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 119.739 1.154 . . . . 0.0 108.928 177.151 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 3.7 t -88.99 90.56 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 N-CA-C 105.306 -2.109 . . . . 0.0 105.306 173.401 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -85.96 133.39 11.77 Favored Glycine 0 C--N 1.333 0.376 0 N-CA-C 110.084 -1.207 . . . . 0.0 110.084 -174.231 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 44.8 t -120.35 127.81 75.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 117.908 0.854 . . . . 0.0 109.277 -179.487 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 17.1 mt -84.64 133.85 43.29 Favored Pre-proline 0 CA--C 1.538 0.485 0 N-CA-C 104.923 -2.251 . . . . 0.0 104.923 169.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_endo -73.19 173.43 13.7 Favored 'Trans proline' 0 N--CA 1.452 -0.967 0 C-N-CA 123.008 2.472 . . . . 0.0 110.773 -179.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -107.12 -43.57 4.58 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 105.278 -2.119 . . . . 0.0 105.278 167.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 38.3 m -135.7 135.01 39.72 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.961 0.904 . . . . 0.0 109.764 173.025 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 4.7 tp -140.96 61.4 1.5 Allowed 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.576 1.55 . . . . 0.0 108.458 -178.254 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -126.76 167.6 16.99 Favored Pre-proline 0 CA--C 1.54 0.583 0 N-CA-C 106.294 -1.743 . . . . 0.0 106.294 172.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -77.35 95.92 1.09 Allowed 'Trans proline' 0 N--CA 1.457 -0.648 0 CA-C-N 120.678 1.278 . . . . 0.0 112.005 -175.102 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . 0.464 ' CE1' ' HG1' ' A' ' 14' ' ' THR . 18.6 p-80 -150.67 -19.3 0.23 Allowed 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 114.561 -1.199 . . . . 0.0 113.586 172.041 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . 0.414 0.0 OUTLIER 65.91 159.19 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 N-CA-C 116.343 1.979 . . . . 0.0 116.343 169.212 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 86.22 160.18 33.72 Favored Glycine 0 CA--C 1.529 0.923 0 N-CA-C 106.866 -2.494 . . . . 0.0 106.866 -168.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 68.6 mt -88.18 152.14 22.19 Favored 'General case' 0 N--CA 1.468 0.448 0 O-C-N 120.965 -1.315 . . . . 0.0 110.595 176.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 56.9 p -69.63 167.79 20.99 Favored Pre-proline 0 CA--C 1.538 0.515 0 CA-C-N 115.32 -0.854 . . . . 0.0 109.264 169.217 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -59.36 -37.19 91.83 Favored 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 122.0 1.8 . . . . 0.0 111.636 172.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 17.4 m -68.18 -40.68 82.2 Favored 'General case' 0 N--CA 1.44 -0.958 0 C-N-CA 123.508 0.723 . . . . 0.0 110.589 -177.355 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 84.3 t -88.75 -30.02 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 O-C-N 121.632 -0.667 . . . . 0.0 110.719 -174.159 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -53.27 -45.94 69.07 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 119.202 0.91 . . . . 0.0 108.771 168.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -69.77 -15.48 63.14 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 114.266 1.21 . . . . 0.0 114.266 179.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 9.3 mmm -76.85 -12.72 60.01 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 117.698 -1.144 . . . . 0.0 112.118 172.265 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 58.3 mt -54.33 -54.47 21.35 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.37 0 CA-C-N 120.193 1.36 . . . . 0.0 108.991 173.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 76.7 mm-40 -66.41 -46.74 59.79 Favored Pre-proline 0 CA--C 1.552 1.023 0 CA-C-N 120.329 1.422 . . . . 0.0 111.059 -173.481 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 0.4 OUTLIER -44.71 -52.77 5.75 Favored 'Trans proline' 0 C--N 1.353 0.801 1 C-N-CA 125.645 4.23 . . . . 0.0 112.5 168.75 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.04 -36.48 75.07 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.983 -1.008 . . . . 0.0 112.267 -177.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 42.6 mt -62.27 -41.77 98.76 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 118.897 0.771 . . . . 0.0 109.054 173.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -59.21 -36.02 74.65 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 119.342 0.973 . . . . 0.0 110.561 174.346 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -62.95 -50.14 71.99 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 118.794 0.724 . . . . 0.0 111.455 172.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 66.1 t -56.28 -49.11 78.2 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.19 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 66.6 mt -58.09 -43.09 86.89 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 123.046 0.538 . . . . 0.0 109.704 179.469 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -65.31 -44.85 86.59 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 118.972 0.805 . . . . 0.0 110.661 -177.231 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -64.64 -34.03 77.33 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 119.15 0.886 . . . . 0.0 111.37 -178.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . 0.337 4.4 pp -75.9 -36.97 59.29 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-O 117.346 -1.311 . . . . 0.0 109.762 176.688 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 14.0 mtp-105 -67.49 -27.6 67.14 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 121.113 1.779 . . . . 0.0 110.811 173.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -73.01 -15.73 61.52 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 118.629 0.65 . . . . 0.0 110.58 174.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 15.3 m -93.88 9.05 38.92 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.964 1.305 . . . . 0.0 110.719 169.222 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 74.0 13.17 81.11 Favored Glycine 0 CA--C 1.527 0.815 0 CA-C-O 117.396 -1.78 . . . . 0.0 112.792 -176.212 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 44.5 t -88.76 132.17 34.3 Favored 'Isoleucine or valine' 0 C--N 1.345 0.387 0 CA-C-N 120.985 2.392 . . . . 0.0 107.362 -176.181 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -104.32 93.94 5.08 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 106.675 -1.602 . . . . 0.0 106.675 169.441 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -59.13 137.68 57.86 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 169.105 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 20.6 mm -85.64 126.88 65.06 Favored Pre-proline 0 C--O 1.231 0.119 0 CA-C-O 117.531 -1.223 . . . . 0.0 107.711 -174.625 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -68.1 91.11 0.38 Allowed 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 122.868 2.379 . . . . 0.0 108.998 175.004 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 32.1 ttp85 51.81 17.99 0.7 Allowed 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 127.573 2.349 . . . . 0.0 114.853 179.404 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 52.6 m . . . . . 0 CA--C 1.544 0.745 0 C-N-CA 124.312 1.045 . . . . 0.0 112.093 -169.25 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 15.3 ptt180 . . . . . 0 N--CA 1.477 0.895 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 73.7 mt -134.56 147.7 29.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 C-N-CA 124.089 0.956 . . . . 0.0 108.544 -172.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 13.7 tp -135.0 146.53 49.13 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 168.304 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 63.1 t -121.4 130.42 74.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 105.513 -2.032 . . . . 0.0 105.513 174.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -121.26 130.23 53.56 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-N 119.004 0.82 . . . . 0.0 110.756 -173.621 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -104.98 132.03 10.92 Favored Glycine 0 C--N 1.334 0.455 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 174.135 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -143.94 159.78 16.0 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-N 118.122 0.961 . . . . 0.0 112.008 -176.167 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 131.72 173.99 13.51 Favored Glycine 0 CA--C 1.527 0.814 0 C-N-CA 126.569 2.033 . . . . 0.0 110.286 170.249 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.436 HD21 ' HB2' ' A' ' 13' ' ' LEU . 5.8 t30 -79.15 93.82 5.27 Favored 'General case' 0 C--O 1.233 0.191 0 O-C-N 121.307 -1.113 . . . . 0.0 110.891 -173.472 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.1 pt -57.46 31.49 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.092 0 N-CA-C 117.48 2.4 . . . . 0.0 117.48 172.285 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 38.3 mt -131.3 -3.75 3.86 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 120.671 1.578 . . . . 0.0 108.808 168.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.436 ' HB2' HD21 ' A' ' 10' ' ' ASN . 2.0 mp -118.1 59.8 0.79 Allowed 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.21 1.004 . . . . 0.0 113.459 -167.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 54.85 -96.92 0.06 Allowed 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 124.495 1.118 . . . . 0.0 111.248 171.201 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 41.1 m-20 -81.79 -15.46 54.16 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 124.601 1.16 . . . . 0.0 110.309 -172.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -72.65 -6.49 44.69 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 120.875 1.67 . . . . 0.0 112.609 178.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -82.3 -12.04 58.25 Favored 'General case' 0 N--CA 1.435 -1.189 0 CA-C-O 115.864 -2.017 . . . . 0.0 109.322 169.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 7.6 tp -52.36 -41.9 36.35 Favored 'Isoleucine or valine' 0 C--N 1.346 0.424 0 CA-C-N 122.57 2.441 . . . . 0.0 113.031 -169.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -60.7 -43.59 98.89 Favored Glycine 0 CA--C 1.524 0.608 0 CA-C-N 119.997 1.271 . . . . 0.0 110.708 177.482 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 55.9 t -65.67 -49.53 77.11 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 CA-C-O 118.768 -0.634 . . . . 0.0 109.609 173.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 26.3 mmt180 -60.66 -32.84 72.02 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 120.389 1.449 . . . . 0.0 112.649 -178.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 31.0 mt -62.85 -47.29 93.56 Favored 'Isoleucine or valine' 0 C--O 1.231 0.124 0 CA-C-N 120.649 1.568 . . . . 0.0 109.846 178.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 27.7 m -72.96 -27.15 24.16 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 CA-C-N 119.14 0.882 . . . . 0.0 111.063 -174.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -71.16 -43.38 67.63 Favored 'General case' 0 C--O 1.232 0.163 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 173.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.86 -40.58 95.85 Favored 'General case' 0 N--CA 1.449 -0.486 0 O-C-N 121.781 -0.574 . . . . 0.0 110.457 178.39 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 6.5 tp -62.57 -40.77 97.94 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 118.444 -0.789 . . . . 0.0 109.874 175.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -61.39 -40.49 94.55 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 119.005 0.82 . . . . 0.0 111.191 178.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -71.91 -36.98 70.15 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 124.107 0.963 . . . . 0.0 111.306 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -95.07 -34.69 12.21 Favored 'General case' 0 C--N 1.341 0.225 0 CA-C-O 117.372 -1.299 . . . . 0.0 113.459 -169.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -119.02 148.7 42.72 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 120.956 1.707 . . . . 0.0 112.182 -173.049 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 40.7 mm -96.06 138.44 21.47 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 N-CA-C 103.804 -2.665 . . . . 0.0 103.804 168.496 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -121.95 148.74 52.13 Favored Pre-proline 0 CA--C 1.534 0.357 0 C-N-CA 123.795 0.838 . . . . 0.0 108.873 -174.018 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -65.68 159.62 47.46 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 122.207 1.938 . . . . 0.0 109.674 169.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -58.51 -31.74 68.17 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 -170.106 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 15.6 p90 -80.11 0.24 32.95 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 118.072 -0.966 . . . . 0.0 113.364 -177.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 88.3 t -113.53 127.27 70.95 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 N-CA-C 105.766 -1.939 . . . . 0.0 105.766 169.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -132.5 143.97 50.12 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 170.064 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -93.33 103.68 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.066 0 N-CA-C 105.37 -2.085 . . . . 0.0 105.37 169.712 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -90.16 162.2 15.38 Favored 'General case' 0 C--O 1.237 0.436 0 N-CA-C 107.813 -1.181 . . . . 0.0 107.813 172.275 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -131.94 122.6 25.86 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 123.836 0.854 . . . . 0.0 109.068 -171.295 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -87.6 -98.63 0.89 Allowed Glycine 0 CA--C 1.526 0.769 0 N-CA-C 107.048 -2.421 . . . . 0.0 107.048 169.673 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 81.08 116.63 0.38 Allowed Glycine 0 C--N 1.34 0.758 0 N-CA-C 108.702 -1.759 . . . . 0.0 108.702 -173.295 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 19.1 p 51.54 57.75 6.23 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.276 1.031 . . . . 0.0 108.773 -178.03 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -115.99 -88.14 0.59 Allowed 'General case' 0 C--N 1.342 0.281 0 CA-C-N 114.259 -1.337 . . . . 0.0 110.986 -169.189 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 75.12 -91.68 0.82 Allowed Glycine 0 C--N 1.34 0.798 0 N-CA-C 109.053 -1.619 . . . . 0.0 109.053 -169.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 66.1 mmm -76.56 -21.56 55.48 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 -177.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -62.21 -14.97 43.48 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 113.187 0.81 . . . . 0.0 113.187 -169.508 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 18.6 mt -79.34 -5.26 54.14 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 114.276 1.213 . . . . 0.0 114.276 -178.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 6.0 tt -38.65 -62.42 0.61 Allowed 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 114.84 1.422 . . . . 0.0 114.84 -170.014 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -90.86 -29.51 13.01 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 111.579 -0.608 . . . . 0.0 111.579 -174.196 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -65.86 -32.56 74.14 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 117.726 0.763 . . . . 0.0 110.974 -176.608 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 52.2 mtp -72.55 -14.47 61.64 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 113.456 0.91 . . . . 0.0 113.456 176.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -69.35 154.84 41.4 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 113.191 0.811 . . . . 0.0 113.191 -169.266 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 60.62 46.44 9.32 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.221 1.808 . . . . 0.0 115.375 168.332 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 18.7 mmt180 -114.48 155.54 26.22 Favored 'General case' 0 N--CA 1.479 0.994 0 O-C-N 121.155 -0.965 . . . . 0.0 108.887 171.516 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -81.4 -30.81 33.48 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 172.675 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -143.47 152.13 41.14 Favored 'General case' 0 C--N 1.343 0.324 0 CA-C-N 119.358 0.981 . . . . 0.0 109.77 168.193 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -137.04 139.73 41.57 Favored 'General case' 0 CA--C 1.51 -0.582 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 174.577 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 39.0 mt -114.32 115.12 48.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 176.147 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.8 mm -89.67 133.21 32.35 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 N-CA-C 106.071 -1.826 . . . . 0.0 106.071 175.013 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -114.26 115.95 28.24 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 103.557 -2.757 . . . . 0.0 103.557 168.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -154.15 161.12 42.08 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 -169.032 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -98.4 140.33 32.83 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.393 0.677 . . . . 0.0 110.583 -178.154 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 33.7 mm -78.66 -32.45 16.08 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 C-N-CA 123.847 0.859 . . . . 0.0 111.474 179.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . 0.296 4.0 t 60.14 45.27 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.89 0 C-N-CA 125.537 1.535 . . . . 0.0 110.809 -173.665 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 6.7 m 68.91 155.14 0.12 Allowed 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 116.985 2.217 . . . . 0.0 116.985 169.497 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 23.6 ttmt -157.88 -174.5 4.88 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 129.901 3.28 . . . . 0.0 104.159 174.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 10.5 ptpt -61.74 -21.25 64.35 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.699 1.2 . . . . 0.0 113.53 169.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 43.5 t-20 -65.34 156.36 32.39 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 118.95 0.795 . . . . 0.0 110.059 172.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 13.7 m -63.45 142.64 97.91 Favored Pre-proline 0 CA--C 1.546 0.795 0 C-N-CA 124.141 0.977 . . . . 0.0 112.197 -169.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -59.34 153.77 51.45 Favored 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 122.64 2.226 . . . . 0.0 112.043 169.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 67.79 18.0 69.91 Favored Glycine 0 CA--C 1.534 1.257 0 O-C-N 121.634 -0.666 . . . . 0.0 113.506 174.156 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 17.5 m -95.49 141.38 29.09 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 125.542 1.537 . . . . 0.0 107.895 177.251 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 30.7 ttp -98.71 145.43 26.91 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 175.36 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 32.0 ttm -130.88 117.73 19.72 Favored 'General case' 0 CA--C 1.528 0.103 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 -170.29 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.6 mp -96.78 122.33 48.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 179.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -117.7 122.69 44.17 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 67.5 mtp85 -102.11 135.36 43.83 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 118.516 -0.754 . . . . 0.0 109.807 176.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 8.2 t70 29.28 -91.69 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 126.681 1.992 . . . . 0.0 116.141 174.189 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -62.55 -26.84 68.79 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 -174.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -79.58 -12.44 59.84 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 122.844 0.458 . . . . 0.0 110.557 -179.414 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 46.4 t -75.39 -51.34 3.33 Favored Pre-proline 0 N--CA 1.446 -0.653 0 CA-C-O 116.66 -1.638 . . . . 0.0 110.777 -174.25 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo -59.33 -41.3 60.04 Favored 'Trans proline' 0 C--N 1.351 0.698 0 CA-C-N 122.865 2.059 . . . . 0.0 111.525 171.545 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -60.88 -29.69 69.7 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 122.997 0.519 . . . . 0.0 111.787 -179.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -79.8 -54.11 6.15 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 122.89 0.476 . . . . 0.0 110.57 170.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -56.73 -34.11 67.2 Favored 'General case' 0 C--O 1.227 -0.093 0 CA-C-N 118.319 0.509 . . . . 0.0 111.448 -171.191 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 3.6 t -64.24 -5.27 4.7 Favored 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 -172.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -54.09 136.1 42.43 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 119.593 1.088 . . . . 0.0 110.204 169.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -81.66 -15.82 53.33 Favored 'General case' 0 N--CA 1.471 0.62 0 O-C-N 122.043 -0.41 . . . . 0.0 111.493 178.018 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 52.9 mt -61.61 -44.72 99.13 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 123.86 0.864 . . . . 0.0 109.601 -169.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 37.8 t -89.86 121.05 69.32 Favored Pre-proline 0 N--CA 1.452 -0.35 0 C-N-CA 124.386 1.075 . . . . 0.0 110.017 171.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_exo -61.93 -37.35 66.33 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 122.844 2.362 . . . . 0.0 110.082 169.068 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 5.6 m80 -59.91 -54.11 49.95 Favored 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 179.37 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -75.58 -25.73 57.31 Favored 'General case' 0 C--O 1.219 -0.526 0 C-N-CA 117.577 -1.649 . . . . 0.0 111.437 -174.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 2.8 tt -58.28 -50.7 72.69 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 120.546 1.521 . . . . 0.0 108.323 171.036 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -59.43 -46.74 93.42 Favored Glycine 0 CA--C 1.527 0.821 0 N-CA-C 110.746 -0.942 . . . . 0.0 110.746 177.008 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 32.0 tp -69.91 -20.57 63.36 Favored 'General case' 0 CA--C 1.547 0.85 0 O-C-N 121.653 -0.91 . . . . 0.0 111.312 -177.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -68.68 -46.86 67.95 Favored 'General case' 0 CA--C 1.534 0.339 0 O-C-N 121.127 -0.983 . . . . 0.0 109.272 171.504 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -71.13 -22.23 62.09 Favored 'General case' 0 C--N 1.339 0.138 0 CA-C-O 119.246 -0.407 . . . . 0.0 111.48 177.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 4.8 t -62.85 -43.32 98.77 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.729 0 CA-C-O 117.948 -1.025 . . . . 0.0 108.851 169.287 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 42.7 mt -60.93 -32.43 71.93 Favored 'General case' 0 C--N 1.34 0.156 0 CA-C-N 120.456 1.48 . . . . 0.0 111.096 175.524 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 66.2 m -68.14 -38.87 82.65 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 119.173 0.897 . . . . 0.0 110.657 173.068 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -65.5 -38.65 90.33 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 119.619 1.1 . . . . 0.0 111.28 174.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -64.19 -36.5 84.27 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 118.879 0.763 . . . . 0.0 110.38 174.19 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 34.9 ttp-105 -65.51 -36.22 83.18 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 121.701 -0.625 . . . . 0.0 109.551 175.181 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 14.3 m-30 -68.48 -40.61 80.87 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 118.873 0.76 . . . . 0.0 111.012 178.227 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 54.4 p -74.24 -26.93 60.53 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 119.481 1.037 . . . . 0.0 111.278 177.603 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 75.93 9.93 85.15 Favored Glycine 0 CA--C 1.531 1.056 0 CA-C-O 119.046 -0.863 . . . . 0.0 111.568 -170.089 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -99.46 24.42 8.16 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 118.949 1.374 . . . . 0.0 111.121 -178.395 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -57.64 135.24 82.56 Favored Pre-proline 0 CA--C 1.543 0.697 0 C-N-CA 126.116 1.766 . . . . 0.0 109.959 178.044 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -52.88 132.93 49.26 Favored 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 122.845 2.363 . . . . 0.0 112.081 177.104 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 31.3 mmtp -65.63 -24.22 66.99 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 119.149 -0.453 . . . . 0.0 111.932 -172.104 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 1.5 tmmt? -140.6 100.99 3.99 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 106.013 -1.847 . . . . 0.0 106.013 169.59 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 23.8 tp -78.51 140.78 38.54 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 174.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -134.79 138.96 44.74 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 107.159 -1.422 . . . . 0.0 107.159 176.831 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.1 tp -135.59 129.83 33.52 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 120.077 1.308 . . . . 0.0 108.92 175.39 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 47.9 t -103.28 105.03 17.55 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 N-CA-C 103.55 -2.759 . . . . 0.0 103.55 168.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -84.92 145.36 21.56 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 110.485 -1.046 . . . . 0.0 110.485 174.276 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 42.0 t -121.17 133.0 69.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 171.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 14.2 mt -88.89 132.11 39.26 Favored Pre-proline 0 CA--C 1.539 0.539 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 169.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -77.7 -178.29 4.49 Favored 'Trans proline' 0 CA--C 1.537 0.64 0 C-N-CA 123.582 2.854 . . . . 0.0 111.862 -175.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -119.05 -52.96 2.29 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.815 0.846 . . . . 0.0 111.207 178.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 66.5 m -118.51 -51.69 2.39 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 119.081 0.855 . . . . 0.0 112.868 -172.421 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER 57.7 52.55 8.08 Favored 'General case' 0 CA--C 1.551 0.997 0 N-CA-C 114.646 1.35 . . . . 0.0 114.646 169.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -115.93 168.51 8.37 Favored Pre-proline 0 N--CA 1.481 1.092 0 CA-C-O 118.421 -0.799 . . . . 0.0 111.182 176.159 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -65.19 89.69 0.2 Allowed 'Trans proline' 0 CA--C 1.548 1.18 0 C-N-CA 123.447 2.765 . . . . 0.0 113.756 -178.26 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 179.86 149.26 0.32 Allowed 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 104.538 -2.393 . . . . 0.0 104.538 175.6 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -110.52 163.49 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-N 119.614 1.097 . . . . 0.0 112.927 -169.83 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 86.16 150.19 15.04 Favored Glycine 0 C--N 1.341 0.814 0 N-CA-C 107.468 -2.253 . . . . 0.0 107.468 -169.489 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -79.03 164.49 24.31 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-O 121.536 0.684 . . . . 0.0 110.031 -169.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 23.6 p -65.93 166.74 14.26 Favored Pre-proline 0 CA--C 1.539 0.556 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 167.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -53.74 -32.13 64.33 Favored 'Trans proline' 0 CA--C 1.537 0.674 0 C-N-CA 121.4 1.4 . . . . 0.0 111.545 169.601 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 22.1 m -69.57 -46.49 66.25 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 117.993 0.36 . . . . 0.0 111.148 179.544 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 22.2 t -94.1 -15.36 7.87 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-N 118.626 0.648 . . . . 0.0 111.25 -169.186 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -57.88 -47.03 83.97 Favored 'General case' 0 C--O 1.233 0.202 0 O-C-N 120.301 -1.499 . . . . 0.0 107.764 169.374 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -72.03 0.23 9.97 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-O 118.04 -0.981 . . . . 0.0 113.135 177.03 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 83.2 mtp -88.92 -10.02 49.39 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-N 120.001 1.273 . . . . 0.0 111.395 171.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 87.8 mt -57.16 -41.52 78.0 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 169.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 39.1 mm-40 -64.26 -60.61 8.28 Favored Pre-proline 0 CA--C 1.541 0.633 0 CA-C-O 117.979 -1.01 . . . . 0.0 112.703 -172.65 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -62.47 -32.98 80.34 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 CA-C-N 121.397 1.535 . . . . 0.0 110.994 178.444 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -68.04 -43.84 77.81 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-N 119.448 1.022 . . . . 0.0 109.75 -179.065 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 58.5 mt -58.21 -43.16 87.51 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 119.187 0.903 . . . . 0.0 109.697 173.105 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -59.62 -38.18 80.62 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 119.096 0.862 . . . . 0.0 110.366 179.775 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 20.0 mm100 -75.15 -33.95 61.57 Favored 'General case' 0 C--N 1.338 0.093 0 CA-C-O 117.817 -1.087 . . . . 0.0 112.97 175.426 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 67.2 t -59.83 -46.3 93.88 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 CA-C-N 120.442 1.474 . . . . 0.0 108.101 172.055 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 29.1 mt -66.72 -41.02 88.6 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 122.921 0.488 . . . . 0.0 110.116 -178.189 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -63.89 -40.16 95.86 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 119.226 0.921 . . . . 0.0 111.394 176.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -67.0 -41.11 87.27 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 122.683 0.393 . . . . 0.0 110.884 178.775 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 34.2 mt -59.51 -42.82 93.08 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 123.03 0.532 . . . . 0.0 109.91 173.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 -64.37 -15.93 61.35 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 117.362 -1.304 . . . . 0.0 111.886 -178.44 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -58.91 -41.81 88.12 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 120.678 1.581 . . . . 0.0 110.902 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 2.7 p -89.66 23.44 2.66 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.193 0.597 . . . . 0.0 111.423 178.081 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 70.32 22.41 77.56 Favored Glycine 0 CA--C 1.531 1.045 0 CA-C-O 118.761 -1.021 . . . . 0.0 113.415 -178.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 40.7 t -100.46 89.84 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.257 0 CA-C-N 119.054 1.427 . . . . 0.0 107.955 -175.38 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -76.76 137.22 39.17 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 169.389 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -85.68 155.2 21.19 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.546 0.738 . . . . 0.0 110.517 176.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 88.9 mt -93.24 116.58 66.7 Favored Pre-proline 0 CA--C 1.541 0.61 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 -178.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -73.66 92.2 0.87 Allowed 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 123.405 2.737 . . . . 0.0 109.808 -176.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 7.6 ttt-85 48.11 16.92 0.1 Allowed 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 128.172 2.589 . . . . 0.0 115.513 -174.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.544 0.741 0 C-N-CA 126.123 1.769 . . . . 0.0 110.813 -172.406 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 9.0 ptp180 . . . . . 0 N--CA 1.482 1.167 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 50.6 mt -142.52 139.42 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 CA-C-N 119.708 1.14 . . . . 0.0 112.603 -168.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -121.68 123.31 41.59 Favored 'General case' 0 N--CA 1.462 0.163 0 N-CA-C 104.776 -2.305 . . . . 0.0 104.776 167.484 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 57.5 t -101.45 99.32 8.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 101.576 -3.49 . . . . 0.0 101.576 169.539 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 14.1 tp -101.34 107.6 18.99 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 124.195 0.998 . . . . 0.0 110.203 -168.061 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -88.52 123.86 6.96 Favored Glycine 0 N--CA 1.45 -0.408 0 N-CA-C 107.337 -2.305 . . . . 0.0 107.337 174.346 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -136.87 164.63 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.707 0 C-N-CA 124.054 0.941 . . . . 0.0 108.58 -176.534 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 145.72 156.93 7.06 Favored Glycine 0 N--CA 1.447 -0.625 0 N-CA-C 109.064 -1.614 . . . . 0.0 109.064 178.215 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -76.47 94.89 3.75 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 171.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.3 pt -70.77 37.74 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 C-N-CA 124.577 1.151 . . . . 0.0 113.567 179.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 23.0 mt -125.15 -8.04 7.09 Favored 'General case' 0 CA--C 1.537 0.466 0 O-C-N 121.148 -0.97 . . . . 0.0 108.768 170.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.0 mp -118.65 67.61 0.78 Allowed 'General case' 0 C--N 1.346 0.414 0 C-N-CA 124.006 0.923 . . . . 0.0 109.118 -169.002 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.3 m 47.3 -111.12 0.35 Allowed 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 114.761 -1.109 . . . . 0.0 111.654 171.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 87.6 m-20 -71.9 -11.25 60.7 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-O 117.614 -1.184 . . . . 0.0 112.302 -170.235 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -66.54 -18.02 65.13 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 121.4 1.909 . . . . 0.0 111.032 171.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -70.6 -12.83 61.81 Favored 'General case' 0 N--CA 1.448 -0.555 0 O-C-N 120.178 -1.576 . . . . 0.0 111.769 171.392 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.4 tp -58.1 -36.45 57.03 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-N 121.271 1.85 . . . . 0.0 111.613 -174.019 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -61.48 -38.38 95.69 Favored Glycine 0 C--N 1.339 0.697 0 CA-C-N 119.365 0.984 . . . . 0.0 111.769 178.037 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 54.8 t -72.42 -47.04 54.01 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 175.111 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 24.7 mmt180 -60.96 -31.18 70.75 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 116.939 -1.505 . . . . 0.0 112.94 -179.244 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 18.4 mt -61.62 -47.74 91.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 CA-C-N 121.565 1.984 . . . . 0.0 110.17 177.078 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 14.4 m -72.78 -33.48 44.11 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-N 119.192 0.906 . . . . 0.0 110.912 -174.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 57.6 mt-10 -63.66 -42.98 98.01 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 118.428 0.558 . . . . 0.0 110.334 171.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.18 -39.37 92.46 Favored 'General case' 0 CA--C 1.537 0.452 0 O-C-N 121.292 -0.88 . . . . 0.0 110.647 176.006 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 6.1 tp -66.06 -39.61 90.23 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 118.451 0.569 . . . . 0.0 110.081 -179.317 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -60.68 -28.9 68.96 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 121.512 0.672 . . . . 0.0 112.131 -178.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 -88.19 -40.21 13.89 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 125.891 1.676 . . . . 0.0 111.14 -178.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 56.4 mtp180 -94.17 -18.44 21.73 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-O 118.449 -0.786 . . . . 0.0 112.364 -170.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 49.8 m-85 -129.58 147.05 51.34 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 119.354 0.979 . . . . 0.0 112.552 177.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 39.5 mm -98.28 137.08 26.84 Favored 'Isoleucine or valine' 0 C--O 1.239 0.518 0 N-CA-C 103.62 -2.733 . . . . 0.0 103.62 168.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -120.19 150.54 51.62 Favored Pre-proline 0 C--O 1.237 0.414 0 C-N-CA 123.297 0.639 . . . . 0.0 110.49 -169.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -59.05 157.56 28.97 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 123.128 2.552 . . . . 0.0 111.227 169.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -61.55 -31.51 71.54 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -175.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 9.6 p90 -75.76 -11.12 59.93 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 -179.512 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 92.5 t -92.87 122.9 44.74 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 173.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -117.62 123.59 46.54 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 169.476 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -86.48 117.78 31.58 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 N-CA-C 104.168 -2.53 . . . . 0.0 104.168 168.512 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 63.8 tp -118.9 130.75 55.89 Favored 'General case' 0 CA--C 1.523 -0.083 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 178.152 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -89.42 119.13 29.61 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 169.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -77.54 -80.14 0.68 Allowed Glycine 0 CA--C 1.528 0.872 0 N-CA-C 106.834 -2.507 . . . . 0.0 106.834 169.189 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 78.48 107.05 0.2 Allowed Glycine 0 C--N 1.345 1.044 0 N-CA-C 109.176 -1.57 . . . . 0.0 109.176 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 10.5 p 53.41 55.47 8.65 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 -177.106 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -120.35 -83.4 0.66 Allowed 'General case' 0 C--N 1.347 0.482 0 CA-C-N 115.005 -0.998 . . . . 0.0 112.255 -169.279 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 58.93 -107.21 1.09 Allowed Glycine 0 CA--C 1.532 1.15 0 N-CA-C 110.511 -1.036 . . . . 0.0 110.511 -178.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 11.7 tpt -55.95 -28.18 55.81 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.665 1.186 . . . . 0.0 112.627 -177.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -56.46 -22.12 30.1 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 113.827 1.047 . . . . 0.0 113.827 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 15.1 mt -103.3 17.95 22.89 Favored 'General case' 0 C--N 1.341 0.233 0 N-CA-C 115.978 1.844 . . . . 0.0 115.978 -167.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 6.2 tt -48.09 -56.35 8.01 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 119.447 1.021 . . . . 0.0 111.109 -178.166 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -66.42 -36.58 91.78 Favored Glycine 0 CA--C 1.528 0.898 0 CA-C-O 119.259 -0.745 . . . . 0.0 112.447 -177.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -73.69 -35.1 65.13 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 118.886 1.343 . . . . 0.0 111.817 -176.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 78.8 mtp -71.88 -12.71 61.4 Favored 'General case' 0 CA--C 1.535 0.401 0 O-C-N 121.962 -0.461 . . . . 0.0 110.323 179.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -84.12 153.63 23.62 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 123.306 0.642 . . . . 0.0 111.57 -170.424 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 54.24 34.8 21.17 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 126.475 1.91 . . . . 0.0 112.847 170.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 26.1 mmt180 -98.31 157.57 16.1 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 173.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -84.67 -51.4 6.85 Favored 'General case' 0 C--O 1.221 -0.42 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 175.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . 0.269 0.0 OUTLIER -120.25 146.43 46.07 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 120.017 1.281 . . . . 0.0 108.272 168.652 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 33.1 tp -130.46 111.63 12.48 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 104.172 -2.529 . . . . 0.0 104.172 173.092 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 52.7 mt -93.24 111.71 25.19 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 N-CA-C 103.801 -2.666 . . . . 0.0 103.801 171.17 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 53.5 mt -83.86 133.69 28.63 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 N-CA-C 105.233 -2.136 . . . . 0.0 105.233 170.651 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -116.97 116.77 28.03 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 102.519 -3.141 . . . . 0.0 102.519 168.038 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -161.57 165.77 27.95 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 123.518 0.727 . . . . 0.0 109.796 -176.248 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -81.34 144.53 31.41 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-O 122.355 1.074 . . . . 0.0 110.031 169.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 12.0 mt -69.1 -51.04 47.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 114.55 -1.205 . . . . 0.0 107.957 170.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . 0.294 9.0 p 42.22 48.45 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.95 0 C-N-CA 125.276 1.43 . . . . 0.0 111.071 179.753 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 8.4 t -162.79 176.42 10.28 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.368 1.467 . . . . 0.0 109.624 -171.572 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 20.0 ttmt 51.14 -161.17 0.08 Allowed 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 127.386 2.274 . . . . 0.0 112.175 -173.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 14.6 ptpt -128.89 12.79 6.26 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 125.036 1.334 . . . . 0.0 112.973 -169.394 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 44.8 t30 -74.75 167.22 22.25 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 178.051 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 2.8 m -56.93 145.87 61.92 Favored Pre-proline 0 CA--C 1.546 0.795 0 C-N-CA 123.812 0.845 . . . . 0.0 112.132 -169.704 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -56.23 155.82 23.18 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 123.84 3.026 . . . . 0.0 112.701 169.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 65.15 17.44 63.62 Favored Glycine 0 CA--C 1.535 1.321 0 CA-C-O 119.696 -0.502 . . . . 0.0 113.242 170.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 3.1 m -95.58 142.19 28.21 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 125.176 1.39 . . . . 0.0 109.11 -175.036 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 44.5 ttp -95.16 141.66 28.51 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 169.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 75.1 mtm -132.02 145.85 51.7 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 169.363 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.5 mp -97.22 119.66 45.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 N-CA-C 105.358 -2.09 . . . . 0.0 105.358 172.093 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.8 mp -113.79 136.02 53.32 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 171.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 36.4 mmt180 -96.39 164.13 12.77 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 123.018 0.527 . . . . 0.0 110.863 178.607 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -1.09 -70.13 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 127.839 2.456 . . . . 0.0 117.438 169.465 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -87.6 -19.87 27.18 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 113.533 0.938 . . . . 0.0 113.533 -170.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -76.77 -37.4 55.95 Favored 'General case' 0 CA--C 1.523 -0.084 0 CA-C-O 121.135 0.493 . . . . 0.0 110.095 -172.627 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -66.85 -52.48 32.49 Favored Pre-proline 0 CA--C 1.538 0.51 0 CA-C-O 117.417 -1.278 . . . . 0.0 112.723 -174.149 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -55.4 -42.01 72.46 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 121.57 1.513 . . . . 0.0 110.551 177.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.8 -15.53 63.53 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 178.118 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -92.69 -46.06 7.75 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 119.854 1.206 . . . . 0.0 110.674 -176.092 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -68.77 -1.72 7.72 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 113.988 1.107 . . . . 0.0 113.988 -169.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 62.5 p -59.51 -21.17 59.79 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.759 1.223 . . . . 0.0 112.587 178.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 42.3 t-20 -65.91 149.88 49.5 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.542 0.737 . . . . 0.0 111.192 -175.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -84.93 -6.33 59.34 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.15 0.98 . . . . 0.0 113.569 -170.036 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 20.3 mt -59.56 -43.53 91.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 C-N-CA 123.676 0.79 . . . . 0.0 111.147 -169.444 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 28.3 t -117.72 125.28 28.16 Favored Pre-proline 0 C--O 1.235 0.295 0 N-CA-C 109.038 -0.726 . . . . 0.0 109.038 174.541 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -71.29 -30.01 16.3 Favored 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 122.578 2.185 . . . . 0.0 110.547 175.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 30.1 t-80 -67.19 -43.38 82.29 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 119.05 0.841 . . . . 0.0 108.815 177.283 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 7.4 mm100 -66.13 -38.8 89.06 Favored 'General case' 0 C--O 1.22 -0.46 0 CA-C-O 117.603 -1.189 . . . . 0.0 110.291 175.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 1.3 tt -56.47 -40.81 75.51 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 120.141 1.337 . . . . 0.0 109.373 174.095 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -60.81 -44.75 97.64 Favored Glycine 0 CA--C 1.529 0.942 0 O-C-N 121.237 -0.915 . . . . 0.0 111.434 175.176 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 51.1 tp -64.24 -32.44 74.03 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 117.893 0.847 . . . . 0.0 110.245 174.446 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -62.07 -51.39 68.15 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 119.517 1.053 . . . . 0.0 109.034 176.148 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -70.91 -28.33 64.44 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.011 -174.425 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -70.02 -41.99 79.4 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.922 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 172.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 32.1 mt -64.31 -35.66 81.57 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 119.521 1.055 . . . . 0.0 110.174 177.083 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 49.8 m -63.38 -37.19 86.32 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 118.983 0.81 . . . . 0.0 110.451 169.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.429 ' HA ' ' CD2' ' A' ' 106' ' ' PHE . . . -66.61 -39.14 88.21 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 119.58 1.082 . . . . 0.0 111.221 177.609 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -63.13 -31.67 72.87 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 118.69 0.677 . . . . 0.0 109.987 172.14 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 58.6 ttt85 -72.37 -34.41 67.95 Favored 'General case' 0 CA--C 1.533 0.32 0 O-C-N 121.103 -0.998 . . . . 0.0 109.864 175.507 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.429 ' CD2' ' HA ' ' A' ' 103' ' ' ALA . 13.9 m-30 -68.42 -44.09 75.76 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 118.829 0.74 . . . . 0.0 110.583 178.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 40.4 p -70.97 -26.77 63.3 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 118.52 0.6 . . . . 0.0 111.745 -179.424 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 73.19 7.07 70.8 Favored Glycine 0 CA--C 1.535 1.282 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 -168.34 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -89.51 16.85 7.0 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 119.467 1.633 . . . . 0.0 110.937 178.302 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -54.88 139.85 61.57 Favored Pre-proline 0 CA--C 1.549 0.918 0 C-N-CA 125.824 1.65 . . . . 0.0 109.702 172.076 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_exo -55.56 156.9 16.59 Favored 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 123.38 2.72 . . . . 0.0 115.697 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 66.7 mmtt -63.76 -40.44 96.7 Favored 'General case' 0 N--CA 1.472 0.661 0 O-C-N 121.768 -0.582 . . . . 0.0 111.418 -179.433 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 5.4 pttm -131.72 146.14 52.01 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 105.663 -1.977 . . . . 0.0 105.663 171.282 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 7.0 tt -140.26 139.36 35.54 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 175.335 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -137.9 134.57 35.19 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 -171.274 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -122.79 118.42 27.95 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 120.409 1.459 . . . . 0.0 108.512 177.798 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 16.1 t -88.05 81.99 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 N-CA-C 105.05 -2.204 . . . . 0.0 105.05 175.335 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -80.76 141.9 23.07 Favored Glycine 0 C--O 1.225 -0.434 0 CA-C-O 119.272 -0.738 . . . . 0.0 111.573 -169.595 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 42.0 t -119.9 123.6 71.18 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.105 0 CA-C-N 117.396 0.598 . . . . 0.0 109.946 177.522 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 25.7 mt -78.23 127.87 79.95 Favored Pre-proline 0 CA--C 1.53 0.207 0 N-CA-C 104.999 -2.222 . . . . 0.0 104.999 169.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -69.15 160.0 51.61 Favored 'Trans proline' 0 N--CA 1.45 -1.062 0 C-N-CA 121.756 1.637 . . . . 0.0 110.966 179.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -94.67 -42.92 8.52 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 105.871 -1.9 . . . . 0.0 105.871 168.144 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 49.9 m -137.28 149.22 46.95 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 123.791 0.837 . . . . 0.0 109.494 173.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.2 tp -143.48 53.54 1.33 Allowed 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.976 1.311 . . . . 0.0 108.499 -175.507 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -114.49 168.18 8.44 Favored Pre-proline 0 CA--C 1.538 0.482 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 -173.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -82.08 84.66 1.82 Allowed 'Trans proline' 0 N--CA 1.454 -0.802 0 CA-C-N 120.952 1.376 . . . . 0.0 112.654 -169.45 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -174.28 145.37 1.01 Allowed 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 103.511 -2.774 . . . . 0.0 103.511 179.401 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -112.03 168.33 4.99 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 N-CA-C 113.352 0.871 . . . . 0.0 113.352 -169.264 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 96.76 148.79 24.69 Favored Glycine 0 CA--C 1.528 0.893 0 N-CA-C 106.066 -2.814 . . . . 0.0 106.066 -168.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -75.3 163.02 27.91 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 118.312 1.056 . . . . 0.0 110.569 177.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 58.4 p -71.05 171.4 8.6 Favored Pre-proline 0 CA--C 1.543 0.706 0 CA-C-N 114.929 -1.032 . . . . 0.0 109.051 168.52 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -58.06 -33.79 97.71 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 121.927 1.751 . . . . 0.0 112.393 172.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 57.7 m -72.65 -40.1 66.62 Favored 'General case' 0 N--CA 1.443 -0.785 0 C-N-CA 123.463 0.705 . . . . 0.0 111.178 -178.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 95.1 t -94.44 -23.85 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 CA-C-N 118.438 0.563 . . . . 0.0 111.523 -169.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -51.37 -44.77 62.21 Favored 'General case' 0 N--CA 1.467 0.402 0 O-C-N 120.836 -1.165 . . . . 0.0 109.497 169.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -71.3 -18.79 62.39 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 114.405 1.261 . . . . 0.0 114.405 -178.69 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 74.8 mtp -67.82 -14.92 63.35 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 118.005 -0.998 . . . . 0.0 112.829 -179.186 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 13.6 mt -48.87 -42.53 13.87 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.387 0 CA-C-N 119.635 1.107 . . . . 0.0 108.362 169.447 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 61.5 mm-40 -64.88 -58.32 13.31 Favored Pre-proline 0 CA--C 1.539 0.553 0 CA-C-N 120.351 1.432 . . . . 0.0 111.5 -172.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -61.32 -37.16 74.9 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 CA-C-N 121.447 1.553 . . . . 0.0 112.36 177.453 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -73.13 -37.83 66.52 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-O 118.569 -0.729 . . . . 0.0 111.499 -176.495 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 32.8 mt -62.24 -43.64 98.38 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-N 119.653 1.115 . . . . 0.0 109.041 170.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -55.78 -36.57 67.53 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 118.742 0.701 . . . . 0.0 110.131 174.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -72.44 -41.35 66.23 Favored 'General case' 0 N--CA 1.454 -0.26 0 O-C-N 121.442 -0.786 . . . . 0.0 112.712 177.527 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 60.1 t -58.76 -47.58 88.68 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 175.47 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 60.0 mt -60.99 -35.31 76.48 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-O 118.763 -0.637 . . . . 0.0 110.788 177.12 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -68.2 -46.22 71.21 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 119.243 0.928 . . . . 0.0 110.54 178.209 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -67.72 -30.06 69.46 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 119.882 1.219 . . . . 0.0 111.162 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 13.9 mt -63.06 -52.68 61.82 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 169.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 50.9 mmm-85 -66.04 -26.9 67.72 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 119.765 1.166 . . . . 0.0 112.412 -177.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 71.2 mt-10 -66.5 -30.13 70.38 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 119.569 1.077 . . . . 0.0 109.872 174.558 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 20.4 m -84.0 6.66 21.15 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.388 1.075 . . . . 0.0 111.957 171.118 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 72.06 12.15 75.32 Favored Glycine 0 CA--C 1.526 0.744 0 CA-C-O 117.294 -1.837 . . . . 0.0 112.98 -172.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 55.2 t -91.72 122.25 42.98 Favored 'Isoleucine or valine' 0 C--N 1.346 0.447 0 CA-C-N 121.048 2.424 . . . . 0.0 108.019 -176.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -104.26 93.5 4.85 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 173.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -58.9 146.04 39.07 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.823 169.129 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 22.9 mm -98.76 127.0 36.76 Favored Pre-proline 0 CA--C 1.53 0.21 0 CA-C-O 117.396 -1.287 . . . . 0.0 109.067 -171.454 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -67.96 97.99 0.5 Allowed 'Trans proline' 0 CA--C 1.535 0.536 0 C-N-CA 122.702 2.268 . . . . 0.0 109.753 174.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 23.2 mtp-105 48.32 18.04 0.15 Allowed 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 127.45 2.3 . . . . 0.0 115.327 -178.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 53.3 m . . . . . 0 CA--C 1.541 0.605 0 C-N-CA 124.229 1.012 . . . . 0.0 111.876 -169.582 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 16.2 ptt180 . . . . . 0 N--CA 1.471 0.594 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 84.8 mt -127.39 130.93 70.78 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.14 0 N-CA-C 107.896 -1.149 . . . . 0.0 107.896 -175.609 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -119.61 144.95 46.84 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 105.513 -2.032 . . . . 0.0 105.513 168.799 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 71.4 t -121.95 128.13 75.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 104.891 -2.263 . . . . 0.0 104.891 174.222 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -111.26 130.79 55.55 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-N 118.398 0.544 . . . . 0.0 109.85 -179.55 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -100.61 126.08 8.8 Favored Glycine 0 C--O 1.237 0.32 0 N-CA-C 108.211 -1.956 . . . . 0.0 108.211 171.296 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 1.9 m -141.22 171.56 12.04 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 CA-C-N 117.797 0.799 . . . . 0.0 110.278 -173.225 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 103.03 156.69 25.13 Favored Glycine 0 N--CA 1.442 -0.953 0 C-N-CA 126.352 1.93 . . . . 0.0 110.052 -178.625 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.44 HD22 ' HB2' ' A' ' 12' ' ' LEU . 4.1 t30 -72.51 104.21 3.76 Favored 'General case' 0 N--CA 1.453 -0.321 0 O-C-N 121.709 -0.877 . . . . 0.0 111.247 -169.378 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.1 pt -59.92 30.64 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.954 0 N-CA-C 117.228 2.307 . . . . 0.0 117.228 172.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.44 ' HB2' HD22 ' A' ' 10' ' ' ASN . 5.4 mp -129.79 -6.68 4.55 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 120.593 1.542 . . . . 0.0 108.436 168.439 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.411 ' HB2' HD21 ' A' ' 10' ' ' ASN . 3.0 mp -107.98 57.05 0.62 Allowed 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 119.255 0.934 . . . . 0.0 112.796 -168.123 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER 51.16 -109.83 0.45 Allowed 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 123.898 0.879 . . . . 0.0 110.123 175.176 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -77.85 -4.49 46.88 Favored 'General case' 0 N--CA 1.443 -0.78 0 O-C-N 121.59 -0.694 . . . . 0.0 111.021 -173.714 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -69.63 -12.17 61.43 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 120.647 1.567 . . . . 0.0 111.837 170.193 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -77.97 -9.95 59.35 Favored 'General case' 0 N--CA 1.435 -1.222 0 CA-C-O 115.736 -2.078 . . . . 0.0 109.635 170.497 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.7 tp -55.11 -39.14 49.19 Favored 'Isoleucine or valine' 0 C--N 1.348 0.537 0 CA-C-N 122.395 2.362 . . . . 0.0 111.995 -170.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -61.01 -39.5 97.17 Favored Glycine 0 C--N 1.336 0.58 0 CA-C-N 119.151 0.887 . . . . 0.0 111.038 177.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 97.1 t -74.45 -47.56 39.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 CA-C-O 118.54 -0.743 . . . . 0.0 109.861 176.024 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 76.2 mmt-85 -59.66 -33.84 72.06 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 119.983 1.265 . . . . 0.0 111.76 -179.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 22.8 mt -56.45 -51.49 64.1 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-N 120.363 1.438 . . . . 0.0 110.181 173.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 24.8 m -75.2 -25.98 18.54 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-N 119.075 0.852 . . . . 0.0 111.206 -172.56 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -69.88 -45.72 67.07 Favored 'General case' 0 C--O 1.233 0.187 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 174.355 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -67.35 -40.2 85.8 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 122.723 0.409 . . . . 0.0 110.386 -179.18 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.7 tp -61.56 -38.41 87.39 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 118.441 -0.79 . . . . 0.0 110.554 177.515 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -64.3 -42.21 96.49 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 118.956 0.798 . . . . 0.0 110.292 177.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -68.59 -36.37 78.62 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 122.873 0.469 . . . . 0.0 111.466 178.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 79.1 mmt-85 -94.36 -40.55 9.88 Favored 'General case' 0 C--N 1.339 0.122 0 CA-C-O 116.951 -1.499 . . . . 0.0 112.771 -170.3 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -117.19 130.33 56.52 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 121.588 1.994 . . . . 0.0 113.244 -169.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 40.2 mm -83.29 134.92 25.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 105.607 -1.997 . . . . 0.0 105.607 168.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.6 mp -133.34 150.69 75.9 Favored Pre-proline 0 CA--C 1.54 0.565 0 C-N-CA 126.99 2.116 . . . . 0.0 108.552 -169.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -71.01 165.05 33.64 Favored 'Trans proline' 0 CA--C 1.536 0.616 0 C-N-CA 122.815 2.343 . . . . 0.0 111.123 175.315 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -59.48 -31.45 69.35 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 -169.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 46.3 p90 -78.55 2.4 19.3 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 113.361 0.874 . . . . 0.0 113.361 -178.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.7 t -111.2 127.47 68.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 172.257 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -125.12 145.75 49.8 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 109.055 -0.721 . . . . 0.0 109.055 173.421 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -113.52 109.3 28.04 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 N-CA-C 105.762 -1.94 . . . . 0.0 105.762 172.159 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 64.4 tp -113.67 142.13 46.38 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 -174.118 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -100.38 127.52 46.68 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 123.642 0.777 . . . . 0.0 110.411 178.117 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -121.78 -22.56 2.7 Favored Glycine 0 CA--C 1.533 1.161 0 CA-C-O 118.51 -1.161 . . . . 0.0 113.012 169.586 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 42.64 -107.6 0.12 Allowed Glycine 0 C--N 1.339 0.742 0 C-N-CA 125.389 1.471 . . . . 0.0 113.938 177.091 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.8 p -67.48 -3.68 9.26 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 128.645 2.778 . . . . 0.0 114.108 -174.415 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.36 -56.88 14.15 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 124.07 0.948 . . . . 0.0 112.498 179.282 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 61.17 -99.64 0.21 Allowed Glycine 0 C--N 1.338 0.677 0 N-CA-C 108.614 -1.794 . . . . 0.0 108.614 -170.365 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.9 -28.15 68.08 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 126.098 1.759 . . . . 0.0 111.604 177.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -68.16 -4.15 12.91 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 113.802 1.038 . . . . 0.0 113.802 -168.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 22.4 mt -92.46 12.34 23.17 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 113.677 0.992 . . . . 0.0 113.677 177.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 6.1 tt -36.6 -60.48 0.59 Allowed 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.263 1.425 . . . . 0.0 114.713 -173.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -94.86 -26.61 12.51 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 123.205 0.431 . . . . 0.0 112.349 -175.51 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -57.69 -35.98 71.33 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 117.693 0.746 . . . . 0.0 111.769 179.066 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 20.7 mtp -83.05 -1.22 52.13 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 113.24 0.83 . . . . 0.0 113.24 -176.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -81.8 158.22 24.18 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.351 0.66 . . . . 0.0 111.995 -174.305 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 55.09 52.17 12.17 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 127.285 2.234 . . . . 0.0 115.655 168.416 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 20.7 mmt180 -115.07 163.2 15.96 Favored 'General case' 0 N--CA 1.482 1.174 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 170.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -80.46 -43.34 21.06 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 173.143 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . 0.294 0.1 OUTLIER -139.18 137.57 36.16 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 120.209 1.368 . . . . 0.0 110.101 168.319 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 24.1 tp -119.34 129.78 55.03 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 174.326 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 11.7 mt -103.1 115.91 45.9 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 174.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 9.5 mt -92.55 123.21 44.57 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 176.272 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -104.92 114.79 29.21 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 104.473 -2.417 . . . . 0.0 104.473 169.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -149.85 162.37 40.43 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.424 0.631 . . . . 0.0 110.961 -178.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -72.99 179.97 3.5 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 168.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . 0.301 93.2 mt -110.13 -83.15 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 CA-C-O 117.727 -1.13 . . . . 0.0 110.958 175.683 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . 0.292 1.7 m 41.0 35.86 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.856 0 C-N-CA 125.712 1.605 . . . . 0.0 112.984 -169.326 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 49.9 m -134.12 2.77 3.36 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.435 1.494 . . . . 0.0 112.065 -173.453 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -154.34 156.36 36.76 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 177.032 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 9.7 ptpt -78.65 3.04 17.44 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 115.377 1.621 . . . . 0.0 115.377 -169.717 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 32.3 t-20 -69.7 161.9 28.8 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 118.955 0.798 . . . . 0.0 110.47 -173.677 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 11.9 m -55.72 143.34 60.0 Favored Pre-proline 0 CA--C 1.545 0.766 0 C-N-CA 124.669 1.188 . . . . 0.0 112.698 -169.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -57.28 151.83 49.69 Favored 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 122.33 2.02 . . . . 0.0 111.166 169.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 71.47 18.78 77.26 Favored Glycine 0 CA--C 1.533 1.189 0 O-C-N 121.458 -0.776 . . . . 0.0 113.468 175.213 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 6.9 m -104.78 139.95 38.81 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 125.474 1.51 . . . . 0.0 108.02 177.068 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 47.5 ttp -96.2 143.36 27.37 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 173.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 33.6 ttm -135.51 123.09 22.15 Favored 'General case' 0 CA--C 1.528 0.128 0 N-CA-C 106.429 -1.693 . . . . 0.0 106.429 -174.248 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 35.8 mm -103.67 119.64 52.59 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 178.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -114.01 134.22 54.99 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 -174.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 60.6 mtm180 -109.37 132.74 53.84 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 118.459 -0.781 . . . . 0.0 109.637 -174.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 37.8 t70 40.85 -104.76 0.05 Allowed 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 114.26 1.207 . . . . 0.0 114.26 169.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -60.02 -26.11 65.83 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.778 1.231 . . . . 0.0 113.894 -177.253 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -73.73 -20.9 60.39 Favored 'General case' 0 CA--C 1.534 0.331 0 O-C-N 121.829 -0.544 . . . . 0.0 110.085 -179.284 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 46.9 t -75.0 -55.46 2.31 Favored Pre-proline 0 N--CA 1.449 -0.494 0 CA-C-O 117.404 -1.284 . . . . 0.0 111.218 -169.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -66.27 -30.7 45.28 Favored 'Trans proline' 0 N--CA 1.448 -1.193 0 CA-C-N 121.659 1.628 . . . . 0.0 110.191 178.04 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.07 -27.32 68.7 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 118.417 0.553 . . . . 0.0 111.364 179.322 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -74.05 -56.29 5.11 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 169.379 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -63.23 -25.37 68.3 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 114.157 1.169 . . . . 0.0 114.157 -169.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 7.0 t -69.66 1.09 4.53 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 -175.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 37.2 t-20 -67.12 136.91 55.87 Favored 'General case' 0 CA--C 1.54 0.581 0 O-C-N 120.927 -1.108 . . . . 0.0 109.447 175.643 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 13.3 mptt -82.41 -9.1 59.58 Favored 'General case' 0 N--CA 1.47 0.531 0 O-C-N 121.487 -0.758 . . . . 0.0 111.858 -175.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 89.4 mt -61.25 -36.95 76.25 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 CA-C-N 119.047 0.84 . . . . 0.0 110.038 179.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 8.3 p -99.54 109.82 56.48 Favored Pre-proline 0 CA--C 1.548 0.903 0 C-N-CA 124.693 1.197 . . . . 0.0 109.543 -173.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -70.62 -46.47 0.86 Allowed 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 122.2 1.933 . . . . 0.0 113.21 -169.571 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 3.0 m80 -73.15 -38.4 66.26 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.481 0.657 . . . . 0.0 109.383 -177.042 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -76.11 -26.83 56.77 Favored 'General case' 0 C--O 1.226 -0.147 0 CA-C-O 118.659 -0.686 . . . . 0.0 111.07 -172.211 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -59.14 -37.61 77.7 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 118.901 0.773 . . . . 0.0 108.995 169.423 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -60.39 -41.86 98.68 Favored Glycine 0 CA--C 1.534 1.242 0 O-C-N 121.497 -0.752 . . . . 0.0 111.651 174.343 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -68.59 -31.6 70.9 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 118.133 0.967 . . . . 0.0 110.233 176.135 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -59.69 -45.32 92.45 Favored 'General case' 0 CA--C 1.53 0.179 0 O-C-N 120.77 -1.206 . . . . 0.0 109.032 169.306 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -68.63 -21.88 64.45 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 119.064 -0.493 . . . . 0.0 111.852 178.425 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 44.6 t -64.52 -46.21 93.36 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 168.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 19.8 mt -64.87 -35.46 81.2 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 119.655 1.116 . . . . 0.0 110.53 -179.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 16.4 m -60.93 -44.62 96.95 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 118.871 0.76 . . . . 0.0 109.368 171.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -65.63 -36.64 84.28 Favored 'General case' 0 N--CA 1.449 -0.522 0 O-C-N 121.686 -0.634 . . . . 0.0 111.701 179.105 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 12.4 mt -61.3 -37.59 83.77 Favored 'General case' 0 C--O 1.23 0.073 0 C-N-CA 123.59 0.756 . . . . 0.0 109.982 174.437 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 52.9 tpt85 -71.71 -35.1 70.11 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-O 118.036 -0.983 . . . . 0.0 110.49 174.452 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 18.4 m-30 -69.13 -39.06 79.12 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 119.785 1.175 . . . . 0.0 110.755 -178.571 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 38.9 p -72.59 -22.36 60.99 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 118.759 0.709 . . . . 0.0 111.012 175.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 73.62 11.07 80.4 Favored Glycine 0 CA--C 1.533 1.196 0 N-CA-C 111.005 -0.838 . . . . 0.0 111.005 -169.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -99.43 26.7 5.81 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 118.436 1.118 . . . . 0.0 110.575 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -59.48 129.59 87.12 Favored Pre-proline 0 CA--C 1.544 0.722 0 C-N-CA 124.137 0.975 . . . . 0.0 108.522 171.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_exo -50.37 149.66 12.47 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 123.971 3.114 . . . . 0.0 113.829 178.025 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 33.0 mmtp -59.46 -30.55 68.6 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 119.359 -0.353 . . . . 0.0 110.589 -178.307 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? -137.57 142.25 41.34 Favored 'General case' 0 C--O 1.231 0.129 0 N-CA-C 105.915 -1.883 . . . . 0.0 105.915 169.068 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 8.9 tt -127.78 134.1 49.47 Favored 'General case' 0 CA--C 1.519 -0.216 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 171.667 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.75 129.13 30.03 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 106.784 -1.562 . . . . 0.0 106.784 -169.569 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 7.0 tp -115.06 126.68 54.99 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 120.09 1.314 . . . . 0.0 108.553 178.312 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 32.4 t -98.51 84.44 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 N-CA-C 104.721 -2.326 . . . . 0.0 104.721 169.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -81.43 145.06 24.95 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 -179.013 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 19.0 t -126.79 137.11 58.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 171.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 1.6 mm -85.09 122.24 74.05 Favored Pre-proline 0 CA--C 1.543 0.701 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 177.179 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_exo -58.34 170.45 2.35 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 124.988 3.792 . . . . 0.0 115.711 172.109 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -118.26 -52.33 2.39 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 114.897 -1.047 . . . . 0.0 110.255 179.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 64.6 m -107.43 -53.84 2.56 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 119.203 0.91 . . . . 0.0 112.802 -174.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 57.29 47.55 16.58 Favored 'General case' 0 CA--C 1.549 0.942 0 N-CA-C 114.765 1.394 . . . . 0.0 114.765 175.283 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -124.67 170.17 9.48 Favored Pre-proline 0 N--CA 1.478 0.938 0 CA-C-O 117.888 -1.054 . . . . 0.0 109.89 175.441 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_exo -62.85 87.07 0.12 Allowed 'Trans proline' 0 CA--C 1.549 1.259 0 C-N-CA 123.838 3.025 . . . . 0.0 114.452 -179.368 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -172.76 140.42 0.98 Allowed 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 104.334 -2.469 . . . . 0.0 104.334 172.635 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -102.4 164.17 3.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-N 119.102 0.865 . . . . 0.0 112.889 -169.488 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 82.15 159.31 24.9 Favored Glycine 0 C--N 1.342 0.894 0 N-CA-C 108.977 -1.649 . . . . 0.0 108.977 -170.121 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -82.2 163.17 22.08 Favored 'General case' 0 N--CA 1.439 -0.993 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 -174.584 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 37.7 p -67.99 169.78 8.99 Favored Pre-proline 0 C--O 1.239 0.542 0 CA-C-N 115.107 -0.951 . . . . 0.0 108.944 168.067 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_exo -55.16 -32.37 79.8 Favored 'Trans proline' 0 CA--C 1.539 0.753 0 C-N-CA 121.397 1.398 . . . . 0.0 110.845 169.294 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 18.2 m -68.01 -44.49 76.42 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 119.066 -0.492 . . . . 0.0 111.297 179.604 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 12.3 t -100.59 -13.21 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-N 119.252 0.933 . . . . 0.0 112.277 -169.156 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -57.47 -45.83 84.36 Favored 'General case' 0 CA--C 1.516 -0.341 0 O-C-N 119.752 -1.842 . . . . 0.0 107.808 169.535 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -71.59 2.91 4.47 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-N 115.404 -0.816 . . . . 0.0 113.08 179.268 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 84.1 mtp -97.27 -6.87 33.48 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 118.136 -0.935 . . . . 0.0 111.384 173.609 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 79.2 mt -57.24 -50.06 77.88 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 175.512 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -66.36 -53.2 32.45 Favored Pre-proline 0 CA--C 1.537 0.47 0 CA-C-O 117.411 -1.281 . . . . 0.0 113.298 -170.036 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -60.79 -32.88 93.38 Favored 'Trans proline' 0 C--N 1.351 0.662 0 CA-C-N 121.987 1.745 . . . . 0.0 111.79 175.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -69.24 -38.8 78.66 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-O 118.406 -0.807 . . . . 0.0 109.881 177.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 10.6 mt -57.78 -44.17 86.06 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 119.612 1.097 . . . . 0.0 108.755 173.065 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -62.72 -36.84 84.28 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 118.328 0.513 . . . . 0.0 111.443 -176.577 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 42.9 mm-40 -74.27 -33.36 63.24 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 118.686 0.675 . . . . 0.0 112.206 177.28 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 75.2 t -62.05 -49.03 85.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-N 119.475 1.034 . . . . 0.0 108.28 169.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 56.3 mt -60.57 -39.12 86.85 Favored 'General case' 0 CA--C 1.531 0.244 0 O-C-N 121.81 -0.556 . . . . 0.0 110.717 -179.502 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -58.77 -39.3 80.61 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 119.038 -0.506 . . . . 0.0 112.147 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -64.93 -48.17 75.06 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 119.094 0.861 . . . . 0.0 110.406 178.17 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . 0.284 4.1 pp -68.01 -23.71 65.04 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 118.73 -0.652 . . . . 0.0 112.174 178.678 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 81.7 mtm-85 -67.1 -26.97 66.97 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 119.937 1.244 . . . . 0.0 111.407 171.014 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -66.89 -34.17 77.2 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 120.422 1.465 . . . . 0.0 109.318 175.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 23.1 m -82.32 18.45 1.43 Allowed 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.478 1.111 . . . . 0.0 112.615 172.529 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 68.21 19.65 72.41 Favored Glycine 0 CA--C 1.529 0.959 0 CA-C-O 118.706 -1.052 . . . . 0.0 113.745 173.347 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 58.1 t -80.48 124.97 39.01 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 CA-C-N 119.18 1.49 . . . . 0.0 107.317 176.518 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -100.67 95.72 6.86 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 105.222 -2.14 . . . . 0.0 105.222 169.509 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -70.43 141.64 52.07 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 177.158 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 8.8 mm -108.81 124.76 33.35 Favored Pre-proline 0 CA--C 1.529 0.151 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 -179.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -64.35 103.21 0.43 Allowed 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 121.918 1.745 . . . . 0.0 107.954 169.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 87.2 mtt180 56.91 -8.56 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 128.052 2.541 . . . . 0.0 117.017 179.469 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 2.4 t . . . . . 0 CA--C 1.543 0.708 0 C-N-CA 125.765 1.626 . . . . 0.0 111.575 -177.088 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 8.7 ptp180 . . . . . 0 N--CA 1.482 1.133 0 CA-C-O 117.725 -1.131 . . . . 0.0 108.114 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 53.7 mt -143.8 137.65 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 CA-C-N 119.718 1.145 . . . . 0.0 112.424 -168.578 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -121.07 126.7 50.49 Favored 'General case' 0 CA--C 1.521 -0.142 0 N-CA-C 104.255 -2.498 . . . . 0.0 104.255 167.487 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 61.7 t -107.95 100.03 9.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 N-CA-C 102.743 -3.058 . . . . 0.0 102.743 169.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 8.2 mt -95.54 116.05 28.29 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 -171.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -93.2 118.53 5.67 Favored Glycine 0 N--CA 1.446 -0.697 0 N-CA-C 106.136 -2.785 . . . . 0.0 106.136 169.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -134.62 -171.92 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 -174.506 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 106.43 157.43 21.6 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.217 -1.153 . . . . 0.0 110.217 -171.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -81.43 96.8 7.49 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 124.773 1.229 . . . . 0.0 109.055 -174.41 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.1 pt -71.97 41.81 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 C-N-CA 124.596 1.158 . . . . 0.0 113.766 -177.294 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 20.2 mt -130.1 -5.52 4.42 Favored 'General case' 0 CA--C 1.534 0.35 0 O-C-N 121.027 -1.046 . . . . 0.0 109.548 173.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -124.6 72.9 1.23 Allowed 'General case' 0 C--N 1.343 0.312 0 C-N-CA 123.559 0.744 . . . . 0.0 110.308 -168.511 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER 47.25 -98.46 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.303 1.041 . . . . 0.0 113.419 175.368 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -77.42 -18.54 57.14 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 125.347 1.459 . . . . 0.0 112.207 -169.531 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -72.63 -8.27 54.45 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 120.275 1.398 . . . . 0.0 112.491 -176.53 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.43 -12.0 60.92 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-O 117.057 -1.449 . . . . 0.0 110.862 169.389 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 9.2 tp -56.82 -39.72 66.36 Favored 'Isoleucine or valine' 0 C--N 1.341 0.234 0 CA-C-N 121.107 1.776 . . . . 0.0 112.275 -170.117 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -58.73 -46.82 92.86 Favored Glycine 0 C--N 1.339 0.708 0 CA-C-N 119.484 1.038 . . . . 0.0 111.229 176.25 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 62.4 t -62.95 -47.92 90.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-O 118.618 -0.706 . . . . 0.0 109.477 175.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 20.3 mmt180 -63.73 -31.95 73.29 Favored 'General case' 0 C--N 1.346 0.452 0 CA-C-O 117.298 -1.334 . . . . 0.0 111.688 -176.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 18.2 mt -60.6 -48.16 89.78 Favored 'Isoleucine or valine' 0 C--N 1.341 0.233 0 CA-C-N 121.033 1.742 . . . . 0.0 109.62 176.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 18.8 m -74.64 -33.45 31.9 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-N 119.429 1.013 . . . . 0.0 111.368 -173.486 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 62.8 mt-10 -63.29 -44.41 95.12 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 118.383 0.538 . . . . 0.0 109.934 172.206 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -66.33 -37.6 85.74 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 119.427 1.012 . . . . 0.0 110.197 177.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.8 tp -63.79 -39.78 95.07 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 119.08 0.855 . . . . 0.0 109.088 -178.636 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -62.16 -22.5 65.92 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.251 0.62 . . . . 0.0 112.578 179.302 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 90.3 mt-30 -94.32 -45.09 7.64 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.213 1.405 . . . . 0.0 110.201 -178.704 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 80.4 mtt180 -81.69 -25.33 35.6 Favored 'General case' 0 CA--C 1.528 0.109 0 CA-C-O 118.753 -0.641 . . . . 0.0 111.165 -173.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 56.5 m-85 -125.54 151.33 46.51 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-N 118.611 0.642 . . . . 0.0 111.019 -179.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 46.3 mm -104.56 133.64 48.11 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 103.51 -2.774 . . . . 0.0 103.51 168.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -113.04 146.76 35.83 Favored Pre-proline 0 C--O 1.237 0.4 0 C-N-CA 123.28 0.632 . . . . 0.0 109.703 -169.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -65.17 157.89 55.06 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 122.458 2.105 . . . . 0.0 109.9 170.564 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -57.49 -34.01 68.61 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 -169.408 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 12.0 p90 -76.26 -10.73 59.63 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 -177.171 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 69.1 t -91.84 119.37 39.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 172.002 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -111.84 114.68 27.78 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 107.343 -1.354 . . . . 0.0 107.343 169.536 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -85.06 102.43 10.97 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 N-CA-C 104.484 -2.413 . . . . 0.0 104.484 168.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 59.5 tp -107.54 128.37 54.46 Favored 'General case' 0 C--O 1.232 0.151 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 -173.244 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -79.3 119.43 22.35 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 169.539 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -78.41 -80.1 0.74 Allowed Glycine 0 C--N 1.338 0.664 0 N-CA-C 106.64 -2.584 . . . . 0.0 106.64 169.527 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 78.28 99.37 0.21 Allowed Glycine 0 C--N 1.342 0.903 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 176.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 13.1 p 53.47 55.62 8.41 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.113 0.965 . . . . 0.0 108.69 -177.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -118.03 -79.89 0.6 Allowed 'General case' 0 C--N 1.348 0.503 0 CA-C-N 114.487 -1.233 . . . . 0.0 111.071 -170.051 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 59.42 -110.2 2.6 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 110.077 -1.209 . . . . 0.0 110.077 -179.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -53.14 -33.03 50.68 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.973 1.309 . . . . 0.0 110.962 -176.387 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -54.43 -22.3 12.18 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 113.784 1.031 . . . . 0.0 113.784 -175.474 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 14.5 mt -95.73 17.89 14.13 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 113.57 0.952 . . . . 0.0 113.57 -169.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 4.6 tt -45.78 -60.11 2.41 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 123.239 0.616 . . . . 0.0 112.055 -177.165 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -67.78 -32.52 78.06 Favored Glycine 0 CA--C 1.532 1.146 0 CA-C-N 116.002 -0.545 . . . . 0.0 112.291 -178.076 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -78.47 -32.37 48.33 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 118.836 1.318 . . . . 0.0 112.699 -173.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 53.8 mtp -74.8 -16.98 60.69 Favored 'General case' 0 N--CA 1.454 -0.225 0 O-C-N 121.758 -0.589 . . . . 0.0 110.868 178.261 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -81.13 156.4 25.77 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 123.375 0.67 . . . . 0.0 111.257 -173.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 53.76 36.08 23.01 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 126.588 1.955 . . . . 0.0 113.512 173.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 26.4 mmt180 -100.94 157.29 16.85 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 173.047 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -82.63 -54.68 4.97 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 176.008 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . 0.263 0.0 OUTLIER -116.83 149.95 39.17 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-N 119.522 1.055 . . . . 0.0 108.589 168.551 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 12.6 tp -133.69 115.82 15.06 Favored 'General case' 0 CA--C 1.511 -0.543 0 N-CA-C 104.955 -2.239 . . . . 0.0 104.955 171.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 33.8 mt -97.95 111.95 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 N-CA-C 104.885 -2.265 . . . . 0.0 104.885 171.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 12.2 mt -85.18 134.41 27.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 106.058 -1.83 . . . . 0.0 106.058 171.589 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -117.0 118.41 32.32 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 102.591 -3.114 . . . . 0.0 102.591 168.402 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -156.71 162.12 39.8 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 -175.093 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -85.33 149.66 25.3 Favored 'General case' 0 CA--C 1.534 0.357 0 O-C-N 121.536 -0.727 . . . . 0.0 109.974 170.026 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 11.0 mt -80.46 -30.94 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 C-N-CA 124.7 1.2 . . . . 0.0 110.171 175.678 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . 0.361 2.5 t 60.27 43.77 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.086 0 C-N-CA 126.321 1.848 . . . . 0.0 113.326 -176.402 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 12.8 m 62.04 139.15 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 128.424 2.69 . . . . 0.0 118.172 168.526 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -130.73 -90.04 0.46 Allowed 'General case' 0 N--CA 1.463 0.181 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 169.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 87.9 mttt -139.36 35.41 2.07 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.778 1.231 . . . . 0.0 110.0 -176.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 42.1 t-20 -138.0 161.72 35.98 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.561 1.144 . . . . 0.0 109.844 -171.105 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 2.1 m -62.5 148.3 90.67 Favored Pre-proline 0 CA--C 1.547 0.865 0 C-N-CA 124.666 1.186 . . . . 0.0 113.131 -169.294 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_exo -56.85 157.91 18.52 Favored 'Trans proline' 0 CA--C 1.532 0.419 0 C-N-CA 124.481 3.454 . . . . 0.0 113.038 169.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 64.15 16.3 59.82 Favored Glycine 0 CA--C 1.531 1.064 0 CA-C-O 119.491 -0.616 . . . . 0.0 113.809 171.317 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 3.0 m -94.51 146.64 23.96 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 124.672 1.189 . . . . 0.0 109.629 -172.092 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 31.7 ttp -98.04 141.78 30.57 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 171.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 64.3 mtm -133.33 129.73 37.89 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 169.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 38.9 mm -108.21 121.93 61.92 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 -179.528 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.3 mp -121.33 139.01 53.99 Favored 'General case' 0 C--O 1.236 0.367 0 O-C-N 123.833 0.708 . . . . 0.0 109.3 -172.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 52.5 ttp180 -83.95 165.15 18.89 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.922 0.889 . . . . 0.0 110.049 -177.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -30.67 -55.1 0.2 Allowed 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 116.353 1.983 . . . . 0.0 116.353 -175.392 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -87.91 -16.65 33.29 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 -174.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -76.13 -35.09 59.4 Favored 'General case' 0 N--CA 1.461 0.084 0 O-C-N 121.817 -0.552 . . . . 0.0 109.574 -178.254 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 88.3 t -59.14 -54.54 55.37 Favored Pre-proline 0 CA--C 1.547 0.848 0 C-N-CA 125.635 1.574 . . . . 0.0 111.787 -175.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -53.86 -42.77 63.83 Favored 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 122.781 2.321 . . . . 0.0 112.41 174.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -71.26 -10.82 60.39 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -91.66 -40.2 11.42 Favored 'General case' 0 C--N 1.343 0.315 0 CA-C-N 120.073 1.306 . . . . 0.0 111.82 -176.539 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 -75.52 10.12 1.85 Allowed 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 112.967 0.728 . . . . 0.0 112.967 -171.525 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 75.2 p -60.14 -24.29 64.59 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.154 0.981 . . . . 0.0 111.22 171.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 61.5 t-20 -49.04 118.9 2.87 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.503 1.121 . . . . 0.0 111.235 177.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -74.67 -18.45 60.52 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -174.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 42.1 mt -67.13 -45.59 86.27 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -176.527 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.3 m -73.18 110.54 8.84 Favored Pre-proline 0 CA--C 1.545 0.762 0 C-N-CA 126.291 1.837 . . . . 0.0 112.05 -168.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -76.15 -62.95 0.03 OUTLIER 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 122.254 1.97 . . . . 0.0 112.333 -169.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 6.6 t-80 -56.66 -40.04 74.81 Favored 'General case' 0 N--CA 1.466 0.335 0 O-C-N 121.442 -0.786 . . . . 0.0 110.225 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 22.0 mp0 -62.29 -27.69 69.2 Favored 'General case' 0 N--CA 1.44 -0.955 0 C-N-CA 124.972 1.309 . . . . 0.0 110.082 -172.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 30.9 mt -72.09 -36.72 69.59 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 120.025 1.284 . . . . 0.0 110.447 174.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -66.69 -42.96 92.97 Favored Glycine 0 CA--C 1.528 0.885 0 N-CA-C 110.238 -1.145 . . . . 0.0 110.238 173.387 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -59.79 -41.45 91.2 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.197 0.599 . . . . 0.0 109.791 173.35 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -59.25 -44.65 92.36 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 123.01 0.524 . . . . 0.0 110.542 175.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -66.11 -26.76 67.61 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 118.806 -0.616 . . . . 0.0 111.899 -179.608 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 92.1 t -63.93 -45.84 95.78 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 168.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 87.9 mt -67.07 -33.4 75.43 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 119.266 0.939 . . . . 0.0 110.722 -176.182 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 15.8 m -60.78 -49.25 78.24 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 119.028 0.831 . . . . 0.0 109.957 169.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -58.1 -41.03 82.63 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 118.185 0.448 . . . . 0.0 111.019 176.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -63.48 -32.71 74.24 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 123.741 0.816 . . . . 0.0 110.951 179.74 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 17.6 ptm180 -83.68 -27.86 28.75 Favored 'General case' 0 C--N 1.344 0.369 0 CA-C-N 120.455 1.48 . . . . 0.0 112.19 173.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 16.7 m-30 -60.47 -46.58 89.55 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 118.454 0.57 . . . . 0.0 109.843 172.301 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 41.4 p -77.29 -26.8 52.67 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 123.611 0.764 . . . . 0.0 111.54 178.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 75.66 6.35 81.12 Favored Glycine 0 CA--C 1.534 1.232 0 N-CA-C 109.881 -1.288 . . . . 0.0 109.881 -168.497 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -85.24 19.99 2.09 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 119.768 1.784 . . . . 0.0 111.454 179.088 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -56.28 140.03 72.44 Favored Pre-proline 0 CA--C 1.546 0.814 0 C-N-CA 126.034 1.734 . . . . 0.0 110.307 170.058 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 99.6 Cg_exo -57.97 161.37 13.26 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 123.396 2.731 . . . . 0.0 115.531 179.365 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -65.91 -38.63 89.2 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 119.164 -0.446 . . . . 0.0 111.671 176.339 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 4.5 pttm -142.75 89.64 2.15 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 124.259 1.024 . . . . 0.0 108.342 177.7 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 7.4 tt -76.33 142.6 41.19 Favored 'General case' 0 CA--C 1.534 0.356 0 O-C-N 120.961 -1.087 . . . . 0.0 108.592 169.418 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.9 140.81 46.07 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.334 1.454 . . . . 0.0 107.698 174.696 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 14.6 tp -118.59 134.41 55.13 Favored 'General case' 0 N--CA 1.467 0.411 0 O-C-N 120.48 -1.388 . . . . 0.0 108.496 175.291 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 20.4 t -105.92 85.09 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 N-CA-C 104.788 -2.301 . . . . 0.0 104.788 169.154 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -81.31 144.66 24.77 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 110.41 -1.076 . . . . 0.0 110.41 179.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 39.2 t -128.43 130.98 69.3 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 CA-C-N 117.405 0.603 . . . . 0.0 109.989 179.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 16.8 mt -85.17 132.92 43.9 Favored Pre-proline 0 CA--C 1.539 0.529 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 176.396 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -77.01 -179.06 5.05 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 123.075 2.517 . . . . 0.0 111.617 -177.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -110.09 -51.18 2.9 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.994 0.918 . . . . 0.0 109.807 169.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 66.4 m -118.65 -54.53 2.25 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 118.201 0.455 . . . . 0.0 111.964 -169.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER 54.54 52.84 11.61 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.652 1.181 . . . . 0.0 112.163 -177.293 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -119.25 165.92 15.87 Favored Pre-proline 0 CA--C 1.537 0.472 0 C-N-CA 123.468 0.707 . . . . 0.0 109.954 -179.372 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -78.32 81.78 2.64 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 121.755 1.636 . . . . 0.0 112.634 -169.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -171.09 141.59 1.68 Allowed 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 102.218 -3.253 . . . . 0.0 102.218 177.293 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -108.21 166.59 4.25 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 N-CA-C 113.596 0.962 . . . . 0.0 113.596 -169.286 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 97.33 141.21 11.94 Favored Glycine 0 C--N 1.338 0.646 0 N-CA-C 105.751 -2.94 . . . . 0.0 105.751 -168.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -67.41 158.49 31.59 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 117.861 0.83 . . . . 0.0 109.882 176.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 63.4 p -69.14 169.75 10.78 Favored Pre-proline 0 CA--C 1.543 0.681 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 168.018 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -58.02 -37.13 97.12 Favored 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 121.57 1.513 . . . . 0.0 111.388 173.305 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 82.8 m -64.33 -33.75 76.55 Favored 'General case' 0 N--CA 1.443 -0.785 0 C-N-CA 124.415 1.086 . . . . 0.0 111.436 -178.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 73.8 t -103.23 -27.59 3.2 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 O-C-N 121.81 -0.556 . . . . 0.0 111.511 -172.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -51.73 -49.37 62.69 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 119.035 0.834 . . . . 0.0 108.88 169.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -61.89 -20.88 64.22 Favored 'General case' 0 N--CA 1.447 -0.575 0 N-CA-C 112.994 0.738 . . . . 0.0 112.994 179.373 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 3.0 mmm -78.04 -7.89 57.48 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 -179.619 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 72.5 mt -55.95 -50.59 68.31 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.295 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 170.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -70.51 -44.89 18.4 Favored Pre-proline 0 CA--C 1.538 0.481 0 CA-C-O 117.284 -1.341 . . . . 0.0 113.756 -168.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -57.66 -41.33 71.75 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 CA-C-N 122.076 1.777 . . . . 0.0 111.152 172.412 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.01 -35.89 74.69 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-O 118.263 -0.875 . . . . 0.0 112.046 179.285 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 39.0 mt -61.09 -48.64 80.75 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-N 120.087 1.312 . . . . 0.0 108.929 172.249 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -54.73 -35.31 63.55 Favored 'General case' 0 CA--C 1.531 0.237 0 O-C-N 123.398 0.436 . . . . 0.0 109.995 175.288 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 2.1 mm100 -78.7 -35.74 44.58 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 45.7 t -59.27 -48.27 87.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 169.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 44.0 mt -60.23 -36.55 77.99 Favored 'General case' 0 C--O 1.226 -0.148 0 C-N-CA 123.413 0.685 . . . . 0.0 110.88 177.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -70.1 -44.23 69.44 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 119.139 0.881 . . . . 0.0 110.856 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -66.53 -30.99 71.43 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 119.676 1.126 . . . . 0.0 111.225 177.433 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 12.9 mt -62.27 -52.99 61.5 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 169.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 93.6 mtt-85 -64.73 -28.65 69.74 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 120.231 1.378 . . . . 0.0 112.432 -178.413 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -69.34 -28.75 66.51 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 119.203 0.91 . . . . 0.0 109.982 176.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 51.0 m -82.51 8.24 12.22 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.392 1.077 . . . . 0.0 111.906 169.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 72.83 10.52 77.09 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-O 117.291 -1.838 . . . . 0.0 113.11 -174.56 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 38.2 t -91.05 119.54 38.39 Favored 'Isoleucine or valine' 0 C--N 1.345 0.378 0 CA-C-N 121.025 2.412 . . . . 0.0 108.48 -176.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -97.57 91.32 5.38 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 172.385 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -55.9 139.11 47.08 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 169.051 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 20.5 mt -83.33 126.87 70.71 Favored Pre-proline 0 CA--C 1.529 0.161 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 -173.263 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -68.47 89.83 0.4 Allowed 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 123.045 2.497 . . . . 0.0 109.029 174.64 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 29.1 ttp180 52.34 17.13 0.69 Allowed 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 127.628 2.371 . . . . 0.0 114.567 179.489 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 57.7 m . . . . . 0 CA--C 1.544 0.746 0 C-N-CA 124.057 0.943 . . . . 0.0 111.145 -169.015 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 38.9 ttm180 . . . . . 0 N--CA 1.475 0.792 0 CA-C-O 118.852 -0.594 . . . . 0.0 109.693 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 5.5 mt -119.73 132.7 68.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 -174.526 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 43.3 tp -113.61 145.72 40.84 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 105.849 -1.908 . . . . 0.0 105.849 167.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 30.2 t -124.32 131.37 72.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 N-CA-C 105.017 -2.216 . . . . 0.0 105.017 169.213 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 6.6 mt -125.36 117.3 23.43 Favored 'General case' 0 CA--C 1.511 -0.547 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 -173.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -87.88 133.29 11.71 Favored Glycine 0 CA--C 1.521 0.424 0 N-CA-C 107.709 -2.157 . . . . 0.0 107.709 169.652 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.5 m -142.27 133.01 24.76 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 CA-C-N 119.317 1.559 . . . . 0.0 112.507 -170.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 144.79 169.59 13.42 Favored Glycine 0 CA--C 1.525 0.684 0 C-N-CA 125.948 1.737 . . . . 0.0 109.123 169.572 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.402 HD22 HD11 ' A' ' 13' ' ' LEU . 0.2 OUTLIER -76.94 116.77 17.9 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 122.81 1.29 . . . . 0.0 111.45 -176.459 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.1 pt -63.99 36.34 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.861 0 N-CA-C 116.096 1.888 . . . . 0.0 116.096 172.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 5.4 mp -129.52 -9.53 4.59 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 120.545 1.52 . . . . 0.0 110.025 168.525 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.402 HD11 HD22 ' A' ' 10' ' ' ASN . 4.7 mp -106.59 56.47 0.65 Allowed 'General case' 0 C--N 1.343 0.299 0 N-CA-C 114.739 1.385 . . . . 0.0 114.739 -168.917 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.255 0.2 OUTLIER 54.95 -109.59 0.51 Allowed 'General case' 0 C--O 1.238 0.45 0 C-N-CA 123.428 0.691 . . . . 0.0 110.921 170.428 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -77.9 -7.45 56.75 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.435 0.694 . . . . 0.0 111.831 -175.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 23.0 tp10 -55.85 -32.59 63.76 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 120.012 1.278 . . . . 0.0 111.417 169.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.9 5.0 14.97 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-O 115.888 -2.006 . . . . 0.0 110.082 -179.1 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 6.6 tp -57.07 -42.82 80.13 Favored 'Isoleucine or valine' 0 C--N 1.342 0.242 0 CA-C-N 123.369 2.804 . . . . 0.0 110.92 -179.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -61.23 -43.18 99.71 Favored Glycine 0 CA--C 1.526 0.727 0 CA-C-N 119.564 1.075 . . . . 0.0 111.465 175.428 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 83.2 t -66.93 -51.46 54.62 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 CA-C-N 117.449 0.624 . . . . 0.0 109.559 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 74.4 mmt-85 -57.55 -34.76 69.51 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 117.142 -1.409 . . . . 0.0 112.479 176.578 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 24.2 mt -60.72 -47.73 91.84 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-N 121.839 2.109 . . . . 0.0 110.507 175.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 35.2 m -74.26 -27.2 21.39 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-N 120.25 1.386 . . . . 0.0 111.416 -175.426 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -69.18 -45.69 69.36 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 174.597 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -64.32 -45.11 89.3 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 123.313 0.645 . . . . 0.0 110.509 -179.442 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 8.1 tp -61.78 -41.58 97.9 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-O 118.86 -0.59 . . . . 0.0 110.068 179.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -60.05 -38.73 83.67 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 118.209 0.459 . . . . 0.0 110.965 177.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 9.5 mm-40 -75.75 -40.6 55.17 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 118.631 0.651 . . . . 0.0 111.065 -179.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 41.5 mmt180 -87.4 -31.57 20.01 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 117.637 -1.173 . . . . 0.0 113.02 -169.498 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 72.0 m-85 -122.54 137.76 54.78 Favored 'General case' 0 CA--C 1.522 -0.134 0 CA-C-N 120.76 1.618 . . . . 0.0 111.969 -176.05 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 43.7 mm -90.87 137.65 21.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 N-CA-C 105.591 -2.003 . . . . 0.0 105.591 168.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -124.25 154.98 68.83 Favored Pre-proline 0 CA--C 1.541 0.62 0 C-N-CA 124.985 1.314 . . . . 0.0 109.902 -170.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -59.44 157.13 32.61 Favored 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 123.318 2.679 . . . . 0.0 112.041 169.697 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -63.19 -31.38 72.51 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -171.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 18.8 p90 -72.66 -6.19 42.67 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 118.186 -0.911 . . . . 0.0 112.699 178.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 38.2 t -100.9 130.73 49.81 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 CA-C-N 120.054 1.297 . . . . 0.0 108.32 175.391 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -118.55 135.35 54.46 Favored 'General case' 0 CA--C 1.529 0.171 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 170.078 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -106.47 118.12 53.54 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 N-CA-C 104.691 -2.337 . . . . 0.0 104.691 169.368 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 48.7 tp -127.19 126.4 42.75 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-O 120.889 0.376 . . . . 0.0 110.307 -174.735 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -78.0 119.42 21.42 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 168.715 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -57.51 -55.84 28.28 Favored Glycine 0 CA--C 1.53 0.975 0 N-CA-C 109.073 -1.611 . . . . 0.0 109.073 172.411 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 74.74 87.56 0.24 Allowed Glycine 0 C--N 1.341 0.833 0 N-CA-C 111.451 -0.66 . . . . 0.0 111.451 169.699 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 20.3 p 50.81 58.91 5.02 Favored 'General case' 0 CA--C 1.546 0.8 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 -177.532 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -116.65 -86.72 0.62 Allowed 'General case' 0 C--N 1.348 0.508 0 CA-C-N 114.495 -1.23 . . . . 0.0 111.352 -169.334 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 65.76 -94.97 0.22 Allowed Glycine 0 C--N 1.341 0.836 0 N-CA-C 108.947 -1.661 . . . . 0.0 108.947 -169.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 3.5 tpt -62.77 -31.41 72.37 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 125.288 1.435 . . . . 0.0 111.764 179.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -66.36 -7.69 20.7 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -169.32 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 70.9 mt -84.26 3.74 34.06 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 113.854 1.057 . . . . 0.0 113.854 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 6.0 tt -41.36 -59.0 1.68 Allowed 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 114.107 1.151 . . . . 0.0 114.107 -170.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -93.34 -26.02 17.12 Favored Glycine 0 CA--C 1.527 0.786 0 C-N-CA 123.698 0.666 . . . . 0.0 111.896 -178.461 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -62.06 -34.7 76.74 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 118.639 1.22 . . . . 0.0 111.335 179.467 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 26.8 mtp -78.28 -3.58 43.6 Favored 'General case' 0 CA--C 1.529 0.137 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 178.378 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.5 157.84 36.84 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 118.817 0.735 . . . . 0.0 110.824 -178.124 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 55.3 39.51 31.31 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.827 1.651 . . . . 0.0 114.66 168.311 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 13.4 mmt180 -107.11 148.86 28.28 Favored 'General case' 0 N--CA 1.473 0.714 0 O-C-N 121.121 -0.987 . . . . 0.0 109.411 176.11 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -82.49 -36.05 26.82 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 171.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 1.7 t-160 -138.45 137.93 37.66 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 -176.002 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 20.8 tp -136.41 131.47 34.19 Favored 'General case' 0 CA--C 1.507 -0.686 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 169.275 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 3.8 mp -112.42 119.81 61.15 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 169.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 5.3 mt -96.55 117.71 41.48 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 177.097 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -84.56 113.41 21.22 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 103.2 -2.889 . . . . 0.0 103.2 169.519 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -124.16 155.37 38.59 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 114.358 1.244 . . . . 0.0 114.358 -167.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -113.18 119.4 37.65 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 169.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 92.0 mt -76.71 -26.01 16.22 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.753 0 O-C-N 124.148 0.905 . . . . 0.0 111.558 -171.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . 0.286 47.4 t 69.75 -62.58 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 C-N-CA 128.887 2.875 . . . . 0.0 111.572 -170.61 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 5.5 m -151.68 138.84 19.23 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 177.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 73.3 tttt -157.3 170.06 23.32 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 127.534 2.334 . . . . 0.0 105.234 168.735 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.01 -22.5 65.89 Favored 'General case' 0 N--CA 1.473 0.675 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 -170.314 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -71.16 164.92 24.66 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 123.087 0.555 . . . . 0.0 110.292 -177.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 18.6 m -61.57 149.57 83.76 Favored Pre-proline 0 CA--C 1.55 0.949 0 C-N-CA 124.257 1.023 . . . . 0.0 112.125 -171.232 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -54.21 152.53 24.77 Favored 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 122.77 2.313 . . . . 0.0 112.255 169.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 69.65 7.36 58.25 Favored Glycine 0 CA--C 1.531 1.036 0 CA-C-O 118.661 -1.077 . . . . 0.0 114.44 175.276 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 20.5 m -89.19 148.14 23.79 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 119.608 1.704 . . . . 0.0 110.043 -173.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 25.5 ttp -90.77 147.6 23.11 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.264 178.316 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 19.9 ttm -141.54 116.48 9.86 Favored 'General case' 0 CA--C 1.528 0.118 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 -177.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.6 mp -96.28 122.96 48.29 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 177.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -115.52 126.81 54.73 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 179.228 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 74.9 mtm180 -91.63 177.26 6.26 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 123.354 0.662 . . . . 0.0 109.68 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -48.19 -47.86 35.08 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 115.341 1.608 . . . . 0.0 115.341 -169.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -76.18 -15.89 59.96 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 119.046 0.839 . . . . 0.0 112.198 -178.33 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -96.36 -23.68 16.52 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 123.863 0.865 . . . . 0.0 110.714 -169.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -68.57 -37.99 11.41 Favored Pre-proline 0 CA--C 1.535 0.37 0 O-C-N 120.608 -1.308 . . . . 0.0 112.554 178.19 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -62.78 -12.04 26.96 Favored 'Trans proline' 0 CA--C 1.546 1.105 0 C-N-CA 121.55 1.5 . . . . 0.0 112.746 168.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -98.9 4.59 47.44 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.91 0.884 . . . . 0.0 111.742 173.436 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -111.76 -57.25 2.28 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 124.025 0.93 . . . . 0.0 111.166 -175.701 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -66.14 -15.89 63.5 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 118.764 0.711 . . . . 0.0 111.534 -170.307 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 68.4 p -85.29 -9.94 57.08 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 125.539 1.535 . . . . 0.0 113.139 -168.482 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -59.38 152.04 22.28 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 118.476 0.58 . . . . 0.0 109.926 174.584 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -78.5 -10.05 59.56 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 113.456 0.91 . . . . 0.0 113.456 -169.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 4.8 mp -84.76 -53.46 10.78 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 CA-C-N 119.396 0.998 . . . . 0.0 109.44 -171.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 3.9 m -59.95 109.23 1.81 Allowed Pre-proline 0 CA--C 1.549 0.908 0 C-N-CA 124.1 0.96 . . . . 0.0 111.814 -169.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -71.9 -54.15 0.15 Allowed 'Trans proline' 0 C--N 1.354 0.821 0 CA-C-N 120.817 1.328 . . . . 0.0 112.438 -169.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 18.2 m80 -80.93 -32.25 34.68 Favored 'General case' 0 N--CA 1.467 0.408 0 O-C-N 121.984 -0.447 . . . . 0.0 110.108 -175.126 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 3.9 mm-40 -71.16 -23.12 61.99 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 118.485 -0.769 . . . . 0.0 110.523 -179.112 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 10.4 mt -62.98 -30.52 71.65 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 120.387 1.448 . . . . 0.0 110.974 169.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -64.1 -40.75 98.4 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 109.916 -1.274 . . . . 0.0 109.916 171.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 22.5 tp -67.93 -30.93 70.36 Favored 'General case' 0 CA--C 1.532 0.287 0 O-C-N 122.142 -0.622 . . . . 0.0 110.546 174.658 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -58.87 -44.11 91.0 Favored 'General case' 0 N--CA 1.451 -0.389 0 O-C-N 120.796 -1.19 . . . . 0.0 108.895 171.131 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -70.89 -20.38 62.51 Favored 'General case' 0 N--CA 1.456 -0.13 0 O-C-N 121.789 -0.57 . . . . 0.0 111.494 177.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 55.2 t -70.04 -41.26 79.19 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.871 0 CA-C-O 117.764 -1.113 . . . . 0.0 108.126 169.315 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 6.8 mp -60.69 -38.21 84.23 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 120.602 1.546 . . . . 0.0 109.887 175.312 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 16.4 m -63.46 -45.1 92.38 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 174.546 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -65.65 -41.48 92.53 Favored 'General case' 0 N--CA 1.447 -0.587 0 O-C-N 121.535 -0.728 . . . . 0.0 110.554 -178.448 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 28.3 mt -58.96 -39.6 82.18 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 124.665 1.186 . . . . 0.0 110.306 174.609 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 41.3 ttm180 -67.4 -36.56 81.54 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 118.771 -0.633 . . . . 0.0 109.983 175.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 13.5 m-30 -68.51 -41.11 80.43 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 118.963 0.801 . . . . 0.0 111.051 178.38 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 55.8 p -75.93 -27.1 57.48 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 118.827 0.739 . . . . 0.0 110.994 179.546 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 78.4 10.03 86.54 Favored Glycine 0 CA--C 1.534 1.271 0 CA-C-O 119.278 -0.734 . . . . 0.0 111.465 -169.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 -94.07 15.21 17.6 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 118.807 1.303 . . . . 0.0 112.268 -177.392 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 8.1 t80 -53.69 132.24 55.89 Favored Pre-proline 0 CA--C 1.539 0.55 0 C-N-CA 125.349 1.459 . . . . 0.0 110.317 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_exo -50.5 136.37 40.61 Favored 'Trans proline' 0 C--N 1.354 0.817 0 C-N-CA 123.461 2.774 . . . . 0.0 112.32 178.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -63.19 -24.1 67.73 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 119.287 -0.387 . . . . 0.0 111.796 -173.64 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 57.2 tttm -141.85 108.31 5.31 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 169.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -85.89 142.01 29.17 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 169.123 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.62 153.25 45.98 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 105.951 -1.87 . . . . 0.0 105.951 171.885 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -145.29 138.23 26.25 Favored 'General case' 0 C--N 1.33 -0.276 0 O-C-N 120.512 -1.368 . . . . 0.0 108.636 176.259 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 48.8 t -110.12 95.91 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 N-CA-C 103.635 -2.728 . . . . 0.0 103.635 169.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -87.44 151.96 23.84 Favored Glycine 0 C--N 1.332 0.351 0 N-CA-C 110.101 -1.2 . . . . 0.0 110.101 178.059 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 44.9 t -132.77 137.15 54.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 178.691 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 51.0 mt -86.76 129.83 51.08 Favored Pre-proline 0 CA--C 1.542 0.659 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 170.491 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -74.04 171.98 16.87 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 124.03 3.153 . . . . 0.0 112.561 -179.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -109.4 -43.89 4.02 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.461 1.105 . . . . 0.0 108.599 169.443 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 63.8 m -128.73 152.09 48.81 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.473 0.709 . . . . 0.0 111.266 176.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.4 tp -152.54 54.5 0.79 Allowed 'General case' 0 CA--C 1.548 0.893 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 -169.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -127.35 170.14 10.77 Favored Pre-proline 0 N--CA 1.479 1.002 0 CA-C-O 117.756 -1.116 . . . . 0.0 110.595 -178.43 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_exo -63.45 88.56 0.14 Allowed 'Trans proline' 0 CA--C 1.548 1.201 0 C-N-CA 123.806 3.004 . . . . 0.0 114.409 -176.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 179.0 145.72 0.15 Allowed 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 104.415 -2.439 . . . . 0.0 104.415 175.303 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -118.09 167.09 11.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 CA-C-N 120.032 1.287 . . . . 0.0 112.886 -172.798 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 91.56 148.9 22.87 Favored Glycine 0 C--N 1.34 0.796 0 N-CA-C 106.809 -2.516 . . . . 0.0 106.809 -168.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -82.84 162.28 21.68 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-O 121.447 0.642 . . . . 0.0 111.115 -169.396 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 39.8 p -68.92 168.61 14.37 Favored Pre-proline 0 CA--C 1.541 0.619 0 CA-C-N 114.911 -1.041 . . . . 0.0 109.535 168.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -57.1 -32.81 94.42 Favored 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 121.302 1.335 . . . . 0.0 110.906 169.397 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 23.8 m -68.34 -38.69 81.74 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 118.999 -0.524 . . . . 0.0 111.905 179.323 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 20.2 t -108.62 -10.48 11.12 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 CA-C-N 119.471 1.032 . . . . 0.0 112.021 -169.195 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -60.11 -46.87 88.15 Favored 'General case' 0 N--CA 1.465 0.318 0 O-C-N 119.733 -1.854 . . . . 0.0 107.436 169.082 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -71.74 6.55 1.91 Allowed 'General case' 0 N--CA 1.439 -1.015 0 CA-C-O 117.965 -1.017 . . . . 0.0 112.661 176.312 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 26.5 mmm -94.1 -11.54 30.35 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 119.778 1.172 . . . . 0.0 111.083 170.014 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 72.6 mt -61.76 -46.36 96.7 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 179.003 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -69.9 -54.87 9.41 Favored Pre-proline 0 CA--C 1.536 0.405 0 CA-C-O 117.394 -1.289 . . . . 0.0 112.814 -172.331 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -59.82 -34.81 95.53 Favored 'Trans proline' 0 C--N 1.349 0.569 0 CA-C-N 122.301 1.857 . . . . 0.0 111.327 177.031 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -71.11 -45.03 64.45 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-O 118.719 -0.658 . . . . 0.0 110.497 -177.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -63.68 -36.8 85.02 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 119.235 0.925 . . . . 0.0 109.916 177.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -61.88 -39.03 90.51 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 118.007 0.367 . . . . 0.0 111.076 175.585 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 42.4 mm-40 -74.3 -28.37 61.15 Favored 'General case' 0 CA--C 1.535 0.399 0 O-C-N 121.44 -0.787 . . . . 0.0 111.828 176.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 70.4 t -62.93 -46.96 95.0 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 169.502 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 56.8 mt -65.67 -33.63 76.32 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 119.055 0.843 . . . . 0.0 111.143 179.148 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -60.0 -35.59 75.38 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 118.513 0.597 . . . . 0.0 111.275 177.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -61.73 -44.95 95.92 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 118.388 0.54 . . . . 0.0 111.244 175.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 7.1 mp -61.41 -40.55 94.8 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 122.726 0.41 . . . . 0.0 110.082 176.454 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 83.5 mtm-85 -65.59 -16.59 63.86 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 117.504 -1.236 . . . . 0.0 112.594 178.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -58.57 -30.7 67.36 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 120.781 1.628 . . . . 0.0 111.351 177.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 6.7 m -113.39 30.37 7.26 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.503 1.121 . . . . 0.0 111.129 177.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 64.31 23.57 68.36 Favored Glycine 0 CA--C 1.529 0.967 0 CA-C-O 118.566 -1.13 . . . . 0.0 113.821 174.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 60.4 t -87.63 131.35 35.57 Favored 'Isoleucine or valine' 0 C--N 1.34 0.194 0 N-CA-C 106.362 -1.718 . . . . 0.0 106.362 174.112 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -120.68 123.29 42.39 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 -177.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -82.15 144.36 30.79 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 172.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 6.9 mm -101.53 123.89 42.78 Favored Pre-proline 0 CA--C 1.53 0.207 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 -173.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -60.6 108.97 0.58 Allowed 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.188 1.926 . . . . 0.0 108.182 173.449 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 34.3 ptt180 43.8 15.62 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 128.825 2.85 . . . . 0.0 116.239 -177.397 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 3.8 m . . . . . 0 CA--C 1.547 0.837 0 C-N-CA 125.366 1.466 . . . . 0.0 112.732 -168.662 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 6.0 ptp180 . . . . . 0 N--CA 1.475 0.814 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 66.7 mt -141.54 133.32 27.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-N 119.12 0.873 . . . . 0.0 110.172 -169.975 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -116.39 128.64 55.69 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 105.952 -1.87 . . . . 0.0 105.952 168.419 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.0 t -106.95 98.1 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 103.466 -2.79 . . . . 0.0 103.466 172.844 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.8 mt -99.09 110.42 23.0 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 123.912 0.885 . . . . 0.0 110.17 -169.433 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -89.69 121.42 6.12 Favored Glycine 0 N--CA 1.446 -0.659 0 N-CA-C 107.102 -2.399 . . . . 0.0 107.102 170.313 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 13.0 m -134.21 -171.89 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.016 0 C-N-CA 124.321 1.048 . . . . 0.0 108.258 -178.148 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 110.66 154.63 13.91 Favored Glycine 0 C--N 1.336 0.539 0 N-CA-C 110.453 -1.059 . . . . 0.0 110.453 -173.233 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -77.36 96.84 4.73 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 123.788 0.835 . . . . 0.0 109.224 -179.143 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.3 pt -72.47 36.4 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 C-N-CA 124.504 1.122 . . . . 0.0 113.96 -179.077 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 28.0 mt -121.95 -8.75 8.83 Favored 'General case' 0 CA--C 1.531 0.248 0 O-C-N 121.091 -1.005 . . . . 0.0 108.729 171.55 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -127.27 83.95 2.21 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 -169.12 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.1 m 35.74 -104.2 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 113.266 -1.788 . . . . 0.0 114.698 169.65 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -68.08 -19.73 64.89 Favored 'General case' 0 N--CA 1.437 -1.097 0 CA-C-O 117.975 -1.012 . . . . 0.0 112.475 -169.187 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -68.03 -23.69 65.02 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 121.208 1.822 . . . . 0.0 111.818 178.976 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.36 -12.45 52.13 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-O 116.01 -1.948 . . . . 0.0 110.588 172.783 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 6.7 tp -53.74 -38.3 34.84 Favored 'Isoleucine or valine' 0 C--N 1.342 0.26 0 CA-C-N 122.176 2.262 . . . . 0.0 110.271 -177.742 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -61.47 -43.62 99.08 Favored Glycine 0 C--N 1.337 0.596 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 -178.879 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 57.8 t -70.18 -47.21 68.77 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 176.094 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 20.4 mmt180 -61.19 -31.86 71.61 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 117.016 -1.468 . . . . 0.0 112.505 -177.918 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 19.8 mt -58.93 -48.66 85.74 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 CA-C-N 121.74 2.063 . . . . 0.0 109.756 175.68 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.8 m -76.32 -31.07 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-N 119.432 1.015 . . . . 0.0 110.897 -172.202 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 59.2 mt-10 -64.99 -41.49 95.37 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 119.107 -0.473 . . . . 0.0 110.083 171.545 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -66.09 -37.03 84.76 Favored 'General case' 0 C--N 1.344 0.328 0 CA-C-N 119.42 1.009 . . . . 0.0 110.803 175.55 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 6.5 tp -63.07 -41.2 99.39 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 119.075 0.852 . . . . 0.0 110.036 -177.267 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -59.46 -27.68 66.31 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.516 0.726 . . . . 0.0 112.882 -179.991 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 50.6 mt-30 -95.05 -37.34 11.15 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 125.865 1.666 . . . . 0.0 111.41 -175.875 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 75.4 mtt180 -89.61 -27.28 20.3 Favored 'General case' 0 C--O 1.224 -0.244 0 CA-C-O 118.099 -0.953 . . . . 0.0 112.46 -175.965 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 52.6 m-85 -122.93 145.28 48.61 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 119.796 1.18 . . . . 0.0 112.967 -175.391 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 38.9 mm -95.39 139.07 19.56 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 N-CA-C 103.949 -2.611 . . . . 0.0 103.949 168.871 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 42.9 mt -128.81 147.19 63.48 Favored Pre-proline 0 CA--C 1.532 0.284 0 C-N-CA 123.457 0.703 . . . . 0.0 110.185 -168.835 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -67.77 158.55 56.76 Favored 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 122.76 2.306 . . . . 0.0 110.479 172.126 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -59.17 -33.42 70.91 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 114.436 1.273 . . . . 0.0 114.436 -169.403 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 10.0 p90 -75.05 -13.42 60.49 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 118.927 -0.559 . . . . 0.0 112.49 -177.746 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 75.0 t -88.09 122.47 39.72 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 170.531 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -124.18 129.41 50.77 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 169.67 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -82.81 137.46 20.97 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.809 0 N-CA-C 106.068 -1.827 . . . . 0.0 106.068 167.81 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 52.2 tp -128.36 136.45 50.95 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 169.717 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -93.15 120.94 33.99 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 169.246 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -72.8 -71.73 1.05 Allowed Glycine 0 CA--C 1.526 0.74 0 N-CA-C 108.981 -1.647 . . . . 0.0 108.981 174.159 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 84.98 92.56 0.78 Allowed Glycine 0 C--N 1.342 0.884 0 N-CA-C 107.942 -2.063 . . . . 0.0 107.942 -177.862 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 44.2 p 55.18 30.61 14.83 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 125.009 1.324 . . . . 0.0 111.893 176.879 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -81.61 -65.49 1.01 Allowed 'General case' 0 C--N 1.348 0.507 0 N-CA-C 115.25 1.574 . . . . 0.0 115.25 -168.194 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 60.95 -109.68 2.57 Favored Glycine 0 CA--C 1.528 0.865 0 N-CA-C 110.262 -1.135 . . . . 0.0 110.262 -175.376 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.32 -21.23 66.25 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.315 1.046 . . . . 0.0 112.061 -175.409 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -60.68 -18.85 56.46 Favored 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 113.534 0.938 . . . . 0.0 113.534 -175.158 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 11.4 mt -98.64 15.08 26.27 Favored 'General case' 0 C--N 1.347 0.458 0 N-CA-C 115.155 1.539 . . . . 0.0 115.155 -169.412 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 5.6 tt -48.2 -58.59 4.31 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 119.703 1.138 . . . . 0.0 111.244 -175.477 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -63.15 -31.59 81.23 Favored Glycine 0 CA--C 1.53 1.025 0 CA-C-O 119.419 -0.656 . . . . 0.0 112.368 -176.153 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -81.19 -35.89 30.81 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 118.509 1.155 . . . . 0.0 112.375 -177.556 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 32.6 mtp -74.07 -27.11 60.75 Favored 'General case' 0 N--CA 1.452 -0.361 0 O-C-N 122.102 -0.374 . . . . 0.0 110.045 178.415 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.51 157.59 31.8 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-O 121.677 0.751 . . . . 0.0 111.608 -179.691 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 16.3 m120 63.24 4.07 1.53 Allowed 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 127.27 2.228 . . . . 0.0 115.64 169.769 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 26.9 mmt180 -76.69 158.49 30.96 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 119.97 1.259 . . . . 0.0 109.05 178.759 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -84.38 -54.24 4.91 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 175.392 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . 0.27 0.0 OUTLIER -124.24 147.18 48.26 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-N 119.812 1.187 . . . . 0.0 108.308 169.28 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 19.0 tp -138.48 113.34 9.14 Favored 'General case' 0 CA--C 1.507 -0.678 0 N-CA-C 104.819 -2.289 . . . . 0.0 104.819 -175.272 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 24.5 mt -95.75 112.36 27.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 105.351 -2.092 . . . . 0.0 105.351 176.976 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 41.5 mt -86.96 137.84 20.16 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 N-CA-C 106.722 -1.584 . . . . 0.0 106.722 171.405 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -122.77 117.2 25.12 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 103.567 -2.753 . . . . 0.0 103.567 168.002 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -153.78 158.26 40.64 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 124.91 1.284 . . . . 0.0 108.208 -178.83 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -88.05 152.96 21.65 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 169.537 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 81.1 mt -87.52 -21.92 7.02 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 C-N-CA 125.114 1.366 . . . . 0.0 110.485 -178.786 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . 0.299 96.2 t 69.73 -45.31 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.175 0 C-N-CA 129.448 3.099 . . . . 0.0 113.966 -175.935 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.8 p -165.29 151.29 9.75 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 119.839 1.199 . . . . 0.0 111.939 172.331 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 13.4 tppt? -162.79 176.25 10.45 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 127.477 2.311 . . . . 0.0 105.05 169.449 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 13.7 ptpt -61.26 -26.72 67.95 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 175.946 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 34.2 t-20 -75.74 165.59 24.81 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.815 0.846 . . . . 0.0 110.53 -174.658 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 2.5 m -61.92 152.48 76.61 Favored Pre-proline 0 CA--C 1.547 0.862 0 C-N-CA 124.486 1.114 . . . . 0.0 112.542 -170.186 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -59.37 160.45 19.79 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 124.494 3.463 . . . . 0.0 113.35 169.655 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 61.35 23.89 62.91 Favored Glycine 0 CA--C 1.537 1.461 0 CA-C-O 119.66 -0.522 . . . . 0.0 112.699 170.773 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 3.3 m -105.91 141.36 37.44 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 125.41 1.484 . . . . 0.0 109.314 -170.49 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 41.6 ttp -94.25 142.89 26.89 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 170.372 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 69.6 mtm -132.8 139.91 47.74 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 170.427 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 6.8 mm -93.31 122.46 44.82 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 177.199 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -112.19 123.82 51.1 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 175.726 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 82.1 mtp180 -81.3 170.71 15.71 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 123.004 0.522 . . . . 0.0 110.333 175.842 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -35.59 -55.47 0.68 Allowed 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 116.15 1.908 . . . . 0.0 116.15 -173.827 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -88.61 -9.33 52.57 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -176.001 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -87.64 -40.52 14.11 Favored 'General case' 0 N--CA 1.454 -0.26 0 O-C-N 121.911 -0.493 . . . . 0.0 109.866 -174.868 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 1.4 m -53.5 -47.66 95.58 Favored Pre-proline 0 CA--C 1.54 0.574 0 CA-C-O 117.928 -1.034 . . . . 0.0 112.27 -179.79 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -61.53 -40.09 50.13 Favored 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 122.284 1.99 . . . . 0.0 110.305 179.907 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.48 -4.16 44.14 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.874 0.869 . . . . 0.0 113.103 177.497 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -87.6 -40.78 13.93 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-N 119.338 0.972 . . . . 0.0 110.005 -179.325 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -79.91 24.66 0.39 Allowed 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.538 0.735 . . . . 0.0 112.763 -171.016 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 20.3 p -65.76 -21.99 66.55 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.489 1.116 . . . . 0.0 112.973 179.082 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 51.5 t-20 -61.69 127.49 31.69 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.659 0.783 . . . . 0.0 110.388 -177.257 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 47.8 mmtm -79.12 -19.2 51.7 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 -176.959 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 91.0 mt -64.16 -46.24 94.11 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 C-N-CA 123.786 0.834 . . . . 0.0 108.804 -178.831 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.8 m -67.22 109.07 3.05 Favored Pre-proline 0 CA--C 1.549 0.933 0 C-N-CA 126.589 1.956 . . . . 0.0 110.962 -169.718 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -71.99 -63.0 0.04 OUTLIER 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 122.342 2.028 . . . . 0.0 112.805 -169.063 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 12.4 t-80 -59.32 -40.41 86.21 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 123.61 0.764 . . . . 0.0 110.227 -179.166 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.4 ' H ' ' CD ' ' A' ' 94' ' ' GLN . 22.1 mp0 -63.58 -29.98 71.16 Favored 'General case' 0 N--CA 1.441 -0.911 0 C-N-CA 124.924 1.29 . . . . 0.0 110.106 -174.384 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 20.8 mt -67.72 -44.73 76.94 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 120.393 1.451 . . . . 0.0 110.691 172.909 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -61.69 -40.14 98.37 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 110.238 -1.145 . . . . 0.0 110.238 176.554 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 39.1 tp -65.95 -39.53 90.53 Favored 'General case' 0 CA--C 1.534 0.335 0 O-C-N 122.289 -0.536 . . . . 0.0 109.979 176.225 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -62.21 -42.45 99.31 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 119.172 0.896 . . . . 0.0 109.776 176.664 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -67.64 -28.84 68.05 Favored 'General case' 0 N--CA 1.454 -0.257 0 O-C-N 122.007 -0.433 . . . . 0.0 110.755 178.382 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -73.92 -37.39 47.74 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 O-C-N 121.336 -0.853 . . . . 0.0 111.289 173.654 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 31.5 mt -67.83 -37.62 82.17 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 176.762 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 75.7 m -65.39 -37.13 86.05 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-O 118.34 -0.838 . . . . 0.0 110.055 171.532 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.445 ' HA ' ' CD2' ' A' ' 106' ' ' PHE . . . -64.2 -40.52 96.26 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-N 119.953 1.252 . . . . 0.0 110.661 175.705 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 4.0 mt -64.71 -32.82 74.66 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 118.638 0.653 . . . . 0.0 110.562 174.841 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 51.5 ttp180 -72.15 -29.04 63.65 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 118.763 -0.637 . . . . 0.0 110.033 176.36 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.445 ' CD2' ' HA ' ' A' ' 103' ' ' ALA . 13.6 m-30 -72.12 -47.1 53.67 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 119.118 0.872 . . . . 0.0 110.369 175.467 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 41.6 p -72.68 -25.84 61.4 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 118.313 0.506 . . . . 0.0 111.853 -176.761 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 73.43 7.55 73.39 Favored Glycine 0 CA--C 1.535 1.312 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 -168.495 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -87.55 20.22 3.01 Favored 'General case' 0 C--N 1.348 0.522 0 CA-C-N 119.456 1.628 . . . . 0.0 110.689 176.536 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -58.45 138.2 85.45 Favored Pre-proline 0 CA--C 1.547 0.854 0 C-N-CA 125.903 1.681 . . . . 0.0 109.341 169.952 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_exo -58.0 163.81 9.09 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 123.66 2.907 . . . . 0.0 115.386 -179.359 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -67.72 -37.02 81.66 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 119.024 -0.513 . . . . 0.0 112.112 174.628 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 10.6 ttmm -141.58 74.41 1.45 Allowed 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 -175.474 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 5.5 tt -71.47 138.35 48.94 Favored 'General case' 0 CA--C 1.533 0.289 0 O-C-N 119.959 -1.713 . . . . 0.0 107.516 171.831 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -134.38 141.95 47.03 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 175.763 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -129.26 119.93 24.84 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 120.128 1.331 . . . . 0.0 109.228 -179.939 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 6.2 t -86.5 87.81 2.7 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 N-CA-C 105.61 -1.996 . . . . 0.0 105.61 175.84 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -81.38 135.17 14.07 Favored Glycine 0 C--N 1.334 0.447 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -172.901 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 54.7 t -121.94 123.56 69.41 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.238 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.988 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 42.5 mt -84.67 133.11 44.62 Favored Pre-proline 0 CA--C 1.538 0.492 0 N-CA-C 105.52 -2.029 . . . . 0.0 105.52 169.775 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -75.04 175.33 11.38 Favored 'Trans proline' 0 N--CA 1.449 -1.09 0 C-N-CA 122.287 1.992 . . . . 0.0 111.589 -176.706 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -94.56 -49.23 5.75 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 114.442 -1.253 . . . . 0.0 108.293 169.236 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 97.3 p -127.91 -52.77 1.32 Allowed 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 113.164 0.802 . . . . 0.0 113.164 -170.203 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.8 tp 52.51 34.75 16.12 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 124.362 1.065 . . . . 0.0 113.229 -169.398 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -76.36 164.02 62.53 Favored Pre-proline 0 CA--C 1.549 0.931 0 O-C-N 120.95 -1.094 . . . . 0.0 110.65 174.053 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -80.03 88.25 1.44 Allowed 'Trans proline' 0 CA--C 1.544 0.999 0 C-N-CA 121.66 1.573 . . . . 0.0 112.577 -172.194 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -176.5 154.96 1.33 Allowed 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 104.413 -2.44 . . . . 0.0 104.413 -179.946 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -110.79 162.64 8.18 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-N 120.447 1.476 . . . . 0.0 113.149 -169.663 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 93.71 143.14 12.86 Favored Glycine 0 CA--C 1.53 0.998 0 N-CA-C 106.374 -2.69 . . . . 0.0 106.374 -169.166 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -71.92 165.15 24.76 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 119.576 1.688 . . . . 0.0 110.602 -177.701 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 39.5 p -67.92 166.36 24.2 Favored Pre-proline 0 CA--C 1.539 0.533 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 167.826 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -59.73 -30.57 92.42 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 CA-C-N 120.588 1.246 . . . . 0.0 111.514 173.026 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 79.1 m -67.7 -41.85 82.97 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-N 118.903 0.774 . . . . 0.0 110.105 179.904 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 91.0 t -95.32 -26.26 4.34 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.214 0 CA-C-N 118.329 0.513 . . . . 0.0 110.751 -169.973 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -52.4 -46.91 66.5 Favored 'General case' 0 N--CA 1.464 0.243 0 O-C-N 120.567 -1.333 . . . . 0.0 108.418 169.409 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -69.84 -16.28 63.24 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 113.952 1.093 . . . . 0.0 113.952 -177.935 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 84.0 mtp -71.13 -12.09 61.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 117.24 -1.362 . . . . 0.0 112.6 173.679 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 35.3 mt -53.13 -47.33 55.51 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.28 0 CA-C-N 120.451 1.478 . . . . 0.0 109.226 175.307 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -73.38 -47.1 7.65 Favored Pre-proline 0 CA--C 1.544 0.73 0 CA-C-N 120.296 1.407 . . . . 0.0 112.109 -169.875 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -54.39 -44.78 46.3 Favored 'Trans proline' 0 C--N 1.353 0.802 0 C-N-CA 122.452 2.101 . . . . 0.0 112.179 170.174 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -67.81 -39.41 83.95 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 118.518 -0.753 . . . . 0.0 111.195 -179.055 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 29.0 mt -59.88 -45.57 92.08 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-N 119.79 1.177 . . . . 0.0 109.284 173.075 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -58.18 -33.67 69.51 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 118.993 0.815 . . . . 0.0 110.099 175.689 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -69.72 -39.9 76.57 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 118.778 0.717 . . . . 0.0 111.267 175.412 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 81.1 t -59.36 -44.81 93.28 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 172.596 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 14.7 mt -58.91 -42.65 90.13 Favored 'General case' 0 C--N 1.342 0.246 0 CA-C-N 119.017 0.826 . . . . 0.0 109.576 176.909 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -66.9 -43.63 82.91 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 119.146 0.885 . . . . 0.0 110.687 -176.796 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -67.71 -29.4 68.64 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 119.127 0.876 . . . . 0.0 111.131 179.186 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 41.6 mt -64.76 -49.67 69.86 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 170.298 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 14.7 mtp-105 -68.77 -16.8 63.9 Favored 'General case' 0 CA--C 1.527 0.095 0 CA-C-O 118.219 -0.896 . . . . 0.0 111.557 -177.82 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 30.6 mm-40 -65.6 -23.56 66.86 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 120.32 1.418 . . . . 0.0 111.299 170.826 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 58.4 m -100.73 17.2 22.6 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 119.054 0.843 . . . . 0.0 110.221 168.467 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 68.44 18.33 71.54 Favored Glycine 0 C--N 1.336 0.55 0 CA-C-O 117.656 -1.635 . . . . 0.0 111.958 -176.179 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 42.7 t -91.93 119.01 38.59 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 CA-C-N 120.344 2.072 . . . . 0.0 106.149 -177.121 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -111.26 89.23 2.99 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 178.383 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -49.55 138.3 13.99 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 114.833 -1.076 . . . . 0.0 109.72 169.663 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 15.8 mm -84.79 128.99 58.49 Favored Pre-proline 0 C--O 1.232 0.161 0 CA-C-O 117.483 -1.246 . . . . 0.0 107.902 -174.125 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -66.69 92.09 0.3 Allowed 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 122.922 2.414 . . . . 0.0 108.916 171.376 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 10.1 ttt-85 49.21 19.28 0.3 Allowed 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 128.441 2.696 . . . . 0.0 115.804 179.624 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 64.0 m . . . . . 0 CA--C 1.541 0.615 0 C-N-CA 124.64 1.176 . . . . 0.0 111.886 -169.624 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 tpt . . . . . 0 N--CA 1.472 0.633 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.4 ptp180 -158.89 125.35 4.61 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 103.749 -2.686 . . . . 0.0 103.749 160.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 20.8 mt -129.64 141.61 46.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 -166.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -115.83 146.86 41.62 Favored 'General case' 0 CA--C 1.513 -0.479 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 163.496 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 57.7 t -126.83 106.63 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.715 0 N-CA-C 103.945 -2.613 . . . . 0.0 103.945 170.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -113.37 119.13 36.58 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 -163.235 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -93.87 134.61 12.16 Favored Glycine 0 N--CA 1.451 -0.361 0 N-CA-C 107.909 -2.076 . . . . 0.0 107.909 175.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.7 m -140.96 167.08 17.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 C-N-CA 124.537 1.135 . . . . 0.0 109.457 -178.056 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 127.52 177.44 14.87 Favored Glycine 0 CA--C 1.527 0.821 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 -177.162 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.404 ' HB2' ' CE1' ' A' ' 93' ' ' HIS . 61.2 t-20 -91.76 117.88 30.17 Favored 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 178.332 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 41.3 pt -75.39 24.76 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.793 0 C-N-CA 124.483 1.113 . . . . 0.0 112.125 176.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 38.8 mt -137.45 -3.95 1.88 Allowed 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.594 1.557 . . . . 0.0 112.349 -177.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.5 tp -121.85 52.22 1.28 Allowed 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 120.158 1.345 . . . . 0.0 109.799 -163.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.408 ' HB ' ' H ' ' A' ' 15' ' ' ASP . 0.2 OUTLIER 42.25 -114.5 0.27 Allowed 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 126.502 1.921 . . . . 0.0 110.395 -169.591 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.408 ' H ' ' HB ' ' A' ' 14' ' ' THR . 36.5 m-20 -53.68 -26.21 21.63 Favored 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 126.54 1.936 . . . . 0.0 111.982 -171.514 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -60.04 -20.79 59.73 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 120.172 1.351 . . . . 0.0 111.752 -177.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.09 -11.51 40.5 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 117.773 -1.108 . . . . 0.0 113.415 172.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 7.1 tp -56.33 -44.41 79.73 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-N 120.32 1.418 . . . . 0.0 112.137 -171.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -59.16 -42.19 97.02 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 110.605 -0.998 . . . . 0.0 110.605 -178.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 60.3 t -67.57 -46.7 82.51 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 CA-C-O 118.978 -0.534 . . . . 0.0 110.14 175.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 9.8 mmt180 -58.37 -33.35 69.49 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 119.823 1.192 . . . . 0.0 112.823 -179.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 41.7 mt -57.98 -51.06 75.37 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 177.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 18.0 m -73.49 -35.75 46.16 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 CA-C-N 119.19 0.905 . . . . 0.0 111.717 -173.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -58.56 -47.13 85.27 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 118.811 0.732 . . . . 0.0 110.225 171.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -71.33 -22.13 61.96 Favored 'General case' 0 CA--C 1.531 0.234 0 O-C-N 121.689 -0.632 . . . . 0.0 112.462 -178.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 27.4 tp -73.79 -49.6 24.55 Favored 'General case' 0 C--N 1.339 0.137 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 175.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -52.65 -43.47 65.49 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.068 1.347 . . . . 0.0 111.172 178.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 66.5 mt-30 -85.06 -0.09 53.31 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.702 0.801 . . . . 0.0 113.033 -173.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 85.5 mtt180 -127.66 -23.14 3.48 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-O 116.695 -1.622 . . . . 0.0 112.931 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -134.74 128.75 33.51 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-N 120.823 1.647 . . . . 0.0 109.313 -172.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 48.7 mm -79.77 142.87 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 N-CA-C 105.605 -1.998 . . . . 0.0 105.605 163.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -114.93 154.9 47.0 Favored Pre-proline 0 N--CA 1.453 -0.311 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 178.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -54.81 152.51 28.31 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 121.169 1.246 . . . . 0.0 110.224 158.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -41.41 -46.72 3.45 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 127.575 2.35 . . . . 0.0 113.624 -178.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -78.57 19.9 0.46 Allowed 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 114.149 1.166 . . . . 0.0 114.149 -168.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 10.7 t -126.04 89.08 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 C-N-CA 125.489 1.516 . . . . 0.0 109.023 179.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -71.23 130.16 40.73 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 171.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -93.68 137.19 23.3 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 N-CA-C 105.682 -1.97 . . . . 0.0 105.682 157.213 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 60.5 tp -143.63 129.72 19.65 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 -175.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 30.7 t0 -84.8 133.21 34.35 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 166.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -115.02 31.5 6.24 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 126.351 1.929 . . . . 0.0 111.271 175.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -21.33 110.55 0.01 OUTLIER Glycine 0 CA--C 1.527 0.789 0 C-N-CA 129.026 3.203 . . . . 0.0 114.911 177.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER 59.68 -2.02 0.14 Allowed 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 116.542 2.053 . . . . 0.0 116.542 177.699 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.93 -63.04 1.38 Allowed 'General case' 0 C--N 1.34 0.156 0 CA-C-N 120.211 1.368 . . . . 0.0 112.909 -169.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 57.68 -94.24 0.04 OUTLIER Glycine 0 CA--C 1.533 1.177 0 N-CA-C 110.141 -1.184 . . . . 0.0 110.141 -163.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 7.8 tpt -57.63 -37.69 73.72 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 125.257 1.423 . . . . 0.0 113.147 -169.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -58.2 -26.56 62.94 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.708 0.766 . . . . 0.0 112.108 -173.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 83.1 mt -73.45 2.46 7.73 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 124.721 1.208 . . . . 0.0 112.489 -174.34 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 5.0 tt -43.98 -46.25 8.19 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 125.676 1.591 . . . . 0.0 111.594 174.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -84.05 -31.44 25.96 Favored Glycine 0 CA--C 1.525 0.674 0 CA-C-O 118.827 -0.985 . . . . 0.0 112.323 -178.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -75.6 -44.23 44.01 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 118.739 1.269 . . . . 0.0 110.904 -172.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 37.3 mtp -69.08 -11.32 60.68 Favored 'General case' 0 CA--C 1.54 0.574 0 O-C-N 121.974 -0.454 . . . . 0.0 111.675 -177.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -75.4 153.9 37.46 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 124.818 1.247 . . . . 0.0 110.446 -176.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 62.15 -5.67 0.16 Allowed 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 127.229 2.211 . . . . 0.0 114.107 167.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 8.6 mmt180 -66.29 148.4 51.9 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 175.084 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -80.05 -44.76 19.52 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 -175.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 4.0 t-160 -139.18 131.09 27.72 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 103.118 -2.919 . . . . 0.0 103.118 -177.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 30.1 tp -129.29 122.49 29.71 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 -178.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 52.3 mt -103.07 109.36 26.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 105.318 -2.105 . . . . 0.0 105.318 171.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 21.4 mt -83.39 148.33 5.17 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 168.021 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -131.05 128.8 41.0 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 164.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -153.25 168.37 26.22 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.324 1.05 . . . . 0.0 110.426 -163.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -92.1 129.9 37.95 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 163.122 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 34.9 mt -76.56 -24.71 15.89 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 C-N-CA 123.668 0.787 . . . . 0.0 110.503 175.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . 0.255 26.1 t 64.52 -35.03 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 C-N-CA 128.202 2.601 . . . . 0.0 113.687 -179.701 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -153.68 133.75 13.27 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 121.925 2.148 . . . . 0.0 113.883 -174.324 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.43 ' HG3' ' H ' ' A' ' 68' ' ' LYS . 3.6 tppt? -156.87 -175.73 5.59 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 105.557 -2.016 . . . . 0.0 105.557 147.236 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.43 ' H ' ' HG3' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -85.37 67.01 9.98 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 166.225 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 52.3 t30 -150.36 155.72 40.15 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 119.052 0.842 . . . . 0.0 109.0 178.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 8.1 m -60.02 140.41 90.53 Favored Pre-proline 0 CA--C 1.543 0.699 0 C-N-CA 126.674 1.99 . . . . 0.0 112.124 -165.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_exo -43.97 149.79 0.73 Allowed 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 124.22 3.28 . . . . 0.0 113.492 168.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 66.39 -7.91 1.21 Allowed Glycine 0 CA--C 1.532 1.101 0 C-N-CA 124.86 1.219 . . . . 0.0 115.554 178.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 30.4 m -64.88 149.83 48.85 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 120.202 2.001 . . . . 0.0 109.421 -178.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 28.9 ttp -94.43 147.36 23.32 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 174.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 42.0 mtt -129.23 146.15 51.2 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 106.095 -1.817 . . . . 0.0 106.095 162.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 33.2 mm -117.81 130.17 73.09 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 N-CA-C 103.266 -2.864 . . . . 0.0 103.266 171.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -123.74 143.55 50.22 Favored 'General case' 0 C--O 1.242 0.684 0 N-CA-C 105.013 -2.217 . . . . 0.0 105.013 176.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 79.9 mtm180 -114.73 165.88 12.34 Favored 'General case' 0 C--O 1.222 -0.36 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 177.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -22.29 -66.43 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 127.866 2.466 . . . . 0.0 116.072 -159.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -62.16 -33.52 74.67 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.879 1.672 . . . . 0.0 113.804 -176.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -76.35 -26.87 56.16 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.122 1.369 . . . . 0.0 110.741 -175.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 26.4 t -69.1 -50.89 19.47 Favored Pre-proline 0 CA--C 1.544 0.742 0 CA-C-O 117.69 -1.148 . . . . 0.0 112.394 -169.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -57.25 -39.89 86.68 Favored 'Trans proline' 0 C--N 1.353 0.802 0 CA-C-N 121.602 1.608 . . . . 0.0 111.374 174.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -62.84 -45.4 92.77 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 123.053 0.541 . . . . 0.0 110.59 -179.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -58.03 -47.52 82.85 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 123.817 0.847 . . . . 0.0 110.027 176.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 -75.88 1.36 15.3 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 -175.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 70.9 p -63.7 -13.36 42.41 Favored 'General case' 0 CA--C 1.543 0.685 0 O-C-N 120.198 -1.564 . . . . 0.0 112.315 166.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 41.1 t30 -58.72 109.89 0.89 Allowed 'General case' 0 C--N 1.346 0.454 0 C-N-CA 125.357 1.463 . . . . 0.0 111.712 -178.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 32.4 mmtp -67.87 -16.13 63.94 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 113.298 0.851 . . . . 0.0 113.298 -175.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 41.1 mt -75.03 -21.02 16.54 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 C-N-CA 123.358 0.663 . . . . 0.0 109.536 -179.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 14.6 m -100.56 104.71 32.52 Favored Pre-proline 0 CA--C 1.546 0.819 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 -172.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -72.4 -54.51 0.13 Allowed 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.295 1.996 . . . . 0.0 113.622 -160.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . 0.404 ' CE1' ' HB2' ' A' ' 10' ' ' ASN . 20.3 m80 -65.3 -36.1 83.04 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 177.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 23.1 mp0 -64.66 -30.03 71.04 Favored 'General case' 0 N--CA 1.441 -0.901 0 C-N-CA 125.02 1.328 . . . . 0.0 110.378 -176.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -64.94 -33.63 76.49 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 119.103 0.865 . . . . 0.0 111.535 171.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -78.72 -30.38 48.51 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 110.759 -0.937 . . . . 0.0 110.759 172.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.8 -37.62 88.06 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 118.339 1.07 . . . . 0.0 108.466 171.398 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -60.95 -43.42 98.72 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 117.929 -1.034 . . . . 0.0 109.924 175.007 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -74.15 -24.03 59.35 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 119.638 1.108 . . . . 0.0 113.158 177.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 38.1 t -62.48 -44.91 99.75 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 O-C-N 119.742 -1.848 . . . . 0.0 109.366 164.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 72.9 mt -67.94 -29.74 68.88 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 119.352 0.978 . . . . 0.0 110.811 178.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 44.5 m -62.19 -57.61 10.83 Favored 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 167.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.31 -35.4 78.93 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.795 1.238 . . . . 0.0 113.112 -174.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 13.8 mt -65.1 -42.37 94.09 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-N 118.929 0.786 . . . . 0.0 109.709 173.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 76.5 ttt180 -64.89 -34.65 78.9 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-O 117.677 -1.154 . . . . 0.0 110.649 172.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 13.0 m-30 -66.22 -39.22 89.43 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 120.069 1.304 . . . . 0.0 110.715 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 40.8 p -78.37 -28.05 46.98 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 119.119 0.872 . . . . 0.0 110.828 177.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 83.65 1.56 90.03 Favored Glycine 0 CA--C 1.531 1.056 0 CA-C-O 118.158 -1.357 . . . . 0.0 112.443 -166.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -87.08 21.01 2.47 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 120.479 2.139 . . . . 0.0 111.545 -179.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -61.19 139.01 94.55 Favored Pre-proline 0 CA--C 1.549 0.927 0 C-N-CA 126.274 1.83 . . . . 0.0 109.93 170.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -55.42 167.98 1.7 Allowed 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 123.923 3.082 . . . . 0.0 115.866 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -74.67 -23.12 58.6 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 123.461 0.704 . . . . 0.0 111.686 169.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 52.2 tttm -158.93 84.29 0.81 Allowed 'General case' 0 C--O 1.241 0.632 0 N-CA-C 106.522 -1.659 . . . . 0.0 106.522 -169.109 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.7 tt -79.21 141.88 36.75 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 119.186 -1.006 . . . . 0.0 108.914 165.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -138.9 146.76 41.5 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.88 1.672 . . . . 0.0 107.369 177.458 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -133.11 113.98 13.36 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 -179.274 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 45.1 t -93.35 86.66 2.15 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 173.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.55 150.36 16.94 Favored Glycine 0 C--N 1.338 0.671 0 N-CA-C 111.001 -0.84 . . . . 0.0 111.001 -166.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 22.7 t -129.11 135.84 61.03 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 -169.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 25.0 mt -78.3 135.93 61.23 Favored Pre-proline 0 CA--C 1.549 0.919 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 170.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -75.92 -161.53 0.13 Allowed 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 124.288 3.325 . . . . 0.0 111.522 178.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -138.75 -62.03 0.56 Allowed 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.83 1.652 . . . . 0.0 108.518 173.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 57.6 m -99.24 -48.19 4.91 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 119.104 0.865 . . . . 0.0 111.737 -177.106 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 51.58 45.91 27.34 Favored 'General case' 0 CA--C 1.549 0.911 0 N-CA-C 114.336 1.235 . . . . 0.0 114.336 -177.494 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -110.18 161.84 22.86 Favored Pre-proline 0 CA--C 1.542 0.642 0 C-N-CA 124.195 0.998 . . . . 0.0 110.989 -177.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -72.31 68.94 3.37 Favored 'Trans proline' 0 CA--C 1.543 0.954 0 C-N-CA 124.485 3.457 . . . . 0.0 113.982 -177.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 5.7 p-80 -148.16 173.18 13.24 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 126.874 2.07 . . . . 0.0 106.938 162.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -118.32 144.82 25.39 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.158 0 O-C-N 121.069 -1.019 . . . . 0.0 110.151 -171.185 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 142.09 176.25 16.14 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 105.997 -2.841 . . . . 0.0 105.997 -172.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -98.57 161.76 13.5 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 104.676 -2.342 . . . . 0.0 104.676 150.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 65.7 p -62.12 158.34 46.22 Favored Pre-proline 0 CA--C 1.543 0.71 0 C-N-CA 119.176 -1.01 . . . . 0.0 108.608 155.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -51.85 -38.49 67.97 Favored 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 122.046 1.83 . . . . 0.0 112.03 171.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 6.3 m -53.01 -30.98 38.51 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 126.12 1.768 . . . . 0.0 112.278 176.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 63.9 t -115.51 -18.88 6.96 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 CA-C-N 118.719 0.691 . . . . 0.0 111.014 -170.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -59.52 -43.25 93.49 Favored 'General case' 0 CA--C 1.534 0.338 0 O-C-N 121.325 -0.859 . . . . 0.0 108.73 165.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -59.45 -30.47 68.53 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.154 -0.476 . . . . 0.0 112.096 173.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 15.1 mmm -73.18 -8.47 55.94 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 117.458 -1.258 . . . . 0.0 113.789 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 96.7 mt -58.18 -50.05 79.62 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-N 120.438 1.472 . . . . 0.0 108.458 177.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -78.07 -40.37 1.92 Allowed Pre-proline 0 CA--C 1.535 0.376 0 CA-C-O 117.163 -1.398 . . . . 0.0 114.588 -168.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -54.34 -35.96 85.58 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 CA-C-N 122.38 1.886 . . . . 0.0 112.224 167.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -75.88 -32.85 59.88 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-O 117.981 -1.009 . . . . 0.0 111.313 175.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 53.5 mt -59.18 -48.59 81.03 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 120.579 1.536 . . . . 0.0 108.229 169.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -60.15 -29.53 68.72 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 119.375 0.989 . . . . 0.0 111.565 -179.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 32.6 mm-40 -86.39 -31.86 21.24 Favored 'General case' 0 CA--C 1.529 0.145 0 O-C-N 120.999 -1.063 . . . . 0.0 113.57 176.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 72.2 t -63.83 -40.97 90.97 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 CA-C-N 120.99 1.723 . . . . 0.0 108.736 166.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 83.6 mt -66.39 -39.8 89.28 Favored 'General case' 0 N--CA 1.463 0.179 0 C-N-CA 123.653 0.781 . . . . 0.0 110.722 176.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -64.01 -46.15 85.78 Favored 'General case' 0 C--O 1.227 -0.126 0 CA-C-N 118.748 0.704 . . . . 0.0 110.598 174.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -59.05 -42.88 91.37 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 118.847 -0.597 . . . . 0.0 110.776 178.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 31.1 mt -58.0 -45.23 87.15 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 119.174 0.897 . . . . 0.0 110.27 173.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 64.8 mtt180 -66.38 -18.88 65.62 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 117.096 -1.43 . . . . 0.0 112.791 178.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -60.9 -27.0 67.85 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 121.328 1.877 . . . . 0.0 110.807 171.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 16.7 m -101.89 13.91 33.47 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.107 0.963 . . . . 0.0 111.642 175.01 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 71.85 10.39 72.27 Favored Glycine 0 CA--C 1.53 1.0 0 CA-C-O 118.777 -1.013 . . . . 0.0 113.542 -179.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 61.0 t -79.69 102.92 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 CA-C-N 119.31 1.555 . . . . 0.0 107.301 178.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -72.93 152.87 41.22 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 164.038 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -131.57 150.91 51.98 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 125.351 1.46 . . . . 0.0 107.243 174.269 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 7.7 mm -114.31 122.72 33.77 Favored Pre-proline 0 CA--C 1.53 0.203 0 N-CA-C 107.58 -1.266 . . . . 0.0 107.58 -163.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -62.41 116.66 3.65 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 122.162 1.908 . . . . 0.0 108.031 176.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 59.7 mtm180 40.09 8.16 0.0 OUTLIER 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 129.573 3.149 . . . . 0.0 117.576 -172.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 70.7 m 47.85 54.61 9.7 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 121.231 1.832 . . . . 0.0 110.381 -158.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -137.26 122.04 18.72 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 101.997 -3.335 . . . . 0.0 101.997 -170.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 61.7 m . . . . . 0 C--O 1.249 1.036 0 CA-C-O 116.285 -1.817 . . . . 0.0 109.44 -155.273 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.2 ttt . . . . . 0 N--CA 1.501 2.086 0 CA-C-O 119.612 -0.232 . . . . 0.0 110.668 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 39.1 mmt180 -63.31 126.0 25.98 Favored 'General case' 0 N--CA 1.479 0.977 0 O-C-N 119.879 -1.763 . . . . 0.0 108.813 175.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 3.9 mt -123.39 121.67 63.31 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 -176.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -106.81 139.28 41.49 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 168.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 58.0 t -126.87 101.43 7.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 105.467 -2.049 . . . . 0.0 105.467 -177.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.3 mt -98.76 109.36 22.13 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.475 1.11 . . . . 0.0 109.581 -169.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -87.15 127.13 8.29 Favored Glycine 0 C--O 1.237 0.324 0 N-CA-C 106.958 -2.457 . . . . 0.0 106.958 169.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 15.3 m -138.69 172.69 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 CA-C-N 117.588 0.694 . . . . 0.0 111.202 -169.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 101.16 163.45 27.59 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 127.189 2.328 . . . . 0.0 111.731 179.202 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.43 HD22 ' HB2' ' A' ' 12' ' ' LEU . 6.9 t30 -77.32 102.13 6.61 Favored 'General case' 0 C--N 1.332 -0.167 0 O-C-N 121.88 -0.777 . . . . 0.0 111.043 -169.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -56.52 7.51 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.935 0 N-CA-C 117.742 2.497 . . . . 0.0 117.742 179.164 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.43 ' HB2' HD22 ' A' ' 10' ' ' ASN . 67.7 mt -109.54 1.3 19.65 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 122.127 2.24 . . . . 0.0 109.743 -177.438 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.4 mp -111.84 63.02 0.62 Allowed 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 123.895 0.878 . . . . 0.0 111.4 -169.039 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 52.83 -100.15 0.09 Allowed 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.664 0.786 . . . . 0.0 111.152 176.59 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 -83.69 -9.1 59.08 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 124.262 1.025 . . . . 0.0 111.881 -174.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -71.79 -8.41 54.12 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 120.485 1.493 . . . . 0.0 112.454 -175.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -75.37 -14.35 60.46 Favored 'General case' 0 N--CA 1.434 -1.252 0 CA-C-O 115.724 -2.084 . . . . 0.0 109.349 170.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 7.9 tp -52.48 -39.2 28.33 Favored 'Isoleucine or valine' 0 C--N 1.344 0.358 0 CA-C-N 122.588 2.449 . . . . 0.0 112.878 -169.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -61.46 -45.52 96.21 Favored Glycine 0 CA--C 1.525 0.718 0 CA-C-N 119.422 1.01 . . . . 0.0 111.148 177.018 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 69.9 t -64.2 -48.53 85.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-O 118.845 -0.598 . . . . 0.0 110.039 172.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 78.4 mmt-85 -59.07 -33.88 71.32 Favored 'General case' 0 C--O 1.223 -0.336 0 CA-C-O 117.755 -1.116 . . . . 0.0 112.263 -179.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 28.6 mt -63.64 -45.07 98.51 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 CA-C-N 120.679 1.581 . . . . 0.0 109.656 177.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 14.5 m -75.81 -26.0 17.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-N 119.67 1.123 . . . . 0.0 111.071 -176.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 -70.75 -44.92 65.78 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 173.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.69 -42.37 97.02 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 122.885 0.474 . . . . 0.0 109.809 176.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 8.2 tp -65.45 -42.91 91.85 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 118.16 -0.924 . . . . 0.0 110.48 178.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -58.22 -43.98 87.98 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 119.042 0.837 . . . . 0.0 110.73 178.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -72.64 -39.7 66.98 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.715 0.806 . . . . 0.0 111.27 -177.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -95.82 -40.56 9.27 Favored 'General case' 0 C--N 1.34 0.172 0 CA-C-O 117.044 -1.455 . . . . 0.0 113.704 -169.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -109.64 124.14 50.67 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 121.735 2.062 . . . . 0.0 112.151 -169.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 47.2 mm -76.78 137.43 22.54 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 N-CA-C 105.739 -1.948 . . . . 0.0 105.739 169.13 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 29.5 mt -135.25 156.28 78.18 Favored Pre-proline 0 CA--C 1.535 0.4 0 C-N-CA 124.665 1.186 . . . . 0.0 110.83 -169.267 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -60.06 155.86 42.58 Favored 'Trans proline' 0 CA--C 1.535 0.569 0 C-N-CA 123.344 2.696 . . . . 0.0 111.775 169.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -62.26 -30.49 71.16 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -173.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 11.5 p90 -73.54 -6.42 46.42 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 118.207 -0.901 . . . . 0.0 112.752 -179.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 19.7 t -99.28 127.26 52.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 CA-C-N 119.861 1.21 . . . . 0.0 108.264 175.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -127.19 137.27 52.89 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 173.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -102.36 104.15 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 N-CA-C 105.862 -1.903 . . . . 0.0 105.862 176.664 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 56.7 tp -95.88 121.39 37.56 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -79.92 109.46 14.38 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 106.254 -1.758 . . . . 0.0 106.254 169.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -103.86 -27.92 6.12 Favored Glycine 0 CA--C 1.534 1.233 0 CA-C-O 119.248 -0.751 . . . . 0.0 112.373 173.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 40.17 -111.99 0.27 Allowed Glycine 0 C--N 1.34 0.775 0 C-N-CA 125.327 1.442 . . . . 0.0 113.122 -177.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 12.1 p -65.01 -3.49 3.6 Favored 'General case' 0 C--N 1.316 -0.869 0 C-N-CA 128.756 2.823 . . . . 0.0 113.806 -172.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -50.3 -66.3 0.41 Allowed 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 114.974 1.472 . . . . 0.0 114.974 -179.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 64.15 -94.62 0.15 Allowed Glycine 0 CA--C 1.531 1.065 0 N-CA-C 109.416 -1.473 . . . . 0.0 109.416 -169.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 10.4 tpt -69.33 -26.99 64.98 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 126.776 2.03 . . . . 0.0 112.255 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -70.17 -4.68 22.65 Favored 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -169.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 66.2 mt -87.79 -6.01 58.36 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 124.636 1.175 . . . . 0.0 114.063 -171.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 5.2 tt -43.39 -59.74 2.0 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 114.19 1.182 . . . . 0.0 114.19 -169.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -72.25 -36.4 59.93 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 111.723 -0.551 . . . . 0.0 111.723 -170.193 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -68.01 -37.77 81.81 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 117.932 0.866 . . . . 0.0 110.214 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 36.2 mtp -74.13 -18.13 60.83 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 120.664 -0.414 . . . . 0.0 111.782 -174.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -75.73 151.04 37.7 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 121.635 0.731 . . . . 0.0 111.129 -177.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 55.62 44.16 27.02 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 126.373 1.869 . . . . 0.0 114.201 168.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 27.2 mmt180 -108.01 156.98 18.64 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 174.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -78.62 -41.9 30.32 Favored 'General case' 0 N--CA 1.467 0.385 0 O-C-N 121.438 -0.789 . . . . 0.0 109.771 171.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -134.23 133.14 40.52 Favored 'General case' 0 C--O 1.232 0.168 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 -175.171 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 26.1 tp -135.42 131.77 36.65 Favored 'General case' 0 CA--C 1.512 -0.482 0 O-C-N 121.486 -0.759 . . . . 0.0 109.242 169.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 10.6 mt -114.07 123.44 69.73 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 N-CA-C 106.006 -1.85 . . . . 0.0 106.006 178.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 15.5 mt -101.49 127.53 54.75 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 N-CA-C 104.803 -2.295 . . . . 0.0 104.803 177.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -115.64 121.48 42.69 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 105.749 -1.945 . . . . 0.0 105.749 176.079 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -155.41 149.29 25.46 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 118.561 0.619 . . . . 0.0 112.437 -169.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -76.82 116.92 17.92 Favored 'General case' 0 CA--C 1.529 0.136 0 N-CA-C 105.53 -2.026 . . . . 0.0 105.53 168.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.7 tt -68.79 -25.46 30.48 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.772 0 CA-C-O 117.684 -1.151 . . . . 0.0 113.102 -169.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . 0.281 92.9 t 55.28 17.03 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.556 1.202 0 C-N-CA 125.278 1.431 . . . . 0.0 112.806 172.212 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 48.7 m -126.86 164.05 22.26 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 125.057 1.343 . . . . 0.0 111.3 -170.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.487 ' HG3' ' H ' ' A' ' 68' ' ' LYS . 4.6 tppt? 59.72 -172.06 0.12 Allowed 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.12 1.768 . . . . 0.0 111.738 177.417 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.487 ' H ' ' HG3' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -128.66 20.48 6.07 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.223 1.409 . . . . 0.0 112.401 -175.809 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 51.0 t30 -71.48 163.85 26.93 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 108.096 -1.075 . . . . 0.0 108.096 172.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 12.6 m -58.14 142.67 80.17 Favored Pre-proline 0 CA--C 1.546 0.801 0 C-N-CA 123.964 0.906 . . . . 0.0 112.18 -169.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -57.38 152.38 47.03 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.554 2.169 . . . . 0.0 111.453 170.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 67.7 16.48 67.94 Favored Glycine 0 CA--C 1.533 1.169 0 CA-C-O 119.128 -0.818 . . . . 0.0 113.756 177.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 48.7 m -96.32 153.89 17.56 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 118.955 1.377 . . . . 0.0 108.784 175.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 9.6 ttp -97.97 141.77 30.52 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 123.589 0.756 . . . . 0.0 110.222 -179.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 13.6 mtp -126.48 119.31 26.88 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 176.053 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 46.0 mm -103.07 123.81 56.75 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 177.086 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 48.2 mt -125.0 129.28 50.0 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 107.548 -1.278 . . . . 0.0 107.548 -177.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 65.7 mtm180 -104.99 131.49 52.44 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 -169.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 6.9 t70 36.32 -98.11 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 116.168 1.914 . . . . 0.0 116.168 169.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -62.74 -27.57 69.36 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.966 0.906 . . . . 0.0 112.932 -176.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -73.49 -15.47 61.32 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.385 0.674 . . . . 0.0 111.005 -177.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 81.4 t -79.52 -60.84 0.5 Allowed Pre-proline 0 N--CA 1.442 -0.832 0 CA-C-O 117.963 -1.018 . . . . 0.0 110.466 -169.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -59.85 -31.69 94.25 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 CA-C-N 120.846 1.338 . . . . 0.0 111.65 175.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.14 -13.69 62.41 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -177.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -98.14 -38.38 9.35 Favored 'General case' 0 C--N 1.344 0.332 0 CA-C-N 118.713 0.688 . . . . 0.0 109.267 169.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -59.34 -12.79 6.34 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 113.101 0.778 . . . . 0.0 113.101 177.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 70.7 p -52.86 -27.78 19.99 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 113.857 1.058 . . . . 0.0 113.857 169.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -60.23 146.25 44.34 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 122.948 0.499 . . . . 0.0 111.66 -169.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 46.6 mmtm -99.51 -0.16 41.19 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.7 0.8 . . . . 0.0 111.981 177.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 74.8 mt -66.95 -41.13 87.07 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 178.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 5.8 m -96.81 109.43 48.61 Favored Pre-proline 0 CA--C 1.543 0.68 0 C-N-CA 125.737 1.615 . . . . 0.0 109.223 -172.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -68.3 -47.22 1.69 Allowed 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.002 1.802 . . . . 0.0 112.937 -169.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 15.7 m80 -73.94 -22.47 59.65 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 122.729 0.411 . . . . 0.0 111.328 -171.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -68.9 -24.75 64.34 Favored 'General case' 0 C--O 1.222 -0.343 0 CA-C-O 117.72 -1.134 . . . . 0.0 111.847 177.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 2.8 tt -60.77 -43.42 98.08 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 120.387 1.449 . . . . 0.0 109.652 -174.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -59.99 -41.6 97.98 Favored Glycine 0 CA--C 1.529 0.94 0 O-C-N 121.628 -0.67 . . . . 0.0 111.52 176.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -71.62 -32.6 68.14 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 118.526 1.163 . . . . 0.0 110.717 179.083 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -60.3 -45.2 94.18 Favored 'General case' 0 N--CA 1.454 -0.254 0 O-C-N 120.943 -1.098 . . . . 0.0 109.067 171.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -69.9 -23.85 63.3 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 118.979 -0.534 . . . . 0.0 112.104 177.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 20.9 t -66.5 -45.05 89.9 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.697 0 CA-C-N 119.223 0.92 . . . . 0.0 108.552 169.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 93.8 mt -64.44 -34.22 77.68 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 119.377 0.99 . . . . 0.0 110.245 179.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 20.3 m -64.91 -41.41 95.6 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 118.88 0.763 . . . . 0.0 110.318 169.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.451 ' HA ' ' CD2' ' A' ' 106' ' ' PHE . . . -64.39 -36.8 85.33 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 119.121 0.873 . . . . 0.0 111.527 178.296 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.6 mt -66.8 -35.6 80.44 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 118.412 0.551 . . . . 0.0 110.272 176.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 77.7 ttt-85 -65.92 -38.79 89.62 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 118.459 -0.781 . . . . 0.0 109.909 171.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.451 ' CD2' ' HA ' ' A' ' 103' ' ' ALA . 15.6 m-30 -64.09 -44.05 93.53 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 119.372 0.987 . . . . 0.0 110.586 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 42.3 p -75.71 -22.8 56.28 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 118.325 0.511 . . . . 0.0 111.403 178.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 74.47 12.59 82.21 Favored Glycine 0 CA--C 1.531 1.09 0 N-CA-C 111.118 -0.793 . . . . 0.0 111.118 -169.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -98.79 25.29 6.7 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 118.644 1.222 . . . . 0.0 110.97 -178.006 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -57.56 135.58 82.26 Favored Pre-proline 0 CA--C 1.544 0.724 0 C-N-CA 124.111 0.964 . . . . 0.0 109.209 170.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -54.55 151.71 29.87 Favored 'Trans proline' 0 C--N 1.35 0.658 0 C-N-CA 123.643 2.895 . . . . 0.0 114.108 -179.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -60.09 -29.81 68.83 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 119.012 -0.518 . . . . 0.0 110.44 177.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 23.1 ttpp -146.54 125.84 13.07 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 169.161 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.4 tt -105.92 147.38 28.83 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 169.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -143.42 138.9 29.67 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 -177.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.7 tp -125.09 129.39 50.14 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 120.429 1.468 . . . . 0.0 108.828 175.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 53.5 t -102.5 98.95 7.45 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 N-CA-C 104.759 -2.311 . . . . 0.0 104.759 168.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -84.77 140.27 18.59 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 109.981 -1.248 . . . . 0.0 109.981 174.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 40.9 t -119.95 138.25 51.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 173.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 5.4 mt -86.92 126.92 61.65 Favored Pre-proline 0 CA--C 1.54 0.591 0 CA-C-N 119.395 0.998 . . . . 0.0 108.389 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -77.0 167.28 25.39 Favored 'Trans proline' 0 CA--C 1.542 0.884 0 C-N-CA 123.657 2.904 . . . . 0.0 112.25 -178.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -107.38 -58.89 1.9 Allowed 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.673 0.789 . . . . 0.0 109.924 -178.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 4.0 m -105.28 -58.06 1.95 Allowed 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 122.934 0.494 . . . . 0.0 112.04 -170.27 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER 56.46 52.37 10.03 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 126.176 1.79 . . . . 0.0 115.334 171.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -121.71 165.21 20.76 Favored Pre-proline 0 N--CA 1.475 0.796 0 CA-C-O 117.826 -1.083 . . . . 0.0 108.87 172.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -67.47 84.09 0.38 Allowed 'Trans proline' 0 CA--C 1.546 1.084 0 C-N-CA 123.345 2.697 . . . . 0.0 112.551 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -168.85 152.4 5.35 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 104.501 -2.407 . . . . 0.0 104.501 174.241 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -120.27 152.87 23.22 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-O 121.999 0.904 . . . . 0.0 113.286 -169.654 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 120.8 130.73 3.92 Favored Glycine 0 CA--C 1.527 0.814 0 N-CA-C 105.98 -2.848 . . . . 0.0 105.98 -169.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 7.0 mp -77.8 149.39 34.43 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 177.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 54.6 p -67.22 163.19 48.21 Favored Pre-proline 0 CA--C 1.534 0.349 0 CA-C-O 119.148 -0.453 . . . . 0.0 109.942 169.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -58.71 -34.67 99.08 Favored 'Trans proline' 0 CA--C 1.537 0.65 0 C-N-CA 121.099 1.199 . . . . 0.0 109.574 169.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 4.5 m -63.34 -39.06 93.51 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.187 0.995 . . . . 0.0 111.18 -176.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 21.8 t -102.48 -25.89 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 CA-C-N 119.319 0.963 . . . . 0.0 112.146 -176.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -54.1 -43.01 70.02 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 120.825 1.648 . . . . 0.0 109.986 169.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -73.04 -2.43 21.18 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-O 118.332 -0.842 . . . . 0.0 113.107 -176.033 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 16.4 mmm -89.58 -7.09 55.56 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-O 116.953 -1.499 . . . . 0.0 111.022 170.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 91.6 mt -58.9 -47.64 88.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 CA-C-N 121.631 2.014 . . . . 0.0 109.301 -179.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 61.6 mt-10 -73.21 -51.14 6.08 Favored Pre-proline 0 CA--C 1.536 0.425 0 CA-C-O 117.39 -1.29 . . . . 0.0 110.809 -178.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -40.49 -51.99 3.23 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 124.447 3.431 . . . . 0.0 113.672 169.041 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -74.16 -45.33 49.31 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 114.538 -1.21 . . . . 0.0 111.451 -174.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -62.37 -36.02 80.96 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 119.594 1.088 . . . . 0.0 109.984 178.28 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -62.86 -33.04 74.45 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 118.744 -0.645 . . . . 0.0 111.085 176.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 42.9 mm-40 -78.47 -29.97 47.12 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 119.502 1.046 . . . . 0.0 111.892 174.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 67.7 t -61.41 -43.43 96.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 169.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 71.4 mt -69.65 -33.41 72.57 Favored 'General case' 0 N--CA 1.463 0.179 0 O-C-N 120.752 -1.217 . . . . 0.0 111.622 176.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -58.86 -33.6 70.65 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 118.923 0.783 . . . . 0.0 111.455 176.151 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -62.42 -46.79 86.95 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 118.531 0.605 . . . . 0.0 111.292 174.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 7.1 mp -58.44 -43.4 88.76 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.021 0.529 . . . . 0.0 109.866 174.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 84.7 mtt180 -65.38 -17.56 64.63 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 117.418 -1.277 . . . . 0.0 111.896 -177.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -58.16 -34.38 70.24 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 120.616 1.553 . . . . 0.0 111.33 175.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 8.1 m -107.39 28.57 7.98 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.598 1.159 . . . . 0.0 110.956 -179.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 64.22 23.8 68.39 Favored Glycine 0 CA--C 1.53 1.003 0 CA-C-O 118.725 -1.042 . . . . 0.0 113.917 176.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 59.4 t -93.77 134.47 31.31 Favored 'Isoleucine or valine' 0 C--N 1.341 0.213 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 174.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -122.6 145.05 48.7 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 178.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -107.46 143.09 36.32 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 124.06 0.944 . . . . 0.0 109.351 174.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 23.3 mm -105.62 125.97 31.97 Favored Pre-proline 0 C--O 1.234 0.253 0 CA-C-O 117.879 -1.058 . . . . 0.0 108.649 -173.193 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -57.61 110.42 0.62 Allowed 'Trans proline' 0 N--CA 1.461 -0.383 0 C-N-CA 122.608 2.206 . . . . 0.0 108.919 169.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 82.7 mtm180 51.51 30.68 6.63 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.179 0.992 . . . . 0.0 112.715 171.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 17.4 p 46.12 26.23 0.41 Allowed 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 126.714 2.006 . . . . 0.0 114.872 -171.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -76.73 142.46 40.45 Favored 'General case' 0 C--O 1.239 0.527 0 O-C-N 121.118 -0.989 . . . . 0.0 110.645 -176.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 15.5 m . . . . . 0 C--O 1.255 1.346 0 C-N-CA 124.443 1.097 . . . . 0.0 111.126 -174.029 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.919 0 CA-C-O 118.627 -0.702 . . . . 0.0 110.998 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -58.17 128.64 38.15 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 119.883 1.219 . . . . 0.0 110.633 174.783 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 5.7 mt -125.52 129.55 72.82 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -120.36 141.11 50.38 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 106.105 -1.813 . . . . 0.0 106.105 168.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 91.6 t -121.42 127.41 75.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 106.722 -1.584 . . . . 0.0 106.722 -176.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.2 tp -109.03 111.61 23.36 Favored 'General case' 0 CA--C 1.515 -0.4 0 C-N-CA 123.468 0.707 . . . . 0.0 111.02 -169.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -94.07 118.24 5.7 Favored Glycine 0 N--CA 1.446 -0.67 0 N-CA-C 104.394 -3.482 . . . . 0.0 104.394 168.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.4 m -141.32 163.74 20.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 -171.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 121.73 160.47 11.01 Favored Glycine 0 C--N 1.338 0.661 0 C-N-CA 124.818 1.199 . . . . 0.0 110.495 176.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.485 ' ND2' ' H ' ' A' ' 12' ' ' LEU . 12.4 t30 -79.22 101.52 8.03 Favored 'General case' 0 C--N 1.333 -0.122 0 O-C-N 121.351 -1.088 . . . . 0.0 109.988 -179.366 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 27.3 pt -53.41 -15.07 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 N-CA-C 116.13 1.9 . . . . 0.0 116.13 -176.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.485 ' H ' ' ND2' ' A' ' 10' ' ' ASN . 5.2 mp -90.17 -3.79 57.66 Favored 'General case' 0 C--O 1.219 -0.536 0 CA-C-N 121.024 1.738 . . . . 0.0 107.558 -170.506 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.3 mp -101.78 55.42 0.81 Allowed 'General case' 0 N--CA 1.439 -0.987 0 C-N-CA 123.477 0.711 . . . . 0.0 109.727 -174.334 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.254 0.1 OUTLIER 49.6 -102.11 0.1 Allowed 'General case' 0 C--O 1.236 0.345 0 CA-C-N 114.348 -1.296 . . . . 0.0 111.331 177.052 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -72.21 -12.34 61.13 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 123.891 0.876 . . . . 0.0 111.319 -172.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -73.07 -2.5 21.56 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-N 119.377 0.99 . . . . 0.0 112.338 176.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.82 -11.85 59.8 Favored 'General case' 0 N--CA 1.439 -1.014 0 CA-C-O 116.436 -1.745 . . . . 0.0 108.564 169.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 7.3 tp -53.47 -41.1 43.84 Favored 'Isoleucine or valine' 0 C--N 1.344 0.345 0 CA-C-N 122.094 2.225 . . . . 0.0 112.44 -169.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -62.03 -49.06 78.91 Favored Glycine 0 CA--C 1.523 0.555 0 CA-C-N 119.257 0.935 . . . . 0.0 111.707 177.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 58.3 t -65.16 -47.27 88.24 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 178.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 71.4 mmt-85 -59.64 -35.02 73.57 Favored 'General case' 0 C--N 1.343 0.292 0 CA-C-O 117.041 -1.457 . . . . 0.0 113.146 177.326 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 27.8 mt -62.74 -45.6 98.43 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 CA-C-N 121.925 2.148 . . . . 0.0 109.995 177.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 22.2 m -74.47 -27.82 21.71 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-N 119.995 1.27 . . . . 0.0 111.632 -175.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -68.63 -44.44 74.22 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 174.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -66.09 -40.11 90.54 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 122.559 0.344 . . . . 0.0 110.28 -179.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 7.8 tp -62.33 -42.59 99.5 Favored 'General case' 0 CA--C 1.527 0.096 0 CA-C-O 118.733 -0.651 . . . . 0.0 109.933 178.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -61.36 -38.62 87.64 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 118.506 0.594 . . . . 0.0 110.835 -178.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 -74.01 -43.21 58.76 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.38 0.672 . . . . 0.0 111.036 177.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 87.9 mtt180 -86.31 -31.13 21.75 Favored 'General case' 0 C--N 1.339 0.124 0 CA-C-O 116.87 -1.538 . . . . 0.0 114.221 -169.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -125.96 138.25 53.75 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 121.369 1.895 . . . . 0.0 112.836 -173.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 49.5 mm -91.71 149.84 3.99 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 N-CA-C 106.366 -1.716 . . . . 0.0 106.366 168.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 51.2 mt -137.44 151.34 71.03 Favored Pre-proline 0 C--O 1.237 0.412 0 C-N-CA 124.218 1.007 . . . . 0.0 110.775 -169.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -67.76 159.97 50.38 Favored 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 122.483 2.122 . . . . 0.0 110.111 169.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -57.71 -32.55 67.5 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 114.51 1.3 . . . . 0.0 114.51 -169.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 31.5 p90 -75.89 -5.61 46.91 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 117.8 -1.095 . . . . 0.0 112.676 -176.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 26.0 t -108.61 129.9 62.3 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 CA-C-N 120.087 1.312 . . . . 0.0 107.888 175.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -136.95 150.98 48.51 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 121.491 0.662 . . . . 0.0 110.113 174.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -103.21 131.01 52.52 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 170.555 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 10.5 tt -123.77 127.68 48.47 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 175.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -91.2 115.15 27.79 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 172.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -71.58 -23.92 77.43 Favored Glycine 0 CA--C 1.533 1.186 0 CA-C-O 118.373 -1.237 . . . . 0.0 112.795 179.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 62.85 77.09 0.22 Allowed Glycine 0 CA--C 1.529 0.949 0 CA-C-N 118.424 1.112 . . . . 0.0 112.886 173.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . 0.28 14.9 p 55.75 32.84 20.24 Favored 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 125.075 1.35 . . . . 0.0 112.761 173.181 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -75.14 -69.26 0.48 Allowed 'General case' 0 C--N 1.345 0.385 0 N-CA-C 114.722 1.378 . . . . 0.0 114.722 -169.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 70.06 -99.1 0.67 Allowed Glycine 0 C--N 1.337 0.584 0 N-CA-C 108.436 -1.866 . . . . 0.0 108.436 -171.038 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 10.1 tpt -67.51 -27.76 67.26 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 125.057 1.343 . . . . 0.0 111.38 -178.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -70.2 -4.65 22.64 Favored 'General case' 0 CA--C 1.548 0.881 0 CA-C-O 121.234 0.54 . . . . 0.0 110.685 -173.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 81.9 mt -81.76 2.13 31.35 Favored 'General case' 0 CA--C 1.535 0.382 0 O-C-N 120.316 -1.49 . . . . 0.0 113.62 -179.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 6.5 tt -50.16 -53.99 23.87 Favored 'General case' 0 C--N 1.339 0.151 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 -170.129 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -87.68 -31.91 14.5 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 -177.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -52.87 -49.3 66.12 Favored 'General case' 0 C--N 1.34 0.164 0 C-N-CA 123.03 0.532 . . . . 0.0 110.257 178.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 28.1 mtp -78.13 -8.71 58.61 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 114.306 1.224 . . . . 0.0 114.306 -169.052 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.79 146.65 54.2 Favored 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 113.78 1.03 . . . . 0.0 113.78 -169.131 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . 0.25 14.7 p30 53.08 13.81 0.42 Allowed 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 128.86 2.864 . . . . 0.0 117.975 169.114 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 89.8 mtt180 -68.08 151.93 46.29 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 121.333 -0.855 . . . . 0.0 109.835 173.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -81.68 -61.75 1.84 Allowed 'General case' 0 C--O 1.222 -0.363 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 176.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 2.3 t-160 -114.85 124.22 51.19 Favored 'General case' 0 C--O 1.231 0.103 0 N-CA-C 105.609 -1.997 . . . . 0.0 105.609 -177.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 54.0 tp -133.24 119.96 20.5 Favored 'General case' 0 CA--C 1.506 -0.713 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 178.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 4.4 mp -103.04 120.09 52.4 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 N-CA-C 105.445 -2.057 . . . . 0.0 105.445 175.194 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 8.1 mt -96.92 132.94 40.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 104.392 -2.447 . . . . 0.0 104.392 176.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -121.55 126.4 49.08 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 172.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -162.46 162.6 27.64 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 122.602 0.361 . . . . 0.0 110.056 177.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -74.06 136.44 43.07 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 104.923 -2.251 . . . . 0.0 104.923 168.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -87.47 -22.03 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 N-CA-C 113.182 0.808 . . . . 0.0 113.182 -168.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.7 t 51.73 31.95 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.221 0 C-N-CA 126.115 1.766 . . . . 0.0 112.569 174.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 19.8 m -137.54 159.75 41.08 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 124.313 1.045 . . . . 0.0 111.711 -172.245 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 22.6 ttmt 63.55 173.93 0.17 Allowed 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 126.732 2.013 . . . . 0.0 112.685 170.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.32 7.98 35.87 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.543 1.137 . . . . 0.0 112.027 -170.02 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 41.4 t-20 -73.66 165.55 24.9 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.368 0.667 . . . . 0.0 109.489 -174.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 10.7 m -58.75 141.59 84.82 Favored Pre-proline 0 CA--C 1.55 0.947 0 C-N-CA 124.199 1.0 . . . . 0.0 112.578 -169.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -55.25 150.16 41.87 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 123.503 2.802 . . . . 0.0 112.132 169.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 68.18 15.2 67.33 Favored Glycine 0 CA--C 1.531 1.032 0 CA-C-O 119.091 -0.839 . . . . 0.0 113.825 176.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 20.9 m -90.92 149.92 21.7 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 118.973 1.386 . . . . 0.0 108.895 175.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 16.7 ttp -95.41 139.12 32.15 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 176.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 3.4 ttt -135.44 115.04 12.72 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 107.275 -1.379 . . . . 0.0 107.275 -170.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 24.0 mm -100.78 122.04 52.32 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 -169.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -117.48 125.24 50.56 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 179.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -90.7 170.53 10.06 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 178.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -28.97 -61.69 0.12 Allowed 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 117.02 2.23 . . . . 0.0 117.02 -170.12 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -78.51 -17.25 56.49 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 119.302 0.955 . . . . 0.0 113.307 -174.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -87.96 -30.69 19.84 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 123.555 0.742 . . . . 0.0 110.417 -170.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . 0.256 0.5 OUTLIER -67.46 -47.31 47.76 Favored Pre-proline 0 N--CA 1.453 -0.289 0 CA-C-O 116.624 -1.655 . . . . 0.0 112.023 -171.351 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -65.63 -35.63 36.72 Favored 'Trans proline' 0 N--CA 1.453 -0.883 0 CA-C-N 122.176 1.813 . . . . 0.0 109.988 179.792 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.2 -26.36 67.36 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.033 0.533 . . . . 0.0 111.199 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -78.39 -52.96 7.81 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 169.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -58.2 -23.06 54.3 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 -174.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -66.86 -6.79 17.75 Favored 'General case' 0 CA--C 1.551 1.009 0 CA-C-N 119.103 0.865 . . . . 0.0 112.26 176.638 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 32.6 t30 -50.2 127.68 17.56 Favored 'General case' 0 C--N 1.344 0.346 0 O-C-N 121.27 -0.894 . . . . 0.0 110.912 173.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 30.5 mmmt -66.91 -26.73 67.01 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 118.541 -0.742 . . . . 0.0 111.994 -178.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 62.1 mt -65.62 -49.6 76.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 -177.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.4 m -65.02 114.41 14.89 Favored Pre-proline 0 CA--C 1.545 0.774 0 C-N-CA 124.609 1.164 . . . . 0.0 109.854 -176.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -70.92 -75.85 0.01 OUTLIER 'Trans proline' 0 CA--C 1.539 0.76 0 C-N-CA 122.761 2.307 . . . . 0.0 112.896 -169.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 13.1 m80 -69.33 -26.66 64.82 Favored 'General case' 0 N--CA 1.47 0.562 0 O-C-N 121.093 -1.004 . . . . 0.0 110.784 -174.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 25.8 mp0 -63.78 -28.87 70.17 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 124.432 1.093 . . . . 0.0 110.659 179.013 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 52.6 tp -64.18 -35.49 80.97 Favored 'General case' 0 C--N 1.342 0.246 0 CA-C-N 119.722 1.146 . . . . 0.0 110.54 174.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -64.64 -40.12 97.27 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 110.552 -1.019 . . . . 0.0 110.552 172.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 19.1 tp -66.2 -32.44 73.88 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 117.976 0.888 . . . . 0.0 110.907 175.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -64.1 -45.19 89.75 Favored 'General case' 0 N--CA 1.466 0.36 0 O-C-N 120.952 -1.092 . . . . 0.0 110.791 171.202 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -70.35 -24.2 62.94 Favored 'General case' 0 CA--C 1.52 -0.18 0 O-C-N 121.602 -0.686 . . . . 0.0 111.574 178.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 7.0 t -68.14 -44.97 83.98 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 CA-C-N 118.722 0.692 . . . . 0.0 110.397 169.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 59.8 mt -62.26 -36.89 83.45 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 119.25 0.932 . . . . 0.0 109.697 176.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 44.5 m -65.03 -40.18 94.44 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 118.005 0.366 . . . . 0.0 110.299 172.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -64.52 -40.34 95.44 Favored 'General case' 0 N--CA 1.454 -0.237 0 O-C-N 121.112 -0.992 . . . . 0.0 110.729 178.231 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 12.6 mt -64.0 -37.61 88.05 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-O 120.98 0.419 . . . . 0.0 110.58 175.155 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 21.1 tpp180 -63.89 -37.82 88.8 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 118.652 -0.689 . . . . 0.0 109.982 173.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 14.6 m-30 -66.18 -42.61 88.65 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 119.124 0.875 . . . . 0.0 110.798 179.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 41.7 p -76.13 -18.72 59.02 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 118.819 0.736 . . . . 0.0 111.722 178.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 76.42 9.72 85.83 Favored Glycine 0 CA--C 1.532 1.127 0 CA-C-O 119.073 -0.848 . . . . 0.0 111.229 -169.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -93.5 31.04 1.6 Allowed 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 118.991 1.395 . . . . 0.0 110.675 178.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -62.24 140.22 96.24 Favored Pre-proline 0 CA--C 1.542 0.647 0 C-N-CA 123.793 0.837 . . . . 0.0 109.724 174.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -66.66 142.9 65.97 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.382 2.055 . . . . 0.0 110.35 -177.364 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -64.48 -29.4 70.44 Favored 'General case' 0 CA--C 1.538 0.504 0 O-C-N 122.141 -0.349 . . . . 0.0 111.483 -174.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 23.9 tptp -143.41 82.78 1.75 Allowed 'General case' 0 C--O 1.234 0.277 0 N-CA-C 106.172 -1.788 . . . . 0.0 106.172 -176.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 24.5 tp -77.02 136.52 38.69 Favored 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 169.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -138.39 144.24 40.15 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 170.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 11.2 tp -128.83 129.83 46.12 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 119.606 1.094 . . . . 0.0 109.464 176.031 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 21.7 t -98.34 101.21 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 N-CA-C 104.215 -2.513 . . . . 0.0 104.215 168.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -82.93 146.7 24.33 Favored Glycine 0 CA--C 1.521 0.454 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 171.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 47.9 t -127.42 143.5 40.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 170.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 13.2 mt -94.14 130.13 35.2 Favored Pre-proline 0 CA--C 1.537 0.458 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 -176.139 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -79.33 166.6 22.26 Favored 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 122.967 2.445 . . . . 0.0 113.026 -174.154 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -111.05 -53.71 2.68 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.371 1.068 . . . . 0.0 110.331 -178.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 73.6 m -111.84 -53.55 2.7 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 118.73 0.695 . . . . 0.0 112.248 -173.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER 56.11 44.71 24.79 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 125.215 1.406 . . . . 0.0 114.609 177.07 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -119.43 171.38 5.51 Favored Pre-proline 0 N--CA 1.477 0.892 0 O-C-N 121.205 -0.934 . . . . 0.0 109.924 175.091 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -65.85 91.0 0.24 Allowed 'Trans proline' 0 CA--C 1.549 1.267 0 C-N-CA 123.447 2.765 . . . . 0.0 114.145 -177.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -167.62 131.64 1.78 Allowed 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 105.102 -2.185 . . . . 0.0 105.102 169.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -80.28 152.91 4.48 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 123.612 0.765 . . . . 0.0 110.293 -171.452 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 80.37 160.79 23.22 Favored Glycine 0 CA--C 1.53 1.0 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.916 179.334 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -76.45 163.17 27.21 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-O 121.188 0.518 . . . . 0.0 112.218 -169.194 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 40.7 p -69.81 169.93 11.3 Favored Pre-proline 0 CA--C 1.541 0.597 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 167.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -55.88 -31.76 82.55 Favored 'Trans proline' 0 CA--C 1.542 0.925 0 C-N-CA 121.315 1.344 . . . . 0.0 111.041 169.097 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 25.3 m -68.18 -45.27 73.91 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 118.976 -0.535 . . . . 0.0 111.505 179.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 5.8 t -99.19 -12.16 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 CA-C-N 119.451 1.023 . . . . 0.0 111.652 -169.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -57.6 -45.55 85.15 Favored 'General case' 0 N--CA 1.465 0.292 0 O-C-N 119.898 -1.751 . . . . 0.0 108.102 169.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -68.19 -2.02 7.25 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-O 118.382 -0.818 . . . . 0.0 112.741 178.021 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 12.9 mmm -92.84 -6.94 47.7 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 119.356 0.98 . . . . 0.0 111.266 175.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 86.6 mt -59.42 -45.26 93.71 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 CA-C-N 119.421 1.01 . . . . 0.0 108.921 175.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -76.07 -47.02 3.71 Favored Pre-proline 0 CA--C 1.543 0.677 0 CA-C-O 117.252 -1.356 . . . . 0.0 113.129 -170.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -55.0 -41.76 75.79 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 122.07 1.847 . . . . 0.0 111.399 170.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -68.36 -41.48 80.6 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 118.162 -0.923 . . . . 0.0 110.718 -177.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 27.1 mt -55.83 -47.48 77.16 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 119.713 1.142 . . . . 0.0 109.223 172.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -62.31 -33.97 75.71 Favored 'General case' 0 N--CA 1.443 -0.817 0 C-N-CA 122.768 0.427 . . . . 0.0 109.849 -177.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 38.9 tp60 -80.29 -34.14 37.13 Favored 'General case' 0 N--CA 1.431 -1.375 0 C-N-CA 123.409 0.684 . . . . 0.0 111.307 -178.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 49.0 t -60.45 -48.77 87.01 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 170.176 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 30.2 mt -62.81 -30.53 71.55 Favored 'General case' 0 C--N 1.331 -0.203 0 O-C-N 121.995 -0.441 . . . . 0.0 110.406 178.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -67.22 -39.37 86.23 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 121.036 -1.04 . . . . 0.0 111.129 176.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -62.06 -47.48 84.52 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 118.608 0.64 . . . . 0.0 110.76 177.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 6.0 mp -58.01 -41.97 84.23 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 174.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 85.0 mtm180 -70.12 -13.83 62.38 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 117.319 -1.324 . . . . 0.0 113.327 -179.051 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -57.29 -33.25 67.48 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 120.959 1.709 . . . . 0.0 110.208 172.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 4.6 m -103.01 22.22 14.34 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.113 1.365 . . . . 0.0 111.502 179.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 68.75 23.26 75.65 Favored Glycine 0 CA--C 1.532 1.155 0 CA-C-O 118.402 -1.221 . . . . 0.0 114.355 178.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 60.9 t -102.41 97.84 6.12 Favored 'Isoleucine or valine' 0 C--N 1.342 0.261 0 CA-C-N 119.52 1.66 . . . . 0.0 107.607 177.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -97.96 136.58 38.04 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 169.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -77.18 161.18 28.4 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.273 0.629 . . . . 0.0 110.619 178.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 5.2 mt -83.57 121.55 76.47 Favored Pre-proline 0 CA--C 1.54 0.565 0 N-CA-C 105.307 -2.109 . . . . 0.0 105.307 175.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -65.94 107.86 1.19 Allowed 'Trans proline' 0 C--N 1.35 0.656 0 N-CA-C 105.781 -2.43 . . . . 0.0 105.781 169.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 22.5 tpt180 47.86 -121.64 1.37 Allowed 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 104.965 -2.235 . . . . 0.0 104.965 -168.049 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 8.1 p -153.66 159.89 42.2 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 121.521 1.964 . . . . 0.0 109.958 169.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -72.21 -39.34 68.64 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 110.289 -0.263 . . . . 0.0 110.289 170.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 14.9 m . . . . . 0 C--O 1.254 1.328 0 C-N-CA 124.15 0.98 . . . . 0.0 109.125 169.876 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.4 ttt . . . . . 0 N--CA 1.5 2.036 0 CA-C-O 120.121 0.01 . . . . 0.0 111.018 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 31.6 ptt-85 -62.18 126.62 27.97 Favored 'General case' 0 N--CA 1.476 0.848 0 O-C-N 120.219 -1.551 . . . . 0.0 110.252 176.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 4.4 mt -122.19 128.74 75.61 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 -176.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 15.3 tp -115.21 140.77 48.81 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 105.686 -1.968 . . . . 0.0 105.686 168.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 74.9 t -120.01 113.24 39.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 106.152 -1.795 . . . . 0.0 106.152 177.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -93.26 120.84 34.0 Favored 'General case' 0 CA--C 1.516 -0.338 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 -177.534 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -100.03 120.27 6.81 Favored Glycine 0 CA--C 1.499 -0.92 0 N-CA-C 105.679 -2.968 . . . . 0.0 105.679 170.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 11.4 m -148.94 162.47 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.971 0 CA-C-O 121.174 0.511 . . . . 0.0 110.579 -168.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 119.77 146.67 7.81 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 126.382 1.944 . . . . 0.0 108.996 177.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.451 HD22 ' HB2' ' A' ' 12' ' ' LEU . 2.0 t30 -62.57 116.14 4.88 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 123.781 1.753 . . . . 0.0 114.675 -168.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.3 pt -67.84 40.71 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.812 0 CA-C-N 112.264 -2.244 . . . . 0.0 114.981 170.037 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.451 ' HB2' HD22 ' A' ' 10' ' ' ASN . 75.0 mt -132.62 -12.65 3.01 Favored 'General case' 0 C--N 1.343 0.325 0 CA-C-N 121.563 1.983 . . . . 0.0 111.416 170.622 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.7 mp -115.32 62.77 0.69 Allowed 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 -167.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 56.9 -97.63 0.08 Allowed 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 123.51 0.724 . . . . 0.0 111.246 170.387 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -84.18 -9.47 58.52 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 124.39 1.076 . . . . 0.0 110.906 -175.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -70.68 -14.98 62.67 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 119.859 1.208 . . . . 0.0 112.56 -176.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.2 -6.04 55.67 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-O 115.697 -2.097 . . . . 0.0 110.024 172.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 6.4 tp -49.88 -44.37 20.9 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-N 122.062 2.21 . . . . 0.0 111.94 -171.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -62.78 -42.24 99.72 Favored Glycine 0 N--CA 1.446 -0.634 0 CA-C-N 118.88 0.764 . . . . 0.0 111.629 178.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 73.6 t -63.86 -52.92 50.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 173.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 1.4 mmp_? -60.74 -31.89 71.2 Favored 'General case' 0 CA--C 1.531 0.245 0 O-C-N 120.949 -1.094 . . . . 0.0 112.73 -175.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 25.0 mt -60.54 -44.94 97.68 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 CA-C-N 120.145 1.339 . . . . 0.0 110.287 176.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 17.9 m -75.35 -25.44 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-N 120.203 1.365 . . . . 0.0 111.323 -176.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -68.03 -42.92 79.87 Favored 'General case' 0 C--N 1.341 0.2 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 173.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.81 -41.95 91.24 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-O 119.363 -0.351 . . . . 0.0 110.277 179.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 10.4 tp -61.12 -45.11 96.02 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 118.453 -0.784 . . . . 0.0 109.816 176.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -59.89 -39.91 86.97 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 118.467 0.576 . . . . 0.0 111.216 -178.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 50.6 mm-40 -73.58 -40.73 63.66 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 122.938 0.495 . . . . 0.0 111.355 178.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 91.0 mtt180 -90.24 -38.03 13.71 Favored 'General case' 0 C--N 1.342 0.259 0 CA-C-O 117.343 -1.313 . . . . 0.0 114.288 -169.293 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 66.2 m-85 -115.33 136.23 53.31 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 120.991 1.723 . . . . 0.0 113.348 -169.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 39.8 mm -86.48 134.29 27.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 N-CA-C 105.805 -1.924 . . . . 0.0 105.805 168.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 7.3 mp -119.91 150.32 50.54 Favored Pre-proline 0 CA--C 1.539 0.523 0 C-N-CA 125.305 1.442 . . . . 0.0 110.691 -169.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -62.34 153.86 67.6 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 122.888 2.392 . . . . 0.0 109.785 168.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -61.21 -33.6 73.74 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 -169.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 18.0 p90 -74.21 -8.04 54.78 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 118.016 -0.992 . . . . 0.0 112.453 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 12.4 t -101.11 128.03 53.74 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 CA-C-N 119.926 1.239 . . . . 0.0 108.079 174.205 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -133.45 147.66 51.7 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.063 0.545 . . . . 0.0 110.155 175.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -100.17 136.78 30.04 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 N-CA-C 107.459 -1.312 . . . . 0.0 107.459 169.556 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -128.11 144.79 51.13 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 173.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -118.11 114.43 23.08 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 124.131 0.972 . . . . 0.0 108.483 -175.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -93.31 -4.54 64.29 Favored Glycine 0 CA--C 1.533 1.207 0 CA-C-O 119.032 -0.871 . . . . 0.0 113.277 176.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 60.57 -125.82 39.49 Favored Glycine 0 N--CA 1.431 -1.665 0 N-CA-C 108.22 -1.952 . . . . 0.0 108.22 -171.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 12.1 p -54.55 -37.41 65.41 Favored 'General case' 0 C--N 1.313 -0.985 0 C-N-CA 127.501 2.32 . . . . 0.0 111.271 176.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 50.07 -131.32 1.94 Allowed 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 169.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 79.73 -104.92 2.24 Favored Glycine 0 N--CA 1.443 -0.847 0 N-CA-C 106.899 -2.481 . . . . 0.0 106.899 -169.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 66.4 mmm -72.23 -19.55 61.7 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 112.535 0.568 . . . . 0.0 112.535 -175.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -60.67 -18.48 54.06 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 120.871 0.367 . . . . 0.0 111.941 -174.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 28.4 mt -88.71 -2.68 58.72 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 124.929 1.291 . . . . 0.0 114.136 -169.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 5.0 tt -46.9 -53.97 11.01 Favored 'General case' 0 C--N 1.344 0.354 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 -169.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -86.93 -31.24 18.29 Favored Glycine 0 CA--C 1.522 0.493 0 N-CA-C 111.011 -0.836 . . . . 0.0 111.011 -179.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -72.24 -27.75 62.71 Favored 'General case' 0 C--O 1.233 0.199 0 O-C-N 121.735 -0.862 . . . . 0.0 111.217 -170.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 28.8 mtp -81.9 -6.81 59.42 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 176.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -68.61 145.2 54.15 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 118.997 0.817 . . . . 0.0 111.474 -170.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 55.79 21.85 5.06 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 116.741 2.126 . . . . 0.0 116.741 168.577 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 26.2 mmt180 -77.79 148.95 34.52 Favored 'General case' 0 N--CA 1.473 0.681 0 O-C-N 120.593 -1.317 . . . . 0.0 108.867 178.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -83.4 -30.64 27.19 Favored 'General case' 0 N--CA 1.47 0.572 0 O-C-N 121.7 -0.625 . . . . 0.0 109.607 179.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 4.0 t60 -141.33 129.53 22.22 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 105.523 -2.028 . . . . 0.0 105.523 177.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -130.84 127.95 39.64 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-N 118.671 0.669 . . . . 0.0 109.327 171.095 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 29.7 mt -109.69 116.91 53.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 N-CA-C 104.904 -2.258 . . . . 0.0 104.904 174.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 38.8 mt -93.36 127.47 45.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 105.517 -2.031 . . . . 0.0 105.517 177.077 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -110.4 114.97 28.83 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 103.868 -2.641 . . . . 0.0 103.868 169.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -150.48 161.46 42.48 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.813 0.845 . . . . 0.0 110.154 -178.427 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -76.02 151.79 37.08 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 169.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 9.7 mm -84.05 -49.49 16.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-O 118.817 -0.611 . . . . 0.0 110.925 -177.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . 0.252 2.7 t 52.64 28.6 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.164 0 C-N-CA 125.954 1.702 . . . . 0.0 112.907 177.595 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 16.3 m -132.46 157.62 44.13 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 124.481 1.112 . . . . 0.0 111.934 -171.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.403 ' HG2' ' H ' ' A' ' 68' ' ' LYS . 19.7 ttmt 57.87 -167.48 0.14 Allowed 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 126.265 1.826 . . . . 0.0 112.447 171.093 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.403 ' H ' ' HG2' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -114.37 17.98 17.17 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.86 1.264 . . . . 0.0 110.995 -175.177 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -70.84 158.45 36.35 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.529 0.732 . . . . 0.0 109.144 -177.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 8.5 m -59.74 138.71 90.07 Favored Pre-proline 0 CA--C 1.545 0.779 0 C-N-CA 124.078 0.951 . . . . 0.0 111.991 -169.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_exo -55.2 149.01 46.84 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.998 2.465 . . . . 0.0 111.709 170.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 68.95 16.43 70.49 Favored Glycine 0 CA--C 1.533 1.157 0 CA-C-O 119.721 -0.488 . . . . 0.0 113.684 174.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 18.3 m -91.6 141.24 28.92 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 173.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 26.3 ttp -96.12 141.14 29.85 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 175.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 25.9 ttm -129.5 100.61 5.61 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 -173.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 38.4 mm -92.81 119.18 40.03 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 -178.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 44.0 mt -125.46 141.29 52.14 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 -173.281 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 88.2 mtt-85 -113.28 142.89 45.29 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 123.113 0.565 . . . . 0.0 110.425 -178.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 33.6 t70 38.05 -102.11 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 125.6 1.56 . . . . 0.0 114.228 169.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -59.91 -31.06 69.47 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.851 1.26 . . . . 0.0 113.725 -173.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -75.56 -19.52 59.24 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 118.388 0.54 . . . . 0.0 111.173 -176.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 78.9 t -73.96 -60.84 1.42 Allowed Pre-proline 0 N--CA 1.443 -0.781 0 CA-C-O 117.822 -1.085 . . . . 0.0 111.196 -169.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -63.8 -30.98 68.73 Favored 'Trans proline' 0 N--CA 1.447 -1.222 0 CA-C-N 121.315 1.506 . . . . 0.0 110.591 177.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.6 -26.45 67.1 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 122.631 0.372 . . . . 0.0 111.074 -178.028 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -77.98 -54.86 5.81 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 169.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -59.05 -24.56 62.97 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 114.033 1.123 . . . . 0.0 114.033 -170.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.9 t -67.3 -7.93 28.3 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-N 118.948 0.794 . . . . 0.0 112.546 178.021 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . 0.454 HD22 ' HB ' ' A' ' 90' ' ' ILE . 10.1 t30 -51.69 126.54 18.0 Favored 'General case' 0 C--N 1.344 0.347 0 O-C-N 121.409 -0.807 . . . . 0.0 109.754 172.075 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 37.0 mtmt -73.12 -23.51 60.5 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 118.718 -0.658 . . . . 0.0 112.45 -174.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.454 ' HB ' HD22 ' A' ' 88' ' ' ASN . 70.9 mt -67.23 -44.83 87.36 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 -178.054 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.9 m -62.39 113.37 8.6 Favored Pre-proline 0 CA--C 1.544 0.724 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 170.404 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -77.15 -63.68 0.03 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.623 0 CA-C-N 121.215 1.47 . . . . 0.0 113.041 -169.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 6.4 p-80 -78.62 -25.23 45.06 Favored 'General case' 0 N--CA 1.468 0.445 0 O-C-N 121.127 -0.983 . . . . 0.0 110.754 -178.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 22.0 mp0 -59.36 -33.51 71.25 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 119.739 1.154 . . . . 0.0 110.084 171.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -60.63 -41.83 95.65 Favored 'General case' 0 C--O 1.224 -0.248 0 CA-C-N 119.249 0.932 . . . . 0.0 109.14 173.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -61.29 -38.01 94.98 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 110.781 -0.927 . . . . 0.0 110.781 174.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 10.4 tp -69.23 -33.52 73.42 Favored 'General case' 0 CA--C 1.538 0.483 0 O-C-N 120.676 -1.484 . . . . 0.0 110.624 176.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -63.41 -41.3 98.72 Favored 'General case' 0 C--N 1.333 -0.132 0 O-C-N 121.037 -1.039 . . . . 0.0 109.822 171.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -71.2 -22.27 62.04 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 118.877 -0.583 . . . . 0.0 111.775 176.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 6.3 t -73.54 -44.16 54.02 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 CA-C-N 119.526 1.057 . . . . 0.0 109.839 169.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 64.4 mt -58.97 -37.42 76.76 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 119.093 0.86 . . . . 0.0 108.735 174.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 35.8 m -68.33 -39.17 82.01 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 118.708 -0.663 . . . . 0.0 110.554 172.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.413 ' HA ' ' CD2' ' A' ' 106' ' ' PHE . . . -63.77 -39.76 95.03 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 119.879 1.218 . . . . 0.0 110.459 179.583 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 18.8 mt -65.88 -38.84 89.85 Favored 'General case' 0 CA--C 1.519 -0.244 0 C-N-CA 123.119 0.567 . . . . 0.0 110.596 174.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 80.2 ttt180 -62.17 -37.83 86.76 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 118.552 -0.737 . . . . 0.0 109.985 173.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.413 ' CD2' ' HA ' ' A' ' 103' ' ' ALA . 14.1 m-30 -65.73 -42.51 90.94 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 119.346 0.975 . . . . 0.0 110.489 -179.791 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 42.6 p -78.55 -19.77 52.13 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 118.345 0.521 . . . . 0.0 111.624 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 78.56 10.33 86.29 Favored Glycine 0 CA--C 1.532 1.143 0 CA-C-O 119.034 -0.87 . . . . 0.0 111.036 -169.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 30.4 mm-40 -88.9 21.68 3.0 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 119.078 1.439 . . . . 0.0 111.931 -179.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -61.8 140.95 95.41 Favored Pre-proline 0 CA--C 1.543 0.684 0 C-N-CA 123.95 0.9 . . . . 0.0 110.509 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -64.72 148.16 90.08 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 122.493 2.128 . . . . 0.0 111.675 -176.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -64.75 -26.08 68.21 Favored 'General case' 0 CA--C 1.537 0.476 0 O-C-N 122.13 -0.357 . . . . 0.0 111.137 -178.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -140.45 133.29 29.1 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 169.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -124.96 123.22 39.42 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 177.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.2 m -131.62 142.6 49.91 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 -172.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -131.58 123.81 28.68 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 119.681 1.128 . . . . 0.0 109.525 -179.545 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 23.4 t -96.4 78.7 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 105.489 -2.041 . . . . 0.0 105.489 174.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -77.01 145.09 30.61 Favored Glycine 0 N--CA 1.449 -0.471 0 N-CA-C 109.905 -1.278 . . . . 0.0 109.905 -176.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 63.3 t -129.03 137.57 56.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 174.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 18.8 mt -88.56 131.65 41.32 Favored Pre-proline 0 CA--C 1.542 0.656 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 175.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -70.74 171.49 15.43 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 124.147 3.231 . . . . 0.0 113.534 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -113.08 -60.74 1.84 Allowed 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.033 0.933 . . . . 0.0 110.454 176.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 67.8 m -104.56 -52.32 2.92 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 118.791 0.723 . . . . 0.0 112.756 -171.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER 58.48 46.98 14.22 Favored 'General case' 0 CA--C 1.548 0.887 0 N-CA-C 114.706 1.372 . . . . 0.0 114.706 170.429 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -115.8 165.03 15.56 Favored Pre-proline 0 N--CA 1.475 0.81 0 CA-C-O 117.923 -1.037 . . . . 0.0 110.407 175.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -63.94 87.58 0.15 Allowed 'Trans proline' 0 CA--C 1.547 1.136 0 C-N-CA 123.706 2.937 . . . . 0.0 113.736 -179.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -176.76 145.8 0.53 Allowed 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 104.067 -2.568 . . . . 0.0 104.067 174.574 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -108.94 161.72 7.12 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 CA-C-N 119.014 0.825 . . . . 0.0 111.346 -176.463 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 105.21 135.21 8.22 Favored Glycine 0 CA--C 1.528 0.865 0 N-CA-C 105.316 -3.114 . . . . 0.0 105.316 -168.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 5.8 mp -81.43 157.94 24.76 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-N 117.915 0.857 . . . . 0.0 109.332 -175.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 63.4 p -64.22 162.7 30.0 Favored Pre-proline 0 CA--C 1.537 0.462 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 168.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -59.15 -28.56 88.12 Favored 'Trans proline' 0 CA--C 1.541 0.853 0 C-N-CA 120.635 0.89 . . . . 0.0 110.628 169.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 28.7 m -64.14 -50.09 69.57 Favored 'General case' 0 C--N 1.344 0.368 0 CA-C-O 118.785 -0.626 . . . . 0.0 110.999 178.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 5.0 t -96.3 -22.68 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 CA-C-N 119.286 0.948 . . . . 0.0 111.343 -169.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -52.59 -45.53 66.53 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 120.241 1.382 . . . . 0.0 108.674 168.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -75.15 8.81 2.36 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 113.978 1.103 . . . . 0.0 113.978 -179.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 85.3 mtp -103.48 -6.75 21.5 Favored 'General case' 0 N--CA 1.432 -1.367 0 CA-C-O 117.563 -1.208 . . . . 0.0 110.077 169.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 95.1 mt -58.92 -44.55 91.12 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.326 0 CA-C-N 120.342 1.428 . . . . 0.0 107.278 174.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 58.1 mt-10 -72.33 -51.87 7.37 Favored Pre-proline 0 CA--C 1.541 0.625 0 CA-C-O 117.595 -1.193 . . . . 0.0 110.786 -177.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -41.39 -50.47 4.55 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 124.867 3.711 . . . . 0.0 113.499 168.758 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -71.22 -42.68 68.6 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 113.725 -1.579 . . . . 0.0 110.497 -176.088 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 26.1 mt -56.4 -42.64 78.27 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 118.656 0.662 . . . . 0.0 109.354 173.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -62.18 -33.49 74.63 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 118.944 0.793 . . . . 0.0 110.426 -179.042 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 43.7 mm-40 -79.43 -31.48 42.6 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 119.059 0.845 . . . . 0.0 112.255 176.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 71.0 t -60.82 -47.81 91.63 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 169.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 29.0 mt -65.75 -35.06 79.64 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.103 0.561 . . . . 0.0 110.319 -179.076 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -62.15 -40.12 94.89 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-O 118.347 -0.835 . . . . 0.0 110.781 178.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -60.9 -47.99 83.87 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 119.154 0.888 . . . . 0.0 111.417 -179.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 10.4 mp -49.86 -52.47 32.47 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 123.379 0.672 . . . . 0.0 109.808 169.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -67.14 -18.37 65.26 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 117.492 -1.242 . . . . 0.0 111.984 -173.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -63.03 -29.49 70.86 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 120.788 1.631 . . . . 0.0 110.349 177.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 5.2 m -110.27 25.26 11.98 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.99 1.316 . . . . 0.0 110.808 179.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 66.54 18.61 68.06 Favored Glycine 0 CA--C 1.531 1.071 0 CA-C-O 118.295 -1.281 . . . . 0.0 114.047 177.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 63.9 t -84.72 137.05 21.52 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 N-CA-C 106.266 -1.753 . . . . 0.0 106.266 173.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -121.1 148.75 43.75 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 178.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -126.12 135.85 52.19 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 169.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . 0.403 ' CG2' ' HA ' ' A' ' 160' ' ' SER . 33.7 mm -101.63 130.27 24.97 Favored Pre-proline 0 C--O 1.23 0.069 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 -171.463 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -57.73 110.64 0.65 Allowed 'Trans proline' 0 CA--C 1.536 0.599 0 C-N-CA 122.022 1.814 . . . . 0.0 108.533 169.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 4.5 tmm_? 49.96 32.28 5.48 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.154 1.381 . . . . 0.0 113.151 173.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' SER . . . . . 0.403 ' HA ' ' CG2' ' A' ' 157' ' ' ILE . 27.5 p 42.43 31.4 0.27 Allowed 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.997 1.719 . . . . 0.0 113.951 -171.479 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -85.51 -28.64 24.83 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 113.621 0.971 . . . . 0.0 113.621 -168.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 11.6 m . . . . . 0 C--O 1.256 1.419 0 C-N-CA 124.081 0.952 . . . . 0.0 110.549 178.295 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.0 tpt . . . . . 0 N--CA 1.498 1.941 0 N-CA-C 110.446 -0.205 . . . . 0.0 110.446 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 6.1 ptp180 -152.49 120.93 6.36 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-O 118.035 -0.983 . . . . 0.0 108.93 178.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 57.2 mt -140.75 135.79 34.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 CA-C-N 119.685 1.13 . . . . 0.0 111.143 -169.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -116.94 130.31 56.62 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 105.593 -2.003 . . . . 0.0 105.593 168.244 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 33.2 t -107.36 103.97 16.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 103.258 -2.867 . . . . 0.0 103.258 169.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.2 mt -101.65 110.34 22.31 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 124.003 0.921 . . . . 0.0 109.795 -169.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -92.23 116.76 5.13 Favored Glycine 0 N--CA 1.45 -0.409 0 N-CA-C 107.773 -2.131 . . . . 0.0 107.773 172.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 12.4 m -133.78 -166.63 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.084 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 -177.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 95.15 131.0 6.3 Favored Glycine 0 N--CA 1.441 -0.976 0 N-CA-C 107.369 -2.293 . . . . 0.0 107.369 -170.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.413 HD22 ' HB2' ' A' ' 12' ' ' LEU . 1.6 t30 -66.16 108.41 2.26 Favored 'General case' 0 N--CA 1.441 -0.915 0 C-N-CA 124.004 0.922 . . . . 0.0 110.937 -169.114 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.1 pt -73.21 40.29 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 C-N-CA 124.675 1.19 . . . . 0.0 113.193 179.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.413 ' HB2' HD22 ' A' ' 10' ' ' ASN . 15.2 mt -125.59 -2.76 7.33 Favored 'General case' 0 CA--C 1.536 0.407 0 O-C-N 121.023 -1.048 . . . . 0.0 108.6 169.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -129.24 65.45 1.46 Allowed 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.589 1.156 . . . . 0.0 108.418 -169.602 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 12.7 m 45.44 -109.6 0.2 Allowed 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 114.325 -1.307 . . . . 0.0 112.445 169.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -56.89 -24.59 53.13 Favored 'General case' 0 N--CA 1.443 -0.815 0 C-N-CA 125.617 1.567 . . . . 0.0 112.501 -172.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -64.73 -21.92 66.86 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 120.288 1.404 . . . . 0.0 111.443 -177.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.99 -9.4 15.57 Favored 'General case' 0 N--CA 1.437 -1.118 0 CA-C-O 116.433 -1.746 . . . . 0.0 111.456 173.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 5.6 tp -52.88 -40.44 36.05 Favored 'Isoleucine or valine' 0 C--N 1.343 0.306 0 CA-C-N 122.172 2.26 . . . . 0.0 111.421 -175.321 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -63.17 -45.23 95.79 Favored Glycine 0 C--N 1.336 0.559 0 CA-C-N 119.245 0.93 . . . . 0.0 111.027 178.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 96.9 t -62.62 -47.6 92.17 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 175.423 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 18.5 mmt180 -61.13 -33.61 73.66 Favored 'General case' 0 C--N 1.34 0.163 0 CA-C-O 117.092 -1.432 . . . . 0.0 112.5 179.062 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 21.9 mt -62.5 -47.04 94.87 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 CA-C-N 121.431 1.923 . . . . 0.0 109.847 177.46 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 26.7 m -74.97 -34.08 31.46 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-N 119.327 0.967 . . . . 0.0 111.157 -175.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 61.0 mt-10 -62.45 -44.14 97.12 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 122.863 0.465 . . . . 0.0 110.33 172.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -67.08 -38.15 85.24 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 119.438 1.017 . . . . 0.0 110.18 177.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 5.9 tp -64.73 -38.72 91.95 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 119.369 0.986 . . . . 0.0 109.652 -177.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -61.89 -25.56 67.63 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 112.573 0.583 . . . . 0.0 112.573 -179.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -94.91 -42.63 8.57 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 126.014 1.726 . . . . 0.0 111.076 -178.111 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 75.2 mtt180 -82.95 -25.96 31.84 Favored 'General case' 0 N--CA 1.456 -0.144 0 CA-C-O 118.343 -0.836 . . . . 0.0 111.799 -176.243 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 69.5 m-85 -127.06 147.97 50.14 Favored 'General case' 0 CA--C 1.521 -0.161 0 CA-C-N 119.628 1.104 . . . . 0.0 113.346 -177.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 37.7 mm -99.51 135.63 34.07 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 N-CA-C 104.384 -2.45 . . . . 0.0 104.384 168.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -118.51 147.38 41.82 Favored Pre-proline 0 CA--C 1.536 0.413 0 C-N-CA 123.795 0.838 . . . . 0.0 109.878 -169.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -65.93 157.2 60.47 Favored 'Trans proline' 0 CA--C 1.535 0.545 0 C-N-CA 122.637 2.225 . . . . 0.0 110.007 169.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -58.07 -32.56 68.16 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 114.314 1.227 . . . . 0.0 114.314 -169.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 10.6 p90 -77.06 -13.4 59.96 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 118.688 -0.672 . . . . 0.0 112.686 -177.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 75.5 t -88.73 125.54 41.89 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 170.05 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -120.77 128.17 52.65 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 169.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -88.38 124.33 41.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 105.074 -2.195 . . . . 0.0 105.074 168.664 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 52.2 tp -122.93 133.94 54.37 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 118.234 0.47 . . . . 0.0 110.359 174.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -89.81 123.38 33.74 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 169.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -112.92 -24.37 4.92 Favored Glycine 0 CA--C 1.536 1.401 0 CA-C-O 118.235 -1.314 . . . . 0.0 113.466 171.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 57.0 -111.7 3.0 Favored Glycine 0 C--N 1.342 0.907 0 CA-C-N 119.802 1.801 . . . . 0.0 111.714 171.282 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 67.4 p -75.62 7.28 3.86 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.545 1.538 . . . . 0.0 113.522 -174.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.82 -67.2 0.44 Allowed 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 114.397 1.258 . . . . 0.0 114.397 -169.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 60.87 -102.2 0.38 Allowed Glycine 0 CA--C 1.534 1.272 0 N-CA-C 109.125 -1.59 . . . . 0.0 109.125 -169.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.97 -26.59 67.63 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.939 0.896 . . . . 0.0 112.812 -175.037 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -60.22 -15.68 26.69 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 113.799 1.037 . . . . 0.0 113.799 -170.142 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 7.9 mt -96.39 13.99 25.91 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -169.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 4.2 tt -46.75 -60.9 2.1 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 118.539 0.609 . . . . 0.0 111.736 -176.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -64.68 -32.14 83.24 Favored Glycine 0 CA--C 1.531 1.075 0 CA-C-O 119.527 -0.596 . . . . 0.0 112.552 -178.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -78.79 -33.21 46.49 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 118.629 1.214 . . . . 0.0 112.515 -174.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 39.3 mtp -75.62 -21.44 57.75 Favored 'General case' 0 N--CA 1.449 -0.505 0 O-C-N 121.936 -0.478 . . . . 0.0 110.421 178.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.58 153.93 42.38 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-O 121.755 0.788 . . . . 0.0 111.452 -175.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 62.87 9.64 3.81 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 126.959 2.103 . . . . 0.0 115.592 169.248 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 25.1 mmt180 -79.38 160.29 26.75 Favored 'General case' 0 N--CA 1.473 0.709 0 O-C-N 121.017 -1.052 . . . . 0.0 108.565 178.286 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -87.33 -53.16 4.98 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 175.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . 0.259 0.0 OUTLIER -125.4 146.08 49.76 Favored 'General case' 0 CA--C 1.517 -0.295 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 169.206 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 12.6 tp -138.2 116.69 12.05 Favored 'General case' 0 CA--C 1.513 -0.449 0 N-CA-C 104.067 -2.568 . . . . 0.0 104.067 -176.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 10.8 mt -98.08 113.23 32.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 105.562 -2.014 . . . . 0.0 105.562 175.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 48.6 mt -91.4 138.48 19.62 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.558 0 N-CA-C 106.561 -1.644 . . . . 0.0 106.561 173.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -123.4 121.04 34.74 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 105.397 -2.075 . . . . 0.0 105.397 168.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -157.23 161.37 39.23 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.999 1.32 . . . . 0.0 108.979 -173.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -95.06 141.18 29.0 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 121.42 0.629 . . . . 0.0 110.666 176.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 25.7 mt -89.95 -18.55 7.64 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 C-N-CA 124.434 1.093 . . . . 0.0 110.611 -179.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . 0.308 47.2 t 70.54 -48.21 0.19 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.21 0 C-N-CA 128.323 2.649 . . . . 0.0 113.659 174.283 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 11.9 m -147.07 138.72 24.22 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 -176.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 12.0 tppt? -164.56 174.85 10.41 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 127.166 2.186 . . . . 0.0 105.961 168.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.56 -26.98 65.68 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 121.799 -0.563 . . . . 0.0 111.505 175.016 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -70.58 165.45 22.75 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.345 0.658 . . . . 0.0 110.761 -175.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 3.1 m -60.64 153.13 63.98 Favored Pre-proline 0 CA--C 1.547 0.854 0 C-N-CA 124.709 1.204 . . . . 0.0 112.489 -169.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_exo -57.7 158.39 20.3 Favored 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 123.867 3.045 . . . . 0.0 112.422 169.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 65.62 11.21 52.81 Favored Glycine 0 CA--C 1.536 1.38 0 CA-C-O 119.144 -0.809 . . . . 0.0 114.358 172.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 5.6 m -90.32 146.51 24.14 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 118.875 1.337 . . . . 0.0 111.484 -169.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 26.4 ttp -84.63 139.3 32.16 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 173.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 40.6 mtp -128.75 123.62 33.45 Favored 'General case' 0 CA--C 1.519 -0.214 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 176.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 23.3 mm -99.88 116.62 43.56 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 N-CA-C 107.243 -1.391 . . . . 0.0 107.243 177.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -107.85 130.02 55.03 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 106.857 -1.534 . . . . 0.0 106.857 174.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 21.3 mmt180 -85.66 167.13 15.6 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 122.706 0.402 . . . . 0.0 110.857 176.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -32.74 -54.84 0.36 Allowed 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 116.575 2.065 . . . . 0.0 116.575 -174.169 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -88.99 -10.23 48.41 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 113.461 0.911 . . . . 0.0 113.461 -177.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -93.28 -33.23 14.02 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 123.189 0.596 . . . . 0.0 110.436 -176.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.0 m -53.79 -50.35 84.17 Favored Pre-proline 0 CA--C 1.538 0.484 0 CA-C-O 117.987 -1.006 . . . . 0.0 110.997 175.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -64.8 -40.82 20.34 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 121.82 1.68 . . . . 0.0 110.434 -177.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.14 -15.35 59.58 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 173.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -91.25 -36.79 13.7 Favored 'General case' 0 C--N 1.342 0.273 0 CA-C-N 119.755 1.161 . . . . 0.0 110.953 177.068 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -70.73 9.44 0.66 Allowed 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 113.677 0.992 . . . . 0.0 113.677 -177.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 57.2 p -61.14 -24.4 66.25 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.224 1.01 . . . . 0.0 109.443 168.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 56.0 t-20 -50.34 114.76 1.2 Allowed 'General case' 0 C--N 1.348 0.509 0 C-N-CA 124.578 1.151 . . . . 0.0 110.464 170.253 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 34.7 tttm -97.31 1.04 49.04 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.461 1.104 . . . . 0.0 112.356 -174.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 60.0 mt -64.45 -48.26 85.9 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-N 118.724 0.693 . . . . 0.0 109.469 -170.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -100.49 135.64 20.14 Favored Pre-proline 0 CA--C 1.543 0.686 0 CA-C-O 118.968 -0.539 . . . . 0.0 110.545 -171.648 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -70.98 -36.23 7.88 Favored 'Trans proline' 0 CA--C 1.534 0.507 0 C-N-CA 122.794 2.329 . . . . 0.0 111.576 -177.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 47.9 t-80 -59.51 -50.25 74.63 Favored 'General case' 0 C--N 1.343 0.286 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 175.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -58.96 -43.16 91.26 Favored 'General case' 0 C--O 1.224 -0.264 0 CA-C-O 118.437 -0.792 . . . . 0.0 110.224 179.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 39.3 tp -66.06 -39.11 89.83 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 119.3 0.955 . . . . 0.0 111.123 -178.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -65.17 -44.26 94.24 Favored Glycine 0 CA--C 1.528 0.898 0 N-CA-C 110.615 -0.994 . . . . 0.0 110.615 176.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -62.32 -38.79 90.79 Favored 'General case' 0 CA--C 1.537 0.457 0 O-C-N 122.357 -0.496 . . . . 0.0 110.152 175.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -57.72 -46.14 84.8 Favored 'General case' 0 N--CA 1.455 -0.198 0 O-C-N 121.612 -0.68 . . . . 0.0 110.183 175.039 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 17.7 t0 -72.79 -20.88 61.08 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 119.706 -0.187 . . . . 0.0 111.078 -176.286 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 16.8 t -73.17 -44.59 55.64 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.686 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 169.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 74.5 mt -62.42 -36.31 81.97 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 119.119 0.872 . . . . 0.0 109.348 178.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 39.9 m -64.51 -44.21 91.63 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-O 118.469 -0.776 . . . . 0.0 109.952 172.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.44 ' HA ' ' CD2' ' A' ' 106' ' ' PHE . . . -60.48 -40.82 92.69 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 119.896 1.226 . . . . 0.0 111.641 175.311 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.5 mt -64.4 -33.58 76.19 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 123.621 0.768 . . . . 0.0 110.042 176.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 56.0 ttt85 -72.79 -32.58 65.68 Favored 'General case' 0 CA--C 1.534 0.335 0 O-C-N 121.553 -0.717 . . . . 0.0 110.071 174.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.44 ' CD2' ' HA ' ' A' ' 103' ' ' ALA . 14.3 m-30 -68.98 -47.05 66.52 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 119.058 0.844 . . . . 0.0 110.535 178.489 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 39.7 p -73.98 -25.27 59.84 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 123.4 0.68 . . . . 0.0 111.732 -178.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 74.6 8.08 80.54 Favored Glycine 0 CA--C 1.534 1.27 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -168.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -83.94 19.38 1.76 Allowed 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 119.84 1.82 . . . . 0.0 111.049 174.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -59.98 135.81 90.45 Favored Pre-proline 0 CA--C 1.547 0.833 0 C-N-CA 124.591 1.156 . . . . 0.0 109.33 169.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_exo -59.96 163.8 13.27 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 123.553 2.835 . . . . 0.0 115.713 -177.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 36.3 mmtt -64.85 -41.91 95.31 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 113.156 0.798 . . . . 0.0 113.156 172.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 24.1 ttpp -140.93 68.7 1.34 Allowed 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 -173.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.4 tt -68.6 136.84 53.65 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 174.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -131.79 134.49 45.88 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 177.518 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -123.23 117.47 25.38 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 120.469 1.486 . . . . 0.0 108.721 -179.064 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 18.9 t -92.55 91.84 3.55 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 N-CA-C 105.589 -2.004 . . . . 0.0 105.589 172.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -81.67 150.49 29.71 Favored Glycine 0 CA--C 1.522 0.522 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 178.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 40.4 t -129.04 130.56 68.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 178.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 47.6 mt -83.6 131.67 51.68 Favored Pre-proline 0 CA--C 1.534 0.355 0 N-CA-C 103.519 -2.771 . . . . 0.0 103.519 169.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -78.77 178.55 7.42 Favored 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 122.589 2.193 . . . . 0.0 111.164 -177.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -97.84 -56.47 2.49 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 124.001 0.92 . . . . 0.0 108.558 168.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 63.0 m -110.27 -59.31 1.96 Allowed 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 113.72 1.007 . . . . 0.0 113.72 -169.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.2 tp 53.81 33.11 16.25 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 127.37 2.268 . . . . 0.0 114.08 -173.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -82.33 161.32 60.06 Favored Pre-proline 0 CA--C 1.541 0.624 0 O-C-N 121.443 -0.786 . . . . 0.0 109.643 175.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -81.44 89.39 1.26 Allowed 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 122.142 1.895 . . . . 0.0 112.593 -169.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -174.82 179.55 1.63 Allowed 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 103.42 -2.807 . . . . 0.0 103.42 179.612 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -132.44 162.35 39.93 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 CA-C-N 120.558 1.526 . . . . 0.0 114.952 -176.383 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 110.72 143.5 9.59 Favored Glycine 0 CA--C 1.531 1.092 0 N-CA-C 104.73 -3.348 . . . . 0.0 104.73 -168.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 88.6 mt -76.02 156.48 33.97 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 119.308 1.554 . . . . 0.0 109.642 175.141 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 34.9 p -71.67 165.04 53.03 Favored Pre-proline 0 CA--C 1.539 0.526 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 169.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -57.76 -39.94 83.21 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 C-N-CA 121.821 1.681 . . . . 0.0 111.427 173.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 4.1 m -64.61 -40.02 94.75 Favored 'General case' 0 N--CA 1.442 -0.866 0 C-N-CA 124.117 0.967 . . . . 0.0 110.79 -177.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 74.7 t -90.5 -30.99 5.0 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 O-C-N 121.585 -0.697 . . . . 0.0 110.597 -173.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -53.96 -46.46 71.62 Favored 'General case' 0 CA--C 1.533 0.302 0 O-C-N 121.182 -0.948 . . . . 0.0 109.341 169.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -68.05 -14.86 63.3 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 113.69 0.996 . . . . 0.0 113.69 -178.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 5.3 mmm -82.27 -12.41 58.05 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.776 1.63 . . . . 0.0 111.871 174.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 54.1 mt -54.56 -54.12 25.26 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.357 0 CA-C-N 120.576 1.535 . . . . 0.0 108.897 173.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -67.15 -47.75 50.27 Favored Pre-proline 0 CA--C 1.542 0.671 0 CA-C-O 117.556 -1.212 . . . . 0.0 110.827 -173.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 0.3 OUTLIER -43.3 -54.29 3.62 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 125.293 3.995 . . . . 0.0 112.819 168.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -67.97 -37.2 81.24 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.106 -0.952 . . . . 0.0 112.102 179.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 36.1 mt -61.27 -45.35 94.87 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 121.039 1.745 . . . . 0.0 109.108 175.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -58.69 -33.78 70.55 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 118.686 0.676 . . . . 0.0 110.206 177.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 68.0 tp60 -76.6 -36.69 57.35 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 121.392 -0.818 . . . . 0.0 111.914 178.216 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 46.9 t -60.86 -44.93 98.77 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 171.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 71.1 mt -61.59 -36.25 80.15 Favored 'General case' 0 C--O 1.226 -0.176 0 CA-C-O 118.9 -0.571 . . . . 0.0 110.132 176.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -67.21 -44.49 79.43 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 119.241 0.928 . . . . 0.0 111.025 176.009 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -66.77 -27.89 67.96 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 119.161 0.891 . . . . 0.0 111.708 178.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 33.2 mt -69.14 -49.89 52.83 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 170.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 16.8 mmm-85 -63.8 -21.86 66.63 Favored 'General case' 0 CA--C 1.522 -0.126 0 CA-C-O 118.058 -0.972 . . . . 0.0 112.396 -177.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -63.99 -34.29 77.65 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 119.973 1.261 . . . . 0.0 110.947 174.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 26.0 m -91.45 18.29 7.45 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 122.854 0.462 . . . . 0.0 111.573 170.109 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 70.98 16.87 75.07 Favored Glycine 0 C--N 1.337 0.623 0 CA-C-O 117.607 -1.663 . . . . 0.0 112.578 -178.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 39.0 t -90.76 118.75 36.64 Favored 'Isoleucine or valine' 0 C--N 1.347 0.459 0 CA-C-N 120.648 2.224 . . . . 0.0 106.627 -176.244 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -111.0 85.68 2.16 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 106.198 -1.779 . . . . 0.0 106.198 177.042 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -49.12 139.49 10.68 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 114.627 -1.169 . . . . 0.0 110.005 169.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 24.9 mt -91.05 125.71 57.76 Favored Pre-proline 0 CA--C 1.53 0.202 0 CA-C-O 117.331 -1.318 . . . . 0.0 108.296 -169.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -66.54 98.07 0.39 Allowed 'Trans proline' 0 CA--C 1.534 0.52 0 C-N-CA 122.673 2.249 . . . . 0.0 109.236 175.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 60.5 mtm180 49.9 14.88 0.14 Allowed 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 127.218 2.207 . . . . 0.0 115.519 -178.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 58.6 m 47.1 40.29 9.51 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.843 0.857 . . . . 0.0 111.538 -169.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -114.76 123.92 50.46 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 124.434 1.094 . . . . 0.0 108.646 175.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 20.2 m . . . . . 0 C--O 1.254 1.292 0 C-N-CA 125.333 1.453 . . . . 0.0 108.583 -177.255 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.7 tpt . . . . . 0 N--CA 1.498 1.975 0 CA-C-O 119.353 -0.356 . . . . 0.0 110.667 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 7.9 ptp180 -60.77 125.95 25.6 Favored 'General case' 0 N--CA 1.48 1.066 0 O-C-N 120.584 -1.322 . . . . 0.0 111.521 -169.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 27.0 mt -136.41 135.22 49.52 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 C-N-CA 123.171 0.588 . . . . 0.0 110.732 -172.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 8.3 mt -112.28 138.58 48.79 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 105.711 -1.959 . . . . 0.0 105.711 167.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 49.1 t -116.21 104.38 16.59 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.644 0 N-CA-C 103.387 -2.819 . . . . 0.0 103.387 169.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 14.5 tp -101.73 111.28 23.47 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 -168.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -88.28 127.29 8.5 Favored Glycine 0 C--N 1.331 0.304 0 N-CA-C 107.706 -2.158 . . . . 0.0 107.706 176.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -141.14 165.6 19.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 117.434 0.617 . . . . 0.0 110.958 -170.488 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 119.25 174.54 15.82 Favored Glycine 0 CA--C 1.527 0.827 0 C-N-CA 125.986 1.755 . . . . 0.0 111.259 178.111 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.455 HD22 ' HB2' ' A' ' 12' ' ' LEU . 4.6 t30 -82.88 97.6 8.75 Favored 'General case' 0 C--O 1.235 0.338 0 O-C-N 121.409 -1.053 . . . . 0.0 110.41 -175.188 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.2 pt -62.64 35.67 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 N-CA-C 116.476 2.028 . . . . 0.0 116.476 172.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.455 ' HB2' HD22 ' A' ' 10' ' ' ASN . 33.8 mt -128.67 -7.16 5.11 Favored 'General case' 0 C--O 1.223 -0.304 0 CA-C-N 120.304 1.411 . . . . 0.0 108.749 169.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.6 mp -111.4 60.19 0.61 Allowed 'General case' 0 N--CA 1.442 -0.836 0 C-N-CA 124.174 0.989 . . . . 0.0 113.407 -168.106 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 52.72 -102.19 0.13 Allowed 'General case' 0 C--O 1.236 0.362 0 C-N-CA 124.168 0.987 . . . . 0.0 111.265 171.393 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -78.81 -11.87 60.01 Favored 'General case' 0 N--CA 1.441 -0.881 0 C-N-CA 123.715 0.806 . . . . 0.0 111.018 -173.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -74.35 -8.82 57.57 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 120.444 1.474 . . . . 0.0 112.232 177.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -77.34 -10.49 59.47 Favored 'General case' 0 N--CA 1.432 -1.327 0 CA-C-O 116.0 -1.952 . . . . 0.0 108.878 170.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.8 tp -54.48 -37.92 39.68 Favored 'Isoleucine or valine' 0 C--N 1.345 0.385 0 CA-C-N 122.212 2.278 . . . . 0.0 112.25 -169.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -60.1 -45.0 96.76 Favored Glycine 0 CA--C 1.524 0.602 0 CA-C-N 119.55 1.068 . . . . 0.0 111.599 175.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 55.3 t -69.72 -44.41 79.28 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-O 118.528 -0.749 . . . . 0.0 109.911 175.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 23.1 mmm180 -61.47 -33.66 74.14 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 120.469 1.486 . . . . 0.0 111.778 179.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 30.3 mt -62.25 -46.4 96.52 Favored 'Isoleucine or valine' 0 C--N 1.342 0.256 0 CA-C-N 120.459 1.482 . . . . 0.0 109.464 176.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 30.2 m -73.73 -27.15 22.49 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 CA-C-N 119.748 1.158 . . . . 0.0 111.522 -175.186 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 64.1 mt-10 -72.91 -44.06 61.7 Favored 'General case' 0 CA--C 1.528 0.099 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 175.078 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.57 -42.39 96.56 Favored 'General case' 0 N--CA 1.452 -0.356 0 O-C-N 121.978 -0.451 . . . . 0.0 110.586 176.124 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 5.5 tp -65.85 -40.96 92.22 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-O 118.828 -0.606 . . . . 0.0 109.913 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -61.76 -40.34 94.79 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 118.413 0.551 . . . . 0.0 111.081 177.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -71.99 -34.71 69.13 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.633 0.773 . . . . 0.0 112.068 178.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 36.5 mtp180 -100.17 -34.06 10.19 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 117.204 -1.379 . . . . 0.0 114.054 -169.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -121.34 138.23 54.35 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 121.464 1.938 . . . . 0.0 113.153 -170.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 39.9 mm -99.87 141.16 17.49 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 105.542 -2.021 . . . . 0.0 105.542 169.019 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.8 mt -143.49 161.35 47.52 Favored Pre-proline 0 CA--C 1.539 0.549 0 C-N-CA 126.717 2.007 . . . . 0.0 107.407 -174.065 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -55.77 156.76 17.89 Favored 'Trans proline' 0 CA--C 1.536 0.605 0 C-N-CA 123.21 2.606 . . . . 0.0 112.661 177.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -62.46 -27.29 69.02 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 -170.069 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 10.9 p90 -76.36 -2.23 30.77 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 179.109 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 22.0 t -104.26 130.27 55.26 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 175.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -131.85 135.57 46.8 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 174.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -94.84 106.19 17.86 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 N-CA-C 105.744 -1.947 . . . . 0.0 105.744 171.089 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 53.2 tp -105.74 126.14 51.81 Favored 'General case' 0 C--N 1.343 0.307 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 -174.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -80.17 117.92 21.4 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 122.989 0.515 . . . . 0.0 109.754 171.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -77.86 -83.54 0.56 Allowed Glycine 0 CA--C 1.528 0.872 0 N-CA-C 107.408 -2.277 . . . . 0.0 107.408 169.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 79.84 110.96 0.26 Allowed Glycine 0 C--N 1.343 0.94 0 N-CA-C 111.05 -0.82 . . . . 0.0 111.05 178.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.3 p 52.59 61.05 3.39 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.839 1.256 . . . . 0.0 109.085 175.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -120.18 -84.78 0.66 Allowed 'General case' 0 C--N 1.344 0.344 0 CA-C-N 114.43 -1.259 . . . . 0.0 111.026 -169.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 71.09 -93.25 0.5 Allowed Glycine 0 C--N 1.338 0.668 0 N-CA-C 108.491 -1.843 . . . . 0.0 108.491 -170.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 27.7 tpp -78.61 -22.5 46.91 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 124.125 0.97 . . . . 0.0 112.322 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -63.02 -14.23 45.41 Favored 'General case' 0 CA--C 1.547 0.833 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 -169.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 28.8 mt -101.87 13.43 34.83 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.882 0.873 . . . . 0.0 112.843 -174.02 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 4.3 tt -41.6 -61.44 1.08 Allowed 'General case' 0 C--N 1.344 0.338 0 C-N-CA 124.177 0.991 . . . . 0.0 113.152 -175.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -75.82 -34.67 47.66 Favored Glycine 0 CA--C 1.524 0.608 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.15 -173.189 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -64.35 -34.08 77.33 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 117.549 0.675 . . . . 0.0 111.353 179.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 51.7 mtp -72.7 -13.3 61.31 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 111.911 0.337 . . . . 0.0 111.911 179.442 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -85.32 160.63 19.77 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 123.341 0.656 . . . . 0.0 110.414 -176.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 29.2 m120 59.26 19.44 7.56 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.642 1.577 . . . . 0.0 113.845 172.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 20.4 mmt180 -94.37 151.54 19.32 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 106.388 -1.708 . . . . 0.0 106.388 169.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -89.2 -35.83 15.99 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 -179.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 12.6 t-160 -142.14 128.78 20.34 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 105.849 -1.908 . . . . 0.0 105.849 179.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 6.5 tp -134.86 128.56 32.9 Favored 'General case' 0 CA--C 1.508 -0.669 0 N-CA-C 108.984 -0.746 . . . . 0.0 108.984 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 44.6 mt -106.98 108.98 26.51 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 N-CA-C 105.199 -2.148 . . . . 0.0 105.199 -179.212 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.6 mm -78.32 128.91 38.12 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 N-CA-C 105.25 -2.13 . . . . 0.0 105.25 175.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -112.33 116.66 30.72 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 104.703 -2.332 . . . . 0.0 104.703 169.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -155.35 169.6 23.83 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 118.174 0.443 . . . . 0.0 110.19 -177.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -88.31 156.99 18.88 Favored 'General case' 0 CA--C 1.534 0.351 0 O-C-N 121.921 -0.487 . . . . 0.0 109.858 169.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 87.6 mt -115.05 113.94 45.05 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.104 1 N-CA-C 99.939 -4.097 . . . . 0.0 99.939 168.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 67.1 t -65.36 -37.86 81.13 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 N-CA-C 113.442 0.904 . . . . 0.0 113.442 -168.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 15.2 m -151.43 152.42 33.02 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 119.238 0.926 . . . . 0.0 111.483 173.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.401 ' HG3' ' H ' ' A' ' 68' ' ' LYS . 26.7 tptt -158.68 -177.44 6.53 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.593 1.957 . . . . 0.0 106.512 169.25 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.401 ' H ' ' HG3' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -86.2 42.13 0.97 Allowed 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.742 0.817 . . . . 0.0 110.472 -178.931 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 33.6 t-20 -143.83 160.88 39.98 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.826 1.25 . . . . 0.0 109.215 -170.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.6 m -64.59 146.66 98.18 Favored Pre-proline 0 CA--C 1.548 0.871 0 C-N-CA 124.344 1.058 . . . . 0.0 111.847 -169.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -58.6 153.54 48.23 Favored 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 122.713 2.275 . . . . 0.0 111.426 169.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 68.33 16.0 68.66 Favored Glycine 0 CA--C 1.532 1.114 0 CA-C-O 118.711 -1.049 . . . . 0.0 114.345 177.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 25.9 m -96.36 152.34 18.68 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 119.0 1.4 . . . . 0.0 109.627 179.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 18.8 ttp -95.78 145.07 25.62 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 123.614 0.766 . . . . 0.0 110.372 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 10.3 ttm -136.51 121.95 19.45 Favored 'General case' 0 CA--C 1.528 0.127 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 44.6 mm -109.15 122.47 63.86 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 -177.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -121.1 131.66 54.4 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 -171.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 74.5 mtm180 -100.78 176.14 5.4 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.496 0.718 . . . . 0.0 110.551 -176.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -46.74 -47.19 20.68 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 115.99 1.848 . . . . 0.0 115.99 -169.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -78.91 -18.23 54.21 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 119.242 0.928 . . . . 0.0 112.248 -178.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -90.59 -33.12 16.0 Favored 'General case' 0 N--CA 1.457 -0.119 0 C-N-CA 123.606 0.762 . . . . 0.0 110.754 -169.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -70.36 -37.6 7.27 Favored Pre-proline 0 CA--C 1.539 0.525 0 CA-C-O 117.233 -1.365 . . . . 0.0 113.242 -177.036 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_exo -56.26 -25.93 58.75 Favored 'Trans proline' 0 CA--C 1.54 0.781 0 CA-C-N 121.768 1.667 . . . . 0.0 112.21 169.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -92.4 7.62 42.13 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 124.492 1.117 . . . . 0.0 112.68 177.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -126.53 -42.39 1.81 Allowed 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.512 0.725 . . . . 0.0 112.509 -172.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 -61.85 -11.1 11.09 Favored 'General case' 0 CA--C 1.551 1.017 0 CA-C-N 119.47 1.032 . . . . 0.0 111.39 175.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 64.3 p -59.54 -27.55 66.3 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.946 1.698 . . . . 0.0 113.857 -177.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -63.75 139.83 58.81 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 121.347 0.594 . . . . 0.0 110.78 -170.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -76.13 -21.66 56.35 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 122.658 0.383 . . . . 0.0 111.861 -176.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 97.3 mt -72.42 -26.72 24.76 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 C-N-CA 124.28 1.032 . . . . 0.0 110.318 -170.174 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 9.9 m -102.85 84.47 0.66 Allowed Pre-proline 0 CA--C 1.55 0.962 0 C-N-CA 126.084 1.753 . . . . 0.0 108.63 174.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -70.61 -38.27 6.15 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 123.003 2.469 . . . . 0.0 114.364 -169.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 11.1 m80 -68.71 -39.75 80.32 Favored 'General case' 0 N--CA 1.468 0.441 0 O-C-N 121.055 -1.028 . . . . 0.0 108.81 179.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 16.9 mp0 -66.09 -36.55 83.48 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 125.169 1.388 . . . . 0.0 109.253 177.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 59.0 tp -62.01 -35.27 78.04 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 119.431 1.014 . . . . 0.0 110.969 171.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -60.51 -39.27 96.15 Favored Glycine 0 CA--C 1.532 1.116 0 O-C-N 121.392 -0.817 . . . . 0.0 111.069 171.087 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 8.8 tt -75.21 -23.97 57.68 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 117.549 0.675 . . . . 0.0 110.704 175.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -61.02 -43.72 98.47 Favored 'General case' 0 C--O 1.226 -0.17 0 CA-C-N 119.443 1.02 . . . . 0.0 108.666 169.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -69.77 -21.32 63.44 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 119.03 -0.509 . . . . 0.0 110.747 176.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 73.1 t -69.77 -40.89 79.65 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 168.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 5.3 mp -60.98 -36.64 79.97 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 120.973 1.715 . . . . 0.0 110.492 175.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 17.0 m -63.46 -45.26 91.64 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 118.286 0.494 . . . . 0.0 109.873 172.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -65.39 -38.77 90.99 Favored 'General case' 0 N--CA 1.452 -0.366 0 O-C-N 121.563 -0.711 . . . . 0.0 111.505 -179.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 21.7 mt -59.97 -39.59 86.17 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 125.143 1.377 . . . . 0.0 109.832 173.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 52.6 tpt85 -70.64 -33.35 70.89 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 118.037 -0.982 . . . . 0.0 110.484 175.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 15.5 m-30 -68.38 -42.11 79.57 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 119.646 1.112 . . . . 0.0 110.402 178.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 63.9 p -73.25 -26.78 61.25 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 118.561 0.619 . . . . 0.0 110.515 177.247 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 76.91 6.55 85.76 Favored Glycine 0 CA--C 1.532 1.138 0 CA-C-O 119.182 -0.788 . . . . 0.0 111.599 -169.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -96.06 19.73 11.22 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 118.603 1.202 . . . . 0.0 110.809 -175.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -55.82 135.37 72.62 Favored Pre-proline 0 CA--C 1.543 0.694 0 C-N-CA 126.624 1.969 . . . . 0.0 109.752 174.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_exo -56.04 152.74 35.57 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 123.259 2.639 . . . . 0.0 114.796 179.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 8.7 tttt -64.36 -33.27 75.45 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 119.001 -0.523 . . . . 0.0 110.302 177.033 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 63.1 tttm -139.82 97.46 3.26 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 -178.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -83.62 132.58 34.89 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 106.495 -1.669 . . . . 0.0 106.495 169.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -134.22 148.78 50.92 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 176.779 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.8 tt -135.05 133.87 39.8 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 120.177 1.353 . . . . 0.0 110.504 174.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 60.8 t -103.01 103.43 15.08 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 N-CA-C 103.665 -2.717 . . . . 0.0 103.665 169.095 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -92.85 151.91 20.74 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 111.121 -0.792 . . . . 0.0 111.121 177.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 47.1 t -138.95 136.35 42.73 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 N-CA-C 107.705 -1.221 . . . . 0.0 107.705 178.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 32.1 mt -88.73 131.64 41.01 Favored Pre-proline 0 CA--C 1.546 0.802 0 CA-C-N 119.812 1.187 . . . . 0.0 108.961 177.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -75.16 173.55 14.32 Favored 'Trans proline' 0 CA--C 1.543 0.932 0 C-N-CA 124.978 3.785 . . . . 0.0 113.228 -177.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -116.15 -57.35 2.22 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.836 0.855 . . . . 0.0 110.718 179.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 63.4 m -107.07 -51.89 2.85 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 118.54 0.609 . . . . 0.0 112.609 -172.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 57.25 46.71 18.18 Favored 'General case' 0 CA--C 1.552 1.044 0 N-CA-C 114.776 1.399 . . . . 0.0 114.776 172.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -116.38 165.22 15.53 Favored Pre-proline 0 N--CA 1.478 0.962 0 O-C-N 121.155 -0.966 . . . . 0.0 109.618 177.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -66.09 90.89 0.26 Allowed 'Trans proline' 0 CA--C 1.547 1.125 0 C-N-CA 122.868 2.378 . . . . 0.0 112.931 -179.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -176.98 145.24 0.47 Allowed 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 103.91 -2.626 . . . . 0.0 103.91 173.491 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -107.42 165.79 4.3 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 CA-C-N 119.376 0.989 . . . . 0.0 113.319 -169.539 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 85.3 153.81 21.29 Favored Glycine 0 C--N 1.341 0.845 0 N-CA-C 108.11 -1.996 . . . . 0.0 108.11 -169.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -81.74 163.32 22.51 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-O 121.585 0.707 . . . . 0.0 109.108 -172.529 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 39.5 p -69.19 169.32 12.06 Favored Pre-proline 0 C--O 1.238 0.467 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 168.104 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_exo -55.1 -32.2 78.63 Favored 'Trans proline' 0 CA--C 1.541 0.84 0 C-N-CA 121.469 1.446 . . . . 0.0 110.693 169.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 26.5 m -67.09 -44.73 79.26 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 118.992 -0.528 . . . . 0.0 111.419 179.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 4.6 t -101.06 -11.41 8.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 CA-C-N 119.645 1.111 . . . . 0.0 111.624 -169.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -59.04 -45.69 90.12 Favored 'General case' 0 CA--C 1.518 -0.27 0 O-C-N 119.938 -1.726 . . . . 0.0 107.322 169.016 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -71.24 4.63 2.69 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-O 118.482 -0.771 . . . . 0.0 112.406 178.104 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 26.2 mmm -95.57 -10.54 29.3 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 118.127 -0.94 . . . . 0.0 111.282 170.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 57.0 mt -59.9 -46.99 93.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-N 119.31 0.959 . . . . 0.0 108.554 178.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -72.15 -53.05 6.81 Favored Pre-proline 0 CA--C 1.536 0.422 0 CA-C-O 117.286 -1.34 . . . . 0.0 113.05 -171.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -60.02 -35.26 93.62 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 CA-C-N 122.244 1.837 . . . . 0.0 111.256 176.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.28 -43.01 71.31 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 118.84 0.745 . . . . 0.0 110.538 -179.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.05 -37.21 86.6 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 119.695 1.134 . . . . 0.0 109.782 176.34 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -62.36 -35.94 80.69 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 119.05 -0.5 . . . . 0.0 110.783 175.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 35.1 mm-40 -76.31 -29.5 57.34 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 119.152 0.887 . . . . 0.0 111.627 175.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 38.2 t -61.55 -45.42 98.68 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 CA-C-N 120.065 1.302 . . . . 0.0 108.478 169.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 72.8 mt -63.75 -39.03 93.28 Favored 'General case' 0 C--N 1.341 0.206 0 CA-C-N 118.05 0.386 . . . . 0.0 110.207 176.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -60.4 -41.28 93.53 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 118.906 0.776 . . . . 0.0 111.39 177.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -62.35 -47.38 84.46 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 119.233 0.924 . . . . 0.0 111.038 178.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . 0.297 4.2 pp -67.78 -22.23 65.21 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 118.576 0.626 . . . . 0.0 112.48 177.426 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 61.8 mtt180 -71.22 -26.31 62.87 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 117.822 -1.085 . . . . 0.0 111.821 169.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -59.85 -38.0 80.84 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 120.625 1.557 . . . . 0.0 109.42 174.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 11.3 p -87.39 14.81 7.36 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.549 1.14 . . . . 0.0 112.946 178.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 75.52 19.76 79.05 Favored Glycine 0 CA--C 1.534 1.268 0 CA-C-O 118.704 -1.054 . . . . 0.0 114.597 175.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 15.1 t -102.47 146.32 10.67 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 CA-C-N 118.97 1.385 . . . . 0.0 107.805 178.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -134.54 143.78 47.61 Favored 'General case' 0 C--O 1.236 0.392 0 O-C-N 121.096 -1.002 . . . . 0.0 108.929 176.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -94.74 160.52 14.57 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 124.991 1.316 . . . . 0.0 111.518 178.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . 0.415 ' CG2' ' HA ' ' A' ' 160' ' ' SER . 46.1 mt -124.07 130.76 24.27 Favored Pre-proline 0 CA--C 1.533 0.307 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 171.599 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -57.48 110.2 0.58 Allowed 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.561 2.174 . . . . 0.0 109.03 170.053 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 50.05 21.6 0.77 Allowed 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.628 1.571 . . . . 0.0 114.447 177.188 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' SER . . . . . 0.415 ' HA ' ' CG2' ' A' ' 157' ' ' ILE . 1.1 m 46.11 36.46 3.15 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.424 1.09 . . . . 0.0 112.575 -169.563 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -72.43 143.66 48.41 Favored 'General case' 0 C--O 1.239 0.547 0 O-C-N 121.382 -0.824 . . . . 0.0 109.983 178.251 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 14.1 m . . . . . 0 C--O 1.254 1.309 0 C-N-CA 124.578 1.151 . . . . 0.0 111.014 -174.118 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.1 tpt . . . . . 0 N--CA 1.496 1.861 0 CA-C-O 119.503 -0.284 . . . . 0.0 110.298 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 8.3 ptp180 -139.33 121.97 16.34 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 173.139 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 72.7 mt -138.9 133.21 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 CA-C-N 119.332 0.969 . . . . 0.0 111.169 -169.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -115.2 129.74 56.73 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 105.951 -1.87 . . . . 0.0 105.951 168.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.8 t -104.43 105.49 18.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 101.905 -3.369 . . . . 0.0 101.905 169.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 13.0 tp -109.45 104.26 13.31 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 124.533 1.133 . . . . 0.0 110.033 -167.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -91.26 129.85 10.0 Favored Glycine 0 N--CA 1.452 -0.297 0 N-CA-C 106.603 -2.599 . . . . 0.0 106.603 175.083 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 1.4 m -135.32 -28.34 0.48 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.208 0 N-CA-C 117.819 2.525 . . . . 0.0 117.819 -168.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -52.25 151.41 7.65 Favored Glycine 0 CA--C 1.527 0.783 0 CA-C-O 122.22 0.9 . . . . 0.0 114.715 -169.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -61.76 102.39 0.26 Allowed 'General case' 0 N--CA 1.455 -0.225 0 C-N-CA 125.334 1.453 . . . . 0.0 112.372 -169.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.2 pt -76.76 40.97 0.02 OUTLIER 'Isoleucine or valine' 0 C--O 1.222 -0.38 0 C-N-CA 123.93 0.892 . . . . 0.0 113.311 -177.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 19.9 mt -128.11 -7.83 5.4 Favored 'General case' 0 CA--C 1.536 0.429 0 O-C-N 121.177 -0.952 . . . . 0.0 109.018 170.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.3 mp -124.51 67.24 1.08 Allowed 'General case' 0 C--N 1.346 0.417 0 C-N-CA 124.167 0.987 . . . . 0.0 109.235 -168.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.4 m 46.91 -103.16 0.08 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 114.378 -1.283 . . . . 0.0 112.891 171.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -62.95 -26.33 68.77 Favored 'General case' 0 N--CA 1.438 -1.056 0 C-N-CA 125.998 1.719 . . . . 0.0 111.598 -171.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -72.0 -18.79 61.95 Favored 'General case' 0 C--O 1.231 0.101 0 CA-C-N 120.019 1.281 . . . . 0.0 112.003 -174.022 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.86 -15.49 42.73 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-O 117.022 -1.466 . . . . 0.0 111.152 170.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.7 tp -54.2 -37.98 37.61 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 CA-C-N 120.831 1.65 . . . . 0.0 111.136 -174.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -59.54 -43.99 97.14 Favored Glycine 0 CA--C 1.527 0.834 0 N-CA-C 111.244 -0.743 . . . . 0.0 111.244 178.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 74.0 t -70.82 -45.78 71.81 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 176.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 20.0 mmt180 -61.43 -31.71 71.66 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 117.093 -1.432 . . . . 0.0 112.21 -178.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 19.9 mt -58.89 -49.49 82.87 Favored 'Isoleucine or valine' 0 C--N 1.34 0.157 0 CA-C-N 121.286 1.857 . . . . 0.0 109.299 174.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 30.4 m -73.32 -34.13 42.83 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 CA-C-N 119.762 1.164 . . . . 0.0 111.111 -173.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 59.4 mt-10 -64.88 -42.15 95.05 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 118.403 0.547 . . . . 0.0 110.322 173.041 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -68.24 -36.53 79.61 Favored 'General case' 0 C--N 1.34 0.184 0 CA-C-N 118.981 0.809 . . . . 0.0 110.014 179.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.3 tp -65.46 -36.16 83.07 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 118.64 0.654 . . . . 0.0 109.887 -177.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -61.57 -24.16 66.47 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.353 0.661 . . . . 0.0 112.72 179.18 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 -98.85 -39.77 8.43 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 126.45 1.9 . . . . 0.0 110.771 -176.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 21.8 mmt85 -85.02 -32.18 23.06 Favored 'General case' 0 C--N 1.338 0.085 0 CA-C-O 119.449 -0.31 . . . . 0.0 110.242 -173.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 71.5 m-85 -122.02 151.01 41.29 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-O 122.33 1.062 . . . . 0.0 111.826 -176.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 37.0 mt -107.06 134.45 48.7 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 N-CA-C 104.223 -2.51 . . . . 0.0 104.223 169.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -120.13 150.03 50.45 Favored Pre-proline 0 C--O 1.236 0.357 0 C-N-CA 124.005 0.922 . . . . 0.0 110.366 -169.114 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_endo -67.52 156.77 64.73 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 121.977 1.785 . . . . 0.0 108.726 168.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -55.75 -33.25 64.12 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 114.491 1.293 . . . . 0.0 114.491 -169.386 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 17.0 p90 -78.75 -13.2 59.94 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 118.474 -0.774 . . . . 0.0 112.743 -175.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 95.5 t -89.82 121.71 40.34 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 169.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -122.62 125.22 45.2 Favored 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 173.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -81.33 126.63 39.85 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 N-CA-C 106.067 -1.827 . . . . 0.0 106.067 167.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 64.4 tp -125.53 132.94 52.51 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 171.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -88.85 116.92 27.48 Favored 'General case' 0 C--O 1.236 0.395 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 169.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -76.17 -74.37 0.94 Allowed Glycine 0 CA--C 1.529 0.916 0 N-CA-C 108.335 -1.906 . . . . 0.0 108.335 169.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 85.76 98.0 0.75 Allowed Glycine 0 C--N 1.343 0.925 0 N-CA-C 109.729 -1.348 . . . . 0.0 109.729 176.048 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 16.8 p 62.97 16.65 9.42 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.24 1.416 . . . . 0.0 113.378 179.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -70.18 -59.96 2.57 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 114.298 1.222 . . . . 0.0 114.298 -168.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 60.07 -117.09 10.2 Favored Glycine 0 CA--C 1.529 0.91 0 N-CA-C 108.691 -1.764 . . . . 0.0 108.691 -170.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 9.4 tpt -62.22 -21.86 65.48 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.512 1.125 . . . . 0.0 113.68 -173.273 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -60.19 -19.28 53.39 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 -171.087 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 10.0 mt -98.18 20.67 12.03 Favored 'General case' 0 C--N 1.345 0.392 0 CA-C-N 119.522 1.055 . . . . 0.0 113.663 -169.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 6.4 tt -50.5 -57.71 7.45 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 118.988 0.813 . . . . 0.0 110.988 -178.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -64.98 -30.08 77.08 Favored Glycine 0 CA--C 1.53 0.975 0 CA-C-O 119.296 -0.725 . . . . 0.0 112.584 -177.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -79.72 -36.38 37.5 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 118.413 1.107 . . . . 0.0 112.33 -178.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 55.4 mtp -76.25 -28.79 57.26 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 179.219 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.46 157.55 31.76 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 121.96 0.886 . . . . 0.0 110.803 175.079 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 62.14 16.49 8.35 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.377 1.471 . . . . 0.0 114.307 169.6 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 24.6 mmt180 -93.89 154.73 17.55 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 172.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -83.95 -34.91 24.33 Favored 'General case' 0 C--O 1.217 -0.642 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 169.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 4.5 t-160 -144.41 129.06 18.17 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 105.512 -2.033 . . . . 0.0 105.512 -169.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 22.8 tp -134.13 117.87 17.04 Favored 'General case' 0 CA--C 1.499 -1.003 0 N-CA-C 103.434 -2.802 . . . . 0.0 103.434 -173.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 65.7 mt -100.58 107.86 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 N-CA-C 103.907 -2.627 . . . . 0.0 103.907 171.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 63.8 mt -81.2 140.6 16.35 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 N-CA-C 105.885 -1.894 . . . . 0.0 105.885 172.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -120.72 113.18 19.83 Favored 'General case' 0 N--CA 1.446 -0.625 0 N-CA-C 103.635 -2.728 . . . . 0.0 103.635 168.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.419 ' CG ' HE21 ' A' ' 94' ' ' GLN . 38.6 t0 -155.93 157.64 36.62 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 123.574 0.75 . . . . 0.0 109.587 -176.22 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -83.68 149.92 26.19 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 174.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 8.1 mt -76.67 -32.59 20.95 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 C-N-CA 123.731 0.812 . . . . 0.0 110.109 174.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . 0.354 3.3 t 58.49 46.92 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.943 0 C-N-CA 126.148 1.779 . . . . 0.0 112.188 -173.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 8.1 m 63.46 145.28 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 128.327 2.651 . . . . 0.0 118.124 168.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -139.35 -88.34 0.21 Allowed 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 169.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -140.05 31.08 1.99 Allowed 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.56 1.144 . . . . 0.0 111.02 -176.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -134.31 165.22 25.64 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.095 0.958 . . . . 0.0 110.69 -174.289 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 2.8 m -64.87 148.5 97.4 Favored Pre-proline 0 CA--C 1.548 0.867 0 C-N-CA 124.439 1.096 . . . . 0.0 113.071 -169.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_exo -57.05 154.74 31.75 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 124.607 3.538 . . . . 0.0 112.425 169.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 67.04 11.46 58.58 Favored Glycine 0 CA--C 1.532 1.124 0 CA-C-O 119.065 -0.853 . . . . 0.0 113.943 173.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 10.6 m -90.22 140.68 29.45 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 119.146 1.473 . . . . 0.0 109.476 -175.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 28.8 ttp -86.07 142.95 28.35 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 169.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 7.0 ttm -131.53 134.23 45.89 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 169.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 4.9 mm -95.75 121.91 46.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 105.573 -2.01 . . . . 0.0 105.573 176.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.7 mp -116.37 128.86 55.89 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 173.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 22.2 mtp85 -88.53 177.72 6.72 Favored 'General case' 0 CA--C 1.528 0.103 0 O-C-N 123.824 0.703 . . . . 0.0 110.602 178.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -42.24 -50.97 4.88 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 115.336 1.606 . . . . 0.0 115.336 -169.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -86.27 -14.76 42.78 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -175.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -82.18 -36.64 27.13 Favored 'General case' 0 CA--C 1.523 -0.078 0 O-C-N 121.597 -0.69 . . . . 0.0 110.424 -169.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -65.09 -47.86 71.77 Favored Pre-proline 0 CA--C 1.539 0.534 0 CA-C-O 117.397 -1.287 . . . . 0.0 113.454 -175.27 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -53.35 -44.36 49.65 Favored 'Trans proline' 0 C--N 1.352 0.739 0 C-N-CA 121.935 1.757 . . . . 0.0 110.697 174.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -70.22 -13.23 62.09 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 114.142 1.164 . . . . 0.0 114.142 178.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -95.27 -42.64 8.44 Favored 'General case' 0 C--N 1.343 0.323 0 CA-C-N 120.181 1.355 . . . . 0.0 110.558 -177.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 26.5 m-85 -69.01 0.98 3.84 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 -172.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 61.6 p -58.65 -27.85 65.15 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.137 0.975 . . . . 0.0 110.346 169.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 56.8 t-20 -51.52 117.19 2.48 Favored 'General case' 0 C--N 1.345 0.406 0 C-N-CA 124.137 0.975 . . . . 0.0 111.311 -179.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -77.22 -17.0 58.81 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 118.717 -0.659 . . . . 0.0 112.439 -174.289 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 40.2 mt -61.66 -41.13 89.19 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 178.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.5 m -83.18 105.11 4.6 Favored Pre-proline 0 CA--C 1.545 0.777 0 C-N-CA 126.683 1.993 . . . . 0.0 110.523 -169.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -71.95 -61.72 0.05 OUTLIER 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 122.186 1.924 . . . . 0.0 113.181 -169.118 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . 0.403 ' HD1' ' NE2' ' A' ' 94' ' ' GLN . 10.4 t-80 -56.73 -41.66 77.88 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 121.75 0.786 . . . . 0.0 110.46 178.652 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.419 HE21 ' CG ' ' A' ' 62' ' ' ASP . 20.8 mp0 -61.36 -33.13 73.13 Favored 'General case' 0 N--CA 1.433 -1.287 0 CA-C-N 115.08 -0.964 . . . . 0.0 108.939 -175.074 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 1.5 tt -63.13 -46.3 87.94 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 119.457 1.026 . . . . 0.0 108.804 177.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -61.69 -37.32 94.05 Favored Glycine 0 CA--C 1.532 1.14 0 O-C-N 121.089 -1.007 . . . . 0.0 111.014 175.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 54.6 tp -67.96 -30.92 70.33 Favored 'General case' 0 CA--C 1.535 0.382 0 O-C-N 121.755 -0.85 . . . . 0.0 110.353 175.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -60.26 -45.64 92.59 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 172.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 34.0 t0 -63.59 -28.97 70.29 Favored 'General case' 0 C--O 1.238 0.497 0 O-C-N 123.633 0.583 . . . . 0.0 110.592 -178.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 41.8 t -65.49 -50.2 73.69 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 CA-C-N 118.866 0.757 . . . . 0.0 110.126 169.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 33.6 mt -67.26 -31.52 71.92 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 119.202 0.91 . . . . 0.0 110.844 -174.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 48.8 m -64.52 -44.34 91.17 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 119.391 0.996 . . . . 0.0 109.838 169.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.442 ' HA ' ' CD2' ' A' ' 106' ' ' PHE . . . -62.54 -39.51 93.84 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 119.723 1.147 . . . . 0.0 111.276 177.095 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -63.23 -35.25 79.72 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 123.325 0.65 . . . . 0.0 109.819 175.476 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 73.6 ttt-85 -71.66 -31.42 66.79 Favored 'General case' 0 CA--C 1.535 0.39 0 O-C-N 121.554 -0.716 . . . . 0.0 109.937 176.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.442 ' CD2' ' HA ' ' A' ' 103' ' ' ALA . 12.3 m-30 -69.99 -46.47 65.08 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 119.143 0.883 . . . . 0.0 110.702 176.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 35.6 p -74.04 -27.19 60.81 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 122.993 0.517 . . . . 0.0 111.874 -176.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 75.11 7.37 81.81 Favored Glycine 0 CA--C 1.533 1.211 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 -168.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -84.57 16.27 3.29 Favored 'General case' 0 C--N 1.349 0.557 0 CA-C-N 119.734 1.767 . . . . 0.0 111.302 174.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -56.18 137.9 73.94 Favored Pre-proline 0 CA--C 1.542 0.668 0 C-N-CA 125.676 1.59 . . . . 0.0 109.895 170.108 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -62.72 160.24 33.64 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 122.475 2.117 . . . . 0.0 115.695 -176.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 23.7 mmtm -61.01 -40.99 95.67 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 169.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 23.6 ttpp -142.46 73.18 1.4 Allowed 'General case' 0 C--O 1.236 0.356 0 C-N-CA 123.825 0.85 . . . . 0.0 108.972 -172.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 15.2 tp -68.25 137.53 54.82 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 169.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.11 142.75 47.62 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 106.098 -1.815 . . . . 0.0 106.098 174.209 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -130.08 121.62 26.75 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 120.503 1.502 . . . . 0.0 109.055 176.03 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 13.1 t -85.97 87.86 2.63 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 N-CA-C 106.401 -1.703 . . . . 0.0 106.401 173.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -80.96 143.86 24.52 Favored Glycine 0 C--N 1.336 0.56 0 N-CA-C 110.005 -1.238 . . . . 0.0 110.005 -176.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 22.0 t -130.91 134.94 61.04 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.15 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 177.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 36.7 mt -93.63 133.22 28.41 Favored Pre-proline 0 CA--C 1.539 0.552 0 CA-C-N 119.595 1.089 . . . . 0.0 108.106 178.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -78.39 166.54 24.1 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 122.779 2.32 . . . . 0.0 112.372 -174.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -99.77 -50.42 4.04 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.93 0.892 . . . . 0.0 109.644 169.056 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 72.2 m -114.58 -55.16 2.52 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 113.82 1.044 . . . . 0.0 113.82 -169.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER 52.96 42.41 32.18 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 126.564 1.946 . . . . 0.0 112.93 -175.584 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -105.03 165.71 12.74 Favored Pre-proline 0 CA--C 1.542 0.653 0 C-N-CA 123.615 0.766 . . . . 0.0 109.917 178.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -80.94 85.72 1.76 Allowed 'Trans proline' 0 CA--C 1.538 0.722 0 C-N-CA 121.948 1.765 . . . . 0.0 112.977 -169.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -176.05 148.88 0.85 Allowed 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 103.609 -2.738 . . . . 0.0 103.609 178.466 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -110.84 168.63 4.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 CA-C-N 119.718 1.145 . . . . 0.0 113.973 -169.003 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 95.4 145.85 19.68 Favored Glycine 0 C--N 1.34 0.78 0 N-CA-C 106.022 -2.831 . . . . 0.0 106.022 -168.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -73.66 163.54 27.86 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 119.339 1.569 . . . . 0.0 110.379 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 43.0 p -73.06 168.39 25.23 Favored Pre-proline 0 CA--C 1.539 0.54 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 168.391 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -57.13 -35.65 98.96 Favored 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 121.532 1.488 . . . . 0.0 111.185 172.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 99.0 m -66.93 -33.27 75.22 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 124.401 1.081 . . . . 0.0 111.293 -178.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 84.4 t -103.82 -27.55 3.17 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 CA-C-N 118.329 0.513 . . . . 0.0 111.608 -172.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -52.78 -49.28 65.87 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 119.346 0.975 . . . . 0.0 109.27 169.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -62.02 -19.59 63.02 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 4.0 mmm -80.63 -7.4 59.27 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-O 118.436 -0.792 . . . . 0.0 112.4 -179.121 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 71.4 mt -55.69 -51.99 52.97 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.235 0 CA-C-N 119.147 0.885 . . . . 0.0 109.072 172.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -71.36 -43.63 12.57 Favored Pre-proline 0 CA--C 1.535 0.38 0 CA-C-O 116.794 -1.574 . . . . 0.0 113.531 -169.052 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -55.95 -42.82 62.92 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 CA-C-N 121.994 1.748 . . . . 0.0 111.199 169.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.07 -40.09 94.18 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-O 119.004 -0.522 . . . . 0.0 111.959 178.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 74.1 mt -60.32 -45.91 91.74 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 119.589 1.086 . . . . 0.0 108.82 174.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -57.73 -35.28 70.48 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 118.74 0.7 . . . . 0.0 110.687 175.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.62 -44.42 93.98 Favored 'General case' 0 N--CA 1.446 -0.635 0 O-C-N 121.589 -0.695 . . . . 0.0 111.522 173.529 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 63.8 t -57.87 -46.04 87.41 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 N-CA-C 108.245 -1.021 . . . . 0.0 108.245 175.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 13.9 mt -57.9 -42.63 85.12 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 119.439 1.018 . . . . 0.0 110.072 178.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -68.72 -44.44 73.88 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 118.481 -0.771 . . . . 0.0 111.216 -178.014 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -64.62 -32.5 74.19 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 119.702 1.137 . . . . 0.0 110.811 178.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 80.2 mt -64.11 -47.94 78.04 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 170.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 70.9 mtp85 -62.92 -20.91 65.64 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 117.943 -1.027 . . . . 0.0 112.598 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 91.5 mt-10 -63.07 -36.39 83.41 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 120.475 1.489 . . . . 0.0 110.423 173.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 46.4 m -88.87 13.68 12.12 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.511 0.724 . . . . 0.0 111.668 170.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 70.4 21.82 77.53 Favored Glycine 0 CA--C 1.524 0.629 0 CA-C-O 117.877 -1.513 . . . . 0.0 112.434 -177.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 61.4 t -97.05 123.0 49.16 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 CA-C-N 120.089 1.944 . . . . 0.0 105.957 -175.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -105.18 97.15 7.04 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 177.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -58.95 137.12 58.02 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 168.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . 0.412 ' CG2' ' HA ' ' A' ' 160' ' ' SER . 35.4 mm -98.67 122.72 52.31 Favored Pre-proline 0 N--CA 1.461 0.095 0 CA-C-O 117.641 -1.171 . . . . 0.0 108.874 -170.515 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -63.27 105.99 0.53 Allowed 'Trans proline' 0 CA--C 1.534 0.484 0 C-N-CA 122.018 1.812 . . . . 0.0 109.024 171.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 55.8 mtm180 38.94 50.02 1.66 Allowed 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 126.452 1.901 . . . . 0.0 113.509 178.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' SER . . . . . 0.412 ' HA ' ' CG2' ' A' ' 157' ' ' ILE . 35.1 p 50.4 21.19 0.78 Allowed 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 127.068 2.147 . . . . 0.0 115.633 -179.054 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -77.25 -33.41 56.03 Favored 'General case' 0 CA--C 1.536 0.433 0 O-C-N 120.662 -1.274 . . . . 0.0 112.875 -170.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 7.1 m . . . . . 0 C--O 1.254 1.302 0 C-N-CA 123.983 0.913 . . . . 0.0 110.587 -179.361 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.3 ttp . . . . . 0 N--CA 1.497 1.904 0 CA-C-O 119.124 -0.465 . . . . 0.0 110.629 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 29.4 ptt-85 -66.55 131.17 45.44 Favored 'General case' 0 N--CA 1.477 0.89 0 O-C-N 119.772 -1.83 . . . . 0.0 109.96 174.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 3.6 mt -130.86 139.24 51.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 C-N-CA 123.412 0.685 . . . . 0.0 110.068 -169.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.7 mt -112.44 143.18 44.0 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 104.805 -2.294 . . . . 0.0 104.805 167.064 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 67.1 t -123.45 97.89 5.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 102.276 -3.231 . . . . 0.0 102.276 171.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.3 tt -106.53 109.7 21.7 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 -167.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -91.86 138.59 14.32 Favored Glycine 0 N--CA 1.443 -0.865 0 N-CA-C 108.206 -1.958 . . . . 0.0 108.206 176.234 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -148.05 167.26 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.612 0 C-N-CA 123.16 0.584 . . . . 0.0 109.429 -179.548 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 130.95 156.51 8.57 Favored Glycine 0 C--N 1.335 0.496 0 N-CA-C 108.723 -1.751 . . . . 0.0 108.723 170.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.554 ' ND2' ' H ' ' A' ' 12' ' ' LEU . 6.6 t30 -75.45 103.75 5.72 Favored 'General case' 0 N--CA 1.454 -0.265 0 O-C-N 121.042 -1.27 . . . . 0.0 109.473 -174.629 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 26.1 pt -58.06 -15.59 5.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 N-CA-C 115.032 1.493 . . . . 0.0 115.032 -173.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.554 ' H ' ' ND2' ' A' ' 10' ' ' ASN . 5.2 mp -89.01 -6.11 57.44 Favored 'General case' 0 C--O 1.216 -0.683 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 -171.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.5 mp -102.45 53.2 0.79 Allowed 'General case' 0 N--CA 1.434 -1.251 0 C-N-CA 124.143 0.977 . . . . 0.0 109.147 -172.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.258 0.1 OUTLIER 49.91 -107.37 0.26 Allowed 'General case' 0 N--CA 1.44 -0.952 0 CA-C-N 113.901 -1.5 . . . . 0.0 110.677 174.896 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -76.51 -6.27 51.12 Favored 'General case' 0 N--CA 1.439 -0.997 0 O-C-N 122.075 -0.391 . . . . 0.0 111.544 -171.023 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -71.94 -4.67 29.71 Favored 'General case' 0 CA--C 1.546 0.809 0 O-C-N 121.131 -0.98 . . . . 0.0 111.874 169.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -80.14 -15.18 57.64 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-O 116.187 -1.863 . . . . 0.0 109.748 169.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 7.0 tp -53.92 -42.02 51.72 Favored 'Isoleucine or valine' 0 C--N 1.342 0.252 0 CA-C-N 121.561 1.982 . . . . 0.0 112.655 -169.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -63.81 -43.45 97.66 Favored Glycine 0 C--N 1.334 0.435 0 CA-C-N 119.295 0.952 . . . . 0.0 111.716 178.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 97.7 t -64.56 -48.95 82.78 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 173.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 27.4 mmm180 -63.51 -31.41 72.56 Favored 'General case' 0 N--CA 1.467 0.404 0 O-C-N 120.433 -1.417 . . . . 0.0 112.678 -177.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 30.0 mt -60.52 -43.92 95.4 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 CA-C-N 120.446 1.476 . . . . 0.0 109.754 173.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.2 m -76.74 -27.79 17.01 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 CA-C-N 120.179 1.354 . . . . 0.0 111.806 -177.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 60.3 mt-10 -70.19 -41.27 73.95 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 175.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -69.03 -40.67 78.49 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-O 119.163 -0.446 . . . . 0.0 110.795 -179.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 5.7 tp -65.35 -42.2 93.07 Favored 'General case' 0 C--O 1.224 -0.283 0 CA-C-N 119.118 0.872 . . . . 0.0 110.233 178.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -62.6 -40.43 96.88 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 119.003 0.82 . . . . 0.0 110.669 179.211 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -71.15 -38.81 72.19 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 122.601 0.36 . . . . 0.0 111.686 177.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 31.4 mtp180 -92.67 -40.41 10.75 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 117.509 -1.234 . . . . 0.0 113.663 -169.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -117.18 123.82 47.61 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 121.074 1.761 . . . . 0.0 111.73 -170.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 50.0 mm -83.32 141.19 15.2 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 N-CA-C 106.372 -1.714 . . . . 0.0 106.372 169.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 17.8 mt -135.8 155.77 77.78 Favored Pre-proline 0 CA--C 1.539 0.523 0 C-N-CA 124.711 1.204 . . . . 0.0 110.153 -169.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_exo -57.88 157.72 23.31 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 123.612 2.875 . . . . 0.0 112.727 171.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -63.82 -30.21 71.33 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -169.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 11.7 p90 -73.13 -5.27 38.04 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 118.706 -0.664 . . . . 0.0 112.346 178.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 12.0 t -101.32 130.06 51.42 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 174.199 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -119.3 132.04 55.83 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 172.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -99.28 123.69 52.12 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 N-CA-C 104.759 -2.311 . . . . 0.0 104.759 169.059 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 5.8 tt -127.56 138.25 52.84 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 119.302 0.955 . . . . 0.0 110.816 -178.122 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -100.58 119.01 37.9 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 169.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -72.4 -24.28 76.56 Favored Glycine 0 CA--C 1.535 1.336 0 CA-C-O 118.683 -1.065 . . . . 0.0 112.752 177.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 66.91 75.54 0.45 Allowed Glycine 0 CA--C 1.529 0.92 0 CA-C-N 118.409 1.105 . . . . 0.0 112.063 173.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . 0.272 17.7 p 55.05 30.79 14.89 Favored 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 125.359 1.464 . . . . 0.0 112.862 176.26 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -76.91 -68.39 0.61 Allowed 'General case' 0 C--N 1.344 0.367 0 N-CA-C 114.701 1.371 . . . . 0.0 114.701 -169.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 74.91 -89.36 0.77 Allowed Glycine 0 CA--C 1.527 0.784 0 N-CA-C 108.463 -1.855 . . . . 0.0 108.463 -168.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 9.9 tpt -76.51 -22.42 54.46 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 125.051 1.34 . . . . 0.0 112.915 -173.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -66.19 -7.49 18.43 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 113.372 0.879 . . . . 0.0 113.372 -168.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 14.6 mt -84.12 4.09 31.92 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 121.622 -0.674 . . . . 0.0 112.76 -170.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -73.92 80.4 1.66 Allowed 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 125.078 2.371 . . . . 0.0 110.856 -177.605 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 141.54 -35.59 1.79 Allowed Glycine 0 C--N 1.309 -0.931 0 CA-C-N 109.676 -3.42 . . . . 0.0 111.073 169.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -69.17 -41.86 76.67 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-N 117.534 0.667 . . . . 0.0 109.87 -175.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 2.6 ptt? -88.84 1.88 54.56 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 115.449 -0.796 . . . . 0.0 112.176 -172.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -79.09 164.33 24.38 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 123.917 0.887 . . . . 0.0 111.257 -177.093 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 58.01 39.08 26.76 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.773 1.629 . . . . 0.0 113.883 168.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 9.5 mmt180 -109.22 153.45 23.79 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -81.25 -24.87 37.04 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 175.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -145.31 143.12 30.0 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 177.68 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 14.1 tp -140.56 126.23 19.14 Favored 'General case' 0 CA--C 1.505 -0.784 0 N-CA-C 106.016 -1.846 . . . . 0.0 106.016 168.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 36.1 mt -104.12 103.78 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 N-CA-C 103.753 -2.684 . . . . 0.0 103.753 172.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 12.9 mt -77.43 135.25 26.82 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 N-CA-C 105.053 -2.203 . . . . 0.0 105.053 171.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -118.56 120.55 37.83 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 105.604 -1.999 . . . . 0.0 105.604 169.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -156.25 167.14 31.36 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 122.875 0.47 . . . . 0.0 110.017 176.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -78.14 154.41 31.24 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 169.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 13.1 mm -78.8 -48.11 22.33 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.46 0 CA-C-O 118.754 -0.641 . . . . 0.0 110.595 -177.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.1 t 49.17 31.15 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.094 0 C-N-CA 126.7 2.0 . . . . 0.0 113.43 177.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 50.8 m -122.14 -25.81 4.83 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 116.291 1.96 . . . . 0.0 116.291 -169.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -149.21 156.98 42.97 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 120.564 1.529 . . . . 0.0 110.803 -172.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.18 33.41 0.13 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.906 1.683 . . . . 0.0 113.791 177.12 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 46.5 t30 -65.74 164.59 14.29 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 108.523 -0.918 . . . . 0.0 108.523 170.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 5.5 m -58.33 132.74 84.81 Favored Pre-proline 0 CA--C 1.545 0.77 0 CA-C-O 118.951 -0.547 . . . . 0.0 109.612 -178.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -61.42 156.19 47.96 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 122.742 2.294 . . . . 0.0 111.755 175.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 67.92 19.17 71.41 Favored Glycine 0 CA--C 1.535 1.324 0 CA-C-O 119.348 -0.696 . . . . 0.0 113.506 176.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 5.0 m -95.65 143.49 26.88 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 125.431 1.492 . . . . 0.0 108.505 178.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 14.7 ttp -91.64 135.48 33.84 Favored 'General case' 0 C--N 1.339 0.151 0 C-N-CA 123.178 0.591 . . . . 0.0 109.809 178.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 74.5 mmm -128.0 93.18 3.61 Favored 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 -169.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 44.2 mm -89.54 114.68 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 -177.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.8 mp -117.18 135.26 53.91 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 -177.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 40.4 ttm180 -102.92 135.87 43.79 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 123.276 0.63 . . . . 0.0 109.689 -176.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 17.4 t70 33.38 -97.91 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 115.734 1.753 . . . . 0.0 115.734 169.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -60.74 -26.72 67.41 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.514 1.125 . . . . 0.0 113.592 -174.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 -73.79 -25.17 60.0 Favored 'General case' 0 CA--C 1.533 0.311 0 O-C-N 122.023 -0.423 . . . . 0.0 110.483 -177.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 94.7 t -68.11 -62.38 3.25 Favored Pre-proline 0 N--CA 1.443 -0.823 0 CA-C-O 117.835 -1.079 . . . . 0.0 111.155 -168.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -63.69 -33.81 64.93 Favored 'Trans proline' 0 N--CA 1.448 -1.194 0 CA-C-N 121.266 1.488 . . . . 0.0 110.797 178.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.18 -21.22 65.8 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.189 0.596 . . . . 0.0 111.656 -175.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -82.71 -49.56 9.65 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 169.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -60.63 -11.51 7.49 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 113.659 0.985 . . . . 0.0 113.659 -172.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 19.3 p -55.45 -23.92 28.05 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 119.488 1.04 . . . . 0.0 112.81 170.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . 0.522 ' ND2' ' H ' ' A' ' 91' ' ' SER . 5.6 t30 -59.53 128.23 36.01 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 122.943 0.497 . . . . 0.0 110.47 -174.472 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 66.2 mttt -81.28 -16.01 53.8 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 118.516 -0.754 . . . . 0.0 112.719 -175.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.505 ' HB ' HD22 ' A' ' 88' ' ' ASN . 83.6 mt -64.85 -40.44 89.08 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 178.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.522 ' H ' ' ND2' ' A' ' 88' ' ' ASN . 1.5 m -66.43 110.36 4.7 Favored Pre-proline 0 CA--C 1.544 0.743 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 169.48 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_exo -72.82 -47.92 0.32 Allowed 'Trans proline' 0 C--N 1.349 0.585 0 CA-C-N 121.358 1.521 . . . . 0.0 113.155 -169.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 21.5 m80 -91.95 -30.16 16.26 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 123.725 0.81 . . . . 0.0 110.072 -169.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 19.9 mp0 -63.68 -28.18 69.72 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 125.926 1.69 . . . . 0.0 110.192 179.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 60.7 tp -60.4 -36.35 77.91 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 118.986 0.812 . . . . 0.0 111.092 172.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -65.61 -40.96 96.26 Favored Glycine 0 CA--C 1.529 0.954 0 N-CA-C 110.891 -0.884 . . . . 0.0 110.891 173.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -66.42 -35.17 79.64 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 118.157 0.979 . . . . 0.0 110.534 176.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -56.57 -44.39 80.95 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 119.827 1.194 . . . . 0.0 109.912 171.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -71.08 -23.59 62.15 Favored 'General case' 0 N--CA 1.457 -0.111 0 CA-C-O 118.599 -0.715 . . . . 0.0 112.443 176.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 91.2 t -65.45 -46.66 89.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 CA-C-N 120.223 1.374 . . . . 0.0 107.566 169.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 65.9 mt -61.68 -38.78 89.05 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 118.73 0.696 . . . . 0.0 110.058 -179.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 21.3 m -61.93 -42.58 99.27 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 118.654 0.661 . . . . 0.0 110.749 171.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.405 ' HA ' ' CD2' ' A' ' 106' ' ' PHE . . . -64.77 -39.36 93.48 Favored 'General case' 0 N--CA 1.449 -0.516 0 O-C-N 121.442 -0.786 . . . . 0.0 111.442 -179.582 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 17.4 mt -70.03 -31.85 69.69 Favored 'General case' 0 CA--C 1.521 -0.135 0 O-C-N 121.727 -0.608 . . . . 0.0 111.039 176.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 29.0 tpt180 -65.14 -37.09 86.32 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 118.56 -0.733 . . . . 0.0 109.645 171.213 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.405 ' CD2' ' HA ' ' A' ' 103' ' ' ALA . 12.9 m-30 -65.69 -42.64 90.97 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 119.403 1.002 . . . . 0.0 110.759 177.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 49.0 p -76.19 -22.01 55.8 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 118.875 0.761 . . . . 0.0 111.781 179.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 77.73 11.56 85.32 Favored Glycine 0 CA--C 1.533 1.19 0 CA-C-O 118.815 -0.992 . . . . 0.0 111.172 -169.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -97.08 23.95 6.8 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 119.104 1.452 . . . . 0.0 111.39 177.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 12.7 t80 -58.43 136.97 85.6 Favored Pre-proline 0 CA--C 1.546 0.791 0 C-N-CA 125.393 1.477 . . . . 0.0 109.319 172.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -56.92 136.72 78.26 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 122.724 2.283 . . . . 0.0 111.866 179.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -66.53 -24.34 66.36 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 111.827 0.306 . . . . 0.0 111.827 -173.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -135.53 95.34 3.24 Favored 'General case' 0 N--CA 1.464 0.225 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 169.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 38.4 tp -81.25 131.87 35.31 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 169.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -132.94 146.09 51.48 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 106.571 -1.64 . . . . 0.0 106.571 171.607 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -131.81 124.27 29.29 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 120.043 1.292 . . . . 0.0 108.374 175.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 44.7 t -92.22 94.8 4.99 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 N-CA-C 105.683 -1.969 . . . . 0.0 105.683 169.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -84.99 156.18 30.87 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.201 -1.159 . . . . 0.0 110.201 175.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 58.1 t -137.44 143.69 33.53 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 174.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 18.1 mm -85.69 129.06 56.25 Favored Pre-proline 0 CA--C 1.541 0.621 0 CA-C-O 118.007 -0.997 . . . . 0.0 108.484 174.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -75.01 154.89 42.75 Favored 'Trans proline' 0 CA--C 1.536 0.611 0 C-N-CA 122.848 2.365 . . . . 0.0 112.389 177.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -100.36 -42.49 6.6 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 169.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 68.6 m -132.65 152.73 51.59 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 123.695 0.798 . . . . 0.0 110.652 175.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.5 tp -148.47 43.64 1.02 Allowed 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.567 0.747 . . . . 0.0 111.178 -172.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -121.57 170.4 7.62 Favored Pre-proline 0 N--CA 1.472 0.67 0 CA-C-O 118.105 -0.95 . . . . 0.0 109.352 -175.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -66.14 89.44 0.25 Allowed 'Trans proline' 0 CA--C 1.546 1.114 0 C-N-CA 123.199 2.599 . . . . 0.0 114.261 -174.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -166.25 128.74 1.93 Allowed 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 105.059 -2.2 . . . . 0.0 105.059 169.718 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -79.91 154.06 4.58 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 C-N-CA 123.626 0.77 . . . . 0.0 109.78 -171.852 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 78.21 166.68 29.41 Favored Glycine 0 CA--C 1.527 0.823 0 N-CA-C 111.326 -0.71 . . . . 0.0 111.326 -179.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -82.64 165.18 20.24 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-O 121.937 0.875 . . . . 0.0 112.459 -169.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 40.7 p -70.48 168.67 17.8 Favored Pre-proline 0 C--O 1.239 0.544 0 CA-C-N 114.123 -1.399 . . . . 0.0 108.813 167.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -56.93 -32.97 94.25 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 121.348 1.365 . . . . 0.0 110.831 169.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 26.2 m -68.12 -41.38 81.82 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 119.213 -0.423 . . . . 0.0 111.47 -179.006 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 16.7 t -105.3 -10.4 9.89 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-N 118.951 0.796 . . . . 0.0 112.105 -169.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -58.95 -45.45 90.42 Favored 'General case' 0 N--CA 1.466 0.346 0 O-C-N 119.929 -1.732 . . . . 0.0 107.768 168.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -70.67 1.47 5.27 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 115.172 -0.922 . . . . 0.0 112.721 176.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 18.0 mmm -92.03 -8.95 44.53 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 119.587 1.085 . . . . 0.0 111.112 172.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 86.8 mt -59.64 -48.31 87.88 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 CA-C-N 119.404 1.002 . . . . 0.0 108.446 176.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -70.5 -50.69 13.83 Favored Pre-proline 0 CA--C 1.535 0.393 0 CA-C-O 117.266 -1.35 . . . . 0.0 113.655 -170.023 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -58.31 -32.73 96.68 Favored 'Trans proline' 0 N--CA 1.459 -0.53 0 CA-C-N 122.214 1.827 . . . . 0.0 112.092 173.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -69.95 -39.53 75.98 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 119.147 0.885 . . . . 0.0 110.749 176.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 71.3 mt -58.04 -44.72 87.55 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 119.897 1.226 . . . . 0.0 109.099 171.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -60.38 -37.22 80.08 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 118.87 -0.586 . . . . 0.0 110.918 -179.37 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 36.1 mm-40 -77.97 -33.1 51.65 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 119.758 1.163 . . . . 0.0 112.921 177.147 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 52.0 t -59.22 -48.67 86.11 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-N 120.107 1.322 . . . . 0.0 108.362 169.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 32.6 mt -64.44 -37.35 87.23 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.028 0.531 . . . . 0.0 110.203 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -62.81 -40.68 98.13 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 118.938 0.79 . . . . 0.0 111.313 177.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -62.85 -41.57 99.41 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 118.87 0.759 . . . . 0.0 110.689 177.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 4.9 mt -63.01 -39.0 93.44 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 123.081 0.553 . . . . 0.0 111.055 174.213 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 72.1 mtp85 -68.34 -14.35 62.93 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 117.081 -1.438 . . . . 0.0 112.27 177.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -58.77 -30.63 67.7 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 120.978 1.717 . . . . 0.0 111.402 178.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 18.3 m -118.4 34.05 5.36 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.568 0.747 . . . . 0.0 111.005 174.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 65.61 27.02 72.2 Favored Glycine 0 C--N 1.342 0.873 0 CA-C-O 118.561 -1.133 . . . . 0.0 114.215 171.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 24.4 t -87.59 83.05 2.15 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 176.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -76.88 117.88 18.92 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 176.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -81.04 157.67 25.36 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 123.264 0.626 . . . . 0.0 109.728 173.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 12.6 mm -109.97 128.08 25.99 Favored Pre-proline 0 CA--C 1.531 0.238 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 179.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -59.36 110.48 0.71 Allowed 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.168 1.912 . . . . 0.0 108.469 169.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 43.1 mtm105 53.65 13.0 0.44 Allowed 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.664 1.586 . . . . 0.0 114.272 174.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 2.6 m 44.27 45.36 7.14 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.495 1.118 . . . . 0.0 110.636 -168.287 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -136.76 160.15 39.72 Favored 'General case' 0 C--O 1.24 0.561 0 C-N-CA 124.736 1.215 . . . . 0.0 110.218 -174.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 18.0 m . . . . . 0 C--O 1.253 1.258 0 C-N-CA 124.275 1.03 . . . . 0.0 110.603 179.76 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.4 tpt . . . . . 0 N--CA 1.498 1.957 0 CA-C-O 120.632 0.253 . . . . 0.0 111.292 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 28.2 ptt-85 -66.15 118.66 10.19 Favored 'General case' 0 N--CA 1.475 0.787 0 O-C-N 120.048 -1.657 . . . . 0.0 112.08 -172.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 73.0 mt -133.11 144.61 35.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 C-N-CA 123.553 0.741 . . . . 0.0 109.956 -175.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 9.7 mt -123.29 145.88 48.34 Favored 'General case' 0 CA--C 1.521 -0.139 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 168.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 57.4 t -126.87 95.69 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.797 0 N-CA-C 105.629 -1.989 . . . . 0.0 105.629 172.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.6 mt -87.88 116.71 26.23 Favored 'General case' 0 CA--C 1.517 -0.303 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 -171.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -93.82 127.21 8.96 Favored Glycine 0 C--N 1.332 0.312 0 N-CA-C 106.141 -2.784 . . . . 0.0 106.141 169.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.2 m -142.71 164.61 16.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 117.92 0.86 . . . . 0.0 111.481 -169.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 123.0 173.45 14.08 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 126.014 1.769 . . . . 0.0 111.687 172.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.443 HD21 ' HB2' ' A' ' 13' ' ' LEU . 1.5 t30 -81.83 93.46 6.87 Favored 'General case' 0 N--CA 1.462 0.14 0 O-C-N 121.229 -1.16 . . . . 0.0 110.694 -176.312 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -59.13 5.5 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 N-CA-C 117.262 2.319 . . . . 0.0 117.262 -178.372 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.416 ' H ' ' ND2' ' A' ' 10' ' ' ASN . 80.7 mt -108.67 -0.03 20.35 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 121.518 1.963 . . . . 0.0 109.135 -179.019 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.443 ' HB2' HD21 ' A' ' 10' ' ' ASN . 1.9 mp -110.27 62.77 0.6 Allowed 'General case' 0 N--CA 1.44 -0.948 0 C-N-CA 124.465 1.106 . . . . 0.0 110.122 -169.533 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 53.08 -103.89 0.18 Allowed 'General case' 0 CA--C 1.537 0.446 0 O-C-N 123.766 0.667 . . . . 0.0 111.064 175.166 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -82.71 -8.39 59.6 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 118.513 -0.756 . . . . 0.0 112.462 -175.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -71.75 2.72 4.94 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-N 121.327 1.876 . . . . 0.0 113.015 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -85.01 -13.29 51.03 Favored 'General case' 0 N--CA 1.435 -1.189 0 CA-C-O 116.076 -1.916 . . . . 0.0 108.683 169.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 7.7 tp -50.88 -42.1 22.86 Favored 'Isoleucine or valine' 0 C--N 1.344 0.339 0 CA-C-N 121.671 2.032 . . . . 0.0 113.134 -169.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -61.81 -43.45 99.2 Favored Glycine 0 CA--C 1.527 0.834 0 CA-C-N 119.238 0.926 . . . . 0.0 111.995 177.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 55.6 t -65.38 -48.07 84.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-O 118.649 -0.691 . . . . 0.0 109.855 172.041 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 28.7 mmm180 -57.69 -37.39 73.38 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 120.231 1.378 . . . . 0.0 111.719 -178.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 27.0 mt -63.48 -45.54 97.59 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 CA-C-N 119.987 1.267 . . . . 0.0 110.195 -179.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.9 m -74.29 -27.09 21.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-N 119.985 1.266 . . . . 0.0 111.743 -176.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 19.5 mm-40 -70.41 -41.61 72.73 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 173.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.04 -38.37 90.65 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-O 119.025 -0.512 . . . . 0.0 110.045 177.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.8 tp -62.11 -42.98 99.77 Favored 'General case' 0 C--N 1.343 0.313 0 CA-C-O 118.131 -0.938 . . . . 0.0 109.727 175.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -60.5 -43.74 96.74 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 119.266 0.939 . . . . 0.0 110.678 178.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -66.53 -42.34 87.4 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.017 0.527 . . . . 0.0 110.91 179.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 87.1 mtt180 -88.84 -36.63 15.91 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 117.393 -1.289 . . . . 0.0 113.458 -170.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 72.3 m-85 -125.77 133.29 52.1 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-N 121.076 1.762 . . . . 0.0 112.607 -169.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 45.7 mm -85.66 129.81 37.38 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 N-CA-C 104.213 -2.514 . . . . 0.0 104.213 168.088 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -119.22 157.58 50.7 Favored Pre-proline 0 CA--C 1.537 0.444 0 C-N-CA 124.883 1.273 . . . . 0.0 108.902 -179.107 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_exo -57.97 155.46 33.35 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 123.259 2.639 . . . . 0.0 112.064 172.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -62.23 -28.21 69.53 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 112.937 0.717 . . . . 0.0 112.937 -170.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 8.3 p90 -73.98 -6.35 46.88 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 113.097 0.777 . . . . 0.0 113.097 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 38.2 t -102.96 133.51 46.56 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 174.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -132.45 136.34 46.65 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 169.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -88.67 101.55 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.035 0 N-CA-C 105.107 -2.182 . . . . 0.0 105.107 169.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.5 tt -85.57 112.44 20.95 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 106.784 -1.562 . . . . 0.0 106.784 -178.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -77.78 106.42 9.6 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 169.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -69.92 -80.62 0.27 Allowed Glycine 0 CA--C 1.528 0.875 0 N-CA-C 108.231 -1.948 . . . . 0.0 108.231 171.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 77.21 107.61 0.15 Allowed Glycine 0 C--N 1.341 0.848 0 N-CA-C 110.165 -1.174 . . . . 0.0 110.165 -178.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 5.2 p 52.39 57.98 5.87 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.416 1.086 . . . . 0.0 109.333 175.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -113.14 -88.31 0.55 Allowed 'General case' 0 C--N 1.345 0.411 0 CA-C-N 114.685 -1.143 . . . . 0.0 110.735 -169.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 75.09 -93.1 0.85 Allowed Glycine 0 C--N 1.34 0.778 0 N-CA-C 107.596 -2.202 . . . . 0.0 107.596 -169.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.68 -23.27 60.86 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.585 1.154 . . . . 0.0 113.498 -173.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -67.66 -7.24 25.14 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -169.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 26.0 mt -93.76 -12.91 28.09 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 115.475 1.657 . . . . 0.0 115.475 -168.151 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 5.1 tt -45.31 -61.03 1.83 Allowed 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 113.941 1.089 . . . . 0.0 113.941 -169.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -70.21 -35.42 70.25 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 111.255 -0.738 . . . . 0.0 111.255 -170.091 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -77.54 -29.84 52.49 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 118.068 0.934 . . . . 0.0 110.271 -175.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 69.6 mtp -67.34 -16.63 64.36 Favored 'General case' 0 N--CA 1.454 -0.254 0 O-C-N 121.822 -0.549 . . . . 0.0 111.683 175.13 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -63.14 140.97 58.93 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-O 121.926 0.87 . . . . 0.0 112.873 -169.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 53.53 20.39 2.07 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 117.261 2.319 . . . . 0.0 117.261 168.729 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 23.5 mmt180 -71.55 150.36 44.84 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 121.003 1.729 . . . . 0.0 108.5 176.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -79.96 -29.26 39.6 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 121.677 -0.639 . . . . 0.0 109.37 -178.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -147.81 137.25 22.42 Favored 'General case' 0 C--O 1.232 0.161 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 167.372 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.8 tp -126.59 130.73 51.07 Favored 'General case' 0 CA--C 1.515 -0.374 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 175.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 50.0 mt -105.66 120.1 55.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 105.803 -1.925 . . . . 0.0 105.803 173.004 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 7.9 mt -95.98 128.94 46.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 105.15 -2.167 . . . . 0.0 105.15 175.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -113.19 113.5 25.43 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 105.297 -2.112 . . . . 0.0 105.297 169.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.5 t0 -147.78 157.85 43.74 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.422 0.689 . . . . 0.0 110.217 -174.043 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -75.41 158.06 33.25 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 168.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 27.2 mm -95.4 -85.13 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.639 179.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . 0.385 0.3 OUTLIER 55.47 11.56 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 126.388 1.875 . . . . 0.0 114.549 -169.471 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 5.3 m -74.07 -23.61 59.39 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 124.469 1.108 . . . . 0.0 113.684 -178.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 34.1 ttpt -150.23 161.16 42.96 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.149 0.98 . . . . 0.0 108.781 -171.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 14.5 ptpt -65.55 4.49 0.55 Allowed 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 127.347 2.259 . . . . 0.0 115.177 176.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 54.1 t30 -62.9 155.22 27.82 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 119.114 0.87 . . . . 0.0 109.539 -177.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 4.3 m -56.05 137.67 73.23 Favored Pre-proline 0 CA--C 1.545 0.762 0 C-N-CA 124.34 1.056 . . . . 0.0 113.532 -169.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -58.28 155.54 34.6 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 123.668 2.912 . . . . 0.0 111.708 169.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 64.88 24.76 70.23 Favored Glycine 0 CA--C 1.533 1.214 0 O-C-N 121.852 -0.53 . . . . 0.0 112.684 176.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 20.0 m -102.58 137.11 41.25 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 125.816 1.646 . . . . 0.0 106.706 173.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 28.3 ttp -91.8 136.74 32.92 Favored 'General case' 0 C--O 1.232 0.159 0 N-CA-C 107.629 -1.248 . . . . 0.0 107.629 175.079 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 6.4 ttm -124.95 87.01 2.64 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 -169.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 40.4 mm -83.13 117.64 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 57.1 mt -128.55 141.28 51.42 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 123.197 0.599 . . . . 0.0 109.544 -174.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.8 mtt85 -113.88 138.67 50.0 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 123.329 0.652 . . . . 0.0 109.873 -172.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 38.2 t70 38.91 -106.69 0.05 Allowed 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.833 1.253 . . . . 0.0 113.867 169.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -56.8 -29.82 63.1 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.071 1.349 . . . . 0.0 113.923 -175.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -71.25 -25.55 62.52 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 122.881 0.472 . . . . 0.0 110.238 -176.111 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 84.7 t -70.8 -61.92 2.22 Favored Pre-proline 0 N--CA 1.443 -0.812 0 CA-C-O 117.548 -1.215 . . . . 0.0 111.368 -168.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -65.55 -35.57 37.74 Favored 'Trans proline' 0 N--CA 1.452 -0.957 0 CA-C-N 121.384 1.53 . . . . 0.0 111.155 -178.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.1 -36.22 79.42 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 122.572 0.349 . . . . 0.0 110.634 -173.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -71.91 -44.05 64.31 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 118.867 -0.587 . . . . 0.0 109.698 169.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -55.71 -21.37 18.2 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 -174.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.465 HG21 ' H ' ' A' ' 88' ' ' ASN . 1.7 t -83.95 -76.34 0.3 Allowed 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 119.315 0.961 . . . . 0.0 109.895 168.664 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . 0.465 ' H ' HG21 ' A' ' 87' ' ' THR . 46.6 t30 49.45 17.49 0.22 Allowed 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.042 1.337 . . . . 0.0 114.082 -168.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt 50.4 23.92 1.4 Allowed 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.433 1.493 . . . . 0.0 113.421 -171.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 42.9 mt -134.67 -42.99 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 123.879 0.871 . . . . 0.0 110.96 -171.126 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.3 m -64.2 147.05 97.3 Favored Pre-proline 0 CA--C 1.545 0.765 0 CA-C-N 118.893 0.769 . . . . 0.0 112.52 -169.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -79.97 -110.33 0.01 OUTLIER 'Trans proline' 0 CA--C 1.54 0.823 0 C-N-CA 124.218 3.279 . . . . 0.0 109.979 175.088 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 11.7 m80 -59.13 -28.35 66.47 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.773 1.229 . . . . 0.0 112.675 -169.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 22.3 mp0 -57.57 -31.63 66.34 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 126.003 1.721 . . . . 0.0 111.208 175.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 65.9 tp -62.2 -33.86 75.35 Favored 'General case' 0 C--N 1.342 0.253 0 CA-C-N 119.123 0.874 . . . . 0.0 110.54 175.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -64.14 -39.41 97.11 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.616 -0.993 . . . . 0.0 110.616 175.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 19.0 tp -72.88 -33.88 66.34 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 118.332 1.066 . . . . 0.0 110.439 176.022 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -58.09 -46.85 84.81 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 119.752 1.16 . . . . 0.0 109.95 170.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -69.49 -29.25 66.86 Favored 'General case' 0 CA--C 1.522 -0.126 0 C-N-CA 122.618 0.367 . . . . 0.0 111.527 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 10.9 t -64.29 -44.19 97.28 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.785 0 CA-C-O 118.882 -0.58 . . . . 0.0 110.098 170.093 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 52.1 mt -63.07 -39.05 93.56 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 119.274 0.943 . . . . 0.0 110.036 178.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 23.8 m -61.05 -39.49 90.01 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 118.753 0.706 . . . . 0.0 110.19 169.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.512 ' HA ' ' CD2' ' A' ' 106' ' ' PHE . . . -67.44 -38.62 84.8 Favored 'General case' 0 N--CA 1.448 -0.545 0 O-C-N 121.308 -0.87 . . . . 0.0 111.793 -179.048 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -59.47 -41.75 90.45 Favored 'General case' 0 CA--C 1.524 -0.03 0 CA-C-N 118.835 0.743 . . . . 0.0 109.331 172.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 78.3 ttt180 -65.18 -36.2 83.45 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 118.229 -0.891 . . . . 0.0 110.852 177.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.512 ' CD2' ' HA ' ' A' ' 103' ' ' ALA . 15.1 m-30 -61.21 -45.46 94.47 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 119.506 1.048 . . . . 0.0 110.593 178.597 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 14.9 t -82.51 -13.58 56.42 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 122.298 0.239 . . . . 0.0 111.438 -178.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 78.08 27.93 57.22 Favored Glycine 0 CA--C 1.531 1.059 0 N-CA-C 111.623 -0.591 . . . . 0.0 111.623 179.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -110.98 19.36 18.57 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.628 1.171 . . . . 0.0 110.833 -176.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -59.99 137.11 90.83 Favored Pre-proline 0 CA--C 1.544 0.712 0 C-N-CA 123.952 0.901 . . . . 0.0 109.857 -178.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_exo -51.74 144.98 32.55 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 123.069 2.513 . . . . 0.0 112.96 176.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -63.77 -30.71 71.78 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 119.252 -0.404 . . . . 0.0 110.47 -178.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 30.5 mtmm -136.37 138.3 41.45 Favored 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 105.99 -1.856 . . . . 0.0 105.99 169.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 13.9 tp -120.14 134.06 55.35 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 171.007 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -133.41 139.28 46.66 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 177.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 6.2 tp -125.68 128.62 48.09 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 177.229 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 46.4 t -100.18 85.35 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 N-CA-C 104.092 -2.558 . . . . 0.0 104.092 169.214 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -76.86 147.43 33.6 Favored Glycine 0 C--N 1.332 0.327 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 177.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 85.2 t -130.58 138.2 54.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 170.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 2.8 mt -92.44 125.05 57.49 Favored Pre-proline 0 CA--C 1.537 0.447 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -178.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -72.96 158.1 50.28 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 123.835 3.023 . . . . 0.0 112.424 -176.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -99.78 -41.64 7.18 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 171.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 70.5 m -129.78 149.51 51.49 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 123.487 0.715 . . . . 0.0 110.886 178.178 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -155.59 42.79 0.43 Allowed 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 112.951 0.723 . . . . 0.0 112.951 -169.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 81.7 mm-40 -111.19 164.2 15.52 Favored Pre-proline 0 N--CA 1.474 0.726 0 CA-C-O 117.607 -1.187 . . . . 0.0 108.737 179.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -68.25 87.21 0.4 Allowed 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 122.951 2.434 . . . . 0.0 111.919 -179.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -172.7 153.65 2.81 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 104.489 -2.412 . . . . 0.0 104.489 175.47 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -126.34 153.31 34.71 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 CA-C-O 121.956 0.884 . . . . 0.0 112.376 -170.06 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 121.73 127.68 3.4 Favored Glycine 0 CA--C 1.529 0.939 0 N-CA-C 105.497 -3.041 . . . . 0.0 105.497 -169.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 7.0 mp -79.63 151.73 30.4 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 117.67 0.735 . . . . 0.0 109.657 -177.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 62.0 p -69.76 159.07 85.4 Favored Pre-proline 0 C--O 1.237 0.401 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.565 173.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -62.01 -28.9 80.95 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 120.827 1.018 . . . . 0.0 110.014 169.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 24.7 m -63.53 -42.31 98.45 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 118.73 -0.652 . . . . 0.0 111.485 177.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 46.8 t -105.29 -26.61 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-O 118.072 -0.966 . . . . 0.0 112.896 -169.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -52.89 -42.12 65.01 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 120.754 1.615 . . . . 0.0 110.194 169.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -74.43 2.75 8.76 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 113.696 0.999 . . . . 0.0 113.696 -176.134 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 97.7 mmm -87.84 -10.3 51.23 Favored 'General case' 0 N--CA 1.439 -0.996 0 CA-C-O 117.435 -1.269 . . . . 0.0 110.152 169.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 93.6 mt -60.43 -46.18 95.63 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.406 0 CA-C-N 120.955 1.707 . . . . 0.0 109.022 -178.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -71.29 -49.99 11.58 Favored Pre-proline 0 CA--C 1.543 0.71 0 CA-C-N 120.239 1.382 . . . . 0.0 110.959 -179.13 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -41.37 -50.33 4.58 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 125.056 3.837 . . . . 0.0 112.732 168.802 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -73.11 -44.05 60.86 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 114.022 -1.445 . . . . 0.0 110.778 -175.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 34.3 mt -56.01 -41.45 74.9 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-N 118.833 0.742 . . . . 0.0 109.536 175.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -62.13 -35.91 80.17 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 118.853 0.752 . . . . 0.0 110.456 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 19.2 mm100 -78.7 -32.28 46.89 Favored 'General case' 0 N--CA 1.456 -0.127 0 CA-C-O 118.248 -0.882 . . . . 0.0 112.816 175.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 76.3 t -60.21 -47.56 91.63 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-N 119.976 1.262 . . . . 0.0 108.061 170.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 26.6 mt -65.14 -41.02 95.17 Favored 'General case' 0 CA--C 1.528 0.122 0 C-N-CA 122.99 0.516 . . . . 0.0 110.92 -179.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -63.19 -43.59 97.77 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 118.527 0.603 . . . . 0.0 111.163 177.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -64.7 -44.6 89.74 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 122.656 0.383 . . . . 0.0 110.061 179.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 38.9 mt -55.09 -45.2 75.42 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 174.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 73.7 mtp180 -64.97 -18.97 65.73 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 117.711 -1.138 . . . . 0.0 112.965 -177.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -62.15 -32.48 73.09 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 120.767 1.621 . . . . 0.0 110.957 178.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 22.5 m -97.1 28.59 3.5 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.905 0.882 . . . . 0.0 111.458 176.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 70.49 16.64 73.91 Favored Glycine 0 CA--C 1.533 1.185 0 CA-C-O 119.093 -0.837 . . . . 0.0 113.969 173.065 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 39.3 t -79.39 126.01 38.88 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 CA-C-N 118.746 1.273 . . . . 0.0 108.276 -177.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -96.27 128.69 43.42 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 169.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -97.14 147.47 24.03 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 169.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 2.7 mt -115.41 120.66 36.01 Favored Pre-proline 0 N--CA 1.462 0.153 0 N-CA-C 106.636 -1.616 . . . . 0.0 106.636 178.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -61.66 108.03 0.58 Allowed 'Trans proline' 0 N--CA 1.46 -0.472 0 C-N-CA 121.979 1.786 . . . . 0.0 107.625 172.157 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 14.2 ptp180 47.47 7.31 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 129.26 3.024 . . . . 0.0 117.785 -177.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 2.9 t 52.89 -172.41 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 126.114 1.765 . . . . 0.0 112.405 -169.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -146.35 140.89 26.73 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 125.62 1.568 . . . . 0.0 109.032 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 32.3 m . . . . . 0 C--O 1.254 1.297 0 C-N-CA 125.236 1.414 . . . . 0.0 108.555 -176.891 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.7 tpt . . . . . 0 N--CA 1.498 1.942 0 N-CA-C 110.441 -0.207 . . . . 0.0 110.441 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 5.5 ptp85 -149.24 123.14 9.35 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 177.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 55.1 mt -141.67 145.01 24.98 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 CA-C-N 119.46 1.027 . . . . 0.0 112.037 -169.058 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.1 mt -128.17 123.42 34.3 Favored 'General case' 0 CA--C 1.519 -0.216 0 N-CA-C 106.489 -1.671 . . . . 0.0 106.489 167.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 43.6 t -101.85 98.71 7.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 100.69 -3.819 . . . . 0.0 100.69 169.153 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -104.24 109.24 20.98 Favored 'General case' 0 N--CA 1.442 -0.864 0 C-N-CA 123.873 0.869 . . . . 0.0 109.35 -168.152 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -91.42 126.3 8.39 Favored Glycine 0 N--CA 1.444 -0.831 0 N-CA-C 107.743 -2.143 . . . . 0.0 107.743 174.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -142.38 179.73 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.812 0 C-N-CA 124.133 0.973 . . . . 0.0 108.517 -175.011 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 124.5 157.04 9.61 Favored Glycine 0 N--CA 1.447 -0.589 0 N-CA-C 108.471 -1.852 . . . . 0.0 108.471 -169.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -73.6 96.96 2.54 Favored 'General case' 0 N--CA 1.442 -0.85 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 169.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 4.2 pt -56.7 -30.62 32.82 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.241 0 O-C-N 121.438 -0.789 . . . . 0.0 112.068 -179.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 22.2 mt -77.55 13.93 1.14 Allowed 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 119.036 0.834 . . . . 0.0 110.902 -172.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -136.41 82.07 1.92 Allowed 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 123.284 0.634 . . . . 0.0 111.494 171.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 25.6 m 35.41 -105.94 0.03 OUTLIER 'General case' 0 N--CA 1.437 -1.121 0 O-C-N 126.46 2.35 . . . . 0.0 111.772 167.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -59.46 -28.02 66.61 Favored 'General case' 0 N--CA 1.442 -0.842 0 C-N-CA 124.201 1.0 . . . . 0.0 111.961 -169.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -67.09 -18.05 65.15 Favored 'General case' 0 C--N 1.341 0.212 0 CA-C-N 120.423 1.465 . . . . 0.0 111.786 179.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.58 -10.56 56.66 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-O 116.33 -1.795 . . . . 0.0 110.888 173.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 6.6 tp -55.6 -39.94 57.07 Favored 'Isoleucine or valine' 0 C--N 1.342 0.243 0 CA-C-N 121.976 2.171 . . . . 0.0 111.814 -174.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -59.17 -43.52 97.07 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 111.4 -0.68 . . . . 0.0 111.4 178.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 74.0 t -68.76 -48.32 71.74 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 CA-C-O 118.134 -0.936 . . . . 0.0 109.874 174.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 20.9 mmt180 -60.14 -31.56 70.21 Favored 'General case' 0 C--N 1.346 0.431 0 CA-C-N 120.498 1.499 . . . . 0.0 111.787 -177.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 23.2 mt -60.68 -51.35 74.11 Favored 'Isoleucine or valine' 0 C--N 1.343 0.285 0 CA-C-N 120.86 1.663 . . . . 0.0 109.789 174.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 24.6 m -72.38 -33.97 47.38 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 CA-C-N 119.461 1.028 . . . . 0.0 111.221 -174.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 58.1 mt-10 -59.88 -48.29 82.3 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 171.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.56 -36.8 84.83 Favored 'General case' 0 C--N 1.342 0.263 0 CA-C-N 119.151 0.887 . . . . 0.0 111.08 179.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 5.9 tp -63.19 -40.04 96.36 Favored 'General case' 0 C--O 1.224 -0.253 0 CA-C-N 118.471 0.578 . . . . 0.0 109.566 -178.231 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -60.52 -26.5 66.9 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.595 0.758 . . . . 0.0 112.771 179.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -90.67 -44.35 9.56 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 125.495 1.518 . . . . 0.0 110.886 -178.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 75.4 mtt180 -84.45 -26.61 28.1 Favored 'General case' 0 C--O 1.231 0.086 0 CA-C-O 118.792 -0.623 . . . . 0.0 111.529 -172.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 64.4 m-85 -125.97 146.21 49.96 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-O 121.694 0.759 . . . . 0.0 112.364 -177.318 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 34.0 mm -101.7 135.66 37.3 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 N-CA-C 104.909 -2.256 . . . . 0.0 104.909 169.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -119.0 150.93 49.66 Favored Pre-proline 0 CA--C 1.535 0.371 0 C-N-CA 124.287 1.035 . . . . 0.0 109.988 -169.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -65.76 157.16 60.31 Favored 'Trans proline' 0 CA--C 1.539 0.748 0 C-N-CA 122.43 2.087 . . . . 0.0 110.189 169.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -58.08 -33.2 68.81 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 114.557 1.317 . . . . 0.0 114.557 -169.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -74.72 -11.45 60.17 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -177.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 73.1 t -90.02 123.01 42.01 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 171.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -112.36 127.01 55.89 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 169.234 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -91.77 116.07 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 N-CA-C 104.422 -2.436 . . . . 0.0 104.422 168.294 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 59.6 tp -117.57 128.25 54.76 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 118.207 0.458 . . . . 0.0 110.675 -178.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -87.73 117.25 26.43 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 168.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -71.59 -65.31 2.45 Favored Glycine 0 CA--C 1.528 0.871 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 176.292 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 84.33 84.61 0.94 Allowed Glycine 0 C--N 1.343 0.937 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 177.137 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 27.6 p 61.38 20.11 10.82 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 125.118 1.367 . . . . 0.0 113.471 -179.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -76.73 -65.78 0.9 Allowed 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 114.875 1.435 . . . . 0.0 114.875 -168.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 56.78 -108.61 1.28 Allowed Glycine 0 CA--C 1.536 1.349 0 N-CA-C 111.416 -0.674 . . . . 0.0 111.416 -176.167 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 13.2 tpt -59.67 -23.58 63.2 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.968 1.307 . . . . 0.0 112.43 -178.239 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 21.3 mm-40 -60.33 -18.79 52.29 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 113.539 0.941 . . . . 0.0 113.539 -178.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 13.3 mt -99.52 22.25 11.05 Favored 'General case' 0 C--N 1.344 0.35 0 N-CA-C 114.728 1.381 . . . . 0.0 114.728 -168.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 6.7 tt -52.19 -58.17 7.43 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 118.856 0.753 . . . . 0.0 111.15 -178.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -68.76 -33.24 75.28 Favored Glycine 0 CA--C 1.529 0.959 0 N-CA-C 111.338 -0.705 . . . . 0.0 111.338 -178.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -74.73 -38.53 62.26 Favored 'General case' 0 CA--C 1.533 0.299 0 O-C-N 122.081 -0.658 . . . . 0.0 112.058 -173.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 12.9 mtp -76.65 -17.76 58.96 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.568 0.747 . . . . 0.0 111.553 -179.037 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.64 151.97 45.27 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 123.533 0.733 . . . . 0.0 112.433 -169.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 16.7 p30 50.23 13.93 0.13 Allowed 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 128.379 2.671 . . . . 0.0 117.507 169.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 35.8 mmt-85 -70.31 157.24 38.09 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 119.499 1.045 . . . . 0.0 108.474 171.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.01 -46.34 18.37 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 178.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -128.26 149.27 50.55 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-N 120.116 1.325 . . . . 0.0 108.66 169.125 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 16.1 tp -135.46 112.38 10.24 Favored 'General case' 0 CA--C 1.506 -0.719 0 N-CA-C 103.723 -2.695 . . . . 0.0 103.723 177.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 46.6 mt -91.94 110.1 22.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 104.811 -2.292 . . . . 0.0 104.811 172.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 7.3 mt -81.79 135.22 25.43 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 N-CA-C 107.0 -1.482 . . . . 0.0 107.0 170.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -122.66 118.24 27.67 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 102.733 -3.062 . . . . 0.0 102.733 167.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 51.5 t0 -158.51 155.75 29.0 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 125.149 1.38 . . . . 0.0 107.399 -179.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -88.45 143.09 27.2 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 169.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 65.2 mt -80.41 -19.66 11.91 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 C-N-CA 125.016 1.326 . . . . 0.0 110.307 -177.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . 0.317 31.3 t 71.29 -38.38 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 C-N-CA 129.818 3.247 . . . . 0.0 114.543 177.713 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 2.7 p -162.42 147.96 12.63 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 120.021 1.282 . . . . 0.0 112.568 169.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 13.8 tppt? -165.51 174.32 10.06 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 128.252 2.621 . . . . 0.0 104.872 169.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 13.2 ptpt -61.24 -26.18 67.58 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 176.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 36.0 t-20 -74.99 165.73 24.79 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.475 0.71 . . . . 0.0 110.522 -173.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 2.4 m -61.27 151.23 77.02 Favored Pre-proline 0 CA--C 1.548 0.876 0 C-N-CA 124.588 1.155 . . . . 0.0 112.704 -169.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -56.94 158.13 18.14 Favored 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 124.21 3.273 . . . . 0.0 113.556 170.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 65.83 7.7 37.24 Favored Glycine 0 CA--C 1.538 1.485 0 CA-C-O 119.59 -0.561 . . . . 0.0 114.272 170.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 5.0 m -87.31 149.92 24.21 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 125.769 1.627 . . . . 0.0 111.513 -169.181 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 31.0 ttp -93.63 140.93 29.05 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 169.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 56.5 mtm -134.88 125.38 26.64 Favored 'General case' 0 C--O 1.232 0.165 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 169.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 37.6 mm -107.44 123.12 62.51 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 -176.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.9 mp -128.74 143.33 50.9 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.875 -171.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 79.4 mtm180 -91.65 175.82 6.76 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 114.867 -1.06 . . . . 0.0 110.431 -175.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -41.07 -53.61 3.0 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 115.861 1.8 . . . . 0.0 115.861 -169.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -87.78 -14.83 38.6 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 113.199 0.815 . . . . 0.0 113.199 -175.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -78.98 -35.4 43.08 Favored 'General case' 0 N--CA 1.456 -0.128 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 -174.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 94.5 t -60.79 -49.34 89.92 Favored Pre-proline 0 CA--C 1.541 0.618 0 CA-C-O 117.397 -1.287 . . . . 0.0 112.267 -176.081 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_exo -55.41 -39.91 88.46 Favored 'Trans proline' 0 CA--C 1.543 0.943 0 C-N-CA 122.091 1.861 . . . . 0.0 112.146 174.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -76.05 -5.37 46.14 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 177.021 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -87.65 -41.4 13.41 Favored 'General case' 0 C--N 1.341 0.213 0 CA-C-N 119.751 1.159 . . . . 0.0 111.34 -178.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -80.22 22.98 0.5 Allowed 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -169.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 24.5 p -58.65 -26.25 63.57 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.237 1.015 . . . . 0.0 111.964 175.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 36.3 t30 -68.32 115.84 8.21 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.142 0.577 . . . . 0.0 109.652 176.062 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 39.3 mttp -88.81 -6.23 57.51 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 113.051 0.76 . . . . 0.0 113.051 -177.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 97.4 mt -58.45 -48.01 86.5 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 177.133 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 3.9 m -67.21 107.61 1.86 Allowed Pre-proline 0 CA--C 1.542 0.669 0 C-N-CA 127.181 2.192 . . . . 0.0 109.397 -173.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -72.47 -56.65 0.09 OUTLIER 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 122.392 2.061 . . . . 0.0 113.015 -168.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 7.2 t-80 -59.88 -43.85 94.53 Favored 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.449 ' CD ' ' H ' ' A' ' 94' ' ' GLN . 16.9 mp0 -61.29 -39.61 91.09 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 125.587 1.555 . . . . 0.0 108.934 -174.255 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 55.2 tp -64.49 -37.49 87.71 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 118.93 0.786 . . . . 0.0 110.704 175.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -65.38 -46.68 85.13 Favored Glycine 0 CA--C 1.529 0.916 0 N-CA-C 110.986 -0.846 . . . . 0.0 110.986 174.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -58.14 -38.6 76.88 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 117.711 0.755 . . . . 0.0 110.115 173.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -66.06 -45.41 81.43 Favored 'General case' 0 C--N 1.333 -0.142 0 O-C-N 120.838 -1.164 . . . . 0.0 111.254 177.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -69.51 -24.75 63.8 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 118.512 0.596 . . . . 0.0 110.574 -179.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -73.91 -37.88 48.8 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.863 0 O-C-N 121.873 -0.517 . . . . 0.0 110.92 172.0 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 29.6 mt -66.1 -36.32 82.86 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 173.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 46.3 m -65.21 -36.38 83.99 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-O 118.344 -0.836 . . . . 0.0 110.319 171.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.97 -41.53 97.51 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 120.476 1.489 . . . . 0.0 110.686 174.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 11.8 mt -64.24 -32.18 73.66 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 118.79 0.723 . . . . 0.0 111.499 173.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 67.1 ttp85 -71.62 -30.74 66.12 Favored 'General case' 0 CA--C 1.532 0.284 0 O-C-N 121.581 -0.699 . . . . 0.0 109.613 176.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 14.8 m-30 -72.09 -46.32 57.22 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 118.877 0.762 . . . . 0.0 110.368 176.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 35.2 p -73.35 -24.14 60.31 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 118.338 0.517 . . . . 0.0 112.009 -177.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 75.93 8.03 84.46 Favored Glycine 0 CA--C 1.534 1.268 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -168.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -84.84 23.25 1.21 Allowed 'General case' 0 C--N 1.349 0.558 0 CA-C-N 119.812 1.806 . . . . 0.0 111.28 171.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -62.18 138.56 96.05 Favored Pre-proline 0 CA--C 1.547 0.844 0 C-N-CA 124.328 1.051 . . . . 0.0 108.933 169.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -61.42 161.53 23.55 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 123.13 2.553 . . . . 0.0 114.683 -176.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -66.21 -35.87 81.57 Favored 'General case' 0 N--CA 1.471 0.58 0 O-C-N 121.803 -0.561 . . . . 0.0 111.664 174.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 17.9 ttmm -138.53 77.59 1.63 Allowed 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 -176.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -69.79 129.18 38.87 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 106.471 -1.678 . . . . 0.0 106.471 170.132 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -130.41 138.89 50.57 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 175.521 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 17.4 tp -119.78 130.09 54.78 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 119.556 1.071 . . . . 0.0 109.115 176.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 13.3 t -102.59 74.88 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 105.44 -2.059 . . . . 0.0 105.44 169.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -78.55 144.74 28.31 Favored Glycine 0 C--N 1.336 0.539 0 N-CA-C 110.547 -1.021 . . . . 0.0 110.547 -174.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 61.5 t -124.57 134.77 65.88 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.275 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 -178.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 40.1 mt -91.01 135.37 28.68 Favored Pre-proline 0 C--N 1.326 -0.449 0 N-CA-C 104.976 -2.231 . . . . 0.0 104.976 169.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -73.28 170.26 20.3 Favored 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 122.008 1.805 . . . . 0.0 111.202 -177.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -89.71 -48.87 6.98 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 168.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 25.1 m -137.31 -34.23 0.72 Allowed 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 116.205 1.928 . . . . 0.0 116.205 -170.002 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 4.3 tp 50.76 50.1 19.65 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.362 1.465 . . . . 0.0 110.495 -168.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -58.84 151.25 55.14 Favored Pre-proline 0 CA--C 1.54 0.577 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 173.152 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -76.37 76.39 3.94 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 122.427 2.085 . . . . 0.0 108.055 169.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.564 ' CD2' ' H ' ' A' ' 128' ' ' ILE . 7.4 t60 -151.47 -167.79 2.9 Favored 'General case' 0 CA--C 1.552 1.028 0 N-CA-C 104.113 -2.551 . . . . 0.0 104.113 175.139 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.564 ' H ' ' CD2' ' A' ' 127' ' ' HIS . 17.5 mt -125.45 -50.2 1.88 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 CA-C-N 123.688 2.949 . . . . 0.0 110.646 -171.145 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -55.73 148.63 26.69 Favored Glycine 0 CA--C 1.53 0.993 0 N-CA-C 111.223 -0.751 . . . . 0.0 111.223 170.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 76.3 mt -70.2 162.64 28.01 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.11 0.964 . . . . 0.0 112.906 -175.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 18.3 p -74.11 164.35 61.83 Favored Pre-proline 0 CA--C 1.543 0.68 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 168.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -62.29 -35.42 73.77 Favored 'Trans proline' 0 CA--C 1.536 0.625 0 C-N-CA 121.259 1.306 . . . . 0.0 112.133 177.037 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 90.7 m -69.16 -37.02 77.99 Favored 'General case' 0 N--CA 1.443 -0.814 0 O-C-N 121.553 -0.717 . . . . 0.0 110.079 -178.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 75.0 t -85.07 -32.16 7.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 O-C-N 121.583 -0.698 . . . . 0.0 109.985 -177.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -54.22 -46.87 72.62 Favored 'General case' 0 CA--C 1.535 0.386 0 O-C-N 121.273 -0.892 . . . . 0.0 109.512 169.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -68.07 -16.51 64.05 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 -179.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 8.9 mmm -79.25 -11.58 59.95 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 125.57 1.548 . . . . 0.0 112.678 173.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 68.2 mt -55.22 -56.37 11.76 Favored 'Isoleucine or valine' 0 C--N 1.346 0.451 0 CA-C-N 120.902 1.683 . . . . 0.0 109.287 174.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -66.42 -46.28 59.42 Favored Pre-proline 0 CA--C 1.548 0.901 0 CA-C-N 119.629 1.104 . . . . 0.0 110.728 -172.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 0.3 OUTLIER -44.11 -52.09 5.99 Favored 'Trans proline' 0 C--N 1.352 0.732 1 C-N-CA 125.606 4.204 . . . . 0.0 112.881 168.665 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -72.75 -35.73 67.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 118.329 -0.843 . . . . 0.0 112.616 -178.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 39.7 mt -60.55 -45.97 91.91 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 120.23 1.377 . . . . 0.0 109.384 174.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 31.8 mm-40 -54.37 -36.07 63.48 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 118.493 0.588 . . . . 0.0 110.371 173.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 1.5 mm100 -78.16 -34.1 49.89 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 179.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 50.7 t -60.33 -46.48 94.91 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 CA-C-N 119.665 1.121 . . . . 0.0 108.025 170.137 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 55.2 mt -61.35 -35.57 77.79 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 119.211 -0.423 . . . . 0.0 110.509 177.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -71.06 -42.46 69.39 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 119.117 0.872 . . . . 0.0 111.45 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -67.96 -30.66 70.0 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 120.068 1.304 . . . . 0.0 111.132 177.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 21.4 mt -63.09 -51.64 65.83 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 169.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 75.6 mtt180 -63.28 -28.62 70.15 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 119.524 1.056 . . . . 0.0 112.288 -178.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -70.52 -18.46 62.95 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 119.056 0.844 . . . . 0.0 111.023 176.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 9.8 m -94.01 8.26 42.08 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.976 1.31 . . . . 0.0 111.04 169.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 72.31 15.1 76.96 Favored Glycine 0 CA--C 1.529 0.908 0 CA-C-O 116.995 -2.003 . . . . 0.0 112.951 -172.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 61.9 t -96.47 119.77 44.95 Favored 'Isoleucine or valine' 0 C--N 1.348 0.536 0 CA-C-N 121.368 2.584 . . . . 0.0 107.482 -176.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -107.49 91.93 3.86 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 107.065 -1.458 . . . . 0.0 107.065 173.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -52.32 144.32 13.14 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.079 169.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 27.1 mm -89.28 124.64 64.17 Favored Pre-proline 0 C--O 1.232 0.16 0 CA-C-O 117.669 -1.158 . . . . 0.0 108.559 -175.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -63.27 103.78 0.38 Allowed 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 122.369 2.046 . . . . 0.0 108.495 170.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 29.0 ttp180 37.46 50.68 1.12 Allowed 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 127.201 2.2 . . . . 0.0 114.157 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . 0.269 3.4 p 53.29 19.59 1.61 Allowed 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 126.803 2.041 . . . . 0.0 115.657 -179.337 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -81.39 123.13 28.3 Favored 'General case' 0 C--O 1.238 0.492 0 O-C-N 121.018 -1.051 . . . . 0.0 109.637 174.097 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 29.5 m . . . . . 0 C--O 1.251 1.168 0 C-N-CA 125.496 1.518 . . . . 0.0 108.361 -178.872 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.8 tpt . . . . . 0 N--CA 1.497 1.876 0 N-CA-C 110.22 -0.289 . . . . 0.0 110.22 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 23.6 ptt180 -144.33 127.54 16.69 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.64 1.176 . . . . 0.0 108.014 171.127 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 13.5 mt -140.53 141.01 33.33 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -169.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 17.0 tp -123.05 149.57 44.23 Favored 'General case' 0 N--CA 1.462 0.168 0 N-CA-C 107.216 -1.401 . . . . 0.0 107.216 168.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 66.3 t -123.13 122.87 66.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 105.424 -2.065 . . . . 0.0 105.424 169.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -98.18 130.38 44.93 Favored 'General case' 0 CA--C 1.511 -0.536 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 178.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -105.16 115.9 5.08 Favored Glycine 0 CA--C 1.501 -0.819 0 N-CA-C 104.481 -3.448 . . . . 0.0 104.481 169.487 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 6.8 m -138.46 157.83 30.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 118.933 1.366 . . . . 0.0 111.902 -168.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 130.52 -172.76 20.3 Favored Glycine 0 C--N 1.337 0.591 0 O-C-N 124.454 1.096 . . . . 0.0 111.698 169.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -87.07 85.86 7.26 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 123.54 0.736 . . . . 0.0 111.723 -169.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.3 pt -58.16 29.88 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.555 1.138 0 N-CA-C 116.421 2.008 . . . . 0.0 116.421 171.007 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 72.1 mt -125.96 -3.29 7.05 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 120.979 1.718 . . . . 0.0 108.927 169.371 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.6 mp -119.59 64.15 0.8 Allowed 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 124.212 1.005 . . . . 0.0 110.44 -169.095 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER 51.96 -104.01 0.17 Allowed 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.377 170.74 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -71.21 -16.34 62.5 Favored 'General case' 0 N--CA 1.442 -0.874 0 C-N-CA 124.209 1.004 . . . . 0.0 112.722 -175.47 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -73.76 7.93 2.23 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 120.924 1.693 . . . . 0.0 113.096 -179.757 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -89.66 -15.36 32.81 Favored 'General case' 0 N--CA 1.429 -1.508 0 CA-C-O 115.817 -2.04 . . . . 0.0 107.537 169.374 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 7.1 tp -54.96 -38.65 46.12 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.359 0 CA-C-N 122.329 2.331 . . . . 0.0 112.998 -169.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -59.56 -45.83 94.96 Favored Glycine 0 C--N 1.334 0.464 0 N-CA-C 109.934 -1.266 . . . . 0.0 109.934 176.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 34.3 t -65.85 -46.26 89.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 CA-C-O 118.505 -0.759 . . . . 0.0 110.05 173.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 25.5 mmt180 -62.32 -34.85 77.42 Favored 'General case' 0 C--N 1.346 0.422 0 CA-C-N 120.547 1.522 . . . . 0.0 111.963 -176.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 26.2 mt -61.85 -46.46 96.47 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-N 120.03 1.286 . . . . 0.0 110.137 178.373 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 18.7 m -73.77 -28.59 24.65 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 CA-C-N 119.153 0.888 . . . . 0.0 111.247 -174.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 58.1 mt-10 -70.18 -45.56 66.41 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 174.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.55 -44.59 95.95 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 123.002 0.521 . . . . 0.0 110.108 178.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 7.4 tp -63.45 -40.52 97.35 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 118.438 -0.791 . . . . 0.0 110.982 178.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.7 tm-20 -61.76 -42.38 98.91 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 118.7 0.682 . . . . 0.0 110.489 179.149 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 48.7 mm-40 -71.63 -42.8 67.16 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 122.784 0.434 . . . . 0.0 111.536 179.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 40.4 mmt180 -88.05 -35.44 17.54 Favored 'General case' 0 C--N 1.342 0.264 0 CA-C-O 117.37 -1.3 . . . . 0.0 113.441 -169.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 75.9 m-85 -120.12 137.06 54.37 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-N 121.127 1.785 . . . . 0.0 112.056 -173.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 31.6 mm -89.29 134.12 29.48 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 N-CA-C 105.536 -2.024 . . . . 0.0 105.536 168.269 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -119.5 154.85 54.55 Favored Pre-proline 0 CA--C 1.538 0.494 0 C-N-CA 125.563 1.545 . . . . 0.0 108.858 -172.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -63.87 157.9 49.93 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 122.358 2.039 . . . . 0.0 109.991 169.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -58.6 -31.99 68.57 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 113.619 0.97 . . . . 0.0 113.619 -169.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 53.4 p90 -75.38 -1.26 22.99 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 113.931 1.086 . . . . 0.0 113.931 -177.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 59.5 t -111.1 128.2 67.71 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 176.324 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -129.36 143.84 51.0 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 173.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -110.89 108.36 25.26 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 106.282 -1.748 . . . . 0.0 106.282 176.622 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 8.2 tt -106.88 127.06 53.09 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 -172.433 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -81.76 115.95 21.23 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 124.196 0.998 . . . . 0.0 109.824 176.649 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -77.29 -87.66 0.37 Allowed Glycine 0 CA--C 1.531 1.033 0 N-CA-C 108.762 -1.735 . . . . 0.0 108.762 169.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 77.93 106.88 0.18 Allowed Glycine 0 CA--C 1.53 0.976 0 N-CA-C 110.712 -0.955 . . . . 0.0 110.712 -177.145 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 5.3 p 50.99 57.48 6.61 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.017 1.327 . . . . 0.0 109.489 178.126 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -107.9 -87.75 0.48 Allowed 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 114.88 -1.054 . . . . 0.0 110.222 -169.566 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 73.08 -102.04 1.2 Allowed Glycine 0 C--N 1.339 0.709 0 N-CA-C 107.906 -2.077 . . . . 0.0 107.906 -174.399 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 70.8 mmm -68.24 -23.02 64.75 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 122.914 0.486 . . . . 0.0 112.222 -174.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -64.36 -14.91 59.09 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-O 120.793 0.33 . . . . 0.0 111.014 -177.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 59.4 mt -83.34 -10.0 58.73 Favored 'General case' 0 C--N 1.343 0.32 0 N-CA-C 113.912 1.079 . . . . 0.0 113.912 -172.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.5 tt -47.66 -67.91 0.23 Allowed 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 119.367 0.985 . . . . 0.0 113.577 -169.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -71.4 -26.41 73.41 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 111.339 -0.704 . . . . 0.0 111.339 -171.212 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -78.87 -29.67 44.6 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 122.516 0.326 . . . . 0.0 111.457 -178.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 22.3 mtp -83.7 -28.81 28.03 Favored 'General case' 0 CA--C 1.53 0.176 0 O-C-N 121.936 -0.477 . . . . 0.0 111.352 174.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -59.31 153.67 18.29 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-O 121.707 0.765 . . . . 0.0 110.307 175.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 64.45 -8.45 0.2 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 126.673 1.989 . . . . 0.0 115.314 169.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 24.7 mmt180 -68.41 153.33 43.96 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 170.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 83.8 m-20 -90.19 -34.82 15.67 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 118.991 -0.528 . . . . 0.0 109.952 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 2.0 t-160 -140.24 122.18 15.57 Favored 'General case' 0 CA--C 1.514 -0.414 0 N-CA-C 104.262 -2.495 . . . . 0.0 104.262 -172.138 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 50.0 tp -128.46 131.57 48.4 Favored 'General case' 0 CA--C 1.509 -0.624 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 179.072 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 39.6 mt -109.57 121.94 63.38 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 N-CA-C 105.012 -2.218 . . . . 0.0 105.012 169.665 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 22.1 mt -98.26 125.16 51.63 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 177.501 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -104.21 119.45 38.97 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 171.022 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -147.6 151.46 36.27 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 124.692 1.197 . . . . 0.0 110.736 -172.405 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -88.19 121.31 30.44 Favored 'General case' 0 C--N 1.343 0.298 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 168.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 7.9 mm -54.2 -39.19 41.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 C-N-CA 124.362 1.065 . . . . 0.0 111.797 -173.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . 0.319 6.7 p 43.06 43.03 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.974 0 C-N-CA 126.316 1.846 . . . . 0.0 113.145 175.549 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 4.4 t -157.48 -175.33 5.33 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.946 1.698 . . . . 0.0 109.614 -174.476 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 16.1 tptt 63.29 176.16 0.16 Allowed 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 127.327 2.251 . . . . 0.0 113.433 171.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 9.3 ptpt -103.2 0.44 31.69 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 125.404 1.481 . . . . 0.0 112.978 -178.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 49.5 t30 -73.55 162.35 29.34 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.905 0.882 . . . . 0.0 109.08 -177.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.8 m -58.97 142.86 84.73 Favored Pre-proline 0 CA--C 1.545 0.783 0 C-N-CA 124.068 0.947 . . . . 0.0 111.816 -169.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -55.15 155.17 20.1 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 122.775 2.316 . . . . 0.0 112.167 170.169 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 70.6 4.62 53.44 Favored Glycine 0 CA--C 1.531 1.062 0 CA-C-O 118.655 -1.081 . . . . 0.0 114.859 174.421 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 20.8 m -86.04 147.97 25.95 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 119.849 1.825 . . . . 0.0 110.458 -172.161 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 15.7 ttp -87.88 137.66 32.14 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 123.435 0.694 . . . . 0.0 110.414 175.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 47.0 mtp -129.03 111.46 13.01 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 178.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 42.3 mm -99.03 115.62 40.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 177.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.9 mp -116.43 134.92 54.32 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 -174.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 20.5 mmm180 -104.66 138.86 40.35 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 123.084 0.553 . . . . 0.0 109.931 -177.464 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 38.8 t70 33.95 -100.27 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 115.463 1.653 . . . . 0.0 115.463 169.011 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -61.0 -24.13 65.93 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.789 1.236 . . . . 0.0 113.733 -174.219 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -73.68 -26.54 60.78 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 122.66 0.384 . . . . 0.0 110.568 178.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 49.2 t -72.2 -53.17 6.62 Favored Pre-proline 0 N--CA 1.445 -0.715 0 CA-C-O 116.888 -1.53 . . . . 0.0 110.756 -169.195 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -61.92 -40.15 45.99 Favored 'Trans proline' 0 N--CA 1.448 -1.2 0 CA-C-N 121.992 1.747 . . . . 0.0 110.094 174.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -62.12 -30.35 70.97 Favored 'General case' 0 C--N 1.346 0.414 0 C-N-CA 123.364 0.666 . . . . 0.0 112.38 -174.271 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -68.65 -47.08 67.47 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 171.14 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -64.19 -19.23 65.19 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 -169.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 2.2 p -71.17 -17.79 62.52 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 -177.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 3.4 p30 -59.5 148.93 31.28 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -169.239 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -85.59 -13.54 48.48 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 118.816 -0.611 . . . . 0.0 112.618 -173.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 61.9 mt -70.29 -46.65 70.68 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 -178.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 5.0 m -78.1 119.1 76.04 Favored Pre-proline 0 CA--C 1.54 0.558 0 C-N-CA 124.263 1.025 . . . . 0.0 110.642 -174.285 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -81.96 -39.26 0.18 Allowed 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 121.573 1.515 . . . . 0.0 112.267 -177.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 24.3 m-70 -74.33 -29.67 61.71 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.358 0.663 . . . . 0.0 111.552 -171.194 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 90.6 mt-30 -74.53 -17.5 60.73 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 118.387 -0.816 . . . . 0.0 113.116 -169.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 47.5 tp -59.85 -35.04 73.93 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 119.692 1.133 . . . . 0.0 111.618 -172.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -65.66 -42.43 95.41 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 111.482 -0.647 . . . . 0.0 111.482 175.467 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 27.6 tp -70.29 -33.65 71.81 Favored 'General case' 0 CA--C 1.531 0.223 0 O-C-N 120.91 -1.347 . . . . 0.0 109.945 178.328 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -59.34 -50.33 74.41 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 118.908 0.776 . . . . 0.0 109.724 173.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -70.2 -24.74 63.17 Favored 'General case' 0 N--CA 1.457 -0.101 0 CA-C-O 118.682 -0.675 . . . . 0.0 112.02 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 2.5 t -65.09 -45.35 94.53 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 CA-C-N 119.451 1.023 . . . . 0.0 109.973 169.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 59.7 mt -64.91 -37.87 89.08 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 119.659 1.118 . . . . 0.0 109.705 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 18.6 m -61.92 -40.74 96.54 Favored 'General case' 0 C--O 1.224 -0.238 0 CA-C-N 118.605 0.638 . . . . 0.0 110.107 170.018 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.452 ' HA ' ' CD2' ' A' ' 106' ' ' PHE . . . -66.31 -33.88 76.73 Favored 'General case' 0 N--CA 1.448 -0.553 0 O-C-N 121.168 -0.957 . . . . 0.0 111.067 -179.759 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 6.4 mt -67.86 -34.25 76.32 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-N 118.929 0.786 . . . . 0.0 109.629 175.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 80.0 ttt180 -68.38 -36.43 79.16 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 118.846 -0.597 . . . . 0.0 110.06 172.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.452 ' CD2' ' HA ' ' A' ' 103' ' ' ALA . 15.4 m-30 -65.43 -43.38 90.68 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 119.305 0.957 . . . . 0.0 110.572 178.559 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 41.6 p -74.53 -23.25 58.79 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 118.571 0.623 . . . . 0.0 111.303 177.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 75.18 12.55 83.41 Favored Glycine 0 CA--C 1.531 1.086 0 N-CA-C 110.832 -0.907 . . . . 0.0 110.832 -169.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -96.84 22.16 8.63 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 118.766 1.283 . . . . 0.0 111.235 178.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -58.1 132.87 84.03 Favored Pre-proline 0 CA--C 1.544 0.727 0 C-N-CA 124.964 1.306 . . . . 0.0 109.656 171.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_exo -56.58 150.71 50.62 Favored 'Trans proline' 0 N--CA 1.46 -0.479 0 C-N-CA 123.351 2.701 . . . . 0.0 114.932 -178.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -59.88 -34.57 73.34 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.059 177.193 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 59.2 mttp -134.39 130.4 36.81 Favored 'General case' 0 C--O 1.232 0.16 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 173.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 18.2 tp -118.19 139.15 51.72 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 105.19 -2.152 . . . . 0.0 105.19 168.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -141.39 146.34 36.48 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 105.656 -1.979 . . . . 0.0 105.656 -177.669 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -135.37 136.1 41.22 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 119.729 1.15 . . . . 0.0 109.841 172.815 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 47.6 t -103.61 99.63 8.8 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 N-CA-C 103.61 -2.737 . . . . 0.0 103.61 169.278 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -87.24 145.43 19.74 Favored Glycine 0 N--CA 1.444 -0.825 0 N-CA-C 110.317 -1.113 . . . . 0.0 110.317 176.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 53.2 t -127.35 121.19 56.79 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.497 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 175.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 6.5 mt -71.88 132.48 84.87 Favored Pre-proline 0 CA--C 1.539 0.55 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 173.153 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -73.67 179.35 5.7 Favored 'Trans proline' 0 CA--C 1.541 0.848 0 C-N-CA 122.995 2.463 . . . . 0.0 111.91 179.146 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -115.47 -53.71 2.58 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.488 1.115 . . . . 0.0 110.032 177.446 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 56.1 p -110.25 -65.6 1.14 Allowed 'General case' 0 CA--C 1.535 0.365 0 CA-C-N 119.058 0.845 . . . . 0.0 111.954 -172.632 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 56.29 70.34 0.65 Allowed 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.674 1.99 . . . . 0.0 113.702 176.187 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -128.79 169.83 12.05 Favored Pre-proline 0 CA--C 1.542 0.658 0 CA-C-O 118.331 -0.843 . . . . 0.0 109.421 169.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_exo -65.92 85.21 0.24 Allowed 'Trans proline' 0 CA--C 1.547 1.126 0 C-N-CA 123.617 2.878 . . . . 0.0 113.34 -178.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -175.83 151.18 1.1 Allowed 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 104.404 -2.443 . . . . 0.0 104.404 176.368 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -114.3 161.84 12.83 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 -169.654 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 107.42 141.74 10.11 Favored Glycine 0 CA--C 1.528 0.878 0 N-CA-C 106.85 -2.5 . . . . 0.0 106.85 -169.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 68.7 mt -78.54 158.17 28.62 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 118.645 1.223 . . . . 0.0 108.971 175.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 36.3 p -68.19 164.92 38.05 Favored Pre-proline 0 C--O 1.238 0.462 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 168.304 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -56.69 -33.64 94.17 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 121.477 1.451 . . . . 0.0 110.76 169.334 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 5.9 m -66.48 -43.68 84.73 Favored 'General case' 0 CA--C 1.535 0.37 0 O-C-N 122.201 -0.312 . . . . 0.0 110.183 -178.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 94.4 t -88.48 -28.43 5.37 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 CA-C-N 118.683 0.674 . . . . 0.0 110.075 -172.224 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -55.12 -45.85 75.57 Favored 'General case' 0 CA--C 1.533 0.31 0 O-C-N 120.667 -1.27 . . . . 0.0 107.774 167.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -75.48 18.5 0.22 Allowed 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 114.152 1.167 . . . . 0.0 114.152 176.148 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 25.8 mmm -115.03 -8.44 12.46 Favored 'General case' 0 N--CA 1.437 -1.084 0 C-N-CA 125.743 1.617 . . . . 0.0 107.965 169.215 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 96.3 mt -59.5 -49.65 82.85 Favored 'Isoleucine or valine' 0 C--N 1.346 0.423 0 CA-C-N 120.379 1.445 . . . . 0.0 107.859 174.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -70.71 -53.73 8.97 Favored Pre-proline 0 CA--C 1.536 0.408 0 CA-C-O 117.121 -1.418 . . . . 0.0 109.584 -175.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -38.75 -52.63 2.07 Favored 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 123.876 3.051 . . . . 0.0 113.822 169.113 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -74.19 -45.85 45.78 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.085 -1.416 . . . . 0.0 110.808 -172.137 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -62.28 -36.38 81.89 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-N 118.982 0.81 . . . . 0.0 109.722 179.453 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -64.2 -36.0 82.65 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 177.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 11.9 mm100 -74.56 -31.09 61.98 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-O 117.869 -1.063 . . . . 0.0 112.266 172.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 86.7 t -59.83 -46.25 93.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-N 120.446 1.475 . . . . 0.0 108.154 169.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 74.4 mt -62.68 -41.17 98.95 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 118.714 0.688 . . . . 0.0 110.42 177.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -62.78 -41.04 99.08 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 118.813 0.733 . . . . 0.0 111.0 179.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -66.55 -46.37 76.3 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 177.366 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 78.0 mt -57.76 -37.17 73.16 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 122.514 0.326 . . . . 0.0 110.228 177.391 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 67.6 mtp180 -64.07 -19.09 64.98 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 118.019 -0.991 . . . . 0.0 112.284 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -61.89 -30.12 70.67 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 120.182 1.355 . . . . 0.0 110.546 174.17 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 49.1 m -101.16 31.11 3.79 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.021 1.328 . . . . 0.0 111.447 174.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 66.48 21.5 70.66 Favored Glycine 0 CA--C 1.53 0.974 0 CA-C-O 119.251 -0.749 . . . . 0.0 114.248 169.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 81.6 t -72.74 120.03 20.61 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 CA-C-N 118.572 1.186 . . . . 0.0 107.934 178.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -103.45 94.35 5.43 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 105.744 -1.947 . . . . 0.0 105.744 169.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -74.21 144.14 44.85 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 175.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 9.2 mm -112.04 127.88 26.24 Favored Pre-proline 0 CA--C 1.53 0.191 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -62.6 109.58 0.91 Allowed 'Trans proline' 0 N--CA 1.458 -0.599 0 N-CA-C 107.425 -1.798 . . . . 0.0 107.425 170.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 70.2 ttt-85 56.0 -9.43 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 127.799 2.44 . . . . 0.0 116.809 179.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 4.3 m 56.57 1.66 0.08 Allowed 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 126.524 1.93 . . . . 0.0 114.742 -169.564 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -157.1 143.92 18.4 Favored 'General case' 0 C--O 1.239 0.53 0 O-C-N 120.646 -1.284 . . . . 0.0 108.2 -175.32 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 18.1 m . . . . . 0 C--O 1.252 1.237 0 C-N-CA 124.506 1.122 . . . . 0.0 110.354 -169.963 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.0 ttt . . . . . 0 N--CA 1.497 1.906 0 CA-C-O 120.728 0.299 . . . . 0.0 110.916 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 28.5 tpt85 -66.24 120.75 13.79 Favored 'General case' 0 N--CA 1.469 0.486 0 O-C-N 119.886 -1.759 . . . . 0.0 109.466 -175.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.8 mt -120.21 127.39 75.9 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 -172.01 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 19.4 tp -121.23 138.36 54.26 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 105.256 -2.128 . . . . 0.0 105.256 168.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 92.6 t -124.01 110.58 25.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 -177.178 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -93.73 125.37 38.31 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 -174.367 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -99.58 127.7 9.33 Favored Glycine 0 CA--C 1.508 -0.405 0 N-CA-C 106.17 -2.772 . . . . 0.0 106.17 170.435 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.1 m -138.79 167.15 21.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 117.595 0.697 . . . . 0.0 111.272 -169.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 109.59 169.79 20.27 Favored Glycine 0 CA--C 1.525 0.709 0 C-N-CA 125.973 1.749 . . . . 0.0 110.403 179.099 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.489 HD22 ' HB2' ' A' ' 12' ' ' LEU . 8.7 t30 -87.02 104.95 16.79 Favored 'General case' 0 N--CA 1.452 -0.336 0 O-C-N 121.865 -0.785 . . . . 0.0 110.794 -172.45 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.2 pt -63.67 32.99 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.892 0 N-CA-C 115.501 1.667 . . . . 0.0 115.501 175.036 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.489 ' HB2' HD22 ' A' ' 10' ' ' ASN . 42.4 mt -127.39 0.82 6.32 Favored 'General case' 0 C--O 1.222 -0.386 0 CA-C-N 120.504 1.502 . . . . 0.0 108.14 168.785 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.48 ' HB2' HD21 ' A' ' 10' ' ' ASN . 1.3 mp -118.06 52.28 1.02 Allowed 'General case' 0 N--CA 1.441 -0.916 0 C-N-CA 124.002 0.921 . . . . 0.0 112.074 -168.633 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER 53.8 -108.16 0.41 Allowed 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 122.862 0.465 . . . . 0.0 111.498 171.239 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -57.13 -25.18 58.42 Favored 'General case' 0 C--O 1.224 -0.287 0 CA-C-O 118.209 -0.901 . . . . 0.0 113.009 176.357 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -70.53 -0.03 7.7 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 121.535 1.971 . . . . 0.0 113.542 -177.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -89.0 -16.08 32.57 Favored 'General case' 0 N--CA 1.431 -1.39 0 CA-C-O 115.92 -1.99 . . . . 0.0 108.957 169.389 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 5.9 tp -58.34 -38.0 66.71 Favored 'Isoleucine or valine' 0 C--N 1.342 0.278 0 CA-C-N 122.829 2.559 . . . . 0.0 111.798 -169.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -59.71 -38.83 94.42 Favored Glycine 0 C--N 1.338 0.679 0 N-CA-C 110.572 -1.011 . . . . 0.0 110.572 176.304 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 79.0 t -73.29 -48.44 42.6 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.652 0 CA-C-O 118.641 -0.695 . . . . 0.0 109.452 174.374 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 15.6 mmm180 -59.48 -36.14 75.45 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 120.367 1.439 . . . . 0.0 112.621 -176.421 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 33.6 mt -62.18 -46.7 95.86 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 CA-C-N 120.418 1.463 . . . . 0.0 109.983 179.236 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 10.3 m -72.65 -29.33 30.03 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 O-C-N 121.298 -0.876 . . . . 0.0 110.887 -174.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -70.44 -41.72 72.47 Favored 'General case' 0 CA--C 1.528 0.102 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 175.022 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.41 -37.21 82.65 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-O 118.735 -0.65 . . . . 0.0 110.444 178.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 11.9 tp -62.45 -42.59 99.57 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 118.867 0.758 . . . . 0.0 109.939 174.297 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -62.78 -41.19 99.15 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 118.461 0.573 . . . . 0.0 110.815 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -67.42 -42.69 82.79 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.193 0.997 . . . . 0.0 110.635 179.08 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 88.3 mtt180 -94.43 -38.89 10.72 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 114.837 1.421 . . . . 0.0 114.837 -169.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 63.3 m-85 -113.84 137.68 51.32 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 121.391 1.905 . . . . 0.0 114.207 -169.293 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 47.0 mm -85.68 141.84 13.97 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 N-CA-C 104.382 -2.451 . . . . 0.0 104.382 167.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 46.5 mt -135.98 152.87 76.42 Favored Pre-proline 0 CA--C 1.539 0.55 0 C-N-CA 123.496 0.718 . . . . 0.0 110.518 -169.474 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_exo -59.27 155.2 41.75 Favored 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 123.336 2.691 . . . . 0.0 111.829 169.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -63.01 -31.09 72.14 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -171.232 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 26.1 p90 -70.63 -13.96 62.29 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 118.358 -0.83 . . . . 0.0 112.547 179.149 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 42.7 t -94.91 129.25 45.33 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 C-N-CA 124.114 0.966 . . . . 0.0 108.639 178.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -136.13 146.06 46.53 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-O 121.252 0.548 . . . . 0.0 110.607 170.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -105.28 130.35 56.65 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 N-CA-C 105.648 -1.982 . . . . 0.0 105.648 169.024 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 64.5 tp -121.61 126.41 49.02 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-O 121.311 0.577 . . . . 0.0 109.732 175.088 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -77.87 115.69 17.81 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 169.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -64.58 -64.25 3.71 Favored Glycine 0 CA--C 1.531 1.074 0 N-CA-C 108.225 -1.95 . . . . 0.0 108.225 169.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 79.2 106.0 0.23 Allowed Glycine 0 C--N 1.34 0.793 0 N-CA-C 110.765 -0.934 . . . . 0.0 110.765 171.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . 0.254 40.2 p 50.18 61.18 3.33 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 -173.434 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -89.01 -140.36 0.13 Allowed 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 113.608 -1.633 . . . . 0.0 110.925 -169.304 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 75.93 118.85 0.13 Allowed Glycine 0 CA--C 1.537 1.417 0 N-CA-C 109.031 -1.628 . . . . 0.0 109.031 -168.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 1.6 mmt 61.59 -29.37 0.06 Allowed 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 127.521 2.328 . . . . 0.0 116.411 -173.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -59.47 -21.42 60.06 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 118.998 0.817 . . . . 0.0 112.769 -175.03 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 95.8 mt -91.79 9.63 31.88 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 -171.339 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.5 tt -73.15 79.94 1.26 Allowed 'General case' 0 C--O 1.233 0.213 0 CA-C-O 124.843 2.258 . . . . 0.0 110.827 -179.035 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 145.13 -33.64 1.59 Allowed Glycine 0 C--N 1.308 -0.989 0 CA-C-N 110.142 -3.208 . . . . 0.0 111.028 172.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -68.24 -35.3 77.72 Favored 'General case' 0 N--CA 1.466 0.345 0 O-C-N 121.933 -0.745 . . . . 0.0 111.525 -176.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 38.1 mtp -72.38 0.56 9.79 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.891 1.277 . . . . 0.0 113.151 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -75.63 149.13 38.28 Favored 'General case' 0 N--CA 1.457 -0.087 0 N-CA-C 113.777 1.029 . . . . 0.0 113.777 -169.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 55.26 18.15 2.37 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 128.317 2.647 . . . . 0.0 116.412 168.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 27.1 mmt180 -77.91 149.33 34.24 Favored 'General case' 0 N--CA 1.473 0.698 0 O-C-N 120.798 -1.189 . . . . 0.0 109.416 -178.312 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -80.97 -39.55 25.84 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 177.071 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 1.8 m170 -128.07 136.28 50.99 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 169.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 29.2 tp -130.92 123.72 29.53 Favored 'General case' 0 CA--C 1.505 -0.78 0 N-CA-C 105.851 -1.907 . . . . 0.0 105.851 168.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 18.5 mt -111.35 122.41 65.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 104.657 -2.349 . . . . 0.0 104.657 178.038 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 21.0 mt -102.94 126.56 57.18 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 N-CA-C 105.881 -1.896 . . . . 0.0 105.881 -179.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -111.32 119.09 37.72 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 105.261 -2.126 . . . . 0.0 105.261 171.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -149.1 149.93 31.88 Favored 'General case' 0 C--O 1.24 0.557 0 O-C-N 123.4 0.438 . . . . 0.0 110.202 -175.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -68.64 132.01 46.17 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 104.536 -2.394 . . . . 0.0 104.536 168.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.6 tt -74.95 -38.07 42.58 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.778 0 O-C-N 121.582 -0.699 . . . . 0.0 110.797 -169.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.2 t 45.62 44.43 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.822 0 C-N-CA 125.919 1.688 . . . . 0.0 111.144 176.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 67.2 m -138.75 -73.31 0.39 Allowed 'General case' 0 N--CA 1.471 0.577 0 O-C-N 121.54 -0.725 . . . . 0.0 112.552 -169.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 29.3 ttmt -83.02 154.68 24.33 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 122.758 0.423 . . . . 0.0 109.871 -169.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.32 42.8 1.11 Allowed 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 125.283 1.433 . . . . 0.0 109.033 -172.158 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 40.7 t-20 -89.74 172.47 8.9 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 124.26 1.024 . . . . 0.0 108.915 -171.358 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 10.7 m -60.25 133.95 90.7 Favored Pre-proline 0 CA--C 1.544 0.726 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 179.066 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -57.82 153.66 42.41 Favored 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 122.392 2.061 . . . . 0.0 111.615 174.127 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 71.53 9.38 68.88 Favored Glycine 0 CA--C 1.533 1.163 0 CA-C-O 119.703 -0.498 . . . . 0.0 113.803 176.111 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 29.3 m -89.03 146.56 24.78 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 124.971 1.309 . . . . 0.0 107.545 174.244 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 30.0 ttp -101.78 143.13 32.08 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 175.328 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 17.9 ttm -126.5 126.65 44.08 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 179.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 44.0 mm -107.57 121.19 60.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 -179.108 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -115.71 129.37 56.44 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 -174.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 81.0 mtm180 -90.9 173.45 7.97 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 118.293 0.497 . . . . 0.0 110.288 179.159 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -33.39 -66.15 0.16 Allowed 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 116.215 1.931 . . . . 0.0 116.215 -169.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -77.08 -12.34 59.93 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -172.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 21.6 mm-40 -91.78 -21.95 20.42 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 118.558 -0.734 . . . . 0.0 110.664 -178.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 63.0 t -62.97 -51.13 73.25 Favored Pre-proline 0 C--N 1.344 0.331 0 CA-C-N 120.168 1.349 . . . . 0.0 110.967 -179.111 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -66.65 -37.8 20.52 Favored 'Trans proline' 0 N--CA 1.444 -1.393 0 CA-C-N 121.423 1.544 . . . . 0.0 109.708 -179.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.97 -29.04 69.37 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.298 0.639 . . . . 0.0 111.812 -176.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -68.31 -47.65 67.01 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 169.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -64.63 -11.2 32.71 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 114.041 1.126 . . . . 0.0 114.041 -169.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 24.9 p -66.76 -13.65 61.66 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 113.784 1.031 . . . . 0.0 113.784 -175.281 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -59.29 135.03 57.52 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.362 0.665 . . . . 0.0 110.652 -172.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -87.04 -12.48 47.22 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 -170.394 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 76.2 mt -67.82 -43.55 86.11 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 N-CA-C 107.421 -1.325 . . . . 0.0 107.421 174.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -65.78 130.84 94.57 Favored Pre-proline 0 N--CA 1.445 -0.722 0 C-N-CA 125.802 1.641 . . . . 0.0 110.768 -173.132 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -80.78 -87.55 0.0 OUTLIER 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 123.059 2.506 . . . . 0.0 111.416 177.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 19.4 m80 -66.98 -32.15 73.2 Favored 'General case' 0 N--CA 1.469 0.477 0 O-C-N 120.645 -1.285 . . . . 0.0 110.976 -170.312 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 26.2 mp0 -53.86 -42.65 68.8 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 126.365 1.866 . . . . 0.0 109.93 173.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -70.7 -37.1 73.56 Favored 'General case' 0 N--CA 1.457 -0.117 0 O-C-N 121.571 -0.705 . . . . 0.0 109.671 179.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -59.69 -38.87 94.45 Favored Glycine 0 CA--C 1.53 0.983 0 O-C-N 121.254 -0.904 . . . . 0.0 111.44 171.52 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 24.3 tp -70.19 -28.13 65.06 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 118.37 1.085 . . . . 0.0 110.461 174.423 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -56.23 -46.87 79.38 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 120.141 1.337 . . . . 0.0 109.089 169.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -72.56 -24.21 61.08 Favored 'General case' 0 C--O 1.231 0.08 0 CA-C-O 119.193 -0.432 . . . . 0.0 111.952 -179.163 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 74.2 t -65.45 -46.16 90.82 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 169.19 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 76.1 mt -64.03 -35.28 80.19 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 118.961 0.801 . . . . 0.0 110.433 -179.053 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 19.7 m -63.97 -43.29 96.19 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 118.796 0.725 . . . . 0.0 110.197 170.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -64.9 -41.5 95.54 Favored 'General case' 0 N--CA 1.452 -0.367 0 O-C-N 120.972 -1.08 . . . . 0.0 111.387 -178.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -65.33 -31.58 72.79 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 124.486 1.114 . . . . 0.0 110.318 176.148 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 19.1 tpp180 -70.91 -37.85 72.96 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 118.839 -0.6 . . . . 0.0 109.897 173.58 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 15.2 m-30 -65.44 -42.46 92.4 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 118.773 0.715 . . . . 0.0 110.405 -179.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 31.2 p -74.96 -21.5 59.13 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 118.304 0.502 . . . . 0.0 111.603 178.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 74.34 11.19 82.31 Favored Glycine 0 CA--C 1.534 1.262 0 N-CA-C 111.066 -0.814 . . . . 0.0 111.066 -169.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -83.74 2.27 38.72 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 118.77 1.285 . . . . 0.0 111.944 177.041 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -48.67 134.63 13.69 Favored Pre-proline 0 CA--C 1.549 0.92 0 C-N-CA 125.745 1.618 . . . . 0.0 110.989 177.009 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -52.0 150.02 19.49 Favored 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 124.082 3.188 . . . . 0.0 114.258 179.65 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 31.7 mmmt -63.26 -28.92 70.35 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 118.955 -0.545 . . . . 0.0 111.183 177.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 36.0 ttmt -146.69 110.95 5.1 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 171.226 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 26.2 tp -90.1 144.58 25.76 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 169.119 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -141.45 146.46 36.53 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 171.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -131.4 138.99 49.34 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 120.408 1.458 . . . . 0.0 110.436 172.78 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 43.6 t -105.17 105.93 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 N-CA-C 104.808 -2.293 . . . . 0.0 104.808 168.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -90.07 146.05 18.5 Favored Glycine 0 CA--C 1.522 0.516 0 N-CA-C 110.484 -1.046 . . . . 0.0 110.484 174.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 71.0 t -119.31 138.64 49.32 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 175.575 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 14.4 mm -84.94 128.23 61.3 Favored Pre-proline 0 CA--C 1.543 0.679 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 169.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -70.12 152.3 67.41 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 122.786 2.324 . . . . 0.0 113.365 -176.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -99.58 -42.41 6.92 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 169.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 20.2 m -142.66 151.06 41.02 Favored 'General case' 0 C--N 1.344 0.348 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 176.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.5 tp -153.77 49.61 0.67 Allowed 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 118.719 0.691 . . . . 0.0 111.779 -172.275 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -120.32 168.93 9.45 Favored Pre-proline 0 N--CA 1.477 0.919 0 CA-C-O 117.638 -1.172 . . . . 0.0 110.072 -175.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -62.89 84.3 0.11 Allowed 'Trans proline' 0 CA--C 1.547 1.167 0 C-N-CA 124.138 3.225 . . . . 0.0 113.915 -178.219 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -176.52 156.53 1.52 Allowed 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 105.212 -2.144 . . . . 0.0 105.212 174.527 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -130.54 162.17 39.03 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 CA-C-O 121.772 0.796 . . . . 0.0 110.844 174.817 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 122.36 121.96 2.76 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 103.387 -3.885 . . . . 0.0 103.387 -168.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 74.8 mt -78.86 152.21 31.38 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 -171.108 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 68.6 p -69.8 166.04 35.96 Favored Pre-proline 0 C--O 1.241 0.632 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 169.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -60.21 -27.86 85.73 Favored 'Trans proline' 0 CA--C 1.539 0.727 0 CA-C-N 119.677 0.92 . . . . 0.0 110.466 169.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 5.1 m -69.85 -42.11 73.98 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 118.505 0.593 . . . . 0.0 110.35 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 72.7 t -88.46 -36.6 9.33 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 CA-C-O 119.175 -0.44 . . . . 0.0 110.346 -169.348 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -50.7 -44.59 58.01 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 119.204 0.911 . . . . 0.0 109.938 169.428 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -77.76 5.2 9.92 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 113.789 1.033 . . . . 0.0 113.789 -175.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 75.3 mtp -98.18 -7.28 29.68 Favored 'General case' 0 N--CA 1.439 -1.015 0 CA-C-O 117.387 -1.292 . . . . 0.0 110.59 169.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 94.7 mt -57.67 -47.25 86.06 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 CA-C-N 120.225 1.375 . . . . 0.0 108.391 174.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 58.3 mt-10 -73.56 -48.65 6.83 Favored Pre-proline 0 CA--C 1.542 0.667 0 CA-C-O 117.534 -1.222 . . . . 0.0 110.637 -175.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -43.38 -54.38 3.6 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 124.611 3.541 . . . . 0.0 112.645 168.686 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.35 -42.52 71.73 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 114.788 -1.096 . . . . 0.0 110.755 -174.283 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 33.1 mt -54.69 -44.12 73.09 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-N 118.961 0.8 . . . . 0.0 109.45 173.367 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -64.44 -34.65 78.68 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 119.075 0.852 . . . . 0.0 110.887 -176.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -78.43 -32.8 48.74 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 119.231 0.923 . . . . 0.0 112.021 176.52 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 54.0 t -59.59 -47.99 88.97 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 169.355 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 44.7 mt -64.47 -36.97 85.91 Favored 'General case' 0 CA--C 1.519 -0.244 0 C-N-CA 123.061 0.544 . . . . 0.0 110.67 -178.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -58.18 -36.38 72.98 Favored 'General case' 0 N--CA 1.457 -0.118 0 CA-C-N 118.419 0.554 . . . . 0.0 111.21 179.216 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -63.0 -44.84 94.9 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 117.985 0.357 . . . . 0.0 110.91 177.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 6.2 mp -63.21 -40.26 96.99 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 176.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 87.0 mtt180 -64.81 -18.87 65.5 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 117.411 -1.281 . . . . 0.0 111.759 -179.081 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 69.8 mt-10 -56.26 -30.15 62.05 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 120.53 1.514 . . . . 0.0 112.138 176.359 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 19.4 m -113.38 31.53 6.41 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.294 1.038 . . . . 0.0 111.311 179.211 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 65.42 29.98 76.5 Favored Glycine 0 CA--C 1.531 1.05 0 CA-C-O 118.73 -1.039 . . . . 0.0 113.583 175.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 47.1 t -111.14 103.32 15.29 Favored 'Isoleucine or valine' 0 C--N 1.34 0.175 0 N-CA-C 106.684 -1.599 . . . . 0.0 106.684 176.299 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -100.8 144.87 29.24 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 169.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -78.68 157.5 28.59 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.388 0.675 . . . . 0.0 111.357 177.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 11.7 mt -99.14 112.43 63.09 Favored Pre-proline 0 CA--C 1.532 0.263 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -66.98 104.63 0.86 Allowed 'Trans proline' 0 N--CA 1.458 -0.591 0 N-CA-C 107.942 -1.599 . . . . 0.0 107.942 175.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 69.5 ttt180 57.29 -14.08 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 128.344 2.658 . . . . 0.0 116.98 -178.06 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 2.9 t 60.2 -178.15 0.1 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.447 1.499 . . . . 0.0 111.047 -169.648 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -148.71 141.53 24.64 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 125.654 1.581 . . . . 0.0 108.828 -179.007 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 28.9 m . . . . . 0 C--O 1.252 1.231 0 C-N-CA 125.121 1.368 . . . . 0.0 108.526 -177.074 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.0 tpt . . . . . 0 N--CA 1.499 1.991 0 N-CA-C 110.437 -0.208 . . . . 0.0 110.437 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 7.0 ptp180 -145.32 126.5 14.73 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 174.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 38.5 mt -142.69 143.8 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-N 119.612 1.096 . . . . 0.0 110.85 -169.104 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 19.7 tp -131.88 109.86 10.39 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 104.168 -2.531 . . . . 0.0 104.168 167.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 39.2 t -85.84 118.72 32.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 102.441 -3.17 . . . . 0.0 102.441 171.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -119.9 105.52 11.17 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-O 121.114 0.483 . . . . 0.0 110.411 -168.673 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -87.46 115.62 4.36 Favored Glycine 0 N--CA 1.447 -0.614 0 N-CA-C 107.651 -2.18 . . . . 0.0 107.651 174.298 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 14.8 m -123.46 -176.38 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.633 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 174.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 111.49 124.71 4.54 Favored Glycine 0 N--CA 1.441 -1.031 0 N-CA-C 106.75 -2.54 . . . . 0.0 106.75 -175.002 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -64.03 109.46 1.82 Allowed 'General case' 0 N--CA 1.442 -0.85 0 C-N-CA 124.284 1.034 . . . . 0.0 109.917 -169.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.3 pt -75.65 37.77 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 C-N-CA 124.642 1.177 . . . . 0.0 113.463 -178.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 20.8 mt -124.24 0.18 8.35 Favored 'General case' 0 CA--C 1.535 0.398 0 O-C-N 121.118 -0.989 . . . . 0.0 108.502 169.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.2 mp -132.56 72.66 1.5 Allowed 'General case' 0 C--N 1.346 0.446 0 N-CA-C 104.895 -2.261 . . . . 0.0 104.895 -173.454 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.583 ' HG1' ' CE1' ' A' ' 127' ' ' HIS . 98.9 m 17.85 -92.84 0.0 OUTLIER 'General case' 0 CA--C 1.522 -0.115 0 C-N-CA 127.091 2.156 . . . . 0.0 115.364 175.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -53.73 -30.74 45.4 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 125.028 1.331 . . . . 0.0 113.003 -169.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -64.61 -31.54 72.81 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 119.592 1.087 . . . . 0.0 111.901 179.513 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.14 -12.55 8.79 Favored 'General case' 0 N--CA 1.437 -1.091 0 CA-C-O 116.187 -1.863 . . . . 0.0 111.277 176.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 5.4 tp -49.55 -42.13 16.68 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.507 0 CA-C-N 121.813 2.097 . . . . 0.0 110.539 179.157 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -66.65 -36.2 90.97 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 111.256 -0.738 . . . . 0.0 111.256 -176.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 69.8 t -67.81 -45.55 84.08 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 172.313 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 20.7 mmt180 -61.53 -29.14 69.81 Favored 'General case' 0 C--O 1.225 -0.201 0 CA-C-O 117.282 -1.342 . . . . 0.0 112.055 178.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 6.3 mm -60.93 -53.11 53.62 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-N 120.682 1.583 . . . . 0.0 108.736 176.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 34.1 m -71.36 -32.24 46.09 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-N 119.199 0.909 . . . . 0.0 111.505 -173.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 63.4 mt-10 -64.89 -49.57 69.95 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 118.49 0.586 . . . . 0.0 109.883 173.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.1 -36.5 83.8 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 119.198 -0.43 . . . . 0.0 110.231 179.031 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 8.2 tp -62.4 -40.42 96.45 Favored 'General case' 0 C--O 1.225 -0.227 0 CA-C-N 119.49 1.041 . . . . 0.0 109.36 -179.217 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -67.83 -25.47 65.58 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 121.339 0.59 . . . . 0.0 112.303 -178.309 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -81.86 -39.29 24.13 Favored 'General case' 0 N--CA 1.436 -1.128 0 C-N-CA 126.219 1.808 . . . . 0.0 109.685 175.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 23.4 mmt85 -89.63 -32.55 17.03 Favored 'General case' 0 C--O 1.231 0.099 0 CA-C-O 118.662 -0.685 . . . . 0.0 112.1 -169.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -128.22 147.73 50.59 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 118.944 0.793 . . . . 0.0 111.334 -176.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 51.6 mm -97.11 138.97 20.64 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 103.834 -2.654 . . . . 0.0 103.834 168.014 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -117.57 153.38 50.44 Favored Pre-proline 0 CA--C 1.539 0.542 0 C-N-CA 123.277 0.631 . . . . 0.0 111.469 -169.362 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -61.03 161.0 23.76 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 123.711 2.941 . . . . 0.0 112.144 169.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -63.42 -32.94 74.51 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -175.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 7.5 p90 -75.17 -10.25 59.29 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 -179.207 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 96.7 t -92.31 122.93 44.21 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 173.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -114.66 127.34 55.71 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 106.703 -1.591 . . . . 0.0 106.703 169.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -93.98 118.33 39.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 105.076 -2.194 . . . . 0.0 105.076 168.559 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 54.1 tp -118.86 132.21 56.1 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 122.902 0.481 . . . . 0.0 110.352 178.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -91.29 120.99 32.65 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 169.154 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -106.7 -22.5 7.65 Favored Glycine 0 CA--C 1.536 1.361 0 CA-C-O 118.437 -1.202 . . . . 0.0 113.6 171.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 56.05 -110.84 2.16 Favored Glycine 0 C--N 1.342 0.897 0 CA-C-N 119.878 1.839 . . . . 0.0 112.329 172.071 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 75.7 p -79.99 7.21 9.46 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 125.365 1.466 . . . . 0.0 112.557 -172.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -57.82 -59.3 5.44 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 114.291 1.219 . . . . 0.0 114.291 -170.033 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 56.72 -112.33 3.37 Favored Glycine 0 CA--C 1.532 1.144 0 N-CA-C 109.846 -1.302 . . . . 0.0 109.846 -170.269 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 8.2 tpt -64.19 -21.41 66.55 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.319 1.048 . . . . 0.0 113.449 -176.506 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -56.33 -17.67 8.47 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 114.545 1.313 . . . . 0.0 114.545 -170.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 8.8 mt -98.24 17.71 18.01 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 119.499 1.045 . . . . 0.0 112.991 -169.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 10.2 tt -48.04 -50.74 26.88 Favored 'General case' 0 C--N 1.343 0.314 0 N-CA-C 112.764 0.654 . . . . 0.0 112.764 -174.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -80.31 -29.67 44.19 Favored Glycine 0 CA--C 1.528 0.848 0 CA-C-O 119.659 -0.523 . . . . 0.0 111.952 -178.035 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -86.94 -22.7 25.47 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 114.267 1.21 . . . . 0.0 114.267 -169.053 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 47.6 mtp -78.14 -15.64 58.67 Favored 'General case' 0 CA--C 1.535 0.394 0 O-C-N 121.537 -0.727 . . . . 0.0 111.108 173.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.09 150.37 45.56 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 123.708 0.803 . . . . 0.0 112.026 -169.324 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . 0.282 14.4 p30 55.34 17.24 2.03 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 127.923 2.489 . . . . 0.0 117.324 170.048 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.5 159.02 35.04 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 169.155 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -80.61 -52.18 7.88 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 173.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -117.22 147.11 42.79 Favored 'General case' 0 CA--C 1.513 -0.478 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 168.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -134.97 122.56 22.05 Favored 'General case' 0 CA--C 1.508 -0.661 0 N-CA-C 104.698 -2.334 . . . . 0.0 104.698 175.293 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 3.0 mt -104.42 106.07 19.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 106.45 -1.685 . . . . 0.0 106.45 176.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 27.4 mt -79.99 124.76 38.45 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 N-CA-C 105.074 -2.195 . . . . 0.0 105.074 169.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -113.28 121.07 43.3 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 104.121 -2.548 . . . . 0.0 104.121 168.542 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 41.7 t0 -163.67 156.37 18.05 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 123.592 0.757 . . . . 0.0 110.23 -175.237 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -83.25 142.67 30.96 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 169.008 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 72.1 mt -77.07 -44.29 31.42 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 -175.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 14.6 t 53.93 43.46 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.151 0 C-N-CA 124.367 1.067 . . . . 0.0 109.66 -172.059 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 2.4 m -153.76 178.81 9.48 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.212 1.405 . . . . 0.0 109.639 175.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . 0.288 30.6 ttmt 67.61 154.69 0.1 Allowed 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 127.968 2.507 . . . . 0.0 113.345 175.557 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 10.3 ptpt -85.14 -5.65 59.33 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 127.205 2.202 . . . . 0.0 114.774 -169.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 33.9 t-20 -74.38 169.61 17.32 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.221 0.608 . . . . 0.0 109.619 -173.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 4.1 m -57.65 146.31 66.1 Favored Pre-proline 0 CA--C 1.548 0.903 0 C-N-CA 124.111 0.964 . . . . 0.0 112.234 -169.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_exo -53.09 148.13 31.84 Favored 'Trans proline' 0 CA--C 1.535 0.573 0 C-N-CA 124.176 3.251 . . . . 0.0 113.178 171.366 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 74.2 0.01 55.29 Favored Glycine 0 CA--C 1.532 1.096 0 CA-C-O 119.221 -0.766 . . . . 0.0 114.684 174.315 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 27.3 m -73.28 143.39 47.03 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 119.026 1.413 . . . . 0.0 111.155 -169.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 11.0 ttp -85.22 132.5 34.27 Favored 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 169.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 65.5 mtm -133.45 127.59 33.63 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 170.071 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 18.6 mm -108.03 124.86 64.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 -173.308 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.5 mp -121.33 134.59 55.14 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 -174.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 53.1 mtt85 -86.23 174.02 9.38 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.789 0.835 . . . . 0.0 110.016 -177.399 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -40.59 -52.52 2.85 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 115.068 1.507 . . . . 0.0 115.068 -172.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -90.34 -13.81 34.4 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 113.056 0.762 . . . . 0.0 113.056 -175.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -77.61 -37.17 50.84 Favored 'General case' 0 C--N 1.339 0.118 0 CA-C-N 118.551 0.614 . . . . 0.0 109.956 -173.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -64.29 -49.52 72.2 Favored Pre-proline 0 CA--C 1.534 0.33 0 CA-C-O 117.605 -1.188 . . . . 0.0 112.822 -175.345 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_exo -54.96 -39.6 89.91 Favored 'Trans proline' 0 CA--C 1.539 0.757 0 CA-C-N 120.997 1.392 . . . . 0.0 111.557 176.339 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -76.16 -7.98 56.0 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 176.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -92.45 -38.16 12.14 Favored 'General case' 0 C--N 1.342 0.274 0 CA-C-N 120.114 1.325 . . . . 0.0 109.622 174.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -77.84 28.83 0.17 Allowed 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -178.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 32.1 p -74.02 -24.62 59.59 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 121.463 -0.773 . . . . 0.0 110.282 173.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -75.38 152.18 38.1 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 171.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 3.1 mppt? -120.88 28.45 7.92 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.895 0.878 . . . . 0.0 111.033 179.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 25.9 mt -69.99 -44.73 78.22 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 -178.304 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 2.6 p -97.57 116.61 65.84 Favored Pre-proline 0 CA--C 1.545 0.765 0 C-N-CA 124.962 1.305 . . . . 0.0 110.084 -170.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -70.55 -50.09 0.4 Allowed 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 122.535 2.156 . . . . 0.0 114.042 -169.238 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . 0.633 ' HD1' ' NE2' ' A' ' 94' ' ' GLN . 10.7 t-80 -60.99 -45.64 93.97 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 178.364 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.633 ' NE2' ' HD1' ' A' ' 93' ' ' HIS . 23.9 mp0 -64.82 -35.88 82.53 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 118.199 -0.905 . . . . 0.0 110.447 -176.287 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -65.28 -41.21 94.4 Favored 'General case' 0 C--O 1.227 -0.128 0 CA-C-N 119.676 1.125 . . . . 0.0 110.028 173.282 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -61.16 -46.28 94.82 Favored Glycine 0 CA--C 1.534 1.237 0 CA-C-N 119.455 1.025 . . . . 0.0 111.232 175.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -58.07 -41.49 83.49 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.261 0.625 . . . . 0.0 110.007 174.103 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -65.33 -36.21 83.36 Favored 'General case' 0 N--CA 1.444 -0.772 0 O-C-N 121.049 -1.032 . . . . 0.0 110.919 178.311 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -67.15 -22.41 65.77 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 118.616 0.643 . . . . 0.0 110.466 178.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 77.7 t -68.87 -42.08 82.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 168.442 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 42.6 mt -64.65 -35.83 82.3 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-N 119.748 1.158 . . . . 0.0 110.2 179.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 17.0 m -63.79 -45.04 91.49 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 119.229 0.922 . . . . 0.0 110.228 172.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.19 -44.13 97.79 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 119.093 0.861 . . . . 0.0 111.275 176.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.7 mt -60.61 -33.81 73.3 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.238 1.015 . . . . 0.0 109.996 175.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 73.9 ttt-85 -73.68 -34.62 64.97 Favored 'General case' 0 CA--C 1.531 0.238 0 O-C-N 121.141 -0.974 . . . . 0.0 109.792 176.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 14.1 m-30 -69.3 -44.14 72.36 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 123.594 0.758 . . . . 0.0 110.665 179.274 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 36.1 p -73.05 -23.95 60.64 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 118.462 0.573 . . . . 0.0 111.701 179.232 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 73.57 7.57 74.21 Favored Glycine 0 CA--C 1.532 1.148 0 N-CA-C 109.394 -1.482 . . . . 0.0 109.394 -168.383 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -86.04 25.58 1.12 Allowed 'General case' 0 C--N 1.348 0.505 0 CA-C-N 119.851 1.826 . . . . 0.0 110.733 174.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -61.78 139.12 95.49 Favored Pre-proline 0 CA--C 1.546 0.82 0 C-N-CA 124.006 0.922 . . . . 0.0 108.705 169.516 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo -59.71 162.41 15.65 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.963 2.442 . . . . 0.0 114.03 -177.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp -65.07 -37.63 88.16 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 119.061 -0.495 . . . . 0.0 111.475 174.459 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 4.5 pttm -143.5 85.46 1.84 Allowed 'General case' 0 C--O 1.234 0.252 0 C-N-CA 124.031 0.933 . . . . 0.0 108.585 177.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 5.9 tt -75.39 144.8 42.07 Favored 'General case' 0 CA--C 1.537 0.468 0 O-C-N 120.835 -1.165 . . . . 0.0 108.502 169.657 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -137.97 139.64 39.81 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.65 1.18 . . . . 0.0 108.02 177.349 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -118.91 121.12 39.23 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 119.901 1.228 . . . . 0.0 108.658 175.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 3.1 t -89.1 89.98 3.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 N-CA-C 105.855 -1.906 . . . . 0.0 105.855 169.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -81.15 138.78 19.71 Favored Glycine 0 C--N 1.335 0.517 0 N-CA-C 110.273 -1.131 . . . . 0.0 110.273 -178.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 38.9 t -122.15 133.39 68.61 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 174.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 13.4 mt -85.41 135.32 38.87 Favored Pre-proline 0 CA--C 1.535 0.369 0 N-CA-C 105.561 -2.015 . . . . 0.0 105.561 169.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -73.21 167.16 28.05 Favored 'Trans proline' 0 CA--C 1.54 0.786 0 C-N-CA 121.815 1.677 . . . . 0.0 111.732 -179.161 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -94.38 -56.85 2.67 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 168.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 49.0 m -118.73 -55.14 2.21 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -169.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.8 tp 52.21 39.29 26.63 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 126.823 2.049 . . . . 0.0 113.581 -174.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -79.61 163.85 56.64 Favored Pre-proline 0 CA--C 1.544 0.721 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 171.025 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -82.39 94.61 0.88 Allowed 'Trans proline' 0 CA--C 1.542 0.896 0 C-N-CA 121.848 1.699 . . . . 0.0 111.863 -176.132 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.583 ' CE1' ' HG1' ' A' ' 14' ' ' THR . 0.8 OUTLIER -173.48 -176.24 1.27 Allowed 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 104.48 -2.415 . . . . 0.0 104.48 -178.178 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -144.24 154.33 15.27 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 CA-C-N 119.42 1.009 . . . . 0.0 112.325 174.738 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 118.6 85.41 1.01 Allowed Glycine 0 CA--C 1.531 1.035 0 N-CA-C 107.93 -2.068 . . . . 0.0 107.93 -174.245 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 81.9 mt -36.55 139.41 0.18 Allowed 'General case' 0 C--N 1.352 0.711 0 N-CA-C 115.192 1.553 . . . . 0.0 115.192 -169.688 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 4.4 p -58.96 151.89 52.98 Favored Pre-proline 0 CA--C 1.535 0.4 0 CA-C-N 113.97 -1.468 . . . . 0.0 108.74 169.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -60.49 -35.24 91.25 Favored 'Trans proline' 0 CA--C 1.537 0.63 0 C-N-CA 121.726 1.618 . . . . 0.0 111.74 -176.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -60.57 -36.21 77.93 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 123.704 0.802 . . . . 0.0 110.834 177.123 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 61.4 t -94.2 -32.49 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 C-N-CA 122.628 0.371 . . . . 0.0 110.004 -172.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -53.91 -46.45 71.47 Favored 'General case' 0 C--N 1.33 -0.24 0 O-C-N 121.347 -0.846 . . . . 0.0 109.311 169.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -69.06 -16.77 63.77 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 -177.38 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 24.4 mmm -77.94 -8.03 57.57 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 125.47 1.508 . . . . 0.0 113.039 172.135 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 53.5 mt -56.86 -56.06 16.58 Favored 'Isoleucine or valine' 0 C--N 1.344 0.353 0 CA-C-N 120.835 1.652 . . . . 0.0 109.157 176.222 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -67.52 -45.59 47.16 Favored Pre-proline 0 CA--C 1.544 0.714 0 CA-C-O 117.822 -1.085 . . . . 0.0 111.033 -174.227 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -42.94 -58.5 1.3 Allowed 'Trans proline' 0 C--N 1.349 0.578 1 C-N-CA 125.478 4.118 . . . . 0.0 112.979 168.66 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -69.2 -35.91 76.72 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.363 -0.835 . . . . 0.0 112.148 -177.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 25.8 mt -57.07 -41.14 78.26 Favored 'General case' 0 CA--C 1.521 -0.146 0 CA-C-N 119.546 1.066 . . . . 0.0 109.068 171.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -62.25 -35.05 77.78 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 118.862 0.755 . . . . 0.0 110.165 178.376 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -64.24 -46.35 84.18 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 119.623 1.102 . . . . 0.0 111.217 173.064 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 36.2 t -56.65 -48.67 80.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 178.181 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 37.7 mt -62.89 -34.46 77.46 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 118.487 -0.768 . . . . 0.0 110.946 178.104 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -67.2 -46.43 73.89 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 119.81 1.186 . . . . 0.0 110.83 178.125 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -64.46 -32.26 73.82 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 119.679 1.127 . . . . 0.0 111.12 177.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 14.1 mt -63.11 -54.75 32.95 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 171.272 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 78.4 mtm-85 -61.21 -32.05 71.82 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 120.336 1.426 . . . . 0.0 111.765 -178.125 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -70.52 -27.65 64.34 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 118.677 0.671 . . . . 0.0 110.332 179.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 23.5 m -81.12 5.47 16.66 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.601 1.16 . . . . 0.0 111.77 169.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 70.89 13.7 72.5 Favored Glycine 0 CA--C 1.53 0.997 0 CA-C-O 117.641 -1.644 . . . . 0.0 112.497 -171.238 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 58.3 t -90.62 118.05 35.1 Favored 'Isoleucine or valine' 0 C--N 1.347 0.463 0 CA-C-N 120.603 2.202 . . . . 0.0 107.787 -177.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -93.86 96.06 9.5 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 171.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -59.63 139.93 56.8 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 169.004 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 11.1 mm -85.41 123.61 72.71 Favored Pre-proline 0 CA--C 1.534 0.342 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 -174.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -64.2 103.23 0.42 Allowed 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 122.913 2.409 . . . . 0.0 105.928 171.184 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 20.4 tpp85 45.3 -110.28 0.22 Allowed 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 104.954 -2.239 . . . . 0.0 104.954 -166.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 3.7 p -155.55 155.73 33.89 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 119.766 1.166 . . . . 0.0 109.576 169.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -86.38 103.48 14.99 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 174.207 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 45.7 m . . . . . 0 C--O 1.255 1.37 0 C-N-CA 125.827 1.651 . . . . 0.0 108.353 179.161 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.1 tpt . . . . . 0 N--CA 1.498 1.938 0 CA-C-O 119.708 -0.187 . . . . 0.0 110.558 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 8.5 ptp180 -151.43 121.66 7.25 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-O 118.036 -0.983 . . . . 0.0 108.662 177.494 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 52.0 mt -140.31 144.16 28.19 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-N 120.033 1.288 . . . . 0.0 110.873 -169.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 3.1 mt -127.8 122.18 32.07 Favored 'General case' 0 CA--C 1.519 -0.248 0 N-CA-C 107.046 -1.465 . . . . 0.0 107.046 168.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 11.5 t -97.46 111.86 28.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 1 N-CA-C 100.125 -4.028 . . . . 0.0 100.125 168.688 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -117.35 107.32 14.23 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 123.112 0.565 . . . . 0.0 109.497 -168.048 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -89.74 123.82 7.12 Favored Glycine 0 N--CA 1.448 -0.511 0 N-CA-C 108.722 -1.751 . . . . 0.0 108.722 179.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.6 m -132.52 -177.91 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.805 0 C-N-CA 124.053 0.941 . . . . 0.0 109.532 -179.314 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 98.07 131.22 7.07 Favored Glycine 0 N--CA 1.437 -1.281 0 N-CA-C 107.158 -2.377 . . . . 0.0 107.158 -169.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -69.16 131.52 45.08 Favored 'General case' 0 N--CA 1.451 -0.379 0 O-C-N 121.846 -0.797 . . . . 0.0 111.947 -168.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.4 pt -79.06 41.39 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 123.605 0.762 . . . . 0.0 112.961 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 19.4 mt -129.7 -12.09 4.35 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 120.129 1.331 . . . . 0.0 109.833 171.22 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.1 mp -117.1 62.7 0.73 Allowed 'General case' 0 C--N 1.346 0.434 0 CA-C-O 122.116 0.96 . . . . 0.0 109.766 -169.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.9 m 51.71 -119.59 1.48 Allowed 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 114.322 -1.308 . . . . 0.0 112.059 169.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 61.3 m-20 -50.92 -23.07 2.58 Favored 'General case' 0 N--CA 1.44 -0.929 0 C-N-CA 127.866 2.466 . . . . 0.0 114.282 179.083 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -63.28 -26.34 68.73 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 119.643 1.11 . . . . 0.0 110.456 -179.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.74 -8.7 45.34 Favored 'General case' 0 N--CA 1.438 -1.059 0 CA-C-O 116.819 -1.562 . . . . 0.0 111.215 176.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.1 tp -51.67 -45.43 36.93 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.414 0 CA-C-N 121.341 1.882 . . . . 0.0 111.132 -173.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -63.51 -34.63 90.45 Favored Glycine 0 CA--C 1.526 0.771 0 CA-C-N 119.131 0.878 . . . . 0.0 111.324 -177.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 97.8 t -68.18 -48.43 73.9 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 CA-C-N 117.518 0.659 . . . . 0.0 109.32 172.304 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 24.1 mmt180 -57.52 -29.65 64.5 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 117.429 -1.272 . . . . 0.0 112.147 177.287 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 5.7 mm -62.42 -53.98 40.12 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-N 120.818 1.645 . . . . 0.0 109.046 176.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 26.5 m -70.61 -34.7 58.14 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 CA-C-N 118.833 0.742 . . . . 0.0 111.312 -176.206 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 58.3 mt-10 -65.36 -45.03 85.72 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 118.954 0.797 . . . . 0.0 110.015 176.209 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.67 -39.88 95.43 Favored 'General case' 0 N--CA 1.452 -0.342 0 O-C-N 121.808 -0.557 . . . . 0.0 109.982 176.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 5.7 tp -64.55 -39.2 93.32 Favored 'General case' 0 C--O 1.221 -0.4 0 CA-C-N 118.858 0.754 . . . . 0.0 110.169 -178.368 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -61.95 -26.23 68.07 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 121.501 0.667 . . . . 0.0 112.493 -178.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -93.33 -40.86 10.17 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 125.994 1.718 . . . . 0.0 111.125 -178.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 37.3 mmm-85 -83.29 -31.17 27.04 Favored 'General case' 0 C--N 1.333 -0.112 0 C-N-CA 123.021 0.528 . . . . 0.0 110.833 -174.393 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -123.89 146.92 48.09 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-O 122.313 1.054 . . . . 0.0 112.728 -177.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 39.3 mm -98.92 135.29 34.52 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 N-CA-C 104.887 -2.264 . . . . 0.0 104.887 169.404 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -120.24 148.6 47.62 Favored Pre-proline 0 CA--C 1.537 0.447 0 C-N-CA 124.025 0.93 . . . . 0.0 109.943 -169.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -67.4 158.62 56.2 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 123.05 2.5 . . . . 0.0 110.253 170.12 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -57.69 -33.79 68.76 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 114.48 1.289 . . . . 0.0 114.48 -169.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 10.8 p90 -74.37 -12.82 60.63 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 112.786 0.661 . . . . 0.0 112.786 -176.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 74.0 t -89.67 125.61 42.62 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 172.319 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 52.1 mm-40 -113.18 130.6 56.16 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 169.01 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -95.78 116.28 37.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 104.877 -2.268 . . . . 0.0 104.877 168.766 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 65.3 tp -118.19 129.02 55.26 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 118.073 0.397 . . . . 0.0 110.373 -179.149 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -88.7 107.04 18.73 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 106.312 -1.736 . . . . 0.0 106.312 168.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -92.32 -40.33 5.14 Favored Glycine 0 CA--C 1.535 1.308 0 N-CA-C 110.432 -1.067 . . . . 0.0 110.432 169.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 57.3 -103.69 0.33 Allowed Glycine 0 C--N 1.341 0.807 0 CA-C-N 117.773 0.787 . . . . 0.0 112.683 171.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 19.8 p -67.9 -5.82 18.76 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 126.521 1.929 . . . . 0.0 113.237 -179.518 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.48 -63.16 1.39 Allowed 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 -172.16 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 53.69 -110.06 1.31 Allowed Glycine 0 CA--C 1.535 1.283 0 N-CA-C 110.62 -0.992 . . . . 0.0 110.62 -170.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.06 -30.42 66.18 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.553 1.141 . . . . 0.0 111.268 -177.382 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -56.82 -19.74 18.86 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 -174.092 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 20.5 mt -85.12 12.99 6.76 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 113.551 0.945 . . . . 0.0 113.551 -177.437 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 6.3 tt -42.04 -61.0 1.24 Allowed 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.27 1.028 . . . . 0.0 112.63 -172.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -79.73 -30.42 43.96 Favored Glycine 0 CA--C 1.527 0.819 0 N-CA-C 111.392 -0.683 . . . . 0.0 111.392 -179.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -67.43 -36.06 80.5 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 118.428 1.114 . . . . 0.0 112.112 -169.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 36.2 mtp -75.4 -9.93 59.0 Favored 'General case' 0 N--CA 1.451 -0.399 0 O-C-N 122.037 -0.414 . . . . 0.0 111.765 -178.264 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.63 151.62 40.77 Favored 'General case' 0 N--CA 1.445 -0.723 0 C-N-CA 123.149 0.58 . . . . 0.0 112.474 -169.271 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . 0.281 15.5 p30 53.51 21.21 2.38 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 128.749 2.82 . . . . 0.0 116.211 170.041 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 17.4 mmt180 -75.5 160.0 30.67 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 169.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -86.57 -52.39 5.58 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 176.734 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . 0.25 0.0 OUTLIER -124.53 143.31 50.74 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 119.952 1.251 . . . . 0.0 107.713 169.37 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 4.5 tt -139.97 120.8 14.45 Favored 'General case' 0 CA--C 1.501 -0.911 0 N-CA-C 105.476 -2.046 . . . . 0.0 105.476 -178.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 25.8 mt -100.21 106.09 18.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 106.104 -1.813 . . . . 0.0 106.104 179.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 16.9 mt -75.13 133.63 31.04 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 N-CA-C 105.135 -2.172 . . . . 0.0 105.135 169.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -120.16 121.49 38.89 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 104.915 -2.254 . . . . 0.0 104.915 168.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 36.8 t0 -156.75 162.19 39.77 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 118.529 0.604 . . . . 0.0 110.287 -171.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -103.74 157.23 17.21 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 121.927 0.87 . . . . 0.0 109.994 172.227 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 5.1 mp -134.64 88.09 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 N-CA-C 106.892 -1.521 . . . . 0.0 106.892 -176.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 31.5 m -52.48 -21.1 2.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 C-N-CA 125.89 1.676 . . . . 0.0 112.217 168.568 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.6 m -78.01 174.08 11.49 Favored 'General case' 0 N--CA 1.442 -0.845 0 C-N-CA 124.249 1.02 . . . . 0.0 111.852 -169.289 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 18.2 ttmm 67.25 163.12 0.19 Allowed 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 126.108 1.763 . . . . 0.0 111.907 -179.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 23.1 mtmt -77.38 -7.83 56.72 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 125.301 1.44 . . . . 0.0 112.134 179.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 43.5 t-20 -68.16 156.94 36.46 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.232 1.013 . . . . 0.0 110.234 -169.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 2.2 m -62.3 149.18 88.08 Favored Pre-proline 0 CA--C 1.546 0.795 0 C-N-CA 124.663 1.185 . . . . 0.0 113.446 -169.004 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_exo -58.9 159.81 20.14 Favored 'Trans proline' 0 CA--C 1.533 0.465 0 C-N-CA 124.029 3.153 . . . . 0.0 111.625 168.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 65.64 19.15 66.79 Favored Glycine 0 CA--C 1.53 0.986 0 CA-C-O 119.753 -0.471 . . . . 0.0 112.952 172.299 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 2.7 m -99.24 142.46 30.7 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 124.495 1.118 . . . . 0.0 109.448 -172.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 13.4 ttp -91.1 134.88 34.16 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 172.607 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 69.6 mtm -122.28 115.73 22.86 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 170.539 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 28.1 mm -102.87 120.81 53.22 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 -177.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.6 mp -128.09 137.18 52.04 Favored 'General case' 0 C--O 1.236 0.376 0 O-C-N 123.97 0.793 . . . . 0.0 109.812 -173.09 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 53.6 mtt85 -89.16 176.31 7.02 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.237 1.015 . . . . 0.0 110.042 -177.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -38.01 -58.94 0.89 Allowed 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.466 1.507 . . . . 0.0 113.762 -173.119 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -86.61 -15.9 38.36 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -171.447 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -75.13 -36.83 61.57 Favored 'General case' 0 N--CA 1.457 -0.11 0 O-C-N 121.876 -0.515 . . . . 0.0 109.902 -175.336 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -66.37 -49.23 54.39 Favored Pre-proline 0 CA--C 1.535 0.383 0 CA-C-O 117.653 -1.165 . . . . 0.0 112.585 -174.619 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -55.32 -37.78 94.3 Favored 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 121.758 1.639 . . . . 0.0 111.594 174.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.11 -2.37 37.08 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 114.234 1.198 . . . . 0.0 114.234 176.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -102.48 -38.46 7.56 Favored 'General case' 0 C--N 1.344 0.33 0 CA-C-N 119.805 1.184 . . . . 0.0 111.376 179.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 43.9 m-85 -70.41 0.94 5.62 Favored 'General case' 0 CA--C 1.544 0.746 0 O-C-N 121.641 -0.662 . . . . 0.0 112.5 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 64.5 p -57.84 -21.0 40.23 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.577 1.551 . . . . 0.0 112.687 174.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 11.1 p30 -60.82 -30.51 70.12 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 118.66 -0.686 . . . . 0.0 112.489 175.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 30.3 mtmm 50.82 27.34 3.05 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 125.152 1.381 . . . . 0.0 114.32 177.205 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 13.5 mt -72.35 -43.15 65.01 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 O-C-N 121.252 -0.905 . . . . 0.0 109.523 -174.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 3.1 p -113.25 143.2 28.79 Favored Pre-proline 0 CA--C 1.544 0.716 0 C-N-CA 123.675 0.79 . . . . 0.0 112.54 -169.541 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -75.31 -42.26 0.5 Allowed 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 122.76 2.307 . . . . 0.0 113.704 -169.147 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 10.2 t-80 -61.81 -45.42 93.91 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 119.399 1.0 . . . . 0.0 108.885 178.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 21.5 mp0 -62.15 -41.94 98.77 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 125.27 1.428 . . . . 0.0 108.634 -177.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 50.7 tp -64.14 -38.19 90.16 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 119.145 0.884 . . . . 0.0 110.995 174.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -63.1 -51.11 57.69 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 110.556 -1.018 . . . . 0.0 110.556 176.599 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -56.94 -43.05 81.12 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.207 0.603 . . . . 0.0 109.963 175.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -62.77 -37.81 88.13 Favored 'General case' 0 N--CA 1.452 -0.36 0 O-C-N 121.306 -0.871 . . . . 0.0 111.413 177.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -69.3 -22.36 63.8 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 118.851 0.75 . . . . 0.0 110.83 178.327 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 97.6 t -68.04 -42.72 85.47 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 168.631 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 92.1 mt -63.73 -36.75 84.88 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 119.348 0.977 . . . . 0.0 109.934 178.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 70.3 m -64.59 -41.68 96.08 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 119.249 0.931 . . . . 0.0 110.726 171.178 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.49 -44.07 97.74 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 120.254 1.388 . . . . 0.0 110.611 176.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.9 mt -63.37 -33.04 74.67 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.669 1.188 . . . . 0.0 110.765 176.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 65.7 ttp85 -73.65 -31.79 63.68 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.008 0.923 . . . . 0.0 110.001 176.057 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 14.9 m-30 -71.34 -46.04 61.5 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 119.185 0.902 . . . . 0.0 110.473 177.095 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 34.0 p -73.84 -24.33 59.76 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 123.128 0.571 . . . . 0.0 112.132 -178.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 74.63 8.0 80.55 Favored Glycine 0 CA--C 1.536 1.351 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -168.329 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -85.04 22.0 1.51 Allowed 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 119.851 1.826 . . . . 0.0 111.438 174.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -60.48 137.63 92.38 Favored Pre-proline 0 CA--C 1.545 0.771 0 C-N-CA 124.175 0.99 . . . . 0.0 108.737 169.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -61.25 163.36 17.4 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.779 2.319 . . . . 0.0 114.543 -176.192 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 68.3 mmtt -67.96 -35.57 78.61 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 118.941 -0.552 . . . . 0.0 112.37 175.117 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 8.2 ttmm -142.08 66.63 1.34 Allowed 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 -175.382 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 7.8 tt -70.83 138.38 50.26 Favored 'General case' 0 C--O 1.234 0.238 0 O-C-N 120.063 -1.648 . . . . 0.0 108.476 172.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -134.61 136.59 43.02 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 179.487 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -114.06 122.46 46.96 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 119.956 1.253 . . . . 0.0 107.874 175.639 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 21.3 t -95.87 85.52 1.63 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 N-CA-C 106.316 -1.735 . . . . 0.0 106.316 169.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -77.25 148.63 34.57 Favored Glycine 0 N--CA 1.445 -0.741 0 N-CA-C 110.706 -0.958 . . . . 0.0 110.706 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 46.9 t -124.54 165.72 21.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 171.716 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 15.5 mt -117.55 120.21 33.39 Favored Pre-proline 0 N--CA 1.468 0.428 0 CA-C-N 121.232 1.833 . . . . 0.0 108.605 171.069 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -55.16 158.93 10.84 Favored 'Trans proline' 0 N--CA 1.455 -0.775 1 C-N-CA 126.142 4.561 . . . . 0.0 116.093 175.614 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -107.75 -64.24 1.23 Allowed 'General case' 0 C--O 1.236 0.344 0 C-N-CA 124.348 1.059 . . . . 0.0 109.628 178.28 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 70.5 m -106.03 -50.13 3.23 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 119.093 -0.479 . . . . 0.0 110.154 -171.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.2 tp 51.97 32.51 10.19 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 124.126 0.971 . . . . 0.0 112.812 178.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -83.49 164.6 44.5 Favored Pre-proline 0 CA--C 1.544 0.734 0 O-C-N 121.525 -0.734 . . . . 0.0 109.417 176.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -78.65 82.96 2.34 Favored 'Trans proline' 0 CA--C 1.544 1.012 0 C-N-CA 121.869 1.713 . . . . 0.0 111.953 -173.142 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -175.67 153.22 1.4 Allowed 'General case' 0 C--O 1.234 0.269 0 N-CA-C 104.276 -2.491 . . . . 0.0 104.276 -177.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -110.38 160.71 9.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.552 0.692 . . . . 0.0 111.861 -170.234 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 108.11 141.37 9.69 Favored Glycine 0 CA--C 1.529 0.929 0 N-CA-C 106.457 -2.657 . . . . 0.0 106.457 -169.286 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 74.8 mt -80.7 154.03 27.52 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 118.065 0.932 . . . . 0.0 109.667 179.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 68.2 p -70.82 168.47 20.15 Favored Pre-proline 0 CA--C 1.541 0.619 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 169.394 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_exo -59.76 -40.21 66.08 Favored 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 121.717 1.611 . . . . 0.0 111.165 173.447 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 85.3 m -59.67 -37.45 78.8 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 124.619 1.168 . . . . 0.0 111.751 -179.358 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 58.4 t -98.51 -29.32 3.53 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 O-C-N 121.776 -0.578 . . . . 0.0 110.638 -174.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -52.37 -45.37 65.74 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 119.518 1.054 . . . . 0.0 108.793 169.193 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -65.68 -15.97 63.31 Favored 'General case' 0 N--CA 1.447 -0.575 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 -177.589 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 14.1 mmm -83.45 -8.41 59.38 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 125.321 1.448 . . . . 0.0 112.425 175.475 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 54.8 mt -56.75 -56.51 13.84 Favored 'Isoleucine or valine' 0 C--N 1.343 0.293 0 CA-C-N 120.192 1.36 . . . . 0.0 108.788 172.071 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 64.3 mm-40 -63.48 -49.7 76.95 Favored Pre-proline 0 CA--C 1.541 0.618 0 CA-C-O 117.468 -1.253 . . . . 0.0 109.99 -172.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -39.96 -56.58 1.38 Allowed 'Trans proline' 0 C--N 1.35 0.613 1 C-N-CA 125.798 4.332 . . . . 0.0 113.353 168.904 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -69.93 -35.5 74.58 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.649 -178.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 37.3 mt -64.06 -45.99 86.35 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 120.806 1.639 . . . . 0.0 109.345 176.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -54.61 -36.43 64.46 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 118.52 0.6 . . . . 0.0 110.226 174.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 70.8 tp60 -75.86 -38.99 57.4 Favored 'General case' 0 N--CA 1.423 -1.809 0 O-C-N 121.465 -0.772 . . . . 0.0 110.913 -179.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 37.2 t -58.68 -45.18 90.99 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 CA-C-N 119.276 0.943 . . . . 0.0 108.93 173.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 56.8 mt -60.85 -36.82 80.12 Favored 'General case' 0 C--O 1.226 -0.176 0 CA-C-O 119.09 -0.481 . . . . 0.0 110.218 175.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -68.68 -46.11 69.94 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 119.523 1.056 . . . . 0.0 111.29 179.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -66.88 -28.81 68.63 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 119.76 1.164 . . . . 0.0 111.068 178.424 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 23.9 mt -63.39 -51.22 66.71 Favored 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 169.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 96.8 mtt-85 -66.69 -16.06 63.95 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 117.845 -1.074 . . . . 0.0 112.543 179.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 33.1 mm-40 -65.97 -24.38 66.78 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 120.769 1.622 . . . . 0.0 110.899 172.176 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 65.3 m -100.53 18.98 17.72 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 119.436 1.016 . . . . 0.0 110.087 168.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 69.43 20.03 74.99 Favored Glycine 0 C--N 1.337 0.595 0 CA-C-O 117.838 -1.535 . . . . 0.0 112.276 -178.073 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 18.0 t -88.05 117.3 31.53 Favored 'Isoleucine or valine' 0 C--N 1.344 0.358 0 CA-C-N 120.23 2.015 . . . . 0.0 107.393 -172.331 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -101.87 88.14 3.3 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 177.16 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -58.06 141.7 49.2 Favored 'General case' 0 CA--C 1.539 0.558 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 169.223 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 30.9 mm -98.82 122.56 52.52 Favored Pre-proline 0 N--CA 1.463 0.176 0 CA-C-O 117.396 -1.287 . . . . 0.0 108.976 -172.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -63.12 106.53 0.56 Allowed 'Trans proline' 0 N--CA 1.459 -0.529 0 C-N-CA 122.17 1.913 . . . . 0.0 109.017 173.237 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 56.7 mtm180 39.9 48.02 1.98 Allowed 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 125.974 1.71 . . . . 0.0 113.604 179.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . 0.272 2.4 p 53.16 18.31 1.16 Allowed 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 126.698 1.999 . . . . 0.0 115.137 179.628 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -80.8 120.94 25.31 Favored 'General case' 0 C--O 1.238 0.449 0 O-C-N 120.938 -1.101 . . . . 0.0 109.696 177.068 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 14.1 m . . . . . 0 C--O 1.256 1.396 0 C-N-CA 124.199 1.0 . . . . 0.0 110.886 -175.937 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.6 tpt . . . . . 0 N--CA 1.496 1.839 0 CA-C-O 119.611 -0.233 . . . . 0.0 110.483 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 6.4 ptm85 -143.53 125.35 15.13 Favored 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 176.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 33.9 mt -137.72 148.77 25.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 CA-C-N 121.06 1.755 . . . . 0.0 111.922 -169.023 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 16.4 tp -134.55 111.07 9.77 Favored 'General case' 0 C--N 1.341 0.199 0 N-CA-C 105.484 -2.043 . . . . 0.0 105.484 168.081 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 24.9 t -90.68 115.36 29.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 102.927 -2.99 . . . . 0.0 102.927 170.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -115.37 113.03 23.23 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 123.173 0.589 . . . . 0.0 110.927 -168.376 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -94.13 121.65 6.78 Favored Glycine 0 N--CA 1.445 -0.712 0 N-CA-C 108.055 -2.018 . . . . 0.0 108.055 173.625 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.4 m -131.95 -167.68 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 C-N-CA 124.012 0.925 . . . . 0.0 108.625 -177.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 105.49 158.1 22.75 Favored Glycine 0 C--N 1.333 0.38 0 N-CA-C 110.505 -1.038 . . . . 0.0 110.505 -175.556 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -81.65 94.81 7.02 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 124.572 1.149 . . . . 0.0 108.915 -174.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.3 pt -69.82 27.58 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 N-CA-C 114.659 1.355 . . . . 0.0 114.659 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 38.3 mt -114.31 -9.66 12.78 Favored 'General case' 0 C--O 1.224 -0.245 0 O-C-N 121.138 -0.976 . . . . 0.0 108.581 171.34 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.1 mp -120.75 74.35 1.06 Allowed 'General case' 0 CA--C 1.502 -0.879 0 N-CA-C 105.475 -2.046 . . . . 0.0 105.475 -169.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.464 ' HG1' ' CE1' ' A' ' 127' ' ' HIS . 20.1 m 36.08 -106.53 0.04 OUTLIER 'General case' 0 N--CA 1.447 -0.585 0 O-C-N 126.215 2.197 . . . . 0.0 113.012 169.118 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -68.2 -13.67 62.41 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 114.628 1.344 . . . . 0.0 114.628 -170.165 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -65.84 -19.57 65.93 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 121.457 1.935 . . . . 0.0 111.769 173.258 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.58 -10.81 49.19 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 116.165 -1.874 . . . . 0.0 111.162 172.552 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 6.6 tp -54.96 -38.79 46.65 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 CA-C-N 121.753 2.069 . . . . 0.0 110.977 -178.155 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -60.0 -46.04 94.85 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 110.764 -0.935 . . . . 0.0 110.764 178.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 61.7 t -65.11 -47.4 87.91 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 O-C-N 122.175 -0.603 . . . . 0.0 109.68 174.559 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 20.3 mmt180 -60.21 -32.01 70.7 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 117.374 -1.298 . . . . 0.0 112.922 -178.181 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 20.3 mt -62.97 -44.13 99.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-N 121.151 1.796 . . . . 0.0 110.158 179.257 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 28.4 m -73.74 -34.59 41.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 CA-C-N 120.128 1.331 . . . . 0.0 111.542 -178.185 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 57.8 mt-10 -62.22 -42.37 99.25 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 117.957 0.344 . . . . 0.0 110.458 171.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -67.79 -38.29 83.15 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 119.051 0.842 . . . . 0.0 111.23 176.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 7.1 tp -63.51 -39.52 94.64 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 119.418 1.008 . . . . 0.0 109.844 -177.463 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -61.93 -18.83 61.66 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.88 0.872 . . . . 0.0 113.117 -179.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -102.57 -43.61 5.57 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 126.622 1.969 . . . . 0.0 110.992 -178.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 53.5 mmt-85 -74.69 -34.11 62.57 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.259 0.623 . . . . 0.0 110.547 -176.184 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 -124.89 154.03 41.71 Favored 'General case' 0 CA--C 1.521 -0.163 0 CA-C-O 121.417 0.627 . . . . 0.0 111.944 -178.201 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 47.7 mm -106.26 135.27 45.22 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 N-CA-C 103.418 -2.808 . . . . 0.0 103.418 168.047 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -119.07 149.78 47.6 Favored Pre-proline 0 C--O 1.237 0.438 0 CA-C-O 118.661 -0.685 . . . . 0.0 109.953 -169.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -65.95 162.08 36.79 Favored 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 122.992 2.461 . . . . 0.0 111.562 173.167 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -58.25 -33.69 69.65 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 115.046 1.498 . . . . 0.0 115.046 -169.196 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 8.6 p90 -73.06 -8.73 57.05 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 -178.016 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 76.1 t -88.99 128.16 41.27 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 174.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -116.08 124.35 50.19 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 105.913 -1.884 . . . . 0.0 105.913 169.063 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -93.53 112.9 27.33 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 N-CA-C 104.402 -2.444 . . . . 0.0 104.402 168.61 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 61.4 tp -112.36 128.94 56.43 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 -178.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -89.31 118.96 29.37 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 169.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -78.66 -79.98 0.76 Allowed Glycine 0 CA--C 1.526 0.764 0 N-CA-C 107.234 -2.346 . . . . 0.0 107.234 169.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 78.54 104.65 0.2 Allowed Glycine 0 C--N 1.344 0.974 0 N-CA-C 108.675 -1.77 . . . . 0.0 108.675 -177.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 12.9 p 52.74 50.72 17.48 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 123.535 0.734 . . . . 0.0 109.286 -178.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -104.4 -79.66 0.55 Allowed 'General case' 0 C--N 1.348 0.528 0 CA-C-N 115.312 -0.858 . . . . 0.0 112.105 -169.239 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 59.81 -110.55 2.88 Favored Glycine 0 CA--C 1.533 1.164 0 N-CA-C 110.075 -1.21 . . . . 0.0 110.075 -174.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 12.1 tpt -62.52 -21.57 65.63 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.844 1.258 . . . . 0.0 113.442 -173.366 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -63.91 -18.81 64.58 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 114.193 1.183 . . . . 0.0 114.193 -174.23 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 10.3 mt -100.52 14.37 31.53 Favored 'General case' 0 C--N 1.34 0.173 0 N-CA-C 115.643 1.719 . . . . 0.0 115.643 -168.087 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 6.1 tt -49.1 -55.63 11.63 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 118.968 0.804 . . . . 0.0 110.9 -176.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -67.67 -32.64 78.74 Favored Glycine 0 CA--C 1.527 0.809 0 CA-C-O 119.224 -0.764 . . . . 0.0 112.419 -176.491 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -80.76 -35.36 33.38 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 119.049 1.424 . . . . 0.0 110.763 -171.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 79.8 mtp -69.28 -14.07 62.74 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.134 0.973 . . . . 0.0 111.088 176.084 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -68.07 140.11 56.26 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 123.572 0.749 . . . . 0.0 112.199 -169.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 15.7 p30 50.56 22.17 1.02 Allowed 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 127.776 2.43 . . . . 0.0 115.09 172.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 17.9 mmt180 -71.23 150.15 45.56 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 170.315 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 46.1 m-20 -79.85 -53.68 6.55 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -116.22 145.16 43.34 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-N 120.422 1.464 . . . . 0.0 107.474 168.802 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 22.7 tp -132.19 105.83 7.59 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 103.516 -2.772 . . . . 0.0 103.516 176.044 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 28.0 mt -93.69 112.73 27.15 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 N-CA-C 104.205 -2.517 . . . . 0.0 104.205 173.138 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 24.1 mt -93.49 130.72 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 N-CA-C 105.572 -2.01 . . . . 0.0 105.572 176.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -111.83 124.13 51.71 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 105.414 -2.069 . . . . 0.0 105.414 169.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.416 ' CG ' HE21 ' A' ' 94' ' ' GLN . 42.9 t0 -158.59 159.12 35.1 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 124.285 1.034 . . . . 0.0 108.265 -177.031 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -89.25 144.7 25.91 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 170.099 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 31.9 mt -88.27 -25.56 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 C-N-CA 123.917 0.887 . . . . 0.0 110.453 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . 0.461 12.5 m 58.51 -15.08 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 N-CA-C 119.449 3.129 . . . . 0.0 119.449 176.296 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 5.9 p -157.99 131.26 7.59 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 121.101 1.773 . . . . 0.0 113.778 169.037 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 12.7 tppt? -166.39 175.35 8.24 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 128.236 2.614 . . . . 0.0 105.485 169.063 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.0 -23.8 63.2 Favored 'General case' 0 N--CA 1.474 0.741 0 O-C-N 121.662 -0.648 . . . . 0.0 111.62 174.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 -69.14 162.37 27.15 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.078 0.951 . . . . 0.0 110.994 -173.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 3.1 m -61.63 154.22 66.76 Favored Pre-proline 0 CA--C 1.548 0.873 0 C-N-CA 124.922 1.289 . . . . 0.0 112.697 -169.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_exo -57.32 159.34 16.11 Favored 'Trans proline' 0 N--CA 1.462 -0.375 0 C-N-CA 123.878 3.052 . . . . 0.0 112.591 169.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 64.99 10.18 44.91 Favored Glycine 0 CA--C 1.538 1.514 0 CA-C-O 119.314 -0.714 . . . . 0.0 114.508 171.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 3.3 m -90.98 151.93 20.88 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 125.932 1.693 . . . . 0.0 111.305 -169.408 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 29.0 ttp -96.3 139.5 32.35 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 169.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 70.0 mtm -131.14 131.17 43.91 Favored 'General case' 0 N--CA 1.462 0.129 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 169.412 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 9.5 mm -89.25 123.17 41.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 177.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -113.86 123.97 51.09 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 171.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 85.0 mtm180 -87.67 174.36 8.47 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 123.537 0.735 . . . . 0.0 110.515 -178.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -41.37 -53.87 3.19 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 115.884 1.809 . . . . 0.0 115.884 -169.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -84.03 -16.68 43.01 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -177.002 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -82.4 -37.01 26.14 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 -171.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -64.57 -45.51 76.58 Favored Pre-proline 0 CA--C 1.531 0.242 0 CA-C-O 117.221 -1.371 . . . . 0.0 113.862 -176.732 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -53.61 -42.34 66.73 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 121.981 1.787 . . . . 0.0 110.262 174.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -75.54 4.34 7.74 Favored 'General case' 0 CA--C 1.55 0.943 0 N-CA-C 114.466 1.284 . . . . 0.0 114.466 175.28 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -116.18 -41.77 3.12 Favored 'General case' 0 C--N 1.343 0.316 0 CA-C-N 120.09 1.313 . . . . 0.0 111.155 -177.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -62.75 -8.92 7.65 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 178.167 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 63.2 p -51.65 -28.88 15.84 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.928 1.291 . . . . 0.0 112.955 173.216 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 53.8 t-20 -52.46 117.4 2.83 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.279 0.632 . . . . 0.0 111.17 -175.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -74.95 -19.36 60.14 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.733 0.813 . . . . 0.0 112.329 -173.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 52.7 mt -65.47 -48.89 81.27 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 -178.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 6.6 m -76.08 111.49 15.34 Favored Pre-proline 0 CA--C 1.55 0.955 0 C-N-CA 125.406 1.482 . . . . 0.0 110.444 -169.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -70.56 -60.12 0.07 OUTLIER 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 122.931 2.421 . . . . 0.0 113.847 -168.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 6.7 t-80 -62.32 -40.06 95.09 Favored 'General case' 0 N--CA 1.463 0.2 0 O-C-N 121.463 -0.773 . . . . 0.0 109.319 -178.272 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.416 HE21 ' CG ' ' A' ' 62' ' ' ASP . 18.3 mp0 -62.38 -36.65 82.96 Favored 'General case' 0 N--CA 1.44 -0.961 0 C-N-CA 125.241 1.416 . . . . 0.0 108.943 -176.027 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 57.9 tp -66.72 -36.97 83.73 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 119.43 1.014 . . . . 0.0 110.901 174.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -66.89 -40.51 93.58 Favored Glycine 0 CA--C 1.53 1.027 0 O-C-N 120.962 -1.086 . . . . 0.0 110.931 173.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -61.67 -36.38 80.7 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 172.543 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -56.7 -53.54 56.55 Favored 'General case' 0 CA--C 1.52 -0.21 0 O-C-N 121.145 -0.972 . . . . 0.0 109.672 173.037 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -68.0 -28.4 67.38 Favored 'General case' 0 C--O 1.236 0.362 0 O-C-N 122.961 0.163 . . . . 0.0 110.934 -172.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -70.67 -44.47 76.52 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.951 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 174.311 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 20.2 mt -65.89 -33.08 75.02 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 119.04 0.837 . . . . 0.0 111.079 178.254 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 51.5 m -61.4 -41.73 97.6 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 118.769 0.713 . . . . 0.0 109.204 170.306 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.439 ' HA ' ' CD2' ' A' ' 106' ' ' PHE . . . -64.81 -40.35 95.08 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 119.748 1.158 . . . . 0.0 112.219 177.196 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -61.17 -33.28 73.19 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 119.095 0.861 . . . . 0.0 110.63 171.071 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 22.3 ttm-85 -75.5 -29.61 59.58 Favored 'General case' 0 CA--C 1.534 0.346 0 O-C-N 121.125 -0.984 . . . . 0.0 110.582 178.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.439 ' CD2' ' HA ' ' A' ' 103' ' ' ALA . 15.4 m-30 -69.88 -45.23 68.11 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.552 0.741 . . . . 0.0 110.277 177.208 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 32.8 p -74.46 -24.94 59.12 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 122.925 0.49 . . . . 0.0 111.831 -177.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 78.02 8.78 87.3 Favored Glycine 0 CA--C 1.538 1.499 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 -168.399 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -77.11 10.35 2.43 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 119.776 1.788 . . . . 0.0 111.612 171.382 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -57.32 140.09 79.43 Favored Pre-proline 0 CA--C 1.552 1.045 0 C-N-CA 125.346 1.459 . . . . 0.0 110.65 177.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -63.92 160.36 37.76 Favored 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 123.259 2.639 . . . . 0.0 115.402 -175.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -68.27 -35.42 77.85 Favored 'General case' 0 N--CA 1.473 0.675 0 O-C-N 121.663 -0.648 . . . . 0.0 112.163 171.514 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 61.7 mttm -134.52 92.66 2.94 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 124.253 1.021 . . . . 0.0 108.459 176.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 18.3 tp -78.57 131.58 36.81 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 105.072 -2.195 . . . . 0.0 105.072 168.055 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -132.72 139.45 47.64 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 172.004 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -124.72 123.15 39.39 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 119.739 1.154 . . . . 0.0 108.928 177.151 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 3.7 t -88.99 90.56 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 N-CA-C 105.306 -2.109 . . . . 0.0 105.306 173.401 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -85.96 133.39 11.77 Favored Glycine 0 C--N 1.333 0.376 0 N-CA-C 110.084 -1.207 . . . . 0.0 110.084 -174.231 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 44.8 t -120.35 127.81 75.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 117.908 0.854 . . . . 0.0 109.277 -179.487 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 17.1 mt -84.64 133.85 43.29 Favored Pre-proline 0 CA--C 1.538 0.485 0 N-CA-C 104.923 -2.251 . . . . 0.0 104.923 169.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_endo -73.19 173.43 13.7 Favored 'Trans proline' 0 N--CA 1.452 -0.967 0 C-N-CA 123.008 2.472 . . . . 0.0 110.773 -179.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -107.12 -43.57 4.58 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 105.278 -2.119 . . . . 0.0 105.278 167.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 38.3 m -135.7 135.01 39.72 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.961 0.904 . . . . 0.0 109.764 173.025 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 4.7 tp -140.96 61.4 1.5 Allowed 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.576 1.55 . . . . 0.0 108.458 -178.254 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -126.76 167.6 16.99 Favored Pre-proline 0 CA--C 1.54 0.583 0 N-CA-C 106.294 -1.743 . . . . 0.0 106.294 172.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -77.35 95.92 1.09 Allowed 'Trans proline' 0 N--CA 1.457 -0.648 0 CA-C-N 120.678 1.278 . . . . 0.0 112.005 -175.102 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.464 ' CE1' ' HG1' ' A' ' 14' ' ' THR . 18.6 p-80 -150.67 -19.3 0.23 Allowed 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 114.561 -1.199 . . . . 0.0 113.586 172.041 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . 0.414 0.0 OUTLIER 65.91 159.19 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 N-CA-C 116.343 1.979 . . . . 0.0 116.343 169.212 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 86.22 160.18 33.72 Favored Glycine 0 CA--C 1.529 0.923 0 N-CA-C 106.866 -2.494 . . . . 0.0 106.866 -168.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 68.6 mt -88.18 152.14 22.19 Favored 'General case' 0 N--CA 1.468 0.448 0 O-C-N 120.965 -1.315 . . . . 0.0 110.595 176.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 56.9 p -69.63 167.79 20.99 Favored Pre-proline 0 CA--C 1.538 0.515 0 CA-C-N 115.32 -0.854 . . . . 0.0 109.264 169.217 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -59.36 -37.19 91.83 Favored 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 122.0 1.8 . . . . 0.0 111.636 172.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 17.4 m -68.18 -40.68 82.2 Favored 'General case' 0 N--CA 1.44 -0.958 0 C-N-CA 123.508 0.723 . . . . 0.0 110.589 -177.355 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 84.3 t -88.75 -30.02 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 O-C-N 121.632 -0.667 . . . . 0.0 110.719 -174.159 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -53.27 -45.94 69.07 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 119.202 0.91 . . . . 0.0 108.771 168.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -69.77 -15.48 63.14 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 114.266 1.21 . . . . 0.0 114.266 179.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 9.3 mmm -76.85 -12.72 60.01 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 117.698 -1.144 . . . . 0.0 112.118 172.265 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 58.3 mt -54.33 -54.47 21.35 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.37 0 CA-C-N 120.193 1.36 . . . . 0.0 108.991 173.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 76.7 mm-40 -66.41 -46.74 59.79 Favored Pre-proline 0 CA--C 1.552 1.023 0 CA-C-N 120.329 1.422 . . . . 0.0 111.059 -173.481 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 0.4 OUTLIER -44.71 -52.77 5.75 Favored 'Trans proline' 0 C--N 1.353 0.801 1 C-N-CA 125.645 4.23 . . . . 0.0 112.5 168.75 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.04 -36.48 75.07 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.983 -1.008 . . . . 0.0 112.267 -177.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 42.6 mt -62.27 -41.77 98.76 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 118.897 0.771 . . . . 0.0 109.054 173.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -59.21 -36.02 74.65 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 119.342 0.973 . . . . 0.0 110.561 174.346 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -62.95 -50.14 71.99 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 118.794 0.724 . . . . 0.0 111.455 172.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 66.1 t -56.28 -49.11 78.2 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.19 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 66.6 mt -58.09 -43.09 86.89 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 123.046 0.538 . . . . 0.0 109.704 179.469 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -65.31 -44.85 86.59 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 118.972 0.805 . . . . 0.0 110.661 -177.231 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -64.64 -34.03 77.33 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 119.15 0.886 . . . . 0.0 111.37 -178.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . 0.337 4.4 pp -75.9 -36.97 59.29 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-O 117.346 -1.311 . . . . 0.0 109.762 176.688 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 14.0 mtp-105 -67.49 -27.6 67.14 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 121.113 1.779 . . . . 0.0 110.811 173.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -73.01 -15.73 61.52 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 118.629 0.65 . . . . 0.0 110.58 174.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 15.3 m -93.88 9.05 38.92 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.964 1.305 . . . . 0.0 110.719 169.222 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 74.0 13.17 81.11 Favored Glycine 0 CA--C 1.527 0.815 0 CA-C-O 117.396 -1.78 . . . . 0.0 112.792 -176.212 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 44.5 t -88.76 132.17 34.3 Favored 'Isoleucine or valine' 0 C--N 1.345 0.387 0 CA-C-N 120.985 2.392 . . . . 0.0 107.362 -176.181 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -104.32 93.94 5.08 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 106.675 -1.602 . . . . 0.0 106.675 169.441 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -59.13 137.68 57.86 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 169.105 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 20.6 mm -85.64 126.88 65.06 Favored Pre-proline 0 C--O 1.231 0.119 0 CA-C-O 117.531 -1.223 . . . . 0.0 107.711 -174.625 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -68.1 91.11 0.38 Allowed 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 122.868 2.379 . . . . 0.0 108.998 175.004 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 32.1 ttp85 51.81 17.99 0.7 Allowed 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 127.573 2.349 . . . . 0.0 114.853 179.404 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 52.6 m 48.93 32.47 3.82 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.312 1.045 . . . . 0.0 112.093 -169.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -77.89 -33.28 52.05 Favored 'General case' 0 C--O 1.238 0.45 0 O-C-N 121.906 -0.497 . . . . 0.0 110.77 176.103 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 17.2 m . . . . . 0 C--O 1.255 1.354 0 C-N-CA 126.526 1.93 . . . . 0.0 111.871 170.747 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.8 tpt . . . . . 0 N--CA 1.498 1.934 0 N-CA-C 110.34 -0.245 . . . . 0.0 110.34 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 15.3 ptt180 -148.06 111.28 4.9 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.157 0.983 . . . . 0.0 108.352 178.336 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 73.7 mt -134.56 147.7 29.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 C-N-CA 124.089 0.956 . . . . 0.0 108.544 -172.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 13.7 tp -135.0 146.53 49.13 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 168.304 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 63.1 t -121.4 130.42 74.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 105.513 -2.032 . . . . 0.0 105.513 174.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -121.26 130.23 53.56 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-N 119.004 0.82 . . . . 0.0 110.756 -173.621 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -104.98 132.03 10.92 Favored Glycine 0 C--N 1.334 0.455 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 174.135 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -143.94 159.78 16.0 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-N 118.122 0.961 . . . . 0.0 112.008 -176.167 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 131.72 173.99 13.51 Favored Glycine 0 CA--C 1.527 0.814 0 C-N-CA 126.569 2.033 . . . . 0.0 110.286 170.249 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.436 HD21 ' HB2' ' A' ' 13' ' ' LEU . 5.8 t30 -79.15 93.82 5.27 Favored 'General case' 0 C--O 1.233 0.191 0 O-C-N 121.307 -1.113 . . . . 0.0 110.891 -173.472 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.1 pt -57.46 31.49 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.092 0 N-CA-C 117.48 2.4 . . . . 0.0 117.48 172.285 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 38.3 mt -131.3 -3.75 3.86 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 120.671 1.578 . . . . 0.0 108.808 168.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.436 ' HB2' HD21 ' A' ' 10' ' ' ASN . 2.0 mp -118.1 59.8 0.79 Allowed 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.21 1.004 . . . . 0.0 113.459 -167.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 54.85 -96.92 0.06 Allowed 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 124.495 1.118 . . . . 0.0 111.248 171.201 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 41.1 m-20 -81.79 -15.46 54.16 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 124.601 1.16 . . . . 0.0 110.309 -172.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -72.65 -6.49 44.69 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 120.875 1.67 . . . . 0.0 112.609 178.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -82.3 -12.04 58.25 Favored 'General case' 0 N--CA 1.435 -1.189 0 CA-C-O 115.864 -2.017 . . . . 0.0 109.322 169.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 7.6 tp -52.36 -41.9 36.35 Favored 'Isoleucine or valine' 0 C--N 1.346 0.424 0 CA-C-N 122.57 2.441 . . . . 0.0 113.031 -169.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -60.7 -43.59 98.89 Favored Glycine 0 CA--C 1.524 0.608 0 CA-C-N 119.997 1.271 . . . . 0.0 110.708 177.482 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 55.9 t -65.67 -49.53 77.11 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 CA-C-O 118.768 -0.634 . . . . 0.0 109.609 173.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 26.3 mmt180 -60.66 -32.84 72.02 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 120.389 1.449 . . . . 0.0 112.649 -178.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 31.0 mt -62.85 -47.29 93.56 Favored 'Isoleucine or valine' 0 C--O 1.231 0.124 0 CA-C-N 120.649 1.568 . . . . 0.0 109.846 178.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 27.7 m -72.96 -27.15 24.16 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 CA-C-N 119.14 0.882 . . . . 0.0 111.063 -174.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -71.16 -43.38 67.63 Favored 'General case' 0 C--O 1.232 0.163 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 173.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.86 -40.58 95.85 Favored 'General case' 0 N--CA 1.449 -0.486 0 O-C-N 121.781 -0.574 . . . . 0.0 110.457 178.39 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 6.5 tp -62.57 -40.77 97.94 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 118.444 -0.789 . . . . 0.0 109.874 175.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -61.39 -40.49 94.55 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 119.005 0.82 . . . . 0.0 111.191 178.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -71.91 -36.98 70.15 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 124.107 0.963 . . . . 0.0 111.306 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -95.07 -34.69 12.21 Favored 'General case' 0 C--N 1.341 0.225 0 CA-C-O 117.372 -1.299 . . . . 0.0 113.459 -169.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -119.02 148.7 42.72 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 120.956 1.707 . . . . 0.0 112.182 -173.049 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 40.7 mm -96.06 138.44 21.47 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 N-CA-C 103.804 -2.665 . . . . 0.0 103.804 168.496 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -121.95 148.74 52.13 Favored Pre-proline 0 CA--C 1.534 0.357 0 C-N-CA 123.795 0.838 . . . . 0.0 108.873 -174.018 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -65.68 159.62 47.46 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 122.207 1.938 . . . . 0.0 109.674 169.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -58.51 -31.74 68.17 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 -170.106 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 15.6 p90 -80.11 0.24 32.95 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 118.072 -0.966 . . . . 0.0 113.364 -177.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 88.3 t -113.53 127.27 70.95 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 N-CA-C 105.766 -1.939 . . . . 0.0 105.766 169.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -132.5 143.97 50.12 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 170.064 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -93.33 103.68 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.066 0 N-CA-C 105.37 -2.085 . . . . 0.0 105.37 169.712 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -90.16 162.2 15.38 Favored 'General case' 0 C--O 1.237 0.436 0 N-CA-C 107.813 -1.181 . . . . 0.0 107.813 172.275 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -131.94 122.6 25.86 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 123.836 0.854 . . . . 0.0 109.068 -171.295 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -87.6 -98.63 0.89 Allowed Glycine 0 CA--C 1.526 0.769 0 N-CA-C 107.048 -2.421 . . . . 0.0 107.048 169.673 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 81.08 116.63 0.38 Allowed Glycine 0 C--N 1.34 0.758 0 N-CA-C 108.702 -1.759 . . . . 0.0 108.702 -173.295 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 19.1 p 51.54 57.75 6.23 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.276 1.031 . . . . 0.0 108.773 -178.03 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -115.99 -88.14 0.59 Allowed 'General case' 0 C--N 1.342 0.281 0 CA-C-N 114.259 -1.337 . . . . 0.0 110.986 -169.189 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 75.12 -91.68 0.82 Allowed Glycine 0 C--N 1.34 0.798 0 N-CA-C 109.053 -1.619 . . . . 0.0 109.053 -169.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 66.1 mmm -76.56 -21.56 55.48 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 -177.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -62.21 -14.97 43.48 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 113.187 0.81 . . . . 0.0 113.187 -169.508 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 18.6 mt -79.34 -5.26 54.14 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 114.276 1.213 . . . . 0.0 114.276 -178.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 6.0 tt -38.65 -62.42 0.61 Allowed 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 114.84 1.422 . . . . 0.0 114.84 -170.014 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -90.86 -29.51 13.01 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 111.579 -0.608 . . . . 0.0 111.579 -174.196 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -65.86 -32.56 74.14 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 117.726 0.763 . . . . 0.0 110.974 -176.608 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 52.2 mtp -72.55 -14.47 61.64 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 113.456 0.91 . . . . 0.0 113.456 176.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -69.35 154.84 41.4 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 113.191 0.811 . . . . 0.0 113.191 -169.266 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 60.62 46.44 9.32 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.221 1.808 . . . . 0.0 115.375 168.332 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 18.7 mmt180 -114.48 155.54 26.22 Favored 'General case' 0 N--CA 1.479 0.994 0 O-C-N 121.155 -0.965 . . . . 0.0 108.887 171.516 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -81.4 -30.81 33.48 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 172.675 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -143.47 152.13 41.14 Favored 'General case' 0 C--N 1.343 0.324 0 CA-C-N 119.358 0.981 . . . . 0.0 109.77 168.193 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -137.04 139.73 41.57 Favored 'General case' 0 CA--C 1.51 -0.582 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 174.577 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 39.0 mt -114.32 115.12 48.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 176.147 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.8 mm -89.67 133.21 32.35 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 N-CA-C 106.071 -1.826 . . . . 0.0 106.071 175.013 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -114.26 115.95 28.24 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 103.557 -2.757 . . . . 0.0 103.557 168.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -154.15 161.12 42.08 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 -169.032 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -98.4 140.33 32.83 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.393 0.677 . . . . 0.0 110.583 -178.154 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 33.7 mm -78.66 -32.45 16.08 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 C-N-CA 123.847 0.859 . . . . 0.0 111.474 179.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . 0.296 4.0 t 60.14 45.27 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.89 0 C-N-CA 125.537 1.535 . . . . 0.0 110.809 -173.665 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 6.7 m 68.91 155.14 0.12 Allowed 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 116.985 2.217 . . . . 0.0 116.985 169.497 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 23.6 ttmt -157.88 -174.5 4.88 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 129.901 3.28 . . . . 0.0 104.159 174.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 10.5 ptpt -61.74 -21.25 64.35 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.699 1.2 . . . . 0.0 113.53 169.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 43.5 t-20 -65.34 156.36 32.39 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 118.95 0.795 . . . . 0.0 110.059 172.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 13.7 m -63.45 142.64 97.91 Favored Pre-proline 0 CA--C 1.546 0.795 0 C-N-CA 124.141 0.977 . . . . 0.0 112.197 -169.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -59.34 153.77 51.45 Favored 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 122.64 2.226 . . . . 0.0 112.043 169.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 67.79 18.0 69.91 Favored Glycine 0 CA--C 1.534 1.257 0 O-C-N 121.634 -0.666 . . . . 0.0 113.506 174.156 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 17.5 m -95.49 141.38 29.09 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 125.542 1.537 . . . . 0.0 107.895 177.251 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 30.7 ttp -98.71 145.43 26.91 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 175.36 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 32.0 ttm -130.88 117.73 19.72 Favored 'General case' 0 CA--C 1.528 0.103 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 -170.29 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.6 mp -96.78 122.33 48.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 179.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -117.7 122.69 44.17 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 67.5 mtp85 -102.11 135.36 43.83 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 118.516 -0.754 . . . . 0.0 109.807 176.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 8.2 t70 29.28 -91.69 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 126.681 1.992 . . . . 0.0 116.141 174.189 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -62.55 -26.84 68.79 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 -174.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -79.58 -12.44 59.84 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 122.844 0.458 . . . . 0.0 110.557 -179.414 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 46.4 t -75.39 -51.34 3.33 Favored Pre-proline 0 N--CA 1.446 -0.653 0 CA-C-O 116.66 -1.638 . . . . 0.0 110.777 -174.25 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo -59.33 -41.3 60.04 Favored 'Trans proline' 0 C--N 1.351 0.698 0 CA-C-N 122.865 2.059 . . . . 0.0 111.525 171.545 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -60.88 -29.69 69.7 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 122.997 0.519 . . . . 0.0 111.787 -179.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -79.8 -54.11 6.15 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 122.89 0.476 . . . . 0.0 110.57 170.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -56.73 -34.11 67.2 Favored 'General case' 0 C--O 1.227 -0.093 0 CA-C-N 118.319 0.509 . . . . 0.0 111.448 -171.191 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 3.6 t -64.24 -5.27 4.7 Favored 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 -172.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -54.09 136.1 42.43 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 119.593 1.088 . . . . 0.0 110.204 169.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -81.66 -15.82 53.33 Favored 'General case' 0 N--CA 1.471 0.62 0 O-C-N 122.043 -0.41 . . . . 0.0 111.493 178.018 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 52.9 mt -61.61 -44.72 99.13 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 123.86 0.864 . . . . 0.0 109.601 -169.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 37.8 t -89.86 121.05 69.32 Favored Pre-proline 0 N--CA 1.452 -0.35 0 C-N-CA 124.386 1.075 . . . . 0.0 110.017 171.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_exo -61.93 -37.35 66.33 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 122.844 2.362 . . . . 0.0 110.082 169.068 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 5.6 m80 -59.91 -54.11 49.95 Favored 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 179.37 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -75.58 -25.73 57.31 Favored 'General case' 0 C--O 1.219 -0.526 0 C-N-CA 117.577 -1.649 . . . . 0.0 111.437 -174.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 2.8 tt -58.28 -50.7 72.69 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 120.546 1.521 . . . . 0.0 108.323 171.036 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -59.43 -46.74 93.42 Favored Glycine 0 CA--C 1.527 0.821 0 N-CA-C 110.746 -0.942 . . . . 0.0 110.746 177.008 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 32.0 tp -69.91 -20.57 63.36 Favored 'General case' 0 CA--C 1.547 0.85 0 O-C-N 121.653 -0.91 . . . . 0.0 111.312 -177.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -68.68 -46.86 67.95 Favored 'General case' 0 CA--C 1.534 0.339 0 O-C-N 121.127 -0.983 . . . . 0.0 109.272 171.504 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -71.13 -22.23 62.09 Favored 'General case' 0 C--N 1.339 0.138 0 CA-C-O 119.246 -0.407 . . . . 0.0 111.48 177.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 4.8 t -62.85 -43.32 98.77 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.729 0 CA-C-O 117.948 -1.025 . . . . 0.0 108.851 169.287 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 42.7 mt -60.93 -32.43 71.93 Favored 'General case' 0 C--N 1.34 0.156 0 CA-C-N 120.456 1.48 . . . . 0.0 111.096 175.524 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 66.2 m -68.14 -38.87 82.65 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 119.173 0.897 . . . . 0.0 110.657 173.068 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -65.5 -38.65 90.33 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 119.619 1.1 . . . . 0.0 111.28 174.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -64.19 -36.5 84.27 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 118.879 0.763 . . . . 0.0 110.38 174.19 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 34.9 ttp-105 -65.51 -36.22 83.18 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 121.701 -0.625 . . . . 0.0 109.551 175.181 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 14.3 m-30 -68.48 -40.61 80.87 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 118.873 0.76 . . . . 0.0 111.012 178.227 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 54.4 p -74.24 -26.93 60.53 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 119.481 1.037 . . . . 0.0 111.278 177.603 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 75.93 9.93 85.15 Favored Glycine 0 CA--C 1.531 1.056 0 CA-C-O 119.046 -0.863 . . . . 0.0 111.568 -170.089 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -99.46 24.42 8.16 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 118.949 1.374 . . . . 0.0 111.121 -178.395 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -57.64 135.24 82.56 Favored Pre-proline 0 CA--C 1.543 0.697 0 C-N-CA 126.116 1.766 . . . . 0.0 109.959 178.044 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -52.88 132.93 49.26 Favored 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 122.845 2.363 . . . . 0.0 112.081 177.104 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 31.3 mmtp -65.63 -24.22 66.99 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 119.149 -0.453 . . . . 0.0 111.932 -172.104 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 1.5 tmmt? -140.6 100.99 3.99 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 106.013 -1.847 . . . . 0.0 106.013 169.59 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 23.8 tp -78.51 140.78 38.54 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 174.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -134.79 138.96 44.74 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 107.159 -1.422 . . . . 0.0 107.159 176.831 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.1 tp -135.59 129.83 33.52 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 120.077 1.308 . . . . 0.0 108.92 175.39 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 47.9 t -103.28 105.03 17.55 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 N-CA-C 103.55 -2.759 . . . . 0.0 103.55 168.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -84.92 145.36 21.56 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 110.485 -1.046 . . . . 0.0 110.485 174.276 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 42.0 t -121.17 133.0 69.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 171.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 14.2 mt -88.89 132.11 39.26 Favored Pre-proline 0 CA--C 1.539 0.539 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 169.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -77.7 -178.29 4.49 Favored 'Trans proline' 0 CA--C 1.537 0.64 0 C-N-CA 123.582 2.854 . . . . 0.0 111.862 -175.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -119.05 -52.96 2.29 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.815 0.846 . . . . 0.0 111.207 178.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 66.5 m -118.51 -51.69 2.39 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 119.081 0.855 . . . . 0.0 112.868 -172.421 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER 57.7 52.55 8.08 Favored 'General case' 0 CA--C 1.551 0.997 0 N-CA-C 114.646 1.35 . . . . 0.0 114.646 169.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -115.93 168.51 8.37 Favored Pre-proline 0 N--CA 1.481 1.092 0 CA-C-O 118.421 -0.799 . . . . 0.0 111.182 176.159 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -65.19 89.69 0.2 Allowed 'Trans proline' 0 CA--C 1.548 1.18 0 C-N-CA 123.447 2.765 . . . . 0.0 113.756 -178.26 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 179.86 149.26 0.32 Allowed 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 104.538 -2.393 . . . . 0.0 104.538 175.6 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -110.52 163.49 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-N 119.614 1.097 . . . . 0.0 112.927 -169.83 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 86.16 150.19 15.04 Favored Glycine 0 C--N 1.341 0.814 0 N-CA-C 107.468 -2.253 . . . . 0.0 107.468 -169.489 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -79.03 164.49 24.31 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-O 121.536 0.684 . . . . 0.0 110.031 -169.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 23.6 p -65.93 166.74 14.26 Favored Pre-proline 0 CA--C 1.539 0.556 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 167.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -53.74 -32.13 64.33 Favored 'Trans proline' 0 CA--C 1.537 0.674 0 C-N-CA 121.4 1.4 . . . . 0.0 111.545 169.601 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 22.1 m -69.57 -46.49 66.25 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 117.993 0.36 . . . . 0.0 111.148 179.544 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 22.2 t -94.1 -15.36 7.87 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-N 118.626 0.648 . . . . 0.0 111.25 -169.186 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -57.88 -47.03 83.97 Favored 'General case' 0 C--O 1.233 0.202 0 O-C-N 120.301 -1.499 . . . . 0.0 107.764 169.374 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -72.03 0.23 9.97 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-O 118.04 -0.981 . . . . 0.0 113.135 177.03 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 83.2 mtp -88.92 -10.02 49.39 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-N 120.001 1.273 . . . . 0.0 111.395 171.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 87.8 mt -57.16 -41.52 78.0 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 169.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 39.1 mm-40 -64.26 -60.61 8.28 Favored Pre-proline 0 CA--C 1.541 0.633 0 CA-C-O 117.979 -1.01 . . . . 0.0 112.703 -172.65 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -62.47 -32.98 80.34 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 CA-C-N 121.397 1.535 . . . . 0.0 110.994 178.444 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -68.04 -43.84 77.81 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-N 119.448 1.022 . . . . 0.0 109.75 -179.065 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 58.5 mt -58.21 -43.16 87.51 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 119.187 0.903 . . . . 0.0 109.697 173.105 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -59.62 -38.18 80.62 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 119.096 0.862 . . . . 0.0 110.366 179.775 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 20.0 mm100 -75.15 -33.95 61.57 Favored 'General case' 0 C--N 1.338 0.093 0 CA-C-O 117.817 -1.087 . . . . 0.0 112.97 175.426 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 67.2 t -59.83 -46.3 93.88 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 CA-C-N 120.442 1.474 . . . . 0.0 108.101 172.055 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 29.1 mt -66.72 -41.02 88.6 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 122.921 0.488 . . . . 0.0 110.116 -178.189 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -63.89 -40.16 95.86 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 119.226 0.921 . . . . 0.0 111.394 176.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -67.0 -41.11 87.27 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 122.683 0.393 . . . . 0.0 110.884 178.775 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 34.2 mt -59.51 -42.82 93.08 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 123.03 0.532 . . . . 0.0 109.91 173.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 -64.37 -15.93 61.35 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 117.362 -1.304 . . . . 0.0 111.886 -178.44 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -58.91 -41.81 88.12 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 120.678 1.581 . . . . 0.0 110.902 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 2.7 p -89.66 23.44 2.66 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.193 0.597 . . . . 0.0 111.423 178.081 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 70.32 22.41 77.56 Favored Glycine 0 CA--C 1.531 1.045 0 CA-C-O 118.761 -1.021 . . . . 0.0 113.415 -178.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 40.7 t -100.46 89.84 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.257 0 CA-C-N 119.054 1.427 . . . . 0.0 107.955 -175.38 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -76.76 137.22 39.17 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 169.389 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -85.68 155.2 21.19 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.546 0.738 . . . . 0.0 110.517 176.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 88.9 mt -93.24 116.58 66.7 Favored Pre-proline 0 CA--C 1.541 0.61 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 -178.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -73.66 92.2 0.87 Allowed 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 123.405 2.737 . . . . 0.0 109.808 -176.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 7.6 ttt-85 48.11 16.92 0.1 Allowed 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 128.172 2.589 . . . . 0.0 115.513 -174.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 51.5 35.5 14.54 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 126.123 1.769 . . . . 0.0 110.813 -172.406 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -77.37 139.22 39.68 Favored 'General case' 0 C--O 1.24 0.56 0 O-C-N 121.807 -0.558 . . . . 0.0 110.307 -178.274 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 45.8 m . . . . . 0 C--O 1.251 1.171 0 C-N-CA 125.389 1.476 . . . . 0.0 108.398 179.307 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.9 tpt . . . . . 0 N--CA 1.498 1.957 0 N-CA-C 110.416 -0.216 . . . . 0.0 110.416 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 9.0 ptp180 -143.25 127.51 17.67 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 174.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 50.6 mt -142.52 139.42 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 CA-C-N 119.708 1.14 . . . . 0.0 112.603 -168.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -121.68 123.31 41.59 Favored 'General case' 0 N--CA 1.462 0.163 0 N-CA-C 104.776 -2.305 . . . . 0.0 104.776 167.484 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 57.5 t -101.45 99.32 8.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 101.576 -3.49 . . . . 0.0 101.576 169.539 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 14.1 tp -101.34 107.6 18.99 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 124.195 0.998 . . . . 0.0 110.203 -168.061 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -88.52 123.86 6.96 Favored Glycine 0 N--CA 1.45 -0.408 0 N-CA-C 107.337 -2.305 . . . . 0.0 107.337 174.346 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -136.87 164.63 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.707 0 C-N-CA 124.054 0.941 . . . . 0.0 108.58 -176.534 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 145.72 156.93 7.06 Favored Glycine 0 N--CA 1.447 -0.625 0 N-CA-C 109.064 -1.614 . . . . 0.0 109.064 178.215 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -76.47 94.89 3.75 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 171.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.3 pt -70.77 37.74 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 C-N-CA 124.577 1.151 . . . . 0.0 113.567 179.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 23.0 mt -125.15 -8.04 7.09 Favored 'General case' 0 CA--C 1.537 0.466 0 O-C-N 121.148 -0.97 . . . . 0.0 108.768 170.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.0 mp -118.65 67.61 0.78 Allowed 'General case' 0 C--N 1.346 0.414 0 C-N-CA 124.006 0.923 . . . . 0.0 109.118 -169.002 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.3 m 47.3 -111.12 0.35 Allowed 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 114.761 -1.109 . . . . 0.0 111.654 171.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 87.6 m-20 -71.9 -11.25 60.7 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-O 117.614 -1.184 . . . . 0.0 112.302 -170.235 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -66.54 -18.02 65.13 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 121.4 1.909 . . . . 0.0 111.032 171.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -70.6 -12.83 61.81 Favored 'General case' 0 N--CA 1.448 -0.555 0 O-C-N 120.178 -1.576 . . . . 0.0 111.769 171.392 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.4 tp -58.1 -36.45 57.03 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-N 121.271 1.85 . . . . 0.0 111.613 -174.019 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -61.48 -38.38 95.69 Favored Glycine 0 C--N 1.339 0.697 0 CA-C-N 119.365 0.984 . . . . 0.0 111.769 178.037 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 54.8 t -72.42 -47.04 54.01 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 175.111 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 24.7 mmt180 -60.96 -31.18 70.75 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 116.939 -1.505 . . . . 0.0 112.94 -179.244 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 18.4 mt -61.62 -47.74 91.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 CA-C-N 121.565 1.984 . . . . 0.0 110.17 177.078 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 14.4 m -72.78 -33.48 44.11 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-N 119.192 0.906 . . . . 0.0 110.912 -174.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 57.6 mt-10 -63.66 -42.98 98.01 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 118.428 0.558 . . . . 0.0 110.334 171.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.18 -39.37 92.46 Favored 'General case' 0 CA--C 1.537 0.452 0 O-C-N 121.292 -0.88 . . . . 0.0 110.647 176.006 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 6.1 tp -66.06 -39.61 90.23 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 118.451 0.569 . . . . 0.0 110.081 -179.317 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -60.68 -28.9 68.96 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 121.512 0.672 . . . . 0.0 112.131 -178.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 -88.19 -40.21 13.89 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 125.891 1.676 . . . . 0.0 111.14 -178.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 56.4 mtp180 -94.17 -18.44 21.73 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-O 118.449 -0.786 . . . . 0.0 112.364 -170.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 49.8 m-85 -129.58 147.05 51.34 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 119.354 0.979 . . . . 0.0 112.552 177.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 39.5 mm -98.28 137.08 26.84 Favored 'Isoleucine or valine' 0 C--O 1.239 0.518 0 N-CA-C 103.62 -2.733 . . . . 0.0 103.62 168.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -120.19 150.54 51.62 Favored Pre-proline 0 C--O 1.237 0.414 0 C-N-CA 123.297 0.639 . . . . 0.0 110.49 -169.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -59.05 157.56 28.97 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 123.128 2.552 . . . . 0.0 111.227 169.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -61.55 -31.51 71.54 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -175.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 9.6 p90 -75.76 -11.12 59.93 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 -179.512 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 92.5 t -92.87 122.9 44.74 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 173.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -117.62 123.59 46.54 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 169.476 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -86.48 117.78 31.58 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 N-CA-C 104.168 -2.53 . . . . 0.0 104.168 168.512 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 63.8 tp -118.9 130.75 55.89 Favored 'General case' 0 CA--C 1.523 -0.083 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 178.152 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -89.42 119.13 29.61 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 169.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -77.54 -80.14 0.68 Allowed Glycine 0 CA--C 1.528 0.872 0 N-CA-C 106.834 -2.507 . . . . 0.0 106.834 169.189 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 78.48 107.05 0.2 Allowed Glycine 0 C--N 1.345 1.044 0 N-CA-C 109.176 -1.57 . . . . 0.0 109.176 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 10.5 p 53.41 55.47 8.65 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 -177.106 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -120.35 -83.4 0.66 Allowed 'General case' 0 C--N 1.347 0.482 0 CA-C-N 115.005 -0.998 . . . . 0.0 112.255 -169.279 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 58.93 -107.21 1.09 Allowed Glycine 0 CA--C 1.532 1.15 0 N-CA-C 110.511 -1.036 . . . . 0.0 110.511 -178.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 11.7 tpt -55.95 -28.18 55.81 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.665 1.186 . . . . 0.0 112.627 -177.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -56.46 -22.12 30.1 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 113.827 1.047 . . . . 0.0 113.827 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 15.1 mt -103.3 17.95 22.89 Favored 'General case' 0 C--N 1.341 0.233 0 N-CA-C 115.978 1.844 . . . . 0.0 115.978 -167.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 6.2 tt -48.09 -56.35 8.01 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 119.447 1.021 . . . . 0.0 111.109 -178.166 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -66.42 -36.58 91.78 Favored Glycine 0 CA--C 1.528 0.898 0 CA-C-O 119.259 -0.745 . . . . 0.0 112.447 -177.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -73.69 -35.1 65.13 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 118.886 1.343 . . . . 0.0 111.817 -176.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 78.8 mtp -71.88 -12.71 61.4 Favored 'General case' 0 CA--C 1.535 0.401 0 O-C-N 121.962 -0.461 . . . . 0.0 110.323 179.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -84.12 153.63 23.62 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 123.306 0.642 . . . . 0.0 111.57 -170.424 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 54.24 34.8 21.17 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 126.475 1.91 . . . . 0.0 112.847 170.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 26.1 mmt180 -98.31 157.57 16.1 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 173.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -84.67 -51.4 6.85 Favored 'General case' 0 C--O 1.221 -0.42 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 175.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . 0.269 0.0 OUTLIER -120.25 146.43 46.07 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 120.017 1.281 . . . . 0.0 108.272 168.652 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 33.1 tp -130.46 111.63 12.48 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 104.172 -2.529 . . . . 0.0 104.172 173.092 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 52.7 mt -93.24 111.71 25.19 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 N-CA-C 103.801 -2.666 . . . . 0.0 103.801 171.17 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 53.5 mt -83.86 133.69 28.63 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 N-CA-C 105.233 -2.136 . . . . 0.0 105.233 170.651 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -116.97 116.77 28.03 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 102.519 -3.141 . . . . 0.0 102.519 168.038 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -161.57 165.77 27.95 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 123.518 0.727 . . . . 0.0 109.796 -176.248 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -81.34 144.53 31.41 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-O 122.355 1.074 . . . . 0.0 110.031 169.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 12.0 mt -69.1 -51.04 47.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 114.55 -1.205 . . . . 0.0 107.957 170.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . 0.294 9.0 p 42.22 48.45 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.95 0 C-N-CA 125.276 1.43 . . . . 0.0 111.071 179.753 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 8.4 t -162.79 176.42 10.28 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.368 1.467 . . . . 0.0 109.624 -171.572 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 20.0 ttmt 51.14 -161.17 0.08 Allowed 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 127.386 2.274 . . . . 0.0 112.175 -173.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 14.6 ptpt -128.89 12.79 6.26 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 125.036 1.334 . . . . 0.0 112.973 -169.394 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 44.8 t30 -74.75 167.22 22.25 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 178.051 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 2.8 m -56.93 145.87 61.92 Favored Pre-proline 0 CA--C 1.546 0.795 0 C-N-CA 123.812 0.845 . . . . 0.0 112.132 -169.704 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -56.23 155.82 23.18 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 123.84 3.026 . . . . 0.0 112.701 169.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 65.15 17.44 63.62 Favored Glycine 0 CA--C 1.535 1.321 0 CA-C-O 119.696 -0.502 . . . . 0.0 113.242 170.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 3.1 m -95.58 142.19 28.21 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 125.176 1.39 . . . . 0.0 109.11 -175.036 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 44.5 ttp -95.16 141.66 28.51 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 169.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 75.1 mtm -132.02 145.85 51.7 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 169.363 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.5 mp -97.22 119.66 45.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 N-CA-C 105.358 -2.09 . . . . 0.0 105.358 172.093 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.8 mp -113.79 136.02 53.32 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 171.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 36.4 mmt180 -96.39 164.13 12.77 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 123.018 0.527 . . . . 0.0 110.863 178.607 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -1.09 -70.13 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 127.839 2.456 . . . . 0.0 117.438 169.465 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -87.6 -19.87 27.18 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 113.533 0.938 . . . . 0.0 113.533 -170.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -76.77 -37.4 55.95 Favored 'General case' 0 CA--C 1.523 -0.084 0 CA-C-O 121.135 0.493 . . . . 0.0 110.095 -172.627 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -66.85 -52.48 32.49 Favored Pre-proline 0 CA--C 1.538 0.51 0 CA-C-O 117.417 -1.278 . . . . 0.0 112.723 -174.149 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -55.4 -42.01 72.46 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 121.57 1.513 . . . . 0.0 110.551 177.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.8 -15.53 63.53 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 178.118 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -92.69 -46.06 7.75 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 119.854 1.206 . . . . 0.0 110.674 -176.092 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -68.77 -1.72 7.72 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 113.988 1.107 . . . . 0.0 113.988 -169.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 62.5 p -59.51 -21.17 59.79 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.759 1.223 . . . . 0.0 112.587 178.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 42.3 t-20 -65.91 149.88 49.5 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.542 0.737 . . . . 0.0 111.192 -175.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -84.93 -6.33 59.34 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.15 0.98 . . . . 0.0 113.569 -170.036 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 20.3 mt -59.56 -43.53 91.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 C-N-CA 123.676 0.79 . . . . 0.0 111.147 -169.444 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 28.3 t -117.72 125.28 28.16 Favored Pre-proline 0 C--O 1.235 0.295 0 N-CA-C 109.038 -0.726 . . . . 0.0 109.038 174.541 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -71.29 -30.01 16.3 Favored 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 122.578 2.185 . . . . 0.0 110.547 175.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 30.1 t-80 -67.19 -43.38 82.29 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 119.05 0.841 . . . . 0.0 108.815 177.283 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 7.4 mm100 -66.13 -38.8 89.06 Favored 'General case' 0 C--O 1.22 -0.46 0 CA-C-O 117.603 -1.189 . . . . 0.0 110.291 175.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 1.3 tt -56.47 -40.81 75.51 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 120.141 1.337 . . . . 0.0 109.373 174.095 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -60.81 -44.75 97.64 Favored Glycine 0 CA--C 1.529 0.942 0 O-C-N 121.237 -0.915 . . . . 0.0 111.434 175.176 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 51.1 tp -64.24 -32.44 74.03 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 117.893 0.847 . . . . 0.0 110.245 174.446 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -62.07 -51.39 68.15 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 119.517 1.053 . . . . 0.0 109.034 176.148 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -70.91 -28.33 64.44 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.011 -174.425 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -70.02 -41.99 79.4 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.922 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 172.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 32.1 mt -64.31 -35.66 81.57 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 119.521 1.055 . . . . 0.0 110.174 177.083 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 49.8 m -63.38 -37.19 86.32 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 118.983 0.81 . . . . 0.0 110.451 169.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.429 ' HA ' ' CD2' ' A' ' 106' ' ' PHE . . . -66.61 -39.14 88.21 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 119.58 1.082 . . . . 0.0 111.221 177.609 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -63.13 -31.67 72.87 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 118.69 0.677 . . . . 0.0 109.987 172.14 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 58.6 ttt85 -72.37 -34.41 67.95 Favored 'General case' 0 CA--C 1.533 0.32 0 O-C-N 121.103 -0.998 . . . . 0.0 109.864 175.507 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.429 ' CD2' ' HA ' ' A' ' 103' ' ' ALA . 13.9 m-30 -68.42 -44.09 75.76 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 118.829 0.74 . . . . 0.0 110.583 178.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 40.4 p -70.97 -26.77 63.3 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 118.52 0.6 . . . . 0.0 111.745 -179.424 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 73.19 7.07 70.8 Favored Glycine 0 CA--C 1.535 1.282 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 -168.34 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -89.51 16.85 7.0 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 119.467 1.633 . . . . 0.0 110.937 178.302 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -54.88 139.85 61.57 Favored Pre-proline 0 CA--C 1.549 0.918 0 C-N-CA 125.824 1.65 . . . . 0.0 109.702 172.076 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_exo -55.56 156.9 16.59 Favored 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 123.38 2.72 . . . . 0.0 115.697 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 66.7 mmtt -63.76 -40.44 96.7 Favored 'General case' 0 N--CA 1.472 0.661 0 O-C-N 121.768 -0.582 . . . . 0.0 111.418 -179.433 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 5.4 pttm -131.72 146.14 52.01 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 105.663 -1.977 . . . . 0.0 105.663 171.282 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 7.0 tt -140.26 139.36 35.54 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 175.335 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -137.9 134.57 35.19 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 -171.274 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -122.79 118.42 27.95 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 120.409 1.459 . . . . 0.0 108.512 177.798 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 16.1 t -88.05 81.99 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 N-CA-C 105.05 -2.204 . . . . 0.0 105.05 175.335 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -80.76 141.9 23.07 Favored Glycine 0 C--O 1.225 -0.434 0 CA-C-O 119.272 -0.738 . . . . 0.0 111.573 -169.595 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 42.0 t -119.9 123.6 71.18 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.105 0 CA-C-N 117.396 0.598 . . . . 0.0 109.946 177.522 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 25.7 mt -78.23 127.87 79.95 Favored Pre-proline 0 CA--C 1.53 0.207 0 N-CA-C 104.999 -2.222 . . . . 0.0 104.999 169.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -69.15 160.0 51.61 Favored 'Trans proline' 0 N--CA 1.45 -1.062 0 C-N-CA 121.756 1.637 . . . . 0.0 110.966 179.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -94.67 -42.92 8.52 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 105.871 -1.9 . . . . 0.0 105.871 168.144 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 49.9 m -137.28 149.22 46.95 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 123.791 0.837 . . . . 0.0 109.494 173.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.2 tp -143.48 53.54 1.33 Allowed 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.976 1.311 . . . . 0.0 108.499 -175.507 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -114.49 168.18 8.44 Favored Pre-proline 0 CA--C 1.538 0.482 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 -173.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -82.08 84.66 1.82 Allowed 'Trans proline' 0 N--CA 1.454 -0.802 0 CA-C-N 120.952 1.376 . . . . 0.0 112.654 -169.45 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -174.28 145.37 1.01 Allowed 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 103.511 -2.774 . . . . 0.0 103.511 179.401 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -112.03 168.33 4.99 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 N-CA-C 113.352 0.871 . . . . 0.0 113.352 -169.264 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 96.76 148.79 24.69 Favored Glycine 0 CA--C 1.528 0.893 0 N-CA-C 106.066 -2.814 . . . . 0.0 106.066 -168.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -75.3 163.02 27.91 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 118.312 1.056 . . . . 0.0 110.569 177.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 58.4 p -71.05 171.4 8.6 Favored Pre-proline 0 CA--C 1.543 0.706 0 CA-C-N 114.929 -1.032 . . . . 0.0 109.051 168.52 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -58.06 -33.79 97.71 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 121.927 1.751 . . . . 0.0 112.393 172.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 57.7 m -72.65 -40.1 66.62 Favored 'General case' 0 N--CA 1.443 -0.785 0 C-N-CA 123.463 0.705 . . . . 0.0 111.178 -178.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 95.1 t -94.44 -23.85 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 CA-C-N 118.438 0.563 . . . . 0.0 111.523 -169.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -51.37 -44.77 62.21 Favored 'General case' 0 N--CA 1.467 0.402 0 O-C-N 120.836 -1.165 . . . . 0.0 109.497 169.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -71.3 -18.79 62.39 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 114.405 1.261 . . . . 0.0 114.405 -178.69 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 74.8 mtp -67.82 -14.92 63.35 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 118.005 -0.998 . . . . 0.0 112.829 -179.186 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 13.6 mt -48.87 -42.53 13.87 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.387 0 CA-C-N 119.635 1.107 . . . . 0.0 108.362 169.447 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 61.5 mm-40 -64.88 -58.32 13.31 Favored Pre-proline 0 CA--C 1.539 0.553 0 CA-C-N 120.351 1.432 . . . . 0.0 111.5 -172.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -61.32 -37.16 74.9 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 CA-C-N 121.447 1.553 . . . . 0.0 112.36 177.453 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -73.13 -37.83 66.52 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-O 118.569 -0.729 . . . . 0.0 111.499 -176.495 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 32.8 mt -62.24 -43.64 98.38 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-N 119.653 1.115 . . . . 0.0 109.041 170.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -55.78 -36.57 67.53 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 118.742 0.701 . . . . 0.0 110.131 174.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -72.44 -41.35 66.23 Favored 'General case' 0 N--CA 1.454 -0.26 0 O-C-N 121.442 -0.786 . . . . 0.0 112.712 177.527 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 60.1 t -58.76 -47.58 88.68 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 175.47 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 60.0 mt -60.99 -35.31 76.48 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-O 118.763 -0.637 . . . . 0.0 110.788 177.12 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -68.2 -46.22 71.21 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 119.243 0.928 . . . . 0.0 110.54 178.209 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -67.72 -30.06 69.46 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 119.882 1.219 . . . . 0.0 111.162 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 13.9 mt -63.06 -52.68 61.82 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 169.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 50.9 mmm-85 -66.04 -26.9 67.72 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 119.765 1.166 . . . . 0.0 112.412 -177.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 71.2 mt-10 -66.5 -30.13 70.38 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 119.569 1.077 . . . . 0.0 109.872 174.558 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 20.4 m -84.0 6.66 21.15 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.388 1.075 . . . . 0.0 111.957 171.118 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 72.06 12.15 75.32 Favored Glycine 0 CA--C 1.526 0.744 0 CA-C-O 117.294 -1.837 . . . . 0.0 112.98 -172.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 55.2 t -91.72 122.25 42.98 Favored 'Isoleucine or valine' 0 C--N 1.346 0.447 0 CA-C-N 121.048 2.424 . . . . 0.0 108.019 -176.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -104.26 93.5 4.85 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 173.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -58.9 146.04 39.07 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.823 169.129 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 22.9 mm -98.76 127.0 36.76 Favored Pre-proline 0 CA--C 1.53 0.21 0 CA-C-O 117.396 -1.287 . . . . 0.0 109.067 -171.454 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -67.96 97.99 0.5 Allowed 'Trans proline' 0 CA--C 1.535 0.536 0 C-N-CA 122.702 2.268 . . . . 0.0 109.753 174.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 23.2 mtp-105 48.32 18.04 0.15 Allowed 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 127.45 2.3 . . . . 0.0 115.327 -178.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 53.3 m 46.09 39.64 6.14 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.229 1.012 . . . . 0.0 111.876 -169.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -78.9 -31.41 45.38 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 122.68 0.392 . . . . 0.0 111.761 -177.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 11.8 m . . . . . 0 C--O 1.254 1.327 0 C-N-CA 124.467 1.107 . . . . 0.0 110.571 178.837 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.0 tpt . . . . . 0 N--CA 1.496 1.869 0 CA-C-O 120.456 0.169 . . . . 0.0 110.586 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 16.2 ptt180 -149.79 112.61 4.81 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.626 1.17 . . . . 0.0 108.687 176.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 84.8 mt -127.39 130.93 70.78 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.14 0 N-CA-C 107.896 -1.149 . . . . 0.0 107.896 -175.609 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -119.61 144.95 46.84 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 105.513 -2.032 . . . . 0.0 105.513 168.799 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 71.4 t -121.95 128.13 75.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 104.891 -2.263 . . . . 0.0 104.891 174.222 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -111.26 130.79 55.55 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-N 118.398 0.544 . . . . 0.0 109.85 -179.55 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -100.61 126.08 8.8 Favored Glycine 0 C--O 1.237 0.32 0 N-CA-C 108.211 -1.956 . . . . 0.0 108.211 171.296 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 1.9 m -141.22 171.56 12.04 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 CA-C-N 117.797 0.799 . . . . 0.0 110.278 -173.225 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 103.03 156.69 25.13 Favored Glycine 0 N--CA 1.442 -0.953 0 C-N-CA 126.352 1.93 . . . . 0.0 110.052 -178.625 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.44 HD22 ' HB2' ' A' ' 12' ' ' LEU . 4.1 t30 -72.51 104.21 3.76 Favored 'General case' 0 N--CA 1.453 -0.321 0 O-C-N 121.709 -0.877 . . . . 0.0 111.247 -169.378 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.1 pt -59.92 30.64 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.954 0 N-CA-C 117.228 2.307 . . . . 0.0 117.228 172.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.44 ' HB2' HD22 ' A' ' 10' ' ' ASN . 5.4 mp -129.79 -6.68 4.55 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 120.593 1.542 . . . . 0.0 108.436 168.439 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.411 ' HB2' HD21 ' A' ' 10' ' ' ASN . 3.0 mp -107.98 57.05 0.62 Allowed 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 119.255 0.934 . . . . 0.0 112.796 -168.123 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER 51.16 -109.83 0.45 Allowed 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 123.898 0.879 . . . . 0.0 110.123 175.176 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -77.85 -4.49 46.88 Favored 'General case' 0 N--CA 1.443 -0.78 0 O-C-N 121.59 -0.694 . . . . 0.0 111.021 -173.714 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -69.63 -12.17 61.43 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 120.647 1.567 . . . . 0.0 111.837 170.193 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -77.97 -9.95 59.35 Favored 'General case' 0 N--CA 1.435 -1.222 0 CA-C-O 115.736 -2.078 . . . . 0.0 109.635 170.497 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.7 tp -55.11 -39.14 49.19 Favored 'Isoleucine or valine' 0 C--N 1.348 0.537 0 CA-C-N 122.395 2.362 . . . . 0.0 111.995 -170.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -61.01 -39.5 97.17 Favored Glycine 0 C--N 1.336 0.58 0 CA-C-N 119.151 0.887 . . . . 0.0 111.038 177.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 97.1 t -74.45 -47.56 39.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 CA-C-O 118.54 -0.743 . . . . 0.0 109.861 176.024 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 76.2 mmt-85 -59.66 -33.84 72.06 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 119.983 1.265 . . . . 0.0 111.76 -179.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 22.8 mt -56.45 -51.49 64.1 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-N 120.363 1.438 . . . . 0.0 110.181 173.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 24.8 m -75.2 -25.98 18.54 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-N 119.075 0.852 . . . . 0.0 111.206 -172.56 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -69.88 -45.72 67.07 Favored 'General case' 0 C--O 1.233 0.187 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 174.355 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -67.35 -40.2 85.8 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 122.723 0.409 . . . . 0.0 110.386 -179.18 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.7 tp -61.56 -38.41 87.39 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 118.441 -0.79 . . . . 0.0 110.554 177.515 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -64.3 -42.21 96.49 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 118.956 0.798 . . . . 0.0 110.292 177.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -68.59 -36.37 78.62 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 122.873 0.469 . . . . 0.0 111.466 178.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 79.1 mmt-85 -94.36 -40.55 9.88 Favored 'General case' 0 C--N 1.339 0.122 0 CA-C-O 116.951 -1.499 . . . . 0.0 112.771 -170.3 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -117.19 130.33 56.52 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 121.588 1.994 . . . . 0.0 113.244 -169.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 40.2 mm -83.29 134.92 25.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 105.607 -1.997 . . . . 0.0 105.607 168.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.6 mp -133.34 150.69 75.9 Favored Pre-proline 0 CA--C 1.54 0.565 0 C-N-CA 126.99 2.116 . . . . 0.0 108.552 -169.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -71.01 165.05 33.64 Favored 'Trans proline' 0 CA--C 1.536 0.616 0 C-N-CA 122.815 2.343 . . . . 0.0 111.123 175.315 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -59.48 -31.45 69.35 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 -169.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 46.3 p90 -78.55 2.4 19.3 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 113.361 0.874 . . . . 0.0 113.361 -178.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.7 t -111.2 127.47 68.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 172.257 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -125.12 145.75 49.8 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 109.055 -0.721 . . . . 0.0 109.055 173.421 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -113.52 109.3 28.04 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 N-CA-C 105.762 -1.94 . . . . 0.0 105.762 172.159 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 64.4 tp -113.67 142.13 46.38 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 -174.118 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -100.38 127.52 46.68 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 123.642 0.777 . . . . 0.0 110.411 178.117 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -121.78 -22.56 2.7 Favored Glycine 0 CA--C 1.533 1.161 0 CA-C-O 118.51 -1.161 . . . . 0.0 113.012 169.586 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 42.64 -107.6 0.12 Allowed Glycine 0 C--N 1.339 0.742 0 C-N-CA 125.389 1.471 . . . . 0.0 113.938 177.091 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.8 p -67.48 -3.68 9.26 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 128.645 2.778 . . . . 0.0 114.108 -174.415 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.36 -56.88 14.15 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 124.07 0.948 . . . . 0.0 112.498 179.282 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 61.17 -99.64 0.21 Allowed Glycine 0 C--N 1.338 0.677 0 N-CA-C 108.614 -1.794 . . . . 0.0 108.614 -170.365 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.9 -28.15 68.08 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 126.098 1.759 . . . . 0.0 111.604 177.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -68.16 -4.15 12.91 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 113.802 1.038 . . . . 0.0 113.802 -168.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 22.4 mt -92.46 12.34 23.17 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 113.677 0.992 . . . . 0.0 113.677 177.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 6.1 tt -36.6 -60.48 0.59 Allowed 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.263 1.425 . . . . 0.0 114.713 -173.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -94.86 -26.61 12.51 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 123.205 0.431 . . . . 0.0 112.349 -175.51 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -57.69 -35.98 71.33 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 117.693 0.746 . . . . 0.0 111.769 179.066 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 20.7 mtp -83.05 -1.22 52.13 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 113.24 0.83 . . . . 0.0 113.24 -176.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -81.8 158.22 24.18 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.351 0.66 . . . . 0.0 111.995 -174.305 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 55.09 52.17 12.17 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 127.285 2.234 . . . . 0.0 115.655 168.416 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 20.7 mmt180 -115.07 163.2 15.96 Favored 'General case' 0 N--CA 1.482 1.174 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 170.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -80.46 -43.34 21.06 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 173.143 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . 0.294 0.1 OUTLIER -139.18 137.57 36.16 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 120.209 1.368 . . . . 0.0 110.101 168.319 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 24.1 tp -119.34 129.78 55.03 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 174.326 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 11.7 mt -103.1 115.91 45.9 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 174.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 9.5 mt -92.55 123.21 44.57 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 176.272 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -104.92 114.79 29.21 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 104.473 -2.417 . . . . 0.0 104.473 169.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -149.85 162.37 40.43 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.424 0.631 . . . . 0.0 110.961 -178.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -72.99 179.97 3.5 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 168.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . 0.301 93.2 mt -110.13 -83.15 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 CA-C-O 117.727 -1.13 . . . . 0.0 110.958 175.683 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . 0.292 1.7 m 41.0 35.86 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.856 0 C-N-CA 125.712 1.605 . . . . 0.0 112.984 -169.326 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 49.9 m -134.12 2.77 3.36 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.435 1.494 . . . . 0.0 112.065 -173.453 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -154.34 156.36 36.76 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 177.032 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 9.7 ptpt -78.65 3.04 17.44 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 115.377 1.621 . . . . 0.0 115.377 -169.717 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 32.3 t-20 -69.7 161.9 28.8 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 118.955 0.798 . . . . 0.0 110.47 -173.677 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 11.9 m -55.72 143.34 60.0 Favored Pre-proline 0 CA--C 1.545 0.766 0 C-N-CA 124.669 1.188 . . . . 0.0 112.698 -169.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -57.28 151.83 49.69 Favored 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 122.33 2.02 . . . . 0.0 111.166 169.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 71.47 18.78 77.26 Favored Glycine 0 CA--C 1.533 1.189 0 O-C-N 121.458 -0.776 . . . . 0.0 113.468 175.213 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 6.9 m -104.78 139.95 38.81 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 125.474 1.51 . . . . 0.0 108.02 177.068 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 47.5 ttp -96.2 143.36 27.37 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 173.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 33.6 ttm -135.51 123.09 22.15 Favored 'General case' 0 CA--C 1.528 0.128 0 N-CA-C 106.429 -1.693 . . . . 0.0 106.429 -174.248 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 35.8 mm -103.67 119.64 52.59 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 178.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -114.01 134.22 54.99 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 -174.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 60.6 mtm180 -109.37 132.74 53.84 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 118.459 -0.781 . . . . 0.0 109.637 -174.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 37.8 t70 40.85 -104.76 0.05 Allowed 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 114.26 1.207 . . . . 0.0 114.26 169.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -60.02 -26.11 65.83 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.778 1.231 . . . . 0.0 113.894 -177.253 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -73.73 -20.9 60.39 Favored 'General case' 0 CA--C 1.534 0.331 0 O-C-N 121.829 -0.544 . . . . 0.0 110.085 -179.284 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 46.9 t -75.0 -55.46 2.31 Favored Pre-proline 0 N--CA 1.449 -0.494 0 CA-C-O 117.404 -1.284 . . . . 0.0 111.218 -169.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -66.27 -30.7 45.28 Favored 'Trans proline' 0 N--CA 1.448 -1.193 0 CA-C-N 121.659 1.628 . . . . 0.0 110.191 178.04 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.07 -27.32 68.7 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 118.417 0.553 . . . . 0.0 111.364 179.322 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -74.05 -56.29 5.11 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 169.379 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -63.23 -25.37 68.3 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 114.157 1.169 . . . . 0.0 114.157 -169.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 7.0 t -69.66 1.09 4.53 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 -175.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 37.2 t-20 -67.12 136.91 55.87 Favored 'General case' 0 CA--C 1.54 0.581 0 O-C-N 120.927 -1.108 . . . . 0.0 109.447 175.643 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 13.3 mptt -82.41 -9.1 59.58 Favored 'General case' 0 N--CA 1.47 0.531 0 O-C-N 121.487 -0.758 . . . . 0.0 111.858 -175.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 89.4 mt -61.25 -36.95 76.25 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 CA-C-N 119.047 0.84 . . . . 0.0 110.038 179.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 8.3 p -99.54 109.82 56.48 Favored Pre-proline 0 CA--C 1.548 0.903 0 C-N-CA 124.693 1.197 . . . . 0.0 109.543 -173.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -70.62 -46.47 0.86 Allowed 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 122.2 1.933 . . . . 0.0 113.21 -169.571 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 3.0 m80 -73.15 -38.4 66.26 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.481 0.657 . . . . 0.0 109.383 -177.042 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -76.11 -26.83 56.77 Favored 'General case' 0 C--O 1.226 -0.147 0 CA-C-O 118.659 -0.686 . . . . 0.0 111.07 -172.211 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -59.14 -37.61 77.7 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 118.901 0.773 . . . . 0.0 108.995 169.423 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -60.39 -41.86 98.68 Favored Glycine 0 CA--C 1.534 1.242 0 O-C-N 121.497 -0.752 . . . . 0.0 111.651 174.343 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -68.59 -31.6 70.9 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 118.133 0.967 . . . . 0.0 110.233 176.135 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -59.69 -45.32 92.45 Favored 'General case' 0 CA--C 1.53 0.179 0 O-C-N 120.77 -1.206 . . . . 0.0 109.032 169.306 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -68.63 -21.88 64.45 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 119.064 -0.493 . . . . 0.0 111.852 178.425 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 44.6 t -64.52 -46.21 93.36 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 168.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 19.8 mt -64.87 -35.46 81.2 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 119.655 1.116 . . . . 0.0 110.53 -179.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 16.4 m -60.93 -44.62 96.95 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 118.871 0.76 . . . . 0.0 109.368 171.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -65.63 -36.64 84.28 Favored 'General case' 0 N--CA 1.449 -0.522 0 O-C-N 121.686 -0.634 . . . . 0.0 111.701 179.105 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 12.4 mt -61.3 -37.59 83.77 Favored 'General case' 0 C--O 1.23 0.073 0 C-N-CA 123.59 0.756 . . . . 0.0 109.982 174.437 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 52.9 tpt85 -71.71 -35.1 70.11 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-O 118.036 -0.983 . . . . 0.0 110.49 174.452 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 18.4 m-30 -69.13 -39.06 79.12 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 119.785 1.175 . . . . 0.0 110.755 -178.571 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 38.9 p -72.59 -22.36 60.99 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 118.759 0.709 . . . . 0.0 111.012 175.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 73.62 11.07 80.4 Favored Glycine 0 CA--C 1.533 1.196 0 N-CA-C 111.005 -0.838 . . . . 0.0 111.005 -169.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -99.43 26.7 5.81 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 118.436 1.118 . . . . 0.0 110.575 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -59.48 129.59 87.12 Favored Pre-proline 0 CA--C 1.544 0.722 0 C-N-CA 124.137 0.975 . . . . 0.0 108.522 171.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_exo -50.37 149.66 12.47 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 123.971 3.114 . . . . 0.0 113.829 178.025 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 33.0 mmtp -59.46 -30.55 68.6 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 119.359 -0.353 . . . . 0.0 110.589 -178.307 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? -137.57 142.25 41.34 Favored 'General case' 0 C--O 1.231 0.129 0 N-CA-C 105.915 -1.883 . . . . 0.0 105.915 169.068 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 8.9 tt -127.78 134.1 49.47 Favored 'General case' 0 CA--C 1.519 -0.216 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 171.667 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.75 129.13 30.03 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 106.784 -1.562 . . . . 0.0 106.784 -169.569 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 7.0 tp -115.06 126.68 54.99 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 120.09 1.314 . . . . 0.0 108.553 178.312 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 32.4 t -98.51 84.44 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 N-CA-C 104.721 -2.326 . . . . 0.0 104.721 169.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -81.43 145.06 24.95 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 -179.013 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 19.0 t -126.79 137.11 58.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 171.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 1.6 mm -85.09 122.24 74.05 Favored Pre-proline 0 CA--C 1.543 0.701 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 177.179 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_exo -58.34 170.45 2.35 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 124.988 3.792 . . . . 0.0 115.711 172.109 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -118.26 -52.33 2.39 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 114.897 -1.047 . . . . 0.0 110.255 179.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 64.6 m -107.43 -53.84 2.56 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 119.203 0.91 . . . . 0.0 112.802 -174.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 57.29 47.55 16.58 Favored 'General case' 0 CA--C 1.549 0.942 0 N-CA-C 114.765 1.394 . . . . 0.0 114.765 175.283 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -124.67 170.17 9.48 Favored Pre-proline 0 N--CA 1.478 0.938 0 CA-C-O 117.888 -1.054 . . . . 0.0 109.89 175.441 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_exo -62.85 87.07 0.12 Allowed 'Trans proline' 0 CA--C 1.549 1.259 0 C-N-CA 123.838 3.025 . . . . 0.0 114.452 -179.368 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -172.76 140.42 0.98 Allowed 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 104.334 -2.469 . . . . 0.0 104.334 172.635 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -102.4 164.17 3.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-N 119.102 0.865 . . . . 0.0 112.889 -169.488 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 82.15 159.31 24.9 Favored Glycine 0 C--N 1.342 0.894 0 N-CA-C 108.977 -1.649 . . . . 0.0 108.977 -170.121 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -82.2 163.17 22.08 Favored 'General case' 0 N--CA 1.439 -0.993 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 -174.584 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 37.7 p -67.99 169.78 8.99 Favored Pre-proline 0 C--O 1.239 0.542 0 CA-C-N 115.107 -0.951 . . . . 0.0 108.944 168.067 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_exo -55.16 -32.37 79.8 Favored 'Trans proline' 0 CA--C 1.539 0.753 0 C-N-CA 121.397 1.398 . . . . 0.0 110.845 169.294 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 18.2 m -68.01 -44.49 76.42 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 119.066 -0.492 . . . . 0.0 111.297 179.604 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 12.3 t -100.59 -13.21 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-N 119.252 0.933 . . . . 0.0 112.277 -169.156 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -57.47 -45.83 84.36 Favored 'General case' 0 CA--C 1.516 -0.341 0 O-C-N 119.752 -1.842 . . . . 0.0 107.808 169.535 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -71.59 2.91 4.47 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-N 115.404 -0.816 . . . . 0.0 113.08 179.268 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 84.1 mtp -97.27 -6.87 33.48 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 118.136 -0.935 . . . . 0.0 111.384 173.609 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 79.2 mt -57.24 -50.06 77.88 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 175.512 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -66.36 -53.2 32.45 Favored Pre-proline 0 CA--C 1.537 0.47 0 CA-C-O 117.411 -1.281 . . . . 0.0 113.298 -170.036 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -60.79 -32.88 93.38 Favored 'Trans proline' 0 C--N 1.351 0.662 0 CA-C-N 121.987 1.745 . . . . 0.0 111.79 175.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -69.24 -38.8 78.66 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-O 118.406 -0.807 . . . . 0.0 109.881 177.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 10.6 mt -57.78 -44.17 86.06 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 119.612 1.097 . . . . 0.0 108.755 173.065 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -62.72 -36.84 84.28 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 118.328 0.513 . . . . 0.0 111.443 -176.577 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 42.9 mm-40 -74.27 -33.36 63.24 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 118.686 0.675 . . . . 0.0 112.206 177.28 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 75.2 t -62.05 -49.03 85.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-N 119.475 1.034 . . . . 0.0 108.28 169.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 56.3 mt -60.57 -39.12 86.85 Favored 'General case' 0 CA--C 1.531 0.244 0 O-C-N 121.81 -0.556 . . . . 0.0 110.717 -179.502 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -58.77 -39.3 80.61 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 119.038 -0.506 . . . . 0.0 112.147 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -64.93 -48.17 75.06 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 119.094 0.861 . . . . 0.0 110.406 178.17 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . 0.284 4.1 pp -68.01 -23.71 65.04 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 118.73 -0.652 . . . . 0.0 112.174 178.678 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 81.7 mtm-85 -67.1 -26.97 66.97 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 119.937 1.244 . . . . 0.0 111.407 171.014 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -66.89 -34.17 77.2 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 120.422 1.465 . . . . 0.0 109.318 175.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 23.1 m -82.32 18.45 1.43 Allowed 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.478 1.111 . . . . 0.0 112.615 172.529 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 68.21 19.65 72.41 Favored Glycine 0 CA--C 1.529 0.959 0 CA-C-O 118.706 -1.052 . . . . 0.0 113.745 173.347 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 58.1 t -80.48 124.97 39.01 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 CA-C-N 119.18 1.49 . . . . 0.0 107.317 176.518 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -100.67 95.72 6.86 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 105.222 -2.14 . . . . 0.0 105.222 169.509 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -70.43 141.64 52.07 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 177.158 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 8.8 mm -108.81 124.76 33.35 Favored Pre-proline 0 CA--C 1.529 0.151 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 -179.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -64.35 103.21 0.43 Allowed 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 121.918 1.745 . . . . 0.0 107.954 169.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 87.2 mtt180 56.91 -8.56 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 128.052 2.541 . . . . 0.0 117.017 179.469 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 2.4 t 55.67 -167.55 0.1 Allowed 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.765 1.626 . . . . 0.0 111.575 -177.088 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -144.87 146.31 31.99 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 125.597 1.559 . . . . 0.0 108.804 177.69 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 14.4 m . . . . . 0 C--O 1.253 1.267 0 C-N-CA 124.545 1.138 . . . . 0.0 111.043 -173.89 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.7 tpt . . . . . 0 N--CA 1.496 1.859 0 N-CA-C 110.278 -0.268 . . . . 0.0 110.278 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 8.7 ptp180 -143.42 127.31 17.29 Favored 'General case' 0 N--CA 1.482 1.133 0 CA-C-O 117.725 -1.131 . . . . 0.0 108.114 175.013 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 53.7 mt -143.8 137.65 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 CA-C-N 119.718 1.145 . . . . 0.0 112.424 -168.578 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -121.07 126.7 50.49 Favored 'General case' 0 CA--C 1.521 -0.142 0 N-CA-C 104.255 -2.498 . . . . 0.0 104.255 167.487 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 61.7 t -107.95 100.03 9.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 N-CA-C 102.743 -3.058 . . . . 0.0 102.743 169.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 8.2 mt -95.54 116.05 28.29 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 -171.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -93.2 118.53 5.67 Favored Glycine 0 N--CA 1.446 -0.697 0 N-CA-C 106.136 -2.785 . . . . 0.0 106.136 169.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -134.62 -171.92 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 -174.506 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 106.43 157.43 21.6 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.217 -1.153 . . . . 0.0 110.217 -171.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -81.43 96.8 7.49 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 124.773 1.229 . . . . 0.0 109.055 -174.41 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.1 pt -71.97 41.81 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 C-N-CA 124.596 1.158 . . . . 0.0 113.766 -177.294 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 20.2 mt -130.1 -5.52 4.42 Favored 'General case' 0 CA--C 1.534 0.35 0 O-C-N 121.027 -1.046 . . . . 0.0 109.548 173.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -124.6 72.9 1.23 Allowed 'General case' 0 C--N 1.343 0.312 0 C-N-CA 123.559 0.744 . . . . 0.0 110.308 -168.511 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER 47.25 -98.46 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.303 1.041 . . . . 0.0 113.419 175.368 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -77.42 -18.54 57.14 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 125.347 1.459 . . . . 0.0 112.207 -169.531 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -72.63 -8.27 54.45 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 120.275 1.398 . . . . 0.0 112.491 -176.53 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.43 -12.0 60.92 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-O 117.057 -1.449 . . . . 0.0 110.862 169.389 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 9.2 tp -56.82 -39.72 66.36 Favored 'Isoleucine or valine' 0 C--N 1.341 0.234 0 CA-C-N 121.107 1.776 . . . . 0.0 112.275 -170.117 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -58.73 -46.82 92.86 Favored Glycine 0 C--N 1.339 0.708 0 CA-C-N 119.484 1.038 . . . . 0.0 111.229 176.25 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 62.4 t -62.95 -47.92 90.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-O 118.618 -0.706 . . . . 0.0 109.477 175.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 20.3 mmt180 -63.73 -31.95 73.29 Favored 'General case' 0 C--N 1.346 0.452 0 CA-C-O 117.298 -1.334 . . . . 0.0 111.688 -176.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 18.2 mt -60.6 -48.16 89.78 Favored 'Isoleucine or valine' 0 C--N 1.341 0.233 0 CA-C-N 121.033 1.742 . . . . 0.0 109.62 176.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 18.8 m -74.64 -33.45 31.9 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-N 119.429 1.013 . . . . 0.0 111.368 -173.486 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 62.8 mt-10 -63.29 -44.41 95.12 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 118.383 0.538 . . . . 0.0 109.934 172.206 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -66.33 -37.6 85.74 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 119.427 1.012 . . . . 0.0 110.197 177.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.8 tp -63.79 -39.78 95.07 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 119.08 0.855 . . . . 0.0 109.088 -178.636 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -62.16 -22.5 65.92 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.251 0.62 . . . . 0.0 112.578 179.302 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 90.3 mt-30 -94.32 -45.09 7.64 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.213 1.405 . . . . 0.0 110.201 -178.704 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 80.4 mtt180 -81.69 -25.33 35.6 Favored 'General case' 0 CA--C 1.528 0.109 0 CA-C-O 118.753 -0.641 . . . . 0.0 111.165 -173.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 56.5 m-85 -125.54 151.33 46.51 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-N 118.611 0.642 . . . . 0.0 111.019 -179.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 46.3 mm -104.56 133.64 48.11 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 103.51 -2.774 . . . . 0.0 103.51 168.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -113.04 146.76 35.83 Favored Pre-proline 0 C--O 1.237 0.4 0 C-N-CA 123.28 0.632 . . . . 0.0 109.703 -169.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -65.17 157.89 55.06 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 122.458 2.105 . . . . 0.0 109.9 170.564 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -57.49 -34.01 68.61 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 -169.408 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 12.0 p90 -76.26 -10.73 59.63 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 -177.171 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 69.1 t -91.84 119.37 39.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 172.002 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -111.84 114.68 27.78 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 107.343 -1.354 . . . . 0.0 107.343 169.536 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -85.06 102.43 10.97 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 N-CA-C 104.484 -2.413 . . . . 0.0 104.484 168.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 59.5 tp -107.54 128.37 54.46 Favored 'General case' 0 C--O 1.232 0.151 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 -173.244 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -79.3 119.43 22.35 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 169.539 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -78.41 -80.1 0.74 Allowed Glycine 0 C--N 1.338 0.664 0 N-CA-C 106.64 -2.584 . . . . 0.0 106.64 169.527 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 78.28 99.37 0.21 Allowed Glycine 0 C--N 1.342 0.903 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 176.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 13.1 p 53.47 55.62 8.41 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.113 0.965 . . . . 0.0 108.69 -177.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -118.03 -79.89 0.6 Allowed 'General case' 0 C--N 1.348 0.503 0 CA-C-N 114.487 -1.233 . . . . 0.0 111.071 -170.051 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 59.42 -110.2 2.6 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 110.077 -1.209 . . . . 0.0 110.077 -179.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -53.14 -33.03 50.68 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.973 1.309 . . . . 0.0 110.962 -176.387 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -54.43 -22.3 12.18 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 113.784 1.031 . . . . 0.0 113.784 -175.474 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 14.5 mt -95.73 17.89 14.13 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 113.57 0.952 . . . . 0.0 113.57 -169.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 4.6 tt -45.78 -60.11 2.41 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 123.239 0.616 . . . . 0.0 112.055 -177.165 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -67.78 -32.52 78.06 Favored Glycine 0 CA--C 1.532 1.146 0 CA-C-N 116.002 -0.545 . . . . 0.0 112.291 -178.076 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -78.47 -32.37 48.33 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 118.836 1.318 . . . . 0.0 112.699 -173.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 53.8 mtp -74.8 -16.98 60.69 Favored 'General case' 0 N--CA 1.454 -0.225 0 O-C-N 121.758 -0.589 . . . . 0.0 110.868 178.261 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -81.13 156.4 25.77 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 123.375 0.67 . . . . 0.0 111.257 -173.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 53.76 36.08 23.01 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 126.588 1.955 . . . . 0.0 113.512 173.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 26.4 mmt180 -100.94 157.29 16.85 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 173.047 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -82.63 -54.68 4.97 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 176.008 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . 0.263 0.0 OUTLIER -116.83 149.95 39.17 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-N 119.522 1.055 . . . . 0.0 108.589 168.551 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 12.6 tp -133.69 115.82 15.06 Favored 'General case' 0 CA--C 1.511 -0.543 0 N-CA-C 104.955 -2.239 . . . . 0.0 104.955 171.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 33.8 mt -97.95 111.95 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 N-CA-C 104.885 -2.265 . . . . 0.0 104.885 171.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 12.2 mt -85.18 134.41 27.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 106.058 -1.83 . . . . 0.0 106.058 171.589 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -117.0 118.41 32.32 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 102.591 -3.114 . . . . 0.0 102.591 168.402 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -156.71 162.12 39.8 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 -175.093 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -85.33 149.66 25.3 Favored 'General case' 0 CA--C 1.534 0.357 0 O-C-N 121.536 -0.727 . . . . 0.0 109.974 170.026 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 11.0 mt -80.46 -30.94 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 C-N-CA 124.7 1.2 . . . . 0.0 110.171 175.678 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . 0.361 2.5 t 60.27 43.77 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.086 0 C-N-CA 126.321 1.848 . . . . 0.0 113.326 -176.402 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 12.8 m 62.04 139.15 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 128.424 2.69 . . . . 0.0 118.172 168.526 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -130.73 -90.04 0.46 Allowed 'General case' 0 N--CA 1.463 0.181 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 169.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 87.9 mttt -139.36 35.41 2.07 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.778 1.231 . . . . 0.0 110.0 -176.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 42.1 t-20 -138.0 161.72 35.98 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.561 1.144 . . . . 0.0 109.844 -171.105 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 2.1 m -62.5 148.3 90.67 Favored Pre-proline 0 CA--C 1.547 0.865 0 C-N-CA 124.666 1.186 . . . . 0.0 113.131 -169.294 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_exo -56.85 157.91 18.52 Favored 'Trans proline' 0 CA--C 1.532 0.419 0 C-N-CA 124.481 3.454 . . . . 0.0 113.038 169.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 64.15 16.3 59.82 Favored Glycine 0 CA--C 1.531 1.064 0 CA-C-O 119.491 -0.616 . . . . 0.0 113.809 171.317 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 3.0 m -94.51 146.64 23.96 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 124.672 1.189 . . . . 0.0 109.629 -172.092 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 31.7 ttp -98.04 141.78 30.57 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 171.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 64.3 mtm -133.33 129.73 37.89 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 169.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 38.9 mm -108.21 121.93 61.92 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 -179.528 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.3 mp -121.33 139.01 53.99 Favored 'General case' 0 C--O 1.236 0.367 0 O-C-N 123.833 0.708 . . . . 0.0 109.3 -172.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 52.5 ttp180 -83.95 165.15 18.89 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.922 0.889 . . . . 0.0 110.049 -177.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -30.67 -55.1 0.2 Allowed 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 116.353 1.983 . . . . 0.0 116.353 -175.392 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -87.91 -16.65 33.29 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 -174.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -76.13 -35.09 59.4 Favored 'General case' 0 N--CA 1.461 0.084 0 O-C-N 121.817 -0.552 . . . . 0.0 109.574 -178.254 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 88.3 t -59.14 -54.54 55.37 Favored Pre-proline 0 CA--C 1.547 0.848 0 C-N-CA 125.635 1.574 . . . . 0.0 111.787 -175.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -53.86 -42.77 63.83 Favored 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 122.781 2.321 . . . . 0.0 112.41 174.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -71.26 -10.82 60.39 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -91.66 -40.2 11.42 Favored 'General case' 0 C--N 1.343 0.315 0 CA-C-N 120.073 1.306 . . . . 0.0 111.82 -176.539 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 -75.52 10.12 1.85 Allowed 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 112.967 0.728 . . . . 0.0 112.967 -171.525 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 75.2 p -60.14 -24.29 64.59 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.154 0.981 . . . . 0.0 111.22 171.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 61.5 t-20 -49.04 118.9 2.87 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.503 1.121 . . . . 0.0 111.235 177.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -74.67 -18.45 60.52 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -174.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 42.1 mt -67.13 -45.59 86.27 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -176.527 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.3 m -73.18 110.54 8.84 Favored Pre-proline 0 CA--C 1.545 0.762 0 C-N-CA 126.291 1.837 . . . . 0.0 112.05 -168.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -76.15 -62.95 0.03 OUTLIER 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 122.254 1.97 . . . . 0.0 112.333 -169.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 6.6 t-80 -56.66 -40.04 74.81 Favored 'General case' 0 N--CA 1.466 0.335 0 O-C-N 121.442 -0.786 . . . . 0.0 110.225 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 22.0 mp0 -62.29 -27.69 69.2 Favored 'General case' 0 N--CA 1.44 -0.955 0 C-N-CA 124.972 1.309 . . . . 0.0 110.082 -172.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 30.9 mt -72.09 -36.72 69.59 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 120.025 1.284 . . . . 0.0 110.447 174.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -66.69 -42.96 92.97 Favored Glycine 0 CA--C 1.528 0.885 0 N-CA-C 110.238 -1.145 . . . . 0.0 110.238 173.387 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -59.79 -41.45 91.2 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.197 0.599 . . . . 0.0 109.791 173.35 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -59.25 -44.65 92.36 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 123.01 0.524 . . . . 0.0 110.542 175.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -66.11 -26.76 67.61 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 118.806 -0.616 . . . . 0.0 111.899 -179.608 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 92.1 t -63.93 -45.84 95.78 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 168.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 87.9 mt -67.07 -33.4 75.43 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 119.266 0.939 . . . . 0.0 110.722 -176.182 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 15.8 m -60.78 -49.25 78.24 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 119.028 0.831 . . . . 0.0 109.957 169.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -58.1 -41.03 82.63 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 118.185 0.448 . . . . 0.0 111.019 176.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -63.48 -32.71 74.24 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 123.741 0.816 . . . . 0.0 110.951 179.74 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 17.6 ptm180 -83.68 -27.86 28.75 Favored 'General case' 0 C--N 1.344 0.369 0 CA-C-N 120.455 1.48 . . . . 0.0 112.19 173.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 16.7 m-30 -60.47 -46.58 89.55 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 118.454 0.57 . . . . 0.0 109.843 172.301 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 41.4 p -77.29 -26.8 52.67 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 123.611 0.764 . . . . 0.0 111.54 178.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 75.66 6.35 81.12 Favored Glycine 0 CA--C 1.534 1.232 0 N-CA-C 109.881 -1.288 . . . . 0.0 109.881 -168.497 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -85.24 19.99 2.09 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 119.768 1.784 . . . . 0.0 111.454 179.088 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -56.28 140.03 72.44 Favored Pre-proline 0 CA--C 1.546 0.814 0 C-N-CA 126.034 1.734 . . . . 0.0 110.307 170.058 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 99.6 Cg_exo -57.97 161.37 13.26 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 123.396 2.731 . . . . 0.0 115.531 179.365 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -65.91 -38.63 89.2 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 119.164 -0.446 . . . . 0.0 111.671 176.339 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 4.5 pttm -142.75 89.64 2.15 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 124.259 1.024 . . . . 0.0 108.342 177.7 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 7.4 tt -76.33 142.6 41.19 Favored 'General case' 0 CA--C 1.534 0.356 0 O-C-N 120.961 -1.087 . . . . 0.0 108.592 169.418 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.9 140.81 46.07 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.334 1.454 . . . . 0.0 107.698 174.696 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 14.6 tp -118.59 134.41 55.13 Favored 'General case' 0 N--CA 1.467 0.411 0 O-C-N 120.48 -1.388 . . . . 0.0 108.496 175.291 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 20.4 t -105.92 85.09 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 N-CA-C 104.788 -2.301 . . . . 0.0 104.788 169.154 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -81.31 144.66 24.77 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 110.41 -1.076 . . . . 0.0 110.41 179.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 39.2 t -128.43 130.98 69.3 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 CA-C-N 117.405 0.603 . . . . 0.0 109.989 179.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 16.8 mt -85.17 132.92 43.9 Favored Pre-proline 0 CA--C 1.539 0.529 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 176.396 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -77.01 -179.06 5.05 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 123.075 2.517 . . . . 0.0 111.617 -177.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -110.09 -51.18 2.9 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.994 0.918 . . . . 0.0 109.807 169.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 66.4 m -118.65 -54.53 2.25 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 118.201 0.455 . . . . 0.0 111.964 -169.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER 54.54 52.84 11.61 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.652 1.181 . . . . 0.0 112.163 -177.293 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -119.25 165.92 15.87 Favored Pre-proline 0 CA--C 1.537 0.472 0 C-N-CA 123.468 0.707 . . . . 0.0 109.954 -179.372 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -78.32 81.78 2.64 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 121.755 1.636 . . . . 0.0 112.634 -169.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -171.09 141.59 1.68 Allowed 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 102.218 -3.253 . . . . 0.0 102.218 177.293 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -108.21 166.59 4.25 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 N-CA-C 113.596 0.962 . . . . 0.0 113.596 -169.286 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 97.33 141.21 11.94 Favored Glycine 0 C--N 1.338 0.646 0 N-CA-C 105.751 -2.94 . . . . 0.0 105.751 -168.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -67.41 158.49 31.59 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 117.861 0.83 . . . . 0.0 109.882 176.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 63.4 p -69.14 169.75 10.78 Favored Pre-proline 0 CA--C 1.543 0.681 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 168.018 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -58.02 -37.13 97.12 Favored 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 121.57 1.513 . . . . 0.0 111.388 173.305 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 82.8 m -64.33 -33.75 76.55 Favored 'General case' 0 N--CA 1.443 -0.785 0 C-N-CA 124.415 1.086 . . . . 0.0 111.436 -178.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 73.8 t -103.23 -27.59 3.2 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 O-C-N 121.81 -0.556 . . . . 0.0 111.511 -172.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -51.73 -49.37 62.69 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 119.035 0.834 . . . . 0.0 108.88 169.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -61.89 -20.88 64.22 Favored 'General case' 0 N--CA 1.447 -0.575 0 N-CA-C 112.994 0.738 . . . . 0.0 112.994 179.373 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 3.0 mmm -78.04 -7.89 57.48 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 -179.619 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 72.5 mt -55.95 -50.59 68.31 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.295 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 170.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -70.51 -44.89 18.4 Favored Pre-proline 0 CA--C 1.538 0.481 0 CA-C-O 117.284 -1.341 . . . . 0.0 113.756 -168.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -57.66 -41.33 71.75 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 CA-C-N 122.076 1.777 . . . . 0.0 111.152 172.412 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.01 -35.89 74.69 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-O 118.263 -0.875 . . . . 0.0 112.046 179.285 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 39.0 mt -61.09 -48.64 80.75 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-N 120.087 1.312 . . . . 0.0 108.929 172.249 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -54.73 -35.31 63.55 Favored 'General case' 0 CA--C 1.531 0.237 0 O-C-N 123.398 0.436 . . . . 0.0 109.995 175.288 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 2.1 mm100 -78.7 -35.74 44.58 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 45.7 t -59.27 -48.27 87.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 169.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 44.0 mt -60.23 -36.55 77.99 Favored 'General case' 0 C--O 1.226 -0.148 0 C-N-CA 123.413 0.685 . . . . 0.0 110.88 177.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -70.1 -44.23 69.44 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 119.139 0.881 . . . . 0.0 110.856 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -66.53 -30.99 71.43 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 119.676 1.126 . . . . 0.0 111.225 177.433 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 12.9 mt -62.27 -52.99 61.5 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 169.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 93.6 mtt-85 -64.73 -28.65 69.74 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 120.231 1.378 . . . . 0.0 112.432 -178.413 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -69.34 -28.75 66.51 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 119.203 0.91 . . . . 0.0 109.982 176.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 51.0 m -82.51 8.24 12.22 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.392 1.077 . . . . 0.0 111.906 169.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 72.83 10.52 77.09 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-O 117.291 -1.838 . . . . 0.0 113.11 -174.56 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 38.2 t -91.05 119.54 38.39 Favored 'Isoleucine or valine' 0 C--N 1.345 0.378 0 CA-C-N 121.025 2.412 . . . . 0.0 108.48 -176.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -97.57 91.32 5.38 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 172.385 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -55.9 139.11 47.08 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 169.051 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 20.5 mt -83.33 126.87 70.71 Favored Pre-proline 0 CA--C 1.529 0.161 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 -173.263 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -68.47 89.83 0.4 Allowed 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 123.045 2.497 . . . . 0.0 109.029 174.64 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 29.1 ttp180 52.34 17.13 0.69 Allowed 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 127.628 2.371 . . . . 0.0 114.567 179.489 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 57.7 m 48.24 37.07 7.68 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.057 0.943 . . . . 0.0 111.145 -169.015 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -140.73 45.84 1.79 Allowed 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.14 1.376 . . . . 0.0 108.991 -170.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 8.5 m . . . . . 0 C--O 1.258 1.503 0 C-N-CA 124.977 1.311 . . . . 0.0 110.509 -177.816 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.8 ttt . . . . . 0 N--CA 1.499 2.016 0 CA-C-O 119.646 -0.216 . . . . 0.0 110.938 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 38.9 ttm180 -64.42 124.02 20.72 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 120.007 -1.683 . . . . 0.0 109.693 176.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 5.5 mt -119.73 132.7 68.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 -174.526 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 43.3 tp -113.61 145.72 40.84 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 105.849 -1.908 . . . . 0.0 105.849 167.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 30.2 t -124.32 131.37 72.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 N-CA-C 105.017 -2.216 . . . . 0.0 105.017 169.213 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 6.6 mt -125.36 117.3 23.43 Favored 'General case' 0 CA--C 1.511 -0.547 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 -173.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -87.88 133.29 11.71 Favored Glycine 0 CA--C 1.521 0.424 0 N-CA-C 107.709 -2.157 . . . . 0.0 107.709 169.652 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.5 m -142.27 133.01 24.76 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 CA-C-N 119.317 1.559 . . . . 0.0 112.507 -170.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 144.79 169.59 13.42 Favored Glycine 0 CA--C 1.525 0.684 0 C-N-CA 125.948 1.737 . . . . 0.0 109.123 169.572 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.402 HD22 HD11 ' A' ' 13' ' ' LEU . 0.2 OUTLIER -76.94 116.77 17.9 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 122.81 1.29 . . . . 0.0 111.45 -176.459 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.1 pt -63.99 36.34 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.861 0 N-CA-C 116.096 1.888 . . . . 0.0 116.096 172.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 5.4 mp -129.52 -9.53 4.59 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 120.545 1.52 . . . . 0.0 110.025 168.525 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.402 HD11 HD22 ' A' ' 10' ' ' ASN . 4.7 mp -106.59 56.47 0.65 Allowed 'General case' 0 C--N 1.343 0.299 0 N-CA-C 114.739 1.385 . . . . 0.0 114.739 -168.917 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.255 0.2 OUTLIER 54.95 -109.59 0.51 Allowed 'General case' 0 C--O 1.238 0.45 0 C-N-CA 123.428 0.691 . . . . 0.0 110.921 170.428 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -77.9 -7.45 56.75 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.435 0.694 . . . . 0.0 111.831 -175.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 23.0 tp10 -55.85 -32.59 63.76 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 120.012 1.278 . . . . 0.0 111.417 169.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.9 5.0 14.97 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-O 115.888 -2.006 . . . . 0.0 110.082 -179.1 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 6.6 tp -57.07 -42.82 80.13 Favored 'Isoleucine or valine' 0 C--N 1.342 0.242 0 CA-C-N 123.369 2.804 . . . . 0.0 110.92 -179.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -61.23 -43.18 99.71 Favored Glycine 0 CA--C 1.526 0.727 0 CA-C-N 119.564 1.075 . . . . 0.0 111.465 175.428 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 83.2 t -66.93 -51.46 54.62 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 CA-C-N 117.449 0.624 . . . . 0.0 109.559 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 74.4 mmt-85 -57.55 -34.76 69.51 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 117.142 -1.409 . . . . 0.0 112.479 176.578 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 24.2 mt -60.72 -47.73 91.84 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-N 121.839 2.109 . . . . 0.0 110.507 175.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 35.2 m -74.26 -27.2 21.39 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-N 120.25 1.386 . . . . 0.0 111.416 -175.426 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -69.18 -45.69 69.36 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 174.597 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -64.32 -45.11 89.3 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 123.313 0.645 . . . . 0.0 110.509 -179.442 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 8.1 tp -61.78 -41.58 97.9 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-O 118.86 -0.59 . . . . 0.0 110.068 179.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -60.05 -38.73 83.67 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 118.209 0.459 . . . . 0.0 110.965 177.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 9.5 mm-40 -75.75 -40.6 55.17 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 118.631 0.651 . . . . 0.0 111.065 -179.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 41.5 mmt180 -87.4 -31.57 20.01 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 117.637 -1.173 . . . . 0.0 113.02 -169.498 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 72.0 m-85 -122.54 137.76 54.78 Favored 'General case' 0 CA--C 1.522 -0.134 0 CA-C-N 120.76 1.618 . . . . 0.0 111.969 -176.05 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 43.7 mm -90.87 137.65 21.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 N-CA-C 105.591 -2.003 . . . . 0.0 105.591 168.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -124.25 154.98 68.83 Favored Pre-proline 0 CA--C 1.541 0.62 0 C-N-CA 124.985 1.314 . . . . 0.0 109.902 -170.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -59.44 157.13 32.61 Favored 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 123.318 2.679 . . . . 0.0 112.041 169.697 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -63.19 -31.38 72.51 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -171.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 18.8 p90 -72.66 -6.19 42.67 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 118.186 -0.911 . . . . 0.0 112.699 178.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 38.2 t -100.9 130.73 49.81 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 CA-C-N 120.054 1.297 . . . . 0.0 108.32 175.391 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -118.55 135.35 54.46 Favored 'General case' 0 CA--C 1.529 0.171 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 170.078 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -106.47 118.12 53.54 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 N-CA-C 104.691 -2.337 . . . . 0.0 104.691 169.368 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 48.7 tp -127.19 126.4 42.75 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-O 120.889 0.376 . . . . 0.0 110.307 -174.735 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -78.0 119.42 21.42 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 168.715 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -57.51 -55.84 28.28 Favored Glycine 0 CA--C 1.53 0.975 0 N-CA-C 109.073 -1.611 . . . . 0.0 109.073 172.411 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 74.74 87.56 0.24 Allowed Glycine 0 C--N 1.341 0.833 0 N-CA-C 111.451 -0.66 . . . . 0.0 111.451 169.699 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 20.3 p 50.81 58.91 5.02 Favored 'General case' 0 CA--C 1.546 0.8 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 -177.532 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -116.65 -86.72 0.62 Allowed 'General case' 0 C--N 1.348 0.508 0 CA-C-N 114.495 -1.23 . . . . 0.0 111.352 -169.334 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 65.76 -94.97 0.22 Allowed Glycine 0 C--N 1.341 0.836 0 N-CA-C 108.947 -1.661 . . . . 0.0 108.947 -169.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 3.5 tpt -62.77 -31.41 72.37 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 125.288 1.435 . . . . 0.0 111.764 179.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -66.36 -7.69 20.7 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -169.32 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 70.9 mt -84.26 3.74 34.06 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 113.854 1.057 . . . . 0.0 113.854 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 6.0 tt -41.36 -59.0 1.68 Allowed 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 114.107 1.151 . . . . 0.0 114.107 -170.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -93.34 -26.02 17.12 Favored Glycine 0 CA--C 1.527 0.786 0 C-N-CA 123.698 0.666 . . . . 0.0 111.896 -178.461 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -62.06 -34.7 76.74 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 118.639 1.22 . . . . 0.0 111.335 179.467 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 26.8 mtp -78.28 -3.58 43.6 Favored 'General case' 0 CA--C 1.529 0.137 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 178.378 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.5 157.84 36.84 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 118.817 0.735 . . . . 0.0 110.824 -178.124 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 55.3 39.51 31.31 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.827 1.651 . . . . 0.0 114.66 168.311 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 13.4 mmt180 -107.11 148.86 28.28 Favored 'General case' 0 N--CA 1.473 0.714 0 O-C-N 121.121 -0.987 . . . . 0.0 109.411 176.11 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -82.49 -36.05 26.82 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 171.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 1.7 t-160 -138.45 137.93 37.66 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 -176.002 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 20.8 tp -136.41 131.47 34.19 Favored 'General case' 0 CA--C 1.507 -0.686 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 169.275 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 3.8 mp -112.42 119.81 61.15 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 169.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 5.3 mt -96.55 117.71 41.48 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 177.097 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -84.56 113.41 21.22 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 103.2 -2.889 . . . . 0.0 103.2 169.519 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -124.16 155.37 38.59 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 114.358 1.244 . . . . 0.0 114.358 -167.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -113.18 119.4 37.65 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 169.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 92.0 mt -76.71 -26.01 16.22 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.753 0 O-C-N 124.148 0.905 . . . . 0.0 111.558 -171.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . 0.286 47.4 t 69.75 -62.58 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 C-N-CA 128.887 2.875 . . . . 0.0 111.572 -170.61 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 5.5 m -151.68 138.84 19.23 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 177.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 73.3 tttt -157.3 170.06 23.32 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 127.534 2.334 . . . . 0.0 105.234 168.735 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.01 -22.5 65.89 Favored 'General case' 0 N--CA 1.473 0.675 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 -170.314 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -71.16 164.92 24.66 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 123.087 0.555 . . . . 0.0 110.292 -177.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 18.6 m -61.57 149.57 83.76 Favored Pre-proline 0 CA--C 1.55 0.949 0 C-N-CA 124.257 1.023 . . . . 0.0 112.125 -171.232 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -54.21 152.53 24.77 Favored 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 122.77 2.313 . . . . 0.0 112.255 169.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 69.65 7.36 58.25 Favored Glycine 0 CA--C 1.531 1.036 0 CA-C-O 118.661 -1.077 . . . . 0.0 114.44 175.276 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 20.5 m -89.19 148.14 23.79 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 119.608 1.704 . . . . 0.0 110.043 -173.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 25.5 ttp -90.77 147.6 23.11 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.264 178.316 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 19.9 ttm -141.54 116.48 9.86 Favored 'General case' 0 CA--C 1.528 0.118 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 -177.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.6 mp -96.28 122.96 48.29 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 177.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -115.52 126.81 54.73 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 179.228 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 74.9 mtm180 -91.63 177.26 6.26 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 123.354 0.662 . . . . 0.0 109.68 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -48.19 -47.86 35.08 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 115.341 1.608 . . . . 0.0 115.341 -169.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -76.18 -15.89 59.96 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 119.046 0.839 . . . . 0.0 112.198 -178.33 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -96.36 -23.68 16.52 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 123.863 0.865 . . . . 0.0 110.714 -169.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -68.57 -37.99 11.41 Favored Pre-proline 0 CA--C 1.535 0.37 0 O-C-N 120.608 -1.308 . . . . 0.0 112.554 178.19 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -62.78 -12.04 26.96 Favored 'Trans proline' 0 CA--C 1.546 1.105 0 C-N-CA 121.55 1.5 . . . . 0.0 112.746 168.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -98.9 4.59 47.44 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.91 0.884 . . . . 0.0 111.742 173.436 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -111.76 -57.25 2.28 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 124.025 0.93 . . . . 0.0 111.166 -175.701 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -66.14 -15.89 63.5 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 118.764 0.711 . . . . 0.0 111.534 -170.307 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 68.4 p -85.29 -9.94 57.08 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 125.539 1.535 . . . . 0.0 113.139 -168.482 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -59.38 152.04 22.28 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 118.476 0.58 . . . . 0.0 109.926 174.584 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -78.5 -10.05 59.56 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 113.456 0.91 . . . . 0.0 113.456 -169.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 4.8 mp -84.76 -53.46 10.78 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 CA-C-N 119.396 0.998 . . . . 0.0 109.44 -171.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 3.9 m -59.95 109.23 1.81 Allowed Pre-proline 0 CA--C 1.549 0.908 0 C-N-CA 124.1 0.96 . . . . 0.0 111.814 -169.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -71.9 -54.15 0.15 Allowed 'Trans proline' 0 C--N 1.354 0.821 0 CA-C-N 120.817 1.328 . . . . 0.0 112.438 -169.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 18.2 m80 -80.93 -32.25 34.68 Favored 'General case' 0 N--CA 1.467 0.408 0 O-C-N 121.984 -0.447 . . . . 0.0 110.108 -175.126 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 3.9 mm-40 -71.16 -23.12 61.99 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 118.485 -0.769 . . . . 0.0 110.523 -179.112 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 10.4 mt -62.98 -30.52 71.65 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 120.387 1.448 . . . . 0.0 110.974 169.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -64.1 -40.75 98.4 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 109.916 -1.274 . . . . 0.0 109.916 171.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 22.5 tp -67.93 -30.93 70.36 Favored 'General case' 0 CA--C 1.532 0.287 0 O-C-N 122.142 -0.622 . . . . 0.0 110.546 174.658 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -58.87 -44.11 91.0 Favored 'General case' 0 N--CA 1.451 -0.389 0 O-C-N 120.796 -1.19 . . . . 0.0 108.895 171.131 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -70.89 -20.38 62.51 Favored 'General case' 0 N--CA 1.456 -0.13 0 O-C-N 121.789 -0.57 . . . . 0.0 111.494 177.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 55.2 t -70.04 -41.26 79.19 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.871 0 CA-C-O 117.764 -1.113 . . . . 0.0 108.126 169.315 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 6.8 mp -60.69 -38.21 84.23 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 120.602 1.546 . . . . 0.0 109.887 175.312 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 16.4 m -63.46 -45.1 92.38 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 174.546 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -65.65 -41.48 92.53 Favored 'General case' 0 N--CA 1.447 -0.587 0 O-C-N 121.535 -0.728 . . . . 0.0 110.554 -178.448 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 28.3 mt -58.96 -39.6 82.18 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 124.665 1.186 . . . . 0.0 110.306 174.609 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 41.3 ttm180 -67.4 -36.56 81.54 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 118.771 -0.633 . . . . 0.0 109.983 175.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 13.5 m-30 -68.51 -41.11 80.43 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 118.963 0.801 . . . . 0.0 111.051 178.38 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 55.8 p -75.93 -27.1 57.48 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 118.827 0.739 . . . . 0.0 110.994 179.546 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 78.4 10.03 86.54 Favored Glycine 0 CA--C 1.534 1.271 0 CA-C-O 119.278 -0.734 . . . . 0.0 111.465 -169.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 -94.07 15.21 17.6 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 118.807 1.303 . . . . 0.0 112.268 -177.392 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 8.1 t80 -53.69 132.24 55.89 Favored Pre-proline 0 CA--C 1.539 0.55 0 C-N-CA 125.349 1.459 . . . . 0.0 110.317 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_exo -50.5 136.37 40.61 Favored 'Trans proline' 0 C--N 1.354 0.817 0 C-N-CA 123.461 2.774 . . . . 0.0 112.32 178.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -63.19 -24.1 67.73 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 119.287 -0.387 . . . . 0.0 111.796 -173.64 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 57.2 tttm -141.85 108.31 5.31 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 169.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -85.89 142.01 29.17 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 169.123 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.62 153.25 45.98 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 105.951 -1.87 . . . . 0.0 105.951 171.885 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -145.29 138.23 26.25 Favored 'General case' 0 C--N 1.33 -0.276 0 O-C-N 120.512 -1.368 . . . . 0.0 108.636 176.259 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 48.8 t -110.12 95.91 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 N-CA-C 103.635 -2.728 . . . . 0.0 103.635 169.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -87.44 151.96 23.84 Favored Glycine 0 C--N 1.332 0.351 0 N-CA-C 110.101 -1.2 . . . . 0.0 110.101 178.059 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 44.9 t -132.77 137.15 54.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 178.691 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 51.0 mt -86.76 129.83 51.08 Favored Pre-proline 0 CA--C 1.542 0.659 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 170.491 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -74.04 171.98 16.87 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 124.03 3.153 . . . . 0.0 112.561 -179.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -109.4 -43.89 4.02 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.461 1.105 . . . . 0.0 108.599 169.443 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 63.8 m -128.73 152.09 48.81 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.473 0.709 . . . . 0.0 111.266 176.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.4 tp -152.54 54.5 0.79 Allowed 'General case' 0 CA--C 1.548 0.893 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 -169.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -127.35 170.14 10.77 Favored Pre-proline 0 N--CA 1.479 1.002 0 CA-C-O 117.756 -1.116 . . . . 0.0 110.595 -178.43 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_exo -63.45 88.56 0.14 Allowed 'Trans proline' 0 CA--C 1.548 1.201 0 C-N-CA 123.806 3.004 . . . . 0.0 114.409 -176.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 179.0 145.72 0.15 Allowed 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 104.415 -2.439 . . . . 0.0 104.415 175.303 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -118.09 167.09 11.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 CA-C-N 120.032 1.287 . . . . 0.0 112.886 -172.798 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 91.56 148.9 22.87 Favored Glycine 0 C--N 1.34 0.796 0 N-CA-C 106.809 -2.516 . . . . 0.0 106.809 -168.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -82.84 162.28 21.68 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-O 121.447 0.642 . . . . 0.0 111.115 -169.396 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 39.8 p -68.92 168.61 14.37 Favored Pre-proline 0 CA--C 1.541 0.619 0 CA-C-N 114.911 -1.041 . . . . 0.0 109.535 168.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -57.1 -32.81 94.42 Favored 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 121.302 1.335 . . . . 0.0 110.906 169.397 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 23.8 m -68.34 -38.69 81.74 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 118.999 -0.524 . . . . 0.0 111.905 179.323 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 20.2 t -108.62 -10.48 11.12 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 CA-C-N 119.471 1.032 . . . . 0.0 112.021 -169.195 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -60.11 -46.87 88.15 Favored 'General case' 0 N--CA 1.465 0.318 0 O-C-N 119.733 -1.854 . . . . 0.0 107.436 169.082 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -71.74 6.55 1.91 Allowed 'General case' 0 N--CA 1.439 -1.015 0 CA-C-O 117.965 -1.017 . . . . 0.0 112.661 176.312 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 26.5 mmm -94.1 -11.54 30.35 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 119.778 1.172 . . . . 0.0 111.083 170.014 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 72.6 mt -61.76 -46.36 96.7 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 179.003 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -69.9 -54.87 9.41 Favored Pre-proline 0 CA--C 1.536 0.405 0 CA-C-O 117.394 -1.289 . . . . 0.0 112.814 -172.331 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -59.82 -34.81 95.53 Favored 'Trans proline' 0 C--N 1.349 0.569 0 CA-C-N 122.301 1.857 . . . . 0.0 111.327 177.031 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -71.11 -45.03 64.45 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-O 118.719 -0.658 . . . . 0.0 110.497 -177.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -63.68 -36.8 85.02 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 119.235 0.925 . . . . 0.0 109.916 177.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -61.88 -39.03 90.51 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 118.007 0.367 . . . . 0.0 111.076 175.585 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 42.4 mm-40 -74.3 -28.37 61.15 Favored 'General case' 0 CA--C 1.535 0.399 0 O-C-N 121.44 -0.787 . . . . 0.0 111.828 176.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 70.4 t -62.93 -46.96 95.0 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 169.502 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 56.8 mt -65.67 -33.63 76.32 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 119.055 0.843 . . . . 0.0 111.143 179.148 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -60.0 -35.59 75.38 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 118.513 0.597 . . . . 0.0 111.275 177.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -61.73 -44.95 95.92 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 118.388 0.54 . . . . 0.0 111.244 175.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 7.1 mp -61.41 -40.55 94.8 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 122.726 0.41 . . . . 0.0 110.082 176.454 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 83.5 mtm-85 -65.59 -16.59 63.86 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 117.504 -1.236 . . . . 0.0 112.594 178.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -58.57 -30.7 67.36 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 120.781 1.628 . . . . 0.0 111.351 177.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 6.7 m -113.39 30.37 7.26 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.503 1.121 . . . . 0.0 111.129 177.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 64.31 23.57 68.36 Favored Glycine 0 CA--C 1.529 0.967 0 CA-C-O 118.566 -1.13 . . . . 0.0 113.821 174.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 60.4 t -87.63 131.35 35.57 Favored 'Isoleucine or valine' 0 C--N 1.34 0.194 0 N-CA-C 106.362 -1.718 . . . . 0.0 106.362 174.112 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -120.68 123.29 42.39 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 -177.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -82.15 144.36 30.79 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 172.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 6.9 mm -101.53 123.89 42.78 Favored Pre-proline 0 CA--C 1.53 0.207 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 -173.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -60.6 108.97 0.58 Allowed 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.188 1.926 . . . . 0.0 108.182 173.449 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 34.3 ptt180 43.8 15.62 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 128.825 2.85 . . . . 0.0 116.239 -177.397 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 3.8 m 45.83 31.71 1.11 Allowed 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 125.366 1.466 . . . . 0.0 112.732 -168.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -156.24 129.33 8.01 Favored 'General case' 0 C--O 1.235 0.342 0 O-C-N 121.135 -0.978 . . . . 0.0 109.449 177.154 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 12.5 m . . . . . 0 C--O 1.253 1.259 0 C-N-CA 124.317 1.047 . . . . 0.0 111.391 -174.473 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.9 tpt . . . . . 0 N--CA 1.496 1.866 0 N-CA-C 110.46 -0.2 . . . . 0.0 110.46 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 6.0 ptp180 -150.46 123.61 8.85 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 177.221 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 66.7 mt -141.54 133.32 27.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-N 119.12 0.873 . . . . 0.0 110.172 -169.975 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -116.39 128.64 55.69 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 105.952 -1.87 . . . . 0.0 105.952 168.419 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.0 t -106.95 98.1 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 103.466 -2.79 . . . . 0.0 103.466 172.844 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.8 mt -99.09 110.42 23.0 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 123.912 0.885 . . . . 0.0 110.17 -169.433 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -89.69 121.42 6.12 Favored Glycine 0 N--CA 1.446 -0.659 0 N-CA-C 107.102 -2.399 . . . . 0.0 107.102 170.313 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 13.0 m -134.21 -171.89 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.016 0 C-N-CA 124.321 1.048 . . . . 0.0 108.258 -178.148 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 110.66 154.63 13.91 Favored Glycine 0 C--N 1.336 0.539 0 N-CA-C 110.453 -1.059 . . . . 0.0 110.453 -173.233 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -77.36 96.84 4.73 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 123.788 0.835 . . . . 0.0 109.224 -179.143 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.3 pt -72.47 36.4 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 C-N-CA 124.504 1.122 . . . . 0.0 113.96 -179.077 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 28.0 mt -121.95 -8.75 8.83 Favored 'General case' 0 CA--C 1.531 0.248 0 O-C-N 121.091 -1.005 . . . . 0.0 108.729 171.55 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -127.27 83.95 2.21 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 -169.12 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.1 m 35.74 -104.2 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 113.266 -1.788 . . . . 0.0 114.698 169.65 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -68.08 -19.73 64.89 Favored 'General case' 0 N--CA 1.437 -1.097 0 CA-C-O 117.975 -1.012 . . . . 0.0 112.475 -169.187 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -68.03 -23.69 65.02 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 121.208 1.822 . . . . 0.0 111.818 178.976 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.36 -12.45 52.13 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-O 116.01 -1.948 . . . . 0.0 110.588 172.783 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 6.7 tp -53.74 -38.3 34.84 Favored 'Isoleucine or valine' 0 C--N 1.342 0.26 0 CA-C-N 122.176 2.262 . . . . 0.0 110.271 -177.742 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -61.47 -43.62 99.08 Favored Glycine 0 C--N 1.337 0.596 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 -178.879 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 57.8 t -70.18 -47.21 68.77 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 176.094 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 20.4 mmt180 -61.19 -31.86 71.61 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 117.016 -1.468 . . . . 0.0 112.505 -177.918 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 19.8 mt -58.93 -48.66 85.74 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 CA-C-N 121.74 2.063 . . . . 0.0 109.756 175.68 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.8 m -76.32 -31.07 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-N 119.432 1.015 . . . . 0.0 110.897 -172.202 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 59.2 mt-10 -64.99 -41.49 95.37 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 119.107 -0.473 . . . . 0.0 110.083 171.545 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -66.09 -37.03 84.76 Favored 'General case' 0 C--N 1.344 0.328 0 CA-C-N 119.42 1.009 . . . . 0.0 110.803 175.55 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 6.5 tp -63.07 -41.2 99.39 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 119.075 0.852 . . . . 0.0 110.036 -177.267 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -59.46 -27.68 66.31 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.516 0.726 . . . . 0.0 112.882 -179.991 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 50.6 mt-30 -95.05 -37.34 11.15 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 125.865 1.666 . . . . 0.0 111.41 -175.875 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 75.4 mtt180 -89.61 -27.28 20.3 Favored 'General case' 0 C--O 1.224 -0.244 0 CA-C-O 118.099 -0.953 . . . . 0.0 112.46 -175.965 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 52.6 m-85 -122.93 145.28 48.61 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 119.796 1.18 . . . . 0.0 112.967 -175.391 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 38.9 mm -95.39 139.07 19.56 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 N-CA-C 103.949 -2.611 . . . . 0.0 103.949 168.871 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 42.9 mt -128.81 147.19 63.48 Favored Pre-proline 0 CA--C 1.532 0.284 0 C-N-CA 123.457 0.703 . . . . 0.0 110.185 -168.835 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -67.77 158.55 56.76 Favored 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 122.76 2.306 . . . . 0.0 110.479 172.126 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -59.17 -33.42 70.91 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 114.436 1.273 . . . . 0.0 114.436 -169.403 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 10.0 p90 -75.05 -13.42 60.49 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 118.927 -0.559 . . . . 0.0 112.49 -177.746 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 75.0 t -88.09 122.47 39.72 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 170.531 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -124.18 129.41 50.77 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 169.67 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -82.81 137.46 20.97 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.809 0 N-CA-C 106.068 -1.827 . . . . 0.0 106.068 167.81 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 52.2 tp -128.36 136.45 50.95 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 169.717 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -93.15 120.94 33.99 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 169.246 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -72.8 -71.73 1.05 Allowed Glycine 0 CA--C 1.526 0.74 0 N-CA-C 108.981 -1.647 . . . . 0.0 108.981 174.159 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 84.98 92.56 0.78 Allowed Glycine 0 C--N 1.342 0.884 0 N-CA-C 107.942 -2.063 . . . . 0.0 107.942 -177.862 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 44.2 p 55.18 30.61 14.83 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 125.009 1.324 . . . . 0.0 111.893 176.879 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -81.61 -65.49 1.01 Allowed 'General case' 0 C--N 1.348 0.507 0 N-CA-C 115.25 1.574 . . . . 0.0 115.25 -168.194 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 60.95 -109.68 2.57 Favored Glycine 0 CA--C 1.528 0.865 0 N-CA-C 110.262 -1.135 . . . . 0.0 110.262 -175.376 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.32 -21.23 66.25 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.315 1.046 . . . . 0.0 112.061 -175.409 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -60.68 -18.85 56.46 Favored 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 113.534 0.938 . . . . 0.0 113.534 -175.158 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 11.4 mt -98.64 15.08 26.27 Favored 'General case' 0 C--N 1.347 0.458 0 N-CA-C 115.155 1.539 . . . . 0.0 115.155 -169.412 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 5.6 tt -48.2 -58.59 4.31 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 119.703 1.138 . . . . 0.0 111.244 -175.477 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -63.15 -31.59 81.23 Favored Glycine 0 CA--C 1.53 1.025 0 CA-C-O 119.419 -0.656 . . . . 0.0 112.368 -176.153 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -81.19 -35.89 30.81 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 118.509 1.155 . . . . 0.0 112.375 -177.556 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 32.6 mtp -74.07 -27.11 60.75 Favored 'General case' 0 N--CA 1.452 -0.361 0 O-C-N 122.102 -0.374 . . . . 0.0 110.045 178.415 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.51 157.59 31.8 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-O 121.677 0.751 . . . . 0.0 111.608 -179.691 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 16.3 m120 63.24 4.07 1.53 Allowed 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 127.27 2.228 . . . . 0.0 115.64 169.769 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 26.9 mmt180 -76.69 158.49 30.96 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 119.97 1.259 . . . . 0.0 109.05 178.759 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -84.38 -54.24 4.91 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 175.392 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . 0.27 0.0 OUTLIER -124.24 147.18 48.26 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-N 119.812 1.187 . . . . 0.0 108.308 169.28 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 19.0 tp -138.48 113.34 9.14 Favored 'General case' 0 CA--C 1.507 -0.678 0 N-CA-C 104.819 -2.289 . . . . 0.0 104.819 -175.272 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 24.5 mt -95.75 112.36 27.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 105.351 -2.092 . . . . 0.0 105.351 176.976 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 41.5 mt -86.96 137.84 20.16 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 N-CA-C 106.722 -1.584 . . . . 0.0 106.722 171.405 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -122.77 117.2 25.12 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 103.567 -2.753 . . . . 0.0 103.567 168.002 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -153.78 158.26 40.64 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 124.91 1.284 . . . . 0.0 108.208 -178.83 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -88.05 152.96 21.65 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 169.537 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 81.1 mt -87.52 -21.92 7.02 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 C-N-CA 125.114 1.366 . . . . 0.0 110.485 -178.786 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . 0.299 96.2 t 69.73 -45.31 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.175 0 C-N-CA 129.448 3.099 . . . . 0.0 113.966 -175.935 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.8 p -165.29 151.29 9.75 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 119.839 1.199 . . . . 0.0 111.939 172.331 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 13.4 tppt? -162.79 176.25 10.45 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 127.477 2.311 . . . . 0.0 105.05 169.449 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 13.7 ptpt -61.26 -26.72 67.95 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 175.946 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 34.2 t-20 -75.74 165.59 24.81 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.815 0.846 . . . . 0.0 110.53 -174.658 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 2.5 m -61.92 152.48 76.61 Favored Pre-proline 0 CA--C 1.547 0.862 0 C-N-CA 124.486 1.114 . . . . 0.0 112.542 -170.186 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -59.37 160.45 19.79 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 124.494 3.463 . . . . 0.0 113.35 169.655 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 61.35 23.89 62.91 Favored Glycine 0 CA--C 1.537 1.461 0 CA-C-O 119.66 -0.522 . . . . 0.0 112.699 170.773 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 3.3 m -105.91 141.36 37.44 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 125.41 1.484 . . . . 0.0 109.314 -170.49 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 41.6 ttp -94.25 142.89 26.89 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 170.372 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 69.6 mtm -132.8 139.91 47.74 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 170.427 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 6.8 mm -93.31 122.46 44.82 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 177.199 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -112.19 123.82 51.1 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 175.726 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 82.1 mtp180 -81.3 170.71 15.71 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 123.004 0.522 . . . . 0.0 110.333 175.842 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -35.59 -55.47 0.68 Allowed 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 116.15 1.908 . . . . 0.0 116.15 -173.827 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -88.61 -9.33 52.57 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -176.001 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -87.64 -40.52 14.11 Favored 'General case' 0 N--CA 1.454 -0.26 0 O-C-N 121.911 -0.493 . . . . 0.0 109.866 -174.868 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 1.4 m -53.5 -47.66 95.58 Favored Pre-proline 0 CA--C 1.54 0.574 0 CA-C-O 117.928 -1.034 . . . . 0.0 112.27 -179.79 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -61.53 -40.09 50.13 Favored 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 122.284 1.99 . . . . 0.0 110.305 179.907 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.48 -4.16 44.14 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.874 0.869 . . . . 0.0 113.103 177.497 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -87.6 -40.78 13.93 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-N 119.338 0.972 . . . . 0.0 110.005 -179.325 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -79.91 24.66 0.39 Allowed 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.538 0.735 . . . . 0.0 112.763 -171.016 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 20.3 p -65.76 -21.99 66.55 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.489 1.116 . . . . 0.0 112.973 179.082 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 51.5 t-20 -61.69 127.49 31.69 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.659 0.783 . . . . 0.0 110.388 -177.257 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 47.8 mmtm -79.12 -19.2 51.7 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 -176.959 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 91.0 mt -64.16 -46.24 94.11 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 C-N-CA 123.786 0.834 . . . . 0.0 108.804 -178.831 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.8 m -67.22 109.07 3.05 Favored Pre-proline 0 CA--C 1.549 0.933 0 C-N-CA 126.589 1.956 . . . . 0.0 110.962 -169.718 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -71.99 -63.0 0.04 OUTLIER 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 122.342 2.028 . . . . 0.0 112.805 -169.063 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 12.4 t-80 -59.32 -40.41 86.21 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 123.61 0.764 . . . . 0.0 110.227 -179.166 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.4 ' H ' ' CD ' ' A' ' 94' ' ' GLN . 22.1 mp0 -63.58 -29.98 71.16 Favored 'General case' 0 N--CA 1.441 -0.911 0 C-N-CA 124.924 1.29 . . . . 0.0 110.106 -174.384 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 20.8 mt -67.72 -44.73 76.94 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 120.393 1.451 . . . . 0.0 110.691 172.909 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -61.69 -40.14 98.37 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 110.238 -1.145 . . . . 0.0 110.238 176.554 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 39.1 tp -65.95 -39.53 90.53 Favored 'General case' 0 CA--C 1.534 0.335 0 O-C-N 122.289 -0.536 . . . . 0.0 109.979 176.225 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -62.21 -42.45 99.31 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 119.172 0.896 . . . . 0.0 109.776 176.664 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -67.64 -28.84 68.05 Favored 'General case' 0 N--CA 1.454 -0.257 0 O-C-N 122.007 -0.433 . . . . 0.0 110.755 178.382 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -73.92 -37.39 47.74 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 O-C-N 121.336 -0.853 . . . . 0.0 111.289 173.654 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 31.5 mt -67.83 -37.62 82.17 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 176.762 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 75.7 m -65.39 -37.13 86.05 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-O 118.34 -0.838 . . . . 0.0 110.055 171.532 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.445 ' HA ' ' CD2' ' A' ' 106' ' ' PHE . . . -64.2 -40.52 96.26 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-N 119.953 1.252 . . . . 0.0 110.661 175.705 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 4.0 mt -64.71 -32.82 74.66 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 118.638 0.653 . . . . 0.0 110.562 174.841 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 51.5 ttp180 -72.15 -29.04 63.65 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 118.763 -0.637 . . . . 0.0 110.033 176.36 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.445 ' CD2' ' HA ' ' A' ' 103' ' ' ALA . 13.6 m-30 -72.12 -47.1 53.67 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 119.118 0.872 . . . . 0.0 110.369 175.467 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 41.6 p -72.68 -25.84 61.4 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 118.313 0.506 . . . . 0.0 111.853 -176.761 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 73.43 7.55 73.39 Favored Glycine 0 CA--C 1.535 1.312 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 -168.495 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -87.55 20.22 3.01 Favored 'General case' 0 C--N 1.348 0.522 0 CA-C-N 119.456 1.628 . . . . 0.0 110.689 176.536 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -58.45 138.2 85.45 Favored Pre-proline 0 CA--C 1.547 0.854 0 C-N-CA 125.903 1.681 . . . . 0.0 109.341 169.952 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_exo -58.0 163.81 9.09 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 123.66 2.907 . . . . 0.0 115.386 -179.359 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -67.72 -37.02 81.66 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 119.024 -0.513 . . . . 0.0 112.112 174.628 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 10.6 ttmm -141.58 74.41 1.45 Allowed 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 -175.474 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 5.5 tt -71.47 138.35 48.94 Favored 'General case' 0 CA--C 1.533 0.289 0 O-C-N 119.959 -1.713 . . . . 0.0 107.516 171.831 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -134.38 141.95 47.03 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 175.763 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -129.26 119.93 24.84 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 120.128 1.331 . . . . 0.0 109.228 -179.939 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 6.2 t -86.5 87.81 2.7 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 N-CA-C 105.61 -1.996 . . . . 0.0 105.61 175.84 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -81.38 135.17 14.07 Favored Glycine 0 C--N 1.334 0.447 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -172.901 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 54.7 t -121.94 123.56 69.41 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.238 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.988 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 42.5 mt -84.67 133.11 44.62 Favored Pre-proline 0 CA--C 1.538 0.492 0 N-CA-C 105.52 -2.029 . . . . 0.0 105.52 169.775 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -75.04 175.33 11.38 Favored 'Trans proline' 0 N--CA 1.449 -1.09 0 C-N-CA 122.287 1.992 . . . . 0.0 111.589 -176.706 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -94.56 -49.23 5.75 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 114.442 -1.253 . . . . 0.0 108.293 169.236 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 97.3 p -127.91 -52.77 1.32 Allowed 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 113.164 0.802 . . . . 0.0 113.164 -170.203 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.8 tp 52.51 34.75 16.12 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 124.362 1.065 . . . . 0.0 113.229 -169.398 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -76.36 164.02 62.53 Favored Pre-proline 0 CA--C 1.549 0.931 0 O-C-N 120.95 -1.094 . . . . 0.0 110.65 174.053 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -80.03 88.25 1.44 Allowed 'Trans proline' 0 CA--C 1.544 0.999 0 C-N-CA 121.66 1.573 . . . . 0.0 112.577 -172.194 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -176.5 154.96 1.33 Allowed 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 104.413 -2.44 . . . . 0.0 104.413 -179.946 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -110.79 162.64 8.18 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-N 120.447 1.476 . . . . 0.0 113.149 -169.663 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 93.71 143.14 12.86 Favored Glycine 0 CA--C 1.53 0.998 0 N-CA-C 106.374 -2.69 . . . . 0.0 106.374 -169.166 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -71.92 165.15 24.76 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 119.576 1.688 . . . . 0.0 110.602 -177.701 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 39.5 p -67.92 166.36 24.2 Favored Pre-proline 0 CA--C 1.539 0.533 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 167.826 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -59.73 -30.57 92.42 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 CA-C-N 120.588 1.246 . . . . 0.0 111.514 173.026 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 79.1 m -67.7 -41.85 82.97 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-N 118.903 0.774 . . . . 0.0 110.105 179.904 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 91.0 t -95.32 -26.26 4.34 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.214 0 CA-C-N 118.329 0.513 . . . . 0.0 110.751 -169.973 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -52.4 -46.91 66.5 Favored 'General case' 0 N--CA 1.464 0.243 0 O-C-N 120.567 -1.333 . . . . 0.0 108.418 169.409 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -69.84 -16.28 63.24 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 113.952 1.093 . . . . 0.0 113.952 -177.935 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 84.0 mtp -71.13 -12.09 61.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 117.24 -1.362 . . . . 0.0 112.6 173.679 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 35.3 mt -53.13 -47.33 55.51 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.28 0 CA-C-N 120.451 1.478 . . . . 0.0 109.226 175.307 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -73.38 -47.1 7.65 Favored Pre-proline 0 CA--C 1.544 0.73 0 CA-C-N 120.296 1.407 . . . . 0.0 112.109 -169.875 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -54.39 -44.78 46.3 Favored 'Trans proline' 0 C--N 1.353 0.802 0 C-N-CA 122.452 2.101 . . . . 0.0 112.179 170.174 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -67.81 -39.41 83.95 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 118.518 -0.753 . . . . 0.0 111.195 -179.055 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 29.0 mt -59.88 -45.57 92.08 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-N 119.79 1.177 . . . . 0.0 109.284 173.075 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -58.18 -33.67 69.51 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 118.993 0.815 . . . . 0.0 110.099 175.689 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -69.72 -39.9 76.57 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 118.778 0.717 . . . . 0.0 111.267 175.412 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 81.1 t -59.36 -44.81 93.28 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 172.596 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 14.7 mt -58.91 -42.65 90.13 Favored 'General case' 0 C--N 1.342 0.246 0 CA-C-N 119.017 0.826 . . . . 0.0 109.576 176.909 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -66.9 -43.63 82.91 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 119.146 0.885 . . . . 0.0 110.687 -176.796 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -67.71 -29.4 68.64 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 119.127 0.876 . . . . 0.0 111.131 179.186 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 41.6 mt -64.76 -49.67 69.86 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 170.298 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 14.7 mtp-105 -68.77 -16.8 63.9 Favored 'General case' 0 CA--C 1.527 0.095 0 CA-C-O 118.219 -0.896 . . . . 0.0 111.557 -177.82 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 30.6 mm-40 -65.6 -23.56 66.86 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 120.32 1.418 . . . . 0.0 111.299 170.826 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 58.4 m -100.73 17.2 22.6 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 119.054 0.843 . . . . 0.0 110.221 168.467 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 68.44 18.33 71.54 Favored Glycine 0 C--N 1.336 0.55 0 CA-C-O 117.656 -1.635 . . . . 0.0 111.958 -176.179 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 42.7 t -91.93 119.01 38.59 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 CA-C-N 120.344 2.072 . . . . 0.0 106.149 -177.121 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -111.26 89.23 2.99 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 178.383 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -49.55 138.3 13.99 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 114.833 -1.076 . . . . 0.0 109.72 169.663 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 15.8 mm -84.79 128.99 58.49 Favored Pre-proline 0 C--O 1.232 0.161 0 CA-C-O 117.483 -1.246 . . . . 0.0 107.902 -174.125 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -66.69 92.09 0.3 Allowed 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 122.922 2.414 . . . . 0.0 108.916 171.376 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 10.1 ttt-85 49.21 19.28 0.3 Allowed 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 128.441 2.696 . . . . 0.0 115.804 179.624 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 64.0 m 46.18 38.39 4.89 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.64 1.176 . . . . 0.0 111.886 -169.624 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -85.68 53.64 2.84 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.102 0.961 . . . . 0.0 110.005 179.368 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 13.5 m . . . . . 0 C--O 1.252 1.2 0 C-N-CA 125.311 1.444 . . . . 0.0 110.266 -177.712 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.4 ptp180 . . . . . 0 C--O 1.237 0.396 0 N-CA-C 103.749 -2.686 . . . . 0.0 103.749 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 20.8 mt -129.64 141.61 46.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 -166.839 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -115.83 146.86 41.62 Favored 'General case' 0 CA--C 1.513 -0.479 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 163.496 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 57.7 t -126.83 106.63 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.715 0 N-CA-C 103.945 -2.613 . . . . 0.0 103.945 170.845 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -113.37 119.13 36.58 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 -163.235 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -93.87 134.61 12.16 Favored Glycine 0 N--CA 1.451 -0.361 0 N-CA-C 107.909 -2.076 . . . . 0.0 107.909 175.008 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.7 m -140.96 167.08 17.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 C-N-CA 124.537 1.135 . . . . 0.0 109.457 -178.056 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 127.52 177.44 14.87 Favored Glycine 0 CA--C 1.527 0.821 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 -177.162 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.413 ' HB2' ' CE1' ' A' ' 93' ' ' HIS . 61.2 t-20 -91.76 117.88 30.17 Favored 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 178.332 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 41.3 pt -75.39 24.76 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.793 0 C-N-CA 124.483 1.113 . . . . 0.0 112.125 176.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 38.8 mt -137.45 -3.95 1.88 Allowed 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.594 1.557 . . . . 0.0 112.349 -177.31 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.5 tp -121.85 52.22 1.28 Allowed 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 120.158 1.345 . . . . 0.0 109.799 -163.274 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 42.25 -114.5 0.27 Allowed 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 126.502 1.921 . . . . 0.0 110.395 -169.591 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 36.5 m-20 -53.68 -26.21 21.63 Favored 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 126.54 1.936 . . . . 0.0 111.982 -171.514 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -60.04 -20.79 59.73 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 120.172 1.351 . . . . 0.0 111.752 -177.78 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.09 -11.51 40.5 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 117.773 -1.108 . . . . 0.0 113.415 172.545 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 7.1 tp -56.33 -44.41 79.73 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-N 120.32 1.418 . . . . 0.0 112.137 -171.501 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -59.16 -42.19 97.02 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 110.605 -0.998 . . . . 0.0 110.605 -178.559 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 60.3 t -67.57 -46.7 82.51 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 CA-C-O 118.978 -0.534 . . . . 0.0 110.14 175.16 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 9.8 mmt180 -58.37 -33.35 69.49 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 119.823 1.192 . . . . 0.0 112.823 -179.274 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 41.7 mt -57.98 -51.06 75.37 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 177.434 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 18.0 m -73.49 -35.75 46.16 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 CA-C-N 119.19 0.905 . . . . 0.0 111.717 -173.416 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -58.56 -47.13 85.27 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 118.811 0.732 . . . . 0.0 110.225 171.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -71.33 -22.13 61.96 Favored 'General case' 0 CA--C 1.531 0.234 0 O-C-N 121.689 -0.632 . . . . 0.0 112.462 -178.787 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 27.4 tp -73.79 -49.6 24.55 Favored 'General case' 0 C--N 1.339 0.137 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 175.654 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -52.65 -43.47 65.49 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.068 1.347 . . . . 0.0 111.172 178.761 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 66.5 mt-30 -85.06 -0.09 53.31 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.702 0.801 . . . . 0.0 113.033 -173.103 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 85.5 mtt180 -127.66 -23.14 3.48 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-O 116.695 -1.622 . . . . 0.0 112.931 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -134.74 128.75 33.51 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-N 120.823 1.647 . . . . 0.0 109.313 -172.872 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 48.7 mm -79.77 142.87 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 N-CA-C 105.605 -1.998 . . . . 0.0 105.605 163.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -114.93 154.9 47.0 Favored Pre-proline 0 N--CA 1.453 -0.311 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 178.931 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -54.81 152.51 28.31 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 121.169 1.246 . . . . 0.0 110.224 158.679 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -41.41 -46.72 3.45 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 127.575 2.35 . . . . 0.0 113.624 -178.521 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -78.57 19.9 0.46 Allowed 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 114.149 1.166 . . . . 0.0 114.149 -168.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 10.7 t -126.04 89.08 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 C-N-CA 125.489 1.516 . . . . 0.0 109.023 179.074 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -71.23 130.16 40.73 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 171.553 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -93.68 137.19 23.3 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 N-CA-C 105.682 -1.97 . . . . 0.0 105.682 157.213 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 60.5 tp -143.63 129.72 19.65 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 -175.186 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 30.7 t0 -84.8 133.21 34.35 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 166.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -115.02 31.5 6.24 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 126.351 1.929 . . . . 0.0 111.271 175.286 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -21.33 110.55 0.01 OUTLIER Glycine 0 CA--C 1.527 0.789 0 C-N-CA 129.026 3.203 . . . . 0.0 114.911 177.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER 59.68 -2.02 0.14 Allowed 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 116.542 2.053 . . . . 0.0 116.542 177.699 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.93 -63.04 1.38 Allowed 'General case' 0 C--N 1.34 0.156 0 CA-C-N 120.211 1.368 . . . . 0.0 112.909 -169.473 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 57.68 -94.24 0.04 OUTLIER Glycine 0 CA--C 1.533 1.177 0 N-CA-C 110.141 -1.184 . . . . 0.0 110.141 -163.361 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 7.8 tpt -57.63 -37.69 73.72 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 125.257 1.423 . . . . 0.0 113.147 -169.279 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -58.2 -26.56 62.94 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.708 0.766 . . . . 0.0 112.108 -173.633 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 83.1 mt -73.45 2.46 7.73 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 124.721 1.208 . . . . 0.0 112.489 -174.34 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.408 ' HA ' HG13 ' A' ' 100' ' ' VAL . 5.0 tt -43.98 -46.25 8.19 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 125.676 1.591 . . . . 0.0 111.594 174.534 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -84.05 -31.44 25.96 Favored Glycine 0 CA--C 1.525 0.674 0 CA-C-O 118.827 -0.985 . . . . 0.0 112.323 -178.718 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -75.6 -44.23 44.01 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 118.739 1.269 . . . . 0.0 110.904 -172.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 37.3 mtp -69.08 -11.32 60.68 Favored 'General case' 0 CA--C 1.54 0.574 0 O-C-N 121.974 -0.454 . . . . 0.0 111.675 -177.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -75.4 153.9 37.46 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 124.818 1.247 . . . . 0.0 110.446 -176.557 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 62.15 -5.67 0.16 Allowed 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 127.229 2.211 . . . . 0.0 114.107 167.938 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 8.6 mmt180 -66.29 148.4 51.9 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 175.084 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -80.05 -44.76 19.52 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 -175.702 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 4.0 t-160 -139.18 131.09 27.72 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 103.118 -2.919 . . . . 0.0 103.118 -177.105 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 30.1 tp -129.29 122.49 29.71 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 -178.893 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 52.3 mt -103.07 109.36 26.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 105.318 -2.105 . . . . 0.0 105.318 171.305 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 21.4 mt -83.39 148.33 5.17 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 168.021 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -131.05 128.8 41.0 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 164.29 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -153.25 168.37 26.22 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.324 1.05 . . . . 0.0 110.426 -163.694 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -92.1 129.9 37.95 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 163.122 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 34.9 mt -76.56 -24.71 15.89 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 C-N-CA 123.668 0.787 . . . . 0.0 110.503 175.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . 0.255 26.1 t 64.52 -35.03 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 C-N-CA 128.202 2.601 . . . . 0.0 113.687 -179.701 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -153.68 133.75 13.27 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 121.925 2.148 . . . . 0.0 113.883 -174.324 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 3.6 tppt? -156.87 -175.73 5.59 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 105.557 -2.016 . . . . 0.0 105.557 147.236 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.37 67.01 9.98 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 166.225 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 52.3 t30 -150.36 155.72 40.15 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 119.052 0.842 . . . . 0.0 109.0 178.386 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 8.1 m -60.02 140.41 90.53 Favored Pre-proline 0 CA--C 1.543 0.699 0 C-N-CA 126.674 1.99 . . . . 0.0 112.124 -165.879 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_exo -43.97 149.79 0.73 Allowed 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 124.22 3.28 . . . . 0.0 113.492 168.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 66.39 -7.91 1.21 Allowed Glycine 0 CA--C 1.532 1.101 0 C-N-CA 124.86 1.219 . . . . 0.0 115.554 178.387 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 30.4 m -64.88 149.83 48.85 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 120.202 2.001 . . . . 0.0 109.421 -178.391 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 28.9 ttp -94.43 147.36 23.32 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 174.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 42.0 mtt -129.23 146.15 51.2 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 106.095 -1.817 . . . . 0.0 106.095 162.682 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 33.2 mm -117.81 130.17 73.09 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 N-CA-C 103.266 -2.864 . . . . 0.0 103.266 171.335 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -123.74 143.55 50.22 Favored 'General case' 0 C--O 1.242 0.684 0 N-CA-C 105.013 -2.217 . . . . 0.0 105.013 176.266 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 79.9 mtm180 -114.73 165.88 12.34 Favored 'General case' 0 C--O 1.222 -0.36 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 177.369 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -22.29 -66.43 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 127.866 2.466 . . . . 0.0 116.072 -159.14 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -62.16 -33.52 74.67 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.879 1.672 . . . . 0.0 113.804 -176.102 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -76.35 -26.87 56.16 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.122 1.369 . . . . 0.0 110.741 -175.283 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 26.4 t -69.1 -50.89 19.47 Favored Pre-proline 0 CA--C 1.544 0.742 0 CA-C-O 117.69 -1.148 . . . . 0.0 112.394 -169.809 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -57.25 -39.89 86.68 Favored 'Trans proline' 0 C--N 1.353 0.802 0 CA-C-N 121.602 1.608 . . . . 0.0 111.374 174.518 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -62.84 -45.4 92.77 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 123.053 0.541 . . . . 0.0 110.59 -179.274 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -58.03 -47.52 82.85 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 123.817 0.847 . . . . 0.0 110.027 176.845 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 -75.88 1.36 15.3 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 -175.481 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 70.9 p -63.7 -13.36 42.41 Favored 'General case' 0 CA--C 1.543 0.685 0 O-C-N 120.198 -1.564 . . . . 0.0 112.315 166.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 41.1 t30 -58.72 109.89 0.89 Allowed 'General case' 0 C--N 1.346 0.454 0 C-N-CA 125.357 1.463 . . . . 0.0 111.712 -178.177 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 32.4 mmtp -67.87 -16.13 63.94 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 113.298 0.851 . . . . 0.0 113.298 -175.576 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 41.1 mt -75.03 -21.02 16.54 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 C-N-CA 123.358 0.663 . . . . 0.0 109.536 -179.062 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 14.6 m -100.56 104.71 32.52 Favored Pre-proline 0 CA--C 1.546 0.819 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 -172.818 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -72.4 -54.51 0.13 Allowed 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.295 1.996 . . . . 0.0 113.622 -160.167 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' HIS . . . . . 0.413 ' CE1' ' HB2' ' A' ' 10' ' ' ASN . 20.3 m80 -65.3 -36.1 83.04 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 177.784 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 23.1 mp0 -64.66 -30.03 71.04 Favored 'General case' 0 N--CA 1.441 -0.901 0 C-N-CA 125.02 1.328 . . . . 0.0 110.378 -176.264 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -64.94 -33.63 76.49 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 119.103 0.865 . . . . 0.0 111.535 171.898 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -78.72 -30.38 48.51 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 110.759 -0.937 . . . . 0.0 110.759 172.355 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.8 -37.62 88.06 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 118.339 1.07 . . . . 0.0 108.466 171.398 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -60.95 -43.42 98.72 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 117.929 -1.034 . . . . 0.0 109.924 175.007 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -74.15 -24.03 59.35 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 119.638 1.108 . . . . 0.0 113.158 177.637 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.408 HG13 ' HA ' ' A' ' 49' ' ' LEU . 38.1 t -62.48 -44.91 99.75 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 O-C-N 119.742 -1.848 . . . . 0.0 109.366 164.174 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 72.9 mt -67.94 -29.74 68.88 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 119.352 0.978 . . . . 0.0 110.811 178.367 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 44.5 m -62.19 -57.61 10.83 Favored 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 167.534 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.31 -35.4 78.93 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.795 1.238 . . . . 0.0 113.112 -174.772 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 13.8 mt -65.1 -42.37 94.09 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-N 118.929 0.786 . . . . 0.0 109.709 173.416 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 76.5 ttt180 -64.89 -34.65 78.9 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-O 117.677 -1.154 . . . . 0.0 110.649 172.676 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 13.0 m-30 -66.22 -39.22 89.43 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 120.069 1.304 . . . . 0.0 110.715 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 40.8 p -78.37 -28.05 46.98 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 119.119 0.872 . . . . 0.0 110.828 177.025 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 83.65 1.56 90.03 Favored Glycine 0 CA--C 1.531 1.056 0 CA-C-O 118.158 -1.357 . . . . 0.0 112.443 -166.766 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -87.08 21.01 2.47 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 120.479 2.139 . . . . 0.0 111.545 -179.114 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -61.19 139.01 94.55 Favored Pre-proline 0 CA--C 1.549 0.927 0 C-N-CA 126.274 1.83 . . . . 0.0 109.93 170.654 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -55.42 167.98 1.7 Allowed 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 123.923 3.082 . . . . 0.0 115.866 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -74.67 -23.12 58.6 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 123.461 0.704 . . . . 0.0 111.686 169.024 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 52.2 tttm -158.93 84.29 0.81 Allowed 'General case' 0 C--O 1.241 0.632 0 N-CA-C 106.522 -1.659 . . . . 0.0 106.522 -169.109 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.7 tt -79.21 141.88 36.75 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 119.186 -1.006 . . . . 0.0 108.914 165.279 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -138.9 146.76 41.5 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.88 1.672 . . . . 0.0 107.369 177.458 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -133.11 113.98 13.36 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 -179.274 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 45.1 t -93.35 86.66 2.15 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 173.013 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.55 150.36 16.94 Favored Glycine 0 C--N 1.338 0.671 0 N-CA-C 111.001 -0.84 . . . . 0.0 111.001 -166.603 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 22.7 t -129.11 135.84 61.03 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 -169.567 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 25.0 mt -78.3 135.93 61.23 Favored Pre-proline 0 CA--C 1.549 0.919 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 170.929 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -75.92 -161.53 0.13 Allowed 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 124.288 3.325 . . . . 0.0 111.522 178.385 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -138.75 -62.03 0.56 Allowed 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.83 1.652 . . . . 0.0 108.518 173.793 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 57.6 m -99.24 -48.19 4.91 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 119.104 0.865 . . . . 0.0 111.737 -177.106 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 51.58 45.91 27.34 Favored 'General case' 0 CA--C 1.549 0.911 0 N-CA-C 114.336 1.235 . . . . 0.0 114.336 -177.494 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -110.18 161.84 22.86 Favored Pre-proline 0 CA--C 1.542 0.642 0 C-N-CA 124.195 0.998 . . . . 0.0 110.989 -177.32 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -72.31 68.94 3.37 Favored 'Trans proline' 0 CA--C 1.543 0.954 0 C-N-CA 124.485 3.457 . . . . 0.0 113.982 -177.612 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 5.7 p-80 -148.16 173.18 13.24 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 126.874 2.07 . . . . 0.0 106.938 162.141 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -118.32 144.82 25.39 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.158 0 O-C-N 121.069 -1.019 . . . . 0.0 110.151 -171.185 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 142.09 176.25 16.14 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 105.997 -2.841 . . . . 0.0 105.997 -172.152 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -98.57 161.76 13.5 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 104.676 -2.342 . . . . 0.0 104.676 150.075 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 65.7 p -62.12 158.34 46.22 Favored Pre-proline 0 CA--C 1.543 0.71 0 C-N-CA 119.176 -1.01 . . . . 0.0 108.608 155.821 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -51.85 -38.49 67.97 Favored 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 122.046 1.83 . . . . 0.0 112.03 171.075 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 6.3 m -53.01 -30.98 38.51 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 126.12 1.768 . . . . 0.0 112.278 176.442 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 63.9 t -115.51 -18.88 6.96 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 CA-C-N 118.719 0.691 . . . . 0.0 111.014 -170.755 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -59.52 -43.25 93.49 Favored 'General case' 0 CA--C 1.534 0.338 0 O-C-N 121.325 -0.859 . . . . 0.0 108.73 165.713 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -59.45 -30.47 68.53 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.154 -0.476 . . . . 0.0 112.096 173.32 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 15.1 mmm -73.18 -8.47 55.94 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 117.458 -1.258 . . . . 0.0 113.789 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 96.7 mt -58.18 -50.05 79.62 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-N 120.438 1.472 . . . . 0.0 108.458 177.854 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -78.07 -40.37 1.92 Allowed Pre-proline 0 CA--C 1.535 0.376 0 CA-C-O 117.163 -1.398 . . . . 0.0 114.588 -168.401 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -54.34 -35.96 85.58 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 CA-C-N 122.38 1.886 . . . . 0.0 112.224 167.157 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -75.88 -32.85 59.88 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-O 117.981 -1.009 . . . . 0.0 111.313 175.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 53.5 mt -59.18 -48.59 81.03 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 120.579 1.536 . . . . 0.0 108.229 169.319 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -60.15 -29.53 68.72 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 119.375 0.989 . . . . 0.0 111.565 -179.654 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 32.6 mm-40 -86.39 -31.86 21.24 Favored 'General case' 0 CA--C 1.529 0.145 0 O-C-N 120.999 -1.063 . . . . 0.0 113.57 176.819 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 72.2 t -63.83 -40.97 90.97 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 CA-C-N 120.99 1.723 . . . . 0.0 108.736 166.917 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 83.6 mt -66.39 -39.8 89.28 Favored 'General case' 0 N--CA 1.463 0.179 0 C-N-CA 123.653 0.781 . . . . 0.0 110.722 176.737 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -64.01 -46.15 85.78 Favored 'General case' 0 C--O 1.227 -0.126 0 CA-C-N 118.748 0.704 . . . . 0.0 110.598 174.683 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -59.05 -42.88 91.37 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 118.847 -0.597 . . . . 0.0 110.776 178.037 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 31.1 mt -58.0 -45.23 87.15 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 119.174 0.897 . . . . 0.0 110.27 173.685 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 64.8 mtt180 -66.38 -18.88 65.62 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 117.096 -1.43 . . . . 0.0 112.791 178.508 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -60.9 -27.0 67.85 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 121.328 1.877 . . . . 0.0 110.807 171.833 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 16.7 m -101.89 13.91 33.47 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.107 0.963 . . . . 0.0 111.642 175.01 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 71.85 10.39 72.27 Favored Glycine 0 CA--C 1.53 1.0 0 CA-C-O 118.777 -1.013 . . . . 0.0 113.542 -179.145 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 61.0 t -79.69 102.92 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 CA-C-N 119.31 1.555 . . . . 0.0 107.301 178.467 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -72.93 152.87 41.22 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 164.038 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -131.57 150.91 51.98 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 125.351 1.46 . . . . 0.0 107.243 174.269 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 7.7 mm -114.31 122.72 33.77 Favored Pre-proline 0 CA--C 1.53 0.203 0 N-CA-C 107.58 -1.266 . . . . 0.0 107.58 -163.616 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -62.41 116.66 3.65 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 122.162 1.908 . . . . 0.0 108.031 176.233 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 59.7 mtm180 40.09 8.16 0.0 OUTLIER 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 129.573 3.149 . . . . 0.0 117.576 -172.222 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 70.7 m . . . . . 0 N--CA 1.468 0.439 0 CA-C-N 121.231 1.832 . . . . 0.0 110.381 -158.246 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 39.1 mmt180 . . . . . 0 N--CA 1.479 0.977 0 CA-C-O 118.336 -0.84 . . . . 0.0 108.813 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 3.9 mt -123.39 121.67 63.31 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 -176.909 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -106.81 139.28 41.49 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 168.876 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 58.0 t -126.87 101.43 7.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 105.467 -2.049 . . . . 0.0 105.467 -177.529 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.3 mt -98.76 109.36 22.13 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.475 1.11 . . . . 0.0 109.581 -169.741 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -87.15 127.13 8.29 Favored Glycine 0 C--O 1.237 0.324 0 N-CA-C 106.958 -2.457 . . . . 0.0 106.958 169.855 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 15.3 m -138.69 172.69 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 CA-C-N 117.588 0.694 . . . . 0.0 111.202 -169.736 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 101.16 163.45 27.59 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 127.189 2.328 . . . . 0.0 111.731 179.202 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.408 ' HA ' HG22 ' A' ' 43' ' ' THR . 22.7 t-20 -77.32 102.13 6.61 Favored 'General case' 0 C--N 1.332 -0.167 0 O-C-N 121.88 -0.777 . . . . 0.0 111.043 -169.766 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -56.52 7.51 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.935 0 N-CA-C 117.742 2.497 . . . . 0.0 117.742 179.164 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 67.7 mt -109.54 1.3 19.65 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 122.127 2.24 . . . . 0.0 109.743 -177.438 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.4 mp -111.84 63.02 0.62 Allowed 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 123.895 0.878 . . . . 0.0 111.4 -169.039 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.402 ' HB ' ' H ' ' A' ' 15' ' ' ASP . 0.2 OUTLIER 52.83 -100.15 0.09 Allowed 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.664 0.786 . . . . 0.0 111.152 176.59 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.402 ' H ' ' HB ' ' A' ' 14' ' ' THR . 28.6 m-20 -83.69 -9.1 59.08 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 124.262 1.025 . . . . 0.0 111.881 -174.391 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -71.79 -8.41 54.12 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 120.485 1.493 . . . . 0.0 112.454 -175.517 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -75.37 -14.35 60.46 Favored 'General case' 0 N--CA 1.434 -1.252 0 CA-C-O 115.724 -2.084 . . . . 0.0 109.349 170.869 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 7.9 tp -52.48 -39.2 28.33 Favored 'Isoleucine or valine' 0 C--N 1.344 0.358 0 CA-C-N 122.588 2.449 . . . . 0.0 112.878 -169.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -61.46 -45.52 96.21 Favored Glycine 0 CA--C 1.525 0.718 0 CA-C-N 119.422 1.01 . . . . 0.0 111.148 177.018 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 69.9 t -64.2 -48.53 85.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-O 118.845 -0.598 . . . . 0.0 110.039 172.743 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 78.4 mmt-85 -59.07 -33.88 71.32 Favored 'General case' 0 C--O 1.223 -0.336 0 CA-C-O 117.755 -1.116 . . . . 0.0 112.263 -179.637 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 28.6 mt -63.64 -45.07 98.51 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 CA-C-N 120.679 1.581 . . . . 0.0 109.656 177.762 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 14.5 m -75.81 -26.0 17.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-N 119.67 1.123 . . . . 0.0 111.071 -176.489 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 -70.75 -44.92 65.78 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 173.79 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.69 -42.37 97.02 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 122.885 0.474 . . . . 0.0 109.809 176.497 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 8.2 tp -65.45 -42.91 91.85 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 118.16 -0.924 . . . . 0.0 110.48 178.852 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -58.22 -43.98 87.98 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 119.042 0.837 . . . . 0.0 110.73 178.089 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -72.64 -39.7 66.98 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.715 0.806 . . . . 0.0 111.27 -177.84 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -95.82 -40.56 9.27 Favored 'General case' 0 C--N 1.34 0.172 0 CA-C-O 117.044 -1.455 . . . . 0.0 113.704 -169.48 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -109.64 124.14 50.67 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 121.735 2.062 . . . . 0.0 112.151 -169.906 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 47.2 mm -76.78 137.43 22.54 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 N-CA-C 105.739 -1.948 . . . . 0.0 105.739 169.13 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 29.5 mt -135.25 156.28 78.18 Favored Pre-proline 0 CA--C 1.535 0.4 0 C-N-CA 124.665 1.186 . . . . 0.0 110.83 -169.267 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -60.06 155.86 42.58 Favored 'Trans proline' 0 CA--C 1.535 0.569 0 C-N-CA 123.344 2.696 . . . . 0.0 111.775 169.815 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -62.26 -30.49 71.16 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -173.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 11.5 p90 -73.54 -6.42 46.42 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 118.207 -0.901 . . . . 0.0 112.752 -179.273 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 19.7 t -99.28 127.26 52.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 CA-C-N 119.861 1.21 . . . . 0.0 108.264 175.869 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -127.19 137.27 52.89 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 173.523 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -102.36 104.15 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 N-CA-C 105.862 -1.903 . . . . 0.0 105.862 176.664 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 56.7 tp -95.88 121.39 37.56 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.31 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -79.92 109.46 14.38 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 106.254 -1.758 . . . . 0.0 106.254 169.007 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -103.86 -27.92 6.12 Favored Glycine 0 CA--C 1.534 1.233 0 CA-C-O 119.248 -0.751 . . . . 0.0 112.373 173.347 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 40.17 -111.99 0.27 Allowed Glycine 0 C--N 1.34 0.775 0 C-N-CA 125.327 1.442 . . . . 0.0 113.122 -177.438 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.408 HG22 ' HA ' ' A' ' 10' ' ' ASN . 12.1 p -65.01 -3.49 3.6 Favored 'General case' 0 C--N 1.316 -0.869 0 C-N-CA 128.756 2.823 . . . . 0.0 113.806 -172.443 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -50.3 -66.3 0.41 Allowed 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 114.974 1.472 . . . . 0.0 114.974 -179.584 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 64.15 -94.62 0.15 Allowed Glycine 0 CA--C 1.531 1.065 0 N-CA-C 109.416 -1.473 . . . . 0.0 109.416 -169.417 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 10.4 tpt -69.33 -26.99 64.98 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 126.776 2.03 . . . . 0.0 112.255 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -70.17 -4.68 22.65 Favored 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -169.445 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 66.2 mt -87.79 -6.01 58.36 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 124.636 1.175 . . . . 0.0 114.063 -171.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.521 ' HA ' HG13 ' A' ' 100' ' ' VAL . 5.2 tt -43.39 -59.74 2.0 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 114.19 1.182 . . . . 0.0 114.19 -169.464 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -72.25 -36.4 59.93 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 111.723 -0.551 . . . . 0.0 111.723 -170.193 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -68.01 -37.77 81.81 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 117.932 0.866 . . . . 0.0 110.214 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 36.2 mtp -74.13 -18.13 60.83 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 120.664 -0.414 . . . . 0.0 111.782 -174.554 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -75.73 151.04 37.7 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 121.635 0.731 . . . . 0.0 111.129 -177.371 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 55.62 44.16 27.02 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 126.373 1.869 . . . . 0.0 114.201 168.567 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 27.2 mmt180 -108.01 156.98 18.64 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 174.511 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -78.62 -41.9 30.32 Favored 'General case' 0 N--CA 1.467 0.385 0 O-C-N 121.438 -0.789 . . . . 0.0 109.771 171.399 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -134.23 133.14 40.52 Favored 'General case' 0 C--O 1.232 0.168 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 -175.171 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 26.1 tp -135.42 131.77 36.65 Favored 'General case' 0 CA--C 1.512 -0.482 0 O-C-N 121.486 -0.759 . . . . 0.0 109.242 169.423 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 10.6 mt -114.07 123.44 69.73 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 N-CA-C 106.006 -1.85 . . . . 0.0 106.006 178.473 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 15.5 mt -101.49 127.53 54.75 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 N-CA-C 104.803 -2.295 . . . . 0.0 104.803 177.115 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -115.64 121.48 42.69 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 105.749 -1.945 . . . . 0.0 105.749 176.079 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -155.41 149.29 25.46 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 118.561 0.619 . . . . 0.0 112.437 -169.395 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -76.82 116.92 17.92 Favored 'General case' 0 CA--C 1.529 0.136 0 N-CA-C 105.53 -2.026 . . . . 0.0 105.53 168.623 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.7 tt -68.79 -25.46 30.48 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.772 0 CA-C-O 117.684 -1.151 . . . . 0.0 113.102 -169.084 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . 0.281 92.9 t 55.28 17.03 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.556 1.202 0 C-N-CA 125.278 1.431 . . . . 0.0 112.806 172.212 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 48.7 m -126.86 164.05 22.26 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 125.057 1.343 . . . . 0.0 111.3 -170.373 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.47 ' HG3' ' H ' ' A' ' 68' ' ' LYS . 4.6 tppt? 59.72 -172.06 0.12 Allowed 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.12 1.768 . . . . 0.0 111.738 177.417 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.47 ' H ' ' HG3' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -128.66 20.48 6.07 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.223 1.409 . . . . 0.0 112.401 -175.809 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 51.0 t30 -71.48 163.85 26.93 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 108.096 -1.075 . . . . 0.0 108.096 172.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 12.6 m -58.14 142.67 80.17 Favored Pre-proline 0 CA--C 1.546 0.801 0 C-N-CA 123.964 0.906 . . . . 0.0 112.18 -169.626 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -57.38 152.38 47.03 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.554 2.169 . . . . 0.0 111.453 170.06 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 67.7 16.48 67.94 Favored Glycine 0 CA--C 1.533 1.169 0 CA-C-O 119.128 -0.818 . . . . 0.0 113.756 177.49 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 48.7 m -96.32 153.89 17.56 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 118.955 1.377 . . . . 0.0 108.784 175.613 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 9.6 ttp -97.97 141.77 30.52 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 123.589 0.756 . . . . 0.0 110.222 -179.664 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 13.6 mtp -126.48 119.31 26.88 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 176.053 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 46.0 mm -103.07 123.81 56.75 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 177.086 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 48.2 mt -125.0 129.28 50.0 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 107.548 -1.278 . . . . 0.0 107.548 -177.922 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 65.7 mtm180 -104.99 131.49 52.44 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 -169.855 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 6.9 t70 36.32 -98.11 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 116.168 1.914 . . . . 0.0 116.168 169.911 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -62.74 -27.57 69.36 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.966 0.906 . . . . 0.0 112.932 -176.7 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -73.49 -15.47 61.32 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.385 0.674 . . . . 0.0 111.005 -177.373 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.425 HG11 ' CD2' ' A' ' 114' ' ' LEU . 81.4 t -79.52 -60.84 0.5 Allowed Pre-proline 0 N--CA 1.442 -0.832 0 CA-C-O 117.963 -1.018 . . . . 0.0 110.466 -169.485 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -59.85 -31.69 94.25 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 CA-C-N 120.846 1.338 . . . . 0.0 111.65 175.909 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.14 -13.69 62.41 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -177.584 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -98.14 -38.38 9.35 Favored 'General case' 0 C--N 1.344 0.332 0 CA-C-N 118.713 0.688 . . . . 0.0 109.267 169.153 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -59.34 -12.79 6.34 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 113.101 0.778 . . . . 0.0 113.101 177.472 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 70.7 p -52.86 -27.78 19.99 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 113.857 1.058 . . . . 0.0 113.857 169.906 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -60.23 146.25 44.34 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 122.948 0.499 . . . . 0.0 111.66 -169.631 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 46.6 mmtm -99.51 -0.16 41.19 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.7 0.8 . . . . 0.0 111.981 177.525 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 74.8 mt -66.95 -41.13 87.07 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 178.669 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 5.8 m -96.81 109.43 48.61 Favored Pre-proline 0 CA--C 1.543 0.68 0 C-N-CA 125.737 1.615 . . . . 0.0 109.223 -172.806 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -68.3 -47.22 1.69 Allowed 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.002 1.802 . . . . 0.0 112.937 -169.806 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 15.7 m80 -73.94 -22.47 59.65 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 122.729 0.411 . . . . 0.0 111.328 -171.32 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -68.9 -24.75 64.34 Favored 'General case' 0 C--O 1.222 -0.343 0 CA-C-O 117.72 -1.134 . . . . 0.0 111.847 177.435 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 2.8 tt -60.77 -43.42 98.08 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 120.387 1.449 . . . . 0.0 109.652 -174.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -59.99 -41.6 97.98 Favored Glycine 0 CA--C 1.529 0.94 0 O-C-N 121.628 -0.67 . . . . 0.0 111.52 176.261 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -71.62 -32.6 68.14 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 118.526 1.163 . . . . 0.0 110.717 179.083 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -60.3 -45.2 94.18 Favored 'General case' 0 N--CA 1.454 -0.254 0 O-C-N 120.943 -1.098 . . . . 0.0 109.067 171.831 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -69.9 -23.85 63.3 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 118.979 -0.534 . . . . 0.0 112.104 177.84 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.521 HG13 ' HA ' ' A' ' 49' ' ' LEU . 20.9 t -66.5 -45.05 89.9 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.697 0 CA-C-N 119.223 0.92 . . . . 0.0 108.552 169.379 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 93.8 mt -64.44 -34.22 77.68 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 119.377 0.99 . . . . 0.0 110.245 179.345 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 20.3 m -64.91 -41.41 95.6 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 118.88 0.763 . . . . 0.0 110.318 169.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.46 ' HA ' ' CD2' ' A' ' 106' ' ' PHE . . . -64.39 -36.8 85.33 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 119.121 0.873 . . . . 0.0 111.527 178.296 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.6 mt -66.8 -35.6 80.44 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 118.412 0.551 . . . . 0.0 110.272 176.685 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 77.7 ttt-85 -65.92 -38.79 89.62 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 118.459 -0.781 . . . . 0.0 109.909 171.382 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.46 ' CD2' ' HA ' ' A' ' 103' ' ' ALA . 15.6 m-30 -64.09 -44.05 93.53 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 119.372 0.987 . . . . 0.0 110.586 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 42.3 p -75.71 -22.8 56.28 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 118.325 0.511 . . . . 0.0 111.403 178.817 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 74.47 12.59 82.21 Favored Glycine 0 CA--C 1.531 1.09 0 N-CA-C 111.118 -0.793 . . . . 0.0 111.118 -169.401 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -98.79 25.29 6.7 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 118.644 1.222 . . . . 0.0 110.97 -178.006 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -57.56 135.58 82.26 Favored Pre-proline 0 CA--C 1.544 0.724 0 C-N-CA 124.111 0.964 . . . . 0.0 109.209 170.509 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -54.55 151.71 29.87 Favored 'Trans proline' 0 C--N 1.35 0.658 0 C-N-CA 123.643 2.895 . . . . 0.0 114.108 -179.536 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -60.09 -29.81 68.83 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 119.012 -0.518 . . . . 0.0 110.44 177.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 23.1 ttpp -146.54 125.84 13.07 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 169.161 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.425 ' CD2' HG11 ' A' ' 82' ' ' VAL . 3.4 tt -105.92 147.38 28.83 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 169.417 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -143.42 138.9 29.67 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 -177.929 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.7 tp -125.09 129.39 50.14 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 120.429 1.468 . . . . 0.0 108.828 175.792 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 53.5 t -102.5 98.95 7.45 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 N-CA-C 104.759 -2.311 . . . . 0.0 104.759 168.817 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -84.77 140.27 18.59 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 109.981 -1.248 . . . . 0.0 109.981 174.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 40.9 t -119.95 138.25 51.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 173.638 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 5.4 mt -86.92 126.92 61.65 Favored Pre-proline 0 CA--C 1.54 0.591 0 CA-C-N 119.395 0.998 . . . . 0.0 108.389 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -77.0 167.28 25.39 Favored 'Trans proline' 0 CA--C 1.542 0.884 0 C-N-CA 123.657 2.904 . . . . 0.0 112.25 -178.821 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.465 ' HB3' HG21 ' A' ' 131' ' ' THR . 1.6 tm-20 -107.38 -58.89 1.9 Allowed 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.673 0.789 . . . . 0.0 109.924 -178.709 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 4.0 m -105.28 -58.06 1.95 Allowed 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 122.934 0.494 . . . . 0.0 112.04 -170.27 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER 56.46 52.37 10.03 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 126.176 1.79 . . . . 0.0 115.334 171.806 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -121.71 165.21 20.76 Favored Pre-proline 0 N--CA 1.475 0.796 0 CA-C-O 117.826 -1.083 . . . . 0.0 108.87 172.806 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -67.47 84.09 0.38 Allowed 'Trans proline' 0 CA--C 1.546 1.084 0 C-N-CA 123.345 2.697 . . . . 0.0 112.551 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -168.85 152.4 5.35 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 104.501 -2.407 . . . . 0.0 104.501 174.241 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -120.27 152.87 23.22 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-O 121.999 0.904 . . . . 0.0 113.286 -169.654 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 120.8 130.73 3.92 Favored Glycine 0 CA--C 1.527 0.814 0 N-CA-C 105.98 -2.848 . . . . 0.0 105.98 -169.652 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 7.0 mp -77.8 149.39 34.43 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 177.602 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.465 HG21 ' HB3' ' A' ' 122' ' ' GLU . 54.6 p -67.22 163.19 48.21 Favored Pre-proline 0 CA--C 1.534 0.349 0 CA-C-O 119.148 -0.453 . . . . 0.0 109.942 169.799 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -58.71 -34.67 99.08 Favored 'Trans proline' 0 CA--C 1.537 0.65 0 C-N-CA 121.099 1.199 . . . . 0.0 109.574 169.319 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 4.5 m -63.34 -39.06 93.51 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.187 0.995 . . . . 0.0 111.18 -176.48 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 21.8 t -102.48 -25.89 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 CA-C-N 119.319 0.963 . . . . 0.0 112.146 -176.645 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -54.1 -43.01 70.02 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 120.825 1.648 . . . . 0.0 109.986 169.676 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -73.04 -2.43 21.18 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-O 118.332 -0.842 . . . . 0.0 113.107 -176.033 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 16.4 mmm -89.58 -7.09 55.56 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-O 116.953 -1.499 . . . . 0.0 111.022 170.651 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 91.6 mt -58.9 -47.64 88.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 CA-C-N 121.631 2.014 . . . . 0.0 109.301 -179.337 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 61.6 mt-10 -73.21 -51.14 6.08 Favored Pre-proline 0 CA--C 1.536 0.425 0 CA-C-O 117.39 -1.29 . . . . 0.0 110.809 -178.828 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -40.49 -51.99 3.23 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 124.447 3.431 . . . . 0.0 113.672 169.041 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -74.16 -45.33 49.31 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 114.538 -1.21 . . . . 0.0 111.451 -174.027 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -62.37 -36.02 80.96 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 119.594 1.088 . . . . 0.0 109.984 178.28 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -62.86 -33.04 74.45 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 118.744 -0.645 . . . . 0.0 111.085 176.276 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 42.9 mm-40 -78.47 -29.97 47.12 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 119.502 1.046 . . . . 0.0 111.892 174.177 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 67.7 t -61.41 -43.43 96.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 169.563 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 71.4 mt -69.65 -33.41 72.57 Favored 'General case' 0 N--CA 1.463 0.179 0 O-C-N 120.752 -1.217 . . . . 0.0 111.622 176.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -58.86 -33.6 70.65 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 118.923 0.783 . . . . 0.0 111.455 176.151 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -62.42 -46.79 86.95 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 118.531 0.605 . . . . 0.0 111.292 174.917 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 7.1 mp -58.44 -43.4 88.76 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.021 0.529 . . . . 0.0 109.866 174.748 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 84.7 mtt180 -65.38 -17.56 64.63 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 117.418 -1.277 . . . . 0.0 111.896 -177.741 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -58.16 -34.38 70.24 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 120.616 1.553 . . . . 0.0 111.33 175.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 8.1 m -107.39 28.57 7.98 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.598 1.159 . . . . 0.0 110.956 -179.456 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 64.22 23.8 68.39 Favored Glycine 0 CA--C 1.53 1.003 0 CA-C-O 118.725 -1.042 . . . . 0.0 113.917 176.822 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 59.4 t -93.77 134.47 31.31 Favored 'Isoleucine or valine' 0 C--N 1.341 0.213 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 174.744 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -122.6 145.05 48.7 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 178.798 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -107.46 143.09 36.32 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 124.06 0.944 . . . . 0.0 109.351 174.841 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 23.3 mm -105.62 125.97 31.97 Favored Pre-proline 0 C--O 1.234 0.253 0 CA-C-O 117.879 -1.058 . . . . 0.0 108.649 -173.193 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -57.61 110.42 0.62 Allowed 'Trans proline' 0 N--CA 1.461 -0.383 0 C-N-CA 122.608 2.206 . . . . 0.0 108.919 169.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 82.7 mtm180 51.51 30.68 6.63 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.179 0.992 . . . . 0.0 112.715 171.412 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 17.4 p . . . . . 0 CA--C 1.542 0.64 0 C-N-CA 126.714 2.006 . . . . 0.0 114.872 -171.954 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.475 0.795 0 CA-C-O 119.46 -0.305 . . . . 0.0 110.633 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 5.7 mt -125.52 129.55 72.82 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -120.36 141.11 50.38 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 106.105 -1.813 . . . . 0.0 106.105 168.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 91.6 t -121.42 127.41 75.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 106.722 -1.584 . . . . 0.0 106.722 -176.828 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.2 tp -109.03 111.61 23.36 Favored 'General case' 0 CA--C 1.515 -0.4 0 C-N-CA 123.468 0.707 . . . . 0.0 111.02 -169.187 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -94.07 118.24 5.7 Favored Glycine 0 N--CA 1.446 -0.67 0 N-CA-C 104.394 -3.482 . . . . 0.0 104.394 168.768 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.4 m -141.32 163.74 20.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 -171.678 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 121.73 160.47 11.01 Favored Glycine 0 C--N 1.338 0.661 0 C-N-CA 124.818 1.199 . . . . 0.0 110.495 176.519 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.514 ' HA ' HG22 ' A' ' 43' ' ' THR . 27.9 t-20 -79.22 101.52 8.03 Favored 'General case' 0 C--N 1.333 -0.122 0 O-C-N 121.351 -1.088 . . . . 0.0 109.988 -179.366 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 27.3 pt -53.41 -15.07 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 N-CA-C 116.13 1.9 . . . . 0.0 116.13 -176.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.434 ' HA ' HG23 ' A' ' 128' ' ' ILE . 5.2 mp -90.17 -3.79 57.66 Favored 'General case' 0 C--O 1.219 -0.536 0 CA-C-N 121.024 1.738 . . . . 0.0 107.558 -170.506 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.3 mp -101.78 55.42 0.81 Allowed 'General case' 0 N--CA 1.439 -0.987 0 C-N-CA 123.477 0.711 . . . . 0.0 109.727 -174.334 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.426 ' HB ' ' H ' ' A' ' 15' ' ' ASP 0.254 0.1 OUTLIER 49.6 -102.11 0.1 Allowed 'General case' 0 C--O 1.236 0.345 0 CA-C-N 114.348 -1.296 . . . . 0.0 111.331 177.052 . . . . . . . . 4 4 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.426 ' H ' ' HB ' ' A' ' 14' ' ' THR . 17.2 m-20 -72.21 -12.34 61.13 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 123.891 0.876 . . . . 0.0 111.319 -172.706 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -73.07 -2.5 21.56 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-N 119.377 0.99 . . . . 0.0 112.338 176.342 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.82 -11.85 59.8 Favored 'General case' 0 N--CA 1.439 -1.014 0 CA-C-O 116.436 -1.745 . . . . 0.0 108.564 169.343 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 7.3 tp -53.47 -41.1 43.84 Favored 'Isoleucine or valine' 0 C--N 1.344 0.345 0 CA-C-N 122.094 2.225 . . . . 0.0 112.44 -169.917 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -62.03 -49.06 78.91 Favored Glycine 0 CA--C 1.523 0.555 0 CA-C-N 119.257 0.935 . . . . 0.0 111.707 177.373 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 58.3 t -65.16 -47.27 88.24 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 178.755 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 71.4 mmt-85 -59.64 -35.02 73.57 Favored 'General case' 0 C--N 1.343 0.292 0 CA-C-O 117.041 -1.457 . . . . 0.0 113.146 177.326 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 27.8 mt -62.74 -45.6 98.43 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 CA-C-N 121.925 2.148 . . . . 0.0 109.995 177.758 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 22.2 m -74.47 -27.82 21.71 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-N 119.995 1.27 . . . . 0.0 111.632 -175.524 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -68.63 -44.44 74.22 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 174.234 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -66.09 -40.11 90.54 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 122.559 0.344 . . . . 0.0 110.28 -179.258 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 7.8 tp -62.33 -42.59 99.5 Favored 'General case' 0 CA--C 1.527 0.096 0 CA-C-O 118.733 -0.651 . . . . 0.0 109.933 178.169 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -61.36 -38.62 87.64 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 118.506 0.594 . . . . 0.0 110.835 -178.309 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 -74.01 -43.21 58.76 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.38 0.672 . . . . 0.0 111.036 177.66 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 87.9 mtt180 -86.31 -31.13 21.75 Favored 'General case' 0 C--N 1.339 0.124 0 CA-C-O 116.87 -1.538 . . . . 0.0 114.221 -169.577 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -125.96 138.25 53.75 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 121.369 1.895 . . . . 0.0 112.836 -173.717 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 49.5 mm -91.71 149.84 3.99 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 N-CA-C 106.366 -1.716 . . . . 0.0 106.366 168.48 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 51.2 mt -137.44 151.34 71.03 Favored Pre-proline 0 C--O 1.237 0.412 0 C-N-CA 124.218 1.007 . . . . 0.0 110.775 -169.649 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -67.76 159.97 50.38 Favored 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 122.483 2.122 . . . . 0.0 110.111 169.785 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -57.71 -32.55 67.5 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 114.51 1.3 . . . . 0.0 114.51 -169.346 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 31.5 p90 -75.89 -5.61 46.91 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 117.8 -1.095 . . . . 0.0 112.676 -176.81 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 26.0 t -108.61 129.9 62.3 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 CA-C-N 120.087 1.312 . . . . 0.0 107.888 175.46 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -136.95 150.98 48.51 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 121.491 0.662 . . . . 0.0 110.113 174.91 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -103.21 131.01 52.52 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 170.555 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 10.5 tt -123.77 127.68 48.47 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 175.668 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -91.2 115.15 27.79 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 172.477 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -71.58 -23.92 77.43 Favored Glycine 0 CA--C 1.533 1.186 0 CA-C-O 118.373 -1.237 . . . . 0.0 112.795 179.239 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 62.85 77.09 0.22 Allowed Glycine 0 CA--C 1.529 0.949 0 CA-C-N 118.424 1.112 . . . . 0.0 112.886 173.706 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.514 HG22 ' HA ' ' A' ' 10' ' ' ASN 0.28 14.9 p 55.75 32.84 20.24 Favored 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 125.075 1.35 . . . . 0.0 112.761 173.181 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -75.14 -69.26 0.48 Allowed 'General case' 0 C--N 1.345 0.385 0 N-CA-C 114.722 1.378 . . . . 0.0 114.722 -169.333 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 70.06 -99.1 0.67 Allowed Glycine 0 C--N 1.337 0.584 0 N-CA-C 108.436 -1.866 . . . . 0.0 108.436 -171.038 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 10.1 tpt -67.51 -27.76 67.26 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 125.057 1.343 . . . . 0.0 111.38 -178.762 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -70.2 -4.65 22.64 Favored 'General case' 0 CA--C 1.548 0.881 0 CA-C-O 121.234 0.54 . . . . 0.0 110.685 -173.547 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 81.9 mt -81.76 2.13 31.35 Favored 'General case' 0 CA--C 1.535 0.382 0 O-C-N 120.316 -1.49 . . . . 0.0 113.62 -179.335 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.48 ' HA ' HG13 ' A' ' 100' ' ' VAL . 6.5 tt -50.16 -53.99 23.87 Favored 'General case' 0 C--N 1.339 0.151 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 -170.129 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -87.68 -31.91 14.5 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 -177.29 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -52.87 -49.3 66.12 Favored 'General case' 0 C--N 1.34 0.164 0 C-N-CA 123.03 0.532 . . . . 0.0 110.257 178.256 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 28.1 mtp -78.13 -8.71 58.61 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 114.306 1.224 . . . . 0.0 114.306 -169.052 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.79 146.65 54.2 Favored 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 113.78 1.03 . . . . 0.0 113.78 -169.131 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . 0.25 14.7 p30 53.08 13.81 0.42 Allowed 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 128.86 2.864 . . . . 0.0 117.975 169.114 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 89.8 mtt180 -68.08 151.93 46.29 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 121.333 -0.855 . . . . 0.0 109.835 173.537 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -81.68 -61.75 1.84 Allowed 'General case' 0 C--O 1.222 -0.363 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 176.259 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 2.3 t-160 -114.85 124.22 51.19 Favored 'General case' 0 C--O 1.231 0.103 0 N-CA-C 105.609 -1.997 . . . . 0.0 105.609 -177.484 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 54.0 tp -133.24 119.96 20.5 Favored 'General case' 0 CA--C 1.506 -0.713 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 178.435 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 4.4 mp -103.04 120.09 52.4 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 N-CA-C 105.445 -2.057 . . . . 0.0 105.445 175.194 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 8.1 mt -96.92 132.94 40.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 104.392 -2.447 . . . . 0.0 104.392 176.805 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -121.55 126.4 49.08 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 172.876 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -162.46 162.6 27.64 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 122.602 0.361 . . . . 0.0 110.056 177.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -74.06 136.44 43.07 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 104.923 -2.251 . . . . 0.0 104.923 168.106 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -87.47 -22.03 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 N-CA-C 113.182 0.808 . . . . 0.0 113.182 -168.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.7 t 51.73 31.95 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.221 0 C-N-CA 126.115 1.766 . . . . 0.0 112.569 174.011 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 19.8 m -137.54 159.75 41.08 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 124.313 1.045 . . . . 0.0 111.711 -172.245 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 22.6 ttmt 63.55 173.93 0.17 Allowed 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 126.732 2.013 . . . . 0.0 112.685 170.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.32 7.98 35.87 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.543 1.137 . . . . 0.0 112.027 -170.02 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 41.4 t-20 -73.66 165.55 24.9 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.368 0.667 . . . . 0.0 109.489 -174.888 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 10.7 m -58.75 141.59 84.82 Favored Pre-proline 0 CA--C 1.55 0.947 0 C-N-CA 124.199 1.0 . . . . 0.0 112.578 -169.613 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -55.25 150.16 41.87 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 123.503 2.802 . . . . 0.0 112.132 169.803 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 68.18 15.2 67.33 Favored Glycine 0 CA--C 1.531 1.032 0 CA-C-O 119.091 -0.839 . . . . 0.0 113.825 176.66 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 20.9 m -90.92 149.92 21.7 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 118.973 1.386 . . . . 0.0 108.895 175.775 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 16.7 ttp -95.41 139.12 32.15 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 176.522 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 3.4 ttt -135.44 115.04 12.72 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 107.275 -1.379 . . . . 0.0 107.275 -170.322 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 24.0 mm -100.78 122.04 52.32 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 -169.945 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -117.48 125.24 50.56 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 179.216 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -90.7 170.53 10.06 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 178.886 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -28.97 -61.69 0.12 Allowed 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 117.02 2.23 . . . . 0.0 117.02 -170.12 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -78.51 -17.25 56.49 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 119.302 0.955 . . . . 0.0 113.307 -174.158 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -87.96 -30.69 19.84 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 123.555 0.742 . . . . 0.0 110.417 -170.026 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . 0.256 0.5 OUTLIER -67.46 -47.31 47.76 Favored Pre-proline 0 N--CA 1.453 -0.289 0 CA-C-O 116.624 -1.655 . . . . 0.0 112.023 -171.351 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -65.63 -35.63 36.72 Favored 'Trans proline' 0 N--CA 1.453 -0.883 0 CA-C-N 122.176 1.813 . . . . 0.0 109.988 179.792 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.2 -26.36 67.36 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.033 0.533 . . . . 0.0 111.199 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -78.39 -52.96 7.81 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 169.868 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -58.2 -23.06 54.3 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 -174.127 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -66.86 -6.79 17.75 Favored 'General case' 0 CA--C 1.551 1.009 0 CA-C-N 119.103 0.865 . . . . 0.0 112.26 176.638 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 32.6 t30 -50.2 127.68 17.56 Favored 'General case' 0 C--N 1.344 0.346 0 O-C-N 121.27 -0.894 . . . . 0.0 110.912 173.489 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 30.5 mmmt -66.91 -26.73 67.01 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 118.541 -0.742 . . . . 0.0 111.994 -178.616 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 62.1 mt -65.62 -49.6 76.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 -177.204 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.4 m -65.02 114.41 14.89 Favored Pre-proline 0 CA--C 1.545 0.774 0 C-N-CA 124.609 1.164 . . . . 0.0 109.854 -176.854 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -70.92 -75.85 0.01 OUTLIER 'Trans proline' 0 CA--C 1.539 0.76 0 C-N-CA 122.761 2.307 . . . . 0.0 112.896 -169.549 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 13.1 m80 -69.33 -26.66 64.82 Favored 'General case' 0 N--CA 1.47 0.562 0 O-C-N 121.093 -1.004 . . . . 0.0 110.784 -174.873 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 25.8 mp0 -63.78 -28.87 70.17 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 124.432 1.093 . . . . 0.0 110.659 179.013 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 52.6 tp -64.18 -35.49 80.97 Favored 'General case' 0 C--N 1.342 0.246 0 CA-C-N 119.722 1.146 . . . . 0.0 110.54 174.224 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -64.64 -40.12 97.27 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 110.552 -1.019 . . . . 0.0 110.552 172.904 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 19.1 tp -66.2 -32.44 73.88 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 117.976 0.888 . . . . 0.0 110.907 175.854 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -64.1 -45.19 89.75 Favored 'General case' 0 N--CA 1.466 0.36 0 O-C-N 120.952 -1.092 . . . . 0.0 110.791 171.202 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -70.35 -24.2 62.94 Favored 'General case' 0 CA--C 1.52 -0.18 0 O-C-N 121.602 -0.686 . . . . 0.0 111.574 178.366 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.48 HG13 ' HA ' ' A' ' 49' ' ' LEU . 7.0 t -68.14 -44.97 83.98 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 CA-C-N 118.722 0.692 . . . . 0.0 110.397 169.907 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 59.8 mt -62.26 -36.89 83.45 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 119.25 0.932 . . . . 0.0 109.697 176.486 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 44.5 m -65.03 -40.18 94.44 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 118.005 0.366 . . . . 0.0 110.299 172.825 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -64.52 -40.34 95.44 Favored 'General case' 0 N--CA 1.454 -0.237 0 O-C-N 121.112 -0.992 . . . . 0.0 110.729 178.231 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 12.6 mt -64.0 -37.61 88.05 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-O 120.98 0.419 . . . . 0.0 110.58 175.155 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 21.1 tpp180 -63.89 -37.82 88.8 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 118.652 -0.689 . . . . 0.0 109.982 173.885 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 14.6 m-30 -66.18 -42.61 88.65 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 119.124 0.875 . . . . 0.0 110.798 179.278 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 41.7 p -76.13 -18.72 59.02 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 118.819 0.736 . . . . 0.0 111.722 178.886 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 76.42 9.72 85.83 Favored Glycine 0 CA--C 1.532 1.127 0 CA-C-O 119.073 -0.848 . . . . 0.0 111.229 -169.669 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -93.5 31.04 1.6 Allowed 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 118.991 1.395 . . . . 0.0 110.675 178.048 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.418 ' HA ' ' HD3' ' A' ' 111' ' ' PRO . 9.4 t80 -62.24 140.22 96.24 Favored Pre-proline 0 CA--C 1.542 0.647 0 C-N-CA 123.793 0.837 . . . . 0.0 109.724 174.321 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 110' ' ' PHE . 31.2 Cg_exo -66.66 142.9 65.97 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.382 2.055 . . . . 0.0 110.35 -177.364 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -64.48 -29.4 70.44 Favored 'General case' 0 CA--C 1.538 0.504 0 O-C-N 122.141 -0.349 . . . . 0.0 111.483 -174.114 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 23.9 tptp -143.41 82.78 1.75 Allowed 'General case' 0 C--O 1.234 0.277 0 N-CA-C 106.172 -1.788 . . . . 0.0 106.172 -176.889 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 24.5 tp -77.02 136.52 38.69 Favored 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 169.721 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -138.39 144.24 40.15 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 170.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 11.2 tp -128.83 129.83 46.12 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 119.606 1.094 . . . . 0.0 109.464 176.031 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 21.7 t -98.34 101.21 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 N-CA-C 104.215 -2.513 . . . . 0.0 104.215 168.384 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -82.93 146.7 24.33 Favored Glycine 0 CA--C 1.521 0.454 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 171.687 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 47.9 t -127.42 143.5 40.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 170.589 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 13.2 mt -94.14 130.13 35.2 Favored Pre-proline 0 CA--C 1.537 0.458 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 -176.139 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -79.33 166.6 22.26 Favored 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 122.967 2.445 . . . . 0.0 113.026 -174.154 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -111.05 -53.71 2.68 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.371 1.068 . . . . 0.0 110.331 -178.88 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 73.6 m -111.84 -53.55 2.7 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 118.73 0.695 . . . . 0.0 112.248 -173.701 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER 56.11 44.71 24.79 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 125.215 1.406 . . . . 0.0 114.609 177.07 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -119.43 171.38 5.51 Favored Pre-proline 0 N--CA 1.477 0.892 0 O-C-N 121.205 -0.934 . . . . 0.0 109.924 175.091 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -65.85 91.0 0.24 Allowed 'Trans proline' 0 CA--C 1.549 1.267 0 C-N-CA 123.447 2.765 . . . . 0.0 114.145 -177.225 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -167.62 131.64 1.78 Allowed 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 105.102 -2.185 . . . . 0.0 105.102 169.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.434 HG23 ' HA ' ' A' ' 12' ' ' LEU . 0.0 OUTLIER -80.28 152.91 4.48 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 123.612 0.765 . . . . 0.0 110.293 -171.452 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 80.37 160.79 23.22 Favored Glycine 0 CA--C 1.53 1.0 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.916 179.334 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.436 HD22 ' H ' ' A' ' 130' ' ' LEU . 1.1 mm? -76.45 163.17 27.21 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-O 121.188 0.518 . . . . 0.0 112.218 -169.194 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 40.7 p -69.81 169.93 11.3 Favored Pre-proline 0 CA--C 1.541 0.597 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 167.703 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -55.88 -31.76 82.55 Favored 'Trans proline' 0 CA--C 1.542 0.925 0 C-N-CA 121.315 1.344 . . . . 0.0 111.041 169.097 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 25.3 m -68.18 -45.27 73.91 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 118.976 -0.535 . . . . 0.0 111.505 179.5 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 5.8 t -99.19 -12.16 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 CA-C-N 119.451 1.023 . . . . 0.0 111.652 -169.783 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -57.6 -45.55 85.15 Favored 'General case' 0 N--CA 1.465 0.292 0 O-C-N 119.898 -1.751 . . . . 0.0 108.102 169.163 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -68.19 -2.02 7.25 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-O 118.382 -0.818 . . . . 0.0 112.741 178.021 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 12.9 mmm -92.84 -6.94 47.7 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 119.356 0.98 . . . . 0.0 111.266 175.756 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 86.6 mt -59.42 -45.26 93.71 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 CA-C-N 119.421 1.01 . . . . 0.0 108.921 175.537 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -76.07 -47.02 3.71 Favored Pre-proline 0 CA--C 1.543 0.677 0 CA-C-O 117.252 -1.356 . . . . 0.0 113.129 -170.207 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -55.0 -41.76 75.79 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 122.07 1.847 . . . . 0.0 111.399 170.539 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -68.36 -41.48 80.6 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 118.162 -0.923 . . . . 0.0 110.718 -177.898 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 27.1 mt -55.83 -47.48 77.16 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 119.713 1.142 . . . . 0.0 109.223 172.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -62.31 -33.97 75.71 Favored 'General case' 0 N--CA 1.443 -0.817 0 C-N-CA 122.768 0.427 . . . . 0.0 109.849 -177.109 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 38.9 tp60 -80.29 -34.14 37.13 Favored 'General case' 0 N--CA 1.431 -1.375 0 C-N-CA 123.409 0.684 . . . . 0.0 111.307 -178.047 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 49.0 t -60.45 -48.77 87.01 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 170.176 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 30.2 mt -62.81 -30.53 71.55 Favored 'General case' 0 C--N 1.331 -0.203 0 O-C-N 121.995 -0.441 . . . . 0.0 110.406 178.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -67.22 -39.37 86.23 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 121.036 -1.04 . . . . 0.0 111.129 176.423 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -62.06 -47.48 84.52 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 118.608 0.64 . . . . 0.0 110.76 177.522 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 6.0 mp -58.01 -41.97 84.23 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 174.539 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 85.0 mtm180 -70.12 -13.83 62.38 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 117.319 -1.324 . . . . 0.0 113.327 -179.051 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -57.29 -33.25 67.48 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 120.959 1.709 . . . . 0.0 110.208 172.152 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 4.6 m -103.01 22.22 14.34 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.113 1.365 . . . . 0.0 111.502 179.18 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 68.75 23.26 75.65 Favored Glycine 0 CA--C 1.532 1.155 0 CA-C-O 118.402 -1.221 . . . . 0.0 114.355 178.723 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 60.9 t -102.41 97.84 6.12 Favored 'Isoleucine or valine' 0 C--N 1.342 0.261 0 CA-C-N 119.52 1.66 . . . . 0.0 107.607 177.686 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -97.96 136.58 38.04 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 169.532 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -77.18 161.18 28.4 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.273 0.629 . . . . 0.0 110.619 178.169 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 5.2 mt -83.57 121.55 76.47 Favored Pre-proline 0 CA--C 1.54 0.565 0 N-CA-C 105.307 -2.109 . . . . 0.0 105.307 175.511 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -65.94 107.86 1.19 Allowed 'Trans proline' 0 C--N 1.35 0.656 0 N-CA-C 105.781 -2.43 . . . . 0.0 105.781 169.87 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 22.5 tpt180 47.86 -121.64 1.37 Allowed 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 104.965 -2.235 . . . . 0.0 104.965 -168.049 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 8.1 p . . . . . 0 C--O 1.238 0.467 0 CA-C-N 121.521 1.964 . . . . 0.0 109.958 169.757 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 31.6 ptt-85 . . . . . 0 N--CA 1.476 0.848 0 CA-C-O 119.442 -0.313 . . . . 0.0 110.252 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 4.4 mt -122.19 128.74 75.61 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 -176.428 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 15.3 tp -115.21 140.77 48.81 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 105.686 -1.968 . . . . 0.0 105.686 168.38 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 74.9 t -120.01 113.24 39.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 106.152 -1.795 . . . . 0.0 106.152 177.532 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.41 ' HA ' HD13 ' A' ' 6' ' ' LEU . 0.7 OUTLIER -93.26 120.84 34.0 Favored 'General case' 0 CA--C 1.516 -0.338 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 -177.534 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -100.03 120.27 6.81 Favored Glycine 0 CA--C 1.499 -0.92 0 N-CA-C 105.679 -2.968 . . . . 0.0 105.679 170.598 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 11.4 m -148.94 162.47 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.971 0 CA-C-O 121.174 0.511 . . . . 0.0 110.579 -168.814 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 119.77 146.67 7.81 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 126.382 1.944 . . . . 0.0 108.996 177.711 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.494 HD21 ' HB2' ' A' ' 12' ' ' LEU . 2.0 t30 -62.57 116.14 4.88 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 123.781 1.753 . . . . 0.0 114.675 -168.839 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.3 pt -67.84 40.71 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.812 0 CA-C-N 112.264 -2.244 . . . . 0.0 114.981 170.037 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.494 ' HB2' HD21 ' A' ' 10' ' ' ASN . 75.0 mt -132.62 -12.65 3.01 Favored 'General case' 0 C--N 1.343 0.325 0 CA-C-N 121.563 1.983 . . . . 0.0 111.416 170.622 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.7 mp -115.32 62.77 0.69 Allowed 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 -167.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 56.9 -97.63 0.08 Allowed 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 123.51 0.724 . . . . 0.0 111.246 170.387 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -84.18 -9.47 58.52 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 124.39 1.076 . . . . 0.0 110.906 -175.15 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -70.68 -14.98 62.67 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 119.859 1.208 . . . . 0.0 112.56 -176.039 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.2 -6.04 55.67 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-O 115.697 -2.097 . . . . 0.0 110.024 172.677 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 6.4 tp -49.88 -44.37 20.9 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-N 122.062 2.21 . . . . 0.0 111.94 -171.437 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -62.78 -42.24 99.72 Favored Glycine 0 N--CA 1.446 -0.634 0 CA-C-N 118.88 0.764 . . . . 0.0 111.629 178.799 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 73.6 t -63.86 -52.92 50.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 173.853 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 1.4 mmp_? -60.74 -31.89 71.2 Favored 'General case' 0 CA--C 1.531 0.245 0 O-C-N 120.949 -1.094 . . . . 0.0 112.73 -175.414 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 25.0 mt -60.54 -44.94 97.68 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 CA-C-N 120.145 1.339 . . . . 0.0 110.287 176.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 17.9 m -75.35 -25.44 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-N 120.203 1.365 . . . . 0.0 111.323 -176.679 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -68.03 -42.92 79.87 Favored 'General case' 0 C--N 1.341 0.2 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 173.237 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.81 -41.95 91.24 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-O 119.363 -0.351 . . . . 0.0 110.277 179.36 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 10.4 tp -61.12 -45.11 96.02 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 118.453 -0.784 . . . . 0.0 109.816 176.8 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -59.89 -39.91 86.97 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 118.467 0.576 . . . . 0.0 111.216 -178.388 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 50.6 mm-40 -73.58 -40.73 63.66 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 122.938 0.495 . . . . 0.0 111.355 178.253 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 91.0 mtt180 -90.24 -38.03 13.71 Favored 'General case' 0 C--N 1.342 0.259 0 CA-C-O 117.343 -1.313 . . . . 0.0 114.288 -169.293 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 66.2 m-85 -115.33 136.23 53.31 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 120.991 1.723 . . . . 0.0 113.348 -169.751 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 39.8 mm -86.48 134.29 27.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 N-CA-C 105.805 -1.924 . . . . 0.0 105.805 168.284 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 7.3 mp -119.91 150.32 50.54 Favored Pre-proline 0 CA--C 1.539 0.523 0 C-N-CA 125.305 1.442 . . . . 0.0 110.691 -169.672 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -62.34 153.86 67.6 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 122.888 2.392 . . . . 0.0 109.785 168.859 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -61.21 -33.6 73.74 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 -169.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 18.0 p90 -74.21 -8.04 54.78 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 118.016 -0.992 . . . . 0.0 112.453 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 12.4 t -101.11 128.03 53.74 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 CA-C-N 119.926 1.239 . . . . 0.0 108.079 174.205 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -133.45 147.66 51.7 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.063 0.545 . . . . 0.0 110.155 175.226 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -100.17 136.78 30.04 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 N-CA-C 107.459 -1.312 . . . . 0.0 107.459 169.556 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.513 HD13 ' N ' ' A' ' 40' ' ' ASP . 1.5 tm? -128.11 144.79 51.13 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 173.075 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.513 ' N ' HD13 ' A' ' 39' ' ' LEU . 5.8 t0 -118.11 114.43 23.08 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 124.131 0.972 . . . . 0.0 108.483 -175.439 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -93.31 -4.54 64.29 Favored Glycine 0 CA--C 1.533 1.207 0 CA-C-O 119.032 -0.871 . . . . 0.0 113.277 176.764 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 60.57 -125.82 39.49 Favored Glycine 0 N--CA 1.431 -1.665 0 N-CA-C 108.22 -1.952 . . . . 0.0 108.22 -171.801 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 12.1 p -54.55 -37.41 65.41 Favored 'General case' 0 C--N 1.313 -0.985 0 C-N-CA 127.501 2.32 . . . . 0.0 111.271 176.633 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 50.07 -131.32 1.94 Allowed 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 169.348 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 79.73 -104.92 2.24 Favored Glycine 0 N--CA 1.443 -0.847 0 N-CA-C 106.899 -2.481 . . . . 0.0 106.899 -169.358 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 66.4 mmm -72.23 -19.55 61.7 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 112.535 0.568 . . . . 0.0 112.535 -175.511 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -60.67 -18.48 54.06 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 120.871 0.367 . . . . 0.0 111.941 -174.321 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 28.4 mt -88.71 -2.68 58.72 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 124.929 1.291 . . . . 0.0 114.136 -169.015 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.496 ' HA ' HG13 ' A' ' 100' ' ' VAL . 5.0 tt -46.9 -53.97 11.01 Favored 'General case' 0 C--N 1.344 0.354 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 -169.483 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -86.93 -31.24 18.29 Favored Glycine 0 CA--C 1.522 0.493 0 N-CA-C 111.011 -0.836 . . . . 0.0 111.011 -179.244 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -72.24 -27.75 62.71 Favored 'General case' 0 C--O 1.233 0.199 0 O-C-N 121.735 -0.862 . . . . 0.0 111.217 -170.015 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 28.8 mtp -81.9 -6.81 59.42 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 176.133 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -68.61 145.2 54.15 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 118.997 0.817 . . . . 0.0 111.474 -170.36 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 55.79 21.85 5.06 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 116.741 2.126 . . . . 0.0 116.741 168.577 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 26.2 mmt180 -77.79 148.95 34.52 Favored 'General case' 0 N--CA 1.473 0.681 0 O-C-N 120.593 -1.317 . . . . 0.0 108.867 178.104 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -83.4 -30.64 27.19 Favored 'General case' 0 N--CA 1.47 0.572 0 O-C-N 121.7 -0.625 . . . . 0.0 109.607 179.64 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 4.0 t60 -141.33 129.53 22.22 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 105.523 -2.028 . . . . 0.0 105.523 177.114 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.403 HD21 HD23 ' A' ' 6' ' ' LEU . 0.4 OUTLIER -130.84 127.95 39.64 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-N 118.671 0.669 . . . . 0.0 109.327 171.095 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 29.7 mt -109.69 116.91 53.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 N-CA-C 104.904 -2.258 . . . . 0.0 104.904 174.536 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.452 HD11 HD21 ' A' ' 114' ' ' LEU . 38.8 mt -93.36 127.47 45.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 105.517 -2.031 . . . . 0.0 105.517 177.077 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -110.4 114.97 28.83 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 103.868 -2.641 . . . . 0.0 103.868 169.084 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -150.48 161.46 42.48 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.813 0.845 . . . . 0.0 110.154 -178.427 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -76.02 151.79 37.08 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 169.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 9.7 mm -84.05 -49.49 16.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-O 118.817 -0.611 . . . . 0.0 110.925 -177.844 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . 0.252 2.7 t 52.64 28.6 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.164 0 C-N-CA 125.954 1.702 . . . . 0.0 112.907 177.595 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 16.3 m -132.46 157.62 44.13 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 124.481 1.112 . . . . 0.0 111.934 -171.178 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 19.7 ttmt 57.87 -167.48 0.14 Allowed 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 126.265 1.826 . . . . 0.0 112.447 171.093 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.37 17.98 17.17 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.86 1.264 . . . . 0.0 110.995 -175.177 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -70.84 158.45 36.35 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.529 0.732 . . . . 0.0 109.144 -177.384 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 8.5 m -59.74 138.71 90.07 Favored Pre-proline 0 CA--C 1.545 0.779 0 C-N-CA 124.078 0.951 . . . . 0.0 111.991 -169.604 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_exo -55.2 149.01 46.84 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.998 2.465 . . . . 0.0 111.709 170.109 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 68.95 16.43 70.49 Favored Glycine 0 CA--C 1.533 1.157 0 CA-C-O 119.721 -0.488 . . . . 0.0 113.684 174.92 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 18.3 m -91.6 141.24 28.92 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 173.371 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 26.3 ttp -96.12 141.14 29.85 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 175.379 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 25.9 ttm -129.5 100.61 5.61 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 -173.389 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 38.4 mm -92.81 119.18 40.03 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 -178.314 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 44.0 mt -125.46 141.29 52.14 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 -173.281 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 88.2 mtt-85 -113.28 142.89 45.29 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 123.113 0.565 . . . . 0.0 110.425 -178.72 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 33.6 t70 38.05 -102.11 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 125.6 1.56 . . . . 0.0 114.228 169.373 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -59.91 -31.06 69.47 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.851 1.26 . . . . 0.0 113.725 -173.469 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -75.56 -19.52 59.24 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 118.388 0.54 . . . . 0.0 111.173 -176.78 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 78.9 t -73.96 -60.84 1.42 Allowed Pre-proline 0 N--CA 1.443 -0.781 0 CA-C-O 117.822 -1.085 . . . . 0.0 111.196 -169.4 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -63.8 -30.98 68.73 Favored 'Trans proline' 0 N--CA 1.447 -1.222 0 CA-C-N 121.315 1.506 . . . . 0.0 110.591 177.548 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.6 -26.45 67.1 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 122.631 0.372 . . . . 0.0 111.074 -178.028 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.423 HD13 ' C ' ' A' ' 85' ' ' LEU . 3.1 tm? -77.98 -54.86 5.81 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 169.044 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -59.05 -24.56 62.97 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 114.033 1.123 . . . . 0.0 114.033 -170.322 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.9 t -67.3 -7.93 28.3 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-N 118.948 0.794 . . . . 0.0 112.546 178.021 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ASN . . . . . 0.559 HD21 ' HB ' ' A' ' 90' ' ' ILE . 10.1 t30 -51.69 126.54 18.0 Favored 'General case' 0 C--N 1.344 0.347 0 O-C-N 121.409 -0.807 . . . . 0.0 109.754 172.075 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 37.0 mtmt -73.12 -23.51 60.5 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 118.718 -0.658 . . . . 0.0 112.45 -174.652 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.559 ' HB ' HD21 ' A' ' 88' ' ' ASN . 70.9 mt -67.23 -44.83 87.36 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 -178.054 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.9 m -62.39 113.37 8.6 Favored Pre-proline 0 CA--C 1.544 0.724 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 170.404 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -77.15 -63.68 0.03 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.623 0 CA-C-N 121.215 1.47 . . . . 0.0 113.041 -169.112 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' HIS . . . . . 0.418 ' CE1' ' HB3' ' A' ' 10' ' ' ASN . 6.4 p-80 -78.62 -25.23 45.06 Favored 'General case' 0 N--CA 1.468 0.445 0 O-C-N 121.127 -0.983 . . . . 0.0 110.754 -178.226 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 22.0 mp0 -59.36 -33.51 71.25 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 119.739 1.154 . . . . 0.0 110.084 171.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -60.63 -41.83 95.65 Favored 'General case' 0 C--O 1.224 -0.248 0 CA-C-N 119.249 0.932 . . . . 0.0 109.14 173.751 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -61.29 -38.01 94.98 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 110.781 -0.927 . . . . 0.0 110.781 174.614 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 10.4 tp -69.23 -33.52 73.42 Favored 'General case' 0 CA--C 1.538 0.483 0 O-C-N 120.676 -1.484 . . . . 0.0 110.624 176.127 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -63.41 -41.3 98.72 Favored 'General case' 0 C--N 1.333 -0.132 0 O-C-N 121.037 -1.039 . . . . 0.0 109.822 171.559 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -71.2 -22.27 62.04 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 118.877 -0.583 . . . . 0.0 111.775 176.15 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.496 HG13 ' HA ' ' A' ' 49' ' ' LEU . 6.3 t -73.54 -44.16 54.02 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 CA-C-N 119.526 1.057 . . . . 0.0 109.839 169.7 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 64.4 mt -58.97 -37.42 76.76 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 119.093 0.86 . . . . 0.0 108.735 174.795 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 35.8 m -68.33 -39.17 82.01 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 118.708 -0.663 . . . . 0.0 110.554 172.902 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.415 ' HA ' ' CD2' ' A' ' 106' ' ' PHE . . . -63.77 -39.76 95.03 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 119.879 1.218 . . . . 0.0 110.459 179.583 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 18.8 mt -65.88 -38.84 89.85 Favored 'General case' 0 CA--C 1.519 -0.244 0 C-N-CA 123.119 0.567 . . . . 0.0 110.596 174.637 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 80.2 ttt180 -62.17 -37.83 86.76 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 118.552 -0.737 . . . . 0.0 109.985 173.621 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.415 ' CD2' ' HA ' ' A' ' 103' ' ' ALA . 14.1 m-30 -65.73 -42.51 90.94 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 119.346 0.975 . . . . 0.0 110.489 -179.791 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 42.6 p -78.55 -19.77 52.13 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 118.345 0.521 . . . . 0.0 111.624 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 78.56 10.33 86.29 Favored Glycine 0 CA--C 1.532 1.143 0 CA-C-O 119.034 -0.87 . . . . 0.0 111.036 -169.589 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 30.4 mm-40 -88.9 21.68 3.0 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 119.078 1.439 . . . . 0.0 111.931 -179.769 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.428 ' HA ' ' HD3' ' A' ' 111' ' ' PRO . 10.0 t80 -61.8 140.95 95.41 Favored Pre-proline 0 CA--C 1.543 0.684 0 C-N-CA 123.95 0.9 . . . . 0.0 110.509 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 110' ' ' PHE . 52.2 Cg_exo -64.72 148.16 90.08 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 122.493 2.128 . . . . 0.0 111.675 -176.812 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -64.75 -26.08 68.21 Favored 'General case' 0 CA--C 1.537 0.476 0 O-C-N 122.13 -0.357 . . . . 0.0 111.137 -178.631 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -140.45 133.29 29.1 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 169.547 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.452 HD21 HD11 ' A' ' 60' ' ' ILE . 2.8 tm? -124.96 123.22 39.42 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 177.784 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.2 m -131.62 142.6 49.91 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 -172.864 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -131.58 123.81 28.68 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 119.681 1.128 . . . . 0.0 109.525 -179.545 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 23.4 t -96.4 78.7 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 105.489 -2.041 . . . . 0.0 105.489 174.122 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -77.01 145.09 30.61 Favored Glycine 0 N--CA 1.449 -0.471 0 N-CA-C 109.905 -1.278 . . . . 0.0 109.905 -176.316 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 63.3 t -129.03 137.57 56.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 174.786 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 18.8 mt -88.56 131.65 41.32 Favored Pre-proline 0 CA--C 1.542 0.656 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 175.656 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -70.74 171.49 15.43 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 124.147 3.231 . . . . 0.0 113.534 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -113.08 -60.74 1.84 Allowed 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.033 0.933 . . . . 0.0 110.454 176.654 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 67.8 m -104.56 -52.32 2.92 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 118.791 0.723 . . . . 0.0 112.756 -171.304 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER 58.48 46.98 14.22 Favored 'General case' 0 CA--C 1.548 0.887 0 N-CA-C 114.706 1.372 . . . . 0.0 114.706 170.429 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -115.8 165.03 15.56 Favored Pre-proline 0 N--CA 1.475 0.81 0 CA-C-O 117.923 -1.037 . . . . 0.0 110.407 175.466 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -63.94 87.58 0.15 Allowed 'Trans proline' 0 CA--C 1.547 1.136 0 C-N-CA 123.706 2.937 . . . . 0.0 113.736 -179.592 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -176.76 145.8 0.53 Allowed 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 104.067 -2.568 . . . . 0.0 104.067 174.574 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -108.94 161.72 7.12 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 CA-C-N 119.014 0.825 . . . . 0.0 111.346 -176.463 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 105.21 135.21 8.22 Favored Glycine 0 CA--C 1.528 0.865 0 N-CA-C 105.316 -3.114 . . . . 0.0 105.316 -168.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 5.8 mp -81.43 157.94 24.76 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-N 117.915 0.857 . . . . 0.0 109.332 -175.131 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 63.4 p -64.22 162.7 30.0 Favored Pre-proline 0 CA--C 1.537 0.462 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 168.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -59.15 -28.56 88.12 Favored 'Trans proline' 0 CA--C 1.541 0.853 0 C-N-CA 120.635 0.89 . . . . 0.0 110.628 169.496 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 28.7 m -64.14 -50.09 69.57 Favored 'General case' 0 C--N 1.344 0.368 0 CA-C-O 118.785 -0.626 . . . . 0.0 110.999 178.056 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 5.0 t -96.3 -22.68 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 CA-C-N 119.286 0.948 . . . . 0.0 111.343 -169.454 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -52.59 -45.53 66.53 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 120.241 1.382 . . . . 0.0 108.674 168.879 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -75.15 8.81 2.36 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 113.978 1.103 . . . . 0.0 113.978 -179.219 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 85.3 mtp -103.48 -6.75 21.5 Favored 'General case' 0 N--CA 1.432 -1.367 0 CA-C-O 117.563 -1.208 . . . . 0.0 110.077 169.798 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 95.1 mt -58.92 -44.55 91.12 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.326 0 CA-C-N 120.342 1.428 . . . . 0.0 107.278 174.31 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 58.1 mt-10 -72.33 -51.87 7.37 Favored Pre-proline 0 CA--C 1.541 0.625 0 CA-C-O 117.595 -1.193 . . . . 0.0 110.786 -177.737 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -41.39 -50.47 4.55 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 124.867 3.711 . . . . 0.0 113.499 168.758 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -71.22 -42.68 68.6 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 113.725 -1.579 . . . . 0.0 110.497 -176.088 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 26.1 mt -56.4 -42.64 78.27 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 118.656 0.662 . . . . 0.0 109.354 173.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -62.18 -33.49 74.63 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 118.944 0.793 . . . . 0.0 110.426 -179.042 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 43.7 mm-40 -79.43 -31.48 42.6 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 119.059 0.845 . . . . 0.0 112.255 176.749 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 71.0 t -60.82 -47.81 91.63 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 169.522 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 29.0 mt -65.75 -35.06 79.64 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.103 0.561 . . . . 0.0 110.319 -179.076 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -62.15 -40.12 94.89 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-O 118.347 -0.835 . . . . 0.0 110.781 178.506 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -60.9 -47.99 83.87 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 119.154 0.888 . . . . 0.0 111.417 -179.112 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 10.4 mp -49.86 -52.47 32.47 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 123.379 0.672 . . . . 0.0 109.808 169.643 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -67.14 -18.37 65.26 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 117.492 -1.242 . . . . 0.0 111.984 -173.649 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -63.03 -29.49 70.86 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 120.788 1.631 . . . . 0.0 110.349 177.877 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 5.2 m -110.27 25.26 11.98 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.99 1.316 . . . . 0.0 110.808 179.595 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 66.54 18.61 68.06 Favored Glycine 0 CA--C 1.531 1.071 0 CA-C-O 118.295 -1.281 . . . . 0.0 114.047 177.702 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 63.9 t -84.72 137.05 21.52 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 N-CA-C 106.266 -1.753 . . . . 0.0 106.266 173.683 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -121.1 148.75 43.75 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 178.712 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -126.12 135.85 52.19 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 169.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 157' ' ' ILE . . . . . 0.404 ' CG2' ' HA ' ' A' ' 160' ' ' SER . 33.7 mm -101.63 130.27 24.97 Favored Pre-proline 0 C--O 1.23 0.069 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 -171.463 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -57.73 110.64 0.65 Allowed 'Trans proline' 0 CA--C 1.536 0.599 0 C-N-CA 122.022 1.814 . . . . 0.0 108.533 169.69 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 4.5 tmm_? 49.96 32.28 5.48 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.154 1.381 . . . . 0.0 113.151 173.33 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 160' ' ' SER . . . . . 0.404 ' HA ' ' CG2' ' A' ' 157' ' ' ILE . 27.5 p . . . . . 0 CA--C 1.544 0.746 0 C-N-CA 125.997 1.719 . . . . 0.0 113.951 -171.479 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 6.1 ptp180 . . . . . 0 N--CA 1.479 0.986 0 CA-C-O 118.035 -0.983 . . . . 0.0 108.93 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 57.2 mt -140.75 135.79 34.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 CA-C-N 119.685 1.13 . . . . 0.0 111.143 -169.803 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -116.94 130.31 56.62 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 105.593 -2.003 . . . . 0.0 105.593 168.244 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 33.2 t -107.36 103.97 16.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 103.258 -2.867 . . . . 0.0 103.258 169.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.2 mt -101.65 110.34 22.31 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 124.003 0.921 . . . . 0.0 109.795 -169.86 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -92.23 116.76 5.13 Favored Glycine 0 N--CA 1.45 -0.409 0 N-CA-C 107.773 -2.131 . . . . 0.0 107.773 172.486 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 12.4 m -133.78 -166.63 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.084 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 -177.884 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 95.15 131.0 6.3 Favored Glycine 0 N--CA 1.441 -0.976 0 N-CA-C 107.369 -2.293 . . . . 0.0 107.369 -170.82 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 -66.16 108.41 2.26 Favored 'General case' 0 N--CA 1.441 -0.915 0 C-N-CA 124.004 0.922 . . . . 0.0 110.937 -169.114 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.1 pt -73.21 40.29 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 C-N-CA 124.675 1.19 . . . . 0.0 113.193 179.167 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 15.2 mt -125.59 -2.76 7.33 Favored 'General case' 0 CA--C 1.536 0.407 0 O-C-N 121.023 -1.048 . . . . 0.0 108.6 169.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -129.24 65.45 1.46 Allowed 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.589 1.156 . . . . 0.0 108.418 -169.602 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 12.7 m 45.44 -109.6 0.2 Allowed 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 114.325 -1.307 . . . . 0.0 112.445 169.813 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -56.89 -24.59 53.13 Favored 'General case' 0 N--CA 1.443 -0.815 0 C-N-CA 125.617 1.567 . . . . 0.0 112.501 -172.403 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -64.73 -21.92 66.86 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 120.288 1.404 . . . . 0.0 111.443 -177.865 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.99 -9.4 15.57 Favored 'General case' 0 N--CA 1.437 -1.118 0 CA-C-O 116.433 -1.746 . . . . 0.0 111.456 173.709 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 5.6 tp -52.88 -40.44 36.05 Favored 'Isoleucine or valine' 0 C--N 1.343 0.306 0 CA-C-N 122.172 2.26 . . . . 0.0 111.421 -175.321 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -63.17 -45.23 95.79 Favored Glycine 0 C--N 1.336 0.559 0 CA-C-N 119.245 0.93 . . . . 0.0 111.027 178.833 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 96.9 t -62.62 -47.6 92.17 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 175.423 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 18.5 mmt180 -61.13 -33.61 73.66 Favored 'General case' 0 C--N 1.34 0.163 0 CA-C-O 117.092 -1.432 . . . . 0.0 112.5 179.062 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 21.9 mt -62.5 -47.04 94.87 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 CA-C-N 121.431 1.923 . . . . 0.0 109.847 177.46 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 26.7 m -74.97 -34.08 31.46 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-N 119.327 0.967 . . . . 0.0 111.157 -175.447 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 61.0 mt-10 -62.45 -44.14 97.12 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 122.863 0.465 . . . . 0.0 110.33 172.0 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -67.08 -38.15 85.24 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 119.438 1.017 . . . . 0.0 110.18 177.527 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 5.9 tp -64.73 -38.72 91.95 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 119.369 0.986 . . . . 0.0 109.652 -177.71 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -61.89 -25.56 67.63 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 112.573 0.583 . . . . 0.0 112.573 -179.543 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -94.91 -42.63 8.57 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 126.014 1.726 . . . . 0.0 111.076 -178.111 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 75.2 mtt180 -82.95 -25.96 31.84 Favored 'General case' 0 N--CA 1.456 -0.144 0 CA-C-O 118.343 -0.836 . . . . 0.0 111.799 -176.243 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 69.5 m-85 -127.06 147.97 50.14 Favored 'General case' 0 CA--C 1.521 -0.161 0 CA-C-N 119.628 1.104 . . . . 0.0 113.346 -177.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 37.7 mm -99.51 135.63 34.07 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 N-CA-C 104.384 -2.45 . . . . 0.0 104.384 168.92 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -118.51 147.38 41.82 Favored Pre-proline 0 CA--C 1.536 0.413 0 C-N-CA 123.795 0.838 . . . . 0.0 109.878 -169.829 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -65.93 157.2 60.47 Favored 'Trans proline' 0 CA--C 1.535 0.545 0 C-N-CA 122.637 2.225 . . . . 0.0 110.007 169.869 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -58.07 -32.56 68.16 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 114.314 1.227 . . . . 0.0 114.314 -169.459 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 10.6 p90 -77.06 -13.4 59.96 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 118.688 -0.672 . . . . 0.0 112.686 -177.546 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 75.5 t -88.73 125.54 41.89 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 170.05 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -120.77 128.17 52.65 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 169.418 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -88.38 124.33 41.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 105.074 -2.195 . . . . 0.0 105.074 168.664 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 52.2 tp -122.93 133.94 54.37 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 118.234 0.47 . . . . 0.0 110.359 174.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -89.81 123.38 33.74 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 169.683 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -112.92 -24.37 4.92 Favored Glycine 0 CA--C 1.536 1.401 0 CA-C-O 118.235 -1.314 . . . . 0.0 113.466 171.787 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 57.0 -111.7 3.0 Favored Glycine 0 C--N 1.342 0.907 0 CA-C-N 119.802 1.801 . . . . 0.0 111.714 171.282 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 67.4 p -75.62 7.28 3.86 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.545 1.538 . . . . 0.0 113.522 -174.123 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.82 -67.2 0.44 Allowed 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 114.397 1.258 . . . . 0.0 114.397 -169.748 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 60.87 -102.2 0.38 Allowed Glycine 0 CA--C 1.534 1.272 0 N-CA-C 109.125 -1.59 . . . . 0.0 109.125 -169.621 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' MET . . . . . 0.477 ' HA ' HG23 ' A' ' 100' ' ' VAL . 0.0 OUTLIER -65.97 -26.59 67.63 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.939 0.896 . . . . 0.0 112.812 -175.037 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -60.22 -15.68 26.69 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 113.799 1.037 . . . . 0.0 113.799 -170.142 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 7.9 mt -96.39 13.99 25.91 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -169.488 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.525 ' HA ' HG13 ' A' ' 100' ' ' VAL . 4.2 tt -46.75 -60.9 2.1 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 118.539 0.609 . . . . 0.0 111.736 -176.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -64.68 -32.14 83.24 Favored Glycine 0 CA--C 1.531 1.075 0 CA-C-O 119.527 -0.596 . . . . 0.0 112.552 -178.363 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -78.79 -33.21 46.49 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 118.629 1.214 . . . . 0.0 112.515 -174.458 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 39.3 mtp -75.62 -21.44 57.75 Favored 'General case' 0 N--CA 1.449 -0.505 0 O-C-N 121.936 -0.478 . . . . 0.0 110.421 178.591 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.58 153.93 42.38 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-O 121.755 0.788 . . . . 0.0 111.452 -175.831 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 62.87 9.64 3.81 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 126.959 2.103 . . . . 0.0 115.592 169.248 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 25.1 mmt180 -79.38 160.29 26.75 Favored 'General case' 0 N--CA 1.473 0.709 0 O-C-N 121.017 -1.052 . . . . 0.0 108.565 178.286 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -87.33 -53.16 4.98 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 175.521 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . 0.259 0.0 OUTLIER -125.4 146.08 49.76 Favored 'General case' 0 CA--C 1.517 -0.295 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 169.206 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 12.6 tp -138.2 116.69 12.05 Favored 'General case' 0 CA--C 1.513 -0.449 0 N-CA-C 104.067 -2.568 . . . . 0.0 104.067 -176.781 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 10.8 mt -98.08 113.23 32.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 105.562 -2.014 . . . . 0.0 105.562 175.538 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 48.6 mt -91.4 138.48 19.62 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.558 0 N-CA-C 106.561 -1.644 . . . . 0.0 106.561 173.405 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -123.4 121.04 34.74 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 105.397 -2.075 . . . . 0.0 105.397 168.371 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -157.23 161.37 39.23 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.999 1.32 . . . . 0.0 108.979 -173.425 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -95.06 141.18 29.0 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 121.42 0.629 . . . . 0.0 110.666 176.198 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 25.7 mt -89.95 -18.55 7.64 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 C-N-CA 124.434 1.093 . . . . 0.0 110.611 -179.045 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . 0.308 47.2 t 70.54 -48.21 0.19 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.21 0 C-N-CA 128.323 2.649 . . . . 0.0 113.659 174.283 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 11.9 m -147.07 138.72 24.22 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 -176.855 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 12.0 tppt? -164.56 174.85 10.41 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 127.166 2.186 . . . . 0.0 105.961 168.875 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.56 -26.98 65.68 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 121.799 -0.563 . . . . 0.0 111.505 175.016 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -70.58 165.45 22.75 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.345 0.658 . . . . 0.0 110.761 -175.355 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 3.1 m -60.64 153.13 63.98 Favored Pre-proline 0 CA--C 1.547 0.854 0 C-N-CA 124.709 1.204 . . . . 0.0 112.489 -169.847 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_exo -57.7 158.39 20.3 Favored 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 123.867 3.045 . . . . 0.0 112.422 169.648 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.446 ' HA3' HG22 ' A' ' 133' ' ' THR . . . 65.62 11.21 52.81 Favored Glycine 0 CA--C 1.536 1.38 0 CA-C-O 119.144 -0.809 . . . . 0.0 114.358 172.019 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 5.6 m -90.32 146.51 24.14 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 118.875 1.337 . . . . 0.0 111.484 -169.325 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 26.4 ttp -84.63 139.3 32.16 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 173.659 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 40.6 mtp -128.75 123.62 33.45 Favored 'General case' 0 CA--C 1.519 -0.214 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 176.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 23.3 mm -99.88 116.62 43.56 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 N-CA-C 107.243 -1.391 . . . . 0.0 107.243 177.13 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -107.85 130.02 55.03 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 106.857 -1.534 . . . . 0.0 106.857 174.547 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 21.3 mmt180 -85.66 167.13 15.6 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 122.706 0.402 . . . . 0.0 110.857 176.702 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -32.74 -54.84 0.36 Allowed 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 116.575 2.065 . . . . 0.0 116.575 -174.169 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -88.99 -10.23 48.41 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 113.461 0.911 . . . . 0.0 113.461 -177.228 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -93.28 -33.23 14.02 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 123.189 0.596 . . . . 0.0 110.436 -176.246 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.0 m -53.79 -50.35 84.17 Favored Pre-proline 0 CA--C 1.538 0.484 0 CA-C-O 117.987 -1.006 . . . . 0.0 110.997 175.397 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -64.8 -40.82 20.34 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 121.82 1.68 . . . . 0.0 110.434 -177.102 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.14 -15.35 59.58 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 173.288 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -91.25 -36.79 13.7 Favored 'General case' 0 C--N 1.342 0.273 0 CA-C-N 119.755 1.161 . . . . 0.0 110.953 177.068 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.616 ' HB3' ' HB2' ' A' ' 98' ' ' ALA . 62.7 m-85 -70.73 9.44 0.66 Allowed 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 113.677 0.992 . . . . 0.0 113.677 -177.074 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 57.2 p -61.14 -24.4 66.25 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.224 1.01 . . . . 0.0 109.443 168.793 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 56.0 t-20 -50.34 114.76 1.2 Allowed 'General case' 0 C--N 1.348 0.509 0 C-N-CA 124.578 1.151 . . . . 0.0 110.464 170.253 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 34.7 tttm -97.31 1.04 49.04 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.461 1.104 . . . . 0.0 112.356 -174.257 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 60.0 mt -64.45 -48.26 85.9 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-N 118.724 0.693 . . . . 0.0 109.469 -170.378 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -100.49 135.64 20.14 Favored Pre-proline 0 CA--C 1.543 0.686 0 CA-C-O 118.968 -0.539 . . . . 0.0 110.545 -171.648 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -70.98 -36.23 7.88 Favored 'Trans proline' 0 CA--C 1.534 0.507 0 C-N-CA 122.794 2.329 . . . . 0.0 111.576 -177.425 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 47.9 t-80 -59.51 -50.25 74.63 Favored 'General case' 0 C--N 1.343 0.286 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 175.752 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -58.96 -43.16 91.26 Favored 'General case' 0 C--O 1.224 -0.264 0 CA-C-O 118.437 -0.792 . . . . 0.0 110.224 179.433 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 39.3 tp -66.06 -39.11 89.83 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 119.3 0.955 . . . . 0.0 111.123 -178.218 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -65.17 -44.26 94.24 Favored Glycine 0 CA--C 1.528 0.898 0 N-CA-C 110.615 -0.994 . . . . 0.0 110.615 176.743 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -62.32 -38.79 90.79 Favored 'General case' 0 CA--C 1.537 0.457 0 O-C-N 122.357 -0.496 . . . . 0.0 110.152 175.381 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.616 ' HB2' ' HB3' ' A' ' 86' ' ' PHE . . . -57.72 -46.14 84.8 Favored 'General case' 0 N--CA 1.455 -0.198 0 O-C-N 121.612 -0.68 . . . . 0.0 110.183 175.039 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 17.7 t0 -72.79 -20.88 61.08 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 119.706 -0.187 . . . . 0.0 111.078 -176.286 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.525 HG13 ' HA ' ' A' ' 49' ' ' LEU . 16.8 t -73.17 -44.59 55.64 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.686 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 169.486 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 74.5 mt -62.42 -36.31 81.97 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 119.119 0.872 . . . . 0.0 109.348 178.623 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 39.9 m -64.51 -44.21 91.63 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-O 118.469 -0.776 . . . . 0.0 109.952 172.529 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.448 ' HA ' ' CD2' ' A' ' 106' ' ' PHE . . . -60.48 -40.82 92.69 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 119.896 1.226 . . . . 0.0 111.641 175.311 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.5 mt -64.4 -33.58 76.19 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 123.621 0.768 . . . . 0.0 110.042 176.695 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 56.0 ttt85 -72.79 -32.58 65.68 Favored 'General case' 0 CA--C 1.534 0.335 0 O-C-N 121.553 -0.717 . . . . 0.0 110.071 174.578 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.448 ' CD2' ' HA ' ' A' ' 103' ' ' ALA . 14.3 m-30 -68.98 -47.05 66.52 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 119.058 0.844 . . . . 0.0 110.535 178.489 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 39.7 p -73.98 -25.27 59.84 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 123.4 0.68 . . . . 0.0 111.732 -178.771 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 74.6 8.08 80.54 Favored Glycine 0 CA--C 1.534 1.27 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -168.445 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -83.94 19.38 1.76 Allowed 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 119.84 1.82 . . . . 0.0 111.049 174.535 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -59.98 135.81 90.45 Favored Pre-proline 0 CA--C 1.547 0.833 0 C-N-CA 124.591 1.156 . . . . 0.0 109.33 169.825 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_exo -59.96 163.8 13.27 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 123.553 2.835 . . . . 0.0 115.713 -177.478 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 36.3 mmtt -64.85 -41.91 95.31 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 113.156 0.798 . . . . 0.0 113.156 172.66 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 24.1 ttpp -140.93 68.7 1.34 Allowed 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 -173.548 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.4 tt -68.6 136.84 53.65 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 174.932 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -131.79 134.49 45.88 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 177.518 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -123.23 117.47 25.38 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 120.469 1.486 . . . . 0.0 108.721 -179.064 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 18.9 t -92.55 91.84 3.55 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 N-CA-C 105.589 -2.004 . . . . 0.0 105.589 172.414 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -81.67 150.49 29.71 Favored Glycine 0 CA--C 1.522 0.522 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 178.521 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 40.4 t -129.04 130.56 68.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 178.378 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 47.6 mt -83.6 131.67 51.68 Favored Pre-proline 0 CA--C 1.534 0.355 0 N-CA-C 103.519 -2.771 . . . . 0.0 103.519 169.411 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -78.77 178.55 7.42 Favored 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 122.589 2.193 . . . . 0.0 111.164 -177.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -97.84 -56.47 2.49 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 124.001 0.92 . . . . 0.0 108.558 168.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 63.0 m -110.27 -59.31 1.96 Allowed 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 113.72 1.007 . . . . 0.0 113.72 -169.504 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.2 tp 53.81 33.11 16.25 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 127.37 2.268 . . . . 0.0 114.08 -173.264 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -82.33 161.32 60.06 Favored Pre-proline 0 CA--C 1.541 0.624 0 O-C-N 121.443 -0.786 . . . . 0.0 109.643 175.311 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -81.44 89.39 1.26 Allowed 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 122.142 1.895 . . . . 0.0 112.593 -169.756 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -174.82 179.55 1.63 Allowed 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 103.42 -2.807 . . . . 0.0 103.42 179.612 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -132.44 162.35 39.93 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 CA-C-N 120.558 1.526 . . . . 0.0 114.952 -176.383 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 110.72 143.5 9.59 Favored Glycine 0 CA--C 1.531 1.092 0 N-CA-C 104.73 -3.348 . . . . 0.0 104.73 -168.406 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 88.6 mt -76.02 156.48 33.97 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 119.308 1.554 . . . . 0.0 109.642 175.141 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 34.9 p -71.67 165.04 53.03 Favored Pre-proline 0 CA--C 1.539 0.526 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 169.665 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -57.76 -39.94 83.21 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 C-N-CA 121.821 1.681 . . . . 0.0 111.427 173.541 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' THR . . . . . 0.446 HG22 ' HA3' ' A' ' 72' ' ' GLY . 4.1 m -64.61 -40.02 94.75 Favored 'General case' 0 N--CA 1.442 -0.866 0 C-N-CA 124.117 0.967 . . . . 0.0 110.79 -177.873 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 74.7 t -90.5 -30.99 5.0 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 O-C-N 121.585 -0.697 . . . . 0.0 110.597 -173.424 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -53.96 -46.46 71.62 Favored 'General case' 0 CA--C 1.533 0.302 0 O-C-N 121.182 -0.948 . . . . 0.0 109.341 169.403 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -68.05 -14.86 63.3 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 113.69 0.996 . . . . 0.0 113.69 -178.901 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 5.3 mmm -82.27 -12.41 58.05 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.776 1.63 . . . . 0.0 111.871 174.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 54.1 mt -54.56 -54.12 25.26 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.357 0 CA-C-N 120.576 1.535 . . . . 0.0 108.897 173.817 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -67.15 -47.75 50.27 Favored Pre-proline 0 CA--C 1.542 0.671 0 CA-C-O 117.556 -1.212 . . . . 0.0 110.827 -173.154 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 0.3 OUTLIER -43.3 -54.29 3.62 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 125.293 3.995 . . . . 0.0 112.819 168.827 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -67.97 -37.2 81.24 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.106 -0.952 . . . . 0.0 112.102 179.401 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 36.1 mt -61.27 -45.35 94.87 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 121.039 1.745 . . . . 0.0 109.108 175.769 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -58.69 -33.78 70.55 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 118.686 0.676 . . . . 0.0 110.206 177.197 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 68.0 tp60 -76.6 -36.69 57.35 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 121.392 -0.818 . . . . 0.0 111.914 178.216 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 46.9 t -60.86 -44.93 98.77 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 171.797 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 71.1 mt -61.59 -36.25 80.15 Favored 'General case' 0 C--O 1.226 -0.176 0 CA-C-O 118.9 -0.571 . . . . 0.0 110.132 176.867 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -67.21 -44.49 79.43 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 119.241 0.928 . . . . 0.0 111.025 176.009 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -66.77 -27.89 67.96 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 119.161 0.891 . . . . 0.0 111.708 178.685 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 33.2 mt -69.14 -49.89 52.83 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 170.556 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 16.8 mmm-85 -63.8 -21.86 66.63 Favored 'General case' 0 CA--C 1.522 -0.126 0 CA-C-O 118.058 -0.972 . . . . 0.0 112.396 -177.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -63.99 -34.29 77.65 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 119.973 1.261 . . . . 0.0 110.947 174.624 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 26.0 m -91.45 18.29 7.45 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 122.854 0.462 . . . . 0.0 111.573 170.109 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 70.98 16.87 75.07 Favored Glycine 0 C--N 1.337 0.623 0 CA-C-O 117.607 -1.663 . . . . 0.0 112.578 -178.667 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 39.0 t -90.76 118.75 36.64 Favored 'Isoleucine or valine' 0 C--N 1.347 0.459 0 CA-C-N 120.648 2.224 . . . . 0.0 106.627 -176.244 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -111.0 85.68 2.16 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 106.198 -1.779 . . . . 0.0 106.198 177.042 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -49.12 139.49 10.68 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 114.627 -1.169 . . . . 0.0 110.005 169.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 24.9 mt -91.05 125.71 57.76 Favored Pre-proline 0 CA--C 1.53 0.202 0 CA-C-O 117.331 -1.318 . . . . 0.0 108.296 -169.597 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -66.54 98.07 0.39 Allowed 'Trans proline' 0 CA--C 1.534 0.52 0 C-N-CA 122.673 2.249 . . . . 0.0 109.236 175.549 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 60.5 mtm180 49.9 14.88 0.14 Allowed 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 127.218 2.207 . . . . 0.0 115.519 -178.799 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 58.6 m . . . . . 0 CA--C 1.539 0.54 0 C-N-CA 123.843 0.857 . . . . 0.0 111.538 -169.252 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 7.9 ptp180 . . . . . 0 N--CA 1.48 1.066 0 CA-C-O 119.435 -0.317 . . . . 0.0 111.521 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 27.0 mt -136.41 135.22 49.52 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 C-N-CA 123.171 0.588 . . . . 0.0 110.732 -172.59 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 8.3 mt -112.28 138.58 48.79 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 105.711 -1.959 . . . . 0.0 105.711 167.313 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 49.1 t -116.21 104.38 16.59 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.644 0 N-CA-C 103.387 -2.819 . . . . 0.0 103.387 169.39 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 14.5 tp -101.73 111.28 23.47 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 -168.688 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -88.28 127.29 8.5 Favored Glycine 0 C--N 1.331 0.304 0 N-CA-C 107.706 -2.158 . . . . 0.0 107.706 176.561 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -141.14 165.6 19.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 117.434 0.617 . . . . 0.0 110.958 -170.488 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 119.25 174.54 15.82 Favored Glycine 0 CA--C 1.527 0.827 0 C-N-CA 125.986 1.755 . . . . 0.0 111.259 178.111 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 -82.88 97.6 8.75 Favored 'General case' 0 C--O 1.235 0.338 0 O-C-N 121.409 -1.053 . . . . 0.0 110.41 -175.188 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.2 pt -62.64 35.67 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 N-CA-C 116.476 2.028 . . . . 0.0 116.476 172.806 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 33.8 mt -128.67 -7.16 5.11 Favored 'General case' 0 C--O 1.223 -0.304 0 CA-C-N 120.304 1.411 . . . . 0.0 108.749 169.0 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.6 mp -111.4 60.19 0.61 Allowed 'General case' 0 N--CA 1.442 -0.836 0 C-N-CA 124.174 0.989 . . . . 0.0 113.407 -168.106 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.436 ' HB ' ' H ' ' A' ' 15' ' ' ASP . 0.2 OUTLIER 52.72 -102.19 0.13 Allowed 'General case' 0 C--O 1.236 0.362 0 C-N-CA 124.168 0.987 . . . . 0.0 111.265 171.393 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.436 ' H ' ' HB ' ' A' ' 14' ' ' THR . 10.3 m-20 -78.81 -11.87 60.01 Favored 'General case' 0 N--CA 1.441 -0.881 0 C-N-CA 123.715 0.806 . . . . 0.0 111.018 -173.603 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -74.35 -8.82 57.57 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 120.444 1.474 . . . . 0.0 112.232 177.291 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -77.34 -10.49 59.47 Favored 'General case' 0 N--CA 1.432 -1.327 0 CA-C-O 116.0 -1.952 . . . . 0.0 108.878 170.346 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.8 tp -54.48 -37.92 39.68 Favored 'Isoleucine or valine' 0 C--N 1.345 0.385 0 CA-C-N 122.212 2.278 . . . . 0.0 112.25 -169.79 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -60.1 -45.0 96.76 Favored Glycine 0 CA--C 1.524 0.602 0 CA-C-N 119.55 1.068 . . . . 0.0 111.599 175.648 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 55.3 t -69.72 -44.41 79.28 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-O 118.528 -0.749 . . . . 0.0 109.911 175.31 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 23.1 mmm180 -61.47 -33.66 74.14 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 120.469 1.486 . . . . 0.0 111.778 179.461 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 30.3 mt -62.25 -46.4 96.52 Favored 'Isoleucine or valine' 0 C--N 1.342 0.256 0 CA-C-N 120.459 1.482 . . . . 0.0 109.464 176.512 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 30.2 m -73.73 -27.15 22.49 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 CA-C-N 119.748 1.158 . . . . 0.0 111.522 -175.186 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 64.1 mt-10 -72.91 -44.06 61.7 Favored 'General case' 0 CA--C 1.528 0.099 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 175.078 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.57 -42.39 96.56 Favored 'General case' 0 N--CA 1.452 -0.356 0 O-C-N 121.978 -0.451 . . . . 0.0 110.586 176.124 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 5.5 tp -65.85 -40.96 92.22 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-O 118.828 -0.606 . . . . 0.0 109.913 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -61.76 -40.34 94.79 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 118.413 0.551 . . . . 0.0 111.081 177.766 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -71.99 -34.71 69.13 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.633 0.773 . . . . 0.0 112.068 178.196 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 36.5 mtp180 -100.17 -34.06 10.19 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 117.204 -1.379 . . . . 0.0 114.054 -169.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -121.34 138.23 54.35 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 121.464 1.938 . . . . 0.0 113.153 -170.134 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 39.9 mm -99.87 141.16 17.49 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 105.542 -2.021 . . . . 0.0 105.542 169.019 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.8 mt -143.49 161.35 47.52 Favored Pre-proline 0 CA--C 1.539 0.549 0 C-N-CA 126.717 2.007 . . . . 0.0 107.407 -174.065 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -55.77 156.76 17.89 Favored 'Trans proline' 0 CA--C 1.536 0.605 0 C-N-CA 123.21 2.606 . . . . 0.0 112.661 177.708 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -62.46 -27.29 69.02 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 -170.069 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 10.9 p90 -76.36 -2.23 30.77 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 179.109 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 22.0 t -104.26 130.27 55.26 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 175.615 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -131.85 135.57 46.8 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 174.707 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.669 HD12 ' H ' ' A' ' 38' ' ' ILE . 0.1 OUTLIER -94.84 106.19 17.86 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 N-CA-C 105.744 -1.947 . . . . 0.0 105.744 171.089 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 53.2 tp -105.74 126.14 51.81 Favored 'General case' 0 C--N 1.343 0.307 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 -174.444 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -80.17 117.92 21.4 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 122.989 0.515 . . . . 0.0 109.754 171.591 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -77.86 -83.54 0.56 Allowed Glycine 0 CA--C 1.528 0.872 0 N-CA-C 107.408 -2.277 . . . . 0.0 107.408 169.249 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 79.84 110.96 0.26 Allowed Glycine 0 C--N 1.343 0.94 0 N-CA-C 111.05 -0.82 . . . . 0.0 111.05 178.329 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.3 p 52.59 61.05 3.39 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.839 1.256 . . . . 0.0 109.085 175.26 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -120.18 -84.78 0.66 Allowed 'General case' 0 C--N 1.344 0.344 0 CA-C-N 114.43 -1.259 . . . . 0.0 111.026 -169.523 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 71.09 -93.25 0.5 Allowed Glycine 0 C--N 1.338 0.668 0 N-CA-C 108.491 -1.843 . . . . 0.0 108.491 -170.834 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 27.7 tpp -78.61 -22.5 46.91 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 124.125 0.97 . . . . 0.0 112.322 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -63.02 -14.23 45.41 Favored 'General case' 0 CA--C 1.547 0.833 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 -169.885 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 28.8 mt -101.87 13.43 34.83 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.882 0.873 . . . . 0.0 112.843 -174.02 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.598 ' HA ' HG13 ' A' ' 100' ' ' VAL . 4.3 tt -41.6 -61.44 1.08 Allowed 'General case' 0 C--N 1.344 0.338 0 C-N-CA 124.177 0.991 . . . . 0.0 113.152 -175.513 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -75.82 -34.67 47.66 Favored Glycine 0 CA--C 1.524 0.608 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.15 -173.189 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -64.35 -34.08 77.33 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 117.549 0.675 . . . . 0.0 111.353 179.471 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.441 ' SD ' HG11 ' A' ' 100' ' ' VAL . 51.7 mtp -72.7 -13.3 61.31 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 111.911 0.337 . . . . 0.0 111.911 179.442 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -85.32 160.63 19.77 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 123.341 0.656 . . . . 0.0 110.414 -176.56 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 29.2 m120 59.26 19.44 7.56 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.642 1.577 . . . . 0.0 113.845 172.197 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 20.4 mmt180 -94.37 151.54 19.32 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 106.388 -1.708 . . . . 0.0 106.388 169.83 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -89.2 -35.83 15.99 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 -179.387 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 12.6 t-160 -142.14 128.78 20.34 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 105.849 -1.908 . . . . 0.0 105.849 179.645 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 6.5 tp -134.86 128.56 32.9 Favored 'General case' 0 CA--C 1.508 -0.669 0 N-CA-C 108.984 -0.746 . . . . 0.0 108.984 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 44.6 mt -106.98 108.98 26.51 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 N-CA-C 105.199 -2.148 . . . . 0.0 105.199 -179.212 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.6 mm -78.32 128.91 38.12 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 N-CA-C 105.25 -2.13 . . . . 0.0 105.25 175.436 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -112.33 116.66 30.72 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 104.703 -2.332 . . . . 0.0 104.703 169.4 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -155.35 169.6 23.83 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 118.174 0.443 . . . . 0.0 110.19 -177.893 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -88.31 156.99 18.88 Favored 'General case' 0 CA--C 1.534 0.351 0 O-C-N 121.921 -0.487 . . . . 0.0 109.858 169.613 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 87.6 mt -115.05 113.94 45.05 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.104 1 N-CA-C 99.939 -4.097 . . . . 0.0 99.939 168.919 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 67.1 t -65.36 -37.86 81.13 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 N-CA-C 113.442 0.904 . . . . 0.0 113.442 -168.18 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 15.2 m -151.43 152.42 33.02 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 119.238 0.926 . . . . 0.0 111.483 173.236 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 26.7 tptt -158.68 -177.44 6.53 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.593 1.957 . . . . 0.0 106.512 169.25 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.2 42.13 0.97 Allowed 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.742 0.817 . . . . 0.0 110.472 -178.931 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 33.6 t-20 -143.83 160.88 39.98 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.826 1.25 . . . . 0.0 109.215 -170.098 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.6 m -64.59 146.66 98.18 Favored Pre-proline 0 CA--C 1.548 0.871 0 C-N-CA 124.344 1.058 . . . . 0.0 111.847 -169.773 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -58.6 153.54 48.23 Favored 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 122.713 2.275 . . . . 0.0 111.426 169.496 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 68.33 16.0 68.66 Favored Glycine 0 CA--C 1.532 1.114 0 CA-C-O 118.711 -1.049 . . . . 0.0 114.345 177.166 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 25.9 m -96.36 152.34 18.68 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 119.0 1.4 . . . . 0.0 109.627 179.783 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 18.8 ttp -95.78 145.07 25.62 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 123.614 0.766 . . . . 0.0 110.372 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 10.3 ttm -136.51 121.95 19.45 Favored 'General case' 0 CA--C 1.528 0.127 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 44.6 mm -109.15 122.47 63.86 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 -177.548 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -121.1 131.66 54.4 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 -171.393 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 74.5 mtm180 -100.78 176.14 5.4 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.496 0.718 . . . . 0.0 110.551 -176.837 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -46.74 -47.19 20.68 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 115.99 1.848 . . . . 0.0 115.99 -169.711 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -78.91 -18.23 54.21 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 119.242 0.928 . . . . 0.0 112.248 -178.741 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -90.59 -33.12 16.0 Favored 'General case' 0 N--CA 1.457 -0.119 0 C-N-CA 123.606 0.762 . . . . 0.0 110.754 -169.722 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -70.36 -37.6 7.27 Favored Pre-proline 0 CA--C 1.539 0.525 0 CA-C-O 117.233 -1.365 . . . . 0.0 113.242 -177.036 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_exo -56.26 -25.93 58.75 Favored 'Trans proline' 0 CA--C 1.54 0.781 0 CA-C-N 121.768 1.667 . . . . 0.0 112.21 169.577 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -92.4 7.62 42.13 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 124.492 1.117 . . . . 0.0 112.68 177.879 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -126.53 -42.39 1.81 Allowed 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.512 0.725 . . . . 0.0 112.509 -172.921 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.461 ' HB3' ' HB2' ' A' ' 98' ' ' ALA . 74.0 m-85 -61.85 -11.1 11.09 Favored 'General case' 0 CA--C 1.551 1.017 0 CA-C-N 119.47 1.032 . . . . 0.0 111.39 175.447 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 64.3 p -59.54 -27.55 66.3 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.946 1.698 . . . . 0.0 113.857 -177.021 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -63.75 139.83 58.81 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 121.347 0.594 . . . . 0.0 110.78 -170.272 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -76.13 -21.66 56.35 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 122.658 0.383 . . . . 0.0 111.861 -176.66 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 97.3 mt -72.42 -26.72 24.76 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 C-N-CA 124.28 1.032 . . . . 0.0 110.318 -170.174 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 9.9 m -102.85 84.47 0.66 Allowed Pre-proline 0 CA--C 1.55 0.962 0 C-N-CA 126.084 1.753 . . . . 0.0 108.63 174.711 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -70.61 -38.27 6.15 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 123.003 2.469 . . . . 0.0 114.364 -169.231 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 11.1 m80 -68.71 -39.75 80.32 Favored 'General case' 0 N--CA 1.468 0.441 0 O-C-N 121.055 -1.028 . . . . 0.0 108.81 179.707 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 16.9 mp0 -66.09 -36.55 83.48 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 125.169 1.388 . . . . 0.0 109.253 177.229 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 59.0 tp -62.01 -35.27 78.04 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 119.431 1.014 . . . . 0.0 110.969 171.191 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -60.51 -39.27 96.15 Favored Glycine 0 CA--C 1.532 1.116 0 O-C-N 121.392 -0.817 . . . . 0.0 111.069 171.087 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 8.8 tt -75.21 -23.97 57.68 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 117.549 0.675 . . . . 0.0 110.704 175.885 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.461 ' HB2' ' HB3' ' A' ' 86' ' ' PHE . . . -61.02 -43.72 98.47 Favored 'General case' 0 C--O 1.226 -0.17 0 CA-C-N 119.443 1.02 . . . . 0.0 108.666 169.787 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -69.77 -21.32 63.44 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 119.03 -0.509 . . . . 0.0 110.747 176.572 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.598 HG13 ' HA ' ' A' ' 49' ' ' LEU . 73.1 t -69.77 -40.89 79.65 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 168.786 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 5.3 mp -60.98 -36.64 79.97 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 120.973 1.715 . . . . 0.0 110.492 175.021 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 17.0 m -63.46 -45.26 91.64 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 118.286 0.494 . . . . 0.0 109.873 172.201 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -65.39 -38.77 90.99 Favored 'General case' 0 N--CA 1.452 -0.366 0 O-C-N 121.563 -0.711 . . . . 0.0 111.505 -179.376 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 21.7 mt -59.97 -39.59 86.17 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 125.143 1.377 . . . . 0.0 109.832 173.703 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 52.6 tpt85 -70.64 -33.35 70.89 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 118.037 -0.982 . . . . 0.0 110.484 175.605 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 15.5 m-30 -68.38 -42.11 79.57 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 119.646 1.112 . . . . 0.0 110.402 178.389 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 63.9 p -73.25 -26.78 61.25 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 118.561 0.619 . . . . 0.0 110.515 177.247 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 76.91 6.55 85.76 Favored Glycine 0 CA--C 1.532 1.138 0 CA-C-O 119.182 -0.788 . . . . 0.0 111.599 -169.806 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -96.06 19.73 11.22 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 118.603 1.202 . . . . 0.0 110.809 -175.133 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -55.82 135.37 72.62 Favored Pre-proline 0 CA--C 1.543 0.694 0 C-N-CA 126.624 1.969 . . . . 0.0 109.752 174.803 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_exo -56.04 152.74 35.57 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 123.259 2.639 . . . . 0.0 114.796 179.474 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 8.7 tttt -64.36 -33.27 75.45 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 119.001 -0.523 . . . . 0.0 110.302 177.033 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 63.1 tttm -139.82 97.46 3.26 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 -178.359 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -83.62 132.58 34.89 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 106.495 -1.669 . . . . 0.0 106.495 169.662 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -134.22 148.78 50.92 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 176.779 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.8 tt -135.05 133.87 39.8 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 120.177 1.353 . . . . 0.0 110.504 174.885 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 60.8 t -103.01 103.43 15.08 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 N-CA-C 103.665 -2.717 . . . . 0.0 103.665 169.095 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -92.85 151.91 20.74 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 111.121 -0.792 . . . . 0.0 111.121 177.321 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 47.1 t -138.95 136.35 42.73 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 N-CA-C 107.705 -1.221 . . . . 0.0 107.705 178.436 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 32.1 mt -88.73 131.64 41.01 Favored Pre-proline 0 CA--C 1.546 0.802 0 CA-C-N 119.812 1.187 . . . . 0.0 108.961 177.353 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -75.16 173.55 14.32 Favored 'Trans proline' 0 CA--C 1.543 0.932 0 C-N-CA 124.978 3.785 . . . . 0.0 113.228 -177.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -116.15 -57.35 2.22 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.836 0.855 . . . . 0.0 110.718 179.386 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 63.4 m -107.07 -51.89 2.85 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 118.54 0.609 . . . . 0.0 112.609 -172.568 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 57.25 46.71 18.18 Favored 'General case' 0 CA--C 1.552 1.044 0 N-CA-C 114.776 1.399 . . . . 0.0 114.776 172.992 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -116.38 165.22 15.53 Favored Pre-proline 0 N--CA 1.478 0.962 0 O-C-N 121.155 -0.966 . . . . 0.0 109.618 177.428 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -66.09 90.89 0.26 Allowed 'Trans proline' 0 CA--C 1.547 1.125 0 C-N-CA 122.868 2.378 . . . . 0.0 112.931 -179.149 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -176.98 145.24 0.47 Allowed 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 103.91 -2.626 . . . . 0.0 103.91 173.491 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -107.42 165.79 4.3 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 CA-C-N 119.376 0.989 . . . . 0.0 113.319 -169.539 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 85.3 153.81 21.29 Favored Glycine 0 C--N 1.341 0.845 0 N-CA-C 108.11 -1.996 . . . . 0.0 108.11 -169.504 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.418 HD22 ' H ' ' A' ' 130' ' ' LEU . 0.7 OUTLIER -81.74 163.32 22.51 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-O 121.585 0.707 . . . . 0.0 109.108 -172.529 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 39.5 p -69.19 169.32 12.06 Favored Pre-proline 0 C--O 1.238 0.467 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 168.104 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_exo -55.1 -32.2 78.63 Favored 'Trans proline' 0 CA--C 1.541 0.84 0 C-N-CA 121.469 1.446 . . . . 0.0 110.693 169.196 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 26.5 m -67.09 -44.73 79.26 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 118.992 -0.528 . . . . 0.0 111.419 179.551 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 4.6 t -101.06 -11.41 8.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 CA-C-N 119.645 1.111 . . . . 0.0 111.624 -169.863 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -59.04 -45.69 90.12 Favored 'General case' 0 CA--C 1.518 -0.27 0 O-C-N 119.938 -1.726 . . . . 0.0 107.322 169.016 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -71.24 4.63 2.69 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-O 118.482 -0.771 . . . . 0.0 112.406 178.104 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 26.2 mmm -95.57 -10.54 29.3 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 118.127 -0.94 . . . . 0.0 111.282 170.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 57.0 mt -59.9 -46.99 93.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-N 119.31 0.959 . . . . 0.0 108.554 178.907 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -72.15 -53.05 6.81 Favored Pre-proline 0 CA--C 1.536 0.422 0 CA-C-O 117.286 -1.34 . . . . 0.0 113.05 -171.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -60.02 -35.26 93.62 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 CA-C-N 122.244 1.837 . . . . 0.0 111.256 176.538 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.28 -43.01 71.31 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 118.84 0.745 . . . . 0.0 110.538 -179.668 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.05 -37.21 86.6 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 119.695 1.134 . . . . 0.0 109.782 176.34 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -62.36 -35.94 80.69 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 119.05 -0.5 . . . . 0.0 110.783 175.578 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 35.1 mm-40 -76.31 -29.5 57.34 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 119.152 0.887 . . . . 0.0 111.627 175.501 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 38.2 t -61.55 -45.42 98.68 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 CA-C-N 120.065 1.302 . . . . 0.0 108.478 169.446 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 72.8 mt -63.75 -39.03 93.28 Favored 'General case' 0 C--N 1.341 0.206 0 CA-C-N 118.05 0.386 . . . . 0.0 110.207 176.748 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -60.4 -41.28 93.53 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 118.906 0.776 . . . . 0.0 111.39 177.062 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -62.35 -47.38 84.46 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 119.233 0.924 . . . . 0.0 111.038 178.557 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . 0.297 4.2 pp -67.78 -22.23 65.21 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 118.576 0.626 . . . . 0.0 112.48 177.426 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 61.8 mtt180 -71.22 -26.31 62.87 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 117.822 -1.085 . . . . 0.0 111.821 169.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -59.85 -38.0 80.84 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 120.625 1.557 . . . . 0.0 109.42 174.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 11.3 p -87.39 14.81 7.36 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.549 1.14 . . . . 0.0 112.946 178.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 75.52 19.76 79.05 Favored Glycine 0 CA--C 1.534 1.268 0 CA-C-O 118.704 -1.054 . . . . 0.0 114.597 175.296 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 15.1 t -102.47 146.32 10.67 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 CA-C-N 118.97 1.385 . . . . 0.0 107.805 178.347 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -134.54 143.78 47.61 Favored 'General case' 0 C--O 1.236 0.392 0 O-C-N 121.096 -1.002 . . . . 0.0 108.929 176.873 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -94.74 160.52 14.57 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 124.991 1.316 . . . . 0.0 111.518 178.321 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' ILE . . . . . 0.407 ' CG2' ' HA ' ' A' ' 160' ' ' SER . 46.1 mt -124.07 130.76 24.27 Favored Pre-proline 0 CA--C 1.533 0.307 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 171.599 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -57.48 110.2 0.58 Allowed 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.561 2.174 . . . . 0.0 109.03 170.053 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 50.05 21.6 0.77 Allowed 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.628 1.571 . . . . 0.0 114.447 177.188 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 160' ' ' SER . . . . . 0.407 ' HA ' ' CG2' ' A' ' 157' ' ' ILE . 1.1 m . . . . . 0 CA--C 1.544 0.718 0 C-N-CA 124.424 1.09 . . . . 0.0 112.575 -169.563 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 8.3 ptp180 . . . . . 0 N--CA 1.483 1.187 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 72.7 mt -138.9 133.21 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 CA-C-N 119.332 0.969 . . . . 0.0 111.169 -169.429 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -115.2 129.74 56.73 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 105.951 -1.87 . . . . 0.0 105.951 168.529 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.424 HG12 HG12 ' A' ' 23' ' ' VAL . 21.8 t -104.43 105.49 18.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 101.905 -3.369 . . . . 0.0 101.905 169.351 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 13.0 tp -109.45 104.26 13.31 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 124.533 1.133 . . . . 0.0 110.033 -167.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -91.26 129.85 10.0 Favored Glycine 0 N--CA 1.452 -0.297 0 N-CA-C 106.603 -2.599 . . . . 0.0 106.603 175.083 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 1.4 m -135.32 -28.34 0.48 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.208 0 N-CA-C 117.819 2.525 . . . . 0.0 117.819 -168.463 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -52.25 151.41 7.65 Favored Glycine 0 CA--C 1.527 0.783 0 CA-C-O 122.22 0.9 . . . . 0.0 114.715 -169.304 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -61.76 102.39 0.26 Allowed 'General case' 0 N--CA 1.455 -0.225 0 C-N-CA 125.334 1.453 . . . . 0.0 112.372 -169.234 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.2 pt -76.76 40.97 0.02 OUTLIER 'Isoleucine or valine' 0 C--O 1.222 -0.38 0 C-N-CA 123.93 0.892 . . . . 0.0 113.311 -177.382 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 19.9 mt -128.11 -7.83 5.4 Favored 'General case' 0 CA--C 1.536 0.429 0 O-C-N 121.177 -0.952 . . . . 0.0 109.018 170.871 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.3 mp -124.51 67.24 1.08 Allowed 'General case' 0 C--N 1.346 0.417 0 C-N-CA 124.167 0.987 . . . . 0.0 109.235 -168.504 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.468 ' HB ' ' H ' ' A' ' 15' ' ' ASP . 1.4 m 46.91 -103.16 0.08 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 114.378 -1.283 . . . . 0.0 112.891 171.305 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.468 ' H ' ' HB ' ' A' ' 14' ' ' THR . 4.1 m-20 -62.95 -26.33 68.77 Favored 'General case' 0 N--CA 1.438 -1.056 0 C-N-CA 125.998 1.719 . . . . 0.0 111.598 -171.589 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -72.0 -18.79 61.95 Favored 'General case' 0 C--O 1.231 0.101 0 CA-C-N 120.019 1.281 . . . . 0.0 112.003 -174.022 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.86 -15.49 42.73 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-O 117.022 -1.466 . . . . 0.0 111.152 170.832 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.7 tp -54.2 -37.98 37.61 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 CA-C-N 120.831 1.65 . . . . 0.0 111.136 -174.503 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -59.54 -43.99 97.14 Favored Glycine 0 CA--C 1.527 0.834 0 N-CA-C 111.244 -0.743 . . . . 0.0 111.244 178.56 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 74.0 t -70.82 -45.78 71.81 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 176.364 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 20.0 mmt180 -61.43 -31.71 71.66 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 117.093 -1.432 . . . . 0.0 112.21 -178.695 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 19.9 mt -58.89 -49.49 82.87 Favored 'Isoleucine or valine' 0 C--N 1.34 0.157 0 CA-C-N 121.286 1.857 . . . . 0.0 109.299 174.577 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.424 HG12 HG12 ' A' ' 5' ' ' VAL . 30.4 m -73.32 -34.13 42.83 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 CA-C-N 119.762 1.164 . . . . 0.0 111.111 -173.705 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 59.4 mt-10 -64.88 -42.15 95.05 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 118.403 0.547 . . . . 0.0 110.322 173.041 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -68.24 -36.53 79.61 Favored 'General case' 0 C--N 1.34 0.184 0 CA-C-N 118.981 0.809 . . . . 0.0 110.014 179.363 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.3 tp -65.46 -36.16 83.07 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 118.64 0.654 . . . . 0.0 109.887 -177.902 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -61.57 -24.16 66.47 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.353 0.661 . . . . 0.0 112.72 179.18 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 -98.85 -39.77 8.43 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 126.45 1.9 . . . . 0.0 110.771 -176.856 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 21.8 mmt85 -85.02 -32.18 23.06 Favored 'General case' 0 C--N 1.338 0.085 0 CA-C-O 119.449 -0.31 . . . . 0.0 110.242 -173.328 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 71.5 m-85 -122.02 151.01 41.29 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-O 122.33 1.062 . . . . 0.0 111.826 -176.066 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 37.0 mt -107.06 134.45 48.7 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 N-CA-C 104.223 -2.51 . . . . 0.0 104.223 169.39 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -120.13 150.03 50.45 Favored Pre-proline 0 C--O 1.236 0.357 0 C-N-CA 124.005 0.922 . . . . 0.0 110.366 -169.114 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_endo -67.52 156.77 64.73 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 121.977 1.785 . . . . 0.0 108.726 168.944 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -55.75 -33.25 64.12 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 114.491 1.293 . . . . 0.0 114.491 -169.386 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 17.0 p90 -78.75 -13.2 59.94 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 118.474 -0.774 . . . . 0.0 112.743 -175.447 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 95.5 t -89.82 121.71 40.34 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 169.706 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -122.62 125.22 45.2 Favored 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 173.233 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -81.33 126.63 39.85 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 N-CA-C 106.067 -1.827 . . . . 0.0 106.067 167.927 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 64.4 tp -125.53 132.94 52.51 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 171.949 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -88.85 116.92 27.48 Favored 'General case' 0 C--O 1.236 0.395 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 169.77 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -76.17 -74.37 0.94 Allowed Glycine 0 CA--C 1.529 0.916 0 N-CA-C 108.335 -1.906 . . . . 0.0 108.335 169.241 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 85.76 98.0 0.75 Allowed Glycine 0 C--N 1.343 0.925 0 N-CA-C 109.729 -1.348 . . . . 0.0 109.729 176.048 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 16.8 p 62.97 16.65 9.42 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.24 1.416 . . . . 0.0 113.378 179.581 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -70.18 -59.96 2.57 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 114.298 1.222 . . . . 0.0 114.298 -168.787 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.4 ' H ' ' HE2' ' A' ' 93' ' ' HIS . . . 60.07 -117.09 10.2 Favored Glycine 0 CA--C 1.529 0.91 0 N-CA-C 108.691 -1.764 . . . . 0.0 108.691 -170.321 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 9.4 tpt -62.22 -21.86 65.48 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.512 1.125 . . . . 0.0 113.68 -173.273 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -60.19 -19.28 53.39 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 -171.087 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 10.0 mt -98.18 20.67 12.03 Favored 'General case' 0 C--N 1.345 0.392 0 CA-C-N 119.522 1.055 . . . . 0.0 113.663 -169.729 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.586 ' HA ' HG13 ' A' ' 100' ' ' VAL . 6.4 tt -50.5 -57.71 7.45 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 118.988 0.813 . . . . 0.0 110.988 -178.359 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -64.98 -30.08 77.08 Favored Glycine 0 CA--C 1.53 0.975 0 CA-C-O 119.296 -0.725 . . . . 0.0 112.584 -177.094 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -79.72 -36.38 37.5 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 118.413 1.107 . . . . 0.0 112.33 -178.552 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.53 ' SD ' HG11 ' A' ' 100' ' ' VAL . 55.4 mtp -76.25 -28.79 57.26 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 179.219 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.46 157.55 31.76 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 121.96 0.886 . . . . 0.0 110.803 175.079 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 62.14 16.49 8.35 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.377 1.471 . . . . 0.0 114.307 169.6 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 24.6 mmt180 -93.89 154.73 17.55 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 172.327 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -83.95 -34.91 24.33 Favored 'General case' 0 C--O 1.217 -0.642 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 169.859 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 4.5 t-160 -144.41 129.06 18.17 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 105.512 -2.033 . . . . 0.0 105.512 -169.423 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 22.8 tp -134.13 117.87 17.04 Favored 'General case' 0 CA--C 1.499 -1.003 0 N-CA-C 103.434 -2.802 . . . . 0.0 103.434 -173.861 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 65.7 mt -100.58 107.86 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 N-CA-C 103.907 -2.627 . . . . 0.0 103.907 171.578 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.571 HG22 HD23 ' A' ' 116' ' ' LEU . 63.8 mt -81.2 140.6 16.35 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 N-CA-C 105.885 -1.894 . . . . 0.0 105.885 172.902 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -120.72 113.18 19.83 Favored 'General case' 0 N--CA 1.446 -0.625 0 N-CA-C 103.635 -2.728 . . . . 0.0 103.635 168.606 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.407 ' CG ' HE21 ' A' ' 94' ' ' GLN . 38.6 t0 -155.93 157.64 36.62 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 123.574 0.75 . . . . 0.0 109.587 -176.22 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -83.68 149.92 26.19 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 174.641 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 8.1 mt -76.67 -32.59 20.95 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 C-N-CA 123.731 0.812 . . . . 0.0 110.109 174.655 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . 0.354 3.3 t 58.49 46.92 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.943 0 C-N-CA 126.148 1.779 . . . . 0.0 112.188 -173.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 8.1 m 63.46 145.28 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 128.327 2.651 . . . . 0.0 118.124 168.79 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -139.35 -88.34 0.21 Allowed 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 169.636 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -140.05 31.08 1.99 Allowed 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.56 1.144 . . . . 0.0 111.02 -176.383 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -134.31 165.22 25.64 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.095 0.958 . . . . 0.0 110.69 -174.289 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 2.8 m -64.87 148.5 97.4 Favored Pre-proline 0 CA--C 1.548 0.867 0 C-N-CA 124.439 1.096 . . . . 0.0 113.071 -169.664 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_exo -57.05 154.74 31.75 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 124.607 3.538 . . . . 0.0 112.425 169.626 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 67.04 11.46 58.58 Favored Glycine 0 CA--C 1.532 1.124 0 CA-C-O 119.065 -0.853 . . . . 0.0 113.943 173.468 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 10.6 m -90.22 140.68 29.45 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 119.146 1.473 . . . . 0.0 109.476 -175.638 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 28.8 ttp -86.07 142.95 28.35 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 169.526 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 7.0 ttm -131.53 134.23 45.89 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 169.667 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 4.9 mm -95.75 121.91 46.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 105.573 -2.01 . . . . 0.0 105.573 176.763 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.7 mp -116.37 128.86 55.89 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 173.385 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 22.2 mtp85 -88.53 177.72 6.72 Favored 'General case' 0 CA--C 1.528 0.103 0 O-C-N 123.824 0.703 . . . . 0.0 110.602 178.368 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -42.24 -50.97 4.88 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 115.336 1.606 . . . . 0.0 115.336 -169.73 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -86.27 -14.76 42.78 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -175.91 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -82.18 -36.64 27.13 Favored 'General case' 0 CA--C 1.523 -0.078 0 O-C-N 121.597 -0.69 . . . . 0.0 110.424 -169.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.476 HG12 ' CZ ' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -65.09 -47.86 71.77 Favored Pre-proline 0 CA--C 1.539 0.534 0 CA-C-O 117.397 -1.287 . . . . 0.0 113.454 -175.27 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -53.35 -44.36 49.65 Favored 'Trans proline' 0 C--N 1.352 0.739 0 C-N-CA 121.935 1.757 . . . . 0.0 110.697 174.94 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -70.22 -13.23 62.09 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 114.142 1.164 . . . . 0.0 114.142 178.385 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -95.27 -42.64 8.44 Favored 'General case' 0 C--N 1.343 0.323 0 CA-C-N 120.181 1.355 . . . . 0.0 110.558 -177.499 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.501 ' CB ' ' HB2' ' A' ' 98' ' ' ALA . 26.5 m-85 -69.01 0.98 3.84 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 -172.722 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 61.6 p -58.65 -27.85 65.15 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.137 0.975 . . . . 0.0 110.346 169.636 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 56.8 t-20 -51.52 117.19 2.48 Favored 'General case' 0 C--N 1.345 0.406 0 C-N-CA 124.137 0.975 . . . . 0.0 111.311 -179.329 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -77.22 -17.0 58.81 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 118.717 -0.659 . . . . 0.0 112.439 -174.289 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 40.2 mt -61.66 -41.13 89.19 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 178.003 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.5 m -83.18 105.11 4.6 Favored Pre-proline 0 CA--C 1.545 0.777 0 C-N-CA 126.683 1.993 . . . . 0.0 110.523 -169.616 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -71.95 -61.72 0.05 OUTLIER 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 122.186 1.924 . . . . 0.0 113.181 -169.118 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' HIS . . . . . 0.4 ' HE2' ' H ' ' A' ' 45' ' ' GLY . 10.4 t-80 -56.73 -41.66 77.88 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 121.75 0.786 . . . . 0.0 110.46 178.652 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.407 HE21 ' CG ' ' A' ' 62' ' ' ASP . 20.8 mp0 -61.36 -33.13 73.13 Favored 'General case' 0 N--CA 1.433 -1.287 0 CA-C-N 115.08 -0.964 . . . . 0.0 108.939 -175.074 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.426 ' O ' ' HB3' ' A' ' 98' ' ' ALA . 1.5 tt -63.13 -46.3 87.94 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 119.457 1.026 . . . . 0.0 108.804 177.594 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -61.69 -37.32 94.05 Favored Glycine 0 CA--C 1.532 1.14 0 O-C-N 121.089 -1.007 . . . . 0.0 111.014 175.882 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 54.6 tp -67.96 -30.92 70.33 Favored 'General case' 0 CA--C 1.535 0.382 0 O-C-N 121.755 -0.85 . . . . 0.0 110.353 175.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.501 ' HB2' ' CB ' ' A' ' 86' ' ' PHE . . . -60.26 -45.64 92.59 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 172.752 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 34.0 t0 -63.59 -28.97 70.29 Favored 'General case' 0 C--O 1.238 0.497 0 O-C-N 123.633 0.583 . . . . 0.0 110.592 -178.87 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.586 HG13 ' HA ' ' A' ' 49' ' ' LEU . 41.8 t -65.49 -50.2 73.69 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 CA-C-N 118.866 0.757 . . . . 0.0 110.126 169.71 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 33.6 mt -67.26 -31.52 71.92 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 119.202 0.91 . . . . 0.0 110.844 -174.553 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 48.8 m -64.52 -44.34 91.17 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 119.391 0.996 . . . . 0.0 109.838 169.737 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.448 ' HA ' ' CD2' ' A' ' 106' ' ' PHE . . . -62.54 -39.51 93.84 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 119.723 1.147 . . . . 0.0 111.276 177.095 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -63.23 -35.25 79.72 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 123.325 0.65 . . . . 0.0 109.819 175.476 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 73.6 ttt-85 -71.66 -31.42 66.79 Favored 'General case' 0 CA--C 1.535 0.39 0 O-C-N 121.554 -0.716 . . . . 0.0 109.937 176.311 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.448 ' CD2' ' HA ' ' A' ' 103' ' ' ALA . 12.3 m-30 -69.99 -46.47 65.08 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 119.143 0.883 . . . . 0.0 110.702 176.953 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 35.6 p -74.04 -27.19 60.81 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 122.993 0.517 . . . . 0.0 111.874 -176.789 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 75.11 7.37 81.81 Favored Glycine 0 CA--C 1.533 1.211 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 -168.366 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -84.57 16.27 3.29 Favored 'General case' 0 C--N 1.349 0.557 0 CA-C-N 119.734 1.767 . . . . 0.0 111.302 174.129 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -56.18 137.9 73.94 Favored Pre-proline 0 CA--C 1.542 0.668 0 C-N-CA 125.676 1.59 . . . . 0.0 109.895 170.108 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -62.72 160.24 33.64 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 122.475 2.117 . . . . 0.0 115.695 -176.814 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 23.7 mmtm -61.01 -40.99 95.67 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 169.437 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 23.6 ttpp -142.46 73.18 1.4 Allowed 'General case' 0 C--O 1.236 0.356 0 C-N-CA 123.825 0.85 . . . . 0.0 108.972 -172.414 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 15.2 tp -68.25 137.53 54.82 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 169.471 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.11 142.75 47.62 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 106.098 -1.815 . . . . 0.0 106.098 174.209 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.571 HD23 HG22 ' A' ' 60' ' ' ILE . 0.5 OUTLIER -130.08 121.62 26.75 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 120.503 1.502 . . . . 0.0 109.055 176.03 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.428 ' N ' HD22 ' A' ' 116' ' ' LEU . 13.1 t -85.97 87.86 2.63 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 N-CA-C 106.401 -1.703 . . . . 0.0 106.401 173.865 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -80.96 143.86 24.52 Favored Glycine 0 C--N 1.336 0.56 0 N-CA-C 110.005 -1.238 . . . . 0.0 110.005 -176.746 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 22.0 t -130.91 134.94 61.04 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.15 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 177.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 36.7 mt -93.63 133.22 28.41 Favored Pre-proline 0 CA--C 1.539 0.552 0 CA-C-N 119.595 1.089 . . . . 0.0 108.106 178.742 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -78.39 166.54 24.1 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 122.779 2.32 . . . . 0.0 112.372 -174.388 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -99.77 -50.42 4.04 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.93 0.892 . . . . 0.0 109.644 169.056 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 72.2 m -114.58 -55.16 2.52 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 113.82 1.044 . . . . 0.0 113.82 -169.694 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER 52.96 42.41 32.18 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 126.564 1.946 . . . . 0.0 112.93 -175.584 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -105.03 165.71 12.74 Favored Pre-proline 0 CA--C 1.542 0.653 0 C-N-CA 123.615 0.766 . . . . 0.0 109.917 178.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -80.94 85.72 1.76 Allowed 'Trans proline' 0 CA--C 1.538 0.722 0 C-N-CA 121.948 1.765 . . . . 0.0 112.977 -169.725 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -176.05 148.88 0.85 Allowed 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 103.609 -2.738 . . . . 0.0 103.609 178.466 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -110.84 168.63 4.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 CA-C-N 119.718 1.145 . . . . 0.0 113.973 -169.003 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 95.4 145.85 19.68 Favored Glycine 0 C--N 1.34 0.78 0 N-CA-C 106.022 -2.831 . . . . 0.0 106.022 -168.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.534 HD22 ' H ' ' A' ' 130' ' ' LEU . 1.4 mm? -73.66 163.54 27.86 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 119.339 1.569 . . . . 0.0 110.379 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 43.0 p -73.06 168.39 25.23 Favored Pre-proline 0 CA--C 1.539 0.54 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 168.391 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -57.13 -35.65 98.96 Favored 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 121.532 1.488 . . . . 0.0 111.185 172.504 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 99.0 m -66.93 -33.27 75.22 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 124.401 1.081 . . . . 0.0 111.293 -178.315 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 84.4 t -103.82 -27.55 3.17 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 CA-C-N 118.329 0.513 . . . . 0.0 111.608 -172.7 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -52.78 -49.28 65.87 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 119.346 0.975 . . . . 0.0 109.27 169.681 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -62.02 -19.59 63.02 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 4.0 mmm -80.63 -7.4 59.27 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-O 118.436 -0.792 . . . . 0.0 112.4 -179.121 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 71.4 mt -55.69 -51.99 52.97 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.235 0 CA-C-N 119.147 0.885 . . . . 0.0 109.072 172.768 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -71.36 -43.63 12.57 Favored Pre-proline 0 CA--C 1.535 0.38 0 CA-C-O 116.794 -1.574 . . . . 0.0 113.531 -169.052 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -55.95 -42.82 62.92 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 CA-C-N 121.994 1.748 . . . . 0.0 111.199 169.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.07 -40.09 94.18 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-O 119.004 -0.522 . . . . 0.0 111.959 178.21 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 74.1 mt -60.32 -45.91 91.74 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 119.589 1.086 . . . . 0.0 108.82 174.377 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -57.73 -35.28 70.48 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 118.74 0.7 . . . . 0.0 110.687 175.55 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.62 -44.42 93.98 Favored 'General case' 0 N--CA 1.446 -0.635 0 O-C-N 121.589 -0.695 . . . . 0.0 111.522 173.529 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 63.8 t -57.87 -46.04 87.41 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 N-CA-C 108.245 -1.021 . . . . 0.0 108.245 175.464 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 13.9 mt -57.9 -42.63 85.12 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 119.439 1.018 . . . . 0.0 110.072 178.395 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -68.72 -44.44 73.88 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 118.481 -0.771 . . . . 0.0 111.216 -178.014 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -64.62 -32.5 74.19 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 119.702 1.137 . . . . 0.0 110.811 178.793 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 80.2 mt -64.11 -47.94 78.04 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 170.317 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 70.9 mtp85 -62.92 -20.91 65.64 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 117.943 -1.027 . . . . 0.0 112.598 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 91.5 mt-10 -63.07 -36.39 83.41 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 120.475 1.489 . . . . 0.0 110.423 173.72 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 46.4 m -88.87 13.68 12.12 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.511 0.724 . . . . 0.0 111.668 170.531 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 70.4 21.82 77.53 Favored Glycine 0 CA--C 1.524 0.629 0 CA-C-O 117.877 -1.513 . . . . 0.0 112.434 -177.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 61.4 t -97.05 123.0 49.16 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 CA-C-N 120.089 1.944 . . . . 0.0 105.957 -175.562 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -105.18 97.15 7.04 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 177.597 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -58.95 137.12 58.02 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 168.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' ILE . . . . . 0.448 HG21 ' HA ' ' A' ' 160' ' ' SER . 35.4 mm -98.67 122.72 52.31 Favored Pre-proline 0 N--CA 1.461 0.095 0 CA-C-O 117.641 -1.171 . . . . 0.0 108.874 -170.515 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -63.27 105.99 0.53 Allowed 'Trans proline' 0 CA--C 1.534 0.484 0 C-N-CA 122.018 1.812 . . . . 0.0 109.024 171.712 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 55.8 mtm180 38.94 50.02 1.66 Allowed 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 126.452 1.901 . . . . 0.0 113.509 178.158 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 160' ' ' SER . . . . . 0.448 ' HA ' HG21 ' A' ' 157' ' ' ILE . 35.1 p . . . . . 0 CA--C 1.546 0.793 0 C-N-CA 127.068 2.147 . . . . 0.0 115.633 -179.054 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 29.4 ptt-85 . . . . . 0 N--CA 1.477 0.89 0 CA-C-O 119.186 -0.435 . . . . 0.0 109.96 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 3.6 mt -130.86 139.24 51.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 C-N-CA 123.412 0.685 . . . . 0.0 110.068 -169.662 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.7 mt -112.44 143.18 44.0 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 104.805 -2.294 . . . . 0.0 104.805 167.064 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 67.1 t -123.45 97.89 5.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 102.276 -3.231 . . . . 0.0 102.276 171.886 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.3 tt -106.53 109.7 21.7 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 -167.913 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -91.86 138.59 14.32 Favored Glycine 0 N--CA 1.443 -0.865 0 N-CA-C 108.206 -1.958 . . . . 0.0 108.206 176.234 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -148.05 167.26 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.612 0 C-N-CA 123.16 0.584 . . . . 0.0 109.429 -179.548 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 130.95 156.51 8.57 Favored Glycine 0 C--N 1.335 0.496 0 N-CA-C 108.723 -1.751 . . . . 0.0 108.723 170.642 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.545 ' HA ' HG22 ' A' ' 43' ' ' THR . 24.0 t-20 -75.45 103.75 5.72 Favored 'General case' 0 N--CA 1.454 -0.265 0 O-C-N 121.042 -1.27 . . . . 0.0 109.473 -174.629 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 26.1 pt -58.06 -15.59 5.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 N-CA-C 115.032 1.493 . . . . 0.0 115.032 -173.852 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.434 ' HA ' HG23 ' A' ' 128' ' ' ILE . 5.2 mp -89.01 -6.11 57.44 Favored 'General case' 0 C--O 1.216 -0.683 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 -171.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.5 mp -102.45 53.2 0.79 Allowed 'General case' 0 N--CA 1.434 -1.251 0 C-N-CA 124.143 0.977 . . . . 0.0 109.147 -172.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.407 ' HB ' ' H ' ' A' ' 15' ' ' ASP 0.258 0.1 OUTLIER 49.91 -107.37 0.26 Allowed 'General case' 0 N--CA 1.44 -0.952 0 CA-C-N 113.901 -1.5 . . . . 0.0 110.677 174.896 . . . . . . . . 4 4 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.407 ' H ' ' HB ' ' A' ' 14' ' ' THR . 75.3 m-20 -76.51 -6.27 51.12 Favored 'General case' 0 N--CA 1.439 -0.997 0 O-C-N 122.075 -0.391 . . . . 0.0 111.544 -171.023 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -71.94 -4.67 29.71 Favored 'General case' 0 CA--C 1.546 0.809 0 O-C-N 121.131 -0.98 . . . . 0.0 111.874 169.901 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -80.14 -15.18 57.64 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-O 116.187 -1.863 . . . . 0.0 109.748 169.792 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 7.0 tp -53.92 -42.02 51.72 Favored 'Isoleucine or valine' 0 C--N 1.342 0.252 0 CA-C-N 121.561 1.982 . . . . 0.0 112.655 -169.309 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -63.81 -43.45 97.66 Favored Glycine 0 C--N 1.334 0.435 0 CA-C-N 119.295 0.952 . . . . 0.0 111.716 178.855 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 97.7 t -64.56 -48.95 82.78 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 173.814 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 27.4 mmm180 -63.51 -31.41 72.56 Favored 'General case' 0 N--CA 1.467 0.404 0 O-C-N 120.433 -1.417 . . . . 0.0 112.678 -177.048 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 30.0 mt -60.52 -43.92 95.4 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 CA-C-N 120.446 1.476 . . . . 0.0 109.754 173.904 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.2 m -76.74 -27.79 17.01 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 CA-C-N 120.179 1.354 . . . . 0.0 111.806 -177.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 60.3 mt-10 -70.19 -41.27 73.95 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 175.726 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -69.03 -40.67 78.49 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-O 119.163 -0.446 . . . . 0.0 110.795 -179.682 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 5.7 tp -65.35 -42.2 93.07 Favored 'General case' 0 C--O 1.224 -0.283 0 CA-C-N 119.118 0.872 . . . . 0.0 110.233 178.313 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -62.6 -40.43 96.88 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 119.003 0.82 . . . . 0.0 110.669 179.211 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -71.15 -38.81 72.19 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 122.601 0.36 . . . . 0.0 111.686 177.568 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 31.4 mtp180 -92.67 -40.41 10.75 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 117.509 -1.234 . . . . 0.0 113.663 -169.688 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -117.18 123.82 47.61 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 121.074 1.761 . . . . 0.0 111.73 -170.61 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 50.0 mm -83.32 141.19 15.2 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 N-CA-C 106.372 -1.714 . . . . 0.0 106.372 169.611 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 17.8 mt -135.8 155.77 77.78 Favored Pre-proline 0 CA--C 1.539 0.523 0 C-N-CA 124.711 1.204 . . . . 0.0 110.153 -169.532 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_exo -57.88 157.72 23.31 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 123.612 2.875 . . . . 0.0 112.727 171.072 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -63.82 -30.21 71.33 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -169.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 11.7 p90 -73.13 -5.27 38.04 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 118.706 -0.664 . . . . 0.0 112.346 178.613 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 12.0 t -101.32 130.06 51.42 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 174.199 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -119.3 132.04 55.83 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 172.719 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.461 HD12 ' H ' ' A' ' 38' ' ' ILE . 0.1 OUTLIER -99.28 123.69 52.12 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 N-CA-C 104.759 -2.311 . . . . 0.0 104.759 169.059 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 5.8 tt -127.56 138.25 52.84 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 119.302 0.955 . . . . 0.0 110.816 -178.122 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -100.58 119.01 37.9 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 169.927 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -72.4 -24.28 76.56 Favored Glycine 0 CA--C 1.535 1.336 0 CA-C-O 118.683 -1.065 . . . . 0.0 112.752 177.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 66.91 75.54 0.45 Allowed Glycine 0 CA--C 1.529 0.92 0 CA-C-N 118.409 1.105 . . . . 0.0 112.063 173.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.545 HG22 ' HA ' ' A' ' 10' ' ' ASN 0.272 17.7 p 55.05 30.79 14.89 Favored 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 125.359 1.464 . . . . 0.0 112.862 176.26 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -76.91 -68.39 0.61 Allowed 'General case' 0 C--N 1.344 0.367 0 N-CA-C 114.701 1.371 . . . . 0.0 114.701 -169.335 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 74.91 -89.36 0.77 Allowed Glycine 0 CA--C 1.527 0.784 0 N-CA-C 108.463 -1.855 . . . . 0.0 108.463 -168.89 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 9.9 tpt -76.51 -22.42 54.46 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 125.051 1.34 . . . . 0.0 112.915 -173.532 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -66.19 -7.49 18.43 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 113.372 0.879 . . . . 0.0 113.372 -168.789 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.44 HD12 HD23 ' A' ' 97' ' ' LEU . 14.6 mt -84.12 4.09 31.92 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 121.622 -0.674 . . . . 0.0 112.76 -170.606 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -73.92 80.4 1.66 Allowed 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 125.078 2.371 . . . . 0.0 110.856 -177.605 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 141.54 -35.59 1.79 Allowed Glycine 0 C--N 1.309 -0.931 0 CA-C-N 109.676 -3.42 . . . . 0.0 111.073 169.876 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -69.17 -41.86 76.67 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-N 117.534 0.667 . . . . 0.0 109.87 -175.369 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 2.6 ptt? -88.84 1.88 54.56 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 115.449 -0.796 . . . . 0.0 112.176 -172.052 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -79.09 164.33 24.38 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 123.917 0.887 . . . . 0.0 111.257 -177.093 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 58.01 39.08 26.76 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.773 1.629 . . . . 0.0 113.883 168.85 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 9.5 mmt180 -109.22 153.45 23.79 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.385 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -81.25 -24.87 37.04 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 175.324 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -145.31 143.12 30.0 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 177.68 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 14.1 tp -140.56 126.23 19.14 Favored 'General case' 0 CA--C 1.505 -0.784 0 N-CA-C 106.016 -1.846 . . . . 0.0 106.016 168.47 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 36.1 mt -104.12 103.78 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 N-CA-C 103.753 -2.684 . . . . 0.0 103.753 172.901 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 12.9 mt -77.43 135.25 26.82 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 N-CA-C 105.053 -2.203 . . . . 0.0 105.053 171.743 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -118.56 120.55 37.83 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 105.604 -1.999 . . . . 0.0 105.604 169.509 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -156.25 167.14 31.36 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 122.875 0.47 . . . . 0.0 110.017 176.471 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -78.14 154.41 31.24 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 169.818 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 13.1 mm -78.8 -48.11 22.33 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.46 0 CA-C-O 118.754 -0.641 . . . . 0.0 110.595 -177.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.1 t 49.17 31.15 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.094 0 C-N-CA 126.7 2.0 . . . . 0.0 113.43 177.257 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 50.8 m -122.14 -25.81 4.83 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 116.291 1.96 . . . . 0.0 116.291 -169.777 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -149.21 156.98 42.97 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 120.564 1.529 . . . . 0.0 110.803 -172.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.18 33.41 0.13 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.906 1.683 . . . . 0.0 113.791 177.12 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 46.5 t30 -65.74 164.59 14.29 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 108.523 -0.918 . . . . 0.0 108.523 170.911 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 5.5 m -58.33 132.74 84.81 Favored Pre-proline 0 CA--C 1.545 0.77 0 CA-C-O 118.951 -0.547 . . . . 0.0 109.612 -178.473 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -61.42 156.19 47.96 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 122.742 2.294 . . . . 0.0 111.755 175.368 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 67.92 19.17 71.41 Favored Glycine 0 CA--C 1.535 1.324 0 CA-C-O 119.348 -0.696 . . . . 0.0 113.506 176.507 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 5.0 m -95.65 143.49 26.88 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 125.431 1.492 . . . . 0.0 108.505 178.044 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 14.7 ttp -91.64 135.48 33.84 Favored 'General case' 0 C--N 1.339 0.151 0 C-N-CA 123.178 0.591 . . . . 0.0 109.809 178.29 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 74.5 mmm -128.0 93.18 3.61 Favored 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 -169.742 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 44.2 mm -89.54 114.68 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 -177.939 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.8 mp -117.18 135.26 53.91 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 -177.451 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 40.4 ttm180 -102.92 135.87 43.79 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 123.276 0.63 . . . . 0.0 109.689 -176.008 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 17.4 t70 33.38 -97.91 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 115.734 1.753 . . . . 0.0 115.734 169.217 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -60.74 -26.72 67.41 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.514 1.125 . . . . 0.0 113.592 -174.496 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 -73.79 -25.17 60.0 Favored 'General case' 0 CA--C 1.533 0.311 0 O-C-N 122.023 -0.423 . . . . 0.0 110.483 -177.883 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.402 HG22 ' HB3' ' A' ' 116' ' ' LEU . 94.7 t -68.11 -62.38 3.25 Favored Pre-proline 0 N--CA 1.443 -0.823 0 CA-C-O 117.835 -1.079 . . . . 0.0 111.155 -168.956 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -63.69 -33.81 64.93 Favored 'Trans proline' 0 N--CA 1.448 -1.194 0 CA-C-N 121.266 1.488 . . . . 0.0 110.797 178.889 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.18 -21.22 65.8 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.189 0.596 . . . . 0.0 111.656 -175.63 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.436 HD13 ' C ' ' A' ' 85' ' ' LEU . 2.7 tm? -82.71 -49.56 9.65 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 169.296 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -60.63 -11.51 7.49 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 113.659 0.985 . . . . 0.0 113.659 -172.615 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 19.3 p -55.45 -23.92 28.05 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 119.488 1.04 . . . . 0.0 112.81 170.449 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -59.53 128.23 36.01 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 122.943 0.497 . . . . 0.0 110.47 -174.472 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 66.2 mttt -81.28 -16.01 53.8 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 118.516 -0.754 . . . . 0.0 112.719 -175.761 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 83.6 mt -64.85 -40.44 89.08 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 178.861 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.5 m -66.43 110.36 4.7 Favored Pre-proline 0 CA--C 1.544 0.743 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 169.48 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_exo -72.82 -47.92 0.32 Allowed 'Trans proline' 0 C--N 1.349 0.585 0 CA-C-N 121.358 1.521 . . . . 0.0 113.155 -169.152 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 21.5 m80 -91.95 -30.16 16.26 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 123.725 0.81 . . . . 0.0 110.072 -169.879 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 19.9 mp0 -63.68 -28.18 69.72 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 125.926 1.69 . . . . 0.0 110.192 179.521 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 60.7 tp -60.4 -36.35 77.91 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 118.986 0.812 . . . . 0.0 111.092 172.826 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -65.61 -40.96 96.26 Favored Glycine 0 CA--C 1.529 0.954 0 N-CA-C 110.891 -0.884 . . . . 0.0 110.891 173.21 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.44 HD23 HD12 ' A' ' 48' ' ' LEU . 2.3 tm? -66.42 -35.17 79.64 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 118.157 0.979 . . . . 0.0 110.534 176.957 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -56.57 -44.39 80.95 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 119.827 1.194 . . . . 0.0 109.912 171.331 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -71.08 -23.59 62.15 Favored 'General case' 0 N--CA 1.457 -0.111 0 CA-C-O 118.599 -0.715 . . . . 0.0 112.443 176.737 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 91.2 t -65.45 -46.66 89.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 CA-C-N 120.223 1.374 . . . . 0.0 107.566 169.289 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 65.9 mt -61.68 -38.78 89.05 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 118.73 0.696 . . . . 0.0 110.058 -179.6 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 21.3 m -61.93 -42.58 99.27 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 118.654 0.661 . . . . 0.0 110.749 171.759 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.407 ' HA ' ' CD2' ' A' ' 106' ' ' PHE . . . -64.77 -39.36 93.48 Favored 'General case' 0 N--CA 1.449 -0.516 0 O-C-N 121.442 -0.786 . . . . 0.0 111.442 -179.582 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 17.4 mt -70.03 -31.85 69.69 Favored 'General case' 0 CA--C 1.521 -0.135 0 O-C-N 121.727 -0.608 . . . . 0.0 111.039 176.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 29.0 tpt180 -65.14 -37.09 86.32 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 118.56 -0.733 . . . . 0.0 109.645 171.213 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.407 ' CD2' ' HA ' ' A' ' 103' ' ' ALA . 12.9 m-30 -65.69 -42.64 90.97 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 119.403 1.002 . . . . 0.0 110.759 177.919 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 49.0 p -76.19 -22.01 55.8 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 118.875 0.761 . . . . 0.0 111.781 179.767 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 77.73 11.56 85.32 Favored Glycine 0 CA--C 1.533 1.19 0 CA-C-O 118.815 -0.992 . . . . 0.0 111.172 -169.785 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -97.08 23.95 6.8 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 119.104 1.452 . . . . 0.0 111.39 177.905 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 12.7 t80 -58.43 136.97 85.6 Favored Pre-proline 0 CA--C 1.546 0.791 0 C-N-CA 125.393 1.477 . . . . 0.0 109.319 172.57 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -56.92 136.72 78.26 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 122.724 2.283 . . . . 0.0 111.866 179.148 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -66.53 -24.34 66.36 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 111.827 0.306 . . . . 0.0 111.827 -173.482 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -135.53 95.34 3.24 Favored 'General case' 0 N--CA 1.464 0.225 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 169.465 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 38.4 tp -81.25 131.87 35.31 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 169.674 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -132.94 146.09 51.48 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 106.571 -1.64 . . . . 0.0 106.571 171.607 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.402 ' HB3' HG22 ' A' ' 82' ' ' VAL . 0.4 OUTLIER -131.81 124.27 29.29 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 120.043 1.292 . . . . 0.0 108.374 175.92 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 44.7 t -92.22 94.8 4.99 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 N-CA-C 105.683 -1.969 . . . . 0.0 105.683 169.8 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -84.99 156.18 30.87 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.201 -1.159 . . . . 0.0 110.201 175.256 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 58.1 t -137.44 143.69 33.53 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 174.555 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 18.1 mm -85.69 129.06 56.25 Favored Pre-proline 0 CA--C 1.541 0.621 0 CA-C-O 118.007 -0.997 . . . . 0.0 108.484 174.801 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -75.01 154.89 42.75 Favored 'Trans proline' 0 CA--C 1.536 0.611 0 C-N-CA 122.848 2.365 . . . . 0.0 112.389 177.114 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -100.36 -42.49 6.6 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 169.195 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 68.6 m -132.65 152.73 51.59 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 123.695 0.798 . . . . 0.0 110.652 175.879 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.5 tp -148.47 43.64 1.02 Allowed 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.567 0.747 . . . . 0.0 111.178 -172.751 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -121.57 170.4 7.62 Favored Pre-proline 0 N--CA 1.472 0.67 0 CA-C-O 118.105 -0.95 . . . . 0.0 109.352 -175.605 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -66.14 89.44 0.25 Allowed 'Trans proline' 0 CA--C 1.546 1.114 0 C-N-CA 123.199 2.599 . . . . 0.0 114.261 -174.459 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -166.25 128.74 1.93 Allowed 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 105.059 -2.2 . . . . 0.0 105.059 169.718 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.434 HG23 ' HA ' ' A' ' 12' ' ' LEU . 0.0 OUTLIER -79.91 154.06 4.58 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 C-N-CA 123.626 0.77 . . . . 0.0 109.78 -171.852 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 78.21 166.68 29.41 Favored Glycine 0 CA--C 1.527 0.823 0 N-CA-C 111.326 -0.71 . . . . 0.0 111.326 -179.686 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -82.64 165.18 20.24 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-O 121.937 0.875 . . . . 0.0 112.459 -169.345 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 40.7 p -70.48 168.67 17.8 Favored Pre-proline 0 C--O 1.239 0.544 0 CA-C-N 114.123 -1.399 . . . . 0.0 108.813 167.764 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -56.93 -32.97 94.25 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 121.348 1.365 . . . . 0.0 110.831 169.244 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 26.2 m -68.12 -41.38 81.82 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 119.213 -0.423 . . . . 0.0 111.47 -179.006 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 16.7 t -105.3 -10.4 9.89 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-N 118.951 0.796 . . . . 0.0 112.105 -169.235 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -58.95 -45.45 90.42 Favored 'General case' 0 N--CA 1.466 0.346 0 O-C-N 119.929 -1.732 . . . . 0.0 107.768 168.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -70.67 1.47 5.27 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 115.172 -0.922 . . . . 0.0 112.721 176.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 18.0 mmm -92.03 -8.95 44.53 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 119.587 1.085 . . . . 0.0 111.112 172.182 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 86.8 mt -59.64 -48.31 87.88 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 CA-C-N 119.404 1.002 . . . . 0.0 108.446 176.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -70.5 -50.69 13.83 Favored Pre-proline 0 CA--C 1.535 0.393 0 CA-C-O 117.266 -1.35 . . . . 0.0 113.655 -170.023 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -58.31 -32.73 96.68 Favored 'Trans proline' 0 N--CA 1.459 -0.53 0 CA-C-N 122.214 1.827 . . . . 0.0 112.092 173.255 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -69.95 -39.53 75.98 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 119.147 0.885 . . . . 0.0 110.749 176.621 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 71.3 mt -58.04 -44.72 87.55 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 119.897 1.226 . . . . 0.0 109.099 171.717 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -60.38 -37.22 80.08 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 118.87 -0.586 . . . . 0.0 110.918 -179.37 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 36.1 mm-40 -77.97 -33.1 51.65 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 119.758 1.163 . . . . 0.0 112.921 177.147 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 52.0 t -59.22 -48.67 86.11 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-N 120.107 1.322 . . . . 0.0 108.362 169.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 32.6 mt -64.44 -37.35 87.23 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.028 0.531 . . . . 0.0 110.203 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -62.81 -40.68 98.13 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 118.938 0.79 . . . . 0.0 111.313 177.328 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -62.85 -41.57 99.41 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 118.87 0.759 . . . . 0.0 110.689 177.832 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 4.9 mt -63.01 -39.0 93.44 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 123.081 0.553 . . . . 0.0 111.055 174.213 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 72.1 mtp85 -68.34 -14.35 62.93 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 117.081 -1.438 . . . . 0.0 112.27 177.672 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -58.77 -30.63 67.7 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 120.978 1.717 . . . . 0.0 111.402 178.516 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 18.3 m -118.4 34.05 5.36 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.568 0.747 . . . . 0.0 111.005 174.495 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 65.61 27.02 72.2 Favored Glycine 0 C--N 1.342 0.873 0 CA-C-O 118.561 -1.133 . . . . 0.0 114.215 171.043 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 24.4 t -87.59 83.05 2.15 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 176.545 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -76.88 117.88 18.92 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 176.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -81.04 157.67 25.36 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 123.264 0.626 . . . . 0.0 109.728 173.495 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 12.6 mm -109.97 128.08 25.99 Favored Pre-proline 0 CA--C 1.531 0.238 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 179.088 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -59.36 110.48 0.71 Allowed 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.168 1.912 . . . . 0.0 108.469 169.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 43.1 mtm105 53.65 13.0 0.44 Allowed 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.664 1.586 . . . . 0.0 114.272 174.882 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 2.6 m . . . . . 0 CA--C 1.543 0.698 0 C-N-CA 124.495 1.118 . . . . 0.0 110.636 -168.287 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 28.2 ptt-85 . . . . . 0 N--CA 1.475 0.787 0 CA-C-O 119.089 -0.482 . . . . 0.0 112.08 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 73.0 mt -133.11 144.61 35.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 C-N-CA 123.553 0.741 . . . . 0.0 109.956 -175.246 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 9.7 mt -123.29 145.88 48.34 Favored 'General case' 0 CA--C 1.521 -0.139 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 168.059 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 57.4 t -126.87 95.69 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.797 0 N-CA-C 105.629 -1.989 . . . . 0.0 105.629 172.192 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.6 mt -87.88 116.71 26.23 Favored 'General case' 0 CA--C 1.517 -0.303 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 -171.357 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -93.82 127.21 8.96 Favored Glycine 0 C--N 1.332 0.312 0 N-CA-C 106.141 -2.784 . . . . 0.0 106.141 169.651 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.2 m -142.71 164.61 16.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 117.92 0.86 . . . . 0.0 111.481 -169.159 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 123.0 173.45 14.08 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 126.014 1.769 . . . . 0.0 111.687 172.346 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -81.83 93.46 6.87 Favored 'General case' 0 N--CA 1.462 0.14 0 O-C-N 121.229 -1.16 . . . . 0.0 110.694 -176.312 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -59.13 5.5 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 N-CA-C 117.262 2.319 . . . . 0.0 117.262 -178.372 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 80.7 mt -108.67 -0.03 20.35 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 121.518 1.963 . . . . 0.0 109.135 -179.019 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.9 mp -110.27 62.77 0.6 Allowed 'General case' 0 N--CA 1.44 -0.948 0 C-N-CA 124.465 1.106 . . . . 0.0 110.122 -169.533 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.418 ' HB ' ' H ' ' A' ' 15' ' ' ASP . 0.2 OUTLIER 53.08 -103.89 0.18 Allowed 'General case' 0 CA--C 1.537 0.446 0 O-C-N 123.766 0.667 . . . . 0.0 111.064 175.166 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.418 ' H ' ' HB ' ' A' ' 14' ' ' THR . 81.9 m-20 -82.71 -8.39 59.6 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 118.513 -0.756 . . . . 0.0 112.462 -175.823 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -71.75 2.72 4.94 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-N 121.327 1.876 . . . . 0.0 113.015 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -85.01 -13.29 51.03 Favored 'General case' 0 N--CA 1.435 -1.189 0 CA-C-O 116.076 -1.916 . . . . 0.0 108.683 169.517 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 7.7 tp -50.88 -42.1 22.86 Favored 'Isoleucine or valine' 0 C--N 1.344 0.339 0 CA-C-N 121.671 2.032 . . . . 0.0 113.134 -169.349 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -61.81 -43.45 99.2 Favored Glycine 0 CA--C 1.527 0.834 0 CA-C-N 119.238 0.926 . . . . 0.0 111.995 177.816 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 55.6 t -65.38 -48.07 84.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-O 118.649 -0.691 . . . . 0.0 109.855 172.041 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 28.7 mmm180 -57.69 -37.39 73.38 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 120.231 1.378 . . . . 0.0 111.719 -178.403 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 27.0 mt -63.48 -45.54 97.59 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 CA-C-N 119.987 1.267 . . . . 0.0 110.195 -179.561 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.9 m -74.29 -27.09 21.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-N 119.985 1.266 . . . . 0.0 111.743 -176.369 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 19.5 mm-40 -70.41 -41.61 72.73 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 173.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.04 -38.37 90.65 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-O 119.025 -0.512 . . . . 0.0 110.045 177.317 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.8 tp -62.11 -42.98 99.77 Favored 'General case' 0 C--N 1.343 0.313 0 CA-C-O 118.131 -0.938 . . . . 0.0 109.727 175.825 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -60.5 -43.74 96.74 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 119.266 0.939 . . . . 0.0 110.678 178.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -66.53 -42.34 87.4 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.017 0.527 . . . . 0.0 110.91 179.541 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 87.1 mtt180 -88.84 -36.63 15.91 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 117.393 -1.289 . . . . 0.0 113.458 -170.207 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 72.3 m-85 -125.77 133.29 52.1 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-N 121.076 1.762 . . . . 0.0 112.607 -169.819 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 45.7 mm -85.66 129.81 37.38 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 N-CA-C 104.213 -2.514 . . . . 0.0 104.213 168.088 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -119.22 157.58 50.7 Favored Pre-proline 0 CA--C 1.537 0.444 0 C-N-CA 124.883 1.273 . . . . 0.0 108.902 -179.107 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_exo -57.97 155.46 33.35 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 123.259 2.639 . . . . 0.0 112.064 172.697 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -62.23 -28.21 69.53 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 112.937 0.717 . . . . 0.0 112.937 -170.567 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 8.3 p90 -73.98 -6.35 46.88 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 113.097 0.777 . . . . 0.0 113.097 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 38.2 t -102.96 133.51 46.56 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 174.797 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -132.45 136.34 46.65 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 169.579 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -88.67 101.55 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.035 0 N-CA-C 105.107 -2.182 . . . . 0.0 105.107 169.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.5 tt -85.57 112.44 20.95 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 106.784 -1.562 . . . . 0.0 106.784 -178.888 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -77.78 106.42 9.6 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 169.821 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -69.92 -80.62 0.27 Allowed Glycine 0 CA--C 1.528 0.875 0 N-CA-C 108.231 -1.948 . . . . 0.0 108.231 171.742 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 77.21 107.61 0.15 Allowed Glycine 0 C--N 1.341 0.848 0 N-CA-C 110.165 -1.174 . . . . 0.0 110.165 -178.436 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 5.2 p 52.39 57.98 5.87 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.416 1.086 . . . . 0.0 109.333 175.602 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -113.14 -88.31 0.55 Allowed 'General case' 0 C--N 1.345 0.411 0 CA-C-N 114.685 -1.143 . . . . 0.0 110.735 -169.449 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 75.09 -93.1 0.85 Allowed Glycine 0 C--N 1.34 0.778 0 N-CA-C 107.596 -2.202 . . . . 0.0 107.596 -169.596 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.68 -23.27 60.86 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.585 1.154 . . . . 0.0 113.498 -173.838 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -67.66 -7.24 25.14 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -169.869 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 26.0 mt -93.76 -12.91 28.09 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 115.475 1.657 . . . . 0.0 115.475 -168.151 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 5.1 tt -45.31 -61.03 1.83 Allowed 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 113.941 1.089 . . . . 0.0 113.941 -169.305 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -70.21 -35.42 70.25 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 111.255 -0.738 . . . . 0.0 111.255 -170.091 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -77.54 -29.84 52.49 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 118.068 0.934 . . . . 0.0 110.271 -175.619 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 69.6 mtp -67.34 -16.63 64.36 Favored 'General case' 0 N--CA 1.454 -0.254 0 O-C-N 121.822 -0.549 . . . . 0.0 111.683 175.13 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -63.14 140.97 58.93 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-O 121.926 0.87 . . . . 0.0 112.873 -169.663 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 53.53 20.39 2.07 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 117.261 2.319 . . . . 0.0 117.261 168.729 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 23.5 mmt180 -71.55 150.36 44.84 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 121.003 1.729 . . . . 0.0 108.5 176.267 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -79.96 -29.26 39.6 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 121.677 -0.639 . . . . 0.0 109.37 -178.851 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -147.81 137.25 22.42 Favored 'General case' 0 C--O 1.232 0.161 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 167.372 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.8 tp -126.59 130.73 51.07 Favored 'General case' 0 CA--C 1.515 -0.374 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 175.652 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 50.0 mt -105.66 120.1 55.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 105.803 -1.925 . . . . 0.0 105.803 173.004 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 7.9 mt -95.98 128.94 46.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 105.15 -2.167 . . . . 0.0 105.15 175.632 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -113.19 113.5 25.43 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 105.297 -2.112 . . . . 0.0 105.297 169.767 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.5 t0 -147.78 157.85 43.74 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.422 0.689 . . . . 0.0 110.217 -174.043 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -75.41 158.06 33.25 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 168.95 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.461 HD11 ' HA3' ' A' ' 118' ' ' GLY . 27.2 mm -95.4 -85.13 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.639 179.493 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . 0.385 0.3 OUTLIER 55.47 11.56 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 126.388 1.875 . . . . 0.0 114.549 -169.471 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.457 ' H ' HG22 ' A' ' 64' ' ' ILE . 5.3 m -74.07 -23.61 59.39 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 124.469 1.108 . . . . 0.0 113.684 -178.373 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 34.1 ttpt -150.23 161.16 42.96 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.149 0.98 . . . . 0.0 108.781 -171.872 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 14.5 ptpt -65.55 4.49 0.55 Allowed 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 127.347 2.259 . . . . 0.0 115.177 176.676 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 54.1 t30 -62.9 155.22 27.82 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 119.114 0.87 . . . . 0.0 109.539 -177.344 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 4.3 m -56.05 137.67 73.23 Favored Pre-proline 0 CA--C 1.545 0.762 0 C-N-CA 124.34 1.056 . . . . 0.0 113.532 -169.312 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -58.28 155.54 34.6 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 123.668 2.912 . . . . 0.0 111.708 169.389 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 64.88 24.76 70.23 Favored Glycine 0 CA--C 1.533 1.214 0 O-C-N 121.852 -0.53 . . . . 0.0 112.684 176.232 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 20.0 m -102.58 137.11 41.25 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 125.816 1.646 . . . . 0.0 106.706 173.815 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 28.3 ttp -91.8 136.74 32.92 Favored 'General case' 0 C--O 1.232 0.159 0 N-CA-C 107.629 -1.248 . . . . 0.0 107.629 175.079 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 6.4 ttm -124.95 87.01 2.64 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 -169.856 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 40.4 mm -83.13 117.64 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 57.1 mt -128.55 141.28 51.42 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 123.197 0.599 . . . . 0.0 109.544 -174.703 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.8 mtt85 -113.88 138.67 50.0 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 123.329 0.652 . . . . 0.0 109.873 -172.242 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 38.2 t70 38.91 -106.69 0.05 Allowed 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.833 1.253 . . . . 0.0 113.867 169.478 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -56.8 -29.82 63.1 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.071 1.349 . . . . 0.0 113.923 -175.796 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -71.25 -25.55 62.52 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 122.881 0.472 . . . . 0.0 110.238 -176.111 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.458 HG22 ' HB3' ' A' ' 116' ' ' LEU . 84.7 t -70.8 -61.92 2.22 Favored Pre-proline 0 N--CA 1.443 -0.812 0 CA-C-O 117.548 -1.215 . . . . 0.0 111.368 -168.949 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -65.55 -35.57 37.74 Favored 'Trans proline' 0 N--CA 1.452 -0.957 0 CA-C-N 121.384 1.53 . . . . 0.0 111.155 -178.683 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.1 -36.22 79.42 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 122.572 0.349 . . . . 0.0 110.634 -173.743 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -71.91 -44.05 64.31 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 118.867 -0.587 . . . . 0.0 109.698 169.843 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -55.71 -21.37 18.2 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 -174.369 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.447 HG23 ' H ' ' A' ' 88' ' ' ASN . 1.7 t -83.95 -76.34 0.3 Allowed 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 119.315 0.961 . . . . 0.0 109.895 168.664 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ASN . . . . . 0.447 ' H ' HG23 ' A' ' 87' ' ' THR . 46.6 t30 49.45 17.49 0.22 Allowed 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.042 1.337 . . . . 0.0 114.082 -168.794 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt 50.4 23.92 1.4 Allowed 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.433 1.493 . . . . 0.0 113.421 -171.454 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 42.9 mt -134.67 -42.99 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 123.879 0.871 . . . . 0.0 110.96 -171.126 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.3 m -64.2 147.05 97.3 Favored Pre-proline 0 CA--C 1.545 0.765 0 CA-C-N 118.893 0.769 . . . . 0.0 112.52 -169.565 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -79.97 -110.33 0.01 OUTLIER 'Trans proline' 0 CA--C 1.54 0.823 0 C-N-CA 124.218 3.279 . . . . 0.0 109.979 175.088 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 11.7 m80 -59.13 -28.35 66.47 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.773 1.229 . . . . 0.0 112.675 -169.774 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 22.3 mp0 -57.57 -31.63 66.34 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 126.003 1.721 . . . . 0.0 111.208 175.57 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 65.9 tp -62.2 -33.86 75.35 Favored 'General case' 0 C--N 1.342 0.253 0 CA-C-N 119.123 0.874 . . . . 0.0 110.54 175.92 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -64.14 -39.41 97.11 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.616 -0.993 . . . . 0.0 110.616 175.46 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 19.0 tp -72.88 -33.88 66.34 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 118.332 1.066 . . . . 0.0 110.439 176.022 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -58.09 -46.85 84.81 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 119.752 1.16 . . . . 0.0 109.95 170.354 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -69.49 -29.25 66.86 Favored 'General case' 0 CA--C 1.522 -0.126 0 C-N-CA 122.618 0.367 . . . . 0.0 111.527 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 10.9 t -64.29 -44.19 97.28 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.785 0 CA-C-O 118.882 -0.58 . . . . 0.0 110.098 170.093 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 52.1 mt -63.07 -39.05 93.56 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 119.274 0.943 . . . . 0.0 110.036 178.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 23.8 m -61.05 -39.49 90.01 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 118.753 0.706 . . . . 0.0 110.19 169.896 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.517 ' HA ' ' CD2' ' A' ' 106' ' ' PHE . . . -67.44 -38.62 84.8 Favored 'General case' 0 N--CA 1.448 -0.545 0 O-C-N 121.308 -0.87 . . . . 0.0 111.793 -179.048 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -59.47 -41.75 90.45 Favored 'General case' 0 CA--C 1.524 -0.03 0 CA-C-N 118.835 0.743 . . . . 0.0 109.331 172.481 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 78.3 ttt180 -65.18 -36.2 83.45 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 118.229 -0.891 . . . . 0.0 110.852 177.755 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.517 ' CD2' ' HA ' ' A' ' 103' ' ' ALA . 15.1 m-30 -61.21 -45.46 94.47 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 119.506 1.048 . . . . 0.0 110.593 178.597 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 14.9 t -82.51 -13.58 56.42 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 122.298 0.239 . . . . 0.0 111.438 -178.5 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 78.08 27.93 57.22 Favored Glycine 0 CA--C 1.531 1.059 0 N-CA-C 111.623 -0.591 . . . . 0.0 111.623 179.564 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -110.98 19.36 18.57 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.628 1.171 . . . . 0.0 110.833 -176.833 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -59.99 137.11 90.83 Favored Pre-proline 0 CA--C 1.544 0.712 0 C-N-CA 123.952 0.901 . . . . 0.0 109.857 -178.914 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_exo -51.74 144.98 32.55 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 123.069 2.513 . . . . 0.0 112.96 176.392 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -63.77 -30.71 71.78 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 119.252 -0.404 . . . . 0.0 110.47 -178.587 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 30.5 mtmm -136.37 138.3 41.45 Favored 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 105.99 -1.856 . . . . 0.0 105.99 169.57 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 13.9 tp -120.14 134.06 55.35 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 171.007 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -133.41 139.28 46.66 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 177.864 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.458 ' HB3' HG22 ' A' ' 82' ' ' VAL . 6.2 tp -125.68 128.62 48.09 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 177.229 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 46.4 t -100.18 85.35 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 N-CA-C 104.092 -2.558 . . . . 0.0 104.092 169.214 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' GLY . . . . . 0.461 ' HA3' HD11 ' A' ' 64' ' ' ILE . . . -76.86 147.43 33.6 Favored Glycine 0 C--N 1.332 0.327 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 177.02 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 85.2 t -130.58 138.2 54.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 170.489 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 2.8 mt -92.44 125.05 57.49 Favored Pre-proline 0 CA--C 1.537 0.447 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -178.9 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -72.96 158.1 50.28 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 123.835 3.023 . . . . 0.0 112.424 -176.755 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -99.78 -41.64 7.18 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 171.877 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 70.5 m -129.78 149.51 51.49 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 123.487 0.715 . . . . 0.0 110.886 178.178 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -155.59 42.79 0.43 Allowed 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 112.951 0.723 . . . . 0.0 112.951 -169.875 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 81.7 mm-40 -111.19 164.2 15.52 Favored Pre-proline 0 N--CA 1.474 0.726 0 CA-C-O 117.607 -1.187 . . . . 0.0 108.737 179.628 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -68.25 87.21 0.4 Allowed 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 122.951 2.434 . . . . 0.0 111.919 -179.331 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -172.7 153.65 2.81 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 104.489 -2.412 . . . . 0.0 104.489 175.47 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -126.34 153.31 34.71 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 CA-C-O 121.956 0.884 . . . . 0.0 112.376 -170.06 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 121.73 127.68 3.4 Favored Glycine 0 CA--C 1.529 0.939 0 N-CA-C 105.497 -3.041 . . . . 0.0 105.497 -169.305 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 7.0 mp -79.63 151.73 30.4 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 117.67 0.735 . . . . 0.0 109.657 -177.844 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 62.0 p -69.76 159.07 85.4 Favored Pre-proline 0 C--O 1.237 0.401 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.565 173.286 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -62.01 -28.9 80.95 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 120.827 1.018 . . . . 0.0 110.014 169.41 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 24.7 m -63.53 -42.31 98.45 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 118.73 -0.652 . . . . 0.0 111.485 177.381 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 46.8 t -105.29 -26.61 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-O 118.072 -0.966 . . . . 0.0 112.896 -169.268 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -52.89 -42.12 65.01 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 120.754 1.615 . . . . 0.0 110.194 169.646 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -74.43 2.75 8.76 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 113.696 0.999 . . . . 0.0 113.696 -176.134 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 97.7 mmm -87.84 -10.3 51.23 Favored 'General case' 0 N--CA 1.439 -0.996 0 CA-C-O 117.435 -1.269 . . . . 0.0 110.152 169.678 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 93.6 mt -60.43 -46.18 95.63 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.406 0 CA-C-N 120.955 1.707 . . . . 0.0 109.022 -178.362 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -71.29 -49.99 11.58 Favored Pre-proline 0 CA--C 1.543 0.71 0 CA-C-N 120.239 1.382 . . . . 0.0 110.959 -179.13 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -41.37 -50.33 4.58 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 125.056 3.837 . . . . 0.0 112.732 168.802 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -73.11 -44.05 60.86 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 114.022 -1.445 . . . . 0.0 110.778 -175.658 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 34.3 mt -56.01 -41.45 74.9 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-N 118.833 0.742 . . . . 0.0 109.536 175.171 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -62.13 -35.91 80.17 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 118.853 0.752 . . . . 0.0 110.456 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 19.2 mm100 -78.7 -32.28 46.89 Favored 'General case' 0 N--CA 1.456 -0.127 0 CA-C-O 118.248 -0.882 . . . . 0.0 112.816 175.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 76.3 t -60.21 -47.56 91.63 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-N 119.976 1.262 . . . . 0.0 108.061 170.167 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 26.6 mt -65.14 -41.02 95.17 Favored 'General case' 0 CA--C 1.528 0.122 0 C-N-CA 122.99 0.516 . . . . 0.0 110.92 -179.377 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -63.19 -43.59 97.77 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 118.527 0.603 . . . . 0.0 111.163 177.311 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -64.7 -44.6 89.74 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 122.656 0.383 . . . . 0.0 110.061 179.379 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 38.9 mt -55.09 -45.2 75.42 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 174.714 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 73.7 mtp180 -64.97 -18.97 65.73 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 117.711 -1.138 . . . . 0.0 112.965 -177.715 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -62.15 -32.48 73.09 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 120.767 1.621 . . . . 0.0 110.957 178.703 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 22.5 m -97.1 28.59 3.5 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.905 0.882 . . . . 0.0 111.458 176.498 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 70.49 16.64 73.91 Favored Glycine 0 CA--C 1.533 1.185 0 CA-C-O 119.093 -0.837 . . . . 0.0 113.969 173.065 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 39.3 t -79.39 126.01 38.88 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 CA-C-N 118.746 1.273 . . . . 0.0 108.276 -177.322 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -96.27 128.69 43.42 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 169.768 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -97.14 147.47 24.03 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 169.683 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 2.7 mt -115.41 120.66 36.01 Favored Pre-proline 0 N--CA 1.462 0.153 0 N-CA-C 106.636 -1.616 . . . . 0.0 106.636 178.655 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -61.66 108.03 0.58 Allowed 'Trans proline' 0 N--CA 1.46 -0.472 0 C-N-CA 121.979 1.786 . . . . 0.0 107.625 172.157 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 14.2 ptp180 47.47 7.31 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 129.26 3.024 . . . . 0.0 117.785 -177.848 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 2.9 t . . . . . 0 CA--C 1.544 0.747 0 C-N-CA 126.114 1.765 . . . . 0.0 112.405 -169.976 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 5.5 ptp85 . . . . . 0 N--CA 1.477 0.918 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 55.1 mt -141.67 145.01 24.98 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 CA-C-N 119.46 1.027 . . . . 0.0 112.037 -169.058 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.1 mt -128.17 123.42 34.3 Favored 'General case' 0 CA--C 1.519 -0.216 0 N-CA-C 106.489 -1.671 . . . . 0.0 106.489 167.577 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 43.6 t -101.85 98.71 7.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 100.69 -3.819 . . . . 0.0 100.69 169.153 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -104.24 109.24 20.98 Favored 'General case' 0 N--CA 1.442 -0.864 0 C-N-CA 123.873 0.869 . . . . 0.0 109.35 -168.152 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -91.42 126.3 8.39 Favored Glycine 0 N--CA 1.444 -0.831 0 N-CA-C 107.743 -2.143 . . . . 0.0 107.743 174.858 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -142.38 179.73 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.812 0 C-N-CA 124.133 0.973 . . . . 0.0 108.517 -175.011 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 124.5 157.04 9.61 Favored Glycine 0 N--CA 1.447 -0.589 0 N-CA-C 108.471 -1.852 . . . . 0.0 108.471 -169.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -73.6 96.96 2.54 Favored 'General case' 0 N--CA 1.442 -0.85 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 169.898 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 4.2 pt -56.7 -30.62 32.82 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.241 0 O-C-N 121.438 -0.789 . . . . 0.0 112.068 -179.664 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 22.2 mt -77.55 13.93 1.14 Allowed 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 119.036 0.834 . . . . 0.0 110.902 -172.15 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -136.41 82.07 1.92 Allowed 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 123.284 0.634 . . . . 0.0 111.494 171.962 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.427 HG23 ' O ' ' A' ' 129' ' ' GLY . 25.6 m 35.41 -105.94 0.03 OUTLIER 'General case' 0 N--CA 1.437 -1.121 0 O-C-N 126.46 2.35 . . . . 0.0 111.772 167.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -59.46 -28.02 66.61 Favored 'General case' 0 N--CA 1.442 -0.842 0 C-N-CA 124.201 1.0 . . . . 0.0 111.961 -169.683 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -67.09 -18.05 65.15 Favored 'General case' 0 C--N 1.341 0.212 0 CA-C-N 120.423 1.465 . . . . 0.0 111.786 179.088 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.58 -10.56 56.66 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-O 116.33 -1.795 . . . . 0.0 110.888 173.739 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 6.6 tp -55.6 -39.94 57.07 Favored 'Isoleucine or valine' 0 C--N 1.342 0.243 0 CA-C-N 121.976 2.171 . . . . 0.0 111.814 -174.483 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -59.17 -43.52 97.07 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 111.4 -0.68 . . . . 0.0 111.4 178.719 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 74.0 t -68.76 -48.32 71.74 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 CA-C-O 118.134 -0.936 . . . . 0.0 109.874 174.622 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 20.9 mmt180 -60.14 -31.56 70.21 Favored 'General case' 0 C--N 1.346 0.431 0 CA-C-N 120.498 1.499 . . . . 0.0 111.787 -177.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 23.2 mt -60.68 -51.35 74.11 Favored 'Isoleucine or valine' 0 C--N 1.343 0.285 0 CA-C-N 120.86 1.663 . . . . 0.0 109.789 174.604 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 24.6 m -72.38 -33.97 47.38 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 CA-C-N 119.461 1.028 . . . . 0.0 111.221 -174.408 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 58.1 mt-10 -59.88 -48.29 82.3 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 171.511 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.56 -36.8 84.83 Favored 'General case' 0 C--N 1.342 0.263 0 CA-C-N 119.151 0.887 . . . . 0.0 111.08 179.79 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 5.9 tp -63.19 -40.04 96.36 Favored 'General case' 0 C--O 1.224 -0.253 0 CA-C-N 118.471 0.578 . . . . 0.0 109.566 -178.231 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -60.52 -26.5 66.9 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.595 0.758 . . . . 0.0 112.771 179.377 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -90.67 -44.35 9.56 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 125.495 1.518 . . . . 0.0 110.886 -178.603 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 75.4 mtt180 -84.45 -26.61 28.1 Favored 'General case' 0 C--O 1.231 0.086 0 CA-C-O 118.792 -0.623 . . . . 0.0 111.529 -172.924 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 64.4 m-85 -125.97 146.21 49.96 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-O 121.694 0.759 . . . . 0.0 112.364 -177.318 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 34.0 mm -101.7 135.66 37.3 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 N-CA-C 104.909 -2.256 . . . . 0.0 104.909 169.028 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -119.0 150.93 49.66 Favored Pre-proline 0 CA--C 1.535 0.371 0 C-N-CA 124.287 1.035 . . . . 0.0 109.988 -169.492 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -65.76 157.16 60.31 Favored 'Trans proline' 0 CA--C 1.539 0.748 0 C-N-CA 122.43 2.087 . . . . 0.0 110.189 169.795 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -58.08 -33.2 68.81 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 114.557 1.317 . . . . 0.0 114.557 -169.545 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -74.72 -11.45 60.17 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -177.437 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 73.1 t -90.02 123.01 42.01 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 171.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -112.36 127.01 55.89 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 169.234 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -91.77 116.07 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 N-CA-C 104.422 -2.436 . . . . 0.0 104.422 168.294 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 59.6 tp -117.57 128.25 54.76 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 118.207 0.458 . . . . 0.0 110.675 -178.431 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -87.73 117.25 26.43 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 168.5 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -71.59 -65.31 2.45 Favored Glycine 0 CA--C 1.528 0.871 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 176.292 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 84.33 84.61 0.94 Allowed Glycine 0 C--N 1.343 0.937 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 177.137 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 27.6 p 61.38 20.11 10.82 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 125.118 1.367 . . . . 0.0 113.471 -179.449 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -76.73 -65.78 0.9 Allowed 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 114.875 1.435 . . . . 0.0 114.875 -168.458 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 56.78 -108.61 1.28 Allowed Glycine 0 CA--C 1.536 1.349 0 N-CA-C 111.416 -0.674 . . . . 0.0 111.416 -176.167 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 13.2 tpt -59.67 -23.58 63.2 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.968 1.307 . . . . 0.0 112.43 -178.239 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 21.3 mm-40 -60.33 -18.79 52.29 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 113.539 0.941 . . . . 0.0 113.539 -178.903 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 13.3 mt -99.52 22.25 11.05 Favored 'General case' 0 C--N 1.344 0.35 0 N-CA-C 114.728 1.381 . . . . 0.0 114.728 -168.91 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 6.7 tt -52.19 -58.17 7.43 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 118.856 0.753 . . . . 0.0 111.15 -178.465 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -68.76 -33.24 75.28 Favored Glycine 0 CA--C 1.529 0.959 0 N-CA-C 111.338 -0.705 . . . . 0.0 111.338 -178.252 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -74.73 -38.53 62.26 Favored 'General case' 0 CA--C 1.533 0.299 0 O-C-N 122.081 -0.658 . . . . 0.0 112.058 -173.113 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 12.9 mtp -76.65 -17.76 58.96 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.568 0.747 . . . . 0.0 111.553 -179.037 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.64 151.97 45.27 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 123.533 0.733 . . . . 0.0 112.433 -169.512 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 16.7 p30 50.23 13.93 0.13 Allowed 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 128.379 2.671 . . . . 0.0 117.507 169.032 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 35.8 mmt-85 -70.31 157.24 38.09 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 119.499 1.045 . . . . 0.0 108.474 171.306 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.01 -46.34 18.37 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 178.754 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -128.26 149.27 50.55 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-N 120.116 1.325 . . . . 0.0 108.66 169.125 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 16.1 tp -135.46 112.38 10.24 Favored 'General case' 0 CA--C 1.506 -0.719 0 N-CA-C 103.723 -2.695 . . . . 0.0 103.723 177.245 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 46.6 mt -91.94 110.1 22.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 104.811 -2.292 . . . . 0.0 104.811 172.872 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.5 HD13 HD11 ' A' ' 97' ' ' LEU . 7.3 mt -81.79 135.22 25.43 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 N-CA-C 107.0 -1.482 . . . . 0.0 107.0 170.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -122.66 118.24 27.67 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 102.733 -3.062 . . . . 0.0 102.733 167.417 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 51.5 t0 -158.51 155.75 29.0 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 125.149 1.38 . . . . 0.0 107.399 -179.156 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -88.45 143.09 27.2 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 169.694 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 65.2 mt -80.41 -19.66 11.91 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 C-N-CA 125.016 1.326 . . . . 0.0 110.307 -177.76 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . 0.317 31.3 t 71.29 -38.38 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 C-N-CA 129.818 3.247 . . . . 0.0 114.543 177.713 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 2.7 p -162.42 147.96 12.63 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 120.021 1.282 . . . . 0.0 112.568 169.902 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 13.8 tppt? -165.51 174.32 10.06 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 128.252 2.621 . . . . 0.0 104.872 169.325 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 13.2 ptpt -61.24 -26.18 67.58 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 176.226 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 36.0 t-20 -74.99 165.73 24.79 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.475 0.71 . . . . 0.0 110.522 -173.313 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 2.4 m -61.27 151.23 77.02 Favored Pre-proline 0 CA--C 1.548 0.876 0 C-N-CA 124.588 1.155 . . . . 0.0 112.704 -169.929 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -56.94 158.13 18.14 Favored 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 124.21 3.273 . . . . 0.0 113.556 170.314 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 65.83 7.7 37.24 Favored Glycine 0 CA--C 1.538 1.485 0 CA-C-O 119.59 -0.561 . . . . 0.0 114.272 170.492 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 5.0 m -87.31 149.92 24.21 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 125.769 1.627 . . . . 0.0 111.513 -169.181 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 31.0 ttp -93.63 140.93 29.05 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 169.879 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 56.5 mtm -134.88 125.38 26.64 Favored 'General case' 0 C--O 1.232 0.165 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 169.798 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 37.6 mm -107.44 123.12 62.51 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 -176.919 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.9 mp -128.74 143.33 50.9 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.875 -171.53 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 79.4 mtm180 -91.65 175.82 6.76 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 114.867 -1.06 . . . . 0.0 110.431 -175.866 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -41.07 -53.61 3.0 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 115.861 1.8 . . . . 0.0 115.861 -169.527 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -87.78 -14.83 38.6 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 113.199 0.815 . . . . 0.0 113.199 -175.68 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -78.98 -35.4 43.08 Favored 'General case' 0 N--CA 1.456 -0.128 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 -174.538 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 94.5 t -60.79 -49.34 89.92 Favored Pre-proline 0 CA--C 1.541 0.618 0 CA-C-O 117.397 -1.287 . . . . 0.0 112.267 -176.081 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_exo -55.41 -39.91 88.46 Favored 'Trans proline' 0 CA--C 1.543 0.943 0 C-N-CA 122.091 1.861 . . . . 0.0 112.146 174.353 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -76.05 -5.37 46.14 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 177.021 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -87.65 -41.4 13.41 Favored 'General case' 0 C--N 1.341 0.213 0 CA-C-N 119.751 1.159 . . . . 0.0 111.34 -178.739 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -80.22 22.98 0.5 Allowed 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -169.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 24.5 p -58.65 -26.25 63.57 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.237 1.015 . . . . 0.0 111.964 175.814 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 36.3 t30 -68.32 115.84 8.21 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.142 0.577 . . . . 0.0 109.652 176.062 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 39.3 mttp -88.81 -6.23 57.51 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 113.051 0.76 . . . . 0.0 113.051 -177.85 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 97.4 mt -58.45 -48.01 86.5 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 177.133 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 3.9 m -67.21 107.61 1.86 Allowed Pre-proline 0 CA--C 1.542 0.669 0 C-N-CA 127.181 2.192 . . . . 0.0 109.397 -173.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -72.47 -56.65 0.09 OUTLIER 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 122.392 2.061 . . . . 0.0 113.015 -168.567 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 7.2 t-80 -59.88 -43.85 94.53 Favored 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.409 ' H ' ' CD ' ' A' ' 94' ' ' GLN . 16.9 mp0 -61.29 -39.61 91.09 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 125.587 1.555 . . . . 0.0 108.934 -174.255 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 55.2 tp -64.49 -37.49 87.71 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 118.93 0.786 . . . . 0.0 110.704 175.594 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -65.38 -46.68 85.13 Favored Glycine 0 CA--C 1.529 0.916 0 N-CA-C 110.986 -0.846 . . . . 0.0 110.986 174.499 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.5 HD11 HD13 ' A' ' 60' ' ' ILE . 2.9 tm? -58.14 -38.6 76.88 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 117.711 0.755 . . . . 0.0 110.115 173.999 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -66.06 -45.41 81.43 Favored 'General case' 0 C--N 1.333 -0.142 0 O-C-N 120.838 -1.164 . . . . 0.0 111.254 177.165 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -69.51 -24.75 63.8 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 118.512 0.596 . . . . 0.0 110.574 -179.477 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -73.91 -37.88 48.8 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.863 0 O-C-N 121.873 -0.517 . . . . 0.0 110.92 172.0 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 29.6 mt -66.1 -36.32 82.86 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 173.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 46.3 m -65.21 -36.38 83.99 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-O 118.344 -0.836 . . . . 0.0 110.319 171.649 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.97 -41.53 97.51 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 120.476 1.489 . . . . 0.0 110.686 174.252 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 11.8 mt -64.24 -32.18 73.66 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 118.79 0.723 . . . . 0.0 111.499 173.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 67.1 ttp85 -71.62 -30.74 66.12 Favored 'General case' 0 CA--C 1.532 0.284 0 O-C-N 121.581 -0.699 . . . . 0.0 109.613 176.568 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 14.8 m-30 -72.09 -46.32 57.22 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 118.877 0.762 . . . . 0.0 110.368 176.889 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 35.2 p -73.35 -24.14 60.31 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 118.338 0.517 . . . . 0.0 112.009 -177.851 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 75.93 8.03 84.46 Favored Glycine 0 CA--C 1.534 1.268 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -168.391 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -84.84 23.25 1.21 Allowed 'General case' 0 C--N 1.349 0.558 0 CA-C-N 119.812 1.806 . . . . 0.0 111.28 171.799 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -62.18 138.56 96.05 Favored Pre-proline 0 CA--C 1.547 0.844 0 C-N-CA 124.328 1.051 . . . . 0.0 108.933 169.826 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -61.42 161.53 23.55 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 123.13 2.553 . . . . 0.0 114.683 -176.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -66.21 -35.87 81.57 Favored 'General case' 0 N--CA 1.471 0.58 0 O-C-N 121.803 -0.561 . . . . 0.0 111.664 174.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 17.9 ttmm -138.53 77.59 1.63 Allowed 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 -176.848 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -69.79 129.18 38.87 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 106.471 -1.678 . . . . 0.0 106.471 170.132 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -130.41 138.89 50.57 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 175.521 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 17.4 tp -119.78 130.09 54.78 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 119.556 1.071 . . . . 0.0 109.115 176.879 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 13.3 t -102.59 74.88 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 105.44 -2.059 . . . . 0.0 105.44 169.835 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -78.55 144.74 28.31 Favored Glycine 0 C--N 1.336 0.539 0 N-CA-C 110.547 -1.021 . . . . 0.0 110.547 -174.369 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 61.5 t -124.57 134.77 65.88 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.275 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 -178.464 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 40.1 mt -91.01 135.37 28.68 Favored Pre-proline 0 C--N 1.326 -0.449 0 N-CA-C 104.976 -2.231 . . . . 0.0 104.976 169.387 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -73.28 170.26 20.3 Favored 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 122.008 1.805 . . . . 0.0 111.202 -177.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -89.71 -48.87 6.98 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 168.765 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 25.1 m -137.31 -34.23 0.72 Allowed 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 116.205 1.928 . . . . 0.0 116.205 -170.002 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 4.3 tp 50.76 50.1 19.65 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.362 1.465 . . . . 0.0 110.495 -168.564 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -58.84 151.25 55.14 Favored Pre-proline 0 CA--C 1.54 0.577 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 173.152 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -76.37 76.39 3.94 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 122.427 2.085 . . . . 0.0 108.055 169.833 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' HIS . . . . . 0.607 ' CD2' ' H ' ' A' ' 128' ' ' ILE . 7.4 t60 -151.47 -167.79 2.9 Favored 'General case' 0 CA--C 1.552 1.028 0 N-CA-C 104.113 -2.551 . . . . 0.0 104.113 175.139 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.607 ' H ' ' CD2' ' A' ' 127' ' ' HIS . 17.5 mt -125.45 -50.2 1.88 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 CA-C-N 123.688 2.949 . . . . 0.0 110.646 -171.145 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.427 ' O ' HG23 ' A' ' 14' ' ' THR . . . -55.73 148.63 26.69 Favored Glycine 0 CA--C 1.53 0.993 0 N-CA-C 111.223 -0.751 . . . . 0.0 111.223 170.817 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 76.3 mt -70.2 162.64 28.01 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.11 0.964 . . . . 0.0 112.906 -175.611 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 18.3 p -74.11 164.35 61.83 Favored Pre-proline 0 CA--C 1.543 0.68 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 168.584 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -62.29 -35.42 73.77 Favored 'Trans proline' 0 CA--C 1.536 0.625 0 C-N-CA 121.259 1.306 . . . . 0.0 112.133 177.037 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 90.7 m -69.16 -37.02 77.99 Favored 'General case' 0 N--CA 1.443 -0.814 0 O-C-N 121.553 -0.717 . . . . 0.0 110.079 -178.869 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 75.0 t -85.07 -32.16 7.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 O-C-N 121.583 -0.698 . . . . 0.0 109.985 -177.055 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -54.22 -46.87 72.62 Favored 'General case' 0 CA--C 1.535 0.386 0 O-C-N 121.273 -0.892 . . . . 0.0 109.512 169.094 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -68.07 -16.51 64.05 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 -179.795 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 8.9 mmm -79.25 -11.58 59.95 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 125.57 1.548 . . . . 0.0 112.678 173.351 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 68.2 mt -55.22 -56.37 11.76 Favored 'Isoleucine or valine' 0 C--N 1.346 0.451 0 CA-C-N 120.902 1.683 . . . . 0.0 109.287 174.341 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -66.42 -46.28 59.42 Favored Pre-proline 0 CA--C 1.548 0.901 0 CA-C-N 119.629 1.104 . . . . 0.0 110.728 -172.37 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 0.3 OUTLIER -44.11 -52.09 5.99 Favored 'Trans proline' 0 C--N 1.352 0.732 1 C-N-CA 125.606 4.204 . . . . 0.0 112.881 168.665 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -72.75 -35.73 67.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 118.329 -0.843 . . . . 0.0 112.616 -178.929 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 39.7 mt -60.55 -45.97 91.91 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 120.23 1.377 . . . . 0.0 109.384 174.739 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 31.8 mm-40 -54.37 -36.07 63.48 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 118.493 0.588 . . . . 0.0 110.371 173.879 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 1.5 mm100 -78.16 -34.1 49.89 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 179.134 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 50.7 t -60.33 -46.48 94.91 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 CA-C-N 119.665 1.121 . . . . 0.0 108.025 170.137 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 55.2 mt -61.35 -35.57 77.79 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 119.211 -0.423 . . . . 0.0 110.509 177.631 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -71.06 -42.46 69.39 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 119.117 0.872 . . . . 0.0 111.45 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -67.96 -30.66 70.0 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 120.068 1.304 . . . . 0.0 111.132 177.094 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 21.4 mt -63.09 -51.64 65.83 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 169.863 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 75.6 mtt180 -63.28 -28.62 70.15 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 119.524 1.056 . . . . 0.0 112.288 -178.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -70.52 -18.46 62.95 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 119.056 0.844 . . . . 0.0 111.023 176.076 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 9.8 m -94.01 8.26 42.08 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.976 1.31 . . . . 0.0 111.04 169.454 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 72.31 15.1 76.96 Favored Glycine 0 CA--C 1.529 0.908 0 CA-C-O 116.995 -2.003 . . . . 0.0 112.951 -172.096 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 61.9 t -96.47 119.77 44.95 Favored 'Isoleucine or valine' 0 C--N 1.348 0.536 0 CA-C-N 121.368 2.584 . . . . 0.0 107.482 -176.698 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -107.49 91.93 3.86 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 107.065 -1.458 . . . . 0.0 107.065 173.7 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -52.32 144.32 13.14 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.079 169.535 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' ILE . . . . . 0.433 HG21 ' HA ' ' A' ' 160' ' ' SER . 27.1 mm -89.28 124.64 64.17 Favored Pre-proline 0 C--O 1.232 0.16 0 CA-C-O 117.669 -1.158 . . . . 0.0 108.559 -175.767 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -63.27 103.78 0.38 Allowed 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 122.369 2.046 . . . . 0.0 108.495 170.75 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 29.0 ttp180 37.46 50.68 1.12 Allowed 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 127.201 2.2 . . . . 0.0 114.157 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 160' ' ' SER . . . . . 0.433 ' HA ' HG21 ' A' ' 157' ' ' ILE 0.269 3.4 p . . . . . 0 CA--C 1.544 0.744 0 C-N-CA 126.803 2.041 . . . . 0.0 115.657 -179.337 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 23.6 ptt180 . . . . . 0 N--CA 1.475 0.81 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 13.5 mt -140.53 141.01 33.33 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -169.814 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 17.0 tp -123.05 149.57 44.23 Favored 'General case' 0 N--CA 1.462 0.168 0 N-CA-C 107.216 -1.401 . . . . 0.0 107.216 168.956 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 66.3 t -123.13 122.87 66.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 105.424 -2.065 . . . . 0.0 105.424 169.694 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -98.18 130.38 44.93 Favored 'General case' 0 CA--C 1.511 -0.536 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 178.688 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -105.16 115.9 5.08 Favored Glycine 0 CA--C 1.501 -0.819 0 N-CA-C 104.481 -3.448 . . . . 0.0 104.481 169.487 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 6.8 m -138.46 157.83 30.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 118.933 1.366 . . . . 0.0 111.902 -168.613 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 130.52 -172.76 20.3 Favored Glycine 0 C--N 1.337 0.591 0 O-C-N 124.454 1.096 . . . . 0.0 111.698 169.829 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 -87.07 85.86 7.26 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 123.54 0.736 . . . . 0.0 111.723 -169.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.3 pt -58.16 29.88 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.555 1.138 0 N-CA-C 116.421 2.008 . . . . 0.0 116.421 171.007 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 72.1 mt -125.96 -3.29 7.05 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 120.979 1.718 . . . . 0.0 108.927 169.371 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.6 mp -119.59 64.15 0.8 Allowed 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 124.212 1.005 . . . . 0.0 110.44 -169.095 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.466 ' HB ' ' H ' ' A' ' 15' ' ' ASP . 0.1 OUTLIER 51.96 -104.01 0.17 Allowed 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.377 170.74 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.466 ' H ' ' HB ' ' A' ' 14' ' ' THR . 73.2 m-20 -71.21 -16.34 62.5 Favored 'General case' 0 N--CA 1.442 -0.874 0 C-N-CA 124.209 1.004 . . . . 0.0 112.722 -175.47 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -73.76 7.93 2.23 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 120.924 1.693 . . . . 0.0 113.096 -179.757 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -89.66 -15.36 32.81 Favored 'General case' 0 N--CA 1.429 -1.508 0 CA-C-O 115.817 -2.04 . . . . 0.0 107.537 169.374 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 7.1 tp -54.96 -38.65 46.12 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.359 0 CA-C-N 122.329 2.331 . . . . 0.0 112.998 -169.606 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -59.56 -45.83 94.96 Favored Glycine 0 C--N 1.334 0.464 0 N-CA-C 109.934 -1.266 . . . . 0.0 109.934 176.793 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 34.3 t -65.85 -46.26 89.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 CA-C-O 118.505 -0.759 . . . . 0.0 110.05 173.997 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 25.5 mmt180 -62.32 -34.85 77.42 Favored 'General case' 0 C--N 1.346 0.422 0 CA-C-N 120.547 1.522 . . . . 0.0 111.963 -176.829 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 26.2 mt -61.85 -46.46 96.47 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-N 120.03 1.286 . . . . 0.0 110.137 178.373 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 18.7 m -73.77 -28.59 24.65 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 CA-C-N 119.153 0.888 . . . . 0.0 111.247 -174.915 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 58.1 mt-10 -70.18 -45.56 66.41 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 174.86 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.55 -44.59 95.95 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 123.002 0.521 . . . . 0.0 110.108 178.572 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 7.4 tp -63.45 -40.52 97.35 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 118.438 -0.791 . . . . 0.0 110.982 178.824 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.7 tm-20 -61.76 -42.38 98.91 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 118.7 0.682 . . . . 0.0 110.489 179.149 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 48.7 mm-40 -71.63 -42.8 67.16 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 122.784 0.434 . . . . 0.0 111.536 179.534 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 40.4 mmt180 -88.05 -35.44 17.54 Favored 'General case' 0 C--N 1.342 0.264 0 CA-C-O 117.37 -1.3 . . . . 0.0 113.441 -169.579 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 75.9 m-85 -120.12 137.06 54.37 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-N 121.127 1.785 . . . . 0.0 112.056 -173.84 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 31.6 mm -89.29 134.12 29.48 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 N-CA-C 105.536 -2.024 . . . . 0.0 105.536 168.269 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -119.5 154.85 54.55 Favored Pre-proline 0 CA--C 1.538 0.494 0 C-N-CA 125.563 1.545 . . . . 0.0 108.858 -172.735 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -63.87 157.9 49.93 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 122.358 2.039 . . . . 0.0 109.991 169.759 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -58.6 -31.99 68.57 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 113.619 0.97 . . . . 0.0 113.619 -169.536 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 53.4 p90 -75.38 -1.26 22.99 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 113.931 1.086 . . . . 0.0 113.931 -177.712 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 59.5 t -111.1 128.2 67.71 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 176.324 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -129.36 143.84 51.0 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 173.789 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -110.89 108.36 25.26 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 106.282 -1.748 . . . . 0.0 106.282 176.622 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 8.2 tt -106.88 127.06 53.09 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 -172.433 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -81.76 115.95 21.23 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 124.196 0.998 . . . . 0.0 109.824 176.649 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -77.29 -87.66 0.37 Allowed Glycine 0 CA--C 1.531 1.033 0 N-CA-C 108.762 -1.735 . . . . 0.0 108.762 169.764 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 77.93 106.88 0.18 Allowed Glycine 0 CA--C 1.53 0.976 0 N-CA-C 110.712 -0.955 . . . . 0.0 110.712 -177.145 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 5.3 p 50.99 57.48 6.61 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.017 1.327 . . . . 0.0 109.489 178.126 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -107.9 -87.75 0.48 Allowed 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 114.88 -1.054 . . . . 0.0 110.222 -169.566 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 73.08 -102.04 1.2 Allowed Glycine 0 C--N 1.339 0.709 0 N-CA-C 107.906 -2.077 . . . . 0.0 107.906 -174.399 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 70.8 mmm -68.24 -23.02 64.75 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 122.914 0.486 . . . . 0.0 112.222 -174.831 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -64.36 -14.91 59.09 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-O 120.793 0.33 . . . . 0.0 111.014 -177.867 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 59.4 mt -83.34 -10.0 58.73 Favored 'General case' 0 C--N 1.343 0.32 0 N-CA-C 113.912 1.079 . . . . 0.0 113.912 -172.757 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.406 ' HA ' HG13 ' A' ' 100' ' ' VAL . 3.5 tt -47.66 -67.91 0.23 Allowed 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 119.367 0.985 . . . . 0.0 113.577 -169.436 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -71.4 -26.41 73.41 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 111.339 -0.704 . . . . 0.0 111.339 -171.212 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -78.87 -29.67 44.6 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 122.516 0.326 . . . . 0.0 111.457 -178.403 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 22.3 mtp -83.7 -28.81 28.03 Favored 'General case' 0 CA--C 1.53 0.176 0 O-C-N 121.936 -0.477 . . . . 0.0 111.352 174.519 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -59.31 153.67 18.29 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-O 121.707 0.765 . . . . 0.0 110.307 175.416 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 64.45 -8.45 0.2 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 126.673 1.989 . . . . 0.0 115.314 169.893 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 24.7 mmt180 -68.41 153.33 43.96 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 170.449 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 83.8 m-20 -90.19 -34.82 15.67 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 118.991 -0.528 . . . . 0.0 109.952 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 2.0 t-160 -140.24 122.18 15.57 Favored 'General case' 0 CA--C 1.514 -0.414 0 N-CA-C 104.262 -2.495 . . . . 0.0 104.262 -172.138 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 50.0 tp -128.46 131.57 48.4 Favored 'General case' 0 CA--C 1.509 -0.624 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 179.072 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 39.6 mt -109.57 121.94 63.38 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 N-CA-C 105.012 -2.218 . . . . 0.0 105.012 169.665 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 22.1 mt -98.26 125.16 51.63 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 177.501 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -104.21 119.45 38.97 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 171.022 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -147.6 151.46 36.27 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 124.692 1.197 . . . . 0.0 110.736 -172.405 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -88.19 121.31 30.44 Favored 'General case' 0 C--N 1.343 0.298 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 168.911 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 7.9 mm -54.2 -39.19 41.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 C-N-CA 124.362 1.065 . . . . 0.0 111.797 -173.572 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . 0.319 6.7 p 43.06 43.03 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.974 0 C-N-CA 126.316 1.846 . . . . 0.0 113.145 175.549 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 4.4 t -157.48 -175.33 5.33 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.946 1.698 . . . . 0.0 109.614 -174.476 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 16.1 tptt 63.29 176.16 0.16 Allowed 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 127.327 2.251 . . . . 0.0 113.433 171.625 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 9.3 ptpt -103.2 0.44 31.69 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 125.404 1.481 . . . . 0.0 112.978 -178.976 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 49.5 t30 -73.55 162.35 29.34 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.905 0.882 . . . . 0.0 109.08 -177.567 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.8 m -58.97 142.86 84.73 Favored Pre-proline 0 CA--C 1.545 0.783 0 C-N-CA 124.068 0.947 . . . . 0.0 111.816 -169.867 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -55.15 155.17 20.1 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 122.775 2.316 . . . . 0.0 112.167 170.169 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 70.6 4.62 53.44 Favored Glycine 0 CA--C 1.531 1.062 0 CA-C-O 118.655 -1.081 . . . . 0.0 114.859 174.421 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 20.8 m -86.04 147.97 25.95 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 119.849 1.825 . . . . 0.0 110.458 -172.161 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 15.7 ttp -87.88 137.66 32.14 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 123.435 0.694 . . . . 0.0 110.414 175.886 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 47.0 mtp -129.03 111.46 13.01 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 178.929 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 42.3 mm -99.03 115.62 40.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 177.651 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.9 mp -116.43 134.92 54.32 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 -174.867 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 20.5 mmm180 -104.66 138.86 40.35 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 123.084 0.553 . . . . 0.0 109.931 -177.464 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 38.8 t70 33.95 -100.27 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 115.463 1.653 . . . . 0.0 115.463 169.011 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -61.0 -24.13 65.93 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.789 1.236 . . . . 0.0 113.733 -174.219 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -73.68 -26.54 60.78 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 122.66 0.384 . . . . 0.0 110.568 178.536 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 49.2 t -72.2 -53.17 6.62 Favored Pre-proline 0 N--CA 1.445 -0.715 0 CA-C-O 116.888 -1.53 . . . . 0.0 110.756 -169.195 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.404 ' O ' HG23 ' A' ' 87' ' ' THR . 15.4 Cg_exo -61.92 -40.15 45.99 Favored 'Trans proline' 0 N--CA 1.448 -1.2 0 CA-C-N 121.992 1.747 . . . . 0.0 110.094 174.975 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -62.12 -30.35 70.97 Favored 'General case' 0 C--N 1.346 0.414 0 C-N-CA 123.364 0.666 . . . . 0.0 112.38 -174.271 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.502 HD13 ' C ' ' A' ' 85' ' ' LEU . 1.7 tm? -68.65 -47.08 67.47 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 171.14 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -64.19 -19.23 65.19 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 -169.723 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.404 HG23 ' O ' ' A' ' 83' ' ' PRO . 2.2 p -71.17 -17.79 62.52 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 -177.764 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 3.4 p30 -59.5 148.93 31.28 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -169.239 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -85.59 -13.54 48.48 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 118.816 -0.611 . . . . 0.0 112.618 -173.614 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 61.9 mt -70.29 -46.65 70.68 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 -178.507 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 5.0 m -78.1 119.1 76.04 Favored Pre-proline 0 CA--C 1.54 0.558 0 C-N-CA 124.263 1.025 . . . . 0.0 110.642 -174.285 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -81.96 -39.26 0.18 Allowed 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 121.573 1.515 . . . . 0.0 112.267 -177.945 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 24.3 m-70 -74.33 -29.67 61.71 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.358 0.663 . . . . 0.0 111.552 -171.194 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 90.6 mt-30 -74.53 -17.5 60.73 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 118.387 -0.816 . . . . 0.0 113.116 -169.83 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 47.5 tp -59.85 -35.04 73.93 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 119.692 1.133 . . . . 0.0 111.618 -172.277 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -65.66 -42.43 95.41 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 111.482 -0.647 . . . . 0.0 111.482 175.467 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 27.6 tp -70.29 -33.65 71.81 Favored 'General case' 0 CA--C 1.531 0.223 0 O-C-N 120.91 -1.347 . . . . 0.0 109.945 178.328 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -59.34 -50.33 74.41 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 118.908 0.776 . . . . 0.0 109.724 173.719 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -70.2 -24.74 63.17 Favored 'General case' 0 N--CA 1.457 -0.101 0 CA-C-O 118.682 -0.675 . . . . 0.0 112.02 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.406 HG13 ' HA ' ' A' ' 49' ' ' LEU . 2.5 t -65.09 -45.35 94.53 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 CA-C-N 119.451 1.023 . . . . 0.0 109.973 169.737 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 59.7 mt -64.91 -37.87 89.08 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 119.659 1.118 . . . . 0.0 109.705 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 18.6 m -61.92 -40.74 96.54 Favored 'General case' 0 C--O 1.224 -0.238 0 CA-C-N 118.605 0.638 . . . . 0.0 110.107 170.018 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.457 ' HA ' ' CD2' ' A' ' 106' ' ' PHE . . . -66.31 -33.88 76.73 Favored 'General case' 0 N--CA 1.448 -0.553 0 O-C-N 121.168 -0.957 . . . . 0.0 111.067 -179.759 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 6.4 mt -67.86 -34.25 76.32 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-N 118.929 0.786 . . . . 0.0 109.629 175.748 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 80.0 ttt180 -68.38 -36.43 79.16 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 118.846 -0.597 . . . . 0.0 110.06 172.87 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.457 ' CD2' ' HA ' ' A' ' 103' ' ' ALA . 15.4 m-30 -65.43 -43.38 90.68 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 119.305 0.957 . . . . 0.0 110.572 178.559 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 41.6 p -74.53 -23.25 58.79 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 118.571 0.623 . . . . 0.0 111.303 177.97 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 75.18 12.55 83.41 Favored Glycine 0 CA--C 1.531 1.086 0 N-CA-C 110.832 -0.907 . . . . 0.0 110.832 -169.603 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -96.84 22.16 8.63 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 118.766 1.283 . . . . 0.0 111.235 178.8 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -58.1 132.87 84.03 Favored Pre-proline 0 CA--C 1.544 0.727 0 C-N-CA 124.964 1.306 . . . . 0.0 109.656 171.918 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_exo -56.58 150.71 50.62 Favored 'Trans proline' 0 N--CA 1.46 -0.479 0 C-N-CA 123.351 2.701 . . . . 0.0 114.932 -178.485 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -59.88 -34.57 73.34 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.059 177.193 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 59.2 mttp -134.39 130.4 36.81 Favored 'General case' 0 C--O 1.232 0.16 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 173.688 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.443 HD12 ' H ' ' A' ' 115' ' ' THR . 18.2 tp -118.19 139.15 51.72 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 105.19 -2.152 . . . . 0.0 105.19 168.736 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.443 ' H ' HD12 ' A' ' 114' ' ' LEU . 0.2 OUTLIER -141.39 146.34 36.48 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 105.656 -1.979 . . . . 0.0 105.656 -177.669 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -135.37 136.1 41.22 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 119.729 1.15 . . . . 0.0 109.841 172.815 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 47.6 t -103.61 99.63 8.8 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 N-CA-C 103.61 -2.737 . . . . 0.0 103.61 169.278 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -87.24 145.43 19.74 Favored Glycine 0 N--CA 1.444 -0.825 0 N-CA-C 110.317 -1.113 . . . . 0.0 110.317 176.556 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 53.2 t -127.35 121.19 56.79 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.497 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 175.691 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 6.5 mt -71.88 132.48 84.87 Favored Pre-proline 0 CA--C 1.539 0.55 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 173.153 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -73.67 179.35 5.7 Favored 'Trans proline' 0 CA--C 1.541 0.848 0 C-N-CA 122.995 2.463 . . . . 0.0 111.91 179.146 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -115.47 -53.71 2.58 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.488 1.115 . . . . 0.0 110.032 177.446 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 56.1 p -110.25 -65.6 1.14 Allowed 'General case' 0 CA--C 1.535 0.365 0 CA-C-N 119.058 0.845 . . . . 0.0 111.954 -172.632 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 56.29 70.34 0.65 Allowed 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.674 1.99 . . . . 0.0 113.702 176.187 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -128.79 169.83 12.05 Favored Pre-proline 0 CA--C 1.542 0.658 0 CA-C-O 118.331 -0.843 . . . . 0.0 109.421 169.695 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_exo -65.92 85.21 0.24 Allowed 'Trans proline' 0 CA--C 1.547 1.126 0 C-N-CA 123.617 2.878 . . . . 0.0 113.34 -178.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -175.83 151.18 1.1 Allowed 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 104.404 -2.443 . . . . 0.0 104.404 176.368 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -114.3 161.84 12.83 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 -169.654 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 107.42 141.74 10.11 Favored Glycine 0 CA--C 1.528 0.878 0 N-CA-C 106.85 -2.5 . . . . 0.0 106.85 -169.514 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 68.7 mt -78.54 158.17 28.62 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 118.645 1.223 . . . . 0.0 108.971 175.607 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 36.3 p -68.19 164.92 38.05 Favored Pre-proline 0 C--O 1.238 0.462 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 168.304 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -56.69 -33.64 94.17 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 121.477 1.451 . . . . 0.0 110.76 169.334 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 5.9 m -66.48 -43.68 84.73 Favored 'General case' 0 CA--C 1.535 0.37 0 O-C-N 122.201 -0.312 . . . . 0.0 110.183 -178.898 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 94.4 t -88.48 -28.43 5.37 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 CA-C-N 118.683 0.674 . . . . 0.0 110.075 -172.224 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -55.12 -45.85 75.57 Favored 'General case' 0 CA--C 1.533 0.31 0 O-C-N 120.667 -1.27 . . . . 0.0 107.774 167.859 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -75.48 18.5 0.22 Allowed 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 114.152 1.167 . . . . 0.0 114.152 176.148 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 25.8 mmm -115.03 -8.44 12.46 Favored 'General case' 0 N--CA 1.437 -1.084 0 C-N-CA 125.743 1.617 . . . . 0.0 107.965 169.215 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 96.3 mt -59.5 -49.65 82.85 Favored 'Isoleucine or valine' 0 C--N 1.346 0.423 0 CA-C-N 120.379 1.445 . . . . 0.0 107.859 174.582 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -70.71 -53.73 8.97 Favored Pre-proline 0 CA--C 1.536 0.408 0 CA-C-O 117.121 -1.418 . . . . 0.0 109.584 -175.821 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -38.75 -52.63 2.07 Favored 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 123.876 3.051 . . . . 0.0 113.822 169.113 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -74.19 -45.85 45.78 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.085 -1.416 . . . . 0.0 110.808 -172.137 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -62.28 -36.38 81.89 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-N 118.982 0.81 . . . . 0.0 109.722 179.453 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -64.2 -36.0 82.65 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 177.929 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 11.9 mm100 -74.56 -31.09 61.98 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-O 117.869 -1.063 . . . . 0.0 112.266 172.637 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 86.7 t -59.83 -46.25 93.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-N 120.446 1.475 . . . . 0.0 108.154 169.94 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 74.4 mt -62.68 -41.17 98.95 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 118.714 0.688 . . . . 0.0 110.42 177.948 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -62.78 -41.04 99.08 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 118.813 0.733 . . . . 0.0 111.0 179.803 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -66.55 -46.37 76.3 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 177.366 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 78.0 mt -57.76 -37.17 73.16 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 122.514 0.326 . . . . 0.0 110.228 177.391 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 67.6 mtp180 -64.07 -19.09 64.98 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 118.019 -0.991 . . . . 0.0 112.284 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -61.89 -30.12 70.67 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 120.182 1.355 . . . . 0.0 110.546 174.17 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 49.1 m -101.16 31.11 3.79 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.021 1.328 . . . . 0.0 111.447 174.858 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 66.48 21.5 70.66 Favored Glycine 0 CA--C 1.53 0.974 0 CA-C-O 119.251 -0.749 . . . . 0.0 114.248 169.808 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 81.6 t -72.74 120.03 20.61 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 CA-C-N 118.572 1.186 . . . . 0.0 107.934 178.842 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -103.45 94.35 5.43 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 105.744 -1.947 . . . . 0.0 105.744 169.625 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -74.21 144.14 44.85 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 175.701 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 9.2 mm -112.04 127.88 26.24 Favored Pre-proline 0 CA--C 1.53 0.191 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -62.6 109.58 0.91 Allowed 'Trans proline' 0 N--CA 1.458 -0.599 0 N-CA-C 107.425 -1.798 . . . . 0.0 107.425 170.682 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 70.2 ttt-85 56.0 -9.43 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 127.799 2.44 . . . . 0.0 116.809 179.676 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 4.3 m . . . . . 0 CA--C 1.545 0.764 0 C-N-CA 126.524 1.93 . . . . 0.0 114.742 -169.564 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 28.5 tpt85 . . . . . 0 N--CA 1.469 0.486 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.8 mt -120.21 127.39 75.9 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 -172.01 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 19.4 tp -121.23 138.36 54.26 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 105.256 -2.128 . . . . 0.0 105.256 168.519 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 92.6 t -124.01 110.58 25.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 -177.178 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.435 HD13 ' HA ' ' A' ' 6' ' ' LEU . 2.8 mm? -93.73 125.37 38.31 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 -174.367 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -99.58 127.7 9.33 Favored Glycine 0 CA--C 1.508 -0.405 0 N-CA-C 106.17 -2.772 . . . . 0.0 106.17 170.435 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.1 m -138.79 167.15 21.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 117.595 0.697 . . . . 0.0 111.272 -169.932 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 109.59 169.79 20.27 Favored Glycine 0 CA--C 1.525 0.709 0 C-N-CA 125.973 1.749 . . . . 0.0 110.403 179.099 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -87.02 104.95 16.79 Favored 'General case' 0 N--CA 1.452 -0.336 0 O-C-N 121.865 -0.785 . . . . 0.0 110.794 -172.45 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.2 pt -63.67 32.99 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.892 0 N-CA-C 115.501 1.667 . . . . 0.0 115.501 175.036 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 42.4 mt -127.39 0.82 6.32 Favored 'General case' 0 C--O 1.222 -0.386 0 CA-C-N 120.504 1.502 . . . . 0.0 108.14 168.785 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.3 mp -118.06 52.28 1.02 Allowed 'General case' 0 N--CA 1.441 -0.916 0 C-N-CA 124.002 0.921 . . . . 0.0 112.074 -168.633 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER 53.8 -108.16 0.41 Allowed 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 122.862 0.465 . . . . 0.0 111.498 171.239 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -57.13 -25.18 58.42 Favored 'General case' 0 C--O 1.224 -0.287 0 CA-C-O 118.209 -0.901 . . . . 0.0 113.009 176.357 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -70.53 -0.03 7.7 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 121.535 1.971 . . . . 0.0 113.542 -177.598 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -89.0 -16.08 32.57 Favored 'General case' 0 N--CA 1.431 -1.39 0 CA-C-O 115.92 -1.99 . . . . 0.0 108.957 169.389 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 5.9 tp -58.34 -38.0 66.71 Favored 'Isoleucine or valine' 0 C--N 1.342 0.278 0 CA-C-N 122.829 2.559 . . . . 0.0 111.798 -169.619 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -59.71 -38.83 94.42 Favored Glycine 0 C--N 1.338 0.679 0 N-CA-C 110.572 -1.011 . . . . 0.0 110.572 176.304 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 79.0 t -73.29 -48.44 42.6 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.652 0 CA-C-O 118.641 -0.695 . . . . 0.0 109.452 174.374 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 15.6 mmm180 -59.48 -36.14 75.45 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 120.367 1.439 . . . . 0.0 112.621 -176.421 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 33.6 mt -62.18 -46.7 95.86 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 CA-C-N 120.418 1.463 . . . . 0.0 109.983 179.236 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 10.3 m -72.65 -29.33 30.03 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 O-C-N 121.298 -0.876 . . . . 0.0 110.887 -174.853 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -70.44 -41.72 72.47 Favored 'General case' 0 CA--C 1.528 0.102 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 175.022 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.41 -37.21 82.65 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-O 118.735 -0.65 . . . . 0.0 110.444 178.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 11.9 tp -62.45 -42.59 99.57 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 118.867 0.758 . . . . 0.0 109.939 174.297 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -62.78 -41.19 99.15 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 118.461 0.573 . . . . 0.0 110.815 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -67.42 -42.69 82.79 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.193 0.997 . . . . 0.0 110.635 179.08 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 88.3 mtt180 -94.43 -38.89 10.72 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 114.837 1.421 . . . . 0.0 114.837 -169.687 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 63.3 m-85 -113.84 137.68 51.32 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 121.391 1.905 . . . . 0.0 114.207 -169.293 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 47.0 mm -85.68 141.84 13.97 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 N-CA-C 104.382 -2.451 . . . . 0.0 104.382 167.637 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 46.5 mt -135.98 152.87 76.42 Favored Pre-proline 0 CA--C 1.539 0.55 0 C-N-CA 123.496 0.718 . . . . 0.0 110.518 -169.474 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_exo -59.27 155.2 41.75 Favored 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 123.336 2.691 . . . . 0.0 111.829 169.864 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -63.01 -31.09 72.14 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -171.232 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 26.1 p90 -70.63 -13.96 62.29 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 118.358 -0.83 . . . . 0.0 112.547 179.149 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 42.7 t -94.91 129.25 45.33 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 C-N-CA 124.114 0.966 . . . . 0.0 108.639 178.765 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -136.13 146.06 46.53 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-O 121.252 0.548 . . . . 0.0 110.607 170.884 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -105.28 130.35 56.65 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 N-CA-C 105.648 -1.982 . . . . 0.0 105.648 169.024 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 64.5 tp -121.61 126.41 49.02 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-O 121.311 0.577 . . . . 0.0 109.732 175.088 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -77.87 115.69 17.81 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 169.523 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -64.58 -64.25 3.71 Favored Glycine 0 CA--C 1.531 1.074 0 N-CA-C 108.225 -1.95 . . . . 0.0 108.225 169.877 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 79.2 106.0 0.23 Allowed Glycine 0 C--N 1.34 0.793 0 N-CA-C 110.765 -0.934 . . . . 0.0 110.765 171.676 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . 0.254 40.2 p 50.18 61.18 3.33 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 -173.434 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -89.01 -140.36 0.13 Allowed 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 113.608 -1.633 . . . . 0.0 110.925 -169.304 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 75.93 118.85 0.13 Allowed Glycine 0 CA--C 1.537 1.417 0 N-CA-C 109.031 -1.628 . . . . 0.0 109.031 -168.605 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 1.6 mmt 61.59 -29.37 0.06 Allowed 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 127.521 2.328 . . . . 0.0 116.411 -173.622 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -59.47 -21.42 60.06 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 118.998 0.817 . . . . 0.0 112.769 -175.03 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 95.8 mt -91.79 9.63 31.88 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 -171.339 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.5 tt -73.15 79.94 1.26 Allowed 'General case' 0 C--O 1.233 0.213 0 CA-C-O 124.843 2.258 . . . . 0.0 110.827 -179.035 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 145.13 -33.64 1.59 Allowed Glycine 0 C--N 1.308 -0.989 0 CA-C-N 110.142 -3.208 . . . . 0.0 111.028 172.936 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -68.24 -35.3 77.72 Favored 'General case' 0 N--CA 1.466 0.345 0 O-C-N 121.933 -0.745 . . . . 0.0 111.525 -176.89 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 38.1 mtp -72.38 0.56 9.79 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.891 1.277 . . . . 0.0 113.151 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -75.63 149.13 38.28 Favored 'General case' 0 N--CA 1.457 -0.087 0 N-CA-C 113.777 1.029 . . . . 0.0 113.777 -169.923 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 55.26 18.15 2.37 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 128.317 2.647 . . . . 0.0 116.412 168.695 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 27.1 mmt180 -77.91 149.33 34.24 Favored 'General case' 0 N--CA 1.473 0.698 0 O-C-N 120.798 -1.189 . . . . 0.0 109.416 -178.312 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -80.97 -39.55 25.84 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 177.071 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 1.8 m170 -128.07 136.28 50.99 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 169.933 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 29.2 tp -130.92 123.72 29.53 Favored 'General case' 0 CA--C 1.505 -0.78 0 N-CA-C 105.851 -1.907 . . . . 0.0 105.851 168.79 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 18.5 mt -111.35 122.41 65.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 104.657 -2.349 . . . . 0.0 104.657 178.038 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 21.0 mt -102.94 126.56 57.18 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 N-CA-C 105.881 -1.896 . . . . 0.0 105.881 -179.616 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -111.32 119.09 37.72 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 105.261 -2.126 . . . . 0.0 105.261 171.599 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -149.1 149.93 31.88 Favored 'General case' 0 C--O 1.24 0.557 0 O-C-N 123.4 0.438 . . . . 0.0 110.202 -175.73 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -68.64 132.01 46.17 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 104.536 -2.394 . . . . 0.0 104.536 168.363 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.6 tt -74.95 -38.07 42.58 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.778 0 O-C-N 121.582 -0.699 . . . . 0.0 110.797 -169.674 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.2 t 45.62 44.43 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.822 0 C-N-CA 125.919 1.688 . . . . 0.0 111.144 176.939 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 67.2 m -138.75 -73.31 0.39 Allowed 'General case' 0 N--CA 1.471 0.577 0 O-C-N 121.54 -0.725 . . . . 0.0 112.552 -169.716 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 29.3 ttmt -83.02 154.68 24.33 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 122.758 0.423 . . . . 0.0 109.871 -169.79 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.32 42.8 1.11 Allowed 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 125.283 1.433 . . . . 0.0 109.033 -172.158 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 40.7 t-20 -89.74 172.47 8.9 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 124.26 1.024 . . . . 0.0 108.915 -171.358 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 10.7 m -60.25 133.95 90.7 Favored Pre-proline 0 CA--C 1.544 0.726 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 179.066 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -57.82 153.66 42.41 Favored 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 122.392 2.061 . . . . 0.0 111.615 174.127 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 71.53 9.38 68.88 Favored Glycine 0 CA--C 1.533 1.163 0 CA-C-O 119.703 -0.498 . . . . 0.0 113.803 176.111 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 29.3 m -89.03 146.56 24.78 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 124.971 1.309 . . . . 0.0 107.545 174.244 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 30.0 ttp -101.78 143.13 32.08 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 175.328 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 17.9 ttm -126.5 126.65 44.08 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 179.775 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 44.0 mm -107.57 121.19 60.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 -179.108 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -115.71 129.37 56.44 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 -174.625 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 81.0 mtm180 -90.9 173.45 7.97 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 118.293 0.497 . . . . 0.0 110.288 179.159 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -33.39 -66.15 0.16 Allowed 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 116.215 1.931 . . . . 0.0 116.215 -169.758 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -77.08 -12.34 59.93 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -172.986 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 21.6 mm-40 -91.78 -21.95 20.42 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 118.558 -0.734 . . . . 0.0 110.664 -178.784 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.447 HG22 ' HB3' ' A' ' 116' ' ' LEU . 63.0 t -62.97 -51.13 73.25 Favored Pre-proline 0 C--N 1.344 0.331 0 CA-C-N 120.168 1.349 . . . . 0.0 110.967 -179.111 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -66.65 -37.8 20.52 Favored 'Trans proline' 0 N--CA 1.444 -1.393 0 CA-C-N 121.423 1.544 . . . . 0.0 109.708 -179.698 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.97 -29.04 69.37 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.298 0.639 . . . . 0.0 111.812 -176.489 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.521 HD13 ' C ' ' A' ' 85' ' ' LEU . 1.1 tm? -68.31 -47.65 67.01 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 169.743 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.557 ' HB3' ' HB2' ' A' ' 98' ' ' ALA . 12.9 m-85 -64.63 -11.2 32.71 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 114.041 1.126 . . . . 0.0 114.041 -169.422 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 24.9 p -66.76 -13.65 61.66 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 113.784 1.031 . . . . 0.0 113.784 -175.281 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -59.29 135.03 57.52 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.362 0.665 . . . . 0.0 110.652 -172.601 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -87.04 -12.48 47.22 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 -170.394 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 76.2 mt -67.82 -43.55 86.11 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 N-CA-C 107.421 -1.325 . . . . 0.0 107.421 174.291 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -65.78 130.84 94.57 Favored Pre-proline 0 N--CA 1.445 -0.722 0 C-N-CA 125.802 1.641 . . . . 0.0 110.768 -173.132 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -80.78 -87.55 0.0 OUTLIER 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 123.059 2.506 . . . . 0.0 111.416 177.937 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 19.4 m80 -66.98 -32.15 73.2 Favored 'General case' 0 N--CA 1.469 0.477 0 O-C-N 120.645 -1.285 . . . . 0.0 110.976 -170.312 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.418 ' H ' ' CD ' ' A' ' 94' ' ' GLN . 26.2 mp0 -53.86 -42.65 68.8 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 126.365 1.866 . . . . 0.0 109.93 173.536 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.403 ' O ' ' HB3' ' A' ' 98' ' ' ALA . 3.1 tm? -70.7 -37.1 73.56 Favored 'General case' 0 N--CA 1.457 -0.117 0 O-C-N 121.571 -0.705 . . . . 0.0 109.671 179.401 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -59.69 -38.87 94.45 Favored Glycine 0 CA--C 1.53 0.983 0 O-C-N 121.254 -0.904 . . . . 0.0 111.44 171.52 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.445 HD23 ' CZ ' ' A' ' 86' ' ' PHE . 24.3 tp -70.19 -28.13 65.06 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 118.37 1.085 . . . . 0.0 110.461 174.423 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.557 ' HB2' ' HB3' ' A' ' 86' ' ' PHE . . . -56.23 -46.87 79.38 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 120.141 1.337 . . . . 0.0 109.089 169.689 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -72.56 -24.21 61.08 Favored 'General case' 0 C--O 1.231 0.08 0 CA-C-O 119.193 -0.432 . . . . 0.0 111.952 -179.163 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 74.2 t -65.45 -46.16 90.82 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 169.19 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 76.1 mt -64.03 -35.28 80.19 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 118.961 0.801 . . . . 0.0 110.433 -179.053 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 19.7 m -63.97 -43.29 96.19 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 118.796 0.725 . . . . 0.0 110.197 170.848 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -64.9 -41.5 95.54 Favored 'General case' 0 N--CA 1.452 -0.367 0 O-C-N 120.972 -1.08 . . . . 0.0 111.387 -178.953 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -65.33 -31.58 72.79 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 124.486 1.114 . . . . 0.0 110.318 176.148 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 19.1 tpp180 -70.91 -37.85 72.96 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 118.839 -0.6 . . . . 0.0 109.897 173.58 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 15.2 m-30 -65.44 -42.46 92.4 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 118.773 0.715 . . . . 0.0 110.405 -179.572 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 31.2 p -74.96 -21.5 59.13 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 118.304 0.502 . . . . 0.0 111.603 178.543 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 74.34 11.19 82.31 Favored Glycine 0 CA--C 1.534 1.262 0 N-CA-C 111.066 -0.814 . . . . 0.0 111.066 -169.723 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -83.74 2.27 38.72 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 118.77 1.285 . . . . 0.0 111.944 177.041 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -48.67 134.63 13.69 Favored Pre-proline 0 CA--C 1.549 0.92 0 C-N-CA 125.745 1.618 . . . . 0.0 110.989 177.009 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -52.0 150.02 19.49 Favored 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 124.082 3.188 . . . . 0.0 114.258 179.65 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 31.7 mmmt -63.26 -28.92 70.35 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 118.955 -0.545 . . . . 0.0 111.183 177.568 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 36.0 ttmt -146.69 110.95 5.1 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 171.226 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 26.2 tp -90.1 144.58 25.76 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 169.119 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -141.45 146.46 36.53 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 171.932 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.447 ' HB3' HG22 ' A' ' 82' ' ' VAL . 0.8 OUTLIER -131.4 138.99 49.34 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 120.408 1.458 . . . . 0.0 110.436 172.78 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 43.6 t -105.17 105.93 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 N-CA-C 104.808 -2.293 . . . . 0.0 104.808 168.798 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -90.07 146.05 18.5 Favored Glycine 0 CA--C 1.522 0.516 0 N-CA-C 110.484 -1.046 . . . . 0.0 110.484 174.765 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.455 HG13 ' SD ' ' A' ' 137' ' ' MET . 71.0 t -119.31 138.64 49.32 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 175.575 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 14.4 mm -84.94 128.23 61.3 Favored Pre-proline 0 CA--C 1.543 0.679 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 169.955 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -70.12 152.3 67.41 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 122.786 2.324 . . . . 0.0 113.365 -176.464 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -99.58 -42.41 6.92 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 169.599 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 20.2 m -142.66 151.06 41.02 Favored 'General case' 0 C--N 1.344 0.348 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 176.641 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.5 tp -153.77 49.61 0.67 Allowed 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 118.719 0.691 . . . . 0.0 111.779 -172.275 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -120.32 168.93 9.45 Favored Pre-proline 0 N--CA 1.477 0.919 0 CA-C-O 117.638 -1.172 . . . . 0.0 110.072 -175.903 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -62.89 84.3 0.11 Allowed 'Trans proline' 0 CA--C 1.547 1.167 0 C-N-CA 124.138 3.225 . . . . 0.0 113.915 -178.219 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -176.52 156.53 1.52 Allowed 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 105.212 -2.144 . . . . 0.0 105.212 174.527 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -130.54 162.17 39.03 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 CA-C-O 121.772 0.796 . . . . 0.0 110.844 174.817 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 122.36 121.96 2.76 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 103.387 -3.885 . . . . 0.0 103.387 -168.879 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 74.8 mt -78.86 152.21 31.38 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 -171.108 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 68.6 p -69.8 166.04 35.96 Favored Pre-proline 0 C--O 1.241 0.632 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 169.673 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -60.21 -27.86 85.73 Favored 'Trans proline' 0 CA--C 1.539 0.727 0 CA-C-N 119.677 0.92 . . . . 0.0 110.466 169.591 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 5.1 m -69.85 -42.11 73.98 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 118.505 0.593 . . . . 0.0 110.35 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 72.7 t -88.46 -36.6 9.33 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 CA-C-O 119.175 -0.44 . . . . 0.0 110.346 -169.348 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -50.7 -44.59 58.01 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 119.204 0.911 . . . . 0.0 109.938 169.428 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -77.76 5.2 9.92 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 113.789 1.033 . . . . 0.0 113.789 -175.631 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' MET . . . . . 0.455 ' SD ' HG13 ' A' ' 119' ' ' VAL . 75.3 mtp -98.18 -7.28 29.68 Favored 'General case' 0 N--CA 1.439 -1.015 0 CA-C-O 117.387 -1.292 . . . . 0.0 110.59 169.612 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 94.7 mt -57.67 -47.25 86.06 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 CA-C-N 120.225 1.375 . . . . 0.0 108.391 174.317 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 58.3 mt-10 -73.56 -48.65 6.83 Favored Pre-proline 0 CA--C 1.542 0.667 0 CA-C-O 117.534 -1.222 . . . . 0.0 110.637 -175.611 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -43.38 -54.38 3.6 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 124.611 3.541 . . . . 0.0 112.645 168.686 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.35 -42.52 71.73 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 114.788 -1.096 . . . . 0.0 110.755 -174.283 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 33.1 mt -54.69 -44.12 73.09 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-N 118.961 0.8 . . . . 0.0 109.45 173.367 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -64.44 -34.65 78.68 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 119.075 0.852 . . . . 0.0 110.887 -176.837 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -78.43 -32.8 48.74 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 119.231 0.923 . . . . 0.0 112.021 176.52 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 54.0 t -59.59 -47.99 88.97 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 169.355 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 44.7 mt -64.47 -36.97 85.91 Favored 'General case' 0 CA--C 1.519 -0.244 0 C-N-CA 123.061 0.544 . . . . 0.0 110.67 -178.518 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -58.18 -36.38 72.98 Favored 'General case' 0 N--CA 1.457 -0.118 0 CA-C-N 118.419 0.554 . . . . 0.0 111.21 179.216 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -63.0 -44.84 94.9 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 117.985 0.357 . . . . 0.0 110.91 177.439 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 6.2 mp -63.21 -40.26 96.99 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 176.696 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 87.0 mtt180 -64.81 -18.87 65.5 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 117.411 -1.281 . . . . 0.0 111.759 -179.081 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 69.8 mt-10 -56.26 -30.15 62.05 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 120.53 1.514 . . . . 0.0 112.138 176.359 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 19.4 m -113.38 31.53 6.41 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.294 1.038 . . . . 0.0 111.311 179.211 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 65.42 29.98 76.5 Favored Glycine 0 CA--C 1.531 1.05 0 CA-C-O 118.73 -1.039 . . . . 0.0 113.583 175.459 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 47.1 t -111.14 103.32 15.29 Favored 'Isoleucine or valine' 0 C--N 1.34 0.175 0 N-CA-C 106.684 -1.599 . . . . 0.0 106.684 176.299 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -100.8 144.87 29.24 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 169.744 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -78.68 157.5 28.59 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.388 0.675 . . . . 0.0 111.357 177.75 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 11.7 mt -99.14 112.43 63.09 Favored Pre-proline 0 CA--C 1.532 0.263 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -66.98 104.63 0.86 Allowed 'Trans proline' 0 N--CA 1.458 -0.591 0 N-CA-C 107.942 -1.599 . . . . 0.0 107.942 175.607 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 69.5 ttt180 57.29 -14.08 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 128.344 2.658 . . . . 0.0 116.98 -178.06 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 2.9 t . . . . . 0 CA--C 1.542 0.667 0 C-N-CA 125.447 1.499 . . . . 0.0 111.047 -169.648 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 7.0 ptp180 . . . . . 0 N--CA 1.48 1.043 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 38.5 mt -142.69 143.8 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-N 119.612 1.096 . . . . 0.0 110.85 -169.104 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 19.7 tp -131.88 109.86 10.39 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 104.168 -2.531 . . . . 0.0 104.168 167.62 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.422 HG12 HG12 ' A' ' 23' ' ' VAL . 39.2 t -85.84 118.72 32.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 102.441 -3.17 . . . . 0.0 102.441 171.886 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -119.9 105.52 11.17 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-O 121.114 0.483 . . . . 0.0 110.411 -168.673 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -87.46 115.62 4.36 Favored Glycine 0 N--CA 1.447 -0.614 0 N-CA-C 107.651 -2.18 . . . . 0.0 107.651 174.298 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 14.8 m -123.46 -176.38 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.633 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 174.857 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 111.49 124.71 4.54 Favored Glycine 0 N--CA 1.441 -1.031 0 N-CA-C 106.75 -2.54 . . . . 0.0 106.75 -175.002 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -64.03 109.46 1.82 Allowed 'General case' 0 N--CA 1.442 -0.85 0 C-N-CA 124.284 1.034 . . . . 0.0 109.917 -169.539 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.3 pt -75.65 37.77 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 C-N-CA 124.642 1.177 . . . . 0.0 113.463 -178.685 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 20.8 mt -124.24 0.18 8.35 Favored 'General case' 0 CA--C 1.535 0.398 0 O-C-N 121.118 -0.989 . . . . 0.0 108.502 169.619 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.2 mp -132.56 72.66 1.5 Allowed 'General case' 0 C--N 1.346 0.446 0 N-CA-C 104.895 -2.261 . . . . 0.0 104.895 -173.454 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 98.9 m 17.85 -92.84 0.0 OUTLIER 'General case' 0 CA--C 1.522 -0.115 0 C-N-CA 127.091 2.156 . . . . 0.0 115.364 175.932 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -53.73 -30.74 45.4 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 125.028 1.331 . . . . 0.0 113.003 -169.754 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -64.61 -31.54 72.81 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 119.592 1.087 . . . . 0.0 111.901 179.513 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.14 -12.55 8.79 Favored 'General case' 0 N--CA 1.437 -1.091 0 CA-C-O 116.187 -1.863 . . . . 0.0 111.277 176.723 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 5.4 tp -49.55 -42.13 16.68 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.507 0 CA-C-N 121.813 2.097 . . . . 0.0 110.539 179.157 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -66.65 -36.2 90.97 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 111.256 -0.738 . . . . 0.0 111.256 -176.447 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 69.8 t -67.81 -45.55 84.08 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 172.313 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 20.7 mmt180 -61.53 -29.14 69.81 Favored 'General case' 0 C--O 1.225 -0.201 0 CA-C-O 117.282 -1.342 . . . . 0.0 112.055 178.945 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 6.3 mm -60.93 -53.11 53.62 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-N 120.682 1.583 . . . . 0.0 108.736 176.887 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.422 HG12 HG12 ' A' ' 5' ' ' VAL . 34.1 m -71.36 -32.24 46.09 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-N 119.199 0.909 . . . . 0.0 111.505 -173.946 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 63.4 mt-10 -64.89 -49.57 69.95 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 118.49 0.586 . . . . 0.0 109.883 173.456 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.1 -36.5 83.8 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 119.198 -0.43 . . . . 0.0 110.231 179.031 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 8.2 tp -62.4 -40.42 96.45 Favored 'General case' 0 C--O 1.225 -0.227 0 CA-C-N 119.49 1.041 . . . . 0.0 109.36 -179.217 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -67.83 -25.47 65.58 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 121.339 0.59 . . . . 0.0 112.303 -178.309 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -81.86 -39.29 24.13 Favored 'General case' 0 N--CA 1.436 -1.128 0 C-N-CA 126.219 1.808 . . . . 0.0 109.685 175.872 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 23.4 mmt85 -89.63 -32.55 17.03 Favored 'General case' 0 C--O 1.231 0.099 0 CA-C-O 118.662 -0.685 . . . . 0.0 112.1 -169.637 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -128.22 147.73 50.59 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 118.944 0.793 . . . . 0.0 111.334 -176.499 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 51.6 mm -97.11 138.97 20.64 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 103.834 -2.654 . . . . 0.0 103.834 168.014 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -117.57 153.38 50.44 Favored Pre-proline 0 CA--C 1.539 0.542 0 C-N-CA 123.277 0.631 . . . . 0.0 111.469 -169.362 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -61.03 161.0 23.76 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 123.711 2.941 . . . . 0.0 112.144 169.933 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -63.42 -32.94 74.51 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -175.824 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 7.5 p90 -75.17 -10.25 59.29 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 -179.207 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 96.7 t -92.31 122.93 44.21 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 173.924 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -114.66 127.34 55.71 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 106.703 -1.591 . . . . 0.0 106.703 169.348 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -93.98 118.33 39.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 105.076 -2.194 . . . . 0.0 105.076 168.559 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 54.1 tp -118.86 132.21 56.1 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 122.902 0.481 . . . . 0.0 110.352 178.729 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -91.29 120.99 32.65 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 169.154 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -106.7 -22.5 7.65 Favored Glycine 0 CA--C 1.536 1.361 0 CA-C-O 118.437 -1.202 . . . . 0.0 113.6 171.787 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 56.05 -110.84 2.16 Favored Glycine 0 C--N 1.342 0.897 0 CA-C-N 119.878 1.839 . . . . 0.0 112.329 172.071 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 75.7 p -79.99 7.21 9.46 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 125.365 1.466 . . . . 0.0 112.557 -172.919 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -57.82 -59.3 5.44 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 114.291 1.219 . . . . 0.0 114.291 -170.033 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 56.72 -112.33 3.37 Favored Glycine 0 CA--C 1.532 1.144 0 N-CA-C 109.846 -1.302 . . . . 0.0 109.846 -170.269 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 8.2 tpt -64.19 -21.41 66.55 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.319 1.048 . . . . 0.0 113.449 -176.506 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -56.33 -17.67 8.47 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 114.545 1.313 . . . . 0.0 114.545 -170.879 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 8.8 mt -98.24 17.71 18.01 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 119.499 1.045 . . . . 0.0 112.991 -169.806 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.687 ' HA ' HG13 ' A' ' 100' ' ' VAL . 10.2 tt -48.04 -50.74 26.88 Favored 'General case' 0 C--N 1.343 0.314 0 N-CA-C 112.764 0.654 . . . . 0.0 112.764 -174.901 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -80.31 -29.67 44.19 Favored Glycine 0 CA--C 1.528 0.848 0 CA-C-O 119.659 -0.523 . . . . 0.0 111.952 -178.035 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -86.94 -22.7 25.47 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 114.267 1.21 . . . . 0.0 114.267 -169.053 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.413 ' SD ' HG11 ' A' ' 100' ' ' VAL . 47.6 mtp -78.14 -15.64 58.67 Favored 'General case' 0 CA--C 1.535 0.394 0 O-C-N 121.537 -0.727 . . . . 0.0 111.108 173.958 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.09 150.37 45.56 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 123.708 0.803 . . . . 0.0 112.026 -169.324 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . 0.282 14.4 p30 55.34 17.24 2.03 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 127.923 2.489 . . . . 0.0 117.324 170.048 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.5 159.02 35.04 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 169.155 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -80.61 -52.18 7.88 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 173.784 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -117.22 147.11 42.79 Favored 'General case' 0 CA--C 1.513 -0.478 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 168.941 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -134.97 122.56 22.05 Favored 'General case' 0 CA--C 1.508 -0.661 0 N-CA-C 104.698 -2.334 . . . . 0.0 104.698 175.293 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 3.0 mt -104.42 106.07 19.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 106.45 -1.685 . . . . 0.0 106.45 176.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.547 HD13 HD11 ' A' ' 97' ' ' LEU . 27.4 mt -79.99 124.76 38.45 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 N-CA-C 105.074 -2.195 . . . . 0.0 105.074 169.868 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -113.28 121.07 43.3 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 104.121 -2.548 . . . . 0.0 104.121 168.542 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 41.7 t0 -163.67 156.37 18.05 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 123.592 0.757 . . . . 0.0 110.23 -175.237 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -83.25 142.67 30.96 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 169.008 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 72.1 mt -77.07 -44.29 31.42 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 -175.812 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 14.6 t 53.93 43.46 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.151 0 C-N-CA 124.367 1.067 . . . . 0.0 109.66 -172.059 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 2.4 m -153.76 178.81 9.48 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.212 1.405 . . . . 0.0 109.639 175.838 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . 0.288 30.6 ttmt 67.61 154.69 0.1 Allowed 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 127.968 2.507 . . . . 0.0 113.345 175.557 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 10.3 ptpt -85.14 -5.65 59.33 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 127.205 2.202 . . . . 0.0 114.774 -169.548 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 33.9 t-20 -74.38 169.61 17.32 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.221 0.608 . . . . 0.0 109.619 -173.86 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 4.1 m -57.65 146.31 66.1 Favored Pre-proline 0 CA--C 1.548 0.903 0 C-N-CA 124.111 0.964 . . . . 0.0 112.234 -169.735 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_exo -53.09 148.13 31.84 Favored 'Trans proline' 0 CA--C 1.535 0.573 0 C-N-CA 124.176 3.251 . . . . 0.0 113.178 171.366 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.483 ' HA3' HG22 ' A' ' 133' ' ' THR . . . 74.2 0.01 55.29 Favored Glycine 0 CA--C 1.532 1.096 0 CA-C-O 119.221 -0.766 . . . . 0.0 114.684 174.315 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 27.3 m -73.28 143.39 47.03 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 119.026 1.413 . . . . 0.0 111.155 -169.966 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 11.0 ttp -85.22 132.5 34.27 Favored 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 169.635 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 65.5 mtm -133.45 127.59 33.63 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 170.071 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.625 HD12 ' HG3' ' A' ' 144' ' ' GLN . 18.6 mm -108.03 124.86 64.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 -173.308 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.5 mp -121.33 134.59 55.14 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 -174.293 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 53.1 mtt85 -86.23 174.02 9.38 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.789 0.835 . . . . 0.0 110.016 -177.399 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -40.59 -52.52 2.85 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 115.068 1.507 . . . . 0.0 115.068 -172.711 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -90.34 -13.81 34.4 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 113.056 0.762 . . . . 0.0 113.056 -175.371 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -77.61 -37.17 50.84 Favored 'General case' 0 C--N 1.339 0.118 0 CA-C-N 118.551 0.614 . . . . 0.0 109.956 -173.948 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.537 HG12 ' CE2' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -64.29 -49.52 72.2 Favored Pre-proline 0 CA--C 1.534 0.33 0 CA-C-O 117.605 -1.188 . . . . 0.0 112.822 -175.345 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_exo -54.96 -39.6 89.91 Favored 'Trans proline' 0 CA--C 1.539 0.757 0 CA-C-N 120.997 1.392 . . . . 0.0 111.557 176.339 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -76.16 -7.98 56.0 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 176.633 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -92.45 -38.16 12.14 Favored 'General case' 0 C--N 1.342 0.274 0 CA-C-N 120.114 1.325 . . . . 0.0 109.622 174.76 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.537 ' CE2' HG12 ' A' ' 82' ' ' VAL . 26.6 m-85 -77.84 28.83 0.17 Allowed 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -178.573 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 32.1 p -74.02 -24.62 59.59 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 121.463 -0.773 . . . . 0.0 110.282 173.648 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -75.38 152.18 38.1 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 171.743 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 3.1 mppt? -120.88 28.45 7.92 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.895 0.878 . . . . 0.0 111.033 179.57 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 25.9 mt -69.99 -44.73 78.22 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 -178.304 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 2.6 p -97.57 116.61 65.84 Favored Pre-proline 0 CA--C 1.545 0.765 0 C-N-CA 124.962 1.305 . . . . 0.0 110.084 -170.292 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -70.55 -50.09 0.4 Allowed 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 122.535 2.156 . . . . 0.0 114.042 -169.238 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 10.7 t-80 -60.99 -45.64 93.97 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 178.364 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 23.9 mp0 -64.82 -35.88 82.53 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 118.199 -0.905 . . . . 0.0 110.447 -176.287 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -65.28 -41.21 94.4 Favored 'General case' 0 C--O 1.227 -0.128 0 CA-C-N 119.676 1.125 . . . . 0.0 110.028 173.282 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -61.16 -46.28 94.82 Favored Glycine 0 CA--C 1.534 1.237 0 CA-C-N 119.455 1.025 . . . . 0.0 111.232 175.748 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.547 HD11 HD13 ' A' ' 60' ' ' ILE . 2.1 tm? -58.07 -41.49 83.49 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.261 0.625 . . . . 0.0 110.007 174.103 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -65.33 -36.21 83.36 Favored 'General case' 0 N--CA 1.444 -0.772 0 O-C-N 121.049 -1.032 . . . . 0.0 110.919 178.311 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -67.15 -22.41 65.77 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 118.616 0.643 . . . . 0.0 110.466 178.609 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.687 HG13 ' HA ' ' A' ' 49' ' ' LEU . 77.7 t -68.87 -42.08 82.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 168.442 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 42.6 mt -64.65 -35.83 82.3 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-N 119.748 1.158 . . . . 0.0 110.2 179.807 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 17.0 m -63.79 -45.04 91.49 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 119.229 0.922 . . . . 0.0 110.228 172.446 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.19 -44.13 97.79 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 119.093 0.861 . . . . 0.0 111.275 176.986 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.7 mt -60.61 -33.81 73.3 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.238 1.015 . . . . 0.0 109.996 175.835 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 73.9 ttt-85 -73.68 -34.62 64.97 Favored 'General case' 0 CA--C 1.531 0.238 0 O-C-N 121.141 -0.974 . . . . 0.0 109.792 176.762 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 14.1 m-30 -69.3 -44.14 72.36 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 123.594 0.758 . . . . 0.0 110.665 179.274 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 36.1 p -73.05 -23.95 60.64 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 118.462 0.573 . . . . 0.0 111.701 179.232 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 73.57 7.57 74.21 Favored Glycine 0 CA--C 1.532 1.148 0 N-CA-C 109.394 -1.482 . . . . 0.0 109.394 -168.383 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -86.04 25.58 1.12 Allowed 'General case' 0 C--N 1.348 0.505 0 CA-C-N 119.851 1.826 . . . . 0.0 110.733 174.909 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -61.78 139.12 95.49 Favored Pre-proline 0 CA--C 1.546 0.82 0 C-N-CA 124.006 0.922 . . . . 0.0 108.705 169.516 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo -59.71 162.41 15.65 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.963 2.442 . . . . 0.0 114.03 -177.95 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp -65.07 -37.63 88.16 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 119.061 -0.495 . . . . 0.0 111.475 174.459 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 4.5 pttm -143.5 85.46 1.84 Allowed 'General case' 0 C--O 1.234 0.252 0 C-N-CA 124.031 0.933 . . . . 0.0 108.585 177.758 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 5.9 tt -75.39 144.8 42.07 Favored 'General case' 0 CA--C 1.537 0.468 0 O-C-N 120.835 -1.165 . . . . 0.0 108.502 169.657 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -137.97 139.64 39.81 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.65 1.18 . . . . 0.0 108.02 177.349 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -118.91 121.12 39.23 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 119.901 1.228 . . . . 0.0 108.658 175.991 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 3.1 t -89.1 89.98 3.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 N-CA-C 105.855 -1.906 . . . . 0.0 105.855 169.954 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -81.15 138.78 19.71 Favored Glycine 0 C--N 1.335 0.517 0 N-CA-C 110.273 -1.131 . . . . 0.0 110.273 -178.721 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 38.9 t -122.15 133.39 68.61 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 174.628 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 13.4 mt -85.41 135.32 38.87 Favored Pre-proline 0 CA--C 1.535 0.369 0 N-CA-C 105.561 -2.015 . . . . 0.0 105.561 169.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -73.21 167.16 28.05 Favored 'Trans proline' 0 CA--C 1.54 0.786 0 C-N-CA 121.815 1.677 . . . . 0.0 111.732 -179.161 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -94.38 -56.85 2.67 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 168.807 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 49.0 m -118.73 -55.14 2.21 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -169.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.8 tp 52.21 39.29 26.63 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 126.823 2.049 . . . . 0.0 113.581 -174.621 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -79.61 163.85 56.64 Favored Pre-proline 0 CA--C 1.544 0.721 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 171.025 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -82.39 94.61 0.88 Allowed 'Trans proline' 0 CA--C 1.542 0.896 0 C-N-CA 121.848 1.699 . . . . 0.0 111.863 -176.132 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -173.48 -176.24 1.27 Allowed 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 104.48 -2.415 . . . . 0.0 104.48 -178.178 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -144.24 154.33 15.27 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 CA-C-N 119.42 1.009 . . . . 0.0 112.325 174.738 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 118.6 85.41 1.01 Allowed Glycine 0 CA--C 1.531 1.035 0 N-CA-C 107.93 -2.068 . . . . 0.0 107.93 -174.245 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 81.9 mt -36.55 139.41 0.18 Allowed 'General case' 0 C--N 1.352 0.711 0 N-CA-C 115.192 1.553 . . . . 0.0 115.192 -169.688 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 4.4 p -58.96 151.89 52.98 Favored Pre-proline 0 CA--C 1.535 0.4 0 CA-C-N 113.97 -1.468 . . . . 0.0 108.74 169.631 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -60.49 -35.24 91.25 Favored 'Trans proline' 0 CA--C 1.537 0.63 0 C-N-CA 121.726 1.618 . . . . 0.0 111.74 -176.584 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' THR . . . . . 0.483 HG22 ' HA3' ' A' ' 72' ' ' GLY . 1.0 OUTLIER -60.57 -36.21 77.93 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 123.704 0.802 . . . . 0.0 110.834 177.123 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 61.4 t -94.2 -32.49 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 C-N-CA 122.628 0.371 . . . . 0.0 110.004 -172.451 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -53.91 -46.45 71.47 Favored 'General case' 0 C--N 1.33 -0.24 0 O-C-N 121.347 -0.846 . . . . 0.0 109.311 169.422 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -69.06 -16.77 63.77 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 -177.38 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 24.4 mmm -77.94 -8.03 57.57 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 125.47 1.508 . . . . 0.0 113.039 172.135 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 53.5 mt -56.86 -56.06 16.58 Favored 'Isoleucine or valine' 0 C--N 1.344 0.353 0 CA-C-N 120.835 1.652 . . . . 0.0 109.157 176.222 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -67.52 -45.59 47.16 Favored Pre-proline 0 CA--C 1.544 0.714 0 CA-C-O 117.822 -1.085 . . . . 0.0 111.033 -174.227 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -42.94 -58.5 1.3 Allowed 'Trans proline' 0 C--N 1.349 0.578 1 C-N-CA 125.478 4.118 . . . . 0.0 112.979 168.66 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -69.2 -35.91 76.72 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.363 -0.835 . . . . 0.0 112.148 -177.917 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 25.8 mt -57.07 -41.14 78.26 Favored 'General case' 0 CA--C 1.521 -0.146 0 CA-C-N 119.546 1.066 . . . . 0.0 109.068 171.746 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -62.25 -35.05 77.78 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 118.862 0.755 . . . . 0.0 110.165 178.376 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 144' ' ' GLN . . . . . 0.625 ' HG3' HD12 ' A' ' 76' ' ' ILE . 0.4 OUTLIER -64.24 -46.35 84.18 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 119.623 1.102 . . . . 0.0 111.217 173.064 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 36.2 t -56.65 -48.67 80.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 178.181 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 37.7 mt -62.89 -34.46 77.46 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 118.487 -0.768 . . . . 0.0 110.946 178.104 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -67.2 -46.43 73.89 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 119.81 1.186 . . . . 0.0 110.83 178.125 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -64.46 -32.26 73.82 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 119.679 1.127 . . . . 0.0 111.12 177.816 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 14.1 mt -63.11 -54.75 32.95 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 171.272 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 78.4 mtm-85 -61.21 -32.05 71.82 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 120.336 1.426 . . . . 0.0 111.765 -178.125 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -70.52 -27.65 64.34 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 118.677 0.671 . . . . 0.0 110.332 179.808 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 23.5 m -81.12 5.47 16.66 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.601 1.16 . . . . 0.0 111.77 169.884 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 70.89 13.7 72.5 Favored Glycine 0 CA--C 1.53 0.997 0 CA-C-O 117.641 -1.644 . . . . 0.0 112.497 -171.238 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 58.3 t -90.62 118.05 35.1 Favored 'Isoleucine or valine' 0 C--N 1.347 0.463 0 CA-C-N 120.603 2.202 . . . . 0.0 107.787 -177.965 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -93.86 96.06 9.5 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 171.707 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -59.63 139.93 56.8 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 169.004 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 11.1 mm -85.41 123.61 72.71 Favored Pre-proline 0 CA--C 1.534 0.342 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 -174.762 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -64.2 103.23 0.42 Allowed 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 122.913 2.409 . . . . 0.0 105.928 171.184 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 20.4 tpp85 45.3 -110.28 0.22 Allowed 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 104.954 -2.239 . . . . 0.0 104.954 -166.655 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 3.7 p . . . . . 0 C--N 1.324 -0.54 0 CA-C-N 119.766 1.166 . . . . 0.0 109.576 169.947 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 8.5 ptp180 . . . . . 0 N--CA 1.48 1.059 0 CA-C-O 118.036 -0.983 . . . . 0.0 108.662 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 52.0 mt -140.31 144.16 28.19 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-N 120.033 1.288 . . . . 0.0 110.873 -169.732 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 3.1 mt -127.8 122.18 32.07 Favored 'General case' 0 CA--C 1.519 -0.248 0 N-CA-C 107.046 -1.465 . . . . 0.0 107.046 168.682 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.469 HG12 HG12 ' A' ' 23' ' ' VAL . 11.5 t -97.46 111.86 28.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 1 N-CA-C 100.125 -4.028 . . . . 0.0 100.125 168.688 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.525 ' HB2' HD21 ' A' ' 58' ' ' LEU . 0.5 OUTLIER -117.35 107.32 14.23 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 123.112 0.565 . . . . 0.0 109.497 -168.048 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -89.74 123.82 7.12 Favored Glycine 0 N--CA 1.448 -0.511 0 N-CA-C 108.722 -1.751 . . . . 0.0 108.722 179.606 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.6 m -132.52 -177.91 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.805 0 C-N-CA 124.053 0.941 . . . . 0.0 109.532 -179.314 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 98.07 131.22 7.07 Favored Glycine 0 N--CA 1.437 -1.281 0 N-CA-C 107.158 -2.377 . . . . 0.0 107.158 -169.921 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -69.16 131.52 45.08 Favored 'General case' 0 N--CA 1.451 -0.379 0 O-C-N 121.846 -0.797 . . . . 0.0 111.947 -168.866 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.4 pt -79.06 41.39 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 123.605 0.762 . . . . 0.0 112.961 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 19.4 mt -129.7 -12.09 4.35 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 120.129 1.331 . . . . 0.0 109.833 171.22 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.1 mp -117.1 62.7 0.73 Allowed 'General case' 0 C--N 1.346 0.434 0 CA-C-O 122.116 0.96 . . . . 0.0 109.766 -169.662 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.9 m 51.71 -119.59 1.48 Allowed 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 114.322 -1.308 . . . . 0.0 112.059 169.978 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 61.3 m-20 -50.92 -23.07 2.58 Favored 'General case' 0 N--CA 1.44 -0.929 0 C-N-CA 127.866 2.466 . . . . 0.0 114.282 179.083 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.411 ' CD ' HE22 ' A' ' 94' ' ' GLN . 1.6 tp10 -63.28 -26.34 68.73 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 119.643 1.11 . . . . 0.0 110.456 -179.472 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.74 -8.7 45.34 Favored 'General case' 0 N--CA 1.438 -1.059 0 CA-C-O 116.819 -1.562 . . . . 0.0 111.215 176.744 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.1 tp -51.67 -45.43 36.93 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.414 0 CA-C-N 121.341 1.882 . . . . 0.0 111.132 -173.783 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -63.51 -34.63 90.45 Favored Glycine 0 CA--C 1.526 0.771 0 CA-C-N 119.131 0.878 . . . . 0.0 111.324 -177.818 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 97.8 t -68.18 -48.43 73.9 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 CA-C-N 117.518 0.659 . . . . 0.0 109.32 172.304 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 24.1 mmt180 -57.52 -29.65 64.5 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 117.429 -1.272 . . . . 0.0 112.147 177.287 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 5.7 mm -62.42 -53.98 40.12 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-N 120.818 1.645 . . . . 0.0 109.046 176.729 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.469 HG12 HG12 ' A' ' 5' ' ' VAL . 26.5 m -70.61 -34.7 58.14 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 CA-C-N 118.833 0.742 . . . . 0.0 111.312 -176.206 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 58.3 mt-10 -65.36 -45.03 85.72 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 118.954 0.797 . . . . 0.0 110.015 176.209 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.67 -39.88 95.43 Favored 'General case' 0 N--CA 1.452 -0.342 0 O-C-N 121.808 -0.557 . . . . 0.0 109.982 176.814 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 5.7 tp -64.55 -39.2 93.32 Favored 'General case' 0 C--O 1.221 -0.4 0 CA-C-N 118.858 0.754 . . . . 0.0 110.169 -178.368 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -61.95 -26.23 68.07 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 121.501 0.667 . . . . 0.0 112.493 -178.914 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -93.33 -40.86 10.17 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 125.994 1.718 . . . . 0.0 111.125 -178.573 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 37.3 mmm-85 -83.29 -31.17 27.04 Favored 'General case' 0 C--N 1.333 -0.112 0 C-N-CA 123.021 0.528 . . . . 0.0 110.833 -174.393 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -123.89 146.92 48.09 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-O 122.313 1.054 . . . . 0.0 112.728 -177.365 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 39.3 mm -98.92 135.29 34.52 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 N-CA-C 104.887 -2.264 . . . . 0.0 104.887 169.404 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -120.24 148.6 47.62 Favored Pre-proline 0 CA--C 1.537 0.447 0 C-N-CA 124.025 0.93 . . . . 0.0 109.943 -169.758 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -67.4 158.62 56.2 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 123.05 2.5 . . . . 0.0 110.253 170.12 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -57.69 -33.79 68.76 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 114.48 1.289 . . . . 0.0 114.48 -169.662 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 10.8 p90 -74.37 -12.82 60.63 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 112.786 0.661 . . . . 0.0 112.786 -176.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 74.0 t -89.67 125.61 42.62 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 172.319 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 52.1 mm-40 -113.18 130.6 56.16 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 169.01 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -95.78 116.28 37.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 104.877 -2.268 . . . . 0.0 104.877 168.766 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 65.3 tp -118.19 129.02 55.26 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 118.073 0.397 . . . . 0.0 110.373 -179.149 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -88.7 107.04 18.73 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 106.312 -1.736 . . . . 0.0 106.312 168.708 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -92.32 -40.33 5.14 Favored Glycine 0 CA--C 1.535 1.308 0 N-CA-C 110.432 -1.067 . . . . 0.0 110.432 169.869 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 57.3 -103.69 0.33 Allowed Glycine 0 C--N 1.341 0.807 0 CA-C-N 117.773 0.787 . . . . 0.0 112.683 171.78 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 19.8 p -67.9 -5.82 18.76 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 126.521 1.929 . . . . 0.0 113.237 -179.518 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.48 -63.16 1.39 Allowed 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 -172.16 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 53.69 -110.06 1.31 Allowed Glycine 0 CA--C 1.535 1.283 0 N-CA-C 110.62 -0.992 . . . . 0.0 110.62 -170.867 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.06 -30.42 66.18 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.553 1.141 . . . . 0.0 111.268 -177.382 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -56.82 -19.74 18.86 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 -174.092 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 20.5 mt -85.12 12.99 6.76 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 113.551 0.945 . . . . 0.0 113.551 -177.437 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.576 ' HA ' HG13 ' A' ' 100' ' ' VAL . 6.3 tt -42.04 -61.0 1.24 Allowed 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.27 1.028 . . . . 0.0 112.63 -172.824 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -79.73 -30.42 43.96 Favored Glycine 0 CA--C 1.527 0.819 0 N-CA-C 111.392 -0.683 . . . . 0.0 111.392 -179.548 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -67.43 -36.06 80.5 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 118.428 1.114 . . . . 0.0 112.112 -169.919 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.431 ' SD ' HG11 ' A' ' 100' ' ' VAL . 36.2 mtp -75.4 -9.93 59.0 Favored 'General case' 0 N--CA 1.451 -0.399 0 O-C-N 122.037 -0.414 . . . . 0.0 111.765 -178.264 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.63 151.62 40.77 Favored 'General case' 0 N--CA 1.445 -0.723 0 C-N-CA 123.149 0.58 . . . . 0.0 112.474 -169.271 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . 0.281 15.5 p30 53.51 21.21 2.38 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 128.749 2.82 . . . . 0.0 116.211 170.041 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 17.4 mmt180 -75.5 160.0 30.67 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 169.749 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -86.57 -52.39 5.58 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 176.734 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . 0.25 0.0 OUTLIER -124.53 143.31 50.74 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 119.952 1.251 . . . . 0.0 107.713 169.37 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.525 HD21 ' HB2' ' A' ' 6' ' ' LEU . 4.5 tt -139.97 120.8 14.45 Favored 'General case' 0 CA--C 1.501 -0.911 0 N-CA-C 105.476 -2.046 . . . . 0.0 105.476 -178.343 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 25.8 mt -100.21 106.09 18.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 106.104 -1.813 . . . . 0.0 106.104 179.57 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.445 HD13 HD11 ' A' ' 97' ' ' LEU . 16.9 mt -75.13 133.63 31.04 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 N-CA-C 105.135 -2.172 . . . . 0.0 105.135 169.682 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -120.16 121.49 38.89 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 104.915 -2.254 . . . . 0.0 104.915 168.753 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 36.8 t0 -156.75 162.19 39.77 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 118.529 0.604 . . . . 0.0 110.287 -171.863 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.559 ' HB1' ' HD3' ' A' ' 121' ' ' PRO . . . -103.74 157.23 17.21 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 121.927 0.87 . . . . 0.0 109.994 172.227 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 5.1 mp -134.64 88.09 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 N-CA-C 106.892 -1.521 . . . . 0.0 106.892 -176.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.446 HG11 HD22 ' A' ' 124' ' ' LEU . 31.5 m -52.48 -21.1 2.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 C-N-CA 125.89 1.676 . . . . 0.0 112.217 168.568 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.6 m -78.01 174.08 11.49 Favored 'General case' 0 N--CA 1.442 -0.845 0 C-N-CA 124.249 1.02 . . . . 0.0 111.852 -169.289 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 18.2 ttmm 67.25 163.12 0.19 Allowed 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 126.108 1.763 . . . . 0.0 111.907 -179.735 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 23.1 mtmt -77.38 -7.83 56.72 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 125.301 1.44 . . . . 0.0 112.134 179.567 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 43.5 t-20 -68.16 156.94 36.46 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.232 1.013 . . . . 0.0 110.234 -169.812 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 2.2 m -62.3 149.18 88.08 Favored Pre-proline 0 CA--C 1.546 0.795 0 C-N-CA 124.663 1.185 . . . . 0.0 113.446 -169.004 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_exo -58.9 159.81 20.14 Favored 'Trans proline' 0 CA--C 1.533 0.465 0 C-N-CA 124.029 3.153 . . . . 0.0 111.625 168.943 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 65.64 19.15 66.79 Favored Glycine 0 CA--C 1.53 0.986 0 CA-C-O 119.753 -0.471 . . . . 0.0 112.952 172.299 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 2.7 m -99.24 142.46 30.7 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 124.495 1.118 . . . . 0.0 109.448 -172.929 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 13.4 ttp -91.1 134.88 34.16 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 172.607 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 69.6 mtm -122.28 115.73 22.86 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 170.539 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.453 HD12 ' HG2' ' A' ' 144' ' ' GLN . 28.1 mm -102.87 120.81 53.22 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 -177.798 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.6 mp -128.09 137.18 52.04 Favored 'General case' 0 C--O 1.236 0.376 0 O-C-N 123.97 0.793 . . . . 0.0 109.812 -173.09 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 53.6 mtt85 -89.16 176.31 7.02 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.237 1.015 . . . . 0.0 110.042 -177.9 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -38.01 -58.94 0.89 Allowed 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.466 1.507 . . . . 0.0 113.762 -173.119 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -86.61 -15.9 38.36 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -171.447 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -75.13 -36.83 61.57 Favored 'General case' 0 N--CA 1.457 -0.11 0 O-C-N 121.876 -0.515 . . . . 0.0 109.902 -175.336 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.52 HG12 ' CE2' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -66.37 -49.23 54.39 Favored Pre-proline 0 CA--C 1.535 0.383 0 CA-C-O 117.653 -1.165 . . . . 0.0 112.585 -174.619 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -55.32 -37.78 94.3 Favored 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 121.758 1.639 . . . . 0.0 111.594 174.651 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.11 -2.37 37.08 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 114.234 1.198 . . . . 0.0 114.234 176.901 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -102.48 -38.46 7.56 Favored 'General case' 0 C--N 1.344 0.33 0 CA-C-N 119.805 1.184 . . . . 0.0 111.376 179.632 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.52 ' CE2' HG12 ' A' ' 82' ' ' VAL . 43.9 m-85 -70.41 0.94 5.62 Favored 'General case' 0 CA--C 1.544 0.746 0 O-C-N 121.641 -0.662 . . . . 0.0 112.5 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 64.5 p -57.84 -21.0 40.23 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.577 1.551 . . . . 0.0 112.687 174.667 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 11.1 p30 -60.82 -30.51 70.12 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 118.66 -0.686 . . . . 0.0 112.489 175.626 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 30.3 mtmm 50.82 27.34 3.05 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 125.152 1.381 . . . . 0.0 114.32 177.205 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 13.5 mt -72.35 -43.15 65.01 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 O-C-N 121.252 -0.905 . . . . 0.0 109.523 -174.879 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 3.1 p -113.25 143.2 28.79 Favored Pre-proline 0 CA--C 1.544 0.716 0 C-N-CA 123.675 0.79 . . . . 0.0 112.54 -169.541 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -75.31 -42.26 0.5 Allowed 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 122.76 2.307 . . . . 0.0 113.704 -169.147 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 10.2 t-80 -61.81 -45.42 93.91 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 119.399 1.0 . . . . 0.0 108.885 178.361 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.411 HE22 ' CD ' ' A' ' 16' ' ' GLU . 21.5 mp0 -62.15 -41.94 98.77 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 125.27 1.428 . . . . 0.0 108.634 -177.775 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 50.7 tp -64.14 -38.19 90.16 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 119.145 0.884 . . . . 0.0 110.995 174.866 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -63.1 -51.11 57.69 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 110.556 -1.018 . . . . 0.0 110.556 176.599 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.445 HD11 HD13 ' A' ' 60' ' ' ILE . 2.8 tm? -56.94 -43.05 81.12 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.207 0.603 . . . . 0.0 109.963 175.855 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -62.77 -37.81 88.13 Favored 'General case' 0 N--CA 1.452 -0.36 0 O-C-N 121.306 -0.871 . . . . 0.0 111.413 177.61 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -69.3 -22.36 63.8 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 118.851 0.75 . . . . 0.0 110.83 178.327 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.576 HG13 ' HA ' ' A' ' 49' ' ' LEU . 97.6 t -68.04 -42.72 85.47 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 168.631 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 92.1 mt -63.73 -36.75 84.88 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 119.348 0.977 . . . . 0.0 109.934 178.836 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 70.3 m -64.59 -41.68 96.08 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 119.249 0.931 . . . . 0.0 110.726 171.178 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.49 -44.07 97.74 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 120.254 1.388 . . . . 0.0 110.611 176.687 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.9 mt -63.37 -33.04 74.67 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.669 1.188 . . . . 0.0 110.765 176.698 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 65.7 ttp85 -73.65 -31.79 63.68 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.008 0.923 . . . . 0.0 110.001 176.057 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 14.9 m-30 -71.34 -46.04 61.5 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 119.185 0.902 . . . . 0.0 110.473 177.095 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 34.0 p -73.84 -24.33 59.76 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 123.128 0.571 . . . . 0.0 112.132 -178.729 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 74.63 8.0 80.55 Favored Glycine 0 CA--C 1.536 1.351 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -168.329 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -85.04 22.0 1.51 Allowed 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 119.851 1.826 . . . . 0.0 111.438 174.804 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -60.48 137.63 92.38 Favored Pre-proline 0 CA--C 1.545 0.771 0 C-N-CA 124.175 0.99 . . . . 0.0 108.737 169.75 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -61.25 163.36 17.4 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.779 2.319 . . . . 0.0 114.543 -176.192 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 68.3 mmtt -67.96 -35.57 78.61 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 118.941 -0.552 . . . . 0.0 112.37 175.117 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 8.2 ttmm -142.08 66.63 1.34 Allowed 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 -175.382 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 7.8 tt -70.83 138.38 50.26 Favored 'General case' 0 C--O 1.234 0.238 0 O-C-N 120.063 -1.648 . . . . 0.0 108.476 172.794 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -134.61 136.59 43.02 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 179.487 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -114.06 122.46 46.96 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 119.956 1.253 . . . . 0.0 107.874 175.639 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 21.3 t -95.87 85.52 1.63 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 N-CA-C 106.316 -1.735 . . . . 0.0 106.316 169.67 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -77.25 148.63 34.57 Favored Glycine 0 N--CA 1.445 -0.741 0 N-CA-C 110.706 -0.958 . . . . 0.0 110.706 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 46.9 t -124.54 165.72 21.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 171.716 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 15.5 mt -117.55 120.21 33.39 Favored Pre-proline 0 N--CA 1.468 0.428 0 CA-C-N 121.232 1.833 . . . . 0.0 108.605 171.069 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.559 ' HD3' ' HB1' ' A' ' 63' ' ' ALA . 3.3 Cg_exo -55.16 158.93 10.84 Favored 'Trans proline' 0 N--CA 1.455 -0.775 1 C-N-CA 126.142 4.561 . . . . 0.0 116.093 175.614 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -107.75 -64.24 1.23 Allowed 'General case' 0 C--O 1.236 0.344 0 C-N-CA 124.348 1.059 . . . . 0.0 109.628 178.28 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 70.5 m -106.03 -50.13 3.23 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 119.093 -0.479 . . . . 0.0 110.154 -171.923 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.446 HD22 HG11 ' A' ' 65' ' ' VAL . 1.2 tp 51.97 32.51 10.19 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 124.126 0.971 . . . . 0.0 112.812 178.651 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -83.49 164.6 44.5 Favored Pre-proline 0 CA--C 1.544 0.734 0 O-C-N 121.525 -0.734 . . . . 0.0 109.417 176.423 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -78.65 82.96 2.34 Favored 'Trans proline' 0 CA--C 1.544 1.012 0 C-N-CA 121.869 1.713 . . . . 0.0 111.953 -173.142 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -175.67 153.22 1.4 Allowed 'General case' 0 C--O 1.234 0.269 0 N-CA-C 104.276 -2.491 . . . . 0.0 104.276 -177.917 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -110.38 160.71 9.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.552 0.692 . . . . 0.0 111.861 -170.234 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 108.11 141.37 9.69 Favored Glycine 0 CA--C 1.529 0.929 0 N-CA-C 106.457 -2.657 . . . . 0.0 106.457 -169.286 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 74.8 mt -80.7 154.03 27.52 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 118.065 0.932 . . . . 0.0 109.667 179.829 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 68.2 p -70.82 168.47 20.15 Favored Pre-proline 0 CA--C 1.541 0.619 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 169.394 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_exo -59.76 -40.21 66.08 Favored 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 121.717 1.611 . . . . 0.0 111.165 173.447 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 85.3 m -59.67 -37.45 78.8 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 124.619 1.168 . . . . 0.0 111.751 -179.358 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 58.4 t -98.51 -29.32 3.53 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 O-C-N 121.776 -0.578 . . . . 0.0 110.638 -174.482 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -52.37 -45.37 65.74 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 119.518 1.054 . . . . 0.0 108.793 169.193 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -65.68 -15.97 63.31 Favored 'General case' 0 N--CA 1.447 -0.575 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 -177.589 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 14.1 mmm -83.45 -8.41 59.38 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 125.321 1.448 . . . . 0.0 112.425 175.475 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 54.8 mt -56.75 -56.51 13.84 Favored 'Isoleucine or valine' 0 C--N 1.343 0.293 0 CA-C-N 120.192 1.36 . . . . 0.0 108.788 172.071 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 64.3 mm-40 -63.48 -49.7 76.95 Favored Pre-proline 0 CA--C 1.541 0.618 0 CA-C-O 117.468 -1.253 . . . . 0.0 109.99 -172.885 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -39.96 -56.58 1.38 Allowed 'Trans proline' 0 C--N 1.35 0.613 1 C-N-CA 125.798 4.332 . . . . 0.0 113.353 168.904 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -69.93 -35.5 74.58 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.649 -178.951 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 37.3 mt -64.06 -45.99 86.35 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 120.806 1.639 . . . . 0.0 109.345 176.406 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -54.61 -36.43 64.46 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 118.52 0.6 . . . . 0.0 110.226 174.87 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' GLN . . . . . 0.453 ' HG2' HD12 ' A' ' 76' ' ' ILE . 70.8 tp60 -75.86 -38.99 57.4 Favored 'General case' 0 N--CA 1.423 -1.809 0 O-C-N 121.465 -0.772 . . . . 0.0 110.913 -179.562 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 37.2 t -58.68 -45.18 90.99 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 CA-C-N 119.276 0.943 . . . . 0.0 108.93 173.632 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 56.8 mt -60.85 -36.82 80.12 Favored 'General case' 0 C--O 1.226 -0.176 0 CA-C-O 119.09 -0.481 . . . . 0.0 110.218 175.718 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -68.68 -46.11 69.94 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 119.523 1.056 . . . . 0.0 111.29 179.464 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -66.88 -28.81 68.63 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 119.76 1.164 . . . . 0.0 111.068 178.424 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 23.9 mt -63.39 -51.22 66.71 Favored 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 169.778 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 96.8 mtt-85 -66.69 -16.06 63.95 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 117.845 -1.074 . . . . 0.0 112.543 179.33 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 33.1 mm-40 -65.97 -24.38 66.78 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 120.769 1.622 . . . . 0.0 110.899 172.176 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 65.3 m -100.53 18.98 17.72 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 119.436 1.016 . . . . 0.0 110.087 168.409 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 69.43 20.03 74.99 Favored Glycine 0 C--N 1.337 0.595 0 CA-C-O 117.838 -1.535 . . . . 0.0 112.276 -178.073 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 18.0 t -88.05 117.3 31.53 Favored 'Isoleucine or valine' 0 C--N 1.344 0.358 0 CA-C-N 120.23 2.015 . . . . 0.0 107.393 -172.331 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -101.87 88.14 3.3 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 177.16 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -58.06 141.7 49.2 Favored 'General case' 0 CA--C 1.539 0.558 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 169.223 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 157' ' ' ILE . . . . . 0.4 ' CG2' ' HA ' ' A' ' 160' ' ' SER . 30.9 mm -98.82 122.56 52.52 Favored Pre-proline 0 N--CA 1.463 0.176 0 CA-C-O 117.396 -1.287 . . . . 0.0 108.976 -172.0 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -63.12 106.53 0.56 Allowed 'Trans proline' 0 N--CA 1.459 -0.529 0 C-N-CA 122.17 1.913 . . . . 0.0 109.017 173.237 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 56.7 mtm180 39.9 48.02 1.98 Allowed 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 125.974 1.71 . . . . 0.0 113.604 179.273 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 160' ' ' SER . . . . . 0.4 ' HA ' ' CG2' ' A' ' 157' ' ' ILE 0.272 2.4 p . . . . . 0 CA--C 1.545 0.764 0 C-N-CA 126.698 1.999 . . . . 0.0 115.137 179.628 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 6.4 ptm85 . . . . . 0 N--CA 1.482 1.128 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 33.9 mt -137.72 148.77 25.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 CA-C-N 121.06 1.755 . . . . 0.0 111.922 -169.023 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 16.4 tp -134.55 111.07 9.77 Favored 'General case' 0 C--N 1.341 0.199 0 N-CA-C 105.484 -2.043 . . . . 0.0 105.484 168.081 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 24.9 t -90.68 115.36 29.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 102.927 -2.99 . . . . 0.0 102.927 170.403 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -115.37 113.03 23.23 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 123.173 0.589 . . . . 0.0 110.927 -168.376 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -94.13 121.65 6.78 Favored Glycine 0 N--CA 1.445 -0.712 0 N-CA-C 108.055 -2.018 . . . . 0.0 108.055 173.625 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.4 m -131.95 -167.68 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 C-N-CA 124.012 0.925 . . . . 0.0 108.625 -177.756 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 105.49 158.1 22.75 Favored Glycine 0 C--N 1.333 0.38 0 N-CA-C 110.505 -1.038 . . . . 0.0 110.505 -175.556 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -81.65 94.81 7.02 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 124.572 1.149 . . . . 0.0 108.915 -174.403 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.3 pt -69.82 27.58 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 N-CA-C 114.659 1.355 . . . . 0.0 114.659 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 38.3 mt -114.31 -9.66 12.78 Favored 'General case' 0 C--O 1.224 -0.245 0 O-C-N 121.138 -0.976 . . . . 0.0 108.581 171.34 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.1 mp -120.75 74.35 1.06 Allowed 'General case' 0 CA--C 1.502 -0.879 0 N-CA-C 105.475 -2.046 . . . . 0.0 105.475 -169.868 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 20.1 m 36.08 -106.53 0.04 OUTLIER 'General case' 0 N--CA 1.447 -0.585 0 O-C-N 126.215 2.197 . . . . 0.0 113.012 169.118 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -68.2 -13.67 62.41 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 114.628 1.344 . . . . 0.0 114.628 -170.165 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -65.84 -19.57 65.93 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 121.457 1.935 . . . . 0.0 111.769 173.258 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.58 -10.81 49.19 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 116.165 -1.874 . . . . 0.0 111.162 172.552 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 6.6 tp -54.96 -38.79 46.65 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 CA-C-N 121.753 2.069 . . . . 0.0 110.977 -178.155 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -60.0 -46.04 94.85 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 110.764 -0.935 . . . . 0.0 110.764 178.727 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 61.7 t -65.11 -47.4 87.91 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 O-C-N 122.175 -0.603 . . . . 0.0 109.68 174.559 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 20.3 mmt180 -60.21 -32.01 70.7 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 117.374 -1.298 . . . . 0.0 112.922 -178.181 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 20.3 mt -62.97 -44.13 99.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-N 121.151 1.796 . . . . 0.0 110.158 179.257 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 28.4 m -73.74 -34.59 41.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 CA-C-N 120.128 1.331 . . . . 0.0 111.542 -178.185 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 57.8 mt-10 -62.22 -42.37 99.25 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 117.957 0.344 . . . . 0.0 110.458 171.937 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -67.79 -38.29 83.15 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 119.051 0.842 . . . . 0.0 111.23 176.747 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 7.1 tp -63.51 -39.52 94.64 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 119.418 1.008 . . . . 0.0 109.844 -177.463 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -61.93 -18.83 61.66 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.88 0.872 . . . . 0.0 113.117 -179.474 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -102.57 -43.61 5.57 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 126.622 1.969 . . . . 0.0 110.992 -178.888 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 53.5 mmt-85 -74.69 -34.11 62.57 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.259 0.623 . . . . 0.0 110.547 -176.184 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 -124.89 154.03 41.71 Favored 'General case' 0 CA--C 1.521 -0.163 0 CA-C-O 121.417 0.627 . . . . 0.0 111.944 -178.201 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 47.7 mm -106.26 135.27 45.22 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 N-CA-C 103.418 -2.808 . . . . 0.0 103.418 168.047 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -119.07 149.78 47.6 Favored Pre-proline 0 C--O 1.237 0.438 0 CA-C-O 118.661 -0.685 . . . . 0.0 109.953 -169.605 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -65.95 162.08 36.79 Favored 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 122.992 2.461 . . . . 0.0 111.562 173.167 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -58.25 -33.69 69.65 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 115.046 1.498 . . . . 0.0 115.046 -169.196 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 8.6 p90 -73.06 -8.73 57.05 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 -178.016 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 76.1 t -88.99 128.16 41.27 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 174.876 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -116.08 124.35 50.19 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 105.913 -1.884 . . . . 0.0 105.913 169.063 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -93.53 112.9 27.33 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 N-CA-C 104.402 -2.444 . . . . 0.0 104.402 168.61 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 61.4 tp -112.36 128.94 56.43 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 -178.606 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -89.31 118.96 29.37 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 169.515 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -78.66 -79.98 0.76 Allowed Glycine 0 CA--C 1.526 0.764 0 N-CA-C 107.234 -2.346 . . . . 0.0 107.234 169.475 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 78.54 104.65 0.2 Allowed Glycine 0 C--N 1.344 0.974 0 N-CA-C 108.675 -1.77 . . . . 0.0 108.675 -177.762 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 12.9 p 52.74 50.72 17.48 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 123.535 0.734 . . . . 0.0 109.286 -178.792 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -104.4 -79.66 0.55 Allowed 'General case' 0 C--N 1.348 0.528 0 CA-C-N 115.312 -0.858 . . . . 0.0 112.105 -169.239 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 59.81 -110.55 2.88 Favored Glycine 0 CA--C 1.533 1.164 0 N-CA-C 110.075 -1.21 . . . . 0.0 110.075 -174.847 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 12.1 tpt -62.52 -21.57 65.63 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.844 1.258 . . . . 0.0 113.442 -173.366 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -63.91 -18.81 64.58 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 114.193 1.183 . . . . 0.0 114.193 -174.23 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 10.3 mt -100.52 14.37 31.53 Favored 'General case' 0 C--N 1.34 0.173 0 N-CA-C 115.643 1.719 . . . . 0.0 115.643 -168.087 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 6.1 tt -49.1 -55.63 11.63 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 118.968 0.804 . . . . 0.0 110.9 -176.562 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -67.67 -32.64 78.74 Favored Glycine 0 CA--C 1.527 0.809 0 CA-C-O 119.224 -0.764 . . . . 0.0 112.419 -176.491 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -80.76 -35.36 33.38 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 119.049 1.424 . . . . 0.0 110.763 -171.793 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 79.8 mtp -69.28 -14.07 62.74 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.134 0.973 . . . . 0.0 111.088 176.084 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -68.07 140.11 56.26 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 123.572 0.749 . . . . 0.0 112.199 -169.931 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 15.7 p30 50.56 22.17 1.02 Allowed 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 127.776 2.43 . . . . 0.0 115.09 172.746 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 17.9 mmt180 -71.23 150.15 45.56 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 170.315 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 46.1 m-20 -79.85 -53.68 6.55 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -116.22 145.16 43.34 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-N 120.422 1.464 . . . . 0.0 107.474 168.802 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 22.7 tp -132.19 105.83 7.59 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 103.516 -2.772 . . . . 0.0 103.516 176.044 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 28.0 mt -93.69 112.73 27.15 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 N-CA-C 104.205 -2.517 . . . . 0.0 104.205 173.138 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 24.1 mt -93.49 130.72 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 N-CA-C 105.572 -2.01 . . . . 0.0 105.572 176.825 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -111.83 124.13 51.71 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 105.414 -2.069 . . . . 0.0 105.414 169.656 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.406 ' CG ' HE21 ' A' ' 94' ' ' GLN . 42.9 t0 -158.59 159.12 35.1 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 124.285 1.034 . . . . 0.0 108.265 -177.031 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -89.25 144.7 25.91 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 170.099 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 31.9 mt -88.27 -25.56 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 C-N-CA 123.917 0.887 . . . . 0.0 110.453 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . 0.461 12.5 m 58.51 -15.08 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 N-CA-C 119.449 3.129 . . . . 0.0 119.449 176.296 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 5.9 p -157.99 131.26 7.59 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 121.101 1.773 . . . . 0.0 113.778 169.037 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 12.7 tppt? -166.39 175.35 8.24 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 128.236 2.614 . . . . 0.0 105.485 169.063 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.0 -23.8 63.2 Favored 'General case' 0 N--CA 1.474 0.741 0 O-C-N 121.662 -0.648 . . . . 0.0 111.62 174.908 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 -69.14 162.37 27.15 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.078 0.951 . . . . 0.0 110.994 -173.374 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 3.1 m -61.63 154.22 66.76 Favored Pre-proline 0 CA--C 1.548 0.873 0 C-N-CA 124.922 1.289 . . . . 0.0 112.697 -169.751 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_exo -57.32 159.34 16.11 Favored 'Trans proline' 0 N--CA 1.462 -0.375 0 C-N-CA 123.878 3.052 . . . . 0.0 112.591 169.607 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 64.99 10.18 44.91 Favored Glycine 0 CA--C 1.538 1.514 0 CA-C-O 119.314 -0.714 . . . . 0.0 114.508 171.522 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 3.3 m -90.98 151.93 20.88 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 125.932 1.693 . . . . 0.0 111.305 -169.408 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 29.0 ttp -96.3 139.5 32.35 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 169.789 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 70.0 mtm -131.14 131.17 43.91 Favored 'General case' 0 N--CA 1.462 0.129 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 169.412 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 9.5 mm -89.25 123.17 41.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 177.89 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -113.86 123.97 51.09 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 171.803 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 85.0 mtm180 -87.67 174.36 8.47 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 123.537 0.735 . . . . 0.0 110.515 -178.571 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -41.37 -53.87 3.19 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 115.884 1.809 . . . . 0.0 115.884 -169.961 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -84.03 -16.68 43.01 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -177.002 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -82.4 -37.01 26.14 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 -171.564 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.54 HG12 ' CE2' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -64.57 -45.51 76.58 Favored Pre-proline 0 CA--C 1.531 0.242 0 CA-C-O 117.221 -1.371 . . . . 0.0 113.862 -176.732 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -53.61 -42.34 66.73 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 121.981 1.787 . . . . 0.0 110.262 174.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -75.54 4.34 7.74 Favored 'General case' 0 CA--C 1.55 0.943 0 N-CA-C 114.466 1.284 . . . . 0.0 114.466 175.28 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -116.18 -41.77 3.12 Favored 'General case' 0 C--N 1.343 0.316 0 CA-C-N 120.09 1.313 . . . . 0.0 111.155 -177.832 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.676 ' HB3' ' HB2' ' A' ' 98' ' ' ALA . 63.8 m-85 -62.75 -8.92 7.65 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 178.167 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 63.2 p -51.65 -28.88 15.84 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.928 1.291 . . . . 0.0 112.955 173.216 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 53.8 t-20 -52.46 117.4 2.83 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.279 0.632 . . . . 0.0 111.17 -175.54 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -74.95 -19.36 60.14 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.733 0.813 . . . . 0.0 112.329 -173.575 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 52.7 mt -65.47 -48.89 81.27 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 -178.678 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 6.6 m -76.08 111.49 15.34 Favored Pre-proline 0 CA--C 1.55 0.955 0 C-N-CA 125.406 1.482 . . . . 0.0 110.444 -169.809 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -70.56 -60.12 0.07 OUTLIER 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 122.931 2.421 . . . . 0.0 113.847 -168.767 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 6.7 t-80 -62.32 -40.06 95.09 Favored 'General case' 0 N--CA 1.463 0.2 0 O-C-N 121.463 -0.773 . . . . 0.0 109.319 -178.272 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.406 HE21 ' CG ' ' A' ' 62' ' ' ASP . 18.3 mp0 -62.38 -36.65 82.96 Favored 'General case' 0 N--CA 1.44 -0.961 0 C-N-CA 125.241 1.416 . . . . 0.0 108.943 -176.027 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.434 ' O ' ' HB3' ' A' ' 98' ' ' ALA . 57.9 tp -66.72 -36.97 83.73 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 119.43 1.014 . . . . 0.0 110.901 174.892 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -66.89 -40.51 93.58 Favored Glycine 0 CA--C 1.53 1.027 0 O-C-N 120.962 -1.086 . . . . 0.0 110.931 173.889 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.503 HD12 ' CZ ' ' A' ' 86' ' ' PHE . 1.5 tm? -61.67 -36.38 80.7 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 172.543 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.676 ' HB2' ' HB3' ' A' ' 86' ' ' PHE . . . -56.7 -53.54 56.55 Favored 'General case' 0 CA--C 1.52 -0.21 0 O-C-N 121.145 -0.972 . . . . 0.0 109.672 173.037 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -68.0 -28.4 67.38 Favored 'General case' 0 C--O 1.236 0.362 0 O-C-N 122.961 0.163 . . . . 0.0 110.934 -172.564 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -70.67 -44.47 76.52 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.951 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 174.311 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 20.2 mt -65.89 -33.08 75.02 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 119.04 0.837 . . . . 0.0 111.079 178.254 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 51.5 m -61.4 -41.73 97.6 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 118.769 0.713 . . . . 0.0 109.204 170.306 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.438 ' HA ' ' CD2' ' A' ' 106' ' ' PHE . . . -64.81 -40.35 95.08 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 119.748 1.158 . . . . 0.0 112.219 177.196 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -61.17 -33.28 73.19 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 119.095 0.861 . . . . 0.0 110.63 171.071 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 22.3 ttm-85 -75.5 -29.61 59.58 Favored 'General case' 0 CA--C 1.534 0.346 0 O-C-N 121.125 -0.984 . . . . 0.0 110.582 178.804 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.438 ' CD2' ' HA ' ' A' ' 103' ' ' ALA . 15.4 m-30 -69.88 -45.23 68.11 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.552 0.741 . . . . 0.0 110.277 177.208 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 32.8 p -74.46 -24.94 59.12 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 122.925 0.49 . . . . 0.0 111.831 -177.637 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 78.02 8.78 87.3 Favored Glycine 0 CA--C 1.538 1.499 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 -168.399 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -77.11 10.35 2.43 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 119.776 1.788 . . . . 0.0 111.612 171.382 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.434 ' HA ' ' HD3' ' A' ' 111' ' ' PRO . 10.3 t80 -57.32 140.09 79.43 Favored Pre-proline 0 CA--C 1.552 1.045 0 C-N-CA 125.346 1.459 . . . . 0.0 110.65 177.967 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 110' ' ' PHE . 50.3 Cg_exo -63.92 160.36 37.76 Favored 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 123.259 2.639 . . . . 0.0 115.402 -175.554 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -68.27 -35.42 77.85 Favored 'General case' 0 N--CA 1.473 0.675 0 O-C-N 121.663 -0.648 . . . . 0.0 112.163 171.514 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 61.7 mttm -134.52 92.66 2.94 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 124.253 1.021 . . . . 0.0 108.459 176.403 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 18.3 tp -78.57 131.58 36.81 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 105.072 -2.195 . . . . 0.0 105.072 168.055 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -132.72 139.45 47.64 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 172.004 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.428 ' CB ' HG11 ' A' ' 82' ' ' VAL . 0.9 OUTLIER -124.72 123.15 39.39 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 119.739 1.154 . . . . 0.0 108.928 177.151 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 3.7 t -88.99 90.56 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 N-CA-C 105.306 -2.109 . . . . 0.0 105.306 173.401 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -85.96 133.39 11.77 Favored Glycine 0 C--N 1.333 0.376 0 N-CA-C 110.084 -1.207 . . . . 0.0 110.084 -174.231 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 44.8 t -120.35 127.81 75.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 117.908 0.854 . . . . 0.0 109.277 -179.487 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 17.1 mt -84.64 133.85 43.29 Favored Pre-proline 0 CA--C 1.538 0.485 0 N-CA-C 104.923 -2.251 . . . . 0.0 104.923 169.322 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_endo -73.19 173.43 13.7 Favored 'Trans proline' 0 N--CA 1.452 -0.967 0 C-N-CA 123.008 2.472 . . . . 0.0 110.773 -179.574 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -107.12 -43.57 4.58 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 105.278 -2.119 . . . . 0.0 105.278 167.698 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 38.3 m -135.7 135.01 39.72 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.961 0.904 . . . . 0.0 109.764 173.025 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 4.7 tp -140.96 61.4 1.5 Allowed 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.576 1.55 . . . . 0.0 108.458 -178.254 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -126.76 167.6 16.99 Favored Pre-proline 0 CA--C 1.54 0.583 0 N-CA-C 106.294 -1.743 . . . . 0.0 106.294 172.924 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -77.35 95.92 1.09 Allowed 'Trans proline' 0 N--CA 1.457 -0.648 0 CA-C-N 120.678 1.278 . . . . 0.0 112.005 -175.102 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 18.6 p-80 -150.67 -19.3 0.23 Allowed 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 114.561 -1.199 . . . . 0.0 113.586 172.041 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . 0.414 0.0 OUTLIER 65.91 159.19 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 N-CA-C 116.343 1.979 . . . . 0.0 116.343 169.212 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 86.22 160.18 33.72 Favored Glycine 0 CA--C 1.529 0.923 0 N-CA-C 106.866 -2.494 . . . . 0.0 106.866 -168.632 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 68.6 mt -88.18 152.14 22.19 Favored 'General case' 0 N--CA 1.468 0.448 0 O-C-N 120.965 -1.315 . . . . 0.0 110.595 176.572 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 56.9 p -69.63 167.79 20.99 Favored Pre-proline 0 CA--C 1.538 0.515 0 CA-C-N 115.32 -0.854 . . . . 0.0 109.264 169.217 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -59.36 -37.19 91.83 Favored 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 122.0 1.8 . . . . 0.0 111.636 172.857 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 17.4 m -68.18 -40.68 82.2 Favored 'General case' 0 N--CA 1.44 -0.958 0 C-N-CA 123.508 0.723 . . . . 0.0 110.589 -177.355 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 84.3 t -88.75 -30.02 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 O-C-N 121.632 -0.667 . . . . 0.0 110.719 -174.159 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -53.27 -45.94 69.07 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 119.202 0.91 . . . . 0.0 108.771 168.888 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -69.77 -15.48 63.14 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 114.266 1.21 . . . . 0.0 114.266 179.796 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 9.3 mmm -76.85 -12.72 60.01 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 117.698 -1.144 . . . . 0.0 112.118 172.265 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 58.3 mt -54.33 -54.47 21.35 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.37 0 CA-C-N 120.193 1.36 . . . . 0.0 108.991 173.772 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 76.7 mm-40 -66.41 -46.74 59.79 Favored Pre-proline 0 CA--C 1.552 1.023 0 CA-C-N 120.329 1.422 . . . . 0.0 111.059 -173.481 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 0.4 OUTLIER -44.71 -52.77 5.75 Favored 'Trans proline' 0 C--N 1.353 0.801 1 C-N-CA 125.645 4.23 . . . . 0.0 112.5 168.75 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.04 -36.48 75.07 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.983 -1.008 . . . . 0.0 112.267 -177.802 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 42.6 mt -62.27 -41.77 98.76 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 118.897 0.771 . . . . 0.0 109.054 173.977 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -59.21 -36.02 74.65 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 119.342 0.973 . . . . 0.0 110.561 174.346 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -62.95 -50.14 71.99 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 118.794 0.724 . . . . 0.0 111.455 172.97 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 66.1 t -56.28 -49.11 78.2 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.19 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 66.6 mt -58.09 -43.09 86.89 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 123.046 0.538 . . . . 0.0 109.704 179.469 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -65.31 -44.85 86.59 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 118.972 0.805 . . . . 0.0 110.661 -177.231 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -64.64 -34.03 77.33 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 119.15 0.886 . . . . 0.0 111.37 -178.639 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . 0.337 4.4 pp -75.9 -36.97 59.29 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-O 117.346 -1.311 . . . . 0.0 109.762 176.688 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 14.0 mtp-105 -67.49 -27.6 67.14 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 121.113 1.779 . . . . 0.0 110.811 173.973 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -73.01 -15.73 61.52 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 118.629 0.65 . . . . 0.0 110.58 174.705 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 15.3 m -93.88 9.05 38.92 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.964 1.305 . . . . 0.0 110.719 169.222 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 74.0 13.17 81.11 Favored Glycine 0 CA--C 1.527 0.815 0 CA-C-O 117.396 -1.78 . . . . 0.0 112.792 -176.212 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 44.5 t -88.76 132.17 34.3 Favored 'Isoleucine or valine' 0 C--N 1.345 0.387 0 CA-C-N 120.985 2.392 . . . . 0.0 107.362 -176.181 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -104.32 93.94 5.08 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 106.675 -1.602 . . . . 0.0 106.675 169.441 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -59.13 137.68 57.86 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 169.105 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 20.6 mm -85.64 126.88 65.06 Favored Pre-proline 0 C--O 1.231 0.119 0 CA-C-O 117.531 -1.223 . . . . 0.0 107.711 -174.625 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -68.1 91.11 0.38 Allowed 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 122.868 2.379 . . . . 0.0 108.998 175.004 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 32.1 ttp85 51.81 17.99 0.7 Allowed 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 127.573 2.349 . . . . 0.0 114.853 179.404 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 52.6 m . . . . . 0 CA--C 1.544 0.745 0 C-N-CA 124.312 1.045 . . . . 0.0 112.093 -169.25 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 15.3 ptt180 . . . . . 0 N--CA 1.477 0.895 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 73.7 mt -134.56 147.7 29.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 C-N-CA 124.089 0.956 . . . . 0.0 108.544 -172.866 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 13.7 tp -135.0 146.53 49.13 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 168.304 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 63.1 t -121.4 130.42 74.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 105.513 -2.032 . . . . 0.0 105.513 174.616 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -121.26 130.23 53.56 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-N 119.004 0.82 . . . . 0.0 110.756 -173.621 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -104.98 132.03 10.92 Favored Glycine 0 C--N 1.334 0.455 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 174.135 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -143.94 159.78 16.0 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-N 118.122 0.961 . . . . 0.0 112.008 -176.167 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 131.72 173.99 13.51 Favored Glycine 0 CA--C 1.527 0.814 0 C-N-CA 126.569 2.033 . . . . 0.0 110.286 170.249 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -79.15 93.82 5.27 Favored 'General case' 0 C--O 1.233 0.191 0 O-C-N 121.307 -1.113 . . . . 0.0 110.891 -173.472 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.1 pt -57.46 31.49 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.092 0 N-CA-C 117.48 2.4 . . . . 0.0 117.48 172.285 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 38.3 mt -131.3 -3.75 3.86 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 120.671 1.578 . . . . 0.0 108.808 168.897 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.0 mp -118.1 59.8 0.79 Allowed 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.21 1.004 . . . . 0.0 113.459 -167.992 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 54.85 -96.92 0.06 Allowed 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 124.495 1.118 . . . . 0.0 111.248 171.201 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 41.1 m-20 -81.79 -15.46 54.16 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 124.601 1.16 . . . . 0.0 110.309 -172.665 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -72.65 -6.49 44.69 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 120.875 1.67 . . . . 0.0 112.609 178.683 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -82.3 -12.04 58.25 Favored 'General case' 0 N--CA 1.435 -1.189 0 CA-C-O 115.864 -2.017 . . . . 0.0 109.322 169.917 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 7.6 tp -52.36 -41.9 36.35 Favored 'Isoleucine or valine' 0 C--N 1.346 0.424 0 CA-C-N 122.57 2.441 . . . . 0.0 113.031 -169.61 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -60.7 -43.59 98.89 Favored Glycine 0 CA--C 1.524 0.608 0 CA-C-N 119.997 1.271 . . . . 0.0 110.708 177.482 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 55.9 t -65.67 -49.53 77.11 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 CA-C-O 118.768 -0.634 . . . . 0.0 109.609 173.926 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 26.3 mmt180 -60.66 -32.84 72.02 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 120.389 1.449 . . . . 0.0 112.649 -178.985 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 31.0 mt -62.85 -47.29 93.56 Favored 'Isoleucine or valine' 0 C--O 1.231 0.124 0 CA-C-N 120.649 1.568 . . . . 0.0 109.846 178.464 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 27.7 m -72.96 -27.15 24.16 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 CA-C-N 119.14 0.882 . . . . 0.0 111.063 -174.896 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -71.16 -43.38 67.63 Favored 'General case' 0 C--O 1.232 0.163 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 173.76 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.86 -40.58 95.85 Favored 'General case' 0 N--CA 1.449 -0.486 0 O-C-N 121.781 -0.574 . . . . 0.0 110.457 178.39 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 6.5 tp -62.57 -40.77 97.94 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 118.444 -0.789 . . . . 0.0 109.874 175.591 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -61.39 -40.49 94.55 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 119.005 0.82 . . . . 0.0 111.191 178.549 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -71.91 -36.98 70.15 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 124.107 0.963 . . . . 0.0 111.306 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -95.07 -34.69 12.21 Favored 'General case' 0 C--N 1.341 0.225 0 CA-C-O 117.372 -1.299 . . . . 0.0 113.459 -169.957 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -119.02 148.7 42.72 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 120.956 1.707 . . . . 0.0 112.182 -173.049 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 40.7 mm -96.06 138.44 21.47 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 N-CA-C 103.804 -2.665 . . . . 0.0 103.804 168.496 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -121.95 148.74 52.13 Favored Pre-proline 0 CA--C 1.534 0.357 0 C-N-CA 123.795 0.838 . . . . 0.0 108.873 -174.018 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -65.68 159.62 47.46 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 122.207 1.938 . . . . 0.0 109.674 169.749 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -58.51 -31.74 68.17 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 -170.106 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 15.6 p90 -80.11 0.24 32.95 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 118.072 -0.966 . . . . 0.0 113.364 -177.98 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 88.3 t -113.53 127.27 70.95 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 N-CA-C 105.766 -1.939 . . . . 0.0 105.766 169.918 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -132.5 143.97 50.12 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 170.064 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -93.33 103.68 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.066 0 N-CA-C 105.37 -2.085 . . . . 0.0 105.37 169.712 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.496 HD13 ' H ' ' A' ' 40' ' ' ASP . 0.2 OUTLIER -90.16 162.2 15.38 Favored 'General case' 0 C--O 1.237 0.436 0 N-CA-C 107.813 -1.181 . . . . 0.0 107.813 172.275 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.496 ' H ' HD13 ' A' ' 39' ' ' LEU . 10.0 t0 -131.94 122.6 25.86 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 123.836 0.854 . . . . 0.0 109.068 -171.295 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -87.6 -98.63 0.89 Allowed Glycine 0 CA--C 1.526 0.769 0 N-CA-C 107.048 -2.421 . . . . 0.0 107.048 169.673 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 81.08 116.63 0.38 Allowed Glycine 0 C--N 1.34 0.758 0 N-CA-C 108.702 -1.759 . . . . 0.0 108.702 -173.295 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 19.1 p 51.54 57.75 6.23 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.276 1.031 . . . . 0.0 108.773 -178.03 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -115.99 -88.14 0.59 Allowed 'General case' 0 C--N 1.342 0.281 0 CA-C-N 114.259 -1.337 . . . . 0.0 110.986 -169.189 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 75.12 -91.68 0.82 Allowed Glycine 0 C--N 1.34 0.798 0 N-CA-C 109.053 -1.619 . . . . 0.0 109.053 -169.772 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 66.1 mmm -76.56 -21.56 55.48 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 -177.761 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -62.21 -14.97 43.48 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 113.187 0.81 . . . . 0.0 113.187 -169.508 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 18.6 mt -79.34 -5.26 54.14 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 114.276 1.213 . . . . 0.0 114.276 -178.887 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.444 ' HA ' HG13 ' A' ' 100' ' ' VAL . 6.0 tt -38.65 -62.42 0.61 Allowed 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 114.84 1.422 . . . . 0.0 114.84 -170.014 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -90.86 -29.51 13.01 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 111.579 -0.608 . . . . 0.0 111.579 -174.196 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -65.86 -32.56 74.14 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 117.726 0.763 . . . . 0.0 110.974 -176.608 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 52.2 mtp -72.55 -14.47 61.64 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 113.456 0.91 . . . . 0.0 113.456 176.653 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -69.35 154.84 41.4 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 113.191 0.811 . . . . 0.0 113.191 -169.266 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 60.62 46.44 9.32 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.221 1.808 . . . . 0.0 115.375 168.332 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 18.7 mmt180 -114.48 155.54 26.22 Favored 'General case' 0 N--CA 1.479 0.994 0 O-C-N 121.155 -0.965 . . . . 0.0 108.887 171.516 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -81.4 -30.81 33.48 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 172.675 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -143.47 152.13 41.14 Favored 'General case' 0 C--N 1.343 0.324 0 CA-C-N 119.358 0.981 . . . . 0.0 109.77 168.193 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -137.04 139.73 41.57 Favored 'General case' 0 CA--C 1.51 -0.582 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 174.577 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 39.0 mt -114.32 115.12 48.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 176.147 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.8 mm -89.67 133.21 32.35 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 N-CA-C 106.071 -1.826 . . . . 0.0 106.071 175.013 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -114.26 115.95 28.24 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 103.557 -2.757 . . . . 0.0 103.557 168.822 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -154.15 161.12 42.08 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 -169.032 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -98.4 140.33 32.83 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.393 0.677 . . . . 0.0 110.583 -178.154 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 33.7 mm -78.66 -32.45 16.08 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 C-N-CA 123.847 0.859 . . . . 0.0 111.474 179.591 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . 0.296 4.0 t 60.14 45.27 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.89 0 C-N-CA 125.537 1.535 . . . . 0.0 110.809 -173.665 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 6.7 m 68.91 155.14 0.12 Allowed 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 116.985 2.217 . . . . 0.0 116.985 169.497 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 23.6 ttmt -157.88 -174.5 4.88 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 129.901 3.28 . . . . 0.0 104.159 174.46 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 10.5 ptpt -61.74 -21.25 64.35 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.699 1.2 . . . . 0.0 113.53 169.793 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 43.5 t-20 -65.34 156.36 32.39 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 118.95 0.795 . . . . 0.0 110.059 172.634 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 13.7 m -63.45 142.64 97.91 Favored Pre-proline 0 CA--C 1.546 0.795 0 C-N-CA 124.141 0.977 . . . . 0.0 112.197 -169.811 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -59.34 153.77 51.45 Favored 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 122.64 2.226 . . . . 0.0 112.043 169.789 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 67.79 18.0 69.91 Favored Glycine 0 CA--C 1.534 1.257 0 O-C-N 121.634 -0.666 . . . . 0.0 113.506 174.156 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 17.5 m -95.49 141.38 29.09 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 125.542 1.537 . . . . 0.0 107.895 177.251 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 30.7 ttp -98.71 145.43 26.91 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 175.36 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 32.0 ttm -130.88 117.73 19.72 Favored 'General case' 0 CA--C 1.528 0.103 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 -170.29 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.6 mp -96.78 122.33 48.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 179.727 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -117.7 122.69 44.17 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 67.5 mtp85 -102.11 135.36 43.83 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 118.516 -0.754 . . . . 0.0 109.807 176.778 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 8.2 t70 29.28 -91.69 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 126.681 1.992 . . . . 0.0 116.141 174.189 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -62.55 -26.84 68.79 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 -174.665 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -79.58 -12.44 59.84 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 122.844 0.458 . . . . 0.0 110.557 -179.414 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 46.4 t -75.39 -51.34 3.33 Favored Pre-proline 0 N--CA 1.446 -0.653 0 CA-C-O 116.66 -1.638 . . . . 0.0 110.777 -174.25 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo -59.33 -41.3 60.04 Favored 'Trans proline' 0 C--N 1.351 0.698 0 CA-C-N 122.865 2.059 . . . . 0.0 111.525 171.545 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -60.88 -29.69 69.7 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 122.997 0.519 . . . . 0.0 111.787 -179.54 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.506 HD13 ' C ' ' A' ' 85' ' ' LEU . 3.1 tm? -79.8 -54.11 6.15 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 122.89 0.476 . . . . 0.0 110.57 170.756 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -56.73 -34.11 67.2 Favored 'General case' 0 C--O 1.227 -0.093 0 CA-C-N 118.319 0.509 . . . . 0.0 111.448 -171.191 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 3.6 t -64.24 -5.27 4.7 Favored 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 -172.746 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -54.09 136.1 42.43 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 119.593 1.088 . . . . 0.0 110.204 169.54 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -81.66 -15.82 53.33 Favored 'General case' 0 N--CA 1.471 0.62 0 O-C-N 122.043 -0.41 . . . . 0.0 111.493 178.018 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 52.9 mt -61.61 -44.72 99.13 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 123.86 0.864 . . . . 0.0 109.601 -169.845 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 37.8 t -89.86 121.05 69.32 Favored Pre-proline 0 N--CA 1.452 -0.35 0 C-N-CA 124.386 1.075 . . . . 0.0 110.017 171.834 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_exo -61.93 -37.35 66.33 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 122.844 2.362 . . . . 0.0 110.082 169.068 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 5.6 m80 -59.91 -54.11 49.95 Favored 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 179.37 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -75.58 -25.73 57.31 Favored 'General case' 0 C--O 1.219 -0.526 0 C-N-CA 117.577 -1.649 . . . . 0.0 111.437 -174.909 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 2.8 tt -58.28 -50.7 72.69 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 120.546 1.521 . . . . 0.0 108.323 171.036 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -59.43 -46.74 93.42 Favored Glycine 0 CA--C 1.527 0.821 0 N-CA-C 110.746 -0.942 . . . . 0.0 110.746 177.008 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 32.0 tp -69.91 -20.57 63.36 Favored 'General case' 0 CA--C 1.547 0.85 0 O-C-N 121.653 -0.91 . . . . 0.0 111.312 -177.618 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -68.68 -46.86 67.95 Favored 'General case' 0 CA--C 1.534 0.339 0 O-C-N 121.127 -0.983 . . . . 0.0 109.272 171.504 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -71.13 -22.23 62.09 Favored 'General case' 0 C--N 1.339 0.138 0 CA-C-O 119.246 -0.407 . . . . 0.0 111.48 177.895 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.444 HG13 ' HA ' ' A' ' 49' ' ' LEU . 4.8 t -62.85 -43.32 98.77 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.729 0 CA-C-O 117.948 -1.025 . . . . 0.0 108.851 169.287 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 42.7 mt -60.93 -32.43 71.93 Favored 'General case' 0 C--N 1.34 0.156 0 CA-C-N 120.456 1.48 . . . . 0.0 111.096 175.524 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 66.2 m -68.14 -38.87 82.65 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 119.173 0.897 . . . . 0.0 110.657 173.068 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -65.5 -38.65 90.33 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 119.619 1.1 . . . . 0.0 111.28 174.699 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -64.19 -36.5 84.27 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 118.879 0.763 . . . . 0.0 110.38 174.19 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 34.9 ttp-105 -65.51 -36.22 83.18 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 121.701 -0.625 . . . . 0.0 109.551 175.181 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 14.3 m-30 -68.48 -40.61 80.87 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 118.873 0.76 . . . . 0.0 111.012 178.227 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 54.4 p -74.24 -26.93 60.53 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 119.481 1.037 . . . . 0.0 111.278 177.603 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 75.93 9.93 85.15 Favored Glycine 0 CA--C 1.531 1.056 0 CA-C-O 119.046 -0.863 . . . . 0.0 111.568 -170.089 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -99.46 24.42 8.16 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 118.949 1.374 . . . . 0.0 111.121 -178.395 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -57.64 135.24 82.56 Favored Pre-proline 0 CA--C 1.543 0.697 0 C-N-CA 126.116 1.766 . . . . 0.0 109.959 178.044 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -52.88 132.93 49.26 Favored 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 122.845 2.363 . . . . 0.0 112.081 177.104 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 31.3 mmtp -65.63 -24.22 66.99 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 119.149 -0.453 . . . . 0.0 111.932 -172.104 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 1.5 tmmt? -140.6 100.99 3.99 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 106.013 -1.847 . . . . 0.0 106.013 169.59 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 23.8 tp -78.51 140.78 38.54 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 174.978 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -134.79 138.96 44.74 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 107.159 -1.422 . . . . 0.0 107.159 176.831 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.1 tp -135.59 129.83 33.52 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 120.077 1.308 . . . . 0.0 108.92 175.39 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 47.9 t -103.28 105.03 17.55 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 N-CA-C 103.55 -2.759 . . . . 0.0 103.55 168.87 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -84.92 145.36 21.56 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 110.485 -1.046 . . . . 0.0 110.485 174.276 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 42.0 t -121.17 133.0 69.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 171.674 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 14.2 mt -88.89 132.11 39.26 Favored Pre-proline 0 CA--C 1.539 0.539 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 169.822 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -77.7 -178.29 4.49 Favored 'Trans proline' 0 CA--C 1.537 0.64 0 C-N-CA 123.582 2.854 . . . . 0.0 111.862 -175.833 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -119.05 -52.96 2.29 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.815 0.846 . . . . 0.0 111.207 178.935 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 66.5 m -118.51 -51.69 2.39 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 119.081 0.855 . . . . 0.0 112.868 -172.421 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER 57.7 52.55 8.08 Favored 'General case' 0 CA--C 1.551 0.997 0 N-CA-C 114.646 1.35 . . . . 0.0 114.646 169.988 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -115.93 168.51 8.37 Favored Pre-proline 0 N--CA 1.481 1.092 0 CA-C-O 118.421 -0.799 . . . . 0.0 111.182 176.159 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -65.19 89.69 0.2 Allowed 'Trans proline' 0 CA--C 1.548 1.18 0 C-N-CA 123.447 2.765 . . . . 0.0 113.756 -178.26 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 179.86 149.26 0.32 Allowed 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 104.538 -2.393 . . . . 0.0 104.538 175.6 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -110.52 163.49 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-N 119.614 1.097 . . . . 0.0 112.927 -169.83 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 86.16 150.19 15.04 Favored Glycine 0 C--N 1.341 0.814 0 N-CA-C 107.468 -2.253 . . . . 0.0 107.468 -169.489 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -79.03 164.49 24.31 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-O 121.536 0.684 . . . . 0.0 110.031 -169.998 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 23.6 p -65.93 166.74 14.26 Favored Pre-proline 0 CA--C 1.539 0.556 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 167.733 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -53.74 -32.13 64.33 Favored 'Trans proline' 0 CA--C 1.537 0.674 0 C-N-CA 121.4 1.4 . . . . 0.0 111.545 169.601 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 22.1 m -69.57 -46.49 66.25 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 117.993 0.36 . . . . 0.0 111.148 179.544 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 22.2 t -94.1 -15.36 7.87 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-N 118.626 0.648 . . . . 0.0 111.25 -169.186 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -57.88 -47.03 83.97 Favored 'General case' 0 C--O 1.233 0.202 0 O-C-N 120.301 -1.499 . . . . 0.0 107.764 169.374 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -72.03 0.23 9.97 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-O 118.04 -0.981 . . . . 0.0 113.135 177.03 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 83.2 mtp -88.92 -10.02 49.39 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-N 120.001 1.273 . . . . 0.0 111.395 171.786 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 87.8 mt -57.16 -41.52 78.0 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 169.957 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 39.1 mm-40 -64.26 -60.61 8.28 Favored Pre-proline 0 CA--C 1.541 0.633 0 CA-C-O 117.979 -1.01 . . . . 0.0 112.703 -172.65 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -62.47 -32.98 80.34 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 CA-C-N 121.397 1.535 . . . . 0.0 110.994 178.444 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -68.04 -43.84 77.81 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-N 119.448 1.022 . . . . 0.0 109.75 -179.065 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 58.5 mt -58.21 -43.16 87.51 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 119.187 0.903 . . . . 0.0 109.697 173.105 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -59.62 -38.18 80.62 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 119.096 0.862 . . . . 0.0 110.366 179.775 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 20.0 mm100 -75.15 -33.95 61.57 Favored 'General case' 0 C--N 1.338 0.093 0 CA-C-O 117.817 -1.087 . . . . 0.0 112.97 175.426 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 67.2 t -59.83 -46.3 93.88 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 CA-C-N 120.442 1.474 . . . . 0.0 108.101 172.055 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 29.1 mt -66.72 -41.02 88.6 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 122.921 0.488 . . . . 0.0 110.116 -178.189 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -63.89 -40.16 95.86 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 119.226 0.921 . . . . 0.0 111.394 176.812 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -67.0 -41.11 87.27 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 122.683 0.393 . . . . 0.0 110.884 178.775 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 34.2 mt -59.51 -42.82 93.08 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 123.03 0.532 . . . . 0.0 109.91 173.598 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 -64.37 -15.93 61.35 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 117.362 -1.304 . . . . 0.0 111.886 -178.44 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -58.91 -41.81 88.12 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 120.678 1.581 . . . . 0.0 110.902 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 2.7 p -89.66 23.44 2.66 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.193 0.597 . . . . 0.0 111.423 178.081 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 70.32 22.41 77.56 Favored Glycine 0 CA--C 1.531 1.045 0 CA-C-O 118.761 -1.021 . . . . 0.0 113.415 -178.975 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 40.7 t -100.46 89.84 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.257 0 CA-C-N 119.054 1.427 . . . . 0.0 107.955 -175.38 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -76.76 137.22 39.17 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 169.389 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -85.68 155.2 21.19 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.546 0.738 . . . . 0.0 110.517 176.976 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 157' ' ' ILE . . . . . 0.412 HG22 ' H ' ' A' ' 160' ' ' SER . 88.9 mt -93.24 116.58 66.7 Favored Pre-proline 0 CA--C 1.541 0.61 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 -178.623 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -73.66 92.2 0.87 Allowed 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 123.405 2.737 . . . . 0.0 109.808 -176.744 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 7.6 ttt-85 48.11 16.92 0.1 Allowed 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 128.172 2.589 . . . . 0.0 115.513 -174.969 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 160' ' ' SER . . . . . 0.412 ' H ' HG22 ' A' ' 157' ' ' ILE . 1.0 OUTLIER . . . . . 0 CA--C 1.544 0.741 0 C-N-CA 126.123 1.769 . . . . 0.0 110.813 -172.406 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 9.0 ptp180 . . . . . 0 N--CA 1.482 1.167 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 50.6 mt -142.52 139.42 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 CA-C-N 119.708 1.14 . . . . 0.0 112.603 -168.678 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -121.68 123.31 41.59 Favored 'General case' 0 N--CA 1.462 0.163 0 N-CA-C 104.776 -2.305 . . . . 0.0 104.776 167.484 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 57.5 t -101.45 99.32 8.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 101.576 -3.49 . . . . 0.0 101.576 169.539 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 14.1 tp -101.34 107.6 18.99 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 124.195 0.998 . . . . 0.0 110.203 -168.061 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -88.52 123.86 6.96 Favored Glycine 0 N--CA 1.45 -0.408 0 N-CA-C 107.337 -2.305 . . . . 0.0 107.337 174.346 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -136.87 164.63 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.707 0 C-N-CA 124.054 0.941 . . . . 0.0 108.58 -176.534 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 145.72 156.93 7.06 Favored Glycine 0 N--CA 1.447 -0.625 0 N-CA-C 109.064 -1.614 . . . . 0.0 109.064 178.215 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -76.47 94.89 3.75 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 171.449 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.3 pt -70.77 37.74 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 C-N-CA 124.577 1.151 . . . . 0.0 113.567 179.687 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 23.0 mt -125.15 -8.04 7.09 Favored 'General case' 0 CA--C 1.537 0.466 0 O-C-N 121.148 -0.97 . . . . 0.0 108.768 170.954 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.0 mp -118.65 67.61 0.78 Allowed 'General case' 0 C--N 1.346 0.414 0 C-N-CA 124.006 0.923 . . . . 0.0 109.118 -169.002 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.3 m 47.3 -111.12 0.35 Allowed 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 114.761 -1.109 . . . . 0.0 111.654 171.645 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.445 ' O ' HG22 ' A' ' 18' ' ' ILE . 87.6 m-20 -71.9 -11.25 60.7 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-O 117.614 -1.184 . . . . 0.0 112.302 -170.235 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -66.54 -18.02 65.13 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 121.4 1.909 . . . . 0.0 111.032 171.834 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -70.6 -12.83 61.81 Favored 'General case' 0 N--CA 1.448 -0.555 0 O-C-N 120.178 -1.576 . . . . 0.0 111.769 171.392 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.501 HG21 HG11 ' A' ' 119' ' ' VAL . 8.4 tp -58.1 -36.45 57.03 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-N 121.271 1.85 . . . . 0.0 111.613 -174.019 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -61.48 -38.38 95.69 Favored Glycine 0 C--N 1.339 0.697 0 CA-C-N 119.365 0.984 . . . . 0.0 111.769 178.037 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 54.8 t -72.42 -47.04 54.01 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 175.111 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 24.7 mmt180 -60.96 -31.18 70.75 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 116.939 -1.505 . . . . 0.0 112.94 -179.244 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 18.4 mt -61.62 -47.74 91.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 CA-C-N 121.565 1.984 . . . . 0.0 110.17 177.078 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 14.4 m -72.78 -33.48 44.11 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-N 119.192 0.906 . . . . 0.0 110.912 -174.642 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 57.6 mt-10 -63.66 -42.98 98.01 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 118.428 0.558 . . . . 0.0 110.334 171.665 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.18 -39.37 92.46 Favored 'General case' 0 CA--C 1.537 0.452 0 O-C-N 121.292 -0.88 . . . . 0.0 110.647 176.006 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 6.1 tp -66.06 -39.61 90.23 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 118.451 0.569 . . . . 0.0 110.081 -179.317 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -60.68 -28.9 68.96 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 121.512 0.672 . . . . 0.0 112.131 -178.581 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 -88.19 -40.21 13.89 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 125.891 1.676 . . . . 0.0 111.14 -178.851 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 56.4 mtp180 -94.17 -18.44 21.73 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-O 118.449 -0.786 . . . . 0.0 112.364 -170.715 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 49.8 m-85 -129.58 147.05 51.34 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 119.354 0.979 . . . . 0.0 112.552 177.992 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 39.5 mm -98.28 137.08 26.84 Favored 'Isoleucine or valine' 0 C--O 1.239 0.518 0 N-CA-C 103.62 -2.733 . . . . 0.0 103.62 168.784 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -120.19 150.54 51.62 Favored Pre-proline 0 C--O 1.237 0.414 0 C-N-CA 123.297 0.639 . . . . 0.0 110.49 -169.811 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -59.05 157.56 28.97 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 123.128 2.552 . . . . 0.0 111.227 169.64 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -61.55 -31.51 71.54 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -175.696 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 9.6 p90 -75.76 -11.12 59.93 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 -179.512 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 92.5 t -92.87 122.9 44.74 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 173.86 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -117.62 123.59 46.54 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 169.476 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -86.48 117.78 31.58 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 N-CA-C 104.168 -2.53 . . . . 0.0 104.168 168.512 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 63.8 tp -118.9 130.75 55.89 Favored 'General case' 0 CA--C 1.523 -0.083 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 178.152 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -89.42 119.13 29.61 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 169.509 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -77.54 -80.14 0.68 Allowed Glycine 0 CA--C 1.528 0.872 0 N-CA-C 106.834 -2.507 . . . . 0.0 106.834 169.189 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 78.48 107.05 0.2 Allowed Glycine 0 C--N 1.345 1.044 0 N-CA-C 109.176 -1.57 . . . . 0.0 109.176 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 10.5 p 53.41 55.47 8.65 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 -177.106 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -120.35 -83.4 0.66 Allowed 'General case' 0 C--N 1.347 0.482 0 CA-C-N 115.005 -0.998 . . . . 0.0 112.255 -169.279 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 58.93 -107.21 1.09 Allowed Glycine 0 CA--C 1.532 1.15 0 N-CA-C 110.511 -1.036 . . . . 0.0 110.511 -178.368 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 11.7 tpt -55.95 -28.18 55.81 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.665 1.186 . . . . 0.0 112.627 -177.67 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -56.46 -22.12 30.1 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 113.827 1.047 . . . . 0.0 113.827 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 15.1 mt -103.3 17.95 22.89 Favored 'General case' 0 C--N 1.341 0.233 0 N-CA-C 115.978 1.844 . . . . 0.0 115.978 -167.91 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 6.2 tt -48.09 -56.35 8.01 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 119.447 1.021 . . . . 0.0 111.109 -178.166 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -66.42 -36.58 91.78 Favored Glycine 0 CA--C 1.528 0.898 0 CA-C-O 119.259 -0.745 . . . . 0.0 112.447 -177.502 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -73.69 -35.1 65.13 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 118.886 1.343 . . . . 0.0 111.817 -176.728 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 78.8 mtp -71.88 -12.71 61.4 Favored 'General case' 0 CA--C 1.535 0.401 0 O-C-N 121.962 -0.461 . . . . 0.0 110.323 179.798 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -84.12 153.63 23.62 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 123.306 0.642 . . . . 0.0 111.57 -170.424 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 54.24 34.8 21.17 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 126.475 1.91 . . . . 0.0 112.847 170.849 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 26.1 mmt180 -98.31 157.57 16.1 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 173.815 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -84.67 -51.4 6.85 Favored 'General case' 0 C--O 1.221 -0.42 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 175.931 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . 0.269 0.0 OUTLIER -120.25 146.43 46.07 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 120.017 1.281 . . . . 0.0 108.272 168.652 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 33.1 tp -130.46 111.63 12.48 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 104.172 -2.529 . . . . 0.0 104.172 173.092 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 52.7 mt -93.24 111.71 25.19 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 N-CA-C 103.801 -2.666 . . . . 0.0 103.801 171.17 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.46 HG22 HD23 ' A' ' 116' ' ' LEU . 53.5 mt -83.86 133.69 28.63 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 N-CA-C 105.233 -2.136 . . . . 0.0 105.233 170.651 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -116.97 116.77 28.03 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 102.519 -3.141 . . . . 0.0 102.519 168.038 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -161.57 165.77 27.95 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 123.518 0.727 . . . . 0.0 109.796 -176.248 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -81.34 144.53 31.41 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-O 122.355 1.074 . . . . 0.0 110.031 169.717 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 12.0 mt -69.1 -51.04 47.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 114.55 -1.205 . . . . 0.0 107.957 170.759 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . 0.294 9.0 p 42.22 48.45 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.95 0 C-N-CA 125.276 1.43 . . . . 0.0 111.071 179.753 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 8.4 t -162.79 176.42 10.28 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.368 1.467 . . . . 0.0 109.624 -171.572 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 20.0 ttmt 51.14 -161.17 0.08 Allowed 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 127.386 2.274 . . . . 0.0 112.175 -173.586 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 14.6 ptpt -128.89 12.79 6.26 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 125.036 1.334 . . . . 0.0 112.973 -169.394 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 44.8 t30 -74.75 167.22 22.25 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 178.051 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 2.8 m -56.93 145.87 61.92 Favored Pre-proline 0 CA--C 1.546 0.795 0 C-N-CA 123.812 0.845 . . . . 0.0 112.132 -169.704 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -56.23 155.82 23.18 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 123.84 3.026 . . . . 0.0 112.701 169.91 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 65.15 17.44 63.62 Favored Glycine 0 CA--C 1.535 1.321 0 CA-C-O 119.696 -0.502 . . . . 0.0 113.242 170.678 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 3.1 m -95.58 142.19 28.21 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 125.176 1.39 . . . . 0.0 109.11 -175.036 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 44.5 ttp -95.16 141.66 28.51 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 169.92 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 75.1 mtm -132.02 145.85 51.7 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 169.363 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.5 mp -97.22 119.66 45.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 N-CA-C 105.358 -2.09 . . . . 0.0 105.358 172.093 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.8 mp -113.79 136.02 53.32 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 171.717 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 36.4 mmt180 -96.39 164.13 12.77 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 123.018 0.527 . . . . 0.0 110.863 178.607 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -1.09 -70.13 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 127.839 2.456 . . . . 0.0 117.438 169.465 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -87.6 -19.87 27.18 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 113.533 0.938 . . . . 0.0 113.533 -170.474 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -76.77 -37.4 55.95 Favored 'General case' 0 CA--C 1.523 -0.084 0 CA-C-O 121.135 0.493 . . . . 0.0 110.095 -172.627 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.538 HG12 ' CE2' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -66.85 -52.48 32.49 Favored Pre-proline 0 CA--C 1.538 0.51 0 CA-C-O 117.417 -1.278 . . . . 0.0 112.723 -174.149 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -55.4 -42.01 72.46 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 121.57 1.513 . . . . 0.0 110.551 177.694 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.8 -15.53 63.53 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 178.118 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -92.69 -46.06 7.75 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 119.854 1.206 . . . . 0.0 110.674 -176.092 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.538 ' CE2' HG12 ' A' ' 82' ' ' VAL . 43.8 m-85 -68.77 -1.72 7.72 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 113.988 1.107 . . . . 0.0 113.988 -169.649 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 62.5 p -59.51 -21.17 59.79 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.759 1.223 . . . . 0.0 112.587 178.982 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 42.3 t-20 -65.91 149.88 49.5 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.542 0.737 . . . . 0.0 111.192 -175.919 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -84.93 -6.33 59.34 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.15 0.98 . . . . 0.0 113.569 -170.036 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 20.3 mt -59.56 -43.53 91.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 C-N-CA 123.676 0.79 . . . . 0.0 111.147 -169.444 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 28.3 t -117.72 125.28 28.16 Favored Pre-proline 0 C--O 1.235 0.295 0 N-CA-C 109.038 -0.726 . . . . 0.0 109.038 174.541 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -71.29 -30.01 16.3 Favored 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 122.578 2.185 . . . . 0.0 110.547 175.682 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 30.1 t-80 -67.19 -43.38 82.29 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 119.05 0.841 . . . . 0.0 108.815 177.283 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 7.4 mm100 -66.13 -38.8 89.06 Favored 'General case' 0 C--O 1.22 -0.46 0 CA-C-O 117.603 -1.189 . . . . 0.0 110.291 175.823 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 1.3 tt -56.47 -40.81 75.51 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 120.141 1.337 . . . . 0.0 109.373 174.095 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -60.81 -44.75 97.64 Favored Glycine 0 CA--C 1.529 0.942 0 O-C-N 121.237 -0.915 . . . . 0.0 111.434 175.176 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 51.1 tp -64.24 -32.44 74.03 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 117.893 0.847 . . . . 0.0 110.245 174.446 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.474 ' HB2' ' CB ' ' A' ' 86' ' ' PHE . . . -62.07 -51.39 68.15 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 119.517 1.053 . . . . 0.0 109.034 176.148 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -70.91 -28.33 64.44 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.011 -174.425 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -70.02 -41.99 79.4 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.922 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 172.984 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 32.1 mt -64.31 -35.66 81.57 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 119.521 1.055 . . . . 0.0 110.174 177.083 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 49.8 m -63.38 -37.19 86.32 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 118.983 0.81 . . . . 0.0 110.451 169.902 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.425 ' HA ' ' CD2' ' A' ' 106' ' ' PHE . . . -66.61 -39.14 88.21 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 119.58 1.082 . . . . 0.0 111.221 177.609 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -63.13 -31.67 72.87 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 118.69 0.677 . . . . 0.0 109.987 172.14 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 58.6 ttt85 -72.37 -34.41 67.95 Favored 'General case' 0 CA--C 1.533 0.32 0 O-C-N 121.103 -0.998 . . . . 0.0 109.864 175.507 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.425 ' CD2' ' HA ' ' A' ' 103' ' ' ALA . 13.9 m-30 -68.42 -44.09 75.76 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 118.829 0.74 . . . . 0.0 110.583 178.948 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 40.4 p -70.97 -26.77 63.3 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 118.52 0.6 . . . . 0.0 111.745 -179.424 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 73.19 7.07 70.8 Favored Glycine 0 CA--C 1.535 1.282 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 -168.34 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -89.51 16.85 7.0 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 119.467 1.633 . . . . 0.0 110.937 178.302 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -54.88 139.85 61.57 Favored Pre-proline 0 CA--C 1.549 0.918 0 C-N-CA 125.824 1.65 . . . . 0.0 109.702 172.076 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_exo -55.56 156.9 16.59 Favored 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 123.38 2.72 . . . . 0.0 115.697 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 66.7 mmtt -63.76 -40.44 96.7 Favored 'General case' 0 N--CA 1.472 0.661 0 O-C-N 121.768 -0.582 . . . . 0.0 111.418 -179.433 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 5.4 pttm -131.72 146.14 52.01 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 105.663 -1.977 . . . . 0.0 105.663 171.282 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.51 HD23 ' N ' ' A' ' 115' ' ' THR . 7.0 tt -140.26 139.36 35.54 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 175.335 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.51 ' N ' HD23 ' A' ' 114' ' ' LEU . 0.2 OUTLIER -137.9 134.57 35.19 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 -171.274 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.46 HD23 HG22 ' A' ' 60' ' ' ILE . 0.4 OUTLIER -122.79 118.42 27.95 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 120.409 1.459 . . . . 0.0 108.512 177.798 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 16.1 t -88.05 81.99 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 N-CA-C 105.05 -2.204 . . . . 0.0 105.05 175.335 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -80.76 141.9 23.07 Favored Glycine 0 C--O 1.225 -0.434 0 CA-C-O 119.272 -0.738 . . . . 0.0 111.573 -169.595 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.501 HG11 HG21 ' A' ' 18' ' ' ILE . 42.0 t -119.9 123.6 71.18 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.105 0 CA-C-N 117.396 0.598 . . . . 0.0 109.946 177.522 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 25.7 mt -78.23 127.87 79.95 Favored Pre-proline 0 CA--C 1.53 0.207 0 N-CA-C 104.999 -2.222 . . . . 0.0 104.999 169.545 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -69.15 160.0 51.61 Favored 'Trans proline' 0 N--CA 1.45 -1.062 0 C-N-CA 121.756 1.637 . . . . 0.0 110.966 179.584 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -94.67 -42.92 8.52 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 105.871 -1.9 . . . . 0.0 105.871 168.144 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 49.9 m -137.28 149.22 46.95 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 123.791 0.837 . . . . 0.0 109.494 173.682 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.2 tp -143.48 53.54 1.33 Allowed 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.976 1.311 . . . . 0.0 108.499 -175.507 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -114.49 168.18 8.44 Favored Pre-proline 0 CA--C 1.538 0.482 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 -173.749 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -82.08 84.66 1.82 Allowed 'Trans proline' 0 N--CA 1.454 -0.802 0 CA-C-N 120.952 1.376 . . . . 0.0 112.654 -169.45 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -174.28 145.37 1.01 Allowed 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 103.511 -2.774 . . . . 0.0 103.511 179.401 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -112.03 168.33 4.99 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 N-CA-C 113.352 0.871 . . . . 0.0 113.352 -169.264 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 96.76 148.79 24.69 Favored Glycine 0 CA--C 1.528 0.893 0 N-CA-C 106.066 -2.814 . . . . 0.0 106.066 -168.88 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.545 HD22 ' H ' ' A' ' 130' ' ' LEU . 0.7 OUTLIER -75.3 163.02 27.91 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 118.312 1.056 . . . . 0.0 110.569 177.969 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 58.4 p -71.05 171.4 8.6 Favored Pre-proline 0 CA--C 1.543 0.706 0 CA-C-N 114.929 -1.032 . . . . 0.0 109.051 168.52 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -58.06 -33.79 97.71 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 121.927 1.751 . . . . 0.0 112.393 172.985 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 57.7 m -72.65 -40.1 66.62 Favored 'General case' 0 N--CA 1.443 -0.785 0 C-N-CA 123.463 0.705 . . . . 0.0 111.178 -178.949 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 95.1 t -94.44 -23.85 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 CA-C-N 118.438 0.563 . . . . 0.0 111.523 -169.754 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -51.37 -44.77 62.21 Favored 'General case' 0 N--CA 1.467 0.402 0 O-C-N 120.836 -1.165 . . . . 0.0 109.497 169.775 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -71.3 -18.79 62.39 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 114.405 1.261 . . . . 0.0 114.405 -178.69 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' MET . . . . . 0.47 ' SD ' HG13 ' A' ' 119' ' ' VAL . 74.8 mtp -67.82 -14.92 63.35 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 118.005 -0.998 . . . . 0.0 112.829 -179.186 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 13.6 mt -48.87 -42.53 13.87 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.387 0 CA-C-N 119.635 1.107 . . . . 0.0 108.362 169.447 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 61.5 mm-40 -64.88 -58.32 13.31 Favored Pre-proline 0 CA--C 1.539 0.553 0 CA-C-N 120.351 1.432 . . . . 0.0 111.5 -172.872 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -61.32 -37.16 74.9 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 CA-C-N 121.447 1.553 . . . . 0.0 112.36 177.453 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -73.13 -37.83 66.52 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-O 118.569 -0.729 . . . . 0.0 111.499 -176.495 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 32.8 mt -62.24 -43.64 98.38 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-N 119.653 1.115 . . . . 0.0 109.041 170.701 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -55.78 -36.57 67.53 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 118.742 0.701 . . . . 0.0 110.131 174.547 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -72.44 -41.35 66.23 Favored 'General case' 0 N--CA 1.454 -0.26 0 O-C-N 121.442 -0.786 . . . . 0.0 112.712 177.527 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 60.1 t -58.76 -47.58 88.68 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 175.47 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 60.0 mt -60.99 -35.31 76.48 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-O 118.763 -0.637 . . . . 0.0 110.788 177.12 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -68.2 -46.22 71.21 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 119.243 0.928 . . . . 0.0 110.54 178.209 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -67.72 -30.06 69.46 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 119.882 1.219 . . . . 0.0 111.162 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 13.9 mt -63.06 -52.68 61.82 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 169.869 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 50.9 mmm-85 -66.04 -26.9 67.72 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 119.765 1.166 . . . . 0.0 112.412 -177.736 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 71.2 mt-10 -66.5 -30.13 70.38 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 119.569 1.077 . . . . 0.0 109.872 174.558 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 20.4 m -84.0 6.66 21.15 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.388 1.075 . . . . 0.0 111.957 171.118 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 72.06 12.15 75.32 Favored Glycine 0 CA--C 1.526 0.744 0 CA-C-O 117.294 -1.837 . . . . 0.0 112.98 -172.578 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 55.2 t -91.72 122.25 42.98 Favored 'Isoleucine or valine' 0 C--N 1.346 0.447 0 CA-C-N 121.048 2.424 . . . . 0.0 108.019 -176.73 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -104.26 93.5 4.85 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 173.546 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -58.9 146.04 39.07 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.823 169.129 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 22.9 mm -98.76 127.0 36.76 Favored Pre-proline 0 CA--C 1.53 0.21 0 CA-C-O 117.396 -1.287 . . . . 0.0 109.067 -171.454 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -67.96 97.99 0.5 Allowed 'Trans proline' 0 CA--C 1.535 0.536 0 C-N-CA 122.702 2.268 . . . . 0.0 109.753 174.745 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 23.2 mtp-105 48.32 18.04 0.15 Allowed 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 127.45 2.3 . . . . 0.0 115.327 -178.953 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 53.3 m . . . . . 0 CA--C 1.541 0.605 0 C-N-CA 124.229 1.012 . . . . 0.0 111.876 -169.582 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 16.2 ptt180 . . . . . 0 N--CA 1.471 0.594 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 84.8 mt -127.39 130.93 70.78 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.14 0 N-CA-C 107.896 -1.149 . . . . 0.0 107.896 -175.609 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -119.61 144.95 46.84 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 105.513 -2.032 . . . . 0.0 105.513 168.799 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 71.4 t -121.95 128.13 75.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 104.891 -2.263 . . . . 0.0 104.891 174.222 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.43 HD13 ' HA ' ' A' ' 6' ' ' LEU . 2.6 mm? -111.26 130.79 55.55 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-N 118.398 0.544 . . . . 0.0 109.85 -179.55 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -100.61 126.08 8.8 Favored Glycine 0 C--O 1.237 0.32 0 N-CA-C 108.211 -1.956 . . . . 0.0 108.211 171.296 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 1.9 m -141.22 171.56 12.04 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 CA-C-N 117.797 0.799 . . . . 0.0 110.278 -173.225 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 103.03 156.69 25.13 Favored Glycine 0 N--CA 1.442 -0.953 0 C-N-CA 126.352 1.93 . . . . 0.0 110.052 -178.625 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -72.51 104.21 3.76 Favored 'General case' 0 N--CA 1.453 -0.321 0 O-C-N 121.709 -0.877 . . . . 0.0 111.247 -169.378 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.1 pt -59.92 30.64 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.954 0 N-CA-C 117.228 2.307 . . . . 0.0 117.228 172.917 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 5.4 mp -129.79 -6.68 4.55 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 120.593 1.542 . . . . 0.0 108.436 168.439 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.0 mp -107.98 57.05 0.62 Allowed 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 119.255 0.934 . . . . 0.0 112.796 -168.123 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.444 ' HB ' ' H ' ' A' ' 15' ' ' ASP . 0.1 OUTLIER 51.16 -109.83 0.45 Allowed 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 123.898 0.879 . . . . 0.0 110.123 175.176 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.444 ' H ' ' HB ' ' A' ' 14' ' ' THR . 0.3 OUTLIER -77.85 -4.49 46.88 Favored 'General case' 0 N--CA 1.443 -0.78 0 O-C-N 121.59 -0.694 . . . . 0.0 111.021 -173.714 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -69.63 -12.17 61.43 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 120.647 1.567 . . . . 0.0 111.837 170.193 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -77.97 -9.95 59.35 Favored 'General case' 0 N--CA 1.435 -1.222 0 CA-C-O 115.736 -2.078 . . . . 0.0 109.635 170.497 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.7 tp -55.11 -39.14 49.19 Favored 'Isoleucine or valine' 0 C--N 1.348 0.537 0 CA-C-N 122.395 2.362 . . . . 0.0 111.995 -170.945 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -61.01 -39.5 97.17 Favored Glycine 0 C--N 1.336 0.58 0 CA-C-N 119.151 0.887 . . . . 0.0 111.038 177.62 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 97.1 t -74.45 -47.56 39.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 CA-C-O 118.54 -0.743 . . . . 0.0 109.861 176.024 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 76.2 mmt-85 -59.66 -33.84 72.06 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 119.983 1.265 . . . . 0.0 111.76 -179.723 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 22.8 mt -56.45 -51.49 64.1 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-N 120.363 1.438 . . . . 0.0 110.181 173.674 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 24.8 m -75.2 -25.98 18.54 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-N 119.075 0.852 . . . . 0.0 111.206 -172.56 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -69.88 -45.72 67.07 Favored 'General case' 0 C--O 1.233 0.187 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 174.355 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -67.35 -40.2 85.8 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 122.723 0.409 . . . . 0.0 110.386 -179.18 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.7 tp -61.56 -38.41 87.39 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 118.441 -0.79 . . . . 0.0 110.554 177.515 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -64.3 -42.21 96.49 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 118.956 0.798 . . . . 0.0 110.292 177.8 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -68.59 -36.37 78.62 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 122.873 0.469 . . . . 0.0 111.466 178.876 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 79.1 mmt-85 -94.36 -40.55 9.88 Favored 'General case' 0 C--N 1.339 0.122 0 CA-C-O 116.951 -1.499 . . . . 0.0 112.771 -170.3 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -117.19 130.33 56.52 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 121.588 1.994 . . . . 0.0 113.244 -169.948 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 40.2 mm -83.29 134.92 25.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 105.607 -1.997 . . . . 0.0 105.607 168.849 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.6 mp -133.34 150.69 75.9 Favored Pre-proline 0 CA--C 1.54 0.565 0 C-N-CA 126.99 2.116 . . . . 0.0 108.552 -169.934 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -71.01 165.05 33.64 Favored 'Trans proline' 0 CA--C 1.536 0.616 0 C-N-CA 122.815 2.343 . . . . 0.0 111.123 175.315 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -59.48 -31.45 69.35 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 -169.783 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 46.3 p90 -78.55 2.4 19.3 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 113.361 0.874 . . . . 0.0 113.361 -178.938 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.7 t -111.2 127.47 68.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 172.257 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -125.12 145.75 49.8 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 109.055 -0.721 . . . . 0.0 109.055 173.421 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -113.52 109.3 28.04 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 N-CA-C 105.762 -1.94 . . . . 0.0 105.762 172.159 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 64.4 tp -113.67 142.13 46.38 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 -174.118 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -100.38 127.52 46.68 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 123.642 0.777 . . . . 0.0 110.411 178.117 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -121.78 -22.56 2.7 Favored Glycine 0 CA--C 1.533 1.161 0 CA-C-O 118.51 -1.161 . . . . 0.0 113.012 169.586 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 42.64 -107.6 0.12 Allowed Glycine 0 C--N 1.339 0.742 0 C-N-CA 125.389 1.471 . . . . 0.0 113.938 177.091 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.8 p -67.48 -3.68 9.26 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 128.645 2.778 . . . . 0.0 114.108 -174.415 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.36 -56.88 14.15 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 124.07 0.948 . . . . 0.0 112.498 179.282 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 61.17 -99.64 0.21 Allowed Glycine 0 C--N 1.338 0.677 0 N-CA-C 108.614 -1.794 . . . . 0.0 108.614 -170.365 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.9 -28.15 68.08 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 126.098 1.759 . . . . 0.0 111.604 177.974 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -68.16 -4.15 12.91 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 113.802 1.038 . . . . 0.0 113.802 -168.5 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 22.4 mt -92.46 12.34 23.17 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 113.677 0.992 . . . . 0.0 113.677 177.449 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.429 ' HA ' HG13 ' A' ' 100' ' ' VAL . 6.1 tt -36.6 -60.48 0.59 Allowed 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.263 1.425 . . . . 0.0 114.713 -173.94 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -94.86 -26.61 12.51 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 123.205 0.431 . . . . 0.0 112.349 -175.51 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -57.69 -35.98 71.33 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 117.693 0.746 . . . . 0.0 111.769 179.066 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 20.7 mtp -83.05 -1.22 52.13 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 113.24 0.83 . . . . 0.0 113.24 -176.691 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -81.8 158.22 24.18 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.351 0.66 . . . . 0.0 111.995 -174.305 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 55.09 52.17 12.17 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 127.285 2.234 . . . . 0.0 115.655 168.416 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 20.7 mmt180 -115.07 163.2 15.96 Favored 'General case' 0 N--CA 1.482 1.174 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 170.663 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -80.46 -43.34 21.06 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 173.143 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . 0.294 0.1 OUTLIER -139.18 137.57 36.16 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 120.209 1.368 . . . . 0.0 110.101 168.319 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 24.1 tp -119.34 129.78 55.03 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 174.326 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 11.7 mt -103.1 115.91 45.9 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 174.899 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 9.5 mt -92.55 123.21 44.57 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 176.272 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -104.92 114.79 29.21 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 104.473 -2.417 . . . . 0.0 104.473 169.627 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -149.85 162.37 40.43 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.424 0.631 . . . . 0.0 110.961 -178.308 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -72.99 179.97 3.5 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 168.751 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.574 HG22 ' H ' ' A' ' 66' ' ' SER 0.301 93.2 mt -110.13 -83.15 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 CA-C-O 117.727 -1.13 . . . . 0.0 110.958 175.683 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . 0.292 1.7 m 41.0 35.86 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.856 0 C-N-CA 125.712 1.605 . . . . 0.0 112.984 -169.326 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.574 ' H ' HG22 ' A' ' 64' ' ' ILE . 49.9 m -134.12 2.77 3.36 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.435 1.494 . . . . 0.0 112.065 -173.453 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -154.34 156.36 36.76 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 177.032 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 9.7 ptpt -78.65 3.04 17.44 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 115.377 1.621 . . . . 0.0 115.377 -169.717 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 32.3 t-20 -69.7 161.9 28.8 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 118.955 0.798 . . . . 0.0 110.47 -173.677 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 11.9 m -55.72 143.34 60.0 Favored Pre-proline 0 CA--C 1.545 0.766 0 C-N-CA 124.669 1.188 . . . . 0.0 112.698 -169.774 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -57.28 151.83 49.69 Favored 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 122.33 2.02 . . . . 0.0 111.166 169.784 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 71.47 18.78 77.26 Favored Glycine 0 CA--C 1.533 1.189 0 O-C-N 121.458 -0.776 . . . . 0.0 113.468 175.213 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 6.9 m -104.78 139.95 38.81 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 125.474 1.51 . . . . 0.0 108.02 177.068 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 47.5 ttp -96.2 143.36 27.37 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 173.61 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 33.6 ttm -135.51 123.09 22.15 Favored 'General case' 0 CA--C 1.528 0.128 0 N-CA-C 106.429 -1.693 . . . . 0.0 106.429 -174.248 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 35.8 mm -103.67 119.64 52.59 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 178.889 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -114.01 134.22 54.99 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 -174.88 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 60.6 mtm180 -109.37 132.74 53.84 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 118.459 -0.781 . . . . 0.0 109.637 -174.749 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 37.8 t70 40.85 -104.76 0.05 Allowed 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 114.26 1.207 . . . . 0.0 114.26 169.761 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -60.02 -26.11 65.83 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.778 1.231 . . . . 0.0 113.894 -177.253 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -73.73 -20.9 60.39 Favored 'General case' 0 CA--C 1.534 0.331 0 O-C-N 121.829 -0.544 . . . . 0.0 110.085 -179.284 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.413 ' HB ' ' HD3' ' A' ' 83' ' ' PRO . 46.9 t -75.0 -55.46 2.31 Favored Pre-proline 0 N--CA 1.449 -0.494 0 CA-C-O 117.404 -1.284 . . . . 0.0 111.218 -169.874 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.413 ' HD3' ' HB ' ' A' ' 82' ' ' VAL . 6.2 Cg_exo -66.27 -30.7 45.28 Favored 'Trans proline' 0 N--CA 1.448 -1.193 0 CA-C-N 121.659 1.628 . . . . 0.0 110.191 178.04 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.07 -27.32 68.7 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 118.417 0.553 . . . . 0.0 111.364 179.322 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -74.05 -56.29 5.11 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 169.379 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.429 ' HB3' ' HB2' ' A' ' 98' ' ' ALA . 26.1 m-85 -63.23 -25.37 68.3 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 114.157 1.169 . . . . 0.0 114.157 -169.915 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 7.0 t -69.66 1.09 4.53 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 -175.587 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 37.2 t-20 -67.12 136.91 55.87 Favored 'General case' 0 CA--C 1.54 0.581 0 O-C-N 120.927 -1.108 . . . . 0.0 109.447 175.643 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 13.3 mptt -82.41 -9.1 59.58 Favored 'General case' 0 N--CA 1.47 0.531 0 O-C-N 121.487 -0.758 . . . . 0.0 111.858 -175.784 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 89.4 mt -61.25 -36.95 76.25 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 CA-C-N 119.047 0.84 . . . . 0.0 110.038 179.751 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 8.3 p -99.54 109.82 56.48 Favored Pre-proline 0 CA--C 1.548 0.903 0 C-N-CA 124.693 1.197 . . . . 0.0 109.543 -173.545 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -70.62 -46.47 0.86 Allowed 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 122.2 1.933 . . . . 0.0 113.21 -169.571 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 3.0 m80 -73.15 -38.4 66.26 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.481 0.657 . . . . 0.0 109.383 -177.042 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -76.11 -26.83 56.77 Favored 'General case' 0 C--O 1.226 -0.147 0 CA-C-O 118.659 -0.686 . . . . 0.0 111.07 -172.211 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -59.14 -37.61 77.7 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 118.901 0.773 . . . . 0.0 108.995 169.423 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -60.39 -41.86 98.68 Favored Glycine 0 CA--C 1.534 1.242 0 O-C-N 121.497 -0.752 . . . . 0.0 111.651 174.343 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -68.59 -31.6 70.9 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 118.133 0.967 . . . . 0.0 110.233 176.135 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.429 ' HB2' ' HB3' ' A' ' 86' ' ' PHE . . . -59.69 -45.32 92.45 Favored 'General case' 0 CA--C 1.53 0.179 0 O-C-N 120.77 -1.206 . . . . 0.0 109.032 169.306 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -68.63 -21.88 64.45 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 119.064 -0.493 . . . . 0.0 111.852 178.425 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.429 HG13 ' HA ' ' A' ' 49' ' ' LEU . 44.6 t -64.52 -46.21 93.36 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 168.988 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 19.8 mt -64.87 -35.46 81.2 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 119.655 1.116 . . . . 0.0 110.53 -179.781 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 16.4 m -60.93 -44.62 96.95 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 118.871 0.76 . . . . 0.0 109.368 171.5 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -65.63 -36.64 84.28 Favored 'General case' 0 N--CA 1.449 -0.522 0 O-C-N 121.686 -0.634 . . . . 0.0 111.701 179.105 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 12.4 mt -61.3 -37.59 83.77 Favored 'General case' 0 C--O 1.23 0.073 0 C-N-CA 123.59 0.756 . . . . 0.0 109.982 174.437 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 52.9 tpt85 -71.71 -35.1 70.11 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-O 118.036 -0.983 . . . . 0.0 110.49 174.452 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 18.4 m-30 -69.13 -39.06 79.12 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 119.785 1.175 . . . . 0.0 110.755 -178.571 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 38.9 p -72.59 -22.36 60.99 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 118.759 0.709 . . . . 0.0 111.012 175.699 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 73.62 11.07 80.4 Favored Glycine 0 CA--C 1.533 1.196 0 N-CA-C 111.005 -0.838 . . . . 0.0 111.005 -169.642 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -99.43 26.7 5.81 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 118.436 1.118 . . . . 0.0 110.575 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -59.48 129.59 87.12 Favored Pre-proline 0 CA--C 1.544 0.722 0 C-N-CA 124.137 0.975 . . . . 0.0 108.522 171.88 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_exo -50.37 149.66 12.47 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 123.971 3.114 . . . . 0.0 113.829 178.025 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 33.0 mmtp -59.46 -30.55 68.6 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 119.359 -0.353 . . . . 0.0 110.589 -178.307 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? -137.57 142.25 41.34 Favored 'General case' 0 C--O 1.231 0.129 0 N-CA-C 105.915 -1.883 . . . . 0.0 105.915 169.068 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 8.9 tt -127.78 134.1 49.47 Favored 'General case' 0 CA--C 1.519 -0.216 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 171.667 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.75 129.13 30.03 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 106.784 -1.562 . . . . 0.0 106.784 -169.569 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 7.0 tp -115.06 126.68 54.99 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 120.09 1.314 . . . . 0.0 108.553 178.312 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 32.4 t -98.51 84.44 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 N-CA-C 104.721 -2.326 . . . . 0.0 104.721 169.687 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -81.43 145.06 24.95 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 -179.013 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 19.0 t -126.79 137.11 58.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 171.936 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 1.6 mm -85.09 122.24 74.05 Favored Pre-proline 0 CA--C 1.543 0.701 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 177.179 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_exo -58.34 170.45 2.35 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 124.988 3.792 . . . . 0.0 115.711 172.109 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -118.26 -52.33 2.39 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 114.897 -1.047 . . . . 0.0 110.255 179.581 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 64.6 m -107.43 -53.84 2.56 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 119.203 0.91 . . . . 0.0 112.802 -174.716 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 57.29 47.55 16.58 Favored 'General case' 0 CA--C 1.549 0.942 0 N-CA-C 114.765 1.394 . . . . 0.0 114.765 175.283 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -124.67 170.17 9.48 Favored Pre-proline 0 N--CA 1.478 0.938 0 CA-C-O 117.888 -1.054 . . . . 0.0 109.89 175.441 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_exo -62.85 87.07 0.12 Allowed 'Trans proline' 0 CA--C 1.549 1.259 0 C-N-CA 123.838 3.025 . . . . 0.0 114.452 -179.368 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -172.76 140.42 0.98 Allowed 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 104.334 -2.469 . . . . 0.0 104.334 172.635 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -102.4 164.17 3.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-N 119.102 0.865 . . . . 0.0 112.889 -169.488 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 82.15 159.31 24.9 Favored Glycine 0 C--N 1.342 0.894 0 N-CA-C 108.977 -1.649 . . . . 0.0 108.977 -170.121 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -82.2 163.17 22.08 Favored 'General case' 0 N--CA 1.439 -0.993 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 -174.584 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 37.7 p -67.99 169.78 8.99 Favored Pre-proline 0 C--O 1.239 0.542 0 CA-C-N 115.107 -0.951 . . . . 0.0 108.944 168.067 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_exo -55.16 -32.37 79.8 Favored 'Trans proline' 0 CA--C 1.539 0.753 0 C-N-CA 121.397 1.398 . . . . 0.0 110.845 169.294 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 18.2 m -68.01 -44.49 76.42 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 119.066 -0.492 . . . . 0.0 111.297 179.604 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 12.3 t -100.59 -13.21 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-N 119.252 0.933 . . . . 0.0 112.277 -169.156 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -57.47 -45.83 84.36 Favored 'General case' 0 CA--C 1.516 -0.341 0 O-C-N 119.752 -1.842 . . . . 0.0 107.808 169.535 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -71.59 2.91 4.47 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-N 115.404 -0.816 . . . . 0.0 113.08 179.268 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 84.1 mtp -97.27 -6.87 33.48 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 118.136 -0.935 . . . . 0.0 111.384 173.609 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 79.2 mt -57.24 -50.06 77.88 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 175.512 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -66.36 -53.2 32.45 Favored Pre-proline 0 CA--C 1.537 0.47 0 CA-C-O 117.411 -1.281 . . . . 0.0 113.298 -170.036 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -60.79 -32.88 93.38 Favored 'Trans proline' 0 C--N 1.351 0.662 0 CA-C-N 121.987 1.745 . . . . 0.0 111.79 175.863 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -69.24 -38.8 78.66 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-O 118.406 -0.807 . . . . 0.0 109.881 177.623 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 10.6 mt -57.78 -44.17 86.06 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 119.612 1.097 . . . . 0.0 108.755 173.065 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -62.72 -36.84 84.28 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 118.328 0.513 . . . . 0.0 111.443 -176.577 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 42.9 mm-40 -74.27 -33.36 63.24 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 118.686 0.675 . . . . 0.0 112.206 177.28 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 75.2 t -62.05 -49.03 85.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-N 119.475 1.034 . . . . 0.0 108.28 169.726 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 56.3 mt -60.57 -39.12 86.85 Favored 'General case' 0 CA--C 1.531 0.244 0 O-C-N 121.81 -0.556 . . . . 0.0 110.717 -179.502 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -58.77 -39.3 80.61 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 119.038 -0.506 . . . . 0.0 112.147 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -64.93 -48.17 75.06 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 119.094 0.861 . . . . 0.0 110.406 178.17 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . 0.284 4.1 pp -68.01 -23.71 65.04 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 118.73 -0.652 . . . . 0.0 112.174 178.678 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 81.7 mtm-85 -67.1 -26.97 66.97 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 119.937 1.244 . . . . 0.0 111.407 171.014 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -66.89 -34.17 77.2 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 120.422 1.465 . . . . 0.0 109.318 175.843 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 23.1 m -82.32 18.45 1.43 Allowed 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.478 1.111 . . . . 0.0 112.615 172.529 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 68.21 19.65 72.41 Favored Glycine 0 CA--C 1.529 0.959 0 CA-C-O 118.706 -1.052 . . . . 0.0 113.745 173.347 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 58.1 t -80.48 124.97 39.01 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 CA-C-N 119.18 1.49 . . . . 0.0 107.317 176.518 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -100.67 95.72 6.86 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 105.222 -2.14 . . . . 0.0 105.222 169.509 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -70.43 141.64 52.07 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 177.158 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 8.8 mm -108.81 124.76 33.35 Favored Pre-proline 0 CA--C 1.529 0.151 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 -179.806 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -64.35 103.21 0.43 Allowed 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 121.918 1.745 . . . . 0.0 107.954 169.917 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 87.2 mtt180 56.91 -8.56 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 128.052 2.541 . . . . 0.0 117.017 179.469 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 2.4 t . . . . . 0 CA--C 1.543 0.708 0 C-N-CA 125.765 1.626 . . . . 0.0 111.575 -177.088 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 8.7 ptp180 . . . . . 0 N--CA 1.482 1.133 0 CA-C-O 117.725 -1.131 . . . . 0.0 108.114 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 53.7 mt -143.8 137.65 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 CA-C-N 119.718 1.145 . . . . 0.0 112.424 -168.578 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -121.07 126.7 50.49 Favored 'General case' 0 CA--C 1.521 -0.142 0 N-CA-C 104.255 -2.498 . . . . 0.0 104.255 167.487 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 61.7 t -107.95 100.03 9.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 N-CA-C 102.743 -3.058 . . . . 0.0 102.743 169.824 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 8.2 mt -95.54 116.05 28.29 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 -171.595 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -93.2 118.53 5.67 Favored Glycine 0 N--CA 1.446 -0.697 0 N-CA-C 106.136 -2.785 . . . . 0.0 106.136 169.659 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -134.62 -171.92 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 -174.506 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 106.43 157.43 21.6 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.217 -1.153 . . . . 0.0 110.217 -171.434 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -81.43 96.8 7.49 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 124.773 1.229 . . . . 0.0 109.055 -174.41 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.1 pt -71.97 41.81 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 C-N-CA 124.596 1.158 . . . . 0.0 113.766 -177.294 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 20.2 mt -130.1 -5.52 4.42 Favored 'General case' 0 CA--C 1.534 0.35 0 O-C-N 121.027 -1.046 . . . . 0.0 109.548 173.747 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -124.6 72.9 1.23 Allowed 'General case' 0 C--N 1.343 0.312 0 C-N-CA 123.559 0.744 . . . . 0.0 110.308 -168.511 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.452 ' HB ' ' H ' ' A' ' 15' ' ' ASP . 0.6 OUTLIER 47.25 -98.46 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.303 1.041 . . . . 0.0 113.419 175.368 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.452 ' H ' ' HB ' ' A' ' 14' ' ' THR . 69.1 m-20 -77.42 -18.54 57.14 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 125.347 1.459 . . . . 0.0 112.207 -169.531 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -72.63 -8.27 54.45 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 120.275 1.398 . . . . 0.0 112.491 -176.53 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.43 -12.0 60.92 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-O 117.057 -1.449 . . . . 0.0 110.862 169.389 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 9.2 tp -56.82 -39.72 66.36 Favored 'Isoleucine or valine' 0 C--N 1.341 0.234 0 CA-C-N 121.107 1.776 . . . . 0.0 112.275 -170.117 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -58.73 -46.82 92.86 Favored Glycine 0 C--N 1.339 0.708 0 CA-C-N 119.484 1.038 . . . . 0.0 111.229 176.25 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 62.4 t -62.95 -47.92 90.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-O 118.618 -0.706 . . . . 0.0 109.477 175.822 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 20.3 mmt180 -63.73 -31.95 73.29 Favored 'General case' 0 C--N 1.346 0.452 0 CA-C-O 117.298 -1.334 . . . . 0.0 111.688 -176.796 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 18.2 mt -60.6 -48.16 89.78 Favored 'Isoleucine or valine' 0 C--N 1.341 0.233 0 CA-C-N 121.033 1.742 . . . . 0.0 109.62 176.901 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 18.8 m -74.64 -33.45 31.9 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-N 119.429 1.013 . . . . 0.0 111.368 -173.486 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 62.8 mt-10 -63.29 -44.41 95.12 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 118.383 0.538 . . . . 0.0 109.934 172.206 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -66.33 -37.6 85.74 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 119.427 1.012 . . . . 0.0 110.197 177.91 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.8 tp -63.79 -39.78 95.07 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 119.08 0.855 . . . . 0.0 109.088 -178.636 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -62.16 -22.5 65.92 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.251 0.62 . . . . 0.0 112.578 179.302 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 90.3 mt-30 -94.32 -45.09 7.64 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.213 1.405 . . . . 0.0 110.201 -178.704 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 80.4 mtt180 -81.69 -25.33 35.6 Favored 'General case' 0 CA--C 1.528 0.109 0 CA-C-O 118.753 -0.641 . . . . 0.0 111.165 -173.627 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.402 ' HA ' ' H ' ' A' ' 159' ' ' ARG . 56.5 m-85 -125.54 151.33 46.51 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-N 118.611 0.642 . . . . 0.0 111.019 -179.511 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 46.3 mm -104.56 133.64 48.11 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 103.51 -2.774 . . . . 0.0 103.51 168.81 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -113.04 146.76 35.83 Favored Pre-proline 0 C--O 1.237 0.4 0 C-N-CA 123.28 0.632 . . . . 0.0 109.703 -169.801 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -65.17 157.89 55.06 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 122.458 2.105 . . . . 0.0 109.9 170.564 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -57.49 -34.01 68.61 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 -169.408 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 12.0 p90 -76.26 -10.73 59.63 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 -177.171 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 69.1 t -91.84 119.37 39.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 172.002 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -111.84 114.68 27.78 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 107.343 -1.354 . . . . 0.0 107.343 169.536 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -85.06 102.43 10.97 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 N-CA-C 104.484 -2.413 . . . . 0.0 104.484 168.967 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 59.5 tp -107.54 128.37 54.46 Favored 'General case' 0 C--O 1.232 0.151 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 -173.244 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -79.3 119.43 22.35 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 169.539 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -78.41 -80.1 0.74 Allowed Glycine 0 C--N 1.338 0.664 0 N-CA-C 106.64 -2.584 . . . . 0.0 106.64 169.527 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 78.28 99.37 0.21 Allowed Glycine 0 C--N 1.342 0.903 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 176.857 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 13.1 p 53.47 55.62 8.41 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.113 0.965 . . . . 0.0 108.69 -177.586 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -118.03 -79.89 0.6 Allowed 'General case' 0 C--N 1.348 0.503 0 CA-C-N 114.487 -1.233 . . . . 0.0 111.071 -170.051 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 59.42 -110.2 2.6 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 110.077 -1.209 . . . . 0.0 110.077 -179.754 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -53.14 -33.03 50.68 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.973 1.309 . . . . 0.0 110.962 -176.387 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -54.43 -22.3 12.18 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 113.784 1.031 . . . . 0.0 113.784 -175.474 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 14.5 mt -95.73 17.89 14.13 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 113.57 0.952 . . . . 0.0 113.57 -169.537 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.705 ' HA ' HG13 ' A' ' 100' ' ' VAL . 4.6 tt -45.78 -60.11 2.41 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 123.239 0.616 . . . . 0.0 112.055 -177.165 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -67.78 -32.52 78.06 Favored Glycine 0 CA--C 1.532 1.146 0 CA-C-N 116.002 -0.545 . . . . 0.0 112.291 -178.076 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -78.47 -32.37 48.33 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 118.836 1.318 . . . . 0.0 112.699 -173.555 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.534 ' SD ' HG11 ' A' ' 100' ' ' VAL . 53.8 mtp -74.8 -16.98 60.69 Favored 'General case' 0 N--CA 1.454 -0.225 0 O-C-N 121.758 -0.589 . . . . 0.0 110.868 178.261 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -81.13 156.4 25.77 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 123.375 0.67 . . . . 0.0 111.257 -173.68 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 53.76 36.08 23.01 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 126.588 1.955 . . . . 0.0 113.512 173.789 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 26.4 mmt180 -100.94 157.29 16.85 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 173.047 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -82.63 -54.68 4.97 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 176.008 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . 0.263 0.0 OUTLIER -116.83 149.95 39.17 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-N 119.522 1.055 . . . . 0.0 108.589 168.551 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 12.6 tp -133.69 115.82 15.06 Favored 'General case' 0 CA--C 1.511 -0.543 0 N-CA-C 104.955 -2.239 . . . . 0.0 104.955 171.782 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 33.8 mt -97.95 111.95 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 N-CA-C 104.885 -2.265 . . . . 0.0 104.885 171.832 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.552 HD13 HD11 ' A' ' 97' ' ' LEU . 12.2 mt -85.18 134.41 27.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 106.058 -1.83 . . . . 0.0 106.058 171.589 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -117.0 118.41 32.32 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 102.591 -3.114 . . . . 0.0 102.591 168.402 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -156.71 162.12 39.8 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 -175.093 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -85.33 149.66 25.3 Favored 'General case' 0 CA--C 1.534 0.357 0 O-C-N 121.536 -0.727 . . . . 0.0 109.974 170.026 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 11.0 mt -80.46 -30.94 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 C-N-CA 124.7 1.2 . . . . 0.0 110.171 175.678 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . 0.361 2.5 t 60.27 43.77 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.086 0 C-N-CA 126.321 1.848 . . . . 0.0 113.326 -176.402 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 12.8 m 62.04 139.15 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 128.424 2.69 . . . . 0.0 118.172 168.526 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -130.73 -90.04 0.46 Allowed 'General case' 0 N--CA 1.463 0.181 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 169.774 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 87.9 mttt -139.36 35.41 2.07 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.778 1.231 . . . . 0.0 110.0 -176.705 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 42.1 t-20 -138.0 161.72 35.98 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.561 1.144 . . . . 0.0 109.844 -171.105 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 2.1 m -62.5 148.3 90.67 Favored Pre-proline 0 CA--C 1.547 0.865 0 C-N-CA 124.666 1.186 . . . . 0.0 113.131 -169.294 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_exo -56.85 157.91 18.52 Favored 'Trans proline' 0 CA--C 1.532 0.419 0 C-N-CA 124.481 3.454 . . . . 0.0 113.038 169.711 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 64.15 16.3 59.82 Favored Glycine 0 CA--C 1.531 1.064 0 CA-C-O 119.491 -0.616 . . . . 0.0 113.809 171.317 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 3.0 m -94.51 146.64 23.96 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 124.672 1.189 . . . . 0.0 109.629 -172.092 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 31.7 ttp -98.04 141.78 30.57 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 171.676 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 64.3 mtm -133.33 129.73 37.89 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 169.0 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 38.9 mm -108.21 121.93 61.92 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 -179.528 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.3 mp -121.33 139.01 53.99 Favored 'General case' 0 C--O 1.236 0.367 0 O-C-N 123.833 0.708 . . . . 0.0 109.3 -172.811 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 52.5 ttp180 -83.95 165.15 18.89 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.922 0.889 . . . . 0.0 110.049 -177.968 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -30.67 -55.1 0.2 Allowed 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 116.353 1.983 . . . . 0.0 116.353 -175.392 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -87.91 -16.65 33.29 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 -174.764 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -76.13 -35.09 59.4 Favored 'General case' 0 N--CA 1.461 0.084 0 O-C-N 121.817 -0.552 . . . . 0.0 109.574 -178.254 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.455 ' HB ' ' HD3' ' A' ' 83' ' ' PRO . 88.3 t -59.14 -54.54 55.37 Favored Pre-proline 0 CA--C 1.547 0.848 0 C-N-CA 125.635 1.574 . . . . 0.0 111.787 -175.675 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.455 ' HD3' ' HB ' ' A' ' 82' ' ' VAL . 50.3 Cg_exo -53.86 -42.77 63.83 Favored 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 122.781 2.321 . . . . 0.0 112.41 174.935 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -71.26 -10.82 60.39 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -91.66 -40.2 11.42 Favored 'General case' 0 C--N 1.343 0.315 0 CA-C-N 120.073 1.306 . . . . 0.0 111.82 -176.539 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.511 ' CE2' HD12 ' A' ' 97' ' ' LEU . 41.4 m-85 -75.52 10.12 1.85 Allowed 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 112.967 0.728 . . . . 0.0 112.967 -171.525 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 75.2 p -60.14 -24.29 64.59 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.154 0.981 . . . . 0.0 111.22 171.933 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 61.5 t-20 -49.04 118.9 2.87 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.503 1.121 . . . . 0.0 111.235 177.414 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -74.67 -18.45 60.52 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -174.744 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 42.1 mt -67.13 -45.59 86.27 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -176.527 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.3 m -73.18 110.54 8.84 Favored Pre-proline 0 CA--C 1.545 0.762 0 C-N-CA 126.291 1.837 . . . . 0.0 112.05 -168.987 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -76.15 -62.95 0.03 OUTLIER 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 122.254 1.97 . . . . 0.0 112.333 -169.863 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 6.6 t-80 -56.66 -40.04 74.81 Favored 'General case' 0 N--CA 1.466 0.335 0 O-C-N 121.442 -0.786 . . . . 0.0 110.225 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 22.0 mp0 -62.29 -27.69 69.2 Favored 'General case' 0 N--CA 1.44 -0.955 0 C-N-CA 124.972 1.309 . . . . 0.0 110.082 -172.999 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 30.9 mt -72.09 -36.72 69.59 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 120.025 1.284 . . . . 0.0 110.447 174.705 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -66.69 -42.96 92.97 Favored Glycine 0 CA--C 1.528 0.885 0 N-CA-C 110.238 -1.145 . . . . 0.0 110.238 173.387 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.552 HD11 HD13 ' A' ' 60' ' ' ILE . 3.4 tm? -59.79 -41.45 91.2 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.197 0.599 . . . . 0.0 109.791 173.35 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -59.25 -44.65 92.36 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 123.01 0.524 . . . . 0.0 110.542 175.883 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -66.11 -26.76 67.61 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 118.806 -0.616 . . . . 0.0 111.899 -179.608 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.705 HG13 ' HA ' ' A' ' 49' ' ' LEU . 92.1 t -63.93 -45.84 95.78 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 168.845 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 87.9 mt -67.07 -33.4 75.43 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 119.266 0.939 . . . . 0.0 110.722 -176.182 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 15.8 m -60.78 -49.25 78.24 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 119.028 0.831 . . . . 0.0 109.957 169.962 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.402 ' HA ' ' CD2' ' A' ' 106' ' ' PHE . . . -58.1 -41.03 82.63 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 118.185 0.448 . . . . 0.0 111.019 176.737 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -63.48 -32.71 74.24 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 123.741 0.816 . . . . 0.0 110.951 179.74 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 17.6 ptm180 -83.68 -27.86 28.75 Favored 'General case' 0 C--N 1.344 0.369 0 CA-C-N 120.455 1.48 . . . . 0.0 112.19 173.891 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.402 ' CD2' ' HA ' ' A' ' 103' ' ' ALA . 16.7 m-30 -60.47 -46.58 89.55 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 118.454 0.57 . . . . 0.0 109.843 172.301 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 41.4 p -77.29 -26.8 52.67 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 123.611 0.764 . . . . 0.0 111.54 178.941 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 75.66 6.35 81.12 Favored Glycine 0 CA--C 1.534 1.232 0 N-CA-C 109.881 -1.288 . . . . 0.0 109.881 -168.497 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -85.24 19.99 2.09 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 119.768 1.784 . . . . 0.0 111.454 179.088 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -56.28 140.03 72.44 Favored Pre-proline 0 CA--C 1.546 0.814 0 C-N-CA 126.034 1.734 . . . . 0.0 110.307 170.058 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 99.6 Cg_exo -57.97 161.37 13.26 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 123.396 2.731 . . . . 0.0 115.531 179.365 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -65.91 -38.63 89.2 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 119.164 -0.446 . . . . 0.0 111.671 176.339 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 4.5 pttm -142.75 89.64 2.15 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 124.259 1.024 . . . . 0.0 108.342 177.7 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 7.4 tt -76.33 142.6 41.19 Favored 'General case' 0 CA--C 1.534 0.356 0 O-C-N 120.961 -1.087 . . . . 0.0 108.592 169.418 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.9 140.81 46.07 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.334 1.454 . . . . 0.0 107.698 174.696 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 14.6 tp -118.59 134.41 55.13 Favored 'General case' 0 N--CA 1.467 0.411 0 O-C-N 120.48 -1.388 . . . . 0.0 108.496 175.291 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 20.4 t -105.92 85.09 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 N-CA-C 104.788 -2.301 . . . . 0.0 104.788 169.154 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -81.31 144.66 24.77 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 110.41 -1.076 . . . . 0.0 110.41 179.732 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 39.2 t -128.43 130.98 69.3 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 CA-C-N 117.405 0.603 . . . . 0.0 109.989 179.829 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 16.8 mt -85.17 132.92 43.9 Favored Pre-proline 0 CA--C 1.539 0.529 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 176.396 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -77.01 -179.06 5.05 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 123.075 2.517 . . . . 0.0 111.617 -177.569 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.453 ' HB3' HG21 ' A' ' 131' ' ' THR . 6.3 tp10 -110.09 -51.18 2.9 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.994 0.918 . . . . 0.0 109.807 169.753 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 66.4 m -118.65 -54.53 2.25 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 118.201 0.455 . . . . 0.0 111.964 -169.853 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER 54.54 52.84 11.61 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.652 1.181 . . . . 0.0 112.163 -177.293 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -119.25 165.92 15.87 Favored Pre-proline 0 CA--C 1.537 0.472 0 C-N-CA 123.468 0.707 . . . . 0.0 109.954 -179.372 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -78.32 81.78 2.64 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 121.755 1.636 . . . . 0.0 112.634 -169.864 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -171.09 141.59 1.68 Allowed 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 102.218 -3.253 . . . . 0.0 102.218 177.293 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -108.21 166.59 4.25 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 N-CA-C 113.596 0.962 . . . . 0.0 113.596 -169.286 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 97.33 141.21 11.94 Favored Glycine 0 C--N 1.338 0.646 0 N-CA-C 105.751 -2.94 . . . . 0.0 105.751 -168.916 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.61 HD22 ' H ' ' A' ' 130' ' ' LEU . 1.0 OUTLIER -67.41 158.49 31.59 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 117.861 0.83 . . . . 0.0 109.882 176.943 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.453 HG21 ' HB3' ' A' ' 122' ' ' GLU . 63.4 p -69.14 169.75 10.78 Favored Pre-proline 0 CA--C 1.543 0.681 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 168.018 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -58.02 -37.13 97.12 Favored 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 121.57 1.513 . . . . 0.0 111.388 173.305 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 82.8 m -64.33 -33.75 76.55 Favored 'General case' 0 N--CA 1.443 -0.785 0 C-N-CA 124.415 1.086 . . . . 0.0 111.436 -178.85 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 73.8 t -103.23 -27.59 3.2 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 O-C-N 121.81 -0.556 . . . . 0.0 111.511 -172.731 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -51.73 -49.37 62.69 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 119.035 0.834 . . . . 0.0 108.88 169.837 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -61.89 -20.88 64.22 Favored 'General case' 0 N--CA 1.447 -0.575 0 N-CA-C 112.994 0.738 . . . . 0.0 112.994 179.373 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 3.0 mmm -78.04 -7.89 57.48 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 -179.619 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 72.5 mt -55.95 -50.59 68.31 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.295 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 170.79 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -70.51 -44.89 18.4 Favored Pre-proline 0 CA--C 1.538 0.481 0 CA-C-O 117.284 -1.341 . . . . 0.0 113.756 -168.893 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -57.66 -41.33 71.75 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 CA-C-N 122.076 1.777 . . . . 0.0 111.152 172.412 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.01 -35.89 74.69 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-O 118.263 -0.875 . . . . 0.0 112.046 179.285 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 39.0 mt -61.09 -48.64 80.75 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-N 120.087 1.312 . . . . 0.0 108.929 172.249 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -54.73 -35.31 63.55 Favored 'General case' 0 CA--C 1.531 0.237 0 O-C-N 123.398 0.436 . . . . 0.0 109.995 175.288 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 2.1 mm100 -78.7 -35.74 44.58 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 45.7 t -59.27 -48.27 87.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 169.82 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 44.0 mt -60.23 -36.55 77.99 Favored 'General case' 0 C--O 1.226 -0.148 0 C-N-CA 123.413 0.685 . . . . 0.0 110.88 177.833 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -70.1 -44.23 69.44 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 119.139 0.881 . . . . 0.0 110.856 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -66.53 -30.99 71.43 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 119.676 1.126 . . . . 0.0 111.225 177.433 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 12.9 mt -62.27 -52.99 61.5 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 169.845 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 93.6 mtt-85 -64.73 -28.65 69.74 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 120.231 1.378 . . . . 0.0 112.432 -178.413 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -69.34 -28.75 66.51 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 119.203 0.91 . . . . 0.0 109.982 176.712 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 51.0 m -82.51 8.24 12.22 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.392 1.077 . . . . 0.0 111.906 169.713 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 72.83 10.52 77.09 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-O 117.291 -1.838 . . . . 0.0 113.11 -174.56 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 38.2 t -91.05 119.54 38.39 Favored 'Isoleucine or valine' 0 C--N 1.345 0.378 0 CA-C-N 121.025 2.412 . . . . 0.0 108.48 -176.59 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -97.57 91.32 5.38 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 172.385 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -55.9 139.11 47.08 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 169.051 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 20.5 mt -83.33 126.87 70.71 Favored Pre-proline 0 CA--C 1.529 0.161 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 -173.263 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -68.47 89.83 0.4 Allowed 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 123.045 2.497 . . . . 0.0 109.029 174.64 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 159' ' ' ARG . . . . . 0.402 ' H ' ' HA ' ' A' ' 30' ' ' TYR . 29.1 ttp180 52.34 17.13 0.69 Allowed 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 127.628 2.371 . . . . 0.0 114.567 179.489 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 57.7 m . . . . . 0 CA--C 1.544 0.746 0 C-N-CA 124.057 0.943 . . . . 0.0 111.145 -169.015 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 38.9 ttm180 . . . . . 0 N--CA 1.475 0.792 0 CA-C-O 118.852 -0.594 . . . . 0.0 109.693 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 5.5 mt -119.73 132.7 68.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 -174.526 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 43.3 tp -113.61 145.72 40.84 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 105.849 -1.908 . . . . 0.0 105.849 167.869 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 30.2 t -124.32 131.37 72.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 N-CA-C 105.017 -2.216 . . . . 0.0 105.017 169.213 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 6.6 mt -125.36 117.3 23.43 Favored 'General case' 0 CA--C 1.511 -0.547 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 -173.671 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -87.88 133.29 11.71 Favored Glycine 0 CA--C 1.521 0.424 0 N-CA-C 107.709 -2.157 . . . . 0.0 107.709 169.652 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.5 m -142.27 133.01 24.76 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 CA-C-N 119.317 1.559 . . . . 0.0 112.507 -170.997 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 144.79 169.59 13.42 Favored Glycine 0 CA--C 1.525 0.684 0 C-N-CA 125.948 1.737 . . . . 0.0 109.123 169.572 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.548 HD21 HD13 ' A' ' 13' ' ' LEU . 0.2 OUTLIER -76.94 116.77 17.9 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 122.81 1.29 . . . . 0.0 111.45 -176.459 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.1 pt -63.99 36.34 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.861 0 N-CA-C 116.096 1.888 . . . . 0.0 116.096 172.861 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 5.4 mp -129.52 -9.53 4.59 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 120.545 1.52 . . . . 0.0 110.025 168.525 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.548 HD13 HD21 ' A' ' 10' ' ' ASN . 4.7 mp -106.59 56.47 0.65 Allowed 'General case' 0 C--N 1.343 0.299 0 N-CA-C 114.739 1.385 . . . . 0.0 114.739 -168.917 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.255 0.2 OUTLIER 54.95 -109.59 0.51 Allowed 'General case' 0 C--O 1.238 0.45 0 C-N-CA 123.428 0.691 . . . . 0.0 110.921 170.428 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -77.9 -7.45 56.75 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.435 0.694 . . . . 0.0 111.831 -175.935 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 23.0 tp10 -55.85 -32.59 63.76 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 120.012 1.278 . . . . 0.0 111.417 169.924 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.9 5.0 14.97 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-O 115.888 -2.006 . . . . 0.0 110.082 -179.1 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 6.6 tp -57.07 -42.82 80.13 Favored 'Isoleucine or valine' 0 C--N 1.342 0.242 0 CA-C-N 123.369 2.804 . . . . 0.0 110.92 -179.764 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -61.23 -43.18 99.71 Favored Glycine 0 CA--C 1.526 0.727 0 CA-C-N 119.564 1.075 . . . . 0.0 111.465 175.428 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 83.2 t -66.93 -51.46 54.62 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 CA-C-N 117.449 0.624 . . . . 0.0 109.559 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 74.4 mmt-85 -57.55 -34.76 69.51 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 117.142 -1.409 . . . . 0.0 112.479 176.578 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 24.2 mt -60.72 -47.73 91.84 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-N 121.839 2.109 . . . . 0.0 110.507 175.902 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 35.2 m -74.26 -27.2 21.39 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-N 120.25 1.386 . . . . 0.0 111.416 -175.426 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -69.18 -45.69 69.36 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 174.597 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -64.32 -45.11 89.3 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 123.313 0.645 . . . . 0.0 110.509 -179.442 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 8.1 tp -61.78 -41.58 97.9 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-O 118.86 -0.59 . . . . 0.0 110.068 179.672 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -60.05 -38.73 83.67 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 118.209 0.459 . . . . 0.0 110.965 177.922 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 9.5 mm-40 -75.75 -40.6 55.17 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 118.631 0.651 . . . . 0.0 111.065 -179.899 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 41.5 mmt180 -87.4 -31.57 20.01 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 117.637 -1.173 . . . . 0.0 113.02 -169.498 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 72.0 m-85 -122.54 137.76 54.78 Favored 'General case' 0 CA--C 1.522 -0.134 0 CA-C-N 120.76 1.618 . . . . 0.0 111.969 -176.05 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 43.7 mm -90.87 137.65 21.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 N-CA-C 105.591 -2.003 . . . . 0.0 105.591 168.819 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -124.25 154.98 68.83 Favored Pre-proline 0 CA--C 1.541 0.62 0 C-N-CA 124.985 1.314 . . . . 0.0 109.902 -170.906 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -59.44 157.13 32.61 Favored 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 123.318 2.679 . . . . 0.0 112.041 169.697 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -63.19 -31.38 72.51 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -171.969 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 18.8 p90 -72.66 -6.19 42.67 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 118.186 -0.911 . . . . 0.0 112.699 178.816 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 38.2 t -100.9 130.73 49.81 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 CA-C-N 120.054 1.297 . . . . 0.0 108.32 175.391 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -118.55 135.35 54.46 Favored 'General case' 0 CA--C 1.529 0.171 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 170.078 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -106.47 118.12 53.54 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 N-CA-C 104.691 -2.337 . . . . 0.0 104.691 169.368 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 48.7 tp -127.19 126.4 42.75 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-O 120.889 0.376 . . . . 0.0 110.307 -174.735 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -78.0 119.42 21.42 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 168.715 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -57.51 -55.84 28.28 Favored Glycine 0 CA--C 1.53 0.975 0 N-CA-C 109.073 -1.611 . . . . 0.0 109.073 172.411 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 74.74 87.56 0.24 Allowed Glycine 0 C--N 1.341 0.833 0 N-CA-C 111.451 -0.66 . . . . 0.0 111.451 169.699 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 20.3 p 50.81 58.91 5.02 Favored 'General case' 0 CA--C 1.546 0.8 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 -177.532 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -116.65 -86.72 0.62 Allowed 'General case' 0 C--N 1.348 0.508 0 CA-C-N 114.495 -1.23 . . . . 0.0 111.352 -169.334 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 65.76 -94.97 0.22 Allowed Glycine 0 C--N 1.341 0.836 0 N-CA-C 108.947 -1.661 . . . . 0.0 108.947 -169.772 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 3.5 tpt -62.77 -31.41 72.37 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 125.288 1.435 . . . . 0.0 111.764 179.687 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -66.36 -7.69 20.7 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -169.32 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 70.9 mt -84.26 3.74 34.06 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 113.854 1.057 . . . . 0.0 113.854 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.479 ' HA ' HG13 ' A' ' 100' ' ' VAL . 6.0 tt -41.36 -59.0 1.68 Allowed 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 114.107 1.151 . . . . 0.0 114.107 -170.907 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -93.34 -26.02 17.12 Favored Glycine 0 CA--C 1.527 0.786 0 C-N-CA 123.698 0.666 . . . . 0.0 111.896 -178.461 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -62.06 -34.7 76.74 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 118.639 1.22 . . . . 0.0 111.335 179.467 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 26.8 mtp -78.28 -3.58 43.6 Favored 'General case' 0 CA--C 1.529 0.137 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 178.378 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.5 157.84 36.84 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 118.817 0.735 . . . . 0.0 110.824 -178.124 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 55.3 39.51 31.31 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.827 1.651 . . . . 0.0 114.66 168.311 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 13.4 mmt180 -107.11 148.86 28.28 Favored 'General case' 0 N--CA 1.473 0.714 0 O-C-N 121.121 -0.987 . . . . 0.0 109.411 176.11 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -82.49 -36.05 26.82 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 171.927 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 1.7 t-160 -138.45 137.93 37.66 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 -176.002 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 20.8 tp -136.41 131.47 34.19 Favored 'General case' 0 CA--C 1.507 -0.686 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 169.275 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 3.8 mp -112.42 119.81 61.15 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 169.656 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 5.3 mt -96.55 117.71 41.48 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 177.097 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -84.56 113.41 21.22 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 103.2 -2.889 . . . . 0.0 103.2 169.519 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -124.16 155.37 38.59 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 114.358 1.244 . . . . 0.0 114.358 -167.828 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -113.18 119.4 37.65 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 169.843 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 92.0 mt -76.71 -26.01 16.22 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.753 0 O-C-N 124.148 0.905 . . . . 0.0 111.558 -171.703 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . 0.286 47.4 t 69.75 -62.58 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 C-N-CA 128.887 2.875 . . . . 0.0 111.572 -170.61 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 5.5 m -151.68 138.84 19.23 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 177.561 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 73.3 tttt -157.3 170.06 23.32 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 127.534 2.334 . . . . 0.0 105.234 168.735 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.01 -22.5 65.89 Favored 'General case' 0 N--CA 1.473 0.675 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 -170.314 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -71.16 164.92 24.66 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 123.087 0.555 . . . . 0.0 110.292 -177.661 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 18.6 m -61.57 149.57 83.76 Favored Pre-proline 0 CA--C 1.55 0.949 0 C-N-CA 124.257 1.023 . . . . 0.0 112.125 -171.232 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -54.21 152.53 24.77 Favored 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 122.77 2.313 . . . . 0.0 112.255 169.972 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 69.65 7.36 58.25 Favored Glycine 0 CA--C 1.531 1.036 0 CA-C-O 118.661 -1.077 . . . . 0.0 114.44 175.276 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 20.5 m -89.19 148.14 23.79 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 119.608 1.704 . . . . 0.0 110.043 -173.832 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 25.5 ttp -90.77 147.6 23.11 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.264 178.316 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 19.9 ttm -141.54 116.48 9.86 Favored 'General case' 0 CA--C 1.528 0.118 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 -177.887 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.6 mp -96.28 122.96 48.29 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 177.957 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -115.52 126.81 54.73 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 179.228 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 74.9 mtm180 -91.63 177.26 6.26 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 123.354 0.662 . . . . 0.0 109.68 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -48.19 -47.86 35.08 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 115.341 1.608 . . . . 0.0 115.341 -169.7 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -76.18 -15.89 59.96 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 119.046 0.839 . . . . 0.0 112.198 -178.33 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -96.36 -23.68 16.52 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 123.863 0.865 . . . . 0.0 110.714 -169.892 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.427 HG12 ' CE2' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -68.57 -37.99 11.41 Favored Pre-proline 0 CA--C 1.535 0.37 0 O-C-N 120.608 -1.308 . . . . 0.0 112.554 178.19 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -62.78 -12.04 26.96 Favored 'Trans proline' 0 CA--C 1.546 1.105 0 C-N-CA 121.55 1.5 . . . . 0.0 112.746 168.834 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -98.9 4.59 47.44 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.91 0.884 . . . . 0.0 111.742 173.436 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.504 HD13 ' C ' ' A' ' 85' ' ' LEU . 2.1 tm? -111.76 -57.25 2.28 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 124.025 0.93 . . . . 0.0 111.166 -175.701 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.427 ' CE2' HG12 ' A' ' 82' ' ' VAL . 67.4 m-85 -66.14 -15.89 63.5 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 118.764 0.711 . . . . 0.0 111.534 -170.307 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 68.4 p -85.29 -9.94 57.08 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 125.539 1.535 . . . . 0.0 113.139 -168.482 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -59.38 152.04 22.28 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 118.476 0.58 . . . . 0.0 109.926 174.584 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -78.5 -10.05 59.56 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 113.456 0.91 . . . . 0.0 113.456 -169.881 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 4.8 mp -84.76 -53.46 10.78 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 CA-C-N 119.396 0.998 . . . . 0.0 109.44 -171.743 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 3.9 m -59.95 109.23 1.81 Allowed Pre-proline 0 CA--C 1.549 0.908 0 C-N-CA 124.1 0.96 . . . . 0.0 111.814 -169.659 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -71.9 -54.15 0.15 Allowed 'Trans proline' 0 C--N 1.354 0.821 0 CA-C-N 120.817 1.328 . . . . 0.0 112.438 -169.829 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 18.2 m80 -80.93 -32.25 34.68 Favored 'General case' 0 N--CA 1.467 0.408 0 O-C-N 121.984 -0.447 . . . . 0.0 110.108 -175.126 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 3.9 mm-40 -71.16 -23.12 61.99 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 118.485 -0.769 . . . . 0.0 110.523 -179.112 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 10.4 mt -62.98 -30.52 71.65 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 120.387 1.448 . . . . 0.0 110.974 169.916 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -64.1 -40.75 98.4 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 109.916 -1.274 . . . . 0.0 109.916 171.91 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 22.5 tp -67.93 -30.93 70.36 Favored 'General case' 0 CA--C 1.532 0.287 0 O-C-N 122.142 -0.622 . . . . 0.0 110.546 174.658 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -58.87 -44.11 91.0 Favored 'General case' 0 N--CA 1.451 -0.389 0 O-C-N 120.796 -1.19 . . . . 0.0 108.895 171.131 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -70.89 -20.38 62.51 Favored 'General case' 0 N--CA 1.456 -0.13 0 O-C-N 121.789 -0.57 . . . . 0.0 111.494 177.84 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.479 HG13 ' HA ' ' A' ' 49' ' ' LEU . 55.2 t -70.04 -41.26 79.19 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.871 0 CA-C-O 117.764 -1.113 . . . . 0.0 108.126 169.315 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 6.8 mp -60.69 -38.21 84.23 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 120.602 1.546 . . . . 0.0 109.887 175.312 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 16.4 m -63.46 -45.1 92.38 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 174.546 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -65.65 -41.48 92.53 Favored 'General case' 0 N--CA 1.447 -0.587 0 O-C-N 121.535 -0.728 . . . . 0.0 110.554 -178.448 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.405 HD13 ' CD ' ' A' ' 111' ' ' PRO . 28.3 mt -58.96 -39.6 82.18 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 124.665 1.186 . . . . 0.0 110.306 174.609 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 41.3 ttm180 -67.4 -36.56 81.54 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 118.771 -0.633 . . . . 0.0 109.983 175.946 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 13.5 m-30 -68.51 -41.11 80.43 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 118.963 0.801 . . . . 0.0 111.051 178.38 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 55.8 p -75.93 -27.1 57.48 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 118.827 0.739 . . . . 0.0 110.994 179.546 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 78.4 10.03 86.54 Favored Glycine 0 CA--C 1.534 1.271 0 CA-C-O 119.278 -0.734 . . . . 0.0 111.465 -169.676 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 -94.07 15.21 17.6 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 118.807 1.303 . . . . 0.0 112.268 -177.392 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 8.1 t80 -53.69 132.24 55.89 Favored Pre-proline 0 CA--C 1.539 0.55 0 C-N-CA 125.349 1.459 . . . . 0.0 110.317 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.405 ' CD ' HD13 ' A' ' 104' ' ' LEU . 60.7 Cg_exo -50.5 136.37 40.61 Favored 'Trans proline' 0 C--N 1.354 0.817 0 C-N-CA 123.461 2.774 . . . . 0.0 112.32 178.905 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -63.19 -24.1 67.73 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 119.287 -0.387 . . . . 0.0 111.796 -173.64 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 57.2 tttm -141.85 108.31 5.31 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 169.866 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -85.89 142.01 29.17 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 169.123 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.62 153.25 45.98 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 105.951 -1.87 . . . . 0.0 105.951 171.885 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -145.29 138.23 26.25 Favored 'General case' 0 C--N 1.33 -0.276 0 O-C-N 120.512 -1.368 . . . . 0.0 108.636 176.259 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 48.8 t -110.12 95.91 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 N-CA-C 103.635 -2.728 . . . . 0.0 103.635 169.721 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -87.44 151.96 23.84 Favored Glycine 0 C--N 1.332 0.351 0 N-CA-C 110.101 -1.2 . . . . 0.0 110.101 178.059 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 44.9 t -132.77 137.15 54.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 178.691 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 51.0 mt -86.76 129.83 51.08 Favored Pre-proline 0 CA--C 1.542 0.659 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 170.491 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -74.04 171.98 16.87 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 124.03 3.153 . . . . 0.0 112.561 -179.736 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -109.4 -43.89 4.02 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.461 1.105 . . . . 0.0 108.599 169.443 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 63.8 m -128.73 152.09 48.81 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.473 0.709 . . . . 0.0 111.266 176.837 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.4 tp -152.54 54.5 0.79 Allowed 'General case' 0 CA--C 1.548 0.893 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 -169.825 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -127.35 170.14 10.77 Favored Pre-proline 0 N--CA 1.479 1.002 0 CA-C-O 117.756 -1.116 . . . . 0.0 110.595 -178.43 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_exo -63.45 88.56 0.14 Allowed 'Trans proline' 0 CA--C 1.548 1.201 0 C-N-CA 123.806 3.004 . . . . 0.0 114.409 -176.854 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 179.0 145.72 0.15 Allowed 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 104.415 -2.439 . . . . 0.0 104.415 175.303 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -118.09 167.09 11.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 CA-C-N 120.032 1.287 . . . . 0.0 112.886 -172.798 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 91.56 148.9 22.87 Favored Glycine 0 C--N 1.34 0.796 0 N-CA-C 106.809 -2.516 . . . . 0.0 106.809 -168.839 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -82.84 162.28 21.68 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-O 121.447 0.642 . . . . 0.0 111.115 -169.396 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 39.8 p -68.92 168.61 14.37 Favored Pre-proline 0 CA--C 1.541 0.619 0 CA-C-N 114.911 -1.041 . . . . 0.0 109.535 168.702 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -57.1 -32.81 94.42 Favored 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 121.302 1.335 . . . . 0.0 110.906 169.397 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 23.8 m -68.34 -38.69 81.74 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 118.999 -0.524 . . . . 0.0 111.905 179.323 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 20.2 t -108.62 -10.48 11.12 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 CA-C-N 119.471 1.032 . . . . 0.0 112.021 -169.195 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -60.11 -46.87 88.15 Favored 'General case' 0 N--CA 1.465 0.318 0 O-C-N 119.733 -1.854 . . . . 0.0 107.436 169.082 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -71.74 6.55 1.91 Allowed 'General case' 0 N--CA 1.439 -1.015 0 CA-C-O 117.965 -1.017 . . . . 0.0 112.661 176.312 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 26.5 mmm -94.1 -11.54 30.35 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 119.778 1.172 . . . . 0.0 111.083 170.014 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 72.6 mt -61.76 -46.36 96.7 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 179.003 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -69.9 -54.87 9.41 Favored Pre-proline 0 CA--C 1.536 0.405 0 CA-C-O 117.394 -1.289 . . . . 0.0 112.814 -172.331 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -59.82 -34.81 95.53 Favored 'Trans proline' 0 C--N 1.349 0.569 0 CA-C-N 122.301 1.857 . . . . 0.0 111.327 177.031 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -71.11 -45.03 64.45 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-O 118.719 -0.658 . . . . 0.0 110.497 -177.906 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -63.68 -36.8 85.02 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 119.235 0.925 . . . . 0.0 109.916 177.895 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -61.88 -39.03 90.51 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 118.007 0.367 . . . . 0.0 111.076 175.585 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 42.4 mm-40 -74.3 -28.37 61.15 Favored 'General case' 0 CA--C 1.535 0.399 0 O-C-N 121.44 -0.787 . . . . 0.0 111.828 176.885 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 70.4 t -62.93 -46.96 95.0 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 169.502 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 56.8 mt -65.67 -33.63 76.32 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 119.055 0.843 . . . . 0.0 111.143 179.148 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -60.0 -35.59 75.38 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 118.513 0.597 . . . . 0.0 111.275 177.981 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -61.73 -44.95 95.92 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 118.388 0.54 . . . . 0.0 111.244 175.708 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 7.1 mp -61.41 -40.55 94.8 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 122.726 0.41 . . . . 0.0 110.082 176.454 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 83.5 mtm-85 -65.59 -16.59 63.86 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 117.504 -1.236 . . . . 0.0 112.594 178.941 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -58.57 -30.7 67.36 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 120.781 1.628 . . . . 0.0 111.351 177.713 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 6.7 m -113.39 30.37 7.26 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.503 1.121 . . . . 0.0 111.129 177.818 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 64.31 23.57 68.36 Favored Glycine 0 CA--C 1.529 0.967 0 CA-C-O 118.566 -1.13 . . . . 0.0 113.821 174.994 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 60.4 t -87.63 131.35 35.57 Favored 'Isoleucine or valine' 0 C--N 1.34 0.194 0 N-CA-C 106.362 -1.718 . . . . 0.0 106.362 174.112 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -120.68 123.29 42.39 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 -177.732 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -82.15 144.36 30.79 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 172.71 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 6.9 mm -101.53 123.89 42.78 Favored Pre-proline 0 CA--C 1.53 0.207 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 -173.888 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -60.6 108.97 0.58 Allowed 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.188 1.926 . . . . 0.0 108.182 173.449 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 34.3 ptt180 43.8 15.62 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 128.825 2.85 . . . . 0.0 116.239 -177.397 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 3.8 m . . . . . 0 CA--C 1.547 0.837 0 C-N-CA 125.366 1.466 . . . . 0.0 112.732 -168.662 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 6.0 ptp180 . . . . . 0 N--CA 1.475 0.814 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 66.7 mt -141.54 133.32 27.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-N 119.12 0.873 . . . . 0.0 110.172 -169.975 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -116.39 128.64 55.69 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 105.952 -1.87 . . . . 0.0 105.952 168.419 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.0 t -106.95 98.1 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 103.466 -2.79 . . . . 0.0 103.466 172.844 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.8 mt -99.09 110.42 23.0 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 123.912 0.885 . . . . 0.0 110.17 -169.433 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -89.69 121.42 6.12 Favored Glycine 0 N--CA 1.446 -0.659 0 N-CA-C 107.102 -2.399 . . . . 0.0 107.102 170.313 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 13.0 m -134.21 -171.89 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.016 0 C-N-CA 124.321 1.048 . . . . 0.0 108.258 -178.148 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 110.66 154.63 13.91 Favored Glycine 0 C--N 1.336 0.539 0 N-CA-C 110.453 -1.059 . . . . 0.0 110.453 -173.233 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -77.36 96.84 4.73 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 123.788 0.835 . . . . 0.0 109.224 -179.143 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.3 pt -72.47 36.4 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 C-N-CA 124.504 1.122 . . . . 0.0 113.96 -179.077 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 28.0 mt -121.95 -8.75 8.83 Favored 'General case' 0 CA--C 1.531 0.248 0 O-C-N 121.091 -1.005 . . . . 0.0 108.729 171.55 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -127.27 83.95 2.21 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 -169.12 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.443 ' HB ' ' H ' ' A' ' 15' ' ' ASP . 2.1 m 35.74 -104.2 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 113.266 -1.788 . . . . 0.0 114.698 169.65 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.443 ' H ' ' HB ' ' A' ' 14' ' ' THR . 77.2 m-20 -68.08 -19.73 64.89 Favored 'General case' 0 N--CA 1.437 -1.097 0 CA-C-O 117.975 -1.012 . . . . 0.0 112.475 -169.187 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -68.03 -23.69 65.02 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 121.208 1.822 . . . . 0.0 111.818 178.976 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.36 -12.45 52.13 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-O 116.01 -1.948 . . . . 0.0 110.588 172.783 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.401 HG21 HG11 ' A' ' 119' ' ' VAL . 6.7 tp -53.74 -38.3 34.84 Favored 'Isoleucine or valine' 0 C--N 1.342 0.26 0 CA-C-N 122.176 2.262 . . . . 0.0 110.271 -177.742 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -61.47 -43.62 99.08 Favored Glycine 0 C--N 1.337 0.596 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 -178.879 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 57.8 t -70.18 -47.21 68.77 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 176.094 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 20.4 mmt180 -61.19 -31.86 71.61 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 117.016 -1.468 . . . . 0.0 112.505 -177.918 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 19.8 mt -58.93 -48.66 85.74 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 CA-C-N 121.74 2.063 . . . . 0.0 109.756 175.68 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.8 m -76.32 -31.07 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-N 119.432 1.015 . . . . 0.0 110.897 -172.202 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 59.2 mt-10 -64.99 -41.49 95.37 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 119.107 -0.473 . . . . 0.0 110.083 171.545 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -66.09 -37.03 84.76 Favored 'General case' 0 C--N 1.344 0.328 0 CA-C-N 119.42 1.009 . . . . 0.0 110.803 175.55 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 6.5 tp -63.07 -41.2 99.39 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 119.075 0.852 . . . . 0.0 110.036 -177.267 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -59.46 -27.68 66.31 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.516 0.726 . . . . 0.0 112.882 -179.991 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 50.6 mt-30 -95.05 -37.34 11.15 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 125.865 1.666 . . . . 0.0 111.41 -175.875 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 75.4 mtt180 -89.61 -27.28 20.3 Favored 'General case' 0 C--O 1.224 -0.244 0 CA-C-O 118.099 -0.953 . . . . 0.0 112.46 -175.965 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 52.6 m-85 -122.93 145.28 48.61 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 119.796 1.18 . . . . 0.0 112.967 -175.391 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 38.9 mm -95.39 139.07 19.56 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 N-CA-C 103.949 -2.611 . . . . 0.0 103.949 168.871 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 42.9 mt -128.81 147.19 63.48 Favored Pre-proline 0 CA--C 1.532 0.284 0 C-N-CA 123.457 0.703 . . . . 0.0 110.185 -168.835 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -67.77 158.55 56.76 Favored 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 122.76 2.306 . . . . 0.0 110.479 172.126 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -59.17 -33.42 70.91 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 114.436 1.273 . . . . 0.0 114.436 -169.403 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 10.0 p90 -75.05 -13.42 60.49 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 118.927 -0.559 . . . . 0.0 112.49 -177.746 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 75.0 t -88.09 122.47 39.72 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 170.531 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -124.18 129.41 50.77 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 169.67 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -82.81 137.46 20.97 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.809 0 N-CA-C 106.068 -1.827 . . . . 0.0 106.068 167.81 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 52.2 tp -128.36 136.45 50.95 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 169.717 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -93.15 120.94 33.99 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 169.246 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -72.8 -71.73 1.05 Allowed Glycine 0 CA--C 1.526 0.74 0 N-CA-C 108.981 -1.647 . . . . 0.0 108.981 174.159 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 84.98 92.56 0.78 Allowed Glycine 0 C--N 1.342 0.884 0 N-CA-C 107.942 -2.063 . . . . 0.0 107.942 -177.862 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 44.2 p 55.18 30.61 14.83 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 125.009 1.324 . . . . 0.0 111.893 176.879 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -81.61 -65.49 1.01 Allowed 'General case' 0 C--N 1.348 0.507 0 N-CA-C 115.25 1.574 . . . . 0.0 115.25 -168.194 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 60.95 -109.68 2.57 Favored Glycine 0 CA--C 1.528 0.865 0 N-CA-C 110.262 -1.135 . . . . 0.0 110.262 -175.376 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.32 -21.23 66.25 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.315 1.046 . . . . 0.0 112.061 -175.409 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -60.68 -18.85 56.46 Favored 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 113.534 0.938 . . . . 0.0 113.534 -175.158 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 11.4 mt -98.64 15.08 26.27 Favored 'General case' 0 C--N 1.347 0.458 0 N-CA-C 115.155 1.539 . . . . 0.0 115.155 -169.412 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 5.6 tt -48.2 -58.59 4.31 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 119.703 1.138 . . . . 0.0 111.244 -175.477 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -63.15 -31.59 81.23 Favored Glycine 0 CA--C 1.53 1.025 0 CA-C-O 119.419 -0.656 . . . . 0.0 112.368 -176.153 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -81.19 -35.89 30.81 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 118.509 1.155 . . . . 0.0 112.375 -177.556 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 32.6 mtp -74.07 -27.11 60.75 Favored 'General case' 0 N--CA 1.452 -0.361 0 O-C-N 122.102 -0.374 . . . . 0.0 110.045 178.415 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.51 157.59 31.8 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-O 121.677 0.751 . . . . 0.0 111.608 -179.691 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 16.3 m120 63.24 4.07 1.53 Allowed 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 127.27 2.228 . . . . 0.0 115.64 169.769 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 26.9 mmt180 -76.69 158.49 30.96 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 119.97 1.259 . . . . 0.0 109.05 178.759 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -84.38 -54.24 4.91 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 175.392 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . 0.27 0.0 OUTLIER -124.24 147.18 48.26 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-N 119.812 1.187 . . . . 0.0 108.308 169.28 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 19.0 tp -138.48 113.34 9.14 Favored 'General case' 0 CA--C 1.507 -0.678 0 N-CA-C 104.819 -2.289 . . . . 0.0 104.819 -175.272 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 24.5 mt -95.75 112.36 27.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 105.351 -2.092 . . . . 0.0 105.351 176.976 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.479 HG22 HD23 ' A' ' 116' ' ' LEU . 41.5 mt -86.96 137.84 20.16 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 N-CA-C 106.722 -1.584 . . . . 0.0 106.722 171.405 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -122.77 117.2 25.12 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 103.567 -2.753 . . . . 0.0 103.567 168.002 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -153.78 158.26 40.64 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 124.91 1.284 . . . . 0.0 108.208 -178.83 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -88.05 152.96 21.65 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 169.537 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 81.1 mt -87.52 -21.92 7.02 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 C-N-CA 125.114 1.366 . . . . 0.0 110.485 -178.786 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.425 HG13 HD22 ' A' ' 124' ' ' LEU 0.299 96.2 t 69.73 -45.31 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.175 0 C-N-CA 129.448 3.099 . . . . 0.0 113.966 -175.935 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.8 p -165.29 151.29 9.75 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 119.839 1.199 . . . . 0.0 111.939 172.331 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 13.4 tppt? -162.79 176.25 10.45 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 127.477 2.311 . . . . 0.0 105.05 169.449 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 13.7 ptpt -61.26 -26.72 67.95 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 175.946 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 34.2 t-20 -75.74 165.59 24.81 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.815 0.846 . . . . 0.0 110.53 -174.658 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 2.5 m -61.92 152.48 76.61 Favored Pre-proline 0 CA--C 1.547 0.862 0 C-N-CA 124.486 1.114 . . . . 0.0 112.542 -170.186 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -59.37 160.45 19.79 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 124.494 3.463 . . . . 0.0 113.35 169.655 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 61.35 23.89 62.91 Favored Glycine 0 CA--C 1.537 1.461 0 CA-C-O 119.66 -0.522 . . . . 0.0 112.699 170.773 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 3.3 m -105.91 141.36 37.44 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 125.41 1.484 . . . . 0.0 109.314 -170.49 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 41.6 ttp -94.25 142.89 26.89 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 170.372 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 69.6 mtm -132.8 139.91 47.74 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 170.427 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 6.8 mm -93.31 122.46 44.82 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 177.199 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -112.19 123.82 51.1 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 175.726 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 82.1 mtp180 -81.3 170.71 15.71 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 123.004 0.522 . . . . 0.0 110.333 175.842 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -35.59 -55.47 0.68 Allowed 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 116.15 1.908 . . . . 0.0 116.15 -173.827 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -88.61 -9.33 52.57 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -176.001 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -87.64 -40.52 14.11 Favored 'General case' 0 N--CA 1.454 -0.26 0 O-C-N 121.911 -0.493 . . . . 0.0 109.866 -174.868 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 1.4 m -53.5 -47.66 95.58 Favored Pre-proline 0 CA--C 1.54 0.574 0 CA-C-O 117.928 -1.034 . . . . 0.0 112.27 -179.79 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -61.53 -40.09 50.13 Favored 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 122.284 1.99 . . . . 0.0 110.305 179.907 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.48 -4.16 44.14 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.874 0.869 . . . . 0.0 113.103 177.497 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -87.6 -40.78 13.93 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-N 119.338 0.972 . . . . 0.0 110.005 -179.325 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -79.91 24.66 0.39 Allowed 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.538 0.735 . . . . 0.0 112.763 -171.016 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 20.3 p -65.76 -21.99 66.55 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.489 1.116 . . . . 0.0 112.973 179.082 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 51.5 t-20 -61.69 127.49 31.69 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.659 0.783 . . . . 0.0 110.388 -177.257 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 47.8 mmtm -79.12 -19.2 51.7 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 -176.959 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 91.0 mt -64.16 -46.24 94.11 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 C-N-CA 123.786 0.834 . . . . 0.0 108.804 -178.831 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.8 m -67.22 109.07 3.05 Favored Pre-proline 0 CA--C 1.549 0.933 0 C-N-CA 126.589 1.956 . . . . 0.0 110.962 -169.718 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -71.99 -63.0 0.04 OUTLIER 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 122.342 2.028 . . . . 0.0 112.805 -169.063 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 12.4 t-80 -59.32 -40.41 86.21 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 123.61 0.764 . . . . 0.0 110.227 -179.166 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 22.1 mp0 -63.58 -29.98 71.16 Favored 'General case' 0 N--CA 1.441 -0.911 0 C-N-CA 124.924 1.29 . . . . 0.0 110.106 -174.384 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 20.8 mt -67.72 -44.73 76.94 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 120.393 1.451 . . . . 0.0 110.691 172.909 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -61.69 -40.14 98.37 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 110.238 -1.145 . . . . 0.0 110.238 176.554 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 39.1 tp -65.95 -39.53 90.53 Favored 'General case' 0 CA--C 1.534 0.335 0 O-C-N 122.289 -0.536 . . . . 0.0 109.979 176.225 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -62.21 -42.45 99.31 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 119.172 0.896 . . . . 0.0 109.776 176.664 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -67.64 -28.84 68.05 Favored 'General case' 0 N--CA 1.454 -0.257 0 O-C-N 122.007 -0.433 . . . . 0.0 110.755 178.382 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -73.92 -37.39 47.74 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 O-C-N 121.336 -0.853 . . . . 0.0 111.289 173.654 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 31.5 mt -67.83 -37.62 82.17 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 176.762 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 75.7 m -65.39 -37.13 86.05 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-O 118.34 -0.838 . . . . 0.0 110.055 171.532 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.445 ' HA ' ' CD2' ' A' ' 106' ' ' PHE . . . -64.2 -40.52 96.26 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-N 119.953 1.252 . . . . 0.0 110.661 175.705 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 4.0 mt -64.71 -32.82 74.66 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 118.638 0.653 . . . . 0.0 110.562 174.841 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 51.5 ttp180 -72.15 -29.04 63.65 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 118.763 -0.637 . . . . 0.0 110.033 176.36 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.445 ' CD2' ' HA ' ' A' ' 103' ' ' ALA . 13.6 m-30 -72.12 -47.1 53.67 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 119.118 0.872 . . . . 0.0 110.369 175.467 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 41.6 p -72.68 -25.84 61.4 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 118.313 0.506 . . . . 0.0 111.853 -176.761 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 73.43 7.55 73.39 Favored Glycine 0 CA--C 1.535 1.312 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 -168.495 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -87.55 20.22 3.01 Favored 'General case' 0 C--N 1.348 0.522 0 CA-C-N 119.456 1.628 . . . . 0.0 110.689 176.536 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -58.45 138.2 85.45 Favored Pre-proline 0 CA--C 1.547 0.854 0 C-N-CA 125.903 1.681 . . . . 0.0 109.341 169.952 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_exo -58.0 163.81 9.09 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 123.66 2.907 . . . . 0.0 115.386 -179.359 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -67.72 -37.02 81.66 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 119.024 -0.513 . . . . 0.0 112.112 174.628 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 10.6 ttmm -141.58 74.41 1.45 Allowed 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 -175.474 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 5.5 tt -71.47 138.35 48.94 Favored 'General case' 0 CA--C 1.533 0.289 0 O-C-N 119.959 -1.713 . . . . 0.0 107.516 171.831 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -134.38 141.95 47.03 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 175.763 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.479 HD23 HG22 ' A' ' 60' ' ' ILE . 0.3 OUTLIER -129.26 119.93 24.84 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 120.128 1.331 . . . . 0.0 109.228 -179.939 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 6.2 t -86.5 87.81 2.7 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 N-CA-C 105.61 -1.996 . . . . 0.0 105.61 175.84 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -81.38 135.17 14.07 Favored Glycine 0 C--N 1.334 0.447 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -172.901 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.448 HG13 ' SD ' ' A' ' 137' ' ' MET . 54.7 t -121.94 123.56 69.41 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.238 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.988 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 42.5 mt -84.67 133.11 44.62 Favored Pre-proline 0 CA--C 1.538 0.492 0 N-CA-C 105.52 -2.029 . . . . 0.0 105.52 169.775 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -75.04 175.33 11.38 Favored 'Trans proline' 0 N--CA 1.449 -1.09 0 C-N-CA 122.287 1.992 . . . . 0.0 111.589 -176.706 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -94.56 -49.23 5.75 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 114.442 -1.253 . . . . 0.0 108.293 169.236 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 97.3 p -127.91 -52.77 1.32 Allowed 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 113.164 0.802 . . . . 0.0 113.164 -170.203 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.425 HD22 HG13 ' A' ' 65' ' ' VAL . 1.8 tp 52.51 34.75 16.12 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 124.362 1.065 . . . . 0.0 113.229 -169.398 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -76.36 164.02 62.53 Favored Pre-proline 0 CA--C 1.549 0.931 0 O-C-N 120.95 -1.094 . . . . 0.0 110.65 174.053 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -80.03 88.25 1.44 Allowed 'Trans proline' 0 CA--C 1.544 0.999 0 C-N-CA 121.66 1.573 . . . . 0.0 112.577 -172.194 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -176.5 154.96 1.33 Allowed 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 104.413 -2.44 . . . . 0.0 104.413 -179.946 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -110.79 162.64 8.18 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-N 120.447 1.476 . . . . 0.0 113.149 -169.663 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 93.71 143.14 12.86 Favored Glycine 0 CA--C 1.53 0.998 0 N-CA-C 106.374 -2.69 . . . . 0.0 106.374 -169.166 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.658 HD22 ' H ' ' A' ' 130' ' ' LEU . 0.4 OUTLIER -71.92 165.15 24.76 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 119.576 1.688 . . . . 0.0 110.602 -177.701 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 39.5 p -67.92 166.36 24.2 Favored Pre-proline 0 CA--C 1.539 0.533 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 167.826 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -59.73 -30.57 92.42 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 CA-C-N 120.588 1.246 . . . . 0.0 111.514 173.026 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 79.1 m -67.7 -41.85 82.97 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-N 118.903 0.774 . . . . 0.0 110.105 179.904 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 91.0 t -95.32 -26.26 4.34 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.214 0 CA-C-N 118.329 0.513 . . . . 0.0 110.751 -169.973 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -52.4 -46.91 66.5 Favored 'General case' 0 N--CA 1.464 0.243 0 O-C-N 120.567 -1.333 . . . . 0.0 108.418 169.409 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -69.84 -16.28 63.24 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 113.952 1.093 . . . . 0.0 113.952 -177.935 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 137' ' ' MET . . . . . 0.448 ' SD ' HG13 ' A' ' 119' ' ' VAL . 84.0 mtp -71.13 -12.09 61.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 117.24 -1.362 . . . . 0.0 112.6 173.679 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 35.3 mt -53.13 -47.33 55.51 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.28 0 CA-C-N 120.451 1.478 . . . . 0.0 109.226 175.307 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -73.38 -47.1 7.65 Favored Pre-proline 0 CA--C 1.544 0.73 0 CA-C-N 120.296 1.407 . . . . 0.0 112.109 -169.875 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -54.39 -44.78 46.3 Favored 'Trans proline' 0 C--N 1.353 0.802 0 C-N-CA 122.452 2.101 . . . . 0.0 112.179 170.174 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -67.81 -39.41 83.95 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 118.518 -0.753 . . . . 0.0 111.195 -179.055 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 29.0 mt -59.88 -45.57 92.08 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-N 119.79 1.177 . . . . 0.0 109.284 173.075 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -58.18 -33.67 69.51 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 118.993 0.815 . . . . 0.0 110.099 175.689 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -69.72 -39.9 76.57 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 118.778 0.717 . . . . 0.0 111.267 175.412 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 81.1 t -59.36 -44.81 93.28 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 172.596 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 14.7 mt -58.91 -42.65 90.13 Favored 'General case' 0 C--N 1.342 0.246 0 CA-C-N 119.017 0.826 . . . . 0.0 109.576 176.909 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -66.9 -43.63 82.91 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 119.146 0.885 . . . . 0.0 110.687 -176.796 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -67.71 -29.4 68.64 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 119.127 0.876 . . . . 0.0 111.131 179.186 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 41.6 mt -64.76 -49.67 69.86 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 170.298 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 14.7 mtp-105 -68.77 -16.8 63.9 Favored 'General case' 0 CA--C 1.527 0.095 0 CA-C-O 118.219 -0.896 . . . . 0.0 111.557 -177.82 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 30.6 mm-40 -65.6 -23.56 66.86 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 120.32 1.418 . . . . 0.0 111.299 170.826 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 58.4 m -100.73 17.2 22.6 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 119.054 0.843 . . . . 0.0 110.221 168.467 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 68.44 18.33 71.54 Favored Glycine 0 C--N 1.336 0.55 0 CA-C-O 117.656 -1.635 . . . . 0.0 111.958 -176.179 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 42.7 t -91.93 119.01 38.59 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 CA-C-N 120.344 2.072 . . . . 0.0 106.149 -177.121 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -111.26 89.23 2.99 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 178.383 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -49.55 138.3 13.99 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 114.833 -1.076 . . . . 0.0 109.72 169.663 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 15.8 mm -84.79 128.99 58.49 Favored Pre-proline 0 C--O 1.232 0.161 0 CA-C-O 117.483 -1.246 . . . . 0.0 107.902 -174.125 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -66.69 92.09 0.3 Allowed 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 122.922 2.414 . . . . 0.0 108.916 171.376 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 10.1 ttt-85 49.21 19.28 0.3 Allowed 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 128.441 2.696 . . . . 0.0 115.804 179.624 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 64.0 m . . . . . 0 CA--C 1.541 0.615 0 C-N-CA 124.64 1.176 . . . . 0.0 111.886 -169.624 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 tpt . . . . . 0 N--CA 1.472 0.633 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.4 ptp180 -158.89 125.35 4.61 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 103.749 -2.686 . . . . 0.0 103.749 160.818 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 20.8 mt -129.64 141.61 46.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 -166.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -115.83 146.86 41.62 Favored 'General case' 0 CA--C 1.513 -0.479 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 163.496 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 57.7 t -126.83 106.63 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.715 0 N-CA-C 103.945 -2.613 . . . . 0.0 103.945 170.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -113.37 119.13 36.58 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 -163.235 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -93.87 134.61 12.16 Favored Glycine 0 N--CA 1.451 -0.361 0 N-CA-C 107.909 -2.076 . . . . 0.0 107.909 175.008 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.7 m -140.96 167.08 17.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 C-N-CA 124.537 1.135 . . . . 0.0 109.457 -178.056 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 127.52 177.44 14.87 Favored Glycine 0 CA--C 1.527 0.821 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 -177.162 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.413 ' HB2' ' CE1' ' A' ' 93' ' ' HIS . 61.2 t-20 -91.76 117.88 30.17 Favored 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 178.332 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 41.3 pt -75.39 24.76 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.793 0 C-N-CA 124.483 1.113 . . . . 0.0 112.125 176.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 38.8 mt -137.45 -3.95 1.88 Allowed 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.594 1.557 . . . . 0.0 112.349 -177.31 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.5 tp -121.85 52.22 1.28 Allowed 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 120.158 1.345 . . . . 0.0 109.799 -163.274 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 42.25 -114.5 0.27 Allowed 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 126.502 1.921 . . . . 0.0 110.395 -169.591 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 36.5 m-20 -53.68 -26.21 21.63 Favored 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 126.54 1.936 . . . . 0.0 111.982 -171.514 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -60.04 -20.79 59.73 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 120.172 1.351 . . . . 0.0 111.752 -177.78 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.09 -11.51 40.5 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 117.773 -1.108 . . . . 0.0 113.415 172.545 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 7.1 tp -56.33 -44.41 79.73 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-N 120.32 1.418 . . . . 0.0 112.137 -171.501 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -59.16 -42.19 97.02 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 110.605 -0.998 . . . . 0.0 110.605 -178.559 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 60.3 t -67.57 -46.7 82.51 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 CA-C-O 118.978 -0.534 . . . . 0.0 110.14 175.16 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 9.8 mmt180 -58.37 -33.35 69.49 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 119.823 1.192 . . . . 0.0 112.823 -179.274 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 41.7 mt -57.98 -51.06 75.37 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 177.434 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 18.0 m -73.49 -35.75 46.16 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 CA-C-N 119.19 0.905 . . . . 0.0 111.717 -173.416 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -58.56 -47.13 85.27 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 118.811 0.732 . . . . 0.0 110.225 171.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -71.33 -22.13 61.96 Favored 'General case' 0 CA--C 1.531 0.234 0 O-C-N 121.689 -0.632 . . . . 0.0 112.462 -178.787 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 27.4 tp -73.79 -49.6 24.55 Favored 'General case' 0 C--N 1.339 0.137 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 175.654 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -52.65 -43.47 65.49 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.068 1.347 . . . . 0.0 111.172 178.761 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 66.5 mt-30 -85.06 -0.09 53.31 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.702 0.801 . . . . 0.0 113.033 -173.103 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 85.5 mtt180 -127.66 -23.14 3.48 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-O 116.695 -1.622 . . . . 0.0 112.931 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -134.74 128.75 33.51 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-N 120.823 1.647 . . . . 0.0 109.313 -172.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 48.7 mm -79.77 142.87 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 N-CA-C 105.605 -1.998 . . . . 0.0 105.605 163.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -114.93 154.9 47.0 Favored Pre-proline 0 N--CA 1.453 -0.311 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 178.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -54.81 152.51 28.31 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 121.169 1.246 . . . . 0.0 110.224 158.679 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -41.41 -46.72 3.45 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 127.575 2.35 . . . . 0.0 113.624 -178.521 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -78.57 19.9 0.46 Allowed 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 114.149 1.166 . . . . 0.0 114.149 -168.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 10.7 t -126.04 89.08 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 C-N-CA 125.489 1.516 . . . . 0.0 109.023 179.074 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -71.23 130.16 40.73 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 171.553 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -93.68 137.19 23.3 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 N-CA-C 105.682 -1.97 . . . . 0.0 105.682 157.213 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 60.5 tp -143.63 129.72 19.65 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 -175.186 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 30.7 t0 -84.8 133.21 34.35 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 166.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -115.02 31.5 6.24 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 126.351 1.929 . . . . 0.0 111.271 175.286 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -21.33 110.55 0.01 OUTLIER Glycine 0 CA--C 1.527 0.789 0 C-N-CA 129.026 3.203 . . . . 0.0 114.911 177.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER 59.68 -2.02 0.14 Allowed 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 116.542 2.053 . . . . 0.0 116.542 177.699 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.93 -63.04 1.38 Allowed 'General case' 0 C--N 1.34 0.156 0 CA-C-N 120.211 1.368 . . . . 0.0 112.909 -169.473 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 57.68 -94.24 0.04 OUTLIER Glycine 0 CA--C 1.533 1.177 0 N-CA-C 110.141 -1.184 . . . . 0.0 110.141 -163.361 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 7.8 tpt -57.63 -37.69 73.72 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 125.257 1.423 . . . . 0.0 113.147 -169.279 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -58.2 -26.56 62.94 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.708 0.766 . . . . 0.0 112.108 -173.633 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 83.1 mt -73.45 2.46 7.73 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 124.721 1.208 . . . . 0.0 112.489 -174.34 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.408 ' HA ' HG13 ' A' ' 100' ' ' VAL . 5.0 tt -43.98 -46.25 8.19 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 125.676 1.591 . . . . 0.0 111.594 174.534 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -84.05 -31.44 25.96 Favored Glycine 0 CA--C 1.525 0.674 0 CA-C-O 118.827 -0.985 . . . . 0.0 112.323 -178.718 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -75.6 -44.23 44.01 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 118.739 1.269 . . . . 0.0 110.904 -172.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 37.3 mtp -69.08 -11.32 60.68 Favored 'General case' 0 CA--C 1.54 0.574 0 O-C-N 121.974 -0.454 . . . . 0.0 111.675 -177.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -75.4 153.9 37.46 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 124.818 1.247 . . . . 0.0 110.446 -176.557 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 62.15 -5.67 0.16 Allowed 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 127.229 2.211 . . . . 0.0 114.107 167.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 8.6 mmt180 -66.29 148.4 51.9 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 175.084 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -80.05 -44.76 19.52 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 -175.702 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 4.0 t-160 -139.18 131.09 27.72 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 103.118 -2.919 . . . . 0.0 103.118 -177.105 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 30.1 tp -129.29 122.49 29.71 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 -178.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 52.3 mt -103.07 109.36 26.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 105.318 -2.105 . . . . 0.0 105.318 171.305 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 21.4 mt -83.39 148.33 5.17 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 168.021 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -131.05 128.8 41.0 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 164.29 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -153.25 168.37 26.22 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.324 1.05 . . . . 0.0 110.426 -163.694 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -92.1 129.9 37.95 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 163.122 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 34.9 mt -76.56 -24.71 15.89 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 C-N-CA 123.668 0.787 . . . . 0.0 110.503 175.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . 0.255 26.1 t 64.52 -35.03 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 C-N-CA 128.202 2.601 . . . . 0.0 113.687 -179.701 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -153.68 133.75 13.27 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 121.925 2.148 . . . . 0.0 113.883 -174.324 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 3.6 tppt? -156.87 -175.73 5.59 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 105.557 -2.016 . . . . 0.0 105.557 147.236 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.37 67.01 9.98 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 166.225 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 52.3 t30 -150.36 155.72 40.15 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 119.052 0.842 . . . . 0.0 109.0 178.386 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 8.1 m -60.02 140.41 90.53 Favored Pre-proline 0 CA--C 1.543 0.699 0 C-N-CA 126.674 1.99 . . . . 0.0 112.124 -165.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_exo -43.97 149.79 0.73 Allowed 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 124.22 3.28 . . . . 0.0 113.492 168.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 66.39 -7.91 1.21 Allowed Glycine 0 CA--C 1.532 1.101 0 C-N-CA 124.86 1.219 . . . . 0.0 115.554 178.387 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 30.4 m -64.88 149.83 48.85 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 120.202 2.001 . . . . 0.0 109.421 -178.391 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 28.9 ttp -94.43 147.36 23.32 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 174.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 42.0 mtt -129.23 146.15 51.2 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 106.095 -1.817 . . . . 0.0 106.095 162.682 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 33.2 mm -117.81 130.17 73.09 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 N-CA-C 103.266 -2.864 . . . . 0.0 103.266 171.335 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -123.74 143.55 50.22 Favored 'General case' 0 C--O 1.242 0.684 0 N-CA-C 105.013 -2.217 . . . . 0.0 105.013 176.266 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 79.9 mtm180 -114.73 165.88 12.34 Favored 'General case' 0 C--O 1.222 -0.36 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 177.369 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -22.29 -66.43 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 127.866 2.466 . . . . 0.0 116.072 -159.14 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -62.16 -33.52 74.67 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.879 1.672 . . . . 0.0 113.804 -176.102 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -76.35 -26.87 56.16 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.122 1.369 . . . . 0.0 110.741 -175.283 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 26.4 t -69.1 -50.89 19.47 Favored Pre-proline 0 CA--C 1.544 0.742 0 CA-C-O 117.69 -1.148 . . . . 0.0 112.394 -169.809 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -57.25 -39.89 86.68 Favored 'Trans proline' 0 C--N 1.353 0.802 0 CA-C-N 121.602 1.608 . . . . 0.0 111.374 174.518 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -62.84 -45.4 92.77 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 123.053 0.541 . . . . 0.0 110.59 -179.274 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -58.03 -47.52 82.85 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 123.817 0.847 . . . . 0.0 110.027 176.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 -75.88 1.36 15.3 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 -175.481 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 70.9 p -63.7 -13.36 42.41 Favored 'General case' 0 CA--C 1.543 0.685 0 O-C-N 120.198 -1.564 . . . . 0.0 112.315 166.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 41.1 t30 -58.72 109.89 0.89 Allowed 'General case' 0 C--N 1.346 0.454 0 C-N-CA 125.357 1.463 . . . . 0.0 111.712 -178.177 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 32.4 mmtp -67.87 -16.13 63.94 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 113.298 0.851 . . . . 0.0 113.298 -175.576 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 41.1 mt -75.03 -21.02 16.54 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 C-N-CA 123.358 0.663 . . . . 0.0 109.536 -179.062 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 14.6 m -100.56 104.71 32.52 Favored Pre-proline 0 CA--C 1.546 0.819 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 -172.818 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -72.4 -54.51 0.13 Allowed 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.295 1.996 . . . . 0.0 113.622 -160.167 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' HIS . . . . . 0.413 ' CE1' ' HB2' ' A' ' 10' ' ' ASN . 20.3 m80 -65.3 -36.1 83.04 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 177.784 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 23.1 mp0 -64.66 -30.03 71.04 Favored 'General case' 0 N--CA 1.441 -0.901 0 C-N-CA 125.02 1.328 . . . . 0.0 110.378 -176.264 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -64.94 -33.63 76.49 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 119.103 0.865 . . . . 0.0 111.535 171.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -78.72 -30.38 48.51 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 110.759 -0.937 . . . . 0.0 110.759 172.355 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.8 -37.62 88.06 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 118.339 1.07 . . . . 0.0 108.466 171.398 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -60.95 -43.42 98.72 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 117.929 -1.034 . . . . 0.0 109.924 175.007 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -74.15 -24.03 59.35 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 119.638 1.108 . . . . 0.0 113.158 177.637 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.408 HG13 ' HA ' ' A' ' 49' ' ' LEU . 38.1 t -62.48 -44.91 99.75 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 O-C-N 119.742 -1.848 . . . . 0.0 109.366 164.174 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 72.9 mt -67.94 -29.74 68.88 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 119.352 0.978 . . . . 0.0 110.811 178.367 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 44.5 m -62.19 -57.61 10.83 Favored 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 167.534 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.31 -35.4 78.93 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.795 1.238 . . . . 0.0 113.112 -174.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 13.8 mt -65.1 -42.37 94.09 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-N 118.929 0.786 . . . . 0.0 109.709 173.416 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 76.5 ttt180 -64.89 -34.65 78.9 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-O 117.677 -1.154 . . . . 0.0 110.649 172.676 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 13.0 m-30 -66.22 -39.22 89.43 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 120.069 1.304 . . . . 0.0 110.715 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 40.8 p -78.37 -28.05 46.98 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 119.119 0.872 . . . . 0.0 110.828 177.025 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 83.65 1.56 90.03 Favored Glycine 0 CA--C 1.531 1.056 0 CA-C-O 118.158 -1.357 . . . . 0.0 112.443 -166.766 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -87.08 21.01 2.47 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 120.479 2.139 . . . . 0.0 111.545 -179.114 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -61.19 139.01 94.55 Favored Pre-proline 0 CA--C 1.549 0.927 0 C-N-CA 126.274 1.83 . . . . 0.0 109.93 170.654 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -55.42 167.98 1.7 Allowed 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 123.923 3.082 . . . . 0.0 115.866 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -74.67 -23.12 58.6 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 123.461 0.704 . . . . 0.0 111.686 169.024 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 52.2 tttm -158.93 84.29 0.81 Allowed 'General case' 0 C--O 1.241 0.632 0 N-CA-C 106.522 -1.659 . . . . 0.0 106.522 -169.109 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.7 tt -79.21 141.88 36.75 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 119.186 -1.006 . . . . 0.0 108.914 165.279 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -138.9 146.76 41.5 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.88 1.672 . . . . 0.0 107.369 177.458 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -133.11 113.98 13.36 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 -179.274 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 45.1 t -93.35 86.66 2.15 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 173.013 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.55 150.36 16.94 Favored Glycine 0 C--N 1.338 0.671 0 N-CA-C 111.001 -0.84 . . . . 0.0 111.001 -166.603 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 22.7 t -129.11 135.84 61.03 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 -169.567 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 25.0 mt -78.3 135.93 61.23 Favored Pre-proline 0 CA--C 1.549 0.919 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 170.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -75.92 -161.53 0.13 Allowed 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 124.288 3.325 . . . . 0.0 111.522 178.385 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -138.75 -62.03 0.56 Allowed 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.83 1.652 . . . . 0.0 108.518 173.793 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 57.6 m -99.24 -48.19 4.91 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 119.104 0.865 . . . . 0.0 111.737 -177.106 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 51.58 45.91 27.34 Favored 'General case' 0 CA--C 1.549 0.911 0 N-CA-C 114.336 1.235 . . . . 0.0 114.336 -177.494 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -110.18 161.84 22.86 Favored Pre-proline 0 CA--C 1.542 0.642 0 C-N-CA 124.195 0.998 . . . . 0.0 110.989 -177.32 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -72.31 68.94 3.37 Favored 'Trans proline' 0 CA--C 1.543 0.954 0 C-N-CA 124.485 3.457 . . . . 0.0 113.982 -177.612 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 5.7 p-80 -148.16 173.18 13.24 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 126.874 2.07 . . . . 0.0 106.938 162.141 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -118.32 144.82 25.39 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.158 0 O-C-N 121.069 -1.019 . . . . 0.0 110.151 -171.185 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 142.09 176.25 16.14 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 105.997 -2.841 . . . . 0.0 105.997 -172.152 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -98.57 161.76 13.5 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 104.676 -2.342 . . . . 0.0 104.676 150.075 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 65.7 p -62.12 158.34 46.22 Favored Pre-proline 0 CA--C 1.543 0.71 0 C-N-CA 119.176 -1.01 . . . . 0.0 108.608 155.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -51.85 -38.49 67.97 Favored 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 122.046 1.83 . . . . 0.0 112.03 171.075 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 6.3 m -53.01 -30.98 38.51 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 126.12 1.768 . . . . 0.0 112.278 176.442 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 63.9 t -115.51 -18.88 6.96 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 CA-C-N 118.719 0.691 . . . . 0.0 111.014 -170.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -59.52 -43.25 93.49 Favored 'General case' 0 CA--C 1.534 0.338 0 O-C-N 121.325 -0.859 . . . . 0.0 108.73 165.713 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -59.45 -30.47 68.53 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.154 -0.476 . . . . 0.0 112.096 173.32 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 15.1 mmm -73.18 -8.47 55.94 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 117.458 -1.258 . . . . 0.0 113.789 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 96.7 mt -58.18 -50.05 79.62 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-N 120.438 1.472 . . . . 0.0 108.458 177.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -78.07 -40.37 1.92 Allowed Pre-proline 0 CA--C 1.535 0.376 0 CA-C-O 117.163 -1.398 . . . . 0.0 114.588 -168.401 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -54.34 -35.96 85.58 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 CA-C-N 122.38 1.886 . . . . 0.0 112.224 167.157 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -75.88 -32.85 59.88 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-O 117.981 -1.009 . . . . 0.0 111.313 175.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 53.5 mt -59.18 -48.59 81.03 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 120.579 1.536 . . . . 0.0 108.229 169.319 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -60.15 -29.53 68.72 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 119.375 0.989 . . . . 0.0 111.565 -179.654 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 32.6 mm-40 -86.39 -31.86 21.24 Favored 'General case' 0 CA--C 1.529 0.145 0 O-C-N 120.999 -1.063 . . . . 0.0 113.57 176.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 72.2 t -63.83 -40.97 90.97 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 CA-C-N 120.99 1.723 . . . . 0.0 108.736 166.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 83.6 mt -66.39 -39.8 89.28 Favored 'General case' 0 N--CA 1.463 0.179 0 C-N-CA 123.653 0.781 . . . . 0.0 110.722 176.737 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -64.01 -46.15 85.78 Favored 'General case' 0 C--O 1.227 -0.126 0 CA-C-N 118.748 0.704 . . . . 0.0 110.598 174.683 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -59.05 -42.88 91.37 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 118.847 -0.597 . . . . 0.0 110.776 178.037 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 31.1 mt -58.0 -45.23 87.15 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 119.174 0.897 . . . . 0.0 110.27 173.685 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 64.8 mtt180 -66.38 -18.88 65.62 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 117.096 -1.43 . . . . 0.0 112.791 178.508 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -60.9 -27.0 67.85 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 121.328 1.877 . . . . 0.0 110.807 171.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 16.7 m -101.89 13.91 33.47 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.107 0.963 . . . . 0.0 111.642 175.01 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 71.85 10.39 72.27 Favored Glycine 0 CA--C 1.53 1.0 0 CA-C-O 118.777 -1.013 . . . . 0.0 113.542 -179.145 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 61.0 t -79.69 102.92 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 CA-C-N 119.31 1.555 . . . . 0.0 107.301 178.467 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -72.93 152.87 41.22 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 164.038 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -131.57 150.91 51.98 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 125.351 1.46 . . . . 0.0 107.243 174.269 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 7.7 mm -114.31 122.72 33.77 Favored Pre-proline 0 CA--C 1.53 0.203 0 N-CA-C 107.58 -1.266 . . . . 0.0 107.58 -163.616 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -62.41 116.66 3.65 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 122.162 1.908 . . . . 0.0 108.031 176.233 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 59.7 mtm180 40.09 8.16 0.0 OUTLIER 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 129.573 3.149 . . . . 0.0 117.576 -172.222 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 70.7 m 47.85 54.61 9.7 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 121.231 1.832 . . . . 0.0 110.381 -158.246 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -137.26 122.04 18.72 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 101.997 -3.335 . . . . 0.0 101.997 -170.381 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 61.7 m . . . . . 0 C--O 1.249 1.036 0 CA-C-O 116.285 -1.817 . . . . 0.0 109.44 -155.273 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.2 ttt . . . . . 0 N--CA 1.501 2.086 0 CA-C-O 119.612 -0.232 . . . . 0.0 110.668 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 39.1 mmt180 -63.31 126.0 25.98 Favored 'General case' 0 N--CA 1.479 0.977 0 O-C-N 119.879 -1.763 . . . . 0.0 108.813 175.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 3.9 mt -123.39 121.67 63.31 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 -176.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -106.81 139.28 41.49 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 168.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 58.0 t -126.87 101.43 7.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 105.467 -2.049 . . . . 0.0 105.467 -177.529 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.3 mt -98.76 109.36 22.13 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.475 1.11 . . . . 0.0 109.581 -169.741 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -87.15 127.13 8.29 Favored Glycine 0 C--O 1.237 0.324 0 N-CA-C 106.958 -2.457 . . . . 0.0 106.958 169.855 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 15.3 m -138.69 172.69 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 CA-C-N 117.588 0.694 . . . . 0.0 111.202 -169.736 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 101.16 163.45 27.59 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 127.189 2.328 . . . . 0.0 111.731 179.202 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.408 ' HA ' HG22 ' A' ' 43' ' ' THR . 22.7 t-20 -77.32 102.13 6.61 Favored 'General case' 0 C--N 1.332 -0.167 0 O-C-N 121.88 -0.777 . . . . 0.0 111.043 -169.766 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -56.52 7.51 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.935 0 N-CA-C 117.742 2.497 . . . . 0.0 117.742 179.164 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 67.7 mt -109.54 1.3 19.65 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 122.127 2.24 . . . . 0.0 109.743 -177.438 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.4 mp -111.84 63.02 0.62 Allowed 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 123.895 0.878 . . . . 0.0 111.4 -169.039 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.402 ' HB ' ' H ' ' A' ' 15' ' ' ASP . 0.2 OUTLIER 52.83 -100.15 0.09 Allowed 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.664 0.786 . . . . 0.0 111.152 176.59 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.402 ' H ' ' HB ' ' A' ' 14' ' ' THR . 28.6 m-20 -83.69 -9.1 59.08 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 124.262 1.025 . . . . 0.0 111.881 -174.391 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -71.79 -8.41 54.12 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 120.485 1.493 . . . . 0.0 112.454 -175.517 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -75.37 -14.35 60.46 Favored 'General case' 0 N--CA 1.434 -1.252 0 CA-C-O 115.724 -2.084 . . . . 0.0 109.349 170.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 7.9 tp -52.48 -39.2 28.33 Favored 'Isoleucine or valine' 0 C--N 1.344 0.358 0 CA-C-N 122.588 2.449 . . . . 0.0 112.878 -169.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -61.46 -45.52 96.21 Favored Glycine 0 CA--C 1.525 0.718 0 CA-C-N 119.422 1.01 . . . . 0.0 111.148 177.018 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 69.9 t -64.2 -48.53 85.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-O 118.845 -0.598 . . . . 0.0 110.039 172.743 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 78.4 mmt-85 -59.07 -33.88 71.32 Favored 'General case' 0 C--O 1.223 -0.336 0 CA-C-O 117.755 -1.116 . . . . 0.0 112.263 -179.637 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 28.6 mt -63.64 -45.07 98.51 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 CA-C-N 120.679 1.581 . . . . 0.0 109.656 177.762 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 14.5 m -75.81 -26.0 17.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-N 119.67 1.123 . . . . 0.0 111.071 -176.489 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 -70.75 -44.92 65.78 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 173.79 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.69 -42.37 97.02 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 122.885 0.474 . . . . 0.0 109.809 176.497 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 8.2 tp -65.45 -42.91 91.85 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 118.16 -0.924 . . . . 0.0 110.48 178.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -58.22 -43.98 87.98 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 119.042 0.837 . . . . 0.0 110.73 178.089 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -72.64 -39.7 66.98 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.715 0.806 . . . . 0.0 111.27 -177.84 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -95.82 -40.56 9.27 Favored 'General case' 0 C--N 1.34 0.172 0 CA-C-O 117.044 -1.455 . . . . 0.0 113.704 -169.48 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -109.64 124.14 50.67 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 121.735 2.062 . . . . 0.0 112.151 -169.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 47.2 mm -76.78 137.43 22.54 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 N-CA-C 105.739 -1.948 . . . . 0.0 105.739 169.13 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 29.5 mt -135.25 156.28 78.18 Favored Pre-proline 0 CA--C 1.535 0.4 0 C-N-CA 124.665 1.186 . . . . 0.0 110.83 -169.267 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -60.06 155.86 42.58 Favored 'Trans proline' 0 CA--C 1.535 0.569 0 C-N-CA 123.344 2.696 . . . . 0.0 111.775 169.815 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -62.26 -30.49 71.16 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -173.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 11.5 p90 -73.54 -6.42 46.42 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 118.207 -0.901 . . . . 0.0 112.752 -179.273 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 19.7 t -99.28 127.26 52.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 CA-C-N 119.861 1.21 . . . . 0.0 108.264 175.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -127.19 137.27 52.89 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 173.523 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -102.36 104.15 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 N-CA-C 105.862 -1.903 . . . . 0.0 105.862 176.664 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 56.7 tp -95.88 121.39 37.56 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.31 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -79.92 109.46 14.38 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 106.254 -1.758 . . . . 0.0 106.254 169.007 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -103.86 -27.92 6.12 Favored Glycine 0 CA--C 1.534 1.233 0 CA-C-O 119.248 -0.751 . . . . 0.0 112.373 173.347 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 40.17 -111.99 0.27 Allowed Glycine 0 C--N 1.34 0.775 0 C-N-CA 125.327 1.442 . . . . 0.0 113.122 -177.438 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.408 HG22 ' HA ' ' A' ' 10' ' ' ASN . 12.1 p -65.01 -3.49 3.6 Favored 'General case' 0 C--N 1.316 -0.869 0 C-N-CA 128.756 2.823 . . . . 0.0 113.806 -172.443 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -50.3 -66.3 0.41 Allowed 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 114.974 1.472 . . . . 0.0 114.974 -179.584 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 64.15 -94.62 0.15 Allowed Glycine 0 CA--C 1.531 1.065 0 N-CA-C 109.416 -1.473 . . . . 0.0 109.416 -169.417 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 10.4 tpt -69.33 -26.99 64.98 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 126.776 2.03 . . . . 0.0 112.255 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -70.17 -4.68 22.65 Favored 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -169.445 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 66.2 mt -87.79 -6.01 58.36 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 124.636 1.175 . . . . 0.0 114.063 -171.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.521 ' HA ' HG13 ' A' ' 100' ' ' VAL . 5.2 tt -43.39 -59.74 2.0 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 114.19 1.182 . . . . 0.0 114.19 -169.464 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -72.25 -36.4 59.93 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 111.723 -0.551 . . . . 0.0 111.723 -170.193 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -68.01 -37.77 81.81 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 117.932 0.866 . . . . 0.0 110.214 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 36.2 mtp -74.13 -18.13 60.83 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 120.664 -0.414 . . . . 0.0 111.782 -174.554 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -75.73 151.04 37.7 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 121.635 0.731 . . . . 0.0 111.129 -177.371 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 55.62 44.16 27.02 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 126.373 1.869 . . . . 0.0 114.201 168.567 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 27.2 mmt180 -108.01 156.98 18.64 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 174.511 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -78.62 -41.9 30.32 Favored 'General case' 0 N--CA 1.467 0.385 0 O-C-N 121.438 -0.789 . . . . 0.0 109.771 171.399 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -134.23 133.14 40.52 Favored 'General case' 0 C--O 1.232 0.168 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 -175.171 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 26.1 tp -135.42 131.77 36.65 Favored 'General case' 0 CA--C 1.512 -0.482 0 O-C-N 121.486 -0.759 . . . . 0.0 109.242 169.423 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 10.6 mt -114.07 123.44 69.73 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 N-CA-C 106.006 -1.85 . . . . 0.0 106.006 178.473 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 15.5 mt -101.49 127.53 54.75 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 N-CA-C 104.803 -2.295 . . . . 0.0 104.803 177.115 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -115.64 121.48 42.69 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 105.749 -1.945 . . . . 0.0 105.749 176.079 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -155.41 149.29 25.46 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 118.561 0.619 . . . . 0.0 112.437 -169.395 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -76.82 116.92 17.92 Favored 'General case' 0 CA--C 1.529 0.136 0 N-CA-C 105.53 -2.026 . . . . 0.0 105.53 168.623 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.7 tt -68.79 -25.46 30.48 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.772 0 CA-C-O 117.684 -1.151 . . . . 0.0 113.102 -169.084 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . 0.281 92.9 t 55.28 17.03 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.556 1.202 0 C-N-CA 125.278 1.431 . . . . 0.0 112.806 172.212 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 48.7 m -126.86 164.05 22.26 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 125.057 1.343 . . . . 0.0 111.3 -170.373 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.47 ' HG3' ' H ' ' A' ' 68' ' ' LYS . 4.6 tppt? 59.72 -172.06 0.12 Allowed 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.12 1.768 . . . . 0.0 111.738 177.417 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.47 ' H ' ' HG3' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -128.66 20.48 6.07 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.223 1.409 . . . . 0.0 112.401 -175.809 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 51.0 t30 -71.48 163.85 26.93 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 108.096 -1.075 . . . . 0.0 108.096 172.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 12.6 m -58.14 142.67 80.17 Favored Pre-proline 0 CA--C 1.546 0.801 0 C-N-CA 123.964 0.906 . . . . 0.0 112.18 -169.626 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -57.38 152.38 47.03 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.554 2.169 . . . . 0.0 111.453 170.06 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 67.7 16.48 67.94 Favored Glycine 0 CA--C 1.533 1.169 0 CA-C-O 119.128 -0.818 . . . . 0.0 113.756 177.49 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 48.7 m -96.32 153.89 17.56 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 118.955 1.377 . . . . 0.0 108.784 175.613 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 9.6 ttp -97.97 141.77 30.52 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 123.589 0.756 . . . . 0.0 110.222 -179.664 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 13.6 mtp -126.48 119.31 26.88 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 176.053 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 46.0 mm -103.07 123.81 56.75 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 177.086 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 48.2 mt -125.0 129.28 50.0 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 107.548 -1.278 . . . . 0.0 107.548 -177.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 65.7 mtm180 -104.99 131.49 52.44 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 -169.855 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 6.9 t70 36.32 -98.11 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 116.168 1.914 . . . . 0.0 116.168 169.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -62.74 -27.57 69.36 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.966 0.906 . . . . 0.0 112.932 -176.7 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -73.49 -15.47 61.32 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.385 0.674 . . . . 0.0 111.005 -177.373 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.425 HG11 ' CD2' ' A' ' 114' ' ' LEU . 81.4 t -79.52 -60.84 0.5 Allowed Pre-proline 0 N--CA 1.442 -0.832 0 CA-C-O 117.963 -1.018 . . . . 0.0 110.466 -169.485 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -59.85 -31.69 94.25 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 CA-C-N 120.846 1.338 . . . . 0.0 111.65 175.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.14 -13.69 62.41 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -177.584 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -98.14 -38.38 9.35 Favored 'General case' 0 C--N 1.344 0.332 0 CA-C-N 118.713 0.688 . . . . 0.0 109.267 169.153 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -59.34 -12.79 6.34 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 113.101 0.778 . . . . 0.0 113.101 177.472 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 70.7 p -52.86 -27.78 19.99 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 113.857 1.058 . . . . 0.0 113.857 169.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -60.23 146.25 44.34 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 122.948 0.499 . . . . 0.0 111.66 -169.631 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 46.6 mmtm -99.51 -0.16 41.19 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.7 0.8 . . . . 0.0 111.981 177.525 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 74.8 mt -66.95 -41.13 87.07 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 178.669 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 5.8 m -96.81 109.43 48.61 Favored Pre-proline 0 CA--C 1.543 0.68 0 C-N-CA 125.737 1.615 . . . . 0.0 109.223 -172.806 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -68.3 -47.22 1.69 Allowed 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.002 1.802 . . . . 0.0 112.937 -169.806 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 15.7 m80 -73.94 -22.47 59.65 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 122.729 0.411 . . . . 0.0 111.328 -171.32 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -68.9 -24.75 64.34 Favored 'General case' 0 C--O 1.222 -0.343 0 CA-C-O 117.72 -1.134 . . . . 0.0 111.847 177.435 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 2.8 tt -60.77 -43.42 98.08 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 120.387 1.449 . . . . 0.0 109.652 -174.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -59.99 -41.6 97.98 Favored Glycine 0 CA--C 1.529 0.94 0 O-C-N 121.628 -0.67 . . . . 0.0 111.52 176.261 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -71.62 -32.6 68.14 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 118.526 1.163 . . . . 0.0 110.717 179.083 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -60.3 -45.2 94.18 Favored 'General case' 0 N--CA 1.454 -0.254 0 O-C-N 120.943 -1.098 . . . . 0.0 109.067 171.831 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -69.9 -23.85 63.3 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 118.979 -0.534 . . . . 0.0 112.104 177.84 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.521 HG13 ' HA ' ' A' ' 49' ' ' LEU . 20.9 t -66.5 -45.05 89.9 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.697 0 CA-C-N 119.223 0.92 . . . . 0.0 108.552 169.379 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 93.8 mt -64.44 -34.22 77.68 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 119.377 0.99 . . . . 0.0 110.245 179.345 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 20.3 m -64.91 -41.41 95.6 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 118.88 0.763 . . . . 0.0 110.318 169.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.46 ' HA ' ' CD2' ' A' ' 106' ' ' PHE . . . -64.39 -36.8 85.33 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 119.121 0.873 . . . . 0.0 111.527 178.296 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.6 mt -66.8 -35.6 80.44 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 118.412 0.551 . . . . 0.0 110.272 176.685 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 77.7 ttt-85 -65.92 -38.79 89.62 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 118.459 -0.781 . . . . 0.0 109.909 171.382 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.46 ' CD2' ' HA ' ' A' ' 103' ' ' ALA . 15.6 m-30 -64.09 -44.05 93.53 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 119.372 0.987 . . . . 0.0 110.586 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 42.3 p -75.71 -22.8 56.28 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 118.325 0.511 . . . . 0.0 111.403 178.817 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 74.47 12.59 82.21 Favored Glycine 0 CA--C 1.531 1.09 0 N-CA-C 111.118 -0.793 . . . . 0.0 111.118 -169.401 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -98.79 25.29 6.7 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 118.644 1.222 . . . . 0.0 110.97 -178.006 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -57.56 135.58 82.26 Favored Pre-proline 0 CA--C 1.544 0.724 0 C-N-CA 124.111 0.964 . . . . 0.0 109.209 170.509 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -54.55 151.71 29.87 Favored 'Trans proline' 0 C--N 1.35 0.658 0 C-N-CA 123.643 2.895 . . . . 0.0 114.108 -179.536 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -60.09 -29.81 68.83 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 119.012 -0.518 . . . . 0.0 110.44 177.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 23.1 ttpp -146.54 125.84 13.07 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 169.161 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.425 ' CD2' HG11 ' A' ' 82' ' ' VAL . 3.4 tt -105.92 147.38 28.83 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 169.417 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -143.42 138.9 29.67 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 -177.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.7 tp -125.09 129.39 50.14 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 120.429 1.468 . . . . 0.0 108.828 175.792 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 53.5 t -102.5 98.95 7.45 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 N-CA-C 104.759 -2.311 . . . . 0.0 104.759 168.817 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -84.77 140.27 18.59 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 109.981 -1.248 . . . . 0.0 109.981 174.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 40.9 t -119.95 138.25 51.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 173.638 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 5.4 mt -86.92 126.92 61.65 Favored Pre-proline 0 CA--C 1.54 0.591 0 CA-C-N 119.395 0.998 . . . . 0.0 108.389 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -77.0 167.28 25.39 Favored 'Trans proline' 0 CA--C 1.542 0.884 0 C-N-CA 123.657 2.904 . . . . 0.0 112.25 -178.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.465 ' HB3' HG21 ' A' ' 131' ' ' THR . 1.6 tm-20 -107.38 -58.89 1.9 Allowed 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.673 0.789 . . . . 0.0 109.924 -178.709 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 4.0 m -105.28 -58.06 1.95 Allowed 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 122.934 0.494 . . . . 0.0 112.04 -170.27 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER 56.46 52.37 10.03 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 126.176 1.79 . . . . 0.0 115.334 171.806 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -121.71 165.21 20.76 Favored Pre-proline 0 N--CA 1.475 0.796 0 CA-C-O 117.826 -1.083 . . . . 0.0 108.87 172.806 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -67.47 84.09 0.38 Allowed 'Trans proline' 0 CA--C 1.546 1.084 0 C-N-CA 123.345 2.697 . . . . 0.0 112.551 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -168.85 152.4 5.35 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 104.501 -2.407 . . . . 0.0 104.501 174.241 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -120.27 152.87 23.22 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-O 121.999 0.904 . . . . 0.0 113.286 -169.654 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 120.8 130.73 3.92 Favored Glycine 0 CA--C 1.527 0.814 0 N-CA-C 105.98 -2.848 . . . . 0.0 105.98 -169.652 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 7.0 mp -77.8 149.39 34.43 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 177.602 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.465 HG21 ' HB3' ' A' ' 122' ' ' GLU . 54.6 p -67.22 163.19 48.21 Favored Pre-proline 0 CA--C 1.534 0.349 0 CA-C-O 119.148 -0.453 . . . . 0.0 109.942 169.799 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -58.71 -34.67 99.08 Favored 'Trans proline' 0 CA--C 1.537 0.65 0 C-N-CA 121.099 1.199 . . . . 0.0 109.574 169.319 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 4.5 m -63.34 -39.06 93.51 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.187 0.995 . . . . 0.0 111.18 -176.48 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 21.8 t -102.48 -25.89 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 CA-C-N 119.319 0.963 . . . . 0.0 112.146 -176.645 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -54.1 -43.01 70.02 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 120.825 1.648 . . . . 0.0 109.986 169.676 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -73.04 -2.43 21.18 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-O 118.332 -0.842 . . . . 0.0 113.107 -176.033 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 16.4 mmm -89.58 -7.09 55.56 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-O 116.953 -1.499 . . . . 0.0 111.022 170.651 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 91.6 mt -58.9 -47.64 88.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 CA-C-N 121.631 2.014 . . . . 0.0 109.301 -179.337 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 61.6 mt-10 -73.21 -51.14 6.08 Favored Pre-proline 0 CA--C 1.536 0.425 0 CA-C-O 117.39 -1.29 . . . . 0.0 110.809 -178.828 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -40.49 -51.99 3.23 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 124.447 3.431 . . . . 0.0 113.672 169.041 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -74.16 -45.33 49.31 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 114.538 -1.21 . . . . 0.0 111.451 -174.027 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -62.37 -36.02 80.96 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 119.594 1.088 . . . . 0.0 109.984 178.28 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -62.86 -33.04 74.45 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 118.744 -0.645 . . . . 0.0 111.085 176.276 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 42.9 mm-40 -78.47 -29.97 47.12 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 119.502 1.046 . . . . 0.0 111.892 174.177 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 67.7 t -61.41 -43.43 96.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 169.563 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 71.4 mt -69.65 -33.41 72.57 Favored 'General case' 0 N--CA 1.463 0.179 0 O-C-N 120.752 -1.217 . . . . 0.0 111.622 176.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -58.86 -33.6 70.65 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 118.923 0.783 . . . . 0.0 111.455 176.151 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -62.42 -46.79 86.95 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 118.531 0.605 . . . . 0.0 111.292 174.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 7.1 mp -58.44 -43.4 88.76 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.021 0.529 . . . . 0.0 109.866 174.748 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 84.7 mtt180 -65.38 -17.56 64.63 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 117.418 -1.277 . . . . 0.0 111.896 -177.741 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -58.16 -34.38 70.24 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 120.616 1.553 . . . . 0.0 111.33 175.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 8.1 m -107.39 28.57 7.98 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.598 1.159 . . . . 0.0 110.956 -179.456 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 64.22 23.8 68.39 Favored Glycine 0 CA--C 1.53 1.003 0 CA-C-O 118.725 -1.042 . . . . 0.0 113.917 176.822 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 59.4 t -93.77 134.47 31.31 Favored 'Isoleucine or valine' 0 C--N 1.341 0.213 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 174.744 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -122.6 145.05 48.7 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 178.798 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -107.46 143.09 36.32 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 124.06 0.944 . . . . 0.0 109.351 174.841 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 23.3 mm -105.62 125.97 31.97 Favored Pre-proline 0 C--O 1.234 0.253 0 CA-C-O 117.879 -1.058 . . . . 0.0 108.649 -173.193 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -57.61 110.42 0.62 Allowed 'Trans proline' 0 N--CA 1.461 -0.383 0 C-N-CA 122.608 2.206 . . . . 0.0 108.919 169.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 82.7 mtm180 51.51 30.68 6.63 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.179 0.992 . . . . 0.0 112.715 171.412 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 17.4 p 46.12 26.23 0.41 Allowed 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 126.714 2.006 . . . . 0.0 114.872 -171.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -76.73 142.46 40.45 Favored 'General case' 0 C--O 1.239 0.527 0 O-C-N 121.118 -0.989 . . . . 0.0 110.645 -176.368 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 15.5 m . . . . . 0 C--O 1.255 1.346 0 C-N-CA 124.443 1.097 . . . . 0.0 111.126 -174.029 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.46 ' CE ' HD11 ' A' ' 3' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.919 0 CA-C-O 118.627 -0.702 . . . . 0.0 110.998 . . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -58.17 128.64 38.15 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 119.883 1.219 . . . . 0.0 110.633 174.783 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.46 HD11 ' CE ' ' A' ' 1' ' ' MET . 5.7 mt -125.52 129.55 72.82 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 -179.651 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -120.36 141.11 50.38 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 106.105 -1.813 . . . . 0.0 106.105 168.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 91.6 t -121.42 127.41 75.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 106.722 -1.584 . . . . 0.0 106.722 -176.828 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.2 tp -109.03 111.61 23.36 Favored 'General case' 0 CA--C 1.515 -0.4 0 C-N-CA 123.468 0.707 . . . . 0.0 111.02 -169.187 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -94.07 118.24 5.7 Favored Glycine 0 N--CA 1.446 -0.67 0 N-CA-C 104.394 -3.482 . . . . 0.0 104.394 168.768 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.4 m -141.32 163.74 20.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 -171.678 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 121.73 160.47 11.01 Favored Glycine 0 C--N 1.338 0.661 0 C-N-CA 124.818 1.199 . . . . 0.0 110.495 176.519 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.514 ' HA ' HG22 ' A' ' 43' ' ' THR . 27.9 t-20 -79.22 101.52 8.03 Favored 'General case' 0 C--N 1.333 -0.122 0 O-C-N 121.351 -1.088 . . . . 0.0 109.988 -179.366 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 27.3 pt -53.41 -15.07 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 N-CA-C 116.13 1.9 . . . . 0.0 116.13 -176.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.434 ' HA ' HG23 ' A' ' 128' ' ' ILE . 5.2 mp -90.17 -3.79 57.66 Favored 'General case' 0 C--O 1.219 -0.536 0 CA-C-N 121.024 1.738 . . . . 0.0 107.558 -170.506 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.3 mp -101.78 55.42 0.81 Allowed 'General case' 0 N--CA 1.439 -0.987 0 C-N-CA 123.477 0.711 . . . . 0.0 109.727 -174.334 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.426 ' HB ' ' H ' ' A' ' 15' ' ' ASP 0.254 0.1 OUTLIER 49.6 -102.11 0.1 Allowed 'General case' 0 C--O 1.236 0.345 0 CA-C-N 114.348 -1.296 . . . . 0.0 111.331 177.052 . . . . . . . . 4 4 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.426 ' H ' ' HB ' ' A' ' 14' ' ' THR . 17.2 m-20 -72.21 -12.34 61.13 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 123.891 0.876 . . . . 0.0 111.319 -172.706 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -73.07 -2.5 21.56 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-N 119.377 0.99 . . . . 0.0 112.338 176.342 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.82 -11.85 59.8 Favored 'General case' 0 N--CA 1.439 -1.014 0 CA-C-O 116.436 -1.745 . . . . 0.0 108.564 169.343 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 7.3 tp -53.47 -41.1 43.84 Favored 'Isoleucine or valine' 0 C--N 1.344 0.345 0 CA-C-N 122.094 2.225 . . . . 0.0 112.44 -169.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -62.03 -49.06 78.91 Favored Glycine 0 CA--C 1.523 0.555 0 CA-C-N 119.257 0.935 . . . . 0.0 111.707 177.373 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 58.3 t -65.16 -47.27 88.24 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 178.755 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 71.4 mmt-85 -59.64 -35.02 73.57 Favored 'General case' 0 C--N 1.343 0.292 0 CA-C-O 117.041 -1.457 . . . . 0.0 113.146 177.326 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 27.8 mt -62.74 -45.6 98.43 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 CA-C-N 121.925 2.148 . . . . 0.0 109.995 177.758 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 22.2 m -74.47 -27.82 21.71 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-N 119.995 1.27 . . . . 0.0 111.632 -175.524 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -68.63 -44.44 74.22 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 174.234 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -66.09 -40.11 90.54 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 122.559 0.344 . . . . 0.0 110.28 -179.258 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 7.8 tp -62.33 -42.59 99.5 Favored 'General case' 0 CA--C 1.527 0.096 0 CA-C-O 118.733 -0.651 . . . . 0.0 109.933 178.169 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -61.36 -38.62 87.64 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 118.506 0.594 . . . . 0.0 110.835 -178.309 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 -74.01 -43.21 58.76 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.38 0.672 . . . . 0.0 111.036 177.66 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 87.9 mtt180 -86.31 -31.13 21.75 Favored 'General case' 0 C--N 1.339 0.124 0 CA-C-O 116.87 -1.538 . . . . 0.0 114.221 -169.577 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -125.96 138.25 53.75 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 121.369 1.895 . . . . 0.0 112.836 -173.717 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 49.5 mm -91.71 149.84 3.99 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 N-CA-C 106.366 -1.716 . . . . 0.0 106.366 168.48 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 51.2 mt -137.44 151.34 71.03 Favored Pre-proline 0 C--O 1.237 0.412 0 C-N-CA 124.218 1.007 . . . . 0.0 110.775 -169.649 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -67.76 159.97 50.38 Favored 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 122.483 2.122 . . . . 0.0 110.111 169.785 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -57.71 -32.55 67.5 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 114.51 1.3 . . . . 0.0 114.51 -169.346 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 31.5 p90 -75.89 -5.61 46.91 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 117.8 -1.095 . . . . 0.0 112.676 -176.81 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 26.0 t -108.61 129.9 62.3 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 CA-C-N 120.087 1.312 . . . . 0.0 107.888 175.46 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -136.95 150.98 48.51 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 121.491 0.662 . . . . 0.0 110.113 174.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -103.21 131.01 52.52 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 170.555 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 10.5 tt -123.77 127.68 48.47 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 175.668 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -91.2 115.15 27.79 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 172.477 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -71.58 -23.92 77.43 Favored Glycine 0 CA--C 1.533 1.186 0 CA-C-O 118.373 -1.237 . . . . 0.0 112.795 179.239 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 62.85 77.09 0.22 Allowed Glycine 0 CA--C 1.529 0.949 0 CA-C-N 118.424 1.112 . . . . 0.0 112.886 173.706 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.514 HG22 ' HA ' ' A' ' 10' ' ' ASN 0.28 14.9 p 55.75 32.84 20.24 Favored 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 125.075 1.35 . . . . 0.0 112.761 173.181 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -75.14 -69.26 0.48 Allowed 'General case' 0 C--N 1.345 0.385 0 N-CA-C 114.722 1.378 . . . . 0.0 114.722 -169.333 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 70.06 -99.1 0.67 Allowed Glycine 0 C--N 1.337 0.584 0 N-CA-C 108.436 -1.866 . . . . 0.0 108.436 -171.038 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 10.1 tpt -67.51 -27.76 67.26 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 125.057 1.343 . . . . 0.0 111.38 -178.762 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -70.2 -4.65 22.64 Favored 'General case' 0 CA--C 1.548 0.881 0 CA-C-O 121.234 0.54 . . . . 0.0 110.685 -173.547 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 81.9 mt -81.76 2.13 31.35 Favored 'General case' 0 CA--C 1.535 0.382 0 O-C-N 120.316 -1.49 . . . . 0.0 113.62 -179.335 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.48 ' HA ' HG13 ' A' ' 100' ' ' VAL . 6.5 tt -50.16 -53.99 23.87 Favored 'General case' 0 C--N 1.339 0.151 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 -170.129 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -87.68 -31.91 14.5 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 -177.29 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -52.87 -49.3 66.12 Favored 'General case' 0 C--N 1.34 0.164 0 C-N-CA 123.03 0.532 . . . . 0.0 110.257 178.256 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 28.1 mtp -78.13 -8.71 58.61 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 114.306 1.224 . . . . 0.0 114.306 -169.052 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.79 146.65 54.2 Favored 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 113.78 1.03 . . . . 0.0 113.78 -169.131 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . 0.25 14.7 p30 53.08 13.81 0.42 Allowed 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 128.86 2.864 . . . . 0.0 117.975 169.114 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 89.8 mtt180 -68.08 151.93 46.29 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 121.333 -0.855 . . . . 0.0 109.835 173.537 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -81.68 -61.75 1.84 Allowed 'General case' 0 C--O 1.222 -0.363 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 176.259 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 2.3 t-160 -114.85 124.22 51.19 Favored 'General case' 0 C--O 1.231 0.103 0 N-CA-C 105.609 -1.997 . . . . 0.0 105.609 -177.484 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 54.0 tp -133.24 119.96 20.5 Favored 'General case' 0 CA--C 1.506 -0.713 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 178.435 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 4.4 mp -103.04 120.09 52.4 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 N-CA-C 105.445 -2.057 . . . . 0.0 105.445 175.194 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 8.1 mt -96.92 132.94 40.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 104.392 -2.447 . . . . 0.0 104.392 176.805 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -121.55 126.4 49.08 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 172.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -162.46 162.6 27.64 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 122.602 0.361 . . . . 0.0 110.056 177.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -74.06 136.44 43.07 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 104.923 -2.251 . . . . 0.0 104.923 168.106 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -87.47 -22.03 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 N-CA-C 113.182 0.808 . . . . 0.0 113.182 -168.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.7 t 51.73 31.95 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.221 0 C-N-CA 126.115 1.766 . . . . 0.0 112.569 174.011 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 19.8 m -137.54 159.75 41.08 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 124.313 1.045 . . . . 0.0 111.711 -172.245 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 22.6 ttmt 63.55 173.93 0.17 Allowed 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 126.732 2.013 . . . . 0.0 112.685 170.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.32 7.98 35.87 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.543 1.137 . . . . 0.0 112.027 -170.02 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 41.4 t-20 -73.66 165.55 24.9 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.368 0.667 . . . . 0.0 109.489 -174.888 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 10.7 m -58.75 141.59 84.82 Favored Pre-proline 0 CA--C 1.55 0.947 0 C-N-CA 124.199 1.0 . . . . 0.0 112.578 -169.613 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -55.25 150.16 41.87 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 123.503 2.802 . . . . 0.0 112.132 169.803 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 68.18 15.2 67.33 Favored Glycine 0 CA--C 1.531 1.032 0 CA-C-O 119.091 -0.839 . . . . 0.0 113.825 176.66 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 20.9 m -90.92 149.92 21.7 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 118.973 1.386 . . . . 0.0 108.895 175.775 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 16.7 ttp -95.41 139.12 32.15 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 176.522 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 3.4 ttt -135.44 115.04 12.72 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 107.275 -1.379 . . . . 0.0 107.275 -170.322 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 24.0 mm -100.78 122.04 52.32 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 -169.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -117.48 125.24 50.56 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 179.216 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -90.7 170.53 10.06 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 178.886 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -28.97 -61.69 0.12 Allowed 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 117.02 2.23 . . . . 0.0 117.02 -170.12 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -78.51 -17.25 56.49 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 119.302 0.955 . . . . 0.0 113.307 -174.158 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -87.96 -30.69 19.84 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 123.555 0.742 . . . . 0.0 110.417 -170.026 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . 0.256 0.5 OUTLIER -67.46 -47.31 47.76 Favored Pre-proline 0 N--CA 1.453 -0.289 0 CA-C-O 116.624 -1.655 . . . . 0.0 112.023 -171.351 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -65.63 -35.63 36.72 Favored 'Trans proline' 0 N--CA 1.453 -0.883 0 CA-C-N 122.176 1.813 . . . . 0.0 109.988 179.792 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.2 -26.36 67.36 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.033 0.533 . . . . 0.0 111.199 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -78.39 -52.96 7.81 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 169.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -58.2 -23.06 54.3 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 -174.127 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -66.86 -6.79 17.75 Favored 'General case' 0 CA--C 1.551 1.009 0 CA-C-N 119.103 0.865 . . . . 0.0 112.26 176.638 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 32.6 t30 -50.2 127.68 17.56 Favored 'General case' 0 C--N 1.344 0.346 0 O-C-N 121.27 -0.894 . . . . 0.0 110.912 173.489 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 30.5 mmmt -66.91 -26.73 67.01 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 118.541 -0.742 . . . . 0.0 111.994 -178.616 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 62.1 mt -65.62 -49.6 76.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 -177.204 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.4 m -65.02 114.41 14.89 Favored Pre-proline 0 CA--C 1.545 0.774 0 C-N-CA 124.609 1.164 . . . . 0.0 109.854 -176.854 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -70.92 -75.85 0.01 OUTLIER 'Trans proline' 0 CA--C 1.539 0.76 0 C-N-CA 122.761 2.307 . . . . 0.0 112.896 -169.549 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 13.1 m80 -69.33 -26.66 64.82 Favored 'General case' 0 N--CA 1.47 0.562 0 O-C-N 121.093 -1.004 . . . . 0.0 110.784 -174.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 25.8 mp0 -63.78 -28.87 70.17 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 124.432 1.093 . . . . 0.0 110.659 179.013 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 52.6 tp -64.18 -35.49 80.97 Favored 'General case' 0 C--N 1.342 0.246 0 CA-C-N 119.722 1.146 . . . . 0.0 110.54 174.224 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -64.64 -40.12 97.27 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 110.552 -1.019 . . . . 0.0 110.552 172.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 19.1 tp -66.2 -32.44 73.88 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 117.976 0.888 . . . . 0.0 110.907 175.854 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -64.1 -45.19 89.75 Favored 'General case' 0 N--CA 1.466 0.36 0 O-C-N 120.952 -1.092 . . . . 0.0 110.791 171.202 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -70.35 -24.2 62.94 Favored 'General case' 0 CA--C 1.52 -0.18 0 O-C-N 121.602 -0.686 . . . . 0.0 111.574 178.366 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.48 HG13 ' HA ' ' A' ' 49' ' ' LEU . 7.0 t -68.14 -44.97 83.98 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 CA-C-N 118.722 0.692 . . . . 0.0 110.397 169.907 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 59.8 mt -62.26 -36.89 83.45 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 119.25 0.932 . . . . 0.0 109.697 176.486 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 44.5 m -65.03 -40.18 94.44 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 118.005 0.366 . . . . 0.0 110.299 172.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -64.52 -40.34 95.44 Favored 'General case' 0 N--CA 1.454 -0.237 0 O-C-N 121.112 -0.992 . . . . 0.0 110.729 178.231 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 12.6 mt -64.0 -37.61 88.05 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-O 120.98 0.419 . . . . 0.0 110.58 175.155 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 21.1 tpp180 -63.89 -37.82 88.8 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 118.652 -0.689 . . . . 0.0 109.982 173.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 14.6 m-30 -66.18 -42.61 88.65 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 119.124 0.875 . . . . 0.0 110.798 179.278 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 41.7 p -76.13 -18.72 59.02 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 118.819 0.736 . . . . 0.0 111.722 178.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 76.42 9.72 85.83 Favored Glycine 0 CA--C 1.532 1.127 0 CA-C-O 119.073 -0.848 . . . . 0.0 111.229 -169.669 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -93.5 31.04 1.6 Allowed 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 118.991 1.395 . . . . 0.0 110.675 178.048 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.418 ' HA ' ' HD3' ' A' ' 111' ' ' PRO . 9.4 t80 -62.24 140.22 96.24 Favored Pre-proline 0 CA--C 1.542 0.647 0 C-N-CA 123.793 0.837 . . . . 0.0 109.724 174.321 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 110' ' ' PHE . 31.2 Cg_exo -66.66 142.9 65.97 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.382 2.055 . . . . 0.0 110.35 -177.364 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -64.48 -29.4 70.44 Favored 'General case' 0 CA--C 1.538 0.504 0 O-C-N 122.141 -0.349 . . . . 0.0 111.483 -174.114 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 23.9 tptp -143.41 82.78 1.75 Allowed 'General case' 0 C--O 1.234 0.277 0 N-CA-C 106.172 -1.788 . . . . 0.0 106.172 -176.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 24.5 tp -77.02 136.52 38.69 Favored 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 169.721 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -138.39 144.24 40.15 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 170.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 11.2 tp -128.83 129.83 46.12 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 119.606 1.094 . . . . 0.0 109.464 176.031 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 21.7 t -98.34 101.21 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 N-CA-C 104.215 -2.513 . . . . 0.0 104.215 168.384 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -82.93 146.7 24.33 Favored Glycine 0 CA--C 1.521 0.454 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 171.687 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 47.9 t -127.42 143.5 40.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 170.589 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 13.2 mt -94.14 130.13 35.2 Favored Pre-proline 0 CA--C 1.537 0.458 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 -176.139 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -79.33 166.6 22.26 Favored 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 122.967 2.445 . . . . 0.0 113.026 -174.154 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -111.05 -53.71 2.68 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.371 1.068 . . . . 0.0 110.331 -178.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 73.6 m -111.84 -53.55 2.7 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 118.73 0.695 . . . . 0.0 112.248 -173.701 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER 56.11 44.71 24.79 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 125.215 1.406 . . . . 0.0 114.609 177.07 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -119.43 171.38 5.51 Favored Pre-proline 0 N--CA 1.477 0.892 0 O-C-N 121.205 -0.934 . . . . 0.0 109.924 175.091 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -65.85 91.0 0.24 Allowed 'Trans proline' 0 CA--C 1.549 1.267 0 C-N-CA 123.447 2.765 . . . . 0.0 114.145 -177.225 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -167.62 131.64 1.78 Allowed 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 105.102 -2.185 . . . . 0.0 105.102 169.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.434 HG23 ' HA ' ' A' ' 12' ' ' LEU . 0.0 OUTLIER -80.28 152.91 4.48 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 123.612 0.765 . . . . 0.0 110.293 -171.452 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 80.37 160.79 23.22 Favored Glycine 0 CA--C 1.53 1.0 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.916 179.334 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.436 HD22 ' H ' ' A' ' 130' ' ' LEU . 1.1 mm? -76.45 163.17 27.21 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-O 121.188 0.518 . . . . 0.0 112.218 -169.194 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 40.7 p -69.81 169.93 11.3 Favored Pre-proline 0 CA--C 1.541 0.597 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 167.703 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -55.88 -31.76 82.55 Favored 'Trans proline' 0 CA--C 1.542 0.925 0 C-N-CA 121.315 1.344 . . . . 0.0 111.041 169.097 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 25.3 m -68.18 -45.27 73.91 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 118.976 -0.535 . . . . 0.0 111.505 179.5 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 5.8 t -99.19 -12.16 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 CA-C-N 119.451 1.023 . . . . 0.0 111.652 -169.783 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -57.6 -45.55 85.15 Favored 'General case' 0 N--CA 1.465 0.292 0 O-C-N 119.898 -1.751 . . . . 0.0 108.102 169.163 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -68.19 -2.02 7.25 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-O 118.382 -0.818 . . . . 0.0 112.741 178.021 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 12.9 mmm -92.84 -6.94 47.7 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 119.356 0.98 . . . . 0.0 111.266 175.756 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 86.6 mt -59.42 -45.26 93.71 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 CA-C-N 119.421 1.01 . . . . 0.0 108.921 175.537 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -76.07 -47.02 3.71 Favored Pre-proline 0 CA--C 1.543 0.677 0 CA-C-O 117.252 -1.356 . . . . 0.0 113.129 -170.207 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -55.0 -41.76 75.79 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 122.07 1.847 . . . . 0.0 111.399 170.539 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -68.36 -41.48 80.6 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 118.162 -0.923 . . . . 0.0 110.718 -177.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 27.1 mt -55.83 -47.48 77.16 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 119.713 1.142 . . . . 0.0 109.223 172.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -62.31 -33.97 75.71 Favored 'General case' 0 N--CA 1.443 -0.817 0 C-N-CA 122.768 0.427 . . . . 0.0 109.849 -177.109 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 38.9 tp60 -80.29 -34.14 37.13 Favored 'General case' 0 N--CA 1.431 -1.375 0 C-N-CA 123.409 0.684 . . . . 0.0 111.307 -178.047 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 49.0 t -60.45 -48.77 87.01 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 170.176 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 30.2 mt -62.81 -30.53 71.55 Favored 'General case' 0 C--N 1.331 -0.203 0 O-C-N 121.995 -0.441 . . . . 0.0 110.406 178.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -67.22 -39.37 86.23 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 121.036 -1.04 . . . . 0.0 111.129 176.423 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -62.06 -47.48 84.52 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 118.608 0.64 . . . . 0.0 110.76 177.522 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 6.0 mp -58.01 -41.97 84.23 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 174.539 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 85.0 mtm180 -70.12 -13.83 62.38 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 117.319 -1.324 . . . . 0.0 113.327 -179.051 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -57.29 -33.25 67.48 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 120.959 1.709 . . . . 0.0 110.208 172.152 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 4.6 m -103.01 22.22 14.34 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.113 1.365 . . . . 0.0 111.502 179.18 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 68.75 23.26 75.65 Favored Glycine 0 CA--C 1.532 1.155 0 CA-C-O 118.402 -1.221 . . . . 0.0 114.355 178.723 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 60.9 t -102.41 97.84 6.12 Favored 'Isoleucine or valine' 0 C--N 1.342 0.261 0 CA-C-N 119.52 1.66 . . . . 0.0 107.607 177.686 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -97.96 136.58 38.04 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 169.532 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -77.18 161.18 28.4 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.273 0.629 . . . . 0.0 110.619 178.169 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 5.2 mt -83.57 121.55 76.47 Favored Pre-proline 0 CA--C 1.54 0.565 0 N-CA-C 105.307 -2.109 . . . . 0.0 105.307 175.511 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -65.94 107.86 1.19 Allowed 'Trans proline' 0 C--N 1.35 0.656 0 N-CA-C 105.781 -2.43 . . . . 0.0 105.781 169.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 22.5 tpt180 47.86 -121.64 1.37 Allowed 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 104.965 -2.235 . . . . 0.0 104.965 -168.049 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 8.1 p -153.66 159.89 42.2 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 121.521 1.964 . . . . 0.0 109.958 169.757 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -72.21 -39.34 68.64 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 110.289 -0.263 . . . . 0.0 110.289 170.255 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 14.9 m . . . . . 0 C--O 1.254 1.328 0 C-N-CA 124.15 0.98 . . . . 0.0 109.125 169.876 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.4 ttt . . . . . 0 N--CA 1.5 2.036 0 CA-C-O 120.121 0.01 . . . . 0.0 111.018 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 31.6 ptt-85 -62.18 126.62 27.97 Favored 'General case' 0 N--CA 1.476 0.848 0 O-C-N 120.219 -1.551 . . . . 0.0 110.252 176.323 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 4.4 mt -122.19 128.74 75.61 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 -176.428 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 15.3 tp -115.21 140.77 48.81 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 105.686 -1.968 . . . . 0.0 105.686 168.38 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 74.9 t -120.01 113.24 39.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 106.152 -1.795 . . . . 0.0 106.152 177.532 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.41 ' HA ' HD13 ' A' ' 6' ' ' LEU . 0.7 OUTLIER -93.26 120.84 34.0 Favored 'General case' 0 CA--C 1.516 -0.338 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 -177.534 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -100.03 120.27 6.81 Favored Glycine 0 CA--C 1.499 -0.92 0 N-CA-C 105.679 -2.968 . . . . 0.0 105.679 170.598 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 11.4 m -148.94 162.47 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.971 0 CA-C-O 121.174 0.511 . . . . 0.0 110.579 -168.814 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 119.77 146.67 7.81 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 126.382 1.944 . . . . 0.0 108.996 177.711 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.494 HD21 ' HB2' ' A' ' 12' ' ' LEU . 2.0 t30 -62.57 116.14 4.88 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 123.781 1.753 . . . . 0.0 114.675 -168.839 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.3 pt -67.84 40.71 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.812 0 CA-C-N 112.264 -2.244 . . . . 0.0 114.981 170.037 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.494 ' HB2' HD21 ' A' ' 10' ' ' ASN . 75.0 mt -132.62 -12.65 3.01 Favored 'General case' 0 C--N 1.343 0.325 0 CA-C-N 121.563 1.983 . . . . 0.0 111.416 170.622 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.7 mp -115.32 62.77 0.69 Allowed 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 -167.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 56.9 -97.63 0.08 Allowed 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 123.51 0.724 . . . . 0.0 111.246 170.387 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -84.18 -9.47 58.52 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 124.39 1.076 . . . . 0.0 110.906 -175.15 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -70.68 -14.98 62.67 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 119.859 1.208 . . . . 0.0 112.56 -176.039 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.2 -6.04 55.67 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-O 115.697 -2.097 . . . . 0.0 110.024 172.677 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 6.4 tp -49.88 -44.37 20.9 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-N 122.062 2.21 . . . . 0.0 111.94 -171.437 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -62.78 -42.24 99.72 Favored Glycine 0 N--CA 1.446 -0.634 0 CA-C-N 118.88 0.764 . . . . 0.0 111.629 178.799 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 73.6 t -63.86 -52.92 50.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 173.853 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 1.4 mmp_? -60.74 -31.89 71.2 Favored 'General case' 0 CA--C 1.531 0.245 0 O-C-N 120.949 -1.094 . . . . 0.0 112.73 -175.414 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 25.0 mt -60.54 -44.94 97.68 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 CA-C-N 120.145 1.339 . . . . 0.0 110.287 176.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 17.9 m -75.35 -25.44 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-N 120.203 1.365 . . . . 0.0 111.323 -176.679 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -68.03 -42.92 79.87 Favored 'General case' 0 C--N 1.341 0.2 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 173.237 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.81 -41.95 91.24 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-O 119.363 -0.351 . . . . 0.0 110.277 179.36 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 10.4 tp -61.12 -45.11 96.02 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 118.453 -0.784 . . . . 0.0 109.816 176.8 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -59.89 -39.91 86.97 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 118.467 0.576 . . . . 0.0 111.216 -178.388 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 50.6 mm-40 -73.58 -40.73 63.66 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 122.938 0.495 . . . . 0.0 111.355 178.253 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 91.0 mtt180 -90.24 -38.03 13.71 Favored 'General case' 0 C--N 1.342 0.259 0 CA-C-O 117.343 -1.313 . . . . 0.0 114.288 -169.293 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 66.2 m-85 -115.33 136.23 53.31 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 120.991 1.723 . . . . 0.0 113.348 -169.751 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 39.8 mm -86.48 134.29 27.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 N-CA-C 105.805 -1.924 . . . . 0.0 105.805 168.284 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 7.3 mp -119.91 150.32 50.54 Favored Pre-proline 0 CA--C 1.539 0.523 0 C-N-CA 125.305 1.442 . . . . 0.0 110.691 -169.672 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -62.34 153.86 67.6 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 122.888 2.392 . . . . 0.0 109.785 168.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -61.21 -33.6 73.74 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 -169.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 18.0 p90 -74.21 -8.04 54.78 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 118.016 -0.992 . . . . 0.0 112.453 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 12.4 t -101.11 128.03 53.74 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 CA-C-N 119.926 1.239 . . . . 0.0 108.079 174.205 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -133.45 147.66 51.7 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.063 0.545 . . . . 0.0 110.155 175.226 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -100.17 136.78 30.04 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 N-CA-C 107.459 -1.312 . . . . 0.0 107.459 169.556 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.513 HD13 ' N ' ' A' ' 40' ' ' ASP . 1.5 tm? -128.11 144.79 51.13 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 173.075 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.513 ' N ' HD13 ' A' ' 39' ' ' LEU . 5.8 t0 -118.11 114.43 23.08 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 124.131 0.972 . . . . 0.0 108.483 -175.439 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -93.31 -4.54 64.29 Favored Glycine 0 CA--C 1.533 1.207 0 CA-C-O 119.032 -0.871 . . . . 0.0 113.277 176.764 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 60.57 -125.82 39.49 Favored Glycine 0 N--CA 1.431 -1.665 0 N-CA-C 108.22 -1.952 . . . . 0.0 108.22 -171.801 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 12.1 p -54.55 -37.41 65.41 Favored 'General case' 0 C--N 1.313 -0.985 0 C-N-CA 127.501 2.32 . . . . 0.0 111.271 176.633 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 50.07 -131.32 1.94 Allowed 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 169.348 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 79.73 -104.92 2.24 Favored Glycine 0 N--CA 1.443 -0.847 0 N-CA-C 106.899 -2.481 . . . . 0.0 106.899 -169.358 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 66.4 mmm -72.23 -19.55 61.7 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 112.535 0.568 . . . . 0.0 112.535 -175.511 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -60.67 -18.48 54.06 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 120.871 0.367 . . . . 0.0 111.941 -174.321 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 28.4 mt -88.71 -2.68 58.72 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 124.929 1.291 . . . . 0.0 114.136 -169.015 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.496 ' HA ' HG13 ' A' ' 100' ' ' VAL . 5.0 tt -46.9 -53.97 11.01 Favored 'General case' 0 C--N 1.344 0.354 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 -169.483 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -86.93 -31.24 18.29 Favored Glycine 0 CA--C 1.522 0.493 0 N-CA-C 111.011 -0.836 . . . . 0.0 111.011 -179.244 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -72.24 -27.75 62.71 Favored 'General case' 0 C--O 1.233 0.199 0 O-C-N 121.735 -0.862 . . . . 0.0 111.217 -170.015 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 28.8 mtp -81.9 -6.81 59.42 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 176.133 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -68.61 145.2 54.15 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 118.997 0.817 . . . . 0.0 111.474 -170.36 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 55.79 21.85 5.06 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 116.741 2.126 . . . . 0.0 116.741 168.577 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 26.2 mmt180 -77.79 148.95 34.52 Favored 'General case' 0 N--CA 1.473 0.681 0 O-C-N 120.593 -1.317 . . . . 0.0 108.867 178.104 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -83.4 -30.64 27.19 Favored 'General case' 0 N--CA 1.47 0.572 0 O-C-N 121.7 -0.625 . . . . 0.0 109.607 179.64 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 4.0 t60 -141.33 129.53 22.22 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 105.523 -2.028 . . . . 0.0 105.523 177.114 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.403 HD21 HD23 ' A' ' 6' ' ' LEU . 0.4 OUTLIER -130.84 127.95 39.64 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-N 118.671 0.669 . . . . 0.0 109.327 171.095 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 29.7 mt -109.69 116.91 53.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 N-CA-C 104.904 -2.258 . . . . 0.0 104.904 174.536 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.452 HD11 HD21 ' A' ' 114' ' ' LEU . 38.8 mt -93.36 127.47 45.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 105.517 -2.031 . . . . 0.0 105.517 177.077 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -110.4 114.97 28.83 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 103.868 -2.641 . . . . 0.0 103.868 169.084 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -150.48 161.46 42.48 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.813 0.845 . . . . 0.0 110.154 -178.427 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -76.02 151.79 37.08 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 169.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 9.7 mm -84.05 -49.49 16.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-O 118.817 -0.611 . . . . 0.0 110.925 -177.844 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . 0.252 2.7 t 52.64 28.6 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.164 0 C-N-CA 125.954 1.702 . . . . 0.0 112.907 177.595 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 16.3 m -132.46 157.62 44.13 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 124.481 1.112 . . . . 0.0 111.934 -171.178 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 19.7 ttmt 57.87 -167.48 0.14 Allowed 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 126.265 1.826 . . . . 0.0 112.447 171.093 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.37 17.98 17.17 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.86 1.264 . . . . 0.0 110.995 -175.177 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -70.84 158.45 36.35 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.529 0.732 . . . . 0.0 109.144 -177.384 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 8.5 m -59.74 138.71 90.07 Favored Pre-proline 0 CA--C 1.545 0.779 0 C-N-CA 124.078 0.951 . . . . 0.0 111.991 -169.604 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_exo -55.2 149.01 46.84 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.998 2.465 . . . . 0.0 111.709 170.109 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 68.95 16.43 70.49 Favored Glycine 0 CA--C 1.533 1.157 0 CA-C-O 119.721 -0.488 . . . . 0.0 113.684 174.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 18.3 m -91.6 141.24 28.92 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 173.371 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 26.3 ttp -96.12 141.14 29.85 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 175.379 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 25.9 ttm -129.5 100.61 5.61 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 -173.389 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 38.4 mm -92.81 119.18 40.03 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 -178.314 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 44.0 mt -125.46 141.29 52.14 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 -173.281 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 88.2 mtt-85 -113.28 142.89 45.29 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 123.113 0.565 . . . . 0.0 110.425 -178.72 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 33.6 t70 38.05 -102.11 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 125.6 1.56 . . . . 0.0 114.228 169.373 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -59.91 -31.06 69.47 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.851 1.26 . . . . 0.0 113.725 -173.469 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -75.56 -19.52 59.24 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 118.388 0.54 . . . . 0.0 111.173 -176.78 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 78.9 t -73.96 -60.84 1.42 Allowed Pre-proline 0 N--CA 1.443 -0.781 0 CA-C-O 117.822 -1.085 . . . . 0.0 111.196 -169.4 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -63.8 -30.98 68.73 Favored 'Trans proline' 0 N--CA 1.447 -1.222 0 CA-C-N 121.315 1.506 . . . . 0.0 110.591 177.548 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.6 -26.45 67.1 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 122.631 0.372 . . . . 0.0 111.074 -178.028 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.423 HD13 ' C ' ' A' ' 85' ' ' LEU . 3.1 tm? -77.98 -54.86 5.81 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 169.044 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -59.05 -24.56 62.97 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 114.033 1.123 . . . . 0.0 114.033 -170.322 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.9 t -67.3 -7.93 28.3 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-N 118.948 0.794 . . . . 0.0 112.546 178.021 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ASN . . . . . 0.559 HD21 ' HB ' ' A' ' 90' ' ' ILE . 10.1 t30 -51.69 126.54 18.0 Favored 'General case' 0 C--N 1.344 0.347 0 O-C-N 121.409 -0.807 . . . . 0.0 109.754 172.075 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 37.0 mtmt -73.12 -23.51 60.5 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 118.718 -0.658 . . . . 0.0 112.45 -174.652 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.559 ' HB ' HD21 ' A' ' 88' ' ' ASN . 70.9 mt -67.23 -44.83 87.36 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 -178.054 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.9 m -62.39 113.37 8.6 Favored Pre-proline 0 CA--C 1.544 0.724 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 170.404 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -77.15 -63.68 0.03 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.623 0 CA-C-N 121.215 1.47 . . . . 0.0 113.041 -169.112 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' HIS . . . . . 0.418 ' CE1' ' HB3' ' A' ' 10' ' ' ASN . 6.4 p-80 -78.62 -25.23 45.06 Favored 'General case' 0 N--CA 1.468 0.445 0 O-C-N 121.127 -0.983 . . . . 0.0 110.754 -178.226 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 22.0 mp0 -59.36 -33.51 71.25 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 119.739 1.154 . . . . 0.0 110.084 171.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -60.63 -41.83 95.65 Favored 'General case' 0 C--O 1.224 -0.248 0 CA-C-N 119.249 0.932 . . . . 0.0 109.14 173.751 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -61.29 -38.01 94.98 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 110.781 -0.927 . . . . 0.0 110.781 174.614 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 10.4 tp -69.23 -33.52 73.42 Favored 'General case' 0 CA--C 1.538 0.483 0 O-C-N 120.676 -1.484 . . . . 0.0 110.624 176.127 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -63.41 -41.3 98.72 Favored 'General case' 0 C--N 1.333 -0.132 0 O-C-N 121.037 -1.039 . . . . 0.0 109.822 171.559 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -71.2 -22.27 62.04 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 118.877 -0.583 . . . . 0.0 111.775 176.15 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.496 HG13 ' HA ' ' A' ' 49' ' ' LEU . 6.3 t -73.54 -44.16 54.02 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 CA-C-N 119.526 1.057 . . . . 0.0 109.839 169.7 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 64.4 mt -58.97 -37.42 76.76 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 119.093 0.86 . . . . 0.0 108.735 174.795 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 35.8 m -68.33 -39.17 82.01 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 118.708 -0.663 . . . . 0.0 110.554 172.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.415 ' HA ' ' CD2' ' A' ' 106' ' ' PHE . . . -63.77 -39.76 95.03 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 119.879 1.218 . . . . 0.0 110.459 179.583 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 18.8 mt -65.88 -38.84 89.85 Favored 'General case' 0 CA--C 1.519 -0.244 0 C-N-CA 123.119 0.567 . . . . 0.0 110.596 174.637 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 80.2 ttt180 -62.17 -37.83 86.76 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 118.552 -0.737 . . . . 0.0 109.985 173.621 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.415 ' CD2' ' HA ' ' A' ' 103' ' ' ALA . 14.1 m-30 -65.73 -42.51 90.94 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 119.346 0.975 . . . . 0.0 110.489 -179.791 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 42.6 p -78.55 -19.77 52.13 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 118.345 0.521 . . . . 0.0 111.624 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 78.56 10.33 86.29 Favored Glycine 0 CA--C 1.532 1.143 0 CA-C-O 119.034 -0.87 . . . . 0.0 111.036 -169.589 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 30.4 mm-40 -88.9 21.68 3.0 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 119.078 1.439 . . . . 0.0 111.931 -179.769 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.428 ' HA ' ' HD3' ' A' ' 111' ' ' PRO . 10.0 t80 -61.8 140.95 95.41 Favored Pre-proline 0 CA--C 1.543 0.684 0 C-N-CA 123.95 0.9 . . . . 0.0 110.509 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 110' ' ' PHE . 52.2 Cg_exo -64.72 148.16 90.08 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 122.493 2.128 . . . . 0.0 111.675 -176.812 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -64.75 -26.08 68.21 Favored 'General case' 0 CA--C 1.537 0.476 0 O-C-N 122.13 -0.357 . . . . 0.0 111.137 -178.631 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -140.45 133.29 29.1 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 169.547 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.452 HD21 HD11 ' A' ' 60' ' ' ILE . 2.8 tm? -124.96 123.22 39.42 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 177.784 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.2 m -131.62 142.6 49.91 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 -172.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -131.58 123.81 28.68 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 119.681 1.128 . . . . 0.0 109.525 -179.545 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 23.4 t -96.4 78.7 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 105.489 -2.041 . . . . 0.0 105.489 174.122 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -77.01 145.09 30.61 Favored Glycine 0 N--CA 1.449 -0.471 0 N-CA-C 109.905 -1.278 . . . . 0.0 109.905 -176.316 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 63.3 t -129.03 137.57 56.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 174.786 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 18.8 mt -88.56 131.65 41.32 Favored Pre-proline 0 CA--C 1.542 0.656 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 175.656 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -70.74 171.49 15.43 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 124.147 3.231 . . . . 0.0 113.534 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -113.08 -60.74 1.84 Allowed 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.033 0.933 . . . . 0.0 110.454 176.654 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 67.8 m -104.56 -52.32 2.92 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 118.791 0.723 . . . . 0.0 112.756 -171.304 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER 58.48 46.98 14.22 Favored 'General case' 0 CA--C 1.548 0.887 0 N-CA-C 114.706 1.372 . . . . 0.0 114.706 170.429 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -115.8 165.03 15.56 Favored Pre-proline 0 N--CA 1.475 0.81 0 CA-C-O 117.923 -1.037 . . . . 0.0 110.407 175.466 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -63.94 87.58 0.15 Allowed 'Trans proline' 0 CA--C 1.547 1.136 0 C-N-CA 123.706 2.937 . . . . 0.0 113.736 -179.592 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -176.76 145.8 0.53 Allowed 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 104.067 -2.568 . . . . 0.0 104.067 174.574 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -108.94 161.72 7.12 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 CA-C-N 119.014 0.825 . . . . 0.0 111.346 -176.463 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 105.21 135.21 8.22 Favored Glycine 0 CA--C 1.528 0.865 0 N-CA-C 105.316 -3.114 . . . . 0.0 105.316 -168.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 5.8 mp -81.43 157.94 24.76 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-N 117.915 0.857 . . . . 0.0 109.332 -175.131 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 63.4 p -64.22 162.7 30.0 Favored Pre-proline 0 CA--C 1.537 0.462 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 168.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -59.15 -28.56 88.12 Favored 'Trans proline' 0 CA--C 1.541 0.853 0 C-N-CA 120.635 0.89 . . . . 0.0 110.628 169.496 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 28.7 m -64.14 -50.09 69.57 Favored 'General case' 0 C--N 1.344 0.368 0 CA-C-O 118.785 -0.626 . . . . 0.0 110.999 178.056 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 5.0 t -96.3 -22.68 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 CA-C-N 119.286 0.948 . . . . 0.0 111.343 -169.454 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -52.59 -45.53 66.53 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 120.241 1.382 . . . . 0.0 108.674 168.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -75.15 8.81 2.36 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 113.978 1.103 . . . . 0.0 113.978 -179.219 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 85.3 mtp -103.48 -6.75 21.5 Favored 'General case' 0 N--CA 1.432 -1.367 0 CA-C-O 117.563 -1.208 . . . . 0.0 110.077 169.798 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 95.1 mt -58.92 -44.55 91.12 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.326 0 CA-C-N 120.342 1.428 . . . . 0.0 107.278 174.31 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 58.1 mt-10 -72.33 -51.87 7.37 Favored Pre-proline 0 CA--C 1.541 0.625 0 CA-C-O 117.595 -1.193 . . . . 0.0 110.786 -177.737 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -41.39 -50.47 4.55 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 124.867 3.711 . . . . 0.0 113.499 168.758 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -71.22 -42.68 68.6 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 113.725 -1.579 . . . . 0.0 110.497 -176.088 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 26.1 mt -56.4 -42.64 78.27 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 118.656 0.662 . . . . 0.0 109.354 173.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -62.18 -33.49 74.63 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 118.944 0.793 . . . . 0.0 110.426 -179.042 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 43.7 mm-40 -79.43 -31.48 42.6 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 119.059 0.845 . . . . 0.0 112.255 176.749 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 71.0 t -60.82 -47.81 91.63 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 169.522 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 29.0 mt -65.75 -35.06 79.64 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.103 0.561 . . . . 0.0 110.319 -179.076 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -62.15 -40.12 94.89 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-O 118.347 -0.835 . . . . 0.0 110.781 178.506 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -60.9 -47.99 83.87 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 119.154 0.888 . . . . 0.0 111.417 -179.112 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 10.4 mp -49.86 -52.47 32.47 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 123.379 0.672 . . . . 0.0 109.808 169.643 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -67.14 -18.37 65.26 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 117.492 -1.242 . . . . 0.0 111.984 -173.649 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -63.03 -29.49 70.86 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 120.788 1.631 . . . . 0.0 110.349 177.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 5.2 m -110.27 25.26 11.98 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.99 1.316 . . . . 0.0 110.808 179.595 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 66.54 18.61 68.06 Favored Glycine 0 CA--C 1.531 1.071 0 CA-C-O 118.295 -1.281 . . . . 0.0 114.047 177.702 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 63.9 t -84.72 137.05 21.52 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 N-CA-C 106.266 -1.753 . . . . 0.0 106.266 173.683 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -121.1 148.75 43.75 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 178.712 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -126.12 135.85 52.19 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 169.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.404 ' CG2' ' HA ' ' A' ' 160' ' ' SER . 33.7 mm -101.63 130.27 24.97 Favored Pre-proline 0 C--O 1.23 0.069 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 -171.463 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -57.73 110.64 0.65 Allowed 'Trans proline' 0 CA--C 1.536 0.599 0 C-N-CA 122.022 1.814 . . . . 0.0 108.533 169.69 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 4.5 tmm_? 49.96 32.28 5.48 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.154 1.381 . . . . 0.0 113.151 173.33 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' SER . . . . . 0.404 ' HA ' ' CG2' ' A' ' 157' ' ' ILE . 27.5 p 42.43 31.4 0.27 Allowed 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.997 1.719 . . . . 0.0 113.951 -171.479 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -85.51 -28.64 24.83 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 113.621 0.971 . . . . 0.0 113.621 -168.835 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 11.6 m . . . . . 0 C--O 1.256 1.419 0 C-N-CA 124.081 0.952 . . . . 0.0 110.549 178.295 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.0 tpt . . . . . 0 N--CA 1.498 1.941 0 N-CA-C 110.446 -0.205 . . . . 0.0 110.446 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 6.1 ptp180 -152.49 120.93 6.36 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-O 118.035 -0.983 . . . . 0.0 108.93 178.504 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 57.2 mt -140.75 135.79 34.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 CA-C-N 119.685 1.13 . . . . 0.0 111.143 -169.803 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -116.94 130.31 56.62 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 105.593 -2.003 . . . . 0.0 105.593 168.244 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 33.2 t -107.36 103.97 16.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 103.258 -2.867 . . . . 0.0 103.258 169.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.2 mt -101.65 110.34 22.31 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 124.003 0.921 . . . . 0.0 109.795 -169.86 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -92.23 116.76 5.13 Favored Glycine 0 N--CA 1.45 -0.409 0 N-CA-C 107.773 -2.131 . . . . 0.0 107.773 172.486 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 12.4 m -133.78 -166.63 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.084 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 -177.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 95.15 131.0 6.3 Favored Glycine 0 N--CA 1.441 -0.976 0 N-CA-C 107.369 -2.293 . . . . 0.0 107.369 -170.82 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 -66.16 108.41 2.26 Favored 'General case' 0 N--CA 1.441 -0.915 0 C-N-CA 124.004 0.922 . . . . 0.0 110.937 -169.114 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.1 pt -73.21 40.29 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 C-N-CA 124.675 1.19 . . . . 0.0 113.193 179.167 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 15.2 mt -125.59 -2.76 7.33 Favored 'General case' 0 CA--C 1.536 0.407 0 O-C-N 121.023 -1.048 . . . . 0.0 108.6 169.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -129.24 65.45 1.46 Allowed 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.589 1.156 . . . . 0.0 108.418 -169.602 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 12.7 m 45.44 -109.6 0.2 Allowed 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 114.325 -1.307 . . . . 0.0 112.445 169.813 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -56.89 -24.59 53.13 Favored 'General case' 0 N--CA 1.443 -0.815 0 C-N-CA 125.617 1.567 . . . . 0.0 112.501 -172.403 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -64.73 -21.92 66.86 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 120.288 1.404 . . . . 0.0 111.443 -177.865 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.99 -9.4 15.57 Favored 'General case' 0 N--CA 1.437 -1.118 0 CA-C-O 116.433 -1.746 . . . . 0.0 111.456 173.709 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 5.6 tp -52.88 -40.44 36.05 Favored 'Isoleucine or valine' 0 C--N 1.343 0.306 0 CA-C-N 122.172 2.26 . . . . 0.0 111.421 -175.321 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -63.17 -45.23 95.79 Favored Glycine 0 C--N 1.336 0.559 0 CA-C-N 119.245 0.93 . . . . 0.0 111.027 178.833 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 96.9 t -62.62 -47.6 92.17 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 175.423 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 18.5 mmt180 -61.13 -33.61 73.66 Favored 'General case' 0 C--N 1.34 0.163 0 CA-C-O 117.092 -1.432 . . . . 0.0 112.5 179.062 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 21.9 mt -62.5 -47.04 94.87 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 CA-C-N 121.431 1.923 . . . . 0.0 109.847 177.46 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 26.7 m -74.97 -34.08 31.46 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-N 119.327 0.967 . . . . 0.0 111.157 -175.447 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 61.0 mt-10 -62.45 -44.14 97.12 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 122.863 0.465 . . . . 0.0 110.33 172.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -67.08 -38.15 85.24 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 119.438 1.017 . . . . 0.0 110.18 177.527 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 5.9 tp -64.73 -38.72 91.95 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 119.369 0.986 . . . . 0.0 109.652 -177.71 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -61.89 -25.56 67.63 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 112.573 0.583 . . . . 0.0 112.573 -179.543 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -94.91 -42.63 8.57 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 126.014 1.726 . . . . 0.0 111.076 -178.111 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 75.2 mtt180 -82.95 -25.96 31.84 Favored 'General case' 0 N--CA 1.456 -0.144 0 CA-C-O 118.343 -0.836 . . . . 0.0 111.799 -176.243 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 69.5 m-85 -127.06 147.97 50.14 Favored 'General case' 0 CA--C 1.521 -0.161 0 CA-C-N 119.628 1.104 . . . . 0.0 113.346 -177.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 37.7 mm -99.51 135.63 34.07 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 N-CA-C 104.384 -2.45 . . . . 0.0 104.384 168.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -118.51 147.38 41.82 Favored Pre-proline 0 CA--C 1.536 0.413 0 C-N-CA 123.795 0.838 . . . . 0.0 109.878 -169.829 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -65.93 157.2 60.47 Favored 'Trans proline' 0 CA--C 1.535 0.545 0 C-N-CA 122.637 2.225 . . . . 0.0 110.007 169.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -58.07 -32.56 68.16 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 114.314 1.227 . . . . 0.0 114.314 -169.459 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 10.6 p90 -77.06 -13.4 59.96 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 118.688 -0.672 . . . . 0.0 112.686 -177.546 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 75.5 t -88.73 125.54 41.89 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 170.05 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -120.77 128.17 52.65 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 169.418 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -88.38 124.33 41.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 105.074 -2.195 . . . . 0.0 105.074 168.664 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 52.2 tp -122.93 133.94 54.37 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 118.234 0.47 . . . . 0.0 110.359 174.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -89.81 123.38 33.74 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 169.683 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -112.92 -24.37 4.92 Favored Glycine 0 CA--C 1.536 1.401 0 CA-C-O 118.235 -1.314 . . . . 0.0 113.466 171.787 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 57.0 -111.7 3.0 Favored Glycine 0 C--N 1.342 0.907 0 CA-C-N 119.802 1.801 . . . . 0.0 111.714 171.282 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 67.4 p -75.62 7.28 3.86 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.545 1.538 . . . . 0.0 113.522 -174.123 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.82 -67.2 0.44 Allowed 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 114.397 1.258 . . . . 0.0 114.397 -169.748 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 60.87 -102.2 0.38 Allowed Glycine 0 CA--C 1.534 1.272 0 N-CA-C 109.125 -1.59 . . . . 0.0 109.125 -169.621 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' MET . . . . . 0.477 ' HA ' HG23 ' A' ' 100' ' ' VAL . 0.0 OUTLIER -65.97 -26.59 67.63 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.939 0.896 . . . . 0.0 112.812 -175.037 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -60.22 -15.68 26.69 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 113.799 1.037 . . . . 0.0 113.799 -170.142 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 7.9 mt -96.39 13.99 25.91 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -169.488 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.525 ' HA ' HG13 ' A' ' 100' ' ' VAL . 4.2 tt -46.75 -60.9 2.1 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 118.539 0.609 . . . . 0.0 111.736 -176.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -64.68 -32.14 83.24 Favored Glycine 0 CA--C 1.531 1.075 0 CA-C-O 119.527 -0.596 . . . . 0.0 112.552 -178.363 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -78.79 -33.21 46.49 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 118.629 1.214 . . . . 0.0 112.515 -174.458 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 39.3 mtp -75.62 -21.44 57.75 Favored 'General case' 0 N--CA 1.449 -0.505 0 O-C-N 121.936 -0.478 . . . . 0.0 110.421 178.591 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.58 153.93 42.38 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-O 121.755 0.788 . . . . 0.0 111.452 -175.831 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 62.87 9.64 3.81 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 126.959 2.103 . . . . 0.0 115.592 169.248 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 25.1 mmt180 -79.38 160.29 26.75 Favored 'General case' 0 N--CA 1.473 0.709 0 O-C-N 121.017 -1.052 . . . . 0.0 108.565 178.286 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -87.33 -53.16 4.98 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 175.521 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . 0.259 0.0 OUTLIER -125.4 146.08 49.76 Favored 'General case' 0 CA--C 1.517 -0.295 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 169.206 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 12.6 tp -138.2 116.69 12.05 Favored 'General case' 0 CA--C 1.513 -0.449 0 N-CA-C 104.067 -2.568 . . . . 0.0 104.067 -176.781 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 10.8 mt -98.08 113.23 32.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 105.562 -2.014 . . . . 0.0 105.562 175.538 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 48.6 mt -91.4 138.48 19.62 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.558 0 N-CA-C 106.561 -1.644 . . . . 0.0 106.561 173.405 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -123.4 121.04 34.74 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 105.397 -2.075 . . . . 0.0 105.397 168.371 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -157.23 161.37 39.23 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.999 1.32 . . . . 0.0 108.979 -173.425 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -95.06 141.18 29.0 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 121.42 0.629 . . . . 0.0 110.666 176.198 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 25.7 mt -89.95 -18.55 7.64 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 C-N-CA 124.434 1.093 . . . . 0.0 110.611 -179.045 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . 0.308 47.2 t 70.54 -48.21 0.19 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.21 0 C-N-CA 128.323 2.649 . . . . 0.0 113.659 174.283 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 11.9 m -147.07 138.72 24.22 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 -176.855 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 12.0 tppt? -164.56 174.85 10.41 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 127.166 2.186 . . . . 0.0 105.961 168.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.56 -26.98 65.68 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 121.799 -0.563 . . . . 0.0 111.505 175.016 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -70.58 165.45 22.75 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.345 0.658 . . . . 0.0 110.761 -175.355 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 3.1 m -60.64 153.13 63.98 Favored Pre-proline 0 CA--C 1.547 0.854 0 C-N-CA 124.709 1.204 . . . . 0.0 112.489 -169.847 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_exo -57.7 158.39 20.3 Favored 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 123.867 3.045 . . . . 0.0 112.422 169.648 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.446 ' HA3' HG22 ' A' ' 133' ' ' THR . . . 65.62 11.21 52.81 Favored Glycine 0 CA--C 1.536 1.38 0 CA-C-O 119.144 -0.809 . . . . 0.0 114.358 172.019 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 5.6 m -90.32 146.51 24.14 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 118.875 1.337 . . . . 0.0 111.484 -169.325 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 26.4 ttp -84.63 139.3 32.16 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 173.659 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 40.6 mtp -128.75 123.62 33.45 Favored 'General case' 0 CA--C 1.519 -0.214 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 176.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 23.3 mm -99.88 116.62 43.56 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 N-CA-C 107.243 -1.391 . . . . 0.0 107.243 177.13 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -107.85 130.02 55.03 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 106.857 -1.534 . . . . 0.0 106.857 174.547 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 21.3 mmt180 -85.66 167.13 15.6 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 122.706 0.402 . . . . 0.0 110.857 176.702 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -32.74 -54.84 0.36 Allowed 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 116.575 2.065 . . . . 0.0 116.575 -174.169 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -88.99 -10.23 48.41 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 113.461 0.911 . . . . 0.0 113.461 -177.228 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -93.28 -33.23 14.02 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 123.189 0.596 . . . . 0.0 110.436 -176.246 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.0 m -53.79 -50.35 84.17 Favored Pre-proline 0 CA--C 1.538 0.484 0 CA-C-O 117.987 -1.006 . . . . 0.0 110.997 175.397 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -64.8 -40.82 20.34 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 121.82 1.68 . . . . 0.0 110.434 -177.102 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.14 -15.35 59.58 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 173.288 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -91.25 -36.79 13.7 Favored 'General case' 0 C--N 1.342 0.273 0 CA-C-N 119.755 1.161 . . . . 0.0 110.953 177.068 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.616 ' HB3' ' HB2' ' A' ' 98' ' ' ALA . 62.7 m-85 -70.73 9.44 0.66 Allowed 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 113.677 0.992 . . . . 0.0 113.677 -177.074 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 57.2 p -61.14 -24.4 66.25 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.224 1.01 . . . . 0.0 109.443 168.793 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 56.0 t-20 -50.34 114.76 1.2 Allowed 'General case' 0 C--N 1.348 0.509 0 C-N-CA 124.578 1.151 . . . . 0.0 110.464 170.253 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 34.7 tttm -97.31 1.04 49.04 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.461 1.104 . . . . 0.0 112.356 -174.257 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 60.0 mt -64.45 -48.26 85.9 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-N 118.724 0.693 . . . . 0.0 109.469 -170.378 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -100.49 135.64 20.14 Favored Pre-proline 0 CA--C 1.543 0.686 0 CA-C-O 118.968 -0.539 . . . . 0.0 110.545 -171.648 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -70.98 -36.23 7.88 Favored 'Trans proline' 0 CA--C 1.534 0.507 0 C-N-CA 122.794 2.329 . . . . 0.0 111.576 -177.425 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 47.9 t-80 -59.51 -50.25 74.63 Favored 'General case' 0 C--N 1.343 0.286 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 175.752 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -58.96 -43.16 91.26 Favored 'General case' 0 C--O 1.224 -0.264 0 CA-C-O 118.437 -0.792 . . . . 0.0 110.224 179.433 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 39.3 tp -66.06 -39.11 89.83 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 119.3 0.955 . . . . 0.0 111.123 -178.218 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -65.17 -44.26 94.24 Favored Glycine 0 CA--C 1.528 0.898 0 N-CA-C 110.615 -0.994 . . . . 0.0 110.615 176.743 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -62.32 -38.79 90.79 Favored 'General case' 0 CA--C 1.537 0.457 0 O-C-N 122.357 -0.496 . . . . 0.0 110.152 175.381 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.616 ' HB2' ' HB3' ' A' ' 86' ' ' PHE . . . -57.72 -46.14 84.8 Favored 'General case' 0 N--CA 1.455 -0.198 0 O-C-N 121.612 -0.68 . . . . 0.0 110.183 175.039 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 17.7 t0 -72.79 -20.88 61.08 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 119.706 -0.187 . . . . 0.0 111.078 -176.286 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.525 HG13 ' HA ' ' A' ' 49' ' ' LEU . 16.8 t -73.17 -44.59 55.64 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.686 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 169.486 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 74.5 mt -62.42 -36.31 81.97 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 119.119 0.872 . . . . 0.0 109.348 178.623 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 39.9 m -64.51 -44.21 91.63 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-O 118.469 -0.776 . . . . 0.0 109.952 172.529 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.448 ' HA ' ' CD2' ' A' ' 106' ' ' PHE . . . -60.48 -40.82 92.69 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 119.896 1.226 . . . . 0.0 111.641 175.311 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.5 mt -64.4 -33.58 76.19 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 123.621 0.768 . . . . 0.0 110.042 176.695 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 56.0 ttt85 -72.79 -32.58 65.68 Favored 'General case' 0 CA--C 1.534 0.335 0 O-C-N 121.553 -0.717 . . . . 0.0 110.071 174.578 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.448 ' CD2' ' HA ' ' A' ' 103' ' ' ALA . 14.3 m-30 -68.98 -47.05 66.52 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 119.058 0.844 . . . . 0.0 110.535 178.489 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 39.7 p -73.98 -25.27 59.84 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 123.4 0.68 . . . . 0.0 111.732 -178.771 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 74.6 8.08 80.54 Favored Glycine 0 CA--C 1.534 1.27 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -168.445 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -83.94 19.38 1.76 Allowed 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 119.84 1.82 . . . . 0.0 111.049 174.535 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -59.98 135.81 90.45 Favored Pre-proline 0 CA--C 1.547 0.833 0 C-N-CA 124.591 1.156 . . . . 0.0 109.33 169.825 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_exo -59.96 163.8 13.27 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 123.553 2.835 . . . . 0.0 115.713 -177.478 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 36.3 mmtt -64.85 -41.91 95.31 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 113.156 0.798 . . . . 0.0 113.156 172.66 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 24.1 ttpp -140.93 68.7 1.34 Allowed 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 -173.548 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.4 tt -68.6 136.84 53.65 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 174.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -131.79 134.49 45.88 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 177.518 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -123.23 117.47 25.38 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 120.469 1.486 . . . . 0.0 108.721 -179.064 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 18.9 t -92.55 91.84 3.55 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 N-CA-C 105.589 -2.004 . . . . 0.0 105.589 172.414 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -81.67 150.49 29.71 Favored Glycine 0 CA--C 1.522 0.522 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 178.521 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 40.4 t -129.04 130.56 68.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 178.378 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 47.6 mt -83.6 131.67 51.68 Favored Pre-proline 0 CA--C 1.534 0.355 0 N-CA-C 103.519 -2.771 . . . . 0.0 103.519 169.411 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -78.77 178.55 7.42 Favored 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 122.589 2.193 . . . . 0.0 111.164 -177.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -97.84 -56.47 2.49 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 124.001 0.92 . . . . 0.0 108.558 168.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 63.0 m -110.27 -59.31 1.96 Allowed 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 113.72 1.007 . . . . 0.0 113.72 -169.504 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.2 tp 53.81 33.11 16.25 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 127.37 2.268 . . . . 0.0 114.08 -173.264 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -82.33 161.32 60.06 Favored Pre-proline 0 CA--C 1.541 0.624 0 O-C-N 121.443 -0.786 . . . . 0.0 109.643 175.311 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -81.44 89.39 1.26 Allowed 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 122.142 1.895 . . . . 0.0 112.593 -169.756 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -174.82 179.55 1.63 Allowed 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 103.42 -2.807 . . . . 0.0 103.42 179.612 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -132.44 162.35 39.93 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 CA-C-N 120.558 1.526 . . . . 0.0 114.952 -176.383 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 110.72 143.5 9.59 Favored Glycine 0 CA--C 1.531 1.092 0 N-CA-C 104.73 -3.348 . . . . 0.0 104.73 -168.406 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 88.6 mt -76.02 156.48 33.97 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 119.308 1.554 . . . . 0.0 109.642 175.141 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 34.9 p -71.67 165.04 53.03 Favored Pre-proline 0 CA--C 1.539 0.526 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 169.665 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -57.76 -39.94 83.21 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 C-N-CA 121.821 1.681 . . . . 0.0 111.427 173.541 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.446 HG22 ' HA3' ' A' ' 72' ' ' GLY . 4.1 m -64.61 -40.02 94.75 Favored 'General case' 0 N--CA 1.442 -0.866 0 C-N-CA 124.117 0.967 . . . . 0.0 110.79 -177.873 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 74.7 t -90.5 -30.99 5.0 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 O-C-N 121.585 -0.697 . . . . 0.0 110.597 -173.424 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -53.96 -46.46 71.62 Favored 'General case' 0 CA--C 1.533 0.302 0 O-C-N 121.182 -0.948 . . . . 0.0 109.341 169.403 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -68.05 -14.86 63.3 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 113.69 0.996 . . . . 0.0 113.69 -178.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 5.3 mmm -82.27 -12.41 58.05 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.776 1.63 . . . . 0.0 111.871 174.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 54.1 mt -54.56 -54.12 25.26 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.357 0 CA-C-N 120.576 1.535 . . . . 0.0 108.897 173.817 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -67.15 -47.75 50.27 Favored Pre-proline 0 CA--C 1.542 0.671 0 CA-C-O 117.556 -1.212 . . . . 0.0 110.827 -173.154 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 0.3 OUTLIER -43.3 -54.29 3.62 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 125.293 3.995 . . . . 0.0 112.819 168.827 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -67.97 -37.2 81.24 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.106 -0.952 . . . . 0.0 112.102 179.401 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 36.1 mt -61.27 -45.35 94.87 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 121.039 1.745 . . . . 0.0 109.108 175.769 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -58.69 -33.78 70.55 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 118.686 0.676 . . . . 0.0 110.206 177.197 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 68.0 tp60 -76.6 -36.69 57.35 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 121.392 -0.818 . . . . 0.0 111.914 178.216 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 46.9 t -60.86 -44.93 98.77 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 171.797 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 71.1 mt -61.59 -36.25 80.15 Favored 'General case' 0 C--O 1.226 -0.176 0 CA-C-O 118.9 -0.571 . . . . 0.0 110.132 176.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -67.21 -44.49 79.43 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 119.241 0.928 . . . . 0.0 111.025 176.009 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -66.77 -27.89 67.96 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 119.161 0.891 . . . . 0.0 111.708 178.685 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 33.2 mt -69.14 -49.89 52.83 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 170.556 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 16.8 mmm-85 -63.8 -21.86 66.63 Favored 'General case' 0 CA--C 1.522 -0.126 0 CA-C-O 118.058 -0.972 . . . . 0.0 112.396 -177.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -63.99 -34.29 77.65 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 119.973 1.261 . . . . 0.0 110.947 174.624 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 26.0 m -91.45 18.29 7.45 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 122.854 0.462 . . . . 0.0 111.573 170.109 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 70.98 16.87 75.07 Favored Glycine 0 C--N 1.337 0.623 0 CA-C-O 117.607 -1.663 . . . . 0.0 112.578 -178.667 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 39.0 t -90.76 118.75 36.64 Favored 'Isoleucine or valine' 0 C--N 1.347 0.459 0 CA-C-N 120.648 2.224 . . . . 0.0 106.627 -176.244 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -111.0 85.68 2.16 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 106.198 -1.779 . . . . 0.0 106.198 177.042 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -49.12 139.49 10.68 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 114.627 -1.169 . . . . 0.0 110.005 169.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 24.9 mt -91.05 125.71 57.76 Favored Pre-proline 0 CA--C 1.53 0.202 0 CA-C-O 117.331 -1.318 . . . . 0.0 108.296 -169.597 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -66.54 98.07 0.39 Allowed 'Trans proline' 0 CA--C 1.534 0.52 0 C-N-CA 122.673 2.249 . . . . 0.0 109.236 175.549 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 60.5 mtm180 49.9 14.88 0.14 Allowed 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 127.218 2.207 . . . . 0.0 115.519 -178.799 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 58.6 m 47.1 40.29 9.51 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.843 0.857 . . . . 0.0 111.538 -169.252 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -114.76 123.92 50.46 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 124.434 1.094 . . . . 0.0 108.646 175.498 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 20.2 m . . . . . 0 C--O 1.254 1.292 0 C-N-CA 125.333 1.453 . . . . 0.0 108.583 -177.255 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.7 tpt . . . . . 0 N--CA 1.498 1.975 0 CA-C-O 119.353 -0.356 . . . . 0.0 110.667 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 7.9 ptp180 -60.77 125.95 25.6 Favored 'General case' 0 N--CA 1.48 1.066 0 O-C-N 120.584 -1.322 . . . . 0.0 111.521 -169.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 27.0 mt -136.41 135.22 49.52 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 C-N-CA 123.171 0.588 . . . . 0.0 110.732 -172.59 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 8.3 mt -112.28 138.58 48.79 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 105.711 -1.959 . . . . 0.0 105.711 167.313 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 49.1 t -116.21 104.38 16.59 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.644 0 N-CA-C 103.387 -2.819 . . . . 0.0 103.387 169.39 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 14.5 tp -101.73 111.28 23.47 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 -168.688 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -88.28 127.29 8.5 Favored Glycine 0 C--N 1.331 0.304 0 N-CA-C 107.706 -2.158 . . . . 0.0 107.706 176.561 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -141.14 165.6 19.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 117.434 0.617 . . . . 0.0 110.958 -170.488 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 119.25 174.54 15.82 Favored Glycine 0 CA--C 1.527 0.827 0 C-N-CA 125.986 1.755 . . . . 0.0 111.259 178.111 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 -82.88 97.6 8.75 Favored 'General case' 0 C--O 1.235 0.338 0 O-C-N 121.409 -1.053 . . . . 0.0 110.41 -175.188 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.2 pt -62.64 35.67 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 N-CA-C 116.476 2.028 . . . . 0.0 116.476 172.806 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 33.8 mt -128.67 -7.16 5.11 Favored 'General case' 0 C--O 1.223 -0.304 0 CA-C-N 120.304 1.411 . . . . 0.0 108.749 169.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.6 mp -111.4 60.19 0.61 Allowed 'General case' 0 N--CA 1.442 -0.836 0 C-N-CA 124.174 0.989 . . . . 0.0 113.407 -168.106 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.436 ' HB ' ' H ' ' A' ' 15' ' ' ASP . 0.2 OUTLIER 52.72 -102.19 0.13 Allowed 'General case' 0 C--O 1.236 0.362 0 C-N-CA 124.168 0.987 . . . . 0.0 111.265 171.393 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.436 ' H ' ' HB ' ' A' ' 14' ' ' THR . 10.3 m-20 -78.81 -11.87 60.01 Favored 'General case' 0 N--CA 1.441 -0.881 0 C-N-CA 123.715 0.806 . . . . 0.0 111.018 -173.603 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -74.35 -8.82 57.57 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 120.444 1.474 . . . . 0.0 112.232 177.291 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -77.34 -10.49 59.47 Favored 'General case' 0 N--CA 1.432 -1.327 0 CA-C-O 116.0 -1.952 . . . . 0.0 108.878 170.346 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.8 tp -54.48 -37.92 39.68 Favored 'Isoleucine or valine' 0 C--N 1.345 0.385 0 CA-C-N 122.212 2.278 . . . . 0.0 112.25 -169.79 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -60.1 -45.0 96.76 Favored Glycine 0 CA--C 1.524 0.602 0 CA-C-N 119.55 1.068 . . . . 0.0 111.599 175.648 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 55.3 t -69.72 -44.41 79.28 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-O 118.528 -0.749 . . . . 0.0 109.911 175.31 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 23.1 mmm180 -61.47 -33.66 74.14 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 120.469 1.486 . . . . 0.0 111.778 179.461 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 30.3 mt -62.25 -46.4 96.52 Favored 'Isoleucine or valine' 0 C--N 1.342 0.256 0 CA-C-N 120.459 1.482 . . . . 0.0 109.464 176.512 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 30.2 m -73.73 -27.15 22.49 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 CA-C-N 119.748 1.158 . . . . 0.0 111.522 -175.186 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 64.1 mt-10 -72.91 -44.06 61.7 Favored 'General case' 0 CA--C 1.528 0.099 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 175.078 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.57 -42.39 96.56 Favored 'General case' 0 N--CA 1.452 -0.356 0 O-C-N 121.978 -0.451 . . . . 0.0 110.586 176.124 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 5.5 tp -65.85 -40.96 92.22 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-O 118.828 -0.606 . . . . 0.0 109.913 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -61.76 -40.34 94.79 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 118.413 0.551 . . . . 0.0 111.081 177.766 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -71.99 -34.71 69.13 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.633 0.773 . . . . 0.0 112.068 178.196 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 36.5 mtp180 -100.17 -34.06 10.19 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 117.204 -1.379 . . . . 0.0 114.054 -169.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -121.34 138.23 54.35 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 121.464 1.938 . . . . 0.0 113.153 -170.134 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 39.9 mm -99.87 141.16 17.49 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 105.542 -2.021 . . . . 0.0 105.542 169.019 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.8 mt -143.49 161.35 47.52 Favored Pre-proline 0 CA--C 1.539 0.549 0 C-N-CA 126.717 2.007 . . . . 0.0 107.407 -174.065 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -55.77 156.76 17.89 Favored 'Trans proline' 0 CA--C 1.536 0.605 0 C-N-CA 123.21 2.606 . . . . 0.0 112.661 177.708 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -62.46 -27.29 69.02 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 -170.069 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 10.9 p90 -76.36 -2.23 30.77 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 179.109 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 22.0 t -104.26 130.27 55.26 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 175.615 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -131.85 135.57 46.8 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 174.707 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.669 HD12 ' H ' ' A' ' 38' ' ' ILE . 0.1 OUTLIER -94.84 106.19 17.86 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 N-CA-C 105.744 -1.947 . . . . 0.0 105.744 171.089 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 53.2 tp -105.74 126.14 51.81 Favored 'General case' 0 C--N 1.343 0.307 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 -174.444 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -80.17 117.92 21.4 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 122.989 0.515 . . . . 0.0 109.754 171.591 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -77.86 -83.54 0.56 Allowed Glycine 0 CA--C 1.528 0.872 0 N-CA-C 107.408 -2.277 . . . . 0.0 107.408 169.249 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 79.84 110.96 0.26 Allowed Glycine 0 C--N 1.343 0.94 0 N-CA-C 111.05 -0.82 . . . . 0.0 111.05 178.329 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.3 p 52.59 61.05 3.39 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.839 1.256 . . . . 0.0 109.085 175.26 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -120.18 -84.78 0.66 Allowed 'General case' 0 C--N 1.344 0.344 0 CA-C-N 114.43 -1.259 . . . . 0.0 111.026 -169.523 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 71.09 -93.25 0.5 Allowed Glycine 0 C--N 1.338 0.668 0 N-CA-C 108.491 -1.843 . . . . 0.0 108.491 -170.834 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 27.7 tpp -78.61 -22.5 46.91 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 124.125 0.97 . . . . 0.0 112.322 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -63.02 -14.23 45.41 Favored 'General case' 0 CA--C 1.547 0.833 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 -169.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 28.8 mt -101.87 13.43 34.83 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.882 0.873 . . . . 0.0 112.843 -174.02 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.598 ' HA ' HG13 ' A' ' 100' ' ' VAL . 4.3 tt -41.6 -61.44 1.08 Allowed 'General case' 0 C--N 1.344 0.338 0 C-N-CA 124.177 0.991 . . . . 0.0 113.152 -175.513 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -75.82 -34.67 47.66 Favored Glycine 0 CA--C 1.524 0.608 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.15 -173.189 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -64.35 -34.08 77.33 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 117.549 0.675 . . . . 0.0 111.353 179.471 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.441 ' SD ' HG11 ' A' ' 100' ' ' VAL . 51.7 mtp -72.7 -13.3 61.31 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 111.911 0.337 . . . . 0.0 111.911 179.442 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -85.32 160.63 19.77 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 123.341 0.656 . . . . 0.0 110.414 -176.56 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 29.2 m120 59.26 19.44 7.56 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.642 1.577 . . . . 0.0 113.845 172.197 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 20.4 mmt180 -94.37 151.54 19.32 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 106.388 -1.708 . . . . 0.0 106.388 169.83 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -89.2 -35.83 15.99 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 -179.387 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 12.6 t-160 -142.14 128.78 20.34 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 105.849 -1.908 . . . . 0.0 105.849 179.645 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 6.5 tp -134.86 128.56 32.9 Favored 'General case' 0 CA--C 1.508 -0.669 0 N-CA-C 108.984 -0.746 . . . . 0.0 108.984 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 44.6 mt -106.98 108.98 26.51 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 N-CA-C 105.199 -2.148 . . . . 0.0 105.199 -179.212 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.6 mm -78.32 128.91 38.12 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 N-CA-C 105.25 -2.13 . . . . 0.0 105.25 175.436 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -112.33 116.66 30.72 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 104.703 -2.332 . . . . 0.0 104.703 169.4 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -155.35 169.6 23.83 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 118.174 0.443 . . . . 0.0 110.19 -177.893 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -88.31 156.99 18.88 Favored 'General case' 0 CA--C 1.534 0.351 0 O-C-N 121.921 -0.487 . . . . 0.0 109.858 169.613 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 87.6 mt -115.05 113.94 45.05 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.104 1 N-CA-C 99.939 -4.097 . . . . 0.0 99.939 168.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 67.1 t -65.36 -37.86 81.13 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 N-CA-C 113.442 0.904 . . . . 0.0 113.442 -168.18 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 15.2 m -151.43 152.42 33.02 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 119.238 0.926 . . . . 0.0 111.483 173.236 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 26.7 tptt -158.68 -177.44 6.53 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.593 1.957 . . . . 0.0 106.512 169.25 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.2 42.13 0.97 Allowed 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.742 0.817 . . . . 0.0 110.472 -178.931 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 33.6 t-20 -143.83 160.88 39.98 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.826 1.25 . . . . 0.0 109.215 -170.098 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.6 m -64.59 146.66 98.18 Favored Pre-proline 0 CA--C 1.548 0.871 0 C-N-CA 124.344 1.058 . . . . 0.0 111.847 -169.773 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -58.6 153.54 48.23 Favored 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 122.713 2.275 . . . . 0.0 111.426 169.496 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 68.33 16.0 68.66 Favored Glycine 0 CA--C 1.532 1.114 0 CA-C-O 118.711 -1.049 . . . . 0.0 114.345 177.166 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 25.9 m -96.36 152.34 18.68 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 119.0 1.4 . . . . 0.0 109.627 179.783 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 18.8 ttp -95.78 145.07 25.62 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 123.614 0.766 . . . . 0.0 110.372 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 10.3 ttm -136.51 121.95 19.45 Favored 'General case' 0 CA--C 1.528 0.127 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 44.6 mm -109.15 122.47 63.86 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 -177.548 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -121.1 131.66 54.4 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 -171.393 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 74.5 mtm180 -100.78 176.14 5.4 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.496 0.718 . . . . 0.0 110.551 -176.837 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -46.74 -47.19 20.68 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 115.99 1.848 . . . . 0.0 115.99 -169.711 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -78.91 -18.23 54.21 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 119.242 0.928 . . . . 0.0 112.248 -178.741 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -90.59 -33.12 16.0 Favored 'General case' 0 N--CA 1.457 -0.119 0 C-N-CA 123.606 0.762 . . . . 0.0 110.754 -169.722 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -70.36 -37.6 7.27 Favored Pre-proline 0 CA--C 1.539 0.525 0 CA-C-O 117.233 -1.365 . . . . 0.0 113.242 -177.036 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_exo -56.26 -25.93 58.75 Favored 'Trans proline' 0 CA--C 1.54 0.781 0 CA-C-N 121.768 1.667 . . . . 0.0 112.21 169.577 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -92.4 7.62 42.13 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 124.492 1.117 . . . . 0.0 112.68 177.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -126.53 -42.39 1.81 Allowed 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.512 0.725 . . . . 0.0 112.509 -172.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.461 ' HB3' ' HB2' ' A' ' 98' ' ' ALA . 74.0 m-85 -61.85 -11.1 11.09 Favored 'General case' 0 CA--C 1.551 1.017 0 CA-C-N 119.47 1.032 . . . . 0.0 111.39 175.447 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 64.3 p -59.54 -27.55 66.3 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.946 1.698 . . . . 0.0 113.857 -177.021 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -63.75 139.83 58.81 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 121.347 0.594 . . . . 0.0 110.78 -170.272 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -76.13 -21.66 56.35 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 122.658 0.383 . . . . 0.0 111.861 -176.66 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 97.3 mt -72.42 -26.72 24.76 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 C-N-CA 124.28 1.032 . . . . 0.0 110.318 -170.174 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 9.9 m -102.85 84.47 0.66 Allowed Pre-proline 0 CA--C 1.55 0.962 0 C-N-CA 126.084 1.753 . . . . 0.0 108.63 174.711 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -70.61 -38.27 6.15 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 123.003 2.469 . . . . 0.0 114.364 -169.231 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 11.1 m80 -68.71 -39.75 80.32 Favored 'General case' 0 N--CA 1.468 0.441 0 O-C-N 121.055 -1.028 . . . . 0.0 108.81 179.707 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 16.9 mp0 -66.09 -36.55 83.48 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 125.169 1.388 . . . . 0.0 109.253 177.229 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 59.0 tp -62.01 -35.27 78.04 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 119.431 1.014 . . . . 0.0 110.969 171.191 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -60.51 -39.27 96.15 Favored Glycine 0 CA--C 1.532 1.116 0 O-C-N 121.392 -0.817 . . . . 0.0 111.069 171.087 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 8.8 tt -75.21 -23.97 57.68 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 117.549 0.675 . . . . 0.0 110.704 175.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.461 ' HB2' ' HB3' ' A' ' 86' ' ' PHE . . . -61.02 -43.72 98.47 Favored 'General case' 0 C--O 1.226 -0.17 0 CA-C-N 119.443 1.02 . . . . 0.0 108.666 169.787 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -69.77 -21.32 63.44 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 119.03 -0.509 . . . . 0.0 110.747 176.572 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.598 HG13 ' HA ' ' A' ' 49' ' ' LEU . 73.1 t -69.77 -40.89 79.65 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 168.786 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 5.3 mp -60.98 -36.64 79.97 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 120.973 1.715 . . . . 0.0 110.492 175.021 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 17.0 m -63.46 -45.26 91.64 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 118.286 0.494 . . . . 0.0 109.873 172.201 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -65.39 -38.77 90.99 Favored 'General case' 0 N--CA 1.452 -0.366 0 O-C-N 121.563 -0.711 . . . . 0.0 111.505 -179.376 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 21.7 mt -59.97 -39.59 86.17 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 125.143 1.377 . . . . 0.0 109.832 173.703 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 52.6 tpt85 -70.64 -33.35 70.89 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 118.037 -0.982 . . . . 0.0 110.484 175.605 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 15.5 m-30 -68.38 -42.11 79.57 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 119.646 1.112 . . . . 0.0 110.402 178.389 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 63.9 p -73.25 -26.78 61.25 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 118.561 0.619 . . . . 0.0 110.515 177.247 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 76.91 6.55 85.76 Favored Glycine 0 CA--C 1.532 1.138 0 CA-C-O 119.182 -0.788 . . . . 0.0 111.599 -169.806 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -96.06 19.73 11.22 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 118.603 1.202 . . . . 0.0 110.809 -175.133 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -55.82 135.37 72.62 Favored Pre-proline 0 CA--C 1.543 0.694 0 C-N-CA 126.624 1.969 . . . . 0.0 109.752 174.803 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_exo -56.04 152.74 35.57 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 123.259 2.639 . . . . 0.0 114.796 179.474 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 8.7 tttt -64.36 -33.27 75.45 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 119.001 -0.523 . . . . 0.0 110.302 177.033 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 63.1 tttm -139.82 97.46 3.26 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 -178.359 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -83.62 132.58 34.89 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 106.495 -1.669 . . . . 0.0 106.495 169.662 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -134.22 148.78 50.92 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 176.779 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.8 tt -135.05 133.87 39.8 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 120.177 1.353 . . . . 0.0 110.504 174.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 60.8 t -103.01 103.43 15.08 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 N-CA-C 103.665 -2.717 . . . . 0.0 103.665 169.095 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -92.85 151.91 20.74 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 111.121 -0.792 . . . . 0.0 111.121 177.321 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 47.1 t -138.95 136.35 42.73 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 N-CA-C 107.705 -1.221 . . . . 0.0 107.705 178.436 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 32.1 mt -88.73 131.64 41.01 Favored Pre-proline 0 CA--C 1.546 0.802 0 CA-C-N 119.812 1.187 . . . . 0.0 108.961 177.353 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -75.16 173.55 14.32 Favored 'Trans proline' 0 CA--C 1.543 0.932 0 C-N-CA 124.978 3.785 . . . . 0.0 113.228 -177.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -116.15 -57.35 2.22 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.836 0.855 . . . . 0.0 110.718 179.386 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 63.4 m -107.07 -51.89 2.85 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 118.54 0.609 . . . . 0.0 112.609 -172.568 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 57.25 46.71 18.18 Favored 'General case' 0 CA--C 1.552 1.044 0 N-CA-C 114.776 1.399 . . . . 0.0 114.776 172.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -116.38 165.22 15.53 Favored Pre-proline 0 N--CA 1.478 0.962 0 O-C-N 121.155 -0.966 . . . . 0.0 109.618 177.428 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -66.09 90.89 0.26 Allowed 'Trans proline' 0 CA--C 1.547 1.125 0 C-N-CA 122.868 2.378 . . . . 0.0 112.931 -179.149 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -176.98 145.24 0.47 Allowed 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 103.91 -2.626 . . . . 0.0 103.91 173.491 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -107.42 165.79 4.3 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 CA-C-N 119.376 0.989 . . . . 0.0 113.319 -169.539 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 85.3 153.81 21.29 Favored Glycine 0 C--N 1.341 0.845 0 N-CA-C 108.11 -1.996 . . . . 0.0 108.11 -169.504 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.418 HD22 ' H ' ' A' ' 130' ' ' LEU . 0.7 OUTLIER -81.74 163.32 22.51 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-O 121.585 0.707 . . . . 0.0 109.108 -172.529 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 39.5 p -69.19 169.32 12.06 Favored Pre-proline 0 C--O 1.238 0.467 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 168.104 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_exo -55.1 -32.2 78.63 Favored 'Trans proline' 0 CA--C 1.541 0.84 0 C-N-CA 121.469 1.446 . . . . 0.0 110.693 169.196 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 26.5 m -67.09 -44.73 79.26 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 118.992 -0.528 . . . . 0.0 111.419 179.551 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 4.6 t -101.06 -11.41 8.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 CA-C-N 119.645 1.111 . . . . 0.0 111.624 -169.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -59.04 -45.69 90.12 Favored 'General case' 0 CA--C 1.518 -0.27 0 O-C-N 119.938 -1.726 . . . . 0.0 107.322 169.016 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -71.24 4.63 2.69 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-O 118.482 -0.771 . . . . 0.0 112.406 178.104 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 26.2 mmm -95.57 -10.54 29.3 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 118.127 -0.94 . . . . 0.0 111.282 170.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 57.0 mt -59.9 -46.99 93.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-N 119.31 0.959 . . . . 0.0 108.554 178.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -72.15 -53.05 6.81 Favored Pre-proline 0 CA--C 1.536 0.422 0 CA-C-O 117.286 -1.34 . . . . 0.0 113.05 -171.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -60.02 -35.26 93.62 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 CA-C-N 122.244 1.837 . . . . 0.0 111.256 176.538 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.28 -43.01 71.31 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 118.84 0.745 . . . . 0.0 110.538 -179.668 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.05 -37.21 86.6 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 119.695 1.134 . . . . 0.0 109.782 176.34 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -62.36 -35.94 80.69 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 119.05 -0.5 . . . . 0.0 110.783 175.578 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 35.1 mm-40 -76.31 -29.5 57.34 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 119.152 0.887 . . . . 0.0 111.627 175.501 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 38.2 t -61.55 -45.42 98.68 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 CA-C-N 120.065 1.302 . . . . 0.0 108.478 169.446 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 72.8 mt -63.75 -39.03 93.28 Favored 'General case' 0 C--N 1.341 0.206 0 CA-C-N 118.05 0.386 . . . . 0.0 110.207 176.748 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -60.4 -41.28 93.53 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 118.906 0.776 . . . . 0.0 111.39 177.062 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -62.35 -47.38 84.46 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 119.233 0.924 . . . . 0.0 111.038 178.557 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . 0.297 4.2 pp -67.78 -22.23 65.21 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 118.576 0.626 . . . . 0.0 112.48 177.426 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 61.8 mtt180 -71.22 -26.31 62.87 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 117.822 -1.085 . . . . 0.0 111.821 169.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -59.85 -38.0 80.84 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 120.625 1.557 . . . . 0.0 109.42 174.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 11.3 p -87.39 14.81 7.36 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.549 1.14 . . . . 0.0 112.946 178.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 75.52 19.76 79.05 Favored Glycine 0 CA--C 1.534 1.268 0 CA-C-O 118.704 -1.054 . . . . 0.0 114.597 175.296 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 15.1 t -102.47 146.32 10.67 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 CA-C-N 118.97 1.385 . . . . 0.0 107.805 178.347 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -134.54 143.78 47.61 Favored 'General case' 0 C--O 1.236 0.392 0 O-C-N 121.096 -1.002 . . . . 0.0 108.929 176.873 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -94.74 160.52 14.57 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 124.991 1.316 . . . . 0.0 111.518 178.321 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.407 ' CG2' ' HA ' ' A' ' 160' ' ' SER . 46.1 mt -124.07 130.76 24.27 Favored Pre-proline 0 CA--C 1.533 0.307 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 171.599 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -57.48 110.2 0.58 Allowed 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.561 2.174 . . . . 0.0 109.03 170.053 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 50.05 21.6 0.77 Allowed 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.628 1.571 . . . . 0.0 114.447 177.188 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' SER . . . . . 0.407 ' HA ' ' CG2' ' A' ' 157' ' ' ILE . 1.1 m 46.11 36.46 3.15 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.424 1.09 . . . . 0.0 112.575 -169.563 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -72.43 143.66 48.41 Favored 'General case' 0 C--O 1.239 0.547 0 O-C-N 121.382 -0.824 . . . . 0.0 109.983 178.251 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 14.1 m . . . . . 0 C--O 1.254 1.309 0 C-N-CA 124.578 1.151 . . . . 0.0 111.014 -174.118 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.1 tpt . . . . . 0 N--CA 1.496 1.861 0 CA-C-O 119.503 -0.284 . . . . 0.0 110.298 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 8.3 ptp180 -139.33 121.97 16.34 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 173.139 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 72.7 mt -138.9 133.21 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 CA-C-N 119.332 0.969 . . . . 0.0 111.169 -169.429 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -115.2 129.74 56.73 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 105.951 -1.87 . . . . 0.0 105.951 168.529 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.424 HG12 HG12 ' A' ' 23' ' ' VAL . 21.8 t -104.43 105.49 18.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 101.905 -3.369 . . . . 0.0 101.905 169.351 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 13.0 tp -109.45 104.26 13.31 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 124.533 1.133 . . . . 0.0 110.033 -167.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -91.26 129.85 10.0 Favored Glycine 0 N--CA 1.452 -0.297 0 N-CA-C 106.603 -2.599 . . . . 0.0 106.603 175.083 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 1.4 m -135.32 -28.34 0.48 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.208 0 N-CA-C 117.819 2.525 . . . . 0.0 117.819 -168.463 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -52.25 151.41 7.65 Favored Glycine 0 CA--C 1.527 0.783 0 CA-C-O 122.22 0.9 . . . . 0.0 114.715 -169.304 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -61.76 102.39 0.26 Allowed 'General case' 0 N--CA 1.455 -0.225 0 C-N-CA 125.334 1.453 . . . . 0.0 112.372 -169.234 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.2 pt -76.76 40.97 0.02 OUTLIER 'Isoleucine or valine' 0 C--O 1.222 -0.38 0 C-N-CA 123.93 0.892 . . . . 0.0 113.311 -177.382 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 19.9 mt -128.11 -7.83 5.4 Favored 'General case' 0 CA--C 1.536 0.429 0 O-C-N 121.177 -0.952 . . . . 0.0 109.018 170.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.3 mp -124.51 67.24 1.08 Allowed 'General case' 0 C--N 1.346 0.417 0 C-N-CA 124.167 0.987 . . . . 0.0 109.235 -168.504 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.468 ' HB ' ' H ' ' A' ' 15' ' ' ASP . 1.4 m 46.91 -103.16 0.08 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 114.378 -1.283 . . . . 0.0 112.891 171.305 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.468 ' H ' ' HB ' ' A' ' 14' ' ' THR . 4.1 m-20 -62.95 -26.33 68.77 Favored 'General case' 0 N--CA 1.438 -1.056 0 C-N-CA 125.998 1.719 . . . . 0.0 111.598 -171.589 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -72.0 -18.79 61.95 Favored 'General case' 0 C--O 1.231 0.101 0 CA-C-N 120.019 1.281 . . . . 0.0 112.003 -174.022 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.86 -15.49 42.73 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-O 117.022 -1.466 . . . . 0.0 111.152 170.832 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.7 tp -54.2 -37.98 37.61 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 CA-C-N 120.831 1.65 . . . . 0.0 111.136 -174.503 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -59.54 -43.99 97.14 Favored Glycine 0 CA--C 1.527 0.834 0 N-CA-C 111.244 -0.743 . . . . 0.0 111.244 178.56 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 74.0 t -70.82 -45.78 71.81 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 176.364 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 20.0 mmt180 -61.43 -31.71 71.66 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 117.093 -1.432 . . . . 0.0 112.21 -178.695 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 19.9 mt -58.89 -49.49 82.87 Favored 'Isoleucine or valine' 0 C--N 1.34 0.157 0 CA-C-N 121.286 1.857 . . . . 0.0 109.299 174.577 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.424 HG12 HG12 ' A' ' 5' ' ' VAL . 30.4 m -73.32 -34.13 42.83 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 CA-C-N 119.762 1.164 . . . . 0.0 111.111 -173.705 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 59.4 mt-10 -64.88 -42.15 95.05 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 118.403 0.547 . . . . 0.0 110.322 173.041 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -68.24 -36.53 79.61 Favored 'General case' 0 C--N 1.34 0.184 0 CA-C-N 118.981 0.809 . . . . 0.0 110.014 179.363 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.3 tp -65.46 -36.16 83.07 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 118.64 0.654 . . . . 0.0 109.887 -177.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -61.57 -24.16 66.47 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.353 0.661 . . . . 0.0 112.72 179.18 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 -98.85 -39.77 8.43 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 126.45 1.9 . . . . 0.0 110.771 -176.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 21.8 mmt85 -85.02 -32.18 23.06 Favored 'General case' 0 C--N 1.338 0.085 0 CA-C-O 119.449 -0.31 . . . . 0.0 110.242 -173.328 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 71.5 m-85 -122.02 151.01 41.29 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-O 122.33 1.062 . . . . 0.0 111.826 -176.066 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 37.0 mt -107.06 134.45 48.7 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 N-CA-C 104.223 -2.51 . . . . 0.0 104.223 169.39 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -120.13 150.03 50.45 Favored Pre-proline 0 C--O 1.236 0.357 0 C-N-CA 124.005 0.922 . . . . 0.0 110.366 -169.114 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_endo -67.52 156.77 64.73 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 121.977 1.785 . . . . 0.0 108.726 168.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -55.75 -33.25 64.12 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 114.491 1.293 . . . . 0.0 114.491 -169.386 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 17.0 p90 -78.75 -13.2 59.94 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 118.474 -0.774 . . . . 0.0 112.743 -175.447 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 95.5 t -89.82 121.71 40.34 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 169.706 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -122.62 125.22 45.2 Favored 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 173.233 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -81.33 126.63 39.85 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 N-CA-C 106.067 -1.827 . . . . 0.0 106.067 167.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 64.4 tp -125.53 132.94 52.51 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 171.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -88.85 116.92 27.48 Favored 'General case' 0 C--O 1.236 0.395 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 169.77 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -76.17 -74.37 0.94 Allowed Glycine 0 CA--C 1.529 0.916 0 N-CA-C 108.335 -1.906 . . . . 0.0 108.335 169.241 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 85.76 98.0 0.75 Allowed Glycine 0 C--N 1.343 0.925 0 N-CA-C 109.729 -1.348 . . . . 0.0 109.729 176.048 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 16.8 p 62.97 16.65 9.42 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.24 1.416 . . . . 0.0 113.378 179.581 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -70.18 -59.96 2.57 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 114.298 1.222 . . . . 0.0 114.298 -168.787 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.4 ' H ' ' HE2' ' A' ' 93' ' ' HIS . . . 60.07 -117.09 10.2 Favored Glycine 0 CA--C 1.529 0.91 0 N-CA-C 108.691 -1.764 . . . . 0.0 108.691 -170.321 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 9.4 tpt -62.22 -21.86 65.48 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.512 1.125 . . . . 0.0 113.68 -173.273 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -60.19 -19.28 53.39 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 -171.087 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 10.0 mt -98.18 20.67 12.03 Favored 'General case' 0 C--N 1.345 0.392 0 CA-C-N 119.522 1.055 . . . . 0.0 113.663 -169.729 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.586 ' HA ' HG13 ' A' ' 100' ' ' VAL . 6.4 tt -50.5 -57.71 7.45 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 118.988 0.813 . . . . 0.0 110.988 -178.359 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -64.98 -30.08 77.08 Favored Glycine 0 CA--C 1.53 0.975 0 CA-C-O 119.296 -0.725 . . . . 0.0 112.584 -177.094 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -79.72 -36.38 37.5 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 118.413 1.107 . . . . 0.0 112.33 -178.552 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.53 ' SD ' HG11 ' A' ' 100' ' ' VAL . 55.4 mtp -76.25 -28.79 57.26 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 179.219 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.46 157.55 31.76 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 121.96 0.886 . . . . 0.0 110.803 175.079 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 62.14 16.49 8.35 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.377 1.471 . . . . 0.0 114.307 169.6 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 24.6 mmt180 -93.89 154.73 17.55 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 172.327 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -83.95 -34.91 24.33 Favored 'General case' 0 C--O 1.217 -0.642 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 169.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 4.5 t-160 -144.41 129.06 18.17 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 105.512 -2.033 . . . . 0.0 105.512 -169.423 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 22.8 tp -134.13 117.87 17.04 Favored 'General case' 0 CA--C 1.499 -1.003 0 N-CA-C 103.434 -2.802 . . . . 0.0 103.434 -173.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 65.7 mt -100.58 107.86 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 N-CA-C 103.907 -2.627 . . . . 0.0 103.907 171.578 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.571 HG22 HD23 ' A' ' 116' ' ' LEU . 63.8 mt -81.2 140.6 16.35 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 N-CA-C 105.885 -1.894 . . . . 0.0 105.885 172.902 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -120.72 113.18 19.83 Favored 'General case' 0 N--CA 1.446 -0.625 0 N-CA-C 103.635 -2.728 . . . . 0.0 103.635 168.606 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.407 ' CG ' HE21 ' A' ' 94' ' ' GLN . 38.6 t0 -155.93 157.64 36.62 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 123.574 0.75 . . . . 0.0 109.587 -176.22 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -83.68 149.92 26.19 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 174.641 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 8.1 mt -76.67 -32.59 20.95 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 C-N-CA 123.731 0.812 . . . . 0.0 110.109 174.655 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . 0.354 3.3 t 58.49 46.92 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.943 0 C-N-CA 126.148 1.779 . . . . 0.0 112.188 -173.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 8.1 m 63.46 145.28 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 128.327 2.651 . . . . 0.0 118.124 168.79 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -139.35 -88.34 0.21 Allowed 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 169.636 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -140.05 31.08 1.99 Allowed 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.56 1.144 . . . . 0.0 111.02 -176.383 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -134.31 165.22 25.64 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.095 0.958 . . . . 0.0 110.69 -174.289 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 2.8 m -64.87 148.5 97.4 Favored Pre-proline 0 CA--C 1.548 0.867 0 C-N-CA 124.439 1.096 . . . . 0.0 113.071 -169.664 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_exo -57.05 154.74 31.75 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 124.607 3.538 . . . . 0.0 112.425 169.626 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 67.04 11.46 58.58 Favored Glycine 0 CA--C 1.532 1.124 0 CA-C-O 119.065 -0.853 . . . . 0.0 113.943 173.468 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 10.6 m -90.22 140.68 29.45 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 119.146 1.473 . . . . 0.0 109.476 -175.638 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 28.8 ttp -86.07 142.95 28.35 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 169.526 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 7.0 ttm -131.53 134.23 45.89 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 169.667 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 4.9 mm -95.75 121.91 46.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 105.573 -2.01 . . . . 0.0 105.573 176.763 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.7 mp -116.37 128.86 55.89 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 173.385 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 22.2 mtp85 -88.53 177.72 6.72 Favored 'General case' 0 CA--C 1.528 0.103 0 O-C-N 123.824 0.703 . . . . 0.0 110.602 178.368 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -42.24 -50.97 4.88 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 115.336 1.606 . . . . 0.0 115.336 -169.73 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -86.27 -14.76 42.78 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -175.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -82.18 -36.64 27.13 Favored 'General case' 0 CA--C 1.523 -0.078 0 O-C-N 121.597 -0.69 . . . . 0.0 110.424 -169.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.476 HG12 ' CZ ' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -65.09 -47.86 71.77 Favored Pre-proline 0 CA--C 1.539 0.534 0 CA-C-O 117.397 -1.287 . . . . 0.0 113.454 -175.27 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -53.35 -44.36 49.65 Favored 'Trans proline' 0 C--N 1.352 0.739 0 C-N-CA 121.935 1.757 . . . . 0.0 110.697 174.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -70.22 -13.23 62.09 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 114.142 1.164 . . . . 0.0 114.142 178.385 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -95.27 -42.64 8.44 Favored 'General case' 0 C--N 1.343 0.323 0 CA-C-N 120.181 1.355 . . . . 0.0 110.558 -177.499 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.501 ' CB ' ' HB2' ' A' ' 98' ' ' ALA . 26.5 m-85 -69.01 0.98 3.84 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 -172.722 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 61.6 p -58.65 -27.85 65.15 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.137 0.975 . . . . 0.0 110.346 169.636 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 56.8 t-20 -51.52 117.19 2.48 Favored 'General case' 0 C--N 1.345 0.406 0 C-N-CA 124.137 0.975 . . . . 0.0 111.311 -179.329 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -77.22 -17.0 58.81 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 118.717 -0.659 . . . . 0.0 112.439 -174.289 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 40.2 mt -61.66 -41.13 89.19 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 178.003 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.5 m -83.18 105.11 4.6 Favored Pre-proline 0 CA--C 1.545 0.777 0 C-N-CA 126.683 1.993 . . . . 0.0 110.523 -169.616 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -71.95 -61.72 0.05 OUTLIER 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 122.186 1.924 . . . . 0.0 113.181 -169.118 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' HIS . . . . . 0.4 ' HE2' ' H ' ' A' ' 45' ' ' GLY . 10.4 t-80 -56.73 -41.66 77.88 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 121.75 0.786 . . . . 0.0 110.46 178.652 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.407 HE21 ' CG ' ' A' ' 62' ' ' ASP . 20.8 mp0 -61.36 -33.13 73.13 Favored 'General case' 0 N--CA 1.433 -1.287 0 CA-C-N 115.08 -0.964 . . . . 0.0 108.939 -175.074 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.426 ' O ' ' HB3' ' A' ' 98' ' ' ALA . 1.5 tt -63.13 -46.3 87.94 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 119.457 1.026 . . . . 0.0 108.804 177.594 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -61.69 -37.32 94.05 Favored Glycine 0 CA--C 1.532 1.14 0 O-C-N 121.089 -1.007 . . . . 0.0 111.014 175.882 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 54.6 tp -67.96 -30.92 70.33 Favored 'General case' 0 CA--C 1.535 0.382 0 O-C-N 121.755 -0.85 . . . . 0.0 110.353 175.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.501 ' HB2' ' CB ' ' A' ' 86' ' ' PHE . . . -60.26 -45.64 92.59 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 172.752 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 34.0 t0 -63.59 -28.97 70.29 Favored 'General case' 0 C--O 1.238 0.497 0 O-C-N 123.633 0.583 . . . . 0.0 110.592 -178.87 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.586 HG13 ' HA ' ' A' ' 49' ' ' LEU . 41.8 t -65.49 -50.2 73.69 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 CA-C-N 118.866 0.757 . . . . 0.0 110.126 169.71 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 33.6 mt -67.26 -31.52 71.92 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 119.202 0.91 . . . . 0.0 110.844 -174.553 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 48.8 m -64.52 -44.34 91.17 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 119.391 0.996 . . . . 0.0 109.838 169.737 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.448 ' HA ' ' CD2' ' A' ' 106' ' ' PHE . . . -62.54 -39.51 93.84 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 119.723 1.147 . . . . 0.0 111.276 177.095 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -63.23 -35.25 79.72 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 123.325 0.65 . . . . 0.0 109.819 175.476 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 73.6 ttt-85 -71.66 -31.42 66.79 Favored 'General case' 0 CA--C 1.535 0.39 0 O-C-N 121.554 -0.716 . . . . 0.0 109.937 176.311 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.448 ' CD2' ' HA ' ' A' ' 103' ' ' ALA . 12.3 m-30 -69.99 -46.47 65.08 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 119.143 0.883 . . . . 0.0 110.702 176.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 35.6 p -74.04 -27.19 60.81 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 122.993 0.517 . . . . 0.0 111.874 -176.789 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 75.11 7.37 81.81 Favored Glycine 0 CA--C 1.533 1.211 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 -168.366 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -84.57 16.27 3.29 Favored 'General case' 0 C--N 1.349 0.557 0 CA-C-N 119.734 1.767 . . . . 0.0 111.302 174.129 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -56.18 137.9 73.94 Favored Pre-proline 0 CA--C 1.542 0.668 0 C-N-CA 125.676 1.59 . . . . 0.0 109.895 170.108 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -62.72 160.24 33.64 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 122.475 2.117 . . . . 0.0 115.695 -176.814 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 23.7 mmtm -61.01 -40.99 95.67 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 169.437 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 23.6 ttpp -142.46 73.18 1.4 Allowed 'General case' 0 C--O 1.236 0.356 0 C-N-CA 123.825 0.85 . . . . 0.0 108.972 -172.414 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 15.2 tp -68.25 137.53 54.82 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 169.471 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.11 142.75 47.62 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 106.098 -1.815 . . . . 0.0 106.098 174.209 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.571 HD23 HG22 ' A' ' 60' ' ' ILE . 0.5 OUTLIER -130.08 121.62 26.75 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 120.503 1.502 . . . . 0.0 109.055 176.03 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.428 ' N ' HD22 ' A' ' 116' ' ' LEU . 13.1 t -85.97 87.86 2.63 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 N-CA-C 106.401 -1.703 . . . . 0.0 106.401 173.865 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -80.96 143.86 24.52 Favored Glycine 0 C--N 1.336 0.56 0 N-CA-C 110.005 -1.238 . . . . 0.0 110.005 -176.746 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 22.0 t -130.91 134.94 61.04 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.15 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 177.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 36.7 mt -93.63 133.22 28.41 Favored Pre-proline 0 CA--C 1.539 0.552 0 CA-C-N 119.595 1.089 . . . . 0.0 108.106 178.742 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -78.39 166.54 24.1 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 122.779 2.32 . . . . 0.0 112.372 -174.388 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -99.77 -50.42 4.04 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.93 0.892 . . . . 0.0 109.644 169.056 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 72.2 m -114.58 -55.16 2.52 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 113.82 1.044 . . . . 0.0 113.82 -169.694 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER 52.96 42.41 32.18 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 126.564 1.946 . . . . 0.0 112.93 -175.584 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -105.03 165.71 12.74 Favored Pre-proline 0 CA--C 1.542 0.653 0 C-N-CA 123.615 0.766 . . . . 0.0 109.917 178.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -80.94 85.72 1.76 Allowed 'Trans proline' 0 CA--C 1.538 0.722 0 C-N-CA 121.948 1.765 . . . . 0.0 112.977 -169.725 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -176.05 148.88 0.85 Allowed 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 103.609 -2.738 . . . . 0.0 103.609 178.466 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -110.84 168.63 4.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 CA-C-N 119.718 1.145 . . . . 0.0 113.973 -169.003 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 95.4 145.85 19.68 Favored Glycine 0 C--N 1.34 0.78 0 N-CA-C 106.022 -2.831 . . . . 0.0 106.022 -168.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.534 HD22 ' H ' ' A' ' 130' ' ' LEU . 1.4 mm? -73.66 163.54 27.86 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 119.339 1.569 . . . . 0.0 110.379 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 43.0 p -73.06 168.39 25.23 Favored Pre-proline 0 CA--C 1.539 0.54 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 168.391 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -57.13 -35.65 98.96 Favored 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 121.532 1.488 . . . . 0.0 111.185 172.504 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 99.0 m -66.93 -33.27 75.22 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 124.401 1.081 . . . . 0.0 111.293 -178.315 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 84.4 t -103.82 -27.55 3.17 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 CA-C-N 118.329 0.513 . . . . 0.0 111.608 -172.7 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -52.78 -49.28 65.87 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 119.346 0.975 . . . . 0.0 109.27 169.681 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -62.02 -19.59 63.02 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 4.0 mmm -80.63 -7.4 59.27 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-O 118.436 -0.792 . . . . 0.0 112.4 -179.121 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 71.4 mt -55.69 -51.99 52.97 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.235 0 CA-C-N 119.147 0.885 . . . . 0.0 109.072 172.768 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -71.36 -43.63 12.57 Favored Pre-proline 0 CA--C 1.535 0.38 0 CA-C-O 116.794 -1.574 . . . . 0.0 113.531 -169.052 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -55.95 -42.82 62.92 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 CA-C-N 121.994 1.748 . . . . 0.0 111.199 169.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.07 -40.09 94.18 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-O 119.004 -0.522 . . . . 0.0 111.959 178.21 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 74.1 mt -60.32 -45.91 91.74 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 119.589 1.086 . . . . 0.0 108.82 174.377 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -57.73 -35.28 70.48 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 118.74 0.7 . . . . 0.0 110.687 175.55 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.62 -44.42 93.98 Favored 'General case' 0 N--CA 1.446 -0.635 0 O-C-N 121.589 -0.695 . . . . 0.0 111.522 173.529 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 63.8 t -57.87 -46.04 87.41 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 N-CA-C 108.245 -1.021 . . . . 0.0 108.245 175.464 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 13.9 mt -57.9 -42.63 85.12 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 119.439 1.018 . . . . 0.0 110.072 178.395 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -68.72 -44.44 73.88 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 118.481 -0.771 . . . . 0.0 111.216 -178.014 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -64.62 -32.5 74.19 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 119.702 1.137 . . . . 0.0 110.811 178.793 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 80.2 mt -64.11 -47.94 78.04 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 170.317 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 70.9 mtp85 -62.92 -20.91 65.64 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 117.943 -1.027 . . . . 0.0 112.598 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 91.5 mt-10 -63.07 -36.39 83.41 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 120.475 1.489 . . . . 0.0 110.423 173.72 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 46.4 m -88.87 13.68 12.12 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.511 0.724 . . . . 0.0 111.668 170.531 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 70.4 21.82 77.53 Favored Glycine 0 CA--C 1.524 0.629 0 CA-C-O 117.877 -1.513 . . . . 0.0 112.434 -177.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 61.4 t -97.05 123.0 49.16 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 CA-C-N 120.089 1.944 . . . . 0.0 105.957 -175.562 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -105.18 97.15 7.04 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 177.597 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -58.95 137.12 58.02 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 168.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.448 HG21 ' HA ' ' A' ' 160' ' ' SER . 35.4 mm -98.67 122.72 52.31 Favored Pre-proline 0 N--CA 1.461 0.095 0 CA-C-O 117.641 -1.171 . . . . 0.0 108.874 -170.515 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -63.27 105.99 0.53 Allowed 'Trans proline' 0 CA--C 1.534 0.484 0 C-N-CA 122.018 1.812 . . . . 0.0 109.024 171.712 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 55.8 mtm180 38.94 50.02 1.66 Allowed 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 126.452 1.901 . . . . 0.0 113.509 178.158 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' SER . . . . . 0.448 ' HA ' HG21 ' A' ' 157' ' ' ILE . 35.1 p 50.4 21.19 0.78 Allowed 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 127.068 2.147 . . . . 0.0 115.633 -179.054 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -77.25 -33.41 56.03 Favored 'General case' 0 CA--C 1.536 0.433 0 O-C-N 120.662 -1.274 . . . . 0.0 112.875 -170.546 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 7.1 m . . . . . 0 C--O 1.254 1.302 0 C-N-CA 123.983 0.913 . . . . 0.0 110.587 -179.361 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.3 ttp . . . . . 0 N--CA 1.497 1.904 0 CA-C-O 119.124 -0.465 . . . . 0.0 110.629 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 29.4 ptt-85 -66.55 131.17 45.44 Favored 'General case' 0 N--CA 1.477 0.89 0 O-C-N 119.772 -1.83 . . . . 0.0 109.96 174.181 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 3.6 mt -130.86 139.24 51.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 C-N-CA 123.412 0.685 . . . . 0.0 110.068 -169.662 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.7 mt -112.44 143.18 44.0 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 104.805 -2.294 . . . . 0.0 104.805 167.064 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 67.1 t -123.45 97.89 5.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 102.276 -3.231 . . . . 0.0 102.276 171.886 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.3 tt -106.53 109.7 21.7 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 -167.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -91.86 138.59 14.32 Favored Glycine 0 N--CA 1.443 -0.865 0 N-CA-C 108.206 -1.958 . . . . 0.0 108.206 176.234 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -148.05 167.26 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.612 0 C-N-CA 123.16 0.584 . . . . 0.0 109.429 -179.548 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 130.95 156.51 8.57 Favored Glycine 0 C--N 1.335 0.496 0 N-CA-C 108.723 -1.751 . . . . 0.0 108.723 170.642 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.545 ' HA ' HG22 ' A' ' 43' ' ' THR . 24.0 t-20 -75.45 103.75 5.72 Favored 'General case' 0 N--CA 1.454 -0.265 0 O-C-N 121.042 -1.27 . . . . 0.0 109.473 -174.629 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 26.1 pt -58.06 -15.59 5.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 N-CA-C 115.032 1.493 . . . . 0.0 115.032 -173.852 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.434 ' HA ' HG23 ' A' ' 128' ' ' ILE . 5.2 mp -89.01 -6.11 57.44 Favored 'General case' 0 C--O 1.216 -0.683 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 -171.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.5 mp -102.45 53.2 0.79 Allowed 'General case' 0 N--CA 1.434 -1.251 0 C-N-CA 124.143 0.977 . . . . 0.0 109.147 -172.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.407 ' HB ' ' H ' ' A' ' 15' ' ' ASP 0.258 0.1 OUTLIER 49.91 -107.37 0.26 Allowed 'General case' 0 N--CA 1.44 -0.952 0 CA-C-N 113.901 -1.5 . . . . 0.0 110.677 174.896 . . . . . . . . 4 4 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.407 ' H ' ' HB ' ' A' ' 14' ' ' THR . 75.3 m-20 -76.51 -6.27 51.12 Favored 'General case' 0 N--CA 1.439 -0.997 0 O-C-N 122.075 -0.391 . . . . 0.0 111.544 -171.023 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -71.94 -4.67 29.71 Favored 'General case' 0 CA--C 1.546 0.809 0 O-C-N 121.131 -0.98 . . . . 0.0 111.874 169.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -80.14 -15.18 57.64 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-O 116.187 -1.863 . . . . 0.0 109.748 169.792 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 7.0 tp -53.92 -42.02 51.72 Favored 'Isoleucine or valine' 0 C--N 1.342 0.252 0 CA-C-N 121.561 1.982 . . . . 0.0 112.655 -169.309 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -63.81 -43.45 97.66 Favored Glycine 0 C--N 1.334 0.435 0 CA-C-N 119.295 0.952 . . . . 0.0 111.716 178.855 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 97.7 t -64.56 -48.95 82.78 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 173.814 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 27.4 mmm180 -63.51 -31.41 72.56 Favored 'General case' 0 N--CA 1.467 0.404 0 O-C-N 120.433 -1.417 . . . . 0.0 112.678 -177.048 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 30.0 mt -60.52 -43.92 95.4 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 CA-C-N 120.446 1.476 . . . . 0.0 109.754 173.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.2 m -76.74 -27.79 17.01 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 CA-C-N 120.179 1.354 . . . . 0.0 111.806 -177.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 60.3 mt-10 -70.19 -41.27 73.95 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 175.726 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -69.03 -40.67 78.49 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-O 119.163 -0.446 . . . . 0.0 110.795 -179.682 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 5.7 tp -65.35 -42.2 93.07 Favored 'General case' 0 C--O 1.224 -0.283 0 CA-C-N 119.118 0.872 . . . . 0.0 110.233 178.313 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -62.6 -40.43 96.88 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 119.003 0.82 . . . . 0.0 110.669 179.211 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -71.15 -38.81 72.19 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 122.601 0.36 . . . . 0.0 111.686 177.568 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 31.4 mtp180 -92.67 -40.41 10.75 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 117.509 -1.234 . . . . 0.0 113.663 -169.688 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -117.18 123.82 47.61 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 121.074 1.761 . . . . 0.0 111.73 -170.61 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 50.0 mm -83.32 141.19 15.2 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 N-CA-C 106.372 -1.714 . . . . 0.0 106.372 169.611 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 17.8 mt -135.8 155.77 77.78 Favored Pre-proline 0 CA--C 1.539 0.523 0 C-N-CA 124.711 1.204 . . . . 0.0 110.153 -169.532 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_exo -57.88 157.72 23.31 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 123.612 2.875 . . . . 0.0 112.727 171.072 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -63.82 -30.21 71.33 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -169.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 11.7 p90 -73.13 -5.27 38.04 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 118.706 -0.664 . . . . 0.0 112.346 178.613 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 12.0 t -101.32 130.06 51.42 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 174.199 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -119.3 132.04 55.83 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 172.719 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.461 HD12 ' H ' ' A' ' 38' ' ' ILE . 0.1 OUTLIER -99.28 123.69 52.12 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 N-CA-C 104.759 -2.311 . . . . 0.0 104.759 169.059 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 5.8 tt -127.56 138.25 52.84 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 119.302 0.955 . . . . 0.0 110.816 -178.122 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -100.58 119.01 37.9 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 169.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -72.4 -24.28 76.56 Favored Glycine 0 CA--C 1.535 1.336 0 CA-C-O 118.683 -1.065 . . . . 0.0 112.752 177.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 66.91 75.54 0.45 Allowed Glycine 0 CA--C 1.529 0.92 0 CA-C-N 118.409 1.105 . . . . 0.0 112.063 173.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.545 HG22 ' HA ' ' A' ' 10' ' ' ASN 0.272 17.7 p 55.05 30.79 14.89 Favored 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 125.359 1.464 . . . . 0.0 112.862 176.26 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -76.91 -68.39 0.61 Allowed 'General case' 0 C--N 1.344 0.367 0 N-CA-C 114.701 1.371 . . . . 0.0 114.701 -169.335 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 74.91 -89.36 0.77 Allowed Glycine 0 CA--C 1.527 0.784 0 N-CA-C 108.463 -1.855 . . . . 0.0 108.463 -168.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 9.9 tpt -76.51 -22.42 54.46 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 125.051 1.34 . . . . 0.0 112.915 -173.532 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -66.19 -7.49 18.43 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 113.372 0.879 . . . . 0.0 113.372 -168.789 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.44 HD12 HD23 ' A' ' 97' ' ' LEU . 14.6 mt -84.12 4.09 31.92 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 121.622 -0.674 . . . . 0.0 112.76 -170.606 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -73.92 80.4 1.66 Allowed 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 125.078 2.371 . . . . 0.0 110.856 -177.605 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 141.54 -35.59 1.79 Allowed Glycine 0 C--N 1.309 -0.931 0 CA-C-N 109.676 -3.42 . . . . 0.0 111.073 169.876 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -69.17 -41.86 76.67 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-N 117.534 0.667 . . . . 0.0 109.87 -175.369 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 2.6 ptt? -88.84 1.88 54.56 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 115.449 -0.796 . . . . 0.0 112.176 -172.052 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -79.09 164.33 24.38 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 123.917 0.887 . . . . 0.0 111.257 -177.093 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 58.01 39.08 26.76 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.773 1.629 . . . . 0.0 113.883 168.85 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 9.5 mmt180 -109.22 153.45 23.79 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.385 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -81.25 -24.87 37.04 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 175.324 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -145.31 143.12 30.0 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 177.68 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 14.1 tp -140.56 126.23 19.14 Favored 'General case' 0 CA--C 1.505 -0.784 0 N-CA-C 106.016 -1.846 . . . . 0.0 106.016 168.47 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 36.1 mt -104.12 103.78 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 N-CA-C 103.753 -2.684 . . . . 0.0 103.753 172.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 12.9 mt -77.43 135.25 26.82 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 N-CA-C 105.053 -2.203 . . . . 0.0 105.053 171.743 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -118.56 120.55 37.83 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 105.604 -1.999 . . . . 0.0 105.604 169.509 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -156.25 167.14 31.36 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 122.875 0.47 . . . . 0.0 110.017 176.471 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -78.14 154.41 31.24 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 169.818 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 13.1 mm -78.8 -48.11 22.33 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.46 0 CA-C-O 118.754 -0.641 . . . . 0.0 110.595 -177.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.1 t 49.17 31.15 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.094 0 C-N-CA 126.7 2.0 . . . . 0.0 113.43 177.257 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 50.8 m -122.14 -25.81 4.83 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 116.291 1.96 . . . . 0.0 116.291 -169.777 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -149.21 156.98 42.97 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 120.564 1.529 . . . . 0.0 110.803 -172.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.18 33.41 0.13 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.906 1.683 . . . . 0.0 113.791 177.12 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 46.5 t30 -65.74 164.59 14.29 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 108.523 -0.918 . . . . 0.0 108.523 170.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 5.5 m -58.33 132.74 84.81 Favored Pre-proline 0 CA--C 1.545 0.77 0 CA-C-O 118.951 -0.547 . . . . 0.0 109.612 -178.473 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -61.42 156.19 47.96 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 122.742 2.294 . . . . 0.0 111.755 175.368 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 67.92 19.17 71.41 Favored Glycine 0 CA--C 1.535 1.324 0 CA-C-O 119.348 -0.696 . . . . 0.0 113.506 176.507 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 5.0 m -95.65 143.49 26.88 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 125.431 1.492 . . . . 0.0 108.505 178.044 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 14.7 ttp -91.64 135.48 33.84 Favored 'General case' 0 C--N 1.339 0.151 0 C-N-CA 123.178 0.591 . . . . 0.0 109.809 178.29 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 74.5 mmm -128.0 93.18 3.61 Favored 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 -169.742 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 44.2 mm -89.54 114.68 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 -177.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.8 mp -117.18 135.26 53.91 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 -177.451 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 40.4 ttm180 -102.92 135.87 43.79 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 123.276 0.63 . . . . 0.0 109.689 -176.008 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 17.4 t70 33.38 -97.91 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 115.734 1.753 . . . . 0.0 115.734 169.217 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -60.74 -26.72 67.41 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.514 1.125 . . . . 0.0 113.592 -174.496 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 -73.79 -25.17 60.0 Favored 'General case' 0 CA--C 1.533 0.311 0 O-C-N 122.023 -0.423 . . . . 0.0 110.483 -177.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.402 HG22 ' HB3' ' A' ' 116' ' ' LEU . 94.7 t -68.11 -62.38 3.25 Favored Pre-proline 0 N--CA 1.443 -0.823 0 CA-C-O 117.835 -1.079 . . . . 0.0 111.155 -168.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -63.69 -33.81 64.93 Favored 'Trans proline' 0 N--CA 1.448 -1.194 0 CA-C-N 121.266 1.488 . . . . 0.0 110.797 178.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.18 -21.22 65.8 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.189 0.596 . . . . 0.0 111.656 -175.63 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.436 HD13 ' C ' ' A' ' 85' ' ' LEU . 2.7 tm? -82.71 -49.56 9.65 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 169.296 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -60.63 -11.51 7.49 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 113.659 0.985 . . . . 0.0 113.659 -172.615 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 19.3 p -55.45 -23.92 28.05 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 119.488 1.04 . . . . 0.0 112.81 170.449 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -59.53 128.23 36.01 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 122.943 0.497 . . . . 0.0 110.47 -174.472 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 66.2 mttt -81.28 -16.01 53.8 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 118.516 -0.754 . . . . 0.0 112.719 -175.761 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 83.6 mt -64.85 -40.44 89.08 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 178.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.5 m -66.43 110.36 4.7 Favored Pre-proline 0 CA--C 1.544 0.743 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 169.48 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_exo -72.82 -47.92 0.32 Allowed 'Trans proline' 0 C--N 1.349 0.585 0 CA-C-N 121.358 1.521 . . . . 0.0 113.155 -169.152 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 21.5 m80 -91.95 -30.16 16.26 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 123.725 0.81 . . . . 0.0 110.072 -169.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 19.9 mp0 -63.68 -28.18 69.72 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 125.926 1.69 . . . . 0.0 110.192 179.521 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 60.7 tp -60.4 -36.35 77.91 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 118.986 0.812 . . . . 0.0 111.092 172.826 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -65.61 -40.96 96.26 Favored Glycine 0 CA--C 1.529 0.954 0 N-CA-C 110.891 -0.884 . . . . 0.0 110.891 173.21 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.44 HD23 HD12 ' A' ' 48' ' ' LEU . 2.3 tm? -66.42 -35.17 79.64 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 118.157 0.979 . . . . 0.0 110.534 176.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -56.57 -44.39 80.95 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 119.827 1.194 . . . . 0.0 109.912 171.331 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -71.08 -23.59 62.15 Favored 'General case' 0 N--CA 1.457 -0.111 0 CA-C-O 118.599 -0.715 . . . . 0.0 112.443 176.737 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 91.2 t -65.45 -46.66 89.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 CA-C-N 120.223 1.374 . . . . 0.0 107.566 169.289 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 65.9 mt -61.68 -38.78 89.05 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 118.73 0.696 . . . . 0.0 110.058 -179.6 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 21.3 m -61.93 -42.58 99.27 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 118.654 0.661 . . . . 0.0 110.749 171.759 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.407 ' HA ' ' CD2' ' A' ' 106' ' ' PHE . . . -64.77 -39.36 93.48 Favored 'General case' 0 N--CA 1.449 -0.516 0 O-C-N 121.442 -0.786 . . . . 0.0 111.442 -179.582 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 17.4 mt -70.03 -31.85 69.69 Favored 'General case' 0 CA--C 1.521 -0.135 0 O-C-N 121.727 -0.608 . . . . 0.0 111.039 176.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 29.0 tpt180 -65.14 -37.09 86.32 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 118.56 -0.733 . . . . 0.0 109.645 171.213 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.407 ' CD2' ' HA ' ' A' ' 103' ' ' ALA . 12.9 m-30 -65.69 -42.64 90.97 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 119.403 1.002 . . . . 0.0 110.759 177.919 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 49.0 p -76.19 -22.01 55.8 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 118.875 0.761 . . . . 0.0 111.781 179.767 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 77.73 11.56 85.32 Favored Glycine 0 CA--C 1.533 1.19 0 CA-C-O 118.815 -0.992 . . . . 0.0 111.172 -169.785 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -97.08 23.95 6.8 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 119.104 1.452 . . . . 0.0 111.39 177.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 12.7 t80 -58.43 136.97 85.6 Favored Pre-proline 0 CA--C 1.546 0.791 0 C-N-CA 125.393 1.477 . . . . 0.0 109.319 172.57 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -56.92 136.72 78.26 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 122.724 2.283 . . . . 0.0 111.866 179.148 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -66.53 -24.34 66.36 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 111.827 0.306 . . . . 0.0 111.827 -173.482 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -135.53 95.34 3.24 Favored 'General case' 0 N--CA 1.464 0.225 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 169.465 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 38.4 tp -81.25 131.87 35.31 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 169.674 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -132.94 146.09 51.48 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 106.571 -1.64 . . . . 0.0 106.571 171.607 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.402 ' HB3' HG22 ' A' ' 82' ' ' VAL . 0.4 OUTLIER -131.81 124.27 29.29 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 120.043 1.292 . . . . 0.0 108.374 175.92 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 44.7 t -92.22 94.8 4.99 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 N-CA-C 105.683 -1.969 . . . . 0.0 105.683 169.8 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -84.99 156.18 30.87 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.201 -1.159 . . . . 0.0 110.201 175.256 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 58.1 t -137.44 143.69 33.53 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 174.555 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 18.1 mm -85.69 129.06 56.25 Favored Pre-proline 0 CA--C 1.541 0.621 0 CA-C-O 118.007 -0.997 . . . . 0.0 108.484 174.801 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -75.01 154.89 42.75 Favored 'Trans proline' 0 CA--C 1.536 0.611 0 C-N-CA 122.848 2.365 . . . . 0.0 112.389 177.114 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -100.36 -42.49 6.6 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 169.195 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 68.6 m -132.65 152.73 51.59 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 123.695 0.798 . . . . 0.0 110.652 175.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.5 tp -148.47 43.64 1.02 Allowed 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.567 0.747 . . . . 0.0 111.178 -172.751 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -121.57 170.4 7.62 Favored Pre-proline 0 N--CA 1.472 0.67 0 CA-C-O 118.105 -0.95 . . . . 0.0 109.352 -175.605 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -66.14 89.44 0.25 Allowed 'Trans proline' 0 CA--C 1.546 1.114 0 C-N-CA 123.199 2.599 . . . . 0.0 114.261 -174.459 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -166.25 128.74 1.93 Allowed 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 105.059 -2.2 . . . . 0.0 105.059 169.718 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.434 HG23 ' HA ' ' A' ' 12' ' ' LEU . 0.0 OUTLIER -79.91 154.06 4.58 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 C-N-CA 123.626 0.77 . . . . 0.0 109.78 -171.852 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 78.21 166.68 29.41 Favored Glycine 0 CA--C 1.527 0.823 0 N-CA-C 111.326 -0.71 . . . . 0.0 111.326 -179.686 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -82.64 165.18 20.24 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-O 121.937 0.875 . . . . 0.0 112.459 -169.345 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 40.7 p -70.48 168.67 17.8 Favored Pre-proline 0 C--O 1.239 0.544 0 CA-C-N 114.123 -1.399 . . . . 0.0 108.813 167.764 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -56.93 -32.97 94.25 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 121.348 1.365 . . . . 0.0 110.831 169.244 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 26.2 m -68.12 -41.38 81.82 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 119.213 -0.423 . . . . 0.0 111.47 -179.006 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 16.7 t -105.3 -10.4 9.89 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-N 118.951 0.796 . . . . 0.0 112.105 -169.235 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -58.95 -45.45 90.42 Favored 'General case' 0 N--CA 1.466 0.346 0 O-C-N 119.929 -1.732 . . . . 0.0 107.768 168.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -70.67 1.47 5.27 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 115.172 -0.922 . . . . 0.0 112.721 176.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 18.0 mmm -92.03 -8.95 44.53 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 119.587 1.085 . . . . 0.0 111.112 172.182 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 86.8 mt -59.64 -48.31 87.88 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 CA-C-N 119.404 1.002 . . . . 0.0 108.446 176.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -70.5 -50.69 13.83 Favored Pre-proline 0 CA--C 1.535 0.393 0 CA-C-O 117.266 -1.35 . . . . 0.0 113.655 -170.023 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -58.31 -32.73 96.68 Favored 'Trans proline' 0 N--CA 1.459 -0.53 0 CA-C-N 122.214 1.827 . . . . 0.0 112.092 173.255 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -69.95 -39.53 75.98 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 119.147 0.885 . . . . 0.0 110.749 176.621 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 71.3 mt -58.04 -44.72 87.55 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 119.897 1.226 . . . . 0.0 109.099 171.717 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -60.38 -37.22 80.08 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 118.87 -0.586 . . . . 0.0 110.918 -179.37 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 36.1 mm-40 -77.97 -33.1 51.65 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 119.758 1.163 . . . . 0.0 112.921 177.147 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 52.0 t -59.22 -48.67 86.11 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-N 120.107 1.322 . . . . 0.0 108.362 169.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 32.6 mt -64.44 -37.35 87.23 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.028 0.531 . . . . 0.0 110.203 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -62.81 -40.68 98.13 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 118.938 0.79 . . . . 0.0 111.313 177.328 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -62.85 -41.57 99.41 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 118.87 0.759 . . . . 0.0 110.689 177.832 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 4.9 mt -63.01 -39.0 93.44 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 123.081 0.553 . . . . 0.0 111.055 174.213 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 72.1 mtp85 -68.34 -14.35 62.93 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 117.081 -1.438 . . . . 0.0 112.27 177.672 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -58.77 -30.63 67.7 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 120.978 1.717 . . . . 0.0 111.402 178.516 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 18.3 m -118.4 34.05 5.36 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.568 0.747 . . . . 0.0 111.005 174.495 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 65.61 27.02 72.2 Favored Glycine 0 C--N 1.342 0.873 0 CA-C-O 118.561 -1.133 . . . . 0.0 114.215 171.043 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 24.4 t -87.59 83.05 2.15 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 176.545 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -76.88 117.88 18.92 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 176.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -81.04 157.67 25.36 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 123.264 0.626 . . . . 0.0 109.728 173.495 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 12.6 mm -109.97 128.08 25.99 Favored Pre-proline 0 CA--C 1.531 0.238 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 179.088 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -59.36 110.48 0.71 Allowed 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.168 1.912 . . . . 0.0 108.469 169.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 43.1 mtm105 53.65 13.0 0.44 Allowed 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.664 1.586 . . . . 0.0 114.272 174.882 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 2.6 m 44.27 45.36 7.14 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.495 1.118 . . . . 0.0 110.636 -168.287 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -136.76 160.15 39.72 Favored 'General case' 0 C--O 1.24 0.561 0 C-N-CA 124.736 1.215 . . . . 0.0 110.218 -174.106 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 18.0 m . . . . . 0 C--O 1.253 1.258 0 C-N-CA 124.275 1.03 . . . . 0.0 110.603 179.76 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.4 tpt . . . . . 0 N--CA 1.498 1.957 0 CA-C-O 120.632 0.253 . . . . 0.0 111.292 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 28.2 ptt-85 -66.15 118.66 10.19 Favored 'General case' 0 N--CA 1.475 0.787 0 O-C-N 120.048 -1.657 . . . . 0.0 112.08 -172.262 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 73.0 mt -133.11 144.61 35.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 C-N-CA 123.553 0.741 . . . . 0.0 109.956 -175.246 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 9.7 mt -123.29 145.88 48.34 Favored 'General case' 0 CA--C 1.521 -0.139 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 168.059 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 57.4 t -126.87 95.69 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.797 0 N-CA-C 105.629 -1.989 . . . . 0.0 105.629 172.192 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.6 mt -87.88 116.71 26.23 Favored 'General case' 0 CA--C 1.517 -0.303 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 -171.357 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -93.82 127.21 8.96 Favored Glycine 0 C--N 1.332 0.312 0 N-CA-C 106.141 -2.784 . . . . 0.0 106.141 169.651 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.2 m -142.71 164.61 16.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 117.92 0.86 . . . . 0.0 111.481 -169.159 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 123.0 173.45 14.08 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 126.014 1.769 . . . . 0.0 111.687 172.346 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -81.83 93.46 6.87 Favored 'General case' 0 N--CA 1.462 0.14 0 O-C-N 121.229 -1.16 . . . . 0.0 110.694 -176.312 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -59.13 5.5 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 N-CA-C 117.262 2.319 . . . . 0.0 117.262 -178.372 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 80.7 mt -108.67 -0.03 20.35 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 121.518 1.963 . . . . 0.0 109.135 -179.019 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.9 mp -110.27 62.77 0.6 Allowed 'General case' 0 N--CA 1.44 -0.948 0 C-N-CA 124.465 1.106 . . . . 0.0 110.122 -169.533 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.418 ' HB ' ' H ' ' A' ' 15' ' ' ASP . 0.2 OUTLIER 53.08 -103.89 0.18 Allowed 'General case' 0 CA--C 1.537 0.446 0 O-C-N 123.766 0.667 . . . . 0.0 111.064 175.166 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.418 ' H ' ' HB ' ' A' ' 14' ' ' THR . 81.9 m-20 -82.71 -8.39 59.6 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 118.513 -0.756 . . . . 0.0 112.462 -175.823 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -71.75 2.72 4.94 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-N 121.327 1.876 . . . . 0.0 113.015 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -85.01 -13.29 51.03 Favored 'General case' 0 N--CA 1.435 -1.189 0 CA-C-O 116.076 -1.916 . . . . 0.0 108.683 169.517 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 7.7 tp -50.88 -42.1 22.86 Favored 'Isoleucine or valine' 0 C--N 1.344 0.339 0 CA-C-N 121.671 2.032 . . . . 0.0 113.134 -169.349 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -61.81 -43.45 99.2 Favored Glycine 0 CA--C 1.527 0.834 0 CA-C-N 119.238 0.926 . . . . 0.0 111.995 177.816 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 55.6 t -65.38 -48.07 84.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-O 118.649 -0.691 . . . . 0.0 109.855 172.041 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 28.7 mmm180 -57.69 -37.39 73.38 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 120.231 1.378 . . . . 0.0 111.719 -178.403 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 27.0 mt -63.48 -45.54 97.59 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 CA-C-N 119.987 1.267 . . . . 0.0 110.195 -179.561 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.9 m -74.29 -27.09 21.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-N 119.985 1.266 . . . . 0.0 111.743 -176.369 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 19.5 mm-40 -70.41 -41.61 72.73 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 173.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.04 -38.37 90.65 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-O 119.025 -0.512 . . . . 0.0 110.045 177.317 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.8 tp -62.11 -42.98 99.77 Favored 'General case' 0 C--N 1.343 0.313 0 CA-C-O 118.131 -0.938 . . . . 0.0 109.727 175.825 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -60.5 -43.74 96.74 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 119.266 0.939 . . . . 0.0 110.678 178.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -66.53 -42.34 87.4 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.017 0.527 . . . . 0.0 110.91 179.541 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 87.1 mtt180 -88.84 -36.63 15.91 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 117.393 -1.289 . . . . 0.0 113.458 -170.207 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 72.3 m-85 -125.77 133.29 52.1 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-N 121.076 1.762 . . . . 0.0 112.607 -169.819 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 45.7 mm -85.66 129.81 37.38 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 N-CA-C 104.213 -2.514 . . . . 0.0 104.213 168.088 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -119.22 157.58 50.7 Favored Pre-proline 0 CA--C 1.537 0.444 0 C-N-CA 124.883 1.273 . . . . 0.0 108.902 -179.107 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_exo -57.97 155.46 33.35 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 123.259 2.639 . . . . 0.0 112.064 172.697 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -62.23 -28.21 69.53 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 112.937 0.717 . . . . 0.0 112.937 -170.567 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 8.3 p90 -73.98 -6.35 46.88 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 113.097 0.777 . . . . 0.0 113.097 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 38.2 t -102.96 133.51 46.56 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 174.797 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -132.45 136.34 46.65 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 169.579 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -88.67 101.55 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.035 0 N-CA-C 105.107 -2.182 . . . . 0.0 105.107 169.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.5 tt -85.57 112.44 20.95 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 106.784 -1.562 . . . . 0.0 106.784 -178.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -77.78 106.42 9.6 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 169.821 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -69.92 -80.62 0.27 Allowed Glycine 0 CA--C 1.528 0.875 0 N-CA-C 108.231 -1.948 . . . . 0.0 108.231 171.742 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 77.21 107.61 0.15 Allowed Glycine 0 C--N 1.341 0.848 0 N-CA-C 110.165 -1.174 . . . . 0.0 110.165 -178.436 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 5.2 p 52.39 57.98 5.87 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.416 1.086 . . . . 0.0 109.333 175.602 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -113.14 -88.31 0.55 Allowed 'General case' 0 C--N 1.345 0.411 0 CA-C-N 114.685 -1.143 . . . . 0.0 110.735 -169.449 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 75.09 -93.1 0.85 Allowed Glycine 0 C--N 1.34 0.778 0 N-CA-C 107.596 -2.202 . . . . 0.0 107.596 -169.596 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.68 -23.27 60.86 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.585 1.154 . . . . 0.0 113.498 -173.838 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -67.66 -7.24 25.14 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -169.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 26.0 mt -93.76 -12.91 28.09 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 115.475 1.657 . . . . 0.0 115.475 -168.151 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 5.1 tt -45.31 -61.03 1.83 Allowed 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 113.941 1.089 . . . . 0.0 113.941 -169.305 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -70.21 -35.42 70.25 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 111.255 -0.738 . . . . 0.0 111.255 -170.091 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -77.54 -29.84 52.49 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 118.068 0.934 . . . . 0.0 110.271 -175.619 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 69.6 mtp -67.34 -16.63 64.36 Favored 'General case' 0 N--CA 1.454 -0.254 0 O-C-N 121.822 -0.549 . . . . 0.0 111.683 175.13 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -63.14 140.97 58.93 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-O 121.926 0.87 . . . . 0.0 112.873 -169.663 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 53.53 20.39 2.07 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 117.261 2.319 . . . . 0.0 117.261 168.729 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 23.5 mmt180 -71.55 150.36 44.84 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 121.003 1.729 . . . . 0.0 108.5 176.267 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -79.96 -29.26 39.6 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 121.677 -0.639 . . . . 0.0 109.37 -178.851 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -147.81 137.25 22.42 Favored 'General case' 0 C--O 1.232 0.161 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 167.372 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.8 tp -126.59 130.73 51.07 Favored 'General case' 0 CA--C 1.515 -0.374 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 175.652 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 50.0 mt -105.66 120.1 55.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 105.803 -1.925 . . . . 0.0 105.803 173.004 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 7.9 mt -95.98 128.94 46.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 105.15 -2.167 . . . . 0.0 105.15 175.632 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -113.19 113.5 25.43 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 105.297 -2.112 . . . . 0.0 105.297 169.767 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.5 t0 -147.78 157.85 43.74 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.422 0.689 . . . . 0.0 110.217 -174.043 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -75.41 158.06 33.25 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 168.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.461 HD11 ' HA3' ' A' ' 118' ' ' GLY . 27.2 mm -95.4 -85.13 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.639 179.493 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . 0.385 0.3 OUTLIER 55.47 11.56 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 126.388 1.875 . . . . 0.0 114.549 -169.471 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.457 ' H ' HG22 ' A' ' 64' ' ' ILE . 5.3 m -74.07 -23.61 59.39 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 124.469 1.108 . . . . 0.0 113.684 -178.373 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 34.1 ttpt -150.23 161.16 42.96 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.149 0.98 . . . . 0.0 108.781 -171.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 14.5 ptpt -65.55 4.49 0.55 Allowed 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 127.347 2.259 . . . . 0.0 115.177 176.676 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 54.1 t30 -62.9 155.22 27.82 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 119.114 0.87 . . . . 0.0 109.539 -177.344 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 4.3 m -56.05 137.67 73.23 Favored Pre-proline 0 CA--C 1.545 0.762 0 C-N-CA 124.34 1.056 . . . . 0.0 113.532 -169.312 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -58.28 155.54 34.6 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 123.668 2.912 . . . . 0.0 111.708 169.389 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 64.88 24.76 70.23 Favored Glycine 0 CA--C 1.533 1.214 0 O-C-N 121.852 -0.53 . . . . 0.0 112.684 176.232 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 20.0 m -102.58 137.11 41.25 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 125.816 1.646 . . . . 0.0 106.706 173.815 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 28.3 ttp -91.8 136.74 32.92 Favored 'General case' 0 C--O 1.232 0.159 0 N-CA-C 107.629 -1.248 . . . . 0.0 107.629 175.079 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 6.4 ttm -124.95 87.01 2.64 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 -169.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 40.4 mm -83.13 117.64 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 57.1 mt -128.55 141.28 51.42 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 123.197 0.599 . . . . 0.0 109.544 -174.703 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.8 mtt85 -113.88 138.67 50.0 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 123.329 0.652 . . . . 0.0 109.873 -172.242 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 38.2 t70 38.91 -106.69 0.05 Allowed 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.833 1.253 . . . . 0.0 113.867 169.478 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -56.8 -29.82 63.1 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.071 1.349 . . . . 0.0 113.923 -175.796 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -71.25 -25.55 62.52 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 122.881 0.472 . . . . 0.0 110.238 -176.111 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.458 HG22 ' HB3' ' A' ' 116' ' ' LEU . 84.7 t -70.8 -61.92 2.22 Favored Pre-proline 0 N--CA 1.443 -0.812 0 CA-C-O 117.548 -1.215 . . . . 0.0 111.368 -168.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -65.55 -35.57 37.74 Favored 'Trans proline' 0 N--CA 1.452 -0.957 0 CA-C-N 121.384 1.53 . . . . 0.0 111.155 -178.683 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.1 -36.22 79.42 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 122.572 0.349 . . . . 0.0 110.634 -173.743 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -71.91 -44.05 64.31 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 118.867 -0.587 . . . . 0.0 109.698 169.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -55.71 -21.37 18.2 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 -174.369 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.447 HG23 ' H ' ' A' ' 88' ' ' ASN . 1.7 t -83.95 -76.34 0.3 Allowed 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 119.315 0.961 . . . . 0.0 109.895 168.664 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ASN . . . . . 0.447 ' H ' HG23 ' A' ' 87' ' ' THR . 46.6 t30 49.45 17.49 0.22 Allowed 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.042 1.337 . . . . 0.0 114.082 -168.794 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt 50.4 23.92 1.4 Allowed 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.433 1.493 . . . . 0.0 113.421 -171.454 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 42.9 mt -134.67 -42.99 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 123.879 0.871 . . . . 0.0 110.96 -171.126 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.3 m -64.2 147.05 97.3 Favored Pre-proline 0 CA--C 1.545 0.765 0 CA-C-N 118.893 0.769 . . . . 0.0 112.52 -169.565 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -79.97 -110.33 0.01 OUTLIER 'Trans proline' 0 CA--C 1.54 0.823 0 C-N-CA 124.218 3.279 . . . . 0.0 109.979 175.088 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 11.7 m80 -59.13 -28.35 66.47 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.773 1.229 . . . . 0.0 112.675 -169.774 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 22.3 mp0 -57.57 -31.63 66.34 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 126.003 1.721 . . . . 0.0 111.208 175.57 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 65.9 tp -62.2 -33.86 75.35 Favored 'General case' 0 C--N 1.342 0.253 0 CA-C-N 119.123 0.874 . . . . 0.0 110.54 175.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -64.14 -39.41 97.11 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.616 -0.993 . . . . 0.0 110.616 175.46 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 19.0 tp -72.88 -33.88 66.34 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 118.332 1.066 . . . . 0.0 110.439 176.022 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -58.09 -46.85 84.81 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 119.752 1.16 . . . . 0.0 109.95 170.354 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -69.49 -29.25 66.86 Favored 'General case' 0 CA--C 1.522 -0.126 0 C-N-CA 122.618 0.367 . . . . 0.0 111.527 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 10.9 t -64.29 -44.19 97.28 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.785 0 CA-C-O 118.882 -0.58 . . . . 0.0 110.098 170.093 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 52.1 mt -63.07 -39.05 93.56 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 119.274 0.943 . . . . 0.0 110.036 178.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 23.8 m -61.05 -39.49 90.01 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 118.753 0.706 . . . . 0.0 110.19 169.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.517 ' HA ' ' CD2' ' A' ' 106' ' ' PHE . . . -67.44 -38.62 84.8 Favored 'General case' 0 N--CA 1.448 -0.545 0 O-C-N 121.308 -0.87 . . . . 0.0 111.793 -179.048 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -59.47 -41.75 90.45 Favored 'General case' 0 CA--C 1.524 -0.03 0 CA-C-N 118.835 0.743 . . . . 0.0 109.331 172.481 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 78.3 ttt180 -65.18 -36.2 83.45 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 118.229 -0.891 . . . . 0.0 110.852 177.755 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.517 ' CD2' ' HA ' ' A' ' 103' ' ' ALA . 15.1 m-30 -61.21 -45.46 94.47 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 119.506 1.048 . . . . 0.0 110.593 178.597 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 14.9 t -82.51 -13.58 56.42 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 122.298 0.239 . . . . 0.0 111.438 -178.5 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 78.08 27.93 57.22 Favored Glycine 0 CA--C 1.531 1.059 0 N-CA-C 111.623 -0.591 . . . . 0.0 111.623 179.564 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -110.98 19.36 18.57 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.628 1.171 . . . . 0.0 110.833 -176.833 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -59.99 137.11 90.83 Favored Pre-proline 0 CA--C 1.544 0.712 0 C-N-CA 123.952 0.901 . . . . 0.0 109.857 -178.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_exo -51.74 144.98 32.55 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 123.069 2.513 . . . . 0.0 112.96 176.392 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -63.77 -30.71 71.78 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 119.252 -0.404 . . . . 0.0 110.47 -178.587 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 30.5 mtmm -136.37 138.3 41.45 Favored 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 105.99 -1.856 . . . . 0.0 105.99 169.57 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 13.9 tp -120.14 134.06 55.35 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 171.007 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -133.41 139.28 46.66 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 177.864 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.458 ' HB3' HG22 ' A' ' 82' ' ' VAL . 6.2 tp -125.68 128.62 48.09 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 177.229 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 46.4 t -100.18 85.35 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 N-CA-C 104.092 -2.558 . . . . 0.0 104.092 169.214 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' GLY . . . . . 0.461 ' HA3' HD11 ' A' ' 64' ' ' ILE . . . -76.86 147.43 33.6 Favored Glycine 0 C--N 1.332 0.327 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 177.02 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 85.2 t -130.58 138.2 54.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 170.489 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 2.8 mt -92.44 125.05 57.49 Favored Pre-proline 0 CA--C 1.537 0.447 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -178.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -72.96 158.1 50.28 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 123.835 3.023 . . . . 0.0 112.424 -176.755 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -99.78 -41.64 7.18 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 171.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 70.5 m -129.78 149.51 51.49 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 123.487 0.715 . . . . 0.0 110.886 178.178 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -155.59 42.79 0.43 Allowed 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 112.951 0.723 . . . . 0.0 112.951 -169.875 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 81.7 mm-40 -111.19 164.2 15.52 Favored Pre-proline 0 N--CA 1.474 0.726 0 CA-C-O 117.607 -1.187 . . . . 0.0 108.737 179.628 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -68.25 87.21 0.4 Allowed 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 122.951 2.434 . . . . 0.0 111.919 -179.331 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -172.7 153.65 2.81 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 104.489 -2.412 . . . . 0.0 104.489 175.47 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -126.34 153.31 34.71 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 CA-C-O 121.956 0.884 . . . . 0.0 112.376 -170.06 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 121.73 127.68 3.4 Favored Glycine 0 CA--C 1.529 0.939 0 N-CA-C 105.497 -3.041 . . . . 0.0 105.497 -169.305 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 7.0 mp -79.63 151.73 30.4 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 117.67 0.735 . . . . 0.0 109.657 -177.844 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 62.0 p -69.76 159.07 85.4 Favored Pre-proline 0 C--O 1.237 0.401 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.565 173.286 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -62.01 -28.9 80.95 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 120.827 1.018 . . . . 0.0 110.014 169.41 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 24.7 m -63.53 -42.31 98.45 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 118.73 -0.652 . . . . 0.0 111.485 177.381 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 46.8 t -105.29 -26.61 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-O 118.072 -0.966 . . . . 0.0 112.896 -169.268 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -52.89 -42.12 65.01 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 120.754 1.615 . . . . 0.0 110.194 169.646 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -74.43 2.75 8.76 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 113.696 0.999 . . . . 0.0 113.696 -176.134 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 97.7 mmm -87.84 -10.3 51.23 Favored 'General case' 0 N--CA 1.439 -0.996 0 CA-C-O 117.435 -1.269 . . . . 0.0 110.152 169.678 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 93.6 mt -60.43 -46.18 95.63 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.406 0 CA-C-N 120.955 1.707 . . . . 0.0 109.022 -178.362 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -71.29 -49.99 11.58 Favored Pre-proline 0 CA--C 1.543 0.71 0 CA-C-N 120.239 1.382 . . . . 0.0 110.959 -179.13 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -41.37 -50.33 4.58 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 125.056 3.837 . . . . 0.0 112.732 168.802 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -73.11 -44.05 60.86 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 114.022 -1.445 . . . . 0.0 110.778 -175.658 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 34.3 mt -56.01 -41.45 74.9 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-N 118.833 0.742 . . . . 0.0 109.536 175.171 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -62.13 -35.91 80.17 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 118.853 0.752 . . . . 0.0 110.456 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 19.2 mm100 -78.7 -32.28 46.89 Favored 'General case' 0 N--CA 1.456 -0.127 0 CA-C-O 118.248 -0.882 . . . . 0.0 112.816 175.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 76.3 t -60.21 -47.56 91.63 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-N 119.976 1.262 . . . . 0.0 108.061 170.167 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 26.6 mt -65.14 -41.02 95.17 Favored 'General case' 0 CA--C 1.528 0.122 0 C-N-CA 122.99 0.516 . . . . 0.0 110.92 -179.377 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -63.19 -43.59 97.77 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 118.527 0.603 . . . . 0.0 111.163 177.311 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -64.7 -44.6 89.74 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 122.656 0.383 . . . . 0.0 110.061 179.379 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 38.9 mt -55.09 -45.2 75.42 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 174.714 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 73.7 mtp180 -64.97 -18.97 65.73 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 117.711 -1.138 . . . . 0.0 112.965 -177.715 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -62.15 -32.48 73.09 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 120.767 1.621 . . . . 0.0 110.957 178.703 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 22.5 m -97.1 28.59 3.5 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.905 0.882 . . . . 0.0 111.458 176.498 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 70.49 16.64 73.91 Favored Glycine 0 CA--C 1.533 1.185 0 CA-C-O 119.093 -0.837 . . . . 0.0 113.969 173.065 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 39.3 t -79.39 126.01 38.88 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 CA-C-N 118.746 1.273 . . . . 0.0 108.276 -177.322 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -96.27 128.69 43.42 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 169.768 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -97.14 147.47 24.03 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 169.683 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 2.7 mt -115.41 120.66 36.01 Favored Pre-proline 0 N--CA 1.462 0.153 0 N-CA-C 106.636 -1.616 . . . . 0.0 106.636 178.655 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -61.66 108.03 0.58 Allowed 'Trans proline' 0 N--CA 1.46 -0.472 0 C-N-CA 121.979 1.786 . . . . 0.0 107.625 172.157 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 14.2 ptp180 47.47 7.31 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 129.26 3.024 . . . . 0.0 117.785 -177.848 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 2.9 t 52.89 -172.41 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 126.114 1.765 . . . . 0.0 112.405 -169.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -146.35 140.89 26.73 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 125.62 1.568 . . . . 0.0 109.032 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 32.3 m . . . . . 0 C--O 1.254 1.297 0 C-N-CA 125.236 1.414 . . . . 0.0 108.555 -176.891 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.7 tpt . . . . . 0 N--CA 1.498 1.942 0 N-CA-C 110.441 -0.207 . . . . 0.0 110.441 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 5.5 ptp85 -149.24 123.14 9.35 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 177.448 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 55.1 mt -141.67 145.01 24.98 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 CA-C-N 119.46 1.027 . . . . 0.0 112.037 -169.058 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.1 mt -128.17 123.42 34.3 Favored 'General case' 0 CA--C 1.519 -0.216 0 N-CA-C 106.489 -1.671 . . . . 0.0 106.489 167.577 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 43.6 t -101.85 98.71 7.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 100.69 -3.819 . . . . 0.0 100.69 169.153 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -104.24 109.24 20.98 Favored 'General case' 0 N--CA 1.442 -0.864 0 C-N-CA 123.873 0.869 . . . . 0.0 109.35 -168.152 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -91.42 126.3 8.39 Favored Glycine 0 N--CA 1.444 -0.831 0 N-CA-C 107.743 -2.143 . . . . 0.0 107.743 174.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -142.38 179.73 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.812 0 C-N-CA 124.133 0.973 . . . . 0.0 108.517 -175.011 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 124.5 157.04 9.61 Favored Glycine 0 N--CA 1.447 -0.589 0 N-CA-C 108.471 -1.852 . . . . 0.0 108.471 -169.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -73.6 96.96 2.54 Favored 'General case' 0 N--CA 1.442 -0.85 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 169.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 4.2 pt -56.7 -30.62 32.82 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.241 0 O-C-N 121.438 -0.789 . . . . 0.0 112.068 -179.664 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 22.2 mt -77.55 13.93 1.14 Allowed 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 119.036 0.834 . . . . 0.0 110.902 -172.15 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -136.41 82.07 1.92 Allowed 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 123.284 0.634 . . . . 0.0 111.494 171.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.427 HG23 ' O ' ' A' ' 129' ' ' GLY . 25.6 m 35.41 -105.94 0.03 OUTLIER 'General case' 0 N--CA 1.437 -1.121 0 O-C-N 126.46 2.35 . . . . 0.0 111.772 167.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -59.46 -28.02 66.61 Favored 'General case' 0 N--CA 1.442 -0.842 0 C-N-CA 124.201 1.0 . . . . 0.0 111.961 -169.683 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -67.09 -18.05 65.15 Favored 'General case' 0 C--N 1.341 0.212 0 CA-C-N 120.423 1.465 . . . . 0.0 111.786 179.088 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.58 -10.56 56.66 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-O 116.33 -1.795 . . . . 0.0 110.888 173.739 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 6.6 tp -55.6 -39.94 57.07 Favored 'Isoleucine or valine' 0 C--N 1.342 0.243 0 CA-C-N 121.976 2.171 . . . . 0.0 111.814 -174.483 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -59.17 -43.52 97.07 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 111.4 -0.68 . . . . 0.0 111.4 178.719 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 74.0 t -68.76 -48.32 71.74 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 CA-C-O 118.134 -0.936 . . . . 0.0 109.874 174.622 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 20.9 mmt180 -60.14 -31.56 70.21 Favored 'General case' 0 C--N 1.346 0.431 0 CA-C-N 120.498 1.499 . . . . 0.0 111.787 -177.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 23.2 mt -60.68 -51.35 74.11 Favored 'Isoleucine or valine' 0 C--N 1.343 0.285 0 CA-C-N 120.86 1.663 . . . . 0.0 109.789 174.604 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 24.6 m -72.38 -33.97 47.38 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 CA-C-N 119.461 1.028 . . . . 0.0 111.221 -174.408 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 58.1 mt-10 -59.88 -48.29 82.3 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 171.511 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.56 -36.8 84.83 Favored 'General case' 0 C--N 1.342 0.263 0 CA-C-N 119.151 0.887 . . . . 0.0 111.08 179.79 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 5.9 tp -63.19 -40.04 96.36 Favored 'General case' 0 C--O 1.224 -0.253 0 CA-C-N 118.471 0.578 . . . . 0.0 109.566 -178.231 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -60.52 -26.5 66.9 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.595 0.758 . . . . 0.0 112.771 179.377 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -90.67 -44.35 9.56 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 125.495 1.518 . . . . 0.0 110.886 -178.603 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 75.4 mtt180 -84.45 -26.61 28.1 Favored 'General case' 0 C--O 1.231 0.086 0 CA-C-O 118.792 -0.623 . . . . 0.0 111.529 -172.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 64.4 m-85 -125.97 146.21 49.96 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-O 121.694 0.759 . . . . 0.0 112.364 -177.318 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 34.0 mm -101.7 135.66 37.3 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 N-CA-C 104.909 -2.256 . . . . 0.0 104.909 169.028 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -119.0 150.93 49.66 Favored Pre-proline 0 CA--C 1.535 0.371 0 C-N-CA 124.287 1.035 . . . . 0.0 109.988 -169.492 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -65.76 157.16 60.31 Favored 'Trans proline' 0 CA--C 1.539 0.748 0 C-N-CA 122.43 2.087 . . . . 0.0 110.189 169.795 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -58.08 -33.2 68.81 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 114.557 1.317 . . . . 0.0 114.557 -169.545 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -74.72 -11.45 60.17 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -177.437 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 73.1 t -90.02 123.01 42.01 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 171.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -112.36 127.01 55.89 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 169.234 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -91.77 116.07 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 N-CA-C 104.422 -2.436 . . . . 0.0 104.422 168.294 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 59.6 tp -117.57 128.25 54.76 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 118.207 0.458 . . . . 0.0 110.675 -178.431 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -87.73 117.25 26.43 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 168.5 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -71.59 -65.31 2.45 Favored Glycine 0 CA--C 1.528 0.871 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 176.292 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 84.33 84.61 0.94 Allowed Glycine 0 C--N 1.343 0.937 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 177.137 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 27.6 p 61.38 20.11 10.82 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 125.118 1.367 . . . . 0.0 113.471 -179.449 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -76.73 -65.78 0.9 Allowed 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 114.875 1.435 . . . . 0.0 114.875 -168.458 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 56.78 -108.61 1.28 Allowed Glycine 0 CA--C 1.536 1.349 0 N-CA-C 111.416 -0.674 . . . . 0.0 111.416 -176.167 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 13.2 tpt -59.67 -23.58 63.2 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.968 1.307 . . . . 0.0 112.43 -178.239 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 21.3 mm-40 -60.33 -18.79 52.29 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 113.539 0.941 . . . . 0.0 113.539 -178.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 13.3 mt -99.52 22.25 11.05 Favored 'General case' 0 C--N 1.344 0.35 0 N-CA-C 114.728 1.381 . . . . 0.0 114.728 -168.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 6.7 tt -52.19 -58.17 7.43 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 118.856 0.753 . . . . 0.0 111.15 -178.465 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -68.76 -33.24 75.28 Favored Glycine 0 CA--C 1.529 0.959 0 N-CA-C 111.338 -0.705 . . . . 0.0 111.338 -178.252 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -74.73 -38.53 62.26 Favored 'General case' 0 CA--C 1.533 0.299 0 O-C-N 122.081 -0.658 . . . . 0.0 112.058 -173.113 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 12.9 mtp -76.65 -17.76 58.96 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.568 0.747 . . . . 0.0 111.553 -179.037 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.64 151.97 45.27 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 123.533 0.733 . . . . 0.0 112.433 -169.512 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 16.7 p30 50.23 13.93 0.13 Allowed 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 128.379 2.671 . . . . 0.0 117.507 169.032 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 35.8 mmt-85 -70.31 157.24 38.09 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 119.499 1.045 . . . . 0.0 108.474 171.306 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.01 -46.34 18.37 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 178.754 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -128.26 149.27 50.55 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-N 120.116 1.325 . . . . 0.0 108.66 169.125 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 16.1 tp -135.46 112.38 10.24 Favored 'General case' 0 CA--C 1.506 -0.719 0 N-CA-C 103.723 -2.695 . . . . 0.0 103.723 177.245 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 46.6 mt -91.94 110.1 22.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 104.811 -2.292 . . . . 0.0 104.811 172.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.5 HD13 HD11 ' A' ' 97' ' ' LEU . 7.3 mt -81.79 135.22 25.43 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 N-CA-C 107.0 -1.482 . . . . 0.0 107.0 170.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -122.66 118.24 27.67 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 102.733 -3.062 . . . . 0.0 102.733 167.417 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 51.5 t0 -158.51 155.75 29.0 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 125.149 1.38 . . . . 0.0 107.399 -179.156 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -88.45 143.09 27.2 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 169.694 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 65.2 mt -80.41 -19.66 11.91 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 C-N-CA 125.016 1.326 . . . . 0.0 110.307 -177.76 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . 0.317 31.3 t 71.29 -38.38 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 C-N-CA 129.818 3.247 . . . . 0.0 114.543 177.713 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 2.7 p -162.42 147.96 12.63 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 120.021 1.282 . . . . 0.0 112.568 169.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 13.8 tppt? -165.51 174.32 10.06 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 128.252 2.621 . . . . 0.0 104.872 169.325 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 13.2 ptpt -61.24 -26.18 67.58 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 176.226 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 36.0 t-20 -74.99 165.73 24.79 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.475 0.71 . . . . 0.0 110.522 -173.313 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 2.4 m -61.27 151.23 77.02 Favored Pre-proline 0 CA--C 1.548 0.876 0 C-N-CA 124.588 1.155 . . . . 0.0 112.704 -169.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -56.94 158.13 18.14 Favored 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 124.21 3.273 . . . . 0.0 113.556 170.314 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 65.83 7.7 37.24 Favored Glycine 0 CA--C 1.538 1.485 0 CA-C-O 119.59 -0.561 . . . . 0.0 114.272 170.492 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 5.0 m -87.31 149.92 24.21 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 125.769 1.627 . . . . 0.0 111.513 -169.181 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 31.0 ttp -93.63 140.93 29.05 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 169.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 56.5 mtm -134.88 125.38 26.64 Favored 'General case' 0 C--O 1.232 0.165 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 169.798 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 37.6 mm -107.44 123.12 62.51 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 -176.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.9 mp -128.74 143.33 50.9 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.875 -171.53 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 79.4 mtm180 -91.65 175.82 6.76 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 114.867 -1.06 . . . . 0.0 110.431 -175.866 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -41.07 -53.61 3.0 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 115.861 1.8 . . . . 0.0 115.861 -169.527 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -87.78 -14.83 38.6 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 113.199 0.815 . . . . 0.0 113.199 -175.68 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -78.98 -35.4 43.08 Favored 'General case' 0 N--CA 1.456 -0.128 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 -174.538 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 94.5 t -60.79 -49.34 89.92 Favored Pre-proline 0 CA--C 1.541 0.618 0 CA-C-O 117.397 -1.287 . . . . 0.0 112.267 -176.081 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_exo -55.41 -39.91 88.46 Favored 'Trans proline' 0 CA--C 1.543 0.943 0 C-N-CA 122.091 1.861 . . . . 0.0 112.146 174.353 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -76.05 -5.37 46.14 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 177.021 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -87.65 -41.4 13.41 Favored 'General case' 0 C--N 1.341 0.213 0 CA-C-N 119.751 1.159 . . . . 0.0 111.34 -178.739 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -80.22 22.98 0.5 Allowed 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -169.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 24.5 p -58.65 -26.25 63.57 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.237 1.015 . . . . 0.0 111.964 175.814 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 36.3 t30 -68.32 115.84 8.21 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.142 0.577 . . . . 0.0 109.652 176.062 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 39.3 mttp -88.81 -6.23 57.51 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 113.051 0.76 . . . . 0.0 113.051 -177.85 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 97.4 mt -58.45 -48.01 86.5 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 177.133 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 3.9 m -67.21 107.61 1.86 Allowed Pre-proline 0 CA--C 1.542 0.669 0 C-N-CA 127.181 2.192 . . . . 0.0 109.397 -173.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -72.47 -56.65 0.09 OUTLIER 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 122.392 2.061 . . . . 0.0 113.015 -168.567 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 7.2 t-80 -59.88 -43.85 94.53 Favored 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.409 ' H ' ' CD ' ' A' ' 94' ' ' GLN . 16.9 mp0 -61.29 -39.61 91.09 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 125.587 1.555 . . . . 0.0 108.934 -174.255 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 55.2 tp -64.49 -37.49 87.71 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 118.93 0.786 . . . . 0.0 110.704 175.594 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -65.38 -46.68 85.13 Favored Glycine 0 CA--C 1.529 0.916 0 N-CA-C 110.986 -0.846 . . . . 0.0 110.986 174.499 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.5 HD11 HD13 ' A' ' 60' ' ' ILE . 2.9 tm? -58.14 -38.6 76.88 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 117.711 0.755 . . . . 0.0 110.115 173.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -66.06 -45.41 81.43 Favored 'General case' 0 C--N 1.333 -0.142 0 O-C-N 120.838 -1.164 . . . . 0.0 111.254 177.165 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -69.51 -24.75 63.8 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 118.512 0.596 . . . . 0.0 110.574 -179.477 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -73.91 -37.88 48.8 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.863 0 O-C-N 121.873 -0.517 . . . . 0.0 110.92 172.0 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 29.6 mt -66.1 -36.32 82.86 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 173.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 46.3 m -65.21 -36.38 83.99 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-O 118.344 -0.836 . . . . 0.0 110.319 171.649 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.97 -41.53 97.51 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 120.476 1.489 . . . . 0.0 110.686 174.252 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 11.8 mt -64.24 -32.18 73.66 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 118.79 0.723 . . . . 0.0 111.499 173.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 67.1 ttp85 -71.62 -30.74 66.12 Favored 'General case' 0 CA--C 1.532 0.284 0 O-C-N 121.581 -0.699 . . . . 0.0 109.613 176.568 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 14.8 m-30 -72.09 -46.32 57.22 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 118.877 0.762 . . . . 0.0 110.368 176.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 35.2 p -73.35 -24.14 60.31 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 118.338 0.517 . . . . 0.0 112.009 -177.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 75.93 8.03 84.46 Favored Glycine 0 CA--C 1.534 1.268 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -168.391 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -84.84 23.25 1.21 Allowed 'General case' 0 C--N 1.349 0.558 0 CA-C-N 119.812 1.806 . . . . 0.0 111.28 171.799 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -62.18 138.56 96.05 Favored Pre-proline 0 CA--C 1.547 0.844 0 C-N-CA 124.328 1.051 . . . . 0.0 108.933 169.826 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -61.42 161.53 23.55 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 123.13 2.553 . . . . 0.0 114.683 -176.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -66.21 -35.87 81.57 Favored 'General case' 0 N--CA 1.471 0.58 0 O-C-N 121.803 -0.561 . . . . 0.0 111.664 174.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 17.9 ttmm -138.53 77.59 1.63 Allowed 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 -176.848 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -69.79 129.18 38.87 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 106.471 -1.678 . . . . 0.0 106.471 170.132 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -130.41 138.89 50.57 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 175.521 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 17.4 tp -119.78 130.09 54.78 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 119.556 1.071 . . . . 0.0 109.115 176.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 13.3 t -102.59 74.88 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 105.44 -2.059 . . . . 0.0 105.44 169.835 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -78.55 144.74 28.31 Favored Glycine 0 C--N 1.336 0.539 0 N-CA-C 110.547 -1.021 . . . . 0.0 110.547 -174.369 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 61.5 t -124.57 134.77 65.88 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.275 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 -178.464 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 40.1 mt -91.01 135.37 28.68 Favored Pre-proline 0 C--N 1.326 -0.449 0 N-CA-C 104.976 -2.231 . . . . 0.0 104.976 169.387 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -73.28 170.26 20.3 Favored 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 122.008 1.805 . . . . 0.0 111.202 -177.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -89.71 -48.87 6.98 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 168.765 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 25.1 m -137.31 -34.23 0.72 Allowed 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 116.205 1.928 . . . . 0.0 116.205 -170.002 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 4.3 tp 50.76 50.1 19.65 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.362 1.465 . . . . 0.0 110.495 -168.564 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -58.84 151.25 55.14 Favored Pre-proline 0 CA--C 1.54 0.577 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 173.152 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -76.37 76.39 3.94 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 122.427 2.085 . . . . 0.0 108.055 169.833 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.607 ' CD2' ' H ' ' A' ' 128' ' ' ILE . 7.4 t60 -151.47 -167.79 2.9 Favored 'General case' 0 CA--C 1.552 1.028 0 N-CA-C 104.113 -2.551 . . . . 0.0 104.113 175.139 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.607 ' H ' ' CD2' ' A' ' 127' ' ' HIS . 17.5 mt -125.45 -50.2 1.88 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 CA-C-N 123.688 2.949 . . . . 0.0 110.646 -171.145 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.427 ' O ' HG23 ' A' ' 14' ' ' THR . . . -55.73 148.63 26.69 Favored Glycine 0 CA--C 1.53 0.993 0 N-CA-C 111.223 -0.751 . . . . 0.0 111.223 170.817 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 76.3 mt -70.2 162.64 28.01 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.11 0.964 . . . . 0.0 112.906 -175.611 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 18.3 p -74.11 164.35 61.83 Favored Pre-proline 0 CA--C 1.543 0.68 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 168.584 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -62.29 -35.42 73.77 Favored 'Trans proline' 0 CA--C 1.536 0.625 0 C-N-CA 121.259 1.306 . . . . 0.0 112.133 177.037 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 90.7 m -69.16 -37.02 77.99 Favored 'General case' 0 N--CA 1.443 -0.814 0 O-C-N 121.553 -0.717 . . . . 0.0 110.079 -178.869 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 75.0 t -85.07 -32.16 7.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 O-C-N 121.583 -0.698 . . . . 0.0 109.985 -177.055 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -54.22 -46.87 72.62 Favored 'General case' 0 CA--C 1.535 0.386 0 O-C-N 121.273 -0.892 . . . . 0.0 109.512 169.094 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -68.07 -16.51 64.05 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 -179.795 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 8.9 mmm -79.25 -11.58 59.95 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 125.57 1.548 . . . . 0.0 112.678 173.351 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 68.2 mt -55.22 -56.37 11.76 Favored 'Isoleucine or valine' 0 C--N 1.346 0.451 0 CA-C-N 120.902 1.683 . . . . 0.0 109.287 174.341 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -66.42 -46.28 59.42 Favored Pre-proline 0 CA--C 1.548 0.901 0 CA-C-N 119.629 1.104 . . . . 0.0 110.728 -172.37 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 0.3 OUTLIER -44.11 -52.09 5.99 Favored 'Trans proline' 0 C--N 1.352 0.732 1 C-N-CA 125.606 4.204 . . . . 0.0 112.881 168.665 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -72.75 -35.73 67.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 118.329 -0.843 . . . . 0.0 112.616 -178.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 39.7 mt -60.55 -45.97 91.91 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 120.23 1.377 . . . . 0.0 109.384 174.739 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 31.8 mm-40 -54.37 -36.07 63.48 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 118.493 0.588 . . . . 0.0 110.371 173.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 1.5 mm100 -78.16 -34.1 49.89 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 179.134 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 50.7 t -60.33 -46.48 94.91 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 CA-C-N 119.665 1.121 . . . . 0.0 108.025 170.137 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 55.2 mt -61.35 -35.57 77.79 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 119.211 -0.423 . . . . 0.0 110.509 177.631 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -71.06 -42.46 69.39 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 119.117 0.872 . . . . 0.0 111.45 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -67.96 -30.66 70.0 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 120.068 1.304 . . . . 0.0 111.132 177.094 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 21.4 mt -63.09 -51.64 65.83 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 169.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 75.6 mtt180 -63.28 -28.62 70.15 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 119.524 1.056 . . . . 0.0 112.288 -178.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -70.52 -18.46 62.95 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 119.056 0.844 . . . . 0.0 111.023 176.076 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 9.8 m -94.01 8.26 42.08 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.976 1.31 . . . . 0.0 111.04 169.454 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 72.31 15.1 76.96 Favored Glycine 0 CA--C 1.529 0.908 0 CA-C-O 116.995 -2.003 . . . . 0.0 112.951 -172.096 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 61.9 t -96.47 119.77 44.95 Favored 'Isoleucine or valine' 0 C--N 1.348 0.536 0 CA-C-N 121.368 2.584 . . . . 0.0 107.482 -176.698 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -107.49 91.93 3.86 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 107.065 -1.458 . . . . 0.0 107.065 173.7 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -52.32 144.32 13.14 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.079 169.535 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.433 HG21 ' HA ' ' A' ' 160' ' ' SER . 27.1 mm -89.28 124.64 64.17 Favored Pre-proline 0 C--O 1.232 0.16 0 CA-C-O 117.669 -1.158 . . . . 0.0 108.559 -175.767 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -63.27 103.78 0.38 Allowed 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 122.369 2.046 . . . . 0.0 108.495 170.75 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 29.0 ttp180 37.46 50.68 1.12 Allowed 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 127.201 2.2 . . . . 0.0 114.157 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' SER . . . . . 0.433 ' HA ' HG21 ' A' ' 157' ' ' ILE 0.269 3.4 p 53.29 19.59 1.61 Allowed 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 126.803 2.041 . . . . 0.0 115.657 -179.337 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -81.39 123.13 28.3 Favored 'General case' 0 C--O 1.238 0.492 0 O-C-N 121.018 -1.051 . . . . 0.0 109.637 174.097 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 29.5 m . . . . . 0 C--O 1.251 1.168 0 C-N-CA 125.496 1.518 . . . . 0.0 108.361 -178.872 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.8 tpt . . . . . 0 N--CA 1.497 1.876 0 N-CA-C 110.22 -0.289 . . . . 0.0 110.22 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 23.6 ptt180 -144.33 127.54 16.69 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.64 1.176 . . . . 0.0 108.014 171.127 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 13.5 mt -140.53 141.01 33.33 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -169.814 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 17.0 tp -123.05 149.57 44.23 Favored 'General case' 0 N--CA 1.462 0.168 0 N-CA-C 107.216 -1.401 . . . . 0.0 107.216 168.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 66.3 t -123.13 122.87 66.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 105.424 -2.065 . . . . 0.0 105.424 169.694 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -98.18 130.38 44.93 Favored 'General case' 0 CA--C 1.511 -0.536 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 178.688 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -105.16 115.9 5.08 Favored Glycine 0 CA--C 1.501 -0.819 0 N-CA-C 104.481 -3.448 . . . . 0.0 104.481 169.487 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 6.8 m -138.46 157.83 30.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 118.933 1.366 . . . . 0.0 111.902 -168.613 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 130.52 -172.76 20.3 Favored Glycine 0 C--N 1.337 0.591 0 O-C-N 124.454 1.096 . . . . 0.0 111.698 169.829 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 -87.07 85.86 7.26 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 123.54 0.736 . . . . 0.0 111.723 -169.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.3 pt -58.16 29.88 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.555 1.138 0 N-CA-C 116.421 2.008 . . . . 0.0 116.421 171.007 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 72.1 mt -125.96 -3.29 7.05 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 120.979 1.718 . . . . 0.0 108.927 169.371 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.6 mp -119.59 64.15 0.8 Allowed 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 124.212 1.005 . . . . 0.0 110.44 -169.095 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.466 ' HB ' ' H ' ' A' ' 15' ' ' ASP . 0.1 OUTLIER 51.96 -104.01 0.17 Allowed 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.377 170.74 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.466 ' H ' ' HB ' ' A' ' 14' ' ' THR . 73.2 m-20 -71.21 -16.34 62.5 Favored 'General case' 0 N--CA 1.442 -0.874 0 C-N-CA 124.209 1.004 . . . . 0.0 112.722 -175.47 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -73.76 7.93 2.23 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 120.924 1.693 . . . . 0.0 113.096 -179.757 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -89.66 -15.36 32.81 Favored 'General case' 0 N--CA 1.429 -1.508 0 CA-C-O 115.817 -2.04 . . . . 0.0 107.537 169.374 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 7.1 tp -54.96 -38.65 46.12 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.359 0 CA-C-N 122.329 2.331 . . . . 0.0 112.998 -169.606 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -59.56 -45.83 94.96 Favored Glycine 0 C--N 1.334 0.464 0 N-CA-C 109.934 -1.266 . . . . 0.0 109.934 176.793 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 34.3 t -65.85 -46.26 89.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 CA-C-O 118.505 -0.759 . . . . 0.0 110.05 173.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 25.5 mmt180 -62.32 -34.85 77.42 Favored 'General case' 0 C--N 1.346 0.422 0 CA-C-N 120.547 1.522 . . . . 0.0 111.963 -176.829 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 26.2 mt -61.85 -46.46 96.47 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-N 120.03 1.286 . . . . 0.0 110.137 178.373 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 18.7 m -73.77 -28.59 24.65 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 CA-C-N 119.153 0.888 . . . . 0.0 111.247 -174.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 58.1 mt-10 -70.18 -45.56 66.41 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 174.86 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.55 -44.59 95.95 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 123.002 0.521 . . . . 0.0 110.108 178.572 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 7.4 tp -63.45 -40.52 97.35 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 118.438 -0.791 . . . . 0.0 110.982 178.824 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.7 tm-20 -61.76 -42.38 98.91 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 118.7 0.682 . . . . 0.0 110.489 179.149 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 48.7 mm-40 -71.63 -42.8 67.16 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 122.784 0.434 . . . . 0.0 111.536 179.534 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 40.4 mmt180 -88.05 -35.44 17.54 Favored 'General case' 0 C--N 1.342 0.264 0 CA-C-O 117.37 -1.3 . . . . 0.0 113.441 -169.579 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 75.9 m-85 -120.12 137.06 54.37 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-N 121.127 1.785 . . . . 0.0 112.056 -173.84 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 31.6 mm -89.29 134.12 29.48 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 N-CA-C 105.536 -2.024 . . . . 0.0 105.536 168.269 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -119.5 154.85 54.55 Favored Pre-proline 0 CA--C 1.538 0.494 0 C-N-CA 125.563 1.545 . . . . 0.0 108.858 -172.735 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -63.87 157.9 49.93 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 122.358 2.039 . . . . 0.0 109.991 169.759 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -58.6 -31.99 68.57 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 113.619 0.97 . . . . 0.0 113.619 -169.536 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 53.4 p90 -75.38 -1.26 22.99 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 113.931 1.086 . . . . 0.0 113.931 -177.712 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 59.5 t -111.1 128.2 67.71 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 176.324 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -129.36 143.84 51.0 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 173.789 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -110.89 108.36 25.26 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 106.282 -1.748 . . . . 0.0 106.282 176.622 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 8.2 tt -106.88 127.06 53.09 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 -172.433 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -81.76 115.95 21.23 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 124.196 0.998 . . . . 0.0 109.824 176.649 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -77.29 -87.66 0.37 Allowed Glycine 0 CA--C 1.531 1.033 0 N-CA-C 108.762 -1.735 . . . . 0.0 108.762 169.764 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 77.93 106.88 0.18 Allowed Glycine 0 CA--C 1.53 0.976 0 N-CA-C 110.712 -0.955 . . . . 0.0 110.712 -177.145 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 5.3 p 50.99 57.48 6.61 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.017 1.327 . . . . 0.0 109.489 178.126 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -107.9 -87.75 0.48 Allowed 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 114.88 -1.054 . . . . 0.0 110.222 -169.566 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 73.08 -102.04 1.2 Allowed Glycine 0 C--N 1.339 0.709 0 N-CA-C 107.906 -2.077 . . . . 0.0 107.906 -174.399 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 70.8 mmm -68.24 -23.02 64.75 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 122.914 0.486 . . . . 0.0 112.222 -174.831 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -64.36 -14.91 59.09 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-O 120.793 0.33 . . . . 0.0 111.014 -177.867 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 59.4 mt -83.34 -10.0 58.73 Favored 'General case' 0 C--N 1.343 0.32 0 N-CA-C 113.912 1.079 . . . . 0.0 113.912 -172.757 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.406 ' HA ' HG13 ' A' ' 100' ' ' VAL . 3.5 tt -47.66 -67.91 0.23 Allowed 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 119.367 0.985 . . . . 0.0 113.577 -169.436 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -71.4 -26.41 73.41 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 111.339 -0.704 . . . . 0.0 111.339 -171.212 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -78.87 -29.67 44.6 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 122.516 0.326 . . . . 0.0 111.457 -178.403 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 22.3 mtp -83.7 -28.81 28.03 Favored 'General case' 0 CA--C 1.53 0.176 0 O-C-N 121.936 -0.477 . . . . 0.0 111.352 174.519 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -59.31 153.67 18.29 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-O 121.707 0.765 . . . . 0.0 110.307 175.416 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 64.45 -8.45 0.2 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 126.673 1.989 . . . . 0.0 115.314 169.893 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 24.7 mmt180 -68.41 153.33 43.96 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 170.449 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 83.8 m-20 -90.19 -34.82 15.67 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 118.991 -0.528 . . . . 0.0 109.952 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 2.0 t-160 -140.24 122.18 15.57 Favored 'General case' 0 CA--C 1.514 -0.414 0 N-CA-C 104.262 -2.495 . . . . 0.0 104.262 -172.138 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 50.0 tp -128.46 131.57 48.4 Favored 'General case' 0 CA--C 1.509 -0.624 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 179.072 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 39.6 mt -109.57 121.94 63.38 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 N-CA-C 105.012 -2.218 . . . . 0.0 105.012 169.665 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 22.1 mt -98.26 125.16 51.63 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 177.501 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -104.21 119.45 38.97 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 171.022 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -147.6 151.46 36.27 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 124.692 1.197 . . . . 0.0 110.736 -172.405 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -88.19 121.31 30.44 Favored 'General case' 0 C--N 1.343 0.298 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 168.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 7.9 mm -54.2 -39.19 41.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 C-N-CA 124.362 1.065 . . . . 0.0 111.797 -173.572 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . 0.319 6.7 p 43.06 43.03 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.974 0 C-N-CA 126.316 1.846 . . . . 0.0 113.145 175.549 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 4.4 t -157.48 -175.33 5.33 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.946 1.698 . . . . 0.0 109.614 -174.476 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 16.1 tptt 63.29 176.16 0.16 Allowed 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 127.327 2.251 . . . . 0.0 113.433 171.625 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 9.3 ptpt -103.2 0.44 31.69 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 125.404 1.481 . . . . 0.0 112.978 -178.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 49.5 t30 -73.55 162.35 29.34 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.905 0.882 . . . . 0.0 109.08 -177.567 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.8 m -58.97 142.86 84.73 Favored Pre-proline 0 CA--C 1.545 0.783 0 C-N-CA 124.068 0.947 . . . . 0.0 111.816 -169.867 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -55.15 155.17 20.1 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 122.775 2.316 . . . . 0.0 112.167 170.169 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 70.6 4.62 53.44 Favored Glycine 0 CA--C 1.531 1.062 0 CA-C-O 118.655 -1.081 . . . . 0.0 114.859 174.421 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 20.8 m -86.04 147.97 25.95 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 119.849 1.825 . . . . 0.0 110.458 -172.161 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 15.7 ttp -87.88 137.66 32.14 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 123.435 0.694 . . . . 0.0 110.414 175.886 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 47.0 mtp -129.03 111.46 13.01 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 178.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 42.3 mm -99.03 115.62 40.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 177.651 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.9 mp -116.43 134.92 54.32 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 -174.867 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 20.5 mmm180 -104.66 138.86 40.35 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 123.084 0.553 . . . . 0.0 109.931 -177.464 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 38.8 t70 33.95 -100.27 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 115.463 1.653 . . . . 0.0 115.463 169.011 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -61.0 -24.13 65.93 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.789 1.236 . . . . 0.0 113.733 -174.219 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -73.68 -26.54 60.78 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 122.66 0.384 . . . . 0.0 110.568 178.536 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 49.2 t -72.2 -53.17 6.62 Favored Pre-proline 0 N--CA 1.445 -0.715 0 CA-C-O 116.888 -1.53 . . . . 0.0 110.756 -169.195 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.404 ' O ' HG23 ' A' ' 87' ' ' THR . 15.4 Cg_exo -61.92 -40.15 45.99 Favored 'Trans proline' 0 N--CA 1.448 -1.2 0 CA-C-N 121.992 1.747 . . . . 0.0 110.094 174.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -62.12 -30.35 70.97 Favored 'General case' 0 C--N 1.346 0.414 0 C-N-CA 123.364 0.666 . . . . 0.0 112.38 -174.271 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.502 HD13 ' C ' ' A' ' 85' ' ' LEU . 1.7 tm? -68.65 -47.08 67.47 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 171.14 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -64.19 -19.23 65.19 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 -169.723 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.404 HG23 ' O ' ' A' ' 83' ' ' PRO . 2.2 p -71.17 -17.79 62.52 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 -177.764 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 3.4 p30 -59.5 148.93 31.28 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -169.239 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -85.59 -13.54 48.48 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 118.816 -0.611 . . . . 0.0 112.618 -173.614 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 61.9 mt -70.29 -46.65 70.68 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 -178.507 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 5.0 m -78.1 119.1 76.04 Favored Pre-proline 0 CA--C 1.54 0.558 0 C-N-CA 124.263 1.025 . . . . 0.0 110.642 -174.285 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -81.96 -39.26 0.18 Allowed 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 121.573 1.515 . . . . 0.0 112.267 -177.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 24.3 m-70 -74.33 -29.67 61.71 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.358 0.663 . . . . 0.0 111.552 -171.194 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 90.6 mt-30 -74.53 -17.5 60.73 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 118.387 -0.816 . . . . 0.0 113.116 -169.83 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 47.5 tp -59.85 -35.04 73.93 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 119.692 1.133 . . . . 0.0 111.618 -172.277 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -65.66 -42.43 95.41 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 111.482 -0.647 . . . . 0.0 111.482 175.467 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 27.6 tp -70.29 -33.65 71.81 Favored 'General case' 0 CA--C 1.531 0.223 0 O-C-N 120.91 -1.347 . . . . 0.0 109.945 178.328 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -59.34 -50.33 74.41 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 118.908 0.776 . . . . 0.0 109.724 173.719 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -70.2 -24.74 63.17 Favored 'General case' 0 N--CA 1.457 -0.101 0 CA-C-O 118.682 -0.675 . . . . 0.0 112.02 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.406 HG13 ' HA ' ' A' ' 49' ' ' LEU . 2.5 t -65.09 -45.35 94.53 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 CA-C-N 119.451 1.023 . . . . 0.0 109.973 169.737 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 59.7 mt -64.91 -37.87 89.08 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 119.659 1.118 . . . . 0.0 109.705 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 18.6 m -61.92 -40.74 96.54 Favored 'General case' 0 C--O 1.224 -0.238 0 CA-C-N 118.605 0.638 . . . . 0.0 110.107 170.018 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.457 ' HA ' ' CD2' ' A' ' 106' ' ' PHE . . . -66.31 -33.88 76.73 Favored 'General case' 0 N--CA 1.448 -0.553 0 O-C-N 121.168 -0.957 . . . . 0.0 111.067 -179.759 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 6.4 mt -67.86 -34.25 76.32 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-N 118.929 0.786 . . . . 0.0 109.629 175.748 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 80.0 ttt180 -68.38 -36.43 79.16 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 118.846 -0.597 . . . . 0.0 110.06 172.87 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.457 ' CD2' ' HA ' ' A' ' 103' ' ' ALA . 15.4 m-30 -65.43 -43.38 90.68 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 119.305 0.957 . . . . 0.0 110.572 178.559 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 41.6 p -74.53 -23.25 58.79 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 118.571 0.623 . . . . 0.0 111.303 177.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 75.18 12.55 83.41 Favored Glycine 0 CA--C 1.531 1.086 0 N-CA-C 110.832 -0.907 . . . . 0.0 110.832 -169.603 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -96.84 22.16 8.63 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 118.766 1.283 . . . . 0.0 111.235 178.8 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -58.1 132.87 84.03 Favored Pre-proline 0 CA--C 1.544 0.727 0 C-N-CA 124.964 1.306 . . . . 0.0 109.656 171.918 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_exo -56.58 150.71 50.62 Favored 'Trans proline' 0 N--CA 1.46 -0.479 0 C-N-CA 123.351 2.701 . . . . 0.0 114.932 -178.485 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -59.88 -34.57 73.34 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.059 177.193 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 59.2 mttp -134.39 130.4 36.81 Favored 'General case' 0 C--O 1.232 0.16 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 173.688 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.443 HD12 ' H ' ' A' ' 115' ' ' THR . 18.2 tp -118.19 139.15 51.72 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 105.19 -2.152 . . . . 0.0 105.19 168.736 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.443 ' H ' HD12 ' A' ' 114' ' ' LEU . 0.2 OUTLIER -141.39 146.34 36.48 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 105.656 -1.979 . . . . 0.0 105.656 -177.669 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -135.37 136.1 41.22 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 119.729 1.15 . . . . 0.0 109.841 172.815 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 47.6 t -103.61 99.63 8.8 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 N-CA-C 103.61 -2.737 . . . . 0.0 103.61 169.278 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -87.24 145.43 19.74 Favored Glycine 0 N--CA 1.444 -0.825 0 N-CA-C 110.317 -1.113 . . . . 0.0 110.317 176.556 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 53.2 t -127.35 121.19 56.79 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.497 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 175.691 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 6.5 mt -71.88 132.48 84.87 Favored Pre-proline 0 CA--C 1.539 0.55 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 173.153 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -73.67 179.35 5.7 Favored 'Trans proline' 0 CA--C 1.541 0.848 0 C-N-CA 122.995 2.463 . . . . 0.0 111.91 179.146 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -115.47 -53.71 2.58 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.488 1.115 . . . . 0.0 110.032 177.446 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 56.1 p -110.25 -65.6 1.14 Allowed 'General case' 0 CA--C 1.535 0.365 0 CA-C-N 119.058 0.845 . . . . 0.0 111.954 -172.632 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 56.29 70.34 0.65 Allowed 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.674 1.99 . . . . 0.0 113.702 176.187 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -128.79 169.83 12.05 Favored Pre-proline 0 CA--C 1.542 0.658 0 CA-C-O 118.331 -0.843 . . . . 0.0 109.421 169.695 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_exo -65.92 85.21 0.24 Allowed 'Trans proline' 0 CA--C 1.547 1.126 0 C-N-CA 123.617 2.878 . . . . 0.0 113.34 -178.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -175.83 151.18 1.1 Allowed 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 104.404 -2.443 . . . . 0.0 104.404 176.368 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -114.3 161.84 12.83 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 -169.654 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 107.42 141.74 10.11 Favored Glycine 0 CA--C 1.528 0.878 0 N-CA-C 106.85 -2.5 . . . . 0.0 106.85 -169.514 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 68.7 mt -78.54 158.17 28.62 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 118.645 1.223 . . . . 0.0 108.971 175.607 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 36.3 p -68.19 164.92 38.05 Favored Pre-proline 0 C--O 1.238 0.462 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 168.304 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -56.69 -33.64 94.17 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 121.477 1.451 . . . . 0.0 110.76 169.334 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 5.9 m -66.48 -43.68 84.73 Favored 'General case' 0 CA--C 1.535 0.37 0 O-C-N 122.201 -0.312 . . . . 0.0 110.183 -178.898 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 94.4 t -88.48 -28.43 5.37 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 CA-C-N 118.683 0.674 . . . . 0.0 110.075 -172.224 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -55.12 -45.85 75.57 Favored 'General case' 0 CA--C 1.533 0.31 0 O-C-N 120.667 -1.27 . . . . 0.0 107.774 167.859 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -75.48 18.5 0.22 Allowed 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 114.152 1.167 . . . . 0.0 114.152 176.148 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 25.8 mmm -115.03 -8.44 12.46 Favored 'General case' 0 N--CA 1.437 -1.084 0 C-N-CA 125.743 1.617 . . . . 0.0 107.965 169.215 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 96.3 mt -59.5 -49.65 82.85 Favored 'Isoleucine or valine' 0 C--N 1.346 0.423 0 CA-C-N 120.379 1.445 . . . . 0.0 107.859 174.582 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -70.71 -53.73 8.97 Favored Pre-proline 0 CA--C 1.536 0.408 0 CA-C-O 117.121 -1.418 . . . . 0.0 109.584 -175.821 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -38.75 -52.63 2.07 Favored 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 123.876 3.051 . . . . 0.0 113.822 169.113 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -74.19 -45.85 45.78 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.085 -1.416 . . . . 0.0 110.808 -172.137 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -62.28 -36.38 81.89 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-N 118.982 0.81 . . . . 0.0 109.722 179.453 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -64.2 -36.0 82.65 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 177.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 11.9 mm100 -74.56 -31.09 61.98 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-O 117.869 -1.063 . . . . 0.0 112.266 172.637 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 86.7 t -59.83 -46.25 93.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-N 120.446 1.475 . . . . 0.0 108.154 169.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 74.4 mt -62.68 -41.17 98.95 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 118.714 0.688 . . . . 0.0 110.42 177.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -62.78 -41.04 99.08 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 118.813 0.733 . . . . 0.0 111.0 179.803 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -66.55 -46.37 76.3 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 177.366 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 78.0 mt -57.76 -37.17 73.16 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 122.514 0.326 . . . . 0.0 110.228 177.391 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 67.6 mtp180 -64.07 -19.09 64.98 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 118.019 -0.991 . . . . 0.0 112.284 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -61.89 -30.12 70.67 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 120.182 1.355 . . . . 0.0 110.546 174.17 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 49.1 m -101.16 31.11 3.79 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.021 1.328 . . . . 0.0 111.447 174.858 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 66.48 21.5 70.66 Favored Glycine 0 CA--C 1.53 0.974 0 CA-C-O 119.251 -0.749 . . . . 0.0 114.248 169.808 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 81.6 t -72.74 120.03 20.61 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 CA-C-N 118.572 1.186 . . . . 0.0 107.934 178.842 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -103.45 94.35 5.43 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 105.744 -1.947 . . . . 0.0 105.744 169.625 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -74.21 144.14 44.85 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 175.701 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 9.2 mm -112.04 127.88 26.24 Favored Pre-proline 0 CA--C 1.53 0.191 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -62.6 109.58 0.91 Allowed 'Trans proline' 0 N--CA 1.458 -0.599 0 N-CA-C 107.425 -1.798 . . . . 0.0 107.425 170.682 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 70.2 ttt-85 56.0 -9.43 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 127.799 2.44 . . . . 0.0 116.809 179.676 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 4.3 m 56.57 1.66 0.08 Allowed 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 126.524 1.93 . . . . 0.0 114.742 -169.564 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -157.1 143.92 18.4 Favored 'General case' 0 C--O 1.239 0.53 0 O-C-N 120.646 -1.284 . . . . 0.0 108.2 -175.32 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 18.1 m . . . . . 0 C--O 1.252 1.237 0 C-N-CA 124.506 1.122 . . . . 0.0 110.354 -169.963 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.0 ttt . . . . . 0 N--CA 1.497 1.906 0 CA-C-O 120.728 0.299 . . . . 0.0 110.916 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 28.5 tpt85 -66.24 120.75 13.79 Favored 'General case' 0 N--CA 1.469 0.486 0 O-C-N 119.886 -1.759 . . . . 0.0 109.466 -175.814 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.8 mt -120.21 127.39 75.9 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 -172.01 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 19.4 tp -121.23 138.36 54.26 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 105.256 -2.128 . . . . 0.0 105.256 168.519 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 92.6 t -124.01 110.58 25.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 -177.178 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.435 HD13 ' HA ' ' A' ' 6' ' ' LEU . 2.8 mm? -93.73 125.37 38.31 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 -174.367 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -99.58 127.7 9.33 Favored Glycine 0 CA--C 1.508 -0.405 0 N-CA-C 106.17 -2.772 . . . . 0.0 106.17 170.435 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.1 m -138.79 167.15 21.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 117.595 0.697 . . . . 0.0 111.272 -169.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 109.59 169.79 20.27 Favored Glycine 0 CA--C 1.525 0.709 0 C-N-CA 125.973 1.749 . . . . 0.0 110.403 179.099 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -87.02 104.95 16.79 Favored 'General case' 0 N--CA 1.452 -0.336 0 O-C-N 121.865 -0.785 . . . . 0.0 110.794 -172.45 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.2 pt -63.67 32.99 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.892 0 N-CA-C 115.501 1.667 . . . . 0.0 115.501 175.036 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 42.4 mt -127.39 0.82 6.32 Favored 'General case' 0 C--O 1.222 -0.386 0 CA-C-N 120.504 1.502 . . . . 0.0 108.14 168.785 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.3 mp -118.06 52.28 1.02 Allowed 'General case' 0 N--CA 1.441 -0.916 0 C-N-CA 124.002 0.921 . . . . 0.0 112.074 -168.633 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER 53.8 -108.16 0.41 Allowed 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 122.862 0.465 . . . . 0.0 111.498 171.239 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -57.13 -25.18 58.42 Favored 'General case' 0 C--O 1.224 -0.287 0 CA-C-O 118.209 -0.901 . . . . 0.0 113.009 176.357 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -70.53 -0.03 7.7 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 121.535 1.971 . . . . 0.0 113.542 -177.598 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -89.0 -16.08 32.57 Favored 'General case' 0 N--CA 1.431 -1.39 0 CA-C-O 115.92 -1.99 . . . . 0.0 108.957 169.389 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 5.9 tp -58.34 -38.0 66.71 Favored 'Isoleucine or valine' 0 C--N 1.342 0.278 0 CA-C-N 122.829 2.559 . . . . 0.0 111.798 -169.619 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -59.71 -38.83 94.42 Favored Glycine 0 C--N 1.338 0.679 0 N-CA-C 110.572 -1.011 . . . . 0.0 110.572 176.304 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 79.0 t -73.29 -48.44 42.6 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.652 0 CA-C-O 118.641 -0.695 . . . . 0.0 109.452 174.374 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 15.6 mmm180 -59.48 -36.14 75.45 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 120.367 1.439 . . . . 0.0 112.621 -176.421 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 33.6 mt -62.18 -46.7 95.86 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 CA-C-N 120.418 1.463 . . . . 0.0 109.983 179.236 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 10.3 m -72.65 -29.33 30.03 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 O-C-N 121.298 -0.876 . . . . 0.0 110.887 -174.853 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -70.44 -41.72 72.47 Favored 'General case' 0 CA--C 1.528 0.102 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 175.022 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.41 -37.21 82.65 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-O 118.735 -0.65 . . . . 0.0 110.444 178.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 11.9 tp -62.45 -42.59 99.57 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 118.867 0.758 . . . . 0.0 109.939 174.297 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -62.78 -41.19 99.15 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 118.461 0.573 . . . . 0.0 110.815 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -67.42 -42.69 82.79 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.193 0.997 . . . . 0.0 110.635 179.08 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 88.3 mtt180 -94.43 -38.89 10.72 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 114.837 1.421 . . . . 0.0 114.837 -169.687 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 63.3 m-85 -113.84 137.68 51.32 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 121.391 1.905 . . . . 0.0 114.207 -169.293 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 47.0 mm -85.68 141.84 13.97 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 N-CA-C 104.382 -2.451 . . . . 0.0 104.382 167.637 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 46.5 mt -135.98 152.87 76.42 Favored Pre-proline 0 CA--C 1.539 0.55 0 C-N-CA 123.496 0.718 . . . . 0.0 110.518 -169.474 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_exo -59.27 155.2 41.75 Favored 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 123.336 2.691 . . . . 0.0 111.829 169.864 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -63.01 -31.09 72.14 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -171.232 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 26.1 p90 -70.63 -13.96 62.29 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 118.358 -0.83 . . . . 0.0 112.547 179.149 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 42.7 t -94.91 129.25 45.33 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 C-N-CA 124.114 0.966 . . . . 0.0 108.639 178.765 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -136.13 146.06 46.53 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-O 121.252 0.548 . . . . 0.0 110.607 170.884 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -105.28 130.35 56.65 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 N-CA-C 105.648 -1.982 . . . . 0.0 105.648 169.024 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 64.5 tp -121.61 126.41 49.02 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-O 121.311 0.577 . . . . 0.0 109.732 175.088 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -77.87 115.69 17.81 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 169.523 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -64.58 -64.25 3.71 Favored Glycine 0 CA--C 1.531 1.074 0 N-CA-C 108.225 -1.95 . . . . 0.0 108.225 169.877 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 79.2 106.0 0.23 Allowed Glycine 0 C--N 1.34 0.793 0 N-CA-C 110.765 -0.934 . . . . 0.0 110.765 171.676 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . 0.254 40.2 p 50.18 61.18 3.33 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 -173.434 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -89.01 -140.36 0.13 Allowed 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 113.608 -1.633 . . . . 0.0 110.925 -169.304 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 75.93 118.85 0.13 Allowed Glycine 0 CA--C 1.537 1.417 0 N-CA-C 109.031 -1.628 . . . . 0.0 109.031 -168.605 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 1.6 mmt 61.59 -29.37 0.06 Allowed 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 127.521 2.328 . . . . 0.0 116.411 -173.622 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -59.47 -21.42 60.06 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 118.998 0.817 . . . . 0.0 112.769 -175.03 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 95.8 mt -91.79 9.63 31.88 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 -171.339 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.5 tt -73.15 79.94 1.26 Allowed 'General case' 0 C--O 1.233 0.213 0 CA-C-O 124.843 2.258 . . . . 0.0 110.827 -179.035 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 145.13 -33.64 1.59 Allowed Glycine 0 C--N 1.308 -0.989 0 CA-C-N 110.142 -3.208 . . . . 0.0 111.028 172.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -68.24 -35.3 77.72 Favored 'General case' 0 N--CA 1.466 0.345 0 O-C-N 121.933 -0.745 . . . . 0.0 111.525 -176.89 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 38.1 mtp -72.38 0.56 9.79 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.891 1.277 . . . . 0.0 113.151 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -75.63 149.13 38.28 Favored 'General case' 0 N--CA 1.457 -0.087 0 N-CA-C 113.777 1.029 . . . . 0.0 113.777 -169.923 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 55.26 18.15 2.37 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 128.317 2.647 . . . . 0.0 116.412 168.695 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 27.1 mmt180 -77.91 149.33 34.24 Favored 'General case' 0 N--CA 1.473 0.698 0 O-C-N 120.798 -1.189 . . . . 0.0 109.416 -178.312 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -80.97 -39.55 25.84 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 177.071 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 1.8 m170 -128.07 136.28 50.99 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 169.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 29.2 tp -130.92 123.72 29.53 Favored 'General case' 0 CA--C 1.505 -0.78 0 N-CA-C 105.851 -1.907 . . . . 0.0 105.851 168.79 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 18.5 mt -111.35 122.41 65.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 104.657 -2.349 . . . . 0.0 104.657 178.038 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 21.0 mt -102.94 126.56 57.18 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 N-CA-C 105.881 -1.896 . . . . 0.0 105.881 -179.616 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -111.32 119.09 37.72 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 105.261 -2.126 . . . . 0.0 105.261 171.599 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -149.1 149.93 31.88 Favored 'General case' 0 C--O 1.24 0.557 0 O-C-N 123.4 0.438 . . . . 0.0 110.202 -175.73 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -68.64 132.01 46.17 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 104.536 -2.394 . . . . 0.0 104.536 168.363 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.6 tt -74.95 -38.07 42.58 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.778 0 O-C-N 121.582 -0.699 . . . . 0.0 110.797 -169.674 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.2 t 45.62 44.43 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.822 0 C-N-CA 125.919 1.688 . . . . 0.0 111.144 176.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 67.2 m -138.75 -73.31 0.39 Allowed 'General case' 0 N--CA 1.471 0.577 0 O-C-N 121.54 -0.725 . . . . 0.0 112.552 -169.716 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 29.3 ttmt -83.02 154.68 24.33 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 122.758 0.423 . . . . 0.0 109.871 -169.79 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.32 42.8 1.11 Allowed 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 125.283 1.433 . . . . 0.0 109.033 -172.158 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 40.7 t-20 -89.74 172.47 8.9 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 124.26 1.024 . . . . 0.0 108.915 -171.358 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 10.7 m -60.25 133.95 90.7 Favored Pre-proline 0 CA--C 1.544 0.726 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 179.066 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -57.82 153.66 42.41 Favored 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 122.392 2.061 . . . . 0.0 111.615 174.127 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 71.53 9.38 68.88 Favored Glycine 0 CA--C 1.533 1.163 0 CA-C-O 119.703 -0.498 . . . . 0.0 113.803 176.111 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 29.3 m -89.03 146.56 24.78 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 124.971 1.309 . . . . 0.0 107.545 174.244 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 30.0 ttp -101.78 143.13 32.08 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 175.328 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 17.9 ttm -126.5 126.65 44.08 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 179.775 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 44.0 mm -107.57 121.19 60.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 -179.108 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -115.71 129.37 56.44 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 -174.625 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 81.0 mtm180 -90.9 173.45 7.97 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 118.293 0.497 . . . . 0.0 110.288 179.159 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -33.39 -66.15 0.16 Allowed 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 116.215 1.931 . . . . 0.0 116.215 -169.758 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -77.08 -12.34 59.93 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -172.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 21.6 mm-40 -91.78 -21.95 20.42 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 118.558 -0.734 . . . . 0.0 110.664 -178.784 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.447 HG22 ' HB3' ' A' ' 116' ' ' LEU . 63.0 t -62.97 -51.13 73.25 Favored Pre-proline 0 C--N 1.344 0.331 0 CA-C-N 120.168 1.349 . . . . 0.0 110.967 -179.111 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -66.65 -37.8 20.52 Favored 'Trans proline' 0 N--CA 1.444 -1.393 0 CA-C-N 121.423 1.544 . . . . 0.0 109.708 -179.698 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.97 -29.04 69.37 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.298 0.639 . . . . 0.0 111.812 -176.489 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.521 HD13 ' C ' ' A' ' 85' ' ' LEU . 1.1 tm? -68.31 -47.65 67.01 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 169.743 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.557 ' HB3' ' HB2' ' A' ' 98' ' ' ALA . 12.9 m-85 -64.63 -11.2 32.71 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 114.041 1.126 . . . . 0.0 114.041 -169.422 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 24.9 p -66.76 -13.65 61.66 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 113.784 1.031 . . . . 0.0 113.784 -175.281 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -59.29 135.03 57.52 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.362 0.665 . . . . 0.0 110.652 -172.601 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -87.04 -12.48 47.22 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 -170.394 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 76.2 mt -67.82 -43.55 86.11 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 N-CA-C 107.421 -1.325 . . . . 0.0 107.421 174.291 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -65.78 130.84 94.57 Favored Pre-proline 0 N--CA 1.445 -0.722 0 C-N-CA 125.802 1.641 . . . . 0.0 110.768 -173.132 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -80.78 -87.55 0.0 OUTLIER 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 123.059 2.506 . . . . 0.0 111.416 177.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 19.4 m80 -66.98 -32.15 73.2 Favored 'General case' 0 N--CA 1.469 0.477 0 O-C-N 120.645 -1.285 . . . . 0.0 110.976 -170.312 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.418 ' H ' ' CD ' ' A' ' 94' ' ' GLN . 26.2 mp0 -53.86 -42.65 68.8 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 126.365 1.866 . . . . 0.0 109.93 173.536 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.403 ' O ' ' HB3' ' A' ' 98' ' ' ALA . 3.1 tm? -70.7 -37.1 73.56 Favored 'General case' 0 N--CA 1.457 -0.117 0 O-C-N 121.571 -0.705 . . . . 0.0 109.671 179.401 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -59.69 -38.87 94.45 Favored Glycine 0 CA--C 1.53 0.983 0 O-C-N 121.254 -0.904 . . . . 0.0 111.44 171.52 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.445 HD23 ' CZ ' ' A' ' 86' ' ' PHE . 24.3 tp -70.19 -28.13 65.06 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 118.37 1.085 . . . . 0.0 110.461 174.423 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.557 ' HB2' ' HB3' ' A' ' 86' ' ' PHE . . . -56.23 -46.87 79.38 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 120.141 1.337 . . . . 0.0 109.089 169.689 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -72.56 -24.21 61.08 Favored 'General case' 0 C--O 1.231 0.08 0 CA-C-O 119.193 -0.432 . . . . 0.0 111.952 -179.163 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 74.2 t -65.45 -46.16 90.82 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 169.19 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 76.1 mt -64.03 -35.28 80.19 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 118.961 0.801 . . . . 0.0 110.433 -179.053 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 19.7 m -63.97 -43.29 96.19 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 118.796 0.725 . . . . 0.0 110.197 170.848 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -64.9 -41.5 95.54 Favored 'General case' 0 N--CA 1.452 -0.367 0 O-C-N 120.972 -1.08 . . . . 0.0 111.387 -178.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -65.33 -31.58 72.79 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 124.486 1.114 . . . . 0.0 110.318 176.148 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 19.1 tpp180 -70.91 -37.85 72.96 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 118.839 -0.6 . . . . 0.0 109.897 173.58 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 15.2 m-30 -65.44 -42.46 92.4 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 118.773 0.715 . . . . 0.0 110.405 -179.572 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 31.2 p -74.96 -21.5 59.13 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 118.304 0.502 . . . . 0.0 111.603 178.543 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 74.34 11.19 82.31 Favored Glycine 0 CA--C 1.534 1.262 0 N-CA-C 111.066 -0.814 . . . . 0.0 111.066 -169.723 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -83.74 2.27 38.72 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 118.77 1.285 . . . . 0.0 111.944 177.041 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -48.67 134.63 13.69 Favored Pre-proline 0 CA--C 1.549 0.92 0 C-N-CA 125.745 1.618 . . . . 0.0 110.989 177.009 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -52.0 150.02 19.49 Favored 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 124.082 3.188 . . . . 0.0 114.258 179.65 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 31.7 mmmt -63.26 -28.92 70.35 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 118.955 -0.545 . . . . 0.0 111.183 177.568 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 36.0 ttmt -146.69 110.95 5.1 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 171.226 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 26.2 tp -90.1 144.58 25.76 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 169.119 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -141.45 146.46 36.53 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 171.932 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.447 ' HB3' HG22 ' A' ' 82' ' ' VAL . 0.8 OUTLIER -131.4 138.99 49.34 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 120.408 1.458 . . . . 0.0 110.436 172.78 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 43.6 t -105.17 105.93 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 N-CA-C 104.808 -2.293 . . . . 0.0 104.808 168.798 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -90.07 146.05 18.5 Favored Glycine 0 CA--C 1.522 0.516 0 N-CA-C 110.484 -1.046 . . . . 0.0 110.484 174.765 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.455 HG13 ' SD ' ' A' ' 137' ' ' MET . 71.0 t -119.31 138.64 49.32 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 175.575 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 14.4 mm -84.94 128.23 61.3 Favored Pre-proline 0 CA--C 1.543 0.679 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 169.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -70.12 152.3 67.41 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 122.786 2.324 . . . . 0.0 113.365 -176.464 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -99.58 -42.41 6.92 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 169.599 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 20.2 m -142.66 151.06 41.02 Favored 'General case' 0 C--N 1.344 0.348 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 176.641 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.5 tp -153.77 49.61 0.67 Allowed 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 118.719 0.691 . . . . 0.0 111.779 -172.275 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -120.32 168.93 9.45 Favored Pre-proline 0 N--CA 1.477 0.919 0 CA-C-O 117.638 -1.172 . . . . 0.0 110.072 -175.903 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -62.89 84.3 0.11 Allowed 'Trans proline' 0 CA--C 1.547 1.167 0 C-N-CA 124.138 3.225 . . . . 0.0 113.915 -178.219 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -176.52 156.53 1.52 Allowed 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 105.212 -2.144 . . . . 0.0 105.212 174.527 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -130.54 162.17 39.03 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 CA-C-O 121.772 0.796 . . . . 0.0 110.844 174.817 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 122.36 121.96 2.76 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 103.387 -3.885 . . . . 0.0 103.387 -168.879 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 74.8 mt -78.86 152.21 31.38 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 -171.108 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 68.6 p -69.8 166.04 35.96 Favored Pre-proline 0 C--O 1.241 0.632 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 169.673 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -60.21 -27.86 85.73 Favored 'Trans proline' 0 CA--C 1.539 0.727 0 CA-C-N 119.677 0.92 . . . . 0.0 110.466 169.591 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 5.1 m -69.85 -42.11 73.98 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 118.505 0.593 . . . . 0.0 110.35 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 72.7 t -88.46 -36.6 9.33 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 CA-C-O 119.175 -0.44 . . . . 0.0 110.346 -169.348 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -50.7 -44.59 58.01 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 119.204 0.911 . . . . 0.0 109.938 169.428 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -77.76 5.2 9.92 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 113.789 1.033 . . . . 0.0 113.789 -175.631 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' MET . . . . . 0.455 ' SD ' HG13 ' A' ' 119' ' ' VAL . 75.3 mtp -98.18 -7.28 29.68 Favored 'General case' 0 N--CA 1.439 -1.015 0 CA-C-O 117.387 -1.292 . . . . 0.0 110.59 169.612 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 94.7 mt -57.67 -47.25 86.06 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 CA-C-N 120.225 1.375 . . . . 0.0 108.391 174.317 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 58.3 mt-10 -73.56 -48.65 6.83 Favored Pre-proline 0 CA--C 1.542 0.667 0 CA-C-O 117.534 -1.222 . . . . 0.0 110.637 -175.611 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -43.38 -54.38 3.6 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 124.611 3.541 . . . . 0.0 112.645 168.686 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.35 -42.52 71.73 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 114.788 -1.096 . . . . 0.0 110.755 -174.283 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 33.1 mt -54.69 -44.12 73.09 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-N 118.961 0.8 . . . . 0.0 109.45 173.367 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -64.44 -34.65 78.68 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 119.075 0.852 . . . . 0.0 110.887 -176.837 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -78.43 -32.8 48.74 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 119.231 0.923 . . . . 0.0 112.021 176.52 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 54.0 t -59.59 -47.99 88.97 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 169.355 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 44.7 mt -64.47 -36.97 85.91 Favored 'General case' 0 CA--C 1.519 -0.244 0 C-N-CA 123.061 0.544 . . . . 0.0 110.67 -178.518 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -58.18 -36.38 72.98 Favored 'General case' 0 N--CA 1.457 -0.118 0 CA-C-N 118.419 0.554 . . . . 0.0 111.21 179.216 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -63.0 -44.84 94.9 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 117.985 0.357 . . . . 0.0 110.91 177.439 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 6.2 mp -63.21 -40.26 96.99 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 176.696 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 87.0 mtt180 -64.81 -18.87 65.5 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 117.411 -1.281 . . . . 0.0 111.759 -179.081 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 69.8 mt-10 -56.26 -30.15 62.05 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 120.53 1.514 . . . . 0.0 112.138 176.359 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 19.4 m -113.38 31.53 6.41 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.294 1.038 . . . . 0.0 111.311 179.211 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 65.42 29.98 76.5 Favored Glycine 0 CA--C 1.531 1.05 0 CA-C-O 118.73 -1.039 . . . . 0.0 113.583 175.459 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 47.1 t -111.14 103.32 15.29 Favored 'Isoleucine or valine' 0 C--N 1.34 0.175 0 N-CA-C 106.684 -1.599 . . . . 0.0 106.684 176.299 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -100.8 144.87 29.24 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 169.744 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -78.68 157.5 28.59 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.388 0.675 . . . . 0.0 111.357 177.75 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 11.7 mt -99.14 112.43 63.09 Favored Pre-proline 0 CA--C 1.532 0.263 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -66.98 104.63 0.86 Allowed 'Trans proline' 0 N--CA 1.458 -0.591 0 N-CA-C 107.942 -1.599 . . . . 0.0 107.942 175.607 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 69.5 ttt180 57.29 -14.08 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 128.344 2.658 . . . . 0.0 116.98 -178.06 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 2.9 t 60.2 -178.15 0.1 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.447 1.499 . . . . 0.0 111.047 -169.648 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -148.71 141.53 24.64 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 125.654 1.581 . . . . 0.0 108.828 -179.007 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 28.9 m . . . . . 0 C--O 1.252 1.231 0 C-N-CA 125.121 1.368 . . . . 0.0 108.526 -177.074 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.0 tpt . . . . . 0 N--CA 1.499 1.991 0 N-CA-C 110.437 -0.208 . . . . 0.0 110.437 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 7.0 ptp180 -145.32 126.5 14.73 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 174.43 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 38.5 mt -142.69 143.8 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-N 119.612 1.096 . . . . 0.0 110.85 -169.104 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 19.7 tp -131.88 109.86 10.39 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 104.168 -2.531 . . . . 0.0 104.168 167.62 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.422 HG12 HG12 ' A' ' 23' ' ' VAL . 39.2 t -85.84 118.72 32.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 102.441 -3.17 . . . . 0.0 102.441 171.886 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -119.9 105.52 11.17 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-O 121.114 0.483 . . . . 0.0 110.411 -168.673 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -87.46 115.62 4.36 Favored Glycine 0 N--CA 1.447 -0.614 0 N-CA-C 107.651 -2.18 . . . . 0.0 107.651 174.298 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 14.8 m -123.46 -176.38 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.633 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 174.857 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 111.49 124.71 4.54 Favored Glycine 0 N--CA 1.441 -1.031 0 N-CA-C 106.75 -2.54 . . . . 0.0 106.75 -175.002 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -64.03 109.46 1.82 Allowed 'General case' 0 N--CA 1.442 -0.85 0 C-N-CA 124.284 1.034 . . . . 0.0 109.917 -169.539 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.3 pt -75.65 37.77 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 C-N-CA 124.642 1.177 . . . . 0.0 113.463 -178.685 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 20.8 mt -124.24 0.18 8.35 Favored 'General case' 0 CA--C 1.535 0.398 0 O-C-N 121.118 -0.989 . . . . 0.0 108.502 169.619 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.2 mp -132.56 72.66 1.5 Allowed 'General case' 0 C--N 1.346 0.446 0 N-CA-C 104.895 -2.261 . . . . 0.0 104.895 -173.454 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 98.9 m 17.85 -92.84 0.0 OUTLIER 'General case' 0 CA--C 1.522 -0.115 0 C-N-CA 127.091 2.156 . . . . 0.0 115.364 175.932 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -53.73 -30.74 45.4 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 125.028 1.331 . . . . 0.0 113.003 -169.754 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -64.61 -31.54 72.81 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 119.592 1.087 . . . . 0.0 111.901 179.513 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.14 -12.55 8.79 Favored 'General case' 0 N--CA 1.437 -1.091 0 CA-C-O 116.187 -1.863 . . . . 0.0 111.277 176.723 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 5.4 tp -49.55 -42.13 16.68 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.507 0 CA-C-N 121.813 2.097 . . . . 0.0 110.539 179.157 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -66.65 -36.2 90.97 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 111.256 -0.738 . . . . 0.0 111.256 -176.447 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 69.8 t -67.81 -45.55 84.08 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 172.313 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 20.7 mmt180 -61.53 -29.14 69.81 Favored 'General case' 0 C--O 1.225 -0.201 0 CA-C-O 117.282 -1.342 . . . . 0.0 112.055 178.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 6.3 mm -60.93 -53.11 53.62 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-N 120.682 1.583 . . . . 0.0 108.736 176.887 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.422 HG12 HG12 ' A' ' 5' ' ' VAL . 34.1 m -71.36 -32.24 46.09 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-N 119.199 0.909 . . . . 0.0 111.505 -173.946 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 63.4 mt-10 -64.89 -49.57 69.95 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 118.49 0.586 . . . . 0.0 109.883 173.456 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.1 -36.5 83.8 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 119.198 -0.43 . . . . 0.0 110.231 179.031 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 8.2 tp -62.4 -40.42 96.45 Favored 'General case' 0 C--O 1.225 -0.227 0 CA-C-N 119.49 1.041 . . . . 0.0 109.36 -179.217 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -67.83 -25.47 65.58 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 121.339 0.59 . . . . 0.0 112.303 -178.309 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -81.86 -39.29 24.13 Favored 'General case' 0 N--CA 1.436 -1.128 0 C-N-CA 126.219 1.808 . . . . 0.0 109.685 175.872 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 23.4 mmt85 -89.63 -32.55 17.03 Favored 'General case' 0 C--O 1.231 0.099 0 CA-C-O 118.662 -0.685 . . . . 0.0 112.1 -169.637 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -128.22 147.73 50.59 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 118.944 0.793 . . . . 0.0 111.334 -176.499 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 51.6 mm -97.11 138.97 20.64 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 103.834 -2.654 . . . . 0.0 103.834 168.014 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -117.57 153.38 50.44 Favored Pre-proline 0 CA--C 1.539 0.542 0 C-N-CA 123.277 0.631 . . . . 0.0 111.469 -169.362 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -61.03 161.0 23.76 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 123.711 2.941 . . . . 0.0 112.144 169.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -63.42 -32.94 74.51 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -175.824 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 7.5 p90 -75.17 -10.25 59.29 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 -179.207 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 96.7 t -92.31 122.93 44.21 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 173.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -114.66 127.34 55.71 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 106.703 -1.591 . . . . 0.0 106.703 169.348 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -93.98 118.33 39.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 105.076 -2.194 . . . . 0.0 105.076 168.559 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 54.1 tp -118.86 132.21 56.1 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 122.902 0.481 . . . . 0.0 110.352 178.729 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -91.29 120.99 32.65 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 169.154 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -106.7 -22.5 7.65 Favored Glycine 0 CA--C 1.536 1.361 0 CA-C-O 118.437 -1.202 . . . . 0.0 113.6 171.787 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 56.05 -110.84 2.16 Favored Glycine 0 C--N 1.342 0.897 0 CA-C-N 119.878 1.839 . . . . 0.0 112.329 172.071 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 75.7 p -79.99 7.21 9.46 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 125.365 1.466 . . . . 0.0 112.557 -172.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -57.82 -59.3 5.44 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 114.291 1.219 . . . . 0.0 114.291 -170.033 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 56.72 -112.33 3.37 Favored Glycine 0 CA--C 1.532 1.144 0 N-CA-C 109.846 -1.302 . . . . 0.0 109.846 -170.269 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 8.2 tpt -64.19 -21.41 66.55 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.319 1.048 . . . . 0.0 113.449 -176.506 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -56.33 -17.67 8.47 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 114.545 1.313 . . . . 0.0 114.545 -170.879 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 8.8 mt -98.24 17.71 18.01 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 119.499 1.045 . . . . 0.0 112.991 -169.806 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.687 ' HA ' HG13 ' A' ' 100' ' ' VAL . 10.2 tt -48.04 -50.74 26.88 Favored 'General case' 0 C--N 1.343 0.314 0 N-CA-C 112.764 0.654 . . . . 0.0 112.764 -174.901 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -80.31 -29.67 44.19 Favored Glycine 0 CA--C 1.528 0.848 0 CA-C-O 119.659 -0.523 . . . . 0.0 111.952 -178.035 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -86.94 -22.7 25.47 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 114.267 1.21 . . . . 0.0 114.267 -169.053 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.413 ' SD ' HG11 ' A' ' 100' ' ' VAL . 47.6 mtp -78.14 -15.64 58.67 Favored 'General case' 0 CA--C 1.535 0.394 0 O-C-N 121.537 -0.727 . . . . 0.0 111.108 173.958 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.09 150.37 45.56 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 123.708 0.803 . . . . 0.0 112.026 -169.324 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . 0.282 14.4 p30 55.34 17.24 2.03 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 127.923 2.489 . . . . 0.0 117.324 170.048 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.5 159.02 35.04 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 169.155 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -80.61 -52.18 7.88 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 173.784 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -117.22 147.11 42.79 Favored 'General case' 0 CA--C 1.513 -0.478 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 168.941 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -134.97 122.56 22.05 Favored 'General case' 0 CA--C 1.508 -0.661 0 N-CA-C 104.698 -2.334 . . . . 0.0 104.698 175.293 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 3.0 mt -104.42 106.07 19.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 106.45 -1.685 . . . . 0.0 106.45 176.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.547 HD13 HD11 ' A' ' 97' ' ' LEU . 27.4 mt -79.99 124.76 38.45 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 N-CA-C 105.074 -2.195 . . . . 0.0 105.074 169.868 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -113.28 121.07 43.3 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 104.121 -2.548 . . . . 0.0 104.121 168.542 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 41.7 t0 -163.67 156.37 18.05 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 123.592 0.757 . . . . 0.0 110.23 -175.237 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -83.25 142.67 30.96 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 169.008 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 72.1 mt -77.07 -44.29 31.42 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 -175.812 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 14.6 t 53.93 43.46 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.151 0 C-N-CA 124.367 1.067 . . . . 0.0 109.66 -172.059 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 2.4 m -153.76 178.81 9.48 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.212 1.405 . . . . 0.0 109.639 175.838 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . 0.288 30.6 ttmt 67.61 154.69 0.1 Allowed 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 127.968 2.507 . . . . 0.0 113.345 175.557 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 10.3 ptpt -85.14 -5.65 59.33 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 127.205 2.202 . . . . 0.0 114.774 -169.548 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 33.9 t-20 -74.38 169.61 17.32 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.221 0.608 . . . . 0.0 109.619 -173.86 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 4.1 m -57.65 146.31 66.1 Favored Pre-proline 0 CA--C 1.548 0.903 0 C-N-CA 124.111 0.964 . . . . 0.0 112.234 -169.735 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_exo -53.09 148.13 31.84 Favored 'Trans proline' 0 CA--C 1.535 0.573 0 C-N-CA 124.176 3.251 . . . . 0.0 113.178 171.366 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.483 ' HA3' HG22 ' A' ' 133' ' ' THR . . . 74.2 0.01 55.29 Favored Glycine 0 CA--C 1.532 1.096 0 CA-C-O 119.221 -0.766 . . . . 0.0 114.684 174.315 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 27.3 m -73.28 143.39 47.03 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 119.026 1.413 . . . . 0.0 111.155 -169.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 11.0 ttp -85.22 132.5 34.27 Favored 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 169.635 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 65.5 mtm -133.45 127.59 33.63 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 170.071 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.625 HD12 ' HG3' ' A' ' 144' ' ' GLN . 18.6 mm -108.03 124.86 64.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 -173.308 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.5 mp -121.33 134.59 55.14 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 -174.293 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 53.1 mtt85 -86.23 174.02 9.38 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.789 0.835 . . . . 0.0 110.016 -177.399 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -40.59 -52.52 2.85 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 115.068 1.507 . . . . 0.0 115.068 -172.711 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -90.34 -13.81 34.4 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 113.056 0.762 . . . . 0.0 113.056 -175.371 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -77.61 -37.17 50.84 Favored 'General case' 0 C--N 1.339 0.118 0 CA-C-N 118.551 0.614 . . . . 0.0 109.956 -173.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.537 HG12 ' CE2' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -64.29 -49.52 72.2 Favored Pre-proline 0 CA--C 1.534 0.33 0 CA-C-O 117.605 -1.188 . . . . 0.0 112.822 -175.345 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_exo -54.96 -39.6 89.91 Favored 'Trans proline' 0 CA--C 1.539 0.757 0 CA-C-N 120.997 1.392 . . . . 0.0 111.557 176.339 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -76.16 -7.98 56.0 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 176.633 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -92.45 -38.16 12.14 Favored 'General case' 0 C--N 1.342 0.274 0 CA-C-N 120.114 1.325 . . . . 0.0 109.622 174.76 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.537 ' CE2' HG12 ' A' ' 82' ' ' VAL . 26.6 m-85 -77.84 28.83 0.17 Allowed 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -178.573 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 32.1 p -74.02 -24.62 59.59 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 121.463 -0.773 . . . . 0.0 110.282 173.648 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -75.38 152.18 38.1 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 171.743 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 3.1 mppt? -120.88 28.45 7.92 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.895 0.878 . . . . 0.0 111.033 179.57 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 25.9 mt -69.99 -44.73 78.22 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 -178.304 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 2.6 p -97.57 116.61 65.84 Favored Pre-proline 0 CA--C 1.545 0.765 0 C-N-CA 124.962 1.305 . . . . 0.0 110.084 -170.292 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -70.55 -50.09 0.4 Allowed 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 122.535 2.156 . . . . 0.0 114.042 -169.238 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 10.7 t-80 -60.99 -45.64 93.97 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 178.364 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 23.9 mp0 -64.82 -35.88 82.53 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 118.199 -0.905 . . . . 0.0 110.447 -176.287 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -65.28 -41.21 94.4 Favored 'General case' 0 C--O 1.227 -0.128 0 CA-C-N 119.676 1.125 . . . . 0.0 110.028 173.282 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -61.16 -46.28 94.82 Favored Glycine 0 CA--C 1.534 1.237 0 CA-C-N 119.455 1.025 . . . . 0.0 111.232 175.748 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.547 HD11 HD13 ' A' ' 60' ' ' ILE . 2.1 tm? -58.07 -41.49 83.49 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.261 0.625 . . . . 0.0 110.007 174.103 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -65.33 -36.21 83.36 Favored 'General case' 0 N--CA 1.444 -0.772 0 O-C-N 121.049 -1.032 . . . . 0.0 110.919 178.311 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -67.15 -22.41 65.77 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 118.616 0.643 . . . . 0.0 110.466 178.609 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.687 HG13 ' HA ' ' A' ' 49' ' ' LEU . 77.7 t -68.87 -42.08 82.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 168.442 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 42.6 mt -64.65 -35.83 82.3 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-N 119.748 1.158 . . . . 0.0 110.2 179.807 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 17.0 m -63.79 -45.04 91.49 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 119.229 0.922 . . . . 0.0 110.228 172.446 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.19 -44.13 97.79 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 119.093 0.861 . . . . 0.0 111.275 176.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.7 mt -60.61 -33.81 73.3 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.238 1.015 . . . . 0.0 109.996 175.835 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 73.9 ttt-85 -73.68 -34.62 64.97 Favored 'General case' 0 CA--C 1.531 0.238 0 O-C-N 121.141 -0.974 . . . . 0.0 109.792 176.762 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 14.1 m-30 -69.3 -44.14 72.36 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 123.594 0.758 . . . . 0.0 110.665 179.274 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 36.1 p -73.05 -23.95 60.64 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 118.462 0.573 . . . . 0.0 111.701 179.232 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 73.57 7.57 74.21 Favored Glycine 0 CA--C 1.532 1.148 0 N-CA-C 109.394 -1.482 . . . . 0.0 109.394 -168.383 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -86.04 25.58 1.12 Allowed 'General case' 0 C--N 1.348 0.505 0 CA-C-N 119.851 1.826 . . . . 0.0 110.733 174.909 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -61.78 139.12 95.49 Favored Pre-proline 0 CA--C 1.546 0.82 0 C-N-CA 124.006 0.922 . . . . 0.0 108.705 169.516 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo -59.71 162.41 15.65 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.963 2.442 . . . . 0.0 114.03 -177.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp -65.07 -37.63 88.16 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 119.061 -0.495 . . . . 0.0 111.475 174.459 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 4.5 pttm -143.5 85.46 1.84 Allowed 'General case' 0 C--O 1.234 0.252 0 C-N-CA 124.031 0.933 . . . . 0.0 108.585 177.758 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 5.9 tt -75.39 144.8 42.07 Favored 'General case' 0 CA--C 1.537 0.468 0 O-C-N 120.835 -1.165 . . . . 0.0 108.502 169.657 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -137.97 139.64 39.81 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.65 1.18 . . . . 0.0 108.02 177.349 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -118.91 121.12 39.23 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 119.901 1.228 . . . . 0.0 108.658 175.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 3.1 t -89.1 89.98 3.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 N-CA-C 105.855 -1.906 . . . . 0.0 105.855 169.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -81.15 138.78 19.71 Favored Glycine 0 C--N 1.335 0.517 0 N-CA-C 110.273 -1.131 . . . . 0.0 110.273 -178.721 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 38.9 t -122.15 133.39 68.61 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 174.628 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 13.4 mt -85.41 135.32 38.87 Favored Pre-proline 0 CA--C 1.535 0.369 0 N-CA-C 105.561 -2.015 . . . . 0.0 105.561 169.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -73.21 167.16 28.05 Favored 'Trans proline' 0 CA--C 1.54 0.786 0 C-N-CA 121.815 1.677 . . . . 0.0 111.732 -179.161 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -94.38 -56.85 2.67 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 168.807 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 49.0 m -118.73 -55.14 2.21 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -169.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.8 tp 52.21 39.29 26.63 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 126.823 2.049 . . . . 0.0 113.581 -174.621 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -79.61 163.85 56.64 Favored Pre-proline 0 CA--C 1.544 0.721 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 171.025 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -82.39 94.61 0.88 Allowed 'Trans proline' 0 CA--C 1.542 0.896 0 C-N-CA 121.848 1.699 . . . . 0.0 111.863 -176.132 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -173.48 -176.24 1.27 Allowed 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 104.48 -2.415 . . . . 0.0 104.48 -178.178 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -144.24 154.33 15.27 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 CA-C-N 119.42 1.009 . . . . 0.0 112.325 174.738 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 118.6 85.41 1.01 Allowed Glycine 0 CA--C 1.531 1.035 0 N-CA-C 107.93 -2.068 . . . . 0.0 107.93 -174.245 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 81.9 mt -36.55 139.41 0.18 Allowed 'General case' 0 C--N 1.352 0.711 0 N-CA-C 115.192 1.553 . . . . 0.0 115.192 -169.688 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 4.4 p -58.96 151.89 52.98 Favored Pre-proline 0 CA--C 1.535 0.4 0 CA-C-N 113.97 -1.468 . . . . 0.0 108.74 169.631 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -60.49 -35.24 91.25 Favored 'Trans proline' 0 CA--C 1.537 0.63 0 C-N-CA 121.726 1.618 . . . . 0.0 111.74 -176.584 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.483 HG22 ' HA3' ' A' ' 72' ' ' GLY . 1.0 OUTLIER -60.57 -36.21 77.93 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 123.704 0.802 . . . . 0.0 110.834 177.123 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 61.4 t -94.2 -32.49 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 C-N-CA 122.628 0.371 . . . . 0.0 110.004 -172.451 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -53.91 -46.45 71.47 Favored 'General case' 0 C--N 1.33 -0.24 0 O-C-N 121.347 -0.846 . . . . 0.0 109.311 169.422 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -69.06 -16.77 63.77 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 -177.38 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 24.4 mmm -77.94 -8.03 57.57 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 125.47 1.508 . . . . 0.0 113.039 172.135 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 53.5 mt -56.86 -56.06 16.58 Favored 'Isoleucine or valine' 0 C--N 1.344 0.353 0 CA-C-N 120.835 1.652 . . . . 0.0 109.157 176.222 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -67.52 -45.59 47.16 Favored Pre-proline 0 CA--C 1.544 0.714 0 CA-C-O 117.822 -1.085 . . . . 0.0 111.033 -174.227 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -42.94 -58.5 1.3 Allowed 'Trans proline' 0 C--N 1.349 0.578 1 C-N-CA 125.478 4.118 . . . . 0.0 112.979 168.66 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -69.2 -35.91 76.72 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.363 -0.835 . . . . 0.0 112.148 -177.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 25.8 mt -57.07 -41.14 78.26 Favored 'General case' 0 CA--C 1.521 -0.146 0 CA-C-N 119.546 1.066 . . . . 0.0 109.068 171.746 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -62.25 -35.05 77.78 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 118.862 0.755 . . . . 0.0 110.165 178.376 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 144' ' ' GLN . . . . . 0.625 ' HG3' HD12 ' A' ' 76' ' ' ILE . 0.4 OUTLIER -64.24 -46.35 84.18 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 119.623 1.102 . . . . 0.0 111.217 173.064 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 36.2 t -56.65 -48.67 80.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 178.181 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 37.7 mt -62.89 -34.46 77.46 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 118.487 -0.768 . . . . 0.0 110.946 178.104 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -67.2 -46.43 73.89 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 119.81 1.186 . . . . 0.0 110.83 178.125 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -64.46 -32.26 73.82 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 119.679 1.127 . . . . 0.0 111.12 177.816 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 14.1 mt -63.11 -54.75 32.95 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 171.272 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 78.4 mtm-85 -61.21 -32.05 71.82 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 120.336 1.426 . . . . 0.0 111.765 -178.125 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -70.52 -27.65 64.34 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 118.677 0.671 . . . . 0.0 110.332 179.808 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 23.5 m -81.12 5.47 16.66 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.601 1.16 . . . . 0.0 111.77 169.884 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 70.89 13.7 72.5 Favored Glycine 0 CA--C 1.53 0.997 0 CA-C-O 117.641 -1.644 . . . . 0.0 112.497 -171.238 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 58.3 t -90.62 118.05 35.1 Favored 'Isoleucine or valine' 0 C--N 1.347 0.463 0 CA-C-N 120.603 2.202 . . . . 0.0 107.787 -177.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -93.86 96.06 9.5 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 171.707 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -59.63 139.93 56.8 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 169.004 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 11.1 mm -85.41 123.61 72.71 Favored Pre-proline 0 CA--C 1.534 0.342 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 -174.762 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -64.2 103.23 0.42 Allowed 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 122.913 2.409 . . . . 0.0 105.928 171.184 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 20.4 tpp85 45.3 -110.28 0.22 Allowed 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 104.954 -2.239 . . . . 0.0 104.954 -166.655 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 3.7 p -155.55 155.73 33.89 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 119.766 1.166 . . . . 0.0 109.576 169.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -86.38 103.48 14.99 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 174.207 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 45.7 m . . . . . 0 C--O 1.255 1.37 0 C-N-CA 125.827 1.651 . . . . 0.0 108.353 179.161 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.1 tpt . . . . . 0 N--CA 1.498 1.938 0 CA-C-O 119.708 -0.187 . . . . 0.0 110.558 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 8.5 ptp180 -151.43 121.66 7.25 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-O 118.036 -0.983 . . . . 0.0 108.662 177.494 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 52.0 mt -140.31 144.16 28.19 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-N 120.033 1.288 . . . . 0.0 110.873 -169.732 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 3.1 mt -127.8 122.18 32.07 Favored 'General case' 0 CA--C 1.519 -0.248 0 N-CA-C 107.046 -1.465 . . . . 0.0 107.046 168.682 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.469 HG12 HG12 ' A' ' 23' ' ' VAL . 11.5 t -97.46 111.86 28.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 1 N-CA-C 100.125 -4.028 . . . . 0.0 100.125 168.688 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.525 ' HB2' HD21 ' A' ' 58' ' ' LEU . 0.5 OUTLIER -117.35 107.32 14.23 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 123.112 0.565 . . . . 0.0 109.497 -168.048 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -89.74 123.82 7.12 Favored Glycine 0 N--CA 1.448 -0.511 0 N-CA-C 108.722 -1.751 . . . . 0.0 108.722 179.606 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.6 m -132.52 -177.91 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.805 0 C-N-CA 124.053 0.941 . . . . 0.0 109.532 -179.314 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 98.07 131.22 7.07 Favored Glycine 0 N--CA 1.437 -1.281 0 N-CA-C 107.158 -2.377 . . . . 0.0 107.158 -169.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -69.16 131.52 45.08 Favored 'General case' 0 N--CA 1.451 -0.379 0 O-C-N 121.846 -0.797 . . . . 0.0 111.947 -168.866 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.4 pt -79.06 41.39 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 123.605 0.762 . . . . 0.0 112.961 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 19.4 mt -129.7 -12.09 4.35 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 120.129 1.331 . . . . 0.0 109.833 171.22 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.1 mp -117.1 62.7 0.73 Allowed 'General case' 0 C--N 1.346 0.434 0 CA-C-O 122.116 0.96 . . . . 0.0 109.766 -169.662 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.9 m 51.71 -119.59 1.48 Allowed 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 114.322 -1.308 . . . . 0.0 112.059 169.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 61.3 m-20 -50.92 -23.07 2.58 Favored 'General case' 0 N--CA 1.44 -0.929 0 C-N-CA 127.866 2.466 . . . . 0.0 114.282 179.083 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.411 ' CD ' HE22 ' A' ' 94' ' ' GLN . 1.6 tp10 -63.28 -26.34 68.73 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 119.643 1.11 . . . . 0.0 110.456 -179.472 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.74 -8.7 45.34 Favored 'General case' 0 N--CA 1.438 -1.059 0 CA-C-O 116.819 -1.562 . . . . 0.0 111.215 176.744 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.1 tp -51.67 -45.43 36.93 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.414 0 CA-C-N 121.341 1.882 . . . . 0.0 111.132 -173.783 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -63.51 -34.63 90.45 Favored Glycine 0 CA--C 1.526 0.771 0 CA-C-N 119.131 0.878 . . . . 0.0 111.324 -177.818 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 97.8 t -68.18 -48.43 73.9 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 CA-C-N 117.518 0.659 . . . . 0.0 109.32 172.304 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 24.1 mmt180 -57.52 -29.65 64.5 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 117.429 -1.272 . . . . 0.0 112.147 177.287 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 5.7 mm -62.42 -53.98 40.12 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-N 120.818 1.645 . . . . 0.0 109.046 176.729 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.469 HG12 HG12 ' A' ' 5' ' ' VAL . 26.5 m -70.61 -34.7 58.14 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 CA-C-N 118.833 0.742 . . . . 0.0 111.312 -176.206 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 58.3 mt-10 -65.36 -45.03 85.72 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 118.954 0.797 . . . . 0.0 110.015 176.209 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.67 -39.88 95.43 Favored 'General case' 0 N--CA 1.452 -0.342 0 O-C-N 121.808 -0.557 . . . . 0.0 109.982 176.814 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 5.7 tp -64.55 -39.2 93.32 Favored 'General case' 0 C--O 1.221 -0.4 0 CA-C-N 118.858 0.754 . . . . 0.0 110.169 -178.368 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -61.95 -26.23 68.07 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 121.501 0.667 . . . . 0.0 112.493 -178.914 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -93.33 -40.86 10.17 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 125.994 1.718 . . . . 0.0 111.125 -178.573 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 37.3 mmm-85 -83.29 -31.17 27.04 Favored 'General case' 0 C--N 1.333 -0.112 0 C-N-CA 123.021 0.528 . . . . 0.0 110.833 -174.393 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -123.89 146.92 48.09 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-O 122.313 1.054 . . . . 0.0 112.728 -177.365 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 39.3 mm -98.92 135.29 34.52 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 N-CA-C 104.887 -2.264 . . . . 0.0 104.887 169.404 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -120.24 148.6 47.62 Favored Pre-proline 0 CA--C 1.537 0.447 0 C-N-CA 124.025 0.93 . . . . 0.0 109.943 -169.758 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -67.4 158.62 56.2 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 123.05 2.5 . . . . 0.0 110.253 170.12 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -57.69 -33.79 68.76 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 114.48 1.289 . . . . 0.0 114.48 -169.662 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 10.8 p90 -74.37 -12.82 60.63 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 112.786 0.661 . . . . 0.0 112.786 -176.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 74.0 t -89.67 125.61 42.62 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 172.319 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 52.1 mm-40 -113.18 130.6 56.16 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 169.01 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -95.78 116.28 37.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 104.877 -2.268 . . . . 0.0 104.877 168.766 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 65.3 tp -118.19 129.02 55.26 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 118.073 0.397 . . . . 0.0 110.373 -179.149 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -88.7 107.04 18.73 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 106.312 -1.736 . . . . 0.0 106.312 168.708 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -92.32 -40.33 5.14 Favored Glycine 0 CA--C 1.535 1.308 0 N-CA-C 110.432 -1.067 . . . . 0.0 110.432 169.869 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 57.3 -103.69 0.33 Allowed Glycine 0 C--N 1.341 0.807 0 CA-C-N 117.773 0.787 . . . . 0.0 112.683 171.78 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 19.8 p -67.9 -5.82 18.76 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 126.521 1.929 . . . . 0.0 113.237 -179.518 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.48 -63.16 1.39 Allowed 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 -172.16 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 53.69 -110.06 1.31 Allowed Glycine 0 CA--C 1.535 1.283 0 N-CA-C 110.62 -0.992 . . . . 0.0 110.62 -170.867 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.06 -30.42 66.18 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.553 1.141 . . . . 0.0 111.268 -177.382 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -56.82 -19.74 18.86 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 -174.092 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 20.5 mt -85.12 12.99 6.76 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 113.551 0.945 . . . . 0.0 113.551 -177.437 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.576 ' HA ' HG13 ' A' ' 100' ' ' VAL . 6.3 tt -42.04 -61.0 1.24 Allowed 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.27 1.028 . . . . 0.0 112.63 -172.824 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -79.73 -30.42 43.96 Favored Glycine 0 CA--C 1.527 0.819 0 N-CA-C 111.392 -0.683 . . . . 0.0 111.392 -179.548 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -67.43 -36.06 80.5 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 118.428 1.114 . . . . 0.0 112.112 -169.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.431 ' SD ' HG11 ' A' ' 100' ' ' VAL . 36.2 mtp -75.4 -9.93 59.0 Favored 'General case' 0 N--CA 1.451 -0.399 0 O-C-N 122.037 -0.414 . . . . 0.0 111.765 -178.264 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.63 151.62 40.77 Favored 'General case' 0 N--CA 1.445 -0.723 0 C-N-CA 123.149 0.58 . . . . 0.0 112.474 -169.271 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . 0.281 15.5 p30 53.51 21.21 2.38 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 128.749 2.82 . . . . 0.0 116.211 170.041 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 17.4 mmt180 -75.5 160.0 30.67 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 169.749 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -86.57 -52.39 5.58 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 176.734 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . 0.25 0.0 OUTLIER -124.53 143.31 50.74 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 119.952 1.251 . . . . 0.0 107.713 169.37 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.525 HD21 ' HB2' ' A' ' 6' ' ' LEU . 4.5 tt -139.97 120.8 14.45 Favored 'General case' 0 CA--C 1.501 -0.911 0 N-CA-C 105.476 -2.046 . . . . 0.0 105.476 -178.343 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 25.8 mt -100.21 106.09 18.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 106.104 -1.813 . . . . 0.0 106.104 179.57 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.445 HD13 HD11 ' A' ' 97' ' ' LEU . 16.9 mt -75.13 133.63 31.04 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 N-CA-C 105.135 -2.172 . . . . 0.0 105.135 169.682 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -120.16 121.49 38.89 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 104.915 -2.254 . . . . 0.0 104.915 168.753 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 36.8 t0 -156.75 162.19 39.77 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 118.529 0.604 . . . . 0.0 110.287 -171.863 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.559 ' HB1' ' HD3' ' A' ' 121' ' ' PRO . . . -103.74 157.23 17.21 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 121.927 0.87 . . . . 0.0 109.994 172.227 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 5.1 mp -134.64 88.09 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 N-CA-C 106.892 -1.521 . . . . 0.0 106.892 -176.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.446 HG11 HD22 ' A' ' 124' ' ' LEU . 31.5 m -52.48 -21.1 2.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 C-N-CA 125.89 1.676 . . . . 0.0 112.217 168.568 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.6 m -78.01 174.08 11.49 Favored 'General case' 0 N--CA 1.442 -0.845 0 C-N-CA 124.249 1.02 . . . . 0.0 111.852 -169.289 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 18.2 ttmm 67.25 163.12 0.19 Allowed 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 126.108 1.763 . . . . 0.0 111.907 -179.735 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 23.1 mtmt -77.38 -7.83 56.72 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 125.301 1.44 . . . . 0.0 112.134 179.567 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 43.5 t-20 -68.16 156.94 36.46 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.232 1.013 . . . . 0.0 110.234 -169.812 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 2.2 m -62.3 149.18 88.08 Favored Pre-proline 0 CA--C 1.546 0.795 0 C-N-CA 124.663 1.185 . . . . 0.0 113.446 -169.004 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_exo -58.9 159.81 20.14 Favored 'Trans proline' 0 CA--C 1.533 0.465 0 C-N-CA 124.029 3.153 . . . . 0.0 111.625 168.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 65.64 19.15 66.79 Favored Glycine 0 CA--C 1.53 0.986 0 CA-C-O 119.753 -0.471 . . . . 0.0 112.952 172.299 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 2.7 m -99.24 142.46 30.7 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 124.495 1.118 . . . . 0.0 109.448 -172.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 13.4 ttp -91.1 134.88 34.16 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 172.607 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 69.6 mtm -122.28 115.73 22.86 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 170.539 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.453 HD12 ' HG2' ' A' ' 144' ' ' GLN . 28.1 mm -102.87 120.81 53.22 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 -177.798 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.6 mp -128.09 137.18 52.04 Favored 'General case' 0 C--O 1.236 0.376 0 O-C-N 123.97 0.793 . . . . 0.0 109.812 -173.09 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 53.6 mtt85 -89.16 176.31 7.02 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.237 1.015 . . . . 0.0 110.042 -177.9 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -38.01 -58.94 0.89 Allowed 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.466 1.507 . . . . 0.0 113.762 -173.119 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -86.61 -15.9 38.36 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -171.447 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -75.13 -36.83 61.57 Favored 'General case' 0 N--CA 1.457 -0.11 0 O-C-N 121.876 -0.515 . . . . 0.0 109.902 -175.336 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.52 HG12 ' CE2' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -66.37 -49.23 54.39 Favored Pre-proline 0 CA--C 1.535 0.383 0 CA-C-O 117.653 -1.165 . . . . 0.0 112.585 -174.619 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -55.32 -37.78 94.3 Favored 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 121.758 1.639 . . . . 0.0 111.594 174.651 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.11 -2.37 37.08 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 114.234 1.198 . . . . 0.0 114.234 176.901 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -102.48 -38.46 7.56 Favored 'General case' 0 C--N 1.344 0.33 0 CA-C-N 119.805 1.184 . . . . 0.0 111.376 179.632 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.52 ' CE2' HG12 ' A' ' 82' ' ' VAL . 43.9 m-85 -70.41 0.94 5.62 Favored 'General case' 0 CA--C 1.544 0.746 0 O-C-N 121.641 -0.662 . . . . 0.0 112.5 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 64.5 p -57.84 -21.0 40.23 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.577 1.551 . . . . 0.0 112.687 174.667 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 11.1 p30 -60.82 -30.51 70.12 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 118.66 -0.686 . . . . 0.0 112.489 175.626 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 30.3 mtmm 50.82 27.34 3.05 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 125.152 1.381 . . . . 0.0 114.32 177.205 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 13.5 mt -72.35 -43.15 65.01 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 O-C-N 121.252 -0.905 . . . . 0.0 109.523 -174.879 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 3.1 p -113.25 143.2 28.79 Favored Pre-proline 0 CA--C 1.544 0.716 0 C-N-CA 123.675 0.79 . . . . 0.0 112.54 -169.541 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -75.31 -42.26 0.5 Allowed 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 122.76 2.307 . . . . 0.0 113.704 -169.147 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 10.2 t-80 -61.81 -45.42 93.91 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 119.399 1.0 . . . . 0.0 108.885 178.361 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.411 HE22 ' CD ' ' A' ' 16' ' ' GLU . 21.5 mp0 -62.15 -41.94 98.77 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 125.27 1.428 . . . . 0.0 108.634 -177.775 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 50.7 tp -64.14 -38.19 90.16 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 119.145 0.884 . . . . 0.0 110.995 174.866 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -63.1 -51.11 57.69 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 110.556 -1.018 . . . . 0.0 110.556 176.599 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.445 HD11 HD13 ' A' ' 60' ' ' ILE . 2.8 tm? -56.94 -43.05 81.12 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.207 0.603 . . . . 0.0 109.963 175.855 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -62.77 -37.81 88.13 Favored 'General case' 0 N--CA 1.452 -0.36 0 O-C-N 121.306 -0.871 . . . . 0.0 111.413 177.61 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -69.3 -22.36 63.8 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 118.851 0.75 . . . . 0.0 110.83 178.327 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.576 HG13 ' HA ' ' A' ' 49' ' ' LEU . 97.6 t -68.04 -42.72 85.47 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 168.631 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 92.1 mt -63.73 -36.75 84.88 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 119.348 0.977 . . . . 0.0 109.934 178.836 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 70.3 m -64.59 -41.68 96.08 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 119.249 0.931 . . . . 0.0 110.726 171.178 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.49 -44.07 97.74 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 120.254 1.388 . . . . 0.0 110.611 176.687 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.9 mt -63.37 -33.04 74.67 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.669 1.188 . . . . 0.0 110.765 176.698 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 65.7 ttp85 -73.65 -31.79 63.68 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.008 0.923 . . . . 0.0 110.001 176.057 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 14.9 m-30 -71.34 -46.04 61.5 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 119.185 0.902 . . . . 0.0 110.473 177.095 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 34.0 p -73.84 -24.33 59.76 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 123.128 0.571 . . . . 0.0 112.132 -178.729 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 74.63 8.0 80.55 Favored Glycine 0 CA--C 1.536 1.351 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -168.329 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -85.04 22.0 1.51 Allowed 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 119.851 1.826 . . . . 0.0 111.438 174.804 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -60.48 137.63 92.38 Favored Pre-proline 0 CA--C 1.545 0.771 0 C-N-CA 124.175 0.99 . . . . 0.0 108.737 169.75 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -61.25 163.36 17.4 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.779 2.319 . . . . 0.0 114.543 -176.192 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 68.3 mmtt -67.96 -35.57 78.61 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 118.941 -0.552 . . . . 0.0 112.37 175.117 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 8.2 ttmm -142.08 66.63 1.34 Allowed 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 -175.382 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 7.8 tt -70.83 138.38 50.26 Favored 'General case' 0 C--O 1.234 0.238 0 O-C-N 120.063 -1.648 . . . . 0.0 108.476 172.794 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -134.61 136.59 43.02 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 179.487 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -114.06 122.46 46.96 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 119.956 1.253 . . . . 0.0 107.874 175.639 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 21.3 t -95.87 85.52 1.63 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 N-CA-C 106.316 -1.735 . . . . 0.0 106.316 169.67 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -77.25 148.63 34.57 Favored Glycine 0 N--CA 1.445 -0.741 0 N-CA-C 110.706 -0.958 . . . . 0.0 110.706 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 46.9 t -124.54 165.72 21.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 171.716 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 15.5 mt -117.55 120.21 33.39 Favored Pre-proline 0 N--CA 1.468 0.428 0 CA-C-N 121.232 1.833 . . . . 0.0 108.605 171.069 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.559 ' HD3' ' HB1' ' A' ' 63' ' ' ALA . 3.3 Cg_exo -55.16 158.93 10.84 Favored 'Trans proline' 0 N--CA 1.455 -0.775 1 C-N-CA 126.142 4.561 . . . . 0.0 116.093 175.614 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -107.75 -64.24 1.23 Allowed 'General case' 0 C--O 1.236 0.344 0 C-N-CA 124.348 1.059 . . . . 0.0 109.628 178.28 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 70.5 m -106.03 -50.13 3.23 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 119.093 -0.479 . . . . 0.0 110.154 -171.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.446 HD22 HG11 ' A' ' 65' ' ' VAL . 1.2 tp 51.97 32.51 10.19 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 124.126 0.971 . . . . 0.0 112.812 178.651 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -83.49 164.6 44.5 Favored Pre-proline 0 CA--C 1.544 0.734 0 O-C-N 121.525 -0.734 . . . . 0.0 109.417 176.423 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -78.65 82.96 2.34 Favored 'Trans proline' 0 CA--C 1.544 1.012 0 C-N-CA 121.869 1.713 . . . . 0.0 111.953 -173.142 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -175.67 153.22 1.4 Allowed 'General case' 0 C--O 1.234 0.269 0 N-CA-C 104.276 -2.491 . . . . 0.0 104.276 -177.917 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -110.38 160.71 9.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.552 0.692 . . . . 0.0 111.861 -170.234 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 108.11 141.37 9.69 Favored Glycine 0 CA--C 1.529 0.929 0 N-CA-C 106.457 -2.657 . . . . 0.0 106.457 -169.286 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 74.8 mt -80.7 154.03 27.52 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 118.065 0.932 . . . . 0.0 109.667 179.829 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 68.2 p -70.82 168.47 20.15 Favored Pre-proline 0 CA--C 1.541 0.619 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 169.394 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_exo -59.76 -40.21 66.08 Favored 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 121.717 1.611 . . . . 0.0 111.165 173.447 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 85.3 m -59.67 -37.45 78.8 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 124.619 1.168 . . . . 0.0 111.751 -179.358 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 58.4 t -98.51 -29.32 3.53 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 O-C-N 121.776 -0.578 . . . . 0.0 110.638 -174.482 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -52.37 -45.37 65.74 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 119.518 1.054 . . . . 0.0 108.793 169.193 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -65.68 -15.97 63.31 Favored 'General case' 0 N--CA 1.447 -0.575 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 -177.589 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 14.1 mmm -83.45 -8.41 59.38 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 125.321 1.448 . . . . 0.0 112.425 175.475 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 54.8 mt -56.75 -56.51 13.84 Favored 'Isoleucine or valine' 0 C--N 1.343 0.293 0 CA-C-N 120.192 1.36 . . . . 0.0 108.788 172.071 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 64.3 mm-40 -63.48 -49.7 76.95 Favored Pre-proline 0 CA--C 1.541 0.618 0 CA-C-O 117.468 -1.253 . . . . 0.0 109.99 -172.885 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -39.96 -56.58 1.38 Allowed 'Trans proline' 0 C--N 1.35 0.613 1 C-N-CA 125.798 4.332 . . . . 0.0 113.353 168.904 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -69.93 -35.5 74.58 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.649 -178.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 37.3 mt -64.06 -45.99 86.35 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 120.806 1.639 . . . . 0.0 109.345 176.406 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -54.61 -36.43 64.46 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 118.52 0.6 . . . . 0.0 110.226 174.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' GLN . . . . . 0.453 ' HG2' HD12 ' A' ' 76' ' ' ILE . 70.8 tp60 -75.86 -38.99 57.4 Favored 'General case' 0 N--CA 1.423 -1.809 0 O-C-N 121.465 -0.772 . . . . 0.0 110.913 -179.562 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 37.2 t -58.68 -45.18 90.99 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 CA-C-N 119.276 0.943 . . . . 0.0 108.93 173.632 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 56.8 mt -60.85 -36.82 80.12 Favored 'General case' 0 C--O 1.226 -0.176 0 CA-C-O 119.09 -0.481 . . . . 0.0 110.218 175.718 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -68.68 -46.11 69.94 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 119.523 1.056 . . . . 0.0 111.29 179.464 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -66.88 -28.81 68.63 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 119.76 1.164 . . . . 0.0 111.068 178.424 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 23.9 mt -63.39 -51.22 66.71 Favored 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 169.778 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 96.8 mtt-85 -66.69 -16.06 63.95 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 117.845 -1.074 . . . . 0.0 112.543 179.33 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 33.1 mm-40 -65.97 -24.38 66.78 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 120.769 1.622 . . . . 0.0 110.899 172.176 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 65.3 m -100.53 18.98 17.72 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 119.436 1.016 . . . . 0.0 110.087 168.409 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 69.43 20.03 74.99 Favored Glycine 0 C--N 1.337 0.595 0 CA-C-O 117.838 -1.535 . . . . 0.0 112.276 -178.073 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 18.0 t -88.05 117.3 31.53 Favored 'Isoleucine or valine' 0 C--N 1.344 0.358 0 CA-C-N 120.23 2.015 . . . . 0.0 107.393 -172.331 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -101.87 88.14 3.3 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 177.16 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -58.06 141.7 49.2 Favored 'General case' 0 CA--C 1.539 0.558 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 169.223 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.4 ' CG2' ' HA ' ' A' ' 160' ' ' SER . 30.9 mm -98.82 122.56 52.52 Favored Pre-proline 0 N--CA 1.463 0.176 0 CA-C-O 117.396 -1.287 . . . . 0.0 108.976 -172.0 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -63.12 106.53 0.56 Allowed 'Trans proline' 0 N--CA 1.459 -0.529 0 C-N-CA 122.17 1.913 . . . . 0.0 109.017 173.237 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 56.7 mtm180 39.9 48.02 1.98 Allowed 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 125.974 1.71 . . . . 0.0 113.604 179.273 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 160' ' ' SER . . . . . 0.4 ' HA ' ' CG2' ' A' ' 157' ' ' ILE 0.272 2.4 p 53.16 18.31 1.16 Allowed 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 126.698 1.999 . . . . 0.0 115.137 179.628 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -80.8 120.94 25.31 Favored 'General case' 0 C--O 1.238 0.449 0 O-C-N 120.938 -1.101 . . . . 0.0 109.696 177.068 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 14.1 m . . . . . 0 C--O 1.256 1.396 0 C-N-CA 124.199 1.0 . . . . 0.0 110.886 -175.937 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.6 tpt . . . . . 0 N--CA 1.496 1.839 0 CA-C-O 119.611 -0.233 . . . . 0.0 110.483 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 6.4 ptm85 -143.53 125.35 15.13 Favored 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 176.917 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 33.9 mt -137.72 148.77 25.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 CA-C-N 121.06 1.755 . . . . 0.0 111.922 -169.023 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 16.4 tp -134.55 111.07 9.77 Favored 'General case' 0 C--N 1.341 0.199 0 N-CA-C 105.484 -2.043 . . . . 0.0 105.484 168.081 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 24.9 t -90.68 115.36 29.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 102.927 -2.99 . . . . 0.0 102.927 170.403 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -115.37 113.03 23.23 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 123.173 0.589 . . . . 0.0 110.927 -168.376 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -94.13 121.65 6.78 Favored Glycine 0 N--CA 1.445 -0.712 0 N-CA-C 108.055 -2.018 . . . . 0.0 108.055 173.625 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.4 m -131.95 -167.68 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 C-N-CA 124.012 0.925 . . . . 0.0 108.625 -177.756 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 105.49 158.1 22.75 Favored Glycine 0 C--N 1.333 0.38 0 N-CA-C 110.505 -1.038 . . . . 0.0 110.505 -175.556 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -81.65 94.81 7.02 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 124.572 1.149 . . . . 0.0 108.915 -174.403 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.3 pt -69.82 27.58 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 N-CA-C 114.659 1.355 . . . . 0.0 114.659 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 38.3 mt -114.31 -9.66 12.78 Favored 'General case' 0 C--O 1.224 -0.245 0 O-C-N 121.138 -0.976 . . . . 0.0 108.581 171.34 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.1 mp -120.75 74.35 1.06 Allowed 'General case' 0 CA--C 1.502 -0.879 0 N-CA-C 105.475 -2.046 . . . . 0.0 105.475 -169.868 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 20.1 m 36.08 -106.53 0.04 OUTLIER 'General case' 0 N--CA 1.447 -0.585 0 O-C-N 126.215 2.197 . . . . 0.0 113.012 169.118 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -68.2 -13.67 62.41 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 114.628 1.344 . . . . 0.0 114.628 -170.165 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -65.84 -19.57 65.93 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 121.457 1.935 . . . . 0.0 111.769 173.258 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.58 -10.81 49.19 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 116.165 -1.874 . . . . 0.0 111.162 172.552 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 6.6 tp -54.96 -38.79 46.65 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 CA-C-N 121.753 2.069 . . . . 0.0 110.977 -178.155 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -60.0 -46.04 94.85 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 110.764 -0.935 . . . . 0.0 110.764 178.727 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 61.7 t -65.11 -47.4 87.91 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 O-C-N 122.175 -0.603 . . . . 0.0 109.68 174.559 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 20.3 mmt180 -60.21 -32.01 70.7 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 117.374 -1.298 . . . . 0.0 112.922 -178.181 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 20.3 mt -62.97 -44.13 99.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-N 121.151 1.796 . . . . 0.0 110.158 179.257 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 28.4 m -73.74 -34.59 41.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 CA-C-N 120.128 1.331 . . . . 0.0 111.542 -178.185 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 57.8 mt-10 -62.22 -42.37 99.25 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 117.957 0.344 . . . . 0.0 110.458 171.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -67.79 -38.29 83.15 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 119.051 0.842 . . . . 0.0 111.23 176.747 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 7.1 tp -63.51 -39.52 94.64 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 119.418 1.008 . . . . 0.0 109.844 -177.463 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -61.93 -18.83 61.66 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.88 0.872 . . . . 0.0 113.117 -179.474 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -102.57 -43.61 5.57 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 126.622 1.969 . . . . 0.0 110.992 -178.888 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 53.5 mmt-85 -74.69 -34.11 62.57 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.259 0.623 . . . . 0.0 110.547 -176.184 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 -124.89 154.03 41.71 Favored 'General case' 0 CA--C 1.521 -0.163 0 CA-C-O 121.417 0.627 . . . . 0.0 111.944 -178.201 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 47.7 mm -106.26 135.27 45.22 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 N-CA-C 103.418 -2.808 . . . . 0.0 103.418 168.047 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -119.07 149.78 47.6 Favored Pre-proline 0 C--O 1.237 0.438 0 CA-C-O 118.661 -0.685 . . . . 0.0 109.953 -169.605 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -65.95 162.08 36.79 Favored 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 122.992 2.461 . . . . 0.0 111.562 173.167 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -58.25 -33.69 69.65 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 115.046 1.498 . . . . 0.0 115.046 -169.196 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 8.6 p90 -73.06 -8.73 57.05 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 -178.016 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 76.1 t -88.99 128.16 41.27 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 174.876 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -116.08 124.35 50.19 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 105.913 -1.884 . . . . 0.0 105.913 169.063 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -93.53 112.9 27.33 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 N-CA-C 104.402 -2.444 . . . . 0.0 104.402 168.61 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 61.4 tp -112.36 128.94 56.43 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 -178.606 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -89.31 118.96 29.37 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 169.515 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -78.66 -79.98 0.76 Allowed Glycine 0 CA--C 1.526 0.764 0 N-CA-C 107.234 -2.346 . . . . 0.0 107.234 169.475 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 78.54 104.65 0.2 Allowed Glycine 0 C--N 1.344 0.974 0 N-CA-C 108.675 -1.77 . . . . 0.0 108.675 -177.762 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 12.9 p 52.74 50.72 17.48 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 123.535 0.734 . . . . 0.0 109.286 -178.792 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -104.4 -79.66 0.55 Allowed 'General case' 0 C--N 1.348 0.528 0 CA-C-N 115.312 -0.858 . . . . 0.0 112.105 -169.239 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 59.81 -110.55 2.88 Favored Glycine 0 CA--C 1.533 1.164 0 N-CA-C 110.075 -1.21 . . . . 0.0 110.075 -174.847 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 12.1 tpt -62.52 -21.57 65.63 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.844 1.258 . . . . 0.0 113.442 -173.366 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -63.91 -18.81 64.58 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 114.193 1.183 . . . . 0.0 114.193 -174.23 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 10.3 mt -100.52 14.37 31.53 Favored 'General case' 0 C--N 1.34 0.173 0 N-CA-C 115.643 1.719 . . . . 0.0 115.643 -168.087 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 6.1 tt -49.1 -55.63 11.63 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 118.968 0.804 . . . . 0.0 110.9 -176.562 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -67.67 -32.64 78.74 Favored Glycine 0 CA--C 1.527 0.809 0 CA-C-O 119.224 -0.764 . . . . 0.0 112.419 -176.491 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -80.76 -35.36 33.38 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 119.049 1.424 . . . . 0.0 110.763 -171.793 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 79.8 mtp -69.28 -14.07 62.74 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.134 0.973 . . . . 0.0 111.088 176.084 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -68.07 140.11 56.26 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 123.572 0.749 . . . . 0.0 112.199 -169.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 15.7 p30 50.56 22.17 1.02 Allowed 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 127.776 2.43 . . . . 0.0 115.09 172.746 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 17.9 mmt180 -71.23 150.15 45.56 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 170.315 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 46.1 m-20 -79.85 -53.68 6.55 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -116.22 145.16 43.34 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-N 120.422 1.464 . . . . 0.0 107.474 168.802 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 22.7 tp -132.19 105.83 7.59 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 103.516 -2.772 . . . . 0.0 103.516 176.044 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 28.0 mt -93.69 112.73 27.15 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 N-CA-C 104.205 -2.517 . . . . 0.0 104.205 173.138 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 24.1 mt -93.49 130.72 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 N-CA-C 105.572 -2.01 . . . . 0.0 105.572 176.825 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -111.83 124.13 51.71 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 105.414 -2.069 . . . . 0.0 105.414 169.656 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.406 ' CG ' HE21 ' A' ' 94' ' ' GLN . 42.9 t0 -158.59 159.12 35.1 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 124.285 1.034 . . . . 0.0 108.265 -177.031 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -89.25 144.7 25.91 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 170.099 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 31.9 mt -88.27 -25.56 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 C-N-CA 123.917 0.887 . . . . 0.0 110.453 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . 0.461 12.5 m 58.51 -15.08 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 N-CA-C 119.449 3.129 . . . . 0.0 119.449 176.296 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 5.9 p -157.99 131.26 7.59 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 121.101 1.773 . . . . 0.0 113.778 169.037 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 12.7 tppt? -166.39 175.35 8.24 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 128.236 2.614 . . . . 0.0 105.485 169.063 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.0 -23.8 63.2 Favored 'General case' 0 N--CA 1.474 0.741 0 O-C-N 121.662 -0.648 . . . . 0.0 111.62 174.908 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 -69.14 162.37 27.15 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.078 0.951 . . . . 0.0 110.994 -173.374 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 3.1 m -61.63 154.22 66.76 Favored Pre-proline 0 CA--C 1.548 0.873 0 C-N-CA 124.922 1.289 . . . . 0.0 112.697 -169.751 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_exo -57.32 159.34 16.11 Favored 'Trans proline' 0 N--CA 1.462 -0.375 0 C-N-CA 123.878 3.052 . . . . 0.0 112.591 169.607 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 64.99 10.18 44.91 Favored Glycine 0 CA--C 1.538 1.514 0 CA-C-O 119.314 -0.714 . . . . 0.0 114.508 171.522 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 3.3 m -90.98 151.93 20.88 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 125.932 1.693 . . . . 0.0 111.305 -169.408 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 29.0 ttp -96.3 139.5 32.35 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 169.789 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 70.0 mtm -131.14 131.17 43.91 Favored 'General case' 0 N--CA 1.462 0.129 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 169.412 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 9.5 mm -89.25 123.17 41.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 177.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -113.86 123.97 51.09 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 171.803 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 85.0 mtm180 -87.67 174.36 8.47 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 123.537 0.735 . . . . 0.0 110.515 -178.571 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -41.37 -53.87 3.19 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 115.884 1.809 . . . . 0.0 115.884 -169.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -84.03 -16.68 43.01 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -177.002 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -82.4 -37.01 26.14 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 -171.564 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.54 HG12 ' CE2' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -64.57 -45.51 76.58 Favored Pre-proline 0 CA--C 1.531 0.242 0 CA-C-O 117.221 -1.371 . . . . 0.0 113.862 -176.732 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -53.61 -42.34 66.73 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 121.981 1.787 . . . . 0.0 110.262 174.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -75.54 4.34 7.74 Favored 'General case' 0 CA--C 1.55 0.943 0 N-CA-C 114.466 1.284 . . . . 0.0 114.466 175.28 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -116.18 -41.77 3.12 Favored 'General case' 0 C--N 1.343 0.316 0 CA-C-N 120.09 1.313 . . . . 0.0 111.155 -177.832 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.676 ' HB3' ' HB2' ' A' ' 98' ' ' ALA . 63.8 m-85 -62.75 -8.92 7.65 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 178.167 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 63.2 p -51.65 -28.88 15.84 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.928 1.291 . . . . 0.0 112.955 173.216 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 53.8 t-20 -52.46 117.4 2.83 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.279 0.632 . . . . 0.0 111.17 -175.54 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -74.95 -19.36 60.14 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.733 0.813 . . . . 0.0 112.329 -173.575 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 52.7 mt -65.47 -48.89 81.27 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 -178.678 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 6.6 m -76.08 111.49 15.34 Favored Pre-proline 0 CA--C 1.55 0.955 0 C-N-CA 125.406 1.482 . . . . 0.0 110.444 -169.809 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -70.56 -60.12 0.07 OUTLIER 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 122.931 2.421 . . . . 0.0 113.847 -168.767 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 6.7 t-80 -62.32 -40.06 95.09 Favored 'General case' 0 N--CA 1.463 0.2 0 O-C-N 121.463 -0.773 . . . . 0.0 109.319 -178.272 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.406 HE21 ' CG ' ' A' ' 62' ' ' ASP . 18.3 mp0 -62.38 -36.65 82.96 Favored 'General case' 0 N--CA 1.44 -0.961 0 C-N-CA 125.241 1.416 . . . . 0.0 108.943 -176.027 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.434 ' O ' ' HB3' ' A' ' 98' ' ' ALA . 57.9 tp -66.72 -36.97 83.73 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 119.43 1.014 . . . . 0.0 110.901 174.892 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -66.89 -40.51 93.58 Favored Glycine 0 CA--C 1.53 1.027 0 O-C-N 120.962 -1.086 . . . . 0.0 110.931 173.889 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.503 HD12 ' CZ ' ' A' ' 86' ' ' PHE . 1.5 tm? -61.67 -36.38 80.7 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 172.543 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.676 ' HB2' ' HB3' ' A' ' 86' ' ' PHE . . . -56.7 -53.54 56.55 Favored 'General case' 0 CA--C 1.52 -0.21 0 O-C-N 121.145 -0.972 . . . . 0.0 109.672 173.037 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -68.0 -28.4 67.38 Favored 'General case' 0 C--O 1.236 0.362 0 O-C-N 122.961 0.163 . . . . 0.0 110.934 -172.564 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -70.67 -44.47 76.52 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.951 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 174.311 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 20.2 mt -65.89 -33.08 75.02 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 119.04 0.837 . . . . 0.0 111.079 178.254 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 51.5 m -61.4 -41.73 97.6 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 118.769 0.713 . . . . 0.0 109.204 170.306 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.438 ' HA ' ' CD2' ' A' ' 106' ' ' PHE . . . -64.81 -40.35 95.08 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 119.748 1.158 . . . . 0.0 112.219 177.196 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -61.17 -33.28 73.19 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 119.095 0.861 . . . . 0.0 110.63 171.071 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 22.3 ttm-85 -75.5 -29.61 59.58 Favored 'General case' 0 CA--C 1.534 0.346 0 O-C-N 121.125 -0.984 . . . . 0.0 110.582 178.804 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.438 ' CD2' ' HA ' ' A' ' 103' ' ' ALA . 15.4 m-30 -69.88 -45.23 68.11 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.552 0.741 . . . . 0.0 110.277 177.208 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 32.8 p -74.46 -24.94 59.12 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 122.925 0.49 . . . . 0.0 111.831 -177.637 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 78.02 8.78 87.3 Favored Glycine 0 CA--C 1.538 1.499 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 -168.399 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -77.11 10.35 2.43 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 119.776 1.788 . . . . 0.0 111.612 171.382 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.434 ' HA ' ' HD3' ' A' ' 111' ' ' PRO . 10.3 t80 -57.32 140.09 79.43 Favored Pre-proline 0 CA--C 1.552 1.045 0 C-N-CA 125.346 1.459 . . . . 0.0 110.65 177.967 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 110' ' ' PHE . 50.3 Cg_exo -63.92 160.36 37.76 Favored 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 123.259 2.639 . . . . 0.0 115.402 -175.554 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -68.27 -35.42 77.85 Favored 'General case' 0 N--CA 1.473 0.675 0 O-C-N 121.663 -0.648 . . . . 0.0 112.163 171.514 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 61.7 mttm -134.52 92.66 2.94 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 124.253 1.021 . . . . 0.0 108.459 176.403 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 18.3 tp -78.57 131.58 36.81 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 105.072 -2.195 . . . . 0.0 105.072 168.055 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -132.72 139.45 47.64 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 172.004 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.428 ' CB ' HG11 ' A' ' 82' ' ' VAL . 0.9 OUTLIER -124.72 123.15 39.39 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 119.739 1.154 . . . . 0.0 108.928 177.151 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 3.7 t -88.99 90.56 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 N-CA-C 105.306 -2.109 . . . . 0.0 105.306 173.401 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -85.96 133.39 11.77 Favored Glycine 0 C--N 1.333 0.376 0 N-CA-C 110.084 -1.207 . . . . 0.0 110.084 -174.231 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 44.8 t -120.35 127.81 75.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 117.908 0.854 . . . . 0.0 109.277 -179.487 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 17.1 mt -84.64 133.85 43.29 Favored Pre-proline 0 CA--C 1.538 0.485 0 N-CA-C 104.923 -2.251 . . . . 0.0 104.923 169.322 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_endo -73.19 173.43 13.7 Favored 'Trans proline' 0 N--CA 1.452 -0.967 0 C-N-CA 123.008 2.472 . . . . 0.0 110.773 -179.574 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -107.12 -43.57 4.58 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 105.278 -2.119 . . . . 0.0 105.278 167.698 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 38.3 m -135.7 135.01 39.72 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.961 0.904 . . . . 0.0 109.764 173.025 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 4.7 tp -140.96 61.4 1.5 Allowed 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.576 1.55 . . . . 0.0 108.458 -178.254 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -126.76 167.6 16.99 Favored Pre-proline 0 CA--C 1.54 0.583 0 N-CA-C 106.294 -1.743 . . . . 0.0 106.294 172.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -77.35 95.92 1.09 Allowed 'Trans proline' 0 N--CA 1.457 -0.648 0 CA-C-N 120.678 1.278 . . . . 0.0 112.005 -175.102 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 18.6 p-80 -150.67 -19.3 0.23 Allowed 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 114.561 -1.199 . . . . 0.0 113.586 172.041 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . 0.414 0.0 OUTLIER 65.91 159.19 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 N-CA-C 116.343 1.979 . . . . 0.0 116.343 169.212 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 86.22 160.18 33.72 Favored Glycine 0 CA--C 1.529 0.923 0 N-CA-C 106.866 -2.494 . . . . 0.0 106.866 -168.632 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 68.6 mt -88.18 152.14 22.19 Favored 'General case' 0 N--CA 1.468 0.448 0 O-C-N 120.965 -1.315 . . . . 0.0 110.595 176.572 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 56.9 p -69.63 167.79 20.99 Favored Pre-proline 0 CA--C 1.538 0.515 0 CA-C-N 115.32 -0.854 . . . . 0.0 109.264 169.217 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -59.36 -37.19 91.83 Favored 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 122.0 1.8 . . . . 0.0 111.636 172.857 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 17.4 m -68.18 -40.68 82.2 Favored 'General case' 0 N--CA 1.44 -0.958 0 C-N-CA 123.508 0.723 . . . . 0.0 110.589 -177.355 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 84.3 t -88.75 -30.02 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 O-C-N 121.632 -0.667 . . . . 0.0 110.719 -174.159 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -53.27 -45.94 69.07 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 119.202 0.91 . . . . 0.0 108.771 168.888 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -69.77 -15.48 63.14 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 114.266 1.21 . . . . 0.0 114.266 179.796 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 9.3 mmm -76.85 -12.72 60.01 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 117.698 -1.144 . . . . 0.0 112.118 172.265 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 58.3 mt -54.33 -54.47 21.35 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.37 0 CA-C-N 120.193 1.36 . . . . 0.0 108.991 173.772 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 76.7 mm-40 -66.41 -46.74 59.79 Favored Pre-proline 0 CA--C 1.552 1.023 0 CA-C-N 120.329 1.422 . . . . 0.0 111.059 -173.481 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 0.4 OUTLIER -44.71 -52.77 5.75 Favored 'Trans proline' 0 C--N 1.353 0.801 1 C-N-CA 125.645 4.23 . . . . 0.0 112.5 168.75 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.04 -36.48 75.07 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.983 -1.008 . . . . 0.0 112.267 -177.802 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 42.6 mt -62.27 -41.77 98.76 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 118.897 0.771 . . . . 0.0 109.054 173.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -59.21 -36.02 74.65 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 119.342 0.973 . . . . 0.0 110.561 174.346 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -62.95 -50.14 71.99 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 118.794 0.724 . . . . 0.0 111.455 172.97 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 66.1 t -56.28 -49.11 78.2 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.19 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 66.6 mt -58.09 -43.09 86.89 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 123.046 0.538 . . . . 0.0 109.704 179.469 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -65.31 -44.85 86.59 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 118.972 0.805 . . . . 0.0 110.661 -177.231 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -64.64 -34.03 77.33 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 119.15 0.886 . . . . 0.0 111.37 -178.639 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . 0.337 4.4 pp -75.9 -36.97 59.29 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-O 117.346 -1.311 . . . . 0.0 109.762 176.688 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 14.0 mtp-105 -67.49 -27.6 67.14 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 121.113 1.779 . . . . 0.0 110.811 173.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -73.01 -15.73 61.52 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 118.629 0.65 . . . . 0.0 110.58 174.705 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 15.3 m -93.88 9.05 38.92 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.964 1.305 . . . . 0.0 110.719 169.222 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 74.0 13.17 81.11 Favored Glycine 0 CA--C 1.527 0.815 0 CA-C-O 117.396 -1.78 . . . . 0.0 112.792 -176.212 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 44.5 t -88.76 132.17 34.3 Favored 'Isoleucine or valine' 0 C--N 1.345 0.387 0 CA-C-N 120.985 2.392 . . . . 0.0 107.362 -176.181 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -104.32 93.94 5.08 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 106.675 -1.602 . . . . 0.0 106.675 169.441 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -59.13 137.68 57.86 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 169.105 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 20.6 mm -85.64 126.88 65.06 Favored Pre-proline 0 C--O 1.231 0.119 0 CA-C-O 117.531 -1.223 . . . . 0.0 107.711 -174.625 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -68.1 91.11 0.38 Allowed 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 122.868 2.379 . . . . 0.0 108.998 175.004 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 32.1 ttp85 51.81 17.99 0.7 Allowed 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 127.573 2.349 . . . . 0.0 114.853 179.404 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 52.6 m 48.93 32.47 3.82 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.312 1.045 . . . . 0.0 112.093 -169.25 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -77.89 -33.28 52.05 Favored 'General case' 0 C--O 1.238 0.45 0 O-C-N 121.906 -0.497 . . . . 0.0 110.77 176.103 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 17.2 m . . . . . 0 C--O 1.255 1.354 0 C-N-CA 126.526 1.93 . . . . 0.0 111.871 170.747 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.8 tpt . . . . . 0 N--CA 1.498 1.934 0 N-CA-C 110.34 -0.245 . . . . 0.0 110.34 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 15.3 ptt180 -148.06 111.28 4.9 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.157 0.983 . . . . 0.0 108.352 178.336 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 73.7 mt -134.56 147.7 29.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 C-N-CA 124.089 0.956 . . . . 0.0 108.544 -172.866 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 13.7 tp -135.0 146.53 49.13 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 168.304 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 63.1 t -121.4 130.42 74.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 105.513 -2.032 . . . . 0.0 105.513 174.616 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -121.26 130.23 53.56 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-N 119.004 0.82 . . . . 0.0 110.756 -173.621 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -104.98 132.03 10.92 Favored Glycine 0 C--N 1.334 0.455 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 174.135 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -143.94 159.78 16.0 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-N 118.122 0.961 . . . . 0.0 112.008 -176.167 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 131.72 173.99 13.51 Favored Glycine 0 CA--C 1.527 0.814 0 C-N-CA 126.569 2.033 . . . . 0.0 110.286 170.249 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -79.15 93.82 5.27 Favored 'General case' 0 C--O 1.233 0.191 0 O-C-N 121.307 -1.113 . . . . 0.0 110.891 -173.472 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.1 pt -57.46 31.49 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.092 0 N-CA-C 117.48 2.4 . . . . 0.0 117.48 172.285 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 38.3 mt -131.3 -3.75 3.86 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 120.671 1.578 . . . . 0.0 108.808 168.897 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.0 mp -118.1 59.8 0.79 Allowed 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.21 1.004 . . . . 0.0 113.459 -167.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 54.85 -96.92 0.06 Allowed 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 124.495 1.118 . . . . 0.0 111.248 171.201 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 41.1 m-20 -81.79 -15.46 54.16 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 124.601 1.16 . . . . 0.0 110.309 -172.665 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -72.65 -6.49 44.69 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 120.875 1.67 . . . . 0.0 112.609 178.683 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -82.3 -12.04 58.25 Favored 'General case' 0 N--CA 1.435 -1.189 0 CA-C-O 115.864 -2.017 . . . . 0.0 109.322 169.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 7.6 tp -52.36 -41.9 36.35 Favored 'Isoleucine or valine' 0 C--N 1.346 0.424 0 CA-C-N 122.57 2.441 . . . . 0.0 113.031 -169.61 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -60.7 -43.59 98.89 Favored Glycine 0 CA--C 1.524 0.608 0 CA-C-N 119.997 1.271 . . . . 0.0 110.708 177.482 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 55.9 t -65.67 -49.53 77.11 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 CA-C-O 118.768 -0.634 . . . . 0.0 109.609 173.926 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 26.3 mmt180 -60.66 -32.84 72.02 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 120.389 1.449 . . . . 0.0 112.649 -178.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 31.0 mt -62.85 -47.29 93.56 Favored 'Isoleucine or valine' 0 C--O 1.231 0.124 0 CA-C-N 120.649 1.568 . . . . 0.0 109.846 178.464 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 27.7 m -72.96 -27.15 24.16 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 CA-C-N 119.14 0.882 . . . . 0.0 111.063 -174.896 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -71.16 -43.38 67.63 Favored 'General case' 0 C--O 1.232 0.163 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 173.76 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.86 -40.58 95.85 Favored 'General case' 0 N--CA 1.449 -0.486 0 O-C-N 121.781 -0.574 . . . . 0.0 110.457 178.39 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 6.5 tp -62.57 -40.77 97.94 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 118.444 -0.789 . . . . 0.0 109.874 175.591 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -61.39 -40.49 94.55 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 119.005 0.82 . . . . 0.0 111.191 178.549 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -71.91 -36.98 70.15 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 124.107 0.963 . . . . 0.0 111.306 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -95.07 -34.69 12.21 Favored 'General case' 0 C--N 1.341 0.225 0 CA-C-O 117.372 -1.299 . . . . 0.0 113.459 -169.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -119.02 148.7 42.72 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 120.956 1.707 . . . . 0.0 112.182 -173.049 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 40.7 mm -96.06 138.44 21.47 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 N-CA-C 103.804 -2.665 . . . . 0.0 103.804 168.496 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -121.95 148.74 52.13 Favored Pre-proline 0 CA--C 1.534 0.357 0 C-N-CA 123.795 0.838 . . . . 0.0 108.873 -174.018 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -65.68 159.62 47.46 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 122.207 1.938 . . . . 0.0 109.674 169.749 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -58.51 -31.74 68.17 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 -170.106 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 15.6 p90 -80.11 0.24 32.95 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 118.072 -0.966 . . . . 0.0 113.364 -177.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 88.3 t -113.53 127.27 70.95 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 N-CA-C 105.766 -1.939 . . . . 0.0 105.766 169.918 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -132.5 143.97 50.12 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 170.064 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -93.33 103.68 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.066 0 N-CA-C 105.37 -2.085 . . . . 0.0 105.37 169.712 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.496 HD13 ' H ' ' A' ' 40' ' ' ASP . 0.2 OUTLIER -90.16 162.2 15.38 Favored 'General case' 0 C--O 1.237 0.436 0 N-CA-C 107.813 -1.181 . . . . 0.0 107.813 172.275 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.496 ' H ' HD13 ' A' ' 39' ' ' LEU . 10.0 t0 -131.94 122.6 25.86 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 123.836 0.854 . . . . 0.0 109.068 -171.295 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -87.6 -98.63 0.89 Allowed Glycine 0 CA--C 1.526 0.769 0 N-CA-C 107.048 -2.421 . . . . 0.0 107.048 169.673 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 81.08 116.63 0.38 Allowed Glycine 0 C--N 1.34 0.758 0 N-CA-C 108.702 -1.759 . . . . 0.0 108.702 -173.295 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 19.1 p 51.54 57.75 6.23 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.276 1.031 . . . . 0.0 108.773 -178.03 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -115.99 -88.14 0.59 Allowed 'General case' 0 C--N 1.342 0.281 0 CA-C-N 114.259 -1.337 . . . . 0.0 110.986 -169.189 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 75.12 -91.68 0.82 Allowed Glycine 0 C--N 1.34 0.798 0 N-CA-C 109.053 -1.619 . . . . 0.0 109.053 -169.772 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 66.1 mmm -76.56 -21.56 55.48 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 -177.761 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -62.21 -14.97 43.48 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 113.187 0.81 . . . . 0.0 113.187 -169.508 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 18.6 mt -79.34 -5.26 54.14 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 114.276 1.213 . . . . 0.0 114.276 -178.887 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.444 ' HA ' HG13 ' A' ' 100' ' ' VAL . 6.0 tt -38.65 -62.42 0.61 Allowed 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 114.84 1.422 . . . . 0.0 114.84 -170.014 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -90.86 -29.51 13.01 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 111.579 -0.608 . . . . 0.0 111.579 -174.196 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -65.86 -32.56 74.14 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 117.726 0.763 . . . . 0.0 110.974 -176.608 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 52.2 mtp -72.55 -14.47 61.64 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 113.456 0.91 . . . . 0.0 113.456 176.653 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -69.35 154.84 41.4 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 113.191 0.811 . . . . 0.0 113.191 -169.266 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 60.62 46.44 9.32 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.221 1.808 . . . . 0.0 115.375 168.332 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 18.7 mmt180 -114.48 155.54 26.22 Favored 'General case' 0 N--CA 1.479 0.994 0 O-C-N 121.155 -0.965 . . . . 0.0 108.887 171.516 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -81.4 -30.81 33.48 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 172.675 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -143.47 152.13 41.14 Favored 'General case' 0 C--N 1.343 0.324 0 CA-C-N 119.358 0.981 . . . . 0.0 109.77 168.193 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -137.04 139.73 41.57 Favored 'General case' 0 CA--C 1.51 -0.582 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 174.577 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 39.0 mt -114.32 115.12 48.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 176.147 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.8 mm -89.67 133.21 32.35 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 N-CA-C 106.071 -1.826 . . . . 0.0 106.071 175.013 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -114.26 115.95 28.24 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 103.557 -2.757 . . . . 0.0 103.557 168.822 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -154.15 161.12 42.08 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 -169.032 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -98.4 140.33 32.83 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.393 0.677 . . . . 0.0 110.583 -178.154 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 33.7 mm -78.66 -32.45 16.08 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 C-N-CA 123.847 0.859 . . . . 0.0 111.474 179.591 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . 0.296 4.0 t 60.14 45.27 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.89 0 C-N-CA 125.537 1.535 . . . . 0.0 110.809 -173.665 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 6.7 m 68.91 155.14 0.12 Allowed 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 116.985 2.217 . . . . 0.0 116.985 169.497 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 23.6 ttmt -157.88 -174.5 4.88 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 129.901 3.28 . . . . 0.0 104.159 174.46 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 10.5 ptpt -61.74 -21.25 64.35 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.699 1.2 . . . . 0.0 113.53 169.793 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 43.5 t-20 -65.34 156.36 32.39 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 118.95 0.795 . . . . 0.0 110.059 172.634 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 13.7 m -63.45 142.64 97.91 Favored Pre-proline 0 CA--C 1.546 0.795 0 C-N-CA 124.141 0.977 . . . . 0.0 112.197 -169.811 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -59.34 153.77 51.45 Favored 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 122.64 2.226 . . . . 0.0 112.043 169.789 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 67.79 18.0 69.91 Favored Glycine 0 CA--C 1.534 1.257 0 O-C-N 121.634 -0.666 . . . . 0.0 113.506 174.156 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 17.5 m -95.49 141.38 29.09 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 125.542 1.537 . . . . 0.0 107.895 177.251 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 30.7 ttp -98.71 145.43 26.91 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 175.36 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 32.0 ttm -130.88 117.73 19.72 Favored 'General case' 0 CA--C 1.528 0.103 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 -170.29 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.6 mp -96.78 122.33 48.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 179.727 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -117.7 122.69 44.17 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 67.5 mtp85 -102.11 135.36 43.83 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 118.516 -0.754 . . . . 0.0 109.807 176.778 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 8.2 t70 29.28 -91.69 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 126.681 1.992 . . . . 0.0 116.141 174.189 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -62.55 -26.84 68.79 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 -174.665 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -79.58 -12.44 59.84 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 122.844 0.458 . . . . 0.0 110.557 -179.414 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 46.4 t -75.39 -51.34 3.33 Favored Pre-proline 0 N--CA 1.446 -0.653 0 CA-C-O 116.66 -1.638 . . . . 0.0 110.777 -174.25 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo -59.33 -41.3 60.04 Favored 'Trans proline' 0 C--N 1.351 0.698 0 CA-C-N 122.865 2.059 . . . . 0.0 111.525 171.545 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -60.88 -29.69 69.7 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 122.997 0.519 . . . . 0.0 111.787 -179.54 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.506 HD13 ' C ' ' A' ' 85' ' ' LEU . 3.1 tm? -79.8 -54.11 6.15 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 122.89 0.476 . . . . 0.0 110.57 170.756 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -56.73 -34.11 67.2 Favored 'General case' 0 C--O 1.227 -0.093 0 CA-C-N 118.319 0.509 . . . . 0.0 111.448 -171.191 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 3.6 t -64.24 -5.27 4.7 Favored 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 -172.746 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -54.09 136.1 42.43 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 119.593 1.088 . . . . 0.0 110.204 169.54 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -81.66 -15.82 53.33 Favored 'General case' 0 N--CA 1.471 0.62 0 O-C-N 122.043 -0.41 . . . . 0.0 111.493 178.018 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 52.9 mt -61.61 -44.72 99.13 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 123.86 0.864 . . . . 0.0 109.601 -169.845 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 37.8 t -89.86 121.05 69.32 Favored Pre-proline 0 N--CA 1.452 -0.35 0 C-N-CA 124.386 1.075 . . . . 0.0 110.017 171.834 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_exo -61.93 -37.35 66.33 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 122.844 2.362 . . . . 0.0 110.082 169.068 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 5.6 m80 -59.91 -54.11 49.95 Favored 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 179.37 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -75.58 -25.73 57.31 Favored 'General case' 0 C--O 1.219 -0.526 0 C-N-CA 117.577 -1.649 . . . . 0.0 111.437 -174.909 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 2.8 tt -58.28 -50.7 72.69 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 120.546 1.521 . . . . 0.0 108.323 171.036 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -59.43 -46.74 93.42 Favored Glycine 0 CA--C 1.527 0.821 0 N-CA-C 110.746 -0.942 . . . . 0.0 110.746 177.008 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 32.0 tp -69.91 -20.57 63.36 Favored 'General case' 0 CA--C 1.547 0.85 0 O-C-N 121.653 -0.91 . . . . 0.0 111.312 -177.618 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -68.68 -46.86 67.95 Favored 'General case' 0 CA--C 1.534 0.339 0 O-C-N 121.127 -0.983 . . . . 0.0 109.272 171.504 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -71.13 -22.23 62.09 Favored 'General case' 0 C--N 1.339 0.138 0 CA-C-O 119.246 -0.407 . . . . 0.0 111.48 177.895 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.444 HG13 ' HA ' ' A' ' 49' ' ' LEU . 4.8 t -62.85 -43.32 98.77 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.729 0 CA-C-O 117.948 -1.025 . . . . 0.0 108.851 169.287 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 42.7 mt -60.93 -32.43 71.93 Favored 'General case' 0 C--N 1.34 0.156 0 CA-C-N 120.456 1.48 . . . . 0.0 111.096 175.524 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 66.2 m -68.14 -38.87 82.65 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 119.173 0.897 . . . . 0.0 110.657 173.068 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -65.5 -38.65 90.33 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 119.619 1.1 . . . . 0.0 111.28 174.699 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -64.19 -36.5 84.27 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 118.879 0.763 . . . . 0.0 110.38 174.19 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 34.9 ttp-105 -65.51 -36.22 83.18 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 121.701 -0.625 . . . . 0.0 109.551 175.181 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 14.3 m-30 -68.48 -40.61 80.87 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 118.873 0.76 . . . . 0.0 111.012 178.227 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 54.4 p -74.24 -26.93 60.53 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 119.481 1.037 . . . . 0.0 111.278 177.603 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 75.93 9.93 85.15 Favored Glycine 0 CA--C 1.531 1.056 0 CA-C-O 119.046 -0.863 . . . . 0.0 111.568 -170.089 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -99.46 24.42 8.16 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 118.949 1.374 . . . . 0.0 111.121 -178.395 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -57.64 135.24 82.56 Favored Pre-proline 0 CA--C 1.543 0.697 0 C-N-CA 126.116 1.766 . . . . 0.0 109.959 178.044 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -52.88 132.93 49.26 Favored 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 122.845 2.363 . . . . 0.0 112.081 177.104 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 31.3 mmtp -65.63 -24.22 66.99 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 119.149 -0.453 . . . . 0.0 111.932 -172.104 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 1.5 tmmt? -140.6 100.99 3.99 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 106.013 -1.847 . . . . 0.0 106.013 169.59 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 23.8 tp -78.51 140.78 38.54 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 174.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -134.79 138.96 44.74 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 107.159 -1.422 . . . . 0.0 107.159 176.831 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.1 tp -135.59 129.83 33.52 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 120.077 1.308 . . . . 0.0 108.92 175.39 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 47.9 t -103.28 105.03 17.55 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 N-CA-C 103.55 -2.759 . . . . 0.0 103.55 168.87 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -84.92 145.36 21.56 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 110.485 -1.046 . . . . 0.0 110.485 174.276 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 42.0 t -121.17 133.0 69.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 171.674 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 14.2 mt -88.89 132.11 39.26 Favored Pre-proline 0 CA--C 1.539 0.539 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 169.822 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -77.7 -178.29 4.49 Favored 'Trans proline' 0 CA--C 1.537 0.64 0 C-N-CA 123.582 2.854 . . . . 0.0 111.862 -175.833 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -119.05 -52.96 2.29 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.815 0.846 . . . . 0.0 111.207 178.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 66.5 m -118.51 -51.69 2.39 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 119.081 0.855 . . . . 0.0 112.868 -172.421 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER 57.7 52.55 8.08 Favored 'General case' 0 CA--C 1.551 0.997 0 N-CA-C 114.646 1.35 . . . . 0.0 114.646 169.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -115.93 168.51 8.37 Favored Pre-proline 0 N--CA 1.481 1.092 0 CA-C-O 118.421 -0.799 . . . . 0.0 111.182 176.159 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -65.19 89.69 0.2 Allowed 'Trans proline' 0 CA--C 1.548 1.18 0 C-N-CA 123.447 2.765 . . . . 0.0 113.756 -178.26 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 179.86 149.26 0.32 Allowed 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 104.538 -2.393 . . . . 0.0 104.538 175.6 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -110.52 163.49 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-N 119.614 1.097 . . . . 0.0 112.927 -169.83 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 86.16 150.19 15.04 Favored Glycine 0 C--N 1.341 0.814 0 N-CA-C 107.468 -2.253 . . . . 0.0 107.468 -169.489 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -79.03 164.49 24.31 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-O 121.536 0.684 . . . . 0.0 110.031 -169.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 23.6 p -65.93 166.74 14.26 Favored Pre-proline 0 CA--C 1.539 0.556 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 167.733 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -53.74 -32.13 64.33 Favored 'Trans proline' 0 CA--C 1.537 0.674 0 C-N-CA 121.4 1.4 . . . . 0.0 111.545 169.601 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 22.1 m -69.57 -46.49 66.25 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 117.993 0.36 . . . . 0.0 111.148 179.544 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 22.2 t -94.1 -15.36 7.87 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-N 118.626 0.648 . . . . 0.0 111.25 -169.186 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -57.88 -47.03 83.97 Favored 'General case' 0 C--O 1.233 0.202 0 O-C-N 120.301 -1.499 . . . . 0.0 107.764 169.374 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -72.03 0.23 9.97 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-O 118.04 -0.981 . . . . 0.0 113.135 177.03 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 83.2 mtp -88.92 -10.02 49.39 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-N 120.001 1.273 . . . . 0.0 111.395 171.786 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 87.8 mt -57.16 -41.52 78.0 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 169.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 39.1 mm-40 -64.26 -60.61 8.28 Favored Pre-proline 0 CA--C 1.541 0.633 0 CA-C-O 117.979 -1.01 . . . . 0.0 112.703 -172.65 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -62.47 -32.98 80.34 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 CA-C-N 121.397 1.535 . . . . 0.0 110.994 178.444 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -68.04 -43.84 77.81 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-N 119.448 1.022 . . . . 0.0 109.75 -179.065 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 58.5 mt -58.21 -43.16 87.51 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 119.187 0.903 . . . . 0.0 109.697 173.105 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -59.62 -38.18 80.62 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 119.096 0.862 . . . . 0.0 110.366 179.775 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 20.0 mm100 -75.15 -33.95 61.57 Favored 'General case' 0 C--N 1.338 0.093 0 CA-C-O 117.817 -1.087 . . . . 0.0 112.97 175.426 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 67.2 t -59.83 -46.3 93.88 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 CA-C-N 120.442 1.474 . . . . 0.0 108.101 172.055 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 29.1 mt -66.72 -41.02 88.6 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 122.921 0.488 . . . . 0.0 110.116 -178.189 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -63.89 -40.16 95.86 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 119.226 0.921 . . . . 0.0 111.394 176.812 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -67.0 -41.11 87.27 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 122.683 0.393 . . . . 0.0 110.884 178.775 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 34.2 mt -59.51 -42.82 93.08 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 123.03 0.532 . . . . 0.0 109.91 173.598 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 -64.37 -15.93 61.35 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 117.362 -1.304 . . . . 0.0 111.886 -178.44 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -58.91 -41.81 88.12 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 120.678 1.581 . . . . 0.0 110.902 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 2.7 p -89.66 23.44 2.66 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.193 0.597 . . . . 0.0 111.423 178.081 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 70.32 22.41 77.56 Favored Glycine 0 CA--C 1.531 1.045 0 CA-C-O 118.761 -1.021 . . . . 0.0 113.415 -178.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 40.7 t -100.46 89.84 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.257 0 CA-C-N 119.054 1.427 . . . . 0.0 107.955 -175.38 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -76.76 137.22 39.17 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 169.389 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -85.68 155.2 21.19 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.546 0.738 . . . . 0.0 110.517 176.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.412 HG22 ' H ' ' A' ' 160' ' ' SER . 88.9 mt -93.24 116.58 66.7 Favored Pre-proline 0 CA--C 1.541 0.61 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 -178.623 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -73.66 92.2 0.87 Allowed 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 123.405 2.737 . . . . 0.0 109.808 -176.744 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 7.6 ttt-85 48.11 16.92 0.1 Allowed 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 128.172 2.589 . . . . 0.0 115.513 -174.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 160' ' ' SER . . . . . 0.412 ' H ' HG22 ' A' ' 157' ' ' ILE . 1.0 OUTLIER 51.5 35.5 14.54 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 126.123 1.769 . . . . 0.0 110.813 -172.406 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -77.37 139.22 39.68 Favored 'General case' 0 C--O 1.24 0.56 0 O-C-N 121.807 -0.558 . . . . 0.0 110.307 -178.274 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 45.8 m . . . . . 0 C--O 1.251 1.171 0 C-N-CA 125.389 1.476 . . . . 0.0 108.398 179.307 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.9 tpt . . . . . 0 N--CA 1.498 1.957 0 N-CA-C 110.416 -0.216 . . . . 0.0 110.416 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 9.0 ptp180 -143.25 127.51 17.67 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 174.836 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 50.6 mt -142.52 139.42 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 CA-C-N 119.708 1.14 . . . . 0.0 112.603 -168.678 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -121.68 123.31 41.59 Favored 'General case' 0 N--CA 1.462 0.163 0 N-CA-C 104.776 -2.305 . . . . 0.0 104.776 167.484 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 57.5 t -101.45 99.32 8.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 101.576 -3.49 . . . . 0.0 101.576 169.539 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 14.1 tp -101.34 107.6 18.99 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 124.195 0.998 . . . . 0.0 110.203 -168.061 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -88.52 123.86 6.96 Favored Glycine 0 N--CA 1.45 -0.408 0 N-CA-C 107.337 -2.305 . . . . 0.0 107.337 174.346 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -136.87 164.63 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.707 0 C-N-CA 124.054 0.941 . . . . 0.0 108.58 -176.534 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 145.72 156.93 7.06 Favored Glycine 0 N--CA 1.447 -0.625 0 N-CA-C 109.064 -1.614 . . . . 0.0 109.064 178.215 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -76.47 94.89 3.75 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 171.449 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.3 pt -70.77 37.74 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 C-N-CA 124.577 1.151 . . . . 0.0 113.567 179.687 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 23.0 mt -125.15 -8.04 7.09 Favored 'General case' 0 CA--C 1.537 0.466 0 O-C-N 121.148 -0.97 . . . . 0.0 108.768 170.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.0 mp -118.65 67.61 0.78 Allowed 'General case' 0 C--N 1.346 0.414 0 C-N-CA 124.006 0.923 . . . . 0.0 109.118 -169.002 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.3 m 47.3 -111.12 0.35 Allowed 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 114.761 -1.109 . . . . 0.0 111.654 171.645 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.445 ' O ' HG22 ' A' ' 18' ' ' ILE . 87.6 m-20 -71.9 -11.25 60.7 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-O 117.614 -1.184 . . . . 0.0 112.302 -170.235 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -66.54 -18.02 65.13 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 121.4 1.909 . . . . 0.0 111.032 171.834 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -70.6 -12.83 61.81 Favored 'General case' 0 N--CA 1.448 -0.555 0 O-C-N 120.178 -1.576 . . . . 0.0 111.769 171.392 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.501 HG21 HG11 ' A' ' 119' ' ' VAL . 8.4 tp -58.1 -36.45 57.03 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-N 121.271 1.85 . . . . 0.0 111.613 -174.019 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -61.48 -38.38 95.69 Favored Glycine 0 C--N 1.339 0.697 0 CA-C-N 119.365 0.984 . . . . 0.0 111.769 178.037 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 54.8 t -72.42 -47.04 54.01 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 175.111 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 24.7 mmt180 -60.96 -31.18 70.75 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 116.939 -1.505 . . . . 0.0 112.94 -179.244 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 18.4 mt -61.62 -47.74 91.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 CA-C-N 121.565 1.984 . . . . 0.0 110.17 177.078 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 14.4 m -72.78 -33.48 44.11 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-N 119.192 0.906 . . . . 0.0 110.912 -174.642 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 57.6 mt-10 -63.66 -42.98 98.01 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 118.428 0.558 . . . . 0.0 110.334 171.665 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.18 -39.37 92.46 Favored 'General case' 0 CA--C 1.537 0.452 0 O-C-N 121.292 -0.88 . . . . 0.0 110.647 176.006 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 6.1 tp -66.06 -39.61 90.23 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 118.451 0.569 . . . . 0.0 110.081 -179.317 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -60.68 -28.9 68.96 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 121.512 0.672 . . . . 0.0 112.131 -178.581 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 -88.19 -40.21 13.89 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 125.891 1.676 . . . . 0.0 111.14 -178.851 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 56.4 mtp180 -94.17 -18.44 21.73 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-O 118.449 -0.786 . . . . 0.0 112.364 -170.715 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 49.8 m-85 -129.58 147.05 51.34 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 119.354 0.979 . . . . 0.0 112.552 177.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 39.5 mm -98.28 137.08 26.84 Favored 'Isoleucine or valine' 0 C--O 1.239 0.518 0 N-CA-C 103.62 -2.733 . . . . 0.0 103.62 168.784 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -120.19 150.54 51.62 Favored Pre-proline 0 C--O 1.237 0.414 0 C-N-CA 123.297 0.639 . . . . 0.0 110.49 -169.811 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -59.05 157.56 28.97 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 123.128 2.552 . . . . 0.0 111.227 169.64 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -61.55 -31.51 71.54 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -175.696 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 9.6 p90 -75.76 -11.12 59.93 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 -179.512 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 92.5 t -92.87 122.9 44.74 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 173.86 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -117.62 123.59 46.54 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 169.476 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -86.48 117.78 31.58 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 N-CA-C 104.168 -2.53 . . . . 0.0 104.168 168.512 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 63.8 tp -118.9 130.75 55.89 Favored 'General case' 0 CA--C 1.523 -0.083 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 178.152 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -89.42 119.13 29.61 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 169.509 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -77.54 -80.14 0.68 Allowed Glycine 0 CA--C 1.528 0.872 0 N-CA-C 106.834 -2.507 . . . . 0.0 106.834 169.189 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 78.48 107.05 0.2 Allowed Glycine 0 C--N 1.345 1.044 0 N-CA-C 109.176 -1.57 . . . . 0.0 109.176 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 10.5 p 53.41 55.47 8.65 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 -177.106 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -120.35 -83.4 0.66 Allowed 'General case' 0 C--N 1.347 0.482 0 CA-C-N 115.005 -0.998 . . . . 0.0 112.255 -169.279 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 58.93 -107.21 1.09 Allowed Glycine 0 CA--C 1.532 1.15 0 N-CA-C 110.511 -1.036 . . . . 0.0 110.511 -178.368 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 11.7 tpt -55.95 -28.18 55.81 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.665 1.186 . . . . 0.0 112.627 -177.67 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -56.46 -22.12 30.1 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 113.827 1.047 . . . . 0.0 113.827 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 15.1 mt -103.3 17.95 22.89 Favored 'General case' 0 C--N 1.341 0.233 0 N-CA-C 115.978 1.844 . . . . 0.0 115.978 -167.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 6.2 tt -48.09 -56.35 8.01 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 119.447 1.021 . . . . 0.0 111.109 -178.166 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -66.42 -36.58 91.78 Favored Glycine 0 CA--C 1.528 0.898 0 CA-C-O 119.259 -0.745 . . . . 0.0 112.447 -177.502 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -73.69 -35.1 65.13 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 118.886 1.343 . . . . 0.0 111.817 -176.728 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 78.8 mtp -71.88 -12.71 61.4 Favored 'General case' 0 CA--C 1.535 0.401 0 O-C-N 121.962 -0.461 . . . . 0.0 110.323 179.798 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -84.12 153.63 23.62 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 123.306 0.642 . . . . 0.0 111.57 -170.424 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 54.24 34.8 21.17 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 126.475 1.91 . . . . 0.0 112.847 170.849 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 26.1 mmt180 -98.31 157.57 16.1 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 173.815 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -84.67 -51.4 6.85 Favored 'General case' 0 C--O 1.221 -0.42 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 175.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . 0.269 0.0 OUTLIER -120.25 146.43 46.07 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 120.017 1.281 . . . . 0.0 108.272 168.652 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 33.1 tp -130.46 111.63 12.48 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 104.172 -2.529 . . . . 0.0 104.172 173.092 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 52.7 mt -93.24 111.71 25.19 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 N-CA-C 103.801 -2.666 . . . . 0.0 103.801 171.17 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.46 HG22 HD23 ' A' ' 116' ' ' LEU . 53.5 mt -83.86 133.69 28.63 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 N-CA-C 105.233 -2.136 . . . . 0.0 105.233 170.651 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -116.97 116.77 28.03 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 102.519 -3.141 . . . . 0.0 102.519 168.038 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -161.57 165.77 27.95 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 123.518 0.727 . . . . 0.0 109.796 -176.248 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -81.34 144.53 31.41 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-O 122.355 1.074 . . . . 0.0 110.031 169.717 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 12.0 mt -69.1 -51.04 47.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 114.55 -1.205 . . . . 0.0 107.957 170.759 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . 0.294 9.0 p 42.22 48.45 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.95 0 C-N-CA 125.276 1.43 . . . . 0.0 111.071 179.753 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 8.4 t -162.79 176.42 10.28 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.368 1.467 . . . . 0.0 109.624 -171.572 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 20.0 ttmt 51.14 -161.17 0.08 Allowed 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 127.386 2.274 . . . . 0.0 112.175 -173.586 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 14.6 ptpt -128.89 12.79 6.26 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 125.036 1.334 . . . . 0.0 112.973 -169.394 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 44.8 t30 -74.75 167.22 22.25 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 178.051 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 2.8 m -56.93 145.87 61.92 Favored Pre-proline 0 CA--C 1.546 0.795 0 C-N-CA 123.812 0.845 . . . . 0.0 112.132 -169.704 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -56.23 155.82 23.18 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 123.84 3.026 . . . . 0.0 112.701 169.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 65.15 17.44 63.62 Favored Glycine 0 CA--C 1.535 1.321 0 CA-C-O 119.696 -0.502 . . . . 0.0 113.242 170.678 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 3.1 m -95.58 142.19 28.21 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 125.176 1.39 . . . . 0.0 109.11 -175.036 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 44.5 ttp -95.16 141.66 28.51 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 169.92 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 75.1 mtm -132.02 145.85 51.7 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 169.363 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.5 mp -97.22 119.66 45.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 N-CA-C 105.358 -2.09 . . . . 0.0 105.358 172.093 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.8 mp -113.79 136.02 53.32 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 171.717 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 36.4 mmt180 -96.39 164.13 12.77 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 123.018 0.527 . . . . 0.0 110.863 178.607 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -1.09 -70.13 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 127.839 2.456 . . . . 0.0 117.438 169.465 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -87.6 -19.87 27.18 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 113.533 0.938 . . . . 0.0 113.533 -170.474 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -76.77 -37.4 55.95 Favored 'General case' 0 CA--C 1.523 -0.084 0 CA-C-O 121.135 0.493 . . . . 0.0 110.095 -172.627 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.538 HG12 ' CE2' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -66.85 -52.48 32.49 Favored Pre-proline 0 CA--C 1.538 0.51 0 CA-C-O 117.417 -1.278 . . . . 0.0 112.723 -174.149 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -55.4 -42.01 72.46 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 121.57 1.513 . . . . 0.0 110.551 177.694 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.8 -15.53 63.53 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 178.118 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -92.69 -46.06 7.75 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 119.854 1.206 . . . . 0.0 110.674 -176.092 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.538 ' CE2' HG12 ' A' ' 82' ' ' VAL . 43.8 m-85 -68.77 -1.72 7.72 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 113.988 1.107 . . . . 0.0 113.988 -169.649 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 62.5 p -59.51 -21.17 59.79 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.759 1.223 . . . . 0.0 112.587 178.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 42.3 t-20 -65.91 149.88 49.5 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.542 0.737 . . . . 0.0 111.192 -175.919 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -84.93 -6.33 59.34 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.15 0.98 . . . . 0.0 113.569 -170.036 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 20.3 mt -59.56 -43.53 91.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 C-N-CA 123.676 0.79 . . . . 0.0 111.147 -169.444 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 28.3 t -117.72 125.28 28.16 Favored Pre-proline 0 C--O 1.235 0.295 0 N-CA-C 109.038 -0.726 . . . . 0.0 109.038 174.541 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -71.29 -30.01 16.3 Favored 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 122.578 2.185 . . . . 0.0 110.547 175.682 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 30.1 t-80 -67.19 -43.38 82.29 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 119.05 0.841 . . . . 0.0 108.815 177.283 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 7.4 mm100 -66.13 -38.8 89.06 Favored 'General case' 0 C--O 1.22 -0.46 0 CA-C-O 117.603 -1.189 . . . . 0.0 110.291 175.823 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 1.3 tt -56.47 -40.81 75.51 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 120.141 1.337 . . . . 0.0 109.373 174.095 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -60.81 -44.75 97.64 Favored Glycine 0 CA--C 1.529 0.942 0 O-C-N 121.237 -0.915 . . . . 0.0 111.434 175.176 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 51.1 tp -64.24 -32.44 74.03 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 117.893 0.847 . . . . 0.0 110.245 174.446 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.474 ' HB2' ' CB ' ' A' ' 86' ' ' PHE . . . -62.07 -51.39 68.15 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 119.517 1.053 . . . . 0.0 109.034 176.148 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -70.91 -28.33 64.44 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.011 -174.425 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -70.02 -41.99 79.4 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.922 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 172.984 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 32.1 mt -64.31 -35.66 81.57 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 119.521 1.055 . . . . 0.0 110.174 177.083 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 49.8 m -63.38 -37.19 86.32 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 118.983 0.81 . . . . 0.0 110.451 169.902 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.425 ' HA ' ' CD2' ' A' ' 106' ' ' PHE . . . -66.61 -39.14 88.21 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 119.58 1.082 . . . . 0.0 111.221 177.609 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -63.13 -31.67 72.87 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 118.69 0.677 . . . . 0.0 109.987 172.14 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 58.6 ttt85 -72.37 -34.41 67.95 Favored 'General case' 0 CA--C 1.533 0.32 0 O-C-N 121.103 -0.998 . . . . 0.0 109.864 175.507 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.425 ' CD2' ' HA ' ' A' ' 103' ' ' ALA . 13.9 m-30 -68.42 -44.09 75.76 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 118.829 0.74 . . . . 0.0 110.583 178.948 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 40.4 p -70.97 -26.77 63.3 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 118.52 0.6 . . . . 0.0 111.745 -179.424 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 73.19 7.07 70.8 Favored Glycine 0 CA--C 1.535 1.282 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 -168.34 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -89.51 16.85 7.0 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 119.467 1.633 . . . . 0.0 110.937 178.302 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -54.88 139.85 61.57 Favored Pre-proline 0 CA--C 1.549 0.918 0 C-N-CA 125.824 1.65 . . . . 0.0 109.702 172.076 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_exo -55.56 156.9 16.59 Favored 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 123.38 2.72 . . . . 0.0 115.697 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 66.7 mmtt -63.76 -40.44 96.7 Favored 'General case' 0 N--CA 1.472 0.661 0 O-C-N 121.768 -0.582 . . . . 0.0 111.418 -179.433 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 5.4 pttm -131.72 146.14 52.01 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 105.663 -1.977 . . . . 0.0 105.663 171.282 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.51 HD23 ' N ' ' A' ' 115' ' ' THR . 7.0 tt -140.26 139.36 35.54 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 175.335 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.51 ' N ' HD23 ' A' ' 114' ' ' LEU . 0.2 OUTLIER -137.9 134.57 35.19 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 -171.274 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.46 HD23 HG22 ' A' ' 60' ' ' ILE . 0.4 OUTLIER -122.79 118.42 27.95 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 120.409 1.459 . . . . 0.0 108.512 177.798 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 16.1 t -88.05 81.99 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 N-CA-C 105.05 -2.204 . . . . 0.0 105.05 175.335 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -80.76 141.9 23.07 Favored Glycine 0 C--O 1.225 -0.434 0 CA-C-O 119.272 -0.738 . . . . 0.0 111.573 -169.595 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.501 HG11 HG21 ' A' ' 18' ' ' ILE . 42.0 t -119.9 123.6 71.18 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.105 0 CA-C-N 117.396 0.598 . . . . 0.0 109.946 177.522 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 25.7 mt -78.23 127.87 79.95 Favored Pre-proline 0 CA--C 1.53 0.207 0 N-CA-C 104.999 -2.222 . . . . 0.0 104.999 169.545 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -69.15 160.0 51.61 Favored 'Trans proline' 0 N--CA 1.45 -1.062 0 C-N-CA 121.756 1.637 . . . . 0.0 110.966 179.584 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -94.67 -42.92 8.52 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 105.871 -1.9 . . . . 0.0 105.871 168.144 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 49.9 m -137.28 149.22 46.95 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 123.791 0.837 . . . . 0.0 109.494 173.682 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.2 tp -143.48 53.54 1.33 Allowed 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.976 1.311 . . . . 0.0 108.499 -175.507 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -114.49 168.18 8.44 Favored Pre-proline 0 CA--C 1.538 0.482 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 -173.749 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -82.08 84.66 1.82 Allowed 'Trans proline' 0 N--CA 1.454 -0.802 0 CA-C-N 120.952 1.376 . . . . 0.0 112.654 -169.45 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -174.28 145.37 1.01 Allowed 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 103.511 -2.774 . . . . 0.0 103.511 179.401 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -112.03 168.33 4.99 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 N-CA-C 113.352 0.871 . . . . 0.0 113.352 -169.264 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 96.76 148.79 24.69 Favored Glycine 0 CA--C 1.528 0.893 0 N-CA-C 106.066 -2.814 . . . . 0.0 106.066 -168.88 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.545 HD22 ' H ' ' A' ' 130' ' ' LEU . 0.7 OUTLIER -75.3 163.02 27.91 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 118.312 1.056 . . . . 0.0 110.569 177.969 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 58.4 p -71.05 171.4 8.6 Favored Pre-proline 0 CA--C 1.543 0.706 0 CA-C-N 114.929 -1.032 . . . . 0.0 109.051 168.52 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -58.06 -33.79 97.71 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 121.927 1.751 . . . . 0.0 112.393 172.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 57.7 m -72.65 -40.1 66.62 Favored 'General case' 0 N--CA 1.443 -0.785 0 C-N-CA 123.463 0.705 . . . . 0.0 111.178 -178.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 95.1 t -94.44 -23.85 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 CA-C-N 118.438 0.563 . . . . 0.0 111.523 -169.754 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -51.37 -44.77 62.21 Favored 'General case' 0 N--CA 1.467 0.402 0 O-C-N 120.836 -1.165 . . . . 0.0 109.497 169.775 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -71.3 -18.79 62.39 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 114.405 1.261 . . . . 0.0 114.405 -178.69 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' MET . . . . . 0.47 ' SD ' HG13 ' A' ' 119' ' ' VAL . 74.8 mtp -67.82 -14.92 63.35 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 118.005 -0.998 . . . . 0.0 112.829 -179.186 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 13.6 mt -48.87 -42.53 13.87 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.387 0 CA-C-N 119.635 1.107 . . . . 0.0 108.362 169.447 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 61.5 mm-40 -64.88 -58.32 13.31 Favored Pre-proline 0 CA--C 1.539 0.553 0 CA-C-N 120.351 1.432 . . . . 0.0 111.5 -172.872 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -61.32 -37.16 74.9 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 CA-C-N 121.447 1.553 . . . . 0.0 112.36 177.453 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -73.13 -37.83 66.52 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-O 118.569 -0.729 . . . . 0.0 111.499 -176.495 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 32.8 mt -62.24 -43.64 98.38 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-N 119.653 1.115 . . . . 0.0 109.041 170.701 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -55.78 -36.57 67.53 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 118.742 0.701 . . . . 0.0 110.131 174.547 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -72.44 -41.35 66.23 Favored 'General case' 0 N--CA 1.454 -0.26 0 O-C-N 121.442 -0.786 . . . . 0.0 112.712 177.527 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 60.1 t -58.76 -47.58 88.68 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 175.47 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 60.0 mt -60.99 -35.31 76.48 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-O 118.763 -0.637 . . . . 0.0 110.788 177.12 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -68.2 -46.22 71.21 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 119.243 0.928 . . . . 0.0 110.54 178.209 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -67.72 -30.06 69.46 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 119.882 1.219 . . . . 0.0 111.162 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 13.9 mt -63.06 -52.68 61.82 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 169.869 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 50.9 mmm-85 -66.04 -26.9 67.72 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 119.765 1.166 . . . . 0.0 112.412 -177.736 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 71.2 mt-10 -66.5 -30.13 70.38 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 119.569 1.077 . . . . 0.0 109.872 174.558 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 20.4 m -84.0 6.66 21.15 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.388 1.075 . . . . 0.0 111.957 171.118 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 72.06 12.15 75.32 Favored Glycine 0 CA--C 1.526 0.744 0 CA-C-O 117.294 -1.837 . . . . 0.0 112.98 -172.578 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 55.2 t -91.72 122.25 42.98 Favored 'Isoleucine or valine' 0 C--N 1.346 0.447 0 CA-C-N 121.048 2.424 . . . . 0.0 108.019 -176.73 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -104.26 93.5 4.85 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 173.546 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -58.9 146.04 39.07 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.823 169.129 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 22.9 mm -98.76 127.0 36.76 Favored Pre-proline 0 CA--C 1.53 0.21 0 CA-C-O 117.396 -1.287 . . . . 0.0 109.067 -171.454 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -67.96 97.99 0.5 Allowed 'Trans proline' 0 CA--C 1.535 0.536 0 C-N-CA 122.702 2.268 . . . . 0.0 109.753 174.745 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 23.2 mtp-105 48.32 18.04 0.15 Allowed 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 127.45 2.3 . . . . 0.0 115.327 -178.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 53.3 m 46.09 39.64 6.14 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.229 1.012 . . . . 0.0 111.876 -169.582 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -78.9 -31.41 45.38 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 122.68 0.392 . . . . 0.0 111.761 -177.8 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 11.8 m . . . . . 0 C--O 1.254 1.327 0 C-N-CA 124.467 1.107 . . . . 0.0 110.571 178.837 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.0 tpt . . . . . 0 N--CA 1.496 1.869 0 CA-C-O 120.456 0.169 . . . . 0.0 110.586 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 16.2 ptt180 -149.79 112.61 4.81 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.626 1.17 . . . . 0.0 108.687 176.703 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 84.8 mt -127.39 130.93 70.78 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.14 0 N-CA-C 107.896 -1.149 . . . . 0.0 107.896 -175.609 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -119.61 144.95 46.84 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 105.513 -2.032 . . . . 0.0 105.513 168.799 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 71.4 t -121.95 128.13 75.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 104.891 -2.263 . . . . 0.0 104.891 174.222 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.43 HD13 ' HA ' ' A' ' 6' ' ' LEU . 2.6 mm? -111.26 130.79 55.55 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-N 118.398 0.544 . . . . 0.0 109.85 -179.55 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -100.61 126.08 8.8 Favored Glycine 0 C--O 1.237 0.32 0 N-CA-C 108.211 -1.956 . . . . 0.0 108.211 171.296 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 1.9 m -141.22 171.56 12.04 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 CA-C-N 117.797 0.799 . . . . 0.0 110.278 -173.225 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 103.03 156.69 25.13 Favored Glycine 0 N--CA 1.442 -0.953 0 C-N-CA 126.352 1.93 . . . . 0.0 110.052 -178.625 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -72.51 104.21 3.76 Favored 'General case' 0 N--CA 1.453 -0.321 0 O-C-N 121.709 -0.877 . . . . 0.0 111.247 -169.378 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.1 pt -59.92 30.64 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.954 0 N-CA-C 117.228 2.307 . . . . 0.0 117.228 172.917 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 5.4 mp -129.79 -6.68 4.55 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 120.593 1.542 . . . . 0.0 108.436 168.439 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.0 mp -107.98 57.05 0.62 Allowed 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 119.255 0.934 . . . . 0.0 112.796 -168.123 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.444 ' HB ' ' H ' ' A' ' 15' ' ' ASP . 0.1 OUTLIER 51.16 -109.83 0.45 Allowed 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 123.898 0.879 . . . . 0.0 110.123 175.176 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.444 ' H ' ' HB ' ' A' ' 14' ' ' THR . 0.3 OUTLIER -77.85 -4.49 46.88 Favored 'General case' 0 N--CA 1.443 -0.78 0 O-C-N 121.59 -0.694 . . . . 0.0 111.021 -173.714 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -69.63 -12.17 61.43 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 120.647 1.567 . . . . 0.0 111.837 170.193 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -77.97 -9.95 59.35 Favored 'General case' 0 N--CA 1.435 -1.222 0 CA-C-O 115.736 -2.078 . . . . 0.0 109.635 170.497 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.7 tp -55.11 -39.14 49.19 Favored 'Isoleucine or valine' 0 C--N 1.348 0.537 0 CA-C-N 122.395 2.362 . . . . 0.0 111.995 -170.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -61.01 -39.5 97.17 Favored Glycine 0 C--N 1.336 0.58 0 CA-C-N 119.151 0.887 . . . . 0.0 111.038 177.62 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 97.1 t -74.45 -47.56 39.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 CA-C-O 118.54 -0.743 . . . . 0.0 109.861 176.024 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 76.2 mmt-85 -59.66 -33.84 72.06 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 119.983 1.265 . . . . 0.0 111.76 -179.723 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 22.8 mt -56.45 -51.49 64.1 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-N 120.363 1.438 . . . . 0.0 110.181 173.674 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 24.8 m -75.2 -25.98 18.54 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-N 119.075 0.852 . . . . 0.0 111.206 -172.56 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -69.88 -45.72 67.07 Favored 'General case' 0 C--O 1.233 0.187 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 174.355 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -67.35 -40.2 85.8 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 122.723 0.409 . . . . 0.0 110.386 -179.18 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.7 tp -61.56 -38.41 87.39 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 118.441 -0.79 . . . . 0.0 110.554 177.515 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -64.3 -42.21 96.49 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 118.956 0.798 . . . . 0.0 110.292 177.8 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -68.59 -36.37 78.62 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 122.873 0.469 . . . . 0.0 111.466 178.876 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 79.1 mmt-85 -94.36 -40.55 9.88 Favored 'General case' 0 C--N 1.339 0.122 0 CA-C-O 116.951 -1.499 . . . . 0.0 112.771 -170.3 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -117.19 130.33 56.52 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 121.588 1.994 . . . . 0.0 113.244 -169.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 40.2 mm -83.29 134.92 25.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 105.607 -1.997 . . . . 0.0 105.607 168.849 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.6 mp -133.34 150.69 75.9 Favored Pre-proline 0 CA--C 1.54 0.565 0 C-N-CA 126.99 2.116 . . . . 0.0 108.552 -169.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -71.01 165.05 33.64 Favored 'Trans proline' 0 CA--C 1.536 0.616 0 C-N-CA 122.815 2.343 . . . . 0.0 111.123 175.315 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -59.48 -31.45 69.35 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 -169.783 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 46.3 p90 -78.55 2.4 19.3 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 113.361 0.874 . . . . 0.0 113.361 -178.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.7 t -111.2 127.47 68.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 172.257 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -125.12 145.75 49.8 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 109.055 -0.721 . . . . 0.0 109.055 173.421 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -113.52 109.3 28.04 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 N-CA-C 105.762 -1.94 . . . . 0.0 105.762 172.159 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 64.4 tp -113.67 142.13 46.38 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 -174.118 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -100.38 127.52 46.68 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 123.642 0.777 . . . . 0.0 110.411 178.117 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -121.78 -22.56 2.7 Favored Glycine 0 CA--C 1.533 1.161 0 CA-C-O 118.51 -1.161 . . . . 0.0 113.012 169.586 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 42.64 -107.6 0.12 Allowed Glycine 0 C--N 1.339 0.742 0 C-N-CA 125.389 1.471 . . . . 0.0 113.938 177.091 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.8 p -67.48 -3.68 9.26 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 128.645 2.778 . . . . 0.0 114.108 -174.415 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.36 -56.88 14.15 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 124.07 0.948 . . . . 0.0 112.498 179.282 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 61.17 -99.64 0.21 Allowed Glycine 0 C--N 1.338 0.677 0 N-CA-C 108.614 -1.794 . . . . 0.0 108.614 -170.365 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.9 -28.15 68.08 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 126.098 1.759 . . . . 0.0 111.604 177.974 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -68.16 -4.15 12.91 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 113.802 1.038 . . . . 0.0 113.802 -168.5 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 22.4 mt -92.46 12.34 23.17 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 113.677 0.992 . . . . 0.0 113.677 177.449 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.429 ' HA ' HG13 ' A' ' 100' ' ' VAL . 6.1 tt -36.6 -60.48 0.59 Allowed 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.263 1.425 . . . . 0.0 114.713 -173.94 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -94.86 -26.61 12.51 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 123.205 0.431 . . . . 0.0 112.349 -175.51 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -57.69 -35.98 71.33 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 117.693 0.746 . . . . 0.0 111.769 179.066 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 20.7 mtp -83.05 -1.22 52.13 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 113.24 0.83 . . . . 0.0 113.24 -176.691 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -81.8 158.22 24.18 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.351 0.66 . . . . 0.0 111.995 -174.305 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 55.09 52.17 12.17 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 127.285 2.234 . . . . 0.0 115.655 168.416 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 20.7 mmt180 -115.07 163.2 15.96 Favored 'General case' 0 N--CA 1.482 1.174 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 170.663 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -80.46 -43.34 21.06 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 173.143 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . 0.294 0.1 OUTLIER -139.18 137.57 36.16 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 120.209 1.368 . . . . 0.0 110.101 168.319 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 24.1 tp -119.34 129.78 55.03 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 174.326 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 11.7 mt -103.1 115.91 45.9 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 174.899 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 9.5 mt -92.55 123.21 44.57 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 176.272 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -104.92 114.79 29.21 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 104.473 -2.417 . . . . 0.0 104.473 169.627 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -149.85 162.37 40.43 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.424 0.631 . . . . 0.0 110.961 -178.308 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -72.99 179.97 3.5 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 168.751 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.574 HG22 ' H ' ' A' ' 66' ' ' SER 0.301 93.2 mt -110.13 -83.15 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 CA-C-O 117.727 -1.13 . . . . 0.0 110.958 175.683 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . 0.292 1.7 m 41.0 35.86 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.856 0 C-N-CA 125.712 1.605 . . . . 0.0 112.984 -169.326 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.574 ' H ' HG22 ' A' ' 64' ' ' ILE . 49.9 m -134.12 2.77 3.36 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.435 1.494 . . . . 0.0 112.065 -173.453 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -154.34 156.36 36.76 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 177.032 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 9.7 ptpt -78.65 3.04 17.44 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 115.377 1.621 . . . . 0.0 115.377 -169.717 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 32.3 t-20 -69.7 161.9 28.8 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 118.955 0.798 . . . . 0.0 110.47 -173.677 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 11.9 m -55.72 143.34 60.0 Favored Pre-proline 0 CA--C 1.545 0.766 0 C-N-CA 124.669 1.188 . . . . 0.0 112.698 -169.774 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -57.28 151.83 49.69 Favored 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 122.33 2.02 . . . . 0.0 111.166 169.784 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 71.47 18.78 77.26 Favored Glycine 0 CA--C 1.533 1.189 0 O-C-N 121.458 -0.776 . . . . 0.0 113.468 175.213 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 6.9 m -104.78 139.95 38.81 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 125.474 1.51 . . . . 0.0 108.02 177.068 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 47.5 ttp -96.2 143.36 27.37 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 173.61 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 33.6 ttm -135.51 123.09 22.15 Favored 'General case' 0 CA--C 1.528 0.128 0 N-CA-C 106.429 -1.693 . . . . 0.0 106.429 -174.248 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 35.8 mm -103.67 119.64 52.59 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 178.889 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -114.01 134.22 54.99 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 -174.88 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 60.6 mtm180 -109.37 132.74 53.84 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 118.459 -0.781 . . . . 0.0 109.637 -174.749 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 37.8 t70 40.85 -104.76 0.05 Allowed 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 114.26 1.207 . . . . 0.0 114.26 169.761 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -60.02 -26.11 65.83 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.778 1.231 . . . . 0.0 113.894 -177.253 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -73.73 -20.9 60.39 Favored 'General case' 0 CA--C 1.534 0.331 0 O-C-N 121.829 -0.544 . . . . 0.0 110.085 -179.284 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.413 ' HB ' ' HD3' ' A' ' 83' ' ' PRO . 46.9 t -75.0 -55.46 2.31 Favored Pre-proline 0 N--CA 1.449 -0.494 0 CA-C-O 117.404 -1.284 . . . . 0.0 111.218 -169.874 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.413 ' HD3' ' HB ' ' A' ' 82' ' ' VAL . 6.2 Cg_exo -66.27 -30.7 45.28 Favored 'Trans proline' 0 N--CA 1.448 -1.193 0 CA-C-N 121.659 1.628 . . . . 0.0 110.191 178.04 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.07 -27.32 68.7 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 118.417 0.553 . . . . 0.0 111.364 179.322 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -74.05 -56.29 5.11 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 169.379 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.429 ' HB3' ' HB2' ' A' ' 98' ' ' ALA . 26.1 m-85 -63.23 -25.37 68.3 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 114.157 1.169 . . . . 0.0 114.157 -169.915 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 7.0 t -69.66 1.09 4.53 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 -175.587 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 37.2 t-20 -67.12 136.91 55.87 Favored 'General case' 0 CA--C 1.54 0.581 0 O-C-N 120.927 -1.108 . . . . 0.0 109.447 175.643 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 13.3 mptt -82.41 -9.1 59.58 Favored 'General case' 0 N--CA 1.47 0.531 0 O-C-N 121.487 -0.758 . . . . 0.0 111.858 -175.784 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 89.4 mt -61.25 -36.95 76.25 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 CA-C-N 119.047 0.84 . . . . 0.0 110.038 179.751 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 8.3 p -99.54 109.82 56.48 Favored Pre-proline 0 CA--C 1.548 0.903 0 C-N-CA 124.693 1.197 . . . . 0.0 109.543 -173.545 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -70.62 -46.47 0.86 Allowed 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 122.2 1.933 . . . . 0.0 113.21 -169.571 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 3.0 m80 -73.15 -38.4 66.26 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.481 0.657 . . . . 0.0 109.383 -177.042 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -76.11 -26.83 56.77 Favored 'General case' 0 C--O 1.226 -0.147 0 CA-C-O 118.659 -0.686 . . . . 0.0 111.07 -172.211 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -59.14 -37.61 77.7 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 118.901 0.773 . . . . 0.0 108.995 169.423 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -60.39 -41.86 98.68 Favored Glycine 0 CA--C 1.534 1.242 0 O-C-N 121.497 -0.752 . . . . 0.0 111.651 174.343 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -68.59 -31.6 70.9 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 118.133 0.967 . . . . 0.0 110.233 176.135 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.429 ' HB2' ' HB3' ' A' ' 86' ' ' PHE . . . -59.69 -45.32 92.45 Favored 'General case' 0 CA--C 1.53 0.179 0 O-C-N 120.77 -1.206 . . . . 0.0 109.032 169.306 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -68.63 -21.88 64.45 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 119.064 -0.493 . . . . 0.0 111.852 178.425 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.429 HG13 ' HA ' ' A' ' 49' ' ' LEU . 44.6 t -64.52 -46.21 93.36 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 168.988 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 19.8 mt -64.87 -35.46 81.2 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 119.655 1.116 . . . . 0.0 110.53 -179.781 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 16.4 m -60.93 -44.62 96.95 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 118.871 0.76 . . . . 0.0 109.368 171.5 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -65.63 -36.64 84.28 Favored 'General case' 0 N--CA 1.449 -0.522 0 O-C-N 121.686 -0.634 . . . . 0.0 111.701 179.105 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 12.4 mt -61.3 -37.59 83.77 Favored 'General case' 0 C--O 1.23 0.073 0 C-N-CA 123.59 0.756 . . . . 0.0 109.982 174.437 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 52.9 tpt85 -71.71 -35.1 70.11 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-O 118.036 -0.983 . . . . 0.0 110.49 174.452 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 18.4 m-30 -69.13 -39.06 79.12 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 119.785 1.175 . . . . 0.0 110.755 -178.571 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 38.9 p -72.59 -22.36 60.99 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 118.759 0.709 . . . . 0.0 111.012 175.699 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 73.62 11.07 80.4 Favored Glycine 0 CA--C 1.533 1.196 0 N-CA-C 111.005 -0.838 . . . . 0.0 111.005 -169.642 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -99.43 26.7 5.81 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 118.436 1.118 . . . . 0.0 110.575 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -59.48 129.59 87.12 Favored Pre-proline 0 CA--C 1.544 0.722 0 C-N-CA 124.137 0.975 . . . . 0.0 108.522 171.88 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_exo -50.37 149.66 12.47 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 123.971 3.114 . . . . 0.0 113.829 178.025 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 33.0 mmtp -59.46 -30.55 68.6 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 119.359 -0.353 . . . . 0.0 110.589 -178.307 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? -137.57 142.25 41.34 Favored 'General case' 0 C--O 1.231 0.129 0 N-CA-C 105.915 -1.883 . . . . 0.0 105.915 169.068 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 8.9 tt -127.78 134.1 49.47 Favored 'General case' 0 CA--C 1.519 -0.216 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 171.667 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.75 129.13 30.03 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 106.784 -1.562 . . . . 0.0 106.784 -169.569 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 7.0 tp -115.06 126.68 54.99 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 120.09 1.314 . . . . 0.0 108.553 178.312 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 32.4 t -98.51 84.44 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 N-CA-C 104.721 -2.326 . . . . 0.0 104.721 169.687 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -81.43 145.06 24.95 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 -179.013 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 19.0 t -126.79 137.11 58.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 171.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 1.6 mm -85.09 122.24 74.05 Favored Pre-proline 0 CA--C 1.543 0.701 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 177.179 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_exo -58.34 170.45 2.35 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 124.988 3.792 . . . . 0.0 115.711 172.109 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -118.26 -52.33 2.39 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 114.897 -1.047 . . . . 0.0 110.255 179.581 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 64.6 m -107.43 -53.84 2.56 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 119.203 0.91 . . . . 0.0 112.802 -174.716 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 57.29 47.55 16.58 Favored 'General case' 0 CA--C 1.549 0.942 0 N-CA-C 114.765 1.394 . . . . 0.0 114.765 175.283 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -124.67 170.17 9.48 Favored Pre-proline 0 N--CA 1.478 0.938 0 CA-C-O 117.888 -1.054 . . . . 0.0 109.89 175.441 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_exo -62.85 87.07 0.12 Allowed 'Trans proline' 0 CA--C 1.549 1.259 0 C-N-CA 123.838 3.025 . . . . 0.0 114.452 -179.368 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -172.76 140.42 0.98 Allowed 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 104.334 -2.469 . . . . 0.0 104.334 172.635 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -102.4 164.17 3.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-N 119.102 0.865 . . . . 0.0 112.889 -169.488 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 82.15 159.31 24.9 Favored Glycine 0 C--N 1.342 0.894 0 N-CA-C 108.977 -1.649 . . . . 0.0 108.977 -170.121 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -82.2 163.17 22.08 Favored 'General case' 0 N--CA 1.439 -0.993 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 -174.584 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 37.7 p -67.99 169.78 8.99 Favored Pre-proline 0 C--O 1.239 0.542 0 CA-C-N 115.107 -0.951 . . . . 0.0 108.944 168.067 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_exo -55.16 -32.37 79.8 Favored 'Trans proline' 0 CA--C 1.539 0.753 0 C-N-CA 121.397 1.398 . . . . 0.0 110.845 169.294 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 18.2 m -68.01 -44.49 76.42 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 119.066 -0.492 . . . . 0.0 111.297 179.604 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 12.3 t -100.59 -13.21 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-N 119.252 0.933 . . . . 0.0 112.277 -169.156 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -57.47 -45.83 84.36 Favored 'General case' 0 CA--C 1.516 -0.341 0 O-C-N 119.752 -1.842 . . . . 0.0 107.808 169.535 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -71.59 2.91 4.47 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-N 115.404 -0.816 . . . . 0.0 113.08 179.268 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 84.1 mtp -97.27 -6.87 33.48 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 118.136 -0.935 . . . . 0.0 111.384 173.609 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 79.2 mt -57.24 -50.06 77.88 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 175.512 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -66.36 -53.2 32.45 Favored Pre-proline 0 CA--C 1.537 0.47 0 CA-C-O 117.411 -1.281 . . . . 0.0 113.298 -170.036 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -60.79 -32.88 93.38 Favored 'Trans proline' 0 C--N 1.351 0.662 0 CA-C-N 121.987 1.745 . . . . 0.0 111.79 175.863 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -69.24 -38.8 78.66 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-O 118.406 -0.807 . . . . 0.0 109.881 177.623 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 10.6 mt -57.78 -44.17 86.06 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 119.612 1.097 . . . . 0.0 108.755 173.065 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -62.72 -36.84 84.28 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 118.328 0.513 . . . . 0.0 111.443 -176.577 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 42.9 mm-40 -74.27 -33.36 63.24 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 118.686 0.675 . . . . 0.0 112.206 177.28 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 75.2 t -62.05 -49.03 85.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-N 119.475 1.034 . . . . 0.0 108.28 169.726 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 56.3 mt -60.57 -39.12 86.85 Favored 'General case' 0 CA--C 1.531 0.244 0 O-C-N 121.81 -0.556 . . . . 0.0 110.717 -179.502 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -58.77 -39.3 80.61 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 119.038 -0.506 . . . . 0.0 112.147 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -64.93 -48.17 75.06 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 119.094 0.861 . . . . 0.0 110.406 178.17 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . 0.284 4.1 pp -68.01 -23.71 65.04 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 118.73 -0.652 . . . . 0.0 112.174 178.678 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 81.7 mtm-85 -67.1 -26.97 66.97 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 119.937 1.244 . . . . 0.0 111.407 171.014 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -66.89 -34.17 77.2 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 120.422 1.465 . . . . 0.0 109.318 175.843 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 23.1 m -82.32 18.45 1.43 Allowed 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.478 1.111 . . . . 0.0 112.615 172.529 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 68.21 19.65 72.41 Favored Glycine 0 CA--C 1.529 0.959 0 CA-C-O 118.706 -1.052 . . . . 0.0 113.745 173.347 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 58.1 t -80.48 124.97 39.01 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 CA-C-N 119.18 1.49 . . . . 0.0 107.317 176.518 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -100.67 95.72 6.86 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 105.222 -2.14 . . . . 0.0 105.222 169.509 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -70.43 141.64 52.07 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 177.158 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 8.8 mm -108.81 124.76 33.35 Favored Pre-proline 0 CA--C 1.529 0.151 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 -179.806 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -64.35 103.21 0.43 Allowed 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 121.918 1.745 . . . . 0.0 107.954 169.917 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 87.2 mtt180 56.91 -8.56 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 128.052 2.541 . . . . 0.0 117.017 179.469 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 2.4 t 55.67 -167.55 0.1 Allowed 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.765 1.626 . . . . 0.0 111.575 -177.088 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -144.87 146.31 31.99 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 125.597 1.559 . . . . 0.0 108.804 177.69 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 14.4 m . . . . . 0 C--O 1.253 1.267 0 C-N-CA 124.545 1.138 . . . . 0.0 111.043 -173.89 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.7 tpt . . . . . 0 N--CA 1.496 1.859 0 N-CA-C 110.278 -0.268 . . . . 0.0 110.278 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 8.7 ptp180 -143.42 127.31 17.29 Favored 'General case' 0 N--CA 1.482 1.133 0 CA-C-O 117.725 -1.131 . . . . 0.0 108.114 175.013 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 53.7 mt -143.8 137.65 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 CA-C-N 119.718 1.145 . . . . 0.0 112.424 -168.578 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -121.07 126.7 50.49 Favored 'General case' 0 CA--C 1.521 -0.142 0 N-CA-C 104.255 -2.498 . . . . 0.0 104.255 167.487 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 61.7 t -107.95 100.03 9.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 N-CA-C 102.743 -3.058 . . . . 0.0 102.743 169.824 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 8.2 mt -95.54 116.05 28.29 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 -171.595 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -93.2 118.53 5.67 Favored Glycine 0 N--CA 1.446 -0.697 0 N-CA-C 106.136 -2.785 . . . . 0.0 106.136 169.659 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -134.62 -171.92 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 -174.506 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 106.43 157.43 21.6 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.217 -1.153 . . . . 0.0 110.217 -171.434 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -81.43 96.8 7.49 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 124.773 1.229 . . . . 0.0 109.055 -174.41 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.1 pt -71.97 41.81 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 C-N-CA 124.596 1.158 . . . . 0.0 113.766 -177.294 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 20.2 mt -130.1 -5.52 4.42 Favored 'General case' 0 CA--C 1.534 0.35 0 O-C-N 121.027 -1.046 . . . . 0.0 109.548 173.747 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -124.6 72.9 1.23 Allowed 'General case' 0 C--N 1.343 0.312 0 C-N-CA 123.559 0.744 . . . . 0.0 110.308 -168.511 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.452 ' HB ' ' H ' ' A' ' 15' ' ' ASP . 0.6 OUTLIER 47.25 -98.46 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.303 1.041 . . . . 0.0 113.419 175.368 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.452 ' H ' ' HB ' ' A' ' 14' ' ' THR . 69.1 m-20 -77.42 -18.54 57.14 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 125.347 1.459 . . . . 0.0 112.207 -169.531 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -72.63 -8.27 54.45 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 120.275 1.398 . . . . 0.0 112.491 -176.53 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.43 -12.0 60.92 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-O 117.057 -1.449 . . . . 0.0 110.862 169.389 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 9.2 tp -56.82 -39.72 66.36 Favored 'Isoleucine or valine' 0 C--N 1.341 0.234 0 CA-C-N 121.107 1.776 . . . . 0.0 112.275 -170.117 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -58.73 -46.82 92.86 Favored Glycine 0 C--N 1.339 0.708 0 CA-C-N 119.484 1.038 . . . . 0.0 111.229 176.25 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 62.4 t -62.95 -47.92 90.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-O 118.618 -0.706 . . . . 0.0 109.477 175.822 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 20.3 mmt180 -63.73 -31.95 73.29 Favored 'General case' 0 C--N 1.346 0.452 0 CA-C-O 117.298 -1.334 . . . . 0.0 111.688 -176.796 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 18.2 mt -60.6 -48.16 89.78 Favored 'Isoleucine or valine' 0 C--N 1.341 0.233 0 CA-C-N 121.033 1.742 . . . . 0.0 109.62 176.901 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 18.8 m -74.64 -33.45 31.9 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-N 119.429 1.013 . . . . 0.0 111.368 -173.486 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 62.8 mt-10 -63.29 -44.41 95.12 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 118.383 0.538 . . . . 0.0 109.934 172.206 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -66.33 -37.6 85.74 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 119.427 1.012 . . . . 0.0 110.197 177.91 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.8 tp -63.79 -39.78 95.07 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 119.08 0.855 . . . . 0.0 109.088 -178.636 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -62.16 -22.5 65.92 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.251 0.62 . . . . 0.0 112.578 179.302 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 90.3 mt-30 -94.32 -45.09 7.64 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.213 1.405 . . . . 0.0 110.201 -178.704 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 80.4 mtt180 -81.69 -25.33 35.6 Favored 'General case' 0 CA--C 1.528 0.109 0 CA-C-O 118.753 -0.641 . . . . 0.0 111.165 -173.627 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.402 ' HA ' ' H ' ' A' ' 159' ' ' ARG . 56.5 m-85 -125.54 151.33 46.51 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-N 118.611 0.642 . . . . 0.0 111.019 -179.511 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 46.3 mm -104.56 133.64 48.11 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 103.51 -2.774 . . . . 0.0 103.51 168.81 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -113.04 146.76 35.83 Favored Pre-proline 0 C--O 1.237 0.4 0 C-N-CA 123.28 0.632 . . . . 0.0 109.703 -169.801 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -65.17 157.89 55.06 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 122.458 2.105 . . . . 0.0 109.9 170.564 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -57.49 -34.01 68.61 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 -169.408 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 12.0 p90 -76.26 -10.73 59.63 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 -177.171 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 69.1 t -91.84 119.37 39.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 172.002 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -111.84 114.68 27.78 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 107.343 -1.354 . . . . 0.0 107.343 169.536 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -85.06 102.43 10.97 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 N-CA-C 104.484 -2.413 . . . . 0.0 104.484 168.967 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 59.5 tp -107.54 128.37 54.46 Favored 'General case' 0 C--O 1.232 0.151 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 -173.244 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -79.3 119.43 22.35 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 169.539 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -78.41 -80.1 0.74 Allowed Glycine 0 C--N 1.338 0.664 0 N-CA-C 106.64 -2.584 . . . . 0.0 106.64 169.527 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 78.28 99.37 0.21 Allowed Glycine 0 C--N 1.342 0.903 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 176.857 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 13.1 p 53.47 55.62 8.41 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.113 0.965 . . . . 0.0 108.69 -177.586 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -118.03 -79.89 0.6 Allowed 'General case' 0 C--N 1.348 0.503 0 CA-C-N 114.487 -1.233 . . . . 0.0 111.071 -170.051 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 59.42 -110.2 2.6 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 110.077 -1.209 . . . . 0.0 110.077 -179.754 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -53.14 -33.03 50.68 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.973 1.309 . . . . 0.0 110.962 -176.387 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -54.43 -22.3 12.18 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 113.784 1.031 . . . . 0.0 113.784 -175.474 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 14.5 mt -95.73 17.89 14.13 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 113.57 0.952 . . . . 0.0 113.57 -169.537 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.705 ' HA ' HG13 ' A' ' 100' ' ' VAL . 4.6 tt -45.78 -60.11 2.41 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 123.239 0.616 . . . . 0.0 112.055 -177.165 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -67.78 -32.52 78.06 Favored Glycine 0 CA--C 1.532 1.146 0 CA-C-N 116.002 -0.545 . . . . 0.0 112.291 -178.076 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -78.47 -32.37 48.33 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 118.836 1.318 . . . . 0.0 112.699 -173.555 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.534 ' SD ' HG11 ' A' ' 100' ' ' VAL . 53.8 mtp -74.8 -16.98 60.69 Favored 'General case' 0 N--CA 1.454 -0.225 0 O-C-N 121.758 -0.589 . . . . 0.0 110.868 178.261 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -81.13 156.4 25.77 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 123.375 0.67 . . . . 0.0 111.257 -173.68 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 53.76 36.08 23.01 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 126.588 1.955 . . . . 0.0 113.512 173.789 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 26.4 mmt180 -100.94 157.29 16.85 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 173.047 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -82.63 -54.68 4.97 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 176.008 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . 0.263 0.0 OUTLIER -116.83 149.95 39.17 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-N 119.522 1.055 . . . . 0.0 108.589 168.551 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 12.6 tp -133.69 115.82 15.06 Favored 'General case' 0 CA--C 1.511 -0.543 0 N-CA-C 104.955 -2.239 . . . . 0.0 104.955 171.782 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 33.8 mt -97.95 111.95 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 N-CA-C 104.885 -2.265 . . . . 0.0 104.885 171.832 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.552 HD13 HD11 ' A' ' 97' ' ' LEU . 12.2 mt -85.18 134.41 27.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 106.058 -1.83 . . . . 0.0 106.058 171.589 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -117.0 118.41 32.32 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 102.591 -3.114 . . . . 0.0 102.591 168.402 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -156.71 162.12 39.8 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 -175.093 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -85.33 149.66 25.3 Favored 'General case' 0 CA--C 1.534 0.357 0 O-C-N 121.536 -0.727 . . . . 0.0 109.974 170.026 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 11.0 mt -80.46 -30.94 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 C-N-CA 124.7 1.2 . . . . 0.0 110.171 175.678 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . 0.361 2.5 t 60.27 43.77 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.086 0 C-N-CA 126.321 1.848 . . . . 0.0 113.326 -176.402 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 12.8 m 62.04 139.15 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 128.424 2.69 . . . . 0.0 118.172 168.526 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -130.73 -90.04 0.46 Allowed 'General case' 0 N--CA 1.463 0.181 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 169.774 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 87.9 mttt -139.36 35.41 2.07 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.778 1.231 . . . . 0.0 110.0 -176.705 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 42.1 t-20 -138.0 161.72 35.98 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.561 1.144 . . . . 0.0 109.844 -171.105 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 2.1 m -62.5 148.3 90.67 Favored Pre-proline 0 CA--C 1.547 0.865 0 C-N-CA 124.666 1.186 . . . . 0.0 113.131 -169.294 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_exo -56.85 157.91 18.52 Favored 'Trans proline' 0 CA--C 1.532 0.419 0 C-N-CA 124.481 3.454 . . . . 0.0 113.038 169.711 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 64.15 16.3 59.82 Favored Glycine 0 CA--C 1.531 1.064 0 CA-C-O 119.491 -0.616 . . . . 0.0 113.809 171.317 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 3.0 m -94.51 146.64 23.96 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 124.672 1.189 . . . . 0.0 109.629 -172.092 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 31.7 ttp -98.04 141.78 30.57 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 171.676 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 64.3 mtm -133.33 129.73 37.89 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 169.0 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 38.9 mm -108.21 121.93 61.92 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 -179.528 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.3 mp -121.33 139.01 53.99 Favored 'General case' 0 C--O 1.236 0.367 0 O-C-N 123.833 0.708 . . . . 0.0 109.3 -172.811 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 52.5 ttp180 -83.95 165.15 18.89 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.922 0.889 . . . . 0.0 110.049 -177.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -30.67 -55.1 0.2 Allowed 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 116.353 1.983 . . . . 0.0 116.353 -175.392 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -87.91 -16.65 33.29 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 -174.764 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -76.13 -35.09 59.4 Favored 'General case' 0 N--CA 1.461 0.084 0 O-C-N 121.817 -0.552 . . . . 0.0 109.574 -178.254 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.455 ' HB ' ' HD3' ' A' ' 83' ' ' PRO . 88.3 t -59.14 -54.54 55.37 Favored Pre-proline 0 CA--C 1.547 0.848 0 C-N-CA 125.635 1.574 . . . . 0.0 111.787 -175.675 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.455 ' HD3' ' HB ' ' A' ' 82' ' ' VAL . 50.3 Cg_exo -53.86 -42.77 63.83 Favored 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 122.781 2.321 . . . . 0.0 112.41 174.935 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -71.26 -10.82 60.39 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -91.66 -40.2 11.42 Favored 'General case' 0 C--N 1.343 0.315 0 CA-C-N 120.073 1.306 . . . . 0.0 111.82 -176.539 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.511 ' CE2' HD12 ' A' ' 97' ' ' LEU . 41.4 m-85 -75.52 10.12 1.85 Allowed 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 112.967 0.728 . . . . 0.0 112.967 -171.525 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 75.2 p -60.14 -24.29 64.59 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.154 0.981 . . . . 0.0 111.22 171.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 61.5 t-20 -49.04 118.9 2.87 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.503 1.121 . . . . 0.0 111.235 177.414 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -74.67 -18.45 60.52 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -174.744 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 42.1 mt -67.13 -45.59 86.27 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -176.527 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.3 m -73.18 110.54 8.84 Favored Pre-proline 0 CA--C 1.545 0.762 0 C-N-CA 126.291 1.837 . . . . 0.0 112.05 -168.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -76.15 -62.95 0.03 OUTLIER 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 122.254 1.97 . . . . 0.0 112.333 -169.863 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 6.6 t-80 -56.66 -40.04 74.81 Favored 'General case' 0 N--CA 1.466 0.335 0 O-C-N 121.442 -0.786 . . . . 0.0 110.225 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 22.0 mp0 -62.29 -27.69 69.2 Favored 'General case' 0 N--CA 1.44 -0.955 0 C-N-CA 124.972 1.309 . . . . 0.0 110.082 -172.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 30.9 mt -72.09 -36.72 69.59 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 120.025 1.284 . . . . 0.0 110.447 174.705 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -66.69 -42.96 92.97 Favored Glycine 0 CA--C 1.528 0.885 0 N-CA-C 110.238 -1.145 . . . . 0.0 110.238 173.387 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.552 HD11 HD13 ' A' ' 60' ' ' ILE . 3.4 tm? -59.79 -41.45 91.2 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.197 0.599 . . . . 0.0 109.791 173.35 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -59.25 -44.65 92.36 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 123.01 0.524 . . . . 0.0 110.542 175.883 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -66.11 -26.76 67.61 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 118.806 -0.616 . . . . 0.0 111.899 -179.608 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.705 HG13 ' HA ' ' A' ' 49' ' ' LEU . 92.1 t -63.93 -45.84 95.78 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 168.845 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 87.9 mt -67.07 -33.4 75.43 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 119.266 0.939 . . . . 0.0 110.722 -176.182 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 15.8 m -60.78 -49.25 78.24 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 119.028 0.831 . . . . 0.0 109.957 169.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.402 ' HA ' ' CD2' ' A' ' 106' ' ' PHE . . . -58.1 -41.03 82.63 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 118.185 0.448 . . . . 0.0 111.019 176.737 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -63.48 -32.71 74.24 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 123.741 0.816 . . . . 0.0 110.951 179.74 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 17.6 ptm180 -83.68 -27.86 28.75 Favored 'General case' 0 C--N 1.344 0.369 0 CA-C-N 120.455 1.48 . . . . 0.0 112.19 173.891 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.402 ' CD2' ' HA ' ' A' ' 103' ' ' ALA . 16.7 m-30 -60.47 -46.58 89.55 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 118.454 0.57 . . . . 0.0 109.843 172.301 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 41.4 p -77.29 -26.8 52.67 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 123.611 0.764 . . . . 0.0 111.54 178.941 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 75.66 6.35 81.12 Favored Glycine 0 CA--C 1.534 1.232 0 N-CA-C 109.881 -1.288 . . . . 0.0 109.881 -168.497 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -85.24 19.99 2.09 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 119.768 1.784 . . . . 0.0 111.454 179.088 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -56.28 140.03 72.44 Favored Pre-proline 0 CA--C 1.546 0.814 0 C-N-CA 126.034 1.734 . . . . 0.0 110.307 170.058 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 99.6 Cg_exo -57.97 161.37 13.26 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 123.396 2.731 . . . . 0.0 115.531 179.365 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -65.91 -38.63 89.2 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 119.164 -0.446 . . . . 0.0 111.671 176.339 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 4.5 pttm -142.75 89.64 2.15 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 124.259 1.024 . . . . 0.0 108.342 177.7 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 7.4 tt -76.33 142.6 41.19 Favored 'General case' 0 CA--C 1.534 0.356 0 O-C-N 120.961 -1.087 . . . . 0.0 108.592 169.418 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.9 140.81 46.07 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.334 1.454 . . . . 0.0 107.698 174.696 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 14.6 tp -118.59 134.41 55.13 Favored 'General case' 0 N--CA 1.467 0.411 0 O-C-N 120.48 -1.388 . . . . 0.0 108.496 175.291 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 20.4 t -105.92 85.09 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 N-CA-C 104.788 -2.301 . . . . 0.0 104.788 169.154 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -81.31 144.66 24.77 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 110.41 -1.076 . . . . 0.0 110.41 179.732 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 39.2 t -128.43 130.98 69.3 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 CA-C-N 117.405 0.603 . . . . 0.0 109.989 179.829 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 16.8 mt -85.17 132.92 43.9 Favored Pre-proline 0 CA--C 1.539 0.529 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 176.396 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -77.01 -179.06 5.05 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 123.075 2.517 . . . . 0.0 111.617 -177.569 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.453 ' HB3' HG21 ' A' ' 131' ' ' THR . 6.3 tp10 -110.09 -51.18 2.9 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.994 0.918 . . . . 0.0 109.807 169.753 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 66.4 m -118.65 -54.53 2.25 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 118.201 0.455 . . . . 0.0 111.964 -169.853 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER 54.54 52.84 11.61 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.652 1.181 . . . . 0.0 112.163 -177.293 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -119.25 165.92 15.87 Favored Pre-proline 0 CA--C 1.537 0.472 0 C-N-CA 123.468 0.707 . . . . 0.0 109.954 -179.372 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -78.32 81.78 2.64 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 121.755 1.636 . . . . 0.0 112.634 -169.864 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -171.09 141.59 1.68 Allowed 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 102.218 -3.253 . . . . 0.0 102.218 177.293 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -108.21 166.59 4.25 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 N-CA-C 113.596 0.962 . . . . 0.0 113.596 -169.286 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 97.33 141.21 11.94 Favored Glycine 0 C--N 1.338 0.646 0 N-CA-C 105.751 -2.94 . . . . 0.0 105.751 -168.916 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.61 HD22 ' H ' ' A' ' 130' ' ' LEU . 1.0 OUTLIER -67.41 158.49 31.59 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 117.861 0.83 . . . . 0.0 109.882 176.943 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.453 HG21 ' HB3' ' A' ' 122' ' ' GLU . 63.4 p -69.14 169.75 10.78 Favored Pre-proline 0 CA--C 1.543 0.681 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 168.018 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -58.02 -37.13 97.12 Favored 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 121.57 1.513 . . . . 0.0 111.388 173.305 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 82.8 m -64.33 -33.75 76.55 Favored 'General case' 0 N--CA 1.443 -0.785 0 C-N-CA 124.415 1.086 . . . . 0.0 111.436 -178.85 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 73.8 t -103.23 -27.59 3.2 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 O-C-N 121.81 -0.556 . . . . 0.0 111.511 -172.731 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -51.73 -49.37 62.69 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 119.035 0.834 . . . . 0.0 108.88 169.837 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -61.89 -20.88 64.22 Favored 'General case' 0 N--CA 1.447 -0.575 0 N-CA-C 112.994 0.738 . . . . 0.0 112.994 179.373 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 3.0 mmm -78.04 -7.89 57.48 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 -179.619 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 72.5 mt -55.95 -50.59 68.31 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.295 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 170.79 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -70.51 -44.89 18.4 Favored Pre-proline 0 CA--C 1.538 0.481 0 CA-C-O 117.284 -1.341 . . . . 0.0 113.756 -168.893 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -57.66 -41.33 71.75 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 CA-C-N 122.076 1.777 . . . . 0.0 111.152 172.412 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.01 -35.89 74.69 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-O 118.263 -0.875 . . . . 0.0 112.046 179.285 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 39.0 mt -61.09 -48.64 80.75 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-N 120.087 1.312 . . . . 0.0 108.929 172.249 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -54.73 -35.31 63.55 Favored 'General case' 0 CA--C 1.531 0.237 0 O-C-N 123.398 0.436 . . . . 0.0 109.995 175.288 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 2.1 mm100 -78.7 -35.74 44.58 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 45.7 t -59.27 -48.27 87.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 169.82 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 44.0 mt -60.23 -36.55 77.99 Favored 'General case' 0 C--O 1.226 -0.148 0 C-N-CA 123.413 0.685 . . . . 0.0 110.88 177.833 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -70.1 -44.23 69.44 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 119.139 0.881 . . . . 0.0 110.856 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -66.53 -30.99 71.43 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 119.676 1.126 . . . . 0.0 111.225 177.433 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 12.9 mt -62.27 -52.99 61.5 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 169.845 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 93.6 mtt-85 -64.73 -28.65 69.74 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 120.231 1.378 . . . . 0.0 112.432 -178.413 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -69.34 -28.75 66.51 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 119.203 0.91 . . . . 0.0 109.982 176.712 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 51.0 m -82.51 8.24 12.22 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.392 1.077 . . . . 0.0 111.906 169.713 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 72.83 10.52 77.09 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-O 117.291 -1.838 . . . . 0.0 113.11 -174.56 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 38.2 t -91.05 119.54 38.39 Favored 'Isoleucine or valine' 0 C--N 1.345 0.378 0 CA-C-N 121.025 2.412 . . . . 0.0 108.48 -176.59 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -97.57 91.32 5.38 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 172.385 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -55.9 139.11 47.08 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 169.051 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 20.5 mt -83.33 126.87 70.71 Favored Pre-proline 0 CA--C 1.529 0.161 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 -173.263 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -68.47 89.83 0.4 Allowed 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 123.045 2.497 . . . . 0.0 109.029 174.64 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 159' ' ' ARG . . . . . 0.402 ' H ' ' HA ' ' A' ' 30' ' ' TYR . 29.1 ttp180 52.34 17.13 0.69 Allowed 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 127.628 2.371 . . . . 0.0 114.567 179.489 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 57.7 m 48.24 37.07 7.68 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.057 0.943 . . . . 0.0 111.145 -169.015 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -140.73 45.84 1.79 Allowed 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.14 1.376 . . . . 0.0 108.991 -170.659 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 8.5 m . . . . . 0 C--O 1.258 1.503 0 C-N-CA 124.977 1.311 . . . . 0.0 110.509 -177.816 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.8 ttt . . . . . 0 N--CA 1.499 2.016 0 CA-C-O 119.646 -0.216 . . . . 0.0 110.938 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 38.9 ttm180 -64.42 124.02 20.72 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 120.007 -1.683 . . . . 0.0 109.693 176.617 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 5.5 mt -119.73 132.7 68.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 -174.526 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 43.3 tp -113.61 145.72 40.84 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 105.849 -1.908 . . . . 0.0 105.849 167.869 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 30.2 t -124.32 131.37 72.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 N-CA-C 105.017 -2.216 . . . . 0.0 105.017 169.213 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 6.6 mt -125.36 117.3 23.43 Favored 'General case' 0 CA--C 1.511 -0.547 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 -173.671 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -87.88 133.29 11.71 Favored Glycine 0 CA--C 1.521 0.424 0 N-CA-C 107.709 -2.157 . . . . 0.0 107.709 169.652 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.5 m -142.27 133.01 24.76 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 CA-C-N 119.317 1.559 . . . . 0.0 112.507 -170.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 144.79 169.59 13.42 Favored Glycine 0 CA--C 1.525 0.684 0 C-N-CA 125.948 1.737 . . . . 0.0 109.123 169.572 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.548 HD21 HD13 ' A' ' 13' ' ' LEU . 0.2 OUTLIER -76.94 116.77 17.9 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 122.81 1.29 . . . . 0.0 111.45 -176.459 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.1 pt -63.99 36.34 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.861 0 N-CA-C 116.096 1.888 . . . . 0.0 116.096 172.861 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 5.4 mp -129.52 -9.53 4.59 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 120.545 1.52 . . . . 0.0 110.025 168.525 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.548 HD13 HD21 ' A' ' 10' ' ' ASN . 4.7 mp -106.59 56.47 0.65 Allowed 'General case' 0 C--N 1.343 0.299 0 N-CA-C 114.739 1.385 . . . . 0.0 114.739 -168.917 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.255 0.2 OUTLIER 54.95 -109.59 0.51 Allowed 'General case' 0 C--O 1.238 0.45 0 C-N-CA 123.428 0.691 . . . . 0.0 110.921 170.428 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -77.9 -7.45 56.75 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.435 0.694 . . . . 0.0 111.831 -175.935 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 23.0 tp10 -55.85 -32.59 63.76 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 120.012 1.278 . . . . 0.0 111.417 169.924 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.9 5.0 14.97 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-O 115.888 -2.006 . . . . 0.0 110.082 -179.1 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 6.6 tp -57.07 -42.82 80.13 Favored 'Isoleucine or valine' 0 C--N 1.342 0.242 0 CA-C-N 123.369 2.804 . . . . 0.0 110.92 -179.764 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -61.23 -43.18 99.71 Favored Glycine 0 CA--C 1.526 0.727 0 CA-C-N 119.564 1.075 . . . . 0.0 111.465 175.428 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 83.2 t -66.93 -51.46 54.62 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 CA-C-N 117.449 0.624 . . . . 0.0 109.559 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 74.4 mmt-85 -57.55 -34.76 69.51 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 117.142 -1.409 . . . . 0.0 112.479 176.578 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 24.2 mt -60.72 -47.73 91.84 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-N 121.839 2.109 . . . . 0.0 110.507 175.902 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 35.2 m -74.26 -27.2 21.39 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-N 120.25 1.386 . . . . 0.0 111.416 -175.426 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -69.18 -45.69 69.36 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 174.597 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -64.32 -45.11 89.3 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 123.313 0.645 . . . . 0.0 110.509 -179.442 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 8.1 tp -61.78 -41.58 97.9 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-O 118.86 -0.59 . . . . 0.0 110.068 179.672 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -60.05 -38.73 83.67 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 118.209 0.459 . . . . 0.0 110.965 177.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 9.5 mm-40 -75.75 -40.6 55.17 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 118.631 0.651 . . . . 0.0 111.065 -179.899 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 41.5 mmt180 -87.4 -31.57 20.01 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 117.637 -1.173 . . . . 0.0 113.02 -169.498 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 72.0 m-85 -122.54 137.76 54.78 Favored 'General case' 0 CA--C 1.522 -0.134 0 CA-C-N 120.76 1.618 . . . . 0.0 111.969 -176.05 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 43.7 mm -90.87 137.65 21.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 N-CA-C 105.591 -2.003 . . . . 0.0 105.591 168.819 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -124.25 154.98 68.83 Favored Pre-proline 0 CA--C 1.541 0.62 0 C-N-CA 124.985 1.314 . . . . 0.0 109.902 -170.906 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -59.44 157.13 32.61 Favored 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 123.318 2.679 . . . . 0.0 112.041 169.697 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -63.19 -31.38 72.51 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -171.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 18.8 p90 -72.66 -6.19 42.67 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 118.186 -0.911 . . . . 0.0 112.699 178.816 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 38.2 t -100.9 130.73 49.81 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 CA-C-N 120.054 1.297 . . . . 0.0 108.32 175.391 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -118.55 135.35 54.46 Favored 'General case' 0 CA--C 1.529 0.171 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 170.078 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -106.47 118.12 53.54 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 N-CA-C 104.691 -2.337 . . . . 0.0 104.691 169.368 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 48.7 tp -127.19 126.4 42.75 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-O 120.889 0.376 . . . . 0.0 110.307 -174.735 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -78.0 119.42 21.42 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 168.715 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -57.51 -55.84 28.28 Favored Glycine 0 CA--C 1.53 0.975 0 N-CA-C 109.073 -1.611 . . . . 0.0 109.073 172.411 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 74.74 87.56 0.24 Allowed Glycine 0 C--N 1.341 0.833 0 N-CA-C 111.451 -0.66 . . . . 0.0 111.451 169.699 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 20.3 p 50.81 58.91 5.02 Favored 'General case' 0 CA--C 1.546 0.8 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 -177.532 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -116.65 -86.72 0.62 Allowed 'General case' 0 C--N 1.348 0.508 0 CA-C-N 114.495 -1.23 . . . . 0.0 111.352 -169.334 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 65.76 -94.97 0.22 Allowed Glycine 0 C--N 1.341 0.836 0 N-CA-C 108.947 -1.661 . . . . 0.0 108.947 -169.772 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 3.5 tpt -62.77 -31.41 72.37 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 125.288 1.435 . . . . 0.0 111.764 179.687 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -66.36 -7.69 20.7 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -169.32 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 70.9 mt -84.26 3.74 34.06 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 113.854 1.057 . . . . 0.0 113.854 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.479 ' HA ' HG13 ' A' ' 100' ' ' VAL . 6.0 tt -41.36 -59.0 1.68 Allowed 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 114.107 1.151 . . . . 0.0 114.107 -170.907 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -93.34 -26.02 17.12 Favored Glycine 0 CA--C 1.527 0.786 0 C-N-CA 123.698 0.666 . . . . 0.0 111.896 -178.461 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -62.06 -34.7 76.74 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 118.639 1.22 . . . . 0.0 111.335 179.467 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 26.8 mtp -78.28 -3.58 43.6 Favored 'General case' 0 CA--C 1.529 0.137 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 178.378 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.5 157.84 36.84 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 118.817 0.735 . . . . 0.0 110.824 -178.124 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 55.3 39.51 31.31 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.827 1.651 . . . . 0.0 114.66 168.311 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 13.4 mmt180 -107.11 148.86 28.28 Favored 'General case' 0 N--CA 1.473 0.714 0 O-C-N 121.121 -0.987 . . . . 0.0 109.411 176.11 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -82.49 -36.05 26.82 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 171.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 1.7 t-160 -138.45 137.93 37.66 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 -176.002 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 20.8 tp -136.41 131.47 34.19 Favored 'General case' 0 CA--C 1.507 -0.686 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 169.275 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 3.8 mp -112.42 119.81 61.15 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 169.656 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 5.3 mt -96.55 117.71 41.48 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 177.097 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -84.56 113.41 21.22 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 103.2 -2.889 . . . . 0.0 103.2 169.519 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -124.16 155.37 38.59 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 114.358 1.244 . . . . 0.0 114.358 -167.828 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -113.18 119.4 37.65 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 169.843 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 92.0 mt -76.71 -26.01 16.22 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.753 0 O-C-N 124.148 0.905 . . . . 0.0 111.558 -171.703 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . 0.286 47.4 t 69.75 -62.58 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 C-N-CA 128.887 2.875 . . . . 0.0 111.572 -170.61 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 5.5 m -151.68 138.84 19.23 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 177.561 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 73.3 tttt -157.3 170.06 23.32 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 127.534 2.334 . . . . 0.0 105.234 168.735 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.01 -22.5 65.89 Favored 'General case' 0 N--CA 1.473 0.675 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 -170.314 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -71.16 164.92 24.66 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 123.087 0.555 . . . . 0.0 110.292 -177.661 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 18.6 m -61.57 149.57 83.76 Favored Pre-proline 0 CA--C 1.55 0.949 0 C-N-CA 124.257 1.023 . . . . 0.0 112.125 -171.232 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -54.21 152.53 24.77 Favored 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 122.77 2.313 . . . . 0.0 112.255 169.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 69.65 7.36 58.25 Favored Glycine 0 CA--C 1.531 1.036 0 CA-C-O 118.661 -1.077 . . . . 0.0 114.44 175.276 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 20.5 m -89.19 148.14 23.79 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 119.608 1.704 . . . . 0.0 110.043 -173.832 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 25.5 ttp -90.77 147.6 23.11 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.264 178.316 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 19.9 ttm -141.54 116.48 9.86 Favored 'General case' 0 CA--C 1.528 0.118 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 -177.887 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.6 mp -96.28 122.96 48.29 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 177.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -115.52 126.81 54.73 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 179.228 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 74.9 mtm180 -91.63 177.26 6.26 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 123.354 0.662 . . . . 0.0 109.68 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -48.19 -47.86 35.08 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 115.341 1.608 . . . . 0.0 115.341 -169.7 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -76.18 -15.89 59.96 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 119.046 0.839 . . . . 0.0 112.198 -178.33 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -96.36 -23.68 16.52 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 123.863 0.865 . . . . 0.0 110.714 -169.892 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.427 HG12 ' CE2' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -68.57 -37.99 11.41 Favored Pre-proline 0 CA--C 1.535 0.37 0 O-C-N 120.608 -1.308 . . . . 0.0 112.554 178.19 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -62.78 -12.04 26.96 Favored 'Trans proline' 0 CA--C 1.546 1.105 0 C-N-CA 121.55 1.5 . . . . 0.0 112.746 168.834 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -98.9 4.59 47.44 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.91 0.884 . . . . 0.0 111.742 173.436 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.504 HD13 ' C ' ' A' ' 85' ' ' LEU . 2.1 tm? -111.76 -57.25 2.28 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 124.025 0.93 . . . . 0.0 111.166 -175.701 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.427 ' CE2' HG12 ' A' ' 82' ' ' VAL . 67.4 m-85 -66.14 -15.89 63.5 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 118.764 0.711 . . . . 0.0 111.534 -170.307 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 68.4 p -85.29 -9.94 57.08 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 125.539 1.535 . . . . 0.0 113.139 -168.482 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -59.38 152.04 22.28 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 118.476 0.58 . . . . 0.0 109.926 174.584 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -78.5 -10.05 59.56 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 113.456 0.91 . . . . 0.0 113.456 -169.881 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 4.8 mp -84.76 -53.46 10.78 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 CA-C-N 119.396 0.998 . . . . 0.0 109.44 -171.743 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 3.9 m -59.95 109.23 1.81 Allowed Pre-proline 0 CA--C 1.549 0.908 0 C-N-CA 124.1 0.96 . . . . 0.0 111.814 -169.659 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -71.9 -54.15 0.15 Allowed 'Trans proline' 0 C--N 1.354 0.821 0 CA-C-N 120.817 1.328 . . . . 0.0 112.438 -169.829 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 18.2 m80 -80.93 -32.25 34.68 Favored 'General case' 0 N--CA 1.467 0.408 0 O-C-N 121.984 -0.447 . . . . 0.0 110.108 -175.126 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 3.9 mm-40 -71.16 -23.12 61.99 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 118.485 -0.769 . . . . 0.0 110.523 -179.112 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 10.4 mt -62.98 -30.52 71.65 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 120.387 1.448 . . . . 0.0 110.974 169.916 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -64.1 -40.75 98.4 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 109.916 -1.274 . . . . 0.0 109.916 171.91 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 22.5 tp -67.93 -30.93 70.36 Favored 'General case' 0 CA--C 1.532 0.287 0 O-C-N 122.142 -0.622 . . . . 0.0 110.546 174.658 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -58.87 -44.11 91.0 Favored 'General case' 0 N--CA 1.451 -0.389 0 O-C-N 120.796 -1.19 . . . . 0.0 108.895 171.131 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -70.89 -20.38 62.51 Favored 'General case' 0 N--CA 1.456 -0.13 0 O-C-N 121.789 -0.57 . . . . 0.0 111.494 177.84 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.479 HG13 ' HA ' ' A' ' 49' ' ' LEU . 55.2 t -70.04 -41.26 79.19 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.871 0 CA-C-O 117.764 -1.113 . . . . 0.0 108.126 169.315 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 6.8 mp -60.69 -38.21 84.23 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 120.602 1.546 . . . . 0.0 109.887 175.312 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 16.4 m -63.46 -45.1 92.38 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 174.546 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -65.65 -41.48 92.53 Favored 'General case' 0 N--CA 1.447 -0.587 0 O-C-N 121.535 -0.728 . . . . 0.0 110.554 -178.448 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.405 HD13 ' CD ' ' A' ' 111' ' ' PRO . 28.3 mt -58.96 -39.6 82.18 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 124.665 1.186 . . . . 0.0 110.306 174.609 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 41.3 ttm180 -67.4 -36.56 81.54 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 118.771 -0.633 . . . . 0.0 109.983 175.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 13.5 m-30 -68.51 -41.11 80.43 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 118.963 0.801 . . . . 0.0 111.051 178.38 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 55.8 p -75.93 -27.1 57.48 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 118.827 0.739 . . . . 0.0 110.994 179.546 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 78.4 10.03 86.54 Favored Glycine 0 CA--C 1.534 1.271 0 CA-C-O 119.278 -0.734 . . . . 0.0 111.465 -169.676 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 -94.07 15.21 17.6 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 118.807 1.303 . . . . 0.0 112.268 -177.392 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 8.1 t80 -53.69 132.24 55.89 Favored Pre-proline 0 CA--C 1.539 0.55 0 C-N-CA 125.349 1.459 . . . . 0.0 110.317 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.405 ' CD ' HD13 ' A' ' 104' ' ' LEU . 60.7 Cg_exo -50.5 136.37 40.61 Favored 'Trans proline' 0 C--N 1.354 0.817 0 C-N-CA 123.461 2.774 . . . . 0.0 112.32 178.905 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -63.19 -24.1 67.73 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 119.287 -0.387 . . . . 0.0 111.796 -173.64 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 57.2 tttm -141.85 108.31 5.31 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 169.866 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -85.89 142.01 29.17 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 169.123 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.62 153.25 45.98 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 105.951 -1.87 . . . . 0.0 105.951 171.885 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -145.29 138.23 26.25 Favored 'General case' 0 C--N 1.33 -0.276 0 O-C-N 120.512 -1.368 . . . . 0.0 108.636 176.259 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 48.8 t -110.12 95.91 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 N-CA-C 103.635 -2.728 . . . . 0.0 103.635 169.721 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -87.44 151.96 23.84 Favored Glycine 0 C--N 1.332 0.351 0 N-CA-C 110.101 -1.2 . . . . 0.0 110.101 178.059 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 44.9 t -132.77 137.15 54.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 178.691 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 51.0 mt -86.76 129.83 51.08 Favored Pre-proline 0 CA--C 1.542 0.659 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 170.491 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -74.04 171.98 16.87 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 124.03 3.153 . . . . 0.0 112.561 -179.736 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -109.4 -43.89 4.02 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.461 1.105 . . . . 0.0 108.599 169.443 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 63.8 m -128.73 152.09 48.81 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.473 0.709 . . . . 0.0 111.266 176.837 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.4 tp -152.54 54.5 0.79 Allowed 'General case' 0 CA--C 1.548 0.893 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 -169.825 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -127.35 170.14 10.77 Favored Pre-proline 0 N--CA 1.479 1.002 0 CA-C-O 117.756 -1.116 . . . . 0.0 110.595 -178.43 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_exo -63.45 88.56 0.14 Allowed 'Trans proline' 0 CA--C 1.548 1.201 0 C-N-CA 123.806 3.004 . . . . 0.0 114.409 -176.854 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 179.0 145.72 0.15 Allowed 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 104.415 -2.439 . . . . 0.0 104.415 175.303 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -118.09 167.09 11.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 CA-C-N 120.032 1.287 . . . . 0.0 112.886 -172.798 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 91.56 148.9 22.87 Favored Glycine 0 C--N 1.34 0.796 0 N-CA-C 106.809 -2.516 . . . . 0.0 106.809 -168.839 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -82.84 162.28 21.68 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-O 121.447 0.642 . . . . 0.0 111.115 -169.396 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 39.8 p -68.92 168.61 14.37 Favored Pre-proline 0 CA--C 1.541 0.619 0 CA-C-N 114.911 -1.041 . . . . 0.0 109.535 168.702 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -57.1 -32.81 94.42 Favored 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 121.302 1.335 . . . . 0.0 110.906 169.397 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 23.8 m -68.34 -38.69 81.74 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 118.999 -0.524 . . . . 0.0 111.905 179.323 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 20.2 t -108.62 -10.48 11.12 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 CA-C-N 119.471 1.032 . . . . 0.0 112.021 -169.195 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -60.11 -46.87 88.15 Favored 'General case' 0 N--CA 1.465 0.318 0 O-C-N 119.733 -1.854 . . . . 0.0 107.436 169.082 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -71.74 6.55 1.91 Allowed 'General case' 0 N--CA 1.439 -1.015 0 CA-C-O 117.965 -1.017 . . . . 0.0 112.661 176.312 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 26.5 mmm -94.1 -11.54 30.35 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 119.778 1.172 . . . . 0.0 111.083 170.014 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 72.6 mt -61.76 -46.36 96.7 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 179.003 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -69.9 -54.87 9.41 Favored Pre-proline 0 CA--C 1.536 0.405 0 CA-C-O 117.394 -1.289 . . . . 0.0 112.814 -172.331 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -59.82 -34.81 95.53 Favored 'Trans proline' 0 C--N 1.349 0.569 0 CA-C-N 122.301 1.857 . . . . 0.0 111.327 177.031 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -71.11 -45.03 64.45 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-O 118.719 -0.658 . . . . 0.0 110.497 -177.906 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -63.68 -36.8 85.02 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 119.235 0.925 . . . . 0.0 109.916 177.895 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -61.88 -39.03 90.51 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 118.007 0.367 . . . . 0.0 111.076 175.585 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 42.4 mm-40 -74.3 -28.37 61.15 Favored 'General case' 0 CA--C 1.535 0.399 0 O-C-N 121.44 -0.787 . . . . 0.0 111.828 176.885 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 70.4 t -62.93 -46.96 95.0 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 169.502 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 56.8 mt -65.67 -33.63 76.32 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 119.055 0.843 . . . . 0.0 111.143 179.148 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -60.0 -35.59 75.38 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 118.513 0.597 . . . . 0.0 111.275 177.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -61.73 -44.95 95.92 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 118.388 0.54 . . . . 0.0 111.244 175.708 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 7.1 mp -61.41 -40.55 94.8 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 122.726 0.41 . . . . 0.0 110.082 176.454 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 83.5 mtm-85 -65.59 -16.59 63.86 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 117.504 -1.236 . . . . 0.0 112.594 178.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -58.57 -30.7 67.36 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 120.781 1.628 . . . . 0.0 111.351 177.713 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 6.7 m -113.39 30.37 7.26 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.503 1.121 . . . . 0.0 111.129 177.818 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 64.31 23.57 68.36 Favored Glycine 0 CA--C 1.529 0.967 0 CA-C-O 118.566 -1.13 . . . . 0.0 113.821 174.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 60.4 t -87.63 131.35 35.57 Favored 'Isoleucine or valine' 0 C--N 1.34 0.194 0 N-CA-C 106.362 -1.718 . . . . 0.0 106.362 174.112 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -120.68 123.29 42.39 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 -177.732 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -82.15 144.36 30.79 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 172.71 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 6.9 mm -101.53 123.89 42.78 Favored Pre-proline 0 CA--C 1.53 0.207 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 -173.888 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -60.6 108.97 0.58 Allowed 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.188 1.926 . . . . 0.0 108.182 173.449 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 34.3 ptt180 43.8 15.62 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 128.825 2.85 . . . . 0.0 116.239 -177.397 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 3.8 m 45.83 31.71 1.11 Allowed 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 125.366 1.466 . . . . 0.0 112.732 -168.662 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -156.24 129.33 8.01 Favored 'General case' 0 C--O 1.235 0.342 0 O-C-N 121.135 -0.978 . . . . 0.0 109.449 177.154 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 12.5 m . . . . . 0 C--O 1.253 1.259 0 C-N-CA 124.317 1.047 . . . . 0.0 111.391 -174.473 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.9 tpt . . . . . 0 N--CA 1.496 1.866 0 N-CA-C 110.46 -0.2 . . . . 0.0 110.46 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 6.0 ptp180 -150.46 123.61 8.85 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 177.221 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 66.7 mt -141.54 133.32 27.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-N 119.12 0.873 . . . . 0.0 110.172 -169.975 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -116.39 128.64 55.69 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 105.952 -1.87 . . . . 0.0 105.952 168.419 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.0 t -106.95 98.1 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 103.466 -2.79 . . . . 0.0 103.466 172.844 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.8 mt -99.09 110.42 23.0 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 123.912 0.885 . . . . 0.0 110.17 -169.433 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -89.69 121.42 6.12 Favored Glycine 0 N--CA 1.446 -0.659 0 N-CA-C 107.102 -2.399 . . . . 0.0 107.102 170.313 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 13.0 m -134.21 -171.89 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.016 0 C-N-CA 124.321 1.048 . . . . 0.0 108.258 -178.148 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 110.66 154.63 13.91 Favored Glycine 0 C--N 1.336 0.539 0 N-CA-C 110.453 -1.059 . . . . 0.0 110.453 -173.233 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -77.36 96.84 4.73 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 123.788 0.835 . . . . 0.0 109.224 -179.143 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.3 pt -72.47 36.4 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 C-N-CA 124.504 1.122 . . . . 0.0 113.96 -179.077 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 28.0 mt -121.95 -8.75 8.83 Favored 'General case' 0 CA--C 1.531 0.248 0 O-C-N 121.091 -1.005 . . . . 0.0 108.729 171.55 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -127.27 83.95 2.21 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 -169.12 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.443 ' HB ' ' H ' ' A' ' 15' ' ' ASP . 2.1 m 35.74 -104.2 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 113.266 -1.788 . . . . 0.0 114.698 169.65 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.443 ' H ' ' HB ' ' A' ' 14' ' ' THR . 77.2 m-20 -68.08 -19.73 64.89 Favored 'General case' 0 N--CA 1.437 -1.097 0 CA-C-O 117.975 -1.012 . . . . 0.0 112.475 -169.187 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -68.03 -23.69 65.02 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 121.208 1.822 . . . . 0.0 111.818 178.976 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.36 -12.45 52.13 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-O 116.01 -1.948 . . . . 0.0 110.588 172.783 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.401 HG21 HG11 ' A' ' 119' ' ' VAL . 6.7 tp -53.74 -38.3 34.84 Favored 'Isoleucine or valine' 0 C--N 1.342 0.26 0 CA-C-N 122.176 2.262 . . . . 0.0 110.271 -177.742 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -61.47 -43.62 99.08 Favored Glycine 0 C--N 1.337 0.596 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 -178.879 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 57.8 t -70.18 -47.21 68.77 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 176.094 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 20.4 mmt180 -61.19 -31.86 71.61 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 117.016 -1.468 . . . . 0.0 112.505 -177.918 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 19.8 mt -58.93 -48.66 85.74 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 CA-C-N 121.74 2.063 . . . . 0.0 109.756 175.68 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.8 m -76.32 -31.07 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-N 119.432 1.015 . . . . 0.0 110.897 -172.202 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 59.2 mt-10 -64.99 -41.49 95.37 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 119.107 -0.473 . . . . 0.0 110.083 171.545 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -66.09 -37.03 84.76 Favored 'General case' 0 C--N 1.344 0.328 0 CA-C-N 119.42 1.009 . . . . 0.0 110.803 175.55 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 6.5 tp -63.07 -41.2 99.39 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 119.075 0.852 . . . . 0.0 110.036 -177.267 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -59.46 -27.68 66.31 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.516 0.726 . . . . 0.0 112.882 -179.991 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 50.6 mt-30 -95.05 -37.34 11.15 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 125.865 1.666 . . . . 0.0 111.41 -175.875 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 75.4 mtt180 -89.61 -27.28 20.3 Favored 'General case' 0 C--O 1.224 -0.244 0 CA-C-O 118.099 -0.953 . . . . 0.0 112.46 -175.965 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 52.6 m-85 -122.93 145.28 48.61 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 119.796 1.18 . . . . 0.0 112.967 -175.391 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 38.9 mm -95.39 139.07 19.56 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 N-CA-C 103.949 -2.611 . . . . 0.0 103.949 168.871 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 42.9 mt -128.81 147.19 63.48 Favored Pre-proline 0 CA--C 1.532 0.284 0 C-N-CA 123.457 0.703 . . . . 0.0 110.185 -168.835 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -67.77 158.55 56.76 Favored 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 122.76 2.306 . . . . 0.0 110.479 172.126 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -59.17 -33.42 70.91 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 114.436 1.273 . . . . 0.0 114.436 -169.403 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 10.0 p90 -75.05 -13.42 60.49 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 118.927 -0.559 . . . . 0.0 112.49 -177.746 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 75.0 t -88.09 122.47 39.72 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 170.531 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -124.18 129.41 50.77 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 169.67 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -82.81 137.46 20.97 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.809 0 N-CA-C 106.068 -1.827 . . . . 0.0 106.068 167.81 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 52.2 tp -128.36 136.45 50.95 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 169.717 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -93.15 120.94 33.99 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 169.246 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -72.8 -71.73 1.05 Allowed Glycine 0 CA--C 1.526 0.74 0 N-CA-C 108.981 -1.647 . . . . 0.0 108.981 174.159 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 84.98 92.56 0.78 Allowed Glycine 0 C--N 1.342 0.884 0 N-CA-C 107.942 -2.063 . . . . 0.0 107.942 -177.862 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 44.2 p 55.18 30.61 14.83 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 125.009 1.324 . . . . 0.0 111.893 176.879 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -81.61 -65.49 1.01 Allowed 'General case' 0 C--N 1.348 0.507 0 N-CA-C 115.25 1.574 . . . . 0.0 115.25 -168.194 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 60.95 -109.68 2.57 Favored Glycine 0 CA--C 1.528 0.865 0 N-CA-C 110.262 -1.135 . . . . 0.0 110.262 -175.376 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.32 -21.23 66.25 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.315 1.046 . . . . 0.0 112.061 -175.409 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -60.68 -18.85 56.46 Favored 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 113.534 0.938 . . . . 0.0 113.534 -175.158 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 11.4 mt -98.64 15.08 26.27 Favored 'General case' 0 C--N 1.347 0.458 0 N-CA-C 115.155 1.539 . . . . 0.0 115.155 -169.412 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 5.6 tt -48.2 -58.59 4.31 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 119.703 1.138 . . . . 0.0 111.244 -175.477 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -63.15 -31.59 81.23 Favored Glycine 0 CA--C 1.53 1.025 0 CA-C-O 119.419 -0.656 . . . . 0.0 112.368 -176.153 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -81.19 -35.89 30.81 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 118.509 1.155 . . . . 0.0 112.375 -177.556 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 32.6 mtp -74.07 -27.11 60.75 Favored 'General case' 0 N--CA 1.452 -0.361 0 O-C-N 122.102 -0.374 . . . . 0.0 110.045 178.415 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.51 157.59 31.8 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-O 121.677 0.751 . . . . 0.0 111.608 -179.691 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 16.3 m120 63.24 4.07 1.53 Allowed 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 127.27 2.228 . . . . 0.0 115.64 169.769 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 26.9 mmt180 -76.69 158.49 30.96 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 119.97 1.259 . . . . 0.0 109.05 178.759 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -84.38 -54.24 4.91 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 175.392 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . 0.27 0.0 OUTLIER -124.24 147.18 48.26 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-N 119.812 1.187 . . . . 0.0 108.308 169.28 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 19.0 tp -138.48 113.34 9.14 Favored 'General case' 0 CA--C 1.507 -0.678 0 N-CA-C 104.819 -2.289 . . . . 0.0 104.819 -175.272 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 24.5 mt -95.75 112.36 27.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 105.351 -2.092 . . . . 0.0 105.351 176.976 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.479 HG22 HD23 ' A' ' 116' ' ' LEU . 41.5 mt -86.96 137.84 20.16 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 N-CA-C 106.722 -1.584 . . . . 0.0 106.722 171.405 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -122.77 117.2 25.12 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 103.567 -2.753 . . . . 0.0 103.567 168.002 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -153.78 158.26 40.64 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 124.91 1.284 . . . . 0.0 108.208 -178.83 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -88.05 152.96 21.65 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 169.537 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 81.1 mt -87.52 -21.92 7.02 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 C-N-CA 125.114 1.366 . . . . 0.0 110.485 -178.786 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.425 HG13 HD22 ' A' ' 124' ' ' LEU 0.299 96.2 t 69.73 -45.31 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.175 0 C-N-CA 129.448 3.099 . . . . 0.0 113.966 -175.935 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.8 p -165.29 151.29 9.75 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 119.839 1.199 . . . . 0.0 111.939 172.331 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 13.4 tppt? -162.79 176.25 10.45 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 127.477 2.311 . . . . 0.0 105.05 169.449 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 13.7 ptpt -61.26 -26.72 67.95 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 175.946 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 34.2 t-20 -75.74 165.59 24.81 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.815 0.846 . . . . 0.0 110.53 -174.658 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 2.5 m -61.92 152.48 76.61 Favored Pre-proline 0 CA--C 1.547 0.862 0 C-N-CA 124.486 1.114 . . . . 0.0 112.542 -170.186 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -59.37 160.45 19.79 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 124.494 3.463 . . . . 0.0 113.35 169.655 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 61.35 23.89 62.91 Favored Glycine 0 CA--C 1.537 1.461 0 CA-C-O 119.66 -0.522 . . . . 0.0 112.699 170.773 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 3.3 m -105.91 141.36 37.44 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 125.41 1.484 . . . . 0.0 109.314 -170.49 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 41.6 ttp -94.25 142.89 26.89 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 170.372 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 69.6 mtm -132.8 139.91 47.74 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 170.427 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 6.8 mm -93.31 122.46 44.82 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 177.199 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -112.19 123.82 51.1 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 175.726 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 82.1 mtp180 -81.3 170.71 15.71 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 123.004 0.522 . . . . 0.0 110.333 175.842 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -35.59 -55.47 0.68 Allowed 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 116.15 1.908 . . . . 0.0 116.15 -173.827 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -88.61 -9.33 52.57 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -176.001 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -87.64 -40.52 14.11 Favored 'General case' 0 N--CA 1.454 -0.26 0 O-C-N 121.911 -0.493 . . . . 0.0 109.866 -174.868 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 1.4 m -53.5 -47.66 95.58 Favored Pre-proline 0 CA--C 1.54 0.574 0 CA-C-O 117.928 -1.034 . . . . 0.0 112.27 -179.79 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -61.53 -40.09 50.13 Favored 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 122.284 1.99 . . . . 0.0 110.305 179.907 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.48 -4.16 44.14 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.874 0.869 . . . . 0.0 113.103 177.497 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -87.6 -40.78 13.93 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-N 119.338 0.972 . . . . 0.0 110.005 -179.325 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -79.91 24.66 0.39 Allowed 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.538 0.735 . . . . 0.0 112.763 -171.016 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 20.3 p -65.76 -21.99 66.55 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.489 1.116 . . . . 0.0 112.973 179.082 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 51.5 t-20 -61.69 127.49 31.69 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.659 0.783 . . . . 0.0 110.388 -177.257 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 47.8 mmtm -79.12 -19.2 51.7 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 -176.959 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 91.0 mt -64.16 -46.24 94.11 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 C-N-CA 123.786 0.834 . . . . 0.0 108.804 -178.831 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.8 m -67.22 109.07 3.05 Favored Pre-proline 0 CA--C 1.549 0.933 0 C-N-CA 126.589 1.956 . . . . 0.0 110.962 -169.718 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -71.99 -63.0 0.04 OUTLIER 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 122.342 2.028 . . . . 0.0 112.805 -169.063 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 12.4 t-80 -59.32 -40.41 86.21 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 123.61 0.764 . . . . 0.0 110.227 -179.166 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 22.1 mp0 -63.58 -29.98 71.16 Favored 'General case' 0 N--CA 1.441 -0.911 0 C-N-CA 124.924 1.29 . . . . 0.0 110.106 -174.384 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 20.8 mt -67.72 -44.73 76.94 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 120.393 1.451 . . . . 0.0 110.691 172.909 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -61.69 -40.14 98.37 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 110.238 -1.145 . . . . 0.0 110.238 176.554 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 39.1 tp -65.95 -39.53 90.53 Favored 'General case' 0 CA--C 1.534 0.335 0 O-C-N 122.289 -0.536 . . . . 0.0 109.979 176.225 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -62.21 -42.45 99.31 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 119.172 0.896 . . . . 0.0 109.776 176.664 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -67.64 -28.84 68.05 Favored 'General case' 0 N--CA 1.454 -0.257 0 O-C-N 122.007 -0.433 . . . . 0.0 110.755 178.382 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -73.92 -37.39 47.74 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 O-C-N 121.336 -0.853 . . . . 0.0 111.289 173.654 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 31.5 mt -67.83 -37.62 82.17 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 176.762 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 75.7 m -65.39 -37.13 86.05 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-O 118.34 -0.838 . . . . 0.0 110.055 171.532 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.445 ' HA ' ' CD2' ' A' ' 106' ' ' PHE . . . -64.2 -40.52 96.26 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-N 119.953 1.252 . . . . 0.0 110.661 175.705 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 4.0 mt -64.71 -32.82 74.66 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 118.638 0.653 . . . . 0.0 110.562 174.841 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 51.5 ttp180 -72.15 -29.04 63.65 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 118.763 -0.637 . . . . 0.0 110.033 176.36 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.445 ' CD2' ' HA ' ' A' ' 103' ' ' ALA . 13.6 m-30 -72.12 -47.1 53.67 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 119.118 0.872 . . . . 0.0 110.369 175.467 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 41.6 p -72.68 -25.84 61.4 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 118.313 0.506 . . . . 0.0 111.853 -176.761 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 73.43 7.55 73.39 Favored Glycine 0 CA--C 1.535 1.312 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 -168.495 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -87.55 20.22 3.01 Favored 'General case' 0 C--N 1.348 0.522 0 CA-C-N 119.456 1.628 . . . . 0.0 110.689 176.536 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -58.45 138.2 85.45 Favored Pre-proline 0 CA--C 1.547 0.854 0 C-N-CA 125.903 1.681 . . . . 0.0 109.341 169.952 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_exo -58.0 163.81 9.09 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 123.66 2.907 . . . . 0.0 115.386 -179.359 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -67.72 -37.02 81.66 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 119.024 -0.513 . . . . 0.0 112.112 174.628 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 10.6 ttmm -141.58 74.41 1.45 Allowed 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 -175.474 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 5.5 tt -71.47 138.35 48.94 Favored 'General case' 0 CA--C 1.533 0.289 0 O-C-N 119.959 -1.713 . . . . 0.0 107.516 171.831 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -134.38 141.95 47.03 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 175.763 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.479 HD23 HG22 ' A' ' 60' ' ' ILE . 0.3 OUTLIER -129.26 119.93 24.84 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 120.128 1.331 . . . . 0.0 109.228 -179.939 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 6.2 t -86.5 87.81 2.7 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 N-CA-C 105.61 -1.996 . . . . 0.0 105.61 175.84 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -81.38 135.17 14.07 Favored Glycine 0 C--N 1.334 0.447 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -172.901 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.448 HG13 ' SD ' ' A' ' 137' ' ' MET . 54.7 t -121.94 123.56 69.41 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.238 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.988 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 42.5 mt -84.67 133.11 44.62 Favored Pre-proline 0 CA--C 1.538 0.492 0 N-CA-C 105.52 -2.029 . . . . 0.0 105.52 169.775 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -75.04 175.33 11.38 Favored 'Trans proline' 0 N--CA 1.449 -1.09 0 C-N-CA 122.287 1.992 . . . . 0.0 111.589 -176.706 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -94.56 -49.23 5.75 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 114.442 -1.253 . . . . 0.0 108.293 169.236 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 97.3 p -127.91 -52.77 1.32 Allowed 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 113.164 0.802 . . . . 0.0 113.164 -170.203 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.425 HD22 HG13 ' A' ' 65' ' ' VAL . 1.8 tp 52.51 34.75 16.12 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 124.362 1.065 . . . . 0.0 113.229 -169.398 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -76.36 164.02 62.53 Favored Pre-proline 0 CA--C 1.549 0.931 0 O-C-N 120.95 -1.094 . . . . 0.0 110.65 174.053 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -80.03 88.25 1.44 Allowed 'Trans proline' 0 CA--C 1.544 0.999 0 C-N-CA 121.66 1.573 . . . . 0.0 112.577 -172.194 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -176.5 154.96 1.33 Allowed 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 104.413 -2.44 . . . . 0.0 104.413 -179.946 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -110.79 162.64 8.18 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-N 120.447 1.476 . . . . 0.0 113.149 -169.663 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 93.71 143.14 12.86 Favored Glycine 0 CA--C 1.53 0.998 0 N-CA-C 106.374 -2.69 . . . . 0.0 106.374 -169.166 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.658 HD22 ' H ' ' A' ' 130' ' ' LEU . 0.4 OUTLIER -71.92 165.15 24.76 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 119.576 1.688 . . . . 0.0 110.602 -177.701 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 39.5 p -67.92 166.36 24.2 Favored Pre-proline 0 CA--C 1.539 0.533 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 167.826 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -59.73 -30.57 92.42 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 CA-C-N 120.588 1.246 . . . . 0.0 111.514 173.026 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 79.1 m -67.7 -41.85 82.97 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-N 118.903 0.774 . . . . 0.0 110.105 179.904 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 91.0 t -95.32 -26.26 4.34 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.214 0 CA-C-N 118.329 0.513 . . . . 0.0 110.751 -169.973 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -52.4 -46.91 66.5 Favored 'General case' 0 N--CA 1.464 0.243 0 O-C-N 120.567 -1.333 . . . . 0.0 108.418 169.409 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -69.84 -16.28 63.24 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 113.952 1.093 . . . . 0.0 113.952 -177.935 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 137' ' ' MET . . . . . 0.448 ' SD ' HG13 ' A' ' 119' ' ' VAL . 84.0 mtp -71.13 -12.09 61.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 117.24 -1.362 . . . . 0.0 112.6 173.679 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 35.3 mt -53.13 -47.33 55.51 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.28 0 CA-C-N 120.451 1.478 . . . . 0.0 109.226 175.307 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -73.38 -47.1 7.65 Favored Pre-proline 0 CA--C 1.544 0.73 0 CA-C-N 120.296 1.407 . . . . 0.0 112.109 -169.875 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -54.39 -44.78 46.3 Favored 'Trans proline' 0 C--N 1.353 0.802 0 C-N-CA 122.452 2.101 . . . . 0.0 112.179 170.174 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -67.81 -39.41 83.95 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 118.518 -0.753 . . . . 0.0 111.195 -179.055 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 29.0 mt -59.88 -45.57 92.08 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-N 119.79 1.177 . . . . 0.0 109.284 173.075 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -58.18 -33.67 69.51 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 118.993 0.815 . . . . 0.0 110.099 175.689 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -69.72 -39.9 76.57 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 118.778 0.717 . . . . 0.0 111.267 175.412 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 81.1 t -59.36 -44.81 93.28 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 172.596 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 14.7 mt -58.91 -42.65 90.13 Favored 'General case' 0 C--N 1.342 0.246 0 CA-C-N 119.017 0.826 . . . . 0.0 109.576 176.909 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -66.9 -43.63 82.91 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 119.146 0.885 . . . . 0.0 110.687 -176.796 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -67.71 -29.4 68.64 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 119.127 0.876 . . . . 0.0 111.131 179.186 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 41.6 mt -64.76 -49.67 69.86 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 170.298 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 14.7 mtp-105 -68.77 -16.8 63.9 Favored 'General case' 0 CA--C 1.527 0.095 0 CA-C-O 118.219 -0.896 . . . . 0.0 111.557 -177.82 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 30.6 mm-40 -65.6 -23.56 66.86 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 120.32 1.418 . . . . 0.0 111.299 170.826 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 58.4 m -100.73 17.2 22.6 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 119.054 0.843 . . . . 0.0 110.221 168.467 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 68.44 18.33 71.54 Favored Glycine 0 C--N 1.336 0.55 0 CA-C-O 117.656 -1.635 . . . . 0.0 111.958 -176.179 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 42.7 t -91.93 119.01 38.59 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 CA-C-N 120.344 2.072 . . . . 0.0 106.149 -177.121 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -111.26 89.23 2.99 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 178.383 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -49.55 138.3 13.99 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 114.833 -1.076 . . . . 0.0 109.72 169.663 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 15.8 mm -84.79 128.99 58.49 Favored Pre-proline 0 C--O 1.232 0.161 0 CA-C-O 117.483 -1.246 . . . . 0.0 107.902 -174.125 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -66.69 92.09 0.3 Allowed 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 122.922 2.414 . . . . 0.0 108.916 171.376 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 10.1 ttt-85 49.21 19.28 0.3 Allowed 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 128.441 2.696 . . . . 0.0 115.804 179.624 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 64.0 m 46.18 38.39 4.89 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.64 1.176 . . . . 0.0 111.886 -169.624 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -85.68 53.64 2.84 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.102 0.961 . . . . 0.0 110.005 179.368 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 13.5 m . . . . . 0 C--O 1.252 1.2 0 C-N-CA 125.311 1.444 . . . . 0.0 110.266 -177.712 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.4 ptp180 . . . . . 0 C--O 1.237 0.396 0 N-CA-C 103.749 -2.686 . . . . 0.0 103.749 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 20.8 mt -129.64 141.61 46.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 -166.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -115.83 146.86 41.62 Favored 'General case' 0 CA--C 1.513 -0.479 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 163.496 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 57.7 t -126.83 106.63 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.715 0 N-CA-C 103.945 -2.613 . . . . 0.0 103.945 170.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -113.37 119.13 36.58 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 -163.235 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -93.87 134.61 12.16 Favored Glycine 0 N--CA 1.451 -0.361 0 N-CA-C 107.909 -2.076 . . . . 0.0 107.909 175.008 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.7 m -140.96 167.08 17.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 C-N-CA 124.537 1.135 . . . . 0.0 109.457 -178.056 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 127.52 177.44 14.87 Favored Glycine 0 CA--C 1.527 0.821 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 -177.162 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.413 ' HB2' ' CE1' ' A' ' 93' ' ' HIS . 61.2 t-20 -91.76 117.88 30.17 Favored 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 178.332 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 41.3 pt -75.39 24.76 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.793 0 C-N-CA 124.483 1.113 . . . . 0.0 112.125 176.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 38.8 mt -137.45 -3.95 1.88 Allowed 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.594 1.557 . . . . 0.0 112.349 -177.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.5 tp -121.85 52.22 1.28 Allowed 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 120.158 1.345 . . . . 0.0 109.799 -163.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 42.25 -114.5 0.27 Allowed 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 126.502 1.921 . . . . 0.0 110.395 -169.591 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 36.5 m-20 -53.68 -26.21 21.63 Favored 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 126.54 1.936 . . . . 0.0 111.982 -171.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -60.04 -20.79 59.73 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 120.172 1.351 . . . . 0.0 111.752 -177.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.09 -11.51 40.5 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 117.773 -1.108 . . . . 0.0 113.415 172.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 7.1 tp -56.33 -44.41 79.73 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-N 120.32 1.418 . . . . 0.0 112.137 -171.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -59.16 -42.19 97.02 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 110.605 -0.998 . . . . 0.0 110.605 -178.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 60.3 t -67.57 -46.7 82.51 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 CA-C-O 118.978 -0.534 . . . . 0.0 110.14 175.16 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 9.8 mmt180 -58.37 -33.35 69.49 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 119.823 1.192 . . . . 0.0 112.823 -179.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 41.7 mt -57.98 -51.06 75.37 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 177.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 18.0 m -73.49 -35.75 46.16 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 CA-C-N 119.19 0.905 . . . . 0.0 111.717 -173.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -58.56 -47.13 85.27 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 118.811 0.732 . . . . 0.0 110.225 171.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -71.33 -22.13 61.96 Favored 'General case' 0 CA--C 1.531 0.234 0 O-C-N 121.689 -0.632 . . . . 0.0 112.462 -178.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 27.4 tp -73.79 -49.6 24.55 Favored 'General case' 0 C--N 1.339 0.137 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 175.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -52.65 -43.47 65.49 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.068 1.347 . . . . 0.0 111.172 178.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 66.5 mt-30 -85.06 -0.09 53.31 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.702 0.801 . . . . 0.0 113.033 -173.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 85.5 mtt180 -127.66 -23.14 3.48 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-O 116.695 -1.622 . . . . 0.0 112.931 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -134.74 128.75 33.51 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-N 120.823 1.647 . . . . 0.0 109.313 -172.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 48.7 mm -79.77 142.87 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 N-CA-C 105.605 -1.998 . . . . 0.0 105.605 163.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -114.93 154.9 47.0 Favored Pre-proline 0 N--CA 1.453 -0.311 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 178.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -54.81 152.51 28.31 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 121.169 1.246 . . . . 0.0 110.224 158.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -41.41 -46.72 3.45 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 127.575 2.35 . . . . 0.0 113.624 -178.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -78.57 19.9 0.46 Allowed 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 114.149 1.166 . . . . 0.0 114.149 -168.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 10.7 t -126.04 89.08 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 C-N-CA 125.489 1.516 . . . . 0.0 109.023 179.074 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -71.23 130.16 40.73 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 171.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -93.68 137.19 23.3 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 N-CA-C 105.682 -1.97 . . . . 0.0 105.682 157.213 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 60.5 tp -143.63 129.72 19.65 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 -175.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 30.7 t0 -84.8 133.21 34.35 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 166.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -115.02 31.5 6.24 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 126.351 1.929 . . . . 0.0 111.271 175.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -21.33 110.55 0.01 OUTLIER Glycine 0 CA--C 1.527 0.789 0 C-N-CA 129.026 3.203 . . . . 0.0 114.911 177.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER 59.68 -2.02 0.14 Allowed 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 116.542 2.053 . . . . 0.0 116.542 177.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.93 -63.04 1.38 Allowed 'General case' 0 C--N 1.34 0.156 0 CA-C-N 120.211 1.368 . . . . 0.0 112.909 -169.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 57.68 -94.24 0.04 OUTLIER Glycine 0 CA--C 1.533 1.177 0 N-CA-C 110.141 -1.184 . . . . 0.0 110.141 -163.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 7.8 tpt -57.63 -37.69 73.72 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 125.257 1.423 . . . . 0.0 113.147 -169.279 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -58.2 -26.56 62.94 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.708 0.766 . . . . 0.0 112.108 -173.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 83.1 mt -73.45 2.46 7.73 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 124.721 1.208 . . . . 0.0 112.489 -174.34 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.408 ' HA ' HG13 ' A' ' 100' ' ' VAL . 5.0 tt -43.98 -46.25 8.19 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 125.676 1.591 . . . . 0.0 111.594 174.534 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -84.05 -31.44 25.96 Favored Glycine 0 CA--C 1.525 0.674 0 CA-C-O 118.827 -0.985 . . . . 0.0 112.323 -178.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -75.6 -44.23 44.01 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 118.739 1.269 . . . . 0.0 110.904 -172.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 37.3 mtp -69.08 -11.32 60.68 Favored 'General case' 0 CA--C 1.54 0.574 0 O-C-N 121.974 -0.454 . . . . 0.0 111.675 -177.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -75.4 153.9 37.46 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 124.818 1.247 . . . . 0.0 110.446 -176.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 62.15 -5.67 0.16 Allowed 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 127.229 2.211 . . . . 0.0 114.107 167.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 8.6 mmt180 -66.29 148.4 51.9 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 175.084 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -80.05 -44.76 19.52 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 -175.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 4.0 t-160 -139.18 131.09 27.72 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 103.118 -2.919 . . . . 0.0 103.118 -177.105 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 30.1 tp -129.29 122.49 29.71 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 -178.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 52.3 mt -103.07 109.36 26.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 105.318 -2.105 . . . . 0.0 105.318 171.305 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 21.4 mt -83.39 148.33 5.17 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 168.021 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -131.05 128.8 41.0 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 164.29 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -153.25 168.37 26.22 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.324 1.05 . . . . 0.0 110.426 -163.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -92.1 129.9 37.95 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 163.122 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 34.9 mt -76.56 -24.71 15.89 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 C-N-CA 123.668 0.787 . . . . 0.0 110.503 175.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . 0.255 26.1 t 64.52 -35.03 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 C-N-CA 128.202 2.601 . . . . 0.0 113.687 -179.701 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -153.68 133.75 13.27 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 121.925 2.148 . . . . 0.0 113.883 -174.324 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 3.6 tppt? -156.87 -175.73 5.59 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 105.557 -2.016 . . . . 0.0 105.557 147.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.37 67.01 9.98 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 166.225 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 52.3 t30 -150.36 155.72 40.15 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 119.052 0.842 . . . . 0.0 109.0 178.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 8.1 m -60.02 140.41 90.53 Favored Pre-proline 0 CA--C 1.543 0.699 0 C-N-CA 126.674 1.99 . . . . 0.0 112.124 -165.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_exo -43.97 149.79 0.73 Allowed 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 124.22 3.28 . . . . 0.0 113.492 168.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 66.39 -7.91 1.21 Allowed Glycine 0 CA--C 1.532 1.101 0 C-N-CA 124.86 1.219 . . . . 0.0 115.554 178.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 30.4 m -64.88 149.83 48.85 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 120.202 2.001 . . . . 0.0 109.421 -178.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 28.9 ttp -94.43 147.36 23.32 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 174.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 42.0 mtt -129.23 146.15 51.2 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 106.095 -1.817 . . . . 0.0 106.095 162.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 33.2 mm -117.81 130.17 73.09 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 N-CA-C 103.266 -2.864 . . . . 0.0 103.266 171.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -123.74 143.55 50.22 Favored 'General case' 0 C--O 1.242 0.684 0 N-CA-C 105.013 -2.217 . . . . 0.0 105.013 176.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 79.9 mtm180 -114.73 165.88 12.34 Favored 'General case' 0 C--O 1.222 -0.36 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 177.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -22.29 -66.43 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 127.866 2.466 . . . . 0.0 116.072 -159.14 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -62.16 -33.52 74.67 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.879 1.672 . . . . 0.0 113.804 -176.102 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -76.35 -26.87 56.16 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.122 1.369 . . . . 0.0 110.741 -175.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 26.4 t -69.1 -50.89 19.47 Favored Pre-proline 0 CA--C 1.544 0.742 0 CA-C-O 117.69 -1.148 . . . . 0.0 112.394 -169.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -57.25 -39.89 86.68 Favored 'Trans proline' 0 C--N 1.353 0.802 0 CA-C-N 121.602 1.608 . . . . 0.0 111.374 174.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -62.84 -45.4 92.77 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 123.053 0.541 . . . . 0.0 110.59 -179.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -58.03 -47.52 82.85 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 123.817 0.847 . . . . 0.0 110.027 176.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 -75.88 1.36 15.3 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 -175.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 70.9 p -63.7 -13.36 42.41 Favored 'General case' 0 CA--C 1.543 0.685 0 O-C-N 120.198 -1.564 . . . . 0.0 112.315 166.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 41.1 t30 -58.72 109.89 0.89 Allowed 'General case' 0 C--N 1.346 0.454 0 C-N-CA 125.357 1.463 . . . . 0.0 111.712 -178.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 32.4 mmtp -67.87 -16.13 63.94 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 113.298 0.851 . . . . 0.0 113.298 -175.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 41.1 mt -75.03 -21.02 16.54 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 C-N-CA 123.358 0.663 . . . . 0.0 109.536 -179.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 14.6 m -100.56 104.71 32.52 Favored Pre-proline 0 CA--C 1.546 0.819 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 -172.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -72.4 -54.51 0.13 Allowed 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.295 1.996 . . . . 0.0 113.622 -160.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . 0.413 ' CE1' ' HB2' ' A' ' 10' ' ' ASN . 20.3 m80 -65.3 -36.1 83.04 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 177.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 23.1 mp0 -64.66 -30.03 71.04 Favored 'General case' 0 N--CA 1.441 -0.901 0 C-N-CA 125.02 1.328 . . . . 0.0 110.378 -176.264 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -64.94 -33.63 76.49 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 119.103 0.865 . . . . 0.0 111.535 171.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -78.72 -30.38 48.51 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 110.759 -0.937 . . . . 0.0 110.759 172.355 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.8 -37.62 88.06 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 118.339 1.07 . . . . 0.0 108.466 171.398 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -60.95 -43.42 98.72 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 117.929 -1.034 . . . . 0.0 109.924 175.007 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -74.15 -24.03 59.35 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 119.638 1.108 . . . . 0.0 113.158 177.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.408 HG13 ' HA ' ' A' ' 49' ' ' LEU . 38.1 t -62.48 -44.91 99.75 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 O-C-N 119.742 -1.848 . . . . 0.0 109.366 164.174 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 72.9 mt -67.94 -29.74 68.88 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 119.352 0.978 . . . . 0.0 110.811 178.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 44.5 m -62.19 -57.61 10.83 Favored 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 167.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.31 -35.4 78.93 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.795 1.238 . . . . 0.0 113.112 -174.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 13.8 mt -65.1 -42.37 94.09 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-N 118.929 0.786 . . . . 0.0 109.709 173.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 76.5 ttt180 -64.89 -34.65 78.9 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-O 117.677 -1.154 . . . . 0.0 110.649 172.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 13.0 m-30 -66.22 -39.22 89.43 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 120.069 1.304 . . . . 0.0 110.715 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 40.8 p -78.37 -28.05 46.98 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 119.119 0.872 . . . . 0.0 110.828 177.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 83.65 1.56 90.03 Favored Glycine 0 CA--C 1.531 1.056 0 CA-C-O 118.158 -1.357 . . . . 0.0 112.443 -166.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -87.08 21.01 2.47 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 120.479 2.139 . . . . 0.0 111.545 -179.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -61.19 139.01 94.55 Favored Pre-proline 0 CA--C 1.549 0.927 0 C-N-CA 126.274 1.83 . . . . 0.0 109.93 170.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -55.42 167.98 1.7 Allowed 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 123.923 3.082 . . . . 0.0 115.866 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -74.67 -23.12 58.6 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 123.461 0.704 . . . . 0.0 111.686 169.024 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 52.2 tttm -158.93 84.29 0.81 Allowed 'General case' 0 C--O 1.241 0.632 0 N-CA-C 106.522 -1.659 . . . . 0.0 106.522 -169.109 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.7 tt -79.21 141.88 36.75 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 119.186 -1.006 . . . . 0.0 108.914 165.279 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -138.9 146.76 41.5 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.88 1.672 . . . . 0.0 107.369 177.458 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -133.11 113.98 13.36 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 -179.274 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 45.1 t -93.35 86.66 2.15 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 173.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.55 150.36 16.94 Favored Glycine 0 C--N 1.338 0.671 0 N-CA-C 111.001 -0.84 . . . . 0.0 111.001 -166.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 22.7 t -129.11 135.84 61.03 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 -169.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 25.0 mt -78.3 135.93 61.23 Favored Pre-proline 0 CA--C 1.549 0.919 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 170.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -75.92 -161.53 0.13 Allowed 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 124.288 3.325 . . . . 0.0 111.522 178.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -138.75 -62.03 0.56 Allowed 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.83 1.652 . . . . 0.0 108.518 173.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 57.6 m -99.24 -48.19 4.91 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 119.104 0.865 . . . . 0.0 111.737 -177.106 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 51.58 45.91 27.34 Favored 'General case' 0 CA--C 1.549 0.911 0 N-CA-C 114.336 1.235 . . . . 0.0 114.336 -177.494 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -110.18 161.84 22.86 Favored Pre-proline 0 CA--C 1.542 0.642 0 C-N-CA 124.195 0.998 . . . . 0.0 110.989 -177.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -72.31 68.94 3.37 Favored 'Trans proline' 0 CA--C 1.543 0.954 0 C-N-CA 124.485 3.457 . . . . 0.0 113.982 -177.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 5.7 p-80 -148.16 173.18 13.24 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 126.874 2.07 . . . . 0.0 106.938 162.141 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -118.32 144.82 25.39 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.158 0 O-C-N 121.069 -1.019 . . . . 0.0 110.151 -171.185 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 142.09 176.25 16.14 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 105.997 -2.841 . . . . 0.0 105.997 -172.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -98.57 161.76 13.5 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 104.676 -2.342 . . . . 0.0 104.676 150.075 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 65.7 p -62.12 158.34 46.22 Favored Pre-proline 0 CA--C 1.543 0.71 0 C-N-CA 119.176 -1.01 . . . . 0.0 108.608 155.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -51.85 -38.49 67.97 Favored 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 122.046 1.83 . . . . 0.0 112.03 171.075 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 6.3 m -53.01 -30.98 38.51 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 126.12 1.768 . . . . 0.0 112.278 176.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 63.9 t -115.51 -18.88 6.96 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 CA-C-N 118.719 0.691 . . . . 0.0 111.014 -170.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -59.52 -43.25 93.49 Favored 'General case' 0 CA--C 1.534 0.338 0 O-C-N 121.325 -0.859 . . . . 0.0 108.73 165.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -59.45 -30.47 68.53 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.154 -0.476 . . . . 0.0 112.096 173.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 15.1 mmm -73.18 -8.47 55.94 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 117.458 -1.258 . . . . 0.0 113.789 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 96.7 mt -58.18 -50.05 79.62 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-N 120.438 1.472 . . . . 0.0 108.458 177.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -78.07 -40.37 1.92 Allowed Pre-proline 0 CA--C 1.535 0.376 0 CA-C-O 117.163 -1.398 . . . . 0.0 114.588 -168.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -54.34 -35.96 85.58 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 CA-C-N 122.38 1.886 . . . . 0.0 112.224 167.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -75.88 -32.85 59.88 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-O 117.981 -1.009 . . . . 0.0 111.313 175.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 53.5 mt -59.18 -48.59 81.03 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 120.579 1.536 . . . . 0.0 108.229 169.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -60.15 -29.53 68.72 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 119.375 0.989 . . . . 0.0 111.565 -179.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 32.6 mm-40 -86.39 -31.86 21.24 Favored 'General case' 0 CA--C 1.529 0.145 0 O-C-N 120.999 -1.063 . . . . 0.0 113.57 176.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 72.2 t -63.83 -40.97 90.97 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 CA-C-N 120.99 1.723 . . . . 0.0 108.736 166.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 83.6 mt -66.39 -39.8 89.28 Favored 'General case' 0 N--CA 1.463 0.179 0 C-N-CA 123.653 0.781 . . . . 0.0 110.722 176.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -64.01 -46.15 85.78 Favored 'General case' 0 C--O 1.227 -0.126 0 CA-C-N 118.748 0.704 . . . . 0.0 110.598 174.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -59.05 -42.88 91.37 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 118.847 -0.597 . . . . 0.0 110.776 178.037 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 31.1 mt -58.0 -45.23 87.15 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 119.174 0.897 . . . . 0.0 110.27 173.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 64.8 mtt180 -66.38 -18.88 65.62 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 117.096 -1.43 . . . . 0.0 112.791 178.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -60.9 -27.0 67.85 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 121.328 1.877 . . . . 0.0 110.807 171.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 16.7 m -101.89 13.91 33.47 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.107 0.963 . . . . 0.0 111.642 175.01 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 71.85 10.39 72.27 Favored Glycine 0 CA--C 1.53 1.0 0 CA-C-O 118.777 -1.013 . . . . 0.0 113.542 -179.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 61.0 t -79.69 102.92 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 CA-C-N 119.31 1.555 . . . . 0.0 107.301 178.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -72.93 152.87 41.22 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 164.038 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -131.57 150.91 51.98 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 125.351 1.46 . . . . 0.0 107.243 174.269 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 7.7 mm -114.31 122.72 33.77 Favored Pre-proline 0 CA--C 1.53 0.203 0 N-CA-C 107.58 -1.266 . . . . 0.0 107.58 -163.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -62.41 116.66 3.65 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 122.162 1.908 . . . . 0.0 108.031 176.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 59.7 mtm180 40.09 8.16 0.0 OUTLIER 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 129.573 3.149 . . . . 0.0 117.576 -172.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 70.7 m . . . . . 0 N--CA 1.468 0.439 0 CA-C-N 121.231 1.832 . . . . 0.0 110.381 -158.246 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 39.1 mmt180 . . . . . 0 N--CA 1.479 0.977 0 CA-C-O 118.336 -0.84 . . . . 0.0 108.813 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 3.9 mt -123.39 121.67 63.31 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 -176.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -106.81 139.28 41.49 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 168.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 58.0 t -126.87 101.43 7.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 105.467 -2.049 . . . . 0.0 105.467 -177.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.3 mt -98.76 109.36 22.13 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.475 1.11 . . . . 0.0 109.581 -169.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -87.15 127.13 8.29 Favored Glycine 0 C--O 1.237 0.324 0 N-CA-C 106.958 -2.457 . . . . 0.0 106.958 169.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 15.3 m -138.69 172.69 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 CA-C-N 117.588 0.694 . . . . 0.0 111.202 -169.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 101.16 163.45 27.59 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 127.189 2.328 . . . . 0.0 111.731 179.202 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.504 HD21 ' HB2' ' A' ' 12' ' ' LEU . 6.9 t30 -77.32 102.13 6.61 Favored 'General case' 0 C--N 1.332 -0.167 0 O-C-N 121.88 -0.777 . . . . 0.0 111.043 -169.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -56.52 7.51 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.935 0 N-CA-C 117.742 2.497 . . . . 0.0 117.742 179.164 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.504 ' HB2' HD21 ' A' ' 10' ' ' ASN . 67.7 mt -109.54 1.3 19.65 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 122.127 2.24 . . . . 0.0 109.743 -177.438 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.4 mp -111.84 63.02 0.62 Allowed 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 123.895 0.878 . . . . 0.0 111.4 -169.039 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.402 ' HB ' ' H ' ' A' ' 15' ' ' ASP . 0.2 OUTLIER 52.83 -100.15 0.09 Allowed 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.664 0.786 . . . . 0.0 111.152 176.59 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.402 ' H ' ' HB ' ' A' ' 14' ' ' THR . 28.6 m-20 -83.69 -9.1 59.08 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 124.262 1.025 . . . . 0.0 111.881 -174.391 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -71.79 -8.41 54.12 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 120.485 1.493 . . . . 0.0 112.454 -175.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -75.37 -14.35 60.46 Favored 'General case' 0 N--CA 1.434 -1.252 0 CA-C-O 115.724 -2.084 . . . . 0.0 109.349 170.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 7.9 tp -52.48 -39.2 28.33 Favored 'Isoleucine or valine' 0 C--N 1.344 0.358 0 CA-C-N 122.588 2.449 . . . . 0.0 112.878 -169.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -61.46 -45.52 96.21 Favored Glycine 0 CA--C 1.525 0.718 0 CA-C-N 119.422 1.01 . . . . 0.0 111.148 177.018 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 69.9 t -64.2 -48.53 85.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-O 118.845 -0.598 . . . . 0.0 110.039 172.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 78.4 mmt-85 -59.07 -33.88 71.32 Favored 'General case' 0 C--O 1.223 -0.336 0 CA-C-O 117.755 -1.116 . . . . 0.0 112.263 -179.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 28.6 mt -63.64 -45.07 98.51 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 CA-C-N 120.679 1.581 . . . . 0.0 109.656 177.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 14.5 m -75.81 -26.0 17.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-N 119.67 1.123 . . . . 0.0 111.071 -176.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 -70.75 -44.92 65.78 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 173.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.69 -42.37 97.02 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 122.885 0.474 . . . . 0.0 109.809 176.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 8.2 tp -65.45 -42.91 91.85 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 118.16 -0.924 . . . . 0.0 110.48 178.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -58.22 -43.98 87.98 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 119.042 0.837 . . . . 0.0 110.73 178.089 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -72.64 -39.7 66.98 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.715 0.806 . . . . 0.0 111.27 -177.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -95.82 -40.56 9.27 Favored 'General case' 0 C--N 1.34 0.172 0 CA-C-O 117.044 -1.455 . . . . 0.0 113.704 -169.48 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -109.64 124.14 50.67 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 121.735 2.062 . . . . 0.0 112.151 -169.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 47.2 mm -76.78 137.43 22.54 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 N-CA-C 105.739 -1.948 . . . . 0.0 105.739 169.13 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 29.5 mt -135.25 156.28 78.18 Favored Pre-proline 0 CA--C 1.535 0.4 0 C-N-CA 124.665 1.186 . . . . 0.0 110.83 -169.267 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -60.06 155.86 42.58 Favored 'Trans proline' 0 CA--C 1.535 0.569 0 C-N-CA 123.344 2.696 . . . . 0.0 111.775 169.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -62.26 -30.49 71.16 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -173.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 11.5 p90 -73.54 -6.42 46.42 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 118.207 -0.901 . . . . 0.0 112.752 -179.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 19.7 t -99.28 127.26 52.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 CA-C-N 119.861 1.21 . . . . 0.0 108.264 175.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -127.19 137.27 52.89 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 173.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -102.36 104.15 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 N-CA-C 105.862 -1.903 . . . . 0.0 105.862 176.664 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 56.7 tp -95.88 121.39 37.56 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.31 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -79.92 109.46 14.38 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 106.254 -1.758 . . . . 0.0 106.254 169.007 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -103.86 -27.92 6.12 Favored Glycine 0 CA--C 1.534 1.233 0 CA-C-O 119.248 -0.751 . . . . 0.0 112.373 173.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 40.17 -111.99 0.27 Allowed Glycine 0 C--N 1.34 0.775 0 C-N-CA 125.327 1.442 . . . . 0.0 113.122 -177.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.408 HG22 ' HA ' ' A' ' 10' ' ' ASN . 12.1 p -65.01 -3.49 3.6 Favored 'General case' 0 C--N 1.316 -0.869 0 C-N-CA 128.756 2.823 . . . . 0.0 113.806 -172.443 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -50.3 -66.3 0.41 Allowed 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 114.974 1.472 . . . . 0.0 114.974 -179.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 64.15 -94.62 0.15 Allowed Glycine 0 CA--C 1.531 1.065 0 N-CA-C 109.416 -1.473 . . . . 0.0 109.416 -169.417 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 10.4 tpt -69.33 -26.99 64.98 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 126.776 2.03 . . . . 0.0 112.255 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -70.17 -4.68 22.65 Favored 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -169.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 66.2 mt -87.79 -6.01 58.36 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 124.636 1.175 . . . . 0.0 114.063 -171.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.521 ' HA ' HG13 ' A' ' 100' ' ' VAL . 5.2 tt -43.39 -59.74 2.0 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 114.19 1.182 . . . . 0.0 114.19 -169.464 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -72.25 -36.4 59.93 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 111.723 -0.551 . . . . 0.0 111.723 -170.193 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -68.01 -37.77 81.81 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 117.932 0.866 . . . . 0.0 110.214 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 36.2 mtp -74.13 -18.13 60.83 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 120.664 -0.414 . . . . 0.0 111.782 -174.554 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -75.73 151.04 37.7 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 121.635 0.731 . . . . 0.0 111.129 -177.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 55.62 44.16 27.02 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 126.373 1.869 . . . . 0.0 114.201 168.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 27.2 mmt180 -108.01 156.98 18.64 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 174.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -78.62 -41.9 30.32 Favored 'General case' 0 N--CA 1.467 0.385 0 O-C-N 121.438 -0.789 . . . . 0.0 109.771 171.399 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -134.23 133.14 40.52 Favored 'General case' 0 C--O 1.232 0.168 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 -175.171 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 26.1 tp -135.42 131.77 36.65 Favored 'General case' 0 CA--C 1.512 -0.482 0 O-C-N 121.486 -0.759 . . . . 0.0 109.242 169.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 10.6 mt -114.07 123.44 69.73 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 N-CA-C 106.006 -1.85 . . . . 0.0 106.006 178.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 15.5 mt -101.49 127.53 54.75 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 N-CA-C 104.803 -2.295 . . . . 0.0 104.803 177.115 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -115.64 121.48 42.69 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 105.749 -1.945 . . . . 0.0 105.749 176.079 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -155.41 149.29 25.46 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 118.561 0.619 . . . . 0.0 112.437 -169.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -76.82 116.92 17.92 Favored 'General case' 0 CA--C 1.529 0.136 0 N-CA-C 105.53 -2.026 . . . . 0.0 105.53 168.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.7 tt -68.79 -25.46 30.48 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.772 0 CA-C-O 117.684 -1.151 . . . . 0.0 113.102 -169.084 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . 0.281 92.9 t 55.28 17.03 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.556 1.202 0 C-N-CA 125.278 1.431 . . . . 0.0 112.806 172.212 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 48.7 m -126.86 164.05 22.26 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 125.057 1.343 . . . . 0.0 111.3 -170.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.47 ' HG3' ' H ' ' A' ' 68' ' ' LYS . 4.6 tppt? 59.72 -172.06 0.12 Allowed 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.12 1.768 . . . . 0.0 111.738 177.417 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.47 ' H ' ' HG3' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -128.66 20.48 6.07 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.223 1.409 . . . . 0.0 112.401 -175.809 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 51.0 t30 -71.48 163.85 26.93 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 108.096 -1.075 . . . . 0.0 108.096 172.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 12.6 m -58.14 142.67 80.17 Favored Pre-proline 0 CA--C 1.546 0.801 0 C-N-CA 123.964 0.906 . . . . 0.0 112.18 -169.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -57.38 152.38 47.03 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.554 2.169 . . . . 0.0 111.453 170.06 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 67.7 16.48 67.94 Favored Glycine 0 CA--C 1.533 1.169 0 CA-C-O 119.128 -0.818 . . . . 0.0 113.756 177.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 48.7 m -96.32 153.89 17.56 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 118.955 1.377 . . . . 0.0 108.784 175.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 9.6 ttp -97.97 141.77 30.52 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 123.589 0.756 . . . . 0.0 110.222 -179.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 13.6 mtp -126.48 119.31 26.88 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 176.053 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 46.0 mm -103.07 123.81 56.75 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 177.086 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 48.2 mt -125.0 129.28 50.0 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 107.548 -1.278 . . . . 0.0 107.548 -177.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 65.7 mtm180 -104.99 131.49 52.44 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 -169.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 6.9 t70 36.32 -98.11 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 116.168 1.914 . . . . 0.0 116.168 169.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -62.74 -27.57 69.36 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.966 0.906 . . . . 0.0 112.932 -176.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -73.49 -15.47 61.32 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.385 0.674 . . . . 0.0 111.005 -177.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.425 HG11 ' CD2' ' A' ' 114' ' ' LEU . 81.4 t -79.52 -60.84 0.5 Allowed Pre-proline 0 N--CA 1.442 -0.832 0 CA-C-O 117.963 -1.018 . . . . 0.0 110.466 -169.485 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -59.85 -31.69 94.25 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 CA-C-N 120.846 1.338 . . . . 0.0 111.65 175.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.14 -13.69 62.41 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -177.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -98.14 -38.38 9.35 Favored 'General case' 0 C--N 1.344 0.332 0 CA-C-N 118.713 0.688 . . . . 0.0 109.267 169.153 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -59.34 -12.79 6.34 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 113.101 0.778 . . . . 0.0 113.101 177.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 70.7 p -52.86 -27.78 19.99 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 113.857 1.058 . . . . 0.0 113.857 169.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -60.23 146.25 44.34 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 122.948 0.499 . . . . 0.0 111.66 -169.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 46.6 mmtm -99.51 -0.16 41.19 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.7 0.8 . . . . 0.0 111.981 177.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 74.8 mt -66.95 -41.13 87.07 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 178.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 5.8 m -96.81 109.43 48.61 Favored Pre-proline 0 CA--C 1.543 0.68 0 C-N-CA 125.737 1.615 . . . . 0.0 109.223 -172.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -68.3 -47.22 1.69 Allowed 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.002 1.802 . . . . 0.0 112.937 -169.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 15.7 m80 -73.94 -22.47 59.65 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 122.729 0.411 . . . . 0.0 111.328 -171.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -68.9 -24.75 64.34 Favored 'General case' 0 C--O 1.222 -0.343 0 CA-C-O 117.72 -1.134 . . . . 0.0 111.847 177.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 2.8 tt -60.77 -43.42 98.08 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 120.387 1.449 . . . . 0.0 109.652 -174.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -59.99 -41.6 97.98 Favored Glycine 0 CA--C 1.529 0.94 0 O-C-N 121.628 -0.67 . . . . 0.0 111.52 176.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -71.62 -32.6 68.14 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 118.526 1.163 . . . . 0.0 110.717 179.083 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -60.3 -45.2 94.18 Favored 'General case' 0 N--CA 1.454 -0.254 0 O-C-N 120.943 -1.098 . . . . 0.0 109.067 171.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -69.9 -23.85 63.3 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 118.979 -0.534 . . . . 0.0 112.104 177.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.521 HG13 ' HA ' ' A' ' 49' ' ' LEU . 20.9 t -66.5 -45.05 89.9 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.697 0 CA-C-N 119.223 0.92 . . . . 0.0 108.552 169.379 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 93.8 mt -64.44 -34.22 77.68 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 119.377 0.99 . . . . 0.0 110.245 179.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 20.3 m -64.91 -41.41 95.6 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 118.88 0.763 . . . . 0.0 110.318 169.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.46 ' HA ' ' CD2' ' A' ' 106' ' ' PHE . . . -64.39 -36.8 85.33 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 119.121 0.873 . . . . 0.0 111.527 178.296 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.6 mt -66.8 -35.6 80.44 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 118.412 0.551 . . . . 0.0 110.272 176.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 77.7 ttt-85 -65.92 -38.79 89.62 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 118.459 -0.781 . . . . 0.0 109.909 171.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.46 ' CD2' ' HA ' ' A' ' 103' ' ' ALA . 15.6 m-30 -64.09 -44.05 93.53 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 119.372 0.987 . . . . 0.0 110.586 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 42.3 p -75.71 -22.8 56.28 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 118.325 0.511 . . . . 0.0 111.403 178.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 74.47 12.59 82.21 Favored Glycine 0 CA--C 1.531 1.09 0 N-CA-C 111.118 -0.793 . . . . 0.0 111.118 -169.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -98.79 25.29 6.7 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 118.644 1.222 . . . . 0.0 110.97 -178.006 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -57.56 135.58 82.26 Favored Pre-proline 0 CA--C 1.544 0.724 0 C-N-CA 124.111 0.964 . . . . 0.0 109.209 170.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -54.55 151.71 29.87 Favored 'Trans proline' 0 C--N 1.35 0.658 0 C-N-CA 123.643 2.895 . . . . 0.0 114.108 -179.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -60.09 -29.81 68.83 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 119.012 -0.518 . . . . 0.0 110.44 177.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 23.1 ttpp -146.54 125.84 13.07 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 169.161 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.425 ' CD2' HG11 ' A' ' 82' ' ' VAL . 3.4 tt -105.92 147.38 28.83 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 169.417 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -143.42 138.9 29.67 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 -177.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.7 tp -125.09 129.39 50.14 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 120.429 1.468 . . . . 0.0 108.828 175.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 53.5 t -102.5 98.95 7.45 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 N-CA-C 104.759 -2.311 . . . . 0.0 104.759 168.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -84.77 140.27 18.59 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 109.981 -1.248 . . . . 0.0 109.981 174.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 40.9 t -119.95 138.25 51.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 173.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 5.4 mt -86.92 126.92 61.65 Favored Pre-proline 0 CA--C 1.54 0.591 0 CA-C-N 119.395 0.998 . . . . 0.0 108.389 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -77.0 167.28 25.39 Favored 'Trans proline' 0 CA--C 1.542 0.884 0 C-N-CA 123.657 2.904 . . . . 0.0 112.25 -178.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.465 ' HB3' HG21 ' A' ' 131' ' ' THR . 1.6 tm-20 -107.38 -58.89 1.9 Allowed 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.673 0.789 . . . . 0.0 109.924 -178.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 4.0 m -105.28 -58.06 1.95 Allowed 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 122.934 0.494 . . . . 0.0 112.04 -170.27 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER 56.46 52.37 10.03 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 126.176 1.79 . . . . 0.0 115.334 171.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -121.71 165.21 20.76 Favored Pre-proline 0 N--CA 1.475 0.796 0 CA-C-O 117.826 -1.083 . . . . 0.0 108.87 172.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -67.47 84.09 0.38 Allowed 'Trans proline' 0 CA--C 1.546 1.084 0 C-N-CA 123.345 2.697 . . . . 0.0 112.551 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -168.85 152.4 5.35 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 104.501 -2.407 . . . . 0.0 104.501 174.241 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -120.27 152.87 23.22 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-O 121.999 0.904 . . . . 0.0 113.286 -169.654 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 120.8 130.73 3.92 Favored Glycine 0 CA--C 1.527 0.814 0 N-CA-C 105.98 -2.848 . . . . 0.0 105.98 -169.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 7.0 mp -77.8 149.39 34.43 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 177.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.465 HG21 ' HB3' ' A' ' 122' ' ' GLU . 54.6 p -67.22 163.19 48.21 Favored Pre-proline 0 CA--C 1.534 0.349 0 CA-C-O 119.148 -0.453 . . . . 0.0 109.942 169.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -58.71 -34.67 99.08 Favored 'Trans proline' 0 CA--C 1.537 0.65 0 C-N-CA 121.099 1.199 . . . . 0.0 109.574 169.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 4.5 m -63.34 -39.06 93.51 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.187 0.995 . . . . 0.0 111.18 -176.48 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 21.8 t -102.48 -25.89 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 CA-C-N 119.319 0.963 . . . . 0.0 112.146 -176.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -54.1 -43.01 70.02 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 120.825 1.648 . . . . 0.0 109.986 169.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -73.04 -2.43 21.18 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-O 118.332 -0.842 . . . . 0.0 113.107 -176.033 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 16.4 mmm -89.58 -7.09 55.56 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-O 116.953 -1.499 . . . . 0.0 111.022 170.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 91.6 mt -58.9 -47.64 88.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 CA-C-N 121.631 2.014 . . . . 0.0 109.301 -179.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 61.6 mt-10 -73.21 -51.14 6.08 Favored Pre-proline 0 CA--C 1.536 0.425 0 CA-C-O 117.39 -1.29 . . . . 0.0 110.809 -178.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -40.49 -51.99 3.23 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 124.447 3.431 . . . . 0.0 113.672 169.041 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -74.16 -45.33 49.31 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 114.538 -1.21 . . . . 0.0 111.451 -174.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -62.37 -36.02 80.96 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 119.594 1.088 . . . . 0.0 109.984 178.28 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -62.86 -33.04 74.45 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 118.744 -0.645 . . . . 0.0 111.085 176.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 42.9 mm-40 -78.47 -29.97 47.12 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 119.502 1.046 . . . . 0.0 111.892 174.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 67.7 t -61.41 -43.43 96.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 169.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 71.4 mt -69.65 -33.41 72.57 Favored 'General case' 0 N--CA 1.463 0.179 0 O-C-N 120.752 -1.217 . . . . 0.0 111.622 176.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -58.86 -33.6 70.65 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 118.923 0.783 . . . . 0.0 111.455 176.151 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -62.42 -46.79 86.95 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 118.531 0.605 . . . . 0.0 111.292 174.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 7.1 mp -58.44 -43.4 88.76 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.021 0.529 . . . . 0.0 109.866 174.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 84.7 mtt180 -65.38 -17.56 64.63 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 117.418 -1.277 . . . . 0.0 111.896 -177.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -58.16 -34.38 70.24 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 120.616 1.553 . . . . 0.0 111.33 175.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 8.1 m -107.39 28.57 7.98 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.598 1.159 . . . . 0.0 110.956 -179.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 64.22 23.8 68.39 Favored Glycine 0 CA--C 1.53 1.003 0 CA-C-O 118.725 -1.042 . . . . 0.0 113.917 176.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 59.4 t -93.77 134.47 31.31 Favored 'Isoleucine or valine' 0 C--N 1.341 0.213 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 174.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -122.6 145.05 48.7 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 178.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -107.46 143.09 36.32 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 124.06 0.944 . . . . 0.0 109.351 174.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 23.3 mm -105.62 125.97 31.97 Favored Pre-proline 0 C--O 1.234 0.253 0 CA-C-O 117.879 -1.058 . . . . 0.0 108.649 -173.193 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -57.61 110.42 0.62 Allowed 'Trans proline' 0 N--CA 1.461 -0.383 0 C-N-CA 122.608 2.206 . . . . 0.0 108.919 169.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 82.7 mtm180 51.51 30.68 6.63 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.179 0.992 . . . . 0.0 112.715 171.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 17.4 p . . . . . 0 CA--C 1.542 0.64 0 C-N-CA 126.714 2.006 . . . . 0.0 114.872 -171.954 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.475 0.795 0 CA-C-O 119.46 -0.305 . . . . 0.0 110.633 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 5.7 mt -125.52 129.55 72.82 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -120.36 141.11 50.38 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 106.105 -1.813 . . . . 0.0 106.105 168.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 91.6 t -121.42 127.41 75.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 106.722 -1.584 . . . . 0.0 106.722 -176.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.2 tp -109.03 111.61 23.36 Favored 'General case' 0 CA--C 1.515 -0.4 0 C-N-CA 123.468 0.707 . . . . 0.0 111.02 -169.187 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -94.07 118.24 5.7 Favored Glycine 0 N--CA 1.446 -0.67 0 N-CA-C 104.394 -3.482 . . . . 0.0 104.394 168.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.4 m -141.32 163.74 20.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 -171.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 121.73 160.47 11.01 Favored Glycine 0 C--N 1.338 0.661 0 C-N-CA 124.818 1.199 . . . . 0.0 110.495 176.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.514 ' HA ' HG22 ' A' ' 43' ' ' THR . 12.4 t30 -79.22 101.52 8.03 Favored 'General case' 0 C--N 1.333 -0.122 0 O-C-N 121.351 -1.088 . . . . 0.0 109.988 -179.366 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 27.3 pt -53.41 -15.07 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 N-CA-C 116.13 1.9 . . . . 0.0 116.13 -176.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.454 ' H ' ' ND2' ' A' ' 10' ' ' ASN . 5.2 mp -90.17 -3.79 57.66 Favored 'General case' 0 C--O 1.219 -0.536 0 CA-C-N 121.024 1.738 . . . . 0.0 107.558 -170.506 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.3 mp -101.78 55.42 0.81 Allowed 'General case' 0 N--CA 1.439 -0.987 0 C-N-CA 123.477 0.711 . . . . 0.0 109.727 -174.334 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.426 ' HB ' ' H ' ' A' ' 15' ' ' ASP 0.254 0.1 OUTLIER 49.6 -102.11 0.1 Allowed 'General case' 0 C--O 1.236 0.345 0 CA-C-N 114.348 -1.296 . . . . 0.0 111.331 177.052 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.426 ' H ' ' HB ' ' A' ' 14' ' ' THR . 17.2 m-20 -72.21 -12.34 61.13 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 123.891 0.876 . . . . 0.0 111.319 -172.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -73.07 -2.5 21.56 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-N 119.377 0.99 . . . . 0.0 112.338 176.342 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.82 -11.85 59.8 Favored 'General case' 0 N--CA 1.439 -1.014 0 CA-C-O 116.436 -1.745 . . . . 0.0 108.564 169.343 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 7.3 tp -53.47 -41.1 43.84 Favored 'Isoleucine or valine' 0 C--N 1.344 0.345 0 CA-C-N 122.094 2.225 . . . . 0.0 112.44 -169.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -62.03 -49.06 78.91 Favored Glycine 0 CA--C 1.523 0.555 0 CA-C-N 119.257 0.935 . . . . 0.0 111.707 177.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 58.3 t -65.16 -47.27 88.24 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 178.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 71.4 mmt-85 -59.64 -35.02 73.57 Favored 'General case' 0 C--N 1.343 0.292 0 CA-C-O 117.041 -1.457 . . . . 0.0 113.146 177.326 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 27.8 mt -62.74 -45.6 98.43 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 CA-C-N 121.925 2.148 . . . . 0.0 109.995 177.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 22.2 m -74.47 -27.82 21.71 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-N 119.995 1.27 . . . . 0.0 111.632 -175.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -68.63 -44.44 74.22 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 174.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -66.09 -40.11 90.54 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 122.559 0.344 . . . . 0.0 110.28 -179.258 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 7.8 tp -62.33 -42.59 99.5 Favored 'General case' 0 CA--C 1.527 0.096 0 CA-C-O 118.733 -0.651 . . . . 0.0 109.933 178.169 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -61.36 -38.62 87.64 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 118.506 0.594 . . . . 0.0 110.835 -178.309 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 -74.01 -43.21 58.76 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.38 0.672 . . . . 0.0 111.036 177.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 87.9 mtt180 -86.31 -31.13 21.75 Favored 'General case' 0 C--N 1.339 0.124 0 CA-C-O 116.87 -1.538 . . . . 0.0 114.221 -169.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -125.96 138.25 53.75 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 121.369 1.895 . . . . 0.0 112.836 -173.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 49.5 mm -91.71 149.84 3.99 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 N-CA-C 106.366 -1.716 . . . . 0.0 106.366 168.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 51.2 mt -137.44 151.34 71.03 Favored Pre-proline 0 C--O 1.237 0.412 0 C-N-CA 124.218 1.007 . . . . 0.0 110.775 -169.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -67.76 159.97 50.38 Favored 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 122.483 2.122 . . . . 0.0 110.111 169.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -57.71 -32.55 67.5 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 114.51 1.3 . . . . 0.0 114.51 -169.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 31.5 p90 -75.89 -5.61 46.91 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 117.8 -1.095 . . . . 0.0 112.676 -176.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 26.0 t -108.61 129.9 62.3 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 CA-C-N 120.087 1.312 . . . . 0.0 107.888 175.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -136.95 150.98 48.51 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 121.491 0.662 . . . . 0.0 110.113 174.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -103.21 131.01 52.52 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 170.555 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 10.5 tt -123.77 127.68 48.47 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 175.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -91.2 115.15 27.79 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 172.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -71.58 -23.92 77.43 Favored Glycine 0 CA--C 1.533 1.186 0 CA-C-O 118.373 -1.237 . . . . 0.0 112.795 179.239 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 62.85 77.09 0.22 Allowed Glycine 0 CA--C 1.529 0.949 0 CA-C-N 118.424 1.112 . . . . 0.0 112.886 173.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.514 HG22 ' HA ' ' A' ' 10' ' ' ASN 0.28 14.9 p 55.75 32.84 20.24 Favored 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 125.075 1.35 . . . . 0.0 112.761 173.181 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -75.14 -69.26 0.48 Allowed 'General case' 0 C--N 1.345 0.385 0 N-CA-C 114.722 1.378 . . . . 0.0 114.722 -169.333 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 70.06 -99.1 0.67 Allowed Glycine 0 C--N 1.337 0.584 0 N-CA-C 108.436 -1.866 . . . . 0.0 108.436 -171.038 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 10.1 tpt -67.51 -27.76 67.26 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 125.057 1.343 . . . . 0.0 111.38 -178.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -70.2 -4.65 22.64 Favored 'General case' 0 CA--C 1.548 0.881 0 CA-C-O 121.234 0.54 . . . . 0.0 110.685 -173.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 81.9 mt -81.76 2.13 31.35 Favored 'General case' 0 CA--C 1.535 0.382 0 O-C-N 120.316 -1.49 . . . . 0.0 113.62 -179.335 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.48 ' HA ' HG13 ' A' ' 100' ' ' VAL . 6.5 tt -50.16 -53.99 23.87 Favored 'General case' 0 C--N 1.339 0.151 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 -170.129 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -87.68 -31.91 14.5 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 -177.29 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -52.87 -49.3 66.12 Favored 'General case' 0 C--N 1.34 0.164 0 C-N-CA 123.03 0.532 . . . . 0.0 110.257 178.256 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 28.1 mtp -78.13 -8.71 58.61 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 114.306 1.224 . . . . 0.0 114.306 -169.052 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.79 146.65 54.2 Favored 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 113.78 1.03 . . . . 0.0 113.78 -169.131 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . 0.25 14.7 p30 53.08 13.81 0.42 Allowed 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 128.86 2.864 . . . . 0.0 117.975 169.114 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 89.8 mtt180 -68.08 151.93 46.29 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 121.333 -0.855 . . . . 0.0 109.835 173.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -81.68 -61.75 1.84 Allowed 'General case' 0 C--O 1.222 -0.363 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 176.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 2.3 t-160 -114.85 124.22 51.19 Favored 'General case' 0 C--O 1.231 0.103 0 N-CA-C 105.609 -1.997 . . . . 0.0 105.609 -177.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 54.0 tp -133.24 119.96 20.5 Favored 'General case' 0 CA--C 1.506 -0.713 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 178.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 4.4 mp -103.04 120.09 52.4 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 N-CA-C 105.445 -2.057 . . . . 0.0 105.445 175.194 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 8.1 mt -96.92 132.94 40.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 104.392 -2.447 . . . . 0.0 104.392 176.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -121.55 126.4 49.08 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 172.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -162.46 162.6 27.64 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 122.602 0.361 . . . . 0.0 110.056 177.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -74.06 136.44 43.07 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 104.923 -2.251 . . . . 0.0 104.923 168.106 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -87.47 -22.03 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 N-CA-C 113.182 0.808 . . . . 0.0 113.182 -168.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.7 t 51.73 31.95 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.221 0 C-N-CA 126.115 1.766 . . . . 0.0 112.569 174.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 19.8 m -137.54 159.75 41.08 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 124.313 1.045 . . . . 0.0 111.711 -172.245 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 22.6 ttmt 63.55 173.93 0.17 Allowed 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 126.732 2.013 . . . . 0.0 112.685 170.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.32 7.98 35.87 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.543 1.137 . . . . 0.0 112.027 -170.02 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 41.4 t-20 -73.66 165.55 24.9 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.368 0.667 . . . . 0.0 109.489 -174.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 10.7 m -58.75 141.59 84.82 Favored Pre-proline 0 CA--C 1.55 0.947 0 C-N-CA 124.199 1.0 . . . . 0.0 112.578 -169.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -55.25 150.16 41.87 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 123.503 2.802 . . . . 0.0 112.132 169.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 68.18 15.2 67.33 Favored Glycine 0 CA--C 1.531 1.032 0 CA-C-O 119.091 -0.839 . . . . 0.0 113.825 176.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 20.9 m -90.92 149.92 21.7 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 118.973 1.386 . . . . 0.0 108.895 175.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 16.7 ttp -95.41 139.12 32.15 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 176.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 3.4 ttt -135.44 115.04 12.72 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 107.275 -1.379 . . . . 0.0 107.275 -170.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 24.0 mm -100.78 122.04 52.32 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 -169.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -117.48 125.24 50.56 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 179.216 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -90.7 170.53 10.06 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 178.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -28.97 -61.69 0.12 Allowed 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 117.02 2.23 . . . . 0.0 117.02 -170.12 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -78.51 -17.25 56.49 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 119.302 0.955 . . . . 0.0 113.307 -174.158 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -87.96 -30.69 19.84 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 123.555 0.742 . . . . 0.0 110.417 -170.026 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . 0.256 0.5 OUTLIER -67.46 -47.31 47.76 Favored Pre-proline 0 N--CA 1.453 -0.289 0 CA-C-O 116.624 -1.655 . . . . 0.0 112.023 -171.351 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -65.63 -35.63 36.72 Favored 'Trans proline' 0 N--CA 1.453 -0.883 0 CA-C-N 122.176 1.813 . . . . 0.0 109.988 179.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.2 -26.36 67.36 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.033 0.533 . . . . 0.0 111.199 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -78.39 -52.96 7.81 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 169.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -58.2 -23.06 54.3 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 -174.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -66.86 -6.79 17.75 Favored 'General case' 0 CA--C 1.551 1.009 0 CA-C-N 119.103 0.865 . . . . 0.0 112.26 176.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 32.6 t30 -50.2 127.68 17.56 Favored 'General case' 0 C--N 1.344 0.346 0 O-C-N 121.27 -0.894 . . . . 0.0 110.912 173.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 30.5 mmmt -66.91 -26.73 67.01 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 118.541 -0.742 . . . . 0.0 111.994 -178.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 62.1 mt -65.62 -49.6 76.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 -177.204 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.4 m -65.02 114.41 14.89 Favored Pre-proline 0 CA--C 1.545 0.774 0 C-N-CA 124.609 1.164 . . . . 0.0 109.854 -176.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -70.92 -75.85 0.01 OUTLIER 'Trans proline' 0 CA--C 1.539 0.76 0 C-N-CA 122.761 2.307 . . . . 0.0 112.896 -169.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 13.1 m80 -69.33 -26.66 64.82 Favored 'General case' 0 N--CA 1.47 0.562 0 O-C-N 121.093 -1.004 . . . . 0.0 110.784 -174.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 25.8 mp0 -63.78 -28.87 70.17 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 124.432 1.093 . . . . 0.0 110.659 179.013 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 52.6 tp -64.18 -35.49 80.97 Favored 'General case' 0 C--N 1.342 0.246 0 CA-C-N 119.722 1.146 . . . . 0.0 110.54 174.224 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -64.64 -40.12 97.27 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 110.552 -1.019 . . . . 0.0 110.552 172.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 19.1 tp -66.2 -32.44 73.88 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 117.976 0.888 . . . . 0.0 110.907 175.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -64.1 -45.19 89.75 Favored 'General case' 0 N--CA 1.466 0.36 0 O-C-N 120.952 -1.092 . . . . 0.0 110.791 171.202 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -70.35 -24.2 62.94 Favored 'General case' 0 CA--C 1.52 -0.18 0 O-C-N 121.602 -0.686 . . . . 0.0 111.574 178.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.48 HG13 ' HA ' ' A' ' 49' ' ' LEU . 7.0 t -68.14 -44.97 83.98 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 CA-C-N 118.722 0.692 . . . . 0.0 110.397 169.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 59.8 mt -62.26 -36.89 83.45 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 119.25 0.932 . . . . 0.0 109.697 176.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 44.5 m -65.03 -40.18 94.44 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 118.005 0.366 . . . . 0.0 110.299 172.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -64.52 -40.34 95.44 Favored 'General case' 0 N--CA 1.454 -0.237 0 O-C-N 121.112 -0.992 . . . . 0.0 110.729 178.231 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 12.6 mt -64.0 -37.61 88.05 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-O 120.98 0.419 . . . . 0.0 110.58 175.155 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 21.1 tpp180 -63.89 -37.82 88.8 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 118.652 -0.689 . . . . 0.0 109.982 173.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 14.6 m-30 -66.18 -42.61 88.65 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 119.124 0.875 . . . . 0.0 110.798 179.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 41.7 p -76.13 -18.72 59.02 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 118.819 0.736 . . . . 0.0 111.722 178.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 76.42 9.72 85.83 Favored Glycine 0 CA--C 1.532 1.127 0 CA-C-O 119.073 -0.848 . . . . 0.0 111.229 -169.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -93.5 31.04 1.6 Allowed 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 118.991 1.395 . . . . 0.0 110.675 178.048 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.418 ' HA ' ' HD3' ' A' ' 111' ' ' PRO . 9.4 t80 -62.24 140.22 96.24 Favored Pre-proline 0 CA--C 1.542 0.647 0 C-N-CA 123.793 0.837 . . . . 0.0 109.724 174.321 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 110' ' ' PHE . 31.2 Cg_exo -66.66 142.9 65.97 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.382 2.055 . . . . 0.0 110.35 -177.364 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -64.48 -29.4 70.44 Favored 'General case' 0 CA--C 1.538 0.504 0 O-C-N 122.141 -0.349 . . . . 0.0 111.483 -174.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 23.9 tptp -143.41 82.78 1.75 Allowed 'General case' 0 C--O 1.234 0.277 0 N-CA-C 106.172 -1.788 . . . . 0.0 106.172 -176.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 24.5 tp -77.02 136.52 38.69 Favored 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 169.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -138.39 144.24 40.15 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 170.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 11.2 tp -128.83 129.83 46.12 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 119.606 1.094 . . . . 0.0 109.464 176.031 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 21.7 t -98.34 101.21 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 N-CA-C 104.215 -2.513 . . . . 0.0 104.215 168.384 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -82.93 146.7 24.33 Favored Glycine 0 CA--C 1.521 0.454 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 171.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 47.9 t -127.42 143.5 40.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 170.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 13.2 mt -94.14 130.13 35.2 Favored Pre-proline 0 CA--C 1.537 0.458 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 -176.139 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -79.33 166.6 22.26 Favored 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 122.967 2.445 . . . . 0.0 113.026 -174.154 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -111.05 -53.71 2.68 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.371 1.068 . . . . 0.0 110.331 -178.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 73.6 m -111.84 -53.55 2.7 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 118.73 0.695 . . . . 0.0 112.248 -173.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER 56.11 44.71 24.79 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 125.215 1.406 . . . . 0.0 114.609 177.07 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -119.43 171.38 5.51 Favored Pre-proline 0 N--CA 1.477 0.892 0 O-C-N 121.205 -0.934 . . . . 0.0 109.924 175.091 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -65.85 91.0 0.24 Allowed 'Trans proline' 0 CA--C 1.549 1.267 0 C-N-CA 123.447 2.765 . . . . 0.0 114.145 -177.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -167.62 131.64 1.78 Allowed 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 105.102 -2.185 . . . . 0.0 105.102 169.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.434 HG23 ' HA ' ' A' ' 12' ' ' LEU . 0.0 OUTLIER -80.28 152.91 4.48 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 123.612 0.765 . . . . 0.0 110.293 -171.452 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 80.37 160.79 23.22 Favored Glycine 0 CA--C 1.53 1.0 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.916 179.334 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.436 HD22 ' H ' ' A' ' 130' ' ' LEU . 1.1 mm? -76.45 163.17 27.21 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-O 121.188 0.518 . . . . 0.0 112.218 -169.194 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 40.7 p -69.81 169.93 11.3 Favored Pre-proline 0 CA--C 1.541 0.597 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 167.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -55.88 -31.76 82.55 Favored 'Trans proline' 0 CA--C 1.542 0.925 0 C-N-CA 121.315 1.344 . . . . 0.0 111.041 169.097 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 25.3 m -68.18 -45.27 73.91 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 118.976 -0.535 . . . . 0.0 111.505 179.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 5.8 t -99.19 -12.16 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 CA-C-N 119.451 1.023 . . . . 0.0 111.652 -169.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -57.6 -45.55 85.15 Favored 'General case' 0 N--CA 1.465 0.292 0 O-C-N 119.898 -1.751 . . . . 0.0 108.102 169.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -68.19 -2.02 7.25 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-O 118.382 -0.818 . . . . 0.0 112.741 178.021 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 12.9 mmm -92.84 -6.94 47.7 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 119.356 0.98 . . . . 0.0 111.266 175.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 86.6 mt -59.42 -45.26 93.71 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 CA-C-N 119.421 1.01 . . . . 0.0 108.921 175.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -76.07 -47.02 3.71 Favored Pre-proline 0 CA--C 1.543 0.677 0 CA-C-O 117.252 -1.356 . . . . 0.0 113.129 -170.207 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -55.0 -41.76 75.79 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 122.07 1.847 . . . . 0.0 111.399 170.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -68.36 -41.48 80.6 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 118.162 -0.923 . . . . 0.0 110.718 -177.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 27.1 mt -55.83 -47.48 77.16 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 119.713 1.142 . . . . 0.0 109.223 172.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -62.31 -33.97 75.71 Favored 'General case' 0 N--CA 1.443 -0.817 0 C-N-CA 122.768 0.427 . . . . 0.0 109.849 -177.109 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 38.9 tp60 -80.29 -34.14 37.13 Favored 'General case' 0 N--CA 1.431 -1.375 0 C-N-CA 123.409 0.684 . . . . 0.0 111.307 -178.047 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 49.0 t -60.45 -48.77 87.01 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 170.176 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 30.2 mt -62.81 -30.53 71.55 Favored 'General case' 0 C--N 1.331 -0.203 0 O-C-N 121.995 -0.441 . . . . 0.0 110.406 178.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -67.22 -39.37 86.23 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 121.036 -1.04 . . . . 0.0 111.129 176.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -62.06 -47.48 84.52 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 118.608 0.64 . . . . 0.0 110.76 177.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 6.0 mp -58.01 -41.97 84.23 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 174.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 85.0 mtm180 -70.12 -13.83 62.38 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 117.319 -1.324 . . . . 0.0 113.327 -179.051 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -57.29 -33.25 67.48 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 120.959 1.709 . . . . 0.0 110.208 172.152 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 4.6 m -103.01 22.22 14.34 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.113 1.365 . . . . 0.0 111.502 179.18 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 68.75 23.26 75.65 Favored Glycine 0 CA--C 1.532 1.155 0 CA-C-O 118.402 -1.221 . . . . 0.0 114.355 178.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 60.9 t -102.41 97.84 6.12 Favored 'Isoleucine or valine' 0 C--N 1.342 0.261 0 CA-C-N 119.52 1.66 . . . . 0.0 107.607 177.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -97.96 136.58 38.04 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 169.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -77.18 161.18 28.4 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.273 0.629 . . . . 0.0 110.619 178.169 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 5.2 mt -83.57 121.55 76.47 Favored Pre-proline 0 CA--C 1.54 0.565 0 N-CA-C 105.307 -2.109 . . . . 0.0 105.307 175.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -65.94 107.86 1.19 Allowed 'Trans proline' 0 C--N 1.35 0.656 0 N-CA-C 105.781 -2.43 . . . . 0.0 105.781 169.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 22.5 tpt180 47.86 -121.64 1.37 Allowed 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 104.965 -2.235 . . . . 0.0 104.965 -168.049 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 8.1 p . . . . . 0 C--O 1.238 0.467 0 CA-C-N 121.521 1.964 . . . . 0.0 109.958 169.757 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 31.6 ptt-85 . . . . . 0 N--CA 1.476 0.848 0 CA-C-O 119.442 -0.313 . . . . 0.0 110.252 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 4.4 mt -122.19 128.74 75.61 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 -176.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 15.3 tp -115.21 140.77 48.81 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 105.686 -1.968 . . . . 0.0 105.686 168.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 74.9 t -120.01 113.24 39.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 106.152 -1.795 . . . . 0.0 106.152 177.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.41 ' HA ' HD13 ' A' ' 6' ' ' LEU . 0.7 OUTLIER -93.26 120.84 34.0 Favored 'General case' 0 CA--C 1.516 -0.338 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 -177.534 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -100.03 120.27 6.81 Favored Glycine 0 CA--C 1.499 -0.92 0 N-CA-C 105.679 -2.968 . . . . 0.0 105.679 170.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 11.4 m -148.94 162.47 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.971 0 CA-C-O 121.174 0.511 . . . . 0.0 110.579 -168.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 119.77 146.67 7.81 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 126.382 1.944 . . . . 0.0 108.996 177.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.494 HD21 ' HB2' ' A' ' 12' ' ' LEU . 2.0 t30 -62.57 116.14 4.88 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 123.781 1.753 . . . . 0.0 114.675 -168.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.3 pt -67.84 40.71 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.812 0 CA-C-N 112.264 -2.244 . . . . 0.0 114.981 170.037 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.494 ' HB2' HD21 ' A' ' 10' ' ' ASN . 75.0 mt -132.62 -12.65 3.01 Favored 'General case' 0 C--N 1.343 0.325 0 CA-C-N 121.563 1.983 . . . . 0.0 111.416 170.622 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.7 mp -115.32 62.77 0.69 Allowed 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 -167.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 56.9 -97.63 0.08 Allowed 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 123.51 0.724 . . . . 0.0 111.246 170.387 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -84.18 -9.47 58.52 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 124.39 1.076 . . . . 0.0 110.906 -175.15 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -70.68 -14.98 62.67 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 119.859 1.208 . . . . 0.0 112.56 -176.039 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.2 -6.04 55.67 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-O 115.697 -2.097 . . . . 0.0 110.024 172.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 6.4 tp -49.88 -44.37 20.9 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-N 122.062 2.21 . . . . 0.0 111.94 -171.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -62.78 -42.24 99.72 Favored Glycine 0 N--CA 1.446 -0.634 0 CA-C-N 118.88 0.764 . . . . 0.0 111.629 178.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 73.6 t -63.86 -52.92 50.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 173.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 1.4 mmp_? -60.74 -31.89 71.2 Favored 'General case' 0 CA--C 1.531 0.245 0 O-C-N 120.949 -1.094 . . . . 0.0 112.73 -175.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 25.0 mt -60.54 -44.94 97.68 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 CA-C-N 120.145 1.339 . . . . 0.0 110.287 176.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 17.9 m -75.35 -25.44 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-N 120.203 1.365 . . . . 0.0 111.323 -176.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -68.03 -42.92 79.87 Favored 'General case' 0 C--N 1.341 0.2 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 173.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.81 -41.95 91.24 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-O 119.363 -0.351 . . . . 0.0 110.277 179.36 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 10.4 tp -61.12 -45.11 96.02 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 118.453 -0.784 . . . . 0.0 109.816 176.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -59.89 -39.91 86.97 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 118.467 0.576 . . . . 0.0 111.216 -178.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 50.6 mm-40 -73.58 -40.73 63.66 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 122.938 0.495 . . . . 0.0 111.355 178.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 91.0 mtt180 -90.24 -38.03 13.71 Favored 'General case' 0 C--N 1.342 0.259 0 CA-C-O 117.343 -1.313 . . . . 0.0 114.288 -169.293 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 66.2 m-85 -115.33 136.23 53.31 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 120.991 1.723 . . . . 0.0 113.348 -169.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 39.8 mm -86.48 134.29 27.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 N-CA-C 105.805 -1.924 . . . . 0.0 105.805 168.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 7.3 mp -119.91 150.32 50.54 Favored Pre-proline 0 CA--C 1.539 0.523 0 C-N-CA 125.305 1.442 . . . . 0.0 110.691 -169.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -62.34 153.86 67.6 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 122.888 2.392 . . . . 0.0 109.785 168.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -61.21 -33.6 73.74 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 -169.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 18.0 p90 -74.21 -8.04 54.78 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 118.016 -0.992 . . . . 0.0 112.453 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 12.4 t -101.11 128.03 53.74 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 CA-C-N 119.926 1.239 . . . . 0.0 108.079 174.205 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -133.45 147.66 51.7 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.063 0.545 . . . . 0.0 110.155 175.226 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -100.17 136.78 30.04 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 N-CA-C 107.459 -1.312 . . . . 0.0 107.459 169.556 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.513 HD13 ' N ' ' A' ' 40' ' ' ASP . 1.5 tm? -128.11 144.79 51.13 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 173.075 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.513 ' N ' HD13 ' A' ' 39' ' ' LEU . 5.8 t0 -118.11 114.43 23.08 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 124.131 0.972 . . . . 0.0 108.483 -175.439 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -93.31 -4.54 64.29 Favored Glycine 0 CA--C 1.533 1.207 0 CA-C-O 119.032 -0.871 . . . . 0.0 113.277 176.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 60.57 -125.82 39.49 Favored Glycine 0 N--CA 1.431 -1.665 0 N-CA-C 108.22 -1.952 . . . . 0.0 108.22 -171.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 12.1 p -54.55 -37.41 65.41 Favored 'General case' 0 C--N 1.313 -0.985 0 C-N-CA 127.501 2.32 . . . . 0.0 111.271 176.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 50.07 -131.32 1.94 Allowed 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 169.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 79.73 -104.92 2.24 Favored Glycine 0 N--CA 1.443 -0.847 0 N-CA-C 106.899 -2.481 . . . . 0.0 106.899 -169.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 66.4 mmm -72.23 -19.55 61.7 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 112.535 0.568 . . . . 0.0 112.535 -175.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -60.67 -18.48 54.06 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 120.871 0.367 . . . . 0.0 111.941 -174.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 28.4 mt -88.71 -2.68 58.72 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 124.929 1.291 . . . . 0.0 114.136 -169.015 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.496 ' HA ' HG13 ' A' ' 100' ' ' VAL . 5.0 tt -46.9 -53.97 11.01 Favored 'General case' 0 C--N 1.344 0.354 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 -169.483 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -86.93 -31.24 18.29 Favored Glycine 0 CA--C 1.522 0.493 0 N-CA-C 111.011 -0.836 . . . . 0.0 111.011 -179.244 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -72.24 -27.75 62.71 Favored 'General case' 0 C--O 1.233 0.199 0 O-C-N 121.735 -0.862 . . . . 0.0 111.217 -170.015 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 28.8 mtp -81.9 -6.81 59.42 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 176.133 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -68.61 145.2 54.15 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 118.997 0.817 . . . . 0.0 111.474 -170.36 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 55.79 21.85 5.06 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 116.741 2.126 . . . . 0.0 116.741 168.577 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 26.2 mmt180 -77.79 148.95 34.52 Favored 'General case' 0 N--CA 1.473 0.681 0 O-C-N 120.593 -1.317 . . . . 0.0 108.867 178.104 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -83.4 -30.64 27.19 Favored 'General case' 0 N--CA 1.47 0.572 0 O-C-N 121.7 -0.625 . . . . 0.0 109.607 179.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 4.0 t60 -141.33 129.53 22.22 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 105.523 -2.028 . . . . 0.0 105.523 177.114 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.403 HD21 HD23 ' A' ' 6' ' ' LEU . 0.4 OUTLIER -130.84 127.95 39.64 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-N 118.671 0.669 . . . . 0.0 109.327 171.095 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 29.7 mt -109.69 116.91 53.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 N-CA-C 104.904 -2.258 . . . . 0.0 104.904 174.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.452 HD11 HD21 ' A' ' 114' ' ' LEU . 38.8 mt -93.36 127.47 45.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 105.517 -2.031 . . . . 0.0 105.517 177.077 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -110.4 114.97 28.83 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 103.868 -2.641 . . . . 0.0 103.868 169.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -150.48 161.46 42.48 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.813 0.845 . . . . 0.0 110.154 -178.427 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -76.02 151.79 37.08 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 169.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 9.7 mm -84.05 -49.49 16.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-O 118.817 -0.611 . . . . 0.0 110.925 -177.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . 0.252 2.7 t 52.64 28.6 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.164 0 C-N-CA 125.954 1.702 . . . . 0.0 112.907 177.595 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 16.3 m -132.46 157.62 44.13 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 124.481 1.112 . . . . 0.0 111.934 -171.178 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 19.7 ttmt 57.87 -167.48 0.14 Allowed 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 126.265 1.826 . . . . 0.0 112.447 171.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.37 17.98 17.17 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.86 1.264 . . . . 0.0 110.995 -175.177 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -70.84 158.45 36.35 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.529 0.732 . . . . 0.0 109.144 -177.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 8.5 m -59.74 138.71 90.07 Favored Pre-proline 0 CA--C 1.545 0.779 0 C-N-CA 124.078 0.951 . . . . 0.0 111.991 -169.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_exo -55.2 149.01 46.84 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.998 2.465 . . . . 0.0 111.709 170.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 68.95 16.43 70.49 Favored Glycine 0 CA--C 1.533 1.157 0 CA-C-O 119.721 -0.488 . . . . 0.0 113.684 174.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 18.3 m -91.6 141.24 28.92 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 173.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 26.3 ttp -96.12 141.14 29.85 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 175.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 25.9 ttm -129.5 100.61 5.61 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 -173.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 38.4 mm -92.81 119.18 40.03 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 -178.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 44.0 mt -125.46 141.29 52.14 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 -173.281 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 88.2 mtt-85 -113.28 142.89 45.29 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 123.113 0.565 . . . . 0.0 110.425 -178.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 33.6 t70 38.05 -102.11 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 125.6 1.56 . . . . 0.0 114.228 169.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -59.91 -31.06 69.47 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.851 1.26 . . . . 0.0 113.725 -173.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -75.56 -19.52 59.24 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 118.388 0.54 . . . . 0.0 111.173 -176.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 78.9 t -73.96 -60.84 1.42 Allowed Pre-proline 0 N--CA 1.443 -0.781 0 CA-C-O 117.822 -1.085 . . . . 0.0 111.196 -169.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -63.8 -30.98 68.73 Favored 'Trans proline' 0 N--CA 1.447 -1.222 0 CA-C-N 121.315 1.506 . . . . 0.0 110.591 177.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.6 -26.45 67.1 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 122.631 0.372 . . . . 0.0 111.074 -178.028 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.423 HD13 ' C ' ' A' ' 85' ' ' LEU . 3.1 tm? -77.98 -54.86 5.81 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 169.044 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -59.05 -24.56 62.97 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 114.033 1.123 . . . . 0.0 114.033 -170.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.9 t -67.3 -7.93 28.3 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-N 118.948 0.794 . . . . 0.0 112.546 178.021 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . 0.559 HD21 ' HB ' ' A' ' 90' ' ' ILE . 10.1 t30 -51.69 126.54 18.0 Favored 'General case' 0 C--N 1.344 0.347 0 O-C-N 121.409 -0.807 . . . . 0.0 109.754 172.075 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 37.0 mtmt -73.12 -23.51 60.5 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 118.718 -0.658 . . . . 0.0 112.45 -174.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.559 ' HB ' HD21 ' A' ' 88' ' ' ASN . 70.9 mt -67.23 -44.83 87.36 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 -178.054 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.9 m -62.39 113.37 8.6 Favored Pre-proline 0 CA--C 1.544 0.724 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 170.404 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -77.15 -63.68 0.03 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.623 0 CA-C-N 121.215 1.47 . . . . 0.0 113.041 -169.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . 0.418 ' CE1' ' HB3' ' A' ' 10' ' ' ASN . 6.4 p-80 -78.62 -25.23 45.06 Favored 'General case' 0 N--CA 1.468 0.445 0 O-C-N 121.127 -0.983 . . . . 0.0 110.754 -178.226 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 22.0 mp0 -59.36 -33.51 71.25 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 119.739 1.154 . . . . 0.0 110.084 171.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -60.63 -41.83 95.65 Favored 'General case' 0 C--O 1.224 -0.248 0 CA-C-N 119.249 0.932 . . . . 0.0 109.14 173.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -61.29 -38.01 94.98 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 110.781 -0.927 . . . . 0.0 110.781 174.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 10.4 tp -69.23 -33.52 73.42 Favored 'General case' 0 CA--C 1.538 0.483 0 O-C-N 120.676 -1.484 . . . . 0.0 110.624 176.127 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -63.41 -41.3 98.72 Favored 'General case' 0 C--N 1.333 -0.132 0 O-C-N 121.037 -1.039 . . . . 0.0 109.822 171.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -71.2 -22.27 62.04 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 118.877 -0.583 . . . . 0.0 111.775 176.15 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.496 HG13 ' HA ' ' A' ' 49' ' ' LEU . 6.3 t -73.54 -44.16 54.02 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 CA-C-N 119.526 1.057 . . . . 0.0 109.839 169.7 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 64.4 mt -58.97 -37.42 76.76 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 119.093 0.86 . . . . 0.0 108.735 174.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 35.8 m -68.33 -39.17 82.01 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 118.708 -0.663 . . . . 0.0 110.554 172.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.415 ' HA ' ' CD2' ' A' ' 106' ' ' PHE . . . -63.77 -39.76 95.03 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 119.879 1.218 . . . . 0.0 110.459 179.583 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 18.8 mt -65.88 -38.84 89.85 Favored 'General case' 0 CA--C 1.519 -0.244 0 C-N-CA 123.119 0.567 . . . . 0.0 110.596 174.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 80.2 ttt180 -62.17 -37.83 86.76 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 118.552 -0.737 . . . . 0.0 109.985 173.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.415 ' CD2' ' HA ' ' A' ' 103' ' ' ALA . 14.1 m-30 -65.73 -42.51 90.94 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 119.346 0.975 . . . . 0.0 110.489 -179.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 42.6 p -78.55 -19.77 52.13 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 118.345 0.521 . . . . 0.0 111.624 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 78.56 10.33 86.29 Favored Glycine 0 CA--C 1.532 1.143 0 CA-C-O 119.034 -0.87 . . . . 0.0 111.036 -169.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 30.4 mm-40 -88.9 21.68 3.0 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 119.078 1.439 . . . . 0.0 111.931 -179.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.428 ' HA ' ' HD3' ' A' ' 111' ' ' PRO . 10.0 t80 -61.8 140.95 95.41 Favored Pre-proline 0 CA--C 1.543 0.684 0 C-N-CA 123.95 0.9 . . . . 0.0 110.509 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 110' ' ' PHE . 52.2 Cg_exo -64.72 148.16 90.08 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 122.493 2.128 . . . . 0.0 111.675 -176.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -64.75 -26.08 68.21 Favored 'General case' 0 CA--C 1.537 0.476 0 O-C-N 122.13 -0.357 . . . . 0.0 111.137 -178.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -140.45 133.29 29.1 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 169.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.452 HD21 HD11 ' A' ' 60' ' ' ILE . 2.8 tm? -124.96 123.22 39.42 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 177.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.2 m -131.62 142.6 49.91 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 -172.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -131.58 123.81 28.68 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 119.681 1.128 . . . . 0.0 109.525 -179.545 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 23.4 t -96.4 78.7 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 105.489 -2.041 . . . . 0.0 105.489 174.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -77.01 145.09 30.61 Favored Glycine 0 N--CA 1.449 -0.471 0 N-CA-C 109.905 -1.278 . . . . 0.0 109.905 -176.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 63.3 t -129.03 137.57 56.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 174.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 18.8 mt -88.56 131.65 41.32 Favored Pre-proline 0 CA--C 1.542 0.656 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 175.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -70.74 171.49 15.43 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 124.147 3.231 . . . . 0.0 113.534 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -113.08 -60.74 1.84 Allowed 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.033 0.933 . . . . 0.0 110.454 176.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 67.8 m -104.56 -52.32 2.92 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 118.791 0.723 . . . . 0.0 112.756 -171.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER 58.48 46.98 14.22 Favored 'General case' 0 CA--C 1.548 0.887 0 N-CA-C 114.706 1.372 . . . . 0.0 114.706 170.429 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -115.8 165.03 15.56 Favored Pre-proline 0 N--CA 1.475 0.81 0 CA-C-O 117.923 -1.037 . . . . 0.0 110.407 175.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -63.94 87.58 0.15 Allowed 'Trans proline' 0 CA--C 1.547 1.136 0 C-N-CA 123.706 2.937 . . . . 0.0 113.736 -179.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -176.76 145.8 0.53 Allowed 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 104.067 -2.568 . . . . 0.0 104.067 174.574 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -108.94 161.72 7.12 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 CA-C-N 119.014 0.825 . . . . 0.0 111.346 -176.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 105.21 135.21 8.22 Favored Glycine 0 CA--C 1.528 0.865 0 N-CA-C 105.316 -3.114 . . . . 0.0 105.316 -168.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 5.8 mp -81.43 157.94 24.76 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-N 117.915 0.857 . . . . 0.0 109.332 -175.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 63.4 p -64.22 162.7 30.0 Favored Pre-proline 0 CA--C 1.537 0.462 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 168.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -59.15 -28.56 88.12 Favored 'Trans proline' 0 CA--C 1.541 0.853 0 C-N-CA 120.635 0.89 . . . . 0.0 110.628 169.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 28.7 m -64.14 -50.09 69.57 Favored 'General case' 0 C--N 1.344 0.368 0 CA-C-O 118.785 -0.626 . . . . 0.0 110.999 178.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 5.0 t -96.3 -22.68 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 CA-C-N 119.286 0.948 . . . . 0.0 111.343 -169.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -52.59 -45.53 66.53 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 120.241 1.382 . . . . 0.0 108.674 168.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -75.15 8.81 2.36 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 113.978 1.103 . . . . 0.0 113.978 -179.219 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 85.3 mtp -103.48 -6.75 21.5 Favored 'General case' 0 N--CA 1.432 -1.367 0 CA-C-O 117.563 -1.208 . . . . 0.0 110.077 169.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 95.1 mt -58.92 -44.55 91.12 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.326 0 CA-C-N 120.342 1.428 . . . . 0.0 107.278 174.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 58.1 mt-10 -72.33 -51.87 7.37 Favored Pre-proline 0 CA--C 1.541 0.625 0 CA-C-O 117.595 -1.193 . . . . 0.0 110.786 -177.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -41.39 -50.47 4.55 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 124.867 3.711 . . . . 0.0 113.499 168.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -71.22 -42.68 68.6 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 113.725 -1.579 . . . . 0.0 110.497 -176.088 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 26.1 mt -56.4 -42.64 78.27 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 118.656 0.662 . . . . 0.0 109.354 173.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -62.18 -33.49 74.63 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 118.944 0.793 . . . . 0.0 110.426 -179.042 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 43.7 mm-40 -79.43 -31.48 42.6 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 119.059 0.845 . . . . 0.0 112.255 176.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 71.0 t -60.82 -47.81 91.63 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 169.522 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 29.0 mt -65.75 -35.06 79.64 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.103 0.561 . . . . 0.0 110.319 -179.076 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -62.15 -40.12 94.89 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-O 118.347 -0.835 . . . . 0.0 110.781 178.506 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -60.9 -47.99 83.87 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 119.154 0.888 . . . . 0.0 111.417 -179.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 10.4 mp -49.86 -52.47 32.47 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 123.379 0.672 . . . . 0.0 109.808 169.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -67.14 -18.37 65.26 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 117.492 -1.242 . . . . 0.0 111.984 -173.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -63.03 -29.49 70.86 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 120.788 1.631 . . . . 0.0 110.349 177.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 5.2 m -110.27 25.26 11.98 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.99 1.316 . . . . 0.0 110.808 179.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 66.54 18.61 68.06 Favored Glycine 0 CA--C 1.531 1.071 0 CA-C-O 118.295 -1.281 . . . . 0.0 114.047 177.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 63.9 t -84.72 137.05 21.52 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 N-CA-C 106.266 -1.753 . . . . 0.0 106.266 173.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -121.1 148.75 43.75 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 178.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -126.12 135.85 52.19 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 169.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . 0.404 ' CG2' ' HA ' ' A' ' 160' ' ' SER . 33.7 mm -101.63 130.27 24.97 Favored Pre-proline 0 C--O 1.23 0.069 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 -171.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -57.73 110.64 0.65 Allowed 'Trans proline' 0 CA--C 1.536 0.599 0 C-N-CA 122.022 1.814 . . . . 0.0 108.533 169.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 4.5 tmm_? 49.96 32.28 5.48 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.154 1.381 . . . . 0.0 113.151 173.33 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . 0.404 ' HA ' ' CG2' ' A' ' 157' ' ' ILE . 27.5 p . . . . . 0 CA--C 1.544 0.746 0 C-N-CA 125.997 1.719 . . . . 0.0 113.951 -171.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 6.1 ptp180 . . . . . 0 N--CA 1.479 0.986 0 CA-C-O 118.035 -0.983 . . . . 0.0 108.93 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 57.2 mt -140.75 135.79 34.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 CA-C-N 119.685 1.13 . . . . 0.0 111.143 -169.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -116.94 130.31 56.62 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 105.593 -2.003 . . . . 0.0 105.593 168.244 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 33.2 t -107.36 103.97 16.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 103.258 -2.867 . . . . 0.0 103.258 169.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.2 mt -101.65 110.34 22.31 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 124.003 0.921 . . . . 0.0 109.795 -169.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -92.23 116.76 5.13 Favored Glycine 0 N--CA 1.45 -0.409 0 N-CA-C 107.773 -2.131 . . . . 0.0 107.773 172.486 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 12.4 m -133.78 -166.63 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.084 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 -177.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 95.15 131.0 6.3 Favored Glycine 0 N--CA 1.441 -0.976 0 N-CA-C 107.369 -2.293 . . . . 0.0 107.369 -170.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.516 HD21 ' HB2' ' A' ' 12' ' ' LEU . 1.6 t30 -66.16 108.41 2.26 Favored 'General case' 0 N--CA 1.441 -0.915 0 C-N-CA 124.004 0.922 . . . . 0.0 110.937 -169.114 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.1 pt -73.21 40.29 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 C-N-CA 124.675 1.19 . . . . 0.0 113.193 179.167 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.516 ' HB2' HD21 ' A' ' 10' ' ' ASN . 15.2 mt -125.59 -2.76 7.33 Favored 'General case' 0 CA--C 1.536 0.407 0 O-C-N 121.023 -1.048 . . . . 0.0 108.6 169.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -129.24 65.45 1.46 Allowed 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.589 1.156 . . . . 0.0 108.418 -169.602 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 12.7 m 45.44 -109.6 0.2 Allowed 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 114.325 -1.307 . . . . 0.0 112.445 169.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -56.89 -24.59 53.13 Favored 'General case' 0 N--CA 1.443 -0.815 0 C-N-CA 125.617 1.567 . . . . 0.0 112.501 -172.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -64.73 -21.92 66.86 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 120.288 1.404 . . . . 0.0 111.443 -177.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.99 -9.4 15.57 Favored 'General case' 0 N--CA 1.437 -1.118 0 CA-C-O 116.433 -1.746 . . . . 0.0 111.456 173.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 5.6 tp -52.88 -40.44 36.05 Favored 'Isoleucine or valine' 0 C--N 1.343 0.306 0 CA-C-N 122.172 2.26 . . . . 0.0 111.421 -175.321 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -63.17 -45.23 95.79 Favored Glycine 0 C--N 1.336 0.559 0 CA-C-N 119.245 0.93 . . . . 0.0 111.027 178.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 96.9 t -62.62 -47.6 92.17 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 175.423 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 18.5 mmt180 -61.13 -33.61 73.66 Favored 'General case' 0 C--N 1.34 0.163 0 CA-C-O 117.092 -1.432 . . . . 0.0 112.5 179.062 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 21.9 mt -62.5 -47.04 94.87 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 CA-C-N 121.431 1.923 . . . . 0.0 109.847 177.46 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 26.7 m -74.97 -34.08 31.46 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-N 119.327 0.967 . . . . 0.0 111.157 -175.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 61.0 mt-10 -62.45 -44.14 97.12 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 122.863 0.465 . . . . 0.0 110.33 172.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -67.08 -38.15 85.24 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 119.438 1.017 . . . . 0.0 110.18 177.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 5.9 tp -64.73 -38.72 91.95 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 119.369 0.986 . . . . 0.0 109.652 -177.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -61.89 -25.56 67.63 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 112.573 0.583 . . . . 0.0 112.573 -179.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -94.91 -42.63 8.57 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 126.014 1.726 . . . . 0.0 111.076 -178.111 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 75.2 mtt180 -82.95 -25.96 31.84 Favored 'General case' 0 N--CA 1.456 -0.144 0 CA-C-O 118.343 -0.836 . . . . 0.0 111.799 -176.243 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 69.5 m-85 -127.06 147.97 50.14 Favored 'General case' 0 CA--C 1.521 -0.161 0 CA-C-N 119.628 1.104 . . . . 0.0 113.346 -177.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 37.7 mm -99.51 135.63 34.07 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 N-CA-C 104.384 -2.45 . . . . 0.0 104.384 168.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -118.51 147.38 41.82 Favored Pre-proline 0 CA--C 1.536 0.413 0 C-N-CA 123.795 0.838 . . . . 0.0 109.878 -169.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -65.93 157.2 60.47 Favored 'Trans proline' 0 CA--C 1.535 0.545 0 C-N-CA 122.637 2.225 . . . . 0.0 110.007 169.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -58.07 -32.56 68.16 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 114.314 1.227 . . . . 0.0 114.314 -169.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 10.6 p90 -77.06 -13.4 59.96 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 118.688 -0.672 . . . . 0.0 112.686 -177.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 75.5 t -88.73 125.54 41.89 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 170.05 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -120.77 128.17 52.65 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 169.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -88.38 124.33 41.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 105.074 -2.195 . . . . 0.0 105.074 168.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 52.2 tp -122.93 133.94 54.37 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 118.234 0.47 . . . . 0.0 110.359 174.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -89.81 123.38 33.74 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 169.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -112.92 -24.37 4.92 Favored Glycine 0 CA--C 1.536 1.401 0 CA-C-O 118.235 -1.314 . . . . 0.0 113.466 171.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 57.0 -111.7 3.0 Favored Glycine 0 C--N 1.342 0.907 0 CA-C-N 119.802 1.801 . . . . 0.0 111.714 171.282 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 67.4 p -75.62 7.28 3.86 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.545 1.538 . . . . 0.0 113.522 -174.123 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.82 -67.2 0.44 Allowed 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 114.397 1.258 . . . . 0.0 114.397 -169.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 60.87 -102.2 0.38 Allowed Glycine 0 CA--C 1.534 1.272 0 N-CA-C 109.125 -1.59 . . . . 0.0 109.125 -169.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . 0.477 ' HA ' HG23 ' A' ' 100' ' ' VAL . 0.0 OUTLIER -65.97 -26.59 67.63 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.939 0.896 . . . . 0.0 112.812 -175.037 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -60.22 -15.68 26.69 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 113.799 1.037 . . . . 0.0 113.799 -170.142 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 7.9 mt -96.39 13.99 25.91 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -169.488 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.525 ' HA ' HG13 ' A' ' 100' ' ' VAL . 4.2 tt -46.75 -60.9 2.1 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 118.539 0.609 . . . . 0.0 111.736 -176.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -64.68 -32.14 83.24 Favored Glycine 0 CA--C 1.531 1.075 0 CA-C-O 119.527 -0.596 . . . . 0.0 112.552 -178.363 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -78.79 -33.21 46.49 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 118.629 1.214 . . . . 0.0 112.515 -174.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 39.3 mtp -75.62 -21.44 57.75 Favored 'General case' 0 N--CA 1.449 -0.505 0 O-C-N 121.936 -0.478 . . . . 0.0 110.421 178.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.58 153.93 42.38 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-O 121.755 0.788 . . . . 0.0 111.452 -175.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 62.87 9.64 3.81 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 126.959 2.103 . . . . 0.0 115.592 169.248 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 25.1 mmt180 -79.38 160.29 26.75 Favored 'General case' 0 N--CA 1.473 0.709 0 O-C-N 121.017 -1.052 . . . . 0.0 108.565 178.286 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -87.33 -53.16 4.98 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 175.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . 0.259 0.0 OUTLIER -125.4 146.08 49.76 Favored 'General case' 0 CA--C 1.517 -0.295 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 169.206 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 12.6 tp -138.2 116.69 12.05 Favored 'General case' 0 CA--C 1.513 -0.449 0 N-CA-C 104.067 -2.568 . . . . 0.0 104.067 -176.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 10.8 mt -98.08 113.23 32.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 105.562 -2.014 . . . . 0.0 105.562 175.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 48.6 mt -91.4 138.48 19.62 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.558 0 N-CA-C 106.561 -1.644 . . . . 0.0 106.561 173.405 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -123.4 121.04 34.74 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 105.397 -2.075 . . . . 0.0 105.397 168.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -157.23 161.37 39.23 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.999 1.32 . . . . 0.0 108.979 -173.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -95.06 141.18 29.0 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 121.42 0.629 . . . . 0.0 110.666 176.198 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 25.7 mt -89.95 -18.55 7.64 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 C-N-CA 124.434 1.093 . . . . 0.0 110.611 -179.045 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . 0.308 47.2 t 70.54 -48.21 0.19 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.21 0 C-N-CA 128.323 2.649 . . . . 0.0 113.659 174.283 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 11.9 m -147.07 138.72 24.22 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 -176.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 12.0 tppt? -164.56 174.85 10.41 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 127.166 2.186 . . . . 0.0 105.961 168.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.56 -26.98 65.68 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 121.799 -0.563 . . . . 0.0 111.505 175.016 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -70.58 165.45 22.75 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.345 0.658 . . . . 0.0 110.761 -175.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 3.1 m -60.64 153.13 63.98 Favored Pre-proline 0 CA--C 1.547 0.854 0 C-N-CA 124.709 1.204 . . . . 0.0 112.489 -169.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_exo -57.7 158.39 20.3 Favored 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 123.867 3.045 . . . . 0.0 112.422 169.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.446 ' HA3' HG22 ' A' ' 133' ' ' THR . . . 65.62 11.21 52.81 Favored Glycine 0 CA--C 1.536 1.38 0 CA-C-O 119.144 -0.809 . . . . 0.0 114.358 172.019 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 5.6 m -90.32 146.51 24.14 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 118.875 1.337 . . . . 0.0 111.484 -169.325 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 26.4 ttp -84.63 139.3 32.16 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 173.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 40.6 mtp -128.75 123.62 33.45 Favored 'General case' 0 CA--C 1.519 -0.214 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 176.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 23.3 mm -99.88 116.62 43.56 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 N-CA-C 107.243 -1.391 . . . . 0.0 107.243 177.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -107.85 130.02 55.03 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 106.857 -1.534 . . . . 0.0 106.857 174.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 21.3 mmt180 -85.66 167.13 15.6 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 122.706 0.402 . . . . 0.0 110.857 176.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -32.74 -54.84 0.36 Allowed 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 116.575 2.065 . . . . 0.0 116.575 -174.169 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -88.99 -10.23 48.41 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 113.461 0.911 . . . . 0.0 113.461 -177.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -93.28 -33.23 14.02 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 123.189 0.596 . . . . 0.0 110.436 -176.246 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.0 m -53.79 -50.35 84.17 Favored Pre-proline 0 CA--C 1.538 0.484 0 CA-C-O 117.987 -1.006 . . . . 0.0 110.997 175.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -64.8 -40.82 20.34 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 121.82 1.68 . . . . 0.0 110.434 -177.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.14 -15.35 59.58 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 173.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -91.25 -36.79 13.7 Favored 'General case' 0 C--N 1.342 0.273 0 CA-C-N 119.755 1.161 . . . . 0.0 110.953 177.068 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.616 ' HB3' ' HB2' ' A' ' 98' ' ' ALA . 62.7 m-85 -70.73 9.44 0.66 Allowed 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 113.677 0.992 . . . . 0.0 113.677 -177.074 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 57.2 p -61.14 -24.4 66.25 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.224 1.01 . . . . 0.0 109.443 168.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 56.0 t-20 -50.34 114.76 1.2 Allowed 'General case' 0 C--N 1.348 0.509 0 C-N-CA 124.578 1.151 . . . . 0.0 110.464 170.253 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 34.7 tttm -97.31 1.04 49.04 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.461 1.104 . . . . 0.0 112.356 -174.257 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 60.0 mt -64.45 -48.26 85.9 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-N 118.724 0.693 . . . . 0.0 109.469 -170.378 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -100.49 135.64 20.14 Favored Pre-proline 0 CA--C 1.543 0.686 0 CA-C-O 118.968 -0.539 . . . . 0.0 110.545 -171.648 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -70.98 -36.23 7.88 Favored 'Trans proline' 0 CA--C 1.534 0.507 0 C-N-CA 122.794 2.329 . . . . 0.0 111.576 -177.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 47.9 t-80 -59.51 -50.25 74.63 Favored 'General case' 0 C--N 1.343 0.286 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 175.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -58.96 -43.16 91.26 Favored 'General case' 0 C--O 1.224 -0.264 0 CA-C-O 118.437 -0.792 . . . . 0.0 110.224 179.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 39.3 tp -66.06 -39.11 89.83 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 119.3 0.955 . . . . 0.0 111.123 -178.218 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -65.17 -44.26 94.24 Favored Glycine 0 CA--C 1.528 0.898 0 N-CA-C 110.615 -0.994 . . . . 0.0 110.615 176.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -62.32 -38.79 90.79 Favored 'General case' 0 CA--C 1.537 0.457 0 O-C-N 122.357 -0.496 . . . . 0.0 110.152 175.381 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.616 ' HB2' ' HB3' ' A' ' 86' ' ' PHE . . . -57.72 -46.14 84.8 Favored 'General case' 0 N--CA 1.455 -0.198 0 O-C-N 121.612 -0.68 . . . . 0.0 110.183 175.039 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 17.7 t0 -72.79 -20.88 61.08 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 119.706 -0.187 . . . . 0.0 111.078 -176.286 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.525 HG13 ' HA ' ' A' ' 49' ' ' LEU . 16.8 t -73.17 -44.59 55.64 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.686 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 169.486 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 74.5 mt -62.42 -36.31 81.97 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 119.119 0.872 . . . . 0.0 109.348 178.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 39.9 m -64.51 -44.21 91.63 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-O 118.469 -0.776 . . . . 0.0 109.952 172.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.448 ' HA ' ' CD2' ' A' ' 106' ' ' PHE . . . -60.48 -40.82 92.69 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 119.896 1.226 . . . . 0.0 111.641 175.311 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.5 mt -64.4 -33.58 76.19 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 123.621 0.768 . . . . 0.0 110.042 176.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 56.0 ttt85 -72.79 -32.58 65.68 Favored 'General case' 0 CA--C 1.534 0.335 0 O-C-N 121.553 -0.717 . . . . 0.0 110.071 174.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.448 ' CD2' ' HA ' ' A' ' 103' ' ' ALA . 14.3 m-30 -68.98 -47.05 66.52 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 119.058 0.844 . . . . 0.0 110.535 178.489 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 39.7 p -73.98 -25.27 59.84 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 123.4 0.68 . . . . 0.0 111.732 -178.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 74.6 8.08 80.54 Favored Glycine 0 CA--C 1.534 1.27 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -168.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -83.94 19.38 1.76 Allowed 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 119.84 1.82 . . . . 0.0 111.049 174.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -59.98 135.81 90.45 Favored Pre-proline 0 CA--C 1.547 0.833 0 C-N-CA 124.591 1.156 . . . . 0.0 109.33 169.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_exo -59.96 163.8 13.27 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 123.553 2.835 . . . . 0.0 115.713 -177.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 36.3 mmtt -64.85 -41.91 95.31 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 113.156 0.798 . . . . 0.0 113.156 172.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 24.1 ttpp -140.93 68.7 1.34 Allowed 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 -173.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.4 tt -68.6 136.84 53.65 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 174.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -131.79 134.49 45.88 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 177.518 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -123.23 117.47 25.38 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 120.469 1.486 . . . . 0.0 108.721 -179.064 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 18.9 t -92.55 91.84 3.55 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 N-CA-C 105.589 -2.004 . . . . 0.0 105.589 172.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -81.67 150.49 29.71 Favored Glycine 0 CA--C 1.522 0.522 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 178.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 40.4 t -129.04 130.56 68.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 178.378 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 47.6 mt -83.6 131.67 51.68 Favored Pre-proline 0 CA--C 1.534 0.355 0 N-CA-C 103.519 -2.771 . . . . 0.0 103.519 169.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -78.77 178.55 7.42 Favored 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 122.589 2.193 . . . . 0.0 111.164 -177.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -97.84 -56.47 2.49 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 124.001 0.92 . . . . 0.0 108.558 168.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 63.0 m -110.27 -59.31 1.96 Allowed 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 113.72 1.007 . . . . 0.0 113.72 -169.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.2 tp 53.81 33.11 16.25 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 127.37 2.268 . . . . 0.0 114.08 -173.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -82.33 161.32 60.06 Favored Pre-proline 0 CA--C 1.541 0.624 0 O-C-N 121.443 -0.786 . . . . 0.0 109.643 175.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -81.44 89.39 1.26 Allowed 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 122.142 1.895 . . . . 0.0 112.593 -169.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -174.82 179.55 1.63 Allowed 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 103.42 -2.807 . . . . 0.0 103.42 179.612 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -132.44 162.35 39.93 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 CA-C-N 120.558 1.526 . . . . 0.0 114.952 -176.383 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 110.72 143.5 9.59 Favored Glycine 0 CA--C 1.531 1.092 0 N-CA-C 104.73 -3.348 . . . . 0.0 104.73 -168.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 88.6 mt -76.02 156.48 33.97 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 119.308 1.554 . . . . 0.0 109.642 175.141 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 34.9 p -71.67 165.04 53.03 Favored Pre-proline 0 CA--C 1.539 0.526 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 169.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -57.76 -39.94 83.21 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 C-N-CA 121.821 1.681 . . . . 0.0 111.427 173.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . 0.446 HG22 ' HA3' ' A' ' 72' ' ' GLY . 4.1 m -64.61 -40.02 94.75 Favored 'General case' 0 N--CA 1.442 -0.866 0 C-N-CA 124.117 0.967 . . . . 0.0 110.79 -177.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 74.7 t -90.5 -30.99 5.0 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 O-C-N 121.585 -0.697 . . . . 0.0 110.597 -173.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -53.96 -46.46 71.62 Favored 'General case' 0 CA--C 1.533 0.302 0 O-C-N 121.182 -0.948 . . . . 0.0 109.341 169.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -68.05 -14.86 63.3 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 113.69 0.996 . . . . 0.0 113.69 -178.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 5.3 mmm -82.27 -12.41 58.05 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.776 1.63 . . . . 0.0 111.871 174.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 54.1 mt -54.56 -54.12 25.26 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.357 0 CA-C-N 120.576 1.535 . . . . 0.0 108.897 173.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -67.15 -47.75 50.27 Favored Pre-proline 0 CA--C 1.542 0.671 0 CA-C-O 117.556 -1.212 . . . . 0.0 110.827 -173.154 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 0.3 OUTLIER -43.3 -54.29 3.62 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 125.293 3.995 . . . . 0.0 112.819 168.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -67.97 -37.2 81.24 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.106 -0.952 . . . . 0.0 112.102 179.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 36.1 mt -61.27 -45.35 94.87 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 121.039 1.745 . . . . 0.0 109.108 175.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -58.69 -33.78 70.55 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 118.686 0.676 . . . . 0.0 110.206 177.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 68.0 tp60 -76.6 -36.69 57.35 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 121.392 -0.818 . . . . 0.0 111.914 178.216 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 46.9 t -60.86 -44.93 98.77 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 171.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 71.1 mt -61.59 -36.25 80.15 Favored 'General case' 0 C--O 1.226 -0.176 0 CA-C-O 118.9 -0.571 . . . . 0.0 110.132 176.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -67.21 -44.49 79.43 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 119.241 0.928 . . . . 0.0 111.025 176.009 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -66.77 -27.89 67.96 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 119.161 0.891 . . . . 0.0 111.708 178.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 33.2 mt -69.14 -49.89 52.83 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 170.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 16.8 mmm-85 -63.8 -21.86 66.63 Favored 'General case' 0 CA--C 1.522 -0.126 0 CA-C-O 118.058 -0.972 . . . . 0.0 112.396 -177.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -63.99 -34.29 77.65 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 119.973 1.261 . . . . 0.0 110.947 174.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 26.0 m -91.45 18.29 7.45 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 122.854 0.462 . . . . 0.0 111.573 170.109 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 70.98 16.87 75.07 Favored Glycine 0 C--N 1.337 0.623 0 CA-C-O 117.607 -1.663 . . . . 0.0 112.578 -178.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 39.0 t -90.76 118.75 36.64 Favored 'Isoleucine or valine' 0 C--N 1.347 0.459 0 CA-C-N 120.648 2.224 . . . . 0.0 106.627 -176.244 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -111.0 85.68 2.16 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 106.198 -1.779 . . . . 0.0 106.198 177.042 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -49.12 139.49 10.68 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 114.627 -1.169 . . . . 0.0 110.005 169.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 24.9 mt -91.05 125.71 57.76 Favored Pre-proline 0 CA--C 1.53 0.202 0 CA-C-O 117.331 -1.318 . . . . 0.0 108.296 -169.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -66.54 98.07 0.39 Allowed 'Trans proline' 0 CA--C 1.534 0.52 0 C-N-CA 122.673 2.249 . . . . 0.0 109.236 175.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 60.5 mtm180 49.9 14.88 0.14 Allowed 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 127.218 2.207 . . . . 0.0 115.519 -178.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 58.6 m . . . . . 0 CA--C 1.539 0.54 0 C-N-CA 123.843 0.857 . . . . 0.0 111.538 -169.252 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 7.9 ptp180 . . . . . 0 N--CA 1.48 1.066 0 CA-C-O 119.435 -0.317 . . . . 0.0 111.521 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 27.0 mt -136.41 135.22 49.52 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 C-N-CA 123.171 0.588 . . . . 0.0 110.732 -172.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 8.3 mt -112.28 138.58 48.79 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 105.711 -1.959 . . . . 0.0 105.711 167.313 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 49.1 t -116.21 104.38 16.59 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.644 0 N-CA-C 103.387 -2.819 . . . . 0.0 103.387 169.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 14.5 tp -101.73 111.28 23.47 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 -168.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -88.28 127.29 8.5 Favored Glycine 0 C--N 1.331 0.304 0 N-CA-C 107.706 -2.158 . . . . 0.0 107.706 176.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -141.14 165.6 19.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 117.434 0.617 . . . . 0.0 110.958 -170.488 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 119.25 174.54 15.82 Favored Glycine 0 CA--C 1.527 0.827 0 C-N-CA 125.986 1.755 . . . . 0.0 111.259 178.111 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.507 HD21 ' HB2' ' A' ' 12' ' ' LEU . 4.6 t30 -82.88 97.6 8.75 Favored 'General case' 0 C--O 1.235 0.338 0 O-C-N 121.409 -1.053 . . . . 0.0 110.41 -175.188 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.2 pt -62.64 35.67 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 N-CA-C 116.476 2.028 . . . . 0.0 116.476 172.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.507 ' HB2' HD21 ' A' ' 10' ' ' ASN . 33.8 mt -128.67 -7.16 5.11 Favored 'General case' 0 C--O 1.223 -0.304 0 CA-C-N 120.304 1.411 . . . . 0.0 108.749 169.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.474 ' HB2' HD22 ' A' ' 10' ' ' ASN . 3.6 mp -111.4 60.19 0.61 Allowed 'General case' 0 N--CA 1.442 -0.836 0 C-N-CA 124.174 0.989 . . . . 0.0 113.407 -168.106 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.436 ' HB ' ' H ' ' A' ' 15' ' ' ASP . 0.2 OUTLIER 52.72 -102.19 0.13 Allowed 'General case' 0 C--O 1.236 0.362 0 C-N-CA 124.168 0.987 . . . . 0.0 111.265 171.393 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.436 ' H ' ' HB ' ' A' ' 14' ' ' THR . 10.3 m-20 -78.81 -11.87 60.01 Favored 'General case' 0 N--CA 1.441 -0.881 0 C-N-CA 123.715 0.806 . . . . 0.0 111.018 -173.603 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -74.35 -8.82 57.57 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 120.444 1.474 . . . . 0.0 112.232 177.291 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -77.34 -10.49 59.47 Favored 'General case' 0 N--CA 1.432 -1.327 0 CA-C-O 116.0 -1.952 . . . . 0.0 108.878 170.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.8 tp -54.48 -37.92 39.68 Favored 'Isoleucine or valine' 0 C--N 1.345 0.385 0 CA-C-N 122.212 2.278 . . . . 0.0 112.25 -169.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -60.1 -45.0 96.76 Favored Glycine 0 CA--C 1.524 0.602 0 CA-C-N 119.55 1.068 . . . . 0.0 111.599 175.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 55.3 t -69.72 -44.41 79.28 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-O 118.528 -0.749 . . . . 0.0 109.911 175.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 23.1 mmm180 -61.47 -33.66 74.14 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 120.469 1.486 . . . . 0.0 111.778 179.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 30.3 mt -62.25 -46.4 96.52 Favored 'Isoleucine or valine' 0 C--N 1.342 0.256 0 CA-C-N 120.459 1.482 . . . . 0.0 109.464 176.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 30.2 m -73.73 -27.15 22.49 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 CA-C-N 119.748 1.158 . . . . 0.0 111.522 -175.186 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 64.1 mt-10 -72.91 -44.06 61.7 Favored 'General case' 0 CA--C 1.528 0.099 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 175.078 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.57 -42.39 96.56 Favored 'General case' 0 N--CA 1.452 -0.356 0 O-C-N 121.978 -0.451 . . . . 0.0 110.586 176.124 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 5.5 tp -65.85 -40.96 92.22 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-O 118.828 -0.606 . . . . 0.0 109.913 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -61.76 -40.34 94.79 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 118.413 0.551 . . . . 0.0 111.081 177.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -71.99 -34.71 69.13 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.633 0.773 . . . . 0.0 112.068 178.196 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 36.5 mtp180 -100.17 -34.06 10.19 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 117.204 -1.379 . . . . 0.0 114.054 -169.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -121.34 138.23 54.35 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 121.464 1.938 . . . . 0.0 113.153 -170.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 39.9 mm -99.87 141.16 17.49 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 105.542 -2.021 . . . . 0.0 105.542 169.019 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.8 mt -143.49 161.35 47.52 Favored Pre-proline 0 CA--C 1.539 0.549 0 C-N-CA 126.717 2.007 . . . . 0.0 107.407 -174.065 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -55.77 156.76 17.89 Favored 'Trans proline' 0 CA--C 1.536 0.605 0 C-N-CA 123.21 2.606 . . . . 0.0 112.661 177.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -62.46 -27.29 69.02 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 -170.069 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 10.9 p90 -76.36 -2.23 30.77 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 179.109 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 22.0 t -104.26 130.27 55.26 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 175.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -131.85 135.57 46.8 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 174.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.669 HD12 ' H ' ' A' ' 38' ' ' ILE . 0.1 OUTLIER -94.84 106.19 17.86 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 N-CA-C 105.744 -1.947 . . . . 0.0 105.744 171.089 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 53.2 tp -105.74 126.14 51.81 Favored 'General case' 0 C--N 1.343 0.307 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 -174.444 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -80.17 117.92 21.4 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 122.989 0.515 . . . . 0.0 109.754 171.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -77.86 -83.54 0.56 Allowed Glycine 0 CA--C 1.528 0.872 0 N-CA-C 107.408 -2.277 . . . . 0.0 107.408 169.249 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 79.84 110.96 0.26 Allowed Glycine 0 C--N 1.343 0.94 0 N-CA-C 111.05 -0.82 . . . . 0.0 111.05 178.329 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.3 p 52.59 61.05 3.39 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.839 1.256 . . . . 0.0 109.085 175.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -120.18 -84.78 0.66 Allowed 'General case' 0 C--N 1.344 0.344 0 CA-C-N 114.43 -1.259 . . . . 0.0 111.026 -169.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 71.09 -93.25 0.5 Allowed Glycine 0 C--N 1.338 0.668 0 N-CA-C 108.491 -1.843 . . . . 0.0 108.491 -170.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 27.7 tpp -78.61 -22.5 46.91 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 124.125 0.97 . . . . 0.0 112.322 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -63.02 -14.23 45.41 Favored 'General case' 0 CA--C 1.547 0.833 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 -169.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 28.8 mt -101.87 13.43 34.83 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.882 0.873 . . . . 0.0 112.843 -174.02 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.598 ' HA ' HG13 ' A' ' 100' ' ' VAL . 4.3 tt -41.6 -61.44 1.08 Allowed 'General case' 0 C--N 1.344 0.338 0 C-N-CA 124.177 0.991 . . . . 0.0 113.152 -175.513 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -75.82 -34.67 47.66 Favored Glycine 0 CA--C 1.524 0.608 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.15 -173.189 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -64.35 -34.08 77.33 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 117.549 0.675 . . . . 0.0 111.353 179.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.441 ' SD ' HG11 ' A' ' 100' ' ' VAL . 51.7 mtp -72.7 -13.3 61.31 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 111.911 0.337 . . . . 0.0 111.911 179.442 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -85.32 160.63 19.77 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 123.341 0.656 . . . . 0.0 110.414 -176.56 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 29.2 m120 59.26 19.44 7.56 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.642 1.577 . . . . 0.0 113.845 172.197 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 20.4 mmt180 -94.37 151.54 19.32 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 106.388 -1.708 . . . . 0.0 106.388 169.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -89.2 -35.83 15.99 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 -179.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 12.6 t-160 -142.14 128.78 20.34 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 105.849 -1.908 . . . . 0.0 105.849 179.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 6.5 tp -134.86 128.56 32.9 Favored 'General case' 0 CA--C 1.508 -0.669 0 N-CA-C 108.984 -0.746 . . . . 0.0 108.984 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 44.6 mt -106.98 108.98 26.51 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 N-CA-C 105.199 -2.148 . . . . 0.0 105.199 -179.212 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.6 mm -78.32 128.91 38.12 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 N-CA-C 105.25 -2.13 . . . . 0.0 105.25 175.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -112.33 116.66 30.72 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 104.703 -2.332 . . . . 0.0 104.703 169.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -155.35 169.6 23.83 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 118.174 0.443 . . . . 0.0 110.19 -177.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -88.31 156.99 18.88 Favored 'General case' 0 CA--C 1.534 0.351 0 O-C-N 121.921 -0.487 . . . . 0.0 109.858 169.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 87.6 mt -115.05 113.94 45.05 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.104 1 N-CA-C 99.939 -4.097 . . . . 0.0 99.939 168.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 67.1 t -65.36 -37.86 81.13 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 N-CA-C 113.442 0.904 . . . . 0.0 113.442 -168.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 15.2 m -151.43 152.42 33.02 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 119.238 0.926 . . . . 0.0 111.483 173.236 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 26.7 tptt -158.68 -177.44 6.53 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.593 1.957 . . . . 0.0 106.512 169.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.2 42.13 0.97 Allowed 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.742 0.817 . . . . 0.0 110.472 -178.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 33.6 t-20 -143.83 160.88 39.98 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.826 1.25 . . . . 0.0 109.215 -170.098 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.6 m -64.59 146.66 98.18 Favored Pre-proline 0 CA--C 1.548 0.871 0 C-N-CA 124.344 1.058 . . . . 0.0 111.847 -169.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -58.6 153.54 48.23 Favored 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 122.713 2.275 . . . . 0.0 111.426 169.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 68.33 16.0 68.66 Favored Glycine 0 CA--C 1.532 1.114 0 CA-C-O 118.711 -1.049 . . . . 0.0 114.345 177.166 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 25.9 m -96.36 152.34 18.68 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 119.0 1.4 . . . . 0.0 109.627 179.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 18.8 ttp -95.78 145.07 25.62 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 123.614 0.766 . . . . 0.0 110.372 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 10.3 ttm -136.51 121.95 19.45 Favored 'General case' 0 CA--C 1.528 0.127 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 44.6 mm -109.15 122.47 63.86 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 -177.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -121.1 131.66 54.4 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 -171.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 74.5 mtm180 -100.78 176.14 5.4 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.496 0.718 . . . . 0.0 110.551 -176.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -46.74 -47.19 20.68 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 115.99 1.848 . . . . 0.0 115.99 -169.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -78.91 -18.23 54.21 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 119.242 0.928 . . . . 0.0 112.248 -178.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -90.59 -33.12 16.0 Favored 'General case' 0 N--CA 1.457 -0.119 0 C-N-CA 123.606 0.762 . . . . 0.0 110.754 -169.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -70.36 -37.6 7.27 Favored Pre-proline 0 CA--C 1.539 0.525 0 CA-C-O 117.233 -1.365 . . . . 0.0 113.242 -177.036 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_exo -56.26 -25.93 58.75 Favored 'Trans proline' 0 CA--C 1.54 0.781 0 CA-C-N 121.768 1.667 . . . . 0.0 112.21 169.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -92.4 7.62 42.13 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 124.492 1.117 . . . . 0.0 112.68 177.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -126.53 -42.39 1.81 Allowed 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.512 0.725 . . . . 0.0 112.509 -172.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.461 ' HB3' ' HB2' ' A' ' 98' ' ' ALA . 74.0 m-85 -61.85 -11.1 11.09 Favored 'General case' 0 CA--C 1.551 1.017 0 CA-C-N 119.47 1.032 . . . . 0.0 111.39 175.447 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 64.3 p -59.54 -27.55 66.3 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.946 1.698 . . . . 0.0 113.857 -177.021 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -63.75 139.83 58.81 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 121.347 0.594 . . . . 0.0 110.78 -170.272 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -76.13 -21.66 56.35 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 122.658 0.383 . . . . 0.0 111.861 -176.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 97.3 mt -72.42 -26.72 24.76 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 C-N-CA 124.28 1.032 . . . . 0.0 110.318 -170.174 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 9.9 m -102.85 84.47 0.66 Allowed Pre-proline 0 CA--C 1.55 0.962 0 C-N-CA 126.084 1.753 . . . . 0.0 108.63 174.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -70.61 -38.27 6.15 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 123.003 2.469 . . . . 0.0 114.364 -169.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 11.1 m80 -68.71 -39.75 80.32 Favored 'General case' 0 N--CA 1.468 0.441 0 O-C-N 121.055 -1.028 . . . . 0.0 108.81 179.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 16.9 mp0 -66.09 -36.55 83.48 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 125.169 1.388 . . . . 0.0 109.253 177.229 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 59.0 tp -62.01 -35.27 78.04 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 119.431 1.014 . . . . 0.0 110.969 171.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -60.51 -39.27 96.15 Favored Glycine 0 CA--C 1.532 1.116 0 O-C-N 121.392 -0.817 . . . . 0.0 111.069 171.087 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 8.8 tt -75.21 -23.97 57.68 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 117.549 0.675 . . . . 0.0 110.704 175.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.461 ' HB2' ' HB3' ' A' ' 86' ' ' PHE . . . -61.02 -43.72 98.47 Favored 'General case' 0 C--O 1.226 -0.17 0 CA-C-N 119.443 1.02 . . . . 0.0 108.666 169.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -69.77 -21.32 63.44 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 119.03 -0.509 . . . . 0.0 110.747 176.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.598 HG13 ' HA ' ' A' ' 49' ' ' LEU . 73.1 t -69.77 -40.89 79.65 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 168.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 5.3 mp -60.98 -36.64 79.97 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 120.973 1.715 . . . . 0.0 110.492 175.021 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 17.0 m -63.46 -45.26 91.64 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 118.286 0.494 . . . . 0.0 109.873 172.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -65.39 -38.77 90.99 Favored 'General case' 0 N--CA 1.452 -0.366 0 O-C-N 121.563 -0.711 . . . . 0.0 111.505 -179.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 21.7 mt -59.97 -39.59 86.17 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 125.143 1.377 . . . . 0.0 109.832 173.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 52.6 tpt85 -70.64 -33.35 70.89 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 118.037 -0.982 . . . . 0.0 110.484 175.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 15.5 m-30 -68.38 -42.11 79.57 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 119.646 1.112 . . . . 0.0 110.402 178.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 63.9 p -73.25 -26.78 61.25 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 118.561 0.619 . . . . 0.0 110.515 177.247 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 76.91 6.55 85.76 Favored Glycine 0 CA--C 1.532 1.138 0 CA-C-O 119.182 -0.788 . . . . 0.0 111.599 -169.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -96.06 19.73 11.22 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 118.603 1.202 . . . . 0.0 110.809 -175.133 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -55.82 135.37 72.62 Favored Pre-proline 0 CA--C 1.543 0.694 0 C-N-CA 126.624 1.969 . . . . 0.0 109.752 174.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_exo -56.04 152.74 35.57 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 123.259 2.639 . . . . 0.0 114.796 179.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 8.7 tttt -64.36 -33.27 75.45 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 119.001 -0.523 . . . . 0.0 110.302 177.033 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 63.1 tttm -139.82 97.46 3.26 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 -178.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -83.62 132.58 34.89 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 106.495 -1.669 . . . . 0.0 106.495 169.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -134.22 148.78 50.92 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 176.779 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.8 tt -135.05 133.87 39.8 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 120.177 1.353 . . . . 0.0 110.504 174.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 60.8 t -103.01 103.43 15.08 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 N-CA-C 103.665 -2.717 . . . . 0.0 103.665 169.095 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -92.85 151.91 20.74 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 111.121 -0.792 . . . . 0.0 111.121 177.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 47.1 t -138.95 136.35 42.73 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 N-CA-C 107.705 -1.221 . . . . 0.0 107.705 178.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 32.1 mt -88.73 131.64 41.01 Favored Pre-proline 0 CA--C 1.546 0.802 0 CA-C-N 119.812 1.187 . . . . 0.0 108.961 177.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -75.16 173.55 14.32 Favored 'Trans proline' 0 CA--C 1.543 0.932 0 C-N-CA 124.978 3.785 . . . . 0.0 113.228 -177.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -116.15 -57.35 2.22 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.836 0.855 . . . . 0.0 110.718 179.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 63.4 m -107.07 -51.89 2.85 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 118.54 0.609 . . . . 0.0 112.609 -172.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 57.25 46.71 18.18 Favored 'General case' 0 CA--C 1.552 1.044 0 N-CA-C 114.776 1.399 . . . . 0.0 114.776 172.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -116.38 165.22 15.53 Favored Pre-proline 0 N--CA 1.478 0.962 0 O-C-N 121.155 -0.966 . . . . 0.0 109.618 177.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -66.09 90.89 0.26 Allowed 'Trans proline' 0 CA--C 1.547 1.125 0 C-N-CA 122.868 2.378 . . . . 0.0 112.931 -179.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -176.98 145.24 0.47 Allowed 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 103.91 -2.626 . . . . 0.0 103.91 173.491 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -107.42 165.79 4.3 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 CA-C-N 119.376 0.989 . . . . 0.0 113.319 -169.539 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 85.3 153.81 21.29 Favored Glycine 0 C--N 1.341 0.845 0 N-CA-C 108.11 -1.996 . . . . 0.0 108.11 -169.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.418 HD22 ' H ' ' A' ' 130' ' ' LEU . 0.7 OUTLIER -81.74 163.32 22.51 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-O 121.585 0.707 . . . . 0.0 109.108 -172.529 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 39.5 p -69.19 169.32 12.06 Favored Pre-proline 0 C--O 1.238 0.467 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 168.104 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_exo -55.1 -32.2 78.63 Favored 'Trans proline' 0 CA--C 1.541 0.84 0 C-N-CA 121.469 1.446 . . . . 0.0 110.693 169.196 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 26.5 m -67.09 -44.73 79.26 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 118.992 -0.528 . . . . 0.0 111.419 179.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 4.6 t -101.06 -11.41 8.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 CA-C-N 119.645 1.111 . . . . 0.0 111.624 -169.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -59.04 -45.69 90.12 Favored 'General case' 0 CA--C 1.518 -0.27 0 O-C-N 119.938 -1.726 . . . . 0.0 107.322 169.016 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -71.24 4.63 2.69 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-O 118.482 -0.771 . . . . 0.0 112.406 178.104 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 26.2 mmm -95.57 -10.54 29.3 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 118.127 -0.94 . . . . 0.0 111.282 170.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 57.0 mt -59.9 -46.99 93.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-N 119.31 0.959 . . . . 0.0 108.554 178.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -72.15 -53.05 6.81 Favored Pre-proline 0 CA--C 1.536 0.422 0 CA-C-O 117.286 -1.34 . . . . 0.0 113.05 -171.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -60.02 -35.26 93.62 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 CA-C-N 122.244 1.837 . . . . 0.0 111.256 176.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.28 -43.01 71.31 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 118.84 0.745 . . . . 0.0 110.538 -179.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.05 -37.21 86.6 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 119.695 1.134 . . . . 0.0 109.782 176.34 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -62.36 -35.94 80.69 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 119.05 -0.5 . . . . 0.0 110.783 175.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 35.1 mm-40 -76.31 -29.5 57.34 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 119.152 0.887 . . . . 0.0 111.627 175.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 38.2 t -61.55 -45.42 98.68 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 CA-C-N 120.065 1.302 . . . . 0.0 108.478 169.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 72.8 mt -63.75 -39.03 93.28 Favored 'General case' 0 C--N 1.341 0.206 0 CA-C-N 118.05 0.386 . . . . 0.0 110.207 176.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -60.4 -41.28 93.53 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 118.906 0.776 . . . . 0.0 111.39 177.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -62.35 -47.38 84.46 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 119.233 0.924 . . . . 0.0 111.038 178.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . 0.297 4.2 pp -67.78 -22.23 65.21 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 118.576 0.626 . . . . 0.0 112.48 177.426 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 61.8 mtt180 -71.22 -26.31 62.87 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 117.822 -1.085 . . . . 0.0 111.821 169.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -59.85 -38.0 80.84 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 120.625 1.557 . . . . 0.0 109.42 174.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 11.3 p -87.39 14.81 7.36 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.549 1.14 . . . . 0.0 112.946 178.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 75.52 19.76 79.05 Favored Glycine 0 CA--C 1.534 1.268 0 CA-C-O 118.704 -1.054 . . . . 0.0 114.597 175.296 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 15.1 t -102.47 146.32 10.67 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 CA-C-N 118.97 1.385 . . . . 0.0 107.805 178.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -134.54 143.78 47.61 Favored 'General case' 0 C--O 1.236 0.392 0 O-C-N 121.096 -1.002 . . . . 0.0 108.929 176.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -94.74 160.52 14.57 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 124.991 1.316 . . . . 0.0 111.518 178.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . 0.407 ' CG2' ' HA ' ' A' ' 160' ' ' SER . 46.1 mt -124.07 130.76 24.27 Favored Pre-proline 0 CA--C 1.533 0.307 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 171.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -57.48 110.2 0.58 Allowed 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.561 2.174 . . . . 0.0 109.03 170.053 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 50.05 21.6 0.77 Allowed 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.628 1.571 . . . . 0.0 114.447 177.188 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . 0.407 ' HA ' ' CG2' ' A' ' 157' ' ' ILE . 1.1 m . . . . . 0 CA--C 1.544 0.718 0 C-N-CA 124.424 1.09 . . . . 0.0 112.575 -169.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 8.3 ptp180 . . . . . 0 N--CA 1.483 1.187 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 72.7 mt -138.9 133.21 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 CA-C-N 119.332 0.969 . . . . 0.0 111.169 -169.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -115.2 129.74 56.73 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 105.951 -1.87 . . . . 0.0 105.951 168.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.424 HG12 HG12 ' A' ' 23' ' ' VAL . 21.8 t -104.43 105.49 18.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 101.905 -3.369 . . . . 0.0 101.905 169.351 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 13.0 tp -109.45 104.26 13.31 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 124.533 1.133 . . . . 0.0 110.033 -167.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -91.26 129.85 10.0 Favored Glycine 0 N--CA 1.452 -0.297 0 N-CA-C 106.603 -2.599 . . . . 0.0 106.603 175.083 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 1.4 m -135.32 -28.34 0.48 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.208 0 N-CA-C 117.819 2.525 . . . . 0.0 117.819 -168.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -52.25 151.41 7.65 Favored Glycine 0 CA--C 1.527 0.783 0 CA-C-O 122.22 0.9 . . . . 0.0 114.715 -169.304 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.411 HD21 ' HB2' ' A' ' 12' ' ' LEU . 5.1 t30 -61.76 102.39 0.26 Allowed 'General case' 0 N--CA 1.455 -0.225 0 C-N-CA 125.334 1.453 . . . . 0.0 112.372 -169.234 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.2 pt -76.76 40.97 0.02 OUTLIER 'Isoleucine or valine' 0 C--O 1.222 -0.38 0 C-N-CA 123.93 0.892 . . . . 0.0 113.311 -177.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.411 ' HB2' HD21 ' A' ' 10' ' ' ASN . 19.9 mt -128.11 -7.83 5.4 Favored 'General case' 0 CA--C 1.536 0.429 0 O-C-N 121.177 -0.952 . . . . 0.0 109.018 170.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.3 mp -124.51 67.24 1.08 Allowed 'General case' 0 C--N 1.346 0.417 0 C-N-CA 124.167 0.987 . . . . 0.0 109.235 -168.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.468 ' HB ' ' H ' ' A' ' 15' ' ' ASP . 1.4 m 46.91 -103.16 0.08 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 114.378 -1.283 . . . . 0.0 112.891 171.305 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.468 ' H ' ' HB ' ' A' ' 14' ' ' THR . 4.1 m-20 -62.95 -26.33 68.77 Favored 'General case' 0 N--CA 1.438 -1.056 0 C-N-CA 125.998 1.719 . . . . 0.0 111.598 -171.589 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -72.0 -18.79 61.95 Favored 'General case' 0 C--O 1.231 0.101 0 CA-C-N 120.019 1.281 . . . . 0.0 112.003 -174.022 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.86 -15.49 42.73 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-O 117.022 -1.466 . . . . 0.0 111.152 170.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.7 tp -54.2 -37.98 37.61 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 CA-C-N 120.831 1.65 . . . . 0.0 111.136 -174.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -59.54 -43.99 97.14 Favored Glycine 0 CA--C 1.527 0.834 0 N-CA-C 111.244 -0.743 . . . . 0.0 111.244 178.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 74.0 t -70.82 -45.78 71.81 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 176.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 20.0 mmt180 -61.43 -31.71 71.66 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 117.093 -1.432 . . . . 0.0 112.21 -178.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 19.9 mt -58.89 -49.49 82.87 Favored 'Isoleucine or valine' 0 C--N 1.34 0.157 0 CA-C-N 121.286 1.857 . . . . 0.0 109.299 174.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.424 HG12 HG12 ' A' ' 5' ' ' VAL . 30.4 m -73.32 -34.13 42.83 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 CA-C-N 119.762 1.164 . . . . 0.0 111.111 -173.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 59.4 mt-10 -64.88 -42.15 95.05 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 118.403 0.547 . . . . 0.0 110.322 173.041 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -68.24 -36.53 79.61 Favored 'General case' 0 C--N 1.34 0.184 0 CA-C-N 118.981 0.809 . . . . 0.0 110.014 179.363 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.3 tp -65.46 -36.16 83.07 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 118.64 0.654 . . . . 0.0 109.887 -177.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -61.57 -24.16 66.47 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.353 0.661 . . . . 0.0 112.72 179.18 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 -98.85 -39.77 8.43 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 126.45 1.9 . . . . 0.0 110.771 -176.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 21.8 mmt85 -85.02 -32.18 23.06 Favored 'General case' 0 C--N 1.338 0.085 0 CA-C-O 119.449 -0.31 . . . . 0.0 110.242 -173.328 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 71.5 m-85 -122.02 151.01 41.29 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-O 122.33 1.062 . . . . 0.0 111.826 -176.066 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 37.0 mt -107.06 134.45 48.7 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 N-CA-C 104.223 -2.51 . . . . 0.0 104.223 169.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -120.13 150.03 50.45 Favored Pre-proline 0 C--O 1.236 0.357 0 C-N-CA 124.005 0.922 . . . . 0.0 110.366 -169.114 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_endo -67.52 156.77 64.73 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 121.977 1.785 . . . . 0.0 108.726 168.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -55.75 -33.25 64.12 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 114.491 1.293 . . . . 0.0 114.491 -169.386 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 17.0 p90 -78.75 -13.2 59.94 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 118.474 -0.774 . . . . 0.0 112.743 -175.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 95.5 t -89.82 121.71 40.34 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 169.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -122.62 125.22 45.2 Favored 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 173.233 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -81.33 126.63 39.85 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 N-CA-C 106.067 -1.827 . . . . 0.0 106.067 167.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 64.4 tp -125.53 132.94 52.51 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 171.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -88.85 116.92 27.48 Favored 'General case' 0 C--O 1.236 0.395 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 169.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -76.17 -74.37 0.94 Allowed Glycine 0 CA--C 1.529 0.916 0 N-CA-C 108.335 -1.906 . . . . 0.0 108.335 169.241 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 85.76 98.0 0.75 Allowed Glycine 0 C--N 1.343 0.925 0 N-CA-C 109.729 -1.348 . . . . 0.0 109.729 176.048 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 16.8 p 62.97 16.65 9.42 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.24 1.416 . . . . 0.0 113.378 179.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -70.18 -59.96 2.57 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 114.298 1.222 . . . . 0.0 114.298 -168.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.4 ' H ' ' HE2' ' A' ' 93' ' ' HIS . . . 60.07 -117.09 10.2 Favored Glycine 0 CA--C 1.529 0.91 0 N-CA-C 108.691 -1.764 . . . . 0.0 108.691 -170.321 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 9.4 tpt -62.22 -21.86 65.48 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.512 1.125 . . . . 0.0 113.68 -173.273 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -60.19 -19.28 53.39 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 -171.087 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 10.0 mt -98.18 20.67 12.03 Favored 'General case' 0 C--N 1.345 0.392 0 CA-C-N 119.522 1.055 . . . . 0.0 113.663 -169.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.586 ' HA ' HG13 ' A' ' 100' ' ' VAL . 6.4 tt -50.5 -57.71 7.45 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 118.988 0.813 . . . . 0.0 110.988 -178.359 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -64.98 -30.08 77.08 Favored Glycine 0 CA--C 1.53 0.975 0 CA-C-O 119.296 -0.725 . . . . 0.0 112.584 -177.094 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -79.72 -36.38 37.5 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 118.413 1.107 . . . . 0.0 112.33 -178.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.53 ' SD ' HG11 ' A' ' 100' ' ' VAL . 55.4 mtp -76.25 -28.79 57.26 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 179.219 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.46 157.55 31.76 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 121.96 0.886 . . . . 0.0 110.803 175.079 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 62.14 16.49 8.35 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.377 1.471 . . . . 0.0 114.307 169.6 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 24.6 mmt180 -93.89 154.73 17.55 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 172.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -83.95 -34.91 24.33 Favored 'General case' 0 C--O 1.217 -0.642 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 169.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 4.5 t-160 -144.41 129.06 18.17 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 105.512 -2.033 . . . . 0.0 105.512 -169.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 22.8 tp -134.13 117.87 17.04 Favored 'General case' 0 CA--C 1.499 -1.003 0 N-CA-C 103.434 -2.802 . . . . 0.0 103.434 -173.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 65.7 mt -100.58 107.86 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 N-CA-C 103.907 -2.627 . . . . 0.0 103.907 171.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.571 HG22 HD23 ' A' ' 116' ' ' LEU . 63.8 mt -81.2 140.6 16.35 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 N-CA-C 105.885 -1.894 . . . . 0.0 105.885 172.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -120.72 113.18 19.83 Favored 'General case' 0 N--CA 1.446 -0.625 0 N-CA-C 103.635 -2.728 . . . . 0.0 103.635 168.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.407 ' CG ' HE21 ' A' ' 94' ' ' GLN . 38.6 t0 -155.93 157.64 36.62 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 123.574 0.75 . . . . 0.0 109.587 -176.22 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -83.68 149.92 26.19 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 174.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 8.1 mt -76.67 -32.59 20.95 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 C-N-CA 123.731 0.812 . . . . 0.0 110.109 174.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . 0.354 3.3 t 58.49 46.92 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.943 0 C-N-CA 126.148 1.779 . . . . 0.0 112.188 -173.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 8.1 m 63.46 145.28 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 128.327 2.651 . . . . 0.0 118.124 168.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -139.35 -88.34 0.21 Allowed 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 169.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -140.05 31.08 1.99 Allowed 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.56 1.144 . . . . 0.0 111.02 -176.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -134.31 165.22 25.64 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.095 0.958 . . . . 0.0 110.69 -174.289 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 2.8 m -64.87 148.5 97.4 Favored Pre-proline 0 CA--C 1.548 0.867 0 C-N-CA 124.439 1.096 . . . . 0.0 113.071 -169.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_exo -57.05 154.74 31.75 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 124.607 3.538 . . . . 0.0 112.425 169.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 67.04 11.46 58.58 Favored Glycine 0 CA--C 1.532 1.124 0 CA-C-O 119.065 -0.853 . . . . 0.0 113.943 173.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 10.6 m -90.22 140.68 29.45 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 119.146 1.473 . . . . 0.0 109.476 -175.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 28.8 ttp -86.07 142.95 28.35 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 169.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 7.0 ttm -131.53 134.23 45.89 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 169.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 4.9 mm -95.75 121.91 46.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 105.573 -2.01 . . . . 0.0 105.573 176.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.7 mp -116.37 128.86 55.89 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 173.385 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 22.2 mtp85 -88.53 177.72 6.72 Favored 'General case' 0 CA--C 1.528 0.103 0 O-C-N 123.824 0.703 . . . . 0.0 110.602 178.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -42.24 -50.97 4.88 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 115.336 1.606 . . . . 0.0 115.336 -169.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -86.27 -14.76 42.78 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -175.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -82.18 -36.64 27.13 Favored 'General case' 0 CA--C 1.523 -0.078 0 O-C-N 121.597 -0.69 . . . . 0.0 110.424 -169.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.476 HG12 ' CZ ' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -65.09 -47.86 71.77 Favored Pre-proline 0 CA--C 1.539 0.534 0 CA-C-O 117.397 -1.287 . . . . 0.0 113.454 -175.27 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -53.35 -44.36 49.65 Favored 'Trans proline' 0 C--N 1.352 0.739 0 C-N-CA 121.935 1.757 . . . . 0.0 110.697 174.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -70.22 -13.23 62.09 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 114.142 1.164 . . . . 0.0 114.142 178.385 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -95.27 -42.64 8.44 Favored 'General case' 0 C--N 1.343 0.323 0 CA-C-N 120.181 1.355 . . . . 0.0 110.558 -177.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.501 ' CB ' ' HB2' ' A' ' 98' ' ' ALA . 26.5 m-85 -69.01 0.98 3.84 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 -172.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 61.6 p -58.65 -27.85 65.15 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.137 0.975 . . . . 0.0 110.346 169.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 56.8 t-20 -51.52 117.19 2.48 Favored 'General case' 0 C--N 1.345 0.406 0 C-N-CA 124.137 0.975 . . . . 0.0 111.311 -179.329 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -77.22 -17.0 58.81 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 118.717 -0.659 . . . . 0.0 112.439 -174.289 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 40.2 mt -61.66 -41.13 89.19 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 178.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.5 m -83.18 105.11 4.6 Favored Pre-proline 0 CA--C 1.545 0.777 0 C-N-CA 126.683 1.993 . . . . 0.0 110.523 -169.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -71.95 -61.72 0.05 OUTLIER 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 122.186 1.924 . . . . 0.0 113.181 -169.118 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . 0.4 ' HE2' ' H ' ' A' ' 45' ' ' GLY . 10.4 t-80 -56.73 -41.66 77.88 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 121.75 0.786 . . . . 0.0 110.46 178.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.407 HE21 ' CG ' ' A' ' 62' ' ' ASP . 20.8 mp0 -61.36 -33.13 73.13 Favored 'General case' 0 N--CA 1.433 -1.287 0 CA-C-N 115.08 -0.964 . . . . 0.0 108.939 -175.074 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.426 ' O ' ' HB3' ' A' ' 98' ' ' ALA . 1.5 tt -63.13 -46.3 87.94 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 119.457 1.026 . . . . 0.0 108.804 177.594 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -61.69 -37.32 94.05 Favored Glycine 0 CA--C 1.532 1.14 0 O-C-N 121.089 -1.007 . . . . 0.0 111.014 175.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 54.6 tp -67.96 -30.92 70.33 Favored 'General case' 0 CA--C 1.535 0.382 0 O-C-N 121.755 -0.85 . . . . 0.0 110.353 175.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.501 ' HB2' ' CB ' ' A' ' 86' ' ' PHE . . . -60.26 -45.64 92.59 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 172.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 34.0 t0 -63.59 -28.97 70.29 Favored 'General case' 0 C--O 1.238 0.497 0 O-C-N 123.633 0.583 . . . . 0.0 110.592 -178.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.586 HG13 ' HA ' ' A' ' 49' ' ' LEU . 41.8 t -65.49 -50.2 73.69 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 CA-C-N 118.866 0.757 . . . . 0.0 110.126 169.71 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 33.6 mt -67.26 -31.52 71.92 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 119.202 0.91 . . . . 0.0 110.844 -174.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 48.8 m -64.52 -44.34 91.17 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 119.391 0.996 . . . . 0.0 109.838 169.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.448 ' HA ' ' CD2' ' A' ' 106' ' ' PHE . . . -62.54 -39.51 93.84 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 119.723 1.147 . . . . 0.0 111.276 177.095 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -63.23 -35.25 79.72 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 123.325 0.65 . . . . 0.0 109.819 175.476 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 73.6 ttt-85 -71.66 -31.42 66.79 Favored 'General case' 0 CA--C 1.535 0.39 0 O-C-N 121.554 -0.716 . . . . 0.0 109.937 176.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.448 ' CD2' ' HA ' ' A' ' 103' ' ' ALA . 12.3 m-30 -69.99 -46.47 65.08 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 119.143 0.883 . . . . 0.0 110.702 176.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 35.6 p -74.04 -27.19 60.81 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 122.993 0.517 . . . . 0.0 111.874 -176.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 75.11 7.37 81.81 Favored Glycine 0 CA--C 1.533 1.211 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 -168.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -84.57 16.27 3.29 Favored 'General case' 0 C--N 1.349 0.557 0 CA-C-N 119.734 1.767 . . . . 0.0 111.302 174.129 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -56.18 137.9 73.94 Favored Pre-proline 0 CA--C 1.542 0.668 0 C-N-CA 125.676 1.59 . . . . 0.0 109.895 170.108 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -62.72 160.24 33.64 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 122.475 2.117 . . . . 0.0 115.695 -176.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 23.7 mmtm -61.01 -40.99 95.67 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 169.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 23.6 ttpp -142.46 73.18 1.4 Allowed 'General case' 0 C--O 1.236 0.356 0 C-N-CA 123.825 0.85 . . . . 0.0 108.972 -172.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 15.2 tp -68.25 137.53 54.82 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 169.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.11 142.75 47.62 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 106.098 -1.815 . . . . 0.0 106.098 174.209 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.571 HD23 HG22 ' A' ' 60' ' ' ILE . 0.5 OUTLIER -130.08 121.62 26.75 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 120.503 1.502 . . . . 0.0 109.055 176.03 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.428 ' N ' HD22 ' A' ' 116' ' ' LEU . 13.1 t -85.97 87.86 2.63 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 N-CA-C 106.401 -1.703 . . . . 0.0 106.401 173.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -80.96 143.86 24.52 Favored Glycine 0 C--N 1.336 0.56 0 N-CA-C 110.005 -1.238 . . . . 0.0 110.005 -176.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 22.0 t -130.91 134.94 61.04 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.15 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 177.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 36.7 mt -93.63 133.22 28.41 Favored Pre-proline 0 CA--C 1.539 0.552 0 CA-C-N 119.595 1.089 . . . . 0.0 108.106 178.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -78.39 166.54 24.1 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 122.779 2.32 . . . . 0.0 112.372 -174.388 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -99.77 -50.42 4.04 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.93 0.892 . . . . 0.0 109.644 169.056 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 72.2 m -114.58 -55.16 2.52 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 113.82 1.044 . . . . 0.0 113.82 -169.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER 52.96 42.41 32.18 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 126.564 1.946 . . . . 0.0 112.93 -175.584 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -105.03 165.71 12.74 Favored Pre-proline 0 CA--C 1.542 0.653 0 C-N-CA 123.615 0.766 . . . . 0.0 109.917 178.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -80.94 85.72 1.76 Allowed 'Trans proline' 0 CA--C 1.538 0.722 0 C-N-CA 121.948 1.765 . . . . 0.0 112.977 -169.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -176.05 148.88 0.85 Allowed 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 103.609 -2.738 . . . . 0.0 103.609 178.466 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -110.84 168.63 4.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 CA-C-N 119.718 1.145 . . . . 0.0 113.973 -169.003 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 95.4 145.85 19.68 Favored Glycine 0 C--N 1.34 0.78 0 N-CA-C 106.022 -2.831 . . . . 0.0 106.022 -168.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.534 HD22 ' H ' ' A' ' 130' ' ' LEU . 1.4 mm? -73.66 163.54 27.86 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 119.339 1.569 . . . . 0.0 110.379 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 43.0 p -73.06 168.39 25.23 Favored Pre-proline 0 CA--C 1.539 0.54 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 168.391 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -57.13 -35.65 98.96 Favored 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 121.532 1.488 . . . . 0.0 111.185 172.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 99.0 m -66.93 -33.27 75.22 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 124.401 1.081 . . . . 0.0 111.293 -178.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 84.4 t -103.82 -27.55 3.17 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 CA-C-N 118.329 0.513 . . . . 0.0 111.608 -172.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -52.78 -49.28 65.87 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 119.346 0.975 . . . . 0.0 109.27 169.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -62.02 -19.59 63.02 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 4.0 mmm -80.63 -7.4 59.27 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-O 118.436 -0.792 . . . . 0.0 112.4 -179.121 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 71.4 mt -55.69 -51.99 52.97 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.235 0 CA-C-N 119.147 0.885 . . . . 0.0 109.072 172.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -71.36 -43.63 12.57 Favored Pre-proline 0 CA--C 1.535 0.38 0 CA-C-O 116.794 -1.574 . . . . 0.0 113.531 -169.052 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -55.95 -42.82 62.92 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 CA-C-N 121.994 1.748 . . . . 0.0 111.199 169.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.07 -40.09 94.18 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-O 119.004 -0.522 . . . . 0.0 111.959 178.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 74.1 mt -60.32 -45.91 91.74 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 119.589 1.086 . . . . 0.0 108.82 174.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -57.73 -35.28 70.48 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 118.74 0.7 . . . . 0.0 110.687 175.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.62 -44.42 93.98 Favored 'General case' 0 N--CA 1.446 -0.635 0 O-C-N 121.589 -0.695 . . . . 0.0 111.522 173.529 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 63.8 t -57.87 -46.04 87.41 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 N-CA-C 108.245 -1.021 . . . . 0.0 108.245 175.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 13.9 mt -57.9 -42.63 85.12 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 119.439 1.018 . . . . 0.0 110.072 178.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -68.72 -44.44 73.88 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 118.481 -0.771 . . . . 0.0 111.216 -178.014 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -64.62 -32.5 74.19 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 119.702 1.137 . . . . 0.0 110.811 178.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 80.2 mt -64.11 -47.94 78.04 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 170.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 70.9 mtp85 -62.92 -20.91 65.64 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 117.943 -1.027 . . . . 0.0 112.598 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 91.5 mt-10 -63.07 -36.39 83.41 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 120.475 1.489 . . . . 0.0 110.423 173.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 46.4 m -88.87 13.68 12.12 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.511 0.724 . . . . 0.0 111.668 170.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 70.4 21.82 77.53 Favored Glycine 0 CA--C 1.524 0.629 0 CA-C-O 117.877 -1.513 . . . . 0.0 112.434 -177.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 61.4 t -97.05 123.0 49.16 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 CA-C-N 120.089 1.944 . . . . 0.0 105.957 -175.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -105.18 97.15 7.04 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 177.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -58.95 137.12 58.02 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 168.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . 0.448 HG21 ' HA ' ' A' ' 160' ' ' SER . 35.4 mm -98.67 122.72 52.31 Favored Pre-proline 0 N--CA 1.461 0.095 0 CA-C-O 117.641 -1.171 . . . . 0.0 108.874 -170.515 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -63.27 105.99 0.53 Allowed 'Trans proline' 0 CA--C 1.534 0.484 0 C-N-CA 122.018 1.812 . . . . 0.0 109.024 171.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 55.8 mtm180 38.94 50.02 1.66 Allowed 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 126.452 1.901 . . . . 0.0 113.509 178.158 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . 0.448 ' HA ' HG21 ' A' ' 157' ' ' ILE . 35.1 p . . . . . 0 CA--C 1.546 0.793 0 C-N-CA 127.068 2.147 . . . . 0.0 115.633 -179.054 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 29.4 ptt-85 . . . . . 0 N--CA 1.477 0.89 0 CA-C-O 119.186 -0.435 . . . . 0.0 109.96 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 3.6 mt -130.86 139.24 51.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 C-N-CA 123.412 0.685 . . . . 0.0 110.068 -169.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.7 mt -112.44 143.18 44.0 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 104.805 -2.294 . . . . 0.0 104.805 167.064 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 67.1 t -123.45 97.89 5.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 102.276 -3.231 . . . . 0.0 102.276 171.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.3 tt -106.53 109.7 21.7 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 -167.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -91.86 138.59 14.32 Favored Glycine 0 N--CA 1.443 -0.865 0 N-CA-C 108.206 -1.958 . . . . 0.0 108.206 176.234 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -148.05 167.26 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.612 0 C-N-CA 123.16 0.584 . . . . 0.0 109.429 -179.548 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 130.95 156.51 8.57 Favored Glycine 0 C--N 1.335 0.496 0 N-CA-C 108.723 -1.751 . . . . 0.0 108.723 170.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.545 ' HA ' HG22 ' A' ' 43' ' ' THR . 6.6 t30 -75.45 103.75 5.72 Favored 'General case' 0 N--CA 1.454 -0.265 0 O-C-N 121.042 -1.27 . . . . 0.0 109.473 -174.629 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 26.1 pt -58.06 -15.59 5.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 N-CA-C 115.032 1.493 . . . . 0.0 115.032 -173.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.472 ' H ' ' ND2' ' A' ' 10' ' ' ASN . 5.2 mp -89.01 -6.11 57.44 Favored 'General case' 0 C--O 1.216 -0.683 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 -171.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.5 mp -102.45 53.2 0.79 Allowed 'General case' 0 N--CA 1.434 -1.251 0 C-N-CA 124.143 0.977 . . . . 0.0 109.147 -172.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.407 ' HB ' ' H ' ' A' ' 15' ' ' ASP 0.258 0.1 OUTLIER 49.91 -107.37 0.26 Allowed 'General case' 0 N--CA 1.44 -0.952 0 CA-C-N 113.901 -1.5 . . . . 0.0 110.677 174.896 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.407 ' H ' ' HB ' ' A' ' 14' ' ' THR . 75.3 m-20 -76.51 -6.27 51.12 Favored 'General case' 0 N--CA 1.439 -0.997 0 O-C-N 122.075 -0.391 . . . . 0.0 111.544 -171.023 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -71.94 -4.67 29.71 Favored 'General case' 0 CA--C 1.546 0.809 0 O-C-N 121.131 -0.98 . . . . 0.0 111.874 169.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -80.14 -15.18 57.64 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-O 116.187 -1.863 . . . . 0.0 109.748 169.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 7.0 tp -53.92 -42.02 51.72 Favored 'Isoleucine or valine' 0 C--N 1.342 0.252 0 CA-C-N 121.561 1.982 . . . . 0.0 112.655 -169.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -63.81 -43.45 97.66 Favored Glycine 0 C--N 1.334 0.435 0 CA-C-N 119.295 0.952 . . . . 0.0 111.716 178.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 97.7 t -64.56 -48.95 82.78 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 173.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 27.4 mmm180 -63.51 -31.41 72.56 Favored 'General case' 0 N--CA 1.467 0.404 0 O-C-N 120.433 -1.417 . . . . 0.0 112.678 -177.048 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 30.0 mt -60.52 -43.92 95.4 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 CA-C-N 120.446 1.476 . . . . 0.0 109.754 173.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.2 m -76.74 -27.79 17.01 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 CA-C-N 120.179 1.354 . . . . 0.0 111.806 -177.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 60.3 mt-10 -70.19 -41.27 73.95 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 175.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -69.03 -40.67 78.49 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-O 119.163 -0.446 . . . . 0.0 110.795 -179.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 5.7 tp -65.35 -42.2 93.07 Favored 'General case' 0 C--O 1.224 -0.283 0 CA-C-N 119.118 0.872 . . . . 0.0 110.233 178.313 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -62.6 -40.43 96.88 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 119.003 0.82 . . . . 0.0 110.669 179.211 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -71.15 -38.81 72.19 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 122.601 0.36 . . . . 0.0 111.686 177.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 31.4 mtp180 -92.67 -40.41 10.75 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 117.509 -1.234 . . . . 0.0 113.663 -169.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -117.18 123.82 47.61 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 121.074 1.761 . . . . 0.0 111.73 -170.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 50.0 mm -83.32 141.19 15.2 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 N-CA-C 106.372 -1.714 . . . . 0.0 106.372 169.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 17.8 mt -135.8 155.77 77.78 Favored Pre-proline 0 CA--C 1.539 0.523 0 C-N-CA 124.711 1.204 . . . . 0.0 110.153 -169.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_exo -57.88 157.72 23.31 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 123.612 2.875 . . . . 0.0 112.727 171.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -63.82 -30.21 71.33 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -169.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 11.7 p90 -73.13 -5.27 38.04 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 118.706 -0.664 . . . . 0.0 112.346 178.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 12.0 t -101.32 130.06 51.42 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 174.199 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -119.3 132.04 55.83 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 172.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.461 HD12 ' H ' ' A' ' 38' ' ' ILE . 0.1 OUTLIER -99.28 123.69 52.12 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 N-CA-C 104.759 -2.311 . . . . 0.0 104.759 169.059 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 5.8 tt -127.56 138.25 52.84 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 119.302 0.955 . . . . 0.0 110.816 -178.122 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -100.58 119.01 37.9 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 169.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -72.4 -24.28 76.56 Favored Glycine 0 CA--C 1.535 1.336 0 CA-C-O 118.683 -1.065 . . . . 0.0 112.752 177.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 66.91 75.54 0.45 Allowed Glycine 0 CA--C 1.529 0.92 0 CA-C-N 118.409 1.105 . . . . 0.0 112.063 173.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.545 HG22 ' HA ' ' A' ' 10' ' ' ASN 0.272 17.7 p 55.05 30.79 14.89 Favored 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 125.359 1.464 . . . . 0.0 112.862 176.26 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -76.91 -68.39 0.61 Allowed 'General case' 0 C--N 1.344 0.367 0 N-CA-C 114.701 1.371 . . . . 0.0 114.701 -169.335 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 74.91 -89.36 0.77 Allowed Glycine 0 CA--C 1.527 0.784 0 N-CA-C 108.463 -1.855 . . . . 0.0 108.463 -168.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 9.9 tpt -76.51 -22.42 54.46 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 125.051 1.34 . . . . 0.0 112.915 -173.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -66.19 -7.49 18.43 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 113.372 0.879 . . . . 0.0 113.372 -168.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.44 HD12 HD23 ' A' ' 97' ' ' LEU . 14.6 mt -84.12 4.09 31.92 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 121.622 -0.674 . . . . 0.0 112.76 -170.606 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -73.92 80.4 1.66 Allowed 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 125.078 2.371 . . . . 0.0 110.856 -177.605 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 141.54 -35.59 1.79 Allowed Glycine 0 C--N 1.309 -0.931 0 CA-C-N 109.676 -3.42 . . . . 0.0 111.073 169.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -69.17 -41.86 76.67 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-N 117.534 0.667 . . . . 0.0 109.87 -175.369 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 2.6 ptt? -88.84 1.88 54.56 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 115.449 -0.796 . . . . 0.0 112.176 -172.052 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -79.09 164.33 24.38 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 123.917 0.887 . . . . 0.0 111.257 -177.093 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 58.01 39.08 26.76 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.773 1.629 . . . . 0.0 113.883 168.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 9.5 mmt180 -109.22 153.45 23.79 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -81.25 -24.87 37.04 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 175.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -145.31 143.12 30.0 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 177.68 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 14.1 tp -140.56 126.23 19.14 Favored 'General case' 0 CA--C 1.505 -0.784 0 N-CA-C 106.016 -1.846 . . . . 0.0 106.016 168.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 36.1 mt -104.12 103.78 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 N-CA-C 103.753 -2.684 . . . . 0.0 103.753 172.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 12.9 mt -77.43 135.25 26.82 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 N-CA-C 105.053 -2.203 . . . . 0.0 105.053 171.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -118.56 120.55 37.83 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 105.604 -1.999 . . . . 0.0 105.604 169.509 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -156.25 167.14 31.36 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 122.875 0.47 . . . . 0.0 110.017 176.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -78.14 154.41 31.24 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 169.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 13.1 mm -78.8 -48.11 22.33 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.46 0 CA-C-O 118.754 -0.641 . . . . 0.0 110.595 -177.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.1 t 49.17 31.15 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.094 0 C-N-CA 126.7 2.0 . . . . 0.0 113.43 177.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 50.8 m -122.14 -25.81 4.83 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 116.291 1.96 . . . . 0.0 116.291 -169.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -149.21 156.98 42.97 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 120.564 1.529 . . . . 0.0 110.803 -172.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.18 33.41 0.13 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.906 1.683 . . . . 0.0 113.791 177.12 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 46.5 t30 -65.74 164.59 14.29 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 108.523 -0.918 . . . . 0.0 108.523 170.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 5.5 m -58.33 132.74 84.81 Favored Pre-proline 0 CA--C 1.545 0.77 0 CA-C-O 118.951 -0.547 . . . . 0.0 109.612 -178.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -61.42 156.19 47.96 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 122.742 2.294 . . . . 0.0 111.755 175.368 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 67.92 19.17 71.41 Favored Glycine 0 CA--C 1.535 1.324 0 CA-C-O 119.348 -0.696 . . . . 0.0 113.506 176.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 5.0 m -95.65 143.49 26.88 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 125.431 1.492 . . . . 0.0 108.505 178.044 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 14.7 ttp -91.64 135.48 33.84 Favored 'General case' 0 C--N 1.339 0.151 0 C-N-CA 123.178 0.591 . . . . 0.0 109.809 178.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 74.5 mmm -128.0 93.18 3.61 Favored 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 -169.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 44.2 mm -89.54 114.68 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 -177.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.8 mp -117.18 135.26 53.91 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 -177.451 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 40.4 ttm180 -102.92 135.87 43.79 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 123.276 0.63 . . . . 0.0 109.689 -176.008 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 17.4 t70 33.38 -97.91 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 115.734 1.753 . . . . 0.0 115.734 169.217 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -60.74 -26.72 67.41 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.514 1.125 . . . . 0.0 113.592 -174.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 -73.79 -25.17 60.0 Favored 'General case' 0 CA--C 1.533 0.311 0 O-C-N 122.023 -0.423 . . . . 0.0 110.483 -177.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.402 HG22 ' HB3' ' A' ' 116' ' ' LEU . 94.7 t -68.11 -62.38 3.25 Favored Pre-proline 0 N--CA 1.443 -0.823 0 CA-C-O 117.835 -1.079 . . . . 0.0 111.155 -168.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -63.69 -33.81 64.93 Favored 'Trans proline' 0 N--CA 1.448 -1.194 0 CA-C-N 121.266 1.488 . . . . 0.0 110.797 178.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.18 -21.22 65.8 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.189 0.596 . . . . 0.0 111.656 -175.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.436 HD13 ' C ' ' A' ' 85' ' ' LEU . 2.7 tm? -82.71 -49.56 9.65 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 169.296 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -60.63 -11.51 7.49 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 113.659 0.985 . . . . 0.0 113.659 -172.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 19.3 p -55.45 -23.92 28.05 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 119.488 1.04 . . . . 0.0 112.81 170.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . 0.617 HD21 ' HB ' ' A' ' 90' ' ' ILE . 5.6 t30 -59.53 128.23 36.01 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 122.943 0.497 . . . . 0.0 110.47 -174.472 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 66.2 mttt -81.28 -16.01 53.8 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 118.516 -0.754 . . . . 0.0 112.719 -175.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.617 ' HB ' HD21 ' A' ' 88' ' ' ASN . 83.6 mt -64.85 -40.44 89.08 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 178.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.529 ' H ' ' ND2' ' A' ' 88' ' ' ASN . 1.5 m -66.43 110.36 4.7 Favored Pre-proline 0 CA--C 1.544 0.743 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 169.48 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_exo -72.82 -47.92 0.32 Allowed 'Trans proline' 0 C--N 1.349 0.585 0 CA-C-N 121.358 1.521 . . . . 0.0 113.155 -169.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 21.5 m80 -91.95 -30.16 16.26 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 123.725 0.81 . . . . 0.0 110.072 -169.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 19.9 mp0 -63.68 -28.18 69.72 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 125.926 1.69 . . . . 0.0 110.192 179.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 60.7 tp -60.4 -36.35 77.91 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 118.986 0.812 . . . . 0.0 111.092 172.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -65.61 -40.96 96.26 Favored Glycine 0 CA--C 1.529 0.954 0 N-CA-C 110.891 -0.884 . . . . 0.0 110.891 173.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.44 HD23 HD12 ' A' ' 48' ' ' LEU . 2.3 tm? -66.42 -35.17 79.64 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 118.157 0.979 . . . . 0.0 110.534 176.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -56.57 -44.39 80.95 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 119.827 1.194 . . . . 0.0 109.912 171.331 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -71.08 -23.59 62.15 Favored 'General case' 0 N--CA 1.457 -0.111 0 CA-C-O 118.599 -0.715 . . . . 0.0 112.443 176.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 91.2 t -65.45 -46.66 89.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 CA-C-N 120.223 1.374 . . . . 0.0 107.566 169.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 65.9 mt -61.68 -38.78 89.05 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 118.73 0.696 . . . . 0.0 110.058 -179.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 21.3 m -61.93 -42.58 99.27 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 118.654 0.661 . . . . 0.0 110.749 171.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.407 ' HA ' ' CD2' ' A' ' 106' ' ' PHE . . . -64.77 -39.36 93.48 Favored 'General case' 0 N--CA 1.449 -0.516 0 O-C-N 121.442 -0.786 . . . . 0.0 111.442 -179.582 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 17.4 mt -70.03 -31.85 69.69 Favored 'General case' 0 CA--C 1.521 -0.135 0 O-C-N 121.727 -0.608 . . . . 0.0 111.039 176.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 29.0 tpt180 -65.14 -37.09 86.32 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 118.56 -0.733 . . . . 0.0 109.645 171.213 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.407 ' CD2' ' HA ' ' A' ' 103' ' ' ALA . 12.9 m-30 -65.69 -42.64 90.97 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 119.403 1.002 . . . . 0.0 110.759 177.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 49.0 p -76.19 -22.01 55.8 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 118.875 0.761 . . . . 0.0 111.781 179.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 77.73 11.56 85.32 Favored Glycine 0 CA--C 1.533 1.19 0 CA-C-O 118.815 -0.992 . . . . 0.0 111.172 -169.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -97.08 23.95 6.8 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 119.104 1.452 . . . . 0.0 111.39 177.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 12.7 t80 -58.43 136.97 85.6 Favored Pre-proline 0 CA--C 1.546 0.791 0 C-N-CA 125.393 1.477 . . . . 0.0 109.319 172.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -56.92 136.72 78.26 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 122.724 2.283 . . . . 0.0 111.866 179.148 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -66.53 -24.34 66.36 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 111.827 0.306 . . . . 0.0 111.827 -173.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -135.53 95.34 3.24 Favored 'General case' 0 N--CA 1.464 0.225 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 169.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 38.4 tp -81.25 131.87 35.31 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 169.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -132.94 146.09 51.48 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 106.571 -1.64 . . . . 0.0 106.571 171.607 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.402 ' HB3' HG22 ' A' ' 82' ' ' VAL . 0.4 OUTLIER -131.81 124.27 29.29 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 120.043 1.292 . . . . 0.0 108.374 175.92 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 44.7 t -92.22 94.8 4.99 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 N-CA-C 105.683 -1.969 . . . . 0.0 105.683 169.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -84.99 156.18 30.87 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.201 -1.159 . . . . 0.0 110.201 175.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 58.1 t -137.44 143.69 33.53 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 174.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 18.1 mm -85.69 129.06 56.25 Favored Pre-proline 0 CA--C 1.541 0.621 0 CA-C-O 118.007 -0.997 . . . . 0.0 108.484 174.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -75.01 154.89 42.75 Favored 'Trans proline' 0 CA--C 1.536 0.611 0 C-N-CA 122.848 2.365 . . . . 0.0 112.389 177.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -100.36 -42.49 6.6 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 169.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 68.6 m -132.65 152.73 51.59 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 123.695 0.798 . . . . 0.0 110.652 175.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.5 tp -148.47 43.64 1.02 Allowed 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.567 0.747 . . . . 0.0 111.178 -172.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -121.57 170.4 7.62 Favored Pre-proline 0 N--CA 1.472 0.67 0 CA-C-O 118.105 -0.95 . . . . 0.0 109.352 -175.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -66.14 89.44 0.25 Allowed 'Trans proline' 0 CA--C 1.546 1.114 0 C-N-CA 123.199 2.599 . . . . 0.0 114.261 -174.459 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -166.25 128.74 1.93 Allowed 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 105.059 -2.2 . . . . 0.0 105.059 169.718 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.434 HG23 ' HA ' ' A' ' 12' ' ' LEU . 0.0 OUTLIER -79.91 154.06 4.58 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 C-N-CA 123.626 0.77 . . . . 0.0 109.78 -171.852 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 78.21 166.68 29.41 Favored Glycine 0 CA--C 1.527 0.823 0 N-CA-C 111.326 -0.71 . . . . 0.0 111.326 -179.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -82.64 165.18 20.24 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-O 121.937 0.875 . . . . 0.0 112.459 -169.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 40.7 p -70.48 168.67 17.8 Favored Pre-proline 0 C--O 1.239 0.544 0 CA-C-N 114.123 -1.399 . . . . 0.0 108.813 167.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -56.93 -32.97 94.25 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 121.348 1.365 . . . . 0.0 110.831 169.244 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 26.2 m -68.12 -41.38 81.82 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 119.213 -0.423 . . . . 0.0 111.47 -179.006 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 16.7 t -105.3 -10.4 9.89 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-N 118.951 0.796 . . . . 0.0 112.105 -169.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -58.95 -45.45 90.42 Favored 'General case' 0 N--CA 1.466 0.346 0 O-C-N 119.929 -1.732 . . . . 0.0 107.768 168.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -70.67 1.47 5.27 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 115.172 -0.922 . . . . 0.0 112.721 176.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 18.0 mmm -92.03 -8.95 44.53 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 119.587 1.085 . . . . 0.0 111.112 172.182 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 86.8 mt -59.64 -48.31 87.88 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 CA-C-N 119.404 1.002 . . . . 0.0 108.446 176.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -70.5 -50.69 13.83 Favored Pre-proline 0 CA--C 1.535 0.393 0 CA-C-O 117.266 -1.35 . . . . 0.0 113.655 -170.023 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -58.31 -32.73 96.68 Favored 'Trans proline' 0 N--CA 1.459 -0.53 0 CA-C-N 122.214 1.827 . . . . 0.0 112.092 173.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -69.95 -39.53 75.98 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 119.147 0.885 . . . . 0.0 110.749 176.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 71.3 mt -58.04 -44.72 87.55 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 119.897 1.226 . . . . 0.0 109.099 171.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -60.38 -37.22 80.08 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 118.87 -0.586 . . . . 0.0 110.918 -179.37 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 36.1 mm-40 -77.97 -33.1 51.65 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 119.758 1.163 . . . . 0.0 112.921 177.147 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 52.0 t -59.22 -48.67 86.11 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-N 120.107 1.322 . . . . 0.0 108.362 169.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 32.6 mt -64.44 -37.35 87.23 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.028 0.531 . . . . 0.0 110.203 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -62.81 -40.68 98.13 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 118.938 0.79 . . . . 0.0 111.313 177.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -62.85 -41.57 99.41 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 118.87 0.759 . . . . 0.0 110.689 177.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 4.9 mt -63.01 -39.0 93.44 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 123.081 0.553 . . . . 0.0 111.055 174.213 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 72.1 mtp85 -68.34 -14.35 62.93 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 117.081 -1.438 . . . . 0.0 112.27 177.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -58.77 -30.63 67.7 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 120.978 1.717 . . . . 0.0 111.402 178.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 18.3 m -118.4 34.05 5.36 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.568 0.747 . . . . 0.0 111.005 174.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 65.61 27.02 72.2 Favored Glycine 0 C--N 1.342 0.873 0 CA-C-O 118.561 -1.133 . . . . 0.0 114.215 171.043 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 24.4 t -87.59 83.05 2.15 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 176.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -76.88 117.88 18.92 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 176.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -81.04 157.67 25.36 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 123.264 0.626 . . . . 0.0 109.728 173.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 12.6 mm -109.97 128.08 25.99 Favored Pre-proline 0 CA--C 1.531 0.238 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 179.088 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -59.36 110.48 0.71 Allowed 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.168 1.912 . . . . 0.0 108.469 169.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 43.1 mtm105 53.65 13.0 0.44 Allowed 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.664 1.586 . . . . 0.0 114.272 174.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 2.6 m . . . . . 0 CA--C 1.543 0.698 0 C-N-CA 124.495 1.118 . . . . 0.0 110.636 -168.287 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 28.2 ptt-85 . . . . . 0 N--CA 1.475 0.787 0 CA-C-O 119.089 -0.482 . . . . 0.0 112.08 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 73.0 mt -133.11 144.61 35.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 C-N-CA 123.553 0.741 . . . . 0.0 109.956 -175.246 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 9.7 mt -123.29 145.88 48.34 Favored 'General case' 0 CA--C 1.521 -0.139 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 168.059 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 57.4 t -126.87 95.69 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.797 0 N-CA-C 105.629 -1.989 . . . . 0.0 105.629 172.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.6 mt -87.88 116.71 26.23 Favored 'General case' 0 CA--C 1.517 -0.303 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 -171.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -93.82 127.21 8.96 Favored Glycine 0 C--N 1.332 0.312 0 N-CA-C 106.141 -2.784 . . . . 0.0 106.141 169.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.2 m -142.71 164.61 16.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 117.92 0.86 . . . . 0.0 111.481 -169.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 123.0 173.45 14.08 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 126.014 1.769 . . . . 0.0 111.687 172.346 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.448 HD22 ' HB2' ' A' ' 13' ' ' LEU . 1.5 t30 -81.83 93.46 6.87 Favored 'General case' 0 N--CA 1.462 0.14 0 O-C-N 121.229 -1.16 . . . . 0.0 110.694 -176.312 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -59.13 5.5 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 N-CA-C 117.262 2.319 . . . . 0.0 117.262 -178.372 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.441 ' H ' ' ND2' ' A' ' 10' ' ' ASN . 80.7 mt -108.67 -0.03 20.35 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 121.518 1.963 . . . . 0.0 109.135 -179.019 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.448 ' HB2' HD22 ' A' ' 10' ' ' ASN . 1.9 mp -110.27 62.77 0.6 Allowed 'General case' 0 N--CA 1.44 -0.948 0 C-N-CA 124.465 1.106 . . . . 0.0 110.122 -169.533 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.418 ' HB ' ' H ' ' A' ' 15' ' ' ASP . 0.2 OUTLIER 53.08 -103.89 0.18 Allowed 'General case' 0 CA--C 1.537 0.446 0 O-C-N 123.766 0.667 . . . . 0.0 111.064 175.166 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.418 ' H ' ' HB ' ' A' ' 14' ' ' THR . 81.9 m-20 -82.71 -8.39 59.6 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 118.513 -0.756 . . . . 0.0 112.462 -175.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -71.75 2.72 4.94 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-N 121.327 1.876 . . . . 0.0 113.015 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -85.01 -13.29 51.03 Favored 'General case' 0 N--CA 1.435 -1.189 0 CA-C-O 116.076 -1.916 . . . . 0.0 108.683 169.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 7.7 tp -50.88 -42.1 22.86 Favored 'Isoleucine or valine' 0 C--N 1.344 0.339 0 CA-C-N 121.671 2.032 . . . . 0.0 113.134 -169.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -61.81 -43.45 99.2 Favored Glycine 0 CA--C 1.527 0.834 0 CA-C-N 119.238 0.926 . . . . 0.0 111.995 177.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 55.6 t -65.38 -48.07 84.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-O 118.649 -0.691 . . . . 0.0 109.855 172.041 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 28.7 mmm180 -57.69 -37.39 73.38 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 120.231 1.378 . . . . 0.0 111.719 -178.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 27.0 mt -63.48 -45.54 97.59 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 CA-C-N 119.987 1.267 . . . . 0.0 110.195 -179.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.9 m -74.29 -27.09 21.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-N 119.985 1.266 . . . . 0.0 111.743 -176.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 19.5 mm-40 -70.41 -41.61 72.73 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 173.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.04 -38.37 90.65 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-O 119.025 -0.512 . . . . 0.0 110.045 177.317 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.8 tp -62.11 -42.98 99.77 Favored 'General case' 0 C--N 1.343 0.313 0 CA-C-O 118.131 -0.938 . . . . 0.0 109.727 175.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -60.5 -43.74 96.74 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 119.266 0.939 . . . . 0.0 110.678 178.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -66.53 -42.34 87.4 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.017 0.527 . . . . 0.0 110.91 179.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 87.1 mtt180 -88.84 -36.63 15.91 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 117.393 -1.289 . . . . 0.0 113.458 -170.207 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 72.3 m-85 -125.77 133.29 52.1 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-N 121.076 1.762 . . . . 0.0 112.607 -169.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 45.7 mm -85.66 129.81 37.38 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 N-CA-C 104.213 -2.514 . . . . 0.0 104.213 168.088 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -119.22 157.58 50.7 Favored Pre-proline 0 CA--C 1.537 0.444 0 C-N-CA 124.883 1.273 . . . . 0.0 108.902 -179.107 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_exo -57.97 155.46 33.35 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 123.259 2.639 . . . . 0.0 112.064 172.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -62.23 -28.21 69.53 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 112.937 0.717 . . . . 0.0 112.937 -170.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 8.3 p90 -73.98 -6.35 46.88 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 113.097 0.777 . . . . 0.0 113.097 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 38.2 t -102.96 133.51 46.56 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 174.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -132.45 136.34 46.65 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 169.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -88.67 101.55 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.035 0 N-CA-C 105.107 -2.182 . . . . 0.0 105.107 169.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.5 tt -85.57 112.44 20.95 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 106.784 -1.562 . . . . 0.0 106.784 -178.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -77.78 106.42 9.6 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 169.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -69.92 -80.62 0.27 Allowed Glycine 0 CA--C 1.528 0.875 0 N-CA-C 108.231 -1.948 . . . . 0.0 108.231 171.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 77.21 107.61 0.15 Allowed Glycine 0 C--N 1.341 0.848 0 N-CA-C 110.165 -1.174 . . . . 0.0 110.165 -178.436 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 5.2 p 52.39 57.98 5.87 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.416 1.086 . . . . 0.0 109.333 175.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -113.14 -88.31 0.55 Allowed 'General case' 0 C--N 1.345 0.411 0 CA-C-N 114.685 -1.143 . . . . 0.0 110.735 -169.449 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 75.09 -93.1 0.85 Allowed Glycine 0 C--N 1.34 0.778 0 N-CA-C 107.596 -2.202 . . . . 0.0 107.596 -169.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.68 -23.27 60.86 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.585 1.154 . . . . 0.0 113.498 -173.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -67.66 -7.24 25.14 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -169.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 26.0 mt -93.76 -12.91 28.09 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 115.475 1.657 . . . . 0.0 115.475 -168.151 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 5.1 tt -45.31 -61.03 1.83 Allowed 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 113.941 1.089 . . . . 0.0 113.941 -169.305 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -70.21 -35.42 70.25 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 111.255 -0.738 . . . . 0.0 111.255 -170.091 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -77.54 -29.84 52.49 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 118.068 0.934 . . . . 0.0 110.271 -175.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 69.6 mtp -67.34 -16.63 64.36 Favored 'General case' 0 N--CA 1.454 -0.254 0 O-C-N 121.822 -0.549 . . . . 0.0 111.683 175.13 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -63.14 140.97 58.93 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-O 121.926 0.87 . . . . 0.0 112.873 -169.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 53.53 20.39 2.07 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 117.261 2.319 . . . . 0.0 117.261 168.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 23.5 mmt180 -71.55 150.36 44.84 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 121.003 1.729 . . . . 0.0 108.5 176.267 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -79.96 -29.26 39.6 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 121.677 -0.639 . . . . 0.0 109.37 -178.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -147.81 137.25 22.42 Favored 'General case' 0 C--O 1.232 0.161 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 167.372 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.8 tp -126.59 130.73 51.07 Favored 'General case' 0 CA--C 1.515 -0.374 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 175.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 50.0 mt -105.66 120.1 55.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 105.803 -1.925 . . . . 0.0 105.803 173.004 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 7.9 mt -95.98 128.94 46.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 105.15 -2.167 . . . . 0.0 105.15 175.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -113.19 113.5 25.43 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 105.297 -2.112 . . . . 0.0 105.297 169.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.5 t0 -147.78 157.85 43.74 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.422 0.689 . . . . 0.0 110.217 -174.043 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -75.41 158.06 33.25 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 168.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.461 HD11 ' HA3' ' A' ' 118' ' ' GLY . 27.2 mm -95.4 -85.13 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.639 179.493 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . 0.385 0.3 OUTLIER 55.47 11.56 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 126.388 1.875 . . . . 0.0 114.549 -169.471 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.457 ' H ' HG22 ' A' ' 64' ' ' ILE . 5.3 m -74.07 -23.61 59.39 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 124.469 1.108 . . . . 0.0 113.684 -178.373 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 34.1 ttpt -150.23 161.16 42.96 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.149 0.98 . . . . 0.0 108.781 -171.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 14.5 ptpt -65.55 4.49 0.55 Allowed 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 127.347 2.259 . . . . 0.0 115.177 176.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 54.1 t30 -62.9 155.22 27.82 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 119.114 0.87 . . . . 0.0 109.539 -177.344 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 4.3 m -56.05 137.67 73.23 Favored Pre-proline 0 CA--C 1.545 0.762 0 C-N-CA 124.34 1.056 . . . . 0.0 113.532 -169.312 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -58.28 155.54 34.6 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 123.668 2.912 . . . . 0.0 111.708 169.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 64.88 24.76 70.23 Favored Glycine 0 CA--C 1.533 1.214 0 O-C-N 121.852 -0.53 . . . . 0.0 112.684 176.232 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 20.0 m -102.58 137.11 41.25 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 125.816 1.646 . . . . 0.0 106.706 173.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 28.3 ttp -91.8 136.74 32.92 Favored 'General case' 0 C--O 1.232 0.159 0 N-CA-C 107.629 -1.248 . . . . 0.0 107.629 175.079 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 6.4 ttm -124.95 87.01 2.64 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 -169.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 40.4 mm -83.13 117.64 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 57.1 mt -128.55 141.28 51.42 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 123.197 0.599 . . . . 0.0 109.544 -174.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.8 mtt85 -113.88 138.67 50.0 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 123.329 0.652 . . . . 0.0 109.873 -172.242 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 38.2 t70 38.91 -106.69 0.05 Allowed 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.833 1.253 . . . . 0.0 113.867 169.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -56.8 -29.82 63.1 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.071 1.349 . . . . 0.0 113.923 -175.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -71.25 -25.55 62.52 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 122.881 0.472 . . . . 0.0 110.238 -176.111 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.458 HG22 ' HB3' ' A' ' 116' ' ' LEU . 84.7 t -70.8 -61.92 2.22 Favored Pre-proline 0 N--CA 1.443 -0.812 0 CA-C-O 117.548 -1.215 . . . . 0.0 111.368 -168.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -65.55 -35.57 37.74 Favored 'Trans proline' 0 N--CA 1.452 -0.957 0 CA-C-N 121.384 1.53 . . . . 0.0 111.155 -178.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.1 -36.22 79.42 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 122.572 0.349 . . . . 0.0 110.634 -173.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -71.91 -44.05 64.31 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 118.867 -0.587 . . . . 0.0 109.698 169.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -55.71 -21.37 18.2 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 -174.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.447 HG23 ' H ' ' A' ' 88' ' ' ASN . 1.7 t -83.95 -76.34 0.3 Allowed 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 119.315 0.961 . . . . 0.0 109.895 168.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . 0.447 ' H ' HG23 ' A' ' 87' ' ' THR . 46.6 t30 49.45 17.49 0.22 Allowed 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.042 1.337 . . . . 0.0 114.082 -168.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt 50.4 23.92 1.4 Allowed 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.433 1.493 . . . . 0.0 113.421 -171.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 42.9 mt -134.67 -42.99 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 123.879 0.871 . . . . 0.0 110.96 -171.126 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.3 m -64.2 147.05 97.3 Favored Pre-proline 0 CA--C 1.545 0.765 0 CA-C-N 118.893 0.769 . . . . 0.0 112.52 -169.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -79.97 -110.33 0.01 OUTLIER 'Trans proline' 0 CA--C 1.54 0.823 0 C-N-CA 124.218 3.279 . . . . 0.0 109.979 175.088 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 11.7 m80 -59.13 -28.35 66.47 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.773 1.229 . . . . 0.0 112.675 -169.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 22.3 mp0 -57.57 -31.63 66.34 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 126.003 1.721 . . . . 0.0 111.208 175.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 65.9 tp -62.2 -33.86 75.35 Favored 'General case' 0 C--N 1.342 0.253 0 CA-C-N 119.123 0.874 . . . . 0.0 110.54 175.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -64.14 -39.41 97.11 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.616 -0.993 . . . . 0.0 110.616 175.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 19.0 tp -72.88 -33.88 66.34 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 118.332 1.066 . . . . 0.0 110.439 176.022 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -58.09 -46.85 84.81 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 119.752 1.16 . . . . 0.0 109.95 170.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -69.49 -29.25 66.86 Favored 'General case' 0 CA--C 1.522 -0.126 0 C-N-CA 122.618 0.367 . . . . 0.0 111.527 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 10.9 t -64.29 -44.19 97.28 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.785 0 CA-C-O 118.882 -0.58 . . . . 0.0 110.098 170.093 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 52.1 mt -63.07 -39.05 93.56 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 119.274 0.943 . . . . 0.0 110.036 178.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 23.8 m -61.05 -39.49 90.01 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 118.753 0.706 . . . . 0.0 110.19 169.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.517 ' HA ' ' CD2' ' A' ' 106' ' ' PHE . . . -67.44 -38.62 84.8 Favored 'General case' 0 N--CA 1.448 -0.545 0 O-C-N 121.308 -0.87 . . . . 0.0 111.793 -179.048 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -59.47 -41.75 90.45 Favored 'General case' 0 CA--C 1.524 -0.03 0 CA-C-N 118.835 0.743 . . . . 0.0 109.331 172.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 78.3 ttt180 -65.18 -36.2 83.45 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 118.229 -0.891 . . . . 0.0 110.852 177.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.517 ' CD2' ' HA ' ' A' ' 103' ' ' ALA . 15.1 m-30 -61.21 -45.46 94.47 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 119.506 1.048 . . . . 0.0 110.593 178.597 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 14.9 t -82.51 -13.58 56.42 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 122.298 0.239 . . . . 0.0 111.438 -178.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 78.08 27.93 57.22 Favored Glycine 0 CA--C 1.531 1.059 0 N-CA-C 111.623 -0.591 . . . . 0.0 111.623 179.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -110.98 19.36 18.57 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.628 1.171 . . . . 0.0 110.833 -176.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -59.99 137.11 90.83 Favored Pre-proline 0 CA--C 1.544 0.712 0 C-N-CA 123.952 0.901 . . . . 0.0 109.857 -178.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_exo -51.74 144.98 32.55 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 123.069 2.513 . . . . 0.0 112.96 176.392 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -63.77 -30.71 71.78 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 119.252 -0.404 . . . . 0.0 110.47 -178.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 30.5 mtmm -136.37 138.3 41.45 Favored 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 105.99 -1.856 . . . . 0.0 105.99 169.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 13.9 tp -120.14 134.06 55.35 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 171.007 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -133.41 139.28 46.66 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 177.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.458 ' HB3' HG22 ' A' ' 82' ' ' VAL . 6.2 tp -125.68 128.62 48.09 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 177.229 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 46.4 t -100.18 85.35 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 N-CA-C 104.092 -2.558 . . . . 0.0 104.092 169.214 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . 0.461 ' HA3' HD11 ' A' ' 64' ' ' ILE . . . -76.86 147.43 33.6 Favored Glycine 0 C--N 1.332 0.327 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 177.02 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 85.2 t -130.58 138.2 54.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 170.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 2.8 mt -92.44 125.05 57.49 Favored Pre-proline 0 CA--C 1.537 0.447 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -178.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -72.96 158.1 50.28 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 123.835 3.023 . . . . 0.0 112.424 -176.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -99.78 -41.64 7.18 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 171.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 70.5 m -129.78 149.51 51.49 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 123.487 0.715 . . . . 0.0 110.886 178.178 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -155.59 42.79 0.43 Allowed 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 112.951 0.723 . . . . 0.0 112.951 -169.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 81.7 mm-40 -111.19 164.2 15.52 Favored Pre-proline 0 N--CA 1.474 0.726 0 CA-C-O 117.607 -1.187 . . . . 0.0 108.737 179.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -68.25 87.21 0.4 Allowed 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 122.951 2.434 . . . . 0.0 111.919 -179.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -172.7 153.65 2.81 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 104.489 -2.412 . . . . 0.0 104.489 175.47 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -126.34 153.31 34.71 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 CA-C-O 121.956 0.884 . . . . 0.0 112.376 -170.06 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 121.73 127.68 3.4 Favored Glycine 0 CA--C 1.529 0.939 0 N-CA-C 105.497 -3.041 . . . . 0.0 105.497 -169.305 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 7.0 mp -79.63 151.73 30.4 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 117.67 0.735 . . . . 0.0 109.657 -177.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 62.0 p -69.76 159.07 85.4 Favored Pre-proline 0 C--O 1.237 0.401 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.565 173.286 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -62.01 -28.9 80.95 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 120.827 1.018 . . . . 0.0 110.014 169.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 24.7 m -63.53 -42.31 98.45 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 118.73 -0.652 . . . . 0.0 111.485 177.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 46.8 t -105.29 -26.61 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-O 118.072 -0.966 . . . . 0.0 112.896 -169.268 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -52.89 -42.12 65.01 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 120.754 1.615 . . . . 0.0 110.194 169.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -74.43 2.75 8.76 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 113.696 0.999 . . . . 0.0 113.696 -176.134 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 97.7 mmm -87.84 -10.3 51.23 Favored 'General case' 0 N--CA 1.439 -0.996 0 CA-C-O 117.435 -1.269 . . . . 0.0 110.152 169.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 93.6 mt -60.43 -46.18 95.63 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.406 0 CA-C-N 120.955 1.707 . . . . 0.0 109.022 -178.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -71.29 -49.99 11.58 Favored Pre-proline 0 CA--C 1.543 0.71 0 CA-C-N 120.239 1.382 . . . . 0.0 110.959 -179.13 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -41.37 -50.33 4.58 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 125.056 3.837 . . . . 0.0 112.732 168.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -73.11 -44.05 60.86 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 114.022 -1.445 . . . . 0.0 110.778 -175.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 34.3 mt -56.01 -41.45 74.9 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-N 118.833 0.742 . . . . 0.0 109.536 175.171 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -62.13 -35.91 80.17 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 118.853 0.752 . . . . 0.0 110.456 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 19.2 mm100 -78.7 -32.28 46.89 Favored 'General case' 0 N--CA 1.456 -0.127 0 CA-C-O 118.248 -0.882 . . . . 0.0 112.816 175.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 76.3 t -60.21 -47.56 91.63 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-N 119.976 1.262 . . . . 0.0 108.061 170.167 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 26.6 mt -65.14 -41.02 95.17 Favored 'General case' 0 CA--C 1.528 0.122 0 C-N-CA 122.99 0.516 . . . . 0.0 110.92 -179.377 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -63.19 -43.59 97.77 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 118.527 0.603 . . . . 0.0 111.163 177.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -64.7 -44.6 89.74 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 122.656 0.383 . . . . 0.0 110.061 179.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 38.9 mt -55.09 -45.2 75.42 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 174.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 73.7 mtp180 -64.97 -18.97 65.73 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 117.711 -1.138 . . . . 0.0 112.965 -177.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -62.15 -32.48 73.09 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 120.767 1.621 . . . . 0.0 110.957 178.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 22.5 m -97.1 28.59 3.5 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.905 0.882 . . . . 0.0 111.458 176.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 70.49 16.64 73.91 Favored Glycine 0 CA--C 1.533 1.185 0 CA-C-O 119.093 -0.837 . . . . 0.0 113.969 173.065 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 39.3 t -79.39 126.01 38.88 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 CA-C-N 118.746 1.273 . . . . 0.0 108.276 -177.322 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -96.27 128.69 43.42 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 169.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -97.14 147.47 24.03 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 169.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 2.7 mt -115.41 120.66 36.01 Favored Pre-proline 0 N--CA 1.462 0.153 0 N-CA-C 106.636 -1.616 . . . . 0.0 106.636 178.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -61.66 108.03 0.58 Allowed 'Trans proline' 0 N--CA 1.46 -0.472 0 C-N-CA 121.979 1.786 . . . . 0.0 107.625 172.157 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 14.2 ptp180 47.47 7.31 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 129.26 3.024 . . . . 0.0 117.785 -177.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 2.9 t . . . . . 0 CA--C 1.544 0.747 0 C-N-CA 126.114 1.765 . . . . 0.0 112.405 -169.976 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 5.5 ptp85 . . . . . 0 N--CA 1.477 0.918 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 55.1 mt -141.67 145.01 24.98 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 CA-C-N 119.46 1.027 . . . . 0.0 112.037 -169.058 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.1 mt -128.17 123.42 34.3 Favored 'General case' 0 CA--C 1.519 -0.216 0 N-CA-C 106.489 -1.671 . . . . 0.0 106.489 167.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 43.6 t -101.85 98.71 7.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 100.69 -3.819 . . . . 0.0 100.69 169.153 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -104.24 109.24 20.98 Favored 'General case' 0 N--CA 1.442 -0.864 0 C-N-CA 123.873 0.869 . . . . 0.0 109.35 -168.152 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -91.42 126.3 8.39 Favored Glycine 0 N--CA 1.444 -0.831 0 N-CA-C 107.743 -2.143 . . . . 0.0 107.743 174.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -142.38 179.73 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.812 0 C-N-CA 124.133 0.973 . . . . 0.0 108.517 -175.011 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 124.5 157.04 9.61 Favored Glycine 0 N--CA 1.447 -0.589 0 N-CA-C 108.471 -1.852 . . . . 0.0 108.471 -169.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -73.6 96.96 2.54 Favored 'General case' 0 N--CA 1.442 -0.85 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 169.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 4.2 pt -56.7 -30.62 32.82 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.241 0 O-C-N 121.438 -0.789 . . . . 0.0 112.068 -179.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 22.2 mt -77.55 13.93 1.14 Allowed 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 119.036 0.834 . . . . 0.0 110.902 -172.15 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -136.41 82.07 1.92 Allowed 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 123.284 0.634 . . . . 0.0 111.494 171.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.427 HG23 ' O ' ' A' ' 129' ' ' GLY . 25.6 m 35.41 -105.94 0.03 OUTLIER 'General case' 0 N--CA 1.437 -1.121 0 O-C-N 126.46 2.35 . . . . 0.0 111.772 167.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -59.46 -28.02 66.61 Favored 'General case' 0 N--CA 1.442 -0.842 0 C-N-CA 124.201 1.0 . . . . 0.0 111.961 -169.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -67.09 -18.05 65.15 Favored 'General case' 0 C--N 1.341 0.212 0 CA-C-N 120.423 1.465 . . . . 0.0 111.786 179.088 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.58 -10.56 56.66 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-O 116.33 -1.795 . . . . 0.0 110.888 173.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 6.6 tp -55.6 -39.94 57.07 Favored 'Isoleucine or valine' 0 C--N 1.342 0.243 0 CA-C-N 121.976 2.171 . . . . 0.0 111.814 -174.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -59.17 -43.52 97.07 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 111.4 -0.68 . . . . 0.0 111.4 178.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 74.0 t -68.76 -48.32 71.74 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 CA-C-O 118.134 -0.936 . . . . 0.0 109.874 174.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 20.9 mmt180 -60.14 -31.56 70.21 Favored 'General case' 0 C--N 1.346 0.431 0 CA-C-N 120.498 1.499 . . . . 0.0 111.787 -177.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 23.2 mt -60.68 -51.35 74.11 Favored 'Isoleucine or valine' 0 C--N 1.343 0.285 0 CA-C-N 120.86 1.663 . . . . 0.0 109.789 174.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 24.6 m -72.38 -33.97 47.38 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 CA-C-N 119.461 1.028 . . . . 0.0 111.221 -174.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 58.1 mt-10 -59.88 -48.29 82.3 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 171.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.56 -36.8 84.83 Favored 'General case' 0 C--N 1.342 0.263 0 CA-C-N 119.151 0.887 . . . . 0.0 111.08 179.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 5.9 tp -63.19 -40.04 96.36 Favored 'General case' 0 C--O 1.224 -0.253 0 CA-C-N 118.471 0.578 . . . . 0.0 109.566 -178.231 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -60.52 -26.5 66.9 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.595 0.758 . . . . 0.0 112.771 179.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -90.67 -44.35 9.56 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 125.495 1.518 . . . . 0.0 110.886 -178.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 75.4 mtt180 -84.45 -26.61 28.1 Favored 'General case' 0 C--O 1.231 0.086 0 CA-C-O 118.792 -0.623 . . . . 0.0 111.529 -172.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 64.4 m-85 -125.97 146.21 49.96 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-O 121.694 0.759 . . . . 0.0 112.364 -177.318 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 34.0 mm -101.7 135.66 37.3 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 N-CA-C 104.909 -2.256 . . . . 0.0 104.909 169.028 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -119.0 150.93 49.66 Favored Pre-proline 0 CA--C 1.535 0.371 0 C-N-CA 124.287 1.035 . . . . 0.0 109.988 -169.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -65.76 157.16 60.31 Favored 'Trans proline' 0 CA--C 1.539 0.748 0 C-N-CA 122.43 2.087 . . . . 0.0 110.189 169.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -58.08 -33.2 68.81 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 114.557 1.317 . . . . 0.0 114.557 -169.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -74.72 -11.45 60.17 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -177.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 73.1 t -90.02 123.01 42.01 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 171.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -112.36 127.01 55.89 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 169.234 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -91.77 116.07 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 N-CA-C 104.422 -2.436 . . . . 0.0 104.422 168.294 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 59.6 tp -117.57 128.25 54.76 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 118.207 0.458 . . . . 0.0 110.675 -178.431 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -87.73 117.25 26.43 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 168.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -71.59 -65.31 2.45 Favored Glycine 0 CA--C 1.528 0.871 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 176.292 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 84.33 84.61 0.94 Allowed Glycine 0 C--N 1.343 0.937 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 177.137 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 27.6 p 61.38 20.11 10.82 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 125.118 1.367 . . . . 0.0 113.471 -179.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -76.73 -65.78 0.9 Allowed 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 114.875 1.435 . . . . 0.0 114.875 -168.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 56.78 -108.61 1.28 Allowed Glycine 0 CA--C 1.536 1.349 0 N-CA-C 111.416 -0.674 . . . . 0.0 111.416 -176.167 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 13.2 tpt -59.67 -23.58 63.2 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.968 1.307 . . . . 0.0 112.43 -178.239 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 21.3 mm-40 -60.33 -18.79 52.29 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 113.539 0.941 . . . . 0.0 113.539 -178.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 13.3 mt -99.52 22.25 11.05 Favored 'General case' 0 C--N 1.344 0.35 0 N-CA-C 114.728 1.381 . . . . 0.0 114.728 -168.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 6.7 tt -52.19 -58.17 7.43 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 118.856 0.753 . . . . 0.0 111.15 -178.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -68.76 -33.24 75.28 Favored Glycine 0 CA--C 1.529 0.959 0 N-CA-C 111.338 -0.705 . . . . 0.0 111.338 -178.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -74.73 -38.53 62.26 Favored 'General case' 0 CA--C 1.533 0.299 0 O-C-N 122.081 -0.658 . . . . 0.0 112.058 -173.113 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 12.9 mtp -76.65 -17.76 58.96 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.568 0.747 . . . . 0.0 111.553 -179.037 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.64 151.97 45.27 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 123.533 0.733 . . . . 0.0 112.433 -169.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 16.7 p30 50.23 13.93 0.13 Allowed 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 128.379 2.671 . . . . 0.0 117.507 169.032 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 35.8 mmt-85 -70.31 157.24 38.09 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 119.499 1.045 . . . . 0.0 108.474 171.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.01 -46.34 18.37 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 178.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -128.26 149.27 50.55 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-N 120.116 1.325 . . . . 0.0 108.66 169.125 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 16.1 tp -135.46 112.38 10.24 Favored 'General case' 0 CA--C 1.506 -0.719 0 N-CA-C 103.723 -2.695 . . . . 0.0 103.723 177.245 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 46.6 mt -91.94 110.1 22.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 104.811 -2.292 . . . . 0.0 104.811 172.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.5 HD13 HD11 ' A' ' 97' ' ' LEU . 7.3 mt -81.79 135.22 25.43 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 N-CA-C 107.0 -1.482 . . . . 0.0 107.0 170.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -122.66 118.24 27.67 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 102.733 -3.062 . . . . 0.0 102.733 167.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 51.5 t0 -158.51 155.75 29.0 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 125.149 1.38 . . . . 0.0 107.399 -179.156 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -88.45 143.09 27.2 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 169.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 65.2 mt -80.41 -19.66 11.91 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 C-N-CA 125.016 1.326 . . . . 0.0 110.307 -177.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . 0.317 31.3 t 71.29 -38.38 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 C-N-CA 129.818 3.247 . . . . 0.0 114.543 177.713 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 2.7 p -162.42 147.96 12.63 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 120.021 1.282 . . . . 0.0 112.568 169.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 13.8 tppt? -165.51 174.32 10.06 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 128.252 2.621 . . . . 0.0 104.872 169.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 13.2 ptpt -61.24 -26.18 67.58 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 176.226 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 36.0 t-20 -74.99 165.73 24.79 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.475 0.71 . . . . 0.0 110.522 -173.313 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 2.4 m -61.27 151.23 77.02 Favored Pre-proline 0 CA--C 1.548 0.876 0 C-N-CA 124.588 1.155 . . . . 0.0 112.704 -169.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -56.94 158.13 18.14 Favored 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 124.21 3.273 . . . . 0.0 113.556 170.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 65.83 7.7 37.24 Favored Glycine 0 CA--C 1.538 1.485 0 CA-C-O 119.59 -0.561 . . . . 0.0 114.272 170.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 5.0 m -87.31 149.92 24.21 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 125.769 1.627 . . . . 0.0 111.513 -169.181 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 31.0 ttp -93.63 140.93 29.05 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 169.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 56.5 mtm -134.88 125.38 26.64 Favored 'General case' 0 C--O 1.232 0.165 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 169.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 37.6 mm -107.44 123.12 62.51 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 -176.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.9 mp -128.74 143.33 50.9 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.875 -171.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 79.4 mtm180 -91.65 175.82 6.76 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 114.867 -1.06 . . . . 0.0 110.431 -175.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -41.07 -53.61 3.0 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 115.861 1.8 . . . . 0.0 115.861 -169.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -87.78 -14.83 38.6 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 113.199 0.815 . . . . 0.0 113.199 -175.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -78.98 -35.4 43.08 Favored 'General case' 0 N--CA 1.456 -0.128 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 -174.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 94.5 t -60.79 -49.34 89.92 Favored Pre-proline 0 CA--C 1.541 0.618 0 CA-C-O 117.397 -1.287 . . . . 0.0 112.267 -176.081 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_exo -55.41 -39.91 88.46 Favored 'Trans proline' 0 CA--C 1.543 0.943 0 C-N-CA 122.091 1.861 . . . . 0.0 112.146 174.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -76.05 -5.37 46.14 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 177.021 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -87.65 -41.4 13.41 Favored 'General case' 0 C--N 1.341 0.213 0 CA-C-N 119.751 1.159 . . . . 0.0 111.34 -178.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -80.22 22.98 0.5 Allowed 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -169.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 24.5 p -58.65 -26.25 63.57 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.237 1.015 . . . . 0.0 111.964 175.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 36.3 t30 -68.32 115.84 8.21 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.142 0.577 . . . . 0.0 109.652 176.062 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 39.3 mttp -88.81 -6.23 57.51 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 113.051 0.76 . . . . 0.0 113.051 -177.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 97.4 mt -58.45 -48.01 86.5 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 177.133 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 3.9 m -67.21 107.61 1.86 Allowed Pre-proline 0 CA--C 1.542 0.669 0 C-N-CA 127.181 2.192 . . . . 0.0 109.397 -173.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -72.47 -56.65 0.09 OUTLIER 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 122.392 2.061 . . . . 0.0 113.015 -168.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 7.2 t-80 -59.88 -43.85 94.53 Favored 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.409 ' H ' ' CD ' ' A' ' 94' ' ' GLN . 16.9 mp0 -61.29 -39.61 91.09 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 125.587 1.555 . . . . 0.0 108.934 -174.255 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 55.2 tp -64.49 -37.49 87.71 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 118.93 0.786 . . . . 0.0 110.704 175.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -65.38 -46.68 85.13 Favored Glycine 0 CA--C 1.529 0.916 0 N-CA-C 110.986 -0.846 . . . . 0.0 110.986 174.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.5 HD11 HD13 ' A' ' 60' ' ' ILE . 2.9 tm? -58.14 -38.6 76.88 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 117.711 0.755 . . . . 0.0 110.115 173.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -66.06 -45.41 81.43 Favored 'General case' 0 C--N 1.333 -0.142 0 O-C-N 120.838 -1.164 . . . . 0.0 111.254 177.165 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -69.51 -24.75 63.8 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 118.512 0.596 . . . . 0.0 110.574 -179.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -73.91 -37.88 48.8 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.863 0 O-C-N 121.873 -0.517 . . . . 0.0 110.92 172.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 29.6 mt -66.1 -36.32 82.86 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 173.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 46.3 m -65.21 -36.38 83.99 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-O 118.344 -0.836 . . . . 0.0 110.319 171.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.97 -41.53 97.51 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 120.476 1.489 . . . . 0.0 110.686 174.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 11.8 mt -64.24 -32.18 73.66 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 118.79 0.723 . . . . 0.0 111.499 173.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 67.1 ttp85 -71.62 -30.74 66.12 Favored 'General case' 0 CA--C 1.532 0.284 0 O-C-N 121.581 -0.699 . . . . 0.0 109.613 176.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 14.8 m-30 -72.09 -46.32 57.22 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 118.877 0.762 . . . . 0.0 110.368 176.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 35.2 p -73.35 -24.14 60.31 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 118.338 0.517 . . . . 0.0 112.009 -177.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 75.93 8.03 84.46 Favored Glycine 0 CA--C 1.534 1.268 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -168.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -84.84 23.25 1.21 Allowed 'General case' 0 C--N 1.349 0.558 0 CA-C-N 119.812 1.806 . . . . 0.0 111.28 171.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -62.18 138.56 96.05 Favored Pre-proline 0 CA--C 1.547 0.844 0 C-N-CA 124.328 1.051 . . . . 0.0 108.933 169.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -61.42 161.53 23.55 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 123.13 2.553 . . . . 0.0 114.683 -176.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -66.21 -35.87 81.57 Favored 'General case' 0 N--CA 1.471 0.58 0 O-C-N 121.803 -0.561 . . . . 0.0 111.664 174.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 17.9 ttmm -138.53 77.59 1.63 Allowed 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 -176.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -69.79 129.18 38.87 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 106.471 -1.678 . . . . 0.0 106.471 170.132 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -130.41 138.89 50.57 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 175.521 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 17.4 tp -119.78 130.09 54.78 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 119.556 1.071 . . . . 0.0 109.115 176.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 13.3 t -102.59 74.88 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 105.44 -2.059 . . . . 0.0 105.44 169.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -78.55 144.74 28.31 Favored Glycine 0 C--N 1.336 0.539 0 N-CA-C 110.547 -1.021 . . . . 0.0 110.547 -174.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 61.5 t -124.57 134.77 65.88 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.275 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 -178.464 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 40.1 mt -91.01 135.37 28.68 Favored Pre-proline 0 C--N 1.326 -0.449 0 N-CA-C 104.976 -2.231 . . . . 0.0 104.976 169.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -73.28 170.26 20.3 Favored 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 122.008 1.805 . . . . 0.0 111.202 -177.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -89.71 -48.87 6.98 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 168.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 25.1 m -137.31 -34.23 0.72 Allowed 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 116.205 1.928 . . . . 0.0 116.205 -170.002 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 4.3 tp 50.76 50.1 19.65 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.362 1.465 . . . . 0.0 110.495 -168.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -58.84 151.25 55.14 Favored Pre-proline 0 CA--C 1.54 0.577 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 173.152 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -76.37 76.39 3.94 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 122.427 2.085 . . . . 0.0 108.055 169.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . 0.607 ' CD2' ' H ' ' A' ' 128' ' ' ILE . 7.4 t60 -151.47 -167.79 2.9 Favored 'General case' 0 CA--C 1.552 1.028 0 N-CA-C 104.113 -2.551 . . . . 0.0 104.113 175.139 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.607 ' H ' ' CD2' ' A' ' 127' ' ' HIS . 17.5 mt -125.45 -50.2 1.88 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 CA-C-N 123.688 2.949 . . . . 0.0 110.646 -171.145 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.427 ' O ' HG23 ' A' ' 14' ' ' THR . . . -55.73 148.63 26.69 Favored Glycine 0 CA--C 1.53 0.993 0 N-CA-C 111.223 -0.751 . . . . 0.0 111.223 170.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 76.3 mt -70.2 162.64 28.01 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.11 0.964 . . . . 0.0 112.906 -175.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 18.3 p -74.11 164.35 61.83 Favored Pre-proline 0 CA--C 1.543 0.68 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 168.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -62.29 -35.42 73.77 Favored 'Trans proline' 0 CA--C 1.536 0.625 0 C-N-CA 121.259 1.306 . . . . 0.0 112.133 177.037 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 90.7 m -69.16 -37.02 77.99 Favored 'General case' 0 N--CA 1.443 -0.814 0 O-C-N 121.553 -0.717 . . . . 0.0 110.079 -178.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 75.0 t -85.07 -32.16 7.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 O-C-N 121.583 -0.698 . . . . 0.0 109.985 -177.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -54.22 -46.87 72.62 Favored 'General case' 0 CA--C 1.535 0.386 0 O-C-N 121.273 -0.892 . . . . 0.0 109.512 169.094 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -68.07 -16.51 64.05 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 -179.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 8.9 mmm -79.25 -11.58 59.95 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 125.57 1.548 . . . . 0.0 112.678 173.351 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 68.2 mt -55.22 -56.37 11.76 Favored 'Isoleucine or valine' 0 C--N 1.346 0.451 0 CA-C-N 120.902 1.683 . . . . 0.0 109.287 174.341 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -66.42 -46.28 59.42 Favored Pre-proline 0 CA--C 1.548 0.901 0 CA-C-N 119.629 1.104 . . . . 0.0 110.728 -172.37 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 0.3 OUTLIER -44.11 -52.09 5.99 Favored 'Trans proline' 0 C--N 1.352 0.732 1 C-N-CA 125.606 4.204 . . . . 0.0 112.881 168.665 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -72.75 -35.73 67.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 118.329 -0.843 . . . . 0.0 112.616 -178.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 39.7 mt -60.55 -45.97 91.91 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 120.23 1.377 . . . . 0.0 109.384 174.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 31.8 mm-40 -54.37 -36.07 63.48 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 118.493 0.588 . . . . 0.0 110.371 173.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 1.5 mm100 -78.16 -34.1 49.89 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 179.134 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 50.7 t -60.33 -46.48 94.91 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 CA-C-N 119.665 1.121 . . . . 0.0 108.025 170.137 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 55.2 mt -61.35 -35.57 77.79 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 119.211 -0.423 . . . . 0.0 110.509 177.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -71.06 -42.46 69.39 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 119.117 0.872 . . . . 0.0 111.45 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -67.96 -30.66 70.0 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 120.068 1.304 . . . . 0.0 111.132 177.094 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 21.4 mt -63.09 -51.64 65.83 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 169.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 75.6 mtt180 -63.28 -28.62 70.15 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 119.524 1.056 . . . . 0.0 112.288 -178.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -70.52 -18.46 62.95 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 119.056 0.844 . . . . 0.0 111.023 176.076 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 9.8 m -94.01 8.26 42.08 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.976 1.31 . . . . 0.0 111.04 169.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 72.31 15.1 76.96 Favored Glycine 0 CA--C 1.529 0.908 0 CA-C-O 116.995 -2.003 . . . . 0.0 112.951 -172.096 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 61.9 t -96.47 119.77 44.95 Favored 'Isoleucine or valine' 0 C--N 1.348 0.536 0 CA-C-N 121.368 2.584 . . . . 0.0 107.482 -176.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -107.49 91.93 3.86 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 107.065 -1.458 . . . . 0.0 107.065 173.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -52.32 144.32 13.14 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.079 169.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . 0.433 HG21 ' HA ' ' A' ' 160' ' ' SER . 27.1 mm -89.28 124.64 64.17 Favored Pre-proline 0 C--O 1.232 0.16 0 CA-C-O 117.669 -1.158 . . . . 0.0 108.559 -175.767 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -63.27 103.78 0.38 Allowed 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 122.369 2.046 . . . . 0.0 108.495 170.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 29.0 ttp180 37.46 50.68 1.12 Allowed 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 127.201 2.2 . . . . 0.0 114.157 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . 0.433 ' HA ' HG21 ' A' ' 157' ' ' ILE 0.269 3.4 p . . . . . 0 CA--C 1.544 0.744 0 C-N-CA 126.803 2.041 . . . . 0.0 115.657 -179.337 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 23.6 ptt180 . . . . . 0 N--CA 1.475 0.81 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 13.5 mt -140.53 141.01 33.33 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -169.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 17.0 tp -123.05 149.57 44.23 Favored 'General case' 0 N--CA 1.462 0.168 0 N-CA-C 107.216 -1.401 . . . . 0.0 107.216 168.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 66.3 t -123.13 122.87 66.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 105.424 -2.065 . . . . 0.0 105.424 169.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -98.18 130.38 44.93 Favored 'General case' 0 CA--C 1.511 -0.536 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 178.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -105.16 115.9 5.08 Favored Glycine 0 CA--C 1.501 -0.819 0 N-CA-C 104.481 -3.448 . . . . 0.0 104.481 169.487 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 6.8 m -138.46 157.83 30.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 118.933 1.366 . . . . 0.0 111.902 -168.613 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 130.52 -172.76 20.3 Favored Glycine 0 C--N 1.337 0.591 0 O-C-N 124.454 1.096 . . . . 0.0 111.698 169.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.42 HD21 ' HB2' ' A' ' 12' ' ' LEU . 3.1 t30 -87.07 85.86 7.26 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 123.54 0.736 . . . . 0.0 111.723 -169.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.3 pt -58.16 29.88 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.555 1.138 0 N-CA-C 116.421 2.008 . . . . 0.0 116.421 171.007 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.42 ' HB2' HD21 ' A' ' 10' ' ' ASN . 72.1 mt -125.96 -3.29 7.05 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 120.979 1.718 . . . . 0.0 108.927 169.371 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.6 mp -119.59 64.15 0.8 Allowed 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 124.212 1.005 . . . . 0.0 110.44 -169.095 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.466 ' HB ' ' H ' ' A' ' 15' ' ' ASP . 0.1 OUTLIER 51.96 -104.01 0.17 Allowed 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.377 170.74 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.466 ' H ' ' HB ' ' A' ' 14' ' ' THR . 73.2 m-20 -71.21 -16.34 62.5 Favored 'General case' 0 N--CA 1.442 -0.874 0 C-N-CA 124.209 1.004 . . . . 0.0 112.722 -175.47 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -73.76 7.93 2.23 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 120.924 1.693 . . . . 0.0 113.096 -179.757 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -89.66 -15.36 32.81 Favored 'General case' 0 N--CA 1.429 -1.508 0 CA-C-O 115.817 -2.04 . . . . 0.0 107.537 169.374 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 7.1 tp -54.96 -38.65 46.12 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.359 0 CA-C-N 122.329 2.331 . . . . 0.0 112.998 -169.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -59.56 -45.83 94.96 Favored Glycine 0 C--N 1.334 0.464 0 N-CA-C 109.934 -1.266 . . . . 0.0 109.934 176.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 34.3 t -65.85 -46.26 89.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 CA-C-O 118.505 -0.759 . . . . 0.0 110.05 173.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 25.5 mmt180 -62.32 -34.85 77.42 Favored 'General case' 0 C--N 1.346 0.422 0 CA-C-N 120.547 1.522 . . . . 0.0 111.963 -176.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 26.2 mt -61.85 -46.46 96.47 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-N 120.03 1.286 . . . . 0.0 110.137 178.373 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 18.7 m -73.77 -28.59 24.65 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 CA-C-N 119.153 0.888 . . . . 0.0 111.247 -174.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 58.1 mt-10 -70.18 -45.56 66.41 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 174.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.55 -44.59 95.95 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 123.002 0.521 . . . . 0.0 110.108 178.572 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 7.4 tp -63.45 -40.52 97.35 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 118.438 -0.791 . . . . 0.0 110.982 178.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.7 tm-20 -61.76 -42.38 98.91 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 118.7 0.682 . . . . 0.0 110.489 179.149 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 48.7 mm-40 -71.63 -42.8 67.16 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 122.784 0.434 . . . . 0.0 111.536 179.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 40.4 mmt180 -88.05 -35.44 17.54 Favored 'General case' 0 C--N 1.342 0.264 0 CA-C-O 117.37 -1.3 . . . . 0.0 113.441 -169.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 75.9 m-85 -120.12 137.06 54.37 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-N 121.127 1.785 . . . . 0.0 112.056 -173.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 31.6 mm -89.29 134.12 29.48 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 N-CA-C 105.536 -2.024 . . . . 0.0 105.536 168.269 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -119.5 154.85 54.55 Favored Pre-proline 0 CA--C 1.538 0.494 0 C-N-CA 125.563 1.545 . . . . 0.0 108.858 -172.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -63.87 157.9 49.93 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 122.358 2.039 . . . . 0.0 109.991 169.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -58.6 -31.99 68.57 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 113.619 0.97 . . . . 0.0 113.619 -169.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 53.4 p90 -75.38 -1.26 22.99 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 113.931 1.086 . . . . 0.0 113.931 -177.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 59.5 t -111.1 128.2 67.71 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 176.324 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -129.36 143.84 51.0 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 173.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -110.89 108.36 25.26 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 106.282 -1.748 . . . . 0.0 106.282 176.622 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 8.2 tt -106.88 127.06 53.09 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 -172.433 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -81.76 115.95 21.23 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 124.196 0.998 . . . . 0.0 109.824 176.649 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -77.29 -87.66 0.37 Allowed Glycine 0 CA--C 1.531 1.033 0 N-CA-C 108.762 -1.735 . . . . 0.0 108.762 169.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 77.93 106.88 0.18 Allowed Glycine 0 CA--C 1.53 0.976 0 N-CA-C 110.712 -0.955 . . . . 0.0 110.712 -177.145 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 5.3 p 50.99 57.48 6.61 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.017 1.327 . . . . 0.0 109.489 178.126 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -107.9 -87.75 0.48 Allowed 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 114.88 -1.054 . . . . 0.0 110.222 -169.566 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 73.08 -102.04 1.2 Allowed Glycine 0 C--N 1.339 0.709 0 N-CA-C 107.906 -2.077 . . . . 0.0 107.906 -174.399 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 70.8 mmm -68.24 -23.02 64.75 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 122.914 0.486 . . . . 0.0 112.222 -174.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -64.36 -14.91 59.09 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-O 120.793 0.33 . . . . 0.0 111.014 -177.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 59.4 mt -83.34 -10.0 58.73 Favored 'General case' 0 C--N 1.343 0.32 0 N-CA-C 113.912 1.079 . . . . 0.0 113.912 -172.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.406 ' HA ' HG13 ' A' ' 100' ' ' VAL . 3.5 tt -47.66 -67.91 0.23 Allowed 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 119.367 0.985 . . . . 0.0 113.577 -169.436 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -71.4 -26.41 73.41 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 111.339 -0.704 . . . . 0.0 111.339 -171.212 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -78.87 -29.67 44.6 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 122.516 0.326 . . . . 0.0 111.457 -178.403 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 22.3 mtp -83.7 -28.81 28.03 Favored 'General case' 0 CA--C 1.53 0.176 0 O-C-N 121.936 -0.477 . . . . 0.0 111.352 174.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -59.31 153.67 18.29 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-O 121.707 0.765 . . . . 0.0 110.307 175.416 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 64.45 -8.45 0.2 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 126.673 1.989 . . . . 0.0 115.314 169.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 24.7 mmt180 -68.41 153.33 43.96 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 170.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 83.8 m-20 -90.19 -34.82 15.67 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 118.991 -0.528 . . . . 0.0 109.952 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 2.0 t-160 -140.24 122.18 15.57 Favored 'General case' 0 CA--C 1.514 -0.414 0 N-CA-C 104.262 -2.495 . . . . 0.0 104.262 -172.138 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 50.0 tp -128.46 131.57 48.4 Favored 'General case' 0 CA--C 1.509 -0.624 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 179.072 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 39.6 mt -109.57 121.94 63.38 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 N-CA-C 105.012 -2.218 . . . . 0.0 105.012 169.665 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 22.1 mt -98.26 125.16 51.63 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 177.501 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -104.21 119.45 38.97 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 171.022 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -147.6 151.46 36.27 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 124.692 1.197 . . . . 0.0 110.736 -172.405 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -88.19 121.31 30.44 Favored 'General case' 0 C--N 1.343 0.298 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 168.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 7.9 mm -54.2 -39.19 41.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 C-N-CA 124.362 1.065 . . . . 0.0 111.797 -173.572 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . 0.319 6.7 p 43.06 43.03 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.974 0 C-N-CA 126.316 1.846 . . . . 0.0 113.145 175.549 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 4.4 t -157.48 -175.33 5.33 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.946 1.698 . . . . 0.0 109.614 -174.476 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 16.1 tptt 63.29 176.16 0.16 Allowed 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 127.327 2.251 . . . . 0.0 113.433 171.625 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 9.3 ptpt -103.2 0.44 31.69 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 125.404 1.481 . . . . 0.0 112.978 -178.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 49.5 t30 -73.55 162.35 29.34 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.905 0.882 . . . . 0.0 109.08 -177.567 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.8 m -58.97 142.86 84.73 Favored Pre-proline 0 CA--C 1.545 0.783 0 C-N-CA 124.068 0.947 . . . . 0.0 111.816 -169.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -55.15 155.17 20.1 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 122.775 2.316 . . . . 0.0 112.167 170.169 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 70.6 4.62 53.44 Favored Glycine 0 CA--C 1.531 1.062 0 CA-C-O 118.655 -1.081 . . . . 0.0 114.859 174.421 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 20.8 m -86.04 147.97 25.95 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 119.849 1.825 . . . . 0.0 110.458 -172.161 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 15.7 ttp -87.88 137.66 32.14 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 123.435 0.694 . . . . 0.0 110.414 175.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 47.0 mtp -129.03 111.46 13.01 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 178.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 42.3 mm -99.03 115.62 40.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 177.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.9 mp -116.43 134.92 54.32 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 -174.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 20.5 mmm180 -104.66 138.86 40.35 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 123.084 0.553 . . . . 0.0 109.931 -177.464 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 38.8 t70 33.95 -100.27 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 115.463 1.653 . . . . 0.0 115.463 169.011 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -61.0 -24.13 65.93 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.789 1.236 . . . . 0.0 113.733 -174.219 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -73.68 -26.54 60.78 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 122.66 0.384 . . . . 0.0 110.568 178.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 49.2 t -72.2 -53.17 6.62 Favored Pre-proline 0 N--CA 1.445 -0.715 0 CA-C-O 116.888 -1.53 . . . . 0.0 110.756 -169.195 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.404 ' O ' HG23 ' A' ' 87' ' ' THR . 15.4 Cg_exo -61.92 -40.15 45.99 Favored 'Trans proline' 0 N--CA 1.448 -1.2 0 CA-C-N 121.992 1.747 . . . . 0.0 110.094 174.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -62.12 -30.35 70.97 Favored 'General case' 0 C--N 1.346 0.414 0 C-N-CA 123.364 0.666 . . . . 0.0 112.38 -174.271 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.502 HD13 ' C ' ' A' ' 85' ' ' LEU . 1.7 tm? -68.65 -47.08 67.47 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 171.14 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -64.19 -19.23 65.19 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 -169.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.404 HG23 ' O ' ' A' ' 83' ' ' PRO . 2.2 p -71.17 -17.79 62.52 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 -177.764 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 3.4 p30 -59.5 148.93 31.28 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -169.239 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -85.59 -13.54 48.48 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 118.816 -0.611 . . . . 0.0 112.618 -173.614 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 61.9 mt -70.29 -46.65 70.68 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 -178.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 5.0 m -78.1 119.1 76.04 Favored Pre-proline 0 CA--C 1.54 0.558 0 C-N-CA 124.263 1.025 . . . . 0.0 110.642 -174.285 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -81.96 -39.26 0.18 Allowed 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 121.573 1.515 . . . . 0.0 112.267 -177.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 24.3 m-70 -74.33 -29.67 61.71 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.358 0.663 . . . . 0.0 111.552 -171.194 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 90.6 mt-30 -74.53 -17.5 60.73 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 118.387 -0.816 . . . . 0.0 113.116 -169.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 47.5 tp -59.85 -35.04 73.93 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 119.692 1.133 . . . . 0.0 111.618 -172.277 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -65.66 -42.43 95.41 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 111.482 -0.647 . . . . 0.0 111.482 175.467 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 27.6 tp -70.29 -33.65 71.81 Favored 'General case' 0 CA--C 1.531 0.223 0 O-C-N 120.91 -1.347 . . . . 0.0 109.945 178.328 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -59.34 -50.33 74.41 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 118.908 0.776 . . . . 0.0 109.724 173.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -70.2 -24.74 63.17 Favored 'General case' 0 N--CA 1.457 -0.101 0 CA-C-O 118.682 -0.675 . . . . 0.0 112.02 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.406 HG13 ' HA ' ' A' ' 49' ' ' LEU . 2.5 t -65.09 -45.35 94.53 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 CA-C-N 119.451 1.023 . . . . 0.0 109.973 169.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 59.7 mt -64.91 -37.87 89.08 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 119.659 1.118 . . . . 0.0 109.705 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 18.6 m -61.92 -40.74 96.54 Favored 'General case' 0 C--O 1.224 -0.238 0 CA-C-N 118.605 0.638 . . . . 0.0 110.107 170.018 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.457 ' HA ' ' CD2' ' A' ' 106' ' ' PHE . . . -66.31 -33.88 76.73 Favored 'General case' 0 N--CA 1.448 -0.553 0 O-C-N 121.168 -0.957 . . . . 0.0 111.067 -179.759 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 6.4 mt -67.86 -34.25 76.32 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-N 118.929 0.786 . . . . 0.0 109.629 175.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 80.0 ttt180 -68.38 -36.43 79.16 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 118.846 -0.597 . . . . 0.0 110.06 172.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.457 ' CD2' ' HA ' ' A' ' 103' ' ' ALA . 15.4 m-30 -65.43 -43.38 90.68 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 119.305 0.957 . . . . 0.0 110.572 178.559 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 41.6 p -74.53 -23.25 58.79 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 118.571 0.623 . . . . 0.0 111.303 177.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 75.18 12.55 83.41 Favored Glycine 0 CA--C 1.531 1.086 0 N-CA-C 110.832 -0.907 . . . . 0.0 110.832 -169.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -96.84 22.16 8.63 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 118.766 1.283 . . . . 0.0 111.235 178.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -58.1 132.87 84.03 Favored Pre-proline 0 CA--C 1.544 0.727 0 C-N-CA 124.964 1.306 . . . . 0.0 109.656 171.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_exo -56.58 150.71 50.62 Favored 'Trans proline' 0 N--CA 1.46 -0.479 0 C-N-CA 123.351 2.701 . . . . 0.0 114.932 -178.485 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -59.88 -34.57 73.34 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.059 177.193 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 59.2 mttp -134.39 130.4 36.81 Favored 'General case' 0 C--O 1.232 0.16 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 173.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.443 HD12 ' H ' ' A' ' 115' ' ' THR . 18.2 tp -118.19 139.15 51.72 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 105.19 -2.152 . . . . 0.0 105.19 168.736 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.443 ' H ' HD12 ' A' ' 114' ' ' LEU . 0.2 OUTLIER -141.39 146.34 36.48 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 105.656 -1.979 . . . . 0.0 105.656 -177.669 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -135.37 136.1 41.22 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 119.729 1.15 . . . . 0.0 109.841 172.815 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 47.6 t -103.61 99.63 8.8 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 N-CA-C 103.61 -2.737 . . . . 0.0 103.61 169.278 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -87.24 145.43 19.74 Favored Glycine 0 N--CA 1.444 -0.825 0 N-CA-C 110.317 -1.113 . . . . 0.0 110.317 176.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 53.2 t -127.35 121.19 56.79 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.497 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 175.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 6.5 mt -71.88 132.48 84.87 Favored Pre-proline 0 CA--C 1.539 0.55 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 173.153 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -73.67 179.35 5.7 Favored 'Trans proline' 0 CA--C 1.541 0.848 0 C-N-CA 122.995 2.463 . . . . 0.0 111.91 179.146 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -115.47 -53.71 2.58 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.488 1.115 . . . . 0.0 110.032 177.446 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 56.1 p -110.25 -65.6 1.14 Allowed 'General case' 0 CA--C 1.535 0.365 0 CA-C-N 119.058 0.845 . . . . 0.0 111.954 -172.632 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 56.29 70.34 0.65 Allowed 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.674 1.99 . . . . 0.0 113.702 176.187 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -128.79 169.83 12.05 Favored Pre-proline 0 CA--C 1.542 0.658 0 CA-C-O 118.331 -0.843 . . . . 0.0 109.421 169.695 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_exo -65.92 85.21 0.24 Allowed 'Trans proline' 0 CA--C 1.547 1.126 0 C-N-CA 123.617 2.878 . . . . 0.0 113.34 -178.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -175.83 151.18 1.1 Allowed 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 104.404 -2.443 . . . . 0.0 104.404 176.368 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -114.3 161.84 12.83 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 -169.654 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 107.42 141.74 10.11 Favored Glycine 0 CA--C 1.528 0.878 0 N-CA-C 106.85 -2.5 . . . . 0.0 106.85 -169.514 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 68.7 mt -78.54 158.17 28.62 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 118.645 1.223 . . . . 0.0 108.971 175.607 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 36.3 p -68.19 164.92 38.05 Favored Pre-proline 0 C--O 1.238 0.462 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 168.304 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -56.69 -33.64 94.17 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 121.477 1.451 . . . . 0.0 110.76 169.334 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 5.9 m -66.48 -43.68 84.73 Favored 'General case' 0 CA--C 1.535 0.37 0 O-C-N 122.201 -0.312 . . . . 0.0 110.183 -178.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 94.4 t -88.48 -28.43 5.37 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 CA-C-N 118.683 0.674 . . . . 0.0 110.075 -172.224 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -55.12 -45.85 75.57 Favored 'General case' 0 CA--C 1.533 0.31 0 O-C-N 120.667 -1.27 . . . . 0.0 107.774 167.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -75.48 18.5 0.22 Allowed 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 114.152 1.167 . . . . 0.0 114.152 176.148 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 25.8 mmm -115.03 -8.44 12.46 Favored 'General case' 0 N--CA 1.437 -1.084 0 C-N-CA 125.743 1.617 . . . . 0.0 107.965 169.215 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 96.3 mt -59.5 -49.65 82.85 Favored 'Isoleucine or valine' 0 C--N 1.346 0.423 0 CA-C-N 120.379 1.445 . . . . 0.0 107.859 174.582 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -70.71 -53.73 8.97 Favored Pre-proline 0 CA--C 1.536 0.408 0 CA-C-O 117.121 -1.418 . . . . 0.0 109.584 -175.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -38.75 -52.63 2.07 Favored 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 123.876 3.051 . . . . 0.0 113.822 169.113 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -74.19 -45.85 45.78 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.085 -1.416 . . . . 0.0 110.808 -172.137 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -62.28 -36.38 81.89 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-N 118.982 0.81 . . . . 0.0 109.722 179.453 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -64.2 -36.0 82.65 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 177.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 11.9 mm100 -74.56 -31.09 61.98 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-O 117.869 -1.063 . . . . 0.0 112.266 172.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 86.7 t -59.83 -46.25 93.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-N 120.446 1.475 . . . . 0.0 108.154 169.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 74.4 mt -62.68 -41.17 98.95 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 118.714 0.688 . . . . 0.0 110.42 177.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -62.78 -41.04 99.08 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 118.813 0.733 . . . . 0.0 111.0 179.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -66.55 -46.37 76.3 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 177.366 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 78.0 mt -57.76 -37.17 73.16 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 122.514 0.326 . . . . 0.0 110.228 177.391 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 67.6 mtp180 -64.07 -19.09 64.98 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 118.019 -0.991 . . . . 0.0 112.284 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -61.89 -30.12 70.67 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 120.182 1.355 . . . . 0.0 110.546 174.17 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 49.1 m -101.16 31.11 3.79 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.021 1.328 . . . . 0.0 111.447 174.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 66.48 21.5 70.66 Favored Glycine 0 CA--C 1.53 0.974 0 CA-C-O 119.251 -0.749 . . . . 0.0 114.248 169.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 81.6 t -72.74 120.03 20.61 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 CA-C-N 118.572 1.186 . . . . 0.0 107.934 178.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -103.45 94.35 5.43 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 105.744 -1.947 . . . . 0.0 105.744 169.625 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -74.21 144.14 44.85 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 175.701 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 9.2 mm -112.04 127.88 26.24 Favored Pre-proline 0 CA--C 1.53 0.191 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -62.6 109.58 0.91 Allowed 'Trans proline' 0 N--CA 1.458 -0.599 0 N-CA-C 107.425 -1.798 . . . . 0.0 107.425 170.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 70.2 ttt-85 56.0 -9.43 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 127.799 2.44 . . . . 0.0 116.809 179.676 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 4.3 m . . . . . 0 CA--C 1.545 0.764 0 C-N-CA 126.524 1.93 . . . . 0.0 114.742 -169.564 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 28.5 tpt85 . . . . . 0 N--CA 1.469 0.486 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.8 mt -120.21 127.39 75.9 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 -172.01 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 19.4 tp -121.23 138.36 54.26 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 105.256 -2.128 . . . . 0.0 105.256 168.519 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 92.6 t -124.01 110.58 25.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 -177.178 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.435 HD13 ' HA ' ' A' ' 6' ' ' LEU . 2.8 mm? -93.73 125.37 38.31 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 -174.367 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -99.58 127.7 9.33 Favored Glycine 0 CA--C 1.508 -0.405 0 N-CA-C 106.17 -2.772 . . . . 0.0 106.17 170.435 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.1 m -138.79 167.15 21.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 117.595 0.697 . . . . 0.0 111.272 -169.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 109.59 169.79 20.27 Favored Glycine 0 CA--C 1.525 0.709 0 C-N-CA 125.973 1.749 . . . . 0.0 110.403 179.099 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.557 HD21 ' HB2' ' A' ' 12' ' ' LEU . 8.7 t30 -87.02 104.95 16.79 Favored 'General case' 0 N--CA 1.452 -0.336 0 O-C-N 121.865 -0.785 . . . . 0.0 110.794 -172.45 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.2 pt -63.67 32.99 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.892 0 N-CA-C 115.501 1.667 . . . . 0.0 115.501 175.036 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.557 ' HB2' HD21 ' A' ' 10' ' ' ASN . 42.4 mt -127.39 0.82 6.32 Favored 'General case' 0 C--O 1.222 -0.386 0 CA-C-N 120.504 1.502 . . . . 0.0 108.14 168.785 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.528 ' HB2' HD22 ' A' ' 10' ' ' ASN . 1.3 mp -118.06 52.28 1.02 Allowed 'General case' 0 N--CA 1.441 -0.916 0 C-N-CA 124.002 0.921 . . . . 0.0 112.074 -168.633 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER 53.8 -108.16 0.41 Allowed 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 122.862 0.465 . . . . 0.0 111.498 171.239 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -57.13 -25.18 58.42 Favored 'General case' 0 C--O 1.224 -0.287 0 CA-C-O 118.209 -0.901 . . . . 0.0 113.009 176.357 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -70.53 -0.03 7.7 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 121.535 1.971 . . . . 0.0 113.542 -177.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -89.0 -16.08 32.57 Favored 'General case' 0 N--CA 1.431 -1.39 0 CA-C-O 115.92 -1.99 . . . . 0.0 108.957 169.389 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 5.9 tp -58.34 -38.0 66.71 Favored 'Isoleucine or valine' 0 C--N 1.342 0.278 0 CA-C-N 122.829 2.559 . . . . 0.0 111.798 -169.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -59.71 -38.83 94.42 Favored Glycine 0 C--N 1.338 0.679 0 N-CA-C 110.572 -1.011 . . . . 0.0 110.572 176.304 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 79.0 t -73.29 -48.44 42.6 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.652 0 CA-C-O 118.641 -0.695 . . . . 0.0 109.452 174.374 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 15.6 mmm180 -59.48 -36.14 75.45 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 120.367 1.439 . . . . 0.0 112.621 -176.421 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 33.6 mt -62.18 -46.7 95.86 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 CA-C-N 120.418 1.463 . . . . 0.0 109.983 179.236 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 10.3 m -72.65 -29.33 30.03 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 O-C-N 121.298 -0.876 . . . . 0.0 110.887 -174.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -70.44 -41.72 72.47 Favored 'General case' 0 CA--C 1.528 0.102 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 175.022 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.41 -37.21 82.65 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-O 118.735 -0.65 . . . . 0.0 110.444 178.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 11.9 tp -62.45 -42.59 99.57 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 118.867 0.758 . . . . 0.0 109.939 174.297 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -62.78 -41.19 99.15 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 118.461 0.573 . . . . 0.0 110.815 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -67.42 -42.69 82.79 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.193 0.997 . . . . 0.0 110.635 179.08 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 88.3 mtt180 -94.43 -38.89 10.72 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 114.837 1.421 . . . . 0.0 114.837 -169.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 63.3 m-85 -113.84 137.68 51.32 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 121.391 1.905 . . . . 0.0 114.207 -169.293 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 47.0 mm -85.68 141.84 13.97 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 N-CA-C 104.382 -2.451 . . . . 0.0 104.382 167.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 46.5 mt -135.98 152.87 76.42 Favored Pre-proline 0 CA--C 1.539 0.55 0 C-N-CA 123.496 0.718 . . . . 0.0 110.518 -169.474 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_exo -59.27 155.2 41.75 Favored 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 123.336 2.691 . . . . 0.0 111.829 169.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -63.01 -31.09 72.14 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -171.232 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 26.1 p90 -70.63 -13.96 62.29 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 118.358 -0.83 . . . . 0.0 112.547 179.149 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 42.7 t -94.91 129.25 45.33 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 C-N-CA 124.114 0.966 . . . . 0.0 108.639 178.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -136.13 146.06 46.53 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-O 121.252 0.548 . . . . 0.0 110.607 170.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -105.28 130.35 56.65 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 N-CA-C 105.648 -1.982 . . . . 0.0 105.648 169.024 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 64.5 tp -121.61 126.41 49.02 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-O 121.311 0.577 . . . . 0.0 109.732 175.088 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -77.87 115.69 17.81 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 169.523 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -64.58 -64.25 3.71 Favored Glycine 0 CA--C 1.531 1.074 0 N-CA-C 108.225 -1.95 . . . . 0.0 108.225 169.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 79.2 106.0 0.23 Allowed Glycine 0 C--N 1.34 0.793 0 N-CA-C 110.765 -0.934 . . . . 0.0 110.765 171.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . 0.254 40.2 p 50.18 61.18 3.33 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 -173.434 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -89.01 -140.36 0.13 Allowed 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 113.608 -1.633 . . . . 0.0 110.925 -169.304 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 75.93 118.85 0.13 Allowed Glycine 0 CA--C 1.537 1.417 0 N-CA-C 109.031 -1.628 . . . . 0.0 109.031 -168.605 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 1.6 mmt 61.59 -29.37 0.06 Allowed 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 127.521 2.328 . . . . 0.0 116.411 -173.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -59.47 -21.42 60.06 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 118.998 0.817 . . . . 0.0 112.769 -175.03 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 95.8 mt -91.79 9.63 31.88 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 -171.339 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.5 tt -73.15 79.94 1.26 Allowed 'General case' 0 C--O 1.233 0.213 0 CA-C-O 124.843 2.258 . . . . 0.0 110.827 -179.035 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 145.13 -33.64 1.59 Allowed Glycine 0 C--N 1.308 -0.989 0 CA-C-N 110.142 -3.208 . . . . 0.0 111.028 172.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -68.24 -35.3 77.72 Favored 'General case' 0 N--CA 1.466 0.345 0 O-C-N 121.933 -0.745 . . . . 0.0 111.525 -176.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 38.1 mtp -72.38 0.56 9.79 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.891 1.277 . . . . 0.0 113.151 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -75.63 149.13 38.28 Favored 'General case' 0 N--CA 1.457 -0.087 0 N-CA-C 113.777 1.029 . . . . 0.0 113.777 -169.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 55.26 18.15 2.37 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 128.317 2.647 . . . . 0.0 116.412 168.695 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 27.1 mmt180 -77.91 149.33 34.24 Favored 'General case' 0 N--CA 1.473 0.698 0 O-C-N 120.798 -1.189 . . . . 0.0 109.416 -178.312 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -80.97 -39.55 25.84 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 177.071 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 1.8 m170 -128.07 136.28 50.99 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 169.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 29.2 tp -130.92 123.72 29.53 Favored 'General case' 0 CA--C 1.505 -0.78 0 N-CA-C 105.851 -1.907 . . . . 0.0 105.851 168.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 18.5 mt -111.35 122.41 65.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 104.657 -2.349 . . . . 0.0 104.657 178.038 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 21.0 mt -102.94 126.56 57.18 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 N-CA-C 105.881 -1.896 . . . . 0.0 105.881 -179.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -111.32 119.09 37.72 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 105.261 -2.126 . . . . 0.0 105.261 171.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -149.1 149.93 31.88 Favored 'General case' 0 C--O 1.24 0.557 0 O-C-N 123.4 0.438 . . . . 0.0 110.202 -175.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -68.64 132.01 46.17 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 104.536 -2.394 . . . . 0.0 104.536 168.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.6 tt -74.95 -38.07 42.58 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.778 0 O-C-N 121.582 -0.699 . . . . 0.0 110.797 -169.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.2 t 45.62 44.43 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.822 0 C-N-CA 125.919 1.688 . . . . 0.0 111.144 176.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 67.2 m -138.75 -73.31 0.39 Allowed 'General case' 0 N--CA 1.471 0.577 0 O-C-N 121.54 -0.725 . . . . 0.0 112.552 -169.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 29.3 ttmt -83.02 154.68 24.33 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 122.758 0.423 . . . . 0.0 109.871 -169.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.32 42.8 1.11 Allowed 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 125.283 1.433 . . . . 0.0 109.033 -172.158 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 40.7 t-20 -89.74 172.47 8.9 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 124.26 1.024 . . . . 0.0 108.915 -171.358 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 10.7 m -60.25 133.95 90.7 Favored Pre-proline 0 CA--C 1.544 0.726 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 179.066 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -57.82 153.66 42.41 Favored 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 122.392 2.061 . . . . 0.0 111.615 174.127 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 71.53 9.38 68.88 Favored Glycine 0 CA--C 1.533 1.163 0 CA-C-O 119.703 -0.498 . . . . 0.0 113.803 176.111 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 29.3 m -89.03 146.56 24.78 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 124.971 1.309 . . . . 0.0 107.545 174.244 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 30.0 ttp -101.78 143.13 32.08 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 175.328 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 17.9 ttm -126.5 126.65 44.08 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 179.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 44.0 mm -107.57 121.19 60.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 -179.108 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -115.71 129.37 56.44 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 -174.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 81.0 mtm180 -90.9 173.45 7.97 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 118.293 0.497 . . . . 0.0 110.288 179.159 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -33.39 -66.15 0.16 Allowed 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 116.215 1.931 . . . . 0.0 116.215 -169.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -77.08 -12.34 59.93 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -172.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 21.6 mm-40 -91.78 -21.95 20.42 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 118.558 -0.734 . . . . 0.0 110.664 -178.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.447 HG22 ' HB3' ' A' ' 116' ' ' LEU . 63.0 t -62.97 -51.13 73.25 Favored Pre-proline 0 C--N 1.344 0.331 0 CA-C-N 120.168 1.349 . . . . 0.0 110.967 -179.111 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -66.65 -37.8 20.52 Favored 'Trans proline' 0 N--CA 1.444 -1.393 0 CA-C-N 121.423 1.544 . . . . 0.0 109.708 -179.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.97 -29.04 69.37 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.298 0.639 . . . . 0.0 111.812 -176.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.521 HD13 ' C ' ' A' ' 85' ' ' LEU . 1.1 tm? -68.31 -47.65 67.01 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 169.743 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.557 ' HB3' ' HB2' ' A' ' 98' ' ' ALA . 12.9 m-85 -64.63 -11.2 32.71 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 114.041 1.126 . . . . 0.0 114.041 -169.422 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 24.9 p -66.76 -13.65 61.66 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 113.784 1.031 . . . . 0.0 113.784 -175.281 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -59.29 135.03 57.52 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.362 0.665 . . . . 0.0 110.652 -172.601 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -87.04 -12.48 47.22 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 -170.394 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 76.2 mt -67.82 -43.55 86.11 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 N-CA-C 107.421 -1.325 . . . . 0.0 107.421 174.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -65.78 130.84 94.57 Favored Pre-proline 0 N--CA 1.445 -0.722 0 C-N-CA 125.802 1.641 . . . . 0.0 110.768 -173.132 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -80.78 -87.55 0.0 OUTLIER 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 123.059 2.506 . . . . 0.0 111.416 177.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 19.4 m80 -66.98 -32.15 73.2 Favored 'General case' 0 N--CA 1.469 0.477 0 O-C-N 120.645 -1.285 . . . . 0.0 110.976 -170.312 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.418 ' H ' ' CD ' ' A' ' 94' ' ' GLN . 26.2 mp0 -53.86 -42.65 68.8 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 126.365 1.866 . . . . 0.0 109.93 173.536 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.403 ' O ' ' HB3' ' A' ' 98' ' ' ALA . 3.1 tm? -70.7 -37.1 73.56 Favored 'General case' 0 N--CA 1.457 -0.117 0 O-C-N 121.571 -0.705 . . . . 0.0 109.671 179.401 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -59.69 -38.87 94.45 Favored Glycine 0 CA--C 1.53 0.983 0 O-C-N 121.254 -0.904 . . . . 0.0 111.44 171.52 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.445 HD23 ' CZ ' ' A' ' 86' ' ' PHE . 24.3 tp -70.19 -28.13 65.06 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 118.37 1.085 . . . . 0.0 110.461 174.423 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.557 ' HB2' ' HB3' ' A' ' 86' ' ' PHE . . . -56.23 -46.87 79.38 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 120.141 1.337 . . . . 0.0 109.089 169.689 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -72.56 -24.21 61.08 Favored 'General case' 0 C--O 1.231 0.08 0 CA-C-O 119.193 -0.432 . . . . 0.0 111.952 -179.163 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 74.2 t -65.45 -46.16 90.82 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 169.19 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 76.1 mt -64.03 -35.28 80.19 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 118.961 0.801 . . . . 0.0 110.433 -179.053 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 19.7 m -63.97 -43.29 96.19 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 118.796 0.725 . . . . 0.0 110.197 170.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -64.9 -41.5 95.54 Favored 'General case' 0 N--CA 1.452 -0.367 0 O-C-N 120.972 -1.08 . . . . 0.0 111.387 -178.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -65.33 -31.58 72.79 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 124.486 1.114 . . . . 0.0 110.318 176.148 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 19.1 tpp180 -70.91 -37.85 72.96 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 118.839 -0.6 . . . . 0.0 109.897 173.58 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 15.2 m-30 -65.44 -42.46 92.4 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 118.773 0.715 . . . . 0.0 110.405 -179.572 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 31.2 p -74.96 -21.5 59.13 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 118.304 0.502 . . . . 0.0 111.603 178.543 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 74.34 11.19 82.31 Favored Glycine 0 CA--C 1.534 1.262 0 N-CA-C 111.066 -0.814 . . . . 0.0 111.066 -169.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -83.74 2.27 38.72 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 118.77 1.285 . . . . 0.0 111.944 177.041 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -48.67 134.63 13.69 Favored Pre-proline 0 CA--C 1.549 0.92 0 C-N-CA 125.745 1.618 . . . . 0.0 110.989 177.009 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -52.0 150.02 19.49 Favored 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 124.082 3.188 . . . . 0.0 114.258 179.65 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 31.7 mmmt -63.26 -28.92 70.35 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 118.955 -0.545 . . . . 0.0 111.183 177.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 36.0 ttmt -146.69 110.95 5.1 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 171.226 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 26.2 tp -90.1 144.58 25.76 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 169.119 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -141.45 146.46 36.53 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 171.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.447 ' HB3' HG22 ' A' ' 82' ' ' VAL . 0.8 OUTLIER -131.4 138.99 49.34 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 120.408 1.458 . . . . 0.0 110.436 172.78 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 43.6 t -105.17 105.93 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 N-CA-C 104.808 -2.293 . . . . 0.0 104.808 168.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -90.07 146.05 18.5 Favored Glycine 0 CA--C 1.522 0.516 0 N-CA-C 110.484 -1.046 . . . . 0.0 110.484 174.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.455 HG13 ' SD ' ' A' ' 137' ' ' MET . 71.0 t -119.31 138.64 49.32 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 175.575 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 14.4 mm -84.94 128.23 61.3 Favored Pre-proline 0 CA--C 1.543 0.679 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 169.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -70.12 152.3 67.41 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 122.786 2.324 . . . . 0.0 113.365 -176.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -99.58 -42.41 6.92 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 169.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 20.2 m -142.66 151.06 41.02 Favored 'General case' 0 C--N 1.344 0.348 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 176.641 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.5 tp -153.77 49.61 0.67 Allowed 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 118.719 0.691 . . . . 0.0 111.779 -172.275 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -120.32 168.93 9.45 Favored Pre-proline 0 N--CA 1.477 0.919 0 CA-C-O 117.638 -1.172 . . . . 0.0 110.072 -175.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -62.89 84.3 0.11 Allowed 'Trans proline' 0 CA--C 1.547 1.167 0 C-N-CA 124.138 3.225 . . . . 0.0 113.915 -178.219 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -176.52 156.53 1.52 Allowed 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 105.212 -2.144 . . . . 0.0 105.212 174.527 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -130.54 162.17 39.03 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 CA-C-O 121.772 0.796 . . . . 0.0 110.844 174.817 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 122.36 121.96 2.76 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 103.387 -3.885 . . . . 0.0 103.387 -168.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 74.8 mt -78.86 152.21 31.38 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 -171.108 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 68.6 p -69.8 166.04 35.96 Favored Pre-proline 0 C--O 1.241 0.632 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 169.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -60.21 -27.86 85.73 Favored 'Trans proline' 0 CA--C 1.539 0.727 0 CA-C-N 119.677 0.92 . . . . 0.0 110.466 169.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 5.1 m -69.85 -42.11 73.98 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 118.505 0.593 . . . . 0.0 110.35 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 72.7 t -88.46 -36.6 9.33 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 CA-C-O 119.175 -0.44 . . . . 0.0 110.346 -169.348 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -50.7 -44.59 58.01 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 119.204 0.911 . . . . 0.0 109.938 169.428 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -77.76 5.2 9.92 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 113.789 1.033 . . . . 0.0 113.789 -175.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . 0.455 ' SD ' HG13 ' A' ' 119' ' ' VAL . 75.3 mtp -98.18 -7.28 29.68 Favored 'General case' 0 N--CA 1.439 -1.015 0 CA-C-O 117.387 -1.292 . . . . 0.0 110.59 169.612 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 94.7 mt -57.67 -47.25 86.06 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 CA-C-N 120.225 1.375 . . . . 0.0 108.391 174.317 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 58.3 mt-10 -73.56 -48.65 6.83 Favored Pre-proline 0 CA--C 1.542 0.667 0 CA-C-O 117.534 -1.222 . . . . 0.0 110.637 -175.611 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -43.38 -54.38 3.6 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 124.611 3.541 . . . . 0.0 112.645 168.686 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.35 -42.52 71.73 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 114.788 -1.096 . . . . 0.0 110.755 -174.283 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 33.1 mt -54.69 -44.12 73.09 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-N 118.961 0.8 . . . . 0.0 109.45 173.367 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -64.44 -34.65 78.68 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 119.075 0.852 . . . . 0.0 110.887 -176.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -78.43 -32.8 48.74 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 119.231 0.923 . . . . 0.0 112.021 176.52 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 54.0 t -59.59 -47.99 88.97 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 169.355 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 44.7 mt -64.47 -36.97 85.91 Favored 'General case' 0 CA--C 1.519 -0.244 0 C-N-CA 123.061 0.544 . . . . 0.0 110.67 -178.518 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -58.18 -36.38 72.98 Favored 'General case' 0 N--CA 1.457 -0.118 0 CA-C-N 118.419 0.554 . . . . 0.0 111.21 179.216 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -63.0 -44.84 94.9 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 117.985 0.357 . . . . 0.0 110.91 177.439 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 6.2 mp -63.21 -40.26 96.99 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 176.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 87.0 mtt180 -64.81 -18.87 65.5 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 117.411 -1.281 . . . . 0.0 111.759 -179.081 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 69.8 mt-10 -56.26 -30.15 62.05 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 120.53 1.514 . . . . 0.0 112.138 176.359 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 19.4 m -113.38 31.53 6.41 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.294 1.038 . . . . 0.0 111.311 179.211 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 65.42 29.98 76.5 Favored Glycine 0 CA--C 1.531 1.05 0 CA-C-O 118.73 -1.039 . . . . 0.0 113.583 175.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 47.1 t -111.14 103.32 15.29 Favored 'Isoleucine or valine' 0 C--N 1.34 0.175 0 N-CA-C 106.684 -1.599 . . . . 0.0 106.684 176.299 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -100.8 144.87 29.24 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 169.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -78.68 157.5 28.59 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.388 0.675 . . . . 0.0 111.357 177.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 11.7 mt -99.14 112.43 63.09 Favored Pre-proline 0 CA--C 1.532 0.263 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -66.98 104.63 0.86 Allowed 'Trans proline' 0 N--CA 1.458 -0.591 0 N-CA-C 107.942 -1.599 . . . . 0.0 107.942 175.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 69.5 ttt180 57.29 -14.08 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 128.344 2.658 . . . . 0.0 116.98 -178.06 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 2.9 t . . . . . 0 CA--C 1.542 0.667 0 C-N-CA 125.447 1.499 . . . . 0.0 111.047 -169.648 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 7.0 ptp180 . . . . . 0 N--CA 1.48 1.043 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 38.5 mt -142.69 143.8 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-N 119.612 1.096 . . . . 0.0 110.85 -169.104 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 19.7 tp -131.88 109.86 10.39 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 104.168 -2.531 . . . . 0.0 104.168 167.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.422 HG12 HG12 ' A' ' 23' ' ' VAL . 39.2 t -85.84 118.72 32.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 102.441 -3.17 . . . . 0.0 102.441 171.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -119.9 105.52 11.17 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-O 121.114 0.483 . . . . 0.0 110.411 -168.673 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -87.46 115.62 4.36 Favored Glycine 0 N--CA 1.447 -0.614 0 N-CA-C 107.651 -2.18 . . . . 0.0 107.651 174.298 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 14.8 m -123.46 -176.38 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.633 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 174.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 111.49 124.71 4.54 Favored Glycine 0 N--CA 1.441 -1.031 0 N-CA-C 106.75 -2.54 . . . . 0.0 106.75 -175.002 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.463 HD21 ' HB2' ' A' ' 12' ' ' LEU . 1.6 t30 -64.03 109.46 1.82 Allowed 'General case' 0 N--CA 1.442 -0.85 0 C-N-CA 124.284 1.034 . . . . 0.0 109.917 -169.539 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.3 pt -75.65 37.77 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 C-N-CA 124.642 1.177 . . . . 0.0 113.463 -178.685 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.463 ' HB2' HD21 ' A' ' 10' ' ' ASN . 20.8 mt -124.24 0.18 8.35 Favored 'General case' 0 CA--C 1.535 0.398 0 O-C-N 121.118 -0.989 . . . . 0.0 108.502 169.619 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.2 mp -132.56 72.66 1.5 Allowed 'General case' 0 C--N 1.346 0.446 0 N-CA-C 104.895 -2.261 . . . . 0.0 104.895 -173.454 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 98.9 m 17.85 -92.84 0.0 OUTLIER 'General case' 0 CA--C 1.522 -0.115 0 C-N-CA 127.091 2.156 . . . . 0.0 115.364 175.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -53.73 -30.74 45.4 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 125.028 1.331 . . . . 0.0 113.003 -169.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -64.61 -31.54 72.81 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 119.592 1.087 . . . . 0.0 111.901 179.513 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.14 -12.55 8.79 Favored 'General case' 0 N--CA 1.437 -1.091 0 CA-C-O 116.187 -1.863 . . . . 0.0 111.277 176.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 5.4 tp -49.55 -42.13 16.68 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.507 0 CA-C-N 121.813 2.097 . . . . 0.0 110.539 179.157 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -66.65 -36.2 90.97 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 111.256 -0.738 . . . . 0.0 111.256 -176.447 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 69.8 t -67.81 -45.55 84.08 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 172.313 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 20.7 mmt180 -61.53 -29.14 69.81 Favored 'General case' 0 C--O 1.225 -0.201 0 CA-C-O 117.282 -1.342 . . . . 0.0 112.055 178.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 6.3 mm -60.93 -53.11 53.62 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-N 120.682 1.583 . . . . 0.0 108.736 176.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.422 HG12 HG12 ' A' ' 5' ' ' VAL . 34.1 m -71.36 -32.24 46.09 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-N 119.199 0.909 . . . . 0.0 111.505 -173.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 63.4 mt-10 -64.89 -49.57 69.95 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 118.49 0.586 . . . . 0.0 109.883 173.456 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.1 -36.5 83.8 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 119.198 -0.43 . . . . 0.0 110.231 179.031 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 8.2 tp -62.4 -40.42 96.45 Favored 'General case' 0 C--O 1.225 -0.227 0 CA-C-N 119.49 1.041 . . . . 0.0 109.36 -179.217 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -67.83 -25.47 65.58 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 121.339 0.59 . . . . 0.0 112.303 -178.309 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -81.86 -39.29 24.13 Favored 'General case' 0 N--CA 1.436 -1.128 0 C-N-CA 126.219 1.808 . . . . 0.0 109.685 175.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 23.4 mmt85 -89.63 -32.55 17.03 Favored 'General case' 0 C--O 1.231 0.099 0 CA-C-O 118.662 -0.685 . . . . 0.0 112.1 -169.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -128.22 147.73 50.59 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 118.944 0.793 . . . . 0.0 111.334 -176.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 51.6 mm -97.11 138.97 20.64 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 103.834 -2.654 . . . . 0.0 103.834 168.014 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -117.57 153.38 50.44 Favored Pre-proline 0 CA--C 1.539 0.542 0 C-N-CA 123.277 0.631 . . . . 0.0 111.469 -169.362 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -61.03 161.0 23.76 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 123.711 2.941 . . . . 0.0 112.144 169.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -63.42 -32.94 74.51 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -175.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 7.5 p90 -75.17 -10.25 59.29 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 -179.207 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 96.7 t -92.31 122.93 44.21 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 173.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -114.66 127.34 55.71 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 106.703 -1.591 . . . . 0.0 106.703 169.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -93.98 118.33 39.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 105.076 -2.194 . . . . 0.0 105.076 168.559 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 54.1 tp -118.86 132.21 56.1 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 122.902 0.481 . . . . 0.0 110.352 178.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -91.29 120.99 32.65 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 169.154 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -106.7 -22.5 7.65 Favored Glycine 0 CA--C 1.536 1.361 0 CA-C-O 118.437 -1.202 . . . . 0.0 113.6 171.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 56.05 -110.84 2.16 Favored Glycine 0 C--N 1.342 0.897 0 CA-C-N 119.878 1.839 . . . . 0.0 112.329 172.071 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 75.7 p -79.99 7.21 9.46 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 125.365 1.466 . . . . 0.0 112.557 -172.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -57.82 -59.3 5.44 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 114.291 1.219 . . . . 0.0 114.291 -170.033 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 56.72 -112.33 3.37 Favored Glycine 0 CA--C 1.532 1.144 0 N-CA-C 109.846 -1.302 . . . . 0.0 109.846 -170.269 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 8.2 tpt -64.19 -21.41 66.55 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.319 1.048 . . . . 0.0 113.449 -176.506 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -56.33 -17.67 8.47 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 114.545 1.313 . . . . 0.0 114.545 -170.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 8.8 mt -98.24 17.71 18.01 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 119.499 1.045 . . . . 0.0 112.991 -169.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.687 ' HA ' HG13 ' A' ' 100' ' ' VAL . 10.2 tt -48.04 -50.74 26.88 Favored 'General case' 0 C--N 1.343 0.314 0 N-CA-C 112.764 0.654 . . . . 0.0 112.764 -174.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -80.31 -29.67 44.19 Favored Glycine 0 CA--C 1.528 0.848 0 CA-C-O 119.659 -0.523 . . . . 0.0 111.952 -178.035 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -86.94 -22.7 25.47 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 114.267 1.21 . . . . 0.0 114.267 -169.053 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.413 ' SD ' HG11 ' A' ' 100' ' ' VAL . 47.6 mtp -78.14 -15.64 58.67 Favored 'General case' 0 CA--C 1.535 0.394 0 O-C-N 121.537 -0.727 . . . . 0.0 111.108 173.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.09 150.37 45.56 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 123.708 0.803 . . . . 0.0 112.026 -169.324 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . 0.282 14.4 p30 55.34 17.24 2.03 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 127.923 2.489 . . . . 0.0 117.324 170.048 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.5 159.02 35.04 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 169.155 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -80.61 -52.18 7.88 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 173.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -117.22 147.11 42.79 Favored 'General case' 0 CA--C 1.513 -0.478 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 168.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -134.97 122.56 22.05 Favored 'General case' 0 CA--C 1.508 -0.661 0 N-CA-C 104.698 -2.334 . . . . 0.0 104.698 175.293 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 3.0 mt -104.42 106.07 19.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 106.45 -1.685 . . . . 0.0 106.45 176.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.547 HD13 HD11 ' A' ' 97' ' ' LEU . 27.4 mt -79.99 124.76 38.45 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 N-CA-C 105.074 -2.195 . . . . 0.0 105.074 169.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -113.28 121.07 43.3 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 104.121 -2.548 . . . . 0.0 104.121 168.542 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 41.7 t0 -163.67 156.37 18.05 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 123.592 0.757 . . . . 0.0 110.23 -175.237 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -83.25 142.67 30.96 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 169.008 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 72.1 mt -77.07 -44.29 31.42 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 -175.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 14.6 t 53.93 43.46 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.151 0 C-N-CA 124.367 1.067 . . . . 0.0 109.66 -172.059 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 2.4 m -153.76 178.81 9.48 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.212 1.405 . . . . 0.0 109.639 175.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . 0.288 30.6 ttmt 67.61 154.69 0.1 Allowed 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 127.968 2.507 . . . . 0.0 113.345 175.557 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 10.3 ptpt -85.14 -5.65 59.33 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 127.205 2.202 . . . . 0.0 114.774 -169.548 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 33.9 t-20 -74.38 169.61 17.32 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.221 0.608 . . . . 0.0 109.619 -173.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 4.1 m -57.65 146.31 66.1 Favored Pre-proline 0 CA--C 1.548 0.903 0 C-N-CA 124.111 0.964 . . . . 0.0 112.234 -169.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_exo -53.09 148.13 31.84 Favored 'Trans proline' 0 CA--C 1.535 0.573 0 C-N-CA 124.176 3.251 . . . . 0.0 113.178 171.366 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.483 ' HA3' HG22 ' A' ' 133' ' ' THR . . . 74.2 0.01 55.29 Favored Glycine 0 CA--C 1.532 1.096 0 CA-C-O 119.221 -0.766 . . . . 0.0 114.684 174.315 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 27.3 m -73.28 143.39 47.03 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 119.026 1.413 . . . . 0.0 111.155 -169.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 11.0 ttp -85.22 132.5 34.27 Favored 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 169.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 65.5 mtm -133.45 127.59 33.63 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 170.071 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.625 HD12 ' HG3' ' A' ' 144' ' ' GLN . 18.6 mm -108.03 124.86 64.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 -173.308 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.5 mp -121.33 134.59 55.14 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 -174.293 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 53.1 mtt85 -86.23 174.02 9.38 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.789 0.835 . . . . 0.0 110.016 -177.399 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -40.59 -52.52 2.85 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 115.068 1.507 . . . . 0.0 115.068 -172.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -90.34 -13.81 34.4 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 113.056 0.762 . . . . 0.0 113.056 -175.371 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -77.61 -37.17 50.84 Favored 'General case' 0 C--N 1.339 0.118 0 CA-C-N 118.551 0.614 . . . . 0.0 109.956 -173.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.537 HG12 ' CE2' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -64.29 -49.52 72.2 Favored Pre-proline 0 CA--C 1.534 0.33 0 CA-C-O 117.605 -1.188 . . . . 0.0 112.822 -175.345 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_exo -54.96 -39.6 89.91 Favored 'Trans proline' 0 CA--C 1.539 0.757 0 CA-C-N 120.997 1.392 . . . . 0.0 111.557 176.339 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -76.16 -7.98 56.0 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 176.633 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -92.45 -38.16 12.14 Favored 'General case' 0 C--N 1.342 0.274 0 CA-C-N 120.114 1.325 . . . . 0.0 109.622 174.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.537 ' CE2' HG12 ' A' ' 82' ' ' VAL . 26.6 m-85 -77.84 28.83 0.17 Allowed 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -178.573 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 32.1 p -74.02 -24.62 59.59 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 121.463 -0.773 . . . . 0.0 110.282 173.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -75.38 152.18 38.1 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 171.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 3.1 mppt? -120.88 28.45 7.92 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.895 0.878 . . . . 0.0 111.033 179.57 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 25.9 mt -69.99 -44.73 78.22 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 -178.304 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 2.6 p -97.57 116.61 65.84 Favored Pre-proline 0 CA--C 1.545 0.765 0 C-N-CA 124.962 1.305 . . . . 0.0 110.084 -170.292 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -70.55 -50.09 0.4 Allowed 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 122.535 2.156 . . . . 0.0 114.042 -169.238 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 10.7 t-80 -60.99 -45.64 93.97 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 178.364 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 23.9 mp0 -64.82 -35.88 82.53 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 118.199 -0.905 . . . . 0.0 110.447 -176.287 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -65.28 -41.21 94.4 Favored 'General case' 0 C--O 1.227 -0.128 0 CA-C-N 119.676 1.125 . . . . 0.0 110.028 173.282 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -61.16 -46.28 94.82 Favored Glycine 0 CA--C 1.534 1.237 0 CA-C-N 119.455 1.025 . . . . 0.0 111.232 175.748 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.547 HD11 HD13 ' A' ' 60' ' ' ILE . 2.1 tm? -58.07 -41.49 83.49 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.261 0.625 . . . . 0.0 110.007 174.103 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -65.33 -36.21 83.36 Favored 'General case' 0 N--CA 1.444 -0.772 0 O-C-N 121.049 -1.032 . . . . 0.0 110.919 178.311 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -67.15 -22.41 65.77 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 118.616 0.643 . . . . 0.0 110.466 178.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.687 HG13 ' HA ' ' A' ' 49' ' ' LEU . 77.7 t -68.87 -42.08 82.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 168.442 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 42.6 mt -64.65 -35.83 82.3 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-N 119.748 1.158 . . . . 0.0 110.2 179.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 17.0 m -63.79 -45.04 91.49 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 119.229 0.922 . . . . 0.0 110.228 172.446 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.19 -44.13 97.79 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 119.093 0.861 . . . . 0.0 111.275 176.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.7 mt -60.61 -33.81 73.3 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.238 1.015 . . . . 0.0 109.996 175.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 73.9 ttt-85 -73.68 -34.62 64.97 Favored 'General case' 0 CA--C 1.531 0.238 0 O-C-N 121.141 -0.974 . . . . 0.0 109.792 176.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 14.1 m-30 -69.3 -44.14 72.36 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 123.594 0.758 . . . . 0.0 110.665 179.274 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 36.1 p -73.05 -23.95 60.64 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 118.462 0.573 . . . . 0.0 111.701 179.232 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 73.57 7.57 74.21 Favored Glycine 0 CA--C 1.532 1.148 0 N-CA-C 109.394 -1.482 . . . . 0.0 109.394 -168.383 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -86.04 25.58 1.12 Allowed 'General case' 0 C--N 1.348 0.505 0 CA-C-N 119.851 1.826 . . . . 0.0 110.733 174.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -61.78 139.12 95.49 Favored Pre-proline 0 CA--C 1.546 0.82 0 C-N-CA 124.006 0.922 . . . . 0.0 108.705 169.516 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo -59.71 162.41 15.65 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.963 2.442 . . . . 0.0 114.03 -177.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp -65.07 -37.63 88.16 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 119.061 -0.495 . . . . 0.0 111.475 174.459 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 4.5 pttm -143.5 85.46 1.84 Allowed 'General case' 0 C--O 1.234 0.252 0 C-N-CA 124.031 0.933 . . . . 0.0 108.585 177.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 5.9 tt -75.39 144.8 42.07 Favored 'General case' 0 CA--C 1.537 0.468 0 O-C-N 120.835 -1.165 . . . . 0.0 108.502 169.657 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -137.97 139.64 39.81 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.65 1.18 . . . . 0.0 108.02 177.349 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -118.91 121.12 39.23 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 119.901 1.228 . . . . 0.0 108.658 175.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 3.1 t -89.1 89.98 3.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 N-CA-C 105.855 -1.906 . . . . 0.0 105.855 169.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -81.15 138.78 19.71 Favored Glycine 0 C--N 1.335 0.517 0 N-CA-C 110.273 -1.131 . . . . 0.0 110.273 -178.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 38.9 t -122.15 133.39 68.61 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 174.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 13.4 mt -85.41 135.32 38.87 Favored Pre-proline 0 CA--C 1.535 0.369 0 N-CA-C 105.561 -2.015 . . . . 0.0 105.561 169.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -73.21 167.16 28.05 Favored 'Trans proline' 0 CA--C 1.54 0.786 0 C-N-CA 121.815 1.677 . . . . 0.0 111.732 -179.161 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -94.38 -56.85 2.67 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 168.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 49.0 m -118.73 -55.14 2.21 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -169.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.8 tp 52.21 39.29 26.63 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 126.823 2.049 . . . . 0.0 113.581 -174.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -79.61 163.85 56.64 Favored Pre-proline 0 CA--C 1.544 0.721 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 171.025 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -82.39 94.61 0.88 Allowed 'Trans proline' 0 CA--C 1.542 0.896 0 C-N-CA 121.848 1.699 . . . . 0.0 111.863 -176.132 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -173.48 -176.24 1.27 Allowed 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 104.48 -2.415 . . . . 0.0 104.48 -178.178 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -144.24 154.33 15.27 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 CA-C-N 119.42 1.009 . . . . 0.0 112.325 174.738 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 118.6 85.41 1.01 Allowed Glycine 0 CA--C 1.531 1.035 0 N-CA-C 107.93 -2.068 . . . . 0.0 107.93 -174.245 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 81.9 mt -36.55 139.41 0.18 Allowed 'General case' 0 C--N 1.352 0.711 0 N-CA-C 115.192 1.553 . . . . 0.0 115.192 -169.688 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 4.4 p -58.96 151.89 52.98 Favored Pre-proline 0 CA--C 1.535 0.4 0 CA-C-N 113.97 -1.468 . . . . 0.0 108.74 169.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -60.49 -35.24 91.25 Favored 'Trans proline' 0 CA--C 1.537 0.63 0 C-N-CA 121.726 1.618 . . . . 0.0 111.74 -176.584 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . 0.483 HG22 ' HA3' ' A' ' 72' ' ' GLY . 1.0 OUTLIER -60.57 -36.21 77.93 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 123.704 0.802 . . . . 0.0 110.834 177.123 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 61.4 t -94.2 -32.49 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 C-N-CA 122.628 0.371 . . . . 0.0 110.004 -172.451 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -53.91 -46.45 71.47 Favored 'General case' 0 C--N 1.33 -0.24 0 O-C-N 121.347 -0.846 . . . . 0.0 109.311 169.422 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -69.06 -16.77 63.77 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 -177.38 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 24.4 mmm -77.94 -8.03 57.57 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 125.47 1.508 . . . . 0.0 113.039 172.135 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 53.5 mt -56.86 -56.06 16.58 Favored 'Isoleucine or valine' 0 C--N 1.344 0.353 0 CA-C-N 120.835 1.652 . . . . 0.0 109.157 176.222 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -67.52 -45.59 47.16 Favored Pre-proline 0 CA--C 1.544 0.714 0 CA-C-O 117.822 -1.085 . . . . 0.0 111.033 -174.227 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -42.94 -58.5 1.3 Allowed 'Trans proline' 0 C--N 1.349 0.578 1 C-N-CA 125.478 4.118 . . . . 0.0 112.979 168.66 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -69.2 -35.91 76.72 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.363 -0.835 . . . . 0.0 112.148 -177.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 25.8 mt -57.07 -41.14 78.26 Favored 'General case' 0 CA--C 1.521 -0.146 0 CA-C-N 119.546 1.066 . . . . 0.0 109.068 171.746 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -62.25 -35.05 77.78 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 118.862 0.755 . . . . 0.0 110.165 178.376 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . 0.625 ' HG3' HD12 ' A' ' 76' ' ' ILE . 0.4 OUTLIER -64.24 -46.35 84.18 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 119.623 1.102 . . . . 0.0 111.217 173.064 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 36.2 t -56.65 -48.67 80.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 178.181 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 37.7 mt -62.89 -34.46 77.46 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 118.487 -0.768 . . . . 0.0 110.946 178.104 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -67.2 -46.43 73.89 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 119.81 1.186 . . . . 0.0 110.83 178.125 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -64.46 -32.26 73.82 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 119.679 1.127 . . . . 0.0 111.12 177.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 14.1 mt -63.11 -54.75 32.95 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 171.272 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 78.4 mtm-85 -61.21 -32.05 71.82 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 120.336 1.426 . . . . 0.0 111.765 -178.125 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -70.52 -27.65 64.34 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 118.677 0.671 . . . . 0.0 110.332 179.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 23.5 m -81.12 5.47 16.66 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.601 1.16 . . . . 0.0 111.77 169.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 70.89 13.7 72.5 Favored Glycine 0 CA--C 1.53 0.997 0 CA-C-O 117.641 -1.644 . . . . 0.0 112.497 -171.238 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 58.3 t -90.62 118.05 35.1 Favored 'Isoleucine or valine' 0 C--N 1.347 0.463 0 CA-C-N 120.603 2.202 . . . . 0.0 107.787 -177.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -93.86 96.06 9.5 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 171.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -59.63 139.93 56.8 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 169.004 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 11.1 mm -85.41 123.61 72.71 Favored Pre-proline 0 CA--C 1.534 0.342 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 -174.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -64.2 103.23 0.42 Allowed 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 122.913 2.409 . . . . 0.0 105.928 171.184 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 20.4 tpp85 45.3 -110.28 0.22 Allowed 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 104.954 -2.239 . . . . 0.0 104.954 -166.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 3.7 p . . . . . 0 C--N 1.324 -0.54 0 CA-C-N 119.766 1.166 . . . . 0.0 109.576 169.947 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 8.5 ptp180 . . . . . 0 N--CA 1.48 1.059 0 CA-C-O 118.036 -0.983 . . . . 0.0 108.662 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 52.0 mt -140.31 144.16 28.19 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-N 120.033 1.288 . . . . 0.0 110.873 -169.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 3.1 mt -127.8 122.18 32.07 Favored 'General case' 0 CA--C 1.519 -0.248 0 N-CA-C 107.046 -1.465 . . . . 0.0 107.046 168.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.469 HG12 HG12 ' A' ' 23' ' ' VAL . 11.5 t -97.46 111.86 28.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 1 N-CA-C 100.125 -4.028 . . . . 0.0 100.125 168.688 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.525 ' HB2' HD21 ' A' ' 58' ' ' LEU . 0.5 OUTLIER -117.35 107.32 14.23 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 123.112 0.565 . . . . 0.0 109.497 -168.048 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -89.74 123.82 7.12 Favored Glycine 0 N--CA 1.448 -0.511 0 N-CA-C 108.722 -1.751 . . . . 0.0 108.722 179.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.6 m -132.52 -177.91 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.805 0 C-N-CA 124.053 0.941 . . . . 0.0 109.532 -179.314 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 98.07 131.22 7.07 Favored Glycine 0 N--CA 1.437 -1.281 0 N-CA-C 107.158 -2.377 . . . . 0.0 107.158 -169.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -69.16 131.52 45.08 Favored 'General case' 0 N--CA 1.451 -0.379 0 O-C-N 121.846 -0.797 . . . . 0.0 111.947 -168.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.4 pt -79.06 41.39 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 123.605 0.762 . . . . 0.0 112.961 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 19.4 mt -129.7 -12.09 4.35 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 120.129 1.331 . . . . 0.0 109.833 171.22 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.1 mp -117.1 62.7 0.73 Allowed 'General case' 0 C--N 1.346 0.434 0 CA-C-O 122.116 0.96 . . . . 0.0 109.766 -169.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.9 m 51.71 -119.59 1.48 Allowed 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 114.322 -1.308 . . . . 0.0 112.059 169.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 61.3 m-20 -50.92 -23.07 2.58 Favored 'General case' 0 N--CA 1.44 -0.929 0 C-N-CA 127.866 2.466 . . . . 0.0 114.282 179.083 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.411 ' CD ' HE22 ' A' ' 94' ' ' GLN . 1.6 tp10 -63.28 -26.34 68.73 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 119.643 1.11 . . . . 0.0 110.456 -179.472 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.74 -8.7 45.34 Favored 'General case' 0 N--CA 1.438 -1.059 0 CA-C-O 116.819 -1.562 . . . . 0.0 111.215 176.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.1 tp -51.67 -45.43 36.93 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.414 0 CA-C-N 121.341 1.882 . . . . 0.0 111.132 -173.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -63.51 -34.63 90.45 Favored Glycine 0 CA--C 1.526 0.771 0 CA-C-N 119.131 0.878 . . . . 0.0 111.324 -177.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 97.8 t -68.18 -48.43 73.9 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 CA-C-N 117.518 0.659 . . . . 0.0 109.32 172.304 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 24.1 mmt180 -57.52 -29.65 64.5 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 117.429 -1.272 . . . . 0.0 112.147 177.287 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 5.7 mm -62.42 -53.98 40.12 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-N 120.818 1.645 . . . . 0.0 109.046 176.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.469 HG12 HG12 ' A' ' 5' ' ' VAL . 26.5 m -70.61 -34.7 58.14 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 CA-C-N 118.833 0.742 . . . . 0.0 111.312 -176.206 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 58.3 mt-10 -65.36 -45.03 85.72 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 118.954 0.797 . . . . 0.0 110.015 176.209 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.67 -39.88 95.43 Favored 'General case' 0 N--CA 1.452 -0.342 0 O-C-N 121.808 -0.557 . . . . 0.0 109.982 176.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 5.7 tp -64.55 -39.2 93.32 Favored 'General case' 0 C--O 1.221 -0.4 0 CA-C-N 118.858 0.754 . . . . 0.0 110.169 -178.368 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -61.95 -26.23 68.07 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 121.501 0.667 . . . . 0.0 112.493 -178.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -93.33 -40.86 10.17 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 125.994 1.718 . . . . 0.0 111.125 -178.573 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 37.3 mmm-85 -83.29 -31.17 27.04 Favored 'General case' 0 C--N 1.333 -0.112 0 C-N-CA 123.021 0.528 . . . . 0.0 110.833 -174.393 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -123.89 146.92 48.09 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-O 122.313 1.054 . . . . 0.0 112.728 -177.365 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 39.3 mm -98.92 135.29 34.52 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 N-CA-C 104.887 -2.264 . . . . 0.0 104.887 169.404 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -120.24 148.6 47.62 Favored Pre-proline 0 CA--C 1.537 0.447 0 C-N-CA 124.025 0.93 . . . . 0.0 109.943 -169.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -67.4 158.62 56.2 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 123.05 2.5 . . . . 0.0 110.253 170.12 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -57.69 -33.79 68.76 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 114.48 1.289 . . . . 0.0 114.48 -169.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 10.8 p90 -74.37 -12.82 60.63 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 112.786 0.661 . . . . 0.0 112.786 -176.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 74.0 t -89.67 125.61 42.62 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 172.319 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 52.1 mm-40 -113.18 130.6 56.16 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 169.01 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -95.78 116.28 37.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 104.877 -2.268 . . . . 0.0 104.877 168.766 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 65.3 tp -118.19 129.02 55.26 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 118.073 0.397 . . . . 0.0 110.373 -179.149 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -88.7 107.04 18.73 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 106.312 -1.736 . . . . 0.0 106.312 168.708 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -92.32 -40.33 5.14 Favored Glycine 0 CA--C 1.535 1.308 0 N-CA-C 110.432 -1.067 . . . . 0.0 110.432 169.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 57.3 -103.69 0.33 Allowed Glycine 0 C--N 1.341 0.807 0 CA-C-N 117.773 0.787 . . . . 0.0 112.683 171.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 19.8 p -67.9 -5.82 18.76 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 126.521 1.929 . . . . 0.0 113.237 -179.518 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.48 -63.16 1.39 Allowed 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 -172.16 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 53.69 -110.06 1.31 Allowed Glycine 0 CA--C 1.535 1.283 0 N-CA-C 110.62 -0.992 . . . . 0.0 110.62 -170.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.06 -30.42 66.18 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.553 1.141 . . . . 0.0 111.268 -177.382 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -56.82 -19.74 18.86 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 -174.092 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 20.5 mt -85.12 12.99 6.76 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 113.551 0.945 . . . . 0.0 113.551 -177.437 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.576 ' HA ' HG13 ' A' ' 100' ' ' VAL . 6.3 tt -42.04 -61.0 1.24 Allowed 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.27 1.028 . . . . 0.0 112.63 -172.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -79.73 -30.42 43.96 Favored Glycine 0 CA--C 1.527 0.819 0 N-CA-C 111.392 -0.683 . . . . 0.0 111.392 -179.548 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -67.43 -36.06 80.5 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 118.428 1.114 . . . . 0.0 112.112 -169.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.431 ' SD ' HG11 ' A' ' 100' ' ' VAL . 36.2 mtp -75.4 -9.93 59.0 Favored 'General case' 0 N--CA 1.451 -0.399 0 O-C-N 122.037 -0.414 . . . . 0.0 111.765 -178.264 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.63 151.62 40.77 Favored 'General case' 0 N--CA 1.445 -0.723 0 C-N-CA 123.149 0.58 . . . . 0.0 112.474 -169.271 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . 0.281 15.5 p30 53.51 21.21 2.38 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 128.749 2.82 . . . . 0.0 116.211 170.041 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 17.4 mmt180 -75.5 160.0 30.67 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 169.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -86.57 -52.39 5.58 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 176.734 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . 0.25 0.0 OUTLIER -124.53 143.31 50.74 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 119.952 1.251 . . . . 0.0 107.713 169.37 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.525 HD21 ' HB2' ' A' ' 6' ' ' LEU . 4.5 tt -139.97 120.8 14.45 Favored 'General case' 0 CA--C 1.501 -0.911 0 N-CA-C 105.476 -2.046 . . . . 0.0 105.476 -178.343 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 25.8 mt -100.21 106.09 18.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 106.104 -1.813 . . . . 0.0 106.104 179.57 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.445 HD13 HD11 ' A' ' 97' ' ' LEU . 16.9 mt -75.13 133.63 31.04 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 N-CA-C 105.135 -2.172 . . . . 0.0 105.135 169.682 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -120.16 121.49 38.89 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 104.915 -2.254 . . . . 0.0 104.915 168.753 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 36.8 t0 -156.75 162.19 39.77 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 118.529 0.604 . . . . 0.0 110.287 -171.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.559 ' HB1' ' HD3' ' A' ' 121' ' ' PRO . . . -103.74 157.23 17.21 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 121.927 0.87 . . . . 0.0 109.994 172.227 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 5.1 mp -134.64 88.09 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 N-CA-C 106.892 -1.521 . . . . 0.0 106.892 -176.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.446 HG11 HD22 ' A' ' 124' ' ' LEU . 31.5 m -52.48 -21.1 2.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 C-N-CA 125.89 1.676 . . . . 0.0 112.217 168.568 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.6 m -78.01 174.08 11.49 Favored 'General case' 0 N--CA 1.442 -0.845 0 C-N-CA 124.249 1.02 . . . . 0.0 111.852 -169.289 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 18.2 ttmm 67.25 163.12 0.19 Allowed 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 126.108 1.763 . . . . 0.0 111.907 -179.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 23.1 mtmt -77.38 -7.83 56.72 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 125.301 1.44 . . . . 0.0 112.134 179.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 43.5 t-20 -68.16 156.94 36.46 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.232 1.013 . . . . 0.0 110.234 -169.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 2.2 m -62.3 149.18 88.08 Favored Pre-proline 0 CA--C 1.546 0.795 0 C-N-CA 124.663 1.185 . . . . 0.0 113.446 -169.004 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_exo -58.9 159.81 20.14 Favored 'Trans proline' 0 CA--C 1.533 0.465 0 C-N-CA 124.029 3.153 . . . . 0.0 111.625 168.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 65.64 19.15 66.79 Favored Glycine 0 CA--C 1.53 0.986 0 CA-C-O 119.753 -0.471 . . . . 0.0 112.952 172.299 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 2.7 m -99.24 142.46 30.7 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 124.495 1.118 . . . . 0.0 109.448 -172.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 13.4 ttp -91.1 134.88 34.16 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 172.607 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 69.6 mtm -122.28 115.73 22.86 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 170.539 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.453 HD12 ' HG2' ' A' ' 144' ' ' GLN . 28.1 mm -102.87 120.81 53.22 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 -177.798 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.6 mp -128.09 137.18 52.04 Favored 'General case' 0 C--O 1.236 0.376 0 O-C-N 123.97 0.793 . . . . 0.0 109.812 -173.09 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 53.6 mtt85 -89.16 176.31 7.02 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.237 1.015 . . . . 0.0 110.042 -177.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -38.01 -58.94 0.89 Allowed 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.466 1.507 . . . . 0.0 113.762 -173.119 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -86.61 -15.9 38.36 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -171.447 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -75.13 -36.83 61.57 Favored 'General case' 0 N--CA 1.457 -0.11 0 O-C-N 121.876 -0.515 . . . . 0.0 109.902 -175.336 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.52 HG12 ' CE2' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -66.37 -49.23 54.39 Favored Pre-proline 0 CA--C 1.535 0.383 0 CA-C-O 117.653 -1.165 . . . . 0.0 112.585 -174.619 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -55.32 -37.78 94.3 Favored 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 121.758 1.639 . . . . 0.0 111.594 174.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.11 -2.37 37.08 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 114.234 1.198 . . . . 0.0 114.234 176.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -102.48 -38.46 7.56 Favored 'General case' 0 C--N 1.344 0.33 0 CA-C-N 119.805 1.184 . . . . 0.0 111.376 179.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.52 ' CE2' HG12 ' A' ' 82' ' ' VAL . 43.9 m-85 -70.41 0.94 5.62 Favored 'General case' 0 CA--C 1.544 0.746 0 O-C-N 121.641 -0.662 . . . . 0.0 112.5 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 64.5 p -57.84 -21.0 40.23 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.577 1.551 . . . . 0.0 112.687 174.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 11.1 p30 -60.82 -30.51 70.12 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 118.66 -0.686 . . . . 0.0 112.489 175.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 30.3 mtmm 50.82 27.34 3.05 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 125.152 1.381 . . . . 0.0 114.32 177.205 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 13.5 mt -72.35 -43.15 65.01 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 O-C-N 121.252 -0.905 . . . . 0.0 109.523 -174.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 3.1 p -113.25 143.2 28.79 Favored Pre-proline 0 CA--C 1.544 0.716 0 C-N-CA 123.675 0.79 . . . . 0.0 112.54 -169.541 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -75.31 -42.26 0.5 Allowed 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 122.76 2.307 . . . . 0.0 113.704 -169.147 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 10.2 t-80 -61.81 -45.42 93.91 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 119.399 1.0 . . . . 0.0 108.885 178.361 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.411 HE22 ' CD ' ' A' ' 16' ' ' GLU . 21.5 mp0 -62.15 -41.94 98.77 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 125.27 1.428 . . . . 0.0 108.634 -177.775 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 50.7 tp -64.14 -38.19 90.16 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 119.145 0.884 . . . . 0.0 110.995 174.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -63.1 -51.11 57.69 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 110.556 -1.018 . . . . 0.0 110.556 176.599 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.445 HD11 HD13 ' A' ' 60' ' ' ILE . 2.8 tm? -56.94 -43.05 81.12 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.207 0.603 . . . . 0.0 109.963 175.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -62.77 -37.81 88.13 Favored 'General case' 0 N--CA 1.452 -0.36 0 O-C-N 121.306 -0.871 . . . . 0.0 111.413 177.61 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -69.3 -22.36 63.8 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 118.851 0.75 . . . . 0.0 110.83 178.327 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.576 HG13 ' HA ' ' A' ' 49' ' ' LEU . 97.6 t -68.04 -42.72 85.47 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 168.631 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 92.1 mt -63.73 -36.75 84.88 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 119.348 0.977 . . . . 0.0 109.934 178.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 70.3 m -64.59 -41.68 96.08 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 119.249 0.931 . . . . 0.0 110.726 171.178 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.49 -44.07 97.74 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 120.254 1.388 . . . . 0.0 110.611 176.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.9 mt -63.37 -33.04 74.67 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.669 1.188 . . . . 0.0 110.765 176.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 65.7 ttp85 -73.65 -31.79 63.68 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.008 0.923 . . . . 0.0 110.001 176.057 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 14.9 m-30 -71.34 -46.04 61.5 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 119.185 0.902 . . . . 0.0 110.473 177.095 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 34.0 p -73.84 -24.33 59.76 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 123.128 0.571 . . . . 0.0 112.132 -178.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 74.63 8.0 80.55 Favored Glycine 0 CA--C 1.536 1.351 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -168.329 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -85.04 22.0 1.51 Allowed 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 119.851 1.826 . . . . 0.0 111.438 174.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -60.48 137.63 92.38 Favored Pre-proline 0 CA--C 1.545 0.771 0 C-N-CA 124.175 0.99 . . . . 0.0 108.737 169.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -61.25 163.36 17.4 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.779 2.319 . . . . 0.0 114.543 -176.192 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 68.3 mmtt -67.96 -35.57 78.61 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 118.941 -0.552 . . . . 0.0 112.37 175.117 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 8.2 ttmm -142.08 66.63 1.34 Allowed 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 -175.382 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 7.8 tt -70.83 138.38 50.26 Favored 'General case' 0 C--O 1.234 0.238 0 O-C-N 120.063 -1.648 . . . . 0.0 108.476 172.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -134.61 136.59 43.02 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 179.487 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -114.06 122.46 46.96 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 119.956 1.253 . . . . 0.0 107.874 175.639 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 21.3 t -95.87 85.52 1.63 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 N-CA-C 106.316 -1.735 . . . . 0.0 106.316 169.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -77.25 148.63 34.57 Favored Glycine 0 N--CA 1.445 -0.741 0 N-CA-C 110.706 -0.958 . . . . 0.0 110.706 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 46.9 t -124.54 165.72 21.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 171.716 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 15.5 mt -117.55 120.21 33.39 Favored Pre-proline 0 N--CA 1.468 0.428 0 CA-C-N 121.232 1.833 . . . . 0.0 108.605 171.069 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.559 ' HD3' ' HB1' ' A' ' 63' ' ' ALA . 3.3 Cg_exo -55.16 158.93 10.84 Favored 'Trans proline' 0 N--CA 1.455 -0.775 1 C-N-CA 126.142 4.561 . . . . 0.0 116.093 175.614 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -107.75 -64.24 1.23 Allowed 'General case' 0 C--O 1.236 0.344 0 C-N-CA 124.348 1.059 . . . . 0.0 109.628 178.28 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 70.5 m -106.03 -50.13 3.23 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 119.093 -0.479 . . . . 0.0 110.154 -171.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.446 HD22 HG11 ' A' ' 65' ' ' VAL . 1.2 tp 51.97 32.51 10.19 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 124.126 0.971 . . . . 0.0 112.812 178.651 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -83.49 164.6 44.5 Favored Pre-proline 0 CA--C 1.544 0.734 0 O-C-N 121.525 -0.734 . . . . 0.0 109.417 176.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -78.65 82.96 2.34 Favored 'Trans proline' 0 CA--C 1.544 1.012 0 C-N-CA 121.869 1.713 . . . . 0.0 111.953 -173.142 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -175.67 153.22 1.4 Allowed 'General case' 0 C--O 1.234 0.269 0 N-CA-C 104.276 -2.491 . . . . 0.0 104.276 -177.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -110.38 160.71 9.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.552 0.692 . . . . 0.0 111.861 -170.234 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 108.11 141.37 9.69 Favored Glycine 0 CA--C 1.529 0.929 0 N-CA-C 106.457 -2.657 . . . . 0.0 106.457 -169.286 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 74.8 mt -80.7 154.03 27.52 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 118.065 0.932 . . . . 0.0 109.667 179.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 68.2 p -70.82 168.47 20.15 Favored Pre-proline 0 CA--C 1.541 0.619 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 169.394 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_exo -59.76 -40.21 66.08 Favored 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 121.717 1.611 . . . . 0.0 111.165 173.447 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 85.3 m -59.67 -37.45 78.8 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 124.619 1.168 . . . . 0.0 111.751 -179.358 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 58.4 t -98.51 -29.32 3.53 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 O-C-N 121.776 -0.578 . . . . 0.0 110.638 -174.482 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -52.37 -45.37 65.74 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 119.518 1.054 . . . . 0.0 108.793 169.193 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -65.68 -15.97 63.31 Favored 'General case' 0 N--CA 1.447 -0.575 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 -177.589 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 14.1 mmm -83.45 -8.41 59.38 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 125.321 1.448 . . . . 0.0 112.425 175.475 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 54.8 mt -56.75 -56.51 13.84 Favored 'Isoleucine or valine' 0 C--N 1.343 0.293 0 CA-C-N 120.192 1.36 . . . . 0.0 108.788 172.071 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 64.3 mm-40 -63.48 -49.7 76.95 Favored Pre-proline 0 CA--C 1.541 0.618 0 CA-C-O 117.468 -1.253 . . . . 0.0 109.99 -172.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -39.96 -56.58 1.38 Allowed 'Trans proline' 0 C--N 1.35 0.613 1 C-N-CA 125.798 4.332 . . . . 0.0 113.353 168.904 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -69.93 -35.5 74.58 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.649 -178.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 37.3 mt -64.06 -45.99 86.35 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 120.806 1.639 . . . . 0.0 109.345 176.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -54.61 -36.43 64.46 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 118.52 0.6 . . . . 0.0 110.226 174.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . 0.453 ' HG2' HD12 ' A' ' 76' ' ' ILE . 70.8 tp60 -75.86 -38.99 57.4 Favored 'General case' 0 N--CA 1.423 -1.809 0 O-C-N 121.465 -0.772 . . . . 0.0 110.913 -179.562 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 37.2 t -58.68 -45.18 90.99 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 CA-C-N 119.276 0.943 . . . . 0.0 108.93 173.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 56.8 mt -60.85 -36.82 80.12 Favored 'General case' 0 C--O 1.226 -0.176 0 CA-C-O 119.09 -0.481 . . . . 0.0 110.218 175.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -68.68 -46.11 69.94 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 119.523 1.056 . . . . 0.0 111.29 179.464 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -66.88 -28.81 68.63 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 119.76 1.164 . . . . 0.0 111.068 178.424 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 23.9 mt -63.39 -51.22 66.71 Favored 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 169.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 96.8 mtt-85 -66.69 -16.06 63.95 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 117.845 -1.074 . . . . 0.0 112.543 179.33 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 33.1 mm-40 -65.97 -24.38 66.78 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 120.769 1.622 . . . . 0.0 110.899 172.176 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 65.3 m -100.53 18.98 17.72 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 119.436 1.016 . . . . 0.0 110.087 168.409 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 69.43 20.03 74.99 Favored Glycine 0 C--N 1.337 0.595 0 CA-C-O 117.838 -1.535 . . . . 0.0 112.276 -178.073 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 18.0 t -88.05 117.3 31.53 Favored 'Isoleucine or valine' 0 C--N 1.344 0.358 0 CA-C-N 120.23 2.015 . . . . 0.0 107.393 -172.331 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -101.87 88.14 3.3 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 177.16 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -58.06 141.7 49.2 Favored 'General case' 0 CA--C 1.539 0.558 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 169.223 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . 0.4 ' CG2' ' HA ' ' A' ' 160' ' ' SER . 30.9 mm -98.82 122.56 52.52 Favored Pre-proline 0 N--CA 1.463 0.176 0 CA-C-O 117.396 -1.287 . . . . 0.0 108.976 -172.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -63.12 106.53 0.56 Allowed 'Trans proline' 0 N--CA 1.459 -0.529 0 C-N-CA 122.17 1.913 . . . . 0.0 109.017 173.237 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 56.7 mtm180 39.9 48.02 1.98 Allowed 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 125.974 1.71 . . . . 0.0 113.604 179.273 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . 0.4 ' HA ' ' CG2' ' A' ' 157' ' ' ILE 0.272 2.4 p . . . . . 0 CA--C 1.545 0.764 0 C-N-CA 126.698 1.999 . . . . 0.0 115.137 179.628 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 6.4 ptm85 . . . . . 0 N--CA 1.482 1.128 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 33.9 mt -137.72 148.77 25.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 CA-C-N 121.06 1.755 . . . . 0.0 111.922 -169.023 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 16.4 tp -134.55 111.07 9.77 Favored 'General case' 0 C--N 1.341 0.199 0 N-CA-C 105.484 -2.043 . . . . 0.0 105.484 168.081 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 24.9 t -90.68 115.36 29.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 102.927 -2.99 . . . . 0.0 102.927 170.403 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -115.37 113.03 23.23 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 123.173 0.589 . . . . 0.0 110.927 -168.376 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -94.13 121.65 6.78 Favored Glycine 0 N--CA 1.445 -0.712 0 N-CA-C 108.055 -2.018 . . . . 0.0 108.055 173.625 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.4 m -131.95 -167.68 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 C-N-CA 124.012 0.925 . . . . 0.0 108.625 -177.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 105.49 158.1 22.75 Favored Glycine 0 C--N 1.333 0.38 0 N-CA-C 110.505 -1.038 . . . . 0.0 110.505 -175.556 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.438 HD21 ' HB2' ' A' ' 12' ' ' LEU . 1.4 t30 -81.65 94.81 7.02 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 124.572 1.149 . . . . 0.0 108.915 -174.403 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.3 pt -69.82 27.58 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 N-CA-C 114.659 1.355 . . . . 0.0 114.659 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.438 ' HB2' HD21 ' A' ' 10' ' ' ASN . 38.3 mt -114.31 -9.66 12.78 Favored 'General case' 0 C--O 1.224 -0.245 0 O-C-N 121.138 -0.976 . . . . 0.0 108.581 171.34 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.1 mp -120.75 74.35 1.06 Allowed 'General case' 0 CA--C 1.502 -0.879 0 N-CA-C 105.475 -2.046 . . . . 0.0 105.475 -169.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 20.1 m 36.08 -106.53 0.04 OUTLIER 'General case' 0 N--CA 1.447 -0.585 0 O-C-N 126.215 2.197 . . . . 0.0 113.012 169.118 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -68.2 -13.67 62.41 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 114.628 1.344 . . . . 0.0 114.628 -170.165 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -65.84 -19.57 65.93 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 121.457 1.935 . . . . 0.0 111.769 173.258 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.58 -10.81 49.19 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 116.165 -1.874 . . . . 0.0 111.162 172.552 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 6.6 tp -54.96 -38.79 46.65 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 CA-C-N 121.753 2.069 . . . . 0.0 110.977 -178.155 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -60.0 -46.04 94.85 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 110.764 -0.935 . . . . 0.0 110.764 178.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 61.7 t -65.11 -47.4 87.91 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 O-C-N 122.175 -0.603 . . . . 0.0 109.68 174.559 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 20.3 mmt180 -60.21 -32.01 70.7 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 117.374 -1.298 . . . . 0.0 112.922 -178.181 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 20.3 mt -62.97 -44.13 99.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-N 121.151 1.796 . . . . 0.0 110.158 179.257 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 28.4 m -73.74 -34.59 41.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 CA-C-N 120.128 1.331 . . . . 0.0 111.542 -178.185 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 57.8 mt-10 -62.22 -42.37 99.25 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 117.957 0.344 . . . . 0.0 110.458 171.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -67.79 -38.29 83.15 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 119.051 0.842 . . . . 0.0 111.23 176.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 7.1 tp -63.51 -39.52 94.64 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 119.418 1.008 . . . . 0.0 109.844 -177.463 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -61.93 -18.83 61.66 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.88 0.872 . . . . 0.0 113.117 -179.474 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -102.57 -43.61 5.57 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 126.622 1.969 . . . . 0.0 110.992 -178.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 53.5 mmt-85 -74.69 -34.11 62.57 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.259 0.623 . . . . 0.0 110.547 -176.184 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 -124.89 154.03 41.71 Favored 'General case' 0 CA--C 1.521 -0.163 0 CA-C-O 121.417 0.627 . . . . 0.0 111.944 -178.201 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 47.7 mm -106.26 135.27 45.22 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 N-CA-C 103.418 -2.808 . . . . 0.0 103.418 168.047 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -119.07 149.78 47.6 Favored Pre-proline 0 C--O 1.237 0.438 0 CA-C-O 118.661 -0.685 . . . . 0.0 109.953 -169.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -65.95 162.08 36.79 Favored 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 122.992 2.461 . . . . 0.0 111.562 173.167 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -58.25 -33.69 69.65 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 115.046 1.498 . . . . 0.0 115.046 -169.196 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 8.6 p90 -73.06 -8.73 57.05 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 -178.016 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 76.1 t -88.99 128.16 41.27 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 174.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -116.08 124.35 50.19 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 105.913 -1.884 . . . . 0.0 105.913 169.063 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -93.53 112.9 27.33 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 N-CA-C 104.402 -2.444 . . . . 0.0 104.402 168.61 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 61.4 tp -112.36 128.94 56.43 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 -178.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -89.31 118.96 29.37 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 169.515 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -78.66 -79.98 0.76 Allowed Glycine 0 CA--C 1.526 0.764 0 N-CA-C 107.234 -2.346 . . . . 0.0 107.234 169.475 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 78.54 104.65 0.2 Allowed Glycine 0 C--N 1.344 0.974 0 N-CA-C 108.675 -1.77 . . . . 0.0 108.675 -177.762 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 12.9 p 52.74 50.72 17.48 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 123.535 0.734 . . . . 0.0 109.286 -178.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -104.4 -79.66 0.55 Allowed 'General case' 0 C--N 1.348 0.528 0 CA-C-N 115.312 -0.858 . . . . 0.0 112.105 -169.239 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 59.81 -110.55 2.88 Favored Glycine 0 CA--C 1.533 1.164 0 N-CA-C 110.075 -1.21 . . . . 0.0 110.075 -174.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 12.1 tpt -62.52 -21.57 65.63 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.844 1.258 . . . . 0.0 113.442 -173.366 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -63.91 -18.81 64.58 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 114.193 1.183 . . . . 0.0 114.193 -174.23 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 10.3 mt -100.52 14.37 31.53 Favored 'General case' 0 C--N 1.34 0.173 0 N-CA-C 115.643 1.719 . . . . 0.0 115.643 -168.087 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 6.1 tt -49.1 -55.63 11.63 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 118.968 0.804 . . . . 0.0 110.9 -176.562 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -67.67 -32.64 78.74 Favored Glycine 0 CA--C 1.527 0.809 0 CA-C-O 119.224 -0.764 . . . . 0.0 112.419 -176.491 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -80.76 -35.36 33.38 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 119.049 1.424 . . . . 0.0 110.763 -171.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 79.8 mtp -69.28 -14.07 62.74 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.134 0.973 . . . . 0.0 111.088 176.084 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -68.07 140.11 56.26 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 123.572 0.749 . . . . 0.0 112.199 -169.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 15.7 p30 50.56 22.17 1.02 Allowed 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 127.776 2.43 . . . . 0.0 115.09 172.746 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 17.9 mmt180 -71.23 150.15 45.56 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 170.315 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 46.1 m-20 -79.85 -53.68 6.55 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -116.22 145.16 43.34 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-N 120.422 1.464 . . . . 0.0 107.474 168.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 22.7 tp -132.19 105.83 7.59 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 103.516 -2.772 . . . . 0.0 103.516 176.044 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 28.0 mt -93.69 112.73 27.15 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 N-CA-C 104.205 -2.517 . . . . 0.0 104.205 173.138 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 24.1 mt -93.49 130.72 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 N-CA-C 105.572 -2.01 . . . . 0.0 105.572 176.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -111.83 124.13 51.71 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 105.414 -2.069 . . . . 0.0 105.414 169.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.406 ' CG ' HE21 ' A' ' 94' ' ' GLN . 42.9 t0 -158.59 159.12 35.1 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 124.285 1.034 . . . . 0.0 108.265 -177.031 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -89.25 144.7 25.91 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 170.099 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 31.9 mt -88.27 -25.56 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 C-N-CA 123.917 0.887 . . . . 0.0 110.453 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . 0.461 12.5 m 58.51 -15.08 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 N-CA-C 119.449 3.129 . . . . 0.0 119.449 176.296 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 5.9 p -157.99 131.26 7.59 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 121.101 1.773 . . . . 0.0 113.778 169.037 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 12.7 tppt? -166.39 175.35 8.24 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 128.236 2.614 . . . . 0.0 105.485 169.063 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.0 -23.8 63.2 Favored 'General case' 0 N--CA 1.474 0.741 0 O-C-N 121.662 -0.648 . . . . 0.0 111.62 174.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 -69.14 162.37 27.15 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.078 0.951 . . . . 0.0 110.994 -173.374 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 3.1 m -61.63 154.22 66.76 Favored Pre-proline 0 CA--C 1.548 0.873 0 C-N-CA 124.922 1.289 . . . . 0.0 112.697 -169.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_exo -57.32 159.34 16.11 Favored 'Trans proline' 0 N--CA 1.462 -0.375 0 C-N-CA 123.878 3.052 . . . . 0.0 112.591 169.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 64.99 10.18 44.91 Favored Glycine 0 CA--C 1.538 1.514 0 CA-C-O 119.314 -0.714 . . . . 0.0 114.508 171.522 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 3.3 m -90.98 151.93 20.88 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 125.932 1.693 . . . . 0.0 111.305 -169.408 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 29.0 ttp -96.3 139.5 32.35 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 169.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 70.0 mtm -131.14 131.17 43.91 Favored 'General case' 0 N--CA 1.462 0.129 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 169.412 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 9.5 mm -89.25 123.17 41.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 177.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -113.86 123.97 51.09 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 171.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 85.0 mtm180 -87.67 174.36 8.47 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 123.537 0.735 . . . . 0.0 110.515 -178.571 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -41.37 -53.87 3.19 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 115.884 1.809 . . . . 0.0 115.884 -169.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -84.03 -16.68 43.01 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -177.002 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -82.4 -37.01 26.14 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 -171.564 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.54 HG12 ' CE2' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -64.57 -45.51 76.58 Favored Pre-proline 0 CA--C 1.531 0.242 0 CA-C-O 117.221 -1.371 . . . . 0.0 113.862 -176.732 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -53.61 -42.34 66.73 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 121.981 1.787 . . . . 0.0 110.262 174.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -75.54 4.34 7.74 Favored 'General case' 0 CA--C 1.55 0.943 0 N-CA-C 114.466 1.284 . . . . 0.0 114.466 175.28 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -116.18 -41.77 3.12 Favored 'General case' 0 C--N 1.343 0.316 0 CA-C-N 120.09 1.313 . . . . 0.0 111.155 -177.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.676 ' HB3' ' HB2' ' A' ' 98' ' ' ALA . 63.8 m-85 -62.75 -8.92 7.65 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 178.167 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 63.2 p -51.65 -28.88 15.84 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.928 1.291 . . . . 0.0 112.955 173.216 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 53.8 t-20 -52.46 117.4 2.83 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.279 0.632 . . . . 0.0 111.17 -175.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -74.95 -19.36 60.14 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.733 0.813 . . . . 0.0 112.329 -173.575 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 52.7 mt -65.47 -48.89 81.27 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 -178.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 6.6 m -76.08 111.49 15.34 Favored Pre-proline 0 CA--C 1.55 0.955 0 C-N-CA 125.406 1.482 . . . . 0.0 110.444 -169.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -70.56 -60.12 0.07 OUTLIER 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 122.931 2.421 . . . . 0.0 113.847 -168.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 6.7 t-80 -62.32 -40.06 95.09 Favored 'General case' 0 N--CA 1.463 0.2 0 O-C-N 121.463 -0.773 . . . . 0.0 109.319 -178.272 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.406 HE21 ' CG ' ' A' ' 62' ' ' ASP . 18.3 mp0 -62.38 -36.65 82.96 Favored 'General case' 0 N--CA 1.44 -0.961 0 C-N-CA 125.241 1.416 . . . . 0.0 108.943 -176.027 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.434 ' O ' ' HB3' ' A' ' 98' ' ' ALA . 57.9 tp -66.72 -36.97 83.73 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 119.43 1.014 . . . . 0.0 110.901 174.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -66.89 -40.51 93.58 Favored Glycine 0 CA--C 1.53 1.027 0 O-C-N 120.962 -1.086 . . . . 0.0 110.931 173.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.503 HD12 ' CZ ' ' A' ' 86' ' ' PHE . 1.5 tm? -61.67 -36.38 80.7 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 172.543 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.676 ' HB2' ' HB3' ' A' ' 86' ' ' PHE . . . -56.7 -53.54 56.55 Favored 'General case' 0 CA--C 1.52 -0.21 0 O-C-N 121.145 -0.972 . . . . 0.0 109.672 173.037 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -68.0 -28.4 67.38 Favored 'General case' 0 C--O 1.236 0.362 0 O-C-N 122.961 0.163 . . . . 0.0 110.934 -172.564 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -70.67 -44.47 76.52 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.951 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 174.311 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 20.2 mt -65.89 -33.08 75.02 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 119.04 0.837 . . . . 0.0 111.079 178.254 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 51.5 m -61.4 -41.73 97.6 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 118.769 0.713 . . . . 0.0 109.204 170.306 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.438 ' HA ' ' CD2' ' A' ' 106' ' ' PHE . . . -64.81 -40.35 95.08 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 119.748 1.158 . . . . 0.0 112.219 177.196 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -61.17 -33.28 73.19 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 119.095 0.861 . . . . 0.0 110.63 171.071 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 22.3 ttm-85 -75.5 -29.61 59.58 Favored 'General case' 0 CA--C 1.534 0.346 0 O-C-N 121.125 -0.984 . . . . 0.0 110.582 178.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.438 ' CD2' ' HA ' ' A' ' 103' ' ' ALA . 15.4 m-30 -69.88 -45.23 68.11 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.552 0.741 . . . . 0.0 110.277 177.208 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 32.8 p -74.46 -24.94 59.12 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 122.925 0.49 . . . . 0.0 111.831 -177.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 78.02 8.78 87.3 Favored Glycine 0 CA--C 1.538 1.499 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 -168.399 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -77.11 10.35 2.43 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 119.776 1.788 . . . . 0.0 111.612 171.382 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.434 ' HA ' ' HD3' ' A' ' 111' ' ' PRO . 10.3 t80 -57.32 140.09 79.43 Favored Pre-proline 0 CA--C 1.552 1.045 0 C-N-CA 125.346 1.459 . . . . 0.0 110.65 177.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 110' ' ' PHE . 50.3 Cg_exo -63.92 160.36 37.76 Favored 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 123.259 2.639 . . . . 0.0 115.402 -175.554 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -68.27 -35.42 77.85 Favored 'General case' 0 N--CA 1.473 0.675 0 O-C-N 121.663 -0.648 . . . . 0.0 112.163 171.514 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 61.7 mttm -134.52 92.66 2.94 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 124.253 1.021 . . . . 0.0 108.459 176.403 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 18.3 tp -78.57 131.58 36.81 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 105.072 -2.195 . . . . 0.0 105.072 168.055 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -132.72 139.45 47.64 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 172.004 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.428 ' CB ' HG11 ' A' ' 82' ' ' VAL . 0.9 OUTLIER -124.72 123.15 39.39 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 119.739 1.154 . . . . 0.0 108.928 177.151 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 3.7 t -88.99 90.56 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 N-CA-C 105.306 -2.109 . . . . 0.0 105.306 173.401 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -85.96 133.39 11.77 Favored Glycine 0 C--N 1.333 0.376 0 N-CA-C 110.084 -1.207 . . . . 0.0 110.084 -174.231 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 44.8 t -120.35 127.81 75.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 117.908 0.854 . . . . 0.0 109.277 -179.487 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 17.1 mt -84.64 133.85 43.29 Favored Pre-proline 0 CA--C 1.538 0.485 0 N-CA-C 104.923 -2.251 . . . . 0.0 104.923 169.322 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_endo -73.19 173.43 13.7 Favored 'Trans proline' 0 N--CA 1.452 -0.967 0 C-N-CA 123.008 2.472 . . . . 0.0 110.773 -179.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -107.12 -43.57 4.58 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 105.278 -2.119 . . . . 0.0 105.278 167.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 38.3 m -135.7 135.01 39.72 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.961 0.904 . . . . 0.0 109.764 173.025 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 4.7 tp -140.96 61.4 1.5 Allowed 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.576 1.55 . . . . 0.0 108.458 -178.254 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -126.76 167.6 16.99 Favored Pre-proline 0 CA--C 1.54 0.583 0 N-CA-C 106.294 -1.743 . . . . 0.0 106.294 172.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -77.35 95.92 1.09 Allowed 'Trans proline' 0 N--CA 1.457 -0.648 0 CA-C-N 120.678 1.278 . . . . 0.0 112.005 -175.102 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 18.6 p-80 -150.67 -19.3 0.23 Allowed 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 114.561 -1.199 . . . . 0.0 113.586 172.041 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . 0.414 0.0 OUTLIER 65.91 159.19 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 N-CA-C 116.343 1.979 . . . . 0.0 116.343 169.212 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 86.22 160.18 33.72 Favored Glycine 0 CA--C 1.529 0.923 0 N-CA-C 106.866 -2.494 . . . . 0.0 106.866 -168.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 68.6 mt -88.18 152.14 22.19 Favored 'General case' 0 N--CA 1.468 0.448 0 O-C-N 120.965 -1.315 . . . . 0.0 110.595 176.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 56.9 p -69.63 167.79 20.99 Favored Pre-proline 0 CA--C 1.538 0.515 0 CA-C-N 115.32 -0.854 . . . . 0.0 109.264 169.217 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -59.36 -37.19 91.83 Favored 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 122.0 1.8 . . . . 0.0 111.636 172.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 17.4 m -68.18 -40.68 82.2 Favored 'General case' 0 N--CA 1.44 -0.958 0 C-N-CA 123.508 0.723 . . . . 0.0 110.589 -177.355 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 84.3 t -88.75 -30.02 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 O-C-N 121.632 -0.667 . . . . 0.0 110.719 -174.159 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -53.27 -45.94 69.07 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 119.202 0.91 . . . . 0.0 108.771 168.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -69.77 -15.48 63.14 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 114.266 1.21 . . . . 0.0 114.266 179.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 9.3 mmm -76.85 -12.72 60.01 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 117.698 -1.144 . . . . 0.0 112.118 172.265 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 58.3 mt -54.33 -54.47 21.35 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.37 0 CA-C-N 120.193 1.36 . . . . 0.0 108.991 173.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 76.7 mm-40 -66.41 -46.74 59.79 Favored Pre-proline 0 CA--C 1.552 1.023 0 CA-C-N 120.329 1.422 . . . . 0.0 111.059 -173.481 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 0.4 OUTLIER -44.71 -52.77 5.75 Favored 'Trans proline' 0 C--N 1.353 0.801 1 C-N-CA 125.645 4.23 . . . . 0.0 112.5 168.75 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.04 -36.48 75.07 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.983 -1.008 . . . . 0.0 112.267 -177.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 42.6 mt -62.27 -41.77 98.76 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 118.897 0.771 . . . . 0.0 109.054 173.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -59.21 -36.02 74.65 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 119.342 0.973 . . . . 0.0 110.561 174.346 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -62.95 -50.14 71.99 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 118.794 0.724 . . . . 0.0 111.455 172.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 66.1 t -56.28 -49.11 78.2 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.19 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 66.6 mt -58.09 -43.09 86.89 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 123.046 0.538 . . . . 0.0 109.704 179.469 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -65.31 -44.85 86.59 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 118.972 0.805 . . . . 0.0 110.661 -177.231 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -64.64 -34.03 77.33 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 119.15 0.886 . . . . 0.0 111.37 -178.639 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . 0.337 4.4 pp -75.9 -36.97 59.29 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-O 117.346 -1.311 . . . . 0.0 109.762 176.688 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 14.0 mtp-105 -67.49 -27.6 67.14 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 121.113 1.779 . . . . 0.0 110.811 173.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -73.01 -15.73 61.52 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 118.629 0.65 . . . . 0.0 110.58 174.705 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 15.3 m -93.88 9.05 38.92 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.964 1.305 . . . . 0.0 110.719 169.222 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 74.0 13.17 81.11 Favored Glycine 0 CA--C 1.527 0.815 0 CA-C-O 117.396 -1.78 . . . . 0.0 112.792 -176.212 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 44.5 t -88.76 132.17 34.3 Favored 'Isoleucine or valine' 0 C--N 1.345 0.387 0 CA-C-N 120.985 2.392 . . . . 0.0 107.362 -176.181 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -104.32 93.94 5.08 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 106.675 -1.602 . . . . 0.0 106.675 169.441 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -59.13 137.68 57.86 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 169.105 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 20.6 mm -85.64 126.88 65.06 Favored Pre-proline 0 C--O 1.231 0.119 0 CA-C-O 117.531 -1.223 . . . . 0.0 107.711 -174.625 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -68.1 91.11 0.38 Allowed 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 122.868 2.379 . . . . 0.0 108.998 175.004 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 32.1 ttp85 51.81 17.99 0.7 Allowed 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 127.573 2.349 . . . . 0.0 114.853 179.404 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 52.6 m . . . . . 0 CA--C 1.544 0.745 0 C-N-CA 124.312 1.045 . . . . 0.0 112.093 -169.25 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 15.3 ptt180 . . . . . 0 N--CA 1.477 0.895 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 73.7 mt -134.56 147.7 29.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 C-N-CA 124.089 0.956 . . . . 0.0 108.544 -172.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 13.7 tp -135.0 146.53 49.13 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 168.304 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 63.1 t -121.4 130.42 74.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 105.513 -2.032 . . . . 0.0 105.513 174.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -121.26 130.23 53.56 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-N 119.004 0.82 . . . . 0.0 110.756 -173.621 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -104.98 132.03 10.92 Favored Glycine 0 C--N 1.334 0.455 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 174.135 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -143.94 159.78 16.0 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-N 118.122 0.961 . . . . 0.0 112.008 -176.167 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 131.72 173.99 13.51 Favored Glycine 0 CA--C 1.527 0.814 0 C-N-CA 126.569 2.033 . . . . 0.0 110.286 170.249 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.476 HD22 ' HB2' ' A' ' 13' ' ' LEU . 5.8 t30 -79.15 93.82 5.27 Favored 'General case' 0 C--O 1.233 0.191 0 O-C-N 121.307 -1.113 . . . . 0.0 110.891 -173.472 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.1 pt -57.46 31.49 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.092 0 N-CA-C 117.48 2.4 . . . . 0.0 117.48 172.285 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.421 ' HB2' HD21 ' A' ' 10' ' ' ASN . 38.3 mt -131.3 -3.75 3.86 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 120.671 1.578 . . . . 0.0 108.808 168.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.476 ' HB2' HD22 ' A' ' 10' ' ' ASN . 2.0 mp -118.1 59.8 0.79 Allowed 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.21 1.004 . . . . 0.0 113.459 -167.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 54.85 -96.92 0.06 Allowed 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 124.495 1.118 . . . . 0.0 111.248 171.201 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 41.1 m-20 -81.79 -15.46 54.16 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 124.601 1.16 . . . . 0.0 110.309 -172.665 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -72.65 -6.49 44.69 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 120.875 1.67 . . . . 0.0 112.609 178.683 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -82.3 -12.04 58.25 Favored 'General case' 0 N--CA 1.435 -1.189 0 CA-C-O 115.864 -2.017 . . . . 0.0 109.322 169.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 7.6 tp -52.36 -41.9 36.35 Favored 'Isoleucine or valine' 0 C--N 1.346 0.424 0 CA-C-N 122.57 2.441 . . . . 0.0 113.031 -169.61 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -60.7 -43.59 98.89 Favored Glycine 0 CA--C 1.524 0.608 0 CA-C-N 119.997 1.271 . . . . 0.0 110.708 177.482 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 55.9 t -65.67 -49.53 77.11 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 CA-C-O 118.768 -0.634 . . . . 0.0 109.609 173.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 26.3 mmt180 -60.66 -32.84 72.02 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 120.389 1.449 . . . . 0.0 112.649 -178.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 31.0 mt -62.85 -47.29 93.56 Favored 'Isoleucine or valine' 0 C--O 1.231 0.124 0 CA-C-N 120.649 1.568 . . . . 0.0 109.846 178.464 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 27.7 m -72.96 -27.15 24.16 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 CA-C-N 119.14 0.882 . . . . 0.0 111.063 -174.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -71.16 -43.38 67.63 Favored 'General case' 0 C--O 1.232 0.163 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 173.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.86 -40.58 95.85 Favored 'General case' 0 N--CA 1.449 -0.486 0 O-C-N 121.781 -0.574 . . . . 0.0 110.457 178.39 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 6.5 tp -62.57 -40.77 97.94 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 118.444 -0.789 . . . . 0.0 109.874 175.591 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -61.39 -40.49 94.55 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 119.005 0.82 . . . . 0.0 111.191 178.549 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -71.91 -36.98 70.15 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 124.107 0.963 . . . . 0.0 111.306 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -95.07 -34.69 12.21 Favored 'General case' 0 C--N 1.341 0.225 0 CA-C-O 117.372 -1.299 . . . . 0.0 113.459 -169.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -119.02 148.7 42.72 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 120.956 1.707 . . . . 0.0 112.182 -173.049 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 40.7 mm -96.06 138.44 21.47 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 N-CA-C 103.804 -2.665 . . . . 0.0 103.804 168.496 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -121.95 148.74 52.13 Favored Pre-proline 0 CA--C 1.534 0.357 0 C-N-CA 123.795 0.838 . . . . 0.0 108.873 -174.018 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -65.68 159.62 47.46 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 122.207 1.938 . . . . 0.0 109.674 169.749 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -58.51 -31.74 68.17 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 -170.106 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 15.6 p90 -80.11 0.24 32.95 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 118.072 -0.966 . . . . 0.0 113.364 -177.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 88.3 t -113.53 127.27 70.95 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 N-CA-C 105.766 -1.939 . . . . 0.0 105.766 169.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -132.5 143.97 50.12 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 170.064 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -93.33 103.68 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.066 0 N-CA-C 105.37 -2.085 . . . . 0.0 105.37 169.712 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.496 HD13 ' H ' ' A' ' 40' ' ' ASP . 0.2 OUTLIER -90.16 162.2 15.38 Favored 'General case' 0 C--O 1.237 0.436 0 N-CA-C 107.813 -1.181 . . . . 0.0 107.813 172.275 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.496 ' H ' HD13 ' A' ' 39' ' ' LEU . 10.0 t0 -131.94 122.6 25.86 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 123.836 0.854 . . . . 0.0 109.068 -171.295 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -87.6 -98.63 0.89 Allowed Glycine 0 CA--C 1.526 0.769 0 N-CA-C 107.048 -2.421 . . . . 0.0 107.048 169.673 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 81.08 116.63 0.38 Allowed Glycine 0 C--N 1.34 0.758 0 N-CA-C 108.702 -1.759 . . . . 0.0 108.702 -173.295 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 19.1 p 51.54 57.75 6.23 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.276 1.031 . . . . 0.0 108.773 -178.03 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -115.99 -88.14 0.59 Allowed 'General case' 0 C--N 1.342 0.281 0 CA-C-N 114.259 -1.337 . . . . 0.0 110.986 -169.189 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 75.12 -91.68 0.82 Allowed Glycine 0 C--N 1.34 0.798 0 N-CA-C 109.053 -1.619 . . . . 0.0 109.053 -169.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 66.1 mmm -76.56 -21.56 55.48 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 -177.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -62.21 -14.97 43.48 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 113.187 0.81 . . . . 0.0 113.187 -169.508 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 18.6 mt -79.34 -5.26 54.14 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 114.276 1.213 . . . . 0.0 114.276 -178.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.444 ' HA ' HG13 ' A' ' 100' ' ' VAL . 6.0 tt -38.65 -62.42 0.61 Allowed 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 114.84 1.422 . . . . 0.0 114.84 -170.014 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -90.86 -29.51 13.01 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 111.579 -0.608 . . . . 0.0 111.579 -174.196 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -65.86 -32.56 74.14 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 117.726 0.763 . . . . 0.0 110.974 -176.608 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 52.2 mtp -72.55 -14.47 61.64 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 113.456 0.91 . . . . 0.0 113.456 176.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -69.35 154.84 41.4 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 113.191 0.811 . . . . 0.0 113.191 -169.266 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 60.62 46.44 9.32 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.221 1.808 . . . . 0.0 115.375 168.332 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 18.7 mmt180 -114.48 155.54 26.22 Favored 'General case' 0 N--CA 1.479 0.994 0 O-C-N 121.155 -0.965 . . . . 0.0 108.887 171.516 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -81.4 -30.81 33.48 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 172.675 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -143.47 152.13 41.14 Favored 'General case' 0 C--N 1.343 0.324 0 CA-C-N 119.358 0.981 . . . . 0.0 109.77 168.193 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -137.04 139.73 41.57 Favored 'General case' 0 CA--C 1.51 -0.582 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 174.577 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 39.0 mt -114.32 115.12 48.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 176.147 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.8 mm -89.67 133.21 32.35 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 N-CA-C 106.071 -1.826 . . . . 0.0 106.071 175.013 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -114.26 115.95 28.24 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 103.557 -2.757 . . . . 0.0 103.557 168.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -154.15 161.12 42.08 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 -169.032 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -98.4 140.33 32.83 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.393 0.677 . . . . 0.0 110.583 -178.154 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 33.7 mm -78.66 -32.45 16.08 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 C-N-CA 123.847 0.859 . . . . 0.0 111.474 179.591 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . 0.296 4.0 t 60.14 45.27 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.89 0 C-N-CA 125.537 1.535 . . . . 0.0 110.809 -173.665 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 6.7 m 68.91 155.14 0.12 Allowed 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 116.985 2.217 . . . . 0.0 116.985 169.497 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 23.6 ttmt -157.88 -174.5 4.88 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 129.901 3.28 . . . . 0.0 104.159 174.46 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 10.5 ptpt -61.74 -21.25 64.35 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.699 1.2 . . . . 0.0 113.53 169.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 43.5 t-20 -65.34 156.36 32.39 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 118.95 0.795 . . . . 0.0 110.059 172.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 13.7 m -63.45 142.64 97.91 Favored Pre-proline 0 CA--C 1.546 0.795 0 C-N-CA 124.141 0.977 . . . . 0.0 112.197 -169.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -59.34 153.77 51.45 Favored 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 122.64 2.226 . . . . 0.0 112.043 169.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 67.79 18.0 69.91 Favored Glycine 0 CA--C 1.534 1.257 0 O-C-N 121.634 -0.666 . . . . 0.0 113.506 174.156 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 17.5 m -95.49 141.38 29.09 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 125.542 1.537 . . . . 0.0 107.895 177.251 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 30.7 ttp -98.71 145.43 26.91 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 175.36 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 32.0 ttm -130.88 117.73 19.72 Favored 'General case' 0 CA--C 1.528 0.103 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 -170.29 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.6 mp -96.78 122.33 48.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 179.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -117.7 122.69 44.17 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 67.5 mtp85 -102.11 135.36 43.83 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 118.516 -0.754 . . . . 0.0 109.807 176.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 8.2 t70 29.28 -91.69 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 126.681 1.992 . . . . 0.0 116.141 174.189 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -62.55 -26.84 68.79 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 -174.665 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -79.58 -12.44 59.84 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 122.844 0.458 . . . . 0.0 110.557 -179.414 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 46.4 t -75.39 -51.34 3.33 Favored Pre-proline 0 N--CA 1.446 -0.653 0 CA-C-O 116.66 -1.638 . . . . 0.0 110.777 -174.25 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo -59.33 -41.3 60.04 Favored 'Trans proline' 0 C--N 1.351 0.698 0 CA-C-N 122.865 2.059 . . . . 0.0 111.525 171.545 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -60.88 -29.69 69.7 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 122.997 0.519 . . . . 0.0 111.787 -179.54 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.506 HD13 ' C ' ' A' ' 85' ' ' LEU . 3.1 tm? -79.8 -54.11 6.15 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 122.89 0.476 . . . . 0.0 110.57 170.756 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -56.73 -34.11 67.2 Favored 'General case' 0 C--O 1.227 -0.093 0 CA-C-N 118.319 0.509 . . . . 0.0 111.448 -171.191 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 3.6 t -64.24 -5.27 4.7 Favored 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 -172.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -54.09 136.1 42.43 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 119.593 1.088 . . . . 0.0 110.204 169.54 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -81.66 -15.82 53.33 Favored 'General case' 0 N--CA 1.471 0.62 0 O-C-N 122.043 -0.41 . . . . 0.0 111.493 178.018 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 52.9 mt -61.61 -44.72 99.13 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 123.86 0.864 . . . . 0.0 109.601 -169.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 37.8 t -89.86 121.05 69.32 Favored Pre-proline 0 N--CA 1.452 -0.35 0 C-N-CA 124.386 1.075 . . . . 0.0 110.017 171.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_exo -61.93 -37.35 66.33 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 122.844 2.362 . . . . 0.0 110.082 169.068 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 5.6 m80 -59.91 -54.11 49.95 Favored 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 179.37 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -75.58 -25.73 57.31 Favored 'General case' 0 C--O 1.219 -0.526 0 C-N-CA 117.577 -1.649 . . . . 0.0 111.437 -174.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 2.8 tt -58.28 -50.7 72.69 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 120.546 1.521 . . . . 0.0 108.323 171.036 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -59.43 -46.74 93.42 Favored Glycine 0 CA--C 1.527 0.821 0 N-CA-C 110.746 -0.942 . . . . 0.0 110.746 177.008 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 32.0 tp -69.91 -20.57 63.36 Favored 'General case' 0 CA--C 1.547 0.85 0 O-C-N 121.653 -0.91 . . . . 0.0 111.312 -177.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -68.68 -46.86 67.95 Favored 'General case' 0 CA--C 1.534 0.339 0 O-C-N 121.127 -0.983 . . . . 0.0 109.272 171.504 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -71.13 -22.23 62.09 Favored 'General case' 0 C--N 1.339 0.138 0 CA-C-O 119.246 -0.407 . . . . 0.0 111.48 177.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.444 HG13 ' HA ' ' A' ' 49' ' ' LEU . 4.8 t -62.85 -43.32 98.77 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.729 0 CA-C-O 117.948 -1.025 . . . . 0.0 108.851 169.287 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 42.7 mt -60.93 -32.43 71.93 Favored 'General case' 0 C--N 1.34 0.156 0 CA-C-N 120.456 1.48 . . . . 0.0 111.096 175.524 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 66.2 m -68.14 -38.87 82.65 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 119.173 0.897 . . . . 0.0 110.657 173.068 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -65.5 -38.65 90.33 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 119.619 1.1 . . . . 0.0 111.28 174.699 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -64.19 -36.5 84.27 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 118.879 0.763 . . . . 0.0 110.38 174.19 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 34.9 ttp-105 -65.51 -36.22 83.18 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 121.701 -0.625 . . . . 0.0 109.551 175.181 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 14.3 m-30 -68.48 -40.61 80.87 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 118.873 0.76 . . . . 0.0 111.012 178.227 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 54.4 p -74.24 -26.93 60.53 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 119.481 1.037 . . . . 0.0 111.278 177.603 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 75.93 9.93 85.15 Favored Glycine 0 CA--C 1.531 1.056 0 CA-C-O 119.046 -0.863 . . . . 0.0 111.568 -170.089 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -99.46 24.42 8.16 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 118.949 1.374 . . . . 0.0 111.121 -178.395 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -57.64 135.24 82.56 Favored Pre-proline 0 CA--C 1.543 0.697 0 C-N-CA 126.116 1.766 . . . . 0.0 109.959 178.044 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -52.88 132.93 49.26 Favored 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 122.845 2.363 . . . . 0.0 112.081 177.104 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 31.3 mmtp -65.63 -24.22 66.99 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 119.149 -0.453 . . . . 0.0 111.932 -172.104 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 1.5 tmmt? -140.6 100.99 3.99 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 106.013 -1.847 . . . . 0.0 106.013 169.59 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 23.8 tp -78.51 140.78 38.54 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 174.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -134.79 138.96 44.74 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 107.159 -1.422 . . . . 0.0 107.159 176.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.1 tp -135.59 129.83 33.52 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 120.077 1.308 . . . . 0.0 108.92 175.39 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 47.9 t -103.28 105.03 17.55 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 N-CA-C 103.55 -2.759 . . . . 0.0 103.55 168.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -84.92 145.36 21.56 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 110.485 -1.046 . . . . 0.0 110.485 174.276 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 42.0 t -121.17 133.0 69.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 171.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 14.2 mt -88.89 132.11 39.26 Favored Pre-proline 0 CA--C 1.539 0.539 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 169.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -77.7 -178.29 4.49 Favored 'Trans proline' 0 CA--C 1.537 0.64 0 C-N-CA 123.582 2.854 . . . . 0.0 111.862 -175.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -119.05 -52.96 2.29 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.815 0.846 . . . . 0.0 111.207 178.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 66.5 m -118.51 -51.69 2.39 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 119.081 0.855 . . . . 0.0 112.868 -172.421 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER 57.7 52.55 8.08 Favored 'General case' 0 CA--C 1.551 0.997 0 N-CA-C 114.646 1.35 . . . . 0.0 114.646 169.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -115.93 168.51 8.37 Favored Pre-proline 0 N--CA 1.481 1.092 0 CA-C-O 118.421 -0.799 . . . . 0.0 111.182 176.159 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -65.19 89.69 0.2 Allowed 'Trans proline' 0 CA--C 1.548 1.18 0 C-N-CA 123.447 2.765 . . . . 0.0 113.756 -178.26 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 179.86 149.26 0.32 Allowed 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 104.538 -2.393 . . . . 0.0 104.538 175.6 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -110.52 163.49 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-N 119.614 1.097 . . . . 0.0 112.927 -169.83 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 86.16 150.19 15.04 Favored Glycine 0 C--N 1.341 0.814 0 N-CA-C 107.468 -2.253 . . . . 0.0 107.468 -169.489 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -79.03 164.49 24.31 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-O 121.536 0.684 . . . . 0.0 110.031 -169.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 23.6 p -65.93 166.74 14.26 Favored Pre-proline 0 CA--C 1.539 0.556 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 167.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -53.74 -32.13 64.33 Favored 'Trans proline' 0 CA--C 1.537 0.674 0 C-N-CA 121.4 1.4 . . . . 0.0 111.545 169.601 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 22.1 m -69.57 -46.49 66.25 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 117.993 0.36 . . . . 0.0 111.148 179.544 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 22.2 t -94.1 -15.36 7.87 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-N 118.626 0.648 . . . . 0.0 111.25 -169.186 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -57.88 -47.03 83.97 Favored 'General case' 0 C--O 1.233 0.202 0 O-C-N 120.301 -1.499 . . . . 0.0 107.764 169.374 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -72.03 0.23 9.97 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-O 118.04 -0.981 . . . . 0.0 113.135 177.03 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 83.2 mtp -88.92 -10.02 49.39 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-N 120.001 1.273 . . . . 0.0 111.395 171.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 87.8 mt -57.16 -41.52 78.0 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 169.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 39.1 mm-40 -64.26 -60.61 8.28 Favored Pre-proline 0 CA--C 1.541 0.633 0 CA-C-O 117.979 -1.01 . . . . 0.0 112.703 -172.65 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -62.47 -32.98 80.34 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 CA-C-N 121.397 1.535 . . . . 0.0 110.994 178.444 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -68.04 -43.84 77.81 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-N 119.448 1.022 . . . . 0.0 109.75 -179.065 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 58.5 mt -58.21 -43.16 87.51 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 119.187 0.903 . . . . 0.0 109.697 173.105 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -59.62 -38.18 80.62 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 119.096 0.862 . . . . 0.0 110.366 179.775 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 20.0 mm100 -75.15 -33.95 61.57 Favored 'General case' 0 C--N 1.338 0.093 0 CA-C-O 117.817 -1.087 . . . . 0.0 112.97 175.426 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 67.2 t -59.83 -46.3 93.88 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 CA-C-N 120.442 1.474 . . . . 0.0 108.101 172.055 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 29.1 mt -66.72 -41.02 88.6 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 122.921 0.488 . . . . 0.0 110.116 -178.189 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -63.89 -40.16 95.86 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 119.226 0.921 . . . . 0.0 111.394 176.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -67.0 -41.11 87.27 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 122.683 0.393 . . . . 0.0 110.884 178.775 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 34.2 mt -59.51 -42.82 93.08 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 123.03 0.532 . . . . 0.0 109.91 173.598 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 -64.37 -15.93 61.35 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 117.362 -1.304 . . . . 0.0 111.886 -178.44 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -58.91 -41.81 88.12 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 120.678 1.581 . . . . 0.0 110.902 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 2.7 p -89.66 23.44 2.66 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.193 0.597 . . . . 0.0 111.423 178.081 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 70.32 22.41 77.56 Favored Glycine 0 CA--C 1.531 1.045 0 CA-C-O 118.761 -1.021 . . . . 0.0 113.415 -178.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 40.7 t -100.46 89.84 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.257 0 CA-C-N 119.054 1.427 . . . . 0.0 107.955 -175.38 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -76.76 137.22 39.17 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 169.389 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -85.68 155.2 21.19 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.546 0.738 . . . . 0.0 110.517 176.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . 0.412 HG22 ' H ' ' A' ' 160' ' ' SER . 88.9 mt -93.24 116.58 66.7 Favored Pre-proline 0 CA--C 1.541 0.61 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 -178.623 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -73.66 92.2 0.87 Allowed 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 123.405 2.737 . . . . 0.0 109.808 -176.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 7.6 ttt-85 48.11 16.92 0.1 Allowed 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 128.172 2.589 . . . . 0.0 115.513 -174.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . 0.412 ' H ' HG22 ' A' ' 157' ' ' ILE . 1.0 OUTLIER . . . . . 0 CA--C 1.544 0.741 0 C-N-CA 126.123 1.769 . . . . 0.0 110.813 -172.406 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 9.0 ptp180 . . . . . 0 N--CA 1.482 1.167 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 50.6 mt -142.52 139.42 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 CA-C-N 119.708 1.14 . . . . 0.0 112.603 -168.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -121.68 123.31 41.59 Favored 'General case' 0 N--CA 1.462 0.163 0 N-CA-C 104.776 -2.305 . . . . 0.0 104.776 167.484 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 57.5 t -101.45 99.32 8.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 101.576 -3.49 . . . . 0.0 101.576 169.539 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 14.1 tp -101.34 107.6 18.99 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 124.195 0.998 . . . . 0.0 110.203 -168.061 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -88.52 123.86 6.96 Favored Glycine 0 N--CA 1.45 -0.408 0 N-CA-C 107.337 -2.305 . . . . 0.0 107.337 174.346 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -136.87 164.63 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.707 0 C-N-CA 124.054 0.941 . . . . 0.0 108.58 -176.534 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 145.72 156.93 7.06 Favored Glycine 0 N--CA 1.447 -0.625 0 N-CA-C 109.064 -1.614 . . . . 0.0 109.064 178.215 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.441 HD21 ' HB2' ' A' ' 12' ' ' LEU . 1.6 t30 -76.47 94.89 3.75 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 171.449 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.3 pt -70.77 37.74 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 C-N-CA 124.577 1.151 . . . . 0.0 113.567 179.687 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.441 ' HB2' HD21 ' A' ' 10' ' ' ASN . 23.0 mt -125.15 -8.04 7.09 Favored 'General case' 0 CA--C 1.537 0.466 0 O-C-N 121.148 -0.97 . . . . 0.0 108.768 170.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.0 mp -118.65 67.61 0.78 Allowed 'General case' 0 C--N 1.346 0.414 0 C-N-CA 124.006 0.923 . . . . 0.0 109.118 -169.002 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.3 m 47.3 -111.12 0.35 Allowed 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 114.761 -1.109 . . . . 0.0 111.654 171.645 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.445 ' O ' HG22 ' A' ' 18' ' ' ILE . 87.6 m-20 -71.9 -11.25 60.7 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-O 117.614 -1.184 . . . . 0.0 112.302 -170.235 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -66.54 -18.02 65.13 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 121.4 1.909 . . . . 0.0 111.032 171.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -70.6 -12.83 61.81 Favored 'General case' 0 N--CA 1.448 -0.555 0 O-C-N 120.178 -1.576 . . . . 0.0 111.769 171.392 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.501 HG21 HG11 ' A' ' 119' ' ' VAL . 8.4 tp -58.1 -36.45 57.03 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-N 121.271 1.85 . . . . 0.0 111.613 -174.019 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -61.48 -38.38 95.69 Favored Glycine 0 C--N 1.339 0.697 0 CA-C-N 119.365 0.984 . . . . 0.0 111.769 178.037 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 54.8 t -72.42 -47.04 54.01 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 175.111 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 24.7 mmt180 -60.96 -31.18 70.75 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 116.939 -1.505 . . . . 0.0 112.94 -179.244 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 18.4 mt -61.62 -47.74 91.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 CA-C-N 121.565 1.984 . . . . 0.0 110.17 177.078 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 14.4 m -72.78 -33.48 44.11 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-N 119.192 0.906 . . . . 0.0 110.912 -174.642 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 57.6 mt-10 -63.66 -42.98 98.01 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 118.428 0.558 . . . . 0.0 110.334 171.665 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.18 -39.37 92.46 Favored 'General case' 0 CA--C 1.537 0.452 0 O-C-N 121.292 -0.88 . . . . 0.0 110.647 176.006 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 6.1 tp -66.06 -39.61 90.23 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 118.451 0.569 . . . . 0.0 110.081 -179.317 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -60.68 -28.9 68.96 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 121.512 0.672 . . . . 0.0 112.131 -178.581 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 -88.19 -40.21 13.89 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 125.891 1.676 . . . . 0.0 111.14 -178.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 56.4 mtp180 -94.17 -18.44 21.73 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-O 118.449 -0.786 . . . . 0.0 112.364 -170.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 49.8 m-85 -129.58 147.05 51.34 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 119.354 0.979 . . . . 0.0 112.552 177.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 39.5 mm -98.28 137.08 26.84 Favored 'Isoleucine or valine' 0 C--O 1.239 0.518 0 N-CA-C 103.62 -2.733 . . . . 0.0 103.62 168.784 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -120.19 150.54 51.62 Favored Pre-proline 0 C--O 1.237 0.414 0 C-N-CA 123.297 0.639 . . . . 0.0 110.49 -169.811 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -59.05 157.56 28.97 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 123.128 2.552 . . . . 0.0 111.227 169.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -61.55 -31.51 71.54 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -175.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 9.6 p90 -75.76 -11.12 59.93 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 -179.512 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 92.5 t -92.87 122.9 44.74 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 173.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -117.62 123.59 46.54 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 169.476 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -86.48 117.78 31.58 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 N-CA-C 104.168 -2.53 . . . . 0.0 104.168 168.512 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 63.8 tp -118.9 130.75 55.89 Favored 'General case' 0 CA--C 1.523 -0.083 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 178.152 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -89.42 119.13 29.61 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 169.509 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -77.54 -80.14 0.68 Allowed Glycine 0 CA--C 1.528 0.872 0 N-CA-C 106.834 -2.507 . . . . 0.0 106.834 169.189 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 78.48 107.05 0.2 Allowed Glycine 0 C--N 1.345 1.044 0 N-CA-C 109.176 -1.57 . . . . 0.0 109.176 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 10.5 p 53.41 55.47 8.65 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 -177.106 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -120.35 -83.4 0.66 Allowed 'General case' 0 C--N 1.347 0.482 0 CA-C-N 115.005 -0.998 . . . . 0.0 112.255 -169.279 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 58.93 -107.21 1.09 Allowed Glycine 0 CA--C 1.532 1.15 0 N-CA-C 110.511 -1.036 . . . . 0.0 110.511 -178.368 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 11.7 tpt -55.95 -28.18 55.81 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.665 1.186 . . . . 0.0 112.627 -177.67 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -56.46 -22.12 30.1 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 113.827 1.047 . . . . 0.0 113.827 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 15.1 mt -103.3 17.95 22.89 Favored 'General case' 0 C--N 1.341 0.233 0 N-CA-C 115.978 1.844 . . . . 0.0 115.978 -167.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 6.2 tt -48.09 -56.35 8.01 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 119.447 1.021 . . . . 0.0 111.109 -178.166 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -66.42 -36.58 91.78 Favored Glycine 0 CA--C 1.528 0.898 0 CA-C-O 119.259 -0.745 . . . . 0.0 112.447 -177.502 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -73.69 -35.1 65.13 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 118.886 1.343 . . . . 0.0 111.817 -176.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 78.8 mtp -71.88 -12.71 61.4 Favored 'General case' 0 CA--C 1.535 0.401 0 O-C-N 121.962 -0.461 . . . . 0.0 110.323 179.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -84.12 153.63 23.62 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 123.306 0.642 . . . . 0.0 111.57 -170.424 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 54.24 34.8 21.17 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 126.475 1.91 . . . . 0.0 112.847 170.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 26.1 mmt180 -98.31 157.57 16.1 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 173.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -84.67 -51.4 6.85 Favored 'General case' 0 C--O 1.221 -0.42 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 175.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . 0.269 0.0 OUTLIER -120.25 146.43 46.07 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 120.017 1.281 . . . . 0.0 108.272 168.652 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 33.1 tp -130.46 111.63 12.48 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 104.172 -2.529 . . . . 0.0 104.172 173.092 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 52.7 mt -93.24 111.71 25.19 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 N-CA-C 103.801 -2.666 . . . . 0.0 103.801 171.17 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.46 HG22 HD23 ' A' ' 116' ' ' LEU . 53.5 mt -83.86 133.69 28.63 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 N-CA-C 105.233 -2.136 . . . . 0.0 105.233 170.651 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -116.97 116.77 28.03 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 102.519 -3.141 . . . . 0.0 102.519 168.038 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -161.57 165.77 27.95 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 123.518 0.727 . . . . 0.0 109.796 -176.248 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -81.34 144.53 31.41 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-O 122.355 1.074 . . . . 0.0 110.031 169.717 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 12.0 mt -69.1 -51.04 47.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 114.55 -1.205 . . . . 0.0 107.957 170.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . 0.294 9.0 p 42.22 48.45 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.95 0 C-N-CA 125.276 1.43 . . . . 0.0 111.071 179.753 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 8.4 t -162.79 176.42 10.28 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.368 1.467 . . . . 0.0 109.624 -171.572 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 20.0 ttmt 51.14 -161.17 0.08 Allowed 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 127.386 2.274 . . . . 0.0 112.175 -173.586 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 14.6 ptpt -128.89 12.79 6.26 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 125.036 1.334 . . . . 0.0 112.973 -169.394 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 44.8 t30 -74.75 167.22 22.25 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 178.051 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 2.8 m -56.93 145.87 61.92 Favored Pre-proline 0 CA--C 1.546 0.795 0 C-N-CA 123.812 0.845 . . . . 0.0 112.132 -169.704 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -56.23 155.82 23.18 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 123.84 3.026 . . . . 0.0 112.701 169.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 65.15 17.44 63.62 Favored Glycine 0 CA--C 1.535 1.321 0 CA-C-O 119.696 -0.502 . . . . 0.0 113.242 170.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 3.1 m -95.58 142.19 28.21 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 125.176 1.39 . . . . 0.0 109.11 -175.036 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 44.5 ttp -95.16 141.66 28.51 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 169.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 75.1 mtm -132.02 145.85 51.7 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 169.363 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.5 mp -97.22 119.66 45.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 N-CA-C 105.358 -2.09 . . . . 0.0 105.358 172.093 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.8 mp -113.79 136.02 53.32 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 171.717 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 36.4 mmt180 -96.39 164.13 12.77 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 123.018 0.527 . . . . 0.0 110.863 178.607 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -1.09 -70.13 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 127.839 2.456 . . . . 0.0 117.438 169.465 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -87.6 -19.87 27.18 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 113.533 0.938 . . . . 0.0 113.533 -170.474 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -76.77 -37.4 55.95 Favored 'General case' 0 CA--C 1.523 -0.084 0 CA-C-O 121.135 0.493 . . . . 0.0 110.095 -172.627 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.538 HG12 ' CE2' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -66.85 -52.48 32.49 Favored Pre-proline 0 CA--C 1.538 0.51 0 CA-C-O 117.417 -1.278 . . . . 0.0 112.723 -174.149 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -55.4 -42.01 72.46 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 121.57 1.513 . . . . 0.0 110.551 177.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.8 -15.53 63.53 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 178.118 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -92.69 -46.06 7.75 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 119.854 1.206 . . . . 0.0 110.674 -176.092 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.538 ' CE2' HG12 ' A' ' 82' ' ' VAL . 43.8 m-85 -68.77 -1.72 7.72 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 113.988 1.107 . . . . 0.0 113.988 -169.649 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 62.5 p -59.51 -21.17 59.79 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.759 1.223 . . . . 0.0 112.587 178.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 42.3 t-20 -65.91 149.88 49.5 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.542 0.737 . . . . 0.0 111.192 -175.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -84.93 -6.33 59.34 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.15 0.98 . . . . 0.0 113.569 -170.036 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 20.3 mt -59.56 -43.53 91.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 C-N-CA 123.676 0.79 . . . . 0.0 111.147 -169.444 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 28.3 t -117.72 125.28 28.16 Favored Pre-proline 0 C--O 1.235 0.295 0 N-CA-C 109.038 -0.726 . . . . 0.0 109.038 174.541 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -71.29 -30.01 16.3 Favored 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 122.578 2.185 . . . . 0.0 110.547 175.682 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 30.1 t-80 -67.19 -43.38 82.29 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 119.05 0.841 . . . . 0.0 108.815 177.283 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 7.4 mm100 -66.13 -38.8 89.06 Favored 'General case' 0 C--O 1.22 -0.46 0 CA-C-O 117.603 -1.189 . . . . 0.0 110.291 175.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 1.3 tt -56.47 -40.81 75.51 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 120.141 1.337 . . . . 0.0 109.373 174.095 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -60.81 -44.75 97.64 Favored Glycine 0 CA--C 1.529 0.942 0 O-C-N 121.237 -0.915 . . . . 0.0 111.434 175.176 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 51.1 tp -64.24 -32.44 74.03 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 117.893 0.847 . . . . 0.0 110.245 174.446 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.474 ' HB2' ' CB ' ' A' ' 86' ' ' PHE . . . -62.07 -51.39 68.15 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 119.517 1.053 . . . . 0.0 109.034 176.148 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -70.91 -28.33 64.44 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.011 -174.425 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -70.02 -41.99 79.4 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.922 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 172.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 32.1 mt -64.31 -35.66 81.57 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 119.521 1.055 . . . . 0.0 110.174 177.083 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 49.8 m -63.38 -37.19 86.32 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 118.983 0.81 . . . . 0.0 110.451 169.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.425 ' HA ' ' CD2' ' A' ' 106' ' ' PHE . . . -66.61 -39.14 88.21 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 119.58 1.082 . . . . 0.0 111.221 177.609 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -63.13 -31.67 72.87 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 118.69 0.677 . . . . 0.0 109.987 172.14 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 58.6 ttt85 -72.37 -34.41 67.95 Favored 'General case' 0 CA--C 1.533 0.32 0 O-C-N 121.103 -0.998 . . . . 0.0 109.864 175.507 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.425 ' CD2' ' HA ' ' A' ' 103' ' ' ALA . 13.9 m-30 -68.42 -44.09 75.76 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 118.829 0.74 . . . . 0.0 110.583 178.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 40.4 p -70.97 -26.77 63.3 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 118.52 0.6 . . . . 0.0 111.745 -179.424 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 73.19 7.07 70.8 Favored Glycine 0 CA--C 1.535 1.282 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 -168.34 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -89.51 16.85 7.0 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 119.467 1.633 . . . . 0.0 110.937 178.302 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -54.88 139.85 61.57 Favored Pre-proline 0 CA--C 1.549 0.918 0 C-N-CA 125.824 1.65 . . . . 0.0 109.702 172.076 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_exo -55.56 156.9 16.59 Favored 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 123.38 2.72 . . . . 0.0 115.697 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 66.7 mmtt -63.76 -40.44 96.7 Favored 'General case' 0 N--CA 1.472 0.661 0 O-C-N 121.768 -0.582 . . . . 0.0 111.418 -179.433 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 5.4 pttm -131.72 146.14 52.01 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 105.663 -1.977 . . . . 0.0 105.663 171.282 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.51 HD23 ' N ' ' A' ' 115' ' ' THR . 7.0 tt -140.26 139.36 35.54 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 175.335 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.51 ' N ' HD23 ' A' ' 114' ' ' LEU . 0.2 OUTLIER -137.9 134.57 35.19 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 -171.274 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.46 HD23 HG22 ' A' ' 60' ' ' ILE . 0.4 OUTLIER -122.79 118.42 27.95 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 120.409 1.459 . . . . 0.0 108.512 177.798 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 16.1 t -88.05 81.99 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 N-CA-C 105.05 -2.204 . . . . 0.0 105.05 175.335 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -80.76 141.9 23.07 Favored Glycine 0 C--O 1.225 -0.434 0 CA-C-O 119.272 -0.738 . . . . 0.0 111.573 -169.595 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.501 HG11 HG21 ' A' ' 18' ' ' ILE . 42.0 t -119.9 123.6 71.18 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.105 0 CA-C-N 117.396 0.598 . . . . 0.0 109.946 177.522 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 25.7 mt -78.23 127.87 79.95 Favored Pre-proline 0 CA--C 1.53 0.207 0 N-CA-C 104.999 -2.222 . . . . 0.0 104.999 169.545 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -69.15 160.0 51.61 Favored 'Trans proline' 0 N--CA 1.45 -1.062 0 C-N-CA 121.756 1.637 . . . . 0.0 110.966 179.584 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -94.67 -42.92 8.52 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 105.871 -1.9 . . . . 0.0 105.871 168.144 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 49.9 m -137.28 149.22 46.95 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 123.791 0.837 . . . . 0.0 109.494 173.682 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.2 tp -143.48 53.54 1.33 Allowed 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.976 1.311 . . . . 0.0 108.499 -175.507 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -114.49 168.18 8.44 Favored Pre-proline 0 CA--C 1.538 0.482 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 -173.749 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -82.08 84.66 1.82 Allowed 'Trans proline' 0 N--CA 1.454 -0.802 0 CA-C-N 120.952 1.376 . . . . 0.0 112.654 -169.45 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -174.28 145.37 1.01 Allowed 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 103.511 -2.774 . . . . 0.0 103.511 179.401 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -112.03 168.33 4.99 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 N-CA-C 113.352 0.871 . . . . 0.0 113.352 -169.264 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 96.76 148.79 24.69 Favored Glycine 0 CA--C 1.528 0.893 0 N-CA-C 106.066 -2.814 . . . . 0.0 106.066 -168.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.545 HD22 ' H ' ' A' ' 130' ' ' LEU . 0.7 OUTLIER -75.3 163.02 27.91 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 118.312 1.056 . . . . 0.0 110.569 177.969 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 58.4 p -71.05 171.4 8.6 Favored Pre-proline 0 CA--C 1.543 0.706 0 CA-C-N 114.929 -1.032 . . . . 0.0 109.051 168.52 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -58.06 -33.79 97.71 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 121.927 1.751 . . . . 0.0 112.393 172.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 57.7 m -72.65 -40.1 66.62 Favored 'General case' 0 N--CA 1.443 -0.785 0 C-N-CA 123.463 0.705 . . . . 0.0 111.178 -178.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 95.1 t -94.44 -23.85 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 CA-C-N 118.438 0.563 . . . . 0.0 111.523 -169.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -51.37 -44.77 62.21 Favored 'General case' 0 N--CA 1.467 0.402 0 O-C-N 120.836 -1.165 . . . . 0.0 109.497 169.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -71.3 -18.79 62.39 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 114.405 1.261 . . . . 0.0 114.405 -178.69 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . 0.47 ' SD ' HG13 ' A' ' 119' ' ' VAL . 74.8 mtp -67.82 -14.92 63.35 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 118.005 -0.998 . . . . 0.0 112.829 -179.186 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 13.6 mt -48.87 -42.53 13.87 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.387 0 CA-C-N 119.635 1.107 . . . . 0.0 108.362 169.447 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 61.5 mm-40 -64.88 -58.32 13.31 Favored Pre-proline 0 CA--C 1.539 0.553 0 CA-C-N 120.351 1.432 . . . . 0.0 111.5 -172.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -61.32 -37.16 74.9 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 CA-C-N 121.447 1.553 . . . . 0.0 112.36 177.453 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -73.13 -37.83 66.52 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-O 118.569 -0.729 . . . . 0.0 111.499 -176.495 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 32.8 mt -62.24 -43.64 98.38 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-N 119.653 1.115 . . . . 0.0 109.041 170.701 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -55.78 -36.57 67.53 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 118.742 0.701 . . . . 0.0 110.131 174.547 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -72.44 -41.35 66.23 Favored 'General case' 0 N--CA 1.454 -0.26 0 O-C-N 121.442 -0.786 . . . . 0.0 112.712 177.527 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 60.1 t -58.76 -47.58 88.68 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 175.47 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 60.0 mt -60.99 -35.31 76.48 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-O 118.763 -0.637 . . . . 0.0 110.788 177.12 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -68.2 -46.22 71.21 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 119.243 0.928 . . . . 0.0 110.54 178.209 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -67.72 -30.06 69.46 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 119.882 1.219 . . . . 0.0 111.162 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 13.9 mt -63.06 -52.68 61.82 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 169.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 50.9 mmm-85 -66.04 -26.9 67.72 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 119.765 1.166 . . . . 0.0 112.412 -177.736 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 71.2 mt-10 -66.5 -30.13 70.38 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 119.569 1.077 . . . . 0.0 109.872 174.558 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 20.4 m -84.0 6.66 21.15 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.388 1.075 . . . . 0.0 111.957 171.118 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 72.06 12.15 75.32 Favored Glycine 0 CA--C 1.526 0.744 0 CA-C-O 117.294 -1.837 . . . . 0.0 112.98 -172.578 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 55.2 t -91.72 122.25 42.98 Favored 'Isoleucine or valine' 0 C--N 1.346 0.447 0 CA-C-N 121.048 2.424 . . . . 0.0 108.019 -176.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -104.26 93.5 4.85 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 173.546 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -58.9 146.04 39.07 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.823 169.129 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 22.9 mm -98.76 127.0 36.76 Favored Pre-proline 0 CA--C 1.53 0.21 0 CA-C-O 117.396 -1.287 . . . . 0.0 109.067 -171.454 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -67.96 97.99 0.5 Allowed 'Trans proline' 0 CA--C 1.535 0.536 0 C-N-CA 122.702 2.268 . . . . 0.0 109.753 174.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 23.2 mtp-105 48.32 18.04 0.15 Allowed 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 127.45 2.3 . . . . 0.0 115.327 -178.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 53.3 m . . . . . 0 CA--C 1.541 0.605 0 C-N-CA 124.229 1.012 . . . . 0.0 111.876 -169.582 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 16.2 ptt180 . . . . . 0 N--CA 1.471 0.594 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 84.8 mt -127.39 130.93 70.78 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.14 0 N-CA-C 107.896 -1.149 . . . . 0.0 107.896 -175.609 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -119.61 144.95 46.84 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 105.513 -2.032 . . . . 0.0 105.513 168.799 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 71.4 t -121.95 128.13 75.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 104.891 -2.263 . . . . 0.0 104.891 174.222 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.43 HD13 ' HA ' ' A' ' 6' ' ' LEU . 2.6 mm? -111.26 130.79 55.55 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-N 118.398 0.544 . . . . 0.0 109.85 -179.55 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -100.61 126.08 8.8 Favored Glycine 0 C--O 1.237 0.32 0 N-CA-C 108.211 -1.956 . . . . 0.0 108.211 171.296 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 1.9 m -141.22 171.56 12.04 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 CA-C-N 117.797 0.799 . . . . 0.0 110.278 -173.225 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 103.03 156.69 25.13 Favored Glycine 0 N--CA 1.442 -0.953 0 C-N-CA 126.352 1.93 . . . . 0.0 110.052 -178.625 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.527 HD21 ' HB2' ' A' ' 12' ' ' LEU . 4.1 t30 -72.51 104.21 3.76 Favored 'General case' 0 N--CA 1.453 -0.321 0 O-C-N 121.709 -0.877 . . . . 0.0 111.247 -169.378 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.1 pt -59.92 30.64 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.954 0 N-CA-C 117.228 2.307 . . . . 0.0 117.228 172.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.527 ' HB2' HD21 ' A' ' 10' ' ' ASN . 5.4 mp -129.79 -6.68 4.55 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 120.593 1.542 . . . . 0.0 108.436 168.439 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.465 ' HB2' HD22 ' A' ' 10' ' ' ASN . 3.0 mp -107.98 57.05 0.62 Allowed 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 119.255 0.934 . . . . 0.0 112.796 -168.123 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.444 ' HB ' ' H ' ' A' ' 15' ' ' ASP . 0.1 OUTLIER 51.16 -109.83 0.45 Allowed 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 123.898 0.879 . . . . 0.0 110.123 175.176 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.444 ' H ' ' HB ' ' A' ' 14' ' ' THR . 0.3 OUTLIER -77.85 -4.49 46.88 Favored 'General case' 0 N--CA 1.443 -0.78 0 O-C-N 121.59 -0.694 . . . . 0.0 111.021 -173.714 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -69.63 -12.17 61.43 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 120.647 1.567 . . . . 0.0 111.837 170.193 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -77.97 -9.95 59.35 Favored 'General case' 0 N--CA 1.435 -1.222 0 CA-C-O 115.736 -2.078 . . . . 0.0 109.635 170.497 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.7 tp -55.11 -39.14 49.19 Favored 'Isoleucine or valine' 0 C--N 1.348 0.537 0 CA-C-N 122.395 2.362 . . . . 0.0 111.995 -170.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -61.01 -39.5 97.17 Favored Glycine 0 C--N 1.336 0.58 0 CA-C-N 119.151 0.887 . . . . 0.0 111.038 177.62 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 97.1 t -74.45 -47.56 39.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 CA-C-O 118.54 -0.743 . . . . 0.0 109.861 176.024 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 76.2 mmt-85 -59.66 -33.84 72.06 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 119.983 1.265 . . . . 0.0 111.76 -179.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 22.8 mt -56.45 -51.49 64.1 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-N 120.363 1.438 . . . . 0.0 110.181 173.674 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 24.8 m -75.2 -25.98 18.54 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-N 119.075 0.852 . . . . 0.0 111.206 -172.56 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -69.88 -45.72 67.07 Favored 'General case' 0 C--O 1.233 0.187 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 174.355 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -67.35 -40.2 85.8 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 122.723 0.409 . . . . 0.0 110.386 -179.18 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.7 tp -61.56 -38.41 87.39 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 118.441 -0.79 . . . . 0.0 110.554 177.515 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -64.3 -42.21 96.49 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 118.956 0.798 . . . . 0.0 110.292 177.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -68.59 -36.37 78.62 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 122.873 0.469 . . . . 0.0 111.466 178.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 79.1 mmt-85 -94.36 -40.55 9.88 Favored 'General case' 0 C--N 1.339 0.122 0 CA-C-O 116.951 -1.499 . . . . 0.0 112.771 -170.3 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -117.19 130.33 56.52 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 121.588 1.994 . . . . 0.0 113.244 -169.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 40.2 mm -83.29 134.92 25.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 105.607 -1.997 . . . . 0.0 105.607 168.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.6 mp -133.34 150.69 75.9 Favored Pre-proline 0 CA--C 1.54 0.565 0 C-N-CA 126.99 2.116 . . . . 0.0 108.552 -169.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -71.01 165.05 33.64 Favored 'Trans proline' 0 CA--C 1.536 0.616 0 C-N-CA 122.815 2.343 . . . . 0.0 111.123 175.315 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -59.48 -31.45 69.35 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 -169.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 46.3 p90 -78.55 2.4 19.3 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 113.361 0.874 . . . . 0.0 113.361 -178.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.7 t -111.2 127.47 68.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 172.257 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -125.12 145.75 49.8 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 109.055 -0.721 . . . . 0.0 109.055 173.421 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -113.52 109.3 28.04 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 N-CA-C 105.762 -1.94 . . . . 0.0 105.762 172.159 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 64.4 tp -113.67 142.13 46.38 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 -174.118 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -100.38 127.52 46.68 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 123.642 0.777 . . . . 0.0 110.411 178.117 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -121.78 -22.56 2.7 Favored Glycine 0 CA--C 1.533 1.161 0 CA-C-O 118.51 -1.161 . . . . 0.0 113.012 169.586 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 42.64 -107.6 0.12 Allowed Glycine 0 C--N 1.339 0.742 0 C-N-CA 125.389 1.471 . . . . 0.0 113.938 177.091 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.8 p -67.48 -3.68 9.26 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 128.645 2.778 . . . . 0.0 114.108 -174.415 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.36 -56.88 14.15 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 124.07 0.948 . . . . 0.0 112.498 179.282 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 61.17 -99.64 0.21 Allowed Glycine 0 C--N 1.338 0.677 0 N-CA-C 108.614 -1.794 . . . . 0.0 108.614 -170.365 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.9 -28.15 68.08 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 126.098 1.759 . . . . 0.0 111.604 177.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -68.16 -4.15 12.91 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 113.802 1.038 . . . . 0.0 113.802 -168.5 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 22.4 mt -92.46 12.34 23.17 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 113.677 0.992 . . . . 0.0 113.677 177.449 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.429 ' HA ' HG13 ' A' ' 100' ' ' VAL . 6.1 tt -36.6 -60.48 0.59 Allowed 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.263 1.425 . . . . 0.0 114.713 -173.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -94.86 -26.61 12.51 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 123.205 0.431 . . . . 0.0 112.349 -175.51 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -57.69 -35.98 71.33 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 117.693 0.746 . . . . 0.0 111.769 179.066 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 20.7 mtp -83.05 -1.22 52.13 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 113.24 0.83 . . . . 0.0 113.24 -176.691 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -81.8 158.22 24.18 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.351 0.66 . . . . 0.0 111.995 -174.305 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 55.09 52.17 12.17 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 127.285 2.234 . . . . 0.0 115.655 168.416 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 20.7 mmt180 -115.07 163.2 15.96 Favored 'General case' 0 N--CA 1.482 1.174 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 170.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -80.46 -43.34 21.06 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 173.143 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . 0.294 0.1 OUTLIER -139.18 137.57 36.16 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 120.209 1.368 . . . . 0.0 110.101 168.319 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 24.1 tp -119.34 129.78 55.03 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 174.326 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 11.7 mt -103.1 115.91 45.9 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 174.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 9.5 mt -92.55 123.21 44.57 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 176.272 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -104.92 114.79 29.21 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 104.473 -2.417 . . . . 0.0 104.473 169.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -149.85 162.37 40.43 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.424 0.631 . . . . 0.0 110.961 -178.308 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -72.99 179.97 3.5 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 168.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.574 HG22 ' H ' ' A' ' 66' ' ' SER 0.301 93.2 mt -110.13 -83.15 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 CA-C-O 117.727 -1.13 . . . . 0.0 110.958 175.683 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . 0.292 1.7 m 41.0 35.86 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.856 0 C-N-CA 125.712 1.605 . . . . 0.0 112.984 -169.326 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.574 ' H ' HG22 ' A' ' 64' ' ' ILE . 49.9 m -134.12 2.77 3.36 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.435 1.494 . . . . 0.0 112.065 -173.453 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -154.34 156.36 36.76 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 177.032 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 9.7 ptpt -78.65 3.04 17.44 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 115.377 1.621 . . . . 0.0 115.377 -169.717 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 32.3 t-20 -69.7 161.9 28.8 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 118.955 0.798 . . . . 0.0 110.47 -173.677 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 11.9 m -55.72 143.34 60.0 Favored Pre-proline 0 CA--C 1.545 0.766 0 C-N-CA 124.669 1.188 . . . . 0.0 112.698 -169.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -57.28 151.83 49.69 Favored 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 122.33 2.02 . . . . 0.0 111.166 169.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 71.47 18.78 77.26 Favored Glycine 0 CA--C 1.533 1.189 0 O-C-N 121.458 -0.776 . . . . 0.0 113.468 175.213 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 6.9 m -104.78 139.95 38.81 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 125.474 1.51 . . . . 0.0 108.02 177.068 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 47.5 ttp -96.2 143.36 27.37 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 173.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 33.6 ttm -135.51 123.09 22.15 Favored 'General case' 0 CA--C 1.528 0.128 0 N-CA-C 106.429 -1.693 . . . . 0.0 106.429 -174.248 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 35.8 mm -103.67 119.64 52.59 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 178.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -114.01 134.22 54.99 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 -174.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 60.6 mtm180 -109.37 132.74 53.84 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 118.459 -0.781 . . . . 0.0 109.637 -174.749 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 37.8 t70 40.85 -104.76 0.05 Allowed 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 114.26 1.207 . . . . 0.0 114.26 169.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -60.02 -26.11 65.83 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.778 1.231 . . . . 0.0 113.894 -177.253 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -73.73 -20.9 60.39 Favored 'General case' 0 CA--C 1.534 0.331 0 O-C-N 121.829 -0.544 . . . . 0.0 110.085 -179.284 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.413 ' HB ' ' HD3' ' A' ' 83' ' ' PRO . 46.9 t -75.0 -55.46 2.31 Favored Pre-proline 0 N--CA 1.449 -0.494 0 CA-C-O 117.404 -1.284 . . . . 0.0 111.218 -169.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.413 ' HD3' ' HB ' ' A' ' 82' ' ' VAL . 6.2 Cg_exo -66.27 -30.7 45.28 Favored 'Trans proline' 0 N--CA 1.448 -1.193 0 CA-C-N 121.659 1.628 . . . . 0.0 110.191 178.04 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.07 -27.32 68.7 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 118.417 0.553 . . . . 0.0 111.364 179.322 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -74.05 -56.29 5.11 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 169.379 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.429 ' HB3' ' HB2' ' A' ' 98' ' ' ALA . 26.1 m-85 -63.23 -25.37 68.3 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 114.157 1.169 . . . . 0.0 114.157 -169.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 7.0 t -69.66 1.09 4.53 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 -175.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 37.2 t-20 -67.12 136.91 55.87 Favored 'General case' 0 CA--C 1.54 0.581 0 O-C-N 120.927 -1.108 . . . . 0.0 109.447 175.643 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 13.3 mptt -82.41 -9.1 59.58 Favored 'General case' 0 N--CA 1.47 0.531 0 O-C-N 121.487 -0.758 . . . . 0.0 111.858 -175.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 89.4 mt -61.25 -36.95 76.25 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 CA-C-N 119.047 0.84 . . . . 0.0 110.038 179.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 8.3 p -99.54 109.82 56.48 Favored Pre-proline 0 CA--C 1.548 0.903 0 C-N-CA 124.693 1.197 . . . . 0.0 109.543 -173.545 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -70.62 -46.47 0.86 Allowed 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 122.2 1.933 . . . . 0.0 113.21 -169.571 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 3.0 m80 -73.15 -38.4 66.26 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.481 0.657 . . . . 0.0 109.383 -177.042 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -76.11 -26.83 56.77 Favored 'General case' 0 C--O 1.226 -0.147 0 CA-C-O 118.659 -0.686 . . . . 0.0 111.07 -172.211 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -59.14 -37.61 77.7 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 118.901 0.773 . . . . 0.0 108.995 169.423 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -60.39 -41.86 98.68 Favored Glycine 0 CA--C 1.534 1.242 0 O-C-N 121.497 -0.752 . . . . 0.0 111.651 174.343 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -68.59 -31.6 70.9 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 118.133 0.967 . . . . 0.0 110.233 176.135 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.429 ' HB2' ' HB3' ' A' ' 86' ' ' PHE . . . -59.69 -45.32 92.45 Favored 'General case' 0 CA--C 1.53 0.179 0 O-C-N 120.77 -1.206 . . . . 0.0 109.032 169.306 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -68.63 -21.88 64.45 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 119.064 -0.493 . . . . 0.0 111.852 178.425 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.429 HG13 ' HA ' ' A' ' 49' ' ' LEU . 44.6 t -64.52 -46.21 93.36 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 168.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 19.8 mt -64.87 -35.46 81.2 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 119.655 1.116 . . . . 0.0 110.53 -179.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 16.4 m -60.93 -44.62 96.95 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 118.871 0.76 . . . . 0.0 109.368 171.5 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -65.63 -36.64 84.28 Favored 'General case' 0 N--CA 1.449 -0.522 0 O-C-N 121.686 -0.634 . . . . 0.0 111.701 179.105 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 12.4 mt -61.3 -37.59 83.77 Favored 'General case' 0 C--O 1.23 0.073 0 C-N-CA 123.59 0.756 . . . . 0.0 109.982 174.437 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 52.9 tpt85 -71.71 -35.1 70.11 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-O 118.036 -0.983 . . . . 0.0 110.49 174.452 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 18.4 m-30 -69.13 -39.06 79.12 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 119.785 1.175 . . . . 0.0 110.755 -178.571 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 38.9 p -72.59 -22.36 60.99 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 118.759 0.709 . . . . 0.0 111.012 175.699 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 73.62 11.07 80.4 Favored Glycine 0 CA--C 1.533 1.196 0 N-CA-C 111.005 -0.838 . . . . 0.0 111.005 -169.642 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -99.43 26.7 5.81 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 118.436 1.118 . . . . 0.0 110.575 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -59.48 129.59 87.12 Favored Pre-proline 0 CA--C 1.544 0.722 0 C-N-CA 124.137 0.975 . . . . 0.0 108.522 171.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_exo -50.37 149.66 12.47 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 123.971 3.114 . . . . 0.0 113.829 178.025 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 33.0 mmtp -59.46 -30.55 68.6 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 119.359 -0.353 . . . . 0.0 110.589 -178.307 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? -137.57 142.25 41.34 Favored 'General case' 0 C--O 1.231 0.129 0 N-CA-C 105.915 -1.883 . . . . 0.0 105.915 169.068 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 8.9 tt -127.78 134.1 49.47 Favored 'General case' 0 CA--C 1.519 -0.216 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 171.667 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.75 129.13 30.03 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 106.784 -1.562 . . . . 0.0 106.784 -169.569 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 7.0 tp -115.06 126.68 54.99 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 120.09 1.314 . . . . 0.0 108.553 178.312 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 32.4 t -98.51 84.44 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 N-CA-C 104.721 -2.326 . . . . 0.0 104.721 169.687 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -81.43 145.06 24.95 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 -179.013 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 19.0 t -126.79 137.11 58.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 171.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 1.6 mm -85.09 122.24 74.05 Favored Pre-proline 0 CA--C 1.543 0.701 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 177.179 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_exo -58.34 170.45 2.35 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 124.988 3.792 . . . . 0.0 115.711 172.109 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -118.26 -52.33 2.39 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 114.897 -1.047 . . . . 0.0 110.255 179.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 64.6 m -107.43 -53.84 2.56 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 119.203 0.91 . . . . 0.0 112.802 -174.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 57.29 47.55 16.58 Favored 'General case' 0 CA--C 1.549 0.942 0 N-CA-C 114.765 1.394 . . . . 0.0 114.765 175.283 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -124.67 170.17 9.48 Favored Pre-proline 0 N--CA 1.478 0.938 0 CA-C-O 117.888 -1.054 . . . . 0.0 109.89 175.441 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_exo -62.85 87.07 0.12 Allowed 'Trans proline' 0 CA--C 1.549 1.259 0 C-N-CA 123.838 3.025 . . . . 0.0 114.452 -179.368 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -172.76 140.42 0.98 Allowed 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 104.334 -2.469 . . . . 0.0 104.334 172.635 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -102.4 164.17 3.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-N 119.102 0.865 . . . . 0.0 112.889 -169.488 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 82.15 159.31 24.9 Favored Glycine 0 C--N 1.342 0.894 0 N-CA-C 108.977 -1.649 . . . . 0.0 108.977 -170.121 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -82.2 163.17 22.08 Favored 'General case' 0 N--CA 1.439 -0.993 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 -174.584 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 37.7 p -67.99 169.78 8.99 Favored Pre-proline 0 C--O 1.239 0.542 0 CA-C-N 115.107 -0.951 . . . . 0.0 108.944 168.067 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_exo -55.16 -32.37 79.8 Favored 'Trans proline' 0 CA--C 1.539 0.753 0 C-N-CA 121.397 1.398 . . . . 0.0 110.845 169.294 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 18.2 m -68.01 -44.49 76.42 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 119.066 -0.492 . . . . 0.0 111.297 179.604 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 12.3 t -100.59 -13.21 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-N 119.252 0.933 . . . . 0.0 112.277 -169.156 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -57.47 -45.83 84.36 Favored 'General case' 0 CA--C 1.516 -0.341 0 O-C-N 119.752 -1.842 . . . . 0.0 107.808 169.535 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -71.59 2.91 4.47 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-N 115.404 -0.816 . . . . 0.0 113.08 179.268 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 84.1 mtp -97.27 -6.87 33.48 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 118.136 -0.935 . . . . 0.0 111.384 173.609 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 79.2 mt -57.24 -50.06 77.88 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 175.512 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -66.36 -53.2 32.45 Favored Pre-proline 0 CA--C 1.537 0.47 0 CA-C-O 117.411 -1.281 . . . . 0.0 113.298 -170.036 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -60.79 -32.88 93.38 Favored 'Trans proline' 0 C--N 1.351 0.662 0 CA-C-N 121.987 1.745 . . . . 0.0 111.79 175.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -69.24 -38.8 78.66 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-O 118.406 -0.807 . . . . 0.0 109.881 177.623 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 10.6 mt -57.78 -44.17 86.06 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 119.612 1.097 . . . . 0.0 108.755 173.065 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -62.72 -36.84 84.28 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 118.328 0.513 . . . . 0.0 111.443 -176.577 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 42.9 mm-40 -74.27 -33.36 63.24 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 118.686 0.675 . . . . 0.0 112.206 177.28 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 75.2 t -62.05 -49.03 85.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-N 119.475 1.034 . . . . 0.0 108.28 169.726 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 56.3 mt -60.57 -39.12 86.85 Favored 'General case' 0 CA--C 1.531 0.244 0 O-C-N 121.81 -0.556 . . . . 0.0 110.717 -179.502 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -58.77 -39.3 80.61 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 119.038 -0.506 . . . . 0.0 112.147 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -64.93 -48.17 75.06 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 119.094 0.861 . . . . 0.0 110.406 178.17 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . 0.284 4.1 pp -68.01 -23.71 65.04 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 118.73 -0.652 . . . . 0.0 112.174 178.678 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 81.7 mtm-85 -67.1 -26.97 66.97 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 119.937 1.244 . . . . 0.0 111.407 171.014 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -66.89 -34.17 77.2 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 120.422 1.465 . . . . 0.0 109.318 175.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 23.1 m -82.32 18.45 1.43 Allowed 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.478 1.111 . . . . 0.0 112.615 172.529 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 68.21 19.65 72.41 Favored Glycine 0 CA--C 1.529 0.959 0 CA-C-O 118.706 -1.052 . . . . 0.0 113.745 173.347 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 58.1 t -80.48 124.97 39.01 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 CA-C-N 119.18 1.49 . . . . 0.0 107.317 176.518 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -100.67 95.72 6.86 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 105.222 -2.14 . . . . 0.0 105.222 169.509 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -70.43 141.64 52.07 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 177.158 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 8.8 mm -108.81 124.76 33.35 Favored Pre-proline 0 CA--C 1.529 0.151 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 -179.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -64.35 103.21 0.43 Allowed 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 121.918 1.745 . . . . 0.0 107.954 169.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 87.2 mtt180 56.91 -8.56 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 128.052 2.541 . . . . 0.0 117.017 179.469 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 2.4 t . . . . . 0 CA--C 1.543 0.708 0 C-N-CA 125.765 1.626 . . . . 0.0 111.575 -177.088 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 8.7 ptp180 . . . . . 0 N--CA 1.482 1.133 0 CA-C-O 117.725 -1.131 . . . . 0.0 108.114 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 53.7 mt -143.8 137.65 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 CA-C-N 119.718 1.145 . . . . 0.0 112.424 -168.578 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -121.07 126.7 50.49 Favored 'General case' 0 CA--C 1.521 -0.142 0 N-CA-C 104.255 -2.498 . . . . 0.0 104.255 167.487 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 61.7 t -107.95 100.03 9.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 N-CA-C 102.743 -3.058 . . . . 0.0 102.743 169.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 8.2 mt -95.54 116.05 28.29 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 -171.595 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -93.2 118.53 5.67 Favored Glycine 0 N--CA 1.446 -0.697 0 N-CA-C 106.136 -2.785 . . . . 0.0 106.136 169.659 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -134.62 -171.92 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 -174.506 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 106.43 157.43 21.6 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.217 -1.153 . . . . 0.0 110.217 -171.434 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -81.43 96.8 7.49 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 124.773 1.229 . . . . 0.0 109.055 -174.41 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.1 pt -71.97 41.81 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 C-N-CA 124.596 1.158 . . . . 0.0 113.766 -177.294 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 20.2 mt -130.1 -5.52 4.42 Favored 'General case' 0 CA--C 1.534 0.35 0 O-C-N 121.027 -1.046 . . . . 0.0 109.548 173.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -124.6 72.9 1.23 Allowed 'General case' 0 C--N 1.343 0.312 0 C-N-CA 123.559 0.744 . . . . 0.0 110.308 -168.511 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.452 ' HB ' ' H ' ' A' ' 15' ' ' ASP . 0.6 OUTLIER 47.25 -98.46 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.303 1.041 . . . . 0.0 113.419 175.368 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.452 ' H ' ' HB ' ' A' ' 14' ' ' THR . 69.1 m-20 -77.42 -18.54 57.14 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 125.347 1.459 . . . . 0.0 112.207 -169.531 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -72.63 -8.27 54.45 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 120.275 1.398 . . . . 0.0 112.491 -176.53 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.43 -12.0 60.92 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-O 117.057 -1.449 . . . . 0.0 110.862 169.389 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 9.2 tp -56.82 -39.72 66.36 Favored 'Isoleucine or valine' 0 C--N 1.341 0.234 0 CA-C-N 121.107 1.776 . . . . 0.0 112.275 -170.117 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -58.73 -46.82 92.86 Favored Glycine 0 C--N 1.339 0.708 0 CA-C-N 119.484 1.038 . . . . 0.0 111.229 176.25 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 62.4 t -62.95 -47.92 90.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-O 118.618 -0.706 . . . . 0.0 109.477 175.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 20.3 mmt180 -63.73 -31.95 73.29 Favored 'General case' 0 C--N 1.346 0.452 0 CA-C-O 117.298 -1.334 . . . . 0.0 111.688 -176.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 18.2 mt -60.6 -48.16 89.78 Favored 'Isoleucine or valine' 0 C--N 1.341 0.233 0 CA-C-N 121.033 1.742 . . . . 0.0 109.62 176.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 18.8 m -74.64 -33.45 31.9 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-N 119.429 1.013 . . . . 0.0 111.368 -173.486 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 62.8 mt-10 -63.29 -44.41 95.12 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 118.383 0.538 . . . . 0.0 109.934 172.206 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -66.33 -37.6 85.74 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 119.427 1.012 . . . . 0.0 110.197 177.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.8 tp -63.79 -39.78 95.07 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 119.08 0.855 . . . . 0.0 109.088 -178.636 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -62.16 -22.5 65.92 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.251 0.62 . . . . 0.0 112.578 179.302 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 90.3 mt-30 -94.32 -45.09 7.64 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.213 1.405 . . . . 0.0 110.201 -178.704 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 80.4 mtt180 -81.69 -25.33 35.6 Favored 'General case' 0 CA--C 1.528 0.109 0 CA-C-O 118.753 -0.641 . . . . 0.0 111.165 -173.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.402 ' HA ' ' H ' ' A' ' 159' ' ' ARG . 56.5 m-85 -125.54 151.33 46.51 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-N 118.611 0.642 . . . . 0.0 111.019 -179.511 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 46.3 mm -104.56 133.64 48.11 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 103.51 -2.774 . . . . 0.0 103.51 168.81 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -113.04 146.76 35.83 Favored Pre-proline 0 C--O 1.237 0.4 0 C-N-CA 123.28 0.632 . . . . 0.0 109.703 -169.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -65.17 157.89 55.06 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 122.458 2.105 . . . . 0.0 109.9 170.564 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -57.49 -34.01 68.61 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 -169.408 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 12.0 p90 -76.26 -10.73 59.63 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 -177.171 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 69.1 t -91.84 119.37 39.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 172.002 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -111.84 114.68 27.78 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 107.343 -1.354 . . . . 0.0 107.343 169.536 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -85.06 102.43 10.97 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 N-CA-C 104.484 -2.413 . . . . 0.0 104.484 168.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 59.5 tp -107.54 128.37 54.46 Favored 'General case' 0 C--O 1.232 0.151 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 -173.244 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -79.3 119.43 22.35 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 169.539 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -78.41 -80.1 0.74 Allowed Glycine 0 C--N 1.338 0.664 0 N-CA-C 106.64 -2.584 . . . . 0.0 106.64 169.527 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 78.28 99.37 0.21 Allowed Glycine 0 C--N 1.342 0.903 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 176.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 13.1 p 53.47 55.62 8.41 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.113 0.965 . . . . 0.0 108.69 -177.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -118.03 -79.89 0.6 Allowed 'General case' 0 C--N 1.348 0.503 0 CA-C-N 114.487 -1.233 . . . . 0.0 111.071 -170.051 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 59.42 -110.2 2.6 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 110.077 -1.209 . . . . 0.0 110.077 -179.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -53.14 -33.03 50.68 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.973 1.309 . . . . 0.0 110.962 -176.387 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -54.43 -22.3 12.18 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 113.784 1.031 . . . . 0.0 113.784 -175.474 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 14.5 mt -95.73 17.89 14.13 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 113.57 0.952 . . . . 0.0 113.57 -169.537 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.705 ' HA ' HG13 ' A' ' 100' ' ' VAL . 4.6 tt -45.78 -60.11 2.41 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 123.239 0.616 . . . . 0.0 112.055 -177.165 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -67.78 -32.52 78.06 Favored Glycine 0 CA--C 1.532 1.146 0 CA-C-N 116.002 -0.545 . . . . 0.0 112.291 -178.076 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -78.47 -32.37 48.33 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 118.836 1.318 . . . . 0.0 112.699 -173.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.534 ' SD ' HG11 ' A' ' 100' ' ' VAL . 53.8 mtp -74.8 -16.98 60.69 Favored 'General case' 0 N--CA 1.454 -0.225 0 O-C-N 121.758 -0.589 . . . . 0.0 110.868 178.261 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -81.13 156.4 25.77 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 123.375 0.67 . . . . 0.0 111.257 -173.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 53.76 36.08 23.01 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 126.588 1.955 . . . . 0.0 113.512 173.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 26.4 mmt180 -100.94 157.29 16.85 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 173.047 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -82.63 -54.68 4.97 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 176.008 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . 0.263 0.0 OUTLIER -116.83 149.95 39.17 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-N 119.522 1.055 . . . . 0.0 108.589 168.551 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 12.6 tp -133.69 115.82 15.06 Favored 'General case' 0 CA--C 1.511 -0.543 0 N-CA-C 104.955 -2.239 . . . . 0.0 104.955 171.782 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 33.8 mt -97.95 111.95 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 N-CA-C 104.885 -2.265 . . . . 0.0 104.885 171.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.552 HD13 HD11 ' A' ' 97' ' ' LEU . 12.2 mt -85.18 134.41 27.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 106.058 -1.83 . . . . 0.0 106.058 171.589 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -117.0 118.41 32.32 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 102.591 -3.114 . . . . 0.0 102.591 168.402 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -156.71 162.12 39.8 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 -175.093 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -85.33 149.66 25.3 Favored 'General case' 0 CA--C 1.534 0.357 0 O-C-N 121.536 -0.727 . . . . 0.0 109.974 170.026 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 11.0 mt -80.46 -30.94 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 C-N-CA 124.7 1.2 . . . . 0.0 110.171 175.678 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . 0.361 2.5 t 60.27 43.77 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.086 0 C-N-CA 126.321 1.848 . . . . 0.0 113.326 -176.402 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 12.8 m 62.04 139.15 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 128.424 2.69 . . . . 0.0 118.172 168.526 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -130.73 -90.04 0.46 Allowed 'General case' 0 N--CA 1.463 0.181 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 169.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 87.9 mttt -139.36 35.41 2.07 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.778 1.231 . . . . 0.0 110.0 -176.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 42.1 t-20 -138.0 161.72 35.98 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.561 1.144 . . . . 0.0 109.844 -171.105 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 2.1 m -62.5 148.3 90.67 Favored Pre-proline 0 CA--C 1.547 0.865 0 C-N-CA 124.666 1.186 . . . . 0.0 113.131 -169.294 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_exo -56.85 157.91 18.52 Favored 'Trans proline' 0 CA--C 1.532 0.419 0 C-N-CA 124.481 3.454 . . . . 0.0 113.038 169.711 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 64.15 16.3 59.82 Favored Glycine 0 CA--C 1.531 1.064 0 CA-C-O 119.491 -0.616 . . . . 0.0 113.809 171.317 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 3.0 m -94.51 146.64 23.96 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 124.672 1.189 . . . . 0.0 109.629 -172.092 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 31.7 ttp -98.04 141.78 30.57 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 171.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 64.3 mtm -133.33 129.73 37.89 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 169.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 38.9 mm -108.21 121.93 61.92 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 -179.528 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.3 mp -121.33 139.01 53.99 Favored 'General case' 0 C--O 1.236 0.367 0 O-C-N 123.833 0.708 . . . . 0.0 109.3 -172.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 52.5 ttp180 -83.95 165.15 18.89 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.922 0.889 . . . . 0.0 110.049 -177.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -30.67 -55.1 0.2 Allowed 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 116.353 1.983 . . . . 0.0 116.353 -175.392 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -87.91 -16.65 33.29 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 -174.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -76.13 -35.09 59.4 Favored 'General case' 0 N--CA 1.461 0.084 0 O-C-N 121.817 -0.552 . . . . 0.0 109.574 -178.254 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.455 ' HB ' ' HD3' ' A' ' 83' ' ' PRO . 88.3 t -59.14 -54.54 55.37 Favored Pre-proline 0 CA--C 1.547 0.848 0 C-N-CA 125.635 1.574 . . . . 0.0 111.787 -175.675 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.455 ' HD3' ' HB ' ' A' ' 82' ' ' VAL . 50.3 Cg_exo -53.86 -42.77 63.83 Favored 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 122.781 2.321 . . . . 0.0 112.41 174.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -71.26 -10.82 60.39 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -91.66 -40.2 11.42 Favored 'General case' 0 C--N 1.343 0.315 0 CA-C-N 120.073 1.306 . . . . 0.0 111.82 -176.539 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.511 ' CE2' HD12 ' A' ' 97' ' ' LEU . 41.4 m-85 -75.52 10.12 1.85 Allowed 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 112.967 0.728 . . . . 0.0 112.967 -171.525 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 75.2 p -60.14 -24.29 64.59 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.154 0.981 . . . . 0.0 111.22 171.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 61.5 t-20 -49.04 118.9 2.87 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.503 1.121 . . . . 0.0 111.235 177.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -74.67 -18.45 60.52 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -174.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 42.1 mt -67.13 -45.59 86.27 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -176.527 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.3 m -73.18 110.54 8.84 Favored Pre-proline 0 CA--C 1.545 0.762 0 C-N-CA 126.291 1.837 . . . . 0.0 112.05 -168.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -76.15 -62.95 0.03 OUTLIER 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 122.254 1.97 . . . . 0.0 112.333 -169.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 6.6 t-80 -56.66 -40.04 74.81 Favored 'General case' 0 N--CA 1.466 0.335 0 O-C-N 121.442 -0.786 . . . . 0.0 110.225 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 22.0 mp0 -62.29 -27.69 69.2 Favored 'General case' 0 N--CA 1.44 -0.955 0 C-N-CA 124.972 1.309 . . . . 0.0 110.082 -172.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 30.9 mt -72.09 -36.72 69.59 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 120.025 1.284 . . . . 0.0 110.447 174.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -66.69 -42.96 92.97 Favored Glycine 0 CA--C 1.528 0.885 0 N-CA-C 110.238 -1.145 . . . . 0.0 110.238 173.387 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.552 HD11 HD13 ' A' ' 60' ' ' ILE . 3.4 tm? -59.79 -41.45 91.2 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.197 0.599 . . . . 0.0 109.791 173.35 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -59.25 -44.65 92.36 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 123.01 0.524 . . . . 0.0 110.542 175.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -66.11 -26.76 67.61 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 118.806 -0.616 . . . . 0.0 111.899 -179.608 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.705 HG13 ' HA ' ' A' ' 49' ' ' LEU . 92.1 t -63.93 -45.84 95.78 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 168.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 87.9 mt -67.07 -33.4 75.43 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 119.266 0.939 . . . . 0.0 110.722 -176.182 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 15.8 m -60.78 -49.25 78.24 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 119.028 0.831 . . . . 0.0 109.957 169.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.402 ' HA ' ' CD2' ' A' ' 106' ' ' PHE . . . -58.1 -41.03 82.63 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 118.185 0.448 . . . . 0.0 111.019 176.737 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -63.48 -32.71 74.24 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 123.741 0.816 . . . . 0.0 110.951 179.74 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 17.6 ptm180 -83.68 -27.86 28.75 Favored 'General case' 0 C--N 1.344 0.369 0 CA-C-N 120.455 1.48 . . . . 0.0 112.19 173.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.402 ' CD2' ' HA ' ' A' ' 103' ' ' ALA . 16.7 m-30 -60.47 -46.58 89.55 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 118.454 0.57 . . . . 0.0 109.843 172.301 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 41.4 p -77.29 -26.8 52.67 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 123.611 0.764 . . . . 0.0 111.54 178.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 75.66 6.35 81.12 Favored Glycine 0 CA--C 1.534 1.232 0 N-CA-C 109.881 -1.288 . . . . 0.0 109.881 -168.497 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -85.24 19.99 2.09 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 119.768 1.784 . . . . 0.0 111.454 179.088 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -56.28 140.03 72.44 Favored Pre-proline 0 CA--C 1.546 0.814 0 C-N-CA 126.034 1.734 . . . . 0.0 110.307 170.058 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 99.6 Cg_exo -57.97 161.37 13.26 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 123.396 2.731 . . . . 0.0 115.531 179.365 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -65.91 -38.63 89.2 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 119.164 -0.446 . . . . 0.0 111.671 176.339 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 4.5 pttm -142.75 89.64 2.15 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 124.259 1.024 . . . . 0.0 108.342 177.7 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 7.4 tt -76.33 142.6 41.19 Favored 'General case' 0 CA--C 1.534 0.356 0 O-C-N 120.961 -1.087 . . . . 0.0 108.592 169.418 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.9 140.81 46.07 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.334 1.454 . . . . 0.0 107.698 174.696 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 14.6 tp -118.59 134.41 55.13 Favored 'General case' 0 N--CA 1.467 0.411 0 O-C-N 120.48 -1.388 . . . . 0.0 108.496 175.291 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 20.4 t -105.92 85.09 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 N-CA-C 104.788 -2.301 . . . . 0.0 104.788 169.154 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -81.31 144.66 24.77 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 110.41 -1.076 . . . . 0.0 110.41 179.732 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 39.2 t -128.43 130.98 69.3 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 CA-C-N 117.405 0.603 . . . . 0.0 109.989 179.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 16.8 mt -85.17 132.92 43.9 Favored Pre-proline 0 CA--C 1.539 0.529 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 176.396 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -77.01 -179.06 5.05 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 123.075 2.517 . . . . 0.0 111.617 -177.569 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.453 ' HB3' HG21 ' A' ' 131' ' ' THR . 6.3 tp10 -110.09 -51.18 2.9 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.994 0.918 . . . . 0.0 109.807 169.753 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 66.4 m -118.65 -54.53 2.25 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 118.201 0.455 . . . . 0.0 111.964 -169.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER 54.54 52.84 11.61 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.652 1.181 . . . . 0.0 112.163 -177.293 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -119.25 165.92 15.87 Favored Pre-proline 0 CA--C 1.537 0.472 0 C-N-CA 123.468 0.707 . . . . 0.0 109.954 -179.372 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -78.32 81.78 2.64 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 121.755 1.636 . . . . 0.0 112.634 -169.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -171.09 141.59 1.68 Allowed 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 102.218 -3.253 . . . . 0.0 102.218 177.293 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -108.21 166.59 4.25 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 N-CA-C 113.596 0.962 . . . . 0.0 113.596 -169.286 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 97.33 141.21 11.94 Favored Glycine 0 C--N 1.338 0.646 0 N-CA-C 105.751 -2.94 . . . . 0.0 105.751 -168.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.61 HD22 ' H ' ' A' ' 130' ' ' LEU . 1.0 OUTLIER -67.41 158.49 31.59 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 117.861 0.83 . . . . 0.0 109.882 176.943 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.453 HG21 ' HB3' ' A' ' 122' ' ' GLU . 63.4 p -69.14 169.75 10.78 Favored Pre-proline 0 CA--C 1.543 0.681 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 168.018 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -58.02 -37.13 97.12 Favored 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 121.57 1.513 . . . . 0.0 111.388 173.305 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 82.8 m -64.33 -33.75 76.55 Favored 'General case' 0 N--CA 1.443 -0.785 0 C-N-CA 124.415 1.086 . . . . 0.0 111.436 -178.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 73.8 t -103.23 -27.59 3.2 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 O-C-N 121.81 -0.556 . . . . 0.0 111.511 -172.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -51.73 -49.37 62.69 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 119.035 0.834 . . . . 0.0 108.88 169.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -61.89 -20.88 64.22 Favored 'General case' 0 N--CA 1.447 -0.575 0 N-CA-C 112.994 0.738 . . . . 0.0 112.994 179.373 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 3.0 mmm -78.04 -7.89 57.48 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 -179.619 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 72.5 mt -55.95 -50.59 68.31 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.295 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 170.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -70.51 -44.89 18.4 Favored Pre-proline 0 CA--C 1.538 0.481 0 CA-C-O 117.284 -1.341 . . . . 0.0 113.756 -168.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -57.66 -41.33 71.75 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 CA-C-N 122.076 1.777 . . . . 0.0 111.152 172.412 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.01 -35.89 74.69 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-O 118.263 -0.875 . . . . 0.0 112.046 179.285 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 39.0 mt -61.09 -48.64 80.75 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-N 120.087 1.312 . . . . 0.0 108.929 172.249 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -54.73 -35.31 63.55 Favored 'General case' 0 CA--C 1.531 0.237 0 O-C-N 123.398 0.436 . . . . 0.0 109.995 175.288 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 2.1 mm100 -78.7 -35.74 44.58 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 45.7 t -59.27 -48.27 87.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 169.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 44.0 mt -60.23 -36.55 77.99 Favored 'General case' 0 C--O 1.226 -0.148 0 C-N-CA 123.413 0.685 . . . . 0.0 110.88 177.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -70.1 -44.23 69.44 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 119.139 0.881 . . . . 0.0 110.856 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -66.53 -30.99 71.43 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 119.676 1.126 . . . . 0.0 111.225 177.433 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 12.9 mt -62.27 -52.99 61.5 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 169.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 93.6 mtt-85 -64.73 -28.65 69.74 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 120.231 1.378 . . . . 0.0 112.432 -178.413 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -69.34 -28.75 66.51 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 119.203 0.91 . . . . 0.0 109.982 176.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 51.0 m -82.51 8.24 12.22 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.392 1.077 . . . . 0.0 111.906 169.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 72.83 10.52 77.09 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-O 117.291 -1.838 . . . . 0.0 113.11 -174.56 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 38.2 t -91.05 119.54 38.39 Favored 'Isoleucine or valine' 0 C--N 1.345 0.378 0 CA-C-N 121.025 2.412 . . . . 0.0 108.48 -176.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -97.57 91.32 5.38 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 172.385 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -55.9 139.11 47.08 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 169.051 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 20.5 mt -83.33 126.87 70.71 Favored Pre-proline 0 CA--C 1.529 0.161 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 -173.263 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -68.47 89.83 0.4 Allowed 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 123.045 2.497 . . . . 0.0 109.029 174.64 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . 0.402 ' H ' ' HA ' ' A' ' 30' ' ' TYR . 29.1 ttp180 52.34 17.13 0.69 Allowed 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 127.628 2.371 . . . . 0.0 114.567 179.489 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 57.7 m . . . . . 0 CA--C 1.544 0.746 0 C-N-CA 124.057 0.943 . . . . 0.0 111.145 -169.015 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 38.9 ttm180 . . . . . 0 N--CA 1.475 0.792 0 CA-C-O 118.852 -0.594 . . . . 0.0 109.693 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 5.5 mt -119.73 132.7 68.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 -174.526 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 43.3 tp -113.61 145.72 40.84 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 105.849 -1.908 . . . . 0.0 105.849 167.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 30.2 t -124.32 131.37 72.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 N-CA-C 105.017 -2.216 . . . . 0.0 105.017 169.213 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 6.6 mt -125.36 117.3 23.43 Favored 'General case' 0 CA--C 1.511 -0.547 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 -173.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -87.88 133.29 11.71 Favored Glycine 0 CA--C 1.521 0.424 0 N-CA-C 107.709 -2.157 . . . . 0.0 107.709 169.652 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.5 m -142.27 133.01 24.76 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 CA-C-N 119.317 1.559 . . . . 0.0 112.507 -170.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 144.79 169.59 13.42 Favored Glycine 0 CA--C 1.525 0.684 0 C-N-CA 125.948 1.737 . . . . 0.0 109.123 169.572 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.548 HD21 HD13 ' A' ' 13' ' ' LEU . 0.2 OUTLIER -76.94 116.77 17.9 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 122.81 1.29 . . . . 0.0 111.45 -176.459 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.1 pt -63.99 36.34 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.861 0 N-CA-C 116.096 1.888 . . . . 0.0 116.096 172.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 5.4 mp -129.52 -9.53 4.59 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 120.545 1.52 . . . . 0.0 110.025 168.525 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.548 HD13 HD21 ' A' ' 10' ' ' ASN . 4.7 mp -106.59 56.47 0.65 Allowed 'General case' 0 C--N 1.343 0.299 0 N-CA-C 114.739 1.385 . . . . 0.0 114.739 -168.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.255 0.2 OUTLIER 54.95 -109.59 0.51 Allowed 'General case' 0 C--O 1.238 0.45 0 C-N-CA 123.428 0.691 . . . . 0.0 110.921 170.428 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -77.9 -7.45 56.75 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.435 0.694 . . . . 0.0 111.831 -175.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 23.0 tp10 -55.85 -32.59 63.76 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 120.012 1.278 . . . . 0.0 111.417 169.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.9 5.0 14.97 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-O 115.888 -2.006 . . . . 0.0 110.082 -179.1 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 6.6 tp -57.07 -42.82 80.13 Favored 'Isoleucine or valine' 0 C--N 1.342 0.242 0 CA-C-N 123.369 2.804 . . . . 0.0 110.92 -179.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -61.23 -43.18 99.71 Favored Glycine 0 CA--C 1.526 0.727 0 CA-C-N 119.564 1.075 . . . . 0.0 111.465 175.428 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 83.2 t -66.93 -51.46 54.62 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 CA-C-N 117.449 0.624 . . . . 0.0 109.559 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 74.4 mmt-85 -57.55 -34.76 69.51 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 117.142 -1.409 . . . . 0.0 112.479 176.578 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 24.2 mt -60.72 -47.73 91.84 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-N 121.839 2.109 . . . . 0.0 110.507 175.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 35.2 m -74.26 -27.2 21.39 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-N 120.25 1.386 . . . . 0.0 111.416 -175.426 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -69.18 -45.69 69.36 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 174.597 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -64.32 -45.11 89.3 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 123.313 0.645 . . . . 0.0 110.509 -179.442 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 8.1 tp -61.78 -41.58 97.9 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-O 118.86 -0.59 . . . . 0.0 110.068 179.672 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -60.05 -38.73 83.67 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 118.209 0.459 . . . . 0.0 110.965 177.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 9.5 mm-40 -75.75 -40.6 55.17 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 118.631 0.651 . . . . 0.0 111.065 -179.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 41.5 mmt180 -87.4 -31.57 20.01 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 117.637 -1.173 . . . . 0.0 113.02 -169.498 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 72.0 m-85 -122.54 137.76 54.78 Favored 'General case' 0 CA--C 1.522 -0.134 0 CA-C-N 120.76 1.618 . . . . 0.0 111.969 -176.05 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 43.7 mm -90.87 137.65 21.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 N-CA-C 105.591 -2.003 . . . . 0.0 105.591 168.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -124.25 154.98 68.83 Favored Pre-proline 0 CA--C 1.541 0.62 0 C-N-CA 124.985 1.314 . . . . 0.0 109.902 -170.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -59.44 157.13 32.61 Favored 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 123.318 2.679 . . . . 0.0 112.041 169.697 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -63.19 -31.38 72.51 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -171.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 18.8 p90 -72.66 -6.19 42.67 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 118.186 -0.911 . . . . 0.0 112.699 178.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 38.2 t -100.9 130.73 49.81 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 CA-C-N 120.054 1.297 . . . . 0.0 108.32 175.391 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -118.55 135.35 54.46 Favored 'General case' 0 CA--C 1.529 0.171 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 170.078 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -106.47 118.12 53.54 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 N-CA-C 104.691 -2.337 . . . . 0.0 104.691 169.368 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 48.7 tp -127.19 126.4 42.75 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-O 120.889 0.376 . . . . 0.0 110.307 -174.735 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -78.0 119.42 21.42 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 168.715 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -57.51 -55.84 28.28 Favored Glycine 0 CA--C 1.53 0.975 0 N-CA-C 109.073 -1.611 . . . . 0.0 109.073 172.411 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 74.74 87.56 0.24 Allowed Glycine 0 C--N 1.341 0.833 0 N-CA-C 111.451 -0.66 . . . . 0.0 111.451 169.699 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 20.3 p 50.81 58.91 5.02 Favored 'General case' 0 CA--C 1.546 0.8 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 -177.532 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -116.65 -86.72 0.62 Allowed 'General case' 0 C--N 1.348 0.508 0 CA-C-N 114.495 -1.23 . . . . 0.0 111.352 -169.334 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 65.76 -94.97 0.22 Allowed Glycine 0 C--N 1.341 0.836 0 N-CA-C 108.947 -1.661 . . . . 0.0 108.947 -169.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 3.5 tpt -62.77 -31.41 72.37 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 125.288 1.435 . . . . 0.0 111.764 179.687 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -66.36 -7.69 20.7 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -169.32 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 70.9 mt -84.26 3.74 34.06 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 113.854 1.057 . . . . 0.0 113.854 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.479 ' HA ' HG13 ' A' ' 100' ' ' VAL . 6.0 tt -41.36 -59.0 1.68 Allowed 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 114.107 1.151 . . . . 0.0 114.107 -170.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -93.34 -26.02 17.12 Favored Glycine 0 CA--C 1.527 0.786 0 C-N-CA 123.698 0.666 . . . . 0.0 111.896 -178.461 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -62.06 -34.7 76.74 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 118.639 1.22 . . . . 0.0 111.335 179.467 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 26.8 mtp -78.28 -3.58 43.6 Favored 'General case' 0 CA--C 1.529 0.137 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 178.378 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.5 157.84 36.84 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 118.817 0.735 . . . . 0.0 110.824 -178.124 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 55.3 39.51 31.31 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.827 1.651 . . . . 0.0 114.66 168.311 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 13.4 mmt180 -107.11 148.86 28.28 Favored 'General case' 0 N--CA 1.473 0.714 0 O-C-N 121.121 -0.987 . . . . 0.0 109.411 176.11 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -82.49 -36.05 26.82 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 171.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 1.7 t-160 -138.45 137.93 37.66 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 -176.002 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 20.8 tp -136.41 131.47 34.19 Favored 'General case' 0 CA--C 1.507 -0.686 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 169.275 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 3.8 mp -112.42 119.81 61.15 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 169.656 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 5.3 mt -96.55 117.71 41.48 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 177.097 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -84.56 113.41 21.22 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 103.2 -2.889 . . . . 0.0 103.2 169.519 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -124.16 155.37 38.59 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 114.358 1.244 . . . . 0.0 114.358 -167.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -113.18 119.4 37.65 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 169.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 92.0 mt -76.71 -26.01 16.22 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.753 0 O-C-N 124.148 0.905 . . . . 0.0 111.558 -171.703 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . 0.286 47.4 t 69.75 -62.58 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 C-N-CA 128.887 2.875 . . . . 0.0 111.572 -170.61 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 5.5 m -151.68 138.84 19.23 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 177.561 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 73.3 tttt -157.3 170.06 23.32 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 127.534 2.334 . . . . 0.0 105.234 168.735 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.01 -22.5 65.89 Favored 'General case' 0 N--CA 1.473 0.675 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 -170.314 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -71.16 164.92 24.66 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 123.087 0.555 . . . . 0.0 110.292 -177.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 18.6 m -61.57 149.57 83.76 Favored Pre-proline 0 CA--C 1.55 0.949 0 C-N-CA 124.257 1.023 . . . . 0.0 112.125 -171.232 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -54.21 152.53 24.77 Favored 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 122.77 2.313 . . . . 0.0 112.255 169.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 69.65 7.36 58.25 Favored Glycine 0 CA--C 1.531 1.036 0 CA-C-O 118.661 -1.077 . . . . 0.0 114.44 175.276 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 20.5 m -89.19 148.14 23.79 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 119.608 1.704 . . . . 0.0 110.043 -173.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 25.5 ttp -90.77 147.6 23.11 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.264 178.316 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 19.9 ttm -141.54 116.48 9.86 Favored 'General case' 0 CA--C 1.528 0.118 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 -177.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.6 mp -96.28 122.96 48.29 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 177.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -115.52 126.81 54.73 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 179.228 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 74.9 mtm180 -91.63 177.26 6.26 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 123.354 0.662 . . . . 0.0 109.68 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -48.19 -47.86 35.08 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 115.341 1.608 . . . . 0.0 115.341 -169.7 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -76.18 -15.89 59.96 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 119.046 0.839 . . . . 0.0 112.198 -178.33 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -96.36 -23.68 16.52 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 123.863 0.865 . . . . 0.0 110.714 -169.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.427 HG12 ' CE2' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -68.57 -37.99 11.41 Favored Pre-proline 0 CA--C 1.535 0.37 0 O-C-N 120.608 -1.308 . . . . 0.0 112.554 178.19 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -62.78 -12.04 26.96 Favored 'Trans proline' 0 CA--C 1.546 1.105 0 C-N-CA 121.55 1.5 . . . . 0.0 112.746 168.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -98.9 4.59 47.44 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.91 0.884 . . . . 0.0 111.742 173.436 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.504 HD13 ' C ' ' A' ' 85' ' ' LEU . 2.1 tm? -111.76 -57.25 2.28 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 124.025 0.93 . . . . 0.0 111.166 -175.701 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.427 ' CE2' HG12 ' A' ' 82' ' ' VAL . 67.4 m-85 -66.14 -15.89 63.5 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 118.764 0.711 . . . . 0.0 111.534 -170.307 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 68.4 p -85.29 -9.94 57.08 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 125.539 1.535 . . . . 0.0 113.139 -168.482 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -59.38 152.04 22.28 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 118.476 0.58 . . . . 0.0 109.926 174.584 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -78.5 -10.05 59.56 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 113.456 0.91 . . . . 0.0 113.456 -169.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 4.8 mp -84.76 -53.46 10.78 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 CA-C-N 119.396 0.998 . . . . 0.0 109.44 -171.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 3.9 m -59.95 109.23 1.81 Allowed Pre-proline 0 CA--C 1.549 0.908 0 C-N-CA 124.1 0.96 . . . . 0.0 111.814 -169.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -71.9 -54.15 0.15 Allowed 'Trans proline' 0 C--N 1.354 0.821 0 CA-C-N 120.817 1.328 . . . . 0.0 112.438 -169.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 18.2 m80 -80.93 -32.25 34.68 Favored 'General case' 0 N--CA 1.467 0.408 0 O-C-N 121.984 -0.447 . . . . 0.0 110.108 -175.126 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 3.9 mm-40 -71.16 -23.12 61.99 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 118.485 -0.769 . . . . 0.0 110.523 -179.112 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 10.4 mt -62.98 -30.52 71.65 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 120.387 1.448 . . . . 0.0 110.974 169.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -64.1 -40.75 98.4 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 109.916 -1.274 . . . . 0.0 109.916 171.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 22.5 tp -67.93 -30.93 70.36 Favored 'General case' 0 CA--C 1.532 0.287 0 O-C-N 122.142 -0.622 . . . . 0.0 110.546 174.658 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -58.87 -44.11 91.0 Favored 'General case' 0 N--CA 1.451 -0.389 0 O-C-N 120.796 -1.19 . . . . 0.0 108.895 171.131 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -70.89 -20.38 62.51 Favored 'General case' 0 N--CA 1.456 -0.13 0 O-C-N 121.789 -0.57 . . . . 0.0 111.494 177.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.479 HG13 ' HA ' ' A' ' 49' ' ' LEU . 55.2 t -70.04 -41.26 79.19 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.871 0 CA-C-O 117.764 -1.113 . . . . 0.0 108.126 169.315 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 6.8 mp -60.69 -38.21 84.23 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 120.602 1.546 . . . . 0.0 109.887 175.312 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 16.4 m -63.46 -45.1 92.38 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 174.546 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -65.65 -41.48 92.53 Favored 'General case' 0 N--CA 1.447 -0.587 0 O-C-N 121.535 -0.728 . . . . 0.0 110.554 -178.448 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.405 HD13 ' CD ' ' A' ' 111' ' ' PRO . 28.3 mt -58.96 -39.6 82.18 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 124.665 1.186 . . . . 0.0 110.306 174.609 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 41.3 ttm180 -67.4 -36.56 81.54 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 118.771 -0.633 . . . . 0.0 109.983 175.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 13.5 m-30 -68.51 -41.11 80.43 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 118.963 0.801 . . . . 0.0 111.051 178.38 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 55.8 p -75.93 -27.1 57.48 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 118.827 0.739 . . . . 0.0 110.994 179.546 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 78.4 10.03 86.54 Favored Glycine 0 CA--C 1.534 1.271 0 CA-C-O 119.278 -0.734 . . . . 0.0 111.465 -169.676 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 -94.07 15.21 17.6 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 118.807 1.303 . . . . 0.0 112.268 -177.392 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 8.1 t80 -53.69 132.24 55.89 Favored Pre-proline 0 CA--C 1.539 0.55 0 C-N-CA 125.349 1.459 . . . . 0.0 110.317 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.405 ' CD ' HD13 ' A' ' 104' ' ' LEU . 60.7 Cg_exo -50.5 136.37 40.61 Favored 'Trans proline' 0 C--N 1.354 0.817 0 C-N-CA 123.461 2.774 . . . . 0.0 112.32 178.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -63.19 -24.1 67.73 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 119.287 -0.387 . . . . 0.0 111.796 -173.64 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 57.2 tttm -141.85 108.31 5.31 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 169.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -85.89 142.01 29.17 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 169.123 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.62 153.25 45.98 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 105.951 -1.87 . . . . 0.0 105.951 171.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -145.29 138.23 26.25 Favored 'General case' 0 C--N 1.33 -0.276 0 O-C-N 120.512 -1.368 . . . . 0.0 108.636 176.259 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 48.8 t -110.12 95.91 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 N-CA-C 103.635 -2.728 . . . . 0.0 103.635 169.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -87.44 151.96 23.84 Favored Glycine 0 C--N 1.332 0.351 0 N-CA-C 110.101 -1.2 . . . . 0.0 110.101 178.059 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 44.9 t -132.77 137.15 54.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 178.691 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 51.0 mt -86.76 129.83 51.08 Favored Pre-proline 0 CA--C 1.542 0.659 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 170.491 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -74.04 171.98 16.87 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 124.03 3.153 . . . . 0.0 112.561 -179.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -109.4 -43.89 4.02 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.461 1.105 . . . . 0.0 108.599 169.443 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 63.8 m -128.73 152.09 48.81 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.473 0.709 . . . . 0.0 111.266 176.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.4 tp -152.54 54.5 0.79 Allowed 'General case' 0 CA--C 1.548 0.893 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 -169.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -127.35 170.14 10.77 Favored Pre-proline 0 N--CA 1.479 1.002 0 CA-C-O 117.756 -1.116 . . . . 0.0 110.595 -178.43 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_exo -63.45 88.56 0.14 Allowed 'Trans proline' 0 CA--C 1.548 1.201 0 C-N-CA 123.806 3.004 . . . . 0.0 114.409 -176.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 179.0 145.72 0.15 Allowed 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 104.415 -2.439 . . . . 0.0 104.415 175.303 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -118.09 167.09 11.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 CA-C-N 120.032 1.287 . . . . 0.0 112.886 -172.798 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 91.56 148.9 22.87 Favored Glycine 0 C--N 1.34 0.796 0 N-CA-C 106.809 -2.516 . . . . 0.0 106.809 -168.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -82.84 162.28 21.68 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-O 121.447 0.642 . . . . 0.0 111.115 -169.396 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 39.8 p -68.92 168.61 14.37 Favored Pre-proline 0 CA--C 1.541 0.619 0 CA-C-N 114.911 -1.041 . . . . 0.0 109.535 168.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -57.1 -32.81 94.42 Favored 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 121.302 1.335 . . . . 0.0 110.906 169.397 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 23.8 m -68.34 -38.69 81.74 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 118.999 -0.524 . . . . 0.0 111.905 179.323 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 20.2 t -108.62 -10.48 11.12 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 CA-C-N 119.471 1.032 . . . . 0.0 112.021 -169.195 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -60.11 -46.87 88.15 Favored 'General case' 0 N--CA 1.465 0.318 0 O-C-N 119.733 -1.854 . . . . 0.0 107.436 169.082 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -71.74 6.55 1.91 Allowed 'General case' 0 N--CA 1.439 -1.015 0 CA-C-O 117.965 -1.017 . . . . 0.0 112.661 176.312 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 26.5 mmm -94.1 -11.54 30.35 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 119.778 1.172 . . . . 0.0 111.083 170.014 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 72.6 mt -61.76 -46.36 96.7 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 179.003 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -69.9 -54.87 9.41 Favored Pre-proline 0 CA--C 1.536 0.405 0 CA-C-O 117.394 -1.289 . . . . 0.0 112.814 -172.331 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -59.82 -34.81 95.53 Favored 'Trans proline' 0 C--N 1.349 0.569 0 CA-C-N 122.301 1.857 . . . . 0.0 111.327 177.031 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -71.11 -45.03 64.45 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-O 118.719 -0.658 . . . . 0.0 110.497 -177.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -63.68 -36.8 85.02 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 119.235 0.925 . . . . 0.0 109.916 177.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -61.88 -39.03 90.51 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 118.007 0.367 . . . . 0.0 111.076 175.585 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 42.4 mm-40 -74.3 -28.37 61.15 Favored 'General case' 0 CA--C 1.535 0.399 0 O-C-N 121.44 -0.787 . . . . 0.0 111.828 176.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 70.4 t -62.93 -46.96 95.0 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 169.502 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 56.8 mt -65.67 -33.63 76.32 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 119.055 0.843 . . . . 0.0 111.143 179.148 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -60.0 -35.59 75.38 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 118.513 0.597 . . . . 0.0 111.275 177.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -61.73 -44.95 95.92 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 118.388 0.54 . . . . 0.0 111.244 175.708 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 7.1 mp -61.41 -40.55 94.8 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 122.726 0.41 . . . . 0.0 110.082 176.454 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 83.5 mtm-85 -65.59 -16.59 63.86 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 117.504 -1.236 . . . . 0.0 112.594 178.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -58.57 -30.7 67.36 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 120.781 1.628 . . . . 0.0 111.351 177.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 6.7 m -113.39 30.37 7.26 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.503 1.121 . . . . 0.0 111.129 177.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 64.31 23.57 68.36 Favored Glycine 0 CA--C 1.529 0.967 0 CA-C-O 118.566 -1.13 . . . . 0.0 113.821 174.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 60.4 t -87.63 131.35 35.57 Favored 'Isoleucine or valine' 0 C--N 1.34 0.194 0 N-CA-C 106.362 -1.718 . . . . 0.0 106.362 174.112 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -120.68 123.29 42.39 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 -177.732 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -82.15 144.36 30.79 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 172.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 6.9 mm -101.53 123.89 42.78 Favored Pre-proline 0 CA--C 1.53 0.207 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 -173.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -60.6 108.97 0.58 Allowed 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.188 1.926 . . . . 0.0 108.182 173.449 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 34.3 ptt180 43.8 15.62 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 128.825 2.85 . . . . 0.0 116.239 -177.397 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 3.8 m . . . . . 0 CA--C 1.547 0.837 0 C-N-CA 125.366 1.466 . . . . 0.0 112.732 -168.662 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 6.0 ptp180 . . . . . 0 N--CA 1.475 0.814 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 66.7 mt -141.54 133.32 27.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-N 119.12 0.873 . . . . 0.0 110.172 -169.975 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -116.39 128.64 55.69 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 105.952 -1.87 . . . . 0.0 105.952 168.419 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.0 t -106.95 98.1 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 103.466 -2.79 . . . . 0.0 103.466 172.844 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.8 mt -99.09 110.42 23.0 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 123.912 0.885 . . . . 0.0 110.17 -169.433 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -89.69 121.42 6.12 Favored Glycine 0 N--CA 1.446 -0.659 0 N-CA-C 107.102 -2.399 . . . . 0.0 107.102 170.313 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 13.0 m -134.21 -171.89 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.016 0 C-N-CA 124.321 1.048 . . . . 0.0 108.258 -178.148 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 110.66 154.63 13.91 Favored Glycine 0 C--N 1.336 0.539 0 N-CA-C 110.453 -1.059 . . . . 0.0 110.453 -173.233 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.446 HD21 ' HB2' ' A' ' 12' ' ' LEU . 3.1 t30 -77.36 96.84 4.73 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 123.788 0.835 . . . . 0.0 109.224 -179.143 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.3 pt -72.47 36.4 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 C-N-CA 124.504 1.122 . . . . 0.0 113.96 -179.077 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.446 ' HB2' HD21 ' A' ' 10' ' ' ASN . 28.0 mt -121.95 -8.75 8.83 Favored 'General case' 0 CA--C 1.531 0.248 0 O-C-N 121.091 -1.005 . . . . 0.0 108.729 171.55 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -127.27 83.95 2.21 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 -169.12 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.443 ' HB ' ' H ' ' A' ' 15' ' ' ASP . 2.1 m 35.74 -104.2 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 113.266 -1.788 . . . . 0.0 114.698 169.65 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.443 ' H ' ' HB ' ' A' ' 14' ' ' THR . 77.2 m-20 -68.08 -19.73 64.89 Favored 'General case' 0 N--CA 1.437 -1.097 0 CA-C-O 117.975 -1.012 . . . . 0.0 112.475 -169.187 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -68.03 -23.69 65.02 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 121.208 1.822 . . . . 0.0 111.818 178.976 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.36 -12.45 52.13 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-O 116.01 -1.948 . . . . 0.0 110.588 172.783 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.401 HG21 HG11 ' A' ' 119' ' ' VAL . 6.7 tp -53.74 -38.3 34.84 Favored 'Isoleucine or valine' 0 C--N 1.342 0.26 0 CA-C-N 122.176 2.262 . . . . 0.0 110.271 -177.742 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -61.47 -43.62 99.08 Favored Glycine 0 C--N 1.337 0.596 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 -178.879 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 57.8 t -70.18 -47.21 68.77 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 176.094 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 20.4 mmt180 -61.19 -31.86 71.61 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 117.016 -1.468 . . . . 0.0 112.505 -177.918 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 19.8 mt -58.93 -48.66 85.74 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 CA-C-N 121.74 2.063 . . . . 0.0 109.756 175.68 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.8 m -76.32 -31.07 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-N 119.432 1.015 . . . . 0.0 110.897 -172.202 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 59.2 mt-10 -64.99 -41.49 95.37 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 119.107 -0.473 . . . . 0.0 110.083 171.545 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -66.09 -37.03 84.76 Favored 'General case' 0 C--N 1.344 0.328 0 CA-C-N 119.42 1.009 . . . . 0.0 110.803 175.55 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 6.5 tp -63.07 -41.2 99.39 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 119.075 0.852 . . . . 0.0 110.036 -177.267 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -59.46 -27.68 66.31 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.516 0.726 . . . . 0.0 112.882 -179.991 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 50.6 mt-30 -95.05 -37.34 11.15 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 125.865 1.666 . . . . 0.0 111.41 -175.875 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 75.4 mtt180 -89.61 -27.28 20.3 Favored 'General case' 0 C--O 1.224 -0.244 0 CA-C-O 118.099 -0.953 . . . . 0.0 112.46 -175.965 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 52.6 m-85 -122.93 145.28 48.61 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 119.796 1.18 . . . . 0.0 112.967 -175.391 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 38.9 mm -95.39 139.07 19.56 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 N-CA-C 103.949 -2.611 . . . . 0.0 103.949 168.871 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 42.9 mt -128.81 147.19 63.48 Favored Pre-proline 0 CA--C 1.532 0.284 0 C-N-CA 123.457 0.703 . . . . 0.0 110.185 -168.835 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -67.77 158.55 56.76 Favored 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 122.76 2.306 . . . . 0.0 110.479 172.126 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -59.17 -33.42 70.91 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 114.436 1.273 . . . . 0.0 114.436 -169.403 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 10.0 p90 -75.05 -13.42 60.49 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 118.927 -0.559 . . . . 0.0 112.49 -177.746 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 75.0 t -88.09 122.47 39.72 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 170.531 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -124.18 129.41 50.77 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 169.67 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -82.81 137.46 20.97 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.809 0 N-CA-C 106.068 -1.827 . . . . 0.0 106.068 167.81 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 52.2 tp -128.36 136.45 50.95 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 169.717 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -93.15 120.94 33.99 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 169.246 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -72.8 -71.73 1.05 Allowed Glycine 0 CA--C 1.526 0.74 0 N-CA-C 108.981 -1.647 . . . . 0.0 108.981 174.159 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 84.98 92.56 0.78 Allowed Glycine 0 C--N 1.342 0.884 0 N-CA-C 107.942 -2.063 . . . . 0.0 107.942 -177.862 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 44.2 p 55.18 30.61 14.83 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 125.009 1.324 . . . . 0.0 111.893 176.879 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -81.61 -65.49 1.01 Allowed 'General case' 0 C--N 1.348 0.507 0 N-CA-C 115.25 1.574 . . . . 0.0 115.25 -168.194 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 60.95 -109.68 2.57 Favored Glycine 0 CA--C 1.528 0.865 0 N-CA-C 110.262 -1.135 . . . . 0.0 110.262 -175.376 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.32 -21.23 66.25 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.315 1.046 . . . . 0.0 112.061 -175.409 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -60.68 -18.85 56.46 Favored 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 113.534 0.938 . . . . 0.0 113.534 -175.158 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 11.4 mt -98.64 15.08 26.27 Favored 'General case' 0 C--N 1.347 0.458 0 N-CA-C 115.155 1.539 . . . . 0.0 115.155 -169.412 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 5.6 tt -48.2 -58.59 4.31 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 119.703 1.138 . . . . 0.0 111.244 -175.477 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -63.15 -31.59 81.23 Favored Glycine 0 CA--C 1.53 1.025 0 CA-C-O 119.419 -0.656 . . . . 0.0 112.368 -176.153 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -81.19 -35.89 30.81 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 118.509 1.155 . . . . 0.0 112.375 -177.556 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 32.6 mtp -74.07 -27.11 60.75 Favored 'General case' 0 N--CA 1.452 -0.361 0 O-C-N 122.102 -0.374 . . . . 0.0 110.045 178.415 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.51 157.59 31.8 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-O 121.677 0.751 . . . . 0.0 111.608 -179.691 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 16.3 m120 63.24 4.07 1.53 Allowed 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 127.27 2.228 . . . . 0.0 115.64 169.769 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 26.9 mmt180 -76.69 158.49 30.96 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 119.97 1.259 . . . . 0.0 109.05 178.759 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -84.38 -54.24 4.91 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 175.392 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . 0.27 0.0 OUTLIER -124.24 147.18 48.26 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-N 119.812 1.187 . . . . 0.0 108.308 169.28 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 19.0 tp -138.48 113.34 9.14 Favored 'General case' 0 CA--C 1.507 -0.678 0 N-CA-C 104.819 -2.289 . . . . 0.0 104.819 -175.272 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 24.5 mt -95.75 112.36 27.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 105.351 -2.092 . . . . 0.0 105.351 176.976 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.479 HG22 HD23 ' A' ' 116' ' ' LEU . 41.5 mt -86.96 137.84 20.16 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 N-CA-C 106.722 -1.584 . . . . 0.0 106.722 171.405 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -122.77 117.2 25.12 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 103.567 -2.753 . . . . 0.0 103.567 168.002 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -153.78 158.26 40.64 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 124.91 1.284 . . . . 0.0 108.208 -178.83 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -88.05 152.96 21.65 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 169.537 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 81.1 mt -87.52 -21.92 7.02 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 C-N-CA 125.114 1.366 . . . . 0.0 110.485 -178.786 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.425 HG13 HD22 ' A' ' 124' ' ' LEU 0.299 96.2 t 69.73 -45.31 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.175 0 C-N-CA 129.448 3.099 . . . . 0.0 113.966 -175.935 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.8 p -165.29 151.29 9.75 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 119.839 1.199 . . . . 0.0 111.939 172.331 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 13.4 tppt? -162.79 176.25 10.45 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 127.477 2.311 . . . . 0.0 105.05 169.449 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 13.7 ptpt -61.26 -26.72 67.95 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 175.946 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 34.2 t-20 -75.74 165.59 24.81 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.815 0.846 . . . . 0.0 110.53 -174.658 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 2.5 m -61.92 152.48 76.61 Favored Pre-proline 0 CA--C 1.547 0.862 0 C-N-CA 124.486 1.114 . . . . 0.0 112.542 -170.186 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -59.37 160.45 19.79 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 124.494 3.463 . . . . 0.0 113.35 169.655 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 61.35 23.89 62.91 Favored Glycine 0 CA--C 1.537 1.461 0 CA-C-O 119.66 -0.522 . . . . 0.0 112.699 170.773 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 3.3 m -105.91 141.36 37.44 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 125.41 1.484 . . . . 0.0 109.314 -170.49 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 41.6 ttp -94.25 142.89 26.89 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 170.372 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 69.6 mtm -132.8 139.91 47.74 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 170.427 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 6.8 mm -93.31 122.46 44.82 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 177.199 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -112.19 123.82 51.1 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 175.726 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 82.1 mtp180 -81.3 170.71 15.71 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 123.004 0.522 . . . . 0.0 110.333 175.842 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -35.59 -55.47 0.68 Allowed 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 116.15 1.908 . . . . 0.0 116.15 -173.827 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -88.61 -9.33 52.57 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -176.001 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -87.64 -40.52 14.11 Favored 'General case' 0 N--CA 1.454 -0.26 0 O-C-N 121.911 -0.493 . . . . 0.0 109.866 -174.868 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 1.4 m -53.5 -47.66 95.58 Favored Pre-proline 0 CA--C 1.54 0.574 0 CA-C-O 117.928 -1.034 . . . . 0.0 112.27 -179.79 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -61.53 -40.09 50.13 Favored 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 122.284 1.99 . . . . 0.0 110.305 179.907 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.48 -4.16 44.14 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.874 0.869 . . . . 0.0 113.103 177.497 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -87.6 -40.78 13.93 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-N 119.338 0.972 . . . . 0.0 110.005 -179.325 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -79.91 24.66 0.39 Allowed 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.538 0.735 . . . . 0.0 112.763 -171.016 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 20.3 p -65.76 -21.99 66.55 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.489 1.116 . . . . 0.0 112.973 179.082 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 51.5 t-20 -61.69 127.49 31.69 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.659 0.783 . . . . 0.0 110.388 -177.257 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 47.8 mmtm -79.12 -19.2 51.7 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 -176.959 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 91.0 mt -64.16 -46.24 94.11 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 C-N-CA 123.786 0.834 . . . . 0.0 108.804 -178.831 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.8 m -67.22 109.07 3.05 Favored Pre-proline 0 CA--C 1.549 0.933 0 C-N-CA 126.589 1.956 . . . . 0.0 110.962 -169.718 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -71.99 -63.0 0.04 OUTLIER 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 122.342 2.028 . . . . 0.0 112.805 -169.063 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 12.4 t-80 -59.32 -40.41 86.21 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 123.61 0.764 . . . . 0.0 110.227 -179.166 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 22.1 mp0 -63.58 -29.98 71.16 Favored 'General case' 0 N--CA 1.441 -0.911 0 C-N-CA 124.924 1.29 . . . . 0.0 110.106 -174.384 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 20.8 mt -67.72 -44.73 76.94 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 120.393 1.451 . . . . 0.0 110.691 172.909 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -61.69 -40.14 98.37 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 110.238 -1.145 . . . . 0.0 110.238 176.554 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 39.1 tp -65.95 -39.53 90.53 Favored 'General case' 0 CA--C 1.534 0.335 0 O-C-N 122.289 -0.536 . . . . 0.0 109.979 176.225 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -62.21 -42.45 99.31 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 119.172 0.896 . . . . 0.0 109.776 176.664 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -67.64 -28.84 68.05 Favored 'General case' 0 N--CA 1.454 -0.257 0 O-C-N 122.007 -0.433 . . . . 0.0 110.755 178.382 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -73.92 -37.39 47.74 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 O-C-N 121.336 -0.853 . . . . 0.0 111.289 173.654 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 31.5 mt -67.83 -37.62 82.17 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 176.762 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 75.7 m -65.39 -37.13 86.05 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-O 118.34 -0.838 . . . . 0.0 110.055 171.532 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.445 ' HA ' ' CD2' ' A' ' 106' ' ' PHE . . . -64.2 -40.52 96.26 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-N 119.953 1.252 . . . . 0.0 110.661 175.705 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 4.0 mt -64.71 -32.82 74.66 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 118.638 0.653 . . . . 0.0 110.562 174.841 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 51.5 ttp180 -72.15 -29.04 63.65 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 118.763 -0.637 . . . . 0.0 110.033 176.36 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.445 ' CD2' ' HA ' ' A' ' 103' ' ' ALA . 13.6 m-30 -72.12 -47.1 53.67 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 119.118 0.872 . . . . 0.0 110.369 175.467 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 41.6 p -72.68 -25.84 61.4 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 118.313 0.506 . . . . 0.0 111.853 -176.761 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 73.43 7.55 73.39 Favored Glycine 0 CA--C 1.535 1.312 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 -168.495 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -87.55 20.22 3.01 Favored 'General case' 0 C--N 1.348 0.522 0 CA-C-N 119.456 1.628 . . . . 0.0 110.689 176.536 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -58.45 138.2 85.45 Favored Pre-proline 0 CA--C 1.547 0.854 0 C-N-CA 125.903 1.681 . . . . 0.0 109.341 169.952 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_exo -58.0 163.81 9.09 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 123.66 2.907 . . . . 0.0 115.386 -179.359 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -67.72 -37.02 81.66 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 119.024 -0.513 . . . . 0.0 112.112 174.628 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 10.6 ttmm -141.58 74.41 1.45 Allowed 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 -175.474 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 5.5 tt -71.47 138.35 48.94 Favored 'General case' 0 CA--C 1.533 0.289 0 O-C-N 119.959 -1.713 . . . . 0.0 107.516 171.831 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -134.38 141.95 47.03 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 175.763 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.479 HD23 HG22 ' A' ' 60' ' ' ILE . 0.3 OUTLIER -129.26 119.93 24.84 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 120.128 1.331 . . . . 0.0 109.228 -179.939 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 6.2 t -86.5 87.81 2.7 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 N-CA-C 105.61 -1.996 . . . . 0.0 105.61 175.84 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -81.38 135.17 14.07 Favored Glycine 0 C--N 1.334 0.447 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -172.901 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.448 HG13 ' SD ' ' A' ' 137' ' ' MET . 54.7 t -121.94 123.56 69.41 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.238 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.988 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 42.5 mt -84.67 133.11 44.62 Favored Pre-proline 0 CA--C 1.538 0.492 0 N-CA-C 105.52 -2.029 . . . . 0.0 105.52 169.775 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -75.04 175.33 11.38 Favored 'Trans proline' 0 N--CA 1.449 -1.09 0 C-N-CA 122.287 1.992 . . . . 0.0 111.589 -176.706 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -94.56 -49.23 5.75 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 114.442 -1.253 . . . . 0.0 108.293 169.236 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 97.3 p -127.91 -52.77 1.32 Allowed 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 113.164 0.802 . . . . 0.0 113.164 -170.203 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.425 HD22 HG13 ' A' ' 65' ' ' VAL . 1.8 tp 52.51 34.75 16.12 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 124.362 1.065 . . . . 0.0 113.229 -169.398 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -76.36 164.02 62.53 Favored Pre-proline 0 CA--C 1.549 0.931 0 O-C-N 120.95 -1.094 . . . . 0.0 110.65 174.053 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -80.03 88.25 1.44 Allowed 'Trans proline' 0 CA--C 1.544 0.999 0 C-N-CA 121.66 1.573 . . . . 0.0 112.577 -172.194 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -176.5 154.96 1.33 Allowed 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 104.413 -2.44 . . . . 0.0 104.413 -179.946 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -110.79 162.64 8.18 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-N 120.447 1.476 . . . . 0.0 113.149 -169.663 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 93.71 143.14 12.86 Favored Glycine 0 CA--C 1.53 0.998 0 N-CA-C 106.374 -2.69 . . . . 0.0 106.374 -169.166 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.658 HD22 ' H ' ' A' ' 130' ' ' LEU . 0.4 OUTLIER -71.92 165.15 24.76 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 119.576 1.688 . . . . 0.0 110.602 -177.701 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 39.5 p -67.92 166.36 24.2 Favored Pre-proline 0 CA--C 1.539 0.533 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 167.826 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -59.73 -30.57 92.42 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 CA-C-N 120.588 1.246 . . . . 0.0 111.514 173.026 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 79.1 m -67.7 -41.85 82.97 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-N 118.903 0.774 . . . . 0.0 110.105 179.904 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 91.0 t -95.32 -26.26 4.34 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.214 0 CA-C-N 118.329 0.513 . . . . 0.0 110.751 -169.973 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -52.4 -46.91 66.5 Favored 'General case' 0 N--CA 1.464 0.243 0 O-C-N 120.567 -1.333 . . . . 0.0 108.418 169.409 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -69.84 -16.28 63.24 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 113.952 1.093 . . . . 0.0 113.952 -177.935 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . 0.448 ' SD ' HG13 ' A' ' 119' ' ' VAL . 84.0 mtp -71.13 -12.09 61.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 117.24 -1.362 . . . . 0.0 112.6 173.679 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 35.3 mt -53.13 -47.33 55.51 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.28 0 CA-C-N 120.451 1.478 . . . . 0.0 109.226 175.307 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -73.38 -47.1 7.65 Favored Pre-proline 0 CA--C 1.544 0.73 0 CA-C-N 120.296 1.407 . . . . 0.0 112.109 -169.875 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -54.39 -44.78 46.3 Favored 'Trans proline' 0 C--N 1.353 0.802 0 C-N-CA 122.452 2.101 . . . . 0.0 112.179 170.174 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -67.81 -39.41 83.95 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 118.518 -0.753 . . . . 0.0 111.195 -179.055 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 29.0 mt -59.88 -45.57 92.08 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-N 119.79 1.177 . . . . 0.0 109.284 173.075 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -58.18 -33.67 69.51 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 118.993 0.815 . . . . 0.0 110.099 175.689 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -69.72 -39.9 76.57 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 118.778 0.717 . . . . 0.0 111.267 175.412 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 81.1 t -59.36 -44.81 93.28 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 172.596 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 14.7 mt -58.91 -42.65 90.13 Favored 'General case' 0 C--N 1.342 0.246 0 CA-C-N 119.017 0.826 . . . . 0.0 109.576 176.909 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -66.9 -43.63 82.91 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 119.146 0.885 . . . . 0.0 110.687 -176.796 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -67.71 -29.4 68.64 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 119.127 0.876 . . . . 0.0 111.131 179.186 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 41.6 mt -64.76 -49.67 69.86 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 170.298 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 14.7 mtp-105 -68.77 -16.8 63.9 Favored 'General case' 0 CA--C 1.527 0.095 0 CA-C-O 118.219 -0.896 . . . . 0.0 111.557 -177.82 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 30.6 mm-40 -65.6 -23.56 66.86 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 120.32 1.418 . . . . 0.0 111.299 170.826 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 58.4 m -100.73 17.2 22.6 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 119.054 0.843 . . . . 0.0 110.221 168.467 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 68.44 18.33 71.54 Favored Glycine 0 C--N 1.336 0.55 0 CA-C-O 117.656 -1.635 . . . . 0.0 111.958 -176.179 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 42.7 t -91.93 119.01 38.59 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 CA-C-N 120.344 2.072 . . . . 0.0 106.149 -177.121 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -111.26 89.23 2.99 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 178.383 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -49.55 138.3 13.99 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 114.833 -1.076 . . . . 0.0 109.72 169.663 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 15.8 mm -84.79 128.99 58.49 Favored Pre-proline 0 C--O 1.232 0.161 0 CA-C-O 117.483 -1.246 . . . . 0.0 107.902 -174.125 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -66.69 92.09 0.3 Allowed 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 122.922 2.414 . . . . 0.0 108.916 171.376 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 10.1 ttt-85 49.21 19.28 0.3 Allowed 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 128.441 2.696 . . . . 0.0 115.804 179.624 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 64.0 m . . . . . 0 CA--C 1.541 0.615 0 C-N-CA 124.64 1.176 . . . . 0.0 111.886 -169.624 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 tpt . . . . . 0 N--CA 1.472 0.633 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.4 ptp180 -158.89 125.35 4.61 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 103.749 -2.686 . . . . 0.0 103.749 160.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 20.8 mt -129.64 141.61 46.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 -166.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -115.83 146.86 41.62 Favored 'General case' 0 CA--C 1.513 -0.479 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 163.496 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 57.7 t -126.83 106.63 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.715 0 N-CA-C 103.945 -2.613 . . . . 0.0 103.945 170.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -113.37 119.13 36.58 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 -163.235 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -93.87 134.61 12.16 Favored Glycine 0 N--CA 1.451 -0.361 0 N-CA-C 107.909 -2.076 . . . . 0.0 107.909 175.008 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.7 m -140.96 167.08 17.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 C-N-CA 124.537 1.135 . . . . 0.0 109.457 -178.056 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 127.52 177.44 14.87 Favored Glycine 0 CA--C 1.527 0.821 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 -177.162 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.413 ' HB2' ' CE1' ' A' ' 93' ' ' HIS . 61.2 t-20 -91.76 117.88 30.17 Favored 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 178.332 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 41.3 pt -75.39 24.76 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.793 0 C-N-CA 124.483 1.113 . . . . 0.0 112.125 176.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 38.8 mt -137.45 -3.95 1.88 Allowed 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.594 1.557 . . . . 0.0 112.349 -177.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.5 tp -121.85 52.22 1.28 Allowed 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 120.158 1.345 . . . . 0.0 109.799 -163.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 42.25 -114.5 0.27 Allowed 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 126.502 1.921 . . . . 0.0 110.395 -169.591 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 36.5 m-20 -53.68 -26.21 21.63 Favored 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 126.54 1.936 . . . . 0.0 111.982 -171.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -60.04 -20.79 59.73 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 120.172 1.351 . . . . 0.0 111.752 -177.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.09 -11.51 40.5 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 117.773 -1.108 . . . . 0.0 113.415 172.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 7.1 tp -56.33 -44.41 79.73 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-N 120.32 1.418 . . . . 0.0 112.137 -171.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -59.16 -42.19 97.02 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 110.605 -0.998 . . . . 0.0 110.605 -178.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 60.3 t -67.57 -46.7 82.51 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 CA-C-O 118.978 -0.534 . . . . 0.0 110.14 175.16 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 9.8 mmt180 -58.37 -33.35 69.49 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 119.823 1.192 . . . . 0.0 112.823 -179.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 41.7 mt -57.98 -51.06 75.37 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 177.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 18.0 m -73.49 -35.75 46.16 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 CA-C-N 119.19 0.905 . . . . 0.0 111.717 -173.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -58.56 -47.13 85.27 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 118.811 0.732 . . . . 0.0 110.225 171.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -71.33 -22.13 61.96 Favored 'General case' 0 CA--C 1.531 0.234 0 O-C-N 121.689 -0.632 . . . . 0.0 112.462 -178.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 27.4 tp -73.79 -49.6 24.55 Favored 'General case' 0 C--N 1.339 0.137 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 175.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -52.65 -43.47 65.49 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.068 1.347 . . . . 0.0 111.172 178.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 66.5 mt-30 -85.06 -0.09 53.31 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.702 0.801 . . . . 0.0 113.033 -173.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 85.5 mtt180 -127.66 -23.14 3.48 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-O 116.695 -1.622 . . . . 0.0 112.931 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -134.74 128.75 33.51 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-N 120.823 1.647 . . . . 0.0 109.313 -172.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 48.7 mm -79.77 142.87 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 N-CA-C 105.605 -1.998 . . . . 0.0 105.605 163.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -114.93 154.9 47.0 Favored Pre-proline 0 N--CA 1.453 -0.311 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 178.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -54.81 152.51 28.31 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 121.169 1.246 . . . . 0.0 110.224 158.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -41.41 -46.72 3.45 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 127.575 2.35 . . . . 0.0 113.624 -178.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -78.57 19.9 0.46 Allowed 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 114.149 1.166 . . . . 0.0 114.149 -168.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 10.7 t -126.04 89.08 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 C-N-CA 125.489 1.516 . . . . 0.0 109.023 179.074 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -71.23 130.16 40.73 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 171.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -93.68 137.19 23.3 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 N-CA-C 105.682 -1.97 . . . . 0.0 105.682 157.213 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 60.5 tp -143.63 129.72 19.65 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 -175.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 30.7 t0 -84.8 133.21 34.35 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 166.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -115.02 31.5 6.24 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 126.351 1.929 . . . . 0.0 111.271 175.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -21.33 110.55 0.01 OUTLIER Glycine 0 CA--C 1.527 0.789 0 C-N-CA 129.026 3.203 . . . . 0.0 114.911 177.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER 59.68 -2.02 0.14 Allowed 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 116.542 2.053 . . . . 0.0 116.542 177.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.93 -63.04 1.38 Allowed 'General case' 0 C--N 1.34 0.156 0 CA-C-N 120.211 1.368 . . . . 0.0 112.909 -169.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 57.68 -94.24 0.04 OUTLIER Glycine 0 CA--C 1.533 1.177 0 N-CA-C 110.141 -1.184 . . . . 0.0 110.141 -163.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 7.8 tpt -57.63 -37.69 73.72 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 125.257 1.423 . . . . 0.0 113.147 -169.279 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -58.2 -26.56 62.94 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.708 0.766 . . . . 0.0 112.108 -173.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 83.1 mt -73.45 2.46 7.73 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 124.721 1.208 . . . . 0.0 112.489 -174.34 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.408 ' HA ' HG13 ' A' ' 100' ' ' VAL . 5.0 tt -43.98 -46.25 8.19 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 125.676 1.591 . . . . 0.0 111.594 174.534 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -84.05 -31.44 25.96 Favored Glycine 0 CA--C 1.525 0.674 0 CA-C-O 118.827 -0.985 . . . . 0.0 112.323 -178.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -75.6 -44.23 44.01 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 118.739 1.269 . . . . 0.0 110.904 -172.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 37.3 mtp -69.08 -11.32 60.68 Favored 'General case' 0 CA--C 1.54 0.574 0 O-C-N 121.974 -0.454 . . . . 0.0 111.675 -177.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -75.4 153.9 37.46 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 124.818 1.247 . . . . 0.0 110.446 -176.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 62.15 -5.67 0.16 Allowed 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 127.229 2.211 . . . . 0.0 114.107 167.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 8.6 mmt180 -66.29 148.4 51.9 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 175.084 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -80.05 -44.76 19.52 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 -175.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 4.0 t-160 -139.18 131.09 27.72 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 103.118 -2.919 . . . . 0.0 103.118 -177.105 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 30.1 tp -129.29 122.49 29.71 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 -178.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 52.3 mt -103.07 109.36 26.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 105.318 -2.105 . . . . 0.0 105.318 171.305 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 21.4 mt -83.39 148.33 5.17 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 168.021 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -131.05 128.8 41.0 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 164.29 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -153.25 168.37 26.22 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.324 1.05 . . . . 0.0 110.426 -163.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -92.1 129.9 37.95 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 163.122 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 34.9 mt -76.56 -24.71 15.89 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 C-N-CA 123.668 0.787 . . . . 0.0 110.503 175.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . 0.255 26.1 t 64.52 -35.03 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 C-N-CA 128.202 2.601 . . . . 0.0 113.687 -179.701 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -153.68 133.75 13.27 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 121.925 2.148 . . . . 0.0 113.883 -174.324 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 3.6 tppt? -156.87 -175.73 5.59 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 105.557 -2.016 . . . . 0.0 105.557 147.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.37 67.01 9.98 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 166.225 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 52.3 t30 -150.36 155.72 40.15 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 119.052 0.842 . . . . 0.0 109.0 178.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 8.1 m -60.02 140.41 90.53 Favored Pre-proline 0 CA--C 1.543 0.699 0 C-N-CA 126.674 1.99 . . . . 0.0 112.124 -165.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_exo -43.97 149.79 0.73 Allowed 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 124.22 3.28 . . . . 0.0 113.492 168.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 66.39 -7.91 1.21 Allowed Glycine 0 CA--C 1.532 1.101 0 C-N-CA 124.86 1.219 . . . . 0.0 115.554 178.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 30.4 m -64.88 149.83 48.85 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 120.202 2.001 . . . . 0.0 109.421 -178.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 28.9 ttp -94.43 147.36 23.32 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 174.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 42.0 mtt -129.23 146.15 51.2 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 106.095 -1.817 . . . . 0.0 106.095 162.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 33.2 mm -117.81 130.17 73.09 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 N-CA-C 103.266 -2.864 . . . . 0.0 103.266 171.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -123.74 143.55 50.22 Favored 'General case' 0 C--O 1.242 0.684 0 N-CA-C 105.013 -2.217 . . . . 0.0 105.013 176.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 79.9 mtm180 -114.73 165.88 12.34 Favored 'General case' 0 C--O 1.222 -0.36 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 177.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -22.29 -66.43 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 127.866 2.466 . . . . 0.0 116.072 -159.14 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -62.16 -33.52 74.67 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.879 1.672 . . . . 0.0 113.804 -176.102 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -76.35 -26.87 56.16 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.122 1.369 . . . . 0.0 110.741 -175.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 26.4 t -69.1 -50.89 19.47 Favored Pre-proline 0 CA--C 1.544 0.742 0 CA-C-O 117.69 -1.148 . . . . 0.0 112.394 -169.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -57.25 -39.89 86.68 Favored 'Trans proline' 0 C--N 1.353 0.802 0 CA-C-N 121.602 1.608 . . . . 0.0 111.374 174.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -62.84 -45.4 92.77 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 123.053 0.541 . . . . 0.0 110.59 -179.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -58.03 -47.52 82.85 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 123.817 0.847 . . . . 0.0 110.027 176.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 -75.88 1.36 15.3 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 -175.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 70.9 p -63.7 -13.36 42.41 Favored 'General case' 0 CA--C 1.543 0.685 0 O-C-N 120.198 -1.564 . . . . 0.0 112.315 166.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 41.1 t30 -58.72 109.89 0.89 Allowed 'General case' 0 C--N 1.346 0.454 0 C-N-CA 125.357 1.463 . . . . 0.0 111.712 -178.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 32.4 mmtp -67.87 -16.13 63.94 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 113.298 0.851 . . . . 0.0 113.298 -175.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 41.1 mt -75.03 -21.02 16.54 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 C-N-CA 123.358 0.663 . . . . 0.0 109.536 -179.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 14.6 m -100.56 104.71 32.52 Favored Pre-proline 0 CA--C 1.546 0.819 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 -172.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -72.4 -54.51 0.13 Allowed 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.295 1.996 . . . . 0.0 113.622 -160.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . 0.413 ' CE1' ' HB2' ' A' ' 10' ' ' ASN . 20.3 m80 -65.3 -36.1 83.04 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 177.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 23.1 mp0 -64.66 -30.03 71.04 Favored 'General case' 0 N--CA 1.441 -0.901 0 C-N-CA 125.02 1.328 . . . . 0.0 110.378 -176.264 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -64.94 -33.63 76.49 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 119.103 0.865 . . . . 0.0 111.535 171.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -78.72 -30.38 48.51 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 110.759 -0.937 . . . . 0.0 110.759 172.355 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.8 -37.62 88.06 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 118.339 1.07 . . . . 0.0 108.466 171.398 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -60.95 -43.42 98.72 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 117.929 -1.034 . . . . 0.0 109.924 175.007 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -74.15 -24.03 59.35 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 119.638 1.108 . . . . 0.0 113.158 177.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.408 HG13 ' HA ' ' A' ' 49' ' ' LEU . 38.1 t -62.48 -44.91 99.75 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 O-C-N 119.742 -1.848 . . . . 0.0 109.366 164.174 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 72.9 mt -67.94 -29.74 68.88 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 119.352 0.978 . . . . 0.0 110.811 178.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 44.5 m -62.19 -57.61 10.83 Favored 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 167.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.31 -35.4 78.93 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.795 1.238 . . . . 0.0 113.112 -174.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 13.8 mt -65.1 -42.37 94.09 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-N 118.929 0.786 . . . . 0.0 109.709 173.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 76.5 ttt180 -64.89 -34.65 78.9 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-O 117.677 -1.154 . . . . 0.0 110.649 172.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 13.0 m-30 -66.22 -39.22 89.43 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 120.069 1.304 . . . . 0.0 110.715 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 40.8 p -78.37 -28.05 46.98 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 119.119 0.872 . . . . 0.0 110.828 177.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 83.65 1.56 90.03 Favored Glycine 0 CA--C 1.531 1.056 0 CA-C-O 118.158 -1.357 . . . . 0.0 112.443 -166.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -87.08 21.01 2.47 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 120.479 2.139 . . . . 0.0 111.545 -179.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -61.19 139.01 94.55 Favored Pre-proline 0 CA--C 1.549 0.927 0 C-N-CA 126.274 1.83 . . . . 0.0 109.93 170.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -55.42 167.98 1.7 Allowed 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 123.923 3.082 . . . . 0.0 115.866 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -74.67 -23.12 58.6 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 123.461 0.704 . . . . 0.0 111.686 169.024 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 52.2 tttm -158.93 84.29 0.81 Allowed 'General case' 0 C--O 1.241 0.632 0 N-CA-C 106.522 -1.659 . . . . 0.0 106.522 -169.109 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.7 tt -79.21 141.88 36.75 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 119.186 -1.006 . . . . 0.0 108.914 165.279 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -138.9 146.76 41.5 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.88 1.672 . . . . 0.0 107.369 177.458 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -133.11 113.98 13.36 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 -179.274 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 45.1 t -93.35 86.66 2.15 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 173.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.55 150.36 16.94 Favored Glycine 0 C--N 1.338 0.671 0 N-CA-C 111.001 -0.84 . . . . 0.0 111.001 -166.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 22.7 t -129.11 135.84 61.03 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 -169.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 25.0 mt -78.3 135.93 61.23 Favored Pre-proline 0 CA--C 1.549 0.919 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 170.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -75.92 -161.53 0.13 Allowed 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 124.288 3.325 . . . . 0.0 111.522 178.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -138.75 -62.03 0.56 Allowed 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.83 1.652 . . . . 0.0 108.518 173.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 57.6 m -99.24 -48.19 4.91 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 119.104 0.865 . . . . 0.0 111.737 -177.106 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 51.58 45.91 27.34 Favored 'General case' 0 CA--C 1.549 0.911 0 N-CA-C 114.336 1.235 . . . . 0.0 114.336 -177.494 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -110.18 161.84 22.86 Favored Pre-proline 0 CA--C 1.542 0.642 0 C-N-CA 124.195 0.998 . . . . 0.0 110.989 -177.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -72.31 68.94 3.37 Favored 'Trans proline' 0 CA--C 1.543 0.954 0 C-N-CA 124.485 3.457 . . . . 0.0 113.982 -177.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 5.7 p-80 -148.16 173.18 13.24 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 126.874 2.07 . . . . 0.0 106.938 162.141 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -118.32 144.82 25.39 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.158 0 O-C-N 121.069 -1.019 . . . . 0.0 110.151 -171.185 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 142.09 176.25 16.14 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 105.997 -2.841 . . . . 0.0 105.997 -172.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -98.57 161.76 13.5 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 104.676 -2.342 . . . . 0.0 104.676 150.075 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 65.7 p -62.12 158.34 46.22 Favored Pre-proline 0 CA--C 1.543 0.71 0 C-N-CA 119.176 -1.01 . . . . 0.0 108.608 155.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -51.85 -38.49 67.97 Favored 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 122.046 1.83 . . . . 0.0 112.03 171.075 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 6.3 m -53.01 -30.98 38.51 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 126.12 1.768 . . . . 0.0 112.278 176.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 63.9 t -115.51 -18.88 6.96 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 CA-C-N 118.719 0.691 . . . . 0.0 111.014 -170.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -59.52 -43.25 93.49 Favored 'General case' 0 CA--C 1.534 0.338 0 O-C-N 121.325 -0.859 . . . . 0.0 108.73 165.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -59.45 -30.47 68.53 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.154 -0.476 . . . . 0.0 112.096 173.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 15.1 mmm -73.18 -8.47 55.94 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 117.458 -1.258 . . . . 0.0 113.789 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 96.7 mt -58.18 -50.05 79.62 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-N 120.438 1.472 . . . . 0.0 108.458 177.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -78.07 -40.37 1.92 Allowed Pre-proline 0 CA--C 1.535 0.376 0 CA-C-O 117.163 -1.398 . . . . 0.0 114.588 -168.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -54.34 -35.96 85.58 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 CA-C-N 122.38 1.886 . . . . 0.0 112.224 167.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -75.88 -32.85 59.88 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-O 117.981 -1.009 . . . . 0.0 111.313 175.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 53.5 mt -59.18 -48.59 81.03 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 120.579 1.536 . . . . 0.0 108.229 169.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -60.15 -29.53 68.72 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 119.375 0.989 . . . . 0.0 111.565 -179.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 32.6 mm-40 -86.39 -31.86 21.24 Favored 'General case' 0 CA--C 1.529 0.145 0 O-C-N 120.999 -1.063 . . . . 0.0 113.57 176.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 72.2 t -63.83 -40.97 90.97 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 CA-C-N 120.99 1.723 . . . . 0.0 108.736 166.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 83.6 mt -66.39 -39.8 89.28 Favored 'General case' 0 N--CA 1.463 0.179 0 C-N-CA 123.653 0.781 . . . . 0.0 110.722 176.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -64.01 -46.15 85.78 Favored 'General case' 0 C--O 1.227 -0.126 0 CA-C-N 118.748 0.704 . . . . 0.0 110.598 174.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -59.05 -42.88 91.37 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 118.847 -0.597 . . . . 0.0 110.776 178.037 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 31.1 mt -58.0 -45.23 87.15 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 119.174 0.897 . . . . 0.0 110.27 173.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 64.8 mtt180 -66.38 -18.88 65.62 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 117.096 -1.43 . . . . 0.0 112.791 178.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -60.9 -27.0 67.85 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 121.328 1.877 . . . . 0.0 110.807 171.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 16.7 m -101.89 13.91 33.47 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.107 0.963 . . . . 0.0 111.642 175.01 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 71.85 10.39 72.27 Favored Glycine 0 CA--C 1.53 1.0 0 CA-C-O 118.777 -1.013 . . . . 0.0 113.542 -179.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 61.0 t -79.69 102.92 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 CA-C-N 119.31 1.555 . . . . 0.0 107.301 178.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -72.93 152.87 41.22 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 164.038 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -131.57 150.91 51.98 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 125.351 1.46 . . . . 0.0 107.243 174.269 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 7.7 mm -114.31 122.72 33.77 Favored Pre-proline 0 CA--C 1.53 0.203 0 N-CA-C 107.58 -1.266 . . . . 0.0 107.58 -163.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -62.41 116.66 3.65 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 122.162 1.908 . . . . 0.0 108.031 176.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 59.7 mtm180 40.09 8.16 0.0 OUTLIER 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 129.573 3.149 . . . . 0.0 117.576 -172.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 70.7 m 47.85 54.61 9.7 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 121.231 1.832 . . . . 0.0 110.381 -158.246 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -137.26 122.04 18.72 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 101.997 -3.335 . . . . 0.0 101.997 -170.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 61.7 m . . . . . 0 C--O 1.249 1.036 0 CA-C-O 116.285 -1.817 . . . . 0.0 109.44 -155.273 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.2 ttt . . . . . 0 N--CA 1.501 2.086 0 CA-C-O 119.612 -0.232 . . . . 0.0 110.668 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 39.1 mmt180 -63.31 126.0 25.98 Favored 'General case' 0 N--CA 1.479 0.977 0 O-C-N 119.879 -1.763 . . . . 0.0 108.813 175.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 3.9 mt -123.39 121.67 63.31 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 -176.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -106.81 139.28 41.49 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 168.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 58.0 t -126.87 101.43 7.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 105.467 -2.049 . . . . 0.0 105.467 -177.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.3 mt -98.76 109.36 22.13 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.475 1.11 . . . . 0.0 109.581 -169.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -87.15 127.13 8.29 Favored Glycine 0 C--O 1.237 0.324 0 N-CA-C 106.958 -2.457 . . . . 0.0 106.958 169.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 15.3 m -138.69 172.69 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 CA-C-N 117.588 0.694 . . . . 0.0 111.202 -169.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 101.16 163.45 27.59 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 127.189 2.328 . . . . 0.0 111.731 179.202 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.504 HD21 ' HB2' ' A' ' 12' ' ' LEU . 6.9 t30 -77.32 102.13 6.61 Favored 'General case' 0 C--N 1.332 -0.167 0 O-C-N 121.88 -0.777 . . . . 0.0 111.043 -169.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -56.52 7.51 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.935 0 N-CA-C 117.742 2.497 . . . . 0.0 117.742 179.164 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.504 ' HB2' HD21 ' A' ' 10' ' ' ASN . 67.7 mt -109.54 1.3 19.65 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 122.127 2.24 . . . . 0.0 109.743 -177.438 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.4 mp -111.84 63.02 0.62 Allowed 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 123.895 0.878 . . . . 0.0 111.4 -169.039 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.402 ' HB ' ' H ' ' A' ' 15' ' ' ASP . 0.2 OUTLIER 52.83 -100.15 0.09 Allowed 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.664 0.786 . . . . 0.0 111.152 176.59 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.402 ' H ' ' HB ' ' A' ' 14' ' ' THR . 28.6 m-20 -83.69 -9.1 59.08 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 124.262 1.025 . . . . 0.0 111.881 -174.391 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -71.79 -8.41 54.12 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 120.485 1.493 . . . . 0.0 112.454 -175.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -75.37 -14.35 60.46 Favored 'General case' 0 N--CA 1.434 -1.252 0 CA-C-O 115.724 -2.084 . . . . 0.0 109.349 170.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 7.9 tp -52.48 -39.2 28.33 Favored 'Isoleucine or valine' 0 C--N 1.344 0.358 0 CA-C-N 122.588 2.449 . . . . 0.0 112.878 -169.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -61.46 -45.52 96.21 Favored Glycine 0 CA--C 1.525 0.718 0 CA-C-N 119.422 1.01 . . . . 0.0 111.148 177.018 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 69.9 t -64.2 -48.53 85.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-O 118.845 -0.598 . . . . 0.0 110.039 172.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 78.4 mmt-85 -59.07 -33.88 71.32 Favored 'General case' 0 C--O 1.223 -0.336 0 CA-C-O 117.755 -1.116 . . . . 0.0 112.263 -179.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 28.6 mt -63.64 -45.07 98.51 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 CA-C-N 120.679 1.581 . . . . 0.0 109.656 177.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 14.5 m -75.81 -26.0 17.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-N 119.67 1.123 . . . . 0.0 111.071 -176.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 -70.75 -44.92 65.78 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 173.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.69 -42.37 97.02 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 122.885 0.474 . . . . 0.0 109.809 176.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 8.2 tp -65.45 -42.91 91.85 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 118.16 -0.924 . . . . 0.0 110.48 178.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -58.22 -43.98 87.98 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 119.042 0.837 . . . . 0.0 110.73 178.089 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -72.64 -39.7 66.98 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.715 0.806 . . . . 0.0 111.27 -177.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -95.82 -40.56 9.27 Favored 'General case' 0 C--N 1.34 0.172 0 CA-C-O 117.044 -1.455 . . . . 0.0 113.704 -169.48 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -109.64 124.14 50.67 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 121.735 2.062 . . . . 0.0 112.151 -169.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 47.2 mm -76.78 137.43 22.54 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 N-CA-C 105.739 -1.948 . . . . 0.0 105.739 169.13 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 29.5 mt -135.25 156.28 78.18 Favored Pre-proline 0 CA--C 1.535 0.4 0 C-N-CA 124.665 1.186 . . . . 0.0 110.83 -169.267 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -60.06 155.86 42.58 Favored 'Trans proline' 0 CA--C 1.535 0.569 0 C-N-CA 123.344 2.696 . . . . 0.0 111.775 169.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -62.26 -30.49 71.16 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -173.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 11.5 p90 -73.54 -6.42 46.42 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 118.207 -0.901 . . . . 0.0 112.752 -179.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 19.7 t -99.28 127.26 52.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 CA-C-N 119.861 1.21 . . . . 0.0 108.264 175.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -127.19 137.27 52.89 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 173.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -102.36 104.15 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 N-CA-C 105.862 -1.903 . . . . 0.0 105.862 176.664 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 56.7 tp -95.88 121.39 37.56 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.31 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -79.92 109.46 14.38 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 106.254 -1.758 . . . . 0.0 106.254 169.007 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -103.86 -27.92 6.12 Favored Glycine 0 CA--C 1.534 1.233 0 CA-C-O 119.248 -0.751 . . . . 0.0 112.373 173.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 40.17 -111.99 0.27 Allowed Glycine 0 C--N 1.34 0.775 0 C-N-CA 125.327 1.442 . . . . 0.0 113.122 -177.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.408 HG22 ' HA ' ' A' ' 10' ' ' ASN . 12.1 p -65.01 -3.49 3.6 Favored 'General case' 0 C--N 1.316 -0.869 0 C-N-CA 128.756 2.823 . . . . 0.0 113.806 -172.443 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -50.3 -66.3 0.41 Allowed 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 114.974 1.472 . . . . 0.0 114.974 -179.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 64.15 -94.62 0.15 Allowed Glycine 0 CA--C 1.531 1.065 0 N-CA-C 109.416 -1.473 . . . . 0.0 109.416 -169.417 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 10.4 tpt -69.33 -26.99 64.98 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 126.776 2.03 . . . . 0.0 112.255 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -70.17 -4.68 22.65 Favored 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -169.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 66.2 mt -87.79 -6.01 58.36 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 124.636 1.175 . . . . 0.0 114.063 -171.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.521 ' HA ' HG13 ' A' ' 100' ' ' VAL . 5.2 tt -43.39 -59.74 2.0 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 114.19 1.182 . . . . 0.0 114.19 -169.464 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -72.25 -36.4 59.93 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 111.723 -0.551 . . . . 0.0 111.723 -170.193 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -68.01 -37.77 81.81 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 117.932 0.866 . . . . 0.0 110.214 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 36.2 mtp -74.13 -18.13 60.83 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 120.664 -0.414 . . . . 0.0 111.782 -174.554 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -75.73 151.04 37.7 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 121.635 0.731 . . . . 0.0 111.129 -177.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 55.62 44.16 27.02 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 126.373 1.869 . . . . 0.0 114.201 168.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 27.2 mmt180 -108.01 156.98 18.64 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 174.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -78.62 -41.9 30.32 Favored 'General case' 0 N--CA 1.467 0.385 0 O-C-N 121.438 -0.789 . . . . 0.0 109.771 171.399 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -134.23 133.14 40.52 Favored 'General case' 0 C--O 1.232 0.168 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 -175.171 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 26.1 tp -135.42 131.77 36.65 Favored 'General case' 0 CA--C 1.512 -0.482 0 O-C-N 121.486 -0.759 . . . . 0.0 109.242 169.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 10.6 mt -114.07 123.44 69.73 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 N-CA-C 106.006 -1.85 . . . . 0.0 106.006 178.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 15.5 mt -101.49 127.53 54.75 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 N-CA-C 104.803 -2.295 . . . . 0.0 104.803 177.115 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -115.64 121.48 42.69 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 105.749 -1.945 . . . . 0.0 105.749 176.079 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -155.41 149.29 25.46 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 118.561 0.619 . . . . 0.0 112.437 -169.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -76.82 116.92 17.92 Favored 'General case' 0 CA--C 1.529 0.136 0 N-CA-C 105.53 -2.026 . . . . 0.0 105.53 168.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.7 tt -68.79 -25.46 30.48 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.772 0 CA-C-O 117.684 -1.151 . . . . 0.0 113.102 -169.084 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . 0.281 92.9 t 55.28 17.03 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.556 1.202 0 C-N-CA 125.278 1.431 . . . . 0.0 112.806 172.212 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 48.7 m -126.86 164.05 22.26 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 125.057 1.343 . . . . 0.0 111.3 -170.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.47 ' HG3' ' H ' ' A' ' 68' ' ' LYS . 4.6 tppt? 59.72 -172.06 0.12 Allowed 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.12 1.768 . . . . 0.0 111.738 177.417 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.47 ' H ' ' HG3' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -128.66 20.48 6.07 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.223 1.409 . . . . 0.0 112.401 -175.809 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 51.0 t30 -71.48 163.85 26.93 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 108.096 -1.075 . . . . 0.0 108.096 172.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 12.6 m -58.14 142.67 80.17 Favored Pre-proline 0 CA--C 1.546 0.801 0 C-N-CA 123.964 0.906 . . . . 0.0 112.18 -169.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -57.38 152.38 47.03 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.554 2.169 . . . . 0.0 111.453 170.06 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 67.7 16.48 67.94 Favored Glycine 0 CA--C 1.533 1.169 0 CA-C-O 119.128 -0.818 . . . . 0.0 113.756 177.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 48.7 m -96.32 153.89 17.56 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 118.955 1.377 . . . . 0.0 108.784 175.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 9.6 ttp -97.97 141.77 30.52 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 123.589 0.756 . . . . 0.0 110.222 -179.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 13.6 mtp -126.48 119.31 26.88 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 176.053 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 46.0 mm -103.07 123.81 56.75 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 177.086 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 48.2 mt -125.0 129.28 50.0 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 107.548 -1.278 . . . . 0.0 107.548 -177.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 65.7 mtm180 -104.99 131.49 52.44 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 -169.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 6.9 t70 36.32 -98.11 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 116.168 1.914 . . . . 0.0 116.168 169.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -62.74 -27.57 69.36 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.966 0.906 . . . . 0.0 112.932 -176.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -73.49 -15.47 61.32 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.385 0.674 . . . . 0.0 111.005 -177.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.425 HG11 ' CD2' ' A' ' 114' ' ' LEU . 81.4 t -79.52 -60.84 0.5 Allowed Pre-proline 0 N--CA 1.442 -0.832 0 CA-C-O 117.963 -1.018 . . . . 0.0 110.466 -169.485 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -59.85 -31.69 94.25 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 CA-C-N 120.846 1.338 . . . . 0.0 111.65 175.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.14 -13.69 62.41 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -177.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -98.14 -38.38 9.35 Favored 'General case' 0 C--N 1.344 0.332 0 CA-C-N 118.713 0.688 . . . . 0.0 109.267 169.153 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -59.34 -12.79 6.34 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 113.101 0.778 . . . . 0.0 113.101 177.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 70.7 p -52.86 -27.78 19.99 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 113.857 1.058 . . . . 0.0 113.857 169.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -60.23 146.25 44.34 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 122.948 0.499 . . . . 0.0 111.66 -169.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 46.6 mmtm -99.51 -0.16 41.19 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.7 0.8 . . . . 0.0 111.981 177.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 74.8 mt -66.95 -41.13 87.07 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 178.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 5.8 m -96.81 109.43 48.61 Favored Pre-proline 0 CA--C 1.543 0.68 0 C-N-CA 125.737 1.615 . . . . 0.0 109.223 -172.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -68.3 -47.22 1.69 Allowed 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.002 1.802 . . . . 0.0 112.937 -169.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 15.7 m80 -73.94 -22.47 59.65 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 122.729 0.411 . . . . 0.0 111.328 -171.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -68.9 -24.75 64.34 Favored 'General case' 0 C--O 1.222 -0.343 0 CA-C-O 117.72 -1.134 . . . . 0.0 111.847 177.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 2.8 tt -60.77 -43.42 98.08 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 120.387 1.449 . . . . 0.0 109.652 -174.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -59.99 -41.6 97.98 Favored Glycine 0 CA--C 1.529 0.94 0 O-C-N 121.628 -0.67 . . . . 0.0 111.52 176.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -71.62 -32.6 68.14 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 118.526 1.163 . . . . 0.0 110.717 179.083 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -60.3 -45.2 94.18 Favored 'General case' 0 N--CA 1.454 -0.254 0 O-C-N 120.943 -1.098 . . . . 0.0 109.067 171.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -69.9 -23.85 63.3 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 118.979 -0.534 . . . . 0.0 112.104 177.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.521 HG13 ' HA ' ' A' ' 49' ' ' LEU . 20.9 t -66.5 -45.05 89.9 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.697 0 CA-C-N 119.223 0.92 . . . . 0.0 108.552 169.379 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 93.8 mt -64.44 -34.22 77.68 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 119.377 0.99 . . . . 0.0 110.245 179.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 20.3 m -64.91 -41.41 95.6 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 118.88 0.763 . . . . 0.0 110.318 169.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.46 ' HA ' ' CD2' ' A' ' 106' ' ' PHE . . . -64.39 -36.8 85.33 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 119.121 0.873 . . . . 0.0 111.527 178.296 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.6 mt -66.8 -35.6 80.44 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 118.412 0.551 . . . . 0.0 110.272 176.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 77.7 ttt-85 -65.92 -38.79 89.62 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 118.459 -0.781 . . . . 0.0 109.909 171.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.46 ' CD2' ' HA ' ' A' ' 103' ' ' ALA . 15.6 m-30 -64.09 -44.05 93.53 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 119.372 0.987 . . . . 0.0 110.586 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 42.3 p -75.71 -22.8 56.28 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 118.325 0.511 . . . . 0.0 111.403 178.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 74.47 12.59 82.21 Favored Glycine 0 CA--C 1.531 1.09 0 N-CA-C 111.118 -0.793 . . . . 0.0 111.118 -169.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -98.79 25.29 6.7 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 118.644 1.222 . . . . 0.0 110.97 -178.006 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -57.56 135.58 82.26 Favored Pre-proline 0 CA--C 1.544 0.724 0 C-N-CA 124.111 0.964 . . . . 0.0 109.209 170.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -54.55 151.71 29.87 Favored 'Trans proline' 0 C--N 1.35 0.658 0 C-N-CA 123.643 2.895 . . . . 0.0 114.108 -179.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -60.09 -29.81 68.83 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 119.012 -0.518 . . . . 0.0 110.44 177.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 23.1 ttpp -146.54 125.84 13.07 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 169.161 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.425 ' CD2' HG11 ' A' ' 82' ' ' VAL . 3.4 tt -105.92 147.38 28.83 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 169.417 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -143.42 138.9 29.67 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 -177.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.7 tp -125.09 129.39 50.14 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 120.429 1.468 . . . . 0.0 108.828 175.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 53.5 t -102.5 98.95 7.45 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 N-CA-C 104.759 -2.311 . . . . 0.0 104.759 168.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -84.77 140.27 18.59 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 109.981 -1.248 . . . . 0.0 109.981 174.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 40.9 t -119.95 138.25 51.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 173.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 5.4 mt -86.92 126.92 61.65 Favored Pre-proline 0 CA--C 1.54 0.591 0 CA-C-N 119.395 0.998 . . . . 0.0 108.389 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -77.0 167.28 25.39 Favored 'Trans proline' 0 CA--C 1.542 0.884 0 C-N-CA 123.657 2.904 . . . . 0.0 112.25 -178.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.465 ' HB3' HG21 ' A' ' 131' ' ' THR . 1.6 tm-20 -107.38 -58.89 1.9 Allowed 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.673 0.789 . . . . 0.0 109.924 -178.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 4.0 m -105.28 -58.06 1.95 Allowed 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 122.934 0.494 . . . . 0.0 112.04 -170.27 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER 56.46 52.37 10.03 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 126.176 1.79 . . . . 0.0 115.334 171.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -121.71 165.21 20.76 Favored Pre-proline 0 N--CA 1.475 0.796 0 CA-C-O 117.826 -1.083 . . . . 0.0 108.87 172.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -67.47 84.09 0.38 Allowed 'Trans proline' 0 CA--C 1.546 1.084 0 C-N-CA 123.345 2.697 . . . . 0.0 112.551 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -168.85 152.4 5.35 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 104.501 -2.407 . . . . 0.0 104.501 174.241 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -120.27 152.87 23.22 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-O 121.999 0.904 . . . . 0.0 113.286 -169.654 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 120.8 130.73 3.92 Favored Glycine 0 CA--C 1.527 0.814 0 N-CA-C 105.98 -2.848 . . . . 0.0 105.98 -169.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 7.0 mp -77.8 149.39 34.43 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 177.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.465 HG21 ' HB3' ' A' ' 122' ' ' GLU . 54.6 p -67.22 163.19 48.21 Favored Pre-proline 0 CA--C 1.534 0.349 0 CA-C-O 119.148 -0.453 . . . . 0.0 109.942 169.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -58.71 -34.67 99.08 Favored 'Trans proline' 0 CA--C 1.537 0.65 0 C-N-CA 121.099 1.199 . . . . 0.0 109.574 169.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 4.5 m -63.34 -39.06 93.51 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.187 0.995 . . . . 0.0 111.18 -176.48 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 21.8 t -102.48 -25.89 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 CA-C-N 119.319 0.963 . . . . 0.0 112.146 -176.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -54.1 -43.01 70.02 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 120.825 1.648 . . . . 0.0 109.986 169.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -73.04 -2.43 21.18 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-O 118.332 -0.842 . . . . 0.0 113.107 -176.033 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 16.4 mmm -89.58 -7.09 55.56 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-O 116.953 -1.499 . . . . 0.0 111.022 170.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 91.6 mt -58.9 -47.64 88.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 CA-C-N 121.631 2.014 . . . . 0.0 109.301 -179.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 61.6 mt-10 -73.21 -51.14 6.08 Favored Pre-proline 0 CA--C 1.536 0.425 0 CA-C-O 117.39 -1.29 . . . . 0.0 110.809 -178.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -40.49 -51.99 3.23 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 124.447 3.431 . . . . 0.0 113.672 169.041 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -74.16 -45.33 49.31 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 114.538 -1.21 . . . . 0.0 111.451 -174.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -62.37 -36.02 80.96 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 119.594 1.088 . . . . 0.0 109.984 178.28 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -62.86 -33.04 74.45 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 118.744 -0.645 . . . . 0.0 111.085 176.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 42.9 mm-40 -78.47 -29.97 47.12 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 119.502 1.046 . . . . 0.0 111.892 174.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 67.7 t -61.41 -43.43 96.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 169.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 71.4 mt -69.65 -33.41 72.57 Favored 'General case' 0 N--CA 1.463 0.179 0 O-C-N 120.752 -1.217 . . . . 0.0 111.622 176.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -58.86 -33.6 70.65 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 118.923 0.783 . . . . 0.0 111.455 176.151 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -62.42 -46.79 86.95 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 118.531 0.605 . . . . 0.0 111.292 174.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 7.1 mp -58.44 -43.4 88.76 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.021 0.529 . . . . 0.0 109.866 174.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 84.7 mtt180 -65.38 -17.56 64.63 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 117.418 -1.277 . . . . 0.0 111.896 -177.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -58.16 -34.38 70.24 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 120.616 1.553 . . . . 0.0 111.33 175.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 8.1 m -107.39 28.57 7.98 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.598 1.159 . . . . 0.0 110.956 -179.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 64.22 23.8 68.39 Favored Glycine 0 CA--C 1.53 1.003 0 CA-C-O 118.725 -1.042 . . . . 0.0 113.917 176.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 59.4 t -93.77 134.47 31.31 Favored 'Isoleucine or valine' 0 C--N 1.341 0.213 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 174.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -122.6 145.05 48.7 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 178.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -107.46 143.09 36.32 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 124.06 0.944 . . . . 0.0 109.351 174.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 23.3 mm -105.62 125.97 31.97 Favored Pre-proline 0 C--O 1.234 0.253 0 CA-C-O 117.879 -1.058 . . . . 0.0 108.649 -173.193 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -57.61 110.42 0.62 Allowed 'Trans proline' 0 N--CA 1.461 -0.383 0 C-N-CA 122.608 2.206 . . . . 0.0 108.919 169.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 82.7 mtm180 51.51 30.68 6.63 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.179 0.992 . . . . 0.0 112.715 171.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 17.4 p 46.12 26.23 0.41 Allowed 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 126.714 2.006 . . . . 0.0 114.872 -171.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -76.73 142.46 40.45 Favored 'General case' 0 C--O 1.239 0.527 0 O-C-N 121.118 -0.989 . . . . 0.0 110.645 -176.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 15.5 m . . . . . 0 C--O 1.255 1.346 0 C-N-CA 124.443 1.097 . . . . 0.0 111.126 -174.029 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.46 ' CE ' HD11 ' A' ' 3' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.919 0 CA-C-O 118.627 -0.702 . . . . 0.0 110.998 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -58.17 128.64 38.15 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 119.883 1.219 . . . . 0.0 110.633 174.783 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.46 HD11 ' CE ' ' A' ' 1' ' ' MET . 5.7 mt -125.52 129.55 72.82 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 -179.651 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -120.36 141.11 50.38 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 106.105 -1.813 . . . . 0.0 106.105 168.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 91.6 t -121.42 127.41 75.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 106.722 -1.584 . . . . 0.0 106.722 -176.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.2 tp -109.03 111.61 23.36 Favored 'General case' 0 CA--C 1.515 -0.4 0 C-N-CA 123.468 0.707 . . . . 0.0 111.02 -169.187 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -94.07 118.24 5.7 Favored Glycine 0 N--CA 1.446 -0.67 0 N-CA-C 104.394 -3.482 . . . . 0.0 104.394 168.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.4 m -141.32 163.74 20.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 -171.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 121.73 160.47 11.01 Favored Glycine 0 C--N 1.338 0.661 0 C-N-CA 124.818 1.199 . . . . 0.0 110.495 176.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.514 ' HA ' HG22 ' A' ' 43' ' ' THR . 12.4 t30 -79.22 101.52 8.03 Favored 'General case' 0 C--N 1.333 -0.122 0 O-C-N 121.351 -1.088 . . . . 0.0 109.988 -179.366 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 27.3 pt -53.41 -15.07 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 N-CA-C 116.13 1.9 . . . . 0.0 116.13 -176.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.454 ' H ' ' ND2' ' A' ' 10' ' ' ASN . 5.2 mp -90.17 -3.79 57.66 Favored 'General case' 0 C--O 1.219 -0.536 0 CA-C-N 121.024 1.738 . . . . 0.0 107.558 -170.506 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.3 mp -101.78 55.42 0.81 Allowed 'General case' 0 N--CA 1.439 -0.987 0 C-N-CA 123.477 0.711 . . . . 0.0 109.727 -174.334 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.426 ' HB ' ' H ' ' A' ' 15' ' ' ASP 0.254 0.1 OUTLIER 49.6 -102.11 0.1 Allowed 'General case' 0 C--O 1.236 0.345 0 CA-C-N 114.348 -1.296 . . . . 0.0 111.331 177.052 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.426 ' H ' ' HB ' ' A' ' 14' ' ' THR . 17.2 m-20 -72.21 -12.34 61.13 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 123.891 0.876 . . . . 0.0 111.319 -172.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -73.07 -2.5 21.56 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-N 119.377 0.99 . . . . 0.0 112.338 176.342 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.82 -11.85 59.8 Favored 'General case' 0 N--CA 1.439 -1.014 0 CA-C-O 116.436 -1.745 . . . . 0.0 108.564 169.343 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 7.3 tp -53.47 -41.1 43.84 Favored 'Isoleucine or valine' 0 C--N 1.344 0.345 0 CA-C-N 122.094 2.225 . . . . 0.0 112.44 -169.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -62.03 -49.06 78.91 Favored Glycine 0 CA--C 1.523 0.555 0 CA-C-N 119.257 0.935 . . . . 0.0 111.707 177.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 58.3 t -65.16 -47.27 88.24 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 178.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 71.4 mmt-85 -59.64 -35.02 73.57 Favored 'General case' 0 C--N 1.343 0.292 0 CA-C-O 117.041 -1.457 . . . . 0.0 113.146 177.326 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 27.8 mt -62.74 -45.6 98.43 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 CA-C-N 121.925 2.148 . . . . 0.0 109.995 177.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 22.2 m -74.47 -27.82 21.71 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-N 119.995 1.27 . . . . 0.0 111.632 -175.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -68.63 -44.44 74.22 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 174.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -66.09 -40.11 90.54 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 122.559 0.344 . . . . 0.0 110.28 -179.258 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 7.8 tp -62.33 -42.59 99.5 Favored 'General case' 0 CA--C 1.527 0.096 0 CA-C-O 118.733 -0.651 . . . . 0.0 109.933 178.169 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -61.36 -38.62 87.64 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 118.506 0.594 . . . . 0.0 110.835 -178.309 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 -74.01 -43.21 58.76 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.38 0.672 . . . . 0.0 111.036 177.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 87.9 mtt180 -86.31 -31.13 21.75 Favored 'General case' 0 C--N 1.339 0.124 0 CA-C-O 116.87 -1.538 . . . . 0.0 114.221 -169.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -125.96 138.25 53.75 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 121.369 1.895 . . . . 0.0 112.836 -173.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 49.5 mm -91.71 149.84 3.99 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 N-CA-C 106.366 -1.716 . . . . 0.0 106.366 168.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 51.2 mt -137.44 151.34 71.03 Favored Pre-proline 0 C--O 1.237 0.412 0 C-N-CA 124.218 1.007 . . . . 0.0 110.775 -169.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -67.76 159.97 50.38 Favored 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 122.483 2.122 . . . . 0.0 110.111 169.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -57.71 -32.55 67.5 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 114.51 1.3 . . . . 0.0 114.51 -169.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 31.5 p90 -75.89 -5.61 46.91 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 117.8 -1.095 . . . . 0.0 112.676 -176.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 26.0 t -108.61 129.9 62.3 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 CA-C-N 120.087 1.312 . . . . 0.0 107.888 175.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -136.95 150.98 48.51 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 121.491 0.662 . . . . 0.0 110.113 174.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -103.21 131.01 52.52 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 170.555 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 10.5 tt -123.77 127.68 48.47 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 175.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -91.2 115.15 27.79 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 172.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -71.58 -23.92 77.43 Favored Glycine 0 CA--C 1.533 1.186 0 CA-C-O 118.373 -1.237 . . . . 0.0 112.795 179.239 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 62.85 77.09 0.22 Allowed Glycine 0 CA--C 1.529 0.949 0 CA-C-N 118.424 1.112 . . . . 0.0 112.886 173.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.514 HG22 ' HA ' ' A' ' 10' ' ' ASN 0.28 14.9 p 55.75 32.84 20.24 Favored 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 125.075 1.35 . . . . 0.0 112.761 173.181 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -75.14 -69.26 0.48 Allowed 'General case' 0 C--N 1.345 0.385 0 N-CA-C 114.722 1.378 . . . . 0.0 114.722 -169.333 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 70.06 -99.1 0.67 Allowed Glycine 0 C--N 1.337 0.584 0 N-CA-C 108.436 -1.866 . . . . 0.0 108.436 -171.038 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 10.1 tpt -67.51 -27.76 67.26 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 125.057 1.343 . . . . 0.0 111.38 -178.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -70.2 -4.65 22.64 Favored 'General case' 0 CA--C 1.548 0.881 0 CA-C-O 121.234 0.54 . . . . 0.0 110.685 -173.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 81.9 mt -81.76 2.13 31.35 Favored 'General case' 0 CA--C 1.535 0.382 0 O-C-N 120.316 -1.49 . . . . 0.0 113.62 -179.335 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.48 ' HA ' HG13 ' A' ' 100' ' ' VAL . 6.5 tt -50.16 -53.99 23.87 Favored 'General case' 0 C--N 1.339 0.151 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 -170.129 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -87.68 -31.91 14.5 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 -177.29 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -52.87 -49.3 66.12 Favored 'General case' 0 C--N 1.34 0.164 0 C-N-CA 123.03 0.532 . . . . 0.0 110.257 178.256 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 28.1 mtp -78.13 -8.71 58.61 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 114.306 1.224 . . . . 0.0 114.306 -169.052 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.79 146.65 54.2 Favored 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 113.78 1.03 . . . . 0.0 113.78 -169.131 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . 0.25 14.7 p30 53.08 13.81 0.42 Allowed 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 128.86 2.864 . . . . 0.0 117.975 169.114 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 89.8 mtt180 -68.08 151.93 46.29 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 121.333 -0.855 . . . . 0.0 109.835 173.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -81.68 -61.75 1.84 Allowed 'General case' 0 C--O 1.222 -0.363 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 176.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 2.3 t-160 -114.85 124.22 51.19 Favored 'General case' 0 C--O 1.231 0.103 0 N-CA-C 105.609 -1.997 . . . . 0.0 105.609 -177.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 54.0 tp -133.24 119.96 20.5 Favored 'General case' 0 CA--C 1.506 -0.713 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 178.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 4.4 mp -103.04 120.09 52.4 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 N-CA-C 105.445 -2.057 . . . . 0.0 105.445 175.194 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 8.1 mt -96.92 132.94 40.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 104.392 -2.447 . . . . 0.0 104.392 176.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -121.55 126.4 49.08 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 172.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -162.46 162.6 27.64 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 122.602 0.361 . . . . 0.0 110.056 177.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -74.06 136.44 43.07 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 104.923 -2.251 . . . . 0.0 104.923 168.106 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -87.47 -22.03 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 N-CA-C 113.182 0.808 . . . . 0.0 113.182 -168.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.7 t 51.73 31.95 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.221 0 C-N-CA 126.115 1.766 . . . . 0.0 112.569 174.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 19.8 m -137.54 159.75 41.08 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 124.313 1.045 . . . . 0.0 111.711 -172.245 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 22.6 ttmt 63.55 173.93 0.17 Allowed 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 126.732 2.013 . . . . 0.0 112.685 170.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.32 7.98 35.87 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.543 1.137 . . . . 0.0 112.027 -170.02 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 41.4 t-20 -73.66 165.55 24.9 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.368 0.667 . . . . 0.0 109.489 -174.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 10.7 m -58.75 141.59 84.82 Favored Pre-proline 0 CA--C 1.55 0.947 0 C-N-CA 124.199 1.0 . . . . 0.0 112.578 -169.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -55.25 150.16 41.87 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 123.503 2.802 . . . . 0.0 112.132 169.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 68.18 15.2 67.33 Favored Glycine 0 CA--C 1.531 1.032 0 CA-C-O 119.091 -0.839 . . . . 0.0 113.825 176.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 20.9 m -90.92 149.92 21.7 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 118.973 1.386 . . . . 0.0 108.895 175.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 16.7 ttp -95.41 139.12 32.15 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 176.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 3.4 ttt -135.44 115.04 12.72 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 107.275 -1.379 . . . . 0.0 107.275 -170.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 24.0 mm -100.78 122.04 52.32 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 -169.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -117.48 125.24 50.56 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 179.216 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -90.7 170.53 10.06 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 178.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -28.97 -61.69 0.12 Allowed 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 117.02 2.23 . . . . 0.0 117.02 -170.12 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -78.51 -17.25 56.49 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 119.302 0.955 . . . . 0.0 113.307 -174.158 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -87.96 -30.69 19.84 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 123.555 0.742 . . . . 0.0 110.417 -170.026 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . 0.256 0.5 OUTLIER -67.46 -47.31 47.76 Favored Pre-proline 0 N--CA 1.453 -0.289 0 CA-C-O 116.624 -1.655 . . . . 0.0 112.023 -171.351 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -65.63 -35.63 36.72 Favored 'Trans proline' 0 N--CA 1.453 -0.883 0 CA-C-N 122.176 1.813 . . . . 0.0 109.988 179.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.2 -26.36 67.36 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.033 0.533 . . . . 0.0 111.199 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -78.39 -52.96 7.81 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 169.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -58.2 -23.06 54.3 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 -174.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -66.86 -6.79 17.75 Favored 'General case' 0 CA--C 1.551 1.009 0 CA-C-N 119.103 0.865 . . . . 0.0 112.26 176.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 32.6 t30 -50.2 127.68 17.56 Favored 'General case' 0 C--N 1.344 0.346 0 O-C-N 121.27 -0.894 . . . . 0.0 110.912 173.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 30.5 mmmt -66.91 -26.73 67.01 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 118.541 -0.742 . . . . 0.0 111.994 -178.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 62.1 mt -65.62 -49.6 76.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 -177.204 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.4 m -65.02 114.41 14.89 Favored Pre-proline 0 CA--C 1.545 0.774 0 C-N-CA 124.609 1.164 . . . . 0.0 109.854 -176.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -70.92 -75.85 0.01 OUTLIER 'Trans proline' 0 CA--C 1.539 0.76 0 C-N-CA 122.761 2.307 . . . . 0.0 112.896 -169.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 13.1 m80 -69.33 -26.66 64.82 Favored 'General case' 0 N--CA 1.47 0.562 0 O-C-N 121.093 -1.004 . . . . 0.0 110.784 -174.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 25.8 mp0 -63.78 -28.87 70.17 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 124.432 1.093 . . . . 0.0 110.659 179.013 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 52.6 tp -64.18 -35.49 80.97 Favored 'General case' 0 C--N 1.342 0.246 0 CA-C-N 119.722 1.146 . . . . 0.0 110.54 174.224 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -64.64 -40.12 97.27 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 110.552 -1.019 . . . . 0.0 110.552 172.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 19.1 tp -66.2 -32.44 73.88 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 117.976 0.888 . . . . 0.0 110.907 175.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -64.1 -45.19 89.75 Favored 'General case' 0 N--CA 1.466 0.36 0 O-C-N 120.952 -1.092 . . . . 0.0 110.791 171.202 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -70.35 -24.2 62.94 Favored 'General case' 0 CA--C 1.52 -0.18 0 O-C-N 121.602 -0.686 . . . . 0.0 111.574 178.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.48 HG13 ' HA ' ' A' ' 49' ' ' LEU . 7.0 t -68.14 -44.97 83.98 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 CA-C-N 118.722 0.692 . . . . 0.0 110.397 169.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 59.8 mt -62.26 -36.89 83.45 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 119.25 0.932 . . . . 0.0 109.697 176.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 44.5 m -65.03 -40.18 94.44 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 118.005 0.366 . . . . 0.0 110.299 172.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -64.52 -40.34 95.44 Favored 'General case' 0 N--CA 1.454 -0.237 0 O-C-N 121.112 -0.992 . . . . 0.0 110.729 178.231 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 12.6 mt -64.0 -37.61 88.05 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-O 120.98 0.419 . . . . 0.0 110.58 175.155 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 21.1 tpp180 -63.89 -37.82 88.8 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 118.652 -0.689 . . . . 0.0 109.982 173.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 14.6 m-30 -66.18 -42.61 88.65 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 119.124 0.875 . . . . 0.0 110.798 179.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 41.7 p -76.13 -18.72 59.02 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 118.819 0.736 . . . . 0.0 111.722 178.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 76.42 9.72 85.83 Favored Glycine 0 CA--C 1.532 1.127 0 CA-C-O 119.073 -0.848 . . . . 0.0 111.229 -169.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -93.5 31.04 1.6 Allowed 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 118.991 1.395 . . . . 0.0 110.675 178.048 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.418 ' HA ' ' HD3' ' A' ' 111' ' ' PRO . 9.4 t80 -62.24 140.22 96.24 Favored Pre-proline 0 CA--C 1.542 0.647 0 C-N-CA 123.793 0.837 . . . . 0.0 109.724 174.321 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 110' ' ' PHE . 31.2 Cg_exo -66.66 142.9 65.97 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.382 2.055 . . . . 0.0 110.35 -177.364 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -64.48 -29.4 70.44 Favored 'General case' 0 CA--C 1.538 0.504 0 O-C-N 122.141 -0.349 . . . . 0.0 111.483 -174.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 23.9 tptp -143.41 82.78 1.75 Allowed 'General case' 0 C--O 1.234 0.277 0 N-CA-C 106.172 -1.788 . . . . 0.0 106.172 -176.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 24.5 tp -77.02 136.52 38.69 Favored 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 169.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -138.39 144.24 40.15 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 170.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 11.2 tp -128.83 129.83 46.12 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 119.606 1.094 . . . . 0.0 109.464 176.031 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 21.7 t -98.34 101.21 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 N-CA-C 104.215 -2.513 . . . . 0.0 104.215 168.384 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -82.93 146.7 24.33 Favored Glycine 0 CA--C 1.521 0.454 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 171.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 47.9 t -127.42 143.5 40.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 170.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 13.2 mt -94.14 130.13 35.2 Favored Pre-proline 0 CA--C 1.537 0.458 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 -176.139 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -79.33 166.6 22.26 Favored 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 122.967 2.445 . . . . 0.0 113.026 -174.154 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -111.05 -53.71 2.68 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.371 1.068 . . . . 0.0 110.331 -178.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 73.6 m -111.84 -53.55 2.7 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 118.73 0.695 . . . . 0.0 112.248 -173.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER 56.11 44.71 24.79 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 125.215 1.406 . . . . 0.0 114.609 177.07 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -119.43 171.38 5.51 Favored Pre-proline 0 N--CA 1.477 0.892 0 O-C-N 121.205 -0.934 . . . . 0.0 109.924 175.091 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -65.85 91.0 0.24 Allowed 'Trans proline' 0 CA--C 1.549 1.267 0 C-N-CA 123.447 2.765 . . . . 0.0 114.145 -177.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -167.62 131.64 1.78 Allowed 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 105.102 -2.185 . . . . 0.0 105.102 169.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.434 HG23 ' HA ' ' A' ' 12' ' ' LEU . 0.0 OUTLIER -80.28 152.91 4.48 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 123.612 0.765 . . . . 0.0 110.293 -171.452 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 80.37 160.79 23.22 Favored Glycine 0 CA--C 1.53 1.0 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.916 179.334 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.436 HD22 ' H ' ' A' ' 130' ' ' LEU . 1.1 mm? -76.45 163.17 27.21 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-O 121.188 0.518 . . . . 0.0 112.218 -169.194 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 40.7 p -69.81 169.93 11.3 Favored Pre-proline 0 CA--C 1.541 0.597 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 167.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -55.88 -31.76 82.55 Favored 'Trans proline' 0 CA--C 1.542 0.925 0 C-N-CA 121.315 1.344 . . . . 0.0 111.041 169.097 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 25.3 m -68.18 -45.27 73.91 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 118.976 -0.535 . . . . 0.0 111.505 179.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 5.8 t -99.19 -12.16 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 CA-C-N 119.451 1.023 . . . . 0.0 111.652 -169.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -57.6 -45.55 85.15 Favored 'General case' 0 N--CA 1.465 0.292 0 O-C-N 119.898 -1.751 . . . . 0.0 108.102 169.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -68.19 -2.02 7.25 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-O 118.382 -0.818 . . . . 0.0 112.741 178.021 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 12.9 mmm -92.84 -6.94 47.7 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 119.356 0.98 . . . . 0.0 111.266 175.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 86.6 mt -59.42 -45.26 93.71 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 CA-C-N 119.421 1.01 . . . . 0.0 108.921 175.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -76.07 -47.02 3.71 Favored Pre-proline 0 CA--C 1.543 0.677 0 CA-C-O 117.252 -1.356 . . . . 0.0 113.129 -170.207 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -55.0 -41.76 75.79 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 122.07 1.847 . . . . 0.0 111.399 170.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -68.36 -41.48 80.6 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 118.162 -0.923 . . . . 0.0 110.718 -177.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 27.1 mt -55.83 -47.48 77.16 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 119.713 1.142 . . . . 0.0 109.223 172.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -62.31 -33.97 75.71 Favored 'General case' 0 N--CA 1.443 -0.817 0 C-N-CA 122.768 0.427 . . . . 0.0 109.849 -177.109 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 38.9 tp60 -80.29 -34.14 37.13 Favored 'General case' 0 N--CA 1.431 -1.375 0 C-N-CA 123.409 0.684 . . . . 0.0 111.307 -178.047 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 49.0 t -60.45 -48.77 87.01 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 170.176 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 30.2 mt -62.81 -30.53 71.55 Favored 'General case' 0 C--N 1.331 -0.203 0 O-C-N 121.995 -0.441 . . . . 0.0 110.406 178.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -67.22 -39.37 86.23 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 121.036 -1.04 . . . . 0.0 111.129 176.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -62.06 -47.48 84.52 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 118.608 0.64 . . . . 0.0 110.76 177.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 6.0 mp -58.01 -41.97 84.23 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 174.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 85.0 mtm180 -70.12 -13.83 62.38 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 117.319 -1.324 . . . . 0.0 113.327 -179.051 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -57.29 -33.25 67.48 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 120.959 1.709 . . . . 0.0 110.208 172.152 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 4.6 m -103.01 22.22 14.34 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.113 1.365 . . . . 0.0 111.502 179.18 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 68.75 23.26 75.65 Favored Glycine 0 CA--C 1.532 1.155 0 CA-C-O 118.402 -1.221 . . . . 0.0 114.355 178.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 60.9 t -102.41 97.84 6.12 Favored 'Isoleucine or valine' 0 C--N 1.342 0.261 0 CA-C-N 119.52 1.66 . . . . 0.0 107.607 177.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -97.96 136.58 38.04 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 169.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -77.18 161.18 28.4 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.273 0.629 . . . . 0.0 110.619 178.169 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 5.2 mt -83.57 121.55 76.47 Favored Pre-proline 0 CA--C 1.54 0.565 0 N-CA-C 105.307 -2.109 . . . . 0.0 105.307 175.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -65.94 107.86 1.19 Allowed 'Trans proline' 0 C--N 1.35 0.656 0 N-CA-C 105.781 -2.43 . . . . 0.0 105.781 169.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 22.5 tpt180 47.86 -121.64 1.37 Allowed 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 104.965 -2.235 . . . . 0.0 104.965 -168.049 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 8.1 p -153.66 159.89 42.2 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 121.521 1.964 . . . . 0.0 109.958 169.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -72.21 -39.34 68.64 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 110.289 -0.263 . . . . 0.0 110.289 170.255 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 14.9 m . . . . . 0 C--O 1.254 1.328 0 C-N-CA 124.15 0.98 . . . . 0.0 109.125 169.876 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.4 ttt . . . . . 0 N--CA 1.5 2.036 0 CA-C-O 120.121 0.01 . . . . 0.0 111.018 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 31.6 ptt-85 -62.18 126.62 27.97 Favored 'General case' 0 N--CA 1.476 0.848 0 O-C-N 120.219 -1.551 . . . . 0.0 110.252 176.323 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 4.4 mt -122.19 128.74 75.61 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 -176.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 15.3 tp -115.21 140.77 48.81 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 105.686 -1.968 . . . . 0.0 105.686 168.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 74.9 t -120.01 113.24 39.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 106.152 -1.795 . . . . 0.0 106.152 177.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.41 ' HA ' HD13 ' A' ' 6' ' ' LEU . 0.7 OUTLIER -93.26 120.84 34.0 Favored 'General case' 0 CA--C 1.516 -0.338 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 -177.534 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -100.03 120.27 6.81 Favored Glycine 0 CA--C 1.499 -0.92 0 N-CA-C 105.679 -2.968 . . . . 0.0 105.679 170.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 11.4 m -148.94 162.47 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.971 0 CA-C-O 121.174 0.511 . . . . 0.0 110.579 -168.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 119.77 146.67 7.81 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 126.382 1.944 . . . . 0.0 108.996 177.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.494 HD21 ' HB2' ' A' ' 12' ' ' LEU . 2.0 t30 -62.57 116.14 4.88 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 123.781 1.753 . . . . 0.0 114.675 -168.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.3 pt -67.84 40.71 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.812 0 CA-C-N 112.264 -2.244 . . . . 0.0 114.981 170.037 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.494 ' HB2' HD21 ' A' ' 10' ' ' ASN . 75.0 mt -132.62 -12.65 3.01 Favored 'General case' 0 C--N 1.343 0.325 0 CA-C-N 121.563 1.983 . . . . 0.0 111.416 170.622 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.7 mp -115.32 62.77 0.69 Allowed 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 -167.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 56.9 -97.63 0.08 Allowed 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 123.51 0.724 . . . . 0.0 111.246 170.387 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -84.18 -9.47 58.52 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 124.39 1.076 . . . . 0.0 110.906 -175.15 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -70.68 -14.98 62.67 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 119.859 1.208 . . . . 0.0 112.56 -176.039 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.2 -6.04 55.67 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-O 115.697 -2.097 . . . . 0.0 110.024 172.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 6.4 tp -49.88 -44.37 20.9 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-N 122.062 2.21 . . . . 0.0 111.94 -171.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -62.78 -42.24 99.72 Favored Glycine 0 N--CA 1.446 -0.634 0 CA-C-N 118.88 0.764 . . . . 0.0 111.629 178.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 73.6 t -63.86 -52.92 50.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 173.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 1.4 mmp_? -60.74 -31.89 71.2 Favored 'General case' 0 CA--C 1.531 0.245 0 O-C-N 120.949 -1.094 . . . . 0.0 112.73 -175.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 25.0 mt -60.54 -44.94 97.68 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 CA-C-N 120.145 1.339 . . . . 0.0 110.287 176.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 17.9 m -75.35 -25.44 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-N 120.203 1.365 . . . . 0.0 111.323 -176.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -68.03 -42.92 79.87 Favored 'General case' 0 C--N 1.341 0.2 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 173.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.81 -41.95 91.24 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-O 119.363 -0.351 . . . . 0.0 110.277 179.36 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 10.4 tp -61.12 -45.11 96.02 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 118.453 -0.784 . . . . 0.0 109.816 176.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -59.89 -39.91 86.97 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 118.467 0.576 . . . . 0.0 111.216 -178.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 50.6 mm-40 -73.58 -40.73 63.66 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 122.938 0.495 . . . . 0.0 111.355 178.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 91.0 mtt180 -90.24 -38.03 13.71 Favored 'General case' 0 C--N 1.342 0.259 0 CA-C-O 117.343 -1.313 . . . . 0.0 114.288 -169.293 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 66.2 m-85 -115.33 136.23 53.31 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 120.991 1.723 . . . . 0.0 113.348 -169.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 39.8 mm -86.48 134.29 27.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 N-CA-C 105.805 -1.924 . . . . 0.0 105.805 168.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 7.3 mp -119.91 150.32 50.54 Favored Pre-proline 0 CA--C 1.539 0.523 0 C-N-CA 125.305 1.442 . . . . 0.0 110.691 -169.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -62.34 153.86 67.6 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 122.888 2.392 . . . . 0.0 109.785 168.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -61.21 -33.6 73.74 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 -169.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 18.0 p90 -74.21 -8.04 54.78 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 118.016 -0.992 . . . . 0.0 112.453 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 12.4 t -101.11 128.03 53.74 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 CA-C-N 119.926 1.239 . . . . 0.0 108.079 174.205 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -133.45 147.66 51.7 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.063 0.545 . . . . 0.0 110.155 175.226 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -100.17 136.78 30.04 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 N-CA-C 107.459 -1.312 . . . . 0.0 107.459 169.556 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.513 HD13 ' N ' ' A' ' 40' ' ' ASP . 1.5 tm? -128.11 144.79 51.13 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 173.075 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.513 ' N ' HD13 ' A' ' 39' ' ' LEU . 5.8 t0 -118.11 114.43 23.08 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 124.131 0.972 . . . . 0.0 108.483 -175.439 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -93.31 -4.54 64.29 Favored Glycine 0 CA--C 1.533 1.207 0 CA-C-O 119.032 -0.871 . . . . 0.0 113.277 176.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 60.57 -125.82 39.49 Favored Glycine 0 N--CA 1.431 -1.665 0 N-CA-C 108.22 -1.952 . . . . 0.0 108.22 -171.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 12.1 p -54.55 -37.41 65.41 Favored 'General case' 0 C--N 1.313 -0.985 0 C-N-CA 127.501 2.32 . . . . 0.0 111.271 176.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 50.07 -131.32 1.94 Allowed 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 169.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 79.73 -104.92 2.24 Favored Glycine 0 N--CA 1.443 -0.847 0 N-CA-C 106.899 -2.481 . . . . 0.0 106.899 -169.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 66.4 mmm -72.23 -19.55 61.7 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 112.535 0.568 . . . . 0.0 112.535 -175.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -60.67 -18.48 54.06 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 120.871 0.367 . . . . 0.0 111.941 -174.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 28.4 mt -88.71 -2.68 58.72 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 124.929 1.291 . . . . 0.0 114.136 -169.015 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.496 ' HA ' HG13 ' A' ' 100' ' ' VAL . 5.0 tt -46.9 -53.97 11.01 Favored 'General case' 0 C--N 1.344 0.354 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 -169.483 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -86.93 -31.24 18.29 Favored Glycine 0 CA--C 1.522 0.493 0 N-CA-C 111.011 -0.836 . . . . 0.0 111.011 -179.244 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -72.24 -27.75 62.71 Favored 'General case' 0 C--O 1.233 0.199 0 O-C-N 121.735 -0.862 . . . . 0.0 111.217 -170.015 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 28.8 mtp -81.9 -6.81 59.42 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 176.133 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -68.61 145.2 54.15 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 118.997 0.817 . . . . 0.0 111.474 -170.36 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 55.79 21.85 5.06 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 116.741 2.126 . . . . 0.0 116.741 168.577 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 26.2 mmt180 -77.79 148.95 34.52 Favored 'General case' 0 N--CA 1.473 0.681 0 O-C-N 120.593 -1.317 . . . . 0.0 108.867 178.104 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -83.4 -30.64 27.19 Favored 'General case' 0 N--CA 1.47 0.572 0 O-C-N 121.7 -0.625 . . . . 0.0 109.607 179.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 4.0 t60 -141.33 129.53 22.22 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 105.523 -2.028 . . . . 0.0 105.523 177.114 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.403 HD21 HD23 ' A' ' 6' ' ' LEU . 0.4 OUTLIER -130.84 127.95 39.64 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-N 118.671 0.669 . . . . 0.0 109.327 171.095 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 29.7 mt -109.69 116.91 53.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 N-CA-C 104.904 -2.258 . . . . 0.0 104.904 174.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.452 HD11 HD21 ' A' ' 114' ' ' LEU . 38.8 mt -93.36 127.47 45.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 105.517 -2.031 . . . . 0.0 105.517 177.077 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -110.4 114.97 28.83 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 103.868 -2.641 . . . . 0.0 103.868 169.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -150.48 161.46 42.48 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.813 0.845 . . . . 0.0 110.154 -178.427 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -76.02 151.79 37.08 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 169.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 9.7 mm -84.05 -49.49 16.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-O 118.817 -0.611 . . . . 0.0 110.925 -177.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . 0.252 2.7 t 52.64 28.6 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.164 0 C-N-CA 125.954 1.702 . . . . 0.0 112.907 177.595 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 16.3 m -132.46 157.62 44.13 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 124.481 1.112 . . . . 0.0 111.934 -171.178 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 19.7 ttmt 57.87 -167.48 0.14 Allowed 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 126.265 1.826 . . . . 0.0 112.447 171.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.37 17.98 17.17 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.86 1.264 . . . . 0.0 110.995 -175.177 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -70.84 158.45 36.35 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.529 0.732 . . . . 0.0 109.144 -177.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 8.5 m -59.74 138.71 90.07 Favored Pre-proline 0 CA--C 1.545 0.779 0 C-N-CA 124.078 0.951 . . . . 0.0 111.991 -169.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_exo -55.2 149.01 46.84 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.998 2.465 . . . . 0.0 111.709 170.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 68.95 16.43 70.49 Favored Glycine 0 CA--C 1.533 1.157 0 CA-C-O 119.721 -0.488 . . . . 0.0 113.684 174.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 18.3 m -91.6 141.24 28.92 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 173.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 26.3 ttp -96.12 141.14 29.85 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 175.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 25.9 ttm -129.5 100.61 5.61 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 -173.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 38.4 mm -92.81 119.18 40.03 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 -178.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 44.0 mt -125.46 141.29 52.14 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 -173.281 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 88.2 mtt-85 -113.28 142.89 45.29 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 123.113 0.565 . . . . 0.0 110.425 -178.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 33.6 t70 38.05 -102.11 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 125.6 1.56 . . . . 0.0 114.228 169.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -59.91 -31.06 69.47 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.851 1.26 . . . . 0.0 113.725 -173.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -75.56 -19.52 59.24 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 118.388 0.54 . . . . 0.0 111.173 -176.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 78.9 t -73.96 -60.84 1.42 Allowed Pre-proline 0 N--CA 1.443 -0.781 0 CA-C-O 117.822 -1.085 . . . . 0.0 111.196 -169.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -63.8 -30.98 68.73 Favored 'Trans proline' 0 N--CA 1.447 -1.222 0 CA-C-N 121.315 1.506 . . . . 0.0 110.591 177.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.6 -26.45 67.1 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 122.631 0.372 . . . . 0.0 111.074 -178.028 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.423 HD13 ' C ' ' A' ' 85' ' ' LEU . 3.1 tm? -77.98 -54.86 5.81 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 169.044 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -59.05 -24.56 62.97 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 114.033 1.123 . . . . 0.0 114.033 -170.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.9 t -67.3 -7.93 28.3 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-N 118.948 0.794 . . . . 0.0 112.546 178.021 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . 0.559 HD21 ' HB ' ' A' ' 90' ' ' ILE . 10.1 t30 -51.69 126.54 18.0 Favored 'General case' 0 C--N 1.344 0.347 0 O-C-N 121.409 -0.807 . . . . 0.0 109.754 172.075 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 37.0 mtmt -73.12 -23.51 60.5 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 118.718 -0.658 . . . . 0.0 112.45 -174.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.559 ' HB ' HD21 ' A' ' 88' ' ' ASN . 70.9 mt -67.23 -44.83 87.36 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 -178.054 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.9 m -62.39 113.37 8.6 Favored Pre-proline 0 CA--C 1.544 0.724 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 170.404 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -77.15 -63.68 0.03 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.623 0 CA-C-N 121.215 1.47 . . . . 0.0 113.041 -169.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . 0.418 ' CE1' ' HB3' ' A' ' 10' ' ' ASN . 6.4 p-80 -78.62 -25.23 45.06 Favored 'General case' 0 N--CA 1.468 0.445 0 O-C-N 121.127 -0.983 . . . . 0.0 110.754 -178.226 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 22.0 mp0 -59.36 -33.51 71.25 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 119.739 1.154 . . . . 0.0 110.084 171.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -60.63 -41.83 95.65 Favored 'General case' 0 C--O 1.224 -0.248 0 CA-C-N 119.249 0.932 . . . . 0.0 109.14 173.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -61.29 -38.01 94.98 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 110.781 -0.927 . . . . 0.0 110.781 174.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 10.4 tp -69.23 -33.52 73.42 Favored 'General case' 0 CA--C 1.538 0.483 0 O-C-N 120.676 -1.484 . . . . 0.0 110.624 176.127 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -63.41 -41.3 98.72 Favored 'General case' 0 C--N 1.333 -0.132 0 O-C-N 121.037 -1.039 . . . . 0.0 109.822 171.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -71.2 -22.27 62.04 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 118.877 -0.583 . . . . 0.0 111.775 176.15 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.496 HG13 ' HA ' ' A' ' 49' ' ' LEU . 6.3 t -73.54 -44.16 54.02 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 CA-C-N 119.526 1.057 . . . . 0.0 109.839 169.7 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 64.4 mt -58.97 -37.42 76.76 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 119.093 0.86 . . . . 0.0 108.735 174.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 35.8 m -68.33 -39.17 82.01 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 118.708 -0.663 . . . . 0.0 110.554 172.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.415 ' HA ' ' CD2' ' A' ' 106' ' ' PHE . . . -63.77 -39.76 95.03 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 119.879 1.218 . . . . 0.0 110.459 179.583 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 18.8 mt -65.88 -38.84 89.85 Favored 'General case' 0 CA--C 1.519 -0.244 0 C-N-CA 123.119 0.567 . . . . 0.0 110.596 174.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 80.2 ttt180 -62.17 -37.83 86.76 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 118.552 -0.737 . . . . 0.0 109.985 173.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.415 ' CD2' ' HA ' ' A' ' 103' ' ' ALA . 14.1 m-30 -65.73 -42.51 90.94 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 119.346 0.975 . . . . 0.0 110.489 -179.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 42.6 p -78.55 -19.77 52.13 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 118.345 0.521 . . . . 0.0 111.624 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 78.56 10.33 86.29 Favored Glycine 0 CA--C 1.532 1.143 0 CA-C-O 119.034 -0.87 . . . . 0.0 111.036 -169.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 30.4 mm-40 -88.9 21.68 3.0 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 119.078 1.439 . . . . 0.0 111.931 -179.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.428 ' HA ' ' HD3' ' A' ' 111' ' ' PRO . 10.0 t80 -61.8 140.95 95.41 Favored Pre-proline 0 CA--C 1.543 0.684 0 C-N-CA 123.95 0.9 . . . . 0.0 110.509 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 110' ' ' PHE . 52.2 Cg_exo -64.72 148.16 90.08 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 122.493 2.128 . . . . 0.0 111.675 -176.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -64.75 -26.08 68.21 Favored 'General case' 0 CA--C 1.537 0.476 0 O-C-N 122.13 -0.357 . . . . 0.0 111.137 -178.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -140.45 133.29 29.1 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 169.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.452 HD21 HD11 ' A' ' 60' ' ' ILE . 2.8 tm? -124.96 123.22 39.42 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 177.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.2 m -131.62 142.6 49.91 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 -172.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -131.58 123.81 28.68 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 119.681 1.128 . . . . 0.0 109.525 -179.545 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 23.4 t -96.4 78.7 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 105.489 -2.041 . . . . 0.0 105.489 174.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -77.01 145.09 30.61 Favored Glycine 0 N--CA 1.449 -0.471 0 N-CA-C 109.905 -1.278 . . . . 0.0 109.905 -176.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 63.3 t -129.03 137.57 56.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 174.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 18.8 mt -88.56 131.65 41.32 Favored Pre-proline 0 CA--C 1.542 0.656 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 175.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -70.74 171.49 15.43 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 124.147 3.231 . . . . 0.0 113.534 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -113.08 -60.74 1.84 Allowed 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.033 0.933 . . . . 0.0 110.454 176.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 67.8 m -104.56 -52.32 2.92 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 118.791 0.723 . . . . 0.0 112.756 -171.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER 58.48 46.98 14.22 Favored 'General case' 0 CA--C 1.548 0.887 0 N-CA-C 114.706 1.372 . . . . 0.0 114.706 170.429 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -115.8 165.03 15.56 Favored Pre-proline 0 N--CA 1.475 0.81 0 CA-C-O 117.923 -1.037 . . . . 0.0 110.407 175.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -63.94 87.58 0.15 Allowed 'Trans proline' 0 CA--C 1.547 1.136 0 C-N-CA 123.706 2.937 . . . . 0.0 113.736 -179.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -176.76 145.8 0.53 Allowed 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 104.067 -2.568 . . . . 0.0 104.067 174.574 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -108.94 161.72 7.12 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 CA-C-N 119.014 0.825 . . . . 0.0 111.346 -176.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 105.21 135.21 8.22 Favored Glycine 0 CA--C 1.528 0.865 0 N-CA-C 105.316 -3.114 . . . . 0.0 105.316 -168.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 5.8 mp -81.43 157.94 24.76 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-N 117.915 0.857 . . . . 0.0 109.332 -175.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 63.4 p -64.22 162.7 30.0 Favored Pre-proline 0 CA--C 1.537 0.462 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 168.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -59.15 -28.56 88.12 Favored 'Trans proline' 0 CA--C 1.541 0.853 0 C-N-CA 120.635 0.89 . . . . 0.0 110.628 169.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 28.7 m -64.14 -50.09 69.57 Favored 'General case' 0 C--N 1.344 0.368 0 CA-C-O 118.785 -0.626 . . . . 0.0 110.999 178.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 5.0 t -96.3 -22.68 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 CA-C-N 119.286 0.948 . . . . 0.0 111.343 -169.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -52.59 -45.53 66.53 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 120.241 1.382 . . . . 0.0 108.674 168.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -75.15 8.81 2.36 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 113.978 1.103 . . . . 0.0 113.978 -179.219 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 85.3 mtp -103.48 -6.75 21.5 Favored 'General case' 0 N--CA 1.432 -1.367 0 CA-C-O 117.563 -1.208 . . . . 0.0 110.077 169.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 95.1 mt -58.92 -44.55 91.12 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.326 0 CA-C-N 120.342 1.428 . . . . 0.0 107.278 174.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 58.1 mt-10 -72.33 -51.87 7.37 Favored Pre-proline 0 CA--C 1.541 0.625 0 CA-C-O 117.595 -1.193 . . . . 0.0 110.786 -177.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -41.39 -50.47 4.55 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 124.867 3.711 . . . . 0.0 113.499 168.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -71.22 -42.68 68.6 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 113.725 -1.579 . . . . 0.0 110.497 -176.088 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 26.1 mt -56.4 -42.64 78.27 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 118.656 0.662 . . . . 0.0 109.354 173.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -62.18 -33.49 74.63 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 118.944 0.793 . . . . 0.0 110.426 -179.042 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 43.7 mm-40 -79.43 -31.48 42.6 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 119.059 0.845 . . . . 0.0 112.255 176.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 71.0 t -60.82 -47.81 91.63 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 169.522 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 29.0 mt -65.75 -35.06 79.64 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.103 0.561 . . . . 0.0 110.319 -179.076 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -62.15 -40.12 94.89 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-O 118.347 -0.835 . . . . 0.0 110.781 178.506 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -60.9 -47.99 83.87 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 119.154 0.888 . . . . 0.0 111.417 -179.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 10.4 mp -49.86 -52.47 32.47 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 123.379 0.672 . . . . 0.0 109.808 169.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -67.14 -18.37 65.26 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 117.492 -1.242 . . . . 0.0 111.984 -173.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -63.03 -29.49 70.86 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 120.788 1.631 . . . . 0.0 110.349 177.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 5.2 m -110.27 25.26 11.98 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.99 1.316 . . . . 0.0 110.808 179.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 66.54 18.61 68.06 Favored Glycine 0 CA--C 1.531 1.071 0 CA-C-O 118.295 -1.281 . . . . 0.0 114.047 177.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 63.9 t -84.72 137.05 21.52 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 N-CA-C 106.266 -1.753 . . . . 0.0 106.266 173.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -121.1 148.75 43.75 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 178.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -126.12 135.85 52.19 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 169.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.404 ' CG2' ' HA ' ' A' ' 160' ' ' SER . 33.7 mm -101.63 130.27 24.97 Favored Pre-proline 0 C--O 1.23 0.069 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 -171.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -57.73 110.64 0.65 Allowed 'Trans proline' 0 CA--C 1.536 0.599 0 C-N-CA 122.022 1.814 . . . . 0.0 108.533 169.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 4.5 tmm_? 49.96 32.28 5.48 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.154 1.381 . . . . 0.0 113.151 173.33 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . 0.404 ' HA ' ' CG2' ' A' ' 157' ' ' ILE . 27.5 p 42.43 31.4 0.27 Allowed 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.997 1.719 . . . . 0.0 113.951 -171.479 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -85.51 -28.64 24.83 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 113.621 0.971 . . . . 0.0 113.621 -168.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 11.6 m . . . . . 0 C--O 1.256 1.419 0 C-N-CA 124.081 0.952 . . . . 0.0 110.549 178.295 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.0 tpt . . . . . 0 N--CA 1.498 1.941 0 N-CA-C 110.446 -0.205 . . . . 0.0 110.446 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 6.1 ptp180 -152.49 120.93 6.36 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-O 118.035 -0.983 . . . . 0.0 108.93 178.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 57.2 mt -140.75 135.79 34.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 CA-C-N 119.685 1.13 . . . . 0.0 111.143 -169.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -116.94 130.31 56.62 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 105.593 -2.003 . . . . 0.0 105.593 168.244 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 33.2 t -107.36 103.97 16.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 103.258 -2.867 . . . . 0.0 103.258 169.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.2 mt -101.65 110.34 22.31 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 124.003 0.921 . . . . 0.0 109.795 -169.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -92.23 116.76 5.13 Favored Glycine 0 N--CA 1.45 -0.409 0 N-CA-C 107.773 -2.131 . . . . 0.0 107.773 172.486 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 12.4 m -133.78 -166.63 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.084 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 -177.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 95.15 131.0 6.3 Favored Glycine 0 N--CA 1.441 -0.976 0 N-CA-C 107.369 -2.293 . . . . 0.0 107.369 -170.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.516 HD21 ' HB2' ' A' ' 12' ' ' LEU . 1.6 t30 -66.16 108.41 2.26 Favored 'General case' 0 N--CA 1.441 -0.915 0 C-N-CA 124.004 0.922 . . . . 0.0 110.937 -169.114 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.1 pt -73.21 40.29 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 C-N-CA 124.675 1.19 . . . . 0.0 113.193 179.167 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.516 ' HB2' HD21 ' A' ' 10' ' ' ASN . 15.2 mt -125.59 -2.76 7.33 Favored 'General case' 0 CA--C 1.536 0.407 0 O-C-N 121.023 -1.048 . . . . 0.0 108.6 169.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -129.24 65.45 1.46 Allowed 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.589 1.156 . . . . 0.0 108.418 -169.602 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 12.7 m 45.44 -109.6 0.2 Allowed 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 114.325 -1.307 . . . . 0.0 112.445 169.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -56.89 -24.59 53.13 Favored 'General case' 0 N--CA 1.443 -0.815 0 C-N-CA 125.617 1.567 . . . . 0.0 112.501 -172.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -64.73 -21.92 66.86 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 120.288 1.404 . . . . 0.0 111.443 -177.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.99 -9.4 15.57 Favored 'General case' 0 N--CA 1.437 -1.118 0 CA-C-O 116.433 -1.746 . . . . 0.0 111.456 173.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 5.6 tp -52.88 -40.44 36.05 Favored 'Isoleucine or valine' 0 C--N 1.343 0.306 0 CA-C-N 122.172 2.26 . . . . 0.0 111.421 -175.321 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -63.17 -45.23 95.79 Favored Glycine 0 C--N 1.336 0.559 0 CA-C-N 119.245 0.93 . . . . 0.0 111.027 178.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 96.9 t -62.62 -47.6 92.17 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 175.423 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 18.5 mmt180 -61.13 -33.61 73.66 Favored 'General case' 0 C--N 1.34 0.163 0 CA-C-O 117.092 -1.432 . . . . 0.0 112.5 179.062 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 21.9 mt -62.5 -47.04 94.87 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 CA-C-N 121.431 1.923 . . . . 0.0 109.847 177.46 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 26.7 m -74.97 -34.08 31.46 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-N 119.327 0.967 . . . . 0.0 111.157 -175.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 61.0 mt-10 -62.45 -44.14 97.12 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 122.863 0.465 . . . . 0.0 110.33 172.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -67.08 -38.15 85.24 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 119.438 1.017 . . . . 0.0 110.18 177.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 5.9 tp -64.73 -38.72 91.95 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 119.369 0.986 . . . . 0.0 109.652 -177.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -61.89 -25.56 67.63 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 112.573 0.583 . . . . 0.0 112.573 -179.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -94.91 -42.63 8.57 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 126.014 1.726 . . . . 0.0 111.076 -178.111 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 75.2 mtt180 -82.95 -25.96 31.84 Favored 'General case' 0 N--CA 1.456 -0.144 0 CA-C-O 118.343 -0.836 . . . . 0.0 111.799 -176.243 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 69.5 m-85 -127.06 147.97 50.14 Favored 'General case' 0 CA--C 1.521 -0.161 0 CA-C-N 119.628 1.104 . . . . 0.0 113.346 -177.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 37.7 mm -99.51 135.63 34.07 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 N-CA-C 104.384 -2.45 . . . . 0.0 104.384 168.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -118.51 147.38 41.82 Favored Pre-proline 0 CA--C 1.536 0.413 0 C-N-CA 123.795 0.838 . . . . 0.0 109.878 -169.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -65.93 157.2 60.47 Favored 'Trans proline' 0 CA--C 1.535 0.545 0 C-N-CA 122.637 2.225 . . . . 0.0 110.007 169.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -58.07 -32.56 68.16 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 114.314 1.227 . . . . 0.0 114.314 -169.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 10.6 p90 -77.06 -13.4 59.96 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 118.688 -0.672 . . . . 0.0 112.686 -177.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 75.5 t -88.73 125.54 41.89 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 170.05 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -120.77 128.17 52.65 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 169.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -88.38 124.33 41.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 105.074 -2.195 . . . . 0.0 105.074 168.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 52.2 tp -122.93 133.94 54.37 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 118.234 0.47 . . . . 0.0 110.359 174.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -89.81 123.38 33.74 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 169.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -112.92 -24.37 4.92 Favored Glycine 0 CA--C 1.536 1.401 0 CA-C-O 118.235 -1.314 . . . . 0.0 113.466 171.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 57.0 -111.7 3.0 Favored Glycine 0 C--N 1.342 0.907 0 CA-C-N 119.802 1.801 . . . . 0.0 111.714 171.282 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 67.4 p -75.62 7.28 3.86 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.545 1.538 . . . . 0.0 113.522 -174.123 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.82 -67.2 0.44 Allowed 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 114.397 1.258 . . . . 0.0 114.397 -169.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 60.87 -102.2 0.38 Allowed Glycine 0 CA--C 1.534 1.272 0 N-CA-C 109.125 -1.59 . . . . 0.0 109.125 -169.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . 0.477 ' HA ' HG23 ' A' ' 100' ' ' VAL . 0.0 OUTLIER -65.97 -26.59 67.63 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.939 0.896 . . . . 0.0 112.812 -175.037 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -60.22 -15.68 26.69 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 113.799 1.037 . . . . 0.0 113.799 -170.142 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 7.9 mt -96.39 13.99 25.91 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -169.488 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.525 ' HA ' HG13 ' A' ' 100' ' ' VAL . 4.2 tt -46.75 -60.9 2.1 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 118.539 0.609 . . . . 0.0 111.736 -176.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -64.68 -32.14 83.24 Favored Glycine 0 CA--C 1.531 1.075 0 CA-C-O 119.527 -0.596 . . . . 0.0 112.552 -178.363 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -78.79 -33.21 46.49 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 118.629 1.214 . . . . 0.0 112.515 -174.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 39.3 mtp -75.62 -21.44 57.75 Favored 'General case' 0 N--CA 1.449 -0.505 0 O-C-N 121.936 -0.478 . . . . 0.0 110.421 178.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.58 153.93 42.38 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-O 121.755 0.788 . . . . 0.0 111.452 -175.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 62.87 9.64 3.81 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 126.959 2.103 . . . . 0.0 115.592 169.248 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 25.1 mmt180 -79.38 160.29 26.75 Favored 'General case' 0 N--CA 1.473 0.709 0 O-C-N 121.017 -1.052 . . . . 0.0 108.565 178.286 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -87.33 -53.16 4.98 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 175.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . 0.259 0.0 OUTLIER -125.4 146.08 49.76 Favored 'General case' 0 CA--C 1.517 -0.295 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 169.206 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 12.6 tp -138.2 116.69 12.05 Favored 'General case' 0 CA--C 1.513 -0.449 0 N-CA-C 104.067 -2.568 . . . . 0.0 104.067 -176.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 10.8 mt -98.08 113.23 32.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 105.562 -2.014 . . . . 0.0 105.562 175.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 48.6 mt -91.4 138.48 19.62 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.558 0 N-CA-C 106.561 -1.644 . . . . 0.0 106.561 173.405 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -123.4 121.04 34.74 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 105.397 -2.075 . . . . 0.0 105.397 168.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -157.23 161.37 39.23 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.999 1.32 . . . . 0.0 108.979 -173.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -95.06 141.18 29.0 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 121.42 0.629 . . . . 0.0 110.666 176.198 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 25.7 mt -89.95 -18.55 7.64 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 C-N-CA 124.434 1.093 . . . . 0.0 110.611 -179.045 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . 0.308 47.2 t 70.54 -48.21 0.19 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.21 0 C-N-CA 128.323 2.649 . . . . 0.0 113.659 174.283 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 11.9 m -147.07 138.72 24.22 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 -176.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 12.0 tppt? -164.56 174.85 10.41 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 127.166 2.186 . . . . 0.0 105.961 168.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.56 -26.98 65.68 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 121.799 -0.563 . . . . 0.0 111.505 175.016 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -70.58 165.45 22.75 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.345 0.658 . . . . 0.0 110.761 -175.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 3.1 m -60.64 153.13 63.98 Favored Pre-proline 0 CA--C 1.547 0.854 0 C-N-CA 124.709 1.204 . . . . 0.0 112.489 -169.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_exo -57.7 158.39 20.3 Favored 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 123.867 3.045 . . . . 0.0 112.422 169.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.446 ' HA3' HG22 ' A' ' 133' ' ' THR . . . 65.62 11.21 52.81 Favored Glycine 0 CA--C 1.536 1.38 0 CA-C-O 119.144 -0.809 . . . . 0.0 114.358 172.019 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 5.6 m -90.32 146.51 24.14 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 118.875 1.337 . . . . 0.0 111.484 -169.325 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 26.4 ttp -84.63 139.3 32.16 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 173.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 40.6 mtp -128.75 123.62 33.45 Favored 'General case' 0 CA--C 1.519 -0.214 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 176.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 23.3 mm -99.88 116.62 43.56 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 N-CA-C 107.243 -1.391 . . . . 0.0 107.243 177.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -107.85 130.02 55.03 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 106.857 -1.534 . . . . 0.0 106.857 174.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 21.3 mmt180 -85.66 167.13 15.6 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 122.706 0.402 . . . . 0.0 110.857 176.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -32.74 -54.84 0.36 Allowed 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 116.575 2.065 . . . . 0.0 116.575 -174.169 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -88.99 -10.23 48.41 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 113.461 0.911 . . . . 0.0 113.461 -177.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -93.28 -33.23 14.02 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 123.189 0.596 . . . . 0.0 110.436 -176.246 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.0 m -53.79 -50.35 84.17 Favored Pre-proline 0 CA--C 1.538 0.484 0 CA-C-O 117.987 -1.006 . . . . 0.0 110.997 175.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -64.8 -40.82 20.34 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 121.82 1.68 . . . . 0.0 110.434 -177.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.14 -15.35 59.58 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 173.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -91.25 -36.79 13.7 Favored 'General case' 0 C--N 1.342 0.273 0 CA-C-N 119.755 1.161 . . . . 0.0 110.953 177.068 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.616 ' HB3' ' HB2' ' A' ' 98' ' ' ALA . 62.7 m-85 -70.73 9.44 0.66 Allowed 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 113.677 0.992 . . . . 0.0 113.677 -177.074 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 57.2 p -61.14 -24.4 66.25 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.224 1.01 . . . . 0.0 109.443 168.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 56.0 t-20 -50.34 114.76 1.2 Allowed 'General case' 0 C--N 1.348 0.509 0 C-N-CA 124.578 1.151 . . . . 0.0 110.464 170.253 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 34.7 tttm -97.31 1.04 49.04 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.461 1.104 . . . . 0.0 112.356 -174.257 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 60.0 mt -64.45 -48.26 85.9 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-N 118.724 0.693 . . . . 0.0 109.469 -170.378 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -100.49 135.64 20.14 Favored Pre-proline 0 CA--C 1.543 0.686 0 CA-C-O 118.968 -0.539 . . . . 0.0 110.545 -171.648 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -70.98 -36.23 7.88 Favored 'Trans proline' 0 CA--C 1.534 0.507 0 C-N-CA 122.794 2.329 . . . . 0.0 111.576 -177.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 47.9 t-80 -59.51 -50.25 74.63 Favored 'General case' 0 C--N 1.343 0.286 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 175.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -58.96 -43.16 91.26 Favored 'General case' 0 C--O 1.224 -0.264 0 CA-C-O 118.437 -0.792 . . . . 0.0 110.224 179.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 39.3 tp -66.06 -39.11 89.83 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 119.3 0.955 . . . . 0.0 111.123 -178.218 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -65.17 -44.26 94.24 Favored Glycine 0 CA--C 1.528 0.898 0 N-CA-C 110.615 -0.994 . . . . 0.0 110.615 176.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -62.32 -38.79 90.79 Favored 'General case' 0 CA--C 1.537 0.457 0 O-C-N 122.357 -0.496 . . . . 0.0 110.152 175.381 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.616 ' HB2' ' HB3' ' A' ' 86' ' ' PHE . . . -57.72 -46.14 84.8 Favored 'General case' 0 N--CA 1.455 -0.198 0 O-C-N 121.612 -0.68 . . . . 0.0 110.183 175.039 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 17.7 t0 -72.79 -20.88 61.08 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 119.706 -0.187 . . . . 0.0 111.078 -176.286 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.525 HG13 ' HA ' ' A' ' 49' ' ' LEU . 16.8 t -73.17 -44.59 55.64 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.686 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 169.486 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 74.5 mt -62.42 -36.31 81.97 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 119.119 0.872 . . . . 0.0 109.348 178.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 39.9 m -64.51 -44.21 91.63 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-O 118.469 -0.776 . . . . 0.0 109.952 172.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.448 ' HA ' ' CD2' ' A' ' 106' ' ' PHE . . . -60.48 -40.82 92.69 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 119.896 1.226 . . . . 0.0 111.641 175.311 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.5 mt -64.4 -33.58 76.19 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 123.621 0.768 . . . . 0.0 110.042 176.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 56.0 ttt85 -72.79 -32.58 65.68 Favored 'General case' 0 CA--C 1.534 0.335 0 O-C-N 121.553 -0.717 . . . . 0.0 110.071 174.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.448 ' CD2' ' HA ' ' A' ' 103' ' ' ALA . 14.3 m-30 -68.98 -47.05 66.52 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 119.058 0.844 . . . . 0.0 110.535 178.489 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 39.7 p -73.98 -25.27 59.84 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 123.4 0.68 . . . . 0.0 111.732 -178.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 74.6 8.08 80.54 Favored Glycine 0 CA--C 1.534 1.27 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -168.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -83.94 19.38 1.76 Allowed 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 119.84 1.82 . . . . 0.0 111.049 174.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -59.98 135.81 90.45 Favored Pre-proline 0 CA--C 1.547 0.833 0 C-N-CA 124.591 1.156 . . . . 0.0 109.33 169.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_exo -59.96 163.8 13.27 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 123.553 2.835 . . . . 0.0 115.713 -177.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 36.3 mmtt -64.85 -41.91 95.31 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 113.156 0.798 . . . . 0.0 113.156 172.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 24.1 ttpp -140.93 68.7 1.34 Allowed 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 -173.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.4 tt -68.6 136.84 53.65 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 174.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -131.79 134.49 45.88 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 177.518 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -123.23 117.47 25.38 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 120.469 1.486 . . . . 0.0 108.721 -179.064 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 18.9 t -92.55 91.84 3.55 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 N-CA-C 105.589 -2.004 . . . . 0.0 105.589 172.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -81.67 150.49 29.71 Favored Glycine 0 CA--C 1.522 0.522 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 178.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 40.4 t -129.04 130.56 68.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 178.378 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 47.6 mt -83.6 131.67 51.68 Favored Pre-proline 0 CA--C 1.534 0.355 0 N-CA-C 103.519 -2.771 . . . . 0.0 103.519 169.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -78.77 178.55 7.42 Favored 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 122.589 2.193 . . . . 0.0 111.164 -177.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -97.84 -56.47 2.49 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 124.001 0.92 . . . . 0.0 108.558 168.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 63.0 m -110.27 -59.31 1.96 Allowed 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 113.72 1.007 . . . . 0.0 113.72 -169.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.2 tp 53.81 33.11 16.25 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 127.37 2.268 . . . . 0.0 114.08 -173.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -82.33 161.32 60.06 Favored Pre-proline 0 CA--C 1.541 0.624 0 O-C-N 121.443 -0.786 . . . . 0.0 109.643 175.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -81.44 89.39 1.26 Allowed 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 122.142 1.895 . . . . 0.0 112.593 -169.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -174.82 179.55 1.63 Allowed 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 103.42 -2.807 . . . . 0.0 103.42 179.612 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -132.44 162.35 39.93 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 CA-C-N 120.558 1.526 . . . . 0.0 114.952 -176.383 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 110.72 143.5 9.59 Favored Glycine 0 CA--C 1.531 1.092 0 N-CA-C 104.73 -3.348 . . . . 0.0 104.73 -168.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 88.6 mt -76.02 156.48 33.97 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 119.308 1.554 . . . . 0.0 109.642 175.141 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 34.9 p -71.67 165.04 53.03 Favored Pre-proline 0 CA--C 1.539 0.526 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 169.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -57.76 -39.94 83.21 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 C-N-CA 121.821 1.681 . . . . 0.0 111.427 173.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.446 HG22 ' HA3' ' A' ' 72' ' ' GLY . 4.1 m -64.61 -40.02 94.75 Favored 'General case' 0 N--CA 1.442 -0.866 0 C-N-CA 124.117 0.967 . . . . 0.0 110.79 -177.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 74.7 t -90.5 -30.99 5.0 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 O-C-N 121.585 -0.697 . . . . 0.0 110.597 -173.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -53.96 -46.46 71.62 Favored 'General case' 0 CA--C 1.533 0.302 0 O-C-N 121.182 -0.948 . . . . 0.0 109.341 169.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -68.05 -14.86 63.3 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 113.69 0.996 . . . . 0.0 113.69 -178.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 5.3 mmm -82.27 -12.41 58.05 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.776 1.63 . . . . 0.0 111.871 174.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 54.1 mt -54.56 -54.12 25.26 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.357 0 CA-C-N 120.576 1.535 . . . . 0.0 108.897 173.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -67.15 -47.75 50.27 Favored Pre-proline 0 CA--C 1.542 0.671 0 CA-C-O 117.556 -1.212 . . . . 0.0 110.827 -173.154 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 0.3 OUTLIER -43.3 -54.29 3.62 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 125.293 3.995 . . . . 0.0 112.819 168.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -67.97 -37.2 81.24 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.106 -0.952 . . . . 0.0 112.102 179.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 36.1 mt -61.27 -45.35 94.87 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 121.039 1.745 . . . . 0.0 109.108 175.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -58.69 -33.78 70.55 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 118.686 0.676 . . . . 0.0 110.206 177.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 68.0 tp60 -76.6 -36.69 57.35 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 121.392 -0.818 . . . . 0.0 111.914 178.216 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 46.9 t -60.86 -44.93 98.77 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 171.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 71.1 mt -61.59 -36.25 80.15 Favored 'General case' 0 C--O 1.226 -0.176 0 CA-C-O 118.9 -0.571 . . . . 0.0 110.132 176.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -67.21 -44.49 79.43 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 119.241 0.928 . . . . 0.0 111.025 176.009 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -66.77 -27.89 67.96 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 119.161 0.891 . . . . 0.0 111.708 178.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 33.2 mt -69.14 -49.89 52.83 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 170.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 16.8 mmm-85 -63.8 -21.86 66.63 Favored 'General case' 0 CA--C 1.522 -0.126 0 CA-C-O 118.058 -0.972 . . . . 0.0 112.396 -177.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -63.99 -34.29 77.65 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 119.973 1.261 . . . . 0.0 110.947 174.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 26.0 m -91.45 18.29 7.45 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 122.854 0.462 . . . . 0.0 111.573 170.109 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 70.98 16.87 75.07 Favored Glycine 0 C--N 1.337 0.623 0 CA-C-O 117.607 -1.663 . . . . 0.0 112.578 -178.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 39.0 t -90.76 118.75 36.64 Favored 'Isoleucine or valine' 0 C--N 1.347 0.459 0 CA-C-N 120.648 2.224 . . . . 0.0 106.627 -176.244 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -111.0 85.68 2.16 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 106.198 -1.779 . . . . 0.0 106.198 177.042 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -49.12 139.49 10.68 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 114.627 -1.169 . . . . 0.0 110.005 169.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 24.9 mt -91.05 125.71 57.76 Favored Pre-proline 0 CA--C 1.53 0.202 0 CA-C-O 117.331 -1.318 . . . . 0.0 108.296 -169.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -66.54 98.07 0.39 Allowed 'Trans proline' 0 CA--C 1.534 0.52 0 C-N-CA 122.673 2.249 . . . . 0.0 109.236 175.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 60.5 mtm180 49.9 14.88 0.14 Allowed 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 127.218 2.207 . . . . 0.0 115.519 -178.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 58.6 m 47.1 40.29 9.51 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.843 0.857 . . . . 0.0 111.538 -169.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -114.76 123.92 50.46 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 124.434 1.094 . . . . 0.0 108.646 175.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 20.2 m . . . . . 0 C--O 1.254 1.292 0 C-N-CA 125.333 1.453 . . . . 0.0 108.583 -177.255 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.7 tpt . . . . . 0 N--CA 1.498 1.975 0 CA-C-O 119.353 -0.356 . . . . 0.0 110.667 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 7.9 ptp180 -60.77 125.95 25.6 Favored 'General case' 0 N--CA 1.48 1.066 0 O-C-N 120.584 -1.322 . . . . 0.0 111.521 -169.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 27.0 mt -136.41 135.22 49.52 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 C-N-CA 123.171 0.588 . . . . 0.0 110.732 -172.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 8.3 mt -112.28 138.58 48.79 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 105.711 -1.959 . . . . 0.0 105.711 167.313 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 49.1 t -116.21 104.38 16.59 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.644 0 N-CA-C 103.387 -2.819 . . . . 0.0 103.387 169.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 14.5 tp -101.73 111.28 23.47 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 -168.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -88.28 127.29 8.5 Favored Glycine 0 C--N 1.331 0.304 0 N-CA-C 107.706 -2.158 . . . . 0.0 107.706 176.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -141.14 165.6 19.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 117.434 0.617 . . . . 0.0 110.958 -170.488 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 119.25 174.54 15.82 Favored Glycine 0 CA--C 1.527 0.827 0 C-N-CA 125.986 1.755 . . . . 0.0 111.259 178.111 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.507 HD21 ' HB2' ' A' ' 12' ' ' LEU . 4.6 t30 -82.88 97.6 8.75 Favored 'General case' 0 C--O 1.235 0.338 0 O-C-N 121.409 -1.053 . . . . 0.0 110.41 -175.188 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.2 pt -62.64 35.67 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 N-CA-C 116.476 2.028 . . . . 0.0 116.476 172.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.507 ' HB2' HD21 ' A' ' 10' ' ' ASN . 33.8 mt -128.67 -7.16 5.11 Favored 'General case' 0 C--O 1.223 -0.304 0 CA-C-N 120.304 1.411 . . . . 0.0 108.749 169.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.474 ' HB2' HD22 ' A' ' 10' ' ' ASN . 3.6 mp -111.4 60.19 0.61 Allowed 'General case' 0 N--CA 1.442 -0.836 0 C-N-CA 124.174 0.989 . . . . 0.0 113.407 -168.106 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.436 ' HB ' ' H ' ' A' ' 15' ' ' ASP . 0.2 OUTLIER 52.72 -102.19 0.13 Allowed 'General case' 0 C--O 1.236 0.362 0 C-N-CA 124.168 0.987 . . . . 0.0 111.265 171.393 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.436 ' H ' ' HB ' ' A' ' 14' ' ' THR . 10.3 m-20 -78.81 -11.87 60.01 Favored 'General case' 0 N--CA 1.441 -0.881 0 C-N-CA 123.715 0.806 . . . . 0.0 111.018 -173.603 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -74.35 -8.82 57.57 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 120.444 1.474 . . . . 0.0 112.232 177.291 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -77.34 -10.49 59.47 Favored 'General case' 0 N--CA 1.432 -1.327 0 CA-C-O 116.0 -1.952 . . . . 0.0 108.878 170.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.8 tp -54.48 -37.92 39.68 Favored 'Isoleucine or valine' 0 C--N 1.345 0.385 0 CA-C-N 122.212 2.278 . . . . 0.0 112.25 -169.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -60.1 -45.0 96.76 Favored Glycine 0 CA--C 1.524 0.602 0 CA-C-N 119.55 1.068 . . . . 0.0 111.599 175.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 55.3 t -69.72 -44.41 79.28 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-O 118.528 -0.749 . . . . 0.0 109.911 175.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 23.1 mmm180 -61.47 -33.66 74.14 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 120.469 1.486 . . . . 0.0 111.778 179.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 30.3 mt -62.25 -46.4 96.52 Favored 'Isoleucine or valine' 0 C--N 1.342 0.256 0 CA-C-N 120.459 1.482 . . . . 0.0 109.464 176.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 30.2 m -73.73 -27.15 22.49 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 CA-C-N 119.748 1.158 . . . . 0.0 111.522 -175.186 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 64.1 mt-10 -72.91 -44.06 61.7 Favored 'General case' 0 CA--C 1.528 0.099 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 175.078 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.57 -42.39 96.56 Favored 'General case' 0 N--CA 1.452 -0.356 0 O-C-N 121.978 -0.451 . . . . 0.0 110.586 176.124 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 5.5 tp -65.85 -40.96 92.22 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-O 118.828 -0.606 . . . . 0.0 109.913 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -61.76 -40.34 94.79 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 118.413 0.551 . . . . 0.0 111.081 177.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -71.99 -34.71 69.13 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.633 0.773 . . . . 0.0 112.068 178.196 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 36.5 mtp180 -100.17 -34.06 10.19 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 117.204 -1.379 . . . . 0.0 114.054 -169.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -121.34 138.23 54.35 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 121.464 1.938 . . . . 0.0 113.153 -170.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 39.9 mm -99.87 141.16 17.49 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 105.542 -2.021 . . . . 0.0 105.542 169.019 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.8 mt -143.49 161.35 47.52 Favored Pre-proline 0 CA--C 1.539 0.549 0 C-N-CA 126.717 2.007 . . . . 0.0 107.407 -174.065 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -55.77 156.76 17.89 Favored 'Trans proline' 0 CA--C 1.536 0.605 0 C-N-CA 123.21 2.606 . . . . 0.0 112.661 177.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -62.46 -27.29 69.02 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 -170.069 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 10.9 p90 -76.36 -2.23 30.77 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 179.109 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 22.0 t -104.26 130.27 55.26 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 175.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -131.85 135.57 46.8 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 174.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.669 HD12 ' H ' ' A' ' 38' ' ' ILE . 0.1 OUTLIER -94.84 106.19 17.86 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 N-CA-C 105.744 -1.947 . . . . 0.0 105.744 171.089 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 53.2 tp -105.74 126.14 51.81 Favored 'General case' 0 C--N 1.343 0.307 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 -174.444 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -80.17 117.92 21.4 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 122.989 0.515 . . . . 0.0 109.754 171.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -77.86 -83.54 0.56 Allowed Glycine 0 CA--C 1.528 0.872 0 N-CA-C 107.408 -2.277 . . . . 0.0 107.408 169.249 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 79.84 110.96 0.26 Allowed Glycine 0 C--N 1.343 0.94 0 N-CA-C 111.05 -0.82 . . . . 0.0 111.05 178.329 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.3 p 52.59 61.05 3.39 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.839 1.256 . . . . 0.0 109.085 175.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -120.18 -84.78 0.66 Allowed 'General case' 0 C--N 1.344 0.344 0 CA-C-N 114.43 -1.259 . . . . 0.0 111.026 -169.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 71.09 -93.25 0.5 Allowed Glycine 0 C--N 1.338 0.668 0 N-CA-C 108.491 -1.843 . . . . 0.0 108.491 -170.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 27.7 tpp -78.61 -22.5 46.91 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 124.125 0.97 . . . . 0.0 112.322 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -63.02 -14.23 45.41 Favored 'General case' 0 CA--C 1.547 0.833 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 -169.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 28.8 mt -101.87 13.43 34.83 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.882 0.873 . . . . 0.0 112.843 -174.02 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.598 ' HA ' HG13 ' A' ' 100' ' ' VAL . 4.3 tt -41.6 -61.44 1.08 Allowed 'General case' 0 C--N 1.344 0.338 0 C-N-CA 124.177 0.991 . . . . 0.0 113.152 -175.513 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -75.82 -34.67 47.66 Favored Glycine 0 CA--C 1.524 0.608 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.15 -173.189 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -64.35 -34.08 77.33 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 117.549 0.675 . . . . 0.0 111.353 179.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.441 ' SD ' HG11 ' A' ' 100' ' ' VAL . 51.7 mtp -72.7 -13.3 61.31 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 111.911 0.337 . . . . 0.0 111.911 179.442 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -85.32 160.63 19.77 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 123.341 0.656 . . . . 0.0 110.414 -176.56 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 29.2 m120 59.26 19.44 7.56 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.642 1.577 . . . . 0.0 113.845 172.197 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 20.4 mmt180 -94.37 151.54 19.32 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 106.388 -1.708 . . . . 0.0 106.388 169.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -89.2 -35.83 15.99 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 -179.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 12.6 t-160 -142.14 128.78 20.34 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 105.849 -1.908 . . . . 0.0 105.849 179.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 6.5 tp -134.86 128.56 32.9 Favored 'General case' 0 CA--C 1.508 -0.669 0 N-CA-C 108.984 -0.746 . . . . 0.0 108.984 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 44.6 mt -106.98 108.98 26.51 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 N-CA-C 105.199 -2.148 . . . . 0.0 105.199 -179.212 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.6 mm -78.32 128.91 38.12 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 N-CA-C 105.25 -2.13 . . . . 0.0 105.25 175.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -112.33 116.66 30.72 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 104.703 -2.332 . . . . 0.0 104.703 169.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -155.35 169.6 23.83 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 118.174 0.443 . . . . 0.0 110.19 -177.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -88.31 156.99 18.88 Favored 'General case' 0 CA--C 1.534 0.351 0 O-C-N 121.921 -0.487 . . . . 0.0 109.858 169.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 87.6 mt -115.05 113.94 45.05 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.104 1 N-CA-C 99.939 -4.097 . . . . 0.0 99.939 168.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 67.1 t -65.36 -37.86 81.13 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 N-CA-C 113.442 0.904 . . . . 0.0 113.442 -168.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 15.2 m -151.43 152.42 33.02 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 119.238 0.926 . . . . 0.0 111.483 173.236 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 26.7 tptt -158.68 -177.44 6.53 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.593 1.957 . . . . 0.0 106.512 169.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.2 42.13 0.97 Allowed 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.742 0.817 . . . . 0.0 110.472 -178.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 33.6 t-20 -143.83 160.88 39.98 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.826 1.25 . . . . 0.0 109.215 -170.098 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.6 m -64.59 146.66 98.18 Favored Pre-proline 0 CA--C 1.548 0.871 0 C-N-CA 124.344 1.058 . . . . 0.0 111.847 -169.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -58.6 153.54 48.23 Favored 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 122.713 2.275 . . . . 0.0 111.426 169.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 68.33 16.0 68.66 Favored Glycine 0 CA--C 1.532 1.114 0 CA-C-O 118.711 -1.049 . . . . 0.0 114.345 177.166 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 25.9 m -96.36 152.34 18.68 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 119.0 1.4 . . . . 0.0 109.627 179.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 18.8 ttp -95.78 145.07 25.62 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 123.614 0.766 . . . . 0.0 110.372 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 10.3 ttm -136.51 121.95 19.45 Favored 'General case' 0 CA--C 1.528 0.127 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 44.6 mm -109.15 122.47 63.86 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 -177.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -121.1 131.66 54.4 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 -171.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 74.5 mtm180 -100.78 176.14 5.4 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.496 0.718 . . . . 0.0 110.551 -176.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -46.74 -47.19 20.68 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 115.99 1.848 . . . . 0.0 115.99 -169.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -78.91 -18.23 54.21 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 119.242 0.928 . . . . 0.0 112.248 -178.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -90.59 -33.12 16.0 Favored 'General case' 0 N--CA 1.457 -0.119 0 C-N-CA 123.606 0.762 . . . . 0.0 110.754 -169.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -70.36 -37.6 7.27 Favored Pre-proline 0 CA--C 1.539 0.525 0 CA-C-O 117.233 -1.365 . . . . 0.0 113.242 -177.036 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_exo -56.26 -25.93 58.75 Favored 'Trans proline' 0 CA--C 1.54 0.781 0 CA-C-N 121.768 1.667 . . . . 0.0 112.21 169.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -92.4 7.62 42.13 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 124.492 1.117 . . . . 0.0 112.68 177.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -126.53 -42.39 1.81 Allowed 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.512 0.725 . . . . 0.0 112.509 -172.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.461 ' HB3' ' HB2' ' A' ' 98' ' ' ALA . 74.0 m-85 -61.85 -11.1 11.09 Favored 'General case' 0 CA--C 1.551 1.017 0 CA-C-N 119.47 1.032 . . . . 0.0 111.39 175.447 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 64.3 p -59.54 -27.55 66.3 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.946 1.698 . . . . 0.0 113.857 -177.021 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -63.75 139.83 58.81 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 121.347 0.594 . . . . 0.0 110.78 -170.272 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -76.13 -21.66 56.35 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 122.658 0.383 . . . . 0.0 111.861 -176.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 97.3 mt -72.42 -26.72 24.76 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 C-N-CA 124.28 1.032 . . . . 0.0 110.318 -170.174 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 9.9 m -102.85 84.47 0.66 Allowed Pre-proline 0 CA--C 1.55 0.962 0 C-N-CA 126.084 1.753 . . . . 0.0 108.63 174.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -70.61 -38.27 6.15 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 123.003 2.469 . . . . 0.0 114.364 -169.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 11.1 m80 -68.71 -39.75 80.32 Favored 'General case' 0 N--CA 1.468 0.441 0 O-C-N 121.055 -1.028 . . . . 0.0 108.81 179.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 16.9 mp0 -66.09 -36.55 83.48 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 125.169 1.388 . . . . 0.0 109.253 177.229 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 59.0 tp -62.01 -35.27 78.04 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 119.431 1.014 . . . . 0.0 110.969 171.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -60.51 -39.27 96.15 Favored Glycine 0 CA--C 1.532 1.116 0 O-C-N 121.392 -0.817 . . . . 0.0 111.069 171.087 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 8.8 tt -75.21 -23.97 57.68 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 117.549 0.675 . . . . 0.0 110.704 175.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.461 ' HB2' ' HB3' ' A' ' 86' ' ' PHE . . . -61.02 -43.72 98.47 Favored 'General case' 0 C--O 1.226 -0.17 0 CA-C-N 119.443 1.02 . . . . 0.0 108.666 169.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -69.77 -21.32 63.44 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 119.03 -0.509 . . . . 0.0 110.747 176.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.598 HG13 ' HA ' ' A' ' 49' ' ' LEU . 73.1 t -69.77 -40.89 79.65 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 168.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 5.3 mp -60.98 -36.64 79.97 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 120.973 1.715 . . . . 0.0 110.492 175.021 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 17.0 m -63.46 -45.26 91.64 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 118.286 0.494 . . . . 0.0 109.873 172.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -65.39 -38.77 90.99 Favored 'General case' 0 N--CA 1.452 -0.366 0 O-C-N 121.563 -0.711 . . . . 0.0 111.505 -179.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 21.7 mt -59.97 -39.59 86.17 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 125.143 1.377 . . . . 0.0 109.832 173.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 52.6 tpt85 -70.64 -33.35 70.89 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 118.037 -0.982 . . . . 0.0 110.484 175.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 15.5 m-30 -68.38 -42.11 79.57 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 119.646 1.112 . . . . 0.0 110.402 178.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 63.9 p -73.25 -26.78 61.25 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 118.561 0.619 . . . . 0.0 110.515 177.247 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 76.91 6.55 85.76 Favored Glycine 0 CA--C 1.532 1.138 0 CA-C-O 119.182 -0.788 . . . . 0.0 111.599 -169.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -96.06 19.73 11.22 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 118.603 1.202 . . . . 0.0 110.809 -175.133 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -55.82 135.37 72.62 Favored Pre-proline 0 CA--C 1.543 0.694 0 C-N-CA 126.624 1.969 . . . . 0.0 109.752 174.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_exo -56.04 152.74 35.57 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 123.259 2.639 . . . . 0.0 114.796 179.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 8.7 tttt -64.36 -33.27 75.45 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 119.001 -0.523 . . . . 0.0 110.302 177.033 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 63.1 tttm -139.82 97.46 3.26 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 -178.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -83.62 132.58 34.89 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 106.495 -1.669 . . . . 0.0 106.495 169.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -134.22 148.78 50.92 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 176.779 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.8 tt -135.05 133.87 39.8 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 120.177 1.353 . . . . 0.0 110.504 174.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 60.8 t -103.01 103.43 15.08 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 N-CA-C 103.665 -2.717 . . . . 0.0 103.665 169.095 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -92.85 151.91 20.74 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 111.121 -0.792 . . . . 0.0 111.121 177.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 47.1 t -138.95 136.35 42.73 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 N-CA-C 107.705 -1.221 . . . . 0.0 107.705 178.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 32.1 mt -88.73 131.64 41.01 Favored Pre-proline 0 CA--C 1.546 0.802 0 CA-C-N 119.812 1.187 . . . . 0.0 108.961 177.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -75.16 173.55 14.32 Favored 'Trans proline' 0 CA--C 1.543 0.932 0 C-N-CA 124.978 3.785 . . . . 0.0 113.228 -177.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -116.15 -57.35 2.22 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.836 0.855 . . . . 0.0 110.718 179.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 63.4 m -107.07 -51.89 2.85 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 118.54 0.609 . . . . 0.0 112.609 -172.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 57.25 46.71 18.18 Favored 'General case' 0 CA--C 1.552 1.044 0 N-CA-C 114.776 1.399 . . . . 0.0 114.776 172.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -116.38 165.22 15.53 Favored Pre-proline 0 N--CA 1.478 0.962 0 O-C-N 121.155 -0.966 . . . . 0.0 109.618 177.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -66.09 90.89 0.26 Allowed 'Trans proline' 0 CA--C 1.547 1.125 0 C-N-CA 122.868 2.378 . . . . 0.0 112.931 -179.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -176.98 145.24 0.47 Allowed 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 103.91 -2.626 . . . . 0.0 103.91 173.491 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -107.42 165.79 4.3 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 CA-C-N 119.376 0.989 . . . . 0.0 113.319 -169.539 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 85.3 153.81 21.29 Favored Glycine 0 C--N 1.341 0.845 0 N-CA-C 108.11 -1.996 . . . . 0.0 108.11 -169.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.418 HD22 ' H ' ' A' ' 130' ' ' LEU . 0.7 OUTLIER -81.74 163.32 22.51 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-O 121.585 0.707 . . . . 0.0 109.108 -172.529 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 39.5 p -69.19 169.32 12.06 Favored Pre-proline 0 C--O 1.238 0.467 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 168.104 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_exo -55.1 -32.2 78.63 Favored 'Trans proline' 0 CA--C 1.541 0.84 0 C-N-CA 121.469 1.446 . . . . 0.0 110.693 169.196 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 26.5 m -67.09 -44.73 79.26 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 118.992 -0.528 . . . . 0.0 111.419 179.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 4.6 t -101.06 -11.41 8.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 CA-C-N 119.645 1.111 . . . . 0.0 111.624 -169.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -59.04 -45.69 90.12 Favored 'General case' 0 CA--C 1.518 -0.27 0 O-C-N 119.938 -1.726 . . . . 0.0 107.322 169.016 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -71.24 4.63 2.69 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-O 118.482 -0.771 . . . . 0.0 112.406 178.104 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 26.2 mmm -95.57 -10.54 29.3 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 118.127 -0.94 . . . . 0.0 111.282 170.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 57.0 mt -59.9 -46.99 93.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-N 119.31 0.959 . . . . 0.0 108.554 178.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -72.15 -53.05 6.81 Favored Pre-proline 0 CA--C 1.536 0.422 0 CA-C-O 117.286 -1.34 . . . . 0.0 113.05 -171.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -60.02 -35.26 93.62 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 CA-C-N 122.244 1.837 . . . . 0.0 111.256 176.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.28 -43.01 71.31 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 118.84 0.745 . . . . 0.0 110.538 -179.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.05 -37.21 86.6 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 119.695 1.134 . . . . 0.0 109.782 176.34 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -62.36 -35.94 80.69 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 119.05 -0.5 . . . . 0.0 110.783 175.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 35.1 mm-40 -76.31 -29.5 57.34 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 119.152 0.887 . . . . 0.0 111.627 175.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 38.2 t -61.55 -45.42 98.68 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 CA-C-N 120.065 1.302 . . . . 0.0 108.478 169.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 72.8 mt -63.75 -39.03 93.28 Favored 'General case' 0 C--N 1.341 0.206 0 CA-C-N 118.05 0.386 . . . . 0.0 110.207 176.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -60.4 -41.28 93.53 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 118.906 0.776 . . . . 0.0 111.39 177.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -62.35 -47.38 84.46 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 119.233 0.924 . . . . 0.0 111.038 178.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . 0.297 4.2 pp -67.78 -22.23 65.21 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 118.576 0.626 . . . . 0.0 112.48 177.426 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 61.8 mtt180 -71.22 -26.31 62.87 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 117.822 -1.085 . . . . 0.0 111.821 169.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -59.85 -38.0 80.84 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 120.625 1.557 . . . . 0.0 109.42 174.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 11.3 p -87.39 14.81 7.36 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.549 1.14 . . . . 0.0 112.946 178.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 75.52 19.76 79.05 Favored Glycine 0 CA--C 1.534 1.268 0 CA-C-O 118.704 -1.054 . . . . 0.0 114.597 175.296 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 15.1 t -102.47 146.32 10.67 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 CA-C-N 118.97 1.385 . . . . 0.0 107.805 178.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -134.54 143.78 47.61 Favored 'General case' 0 C--O 1.236 0.392 0 O-C-N 121.096 -1.002 . . . . 0.0 108.929 176.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -94.74 160.52 14.57 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 124.991 1.316 . . . . 0.0 111.518 178.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.407 ' CG2' ' HA ' ' A' ' 160' ' ' SER . 46.1 mt -124.07 130.76 24.27 Favored Pre-proline 0 CA--C 1.533 0.307 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 171.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -57.48 110.2 0.58 Allowed 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.561 2.174 . . . . 0.0 109.03 170.053 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 50.05 21.6 0.77 Allowed 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.628 1.571 . . . . 0.0 114.447 177.188 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . 0.407 ' HA ' ' CG2' ' A' ' 157' ' ' ILE . 1.1 m 46.11 36.46 3.15 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.424 1.09 . . . . 0.0 112.575 -169.563 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -72.43 143.66 48.41 Favored 'General case' 0 C--O 1.239 0.547 0 O-C-N 121.382 -0.824 . . . . 0.0 109.983 178.251 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 14.1 m . . . . . 0 C--O 1.254 1.309 0 C-N-CA 124.578 1.151 . . . . 0.0 111.014 -174.118 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.1 tpt . . . . . 0 N--CA 1.496 1.861 0 CA-C-O 119.503 -0.284 . . . . 0.0 110.298 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 8.3 ptp180 -139.33 121.97 16.34 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 173.139 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 72.7 mt -138.9 133.21 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 CA-C-N 119.332 0.969 . . . . 0.0 111.169 -169.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -115.2 129.74 56.73 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 105.951 -1.87 . . . . 0.0 105.951 168.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.424 HG12 HG12 ' A' ' 23' ' ' VAL . 21.8 t -104.43 105.49 18.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 101.905 -3.369 . . . . 0.0 101.905 169.351 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 13.0 tp -109.45 104.26 13.31 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 124.533 1.133 . . . . 0.0 110.033 -167.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -91.26 129.85 10.0 Favored Glycine 0 N--CA 1.452 -0.297 0 N-CA-C 106.603 -2.599 . . . . 0.0 106.603 175.083 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 1.4 m -135.32 -28.34 0.48 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.208 0 N-CA-C 117.819 2.525 . . . . 0.0 117.819 -168.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -52.25 151.41 7.65 Favored Glycine 0 CA--C 1.527 0.783 0 CA-C-O 122.22 0.9 . . . . 0.0 114.715 -169.304 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.411 HD21 ' HB2' ' A' ' 12' ' ' LEU . 5.1 t30 -61.76 102.39 0.26 Allowed 'General case' 0 N--CA 1.455 -0.225 0 C-N-CA 125.334 1.453 . . . . 0.0 112.372 -169.234 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.2 pt -76.76 40.97 0.02 OUTLIER 'Isoleucine or valine' 0 C--O 1.222 -0.38 0 C-N-CA 123.93 0.892 . . . . 0.0 113.311 -177.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.411 ' HB2' HD21 ' A' ' 10' ' ' ASN . 19.9 mt -128.11 -7.83 5.4 Favored 'General case' 0 CA--C 1.536 0.429 0 O-C-N 121.177 -0.952 . . . . 0.0 109.018 170.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.3 mp -124.51 67.24 1.08 Allowed 'General case' 0 C--N 1.346 0.417 0 C-N-CA 124.167 0.987 . . . . 0.0 109.235 -168.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.468 ' HB ' ' H ' ' A' ' 15' ' ' ASP . 1.4 m 46.91 -103.16 0.08 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 114.378 -1.283 . . . . 0.0 112.891 171.305 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.468 ' H ' ' HB ' ' A' ' 14' ' ' THR . 4.1 m-20 -62.95 -26.33 68.77 Favored 'General case' 0 N--CA 1.438 -1.056 0 C-N-CA 125.998 1.719 . . . . 0.0 111.598 -171.589 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -72.0 -18.79 61.95 Favored 'General case' 0 C--O 1.231 0.101 0 CA-C-N 120.019 1.281 . . . . 0.0 112.003 -174.022 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.86 -15.49 42.73 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-O 117.022 -1.466 . . . . 0.0 111.152 170.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.7 tp -54.2 -37.98 37.61 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 CA-C-N 120.831 1.65 . . . . 0.0 111.136 -174.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -59.54 -43.99 97.14 Favored Glycine 0 CA--C 1.527 0.834 0 N-CA-C 111.244 -0.743 . . . . 0.0 111.244 178.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 74.0 t -70.82 -45.78 71.81 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 176.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 20.0 mmt180 -61.43 -31.71 71.66 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 117.093 -1.432 . . . . 0.0 112.21 -178.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 19.9 mt -58.89 -49.49 82.87 Favored 'Isoleucine or valine' 0 C--N 1.34 0.157 0 CA-C-N 121.286 1.857 . . . . 0.0 109.299 174.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.424 HG12 HG12 ' A' ' 5' ' ' VAL . 30.4 m -73.32 -34.13 42.83 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 CA-C-N 119.762 1.164 . . . . 0.0 111.111 -173.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 59.4 mt-10 -64.88 -42.15 95.05 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 118.403 0.547 . . . . 0.0 110.322 173.041 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -68.24 -36.53 79.61 Favored 'General case' 0 C--N 1.34 0.184 0 CA-C-N 118.981 0.809 . . . . 0.0 110.014 179.363 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.3 tp -65.46 -36.16 83.07 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 118.64 0.654 . . . . 0.0 109.887 -177.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -61.57 -24.16 66.47 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.353 0.661 . . . . 0.0 112.72 179.18 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 -98.85 -39.77 8.43 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 126.45 1.9 . . . . 0.0 110.771 -176.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 21.8 mmt85 -85.02 -32.18 23.06 Favored 'General case' 0 C--N 1.338 0.085 0 CA-C-O 119.449 -0.31 . . . . 0.0 110.242 -173.328 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 71.5 m-85 -122.02 151.01 41.29 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-O 122.33 1.062 . . . . 0.0 111.826 -176.066 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 37.0 mt -107.06 134.45 48.7 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 N-CA-C 104.223 -2.51 . . . . 0.0 104.223 169.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -120.13 150.03 50.45 Favored Pre-proline 0 C--O 1.236 0.357 0 C-N-CA 124.005 0.922 . . . . 0.0 110.366 -169.114 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_endo -67.52 156.77 64.73 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 121.977 1.785 . . . . 0.0 108.726 168.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -55.75 -33.25 64.12 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 114.491 1.293 . . . . 0.0 114.491 -169.386 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 17.0 p90 -78.75 -13.2 59.94 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 118.474 -0.774 . . . . 0.0 112.743 -175.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 95.5 t -89.82 121.71 40.34 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 169.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -122.62 125.22 45.2 Favored 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 173.233 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -81.33 126.63 39.85 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 N-CA-C 106.067 -1.827 . . . . 0.0 106.067 167.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 64.4 tp -125.53 132.94 52.51 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 171.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -88.85 116.92 27.48 Favored 'General case' 0 C--O 1.236 0.395 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 169.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -76.17 -74.37 0.94 Allowed Glycine 0 CA--C 1.529 0.916 0 N-CA-C 108.335 -1.906 . . . . 0.0 108.335 169.241 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 85.76 98.0 0.75 Allowed Glycine 0 C--N 1.343 0.925 0 N-CA-C 109.729 -1.348 . . . . 0.0 109.729 176.048 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 16.8 p 62.97 16.65 9.42 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.24 1.416 . . . . 0.0 113.378 179.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -70.18 -59.96 2.57 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 114.298 1.222 . . . . 0.0 114.298 -168.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.4 ' H ' ' HE2' ' A' ' 93' ' ' HIS . . . 60.07 -117.09 10.2 Favored Glycine 0 CA--C 1.529 0.91 0 N-CA-C 108.691 -1.764 . . . . 0.0 108.691 -170.321 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 9.4 tpt -62.22 -21.86 65.48 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.512 1.125 . . . . 0.0 113.68 -173.273 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -60.19 -19.28 53.39 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 -171.087 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 10.0 mt -98.18 20.67 12.03 Favored 'General case' 0 C--N 1.345 0.392 0 CA-C-N 119.522 1.055 . . . . 0.0 113.663 -169.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.586 ' HA ' HG13 ' A' ' 100' ' ' VAL . 6.4 tt -50.5 -57.71 7.45 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 118.988 0.813 . . . . 0.0 110.988 -178.359 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -64.98 -30.08 77.08 Favored Glycine 0 CA--C 1.53 0.975 0 CA-C-O 119.296 -0.725 . . . . 0.0 112.584 -177.094 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -79.72 -36.38 37.5 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 118.413 1.107 . . . . 0.0 112.33 -178.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.53 ' SD ' HG11 ' A' ' 100' ' ' VAL . 55.4 mtp -76.25 -28.79 57.26 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 179.219 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.46 157.55 31.76 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 121.96 0.886 . . . . 0.0 110.803 175.079 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 62.14 16.49 8.35 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.377 1.471 . . . . 0.0 114.307 169.6 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 24.6 mmt180 -93.89 154.73 17.55 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 172.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -83.95 -34.91 24.33 Favored 'General case' 0 C--O 1.217 -0.642 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 169.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 4.5 t-160 -144.41 129.06 18.17 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 105.512 -2.033 . . . . 0.0 105.512 -169.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 22.8 tp -134.13 117.87 17.04 Favored 'General case' 0 CA--C 1.499 -1.003 0 N-CA-C 103.434 -2.802 . . . . 0.0 103.434 -173.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 65.7 mt -100.58 107.86 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 N-CA-C 103.907 -2.627 . . . . 0.0 103.907 171.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.571 HG22 HD23 ' A' ' 116' ' ' LEU . 63.8 mt -81.2 140.6 16.35 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 N-CA-C 105.885 -1.894 . . . . 0.0 105.885 172.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -120.72 113.18 19.83 Favored 'General case' 0 N--CA 1.446 -0.625 0 N-CA-C 103.635 -2.728 . . . . 0.0 103.635 168.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.407 ' CG ' HE21 ' A' ' 94' ' ' GLN . 38.6 t0 -155.93 157.64 36.62 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 123.574 0.75 . . . . 0.0 109.587 -176.22 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -83.68 149.92 26.19 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 174.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 8.1 mt -76.67 -32.59 20.95 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 C-N-CA 123.731 0.812 . . . . 0.0 110.109 174.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . 0.354 3.3 t 58.49 46.92 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.943 0 C-N-CA 126.148 1.779 . . . . 0.0 112.188 -173.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 8.1 m 63.46 145.28 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 128.327 2.651 . . . . 0.0 118.124 168.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -139.35 -88.34 0.21 Allowed 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 169.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -140.05 31.08 1.99 Allowed 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.56 1.144 . . . . 0.0 111.02 -176.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -134.31 165.22 25.64 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.095 0.958 . . . . 0.0 110.69 -174.289 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 2.8 m -64.87 148.5 97.4 Favored Pre-proline 0 CA--C 1.548 0.867 0 C-N-CA 124.439 1.096 . . . . 0.0 113.071 -169.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_exo -57.05 154.74 31.75 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 124.607 3.538 . . . . 0.0 112.425 169.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 67.04 11.46 58.58 Favored Glycine 0 CA--C 1.532 1.124 0 CA-C-O 119.065 -0.853 . . . . 0.0 113.943 173.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 10.6 m -90.22 140.68 29.45 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 119.146 1.473 . . . . 0.0 109.476 -175.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 28.8 ttp -86.07 142.95 28.35 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 169.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 7.0 ttm -131.53 134.23 45.89 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 169.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 4.9 mm -95.75 121.91 46.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 105.573 -2.01 . . . . 0.0 105.573 176.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.7 mp -116.37 128.86 55.89 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 173.385 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 22.2 mtp85 -88.53 177.72 6.72 Favored 'General case' 0 CA--C 1.528 0.103 0 O-C-N 123.824 0.703 . . . . 0.0 110.602 178.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -42.24 -50.97 4.88 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 115.336 1.606 . . . . 0.0 115.336 -169.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -86.27 -14.76 42.78 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -175.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -82.18 -36.64 27.13 Favored 'General case' 0 CA--C 1.523 -0.078 0 O-C-N 121.597 -0.69 . . . . 0.0 110.424 -169.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.476 HG12 ' CZ ' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -65.09 -47.86 71.77 Favored Pre-proline 0 CA--C 1.539 0.534 0 CA-C-O 117.397 -1.287 . . . . 0.0 113.454 -175.27 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -53.35 -44.36 49.65 Favored 'Trans proline' 0 C--N 1.352 0.739 0 C-N-CA 121.935 1.757 . . . . 0.0 110.697 174.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -70.22 -13.23 62.09 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 114.142 1.164 . . . . 0.0 114.142 178.385 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -95.27 -42.64 8.44 Favored 'General case' 0 C--N 1.343 0.323 0 CA-C-N 120.181 1.355 . . . . 0.0 110.558 -177.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.501 ' CB ' ' HB2' ' A' ' 98' ' ' ALA . 26.5 m-85 -69.01 0.98 3.84 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 -172.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 61.6 p -58.65 -27.85 65.15 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.137 0.975 . . . . 0.0 110.346 169.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 56.8 t-20 -51.52 117.19 2.48 Favored 'General case' 0 C--N 1.345 0.406 0 C-N-CA 124.137 0.975 . . . . 0.0 111.311 -179.329 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -77.22 -17.0 58.81 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 118.717 -0.659 . . . . 0.0 112.439 -174.289 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 40.2 mt -61.66 -41.13 89.19 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 178.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.5 m -83.18 105.11 4.6 Favored Pre-proline 0 CA--C 1.545 0.777 0 C-N-CA 126.683 1.993 . . . . 0.0 110.523 -169.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -71.95 -61.72 0.05 OUTLIER 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 122.186 1.924 . . . . 0.0 113.181 -169.118 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . 0.4 ' HE2' ' H ' ' A' ' 45' ' ' GLY . 10.4 t-80 -56.73 -41.66 77.88 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 121.75 0.786 . . . . 0.0 110.46 178.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.407 HE21 ' CG ' ' A' ' 62' ' ' ASP . 20.8 mp0 -61.36 -33.13 73.13 Favored 'General case' 0 N--CA 1.433 -1.287 0 CA-C-N 115.08 -0.964 . . . . 0.0 108.939 -175.074 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.426 ' O ' ' HB3' ' A' ' 98' ' ' ALA . 1.5 tt -63.13 -46.3 87.94 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 119.457 1.026 . . . . 0.0 108.804 177.594 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -61.69 -37.32 94.05 Favored Glycine 0 CA--C 1.532 1.14 0 O-C-N 121.089 -1.007 . . . . 0.0 111.014 175.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 54.6 tp -67.96 -30.92 70.33 Favored 'General case' 0 CA--C 1.535 0.382 0 O-C-N 121.755 -0.85 . . . . 0.0 110.353 175.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.501 ' HB2' ' CB ' ' A' ' 86' ' ' PHE . . . -60.26 -45.64 92.59 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 172.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 34.0 t0 -63.59 -28.97 70.29 Favored 'General case' 0 C--O 1.238 0.497 0 O-C-N 123.633 0.583 . . . . 0.0 110.592 -178.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.586 HG13 ' HA ' ' A' ' 49' ' ' LEU . 41.8 t -65.49 -50.2 73.69 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 CA-C-N 118.866 0.757 . . . . 0.0 110.126 169.71 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 33.6 mt -67.26 -31.52 71.92 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 119.202 0.91 . . . . 0.0 110.844 -174.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 48.8 m -64.52 -44.34 91.17 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 119.391 0.996 . . . . 0.0 109.838 169.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.448 ' HA ' ' CD2' ' A' ' 106' ' ' PHE . . . -62.54 -39.51 93.84 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 119.723 1.147 . . . . 0.0 111.276 177.095 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -63.23 -35.25 79.72 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 123.325 0.65 . . . . 0.0 109.819 175.476 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 73.6 ttt-85 -71.66 -31.42 66.79 Favored 'General case' 0 CA--C 1.535 0.39 0 O-C-N 121.554 -0.716 . . . . 0.0 109.937 176.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.448 ' CD2' ' HA ' ' A' ' 103' ' ' ALA . 12.3 m-30 -69.99 -46.47 65.08 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 119.143 0.883 . . . . 0.0 110.702 176.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 35.6 p -74.04 -27.19 60.81 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 122.993 0.517 . . . . 0.0 111.874 -176.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 75.11 7.37 81.81 Favored Glycine 0 CA--C 1.533 1.211 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 -168.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -84.57 16.27 3.29 Favored 'General case' 0 C--N 1.349 0.557 0 CA-C-N 119.734 1.767 . . . . 0.0 111.302 174.129 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -56.18 137.9 73.94 Favored Pre-proline 0 CA--C 1.542 0.668 0 C-N-CA 125.676 1.59 . . . . 0.0 109.895 170.108 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -62.72 160.24 33.64 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 122.475 2.117 . . . . 0.0 115.695 -176.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 23.7 mmtm -61.01 -40.99 95.67 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 169.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 23.6 ttpp -142.46 73.18 1.4 Allowed 'General case' 0 C--O 1.236 0.356 0 C-N-CA 123.825 0.85 . . . . 0.0 108.972 -172.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 15.2 tp -68.25 137.53 54.82 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 169.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.11 142.75 47.62 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 106.098 -1.815 . . . . 0.0 106.098 174.209 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.571 HD23 HG22 ' A' ' 60' ' ' ILE . 0.5 OUTLIER -130.08 121.62 26.75 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 120.503 1.502 . . . . 0.0 109.055 176.03 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.428 ' N ' HD22 ' A' ' 116' ' ' LEU . 13.1 t -85.97 87.86 2.63 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 N-CA-C 106.401 -1.703 . . . . 0.0 106.401 173.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -80.96 143.86 24.52 Favored Glycine 0 C--N 1.336 0.56 0 N-CA-C 110.005 -1.238 . . . . 0.0 110.005 -176.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 22.0 t -130.91 134.94 61.04 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.15 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 177.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 36.7 mt -93.63 133.22 28.41 Favored Pre-proline 0 CA--C 1.539 0.552 0 CA-C-N 119.595 1.089 . . . . 0.0 108.106 178.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -78.39 166.54 24.1 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 122.779 2.32 . . . . 0.0 112.372 -174.388 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -99.77 -50.42 4.04 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.93 0.892 . . . . 0.0 109.644 169.056 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 72.2 m -114.58 -55.16 2.52 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 113.82 1.044 . . . . 0.0 113.82 -169.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER 52.96 42.41 32.18 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 126.564 1.946 . . . . 0.0 112.93 -175.584 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -105.03 165.71 12.74 Favored Pre-proline 0 CA--C 1.542 0.653 0 C-N-CA 123.615 0.766 . . . . 0.0 109.917 178.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -80.94 85.72 1.76 Allowed 'Trans proline' 0 CA--C 1.538 0.722 0 C-N-CA 121.948 1.765 . . . . 0.0 112.977 -169.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -176.05 148.88 0.85 Allowed 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 103.609 -2.738 . . . . 0.0 103.609 178.466 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -110.84 168.63 4.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 CA-C-N 119.718 1.145 . . . . 0.0 113.973 -169.003 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 95.4 145.85 19.68 Favored Glycine 0 C--N 1.34 0.78 0 N-CA-C 106.022 -2.831 . . . . 0.0 106.022 -168.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.534 HD22 ' H ' ' A' ' 130' ' ' LEU . 1.4 mm? -73.66 163.54 27.86 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 119.339 1.569 . . . . 0.0 110.379 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 43.0 p -73.06 168.39 25.23 Favored Pre-proline 0 CA--C 1.539 0.54 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 168.391 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -57.13 -35.65 98.96 Favored 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 121.532 1.488 . . . . 0.0 111.185 172.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 99.0 m -66.93 -33.27 75.22 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 124.401 1.081 . . . . 0.0 111.293 -178.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 84.4 t -103.82 -27.55 3.17 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 CA-C-N 118.329 0.513 . . . . 0.0 111.608 -172.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -52.78 -49.28 65.87 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 119.346 0.975 . . . . 0.0 109.27 169.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -62.02 -19.59 63.02 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 4.0 mmm -80.63 -7.4 59.27 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-O 118.436 -0.792 . . . . 0.0 112.4 -179.121 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 71.4 mt -55.69 -51.99 52.97 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.235 0 CA-C-N 119.147 0.885 . . . . 0.0 109.072 172.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -71.36 -43.63 12.57 Favored Pre-proline 0 CA--C 1.535 0.38 0 CA-C-O 116.794 -1.574 . . . . 0.0 113.531 -169.052 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -55.95 -42.82 62.92 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 CA-C-N 121.994 1.748 . . . . 0.0 111.199 169.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.07 -40.09 94.18 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-O 119.004 -0.522 . . . . 0.0 111.959 178.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 74.1 mt -60.32 -45.91 91.74 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 119.589 1.086 . . . . 0.0 108.82 174.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -57.73 -35.28 70.48 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 118.74 0.7 . . . . 0.0 110.687 175.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.62 -44.42 93.98 Favored 'General case' 0 N--CA 1.446 -0.635 0 O-C-N 121.589 -0.695 . . . . 0.0 111.522 173.529 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 63.8 t -57.87 -46.04 87.41 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 N-CA-C 108.245 -1.021 . . . . 0.0 108.245 175.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 13.9 mt -57.9 -42.63 85.12 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 119.439 1.018 . . . . 0.0 110.072 178.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -68.72 -44.44 73.88 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 118.481 -0.771 . . . . 0.0 111.216 -178.014 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -64.62 -32.5 74.19 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 119.702 1.137 . . . . 0.0 110.811 178.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 80.2 mt -64.11 -47.94 78.04 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 170.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 70.9 mtp85 -62.92 -20.91 65.64 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 117.943 -1.027 . . . . 0.0 112.598 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 91.5 mt-10 -63.07 -36.39 83.41 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 120.475 1.489 . . . . 0.0 110.423 173.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 46.4 m -88.87 13.68 12.12 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.511 0.724 . . . . 0.0 111.668 170.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 70.4 21.82 77.53 Favored Glycine 0 CA--C 1.524 0.629 0 CA-C-O 117.877 -1.513 . . . . 0.0 112.434 -177.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 61.4 t -97.05 123.0 49.16 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 CA-C-N 120.089 1.944 . . . . 0.0 105.957 -175.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -105.18 97.15 7.04 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 177.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -58.95 137.12 58.02 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 168.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.448 HG21 ' HA ' ' A' ' 160' ' ' SER . 35.4 mm -98.67 122.72 52.31 Favored Pre-proline 0 N--CA 1.461 0.095 0 CA-C-O 117.641 -1.171 . . . . 0.0 108.874 -170.515 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -63.27 105.99 0.53 Allowed 'Trans proline' 0 CA--C 1.534 0.484 0 C-N-CA 122.018 1.812 . . . . 0.0 109.024 171.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 55.8 mtm180 38.94 50.02 1.66 Allowed 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 126.452 1.901 . . . . 0.0 113.509 178.158 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . 0.448 ' HA ' HG21 ' A' ' 157' ' ' ILE . 35.1 p 50.4 21.19 0.78 Allowed 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 127.068 2.147 . . . . 0.0 115.633 -179.054 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -77.25 -33.41 56.03 Favored 'General case' 0 CA--C 1.536 0.433 0 O-C-N 120.662 -1.274 . . . . 0.0 112.875 -170.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 7.1 m . . . . . 0 C--O 1.254 1.302 0 C-N-CA 123.983 0.913 . . . . 0.0 110.587 -179.361 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.3 ttp . . . . . 0 N--CA 1.497 1.904 0 CA-C-O 119.124 -0.465 . . . . 0.0 110.629 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 29.4 ptt-85 -66.55 131.17 45.44 Favored 'General case' 0 N--CA 1.477 0.89 0 O-C-N 119.772 -1.83 . . . . 0.0 109.96 174.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 3.6 mt -130.86 139.24 51.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 C-N-CA 123.412 0.685 . . . . 0.0 110.068 -169.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.7 mt -112.44 143.18 44.0 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 104.805 -2.294 . . . . 0.0 104.805 167.064 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 67.1 t -123.45 97.89 5.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 102.276 -3.231 . . . . 0.0 102.276 171.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.3 tt -106.53 109.7 21.7 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 -167.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -91.86 138.59 14.32 Favored Glycine 0 N--CA 1.443 -0.865 0 N-CA-C 108.206 -1.958 . . . . 0.0 108.206 176.234 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -148.05 167.26 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.612 0 C-N-CA 123.16 0.584 . . . . 0.0 109.429 -179.548 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 130.95 156.51 8.57 Favored Glycine 0 C--N 1.335 0.496 0 N-CA-C 108.723 -1.751 . . . . 0.0 108.723 170.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.545 ' HA ' HG22 ' A' ' 43' ' ' THR . 6.6 t30 -75.45 103.75 5.72 Favored 'General case' 0 N--CA 1.454 -0.265 0 O-C-N 121.042 -1.27 . . . . 0.0 109.473 -174.629 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 26.1 pt -58.06 -15.59 5.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 N-CA-C 115.032 1.493 . . . . 0.0 115.032 -173.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.472 ' H ' ' ND2' ' A' ' 10' ' ' ASN . 5.2 mp -89.01 -6.11 57.44 Favored 'General case' 0 C--O 1.216 -0.683 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 -171.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.5 mp -102.45 53.2 0.79 Allowed 'General case' 0 N--CA 1.434 -1.251 0 C-N-CA 124.143 0.977 . . . . 0.0 109.147 -172.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.407 ' HB ' ' H ' ' A' ' 15' ' ' ASP 0.258 0.1 OUTLIER 49.91 -107.37 0.26 Allowed 'General case' 0 N--CA 1.44 -0.952 0 CA-C-N 113.901 -1.5 . . . . 0.0 110.677 174.896 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.407 ' H ' ' HB ' ' A' ' 14' ' ' THR . 75.3 m-20 -76.51 -6.27 51.12 Favored 'General case' 0 N--CA 1.439 -0.997 0 O-C-N 122.075 -0.391 . . . . 0.0 111.544 -171.023 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -71.94 -4.67 29.71 Favored 'General case' 0 CA--C 1.546 0.809 0 O-C-N 121.131 -0.98 . . . . 0.0 111.874 169.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -80.14 -15.18 57.64 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-O 116.187 -1.863 . . . . 0.0 109.748 169.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 7.0 tp -53.92 -42.02 51.72 Favored 'Isoleucine or valine' 0 C--N 1.342 0.252 0 CA-C-N 121.561 1.982 . . . . 0.0 112.655 -169.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -63.81 -43.45 97.66 Favored Glycine 0 C--N 1.334 0.435 0 CA-C-N 119.295 0.952 . . . . 0.0 111.716 178.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 97.7 t -64.56 -48.95 82.78 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 173.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 27.4 mmm180 -63.51 -31.41 72.56 Favored 'General case' 0 N--CA 1.467 0.404 0 O-C-N 120.433 -1.417 . . . . 0.0 112.678 -177.048 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 30.0 mt -60.52 -43.92 95.4 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 CA-C-N 120.446 1.476 . . . . 0.0 109.754 173.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.2 m -76.74 -27.79 17.01 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 CA-C-N 120.179 1.354 . . . . 0.0 111.806 -177.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 60.3 mt-10 -70.19 -41.27 73.95 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 175.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -69.03 -40.67 78.49 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-O 119.163 -0.446 . . . . 0.0 110.795 -179.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 5.7 tp -65.35 -42.2 93.07 Favored 'General case' 0 C--O 1.224 -0.283 0 CA-C-N 119.118 0.872 . . . . 0.0 110.233 178.313 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -62.6 -40.43 96.88 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 119.003 0.82 . . . . 0.0 110.669 179.211 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -71.15 -38.81 72.19 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 122.601 0.36 . . . . 0.0 111.686 177.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 31.4 mtp180 -92.67 -40.41 10.75 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 117.509 -1.234 . . . . 0.0 113.663 -169.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -117.18 123.82 47.61 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 121.074 1.761 . . . . 0.0 111.73 -170.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 50.0 mm -83.32 141.19 15.2 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 N-CA-C 106.372 -1.714 . . . . 0.0 106.372 169.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 17.8 mt -135.8 155.77 77.78 Favored Pre-proline 0 CA--C 1.539 0.523 0 C-N-CA 124.711 1.204 . . . . 0.0 110.153 -169.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_exo -57.88 157.72 23.31 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 123.612 2.875 . . . . 0.0 112.727 171.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -63.82 -30.21 71.33 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -169.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 11.7 p90 -73.13 -5.27 38.04 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 118.706 -0.664 . . . . 0.0 112.346 178.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 12.0 t -101.32 130.06 51.42 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 174.199 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -119.3 132.04 55.83 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 172.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.461 HD12 ' H ' ' A' ' 38' ' ' ILE . 0.1 OUTLIER -99.28 123.69 52.12 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 N-CA-C 104.759 -2.311 . . . . 0.0 104.759 169.059 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 5.8 tt -127.56 138.25 52.84 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 119.302 0.955 . . . . 0.0 110.816 -178.122 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -100.58 119.01 37.9 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 169.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -72.4 -24.28 76.56 Favored Glycine 0 CA--C 1.535 1.336 0 CA-C-O 118.683 -1.065 . . . . 0.0 112.752 177.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 66.91 75.54 0.45 Allowed Glycine 0 CA--C 1.529 0.92 0 CA-C-N 118.409 1.105 . . . . 0.0 112.063 173.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.545 HG22 ' HA ' ' A' ' 10' ' ' ASN 0.272 17.7 p 55.05 30.79 14.89 Favored 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 125.359 1.464 . . . . 0.0 112.862 176.26 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -76.91 -68.39 0.61 Allowed 'General case' 0 C--N 1.344 0.367 0 N-CA-C 114.701 1.371 . . . . 0.0 114.701 -169.335 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 74.91 -89.36 0.77 Allowed Glycine 0 CA--C 1.527 0.784 0 N-CA-C 108.463 -1.855 . . . . 0.0 108.463 -168.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 9.9 tpt -76.51 -22.42 54.46 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 125.051 1.34 . . . . 0.0 112.915 -173.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -66.19 -7.49 18.43 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 113.372 0.879 . . . . 0.0 113.372 -168.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.44 HD12 HD23 ' A' ' 97' ' ' LEU . 14.6 mt -84.12 4.09 31.92 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 121.622 -0.674 . . . . 0.0 112.76 -170.606 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -73.92 80.4 1.66 Allowed 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 125.078 2.371 . . . . 0.0 110.856 -177.605 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 141.54 -35.59 1.79 Allowed Glycine 0 C--N 1.309 -0.931 0 CA-C-N 109.676 -3.42 . . . . 0.0 111.073 169.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -69.17 -41.86 76.67 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-N 117.534 0.667 . . . . 0.0 109.87 -175.369 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 2.6 ptt? -88.84 1.88 54.56 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 115.449 -0.796 . . . . 0.0 112.176 -172.052 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -79.09 164.33 24.38 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 123.917 0.887 . . . . 0.0 111.257 -177.093 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 58.01 39.08 26.76 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.773 1.629 . . . . 0.0 113.883 168.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 9.5 mmt180 -109.22 153.45 23.79 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -81.25 -24.87 37.04 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 175.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -145.31 143.12 30.0 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 177.68 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 14.1 tp -140.56 126.23 19.14 Favored 'General case' 0 CA--C 1.505 -0.784 0 N-CA-C 106.016 -1.846 . . . . 0.0 106.016 168.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 36.1 mt -104.12 103.78 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 N-CA-C 103.753 -2.684 . . . . 0.0 103.753 172.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 12.9 mt -77.43 135.25 26.82 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 N-CA-C 105.053 -2.203 . . . . 0.0 105.053 171.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -118.56 120.55 37.83 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 105.604 -1.999 . . . . 0.0 105.604 169.509 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -156.25 167.14 31.36 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 122.875 0.47 . . . . 0.0 110.017 176.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -78.14 154.41 31.24 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 169.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 13.1 mm -78.8 -48.11 22.33 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.46 0 CA-C-O 118.754 -0.641 . . . . 0.0 110.595 -177.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.1 t 49.17 31.15 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.094 0 C-N-CA 126.7 2.0 . . . . 0.0 113.43 177.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 50.8 m -122.14 -25.81 4.83 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 116.291 1.96 . . . . 0.0 116.291 -169.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -149.21 156.98 42.97 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 120.564 1.529 . . . . 0.0 110.803 -172.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.18 33.41 0.13 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.906 1.683 . . . . 0.0 113.791 177.12 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 46.5 t30 -65.74 164.59 14.29 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 108.523 -0.918 . . . . 0.0 108.523 170.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 5.5 m -58.33 132.74 84.81 Favored Pre-proline 0 CA--C 1.545 0.77 0 CA-C-O 118.951 -0.547 . . . . 0.0 109.612 -178.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -61.42 156.19 47.96 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 122.742 2.294 . . . . 0.0 111.755 175.368 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 67.92 19.17 71.41 Favored Glycine 0 CA--C 1.535 1.324 0 CA-C-O 119.348 -0.696 . . . . 0.0 113.506 176.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 5.0 m -95.65 143.49 26.88 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 125.431 1.492 . . . . 0.0 108.505 178.044 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 14.7 ttp -91.64 135.48 33.84 Favored 'General case' 0 C--N 1.339 0.151 0 C-N-CA 123.178 0.591 . . . . 0.0 109.809 178.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 74.5 mmm -128.0 93.18 3.61 Favored 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 -169.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 44.2 mm -89.54 114.68 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 -177.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.8 mp -117.18 135.26 53.91 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 -177.451 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 40.4 ttm180 -102.92 135.87 43.79 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 123.276 0.63 . . . . 0.0 109.689 -176.008 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 17.4 t70 33.38 -97.91 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 115.734 1.753 . . . . 0.0 115.734 169.217 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -60.74 -26.72 67.41 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.514 1.125 . . . . 0.0 113.592 -174.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 -73.79 -25.17 60.0 Favored 'General case' 0 CA--C 1.533 0.311 0 O-C-N 122.023 -0.423 . . . . 0.0 110.483 -177.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.402 HG22 ' HB3' ' A' ' 116' ' ' LEU . 94.7 t -68.11 -62.38 3.25 Favored Pre-proline 0 N--CA 1.443 -0.823 0 CA-C-O 117.835 -1.079 . . . . 0.0 111.155 -168.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -63.69 -33.81 64.93 Favored 'Trans proline' 0 N--CA 1.448 -1.194 0 CA-C-N 121.266 1.488 . . . . 0.0 110.797 178.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.18 -21.22 65.8 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.189 0.596 . . . . 0.0 111.656 -175.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.436 HD13 ' C ' ' A' ' 85' ' ' LEU . 2.7 tm? -82.71 -49.56 9.65 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 169.296 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -60.63 -11.51 7.49 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 113.659 0.985 . . . . 0.0 113.659 -172.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 19.3 p -55.45 -23.92 28.05 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 119.488 1.04 . . . . 0.0 112.81 170.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . 0.617 HD21 ' HB ' ' A' ' 90' ' ' ILE . 5.6 t30 -59.53 128.23 36.01 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 122.943 0.497 . . . . 0.0 110.47 -174.472 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 66.2 mttt -81.28 -16.01 53.8 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 118.516 -0.754 . . . . 0.0 112.719 -175.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.617 ' HB ' HD21 ' A' ' 88' ' ' ASN . 83.6 mt -64.85 -40.44 89.08 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 178.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.529 ' H ' ' ND2' ' A' ' 88' ' ' ASN . 1.5 m -66.43 110.36 4.7 Favored Pre-proline 0 CA--C 1.544 0.743 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 169.48 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_exo -72.82 -47.92 0.32 Allowed 'Trans proline' 0 C--N 1.349 0.585 0 CA-C-N 121.358 1.521 . . . . 0.0 113.155 -169.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 21.5 m80 -91.95 -30.16 16.26 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 123.725 0.81 . . . . 0.0 110.072 -169.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 19.9 mp0 -63.68 -28.18 69.72 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 125.926 1.69 . . . . 0.0 110.192 179.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 60.7 tp -60.4 -36.35 77.91 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 118.986 0.812 . . . . 0.0 111.092 172.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -65.61 -40.96 96.26 Favored Glycine 0 CA--C 1.529 0.954 0 N-CA-C 110.891 -0.884 . . . . 0.0 110.891 173.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.44 HD23 HD12 ' A' ' 48' ' ' LEU . 2.3 tm? -66.42 -35.17 79.64 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 118.157 0.979 . . . . 0.0 110.534 176.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -56.57 -44.39 80.95 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 119.827 1.194 . . . . 0.0 109.912 171.331 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -71.08 -23.59 62.15 Favored 'General case' 0 N--CA 1.457 -0.111 0 CA-C-O 118.599 -0.715 . . . . 0.0 112.443 176.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 91.2 t -65.45 -46.66 89.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 CA-C-N 120.223 1.374 . . . . 0.0 107.566 169.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 65.9 mt -61.68 -38.78 89.05 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 118.73 0.696 . . . . 0.0 110.058 -179.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 21.3 m -61.93 -42.58 99.27 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 118.654 0.661 . . . . 0.0 110.749 171.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.407 ' HA ' ' CD2' ' A' ' 106' ' ' PHE . . . -64.77 -39.36 93.48 Favored 'General case' 0 N--CA 1.449 -0.516 0 O-C-N 121.442 -0.786 . . . . 0.0 111.442 -179.582 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 17.4 mt -70.03 -31.85 69.69 Favored 'General case' 0 CA--C 1.521 -0.135 0 O-C-N 121.727 -0.608 . . . . 0.0 111.039 176.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 29.0 tpt180 -65.14 -37.09 86.32 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 118.56 -0.733 . . . . 0.0 109.645 171.213 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.407 ' CD2' ' HA ' ' A' ' 103' ' ' ALA . 12.9 m-30 -65.69 -42.64 90.97 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 119.403 1.002 . . . . 0.0 110.759 177.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 49.0 p -76.19 -22.01 55.8 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 118.875 0.761 . . . . 0.0 111.781 179.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 77.73 11.56 85.32 Favored Glycine 0 CA--C 1.533 1.19 0 CA-C-O 118.815 -0.992 . . . . 0.0 111.172 -169.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -97.08 23.95 6.8 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 119.104 1.452 . . . . 0.0 111.39 177.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 12.7 t80 -58.43 136.97 85.6 Favored Pre-proline 0 CA--C 1.546 0.791 0 C-N-CA 125.393 1.477 . . . . 0.0 109.319 172.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -56.92 136.72 78.26 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 122.724 2.283 . . . . 0.0 111.866 179.148 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -66.53 -24.34 66.36 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 111.827 0.306 . . . . 0.0 111.827 -173.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -135.53 95.34 3.24 Favored 'General case' 0 N--CA 1.464 0.225 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 169.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 38.4 tp -81.25 131.87 35.31 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 169.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -132.94 146.09 51.48 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 106.571 -1.64 . . . . 0.0 106.571 171.607 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.402 ' HB3' HG22 ' A' ' 82' ' ' VAL . 0.4 OUTLIER -131.81 124.27 29.29 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 120.043 1.292 . . . . 0.0 108.374 175.92 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 44.7 t -92.22 94.8 4.99 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 N-CA-C 105.683 -1.969 . . . . 0.0 105.683 169.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -84.99 156.18 30.87 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.201 -1.159 . . . . 0.0 110.201 175.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 58.1 t -137.44 143.69 33.53 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 174.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 18.1 mm -85.69 129.06 56.25 Favored Pre-proline 0 CA--C 1.541 0.621 0 CA-C-O 118.007 -0.997 . . . . 0.0 108.484 174.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -75.01 154.89 42.75 Favored 'Trans proline' 0 CA--C 1.536 0.611 0 C-N-CA 122.848 2.365 . . . . 0.0 112.389 177.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -100.36 -42.49 6.6 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 169.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 68.6 m -132.65 152.73 51.59 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 123.695 0.798 . . . . 0.0 110.652 175.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.5 tp -148.47 43.64 1.02 Allowed 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.567 0.747 . . . . 0.0 111.178 -172.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -121.57 170.4 7.62 Favored Pre-proline 0 N--CA 1.472 0.67 0 CA-C-O 118.105 -0.95 . . . . 0.0 109.352 -175.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -66.14 89.44 0.25 Allowed 'Trans proline' 0 CA--C 1.546 1.114 0 C-N-CA 123.199 2.599 . . . . 0.0 114.261 -174.459 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -166.25 128.74 1.93 Allowed 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 105.059 -2.2 . . . . 0.0 105.059 169.718 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.434 HG23 ' HA ' ' A' ' 12' ' ' LEU . 0.0 OUTLIER -79.91 154.06 4.58 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 C-N-CA 123.626 0.77 . . . . 0.0 109.78 -171.852 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 78.21 166.68 29.41 Favored Glycine 0 CA--C 1.527 0.823 0 N-CA-C 111.326 -0.71 . . . . 0.0 111.326 -179.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -82.64 165.18 20.24 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-O 121.937 0.875 . . . . 0.0 112.459 -169.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 40.7 p -70.48 168.67 17.8 Favored Pre-proline 0 C--O 1.239 0.544 0 CA-C-N 114.123 -1.399 . . . . 0.0 108.813 167.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -56.93 -32.97 94.25 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 121.348 1.365 . . . . 0.0 110.831 169.244 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 26.2 m -68.12 -41.38 81.82 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 119.213 -0.423 . . . . 0.0 111.47 -179.006 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 16.7 t -105.3 -10.4 9.89 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-N 118.951 0.796 . . . . 0.0 112.105 -169.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -58.95 -45.45 90.42 Favored 'General case' 0 N--CA 1.466 0.346 0 O-C-N 119.929 -1.732 . . . . 0.0 107.768 168.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -70.67 1.47 5.27 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 115.172 -0.922 . . . . 0.0 112.721 176.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 18.0 mmm -92.03 -8.95 44.53 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 119.587 1.085 . . . . 0.0 111.112 172.182 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 86.8 mt -59.64 -48.31 87.88 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 CA-C-N 119.404 1.002 . . . . 0.0 108.446 176.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -70.5 -50.69 13.83 Favored Pre-proline 0 CA--C 1.535 0.393 0 CA-C-O 117.266 -1.35 . . . . 0.0 113.655 -170.023 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -58.31 -32.73 96.68 Favored 'Trans proline' 0 N--CA 1.459 -0.53 0 CA-C-N 122.214 1.827 . . . . 0.0 112.092 173.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -69.95 -39.53 75.98 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 119.147 0.885 . . . . 0.0 110.749 176.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 71.3 mt -58.04 -44.72 87.55 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 119.897 1.226 . . . . 0.0 109.099 171.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -60.38 -37.22 80.08 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 118.87 -0.586 . . . . 0.0 110.918 -179.37 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 36.1 mm-40 -77.97 -33.1 51.65 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 119.758 1.163 . . . . 0.0 112.921 177.147 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 52.0 t -59.22 -48.67 86.11 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-N 120.107 1.322 . . . . 0.0 108.362 169.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 32.6 mt -64.44 -37.35 87.23 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.028 0.531 . . . . 0.0 110.203 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -62.81 -40.68 98.13 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 118.938 0.79 . . . . 0.0 111.313 177.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -62.85 -41.57 99.41 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 118.87 0.759 . . . . 0.0 110.689 177.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 4.9 mt -63.01 -39.0 93.44 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 123.081 0.553 . . . . 0.0 111.055 174.213 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 72.1 mtp85 -68.34 -14.35 62.93 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 117.081 -1.438 . . . . 0.0 112.27 177.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -58.77 -30.63 67.7 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 120.978 1.717 . . . . 0.0 111.402 178.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 18.3 m -118.4 34.05 5.36 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.568 0.747 . . . . 0.0 111.005 174.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 65.61 27.02 72.2 Favored Glycine 0 C--N 1.342 0.873 0 CA-C-O 118.561 -1.133 . . . . 0.0 114.215 171.043 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 24.4 t -87.59 83.05 2.15 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 176.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -76.88 117.88 18.92 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 176.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -81.04 157.67 25.36 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 123.264 0.626 . . . . 0.0 109.728 173.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 12.6 mm -109.97 128.08 25.99 Favored Pre-proline 0 CA--C 1.531 0.238 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 179.088 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -59.36 110.48 0.71 Allowed 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.168 1.912 . . . . 0.0 108.469 169.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 43.1 mtm105 53.65 13.0 0.44 Allowed 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.664 1.586 . . . . 0.0 114.272 174.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 2.6 m 44.27 45.36 7.14 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.495 1.118 . . . . 0.0 110.636 -168.287 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -136.76 160.15 39.72 Favored 'General case' 0 C--O 1.24 0.561 0 C-N-CA 124.736 1.215 . . . . 0.0 110.218 -174.106 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 18.0 m . . . . . 0 C--O 1.253 1.258 0 C-N-CA 124.275 1.03 . . . . 0.0 110.603 179.76 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.4 tpt . . . . . 0 N--CA 1.498 1.957 0 CA-C-O 120.632 0.253 . . . . 0.0 111.292 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 28.2 ptt-85 -66.15 118.66 10.19 Favored 'General case' 0 N--CA 1.475 0.787 0 O-C-N 120.048 -1.657 . . . . 0.0 112.08 -172.262 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 73.0 mt -133.11 144.61 35.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 C-N-CA 123.553 0.741 . . . . 0.0 109.956 -175.246 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 9.7 mt -123.29 145.88 48.34 Favored 'General case' 0 CA--C 1.521 -0.139 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 168.059 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 57.4 t -126.87 95.69 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.797 0 N-CA-C 105.629 -1.989 . . . . 0.0 105.629 172.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.6 mt -87.88 116.71 26.23 Favored 'General case' 0 CA--C 1.517 -0.303 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 -171.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -93.82 127.21 8.96 Favored Glycine 0 C--N 1.332 0.312 0 N-CA-C 106.141 -2.784 . . . . 0.0 106.141 169.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.2 m -142.71 164.61 16.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 117.92 0.86 . . . . 0.0 111.481 -169.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 123.0 173.45 14.08 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 126.014 1.769 . . . . 0.0 111.687 172.346 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.448 HD22 ' HB2' ' A' ' 13' ' ' LEU . 1.5 t30 -81.83 93.46 6.87 Favored 'General case' 0 N--CA 1.462 0.14 0 O-C-N 121.229 -1.16 . . . . 0.0 110.694 -176.312 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -59.13 5.5 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 N-CA-C 117.262 2.319 . . . . 0.0 117.262 -178.372 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.441 ' H ' ' ND2' ' A' ' 10' ' ' ASN . 80.7 mt -108.67 -0.03 20.35 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 121.518 1.963 . . . . 0.0 109.135 -179.019 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.448 ' HB2' HD22 ' A' ' 10' ' ' ASN . 1.9 mp -110.27 62.77 0.6 Allowed 'General case' 0 N--CA 1.44 -0.948 0 C-N-CA 124.465 1.106 . . . . 0.0 110.122 -169.533 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.418 ' HB ' ' H ' ' A' ' 15' ' ' ASP . 0.2 OUTLIER 53.08 -103.89 0.18 Allowed 'General case' 0 CA--C 1.537 0.446 0 O-C-N 123.766 0.667 . . . . 0.0 111.064 175.166 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.418 ' H ' ' HB ' ' A' ' 14' ' ' THR . 81.9 m-20 -82.71 -8.39 59.6 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 118.513 -0.756 . . . . 0.0 112.462 -175.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -71.75 2.72 4.94 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-N 121.327 1.876 . . . . 0.0 113.015 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -85.01 -13.29 51.03 Favored 'General case' 0 N--CA 1.435 -1.189 0 CA-C-O 116.076 -1.916 . . . . 0.0 108.683 169.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 7.7 tp -50.88 -42.1 22.86 Favored 'Isoleucine or valine' 0 C--N 1.344 0.339 0 CA-C-N 121.671 2.032 . . . . 0.0 113.134 -169.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -61.81 -43.45 99.2 Favored Glycine 0 CA--C 1.527 0.834 0 CA-C-N 119.238 0.926 . . . . 0.0 111.995 177.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 55.6 t -65.38 -48.07 84.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-O 118.649 -0.691 . . . . 0.0 109.855 172.041 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 28.7 mmm180 -57.69 -37.39 73.38 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 120.231 1.378 . . . . 0.0 111.719 -178.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 27.0 mt -63.48 -45.54 97.59 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 CA-C-N 119.987 1.267 . . . . 0.0 110.195 -179.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.9 m -74.29 -27.09 21.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-N 119.985 1.266 . . . . 0.0 111.743 -176.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 19.5 mm-40 -70.41 -41.61 72.73 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 173.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.04 -38.37 90.65 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-O 119.025 -0.512 . . . . 0.0 110.045 177.317 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.8 tp -62.11 -42.98 99.77 Favored 'General case' 0 C--N 1.343 0.313 0 CA-C-O 118.131 -0.938 . . . . 0.0 109.727 175.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -60.5 -43.74 96.74 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 119.266 0.939 . . . . 0.0 110.678 178.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -66.53 -42.34 87.4 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.017 0.527 . . . . 0.0 110.91 179.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 87.1 mtt180 -88.84 -36.63 15.91 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 117.393 -1.289 . . . . 0.0 113.458 -170.207 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 72.3 m-85 -125.77 133.29 52.1 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-N 121.076 1.762 . . . . 0.0 112.607 -169.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 45.7 mm -85.66 129.81 37.38 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 N-CA-C 104.213 -2.514 . . . . 0.0 104.213 168.088 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -119.22 157.58 50.7 Favored Pre-proline 0 CA--C 1.537 0.444 0 C-N-CA 124.883 1.273 . . . . 0.0 108.902 -179.107 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_exo -57.97 155.46 33.35 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 123.259 2.639 . . . . 0.0 112.064 172.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -62.23 -28.21 69.53 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 112.937 0.717 . . . . 0.0 112.937 -170.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 8.3 p90 -73.98 -6.35 46.88 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 113.097 0.777 . . . . 0.0 113.097 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 38.2 t -102.96 133.51 46.56 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 174.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -132.45 136.34 46.65 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 169.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -88.67 101.55 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.035 0 N-CA-C 105.107 -2.182 . . . . 0.0 105.107 169.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.5 tt -85.57 112.44 20.95 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 106.784 -1.562 . . . . 0.0 106.784 -178.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -77.78 106.42 9.6 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 169.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -69.92 -80.62 0.27 Allowed Glycine 0 CA--C 1.528 0.875 0 N-CA-C 108.231 -1.948 . . . . 0.0 108.231 171.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 77.21 107.61 0.15 Allowed Glycine 0 C--N 1.341 0.848 0 N-CA-C 110.165 -1.174 . . . . 0.0 110.165 -178.436 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 5.2 p 52.39 57.98 5.87 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.416 1.086 . . . . 0.0 109.333 175.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -113.14 -88.31 0.55 Allowed 'General case' 0 C--N 1.345 0.411 0 CA-C-N 114.685 -1.143 . . . . 0.0 110.735 -169.449 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 75.09 -93.1 0.85 Allowed Glycine 0 C--N 1.34 0.778 0 N-CA-C 107.596 -2.202 . . . . 0.0 107.596 -169.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.68 -23.27 60.86 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.585 1.154 . . . . 0.0 113.498 -173.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -67.66 -7.24 25.14 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -169.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 26.0 mt -93.76 -12.91 28.09 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 115.475 1.657 . . . . 0.0 115.475 -168.151 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 5.1 tt -45.31 -61.03 1.83 Allowed 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 113.941 1.089 . . . . 0.0 113.941 -169.305 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -70.21 -35.42 70.25 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 111.255 -0.738 . . . . 0.0 111.255 -170.091 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -77.54 -29.84 52.49 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 118.068 0.934 . . . . 0.0 110.271 -175.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 69.6 mtp -67.34 -16.63 64.36 Favored 'General case' 0 N--CA 1.454 -0.254 0 O-C-N 121.822 -0.549 . . . . 0.0 111.683 175.13 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -63.14 140.97 58.93 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-O 121.926 0.87 . . . . 0.0 112.873 -169.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 53.53 20.39 2.07 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 117.261 2.319 . . . . 0.0 117.261 168.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 23.5 mmt180 -71.55 150.36 44.84 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 121.003 1.729 . . . . 0.0 108.5 176.267 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -79.96 -29.26 39.6 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 121.677 -0.639 . . . . 0.0 109.37 -178.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -147.81 137.25 22.42 Favored 'General case' 0 C--O 1.232 0.161 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 167.372 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.8 tp -126.59 130.73 51.07 Favored 'General case' 0 CA--C 1.515 -0.374 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 175.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 50.0 mt -105.66 120.1 55.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 105.803 -1.925 . . . . 0.0 105.803 173.004 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 7.9 mt -95.98 128.94 46.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 105.15 -2.167 . . . . 0.0 105.15 175.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -113.19 113.5 25.43 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 105.297 -2.112 . . . . 0.0 105.297 169.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.5 t0 -147.78 157.85 43.74 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.422 0.689 . . . . 0.0 110.217 -174.043 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -75.41 158.06 33.25 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 168.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.461 HD11 ' HA3' ' A' ' 118' ' ' GLY . 27.2 mm -95.4 -85.13 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.639 179.493 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . 0.385 0.3 OUTLIER 55.47 11.56 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 126.388 1.875 . . . . 0.0 114.549 -169.471 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.457 ' H ' HG22 ' A' ' 64' ' ' ILE . 5.3 m -74.07 -23.61 59.39 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 124.469 1.108 . . . . 0.0 113.684 -178.373 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 34.1 ttpt -150.23 161.16 42.96 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.149 0.98 . . . . 0.0 108.781 -171.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 14.5 ptpt -65.55 4.49 0.55 Allowed 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 127.347 2.259 . . . . 0.0 115.177 176.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 54.1 t30 -62.9 155.22 27.82 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 119.114 0.87 . . . . 0.0 109.539 -177.344 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 4.3 m -56.05 137.67 73.23 Favored Pre-proline 0 CA--C 1.545 0.762 0 C-N-CA 124.34 1.056 . . . . 0.0 113.532 -169.312 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -58.28 155.54 34.6 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 123.668 2.912 . . . . 0.0 111.708 169.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 64.88 24.76 70.23 Favored Glycine 0 CA--C 1.533 1.214 0 O-C-N 121.852 -0.53 . . . . 0.0 112.684 176.232 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 20.0 m -102.58 137.11 41.25 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 125.816 1.646 . . . . 0.0 106.706 173.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 28.3 ttp -91.8 136.74 32.92 Favored 'General case' 0 C--O 1.232 0.159 0 N-CA-C 107.629 -1.248 . . . . 0.0 107.629 175.079 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 6.4 ttm -124.95 87.01 2.64 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 -169.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 40.4 mm -83.13 117.64 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 57.1 mt -128.55 141.28 51.42 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 123.197 0.599 . . . . 0.0 109.544 -174.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.8 mtt85 -113.88 138.67 50.0 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 123.329 0.652 . . . . 0.0 109.873 -172.242 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 38.2 t70 38.91 -106.69 0.05 Allowed 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.833 1.253 . . . . 0.0 113.867 169.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -56.8 -29.82 63.1 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.071 1.349 . . . . 0.0 113.923 -175.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -71.25 -25.55 62.52 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 122.881 0.472 . . . . 0.0 110.238 -176.111 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.458 HG22 ' HB3' ' A' ' 116' ' ' LEU . 84.7 t -70.8 -61.92 2.22 Favored Pre-proline 0 N--CA 1.443 -0.812 0 CA-C-O 117.548 -1.215 . . . . 0.0 111.368 -168.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -65.55 -35.57 37.74 Favored 'Trans proline' 0 N--CA 1.452 -0.957 0 CA-C-N 121.384 1.53 . . . . 0.0 111.155 -178.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.1 -36.22 79.42 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 122.572 0.349 . . . . 0.0 110.634 -173.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -71.91 -44.05 64.31 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 118.867 -0.587 . . . . 0.0 109.698 169.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -55.71 -21.37 18.2 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 -174.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.447 HG23 ' H ' ' A' ' 88' ' ' ASN . 1.7 t -83.95 -76.34 0.3 Allowed 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 119.315 0.961 . . . . 0.0 109.895 168.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . 0.447 ' H ' HG23 ' A' ' 87' ' ' THR . 46.6 t30 49.45 17.49 0.22 Allowed 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.042 1.337 . . . . 0.0 114.082 -168.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt 50.4 23.92 1.4 Allowed 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.433 1.493 . . . . 0.0 113.421 -171.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 42.9 mt -134.67 -42.99 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 123.879 0.871 . . . . 0.0 110.96 -171.126 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.3 m -64.2 147.05 97.3 Favored Pre-proline 0 CA--C 1.545 0.765 0 CA-C-N 118.893 0.769 . . . . 0.0 112.52 -169.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -79.97 -110.33 0.01 OUTLIER 'Trans proline' 0 CA--C 1.54 0.823 0 C-N-CA 124.218 3.279 . . . . 0.0 109.979 175.088 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 11.7 m80 -59.13 -28.35 66.47 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.773 1.229 . . . . 0.0 112.675 -169.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 22.3 mp0 -57.57 -31.63 66.34 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 126.003 1.721 . . . . 0.0 111.208 175.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 65.9 tp -62.2 -33.86 75.35 Favored 'General case' 0 C--N 1.342 0.253 0 CA-C-N 119.123 0.874 . . . . 0.0 110.54 175.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -64.14 -39.41 97.11 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.616 -0.993 . . . . 0.0 110.616 175.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 19.0 tp -72.88 -33.88 66.34 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 118.332 1.066 . . . . 0.0 110.439 176.022 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -58.09 -46.85 84.81 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 119.752 1.16 . . . . 0.0 109.95 170.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -69.49 -29.25 66.86 Favored 'General case' 0 CA--C 1.522 -0.126 0 C-N-CA 122.618 0.367 . . . . 0.0 111.527 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 10.9 t -64.29 -44.19 97.28 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.785 0 CA-C-O 118.882 -0.58 . . . . 0.0 110.098 170.093 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 52.1 mt -63.07 -39.05 93.56 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 119.274 0.943 . . . . 0.0 110.036 178.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 23.8 m -61.05 -39.49 90.01 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 118.753 0.706 . . . . 0.0 110.19 169.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.517 ' HA ' ' CD2' ' A' ' 106' ' ' PHE . . . -67.44 -38.62 84.8 Favored 'General case' 0 N--CA 1.448 -0.545 0 O-C-N 121.308 -0.87 . . . . 0.0 111.793 -179.048 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -59.47 -41.75 90.45 Favored 'General case' 0 CA--C 1.524 -0.03 0 CA-C-N 118.835 0.743 . . . . 0.0 109.331 172.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 78.3 ttt180 -65.18 -36.2 83.45 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 118.229 -0.891 . . . . 0.0 110.852 177.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.517 ' CD2' ' HA ' ' A' ' 103' ' ' ALA . 15.1 m-30 -61.21 -45.46 94.47 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 119.506 1.048 . . . . 0.0 110.593 178.597 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 14.9 t -82.51 -13.58 56.42 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 122.298 0.239 . . . . 0.0 111.438 -178.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 78.08 27.93 57.22 Favored Glycine 0 CA--C 1.531 1.059 0 N-CA-C 111.623 -0.591 . . . . 0.0 111.623 179.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -110.98 19.36 18.57 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.628 1.171 . . . . 0.0 110.833 -176.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -59.99 137.11 90.83 Favored Pre-proline 0 CA--C 1.544 0.712 0 C-N-CA 123.952 0.901 . . . . 0.0 109.857 -178.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_exo -51.74 144.98 32.55 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 123.069 2.513 . . . . 0.0 112.96 176.392 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -63.77 -30.71 71.78 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 119.252 -0.404 . . . . 0.0 110.47 -178.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 30.5 mtmm -136.37 138.3 41.45 Favored 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 105.99 -1.856 . . . . 0.0 105.99 169.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 13.9 tp -120.14 134.06 55.35 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 171.007 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -133.41 139.28 46.66 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 177.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.458 ' HB3' HG22 ' A' ' 82' ' ' VAL . 6.2 tp -125.68 128.62 48.09 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 177.229 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 46.4 t -100.18 85.35 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 N-CA-C 104.092 -2.558 . . . . 0.0 104.092 169.214 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . 0.461 ' HA3' HD11 ' A' ' 64' ' ' ILE . . . -76.86 147.43 33.6 Favored Glycine 0 C--N 1.332 0.327 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 177.02 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 85.2 t -130.58 138.2 54.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 170.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 2.8 mt -92.44 125.05 57.49 Favored Pre-proline 0 CA--C 1.537 0.447 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -178.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -72.96 158.1 50.28 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 123.835 3.023 . . . . 0.0 112.424 -176.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -99.78 -41.64 7.18 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 171.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 70.5 m -129.78 149.51 51.49 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 123.487 0.715 . . . . 0.0 110.886 178.178 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -155.59 42.79 0.43 Allowed 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 112.951 0.723 . . . . 0.0 112.951 -169.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 81.7 mm-40 -111.19 164.2 15.52 Favored Pre-proline 0 N--CA 1.474 0.726 0 CA-C-O 117.607 -1.187 . . . . 0.0 108.737 179.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -68.25 87.21 0.4 Allowed 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 122.951 2.434 . . . . 0.0 111.919 -179.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -172.7 153.65 2.81 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 104.489 -2.412 . . . . 0.0 104.489 175.47 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -126.34 153.31 34.71 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 CA-C-O 121.956 0.884 . . . . 0.0 112.376 -170.06 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 121.73 127.68 3.4 Favored Glycine 0 CA--C 1.529 0.939 0 N-CA-C 105.497 -3.041 . . . . 0.0 105.497 -169.305 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 7.0 mp -79.63 151.73 30.4 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 117.67 0.735 . . . . 0.0 109.657 -177.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 62.0 p -69.76 159.07 85.4 Favored Pre-proline 0 C--O 1.237 0.401 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.565 173.286 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -62.01 -28.9 80.95 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 120.827 1.018 . . . . 0.0 110.014 169.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 24.7 m -63.53 -42.31 98.45 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 118.73 -0.652 . . . . 0.0 111.485 177.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 46.8 t -105.29 -26.61 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-O 118.072 -0.966 . . . . 0.0 112.896 -169.268 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -52.89 -42.12 65.01 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 120.754 1.615 . . . . 0.0 110.194 169.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -74.43 2.75 8.76 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 113.696 0.999 . . . . 0.0 113.696 -176.134 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 97.7 mmm -87.84 -10.3 51.23 Favored 'General case' 0 N--CA 1.439 -0.996 0 CA-C-O 117.435 -1.269 . . . . 0.0 110.152 169.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 93.6 mt -60.43 -46.18 95.63 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.406 0 CA-C-N 120.955 1.707 . . . . 0.0 109.022 -178.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -71.29 -49.99 11.58 Favored Pre-proline 0 CA--C 1.543 0.71 0 CA-C-N 120.239 1.382 . . . . 0.0 110.959 -179.13 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -41.37 -50.33 4.58 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 125.056 3.837 . . . . 0.0 112.732 168.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -73.11 -44.05 60.86 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 114.022 -1.445 . . . . 0.0 110.778 -175.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 34.3 mt -56.01 -41.45 74.9 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-N 118.833 0.742 . . . . 0.0 109.536 175.171 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -62.13 -35.91 80.17 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 118.853 0.752 . . . . 0.0 110.456 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 19.2 mm100 -78.7 -32.28 46.89 Favored 'General case' 0 N--CA 1.456 -0.127 0 CA-C-O 118.248 -0.882 . . . . 0.0 112.816 175.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 76.3 t -60.21 -47.56 91.63 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-N 119.976 1.262 . . . . 0.0 108.061 170.167 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 26.6 mt -65.14 -41.02 95.17 Favored 'General case' 0 CA--C 1.528 0.122 0 C-N-CA 122.99 0.516 . . . . 0.0 110.92 -179.377 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -63.19 -43.59 97.77 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 118.527 0.603 . . . . 0.0 111.163 177.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -64.7 -44.6 89.74 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 122.656 0.383 . . . . 0.0 110.061 179.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 38.9 mt -55.09 -45.2 75.42 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 174.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 73.7 mtp180 -64.97 -18.97 65.73 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 117.711 -1.138 . . . . 0.0 112.965 -177.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -62.15 -32.48 73.09 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 120.767 1.621 . . . . 0.0 110.957 178.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 22.5 m -97.1 28.59 3.5 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.905 0.882 . . . . 0.0 111.458 176.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 70.49 16.64 73.91 Favored Glycine 0 CA--C 1.533 1.185 0 CA-C-O 119.093 -0.837 . . . . 0.0 113.969 173.065 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 39.3 t -79.39 126.01 38.88 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 CA-C-N 118.746 1.273 . . . . 0.0 108.276 -177.322 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -96.27 128.69 43.42 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 169.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -97.14 147.47 24.03 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 169.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 2.7 mt -115.41 120.66 36.01 Favored Pre-proline 0 N--CA 1.462 0.153 0 N-CA-C 106.636 -1.616 . . . . 0.0 106.636 178.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -61.66 108.03 0.58 Allowed 'Trans proline' 0 N--CA 1.46 -0.472 0 C-N-CA 121.979 1.786 . . . . 0.0 107.625 172.157 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 14.2 ptp180 47.47 7.31 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 129.26 3.024 . . . . 0.0 117.785 -177.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 2.9 t 52.89 -172.41 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 126.114 1.765 . . . . 0.0 112.405 -169.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -146.35 140.89 26.73 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 125.62 1.568 . . . . 0.0 109.032 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 32.3 m . . . . . 0 C--O 1.254 1.297 0 C-N-CA 125.236 1.414 . . . . 0.0 108.555 -176.891 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.7 tpt . . . . . 0 N--CA 1.498 1.942 0 N-CA-C 110.441 -0.207 . . . . 0.0 110.441 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 5.5 ptp85 -149.24 123.14 9.35 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 177.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 55.1 mt -141.67 145.01 24.98 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 CA-C-N 119.46 1.027 . . . . 0.0 112.037 -169.058 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.1 mt -128.17 123.42 34.3 Favored 'General case' 0 CA--C 1.519 -0.216 0 N-CA-C 106.489 -1.671 . . . . 0.0 106.489 167.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 43.6 t -101.85 98.71 7.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 100.69 -3.819 . . . . 0.0 100.69 169.153 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -104.24 109.24 20.98 Favored 'General case' 0 N--CA 1.442 -0.864 0 C-N-CA 123.873 0.869 . . . . 0.0 109.35 -168.152 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -91.42 126.3 8.39 Favored Glycine 0 N--CA 1.444 -0.831 0 N-CA-C 107.743 -2.143 . . . . 0.0 107.743 174.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -142.38 179.73 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.812 0 C-N-CA 124.133 0.973 . . . . 0.0 108.517 -175.011 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 124.5 157.04 9.61 Favored Glycine 0 N--CA 1.447 -0.589 0 N-CA-C 108.471 -1.852 . . . . 0.0 108.471 -169.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -73.6 96.96 2.54 Favored 'General case' 0 N--CA 1.442 -0.85 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 169.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 4.2 pt -56.7 -30.62 32.82 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.241 0 O-C-N 121.438 -0.789 . . . . 0.0 112.068 -179.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 22.2 mt -77.55 13.93 1.14 Allowed 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 119.036 0.834 . . . . 0.0 110.902 -172.15 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -136.41 82.07 1.92 Allowed 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 123.284 0.634 . . . . 0.0 111.494 171.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.427 HG23 ' O ' ' A' ' 129' ' ' GLY . 25.6 m 35.41 -105.94 0.03 OUTLIER 'General case' 0 N--CA 1.437 -1.121 0 O-C-N 126.46 2.35 . . . . 0.0 111.772 167.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -59.46 -28.02 66.61 Favored 'General case' 0 N--CA 1.442 -0.842 0 C-N-CA 124.201 1.0 . . . . 0.0 111.961 -169.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -67.09 -18.05 65.15 Favored 'General case' 0 C--N 1.341 0.212 0 CA-C-N 120.423 1.465 . . . . 0.0 111.786 179.088 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.58 -10.56 56.66 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-O 116.33 -1.795 . . . . 0.0 110.888 173.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 6.6 tp -55.6 -39.94 57.07 Favored 'Isoleucine or valine' 0 C--N 1.342 0.243 0 CA-C-N 121.976 2.171 . . . . 0.0 111.814 -174.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -59.17 -43.52 97.07 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 111.4 -0.68 . . . . 0.0 111.4 178.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 74.0 t -68.76 -48.32 71.74 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 CA-C-O 118.134 -0.936 . . . . 0.0 109.874 174.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 20.9 mmt180 -60.14 -31.56 70.21 Favored 'General case' 0 C--N 1.346 0.431 0 CA-C-N 120.498 1.499 . . . . 0.0 111.787 -177.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 23.2 mt -60.68 -51.35 74.11 Favored 'Isoleucine or valine' 0 C--N 1.343 0.285 0 CA-C-N 120.86 1.663 . . . . 0.0 109.789 174.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 24.6 m -72.38 -33.97 47.38 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 CA-C-N 119.461 1.028 . . . . 0.0 111.221 -174.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 58.1 mt-10 -59.88 -48.29 82.3 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 171.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.56 -36.8 84.83 Favored 'General case' 0 C--N 1.342 0.263 0 CA-C-N 119.151 0.887 . . . . 0.0 111.08 179.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 5.9 tp -63.19 -40.04 96.36 Favored 'General case' 0 C--O 1.224 -0.253 0 CA-C-N 118.471 0.578 . . . . 0.0 109.566 -178.231 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -60.52 -26.5 66.9 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.595 0.758 . . . . 0.0 112.771 179.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -90.67 -44.35 9.56 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 125.495 1.518 . . . . 0.0 110.886 -178.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 75.4 mtt180 -84.45 -26.61 28.1 Favored 'General case' 0 C--O 1.231 0.086 0 CA-C-O 118.792 -0.623 . . . . 0.0 111.529 -172.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 64.4 m-85 -125.97 146.21 49.96 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-O 121.694 0.759 . . . . 0.0 112.364 -177.318 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 34.0 mm -101.7 135.66 37.3 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 N-CA-C 104.909 -2.256 . . . . 0.0 104.909 169.028 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -119.0 150.93 49.66 Favored Pre-proline 0 CA--C 1.535 0.371 0 C-N-CA 124.287 1.035 . . . . 0.0 109.988 -169.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -65.76 157.16 60.31 Favored 'Trans proline' 0 CA--C 1.539 0.748 0 C-N-CA 122.43 2.087 . . . . 0.0 110.189 169.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -58.08 -33.2 68.81 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 114.557 1.317 . . . . 0.0 114.557 -169.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -74.72 -11.45 60.17 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -177.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 73.1 t -90.02 123.01 42.01 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 171.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -112.36 127.01 55.89 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 169.234 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -91.77 116.07 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 N-CA-C 104.422 -2.436 . . . . 0.0 104.422 168.294 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 59.6 tp -117.57 128.25 54.76 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 118.207 0.458 . . . . 0.0 110.675 -178.431 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -87.73 117.25 26.43 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 168.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -71.59 -65.31 2.45 Favored Glycine 0 CA--C 1.528 0.871 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 176.292 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 84.33 84.61 0.94 Allowed Glycine 0 C--N 1.343 0.937 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 177.137 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 27.6 p 61.38 20.11 10.82 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 125.118 1.367 . . . . 0.0 113.471 -179.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -76.73 -65.78 0.9 Allowed 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 114.875 1.435 . . . . 0.0 114.875 -168.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 56.78 -108.61 1.28 Allowed Glycine 0 CA--C 1.536 1.349 0 N-CA-C 111.416 -0.674 . . . . 0.0 111.416 -176.167 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 13.2 tpt -59.67 -23.58 63.2 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.968 1.307 . . . . 0.0 112.43 -178.239 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 21.3 mm-40 -60.33 -18.79 52.29 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 113.539 0.941 . . . . 0.0 113.539 -178.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 13.3 mt -99.52 22.25 11.05 Favored 'General case' 0 C--N 1.344 0.35 0 N-CA-C 114.728 1.381 . . . . 0.0 114.728 -168.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 6.7 tt -52.19 -58.17 7.43 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 118.856 0.753 . . . . 0.0 111.15 -178.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -68.76 -33.24 75.28 Favored Glycine 0 CA--C 1.529 0.959 0 N-CA-C 111.338 -0.705 . . . . 0.0 111.338 -178.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -74.73 -38.53 62.26 Favored 'General case' 0 CA--C 1.533 0.299 0 O-C-N 122.081 -0.658 . . . . 0.0 112.058 -173.113 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 12.9 mtp -76.65 -17.76 58.96 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.568 0.747 . . . . 0.0 111.553 -179.037 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.64 151.97 45.27 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 123.533 0.733 . . . . 0.0 112.433 -169.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 16.7 p30 50.23 13.93 0.13 Allowed 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 128.379 2.671 . . . . 0.0 117.507 169.032 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 35.8 mmt-85 -70.31 157.24 38.09 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 119.499 1.045 . . . . 0.0 108.474 171.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.01 -46.34 18.37 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 178.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -128.26 149.27 50.55 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-N 120.116 1.325 . . . . 0.0 108.66 169.125 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 16.1 tp -135.46 112.38 10.24 Favored 'General case' 0 CA--C 1.506 -0.719 0 N-CA-C 103.723 -2.695 . . . . 0.0 103.723 177.245 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 46.6 mt -91.94 110.1 22.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 104.811 -2.292 . . . . 0.0 104.811 172.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.5 HD13 HD11 ' A' ' 97' ' ' LEU . 7.3 mt -81.79 135.22 25.43 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 N-CA-C 107.0 -1.482 . . . . 0.0 107.0 170.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -122.66 118.24 27.67 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 102.733 -3.062 . . . . 0.0 102.733 167.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 51.5 t0 -158.51 155.75 29.0 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 125.149 1.38 . . . . 0.0 107.399 -179.156 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -88.45 143.09 27.2 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 169.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 65.2 mt -80.41 -19.66 11.91 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 C-N-CA 125.016 1.326 . . . . 0.0 110.307 -177.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . 0.317 31.3 t 71.29 -38.38 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 C-N-CA 129.818 3.247 . . . . 0.0 114.543 177.713 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 2.7 p -162.42 147.96 12.63 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 120.021 1.282 . . . . 0.0 112.568 169.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 13.8 tppt? -165.51 174.32 10.06 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 128.252 2.621 . . . . 0.0 104.872 169.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 13.2 ptpt -61.24 -26.18 67.58 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 176.226 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 36.0 t-20 -74.99 165.73 24.79 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.475 0.71 . . . . 0.0 110.522 -173.313 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 2.4 m -61.27 151.23 77.02 Favored Pre-proline 0 CA--C 1.548 0.876 0 C-N-CA 124.588 1.155 . . . . 0.0 112.704 -169.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -56.94 158.13 18.14 Favored 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 124.21 3.273 . . . . 0.0 113.556 170.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 65.83 7.7 37.24 Favored Glycine 0 CA--C 1.538 1.485 0 CA-C-O 119.59 -0.561 . . . . 0.0 114.272 170.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 5.0 m -87.31 149.92 24.21 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 125.769 1.627 . . . . 0.0 111.513 -169.181 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 31.0 ttp -93.63 140.93 29.05 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 169.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 56.5 mtm -134.88 125.38 26.64 Favored 'General case' 0 C--O 1.232 0.165 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 169.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 37.6 mm -107.44 123.12 62.51 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 -176.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.9 mp -128.74 143.33 50.9 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.875 -171.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 79.4 mtm180 -91.65 175.82 6.76 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 114.867 -1.06 . . . . 0.0 110.431 -175.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -41.07 -53.61 3.0 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 115.861 1.8 . . . . 0.0 115.861 -169.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -87.78 -14.83 38.6 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 113.199 0.815 . . . . 0.0 113.199 -175.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -78.98 -35.4 43.08 Favored 'General case' 0 N--CA 1.456 -0.128 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 -174.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 94.5 t -60.79 -49.34 89.92 Favored Pre-proline 0 CA--C 1.541 0.618 0 CA-C-O 117.397 -1.287 . . . . 0.0 112.267 -176.081 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_exo -55.41 -39.91 88.46 Favored 'Trans proline' 0 CA--C 1.543 0.943 0 C-N-CA 122.091 1.861 . . . . 0.0 112.146 174.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -76.05 -5.37 46.14 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 177.021 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -87.65 -41.4 13.41 Favored 'General case' 0 C--N 1.341 0.213 0 CA-C-N 119.751 1.159 . . . . 0.0 111.34 -178.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -80.22 22.98 0.5 Allowed 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -169.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 24.5 p -58.65 -26.25 63.57 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.237 1.015 . . . . 0.0 111.964 175.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 36.3 t30 -68.32 115.84 8.21 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.142 0.577 . . . . 0.0 109.652 176.062 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 39.3 mttp -88.81 -6.23 57.51 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 113.051 0.76 . . . . 0.0 113.051 -177.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 97.4 mt -58.45 -48.01 86.5 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 177.133 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 3.9 m -67.21 107.61 1.86 Allowed Pre-proline 0 CA--C 1.542 0.669 0 C-N-CA 127.181 2.192 . . . . 0.0 109.397 -173.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -72.47 -56.65 0.09 OUTLIER 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 122.392 2.061 . . . . 0.0 113.015 -168.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 7.2 t-80 -59.88 -43.85 94.53 Favored 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.409 ' H ' ' CD ' ' A' ' 94' ' ' GLN . 16.9 mp0 -61.29 -39.61 91.09 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 125.587 1.555 . . . . 0.0 108.934 -174.255 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 55.2 tp -64.49 -37.49 87.71 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 118.93 0.786 . . . . 0.0 110.704 175.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -65.38 -46.68 85.13 Favored Glycine 0 CA--C 1.529 0.916 0 N-CA-C 110.986 -0.846 . . . . 0.0 110.986 174.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.5 HD11 HD13 ' A' ' 60' ' ' ILE . 2.9 tm? -58.14 -38.6 76.88 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 117.711 0.755 . . . . 0.0 110.115 173.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -66.06 -45.41 81.43 Favored 'General case' 0 C--N 1.333 -0.142 0 O-C-N 120.838 -1.164 . . . . 0.0 111.254 177.165 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -69.51 -24.75 63.8 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 118.512 0.596 . . . . 0.0 110.574 -179.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -73.91 -37.88 48.8 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.863 0 O-C-N 121.873 -0.517 . . . . 0.0 110.92 172.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 29.6 mt -66.1 -36.32 82.86 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 173.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 46.3 m -65.21 -36.38 83.99 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-O 118.344 -0.836 . . . . 0.0 110.319 171.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.97 -41.53 97.51 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 120.476 1.489 . . . . 0.0 110.686 174.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 11.8 mt -64.24 -32.18 73.66 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 118.79 0.723 . . . . 0.0 111.499 173.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 67.1 ttp85 -71.62 -30.74 66.12 Favored 'General case' 0 CA--C 1.532 0.284 0 O-C-N 121.581 -0.699 . . . . 0.0 109.613 176.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 14.8 m-30 -72.09 -46.32 57.22 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 118.877 0.762 . . . . 0.0 110.368 176.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 35.2 p -73.35 -24.14 60.31 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 118.338 0.517 . . . . 0.0 112.009 -177.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 75.93 8.03 84.46 Favored Glycine 0 CA--C 1.534 1.268 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -168.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -84.84 23.25 1.21 Allowed 'General case' 0 C--N 1.349 0.558 0 CA-C-N 119.812 1.806 . . . . 0.0 111.28 171.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -62.18 138.56 96.05 Favored Pre-proline 0 CA--C 1.547 0.844 0 C-N-CA 124.328 1.051 . . . . 0.0 108.933 169.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -61.42 161.53 23.55 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 123.13 2.553 . . . . 0.0 114.683 -176.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -66.21 -35.87 81.57 Favored 'General case' 0 N--CA 1.471 0.58 0 O-C-N 121.803 -0.561 . . . . 0.0 111.664 174.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 17.9 ttmm -138.53 77.59 1.63 Allowed 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 -176.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -69.79 129.18 38.87 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 106.471 -1.678 . . . . 0.0 106.471 170.132 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -130.41 138.89 50.57 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 175.521 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 17.4 tp -119.78 130.09 54.78 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 119.556 1.071 . . . . 0.0 109.115 176.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 13.3 t -102.59 74.88 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 105.44 -2.059 . . . . 0.0 105.44 169.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -78.55 144.74 28.31 Favored Glycine 0 C--N 1.336 0.539 0 N-CA-C 110.547 -1.021 . . . . 0.0 110.547 -174.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 61.5 t -124.57 134.77 65.88 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.275 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 -178.464 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 40.1 mt -91.01 135.37 28.68 Favored Pre-proline 0 C--N 1.326 -0.449 0 N-CA-C 104.976 -2.231 . . . . 0.0 104.976 169.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -73.28 170.26 20.3 Favored 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 122.008 1.805 . . . . 0.0 111.202 -177.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -89.71 -48.87 6.98 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 168.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 25.1 m -137.31 -34.23 0.72 Allowed 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 116.205 1.928 . . . . 0.0 116.205 -170.002 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 4.3 tp 50.76 50.1 19.65 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.362 1.465 . . . . 0.0 110.495 -168.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -58.84 151.25 55.14 Favored Pre-proline 0 CA--C 1.54 0.577 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 173.152 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -76.37 76.39 3.94 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 122.427 2.085 . . . . 0.0 108.055 169.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.607 ' CD2' ' H ' ' A' ' 128' ' ' ILE . 7.4 t60 -151.47 -167.79 2.9 Favored 'General case' 0 CA--C 1.552 1.028 0 N-CA-C 104.113 -2.551 . . . . 0.0 104.113 175.139 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.607 ' H ' ' CD2' ' A' ' 127' ' ' HIS . 17.5 mt -125.45 -50.2 1.88 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 CA-C-N 123.688 2.949 . . . . 0.0 110.646 -171.145 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.427 ' O ' HG23 ' A' ' 14' ' ' THR . . . -55.73 148.63 26.69 Favored Glycine 0 CA--C 1.53 0.993 0 N-CA-C 111.223 -0.751 . . . . 0.0 111.223 170.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 76.3 mt -70.2 162.64 28.01 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.11 0.964 . . . . 0.0 112.906 -175.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 18.3 p -74.11 164.35 61.83 Favored Pre-proline 0 CA--C 1.543 0.68 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 168.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -62.29 -35.42 73.77 Favored 'Trans proline' 0 CA--C 1.536 0.625 0 C-N-CA 121.259 1.306 . . . . 0.0 112.133 177.037 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 90.7 m -69.16 -37.02 77.99 Favored 'General case' 0 N--CA 1.443 -0.814 0 O-C-N 121.553 -0.717 . . . . 0.0 110.079 -178.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 75.0 t -85.07 -32.16 7.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 O-C-N 121.583 -0.698 . . . . 0.0 109.985 -177.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -54.22 -46.87 72.62 Favored 'General case' 0 CA--C 1.535 0.386 0 O-C-N 121.273 -0.892 . . . . 0.0 109.512 169.094 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -68.07 -16.51 64.05 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 -179.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 8.9 mmm -79.25 -11.58 59.95 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 125.57 1.548 . . . . 0.0 112.678 173.351 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 68.2 mt -55.22 -56.37 11.76 Favored 'Isoleucine or valine' 0 C--N 1.346 0.451 0 CA-C-N 120.902 1.683 . . . . 0.0 109.287 174.341 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -66.42 -46.28 59.42 Favored Pre-proline 0 CA--C 1.548 0.901 0 CA-C-N 119.629 1.104 . . . . 0.0 110.728 -172.37 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 0.3 OUTLIER -44.11 -52.09 5.99 Favored 'Trans proline' 0 C--N 1.352 0.732 1 C-N-CA 125.606 4.204 . . . . 0.0 112.881 168.665 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -72.75 -35.73 67.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 118.329 -0.843 . . . . 0.0 112.616 -178.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 39.7 mt -60.55 -45.97 91.91 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 120.23 1.377 . . . . 0.0 109.384 174.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 31.8 mm-40 -54.37 -36.07 63.48 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 118.493 0.588 . . . . 0.0 110.371 173.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 1.5 mm100 -78.16 -34.1 49.89 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 179.134 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 50.7 t -60.33 -46.48 94.91 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 CA-C-N 119.665 1.121 . . . . 0.0 108.025 170.137 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 55.2 mt -61.35 -35.57 77.79 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 119.211 -0.423 . . . . 0.0 110.509 177.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -71.06 -42.46 69.39 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 119.117 0.872 . . . . 0.0 111.45 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -67.96 -30.66 70.0 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 120.068 1.304 . . . . 0.0 111.132 177.094 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 21.4 mt -63.09 -51.64 65.83 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 169.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 75.6 mtt180 -63.28 -28.62 70.15 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 119.524 1.056 . . . . 0.0 112.288 -178.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -70.52 -18.46 62.95 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 119.056 0.844 . . . . 0.0 111.023 176.076 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 9.8 m -94.01 8.26 42.08 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.976 1.31 . . . . 0.0 111.04 169.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 72.31 15.1 76.96 Favored Glycine 0 CA--C 1.529 0.908 0 CA-C-O 116.995 -2.003 . . . . 0.0 112.951 -172.096 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 61.9 t -96.47 119.77 44.95 Favored 'Isoleucine or valine' 0 C--N 1.348 0.536 0 CA-C-N 121.368 2.584 . . . . 0.0 107.482 -176.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -107.49 91.93 3.86 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 107.065 -1.458 . . . . 0.0 107.065 173.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -52.32 144.32 13.14 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.079 169.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.433 HG21 ' HA ' ' A' ' 160' ' ' SER . 27.1 mm -89.28 124.64 64.17 Favored Pre-proline 0 C--O 1.232 0.16 0 CA-C-O 117.669 -1.158 . . . . 0.0 108.559 -175.767 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -63.27 103.78 0.38 Allowed 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 122.369 2.046 . . . . 0.0 108.495 170.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 29.0 ttp180 37.46 50.68 1.12 Allowed 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 127.201 2.2 . . . . 0.0 114.157 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . 0.433 ' HA ' HG21 ' A' ' 157' ' ' ILE 0.269 3.4 p 53.29 19.59 1.61 Allowed 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 126.803 2.041 . . . . 0.0 115.657 -179.337 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -81.39 123.13 28.3 Favored 'General case' 0 C--O 1.238 0.492 0 O-C-N 121.018 -1.051 . . . . 0.0 109.637 174.097 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 29.5 m . . . . . 0 C--O 1.251 1.168 0 C-N-CA 125.496 1.518 . . . . 0.0 108.361 -178.872 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.8 tpt . . . . . 0 N--CA 1.497 1.876 0 N-CA-C 110.22 -0.289 . . . . 0.0 110.22 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 23.6 ptt180 -144.33 127.54 16.69 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.64 1.176 . . . . 0.0 108.014 171.127 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 13.5 mt -140.53 141.01 33.33 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -169.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 17.0 tp -123.05 149.57 44.23 Favored 'General case' 0 N--CA 1.462 0.168 0 N-CA-C 107.216 -1.401 . . . . 0.0 107.216 168.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 66.3 t -123.13 122.87 66.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 105.424 -2.065 . . . . 0.0 105.424 169.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -98.18 130.38 44.93 Favored 'General case' 0 CA--C 1.511 -0.536 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 178.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -105.16 115.9 5.08 Favored Glycine 0 CA--C 1.501 -0.819 0 N-CA-C 104.481 -3.448 . . . . 0.0 104.481 169.487 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 6.8 m -138.46 157.83 30.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 118.933 1.366 . . . . 0.0 111.902 -168.613 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 130.52 -172.76 20.3 Favored Glycine 0 C--N 1.337 0.591 0 O-C-N 124.454 1.096 . . . . 0.0 111.698 169.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.42 HD21 ' HB2' ' A' ' 12' ' ' LEU . 3.1 t30 -87.07 85.86 7.26 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 123.54 0.736 . . . . 0.0 111.723 -169.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.3 pt -58.16 29.88 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.555 1.138 0 N-CA-C 116.421 2.008 . . . . 0.0 116.421 171.007 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.42 ' HB2' HD21 ' A' ' 10' ' ' ASN . 72.1 mt -125.96 -3.29 7.05 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 120.979 1.718 . . . . 0.0 108.927 169.371 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.6 mp -119.59 64.15 0.8 Allowed 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 124.212 1.005 . . . . 0.0 110.44 -169.095 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.466 ' HB ' ' H ' ' A' ' 15' ' ' ASP . 0.1 OUTLIER 51.96 -104.01 0.17 Allowed 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.377 170.74 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.466 ' H ' ' HB ' ' A' ' 14' ' ' THR . 73.2 m-20 -71.21 -16.34 62.5 Favored 'General case' 0 N--CA 1.442 -0.874 0 C-N-CA 124.209 1.004 . . . . 0.0 112.722 -175.47 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -73.76 7.93 2.23 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 120.924 1.693 . . . . 0.0 113.096 -179.757 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -89.66 -15.36 32.81 Favored 'General case' 0 N--CA 1.429 -1.508 0 CA-C-O 115.817 -2.04 . . . . 0.0 107.537 169.374 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 7.1 tp -54.96 -38.65 46.12 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.359 0 CA-C-N 122.329 2.331 . . . . 0.0 112.998 -169.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -59.56 -45.83 94.96 Favored Glycine 0 C--N 1.334 0.464 0 N-CA-C 109.934 -1.266 . . . . 0.0 109.934 176.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 34.3 t -65.85 -46.26 89.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 CA-C-O 118.505 -0.759 . . . . 0.0 110.05 173.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 25.5 mmt180 -62.32 -34.85 77.42 Favored 'General case' 0 C--N 1.346 0.422 0 CA-C-N 120.547 1.522 . . . . 0.0 111.963 -176.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 26.2 mt -61.85 -46.46 96.47 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-N 120.03 1.286 . . . . 0.0 110.137 178.373 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 18.7 m -73.77 -28.59 24.65 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 CA-C-N 119.153 0.888 . . . . 0.0 111.247 -174.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 58.1 mt-10 -70.18 -45.56 66.41 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 174.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.55 -44.59 95.95 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 123.002 0.521 . . . . 0.0 110.108 178.572 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 7.4 tp -63.45 -40.52 97.35 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 118.438 -0.791 . . . . 0.0 110.982 178.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.7 tm-20 -61.76 -42.38 98.91 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 118.7 0.682 . . . . 0.0 110.489 179.149 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 48.7 mm-40 -71.63 -42.8 67.16 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 122.784 0.434 . . . . 0.0 111.536 179.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 40.4 mmt180 -88.05 -35.44 17.54 Favored 'General case' 0 C--N 1.342 0.264 0 CA-C-O 117.37 -1.3 . . . . 0.0 113.441 -169.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 75.9 m-85 -120.12 137.06 54.37 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-N 121.127 1.785 . . . . 0.0 112.056 -173.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 31.6 mm -89.29 134.12 29.48 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 N-CA-C 105.536 -2.024 . . . . 0.0 105.536 168.269 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -119.5 154.85 54.55 Favored Pre-proline 0 CA--C 1.538 0.494 0 C-N-CA 125.563 1.545 . . . . 0.0 108.858 -172.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -63.87 157.9 49.93 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 122.358 2.039 . . . . 0.0 109.991 169.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -58.6 -31.99 68.57 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 113.619 0.97 . . . . 0.0 113.619 -169.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 53.4 p90 -75.38 -1.26 22.99 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 113.931 1.086 . . . . 0.0 113.931 -177.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 59.5 t -111.1 128.2 67.71 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 176.324 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -129.36 143.84 51.0 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 173.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -110.89 108.36 25.26 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 106.282 -1.748 . . . . 0.0 106.282 176.622 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 8.2 tt -106.88 127.06 53.09 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 -172.433 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -81.76 115.95 21.23 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 124.196 0.998 . . . . 0.0 109.824 176.649 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -77.29 -87.66 0.37 Allowed Glycine 0 CA--C 1.531 1.033 0 N-CA-C 108.762 -1.735 . . . . 0.0 108.762 169.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 77.93 106.88 0.18 Allowed Glycine 0 CA--C 1.53 0.976 0 N-CA-C 110.712 -0.955 . . . . 0.0 110.712 -177.145 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 5.3 p 50.99 57.48 6.61 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.017 1.327 . . . . 0.0 109.489 178.126 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -107.9 -87.75 0.48 Allowed 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 114.88 -1.054 . . . . 0.0 110.222 -169.566 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 73.08 -102.04 1.2 Allowed Glycine 0 C--N 1.339 0.709 0 N-CA-C 107.906 -2.077 . . . . 0.0 107.906 -174.399 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 70.8 mmm -68.24 -23.02 64.75 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 122.914 0.486 . . . . 0.0 112.222 -174.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -64.36 -14.91 59.09 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-O 120.793 0.33 . . . . 0.0 111.014 -177.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 59.4 mt -83.34 -10.0 58.73 Favored 'General case' 0 C--N 1.343 0.32 0 N-CA-C 113.912 1.079 . . . . 0.0 113.912 -172.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.406 ' HA ' HG13 ' A' ' 100' ' ' VAL . 3.5 tt -47.66 -67.91 0.23 Allowed 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 119.367 0.985 . . . . 0.0 113.577 -169.436 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -71.4 -26.41 73.41 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 111.339 -0.704 . . . . 0.0 111.339 -171.212 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -78.87 -29.67 44.6 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 122.516 0.326 . . . . 0.0 111.457 -178.403 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 22.3 mtp -83.7 -28.81 28.03 Favored 'General case' 0 CA--C 1.53 0.176 0 O-C-N 121.936 -0.477 . . . . 0.0 111.352 174.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -59.31 153.67 18.29 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-O 121.707 0.765 . . . . 0.0 110.307 175.416 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 64.45 -8.45 0.2 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 126.673 1.989 . . . . 0.0 115.314 169.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 24.7 mmt180 -68.41 153.33 43.96 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 170.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 83.8 m-20 -90.19 -34.82 15.67 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 118.991 -0.528 . . . . 0.0 109.952 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 2.0 t-160 -140.24 122.18 15.57 Favored 'General case' 0 CA--C 1.514 -0.414 0 N-CA-C 104.262 -2.495 . . . . 0.0 104.262 -172.138 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 50.0 tp -128.46 131.57 48.4 Favored 'General case' 0 CA--C 1.509 -0.624 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 179.072 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 39.6 mt -109.57 121.94 63.38 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 N-CA-C 105.012 -2.218 . . . . 0.0 105.012 169.665 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 22.1 mt -98.26 125.16 51.63 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 177.501 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -104.21 119.45 38.97 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 171.022 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -147.6 151.46 36.27 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 124.692 1.197 . . . . 0.0 110.736 -172.405 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -88.19 121.31 30.44 Favored 'General case' 0 C--N 1.343 0.298 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 168.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 7.9 mm -54.2 -39.19 41.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 C-N-CA 124.362 1.065 . . . . 0.0 111.797 -173.572 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . 0.319 6.7 p 43.06 43.03 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.974 0 C-N-CA 126.316 1.846 . . . . 0.0 113.145 175.549 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 4.4 t -157.48 -175.33 5.33 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.946 1.698 . . . . 0.0 109.614 -174.476 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 16.1 tptt 63.29 176.16 0.16 Allowed 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 127.327 2.251 . . . . 0.0 113.433 171.625 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 9.3 ptpt -103.2 0.44 31.69 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 125.404 1.481 . . . . 0.0 112.978 -178.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 49.5 t30 -73.55 162.35 29.34 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.905 0.882 . . . . 0.0 109.08 -177.567 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.8 m -58.97 142.86 84.73 Favored Pre-proline 0 CA--C 1.545 0.783 0 C-N-CA 124.068 0.947 . . . . 0.0 111.816 -169.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -55.15 155.17 20.1 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 122.775 2.316 . . . . 0.0 112.167 170.169 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 70.6 4.62 53.44 Favored Glycine 0 CA--C 1.531 1.062 0 CA-C-O 118.655 -1.081 . . . . 0.0 114.859 174.421 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 20.8 m -86.04 147.97 25.95 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 119.849 1.825 . . . . 0.0 110.458 -172.161 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 15.7 ttp -87.88 137.66 32.14 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 123.435 0.694 . . . . 0.0 110.414 175.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 47.0 mtp -129.03 111.46 13.01 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 178.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 42.3 mm -99.03 115.62 40.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 177.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.9 mp -116.43 134.92 54.32 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 -174.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 20.5 mmm180 -104.66 138.86 40.35 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 123.084 0.553 . . . . 0.0 109.931 -177.464 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 38.8 t70 33.95 -100.27 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 115.463 1.653 . . . . 0.0 115.463 169.011 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -61.0 -24.13 65.93 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.789 1.236 . . . . 0.0 113.733 -174.219 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -73.68 -26.54 60.78 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 122.66 0.384 . . . . 0.0 110.568 178.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 49.2 t -72.2 -53.17 6.62 Favored Pre-proline 0 N--CA 1.445 -0.715 0 CA-C-O 116.888 -1.53 . . . . 0.0 110.756 -169.195 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.404 ' O ' HG23 ' A' ' 87' ' ' THR . 15.4 Cg_exo -61.92 -40.15 45.99 Favored 'Trans proline' 0 N--CA 1.448 -1.2 0 CA-C-N 121.992 1.747 . . . . 0.0 110.094 174.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -62.12 -30.35 70.97 Favored 'General case' 0 C--N 1.346 0.414 0 C-N-CA 123.364 0.666 . . . . 0.0 112.38 -174.271 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.502 HD13 ' C ' ' A' ' 85' ' ' LEU . 1.7 tm? -68.65 -47.08 67.47 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 171.14 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -64.19 -19.23 65.19 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 -169.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.404 HG23 ' O ' ' A' ' 83' ' ' PRO . 2.2 p -71.17 -17.79 62.52 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 -177.764 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 3.4 p30 -59.5 148.93 31.28 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -169.239 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -85.59 -13.54 48.48 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 118.816 -0.611 . . . . 0.0 112.618 -173.614 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 61.9 mt -70.29 -46.65 70.68 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 -178.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 5.0 m -78.1 119.1 76.04 Favored Pre-proline 0 CA--C 1.54 0.558 0 C-N-CA 124.263 1.025 . . . . 0.0 110.642 -174.285 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -81.96 -39.26 0.18 Allowed 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 121.573 1.515 . . . . 0.0 112.267 -177.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 24.3 m-70 -74.33 -29.67 61.71 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.358 0.663 . . . . 0.0 111.552 -171.194 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 90.6 mt-30 -74.53 -17.5 60.73 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 118.387 -0.816 . . . . 0.0 113.116 -169.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 47.5 tp -59.85 -35.04 73.93 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 119.692 1.133 . . . . 0.0 111.618 -172.277 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -65.66 -42.43 95.41 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 111.482 -0.647 . . . . 0.0 111.482 175.467 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 27.6 tp -70.29 -33.65 71.81 Favored 'General case' 0 CA--C 1.531 0.223 0 O-C-N 120.91 -1.347 . . . . 0.0 109.945 178.328 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -59.34 -50.33 74.41 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 118.908 0.776 . . . . 0.0 109.724 173.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -70.2 -24.74 63.17 Favored 'General case' 0 N--CA 1.457 -0.101 0 CA-C-O 118.682 -0.675 . . . . 0.0 112.02 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.406 HG13 ' HA ' ' A' ' 49' ' ' LEU . 2.5 t -65.09 -45.35 94.53 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 CA-C-N 119.451 1.023 . . . . 0.0 109.973 169.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 59.7 mt -64.91 -37.87 89.08 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 119.659 1.118 . . . . 0.0 109.705 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 18.6 m -61.92 -40.74 96.54 Favored 'General case' 0 C--O 1.224 -0.238 0 CA-C-N 118.605 0.638 . . . . 0.0 110.107 170.018 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.457 ' HA ' ' CD2' ' A' ' 106' ' ' PHE . . . -66.31 -33.88 76.73 Favored 'General case' 0 N--CA 1.448 -0.553 0 O-C-N 121.168 -0.957 . . . . 0.0 111.067 -179.759 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 6.4 mt -67.86 -34.25 76.32 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-N 118.929 0.786 . . . . 0.0 109.629 175.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 80.0 ttt180 -68.38 -36.43 79.16 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 118.846 -0.597 . . . . 0.0 110.06 172.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.457 ' CD2' ' HA ' ' A' ' 103' ' ' ALA . 15.4 m-30 -65.43 -43.38 90.68 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 119.305 0.957 . . . . 0.0 110.572 178.559 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 41.6 p -74.53 -23.25 58.79 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 118.571 0.623 . . . . 0.0 111.303 177.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 75.18 12.55 83.41 Favored Glycine 0 CA--C 1.531 1.086 0 N-CA-C 110.832 -0.907 . . . . 0.0 110.832 -169.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -96.84 22.16 8.63 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 118.766 1.283 . . . . 0.0 111.235 178.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -58.1 132.87 84.03 Favored Pre-proline 0 CA--C 1.544 0.727 0 C-N-CA 124.964 1.306 . . . . 0.0 109.656 171.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_exo -56.58 150.71 50.62 Favored 'Trans proline' 0 N--CA 1.46 -0.479 0 C-N-CA 123.351 2.701 . . . . 0.0 114.932 -178.485 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -59.88 -34.57 73.34 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.059 177.193 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 59.2 mttp -134.39 130.4 36.81 Favored 'General case' 0 C--O 1.232 0.16 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 173.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.443 HD12 ' H ' ' A' ' 115' ' ' THR . 18.2 tp -118.19 139.15 51.72 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 105.19 -2.152 . . . . 0.0 105.19 168.736 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.443 ' H ' HD12 ' A' ' 114' ' ' LEU . 0.2 OUTLIER -141.39 146.34 36.48 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 105.656 -1.979 . . . . 0.0 105.656 -177.669 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -135.37 136.1 41.22 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 119.729 1.15 . . . . 0.0 109.841 172.815 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 47.6 t -103.61 99.63 8.8 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 N-CA-C 103.61 -2.737 . . . . 0.0 103.61 169.278 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -87.24 145.43 19.74 Favored Glycine 0 N--CA 1.444 -0.825 0 N-CA-C 110.317 -1.113 . . . . 0.0 110.317 176.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 53.2 t -127.35 121.19 56.79 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.497 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 175.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 6.5 mt -71.88 132.48 84.87 Favored Pre-proline 0 CA--C 1.539 0.55 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 173.153 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -73.67 179.35 5.7 Favored 'Trans proline' 0 CA--C 1.541 0.848 0 C-N-CA 122.995 2.463 . . . . 0.0 111.91 179.146 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -115.47 -53.71 2.58 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.488 1.115 . . . . 0.0 110.032 177.446 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 56.1 p -110.25 -65.6 1.14 Allowed 'General case' 0 CA--C 1.535 0.365 0 CA-C-N 119.058 0.845 . . . . 0.0 111.954 -172.632 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 56.29 70.34 0.65 Allowed 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.674 1.99 . . . . 0.0 113.702 176.187 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -128.79 169.83 12.05 Favored Pre-proline 0 CA--C 1.542 0.658 0 CA-C-O 118.331 -0.843 . . . . 0.0 109.421 169.695 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_exo -65.92 85.21 0.24 Allowed 'Trans proline' 0 CA--C 1.547 1.126 0 C-N-CA 123.617 2.878 . . . . 0.0 113.34 -178.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -175.83 151.18 1.1 Allowed 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 104.404 -2.443 . . . . 0.0 104.404 176.368 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -114.3 161.84 12.83 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 -169.654 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 107.42 141.74 10.11 Favored Glycine 0 CA--C 1.528 0.878 0 N-CA-C 106.85 -2.5 . . . . 0.0 106.85 -169.514 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 68.7 mt -78.54 158.17 28.62 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 118.645 1.223 . . . . 0.0 108.971 175.607 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 36.3 p -68.19 164.92 38.05 Favored Pre-proline 0 C--O 1.238 0.462 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 168.304 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -56.69 -33.64 94.17 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 121.477 1.451 . . . . 0.0 110.76 169.334 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 5.9 m -66.48 -43.68 84.73 Favored 'General case' 0 CA--C 1.535 0.37 0 O-C-N 122.201 -0.312 . . . . 0.0 110.183 -178.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 94.4 t -88.48 -28.43 5.37 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 CA-C-N 118.683 0.674 . . . . 0.0 110.075 -172.224 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -55.12 -45.85 75.57 Favored 'General case' 0 CA--C 1.533 0.31 0 O-C-N 120.667 -1.27 . . . . 0.0 107.774 167.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -75.48 18.5 0.22 Allowed 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 114.152 1.167 . . . . 0.0 114.152 176.148 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 25.8 mmm -115.03 -8.44 12.46 Favored 'General case' 0 N--CA 1.437 -1.084 0 C-N-CA 125.743 1.617 . . . . 0.0 107.965 169.215 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 96.3 mt -59.5 -49.65 82.85 Favored 'Isoleucine or valine' 0 C--N 1.346 0.423 0 CA-C-N 120.379 1.445 . . . . 0.0 107.859 174.582 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -70.71 -53.73 8.97 Favored Pre-proline 0 CA--C 1.536 0.408 0 CA-C-O 117.121 -1.418 . . . . 0.0 109.584 -175.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -38.75 -52.63 2.07 Favored 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 123.876 3.051 . . . . 0.0 113.822 169.113 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -74.19 -45.85 45.78 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.085 -1.416 . . . . 0.0 110.808 -172.137 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -62.28 -36.38 81.89 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-N 118.982 0.81 . . . . 0.0 109.722 179.453 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -64.2 -36.0 82.65 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 177.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 11.9 mm100 -74.56 -31.09 61.98 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-O 117.869 -1.063 . . . . 0.0 112.266 172.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 86.7 t -59.83 -46.25 93.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-N 120.446 1.475 . . . . 0.0 108.154 169.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 74.4 mt -62.68 -41.17 98.95 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 118.714 0.688 . . . . 0.0 110.42 177.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -62.78 -41.04 99.08 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 118.813 0.733 . . . . 0.0 111.0 179.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -66.55 -46.37 76.3 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 177.366 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 78.0 mt -57.76 -37.17 73.16 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 122.514 0.326 . . . . 0.0 110.228 177.391 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 67.6 mtp180 -64.07 -19.09 64.98 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 118.019 -0.991 . . . . 0.0 112.284 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -61.89 -30.12 70.67 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 120.182 1.355 . . . . 0.0 110.546 174.17 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 49.1 m -101.16 31.11 3.79 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.021 1.328 . . . . 0.0 111.447 174.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 66.48 21.5 70.66 Favored Glycine 0 CA--C 1.53 0.974 0 CA-C-O 119.251 -0.749 . . . . 0.0 114.248 169.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 81.6 t -72.74 120.03 20.61 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 CA-C-N 118.572 1.186 . . . . 0.0 107.934 178.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -103.45 94.35 5.43 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 105.744 -1.947 . . . . 0.0 105.744 169.625 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -74.21 144.14 44.85 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 175.701 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 9.2 mm -112.04 127.88 26.24 Favored Pre-proline 0 CA--C 1.53 0.191 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -62.6 109.58 0.91 Allowed 'Trans proline' 0 N--CA 1.458 -0.599 0 N-CA-C 107.425 -1.798 . . . . 0.0 107.425 170.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 70.2 ttt-85 56.0 -9.43 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 127.799 2.44 . . . . 0.0 116.809 179.676 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 4.3 m 56.57 1.66 0.08 Allowed 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 126.524 1.93 . . . . 0.0 114.742 -169.564 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -157.1 143.92 18.4 Favored 'General case' 0 C--O 1.239 0.53 0 O-C-N 120.646 -1.284 . . . . 0.0 108.2 -175.32 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 18.1 m . . . . . 0 C--O 1.252 1.237 0 C-N-CA 124.506 1.122 . . . . 0.0 110.354 -169.963 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.0 ttt . . . . . 0 N--CA 1.497 1.906 0 CA-C-O 120.728 0.299 . . . . 0.0 110.916 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 28.5 tpt85 -66.24 120.75 13.79 Favored 'General case' 0 N--CA 1.469 0.486 0 O-C-N 119.886 -1.759 . . . . 0.0 109.466 -175.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.8 mt -120.21 127.39 75.9 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 -172.01 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 19.4 tp -121.23 138.36 54.26 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 105.256 -2.128 . . . . 0.0 105.256 168.519 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 92.6 t -124.01 110.58 25.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 -177.178 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.435 HD13 ' HA ' ' A' ' 6' ' ' LEU . 2.8 mm? -93.73 125.37 38.31 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 -174.367 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -99.58 127.7 9.33 Favored Glycine 0 CA--C 1.508 -0.405 0 N-CA-C 106.17 -2.772 . . . . 0.0 106.17 170.435 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.1 m -138.79 167.15 21.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 117.595 0.697 . . . . 0.0 111.272 -169.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 109.59 169.79 20.27 Favored Glycine 0 CA--C 1.525 0.709 0 C-N-CA 125.973 1.749 . . . . 0.0 110.403 179.099 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.557 HD21 ' HB2' ' A' ' 12' ' ' LEU . 8.7 t30 -87.02 104.95 16.79 Favored 'General case' 0 N--CA 1.452 -0.336 0 O-C-N 121.865 -0.785 . . . . 0.0 110.794 -172.45 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.2 pt -63.67 32.99 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.892 0 N-CA-C 115.501 1.667 . . . . 0.0 115.501 175.036 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.557 ' HB2' HD21 ' A' ' 10' ' ' ASN . 42.4 mt -127.39 0.82 6.32 Favored 'General case' 0 C--O 1.222 -0.386 0 CA-C-N 120.504 1.502 . . . . 0.0 108.14 168.785 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.528 ' HB2' HD22 ' A' ' 10' ' ' ASN . 1.3 mp -118.06 52.28 1.02 Allowed 'General case' 0 N--CA 1.441 -0.916 0 C-N-CA 124.002 0.921 . . . . 0.0 112.074 -168.633 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER 53.8 -108.16 0.41 Allowed 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 122.862 0.465 . . . . 0.0 111.498 171.239 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -57.13 -25.18 58.42 Favored 'General case' 0 C--O 1.224 -0.287 0 CA-C-O 118.209 -0.901 . . . . 0.0 113.009 176.357 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -70.53 -0.03 7.7 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 121.535 1.971 . . . . 0.0 113.542 -177.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -89.0 -16.08 32.57 Favored 'General case' 0 N--CA 1.431 -1.39 0 CA-C-O 115.92 -1.99 . . . . 0.0 108.957 169.389 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 5.9 tp -58.34 -38.0 66.71 Favored 'Isoleucine or valine' 0 C--N 1.342 0.278 0 CA-C-N 122.829 2.559 . . . . 0.0 111.798 -169.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -59.71 -38.83 94.42 Favored Glycine 0 C--N 1.338 0.679 0 N-CA-C 110.572 -1.011 . . . . 0.0 110.572 176.304 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 79.0 t -73.29 -48.44 42.6 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.652 0 CA-C-O 118.641 -0.695 . . . . 0.0 109.452 174.374 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 15.6 mmm180 -59.48 -36.14 75.45 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 120.367 1.439 . . . . 0.0 112.621 -176.421 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 33.6 mt -62.18 -46.7 95.86 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 CA-C-N 120.418 1.463 . . . . 0.0 109.983 179.236 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 10.3 m -72.65 -29.33 30.03 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 O-C-N 121.298 -0.876 . . . . 0.0 110.887 -174.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -70.44 -41.72 72.47 Favored 'General case' 0 CA--C 1.528 0.102 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 175.022 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.41 -37.21 82.65 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-O 118.735 -0.65 . . . . 0.0 110.444 178.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 11.9 tp -62.45 -42.59 99.57 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 118.867 0.758 . . . . 0.0 109.939 174.297 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -62.78 -41.19 99.15 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 118.461 0.573 . . . . 0.0 110.815 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -67.42 -42.69 82.79 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.193 0.997 . . . . 0.0 110.635 179.08 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 88.3 mtt180 -94.43 -38.89 10.72 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 114.837 1.421 . . . . 0.0 114.837 -169.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 63.3 m-85 -113.84 137.68 51.32 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 121.391 1.905 . . . . 0.0 114.207 -169.293 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 47.0 mm -85.68 141.84 13.97 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 N-CA-C 104.382 -2.451 . . . . 0.0 104.382 167.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 46.5 mt -135.98 152.87 76.42 Favored Pre-proline 0 CA--C 1.539 0.55 0 C-N-CA 123.496 0.718 . . . . 0.0 110.518 -169.474 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_exo -59.27 155.2 41.75 Favored 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 123.336 2.691 . . . . 0.0 111.829 169.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -63.01 -31.09 72.14 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -171.232 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 26.1 p90 -70.63 -13.96 62.29 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 118.358 -0.83 . . . . 0.0 112.547 179.149 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 42.7 t -94.91 129.25 45.33 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 C-N-CA 124.114 0.966 . . . . 0.0 108.639 178.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -136.13 146.06 46.53 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-O 121.252 0.548 . . . . 0.0 110.607 170.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -105.28 130.35 56.65 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 N-CA-C 105.648 -1.982 . . . . 0.0 105.648 169.024 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 64.5 tp -121.61 126.41 49.02 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-O 121.311 0.577 . . . . 0.0 109.732 175.088 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -77.87 115.69 17.81 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 169.523 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -64.58 -64.25 3.71 Favored Glycine 0 CA--C 1.531 1.074 0 N-CA-C 108.225 -1.95 . . . . 0.0 108.225 169.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 79.2 106.0 0.23 Allowed Glycine 0 C--N 1.34 0.793 0 N-CA-C 110.765 -0.934 . . . . 0.0 110.765 171.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . 0.254 40.2 p 50.18 61.18 3.33 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 -173.434 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -89.01 -140.36 0.13 Allowed 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 113.608 -1.633 . . . . 0.0 110.925 -169.304 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 75.93 118.85 0.13 Allowed Glycine 0 CA--C 1.537 1.417 0 N-CA-C 109.031 -1.628 . . . . 0.0 109.031 -168.605 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 1.6 mmt 61.59 -29.37 0.06 Allowed 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 127.521 2.328 . . . . 0.0 116.411 -173.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -59.47 -21.42 60.06 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 118.998 0.817 . . . . 0.0 112.769 -175.03 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 95.8 mt -91.79 9.63 31.88 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 -171.339 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.5 tt -73.15 79.94 1.26 Allowed 'General case' 0 C--O 1.233 0.213 0 CA-C-O 124.843 2.258 . . . . 0.0 110.827 -179.035 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 145.13 -33.64 1.59 Allowed Glycine 0 C--N 1.308 -0.989 0 CA-C-N 110.142 -3.208 . . . . 0.0 111.028 172.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -68.24 -35.3 77.72 Favored 'General case' 0 N--CA 1.466 0.345 0 O-C-N 121.933 -0.745 . . . . 0.0 111.525 -176.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 38.1 mtp -72.38 0.56 9.79 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.891 1.277 . . . . 0.0 113.151 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -75.63 149.13 38.28 Favored 'General case' 0 N--CA 1.457 -0.087 0 N-CA-C 113.777 1.029 . . . . 0.0 113.777 -169.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 55.26 18.15 2.37 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 128.317 2.647 . . . . 0.0 116.412 168.695 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 27.1 mmt180 -77.91 149.33 34.24 Favored 'General case' 0 N--CA 1.473 0.698 0 O-C-N 120.798 -1.189 . . . . 0.0 109.416 -178.312 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -80.97 -39.55 25.84 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 177.071 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 1.8 m170 -128.07 136.28 50.99 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 169.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 29.2 tp -130.92 123.72 29.53 Favored 'General case' 0 CA--C 1.505 -0.78 0 N-CA-C 105.851 -1.907 . . . . 0.0 105.851 168.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 18.5 mt -111.35 122.41 65.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 104.657 -2.349 . . . . 0.0 104.657 178.038 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 21.0 mt -102.94 126.56 57.18 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 N-CA-C 105.881 -1.896 . . . . 0.0 105.881 -179.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -111.32 119.09 37.72 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 105.261 -2.126 . . . . 0.0 105.261 171.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -149.1 149.93 31.88 Favored 'General case' 0 C--O 1.24 0.557 0 O-C-N 123.4 0.438 . . . . 0.0 110.202 -175.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -68.64 132.01 46.17 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 104.536 -2.394 . . . . 0.0 104.536 168.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.6 tt -74.95 -38.07 42.58 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.778 0 O-C-N 121.582 -0.699 . . . . 0.0 110.797 -169.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.2 t 45.62 44.43 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.822 0 C-N-CA 125.919 1.688 . . . . 0.0 111.144 176.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 67.2 m -138.75 -73.31 0.39 Allowed 'General case' 0 N--CA 1.471 0.577 0 O-C-N 121.54 -0.725 . . . . 0.0 112.552 -169.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 29.3 ttmt -83.02 154.68 24.33 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 122.758 0.423 . . . . 0.0 109.871 -169.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.32 42.8 1.11 Allowed 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 125.283 1.433 . . . . 0.0 109.033 -172.158 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 40.7 t-20 -89.74 172.47 8.9 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 124.26 1.024 . . . . 0.0 108.915 -171.358 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 10.7 m -60.25 133.95 90.7 Favored Pre-proline 0 CA--C 1.544 0.726 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 179.066 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -57.82 153.66 42.41 Favored 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 122.392 2.061 . . . . 0.0 111.615 174.127 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 71.53 9.38 68.88 Favored Glycine 0 CA--C 1.533 1.163 0 CA-C-O 119.703 -0.498 . . . . 0.0 113.803 176.111 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 29.3 m -89.03 146.56 24.78 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 124.971 1.309 . . . . 0.0 107.545 174.244 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 30.0 ttp -101.78 143.13 32.08 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 175.328 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 17.9 ttm -126.5 126.65 44.08 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 179.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 44.0 mm -107.57 121.19 60.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 -179.108 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -115.71 129.37 56.44 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 -174.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 81.0 mtm180 -90.9 173.45 7.97 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 118.293 0.497 . . . . 0.0 110.288 179.159 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -33.39 -66.15 0.16 Allowed 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 116.215 1.931 . . . . 0.0 116.215 -169.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -77.08 -12.34 59.93 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -172.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 21.6 mm-40 -91.78 -21.95 20.42 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 118.558 -0.734 . . . . 0.0 110.664 -178.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.447 HG22 ' HB3' ' A' ' 116' ' ' LEU . 63.0 t -62.97 -51.13 73.25 Favored Pre-proline 0 C--N 1.344 0.331 0 CA-C-N 120.168 1.349 . . . . 0.0 110.967 -179.111 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -66.65 -37.8 20.52 Favored 'Trans proline' 0 N--CA 1.444 -1.393 0 CA-C-N 121.423 1.544 . . . . 0.0 109.708 -179.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.97 -29.04 69.37 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.298 0.639 . . . . 0.0 111.812 -176.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.521 HD13 ' C ' ' A' ' 85' ' ' LEU . 1.1 tm? -68.31 -47.65 67.01 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 169.743 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.557 ' HB3' ' HB2' ' A' ' 98' ' ' ALA . 12.9 m-85 -64.63 -11.2 32.71 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 114.041 1.126 . . . . 0.0 114.041 -169.422 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 24.9 p -66.76 -13.65 61.66 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 113.784 1.031 . . . . 0.0 113.784 -175.281 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -59.29 135.03 57.52 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.362 0.665 . . . . 0.0 110.652 -172.601 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -87.04 -12.48 47.22 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 -170.394 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 76.2 mt -67.82 -43.55 86.11 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 N-CA-C 107.421 -1.325 . . . . 0.0 107.421 174.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -65.78 130.84 94.57 Favored Pre-proline 0 N--CA 1.445 -0.722 0 C-N-CA 125.802 1.641 . . . . 0.0 110.768 -173.132 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -80.78 -87.55 0.0 OUTLIER 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 123.059 2.506 . . . . 0.0 111.416 177.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 19.4 m80 -66.98 -32.15 73.2 Favored 'General case' 0 N--CA 1.469 0.477 0 O-C-N 120.645 -1.285 . . . . 0.0 110.976 -170.312 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.418 ' H ' ' CD ' ' A' ' 94' ' ' GLN . 26.2 mp0 -53.86 -42.65 68.8 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 126.365 1.866 . . . . 0.0 109.93 173.536 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.403 ' O ' ' HB3' ' A' ' 98' ' ' ALA . 3.1 tm? -70.7 -37.1 73.56 Favored 'General case' 0 N--CA 1.457 -0.117 0 O-C-N 121.571 -0.705 . . . . 0.0 109.671 179.401 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -59.69 -38.87 94.45 Favored Glycine 0 CA--C 1.53 0.983 0 O-C-N 121.254 -0.904 . . . . 0.0 111.44 171.52 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.445 HD23 ' CZ ' ' A' ' 86' ' ' PHE . 24.3 tp -70.19 -28.13 65.06 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 118.37 1.085 . . . . 0.0 110.461 174.423 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.557 ' HB2' ' HB3' ' A' ' 86' ' ' PHE . . . -56.23 -46.87 79.38 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 120.141 1.337 . . . . 0.0 109.089 169.689 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -72.56 -24.21 61.08 Favored 'General case' 0 C--O 1.231 0.08 0 CA-C-O 119.193 -0.432 . . . . 0.0 111.952 -179.163 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 74.2 t -65.45 -46.16 90.82 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 169.19 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 76.1 mt -64.03 -35.28 80.19 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 118.961 0.801 . . . . 0.0 110.433 -179.053 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 19.7 m -63.97 -43.29 96.19 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 118.796 0.725 . . . . 0.0 110.197 170.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -64.9 -41.5 95.54 Favored 'General case' 0 N--CA 1.452 -0.367 0 O-C-N 120.972 -1.08 . . . . 0.0 111.387 -178.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -65.33 -31.58 72.79 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 124.486 1.114 . . . . 0.0 110.318 176.148 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 19.1 tpp180 -70.91 -37.85 72.96 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 118.839 -0.6 . . . . 0.0 109.897 173.58 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 15.2 m-30 -65.44 -42.46 92.4 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 118.773 0.715 . . . . 0.0 110.405 -179.572 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 31.2 p -74.96 -21.5 59.13 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 118.304 0.502 . . . . 0.0 111.603 178.543 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 74.34 11.19 82.31 Favored Glycine 0 CA--C 1.534 1.262 0 N-CA-C 111.066 -0.814 . . . . 0.0 111.066 -169.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -83.74 2.27 38.72 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 118.77 1.285 . . . . 0.0 111.944 177.041 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -48.67 134.63 13.69 Favored Pre-proline 0 CA--C 1.549 0.92 0 C-N-CA 125.745 1.618 . . . . 0.0 110.989 177.009 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -52.0 150.02 19.49 Favored 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 124.082 3.188 . . . . 0.0 114.258 179.65 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 31.7 mmmt -63.26 -28.92 70.35 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 118.955 -0.545 . . . . 0.0 111.183 177.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 36.0 ttmt -146.69 110.95 5.1 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 171.226 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 26.2 tp -90.1 144.58 25.76 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 169.119 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -141.45 146.46 36.53 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 171.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.447 ' HB3' HG22 ' A' ' 82' ' ' VAL . 0.8 OUTLIER -131.4 138.99 49.34 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 120.408 1.458 . . . . 0.0 110.436 172.78 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 43.6 t -105.17 105.93 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 N-CA-C 104.808 -2.293 . . . . 0.0 104.808 168.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -90.07 146.05 18.5 Favored Glycine 0 CA--C 1.522 0.516 0 N-CA-C 110.484 -1.046 . . . . 0.0 110.484 174.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.455 HG13 ' SD ' ' A' ' 137' ' ' MET . 71.0 t -119.31 138.64 49.32 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 175.575 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 14.4 mm -84.94 128.23 61.3 Favored Pre-proline 0 CA--C 1.543 0.679 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 169.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -70.12 152.3 67.41 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 122.786 2.324 . . . . 0.0 113.365 -176.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -99.58 -42.41 6.92 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 169.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 20.2 m -142.66 151.06 41.02 Favored 'General case' 0 C--N 1.344 0.348 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 176.641 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.5 tp -153.77 49.61 0.67 Allowed 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 118.719 0.691 . . . . 0.0 111.779 -172.275 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -120.32 168.93 9.45 Favored Pre-proline 0 N--CA 1.477 0.919 0 CA-C-O 117.638 -1.172 . . . . 0.0 110.072 -175.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -62.89 84.3 0.11 Allowed 'Trans proline' 0 CA--C 1.547 1.167 0 C-N-CA 124.138 3.225 . . . . 0.0 113.915 -178.219 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -176.52 156.53 1.52 Allowed 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 105.212 -2.144 . . . . 0.0 105.212 174.527 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -130.54 162.17 39.03 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 CA-C-O 121.772 0.796 . . . . 0.0 110.844 174.817 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 122.36 121.96 2.76 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 103.387 -3.885 . . . . 0.0 103.387 -168.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 74.8 mt -78.86 152.21 31.38 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 -171.108 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 68.6 p -69.8 166.04 35.96 Favored Pre-proline 0 C--O 1.241 0.632 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 169.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -60.21 -27.86 85.73 Favored 'Trans proline' 0 CA--C 1.539 0.727 0 CA-C-N 119.677 0.92 . . . . 0.0 110.466 169.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 5.1 m -69.85 -42.11 73.98 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 118.505 0.593 . . . . 0.0 110.35 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 72.7 t -88.46 -36.6 9.33 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 CA-C-O 119.175 -0.44 . . . . 0.0 110.346 -169.348 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -50.7 -44.59 58.01 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 119.204 0.911 . . . . 0.0 109.938 169.428 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -77.76 5.2 9.92 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 113.789 1.033 . . . . 0.0 113.789 -175.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . 0.455 ' SD ' HG13 ' A' ' 119' ' ' VAL . 75.3 mtp -98.18 -7.28 29.68 Favored 'General case' 0 N--CA 1.439 -1.015 0 CA-C-O 117.387 -1.292 . . . . 0.0 110.59 169.612 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 94.7 mt -57.67 -47.25 86.06 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 CA-C-N 120.225 1.375 . . . . 0.0 108.391 174.317 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 58.3 mt-10 -73.56 -48.65 6.83 Favored Pre-proline 0 CA--C 1.542 0.667 0 CA-C-O 117.534 -1.222 . . . . 0.0 110.637 -175.611 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -43.38 -54.38 3.6 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 124.611 3.541 . . . . 0.0 112.645 168.686 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.35 -42.52 71.73 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 114.788 -1.096 . . . . 0.0 110.755 -174.283 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 33.1 mt -54.69 -44.12 73.09 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-N 118.961 0.8 . . . . 0.0 109.45 173.367 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -64.44 -34.65 78.68 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 119.075 0.852 . . . . 0.0 110.887 -176.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -78.43 -32.8 48.74 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 119.231 0.923 . . . . 0.0 112.021 176.52 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 54.0 t -59.59 -47.99 88.97 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 169.355 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 44.7 mt -64.47 -36.97 85.91 Favored 'General case' 0 CA--C 1.519 -0.244 0 C-N-CA 123.061 0.544 . . . . 0.0 110.67 -178.518 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -58.18 -36.38 72.98 Favored 'General case' 0 N--CA 1.457 -0.118 0 CA-C-N 118.419 0.554 . . . . 0.0 111.21 179.216 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -63.0 -44.84 94.9 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 117.985 0.357 . . . . 0.0 110.91 177.439 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 6.2 mp -63.21 -40.26 96.99 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 176.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 87.0 mtt180 -64.81 -18.87 65.5 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 117.411 -1.281 . . . . 0.0 111.759 -179.081 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 69.8 mt-10 -56.26 -30.15 62.05 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 120.53 1.514 . . . . 0.0 112.138 176.359 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 19.4 m -113.38 31.53 6.41 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.294 1.038 . . . . 0.0 111.311 179.211 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 65.42 29.98 76.5 Favored Glycine 0 CA--C 1.531 1.05 0 CA-C-O 118.73 -1.039 . . . . 0.0 113.583 175.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 47.1 t -111.14 103.32 15.29 Favored 'Isoleucine or valine' 0 C--N 1.34 0.175 0 N-CA-C 106.684 -1.599 . . . . 0.0 106.684 176.299 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -100.8 144.87 29.24 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 169.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -78.68 157.5 28.59 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.388 0.675 . . . . 0.0 111.357 177.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 11.7 mt -99.14 112.43 63.09 Favored Pre-proline 0 CA--C 1.532 0.263 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -66.98 104.63 0.86 Allowed 'Trans proline' 0 N--CA 1.458 -0.591 0 N-CA-C 107.942 -1.599 . . . . 0.0 107.942 175.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 69.5 ttt180 57.29 -14.08 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 128.344 2.658 . . . . 0.0 116.98 -178.06 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 2.9 t 60.2 -178.15 0.1 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.447 1.499 . . . . 0.0 111.047 -169.648 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -148.71 141.53 24.64 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 125.654 1.581 . . . . 0.0 108.828 -179.007 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 28.9 m . . . . . 0 C--O 1.252 1.231 0 C-N-CA 125.121 1.368 . . . . 0.0 108.526 -177.074 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.0 tpt . . . . . 0 N--CA 1.499 1.991 0 N-CA-C 110.437 -0.208 . . . . 0.0 110.437 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 7.0 ptp180 -145.32 126.5 14.73 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 174.43 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 38.5 mt -142.69 143.8 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-N 119.612 1.096 . . . . 0.0 110.85 -169.104 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 19.7 tp -131.88 109.86 10.39 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 104.168 -2.531 . . . . 0.0 104.168 167.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.422 HG12 HG12 ' A' ' 23' ' ' VAL . 39.2 t -85.84 118.72 32.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 102.441 -3.17 . . . . 0.0 102.441 171.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -119.9 105.52 11.17 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-O 121.114 0.483 . . . . 0.0 110.411 -168.673 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -87.46 115.62 4.36 Favored Glycine 0 N--CA 1.447 -0.614 0 N-CA-C 107.651 -2.18 . . . . 0.0 107.651 174.298 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 14.8 m -123.46 -176.38 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.633 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 174.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 111.49 124.71 4.54 Favored Glycine 0 N--CA 1.441 -1.031 0 N-CA-C 106.75 -2.54 . . . . 0.0 106.75 -175.002 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.463 HD21 ' HB2' ' A' ' 12' ' ' LEU . 1.6 t30 -64.03 109.46 1.82 Allowed 'General case' 0 N--CA 1.442 -0.85 0 C-N-CA 124.284 1.034 . . . . 0.0 109.917 -169.539 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.3 pt -75.65 37.77 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 C-N-CA 124.642 1.177 . . . . 0.0 113.463 -178.685 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.463 ' HB2' HD21 ' A' ' 10' ' ' ASN . 20.8 mt -124.24 0.18 8.35 Favored 'General case' 0 CA--C 1.535 0.398 0 O-C-N 121.118 -0.989 . . . . 0.0 108.502 169.619 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.2 mp -132.56 72.66 1.5 Allowed 'General case' 0 C--N 1.346 0.446 0 N-CA-C 104.895 -2.261 . . . . 0.0 104.895 -173.454 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 98.9 m 17.85 -92.84 0.0 OUTLIER 'General case' 0 CA--C 1.522 -0.115 0 C-N-CA 127.091 2.156 . . . . 0.0 115.364 175.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -53.73 -30.74 45.4 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 125.028 1.331 . . . . 0.0 113.003 -169.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -64.61 -31.54 72.81 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 119.592 1.087 . . . . 0.0 111.901 179.513 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.14 -12.55 8.79 Favored 'General case' 0 N--CA 1.437 -1.091 0 CA-C-O 116.187 -1.863 . . . . 0.0 111.277 176.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 5.4 tp -49.55 -42.13 16.68 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.507 0 CA-C-N 121.813 2.097 . . . . 0.0 110.539 179.157 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -66.65 -36.2 90.97 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 111.256 -0.738 . . . . 0.0 111.256 -176.447 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 69.8 t -67.81 -45.55 84.08 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 172.313 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 20.7 mmt180 -61.53 -29.14 69.81 Favored 'General case' 0 C--O 1.225 -0.201 0 CA-C-O 117.282 -1.342 . . . . 0.0 112.055 178.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 6.3 mm -60.93 -53.11 53.62 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-N 120.682 1.583 . . . . 0.0 108.736 176.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.422 HG12 HG12 ' A' ' 5' ' ' VAL . 34.1 m -71.36 -32.24 46.09 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-N 119.199 0.909 . . . . 0.0 111.505 -173.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 63.4 mt-10 -64.89 -49.57 69.95 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 118.49 0.586 . . . . 0.0 109.883 173.456 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.1 -36.5 83.8 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 119.198 -0.43 . . . . 0.0 110.231 179.031 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 8.2 tp -62.4 -40.42 96.45 Favored 'General case' 0 C--O 1.225 -0.227 0 CA-C-N 119.49 1.041 . . . . 0.0 109.36 -179.217 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -67.83 -25.47 65.58 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 121.339 0.59 . . . . 0.0 112.303 -178.309 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -81.86 -39.29 24.13 Favored 'General case' 0 N--CA 1.436 -1.128 0 C-N-CA 126.219 1.808 . . . . 0.0 109.685 175.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 23.4 mmt85 -89.63 -32.55 17.03 Favored 'General case' 0 C--O 1.231 0.099 0 CA-C-O 118.662 -0.685 . . . . 0.0 112.1 -169.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -128.22 147.73 50.59 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 118.944 0.793 . . . . 0.0 111.334 -176.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 51.6 mm -97.11 138.97 20.64 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 103.834 -2.654 . . . . 0.0 103.834 168.014 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -117.57 153.38 50.44 Favored Pre-proline 0 CA--C 1.539 0.542 0 C-N-CA 123.277 0.631 . . . . 0.0 111.469 -169.362 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -61.03 161.0 23.76 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 123.711 2.941 . . . . 0.0 112.144 169.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -63.42 -32.94 74.51 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -175.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 7.5 p90 -75.17 -10.25 59.29 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 -179.207 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 96.7 t -92.31 122.93 44.21 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 173.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -114.66 127.34 55.71 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 106.703 -1.591 . . . . 0.0 106.703 169.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -93.98 118.33 39.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 105.076 -2.194 . . . . 0.0 105.076 168.559 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 54.1 tp -118.86 132.21 56.1 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 122.902 0.481 . . . . 0.0 110.352 178.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -91.29 120.99 32.65 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 169.154 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -106.7 -22.5 7.65 Favored Glycine 0 CA--C 1.536 1.361 0 CA-C-O 118.437 -1.202 . . . . 0.0 113.6 171.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 56.05 -110.84 2.16 Favored Glycine 0 C--N 1.342 0.897 0 CA-C-N 119.878 1.839 . . . . 0.0 112.329 172.071 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 75.7 p -79.99 7.21 9.46 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 125.365 1.466 . . . . 0.0 112.557 -172.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -57.82 -59.3 5.44 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 114.291 1.219 . . . . 0.0 114.291 -170.033 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 56.72 -112.33 3.37 Favored Glycine 0 CA--C 1.532 1.144 0 N-CA-C 109.846 -1.302 . . . . 0.0 109.846 -170.269 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 8.2 tpt -64.19 -21.41 66.55 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.319 1.048 . . . . 0.0 113.449 -176.506 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -56.33 -17.67 8.47 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 114.545 1.313 . . . . 0.0 114.545 -170.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 8.8 mt -98.24 17.71 18.01 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 119.499 1.045 . . . . 0.0 112.991 -169.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.687 ' HA ' HG13 ' A' ' 100' ' ' VAL . 10.2 tt -48.04 -50.74 26.88 Favored 'General case' 0 C--N 1.343 0.314 0 N-CA-C 112.764 0.654 . . . . 0.0 112.764 -174.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -80.31 -29.67 44.19 Favored Glycine 0 CA--C 1.528 0.848 0 CA-C-O 119.659 -0.523 . . . . 0.0 111.952 -178.035 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -86.94 -22.7 25.47 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 114.267 1.21 . . . . 0.0 114.267 -169.053 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.413 ' SD ' HG11 ' A' ' 100' ' ' VAL . 47.6 mtp -78.14 -15.64 58.67 Favored 'General case' 0 CA--C 1.535 0.394 0 O-C-N 121.537 -0.727 . . . . 0.0 111.108 173.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.09 150.37 45.56 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 123.708 0.803 . . . . 0.0 112.026 -169.324 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . 0.282 14.4 p30 55.34 17.24 2.03 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 127.923 2.489 . . . . 0.0 117.324 170.048 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.5 159.02 35.04 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 169.155 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -80.61 -52.18 7.88 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 173.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -117.22 147.11 42.79 Favored 'General case' 0 CA--C 1.513 -0.478 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 168.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -134.97 122.56 22.05 Favored 'General case' 0 CA--C 1.508 -0.661 0 N-CA-C 104.698 -2.334 . . . . 0.0 104.698 175.293 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 3.0 mt -104.42 106.07 19.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 106.45 -1.685 . . . . 0.0 106.45 176.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.547 HD13 HD11 ' A' ' 97' ' ' LEU . 27.4 mt -79.99 124.76 38.45 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 N-CA-C 105.074 -2.195 . . . . 0.0 105.074 169.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -113.28 121.07 43.3 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 104.121 -2.548 . . . . 0.0 104.121 168.542 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 41.7 t0 -163.67 156.37 18.05 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 123.592 0.757 . . . . 0.0 110.23 -175.237 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -83.25 142.67 30.96 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 169.008 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 72.1 mt -77.07 -44.29 31.42 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 -175.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 14.6 t 53.93 43.46 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.151 0 C-N-CA 124.367 1.067 . . . . 0.0 109.66 -172.059 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 2.4 m -153.76 178.81 9.48 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.212 1.405 . . . . 0.0 109.639 175.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . 0.288 30.6 ttmt 67.61 154.69 0.1 Allowed 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 127.968 2.507 . . . . 0.0 113.345 175.557 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 10.3 ptpt -85.14 -5.65 59.33 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 127.205 2.202 . . . . 0.0 114.774 -169.548 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 33.9 t-20 -74.38 169.61 17.32 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.221 0.608 . . . . 0.0 109.619 -173.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 4.1 m -57.65 146.31 66.1 Favored Pre-proline 0 CA--C 1.548 0.903 0 C-N-CA 124.111 0.964 . . . . 0.0 112.234 -169.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_exo -53.09 148.13 31.84 Favored 'Trans proline' 0 CA--C 1.535 0.573 0 C-N-CA 124.176 3.251 . . . . 0.0 113.178 171.366 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.483 ' HA3' HG22 ' A' ' 133' ' ' THR . . . 74.2 0.01 55.29 Favored Glycine 0 CA--C 1.532 1.096 0 CA-C-O 119.221 -0.766 . . . . 0.0 114.684 174.315 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 27.3 m -73.28 143.39 47.03 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 119.026 1.413 . . . . 0.0 111.155 -169.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 11.0 ttp -85.22 132.5 34.27 Favored 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 169.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 65.5 mtm -133.45 127.59 33.63 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 170.071 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.625 HD12 ' HG3' ' A' ' 144' ' ' GLN . 18.6 mm -108.03 124.86 64.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 -173.308 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.5 mp -121.33 134.59 55.14 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 -174.293 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 53.1 mtt85 -86.23 174.02 9.38 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.789 0.835 . . . . 0.0 110.016 -177.399 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -40.59 -52.52 2.85 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 115.068 1.507 . . . . 0.0 115.068 -172.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -90.34 -13.81 34.4 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 113.056 0.762 . . . . 0.0 113.056 -175.371 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -77.61 -37.17 50.84 Favored 'General case' 0 C--N 1.339 0.118 0 CA-C-N 118.551 0.614 . . . . 0.0 109.956 -173.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.537 HG12 ' CE2' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -64.29 -49.52 72.2 Favored Pre-proline 0 CA--C 1.534 0.33 0 CA-C-O 117.605 -1.188 . . . . 0.0 112.822 -175.345 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_exo -54.96 -39.6 89.91 Favored 'Trans proline' 0 CA--C 1.539 0.757 0 CA-C-N 120.997 1.392 . . . . 0.0 111.557 176.339 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -76.16 -7.98 56.0 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 176.633 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -92.45 -38.16 12.14 Favored 'General case' 0 C--N 1.342 0.274 0 CA-C-N 120.114 1.325 . . . . 0.0 109.622 174.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.537 ' CE2' HG12 ' A' ' 82' ' ' VAL . 26.6 m-85 -77.84 28.83 0.17 Allowed 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -178.573 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 32.1 p -74.02 -24.62 59.59 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 121.463 -0.773 . . . . 0.0 110.282 173.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -75.38 152.18 38.1 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 171.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 3.1 mppt? -120.88 28.45 7.92 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.895 0.878 . . . . 0.0 111.033 179.57 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 25.9 mt -69.99 -44.73 78.22 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 -178.304 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 2.6 p -97.57 116.61 65.84 Favored Pre-proline 0 CA--C 1.545 0.765 0 C-N-CA 124.962 1.305 . . . . 0.0 110.084 -170.292 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -70.55 -50.09 0.4 Allowed 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 122.535 2.156 . . . . 0.0 114.042 -169.238 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 10.7 t-80 -60.99 -45.64 93.97 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 178.364 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 23.9 mp0 -64.82 -35.88 82.53 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 118.199 -0.905 . . . . 0.0 110.447 -176.287 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -65.28 -41.21 94.4 Favored 'General case' 0 C--O 1.227 -0.128 0 CA-C-N 119.676 1.125 . . . . 0.0 110.028 173.282 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -61.16 -46.28 94.82 Favored Glycine 0 CA--C 1.534 1.237 0 CA-C-N 119.455 1.025 . . . . 0.0 111.232 175.748 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.547 HD11 HD13 ' A' ' 60' ' ' ILE . 2.1 tm? -58.07 -41.49 83.49 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.261 0.625 . . . . 0.0 110.007 174.103 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -65.33 -36.21 83.36 Favored 'General case' 0 N--CA 1.444 -0.772 0 O-C-N 121.049 -1.032 . . . . 0.0 110.919 178.311 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -67.15 -22.41 65.77 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 118.616 0.643 . . . . 0.0 110.466 178.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.687 HG13 ' HA ' ' A' ' 49' ' ' LEU . 77.7 t -68.87 -42.08 82.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 168.442 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 42.6 mt -64.65 -35.83 82.3 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-N 119.748 1.158 . . . . 0.0 110.2 179.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 17.0 m -63.79 -45.04 91.49 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 119.229 0.922 . . . . 0.0 110.228 172.446 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.19 -44.13 97.79 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 119.093 0.861 . . . . 0.0 111.275 176.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.7 mt -60.61 -33.81 73.3 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.238 1.015 . . . . 0.0 109.996 175.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 73.9 ttt-85 -73.68 -34.62 64.97 Favored 'General case' 0 CA--C 1.531 0.238 0 O-C-N 121.141 -0.974 . . . . 0.0 109.792 176.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 14.1 m-30 -69.3 -44.14 72.36 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 123.594 0.758 . . . . 0.0 110.665 179.274 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 36.1 p -73.05 -23.95 60.64 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 118.462 0.573 . . . . 0.0 111.701 179.232 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 73.57 7.57 74.21 Favored Glycine 0 CA--C 1.532 1.148 0 N-CA-C 109.394 -1.482 . . . . 0.0 109.394 -168.383 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -86.04 25.58 1.12 Allowed 'General case' 0 C--N 1.348 0.505 0 CA-C-N 119.851 1.826 . . . . 0.0 110.733 174.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -61.78 139.12 95.49 Favored Pre-proline 0 CA--C 1.546 0.82 0 C-N-CA 124.006 0.922 . . . . 0.0 108.705 169.516 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo -59.71 162.41 15.65 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.963 2.442 . . . . 0.0 114.03 -177.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp -65.07 -37.63 88.16 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 119.061 -0.495 . . . . 0.0 111.475 174.459 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 4.5 pttm -143.5 85.46 1.84 Allowed 'General case' 0 C--O 1.234 0.252 0 C-N-CA 124.031 0.933 . . . . 0.0 108.585 177.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 5.9 tt -75.39 144.8 42.07 Favored 'General case' 0 CA--C 1.537 0.468 0 O-C-N 120.835 -1.165 . . . . 0.0 108.502 169.657 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -137.97 139.64 39.81 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.65 1.18 . . . . 0.0 108.02 177.349 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -118.91 121.12 39.23 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 119.901 1.228 . . . . 0.0 108.658 175.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 3.1 t -89.1 89.98 3.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 N-CA-C 105.855 -1.906 . . . . 0.0 105.855 169.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -81.15 138.78 19.71 Favored Glycine 0 C--N 1.335 0.517 0 N-CA-C 110.273 -1.131 . . . . 0.0 110.273 -178.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 38.9 t -122.15 133.39 68.61 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 174.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 13.4 mt -85.41 135.32 38.87 Favored Pre-proline 0 CA--C 1.535 0.369 0 N-CA-C 105.561 -2.015 . . . . 0.0 105.561 169.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -73.21 167.16 28.05 Favored 'Trans proline' 0 CA--C 1.54 0.786 0 C-N-CA 121.815 1.677 . . . . 0.0 111.732 -179.161 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -94.38 -56.85 2.67 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 168.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 49.0 m -118.73 -55.14 2.21 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -169.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.8 tp 52.21 39.29 26.63 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 126.823 2.049 . . . . 0.0 113.581 -174.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -79.61 163.85 56.64 Favored Pre-proline 0 CA--C 1.544 0.721 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 171.025 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -82.39 94.61 0.88 Allowed 'Trans proline' 0 CA--C 1.542 0.896 0 C-N-CA 121.848 1.699 . . . . 0.0 111.863 -176.132 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -173.48 -176.24 1.27 Allowed 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 104.48 -2.415 . . . . 0.0 104.48 -178.178 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -144.24 154.33 15.27 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 CA-C-N 119.42 1.009 . . . . 0.0 112.325 174.738 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 118.6 85.41 1.01 Allowed Glycine 0 CA--C 1.531 1.035 0 N-CA-C 107.93 -2.068 . . . . 0.0 107.93 -174.245 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 81.9 mt -36.55 139.41 0.18 Allowed 'General case' 0 C--N 1.352 0.711 0 N-CA-C 115.192 1.553 . . . . 0.0 115.192 -169.688 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 4.4 p -58.96 151.89 52.98 Favored Pre-proline 0 CA--C 1.535 0.4 0 CA-C-N 113.97 -1.468 . . . . 0.0 108.74 169.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -60.49 -35.24 91.25 Favored 'Trans proline' 0 CA--C 1.537 0.63 0 C-N-CA 121.726 1.618 . . . . 0.0 111.74 -176.584 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.483 HG22 ' HA3' ' A' ' 72' ' ' GLY . 1.0 OUTLIER -60.57 -36.21 77.93 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 123.704 0.802 . . . . 0.0 110.834 177.123 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 61.4 t -94.2 -32.49 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 C-N-CA 122.628 0.371 . . . . 0.0 110.004 -172.451 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -53.91 -46.45 71.47 Favored 'General case' 0 C--N 1.33 -0.24 0 O-C-N 121.347 -0.846 . . . . 0.0 109.311 169.422 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -69.06 -16.77 63.77 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 -177.38 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 24.4 mmm -77.94 -8.03 57.57 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 125.47 1.508 . . . . 0.0 113.039 172.135 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 53.5 mt -56.86 -56.06 16.58 Favored 'Isoleucine or valine' 0 C--N 1.344 0.353 0 CA-C-N 120.835 1.652 . . . . 0.0 109.157 176.222 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -67.52 -45.59 47.16 Favored Pre-proline 0 CA--C 1.544 0.714 0 CA-C-O 117.822 -1.085 . . . . 0.0 111.033 -174.227 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -42.94 -58.5 1.3 Allowed 'Trans proline' 0 C--N 1.349 0.578 1 C-N-CA 125.478 4.118 . . . . 0.0 112.979 168.66 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -69.2 -35.91 76.72 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.363 -0.835 . . . . 0.0 112.148 -177.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 25.8 mt -57.07 -41.14 78.26 Favored 'General case' 0 CA--C 1.521 -0.146 0 CA-C-N 119.546 1.066 . . . . 0.0 109.068 171.746 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -62.25 -35.05 77.78 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 118.862 0.755 . . . . 0.0 110.165 178.376 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . 0.625 ' HG3' HD12 ' A' ' 76' ' ' ILE . 0.4 OUTLIER -64.24 -46.35 84.18 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 119.623 1.102 . . . . 0.0 111.217 173.064 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 36.2 t -56.65 -48.67 80.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 178.181 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 37.7 mt -62.89 -34.46 77.46 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 118.487 -0.768 . . . . 0.0 110.946 178.104 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -67.2 -46.43 73.89 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 119.81 1.186 . . . . 0.0 110.83 178.125 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -64.46 -32.26 73.82 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 119.679 1.127 . . . . 0.0 111.12 177.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 14.1 mt -63.11 -54.75 32.95 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 171.272 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 78.4 mtm-85 -61.21 -32.05 71.82 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 120.336 1.426 . . . . 0.0 111.765 -178.125 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -70.52 -27.65 64.34 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 118.677 0.671 . . . . 0.0 110.332 179.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 23.5 m -81.12 5.47 16.66 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.601 1.16 . . . . 0.0 111.77 169.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 70.89 13.7 72.5 Favored Glycine 0 CA--C 1.53 0.997 0 CA-C-O 117.641 -1.644 . . . . 0.0 112.497 -171.238 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 58.3 t -90.62 118.05 35.1 Favored 'Isoleucine or valine' 0 C--N 1.347 0.463 0 CA-C-N 120.603 2.202 . . . . 0.0 107.787 -177.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -93.86 96.06 9.5 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 171.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -59.63 139.93 56.8 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 169.004 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 11.1 mm -85.41 123.61 72.71 Favored Pre-proline 0 CA--C 1.534 0.342 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 -174.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -64.2 103.23 0.42 Allowed 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 122.913 2.409 . . . . 0.0 105.928 171.184 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 20.4 tpp85 45.3 -110.28 0.22 Allowed 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 104.954 -2.239 . . . . 0.0 104.954 -166.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 3.7 p -155.55 155.73 33.89 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 119.766 1.166 . . . . 0.0 109.576 169.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -86.38 103.48 14.99 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 174.207 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 45.7 m . . . . . 0 C--O 1.255 1.37 0 C-N-CA 125.827 1.651 . . . . 0.0 108.353 179.161 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.1 tpt . . . . . 0 N--CA 1.498 1.938 0 CA-C-O 119.708 -0.187 . . . . 0.0 110.558 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 8.5 ptp180 -151.43 121.66 7.25 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-O 118.036 -0.983 . . . . 0.0 108.662 177.494 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 52.0 mt -140.31 144.16 28.19 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-N 120.033 1.288 . . . . 0.0 110.873 -169.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 3.1 mt -127.8 122.18 32.07 Favored 'General case' 0 CA--C 1.519 -0.248 0 N-CA-C 107.046 -1.465 . . . . 0.0 107.046 168.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.469 HG12 HG12 ' A' ' 23' ' ' VAL . 11.5 t -97.46 111.86 28.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 1 N-CA-C 100.125 -4.028 . . . . 0.0 100.125 168.688 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.525 ' HB2' HD21 ' A' ' 58' ' ' LEU . 0.5 OUTLIER -117.35 107.32 14.23 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 123.112 0.565 . . . . 0.0 109.497 -168.048 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -89.74 123.82 7.12 Favored Glycine 0 N--CA 1.448 -0.511 0 N-CA-C 108.722 -1.751 . . . . 0.0 108.722 179.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.6 m -132.52 -177.91 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.805 0 C-N-CA 124.053 0.941 . . . . 0.0 109.532 -179.314 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 98.07 131.22 7.07 Favored Glycine 0 N--CA 1.437 -1.281 0 N-CA-C 107.158 -2.377 . . . . 0.0 107.158 -169.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -69.16 131.52 45.08 Favored 'General case' 0 N--CA 1.451 -0.379 0 O-C-N 121.846 -0.797 . . . . 0.0 111.947 -168.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.4 pt -79.06 41.39 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 123.605 0.762 . . . . 0.0 112.961 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 19.4 mt -129.7 -12.09 4.35 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 120.129 1.331 . . . . 0.0 109.833 171.22 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.1 mp -117.1 62.7 0.73 Allowed 'General case' 0 C--N 1.346 0.434 0 CA-C-O 122.116 0.96 . . . . 0.0 109.766 -169.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.9 m 51.71 -119.59 1.48 Allowed 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 114.322 -1.308 . . . . 0.0 112.059 169.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 61.3 m-20 -50.92 -23.07 2.58 Favored 'General case' 0 N--CA 1.44 -0.929 0 C-N-CA 127.866 2.466 . . . . 0.0 114.282 179.083 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.411 ' CD ' HE22 ' A' ' 94' ' ' GLN . 1.6 tp10 -63.28 -26.34 68.73 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 119.643 1.11 . . . . 0.0 110.456 -179.472 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.74 -8.7 45.34 Favored 'General case' 0 N--CA 1.438 -1.059 0 CA-C-O 116.819 -1.562 . . . . 0.0 111.215 176.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.1 tp -51.67 -45.43 36.93 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.414 0 CA-C-N 121.341 1.882 . . . . 0.0 111.132 -173.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -63.51 -34.63 90.45 Favored Glycine 0 CA--C 1.526 0.771 0 CA-C-N 119.131 0.878 . . . . 0.0 111.324 -177.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 97.8 t -68.18 -48.43 73.9 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 CA-C-N 117.518 0.659 . . . . 0.0 109.32 172.304 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 24.1 mmt180 -57.52 -29.65 64.5 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 117.429 -1.272 . . . . 0.0 112.147 177.287 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 5.7 mm -62.42 -53.98 40.12 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-N 120.818 1.645 . . . . 0.0 109.046 176.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.469 HG12 HG12 ' A' ' 5' ' ' VAL . 26.5 m -70.61 -34.7 58.14 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 CA-C-N 118.833 0.742 . . . . 0.0 111.312 -176.206 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 58.3 mt-10 -65.36 -45.03 85.72 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 118.954 0.797 . . . . 0.0 110.015 176.209 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.67 -39.88 95.43 Favored 'General case' 0 N--CA 1.452 -0.342 0 O-C-N 121.808 -0.557 . . . . 0.0 109.982 176.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 5.7 tp -64.55 -39.2 93.32 Favored 'General case' 0 C--O 1.221 -0.4 0 CA-C-N 118.858 0.754 . . . . 0.0 110.169 -178.368 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -61.95 -26.23 68.07 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 121.501 0.667 . . . . 0.0 112.493 -178.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -93.33 -40.86 10.17 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 125.994 1.718 . . . . 0.0 111.125 -178.573 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 37.3 mmm-85 -83.29 -31.17 27.04 Favored 'General case' 0 C--N 1.333 -0.112 0 C-N-CA 123.021 0.528 . . . . 0.0 110.833 -174.393 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -123.89 146.92 48.09 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-O 122.313 1.054 . . . . 0.0 112.728 -177.365 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 39.3 mm -98.92 135.29 34.52 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 N-CA-C 104.887 -2.264 . . . . 0.0 104.887 169.404 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -120.24 148.6 47.62 Favored Pre-proline 0 CA--C 1.537 0.447 0 C-N-CA 124.025 0.93 . . . . 0.0 109.943 -169.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -67.4 158.62 56.2 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 123.05 2.5 . . . . 0.0 110.253 170.12 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -57.69 -33.79 68.76 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 114.48 1.289 . . . . 0.0 114.48 -169.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 10.8 p90 -74.37 -12.82 60.63 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 112.786 0.661 . . . . 0.0 112.786 -176.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 74.0 t -89.67 125.61 42.62 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 172.319 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 52.1 mm-40 -113.18 130.6 56.16 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 169.01 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -95.78 116.28 37.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 104.877 -2.268 . . . . 0.0 104.877 168.766 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 65.3 tp -118.19 129.02 55.26 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 118.073 0.397 . . . . 0.0 110.373 -179.149 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -88.7 107.04 18.73 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 106.312 -1.736 . . . . 0.0 106.312 168.708 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -92.32 -40.33 5.14 Favored Glycine 0 CA--C 1.535 1.308 0 N-CA-C 110.432 -1.067 . . . . 0.0 110.432 169.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 57.3 -103.69 0.33 Allowed Glycine 0 C--N 1.341 0.807 0 CA-C-N 117.773 0.787 . . . . 0.0 112.683 171.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 19.8 p -67.9 -5.82 18.76 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 126.521 1.929 . . . . 0.0 113.237 -179.518 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.48 -63.16 1.39 Allowed 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 -172.16 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 53.69 -110.06 1.31 Allowed Glycine 0 CA--C 1.535 1.283 0 N-CA-C 110.62 -0.992 . . . . 0.0 110.62 -170.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.06 -30.42 66.18 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.553 1.141 . . . . 0.0 111.268 -177.382 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -56.82 -19.74 18.86 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 -174.092 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 20.5 mt -85.12 12.99 6.76 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 113.551 0.945 . . . . 0.0 113.551 -177.437 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.576 ' HA ' HG13 ' A' ' 100' ' ' VAL . 6.3 tt -42.04 -61.0 1.24 Allowed 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.27 1.028 . . . . 0.0 112.63 -172.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -79.73 -30.42 43.96 Favored Glycine 0 CA--C 1.527 0.819 0 N-CA-C 111.392 -0.683 . . . . 0.0 111.392 -179.548 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -67.43 -36.06 80.5 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 118.428 1.114 . . . . 0.0 112.112 -169.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.431 ' SD ' HG11 ' A' ' 100' ' ' VAL . 36.2 mtp -75.4 -9.93 59.0 Favored 'General case' 0 N--CA 1.451 -0.399 0 O-C-N 122.037 -0.414 . . . . 0.0 111.765 -178.264 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.63 151.62 40.77 Favored 'General case' 0 N--CA 1.445 -0.723 0 C-N-CA 123.149 0.58 . . . . 0.0 112.474 -169.271 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . 0.281 15.5 p30 53.51 21.21 2.38 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 128.749 2.82 . . . . 0.0 116.211 170.041 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 17.4 mmt180 -75.5 160.0 30.67 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 169.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -86.57 -52.39 5.58 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 176.734 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . 0.25 0.0 OUTLIER -124.53 143.31 50.74 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 119.952 1.251 . . . . 0.0 107.713 169.37 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.525 HD21 ' HB2' ' A' ' 6' ' ' LEU . 4.5 tt -139.97 120.8 14.45 Favored 'General case' 0 CA--C 1.501 -0.911 0 N-CA-C 105.476 -2.046 . . . . 0.0 105.476 -178.343 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 25.8 mt -100.21 106.09 18.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 106.104 -1.813 . . . . 0.0 106.104 179.57 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.445 HD13 HD11 ' A' ' 97' ' ' LEU . 16.9 mt -75.13 133.63 31.04 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 N-CA-C 105.135 -2.172 . . . . 0.0 105.135 169.682 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -120.16 121.49 38.89 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 104.915 -2.254 . . . . 0.0 104.915 168.753 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 36.8 t0 -156.75 162.19 39.77 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 118.529 0.604 . . . . 0.0 110.287 -171.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.559 ' HB1' ' HD3' ' A' ' 121' ' ' PRO . . . -103.74 157.23 17.21 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 121.927 0.87 . . . . 0.0 109.994 172.227 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 5.1 mp -134.64 88.09 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 N-CA-C 106.892 -1.521 . . . . 0.0 106.892 -176.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.446 HG11 HD22 ' A' ' 124' ' ' LEU . 31.5 m -52.48 -21.1 2.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 C-N-CA 125.89 1.676 . . . . 0.0 112.217 168.568 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.6 m -78.01 174.08 11.49 Favored 'General case' 0 N--CA 1.442 -0.845 0 C-N-CA 124.249 1.02 . . . . 0.0 111.852 -169.289 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 18.2 ttmm 67.25 163.12 0.19 Allowed 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 126.108 1.763 . . . . 0.0 111.907 -179.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 23.1 mtmt -77.38 -7.83 56.72 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 125.301 1.44 . . . . 0.0 112.134 179.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 43.5 t-20 -68.16 156.94 36.46 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.232 1.013 . . . . 0.0 110.234 -169.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 2.2 m -62.3 149.18 88.08 Favored Pre-proline 0 CA--C 1.546 0.795 0 C-N-CA 124.663 1.185 . . . . 0.0 113.446 -169.004 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_exo -58.9 159.81 20.14 Favored 'Trans proline' 0 CA--C 1.533 0.465 0 C-N-CA 124.029 3.153 . . . . 0.0 111.625 168.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 65.64 19.15 66.79 Favored Glycine 0 CA--C 1.53 0.986 0 CA-C-O 119.753 -0.471 . . . . 0.0 112.952 172.299 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 2.7 m -99.24 142.46 30.7 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 124.495 1.118 . . . . 0.0 109.448 -172.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 13.4 ttp -91.1 134.88 34.16 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 172.607 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 69.6 mtm -122.28 115.73 22.86 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 170.539 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.453 HD12 ' HG2' ' A' ' 144' ' ' GLN . 28.1 mm -102.87 120.81 53.22 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 -177.798 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.6 mp -128.09 137.18 52.04 Favored 'General case' 0 C--O 1.236 0.376 0 O-C-N 123.97 0.793 . . . . 0.0 109.812 -173.09 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 53.6 mtt85 -89.16 176.31 7.02 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.237 1.015 . . . . 0.0 110.042 -177.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -38.01 -58.94 0.89 Allowed 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.466 1.507 . . . . 0.0 113.762 -173.119 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -86.61 -15.9 38.36 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -171.447 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -75.13 -36.83 61.57 Favored 'General case' 0 N--CA 1.457 -0.11 0 O-C-N 121.876 -0.515 . . . . 0.0 109.902 -175.336 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.52 HG12 ' CE2' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -66.37 -49.23 54.39 Favored Pre-proline 0 CA--C 1.535 0.383 0 CA-C-O 117.653 -1.165 . . . . 0.0 112.585 -174.619 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -55.32 -37.78 94.3 Favored 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 121.758 1.639 . . . . 0.0 111.594 174.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.11 -2.37 37.08 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 114.234 1.198 . . . . 0.0 114.234 176.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -102.48 -38.46 7.56 Favored 'General case' 0 C--N 1.344 0.33 0 CA-C-N 119.805 1.184 . . . . 0.0 111.376 179.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.52 ' CE2' HG12 ' A' ' 82' ' ' VAL . 43.9 m-85 -70.41 0.94 5.62 Favored 'General case' 0 CA--C 1.544 0.746 0 O-C-N 121.641 -0.662 . . . . 0.0 112.5 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 64.5 p -57.84 -21.0 40.23 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.577 1.551 . . . . 0.0 112.687 174.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 11.1 p30 -60.82 -30.51 70.12 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 118.66 -0.686 . . . . 0.0 112.489 175.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 30.3 mtmm 50.82 27.34 3.05 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 125.152 1.381 . . . . 0.0 114.32 177.205 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 13.5 mt -72.35 -43.15 65.01 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 O-C-N 121.252 -0.905 . . . . 0.0 109.523 -174.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 3.1 p -113.25 143.2 28.79 Favored Pre-proline 0 CA--C 1.544 0.716 0 C-N-CA 123.675 0.79 . . . . 0.0 112.54 -169.541 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -75.31 -42.26 0.5 Allowed 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 122.76 2.307 . . . . 0.0 113.704 -169.147 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 10.2 t-80 -61.81 -45.42 93.91 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 119.399 1.0 . . . . 0.0 108.885 178.361 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.411 HE22 ' CD ' ' A' ' 16' ' ' GLU . 21.5 mp0 -62.15 -41.94 98.77 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 125.27 1.428 . . . . 0.0 108.634 -177.775 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 50.7 tp -64.14 -38.19 90.16 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 119.145 0.884 . . . . 0.0 110.995 174.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -63.1 -51.11 57.69 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 110.556 -1.018 . . . . 0.0 110.556 176.599 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.445 HD11 HD13 ' A' ' 60' ' ' ILE . 2.8 tm? -56.94 -43.05 81.12 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.207 0.603 . . . . 0.0 109.963 175.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -62.77 -37.81 88.13 Favored 'General case' 0 N--CA 1.452 -0.36 0 O-C-N 121.306 -0.871 . . . . 0.0 111.413 177.61 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -69.3 -22.36 63.8 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 118.851 0.75 . . . . 0.0 110.83 178.327 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.576 HG13 ' HA ' ' A' ' 49' ' ' LEU . 97.6 t -68.04 -42.72 85.47 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 168.631 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 92.1 mt -63.73 -36.75 84.88 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 119.348 0.977 . . . . 0.0 109.934 178.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 70.3 m -64.59 -41.68 96.08 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 119.249 0.931 . . . . 0.0 110.726 171.178 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.49 -44.07 97.74 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 120.254 1.388 . . . . 0.0 110.611 176.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.9 mt -63.37 -33.04 74.67 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.669 1.188 . . . . 0.0 110.765 176.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 65.7 ttp85 -73.65 -31.79 63.68 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.008 0.923 . . . . 0.0 110.001 176.057 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 14.9 m-30 -71.34 -46.04 61.5 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 119.185 0.902 . . . . 0.0 110.473 177.095 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 34.0 p -73.84 -24.33 59.76 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 123.128 0.571 . . . . 0.0 112.132 -178.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 74.63 8.0 80.55 Favored Glycine 0 CA--C 1.536 1.351 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -168.329 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -85.04 22.0 1.51 Allowed 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 119.851 1.826 . . . . 0.0 111.438 174.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -60.48 137.63 92.38 Favored Pre-proline 0 CA--C 1.545 0.771 0 C-N-CA 124.175 0.99 . . . . 0.0 108.737 169.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -61.25 163.36 17.4 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.779 2.319 . . . . 0.0 114.543 -176.192 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 68.3 mmtt -67.96 -35.57 78.61 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 118.941 -0.552 . . . . 0.0 112.37 175.117 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 8.2 ttmm -142.08 66.63 1.34 Allowed 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 -175.382 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 7.8 tt -70.83 138.38 50.26 Favored 'General case' 0 C--O 1.234 0.238 0 O-C-N 120.063 -1.648 . . . . 0.0 108.476 172.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -134.61 136.59 43.02 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 179.487 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -114.06 122.46 46.96 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 119.956 1.253 . . . . 0.0 107.874 175.639 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 21.3 t -95.87 85.52 1.63 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 N-CA-C 106.316 -1.735 . . . . 0.0 106.316 169.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -77.25 148.63 34.57 Favored Glycine 0 N--CA 1.445 -0.741 0 N-CA-C 110.706 -0.958 . . . . 0.0 110.706 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 46.9 t -124.54 165.72 21.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 171.716 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 15.5 mt -117.55 120.21 33.39 Favored Pre-proline 0 N--CA 1.468 0.428 0 CA-C-N 121.232 1.833 . . . . 0.0 108.605 171.069 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.559 ' HD3' ' HB1' ' A' ' 63' ' ' ALA . 3.3 Cg_exo -55.16 158.93 10.84 Favored 'Trans proline' 0 N--CA 1.455 -0.775 1 C-N-CA 126.142 4.561 . . . . 0.0 116.093 175.614 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -107.75 -64.24 1.23 Allowed 'General case' 0 C--O 1.236 0.344 0 C-N-CA 124.348 1.059 . . . . 0.0 109.628 178.28 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 70.5 m -106.03 -50.13 3.23 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 119.093 -0.479 . . . . 0.0 110.154 -171.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.446 HD22 HG11 ' A' ' 65' ' ' VAL . 1.2 tp 51.97 32.51 10.19 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 124.126 0.971 . . . . 0.0 112.812 178.651 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -83.49 164.6 44.5 Favored Pre-proline 0 CA--C 1.544 0.734 0 O-C-N 121.525 -0.734 . . . . 0.0 109.417 176.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -78.65 82.96 2.34 Favored 'Trans proline' 0 CA--C 1.544 1.012 0 C-N-CA 121.869 1.713 . . . . 0.0 111.953 -173.142 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -175.67 153.22 1.4 Allowed 'General case' 0 C--O 1.234 0.269 0 N-CA-C 104.276 -2.491 . . . . 0.0 104.276 -177.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -110.38 160.71 9.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.552 0.692 . . . . 0.0 111.861 -170.234 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 108.11 141.37 9.69 Favored Glycine 0 CA--C 1.529 0.929 0 N-CA-C 106.457 -2.657 . . . . 0.0 106.457 -169.286 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 74.8 mt -80.7 154.03 27.52 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 118.065 0.932 . . . . 0.0 109.667 179.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 68.2 p -70.82 168.47 20.15 Favored Pre-proline 0 CA--C 1.541 0.619 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 169.394 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_exo -59.76 -40.21 66.08 Favored 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 121.717 1.611 . . . . 0.0 111.165 173.447 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 85.3 m -59.67 -37.45 78.8 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 124.619 1.168 . . . . 0.0 111.751 -179.358 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 58.4 t -98.51 -29.32 3.53 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 O-C-N 121.776 -0.578 . . . . 0.0 110.638 -174.482 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -52.37 -45.37 65.74 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 119.518 1.054 . . . . 0.0 108.793 169.193 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -65.68 -15.97 63.31 Favored 'General case' 0 N--CA 1.447 -0.575 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 -177.589 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 14.1 mmm -83.45 -8.41 59.38 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 125.321 1.448 . . . . 0.0 112.425 175.475 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 54.8 mt -56.75 -56.51 13.84 Favored 'Isoleucine or valine' 0 C--N 1.343 0.293 0 CA-C-N 120.192 1.36 . . . . 0.0 108.788 172.071 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 64.3 mm-40 -63.48 -49.7 76.95 Favored Pre-proline 0 CA--C 1.541 0.618 0 CA-C-O 117.468 -1.253 . . . . 0.0 109.99 -172.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -39.96 -56.58 1.38 Allowed 'Trans proline' 0 C--N 1.35 0.613 1 C-N-CA 125.798 4.332 . . . . 0.0 113.353 168.904 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -69.93 -35.5 74.58 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.649 -178.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 37.3 mt -64.06 -45.99 86.35 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 120.806 1.639 . . . . 0.0 109.345 176.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -54.61 -36.43 64.46 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 118.52 0.6 . . . . 0.0 110.226 174.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . 0.453 ' HG2' HD12 ' A' ' 76' ' ' ILE . 70.8 tp60 -75.86 -38.99 57.4 Favored 'General case' 0 N--CA 1.423 -1.809 0 O-C-N 121.465 -0.772 . . . . 0.0 110.913 -179.562 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 37.2 t -58.68 -45.18 90.99 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 CA-C-N 119.276 0.943 . . . . 0.0 108.93 173.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 56.8 mt -60.85 -36.82 80.12 Favored 'General case' 0 C--O 1.226 -0.176 0 CA-C-O 119.09 -0.481 . . . . 0.0 110.218 175.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -68.68 -46.11 69.94 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 119.523 1.056 . . . . 0.0 111.29 179.464 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -66.88 -28.81 68.63 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 119.76 1.164 . . . . 0.0 111.068 178.424 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 23.9 mt -63.39 -51.22 66.71 Favored 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 169.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 96.8 mtt-85 -66.69 -16.06 63.95 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 117.845 -1.074 . . . . 0.0 112.543 179.33 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 33.1 mm-40 -65.97 -24.38 66.78 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 120.769 1.622 . . . . 0.0 110.899 172.176 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 65.3 m -100.53 18.98 17.72 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 119.436 1.016 . . . . 0.0 110.087 168.409 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 69.43 20.03 74.99 Favored Glycine 0 C--N 1.337 0.595 0 CA-C-O 117.838 -1.535 . . . . 0.0 112.276 -178.073 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 18.0 t -88.05 117.3 31.53 Favored 'Isoleucine or valine' 0 C--N 1.344 0.358 0 CA-C-N 120.23 2.015 . . . . 0.0 107.393 -172.331 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -101.87 88.14 3.3 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 177.16 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -58.06 141.7 49.2 Favored 'General case' 0 CA--C 1.539 0.558 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 169.223 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.4 ' CG2' ' HA ' ' A' ' 160' ' ' SER . 30.9 mm -98.82 122.56 52.52 Favored Pre-proline 0 N--CA 1.463 0.176 0 CA-C-O 117.396 -1.287 . . . . 0.0 108.976 -172.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -63.12 106.53 0.56 Allowed 'Trans proline' 0 N--CA 1.459 -0.529 0 C-N-CA 122.17 1.913 . . . . 0.0 109.017 173.237 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 56.7 mtm180 39.9 48.02 1.98 Allowed 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 125.974 1.71 . . . . 0.0 113.604 179.273 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . 0.4 ' HA ' ' CG2' ' A' ' 157' ' ' ILE 0.272 2.4 p 53.16 18.31 1.16 Allowed 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 126.698 1.999 . . . . 0.0 115.137 179.628 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -80.8 120.94 25.31 Favored 'General case' 0 C--O 1.238 0.449 0 O-C-N 120.938 -1.101 . . . . 0.0 109.696 177.068 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 14.1 m . . . . . 0 C--O 1.256 1.396 0 C-N-CA 124.199 1.0 . . . . 0.0 110.886 -175.937 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.6 tpt . . . . . 0 N--CA 1.496 1.839 0 CA-C-O 119.611 -0.233 . . . . 0.0 110.483 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 6.4 ptm85 -143.53 125.35 15.13 Favored 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 176.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 33.9 mt -137.72 148.77 25.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 CA-C-N 121.06 1.755 . . . . 0.0 111.922 -169.023 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 16.4 tp -134.55 111.07 9.77 Favored 'General case' 0 C--N 1.341 0.199 0 N-CA-C 105.484 -2.043 . . . . 0.0 105.484 168.081 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 24.9 t -90.68 115.36 29.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 102.927 -2.99 . . . . 0.0 102.927 170.403 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -115.37 113.03 23.23 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 123.173 0.589 . . . . 0.0 110.927 -168.376 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -94.13 121.65 6.78 Favored Glycine 0 N--CA 1.445 -0.712 0 N-CA-C 108.055 -2.018 . . . . 0.0 108.055 173.625 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.4 m -131.95 -167.68 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 C-N-CA 124.012 0.925 . . . . 0.0 108.625 -177.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 105.49 158.1 22.75 Favored Glycine 0 C--N 1.333 0.38 0 N-CA-C 110.505 -1.038 . . . . 0.0 110.505 -175.556 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.438 HD21 ' HB2' ' A' ' 12' ' ' LEU . 1.4 t30 -81.65 94.81 7.02 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 124.572 1.149 . . . . 0.0 108.915 -174.403 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.3 pt -69.82 27.58 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 N-CA-C 114.659 1.355 . . . . 0.0 114.659 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.438 ' HB2' HD21 ' A' ' 10' ' ' ASN . 38.3 mt -114.31 -9.66 12.78 Favored 'General case' 0 C--O 1.224 -0.245 0 O-C-N 121.138 -0.976 . . . . 0.0 108.581 171.34 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.1 mp -120.75 74.35 1.06 Allowed 'General case' 0 CA--C 1.502 -0.879 0 N-CA-C 105.475 -2.046 . . . . 0.0 105.475 -169.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 20.1 m 36.08 -106.53 0.04 OUTLIER 'General case' 0 N--CA 1.447 -0.585 0 O-C-N 126.215 2.197 . . . . 0.0 113.012 169.118 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -68.2 -13.67 62.41 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 114.628 1.344 . . . . 0.0 114.628 -170.165 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -65.84 -19.57 65.93 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 121.457 1.935 . . . . 0.0 111.769 173.258 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.58 -10.81 49.19 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 116.165 -1.874 . . . . 0.0 111.162 172.552 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 6.6 tp -54.96 -38.79 46.65 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 CA-C-N 121.753 2.069 . . . . 0.0 110.977 -178.155 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -60.0 -46.04 94.85 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 110.764 -0.935 . . . . 0.0 110.764 178.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 61.7 t -65.11 -47.4 87.91 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 O-C-N 122.175 -0.603 . . . . 0.0 109.68 174.559 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 20.3 mmt180 -60.21 -32.01 70.7 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 117.374 -1.298 . . . . 0.0 112.922 -178.181 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 20.3 mt -62.97 -44.13 99.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-N 121.151 1.796 . . . . 0.0 110.158 179.257 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 28.4 m -73.74 -34.59 41.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 CA-C-N 120.128 1.331 . . . . 0.0 111.542 -178.185 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 57.8 mt-10 -62.22 -42.37 99.25 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 117.957 0.344 . . . . 0.0 110.458 171.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -67.79 -38.29 83.15 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 119.051 0.842 . . . . 0.0 111.23 176.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 7.1 tp -63.51 -39.52 94.64 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 119.418 1.008 . . . . 0.0 109.844 -177.463 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -61.93 -18.83 61.66 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.88 0.872 . . . . 0.0 113.117 -179.474 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -102.57 -43.61 5.57 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 126.622 1.969 . . . . 0.0 110.992 -178.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 53.5 mmt-85 -74.69 -34.11 62.57 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.259 0.623 . . . . 0.0 110.547 -176.184 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 -124.89 154.03 41.71 Favored 'General case' 0 CA--C 1.521 -0.163 0 CA-C-O 121.417 0.627 . . . . 0.0 111.944 -178.201 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 47.7 mm -106.26 135.27 45.22 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 N-CA-C 103.418 -2.808 . . . . 0.0 103.418 168.047 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -119.07 149.78 47.6 Favored Pre-proline 0 C--O 1.237 0.438 0 CA-C-O 118.661 -0.685 . . . . 0.0 109.953 -169.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -65.95 162.08 36.79 Favored 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 122.992 2.461 . . . . 0.0 111.562 173.167 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -58.25 -33.69 69.65 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 115.046 1.498 . . . . 0.0 115.046 -169.196 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 8.6 p90 -73.06 -8.73 57.05 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 -178.016 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 76.1 t -88.99 128.16 41.27 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 174.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -116.08 124.35 50.19 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 105.913 -1.884 . . . . 0.0 105.913 169.063 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -93.53 112.9 27.33 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 N-CA-C 104.402 -2.444 . . . . 0.0 104.402 168.61 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 61.4 tp -112.36 128.94 56.43 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 -178.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -89.31 118.96 29.37 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 169.515 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -78.66 -79.98 0.76 Allowed Glycine 0 CA--C 1.526 0.764 0 N-CA-C 107.234 -2.346 . . . . 0.0 107.234 169.475 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 78.54 104.65 0.2 Allowed Glycine 0 C--N 1.344 0.974 0 N-CA-C 108.675 -1.77 . . . . 0.0 108.675 -177.762 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 12.9 p 52.74 50.72 17.48 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 123.535 0.734 . . . . 0.0 109.286 -178.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -104.4 -79.66 0.55 Allowed 'General case' 0 C--N 1.348 0.528 0 CA-C-N 115.312 -0.858 . . . . 0.0 112.105 -169.239 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 59.81 -110.55 2.88 Favored Glycine 0 CA--C 1.533 1.164 0 N-CA-C 110.075 -1.21 . . . . 0.0 110.075 -174.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 12.1 tpt -62.52 -21.57 65.63 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.844 1.258 . . . . 0.0 113.442 -173.366 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -63.91 -18.81 64.58 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 114.193 1.183 . . . . 0.0 114.193 -174.23 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 10.3 mt -100.52 14.37 31.53 Favored 'General case' 0 C--N 1.34 0.173 0 N-CA-C 115.643 1.719 . . . . 0.0 115.643 -168.087 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 6.1 tt -49.1 -55.63 11.63 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 118.968 0.804 . . . . 0.0 110.9 -176.562 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -67.67 -32.64 78.74 Favored Glycine 0 CA--C 1.527 0.809 0 CA-C-O 119.224 -0.764 . . . . 0.0 112.419 -176.491 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -80.76 -35.36 33.38 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 119.049 1.424 . . . . 0.0 110.763 -171.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 79.8 mtp -69.28 -14.07 62.74 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.134 0.973 . . . . 0.0 111.088 176.084 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -68.07 140.11 56.26 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 123.572 0.749 . . . . 0.0 112.199 -169.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 15.7 p30 50.56 22.17 1.02 Allowed 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 127.776 2.43 . . . . 0.0 115.09 172.746 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 17.9 mmt180 -71.23 150.15 45.56 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 170.315 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 46.1 m-20 -79.85 -53.68 6.55 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -116.22 145.16 43.34 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-N 120.422 1.464 . . . . 0.0 107.474 168.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 22.7 tp -132.19 105.83 7.59 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 103.516 -2.772 . . . . 0.0 103.516 176.044 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 28.0 mt -93.69 112.73 27.15 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 N-CA-C 104.205 -2.517 . . . . 0.0 104.205 173.138 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 24.1 mt -93.49 130.72 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 N-CA-C 105.572 -2.01 . . . . 0.0 105.572 176.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -111.83 124.13 51.71 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 105.414 -2.069 . . . . 0.0 105.414 169.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.406 ' CG ' HE21 ' A' ' 94' ' ' GLN . 42.9 t0 -158.59 159.12 35.1 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 124.285 1.034 . . . . 0.0 108.265 -177.031 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -89.25 144.7 25.91 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 170.099 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 31.9 mt -88.27 -25.56 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 C-N-CA 123.917 0.887 . . . . 0.0 110.453 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . 0.461 12.5 m 58.51 -15.08 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 N-CA-C 119.449 3.129 . . . . 0.0 119.449 176.296 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 5.9 p -157.99 131.26 7.59 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 121.101 1.773 . . . . 0.0 113.778 169.037 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 12.7 tppt? -166.39 175.35 8.24 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 128.236 2.614 . . . . 0.0 105.485 169.063 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.0 -23.8 63.2 Favored 'General case' 0 N--CA 1.474 0.741 0 O-C-N 121.662 -0.648 . . . . 0.0 111.62 174.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 -69.14 162.37 27.15 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.078 0.951 . . . . 0.0 110.994 -173.374 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 3.1 m -61.63 154.22 66.76 Favored Pre-proline 0 CA--C 1.548 0.873 0 C-N-CA 124.922 1.289 . . . . 0.0 112.697 -169.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_exo -57.32 159.34 16.11 Favored 'Trans proline' 0 N--CA 1.462 -0.375 0 C-N-CA 123.878 3.052 . . . . 0.0 112.591 169.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 64.99 10.18 44.91 Favored Glycine 0 CA--C 1.538 1.514 0 CA-C-O 119.314 -0.714 . . . . 0.0 114.508 171.522 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 3.3 m -90.98 151.93 20.88 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 125.932 1.693 . . . . 0.0 111.305 -169.408 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 29.0 ttp -96.3 139.5 32.35 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 169.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 70.0 mtm -131.14 131.17 43.91 Favored 'General case' 0 N--CA 1.462 0.129 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 169.412 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 9.5 mm -89.25 123.17 41.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 177.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -113.86 123.97 51.09 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 171.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 85.0 mtm180 -87.67 174.36 8.47 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 123.537 0.735 . . . . 0.0 110.515 -178.571 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -41.37 -53.87 3.19 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 115.884 1.809 . . . . 0.0 115.884 -169.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -84.03 -16.68 43.01 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -177.002 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -82.4 -37.01 26.14 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 -171.564 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.54 HG12 ' CE2' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -64.57 -45.51 76.58 Favored Pre-proline 0 CA--C 1.531 0.242 0 CA-C-O 117.221 -1.371 . . . . 0.0 113.862 -176.732 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -53.61 -42.34 66.73 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 121.981 1.787 . . . . 0.0 110.262 174.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -75.54 4.34 7.74 Favored 'General case' 0 CA--C 1.55 0.943 0 N-CA-C 114.466 1.284 . . . . 0.0 114.466 175.28 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -116.18 -41.77 3.12 Favored 'General case' 0 C--N 1.343 0.316 0 CA-C-N 120.09 1.313 . . . . 0.0 111.155 -177.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.676 ' HB3' ' HB2' ' A' ' 98' ' ' ALA . 63.8 m-85 -62.75 -8.92 7.65 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 178.167 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 63.2 p -51.65 -28.88 15.84 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.928 1.291 . . . . 0.0 112.955 173.216 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 53.8 t-20 -52.46 117.4 2.83 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.279 0.632 . . . . 0.0 111.17 -175.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -74.95 -19.36 60.14 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.733 0.813 . . . . 0.0 112.329 -173.575 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 52.7 mt -65.47 -48.89 81.27 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 -178.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 6.6 m -76.08 111.49 15.34 Favored Pre-proline 0 CA--C 1.55 0.955 0 C-N-CA 125.406 1.482 . . . . 0.0 110.444 -169.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -70.56 -60.12 0.07 OUTLIER 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 122.931 2.421 . . . . 0.0 113.847 -168.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 6.7 t-80 -62.32 -40.06 95.09 Favored 'General case' 0 N--CA 1.463 0.2 0 O-C-N 121.463 -0.773 . . . . 0.0 109.319 -178.272 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.406 HE21 ' CG ' ' A' ' 62' ' ' ASP . 18.3 mp0 -62.38 -36.65 82.96 Favored 'General case' 0 N--CA 1.44 -0.961 0 C-N-CA 125.241 1.416 . . . . 0.0 108.943 -176.027 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.434 ' O ' ' HB3' ' A' ' 98' ' ' ALA . 57.9 tp -66.72 -36.97 83.73 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 119.43 1.014 . . . . 0.0 110.901 174.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -66.89 -40.51 93.58 Favored Glycine 0 CA--C 1.53 1.027 0 O-C-N 120.962 -1.086 . . . . 0.0 110.931 173.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.503 HD12 ' CZ ' ' A' ' 86' ' ' PHE . 1.5 tm? -61.67 -36.38 80.7 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 172.543 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.676 ' HB2' ' HB3' ' A' ' 86' ' ' PHE . . . -56.7 -53.54 56.55 Favored 'General case' 0 CA--C 1.52 -0.21 0 O-C-N 121.145 -0.972 . . . . 0.0 109.672 173.037 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -68.0 -28.4 67.38 Favored 'General case' 0 C--O 1.236 0.362 0 O-C-N 122.961 0.163 . . . . 0.0 110.934 -172.564 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -70.67 -44.47 76.52 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.951 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 174.311 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 20.2 mt -65.89 -33.08 75.02 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 119.04 0.837 . . . . 0.0 111.079 178.254 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 51.5 m -61.4 -41.73 97.6 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 118.769 0.713 . . . . 0.0 109.204 170.306 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.438 ' HA ' ' CD2' ' A' ' 106' ' ' PHE . . . -64.81 -40.35 95.08 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 119.748 1.158 . . . . 0.0 112.219 177.196 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -61.17 -33.28 73.19 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 119.095 0.861 . . . . 0.0 110.63 171.071 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 22.3 ttm-85 -75.5 -29.61 59.58 Favored 'General case' 0 CA--C 1.534 0.346 0 O-C-N 121.125 -0.984 . . . . 0.0 110.582 178.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.438 ' CD2' ' HA ' ' A' ' 103' ' ' ALA . 15.4 m-30 -69.88 -45.23 68.11 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.552 0.741 . . . . 0.0 110.277 177.208 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 32.8 p -74.46 -24.94 59.12 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 122.925 0.49 . . . . 0.0 111.831 -177.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 78.02 8.78 87.3 Favored Glycine 0 CA--C 1.538 1.499 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 -168.399 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -77.11 10.35 2.43 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 119.776 1.788 . . . . 0.0 111.612 171.382 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.434 ' HA ' ' HD3' ' A' ' 111' ' ' PRO . 10.3 t80 -57.32 140.09 79.43 Favored Pre-proline 0 CA--C 1.552 1.045 0 C-N-CA 125.346 1.459 . . . . 0.0 110.65 177.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 110' ' ' PHE . 50.3 Cg_exo -63.92 160.36 37.76 Favored 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 123.259 2.639 . . . . 0.0 115.402 -175.554 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -68.27 -35.42 77.85 Favored 'General case' 0 N--CA 1.473 0.675 0 O-C-N 121.663 -0.648 . . . . 0.0 112.163 171.514 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 61.7 mttm -134.52 92.66 2.94 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 124.253 1.021 . . . . 0.0 108.459 176.403 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 18.3 tp -78.57 131.58 36.81 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 105.072 -2.195 . . . . 0.0 105.072 168.055 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -132.72 139.45 47.64 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 172.004 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.428 ' CB ' HG11 ' A' ' 82' ' ' VAL . 0.9 OUTLIER -124.72 123.15 39.39 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 119.739 1.154 . . . . 0.0 108.928 177.151 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 3.7 t -88.99 90.56 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 N-CA-C 105.306 -2.109 . . . . 0.0 105.306 173.401 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -85.96 133.39 11.77 Favored Glycine 0 C--N 1.333 0.376 0 N-CA-C 110.084 -1.207 . . . . 0.0 110.084 -174.231 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 44.8 t -120.35 127.81 75.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 117.908 0.854 . . . . 0.0 109.277 -179.487 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 17.1 mt -84.64 133.85 43.29 Favored Pre-proline 0 CA--C 1.538 0.485 0 N-CA-C 104.923 -2.251 . . . . 0.0 104.923 169.322 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_endo -73.19 173.43 13.7 Favored 'Trans proline' 0 N--CA 1.452 -0.967 0 C-N-CA 123.008 2.472 . . . . 0.0 110.773 -179.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -107.12 -43.57 4.58 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 105.278 -2.119 . . . . 0.0 105.278 167.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 38.3 m -135.7 135.01 39.72 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.961 0.904 . . . . 0.0 109.764 173.025 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 4.7 tp -140.96 61.4 1.5 Allowed 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.576 1.55 . . . . 0.0 108.458 -178.254 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -126.76 167.6 16.99 Favored Pre-proline 0 CA--C 1.54 0.583 0 N-CA-C 106.294 -1.743 . . . . 0.0 106.294 172.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -77.35 95.92 1.09 Allowed 'Trans proline' 0 N--CA 1.457 -0.648 0 CA-C-N 120.678 1.278 . . . . 0.0 112.005 -175.102 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 18.6 p-80 -150.67 -19.3 0.23 Allowed 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 114.561 -1.199 . . . . 0.0 113.586 172.041 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . 0.414 0.0 OUTLIER 65.91 159.19 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 N-CA-C 116.343 1.979 . . . . 0.0 116.343 169.212 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 86.22 160.18 33.72 Favored Glycine 0 CA--C 1.529 0.923 0 N-CA-C 106.866 -2.494 . . . . 0.0 106.866 -168.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 68.6 mt -88.18 152.14 22.19 Favored 'General case' 0 N--CA 1.468 0.448 0 O-C-N 120.965 -1.315 . . . . 0.0 110.595 176.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 56.9 p -69.63 167.79 20.99 Favored Pre-proline 0 CA--C 1.538 0.515 0 CA-C-N 115.32 -0.854 . . . . 0.0 109.264 169.217 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -59.36 -37.19 91.83 Favored 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 122.0 1.8 . . . . 0.0 111.636 172.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 17.4 m -68.18 -40.68 82.2 Favored 'General case' 0 N--CA 1.44 -0.958 0 C-N-CA 123.508 0.723 . . . . 0.0 110.589 -177.355 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 84.3 t -88.75 -30.02 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 O-C-N 121.632 -0.667 . . . . 0.0 110.719 -174.159 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -53.27 -45.94 69.07 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 119.202 0.91 . . . . 0.0 108.771 168.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -69.77 -15.48 63.14 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 114.266 1.21 . . . . 0.0 114.266 179.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 9.3 mmm -76.85 -12.72 60.01 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 117.698 -1.144 . . . . 0.0 112.118 172.265 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 58.3 mt -54.33 -54.47 21.35 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.37 0 CA-C-N 120.193 1.36 . . . . 0.0 108.991 173.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 76.7 mm-40 -66.41 -46.74 59.79 Favored Pre-proline 0 CA--C 1.552 1.023 0 CA-C-N 120.329 1.422 . . . . 0.0 111.059 -173.481 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 0.4 OUTLIER -44.71 -52.77 5.75 Favored 'Trans proline' 0 C--N 1.353 0.801 1 C-N-CA 125.645 4.23 . . . . 0.0 112.5 168.75 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.04 -36.48 75.07 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.983 -1.008 . . . . 0.0 112.267 -177.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 42.6 mt -62.27 -41.77 98.76 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 118.897 0.771 . . . . 0.0 109.054 173.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -59.21 -36.02 74.65 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 119.342 0.973 . . . . 0.0 110.561 174.346 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -62.95 -50.14 71.99 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 118.794 0.724 . . . . 0.0 111.455 172.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 66.1 t -56.28 -49.11 78.2 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.19 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 66.6 mt -58.09 -43.09 86.89 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 123.046 0.538 . . . . 0.0 109.704 179.469 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -65.31 -44.85 86.59 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 118.972 0.805 . . . . 0.0 110.661 -177.231 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -64.64 -34.03 77.33 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 119.15 0.886 . . . . 0.0 111.37 -178.639 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . 0.337 4.4 pp -75.9 -36.97 59.29 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-O 117.346 -1.311 . . . . 0.0 109.762 176.688 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 14.0 mtp-105 -67.49 -27.6 67.14 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 121.113 1.779 . . . . 0.0 110.811 173.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -73.01 -15.73 61.52 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 118.629 0.65 . . . . 0.0 110.58 174.705 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 15.3 m -93.88 9.05 38.92 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.964 1.305 . . . . 0.0 110.719 169.222 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 74.0 13.17 81.11 Favored Glycine 0 CA--C 1.527 0.815 0 CA-C-O 117.396 -1.78 . . . . 0.0 112.792 -176.212 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 44.5 t -88.76 132.17 34.3 Favored 'Isoleucine or valine' 0 C--N 1.345 0.387 0 CA-C-N 120.985 2.392 . . . . 0.0 107.362 -176.181 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -104.32 93.94 5.08 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 106.675 -1.602 . . . . 0.0 106.675 169.441 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -59.13 137.68 57.86 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 169.105 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 20.6 mm -85.64 126.88 65.06 Favored Pre-proline 0 C--O 1.231 0.119 0 CA-C-O 117.531 -1.223 . . . . 0.0 107.711 -174.625 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -68.1 91.11 0.38 Allowed 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 122.868 2.379 . . . . 0.0 108.998 175.004 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 32.1 ttp85 51.81 17.99 0.7 Allowed 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 127.573 2.349 . . . . 0.0 114.853 179.404 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 52.6 m 48.93 32.47 3.82 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.312 1.045 . . . . 0.0 112.093 -169.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -77.89 -33.28 52.05 Favored 'General case' 0 C--O 1.238 0.45 0 O-C-N 121.906 -0.497 . . . . 0.0 110.77 176.103 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 17.2 m . . . . . 0 C--O 1.255 1.354 0 C-N-CA 126.526 1.93 . . . . 0.0 111.871 170.747 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.8 tpt . . . . . 0 N--CA 1.498 1.934 0 N-CA-C 110.34 -0.245 . . . . 0.0 110.34 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 15.3 ptt180 -148.06 111.28 4.9 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.157 0.983 . . . . 0.0 108.352 178.336 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 73.7 mt -134.56 147.7 29.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 C-N-CA 124.089 0.956 . . . . 0.0 108.544 -172.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 13.7 tp -135.0 146.53 49.13 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 168.304 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 63.1 t -121.4 130.42 74.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 105.513 -2.032 . . . . 0.0 105.513 174.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -121.26 130.23 53.56 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-N 119.004 0.82 . . . . 0.0 110.756 -173.621 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -104.98 132.03 10.92 Favored Glycine 0 C--N 1.334 0.455 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 174.135 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -143.94 159.78 16.0 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-N 118.122 0.961 . . . . 0.0 112.008 -176.167 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 131.72 173.99 13.51 Favored Glycine 0 CA--C 1.527 0.814 0 C-N-CA 126.569 2.033 . . . . 0.0 110.286 170.249 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.476 HD22 ' HB2' ' A' ' 13' ' ' LEU . 5.8 t30 -79.15 93.82 5.27 Favored 'General case' 0 C--O 1.233 0.191 0 O-C-N 121.307 -1.113 . . . . 0.0 110.891 -173.472 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.1 pt -57.46 31.49 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.092 0 N-CA-C 117.48 2.4 . . . . 0.0 117.48 172.285 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.421 ' HB2' HD21 ' A' ' 10' ' ' ASN . 38.3 mt -131.3 -3.75 3.86 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 120.671 1.578 . . . . 0.0 108.808 168.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.476 ' HB2' HD22 ' A' ' 10' ' ' ASN . 2.0 mp -118.1 59.8 0.79 Allowed 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.21 1.004 . . . . 0.0 113.459 -167.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 54.85 -96.92 0.06 Allowed 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 124.495 1.118 . . . . 0.0 111.248 171.201 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 41.1 m-20 -81.79 -15.46 54.16 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 124.601 1.16 . . . . 0.0 110.309 -172.665 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -72.65 -6.49 44.69 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 120.875 1.67 . . . . 0.0 112.609 178.683 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -82.3 -12.04 58.25 Favored 'General case' 0 N--CA 1.435 -1.189 0 CA-C-O 115.864 -2.017 . . . . 0.0 109.322 169.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 7.6 tp -52.36 -41.9 36.35 Favored 'Isoleucine or valine' 0 C--N 1.346 0.424 0 CA-C-N 122.57 2.441 . . . . 0.0 113.031 -169.61 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -60.7 -43.59 98.89 Favored Glycine 0 CA--C 1.524 0.608 0 CA-C-N 119.997 1.271 . . . . 0.0 110.708 177.482 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 55.9 t -65.67 -49.53 77.11 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 CA-C-O 118.768 -0.634 . . . . 0.0 109.609 173.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 26.3 mmt180 -60.66 -32.84 72.02 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 120.389 1.449 . . . . 0.0 112.649 -178.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 31.0 mt -62.85 -47.29 93.56 Favored 'Isoleucine or valine' 0 C--O 1.231 0.124 0 CA-C-N 120.649 1.568 . . . . 0.0 109.846 178.464 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 27.7 m -72.96 -27.15 24.16 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 CA-C-N 119.14 0.882 . . . . 0.0 111.063 -174.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -71.16 -43.38 67.63 Favored 'General case' 0 C--O 1.232 0.163 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 173.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.86 -40.58 95.85 Favored 'General case' 0 N--CA 1.449 -0.486 0 O-C-N 121.781 -0.574 . . . . 0.0 110.457 178.39 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 6.5 tp -62.57 -40.77 97.94 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 118.444 -0.789 . . . . 0.0 109.874 175.591 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -61.39 -40.49 94.55 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 119.005 0.82 . . . . 0.0 111.191 178.549 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -71.91 -36.98 70.15 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 124.107 0.963 . . . . 0.0 111.306 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -95.07 -34.69 12.21 Favored 'General case' 0 C--N 1.341 0.225 0 CA-C-O 117.372 -1.299 . . . . 0.0 113.459 -169.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -119.02 148.7 42.72 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 120.956 1.707 . . . . 0.0 112.182 -173.049 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 40.7 mm -96.06 138.44 21.47 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 N-CA-C 103.804 -2.665 . . . . 0.0 103.804 168.496 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -121.95 148.74 52.13 Favored Pre-proline 0 CA--C 1.534 0.357 0 C-N-CA 123.795 0.838 . . . . 0.0 108.873 -174.018 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -65.68 159.62 47.46 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 122.207 1.938 . . . . 0.0 109.674 169.749 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -58.51 -31.74 68.17 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 -170.106 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 15.6 p90 -80.11 0.24 32.95 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 118.072 -0.966 . . . . 0.0 113.364 -177.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 88.3 t -113.53 127.27 70.95 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 N-CA-C 105.766 -1.939 . . . . 0.0 105.766 169.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -132.5 143.97 50.12 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 170.064 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -93.33 103.68 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.066 0 N-CA-C 105.37 -2.085 . . . . 0.0 105.37 169.712 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.496 HD13 ' H ' ' A' ' 40' ' ' ASP . 0.2 OUTLIER -90.16 162.2 15.38 Favored 'General case' 0 C--O 1.237 0.436 0 N-CA-C 107.813 -1.181 . . . . 0.0 107.813 172.275 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.496 ' H ' HD13 ' A' ' 39' ' ' LEU . 10.0 t0 -131.94 122.6 25.86 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 123.836 0.854 . . . . 0.0 109.068 -171.295 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -87.6 -98.63 0.89 Allowed Glycine 0 CA--C 1.526 0.769 0 N-CA-C 107.048 -2.421 . . . . 0.0 107.048 169.673 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 81.08 116.63 0.38 Allowed Glycine 0 C--N 1.34 0.758 0 N-CA-C 108.702 -1.759 . . . . 0.0 108.702 -173.295 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 19.1 p 51.54 57.75 6.23 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.276 1.031 . . . . 0.0 108.773 -178.03 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -115.99 -88.14 0.59 Allowed 'General case' 0 C--N 1.342 0.281 0 CA-C-N 114.259 -1.337 . . . . 0.0 110.986 -169.189 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 75.12 -91.68 0.82 Allowed Glycine 0 C--N 1.34 0.798 0 N-CA-C 109.053 -1.619 . . . . 0.0 109.053 -169.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 66.1 mmm -76.56 -21.56 55.48 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 -177.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -62.21 -14.97 43.48 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 113.187 0.81 . . . . 0.0 113.187 -169.508 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 18.6 mt -79.34 -5.26 54.14 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 114.276 1.213 . . . . 0.0 114.276 -178.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.444 ' HA ' HG13 ' A' ' 100' ' ' VAL . 6.0 tt -38.65 -62.42 0.61 Allowed 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 114.84 1.422 . . . . 0.0 114.84 -170.014 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -90.86 -29.51 13.01 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 111.579 -0.608 . . . . 0.0 111.579 -174.196 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -65.86 -32.56 74.14 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 117.726 0.763 . . . . 0.0 110.974 -176.608 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 52.2 mtp -72.55 -14.47 61.64 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 113.456 0.91 . . . . 0.0 113.456 176.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -69.35 154.84 41.4 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 113.191 0.811 . . . . 0.0 113.191 -169.266 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 60.62 46.44 9.32 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.221 1.808 . . . . 0.0 115.375 168.332 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 18.7 mmt180 -114.48 155.54 26.22 Favored 'General case' 0 N--CA 1.479 0.994 0 O-C-N 121.155 -0.965 . . . . 0.0 108.887 171.516 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -81.4 -30.81 33.48 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 172.675 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -143.47 152.13 41.14 Favored 'General case' 0 C--N 1.343 0.324 0 CA-C-N 119.358 0.981 . . . . 0.0 109.77 168.193 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -137.04 139.73 41.57 Favored 'General case' 0 CA--C 1.51 -0.582 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 174.577 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 39.0 mt -114.32 115.12 48.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 176.147 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.8 mm -89.67 133.21 32.35 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 N-CA-C 106.071 -1.826 . . . . 0.0 106.071 175.013 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -114.26 115.95 28.24 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 103.557 -2.757 . . . . 0.0 103.557 168.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -154.15 161.12 42.08 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 -169.032 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -98.4 140.33 32.83 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.393 0.677 . . . . 0.0 110.583 -178.154 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 33.7 mm -78.66 -32.45 16.08 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 C-N-CA 123.847 0.859 . . . . 0.0 111.474 179.591 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . 0.296 4.0 t 60.14 45.27 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.89 0 C-N-CA 125.537 1.535 . . . . 0.0 110.809 -173.665 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 6.7 m 68.91 155.14 0.12 Allowed 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 116.985 2.217 . . . . 0.0 116.985 169.497 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 23.6 ttmt -157.88 -174.5 4.88 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 129.901 3.28 . . . . 0.0 104.159 174.46 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 10.5 ptpt -61.74 -21.25 64.35 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.699 1.2 . . . . 0.0 113.53 169.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 43.5 t-20 -65.34 156.36 32.39 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 118.95 0.795 . . . . 0.0 110.059 172.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 13.7 m -63.45 142.64 97.91 Favored Pre-proline 0 CA--C 1.546 0.795 0 C-N-CA 124.141 0.977 . . . . 0.0 112.197 -169.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -59.34 153.77 51.45 Favored 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 122.64 2.226 . . . . 0.0 112.043 169.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 67.79 18.0 69.91 Favored Glycine 0 CA--C 1.534 1.257 0 O-C-N 121.634 -0.666 . . . . 0.0 113.506 174.156 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 17.5 m -95.49 141.38 29.09 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 125.542 1.537 . . . . 0.0 107.895 177.251 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 30.7 ttp -98.71 145.43 26.91 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 175.36 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 32.0 ttm -130.88 117.73 19.72 Favored 'General case' 0 CA--C 1.528 0.103 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 -170.29 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.6 mp -96.78 122.33 48.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 179.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -117.7 122.69 44.17 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 67.5 mtp85 -102.11 135.36 43.83 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 118.516 -0.754 . . . . 0.0 109.807 176.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 8.2 t70 29.28 -91.69 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 126.681 1.992 . . . . 0.0 116.141 174.189 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -62.55 -26.84 68.79 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 -174.665 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -79.58 -12.44 59.84 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 122.844 0.458 . . . . 0.0 110.557 -179.414 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 46.4 t -75.39 -51.34 3.33 Favored Pre-proline 0 N--CA 1.446 -0.653 0 CA-C-O 116.66 -1.638 . . . . 0.0 110.777 -174.25 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo -59.33 -41.3 60.04 Favored 'Trans proline' 0 C--N 1.351 0.698 0 CA-C-N 122.865 2.059 . . . . 0.0 111.525 171.545 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -60.88 -29.69 69.7 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 122.997 0.519 . . . . 0.0 111.787 -179.54 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.506 HD13 ' C ' ' A' ' 85' ' ' LEU . 3.1 tm? -79.8 -54.11 6.15 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 122.89 0.476 . . . . 0.0 110.57 170.756 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -56.73 -34.11 67.2 Favored 'General case' 0 C--O 1.227 -0.093 0 CA-C-N 118.319 0.509 . . . . 0.0 111.448 -171.191 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 3.6 t -64.24 -5.27 4.7 Favored 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 -172.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -54.09 136.1 42.43 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 119.593 1.088 . . . . 0.0 110.204 169.54 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -81.66 -15.82 53.33 Favored 'General case' 0 N--CA 1.471 0.62 0 O-C-N 122.043 -0.41 . . . . 0.0 111.493 178.018 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 52.9 mt -61.61 -44.72 99.13 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 123.86 0.864 . . . . 0.0 109.601 -169.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 37.8 t -89.86 121.05 69.32 Favored Pre-proline 0 N--CA 1.452 -0.35 0 C-N-CA 124.386 1.075 . . . . 0.0 110.017 171.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_exo -61.93 -37.35 66.33 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 122.844 2.362 . . . . 0.0 110.082 169.068 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 5.6 m80 -59.91 -54.11 49.95 Favored 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 179.37 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -75.58 -25.73 57.31 Favored 'General case' 0 C--O 1.219 -0.526 0 C-N-CA 117.577 -1.649 . . . . 0.0 111.437 -174.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 2.8 tt -58.28 -50.7 72.69 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 120.546 1.521 . . . . 0.0 108.323 171.036 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -59.43 -46.74 93.42 Favored Glycine 0 CA--C 1.527 0.821 0 N-CA-C 110.746 -0.942 . . . . 0.0 110.746 177.008 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 32.0 tp -69.91 -20.57 63.36 Favored 'General case' 0 CA--C 1.547 0.85 0 O-C-N 121.653 -0.91 . . . . 0.0 111.312 -177.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -68.68 -46.86 67.95 Favored 'General case' 0 CA--C 1.534 0.339 0 O-C-N 121.127 -0.983 . . . . 0.0 109.272 171.504 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -71.13 -22.23 62.09 Favored 'General case' 0 C--N 1.339 0.138 0 CA-C-O 119.246 -0.407 . . . . 0.0 111.48 177.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.444 HG13 ' HA ' ' A' ' 49' ' ' LEU . 4.8 t -62.85 -43.32 98.77 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.729 0 CA-C-O 117.948 -1.025 . . . . 0.0 108.851 169.287 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 42.7 mt -60.93 -32.43 71.93 Favored 'General case' 0 C--N 1.34 0.156 0 CA-C-N 120.456 1.48 . . . . 0.0 111.096 175.524 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 66.2 m -68.14 -38.87 82.65 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 119.173 0.897 . . . . 0.0 110.657 173.068 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -65.5 -38.65 90.33 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 119.619 1.1 . . . . 0.0 111.28 174.699 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -64.19 -36.5 84.27 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 118.879 0.763 . . . . 0.0 110.38 174.19 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 34.9 ttp-105 -65.51 -36.22 83.18 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 121.701 -0.625 . . . . 0.0 109.551 175.181 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 14.3 m-30 -68.48 -40.61 80.87 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 118.873 0.76 . . . . 0.0 111.012 178.227 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 54.4 p -74.24 -26.93 60.53 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 119.481 1.037 . . . . 0.0 111.278 177.603 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 75.93 9.93 85.15 Favored Glycine 0 CA--C 1.531 1.056 0 CA-C-O 119.046 -0.863 . . . . 0.0 111.568 -170.089 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -99.46 24.42 8.16 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 118.949 1.374 . . . . 0.0 111.121 -178.395 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -57.64 135.24 82.56 Favored Pre-proline 0 CA--C 1.543 0.697 0 C-N-CA 126.116 1.766 . . . . 0.0 109.959 178.044 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -52.88 132.93 49.26 Favored 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 122.845 2.363 . . . . 0.0 112.081 177.104 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 31.3 mmtp -65.63 -24.22 66.99 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 119.149 -0.453 . . . . 0.0 111.932 -172.104 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 1.5 tmmt? -140.6 100.99 3.99 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 106.013 -1.847 . . . . 0.0 106.013 169.59 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 23.8 tp -78.51 140.78 38.54 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 174.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -134.79 138.96 44.74 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 107.159 -1.422 . . . . 0.0 107.159 176.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.1 tp -135.59 129.83 33.52 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 120.077 1.308 . . . . 0.0 108.92 175.39 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 47.9 t -103.28 105.03 17.55 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 N-CA-C 103.55 -2.759 . . . . 0.0 103.55 168.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -84.92 145.36 21.56 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 110.485 -1.046 . . . . 0.0 110.485 174.276 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 42.0 t -121.17 133.0 69.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 171.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 14.2 mt -88.89 132.11 39.26 Favored Pre-proline 0 CA--C 1.539 0.539 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 169.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -77.7 -178.29 4.49 Favored 'Trans proline' 0 CA--C 1.537 0.64 0 C-N-CA 123.582 2.854 . . . . 0.0 111.862 -175.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -119.05 -52.96 2.29 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.815 0.846 . . . . 0.0 111.207 178.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 66.5 m -118.51 -51.69 2.39 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 119.081 0.855 . . . . 0.0 112.868 -172.421 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER 57.7 52.55 8.08 Favored 'General case' 0 CA--C 1.551 0.997 0 N-CA-C 114.646 1.35 . . . . 0.0 114.646 169.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -115.93 168.51 8.37 Favored Pre-proline 0 N--CA 1.481 1.092 0 CA-C-O 118.421 -0.799 . . . . 0.0 111.182 176.159 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -65.19 89.69 0.2 Allowed 'Trans proline' 0 CA--C 1.548 1.18 0 C-N-CA 123.447 2.765 . . . . 0.0 113.756 -178.26 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 179.86 149.26 0.32 Allowed 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 104.538 -2.393 . . . . 0.0 104.538 175.6 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -110.52 163.49 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-N 119.614 1.097 . . . . 0.0 112.927 -169.83 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 86.16 150.19 15.04 Favored Glycine 0 C--N 1.341 0.814 0 N-CA-C 107.468 -2.253 . . . . 0.0 107.468 -169.489 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -79.03 164.49 24.31 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-O 121.536 0.684 . . . . 0.0 110.031 -169.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 23.6 p -65.93 166.74 14.26 Favored Pre-proline 0 CA--C 1.539 0.556 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 167.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -53.74 -32.13 64.33 Favored 'Trans proline' 0 CA--C 1.537 0.674 0 C-N-CA 121.4 1.4 . . . . 0.0 111.545 169.601 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 22.1 m -69.57 -46.49 66.25 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 117.993 0.36 . . . . 0.0 111.148 179.544 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 22.2 t -94.1 -15.36 7.87 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-N 118.626 0.648 . . . . 0.0 111.25 -169.186 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -57.88 -47.03 83.97 Favored 'General case' 0 C--O 1.233 0.202 0 O-C-N 120.301 -1.499 . . . . 0.0 107.764 169.374 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -72.03 0.23 9.97 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-O 118.04 -0.981 . . . . 0.0 113.135 177.03 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 83.2 mtp -88.92 -10.02 49.39 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-N 120.001 1.273 . . . . 0.0 111.395 171.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 87.8 mt -57.16 -41.52 78.0 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 169.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 39.1 mm-40 -64.26 -60.61 8.28 Favored Pre-proline 0 CA--C 1.541 0.633 0 CA-C-O 117.979 -1.01 . . . . 0.0 112.703 -172.65 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -62.47 -32.98 80.34 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 CA-C-N 121.397 1.535 . . . . 0.0 110.994 178.444 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -68.04 -43.84 77.81 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-N 119.448 1.022 . . . . 0.0 109.75 -179.065 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 58.5 mt -58.21 -43.16 87.51 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 119.187 0.903 . . . . 0.0 109.697 173.105 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -59.62 -38.18 80.62 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 119.096 0.862 . . . . 0.0 110.366 179.775 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 20.0 mm100 -75.15 -33.95 61.57 Favored 'General case' 0 C--N 1.338 0.093 0 CA-C-O 117.817 -1.087 . . . . 0.0 112.97 175.426 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 67.2 t -59.83 -46.3 93.88 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 CA-C-N 120.442 1.474 . . . . 0.0 108.101 172.055 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 29.1 mt -66.72 -41.02 88.6 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 122.921 0.488 . . . . 0.0 110.116 -178.189 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -63.89 -40.16 95.86 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 119.226 0.921 . . . . 0.0 111.394 176.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -67.0 -41.11 87.27 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 122.683 0.393 . . . . 0.0 110.884 178.775 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 34.2 mt -59.51 -42.82 93.08 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 123.03 0.532 . . . . 0.0 109.91 173.598 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 -64.37 -15.93 61.35 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 117.362 -1.304 . . . . 0.0 111.886 -178.44 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -58.91 -41.81 88.12 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 120.678 1.581 . . . . 0.0 110.902 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 2.7 p -89.66 23.44 2.66 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.193 0.597 . . . . 0.0 111.423 178.081 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 70.32 22.41 77.56 Favored Glycine 0 CA--C 1.531 1.045 0 CA-C-O 118.761 -1.021 . . . . 0.0 113.415 -178.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 40.7 t -100.46 89.84 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.257 0 CA-C-N 119.054 1.427 . . . . 0.0 107.955 -175.38 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -76.76 137.22 39.17 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 169.389 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -85.68 155.2 21.19 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.546 0.738 . . . . 0.0 110.517 176.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.412 HG22 ' H ' ' A' ' 160' ' ' SER . 88.9 mt -93.24 116.58 66.7 Favored Pre-proline 0 CA--C 1.541 0.61 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 -178.623 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -73.66 92.2 0.87 Allowed 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 123.405 2.737 . . . . 0.0 109.808 -176.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 7.6 ttt-85 48.11 16.92 0.1 Allowed 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 128.172 2.589 . . . . 0.0 115.513 -174.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . 0.412 ' H ' HG22 ' A' ' 157' ' ' ILE . 1.0 OUTLIER 51.5 35.5 14.54 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 126.123 1.769 . . . . 0.0 110.813 -172.406 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -77.37 139.22 39.68 Favored 'General case' 0 C--O 1.24 0.56 0 O-C-N 121.807 -0.558 . . . . 0.0 110.307 -178.274 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 45.8 m . . . . . 0 C--O 1.251 1.171 0 C-N-CA 125.389 1.476 . . . . 0.0 108.398 179.307 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.9 tpt . . . . . 0 N--CA 1.498 1.957 0 N-CA-C 110.416 -0.216 . . . . 0.0 110.416 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 9.0 ptp180 -143.25 127.51 17.67 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 174.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 50.6 mt -142.52 139.42 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 CA-C-N 119.708 1.14 . . . . 0.0 112.603 -168.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -121.68 123.31 41.59 Favored 'General case' 0 N--CA 1.462 0.163 0 N-CA-C 104.776 -2.305 . . . . 0.0 104.776 167.484 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 57.5 t -101.45 99.32 8.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 101.576 -3.49 . . . . 0.0 101.576 169.539 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 14.1 tp -101.34 107.6 18.99 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 124.195 0.998 . . . . 0.0 110.203 -168.061 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -88.52 123.86 6.96 Favored Glycine 0 N--CA 1.45 -0.408 0 N-CA-C 107.337 -2.305 . . . . 0.0 107.337 174.346 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -136.87 164.63 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.707 0 C-N-CA 124.054 0.941 . . . . 0.0 108.58 -176.534 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 145.72 156.93 7.06 Favored Glycine 0 N--CA 1.447 -0.625 0 N-CA-C 109.064 -1.614 . . . . 0.0 109.064 178.215 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.441 HD21 ' HB2' ' A' ' 12' ' ' LEU . 1.6 t30 -76.47 94.89 3.75 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 171.449 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.3 pt -70.77 37.74 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 C-N-CA 124.577 1.151 . . . . 0.0 113.567 179.687 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.441 ' HB2' HD21 ' A' ' 10' ' ' ASN . 23.0 mt -125.15 -8.04 7.09 Favored 'General case' 0 CA--C 1.537 0.466 0 O-C-N 121.148 -0.97 . . . . 0.0 108.768 170.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.0 mp -118.65 67.61 0.78 Allowed 'General case' 0 C--N 1.346 0.414 0 C-N-CA 124.006 0.923 . . . . 0.0 109.118 -169.002 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.3 m 47.3 -111.12 0.35 Allowed 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 114.761 -1.109 . . . . 0.0 111.654 171.645 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.445 ' O ' HG22 ' A' ' 18' ' ' ILE . 87.6 m-20 -71.9 -11.25 60.7 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-O 117.614 -1.184 . . . . 0.0 112.302 -170.235 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -66.54 -18.02 65.13 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 121.4 1.909 . . . . 0.0 111.032 171.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -70.6 -12.83 61.81 Favored 'General case' 0 N--CA 1.448 -0.555 0 O-C-N 120.178 -1.576 . . . . 0.0 111.769 171.392 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.501 HG21 HG11 ' A' ' 119' ' ' VAL . 8.4 tp -58.1 -36.45 57.03 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-N 121.271 1.85 . . . . 0.0 111.613 -174.019 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -61.48 -38.38 95.69 Favored Glycine 0 C--N 1.339 0.697 0 CA-C-N 119.365 0.984 . . . . 0.0 111.769 178.037 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 54.8 t -72.42 -47.04 54.01 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 175.111 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 24.7 mmt180 -60.96 -31.18 70.75 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 116.939 -1.505 . . . . 0.0 112.94 -179.244 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 18.4 mt -61.62 -47.74 91.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 CA-C-N 121.565 1.984 . . . . 0.0 110.17 177.078 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 14.4 m -72.78 -33.48 44.11 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-N 119.192 0.906 . . . . 0.0 110.912 -174.642 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 57.6 mt-10 -63.66 -42.98 98.01 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 118.428 0.558 . . . . 0.0 110.334 171.665 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.18 -39.37 92.46 Favored 'General case' 0 CA--C 1.537 0.452 0 O-C-N 121.292 -0.88 . . . . 0.0 110.647 176.006 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 6.1 tp -66.06 -39.61 90.23 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 118.451 0.569 . . . . 0.0 110.081 -179.317 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -60.68 -28.9 68.96 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 121.512 0.672 . . . . 0.0 112.131 -178.581 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 -88.19 -40.21 13.89 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 125.891 1.676 . . . . 0.0 111.14 -178.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 56.4 mtp180 -94.17 -18.44 21.73 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-O 118.449 -0.786 . . . . 0.0 112.364 -170.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 49.8 m-85 -129.58 147.05 51.34 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 119.354 0.979 . . . . 0.0 112.552 177.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 39.5 mm -98.28 137.08 26.84 Favored 'Isoleucine or valine' 0 C--O 1.239 0.518 0 N-CA-C 103.62 -2.733 . . . . 0.0 103.62 168.784 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -120.19 150.54 51.62 Favored Pre-proline 0 C--O 1.237 0.414 0 C-N-CA 123.297 0.639 . . . . 0.0 110.49 -169.811 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -59.05 157.56 28.97 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 123.128 2.552 . . . . 0.0 111.227 169.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -61.55 -31.51 71.54 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -175.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 9.6 p90 -75.76 -11.12 59.93 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 -179.512 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 92.5 t -92.87 122.9 44.74 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 173.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -117.62 123.59 46.54 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 169.476 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -86.48 117.78 31.58 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 N-CA-C 104.168 -2.53 . . . . 0.0 104.168 168.512 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 63.8 tp -118.9 130.75 55.89 Favored 'General case' 0 CA--C 1.523 -0.083 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 178.152 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -89.42 119.13 29.61 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 169.509 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -77.54 -80.14 0.68 Allowed Glycine 0 CA--C 1.528 0.872 0 N-CA-C 106.834 -2.507 . . . . 0.0 106.834 169.189 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 78.48 107.05 0.2 Allowed Glycine 0 C--N 1.345 1.044 0 N-CA-C 109.176 -1.57 . . . . 0.0 109.176 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 10.5 p 53.41 55.47 8.65 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 -177.106 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -120.35 -83.4 0.66 Allowed 'General case' 0 C--N 1.347 0.482 0 CA-C-N 115.005 -0.998 . . . . 0.0 112.255 -169.279 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 58.93 -107.21 1.09 Allowed Glycine 0 CA--C 1.532 1.15 0 N-CA-C 110.511 -1.036 . . . . 0.0 110.511 -178.368 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 11.7 tpt -55.95 -28.18 55.81 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.665 1.186 . . . . 0.0 112.627 -177.67 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -56.46 -22.12 30.1 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 113.827 1.047 . . . . 0.0 113.827 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 15.1 mt -103.3 17.95 22.89 Favored 'General case' 0 C--N 1.341 0.233 0 N-CA-C 115.978 1.844 . . . . 0.0 115.978 -167.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 6.2 tt -48.09 -56.35 8.01 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 119.447 1.021 . . . . 0.0 111.109 -178.166 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -66.42 -36.58 91.78 Favored Glycine 0 CA--C 1.528 0.898 0 CA-C-O 119.259 -0.745 . . . . 0.0 112.447 -177.502 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -73.69 -35.1 65.13 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 118.886 1.343 . . . . 0.0 111.817 -176.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 78.8 mtp -71.88 -12.71 61.4 Favored 'General case' 0 CA--C 1.535 0.401 0 O-C-N 121.962 -0.461 . . . . 0.0 110.323 179.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -84.12 153.63 23.62 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 123.306 0.642 . . . . 0.0 111.57 -170.424 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 54.24 34.8 21.17 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 126.475 1.91 . . . . 0.0 112.847 170.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 26.1 mmt180 -98.31 157.57 16.1 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 173.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -84.67 -51.4 6.85 Favored 'General case' 0 C--O 1.221 -0.42 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 175.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . 0.269 0.0 OUTLIER -120.25 146.43 46.07 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 120.017 1.281 . . . . 0.0 108.272 168.652 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 33.1 tp -130.46 111.63 12.48 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 104.172 -2.529 . . . . 0.0 104.172 173.092 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 52.7 mt -93.24 111.71 25.19 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 N-CA-C 103.801 -2.666 . . . . 0.0 103.801 171.17 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.46 HG22 HD23 ' A' ' 116' ' ' LEU . 53.5 mt -83.86 133.69 28.63 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 N-CA-C 105.233 -2.136 . . . . 0.0 105.233 170.651 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -116.97 116.77 28.03 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 102.519 -3.141 . . . . 0.0 102.519 168.038 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -161.57 165.77 27.95 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 123.518 0.727 . . . . 0.0 109.796 -176.248 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -81.34 144.53 31.41 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-O 122.355 1.074 . . . . 0.0 110.031 169.717 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 12.0 mt -69.1 -51.04 47.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 114.55 -1.205 . . . . 0.0 107.957 170.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . 0.294 9.0 p 42.22 48.45 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.95 0 C-N-CA 125.276 1.43 . . . . 0.0 111.071 179.753 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 8.4 t -162.79 176.42 10.28 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.368 1.467 . . . . 0.0 109.624 -171.572 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 20.0 ttmt 51.14 -161.17 0.08 Allowed 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 127.386 2.274 . . . . 0.0 112.175 -173.586 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 14.6 ptpt -128.89 12.79 6.26 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 125.036 1.334 . . . . 0.0 112.973 -169.394 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 44.8 t30 -74.75 167.22 22.25 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 178.051 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 2.8 m -56.93 145.87 61.92 Favored Pre-proline 0 CA--C 1.546 0.795 0 C-N-CA 123.812 0.845 . . . . 0.0 112.132 -169.704 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -56.23 155.82 23.18 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 123.84 3.026 . . . . 0.0 112.701 169.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 65.15 17.44 63.62 Favored Glycine 0 CA--C 1.535 1.321 0 CA-C-O 119.696 -0.502 . . . . 0.0 113.242 170.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 3.1 m -95.58 142.19 28.21 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 125.176 1.39 . . . . 0.0 109.11 -175.036 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 44.5 ttp -95.16 141.66 28.51 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 169.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 75.1 mtm -132.02 145.85 51.7 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 169.363 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.5 mp -97.22 119.66 45.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 N-CA-C 105.358 -2.09 . . . . 0.0 105.358 172.093 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.8 mp -113.79 136.02 53.32 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 171.717 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 36.4 mmt180 -96.39 164.13 12.77 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 123.018 0.527 . . . . 0.0 110.863 178.607 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -1.09 -70.13 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 127.839 2.456 . . . . 0.0 117.438 169.465 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -87.6 -19.87 27.18 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 113.533 0.938 . . . . 0.0 113.533 -170.474 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -76.77 -37.4 55.95 Favored 'General case' 0 CA--C 1.523 -0.084 0 CA-C-O 121.135 0.493 . . . . 0.0 110.095 -172.627 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.538 HG12 ' CE2' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -66.85 -52.48 32.49 Favored Pre-proline 0 CA--C 1.538 0.51 0 CA-C-O 117.417 -1.278 . . . . 0.0 112.723 -174.149 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -55.4 -42.01 72.46 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 121.57 1.513 . . . . 0.0 110.551 177.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.8 -15.53 63.53 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 178.118 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -92.69 -46.06 7.75 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 119.854 1.206 . . . . 0.0 110.674 -176.092 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.538 ' CE2' HG12 ' A' ' 82' ' ' VAL . 43.8 m-85 -68.77 -1.72 7.72 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 113.988 1.107 . . . . 0.0 113.988 -169.649 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 62.5 p -59.51 -21.17 59.79 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.759 1.223 . . . . 0.0 112.587 178.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 42.3 t-20 -65.91 149.88 49.5 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.542 0.737 . . . . 0.0 111.192 -175.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -84.93 -6.33 59.34 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.15 0.98 . . . . 0.0 113.569 -170.036 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 20.3 mt -59.56 -43.53 91.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 C-N-CA 123.676 0.79 . . . . 0.0 111.147 -169.444 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 28.3 t -117.72 125.28 28.16 Favored Pre-proline 0 C--O 1.235 0.295 0 N-CA-C 109.038 -0.726 . . . . 0.0 109.038 174.541 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -71.29 -30.01 16.3 Favored 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 122.578 2.185 . . . . 0.0 110.547 175.682 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 30.1 t-80 -67.19 -43.38 82.29 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 119.05 0.841 . . . . 0.0 108.815 177.283 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 7.4 mm100 -66.13 -38.8 89.06 Favored 'General case' 0 C--O 1.22 -0.46 0 CA-C-O 117.603 -1.189 . . . . 0.0 110.291 175.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 1.3 tt -56.47 -40.81 75.51 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 120.141 1.337 . . . . 0.0 109.373 174.095 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -60.81 -44.75 97.64 Favored Glycine 0 CA--C 1.529 0.942 0 O-C-N 121.237 -0.915 . . . . 0.0 111.434 175.176 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 51.1 tp -64.24 -32.44 74.03 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 117.893 0.847 . . . . 0.0 110.245 174.446 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.474 ' HB2' ' CB ' ' A' ' 86' ' ' PHE . . . -62.07 -51.39 68.15 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 119.517 1.053 . . . . 0.0 109.034 176.148 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -70.91 -28.33 64.44 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.011 -174.425 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -70.02 -41.99 79.4 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.922 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 172.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 32.1 mt -64.31 -35.66 81.57 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 119.521 1.055 . . . . 0.0 110.174 177.083 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 49.8 m -63.38 -37.19 86.32 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 118.983 0.81 . . . . 0.0 110.451 169.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.425 ' HA ' ' CD2' ' A' ' 106' ' ' PHE . . . -66.61 -39.14 88.21 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 119.58 1.082 . . . . 0.0 111.221 177.609 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -63.13 -31.67 72.87 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 118.69 0.677 . . . . 0.0 109.987 172.14 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 58.6 ttt85 -72.37 -34.41 67.95 Favored 'General case' 0 CA--C 1.533 0.32 0 O-C-N 121.103 -0.998 . . . . 0.0 109.864 175.507 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.425 ' CD2' ' HA ' ' A' ' 103' ' ' ALA . 13.9 m-30 -68.42 -44.09 75.76 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 118.829 0.74 . . . . 0.0 110.583 178.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 40.4 p -70.97 -26.77 63.3 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 118.52 0.6 . . . . 0.0 111.745 -179.424 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 73.19 7.07 70.8 Favored Glycine 0 CA--C 1.535 1.282 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 -168.34 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -89.51 16.85 7.0 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 119.467 1.633 . . . . 0.0 110.937 178.302 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -54.88 139.85 61.57 Favored Pre-proline 0 CA--C 1.549 0.918 0 C-N-CA 125.824 1.65 . . . . 0.0 109.702 172.076 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_exo -55.56 156.9 16.59 Favored 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 123.38 2.72 . . . . 0.0 115.697 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 66.7 mmtt -63.76 -40.44 96.7 Favored 'General case' 0 N--CA 1.472 0.661 0 O-C-N 121.768 -0.582 . . . . 0.0 111.418 -179.433 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 5.4 pttm -131.72 146.14 52.01 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 105.663 -1.977 . . . . 0.0 105.663 171.282 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.51 HD23 ' N ' ' A' ' 115' ' ' THR . 7.0 tt -140.26 139.36 35.54 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 175.335 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.51 ' N ' HD23 ' A' ' 114' ' ' LEU . 0.2 OUTLIER -137.9 134.57 35.19 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 -171.274 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.46 HD23 HG22 ' A' ' 60' ' ' ILE . 0.4 OUTLIER -122.79 118.42 27.95 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 120.409 1.459 . . . . 0.0 108.512 177.798 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 16.1 t -88.05 81.99 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 N-CA-C 105.05 -2.204 . . . . 0.0 105.05 175.335 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -80.76 141.9 23.07 Favored Glycine 0 C--O 1.225 -0.434 0 CA-C-O 119.272 -0.738 . . . . 0.0 111.573 -169.595 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.501 HG11 HG21 ' A' ' 18' ' ' ILE . 42.0 t -119.9 123.6 71.18 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.105 0 CA-C-N 117.396 0.598 . . . . 0.0 109.946 177.522 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 25.7 mt -78.23 127.87 79.95 Favored Pre-proline 0 CA--C 1.53 0.207 0 N-CA-C 104.999 -2.222 . . . . 0.0 104.999 169.545 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -69.15 160.0 51.61 Favored 'Trans proline' 0 N--CA 1.45 -1.062 0 C-N-CA 121.756 1.637 . . . . 0.0 110.966 179.584 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -94.67 -42.92 8.52 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 105.871 -1.9 . . . . 0.0 105.871 168.144 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 49.9 m -137.28 149.22 46.95 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 123.791 0.837 . . . . 0.0 109.494 173.682 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.2 tp -143.48 53.54 1.33 Allowed 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.976 1.311 . . . . 0.0 108.499 -175.507 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -114.49 168.18 8.44 Favored Pre-proline 0 CA--C 1.538 0.482 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 -173.749 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -82.08 84.66 1.82 Allowed 'Trans proline' 0 N--CA 1.454 -0.802 0 CA-C-N 120.952 1.376 . . . . 0.0 112.654 -169.45 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -174.28 145.37 1.01 Allowed 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 103.511 -2.774 . . . . 0.0 103.511 179.401 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -112.03 168.33 4.99 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 N-CA-C 113.352 0.871 . . . . 0.0 113.352 -169.264 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 96.76 148.79 24.69 Favored Glycine 0 CA--C 1.528 0.893 0 N-CA-C 106.066 -2.814 . . . . 0.0 106.066 -168.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.545 HD22 ' H ' ' A' ' 130' ' ' LEU . 0.7 OUTLIER -75.3 163.02 27.91 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 118.312 1.056 . . . . 0.0 110.569 177.969 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 58.4 p -71.05 171.4 8.6 Favored Pre-proline 0 CA--C 1.543 0.706 0 CA-C-N 114.929 -1.032 . . . . 0.0 109.051 168.52 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -58.06 -33.79 97.71 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 121.927 1.751 . . . . 0.0 112.393 172.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 57.7 m -72.65 -40.1 66.62 Favored 'General case' 0 N--CA 1.443 -0.785 0 C-N-CA 123.463 0.705 . . . . 0.0 111.178 -178.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 95.1 t -94.44 -23.85 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 CA-C-N 118.438 0.563 . . . . 0.0 111.523 -169.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -51.37 -44.77 62.21 Favored 'General case' 0 N--CA 1.467 0.402 0 O-C-N 120.836 -1.165 . . . . 0.0 109.497 169.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -71.3 -18.79 62.39 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 114.405 1.261 . . . . 0.0 114.405 -178.69 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . 0.47 ' SD ' HG13 ' A' ' 119' ' ' VAL . 74.8 mtp -67.82 -14.92 63.35 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 118.005 -0.998 . . . . 0.0 112.829 -179.186 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 13.6 mt -48.87 -42.53 13.87 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.387 0 CA-C-N 119.635 1.107 . . . . 0.0 108.362 169.447 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 61.5 mm-40 -64.88 -58.32 13.31 Favored Pre-proline 0 CA--C 1.539 0.553 0 CA-C-N 120.351 1.432 . . . . 0.0 111.5 -172.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -61.32 -37.16 74.9 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 CA-C-N 121.447 1.553 . . . . 0.0 112.36 177.453 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -73.13 -37.83 66.52 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-O 118.569 -0.729 . . . . 0.0 111.499 -176.495 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 32.8 mt -62.24 -43.64 98.38 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-N 119.653 1.115 . . . . 0.0 109.041 170.701 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -55.78 -36.57 67.53 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 118.742 0.701 . . . . 0.0 110.131 174.547 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -72.44 -41.35 66.23 Favored 'General case' 0 N--CA 1.454 -0.26 0 O-C-N 121.442 -0.786 . . . . 0.0 112.712 177.527 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 60.1 t -58.76 -47.58 88.68 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 175.47 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 60.0 mt -60.99 -35.31 76.48 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-O 118.763 -0.637 . . . . 0.0 110.788 177.12 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -68.2 -46.22 71.21 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 119.243 0.928 . . . . 0.0 110.54 178.209 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -67.72 -30.06 69.46 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 119.882 1.219 . . . . 0.0 111.162 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 13.9 mt -63.06 -52.68 61.82 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 169.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 50.9 mmm-85 -66.04 -26.9 67.72 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 119.765 1.166 . . . . 0.0 112.412 -177.736 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 71.2 mt-10 -66.5 -30.13 70.38 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 119.569 1.077 . . . . 0.0 109.872 174.558 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 20.4 m -84.0 6.66 21.15 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.388 1.075 . . . . 0.0 111.957 171.118 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 72.06 12.15 75.32 Favored Glycine 0 CA--C 1.526 0.744 0 CA-C-O 117.294 -1.837 . . . . 0.0 112.98 -172.578 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 55.2 t -91.72 122.25 42.98 Favored 'Isoleucine or valine' 0 C--N 1.346 0.447 0 CA-C-N 121.048 2.424 . . . . 0.0 108.019 -176.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -104.26 93.5 4.85 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 173.546 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -58.9 146.04 39.07 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.823 169.129 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 22.9 mm -98.76 127.0 36.76 Favored Pre-proline 0 CA--C 1.53 0.21 0 CA-C-O 117.396 -1.287 . . . . 0.0 109.067 -171.454 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -67.96 97.99 0.5 Allowed 'Trans proline' 0 CA--C 1.535 0.536 0 C-N-CA 122.702 2.268 . . . . 0.0 109.753 174.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 23.2 mtp-105 48.32 18.04 0.15 Allowed 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 127.45 2.3 . . . . 0.0 115.327 -178.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 53.3 m 46.09 39.64 6.14 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.229 1.012 . . . . 0.0 111.876 -169.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -78.9 -31.41 45.38 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 122.68 0.392 . . . . 0.0 111.761 -177.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 11.8 m . . . . . 0 C--O 1.254 1.327 0 C-N-CA 124.467 1.107 . . . . 0.0 110.571 178.837 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.0 tpt . . . . . 0 N--CA 1.496 1.869 0 CA-C-O 120.456 0.169 . . . . 0.0 110.586 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 16.2 ptt180 -149.79 112.61 4.81 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.626 1.17 . . . . 0.0 108.687 176.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 84.8 mt -127.39 130.93 70.78 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.14 0 N-CA-C 107.896 -1.149 . . . . 0.0 107.896 -175.609 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -119.61 144.95 46.84 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 105.513 -2.032 . . . . 0.0 105.513 168.799 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 71.4 t -121.95 128.13 75.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 104.891 -2.263 . . . . 0.0 104.891 174.222 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.43 HD13 ' HA ' ' A' ' 6' ' ' LEU . 2.6 mm? -111.26 130.79 55.55 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-N 118.398 0.544 . . . . 0.0 109.85 -179.55 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -100.61 126.08 8.8 Favored Glycine 0 C--O 1.237 0.32 0 N-CA-C 108.211 -1.956 . . . . 0.0 108.211 171.296 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 1.9 m -141.22 171.56 12.04 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 CA-C-N 117.797 0.799 . . . . 0.0 110.278 -173.225 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 103.03 156.69 25.13 Favored Glycine 0 N--CA 1.442 -0.953 0 C-N-CA 126.352 1.93 . . . . 0.0 110.052 -178.625 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.527 HD21 ' HB2' ' A' ' 12' ' ' LEU . 4.1 t30 -72.51 104.21 3.76 Favored 'General case' 0 N--CA 1.453 -0.321 0 O-C-N 121.709 -0.877 . . . . 0.0 111.247 -169.378 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.1 pt -59.92 30.64 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.954 0 N-CA-C 117.228 2.307 . . . . 0.0 117.228 172.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.527 ' HB2' HD21 ' A' ' 10' ' ' ASN . 5.4 mp -129.79 -6.68 4.55 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 120.593 1.542 . . . . 0.0 108.436 168.439 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.465 ' HB2' HD22 ' A' ' 10' ' ' ASN . 3.0 mp -107.98 57.05 0.62 Allowed 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 119.255 0.934 . . . . 0.0 112.796 -168.123 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.444 ' HB ' ' H ' ' A' ' 15' ' ' ASP . 0.1 OUTLIER 51.16 -109.83 0.45 Allowed 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 123.898 0.879 . . . . 0.0 110.123 175.176 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.444 ' H ' ' HB ' ' A' ' 14' ' ' THR . 0.3 OUTLIER -77.85 -4.49 46.88 Favored 'General case' 0 N--CA 1.443 -0.78 0 O-C-N 121.59 -0.694 . . . . 0.0 111.021 -173.714 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -69.63 -12.17 61.43 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 120.647 1.567 . . . . 0.0 111.837 170.193 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -77.97 -9.95 59.35 Favored 'General case' 0 N--CA 1.435 -1.222 0 CA-C-O 115.736 -2.078 . . . . 0.0 109.635 170.497 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.7 tp -55.11 -39.14 49.19 Favored 'Isoleucine or valine' 0 C--N 1.348 0.537 0 CA-C-N 122.395 2.362 . . . . 0.0 111.995 -170.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -61.01 -39.5 97.17 Favored Glycine 0 C--N 1.336 0.58 0 CA-C-N 119.151 0.887 . . . . 0.0 111.038 177.62 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 97.1 t -74.45 -47.56 39.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 CA-C-O 118.54 -0.743 . . . . 0.0 109.861 176.024 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 76.2 mmt-85 -59.66 -33.84 72.06 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 119.983 1.265 . . . . 0.0 111.76 -179.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 22.8 mt -56.45 -51.49 64.1 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-N 120.363 1.438 . . . . 0.0 110.181 173.674 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 24.8 m -75.2 -25.98 18.54 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-N 119.075 0.852 . . . . 0.0 111.206 -172.56 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -69.88 -45.72 67.07 Favored 'General case' 0 C--O 1.233 0.187 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 174.355 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -67.35 -40.2 85.8 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 122.723 0.409 . . . . 0.0 110.386 -179.18 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.7 tp -61.56 -38.41 87.39 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 118.441 -0.79 . . . . 0.0 110.554 177.515 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -64.3 -42.21 96.49 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 118.956 0.798 . . . . 0.0 110.292 177.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -68.59 -36.37 78.62 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 122.873 0.469 . . . . 0.0 111.466 178.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 79.1 mmt-85 -94.36 -40.55 9.88 Favored 'General case' 0 C--N 1.339 0.122 0 CA-C-O 116.951 -1.499 . . . . 0.0 112.771 -170.3 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -117.19 130.33 56.52 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 121.588 1.994 . . . . 0.0 113.244 -169.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 40.2 mm -83.29 134.92 25.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 105.607 -1.997 . . . . 0.0 105.607 168.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.6 mp -133.34 150.69 75.9 Favored Pre-proline 0 CA--C 1.54 0.565 0 C-N-CA 126.99 2.116 . . . . 0.0 108.552 -169.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -71.01 165.05 33.64 Favored 'Trans proline' 0 CA--C 1.536 0.616 0 C-N-CA 122.815 2.343 . . . . 0.0 111.123 175.315 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -59.48 -31.45 69.35 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 -169.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 46.3 p90 -78.55 2.4 19.3 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 113.361 0.874 . . . . 0.0 113.361 -178.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.7 t -111.2 127.47 68.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 172.257 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -125.12 145.75 49.8 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 109.055 -0.721 . . . . 0.0 109.055 173.421 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -113.52 109.3 28.04 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 N-CA-C 105.762 -1.94 . . . . 0.0 105.762 172.159 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 64.4 tp -113.67 142.13 46.38 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 -174.118 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -100.38 127.52 46.68 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 123.642 0.777 . . . . 0.0 110.411 178.117 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -121.78 -22.56 2.7 Favored Glycine 0 CA--C 1.533 1.161 0 CA-C-O 118.51 -1.161 . . . . 0.0 113.012 169.586 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 42.64 -107.6 0.12 Allowed Glycine 0 C--N 1.339 0.742 0 C-N-CA 125.389 1.471 . . . . 0.0 113.938 177.091 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.8 p -67.48 -3.68 9.26 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 128.645 2.778 . . . . 0.0 114.108 -174.415 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.36 -56.88 14.15 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 124.07 0.948 . . . . 0.0 112.498 179.282 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 61.17 -99.64 0.21 Allowed Glycine 0 C--N 1.338 0.677 0 N-CA-C 108.614 -1.794 . . . . 0.0 108.614 -170.365 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.9 -28.15 68.08 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 126.098 1.759 . . . . 0.0 111.604 177.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -68.16 -4.15 12.91 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 113.802 1.038 . . . . 0.0 113.802 -168.5 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 22.4 mt -92.46 12.34 23.17 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 113.677 0.992 . . . . 0.0 113.677 177.449 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.429 ' HA ' HG13 ' A' ' 100' ' ' VAL . 6.1 tt -36.6 -60.48 0.59 Allowed 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.263 1.425 . . . . 0.0 114.713 -173.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -94.86 -26.61 12.51 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 123.205 0.431 . . . . 0.0 112.349 -175.51 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -57.69 -35.98 71.33 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 117.693 0.746 . . . . 0.0 111.769 179.066 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 20.7 mtp -83.05 -1.22 52.13 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 113.24 0.83 . . . . 0.0 113.24 -176.691 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -81.8 158.22 24.18 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.351 0.66 . . . . 0.0 111.995 -174.305 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 55.09 52.17 12.17 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 127.285 2.234 . . . . 0.0 115.655 168.416 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 20.7 mmt180 -115.07 163.2 15.96 Favored 'General case' 0 N--CA 1.482 1.174 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 170.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -80.46 -43.34 21.06 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 173.143 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . 0.294 0.1 OUTLIER -139.18 137.57 36.16 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 120.209 1.368 . . . . 0.0 110.101 168.319 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 24.1 tp -119.34 129.78 55.03 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 174.326 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 11.7 mt -103.1 115.91 45.9 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 174.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 9.5 mt -92.55 123.21 44.57 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 176.272 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -104.92 114.79 29.21 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 104.473 -2.417 . . . . 0.0 104.473 169.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -149.85 162.37 40.43 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.424 0.631 . . . . 0.0 110.961 -178.308 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -72.99 179.97 3.5 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 168.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.574 HG22 ' H ' ' A' ' 66' ' ' SER 0.301 93.2 mt -110.13 -83.15 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 CA-C-O 117.727 -1.13 . . . . 0.0 110.958 175.683 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . 0.292 1.7 m 41.0 35.86 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.856 0 C-N-CA 125.712 1.605 . . . . 0.0 112.984 -169.326 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.574 ' H ' HG22 ' A' ' 64' ' ' ILE . 49.9 m -134.12 2.77 3.36 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.435 1.494 . . . . 0.0 112.065 -173.453 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -154.34 156.36 36.76 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 177.032 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 9.7 ptpt -78.65 3.04 17.44 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 115.377 1.621 . . . . 0.0 115.377 -169.717 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 32.3 t-20 -69.7 161.9 28.8 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 118.955 0.798 . . . . 0.0 110.47 -173.677 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 11.9 m -55.72 143.34 60.0 Favored Pre-proline 0 CA--C 1.545 0.766 0 C-N-CA 124.669 1.188 . . . . 0.0 112.698 -169.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -57.28 151.83 49.69 Favored 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 122.33 2.02 . . . . 0.0 111.166 169.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 71.47 18.78 77.26 Favored Glycine 0 CA--C 1.533 1.189 0 O-C-N 121.458 -0.776 . . . . 0.0 113.468 175.213 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 6.9 m -104.78 139.95 38.81 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 125.474 1.51 . . . . 0.0 108.02 177.068 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 47.5 ttp -96.2 143.36 27.37 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 173.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 33.6 ttm -135.51 123.09 22.15 Favored 'General case' 0 CA--C 1.528 0.128 0 N-CA-C 106.429 -1.693 . . . . 0.0 106.429 -174.248 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 35.8 mm -103.67 119.64 52.59 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 178.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -114.01 134.22 54.99 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 -174.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 60.6 mtm180 -109.37 132.74 53.84 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 118.459 -0.781 . . . . 0.0 109.637 -174.749 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 37.8 t70 40.85 -104.76 0.05 Allowed 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 114.26 1.207 . . . . 0.0 114.26 169.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -60.02 -26.11 65.83 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.778 1.231 . . . . 0.0 113.894 -177.253 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -73.73 -20.9 60.39 Favored 'General case' 0 CA--C 1.534 0.331 0 O-C-N 121.829 -0.544 . . . . 0.0 110.085 -179.284 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.413 ' HB ' ' HD3' ' A' ' 83' ' ' PRO . 46.9 t -75.0 -55.46 2.31 Favored Pre-proline 0 N--CA 1.449 -0.494 0 CA-C-O 117.404 -1.284 . . . . 0.0 111.218 -169.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.413 ' HD3' ' HB ' ' A' ' 82' ' ' VAL . 6.2 Cg_exo -66.27 -30.7 45.28 Favored 'Trans proline' 0 N--CA 1.448 -1.193 0 CA-C-N 121.659 1.628 . . . . 0.0 110.191 178.04 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.07 -27.32 68.7 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 118.417 0.553 . . . . 0.0 111.364 179.322 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -74.05 -56.29 5.11 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 169.379 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.429 ' HB3' ' HB2' ' A' ' 98' ' ' ALA . 26.1 m-85 -63.23 -25.37 68.3 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 114.157 1.169 . . . . 0.0 114.157 -169.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 7.0 t -69.66 1.09 4.53 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 -175.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 37.2 t-20 -67.12 136.91 55.87 Favored 'General case' 0 CA--C 1.54 0.581 0 O-C-N 120.927 -1.108 . . . . 0.0 109.447 175.643 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 13.3 mptt -82.41 -9.1 59.58 Favored 'General case' 0 N--CA 1.47 0.531 0 O-C-N 121.487 -0.758 . . . . 0.0 111.858 -175.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 89.4 mt -61.25 -36.95 76.25 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 CA-C-N 119.047 0.84 . . . . 0.0 110.038 179.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 8.3 p -99.54 109.82 56.48 Favored Pre-proline 0 CA--C 1.548 0.903 0 C-N-CA 124.693 1.197 . . . . 0.0 109.543 -173.545 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -70.62 -46.47 0.86 Allowed 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 122.2 1.933 . . . . 0.0 113.21 -169.571 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 3.0 m80 -73.15 -38.4 66.26 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.481 0.657 . . . . 0.0 109.383 -177.042 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -76.11 -26.83 56.77 Favored 'General case' 0 C--O 1.226 -0.147 0 CA-C-O 118.659 -0.686 . . . . 0.0 111.07 -172.211 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -59.14 -37.61 77.7 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 118.901 0.773 . . . . 0.0 108.995 169.423 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -60.39 -41.86 98.68 Favored Glycine 0 CA--C 1.534 1.242 0 O-C-N 121.497 -0.752 . . . . 0.0 111.651 174.343 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -68.59 -31.6 70.9 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 118.133 0.967 . . . . 0.0 110.233 176.135 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.429 ' HB2' ' HB3' ' A' ' 86' ' ' PHE . . . -59.69 -45.32 92.45 Favored 'General case' 0 CA--C 1.53 0.179 0 O-C-N 120.77 -1.206 . . . . 0.0 109.032 169.306 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -68.63 -21.88 64.45 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 119.064 -0.493 . . . . 0.0 111.852 178.425 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.429 HG13 ' HA ' ' A' ' 49' ' ' LEU . 44.6 t -64.52 -46.21 93.36 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 168.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 19.8 mt -64.87 -35.46 81.2 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 119.655 1.116 . . . . 0.0 110.53 -179.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 16.4 m -60.93 -44.62 96.95 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 118.871 0.76 . . . . 0.0 109.368 171.5 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -65.63 -36.64 84.28 Favored 'General case' 0 N--CA 1.449 -0.522 0 O-C-N 121.686 -0.634 . . . . 0.0 111.701 179.105 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 12.4 mt -61.3 -37.59 83.77 Favored 'General case' 0 C--O 1.23 0.073 0 C-N-CA 123.59 0.756 . . . . 0.0 109.982 174.437 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 52.9 tpt85 -71.71 -35.1 70.11 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-O 118.036 -0.983 . . . . 0.0 110.49 174.452 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 18.4 m-30 -69.13 -39.06 79.12 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 119.785 1.175 . . . . 0.0 110.755 -178.571 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 38.9 p -72.59 -22.36 60.99 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 118.759 0.709 . . . . 0.0 111.012 175.699 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 73.62 11.07 80.4 Favored Glycine 0 CA--C 1.533 1.196 0 N-CA-C 111.005 -0.838 . . . . 0.0 111.005 -169.642 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -99.43 26.7 5.81 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 118.436 1.118 . . . . 0.0 110.575 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -59.48 129.59 87.12 Favored Pre-proline 0 CA--C 1.544 0.722 0 C-N-CA 124.137 0.975 . . . . 0.0 108.522 171.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_exo -50.37 149.66 12.47 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 123.971 3.114 . . . . 0.0 113.829 178.025 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 33.0 mmtp -59.46 -30.55 68.6 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 119.359 -0.353 . . . . 0.0 110.589 -178.307 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? -137.57 142.25 41.34 Favored 'General case' 0 C--O 1.231 0.129 0 N-CA-C 105.915 -1.883 . . . . 0.0 105.915 169.068 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 8.9 tt -127.78 134.1 49.47 Favored 'General case' 0 CA--C 1.519 -0.216 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 171.667 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.75 129.13 30.03 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 106.784 -1.562 . . . . 0.0 106.784 -169.569 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 7.0 tp -115.06 126.68 54.99 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 120.09 1.314 . . . . 0.0 108.553 178.312 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 32.4 t -98.51 84.44 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 N-CA-C 104.721 -2.326 . . . . 0.0 104.721 169.687 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -81.43 145.06 24.95 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 -179.013 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 19.0 t -126.79 137.11 58.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 171.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 1.6 mm -85.09 122.24 74.05 Favored Pre-proline 0 CA--C 1.543 0.701 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 177.179 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_exo -58.34 170.45 2.35 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 124.988 3.792 . . . . 0.0 115.711 172.109 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -118.26 -52.33 2.39 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 114.897 -1.047 . . . . 0.0 110.255 179.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 64.6 m -107.43 -53.84 2.56 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 119.203 0.91 . . . . 0.0 112.802 -174.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 57.29 47.55 16.58 Favored 'General case' 0 CA--C 1.549 0.942 0 N-CA-C 114.765 1.394 . . . . 0.0 114.765 175.283 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -124.67 170.17 9.48 Favored Pre-proline 0 N--CA 1.478 0.938 0 CA-C-O 117.888 -1.054 . . . . 0.0 109.89 175.441 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_exo -62.85 87.07 0.12 Allowed 'Trans proline' 0 CA--C 1.549 1.259 0 C-N-CA 123.838 3.025 . . . . 0.0 114.452 -179.368 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -172.76 140.42 0.98 Allowed 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 104.334 -2.469 . . . . 0.0 104.334 172.635 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -102.4 164.17 3.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-N 119.102 0.865 . . . . 0.0 112.889 -169.488 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 82.15 159.31 24.9 Favored Glycine 0 C--N 1.342 0.894 0 N-CA-C 108.977 -1.649 . . . . 0.0 108.977 -170.121 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -82.2 163.17 22.08 Favored 'General case' 0 N--CA 1.439 -0.993 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 -174.584 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 37.7 p -67.99 169.78 8.99 Favored Pre-proline 0 C--O 1.239 0.542 0 CA-C-N 115.107 -0.951 . . . . 0.0 108.944 168.067 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_exo -55.16 -32.37 79.8 Favored 'Trans proline' 0 CA--C 1.539 0.753 0 C-N-CA 121.397 1.398 . . . . 0.0 110.845 169.294 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 18.2 m -68.01 -44.49 76.42 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 119.066 -0.492 . . . . 0.0 111.297 179.604 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 12.3 t -100.59 -13.21 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-N 119.252 0.933 . . . . 0.0 112.277 -169.156 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -57.47 -45.83 84.36 Favored 'General case' 0 CA--C 1.516 -0.341 0 O-C-N 119.752 -1.842 . . . . 0.0 107.808 169.535 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -71.59 2.91 4.47 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-N 115.404 -0.816 . . . . 0.0 113.08 179.268 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 84.1 mtp -97.27 -6.87 33.48 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 118.136 -0.935 . . . . 0.0 111.384 173.609 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 79.2 mt -57.24 -50.06 77.88 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 175.512 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -66.36 -53.2 32.45 Favored Pre-proline 0 CA--C 1.537 0.47 0 CA-C-O 117.411 -1.281 . . . . 0.0 113.298 -170.036 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -60.79 -32.88 93.38 Favored 'Trans proline' 0 C--N 1.351 0.662 0 CA-C-N 121.987 1.745 . . . . 0.0 111.79 175.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -69.24 -38.8 78.66 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-O 118.406 -0.807 . . . . 0.0 109.881 177.623 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 10.6 mt -57.78 -44.17 86.06 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 119.612 1.097 . . . . 0.0 108.755 173.065 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -62.72 -36.84 84.28 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 118.328 0.513 . . . . 0.0 111.443 -176.577 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 42.9 mm-40 -74.27 -33.36 63.24 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 118.686 0.675 . . . . 0.0 112.206 177.28 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 75.2 t -62.05 -49.03 85.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-N 119.475 1.034 . . . . 0.0 108.28 169.726 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 56.3 mt -60.57 -39.12 86.85 Favored 'General case' 0 CA--C 1.531 0.244 0 O-C-N 121.81 -0.556 . . . . 0.0 110.717 -179.502 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -58.77 -39.3 80.61 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 119.038 -0.506 . . . . 0.0 112.147 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -64.93 -48.17 75.06 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 119.094 0.861 . . . . 0.0 110.406 178.17 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . 0.284 4.1 pp -68.01 -23.71 65.04 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 118.73 -0.652 . . . . 0.0 112.174 178.678 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 81.7 mtm-85 -67.1 -26.97 66.97 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 119.937 1.244 . . . . 0.0 111.407 171.014 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -66.89 -34.17 77.2 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 120.422 1.465 . . . . 0.0 109.318 175.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 23.1 m -82.32 18.45 1.43 Allowed 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.478 1.111 . . . . 0.0 112.615 172.529 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 68.21 19.65 72.41 Favored Glycine 0 CA--C 1.529 0.959 0 CA-C-O 118.706 -1.052 . . . . 0.0 113.745 173.347 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 58.1 t -80.48 124.97 39.01 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 CA-C-N 119.18 1.49 . . . . 0.0 107.317 176.518 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -100.67 95.72 6.86 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 105.222 -2.14 . . . . 0.0 105.222 169.509 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -70.43 141.64 52.07 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 177.158 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 8.8 mm -108.81 124.76 33.35 Favored Pre-proline 0 CA--C 1.529 0.151 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 -179.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -64.35 103.21 0.43 Allowed 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 121.918 1.745 . . . . 0.0 107.954 169.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 87.2 mtt180 56.91 -8.56 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 128.052 2.541 . . . . 0.0 117.017 179.469 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 2.4 t 55.67 -167.55 0.1 Allowed 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.765 1.626 . . . . 0.0 111.575 -177.088 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -144.87 146.31 31.99 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 125.597 1.559 . . . . 0.0 108.804 177.69 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 14.4 m . . . . . 0 C--O 1.253 1.267 0 C-N-CA 124.545 1.138 . . . . 0.0 111.043 -173.89 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.7 tpt . . . . . 0 N--CA 1.496 1.859 0 N-CA-C 110.278 -0.268 . . . . 0.0 110.278 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 8.7 ptp180 -143.42 127.31 17.29 Favored 'General case' 0 N--CA 1.482 1.133 0 CA-C-O 117.725 -1.131 . . . . 0.0 108.114 175.013 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 53.7 mt -143.8 137.65 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 CA-C-N 119.718 1.145 . . . . 0.0 112.424 -168.578 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -121.07 126.7 50.49 Favored 'General case' 0 CA--C 1.521 -0.142 0 N-CA-C 104.255 -2.498 . . . . 0.0 104.255 167.487 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 61.7 t -107.95 100.03 9.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 N-CA-C 102.743 -3.058 . . . . 0.0 102.743 169.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 8.2 mt -95.54 116.05 28.29 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 -171.595 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -93.2 118.53 5.67 Favored Glycine 0 N--CA 1.446 -0.697 0 N-CA-C 106.136 -2.785 . . . . 0.0 106.136 169.659 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -134.62 -171.92 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 -174.506 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 106.43 157.43 21.6 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.217 -1.153 . . . . 0.0 110.217 -171.434 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -81.43 96.8 7.49 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 124.773 1.229 . . . . 0.0 109.055 -174.41 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.1 pt -71.97 41.81 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 C-N-CA 124.596 1.158 . . . . 0.0 113.766 -177.294 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 20.2 mt -130.1 -5.52 4.42 Favored 'General case' 0 CA--C 1.534 0.35 0 O-C-N 121.027 -1.046 . . . . 0.0 109.548 173.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -124.6 72.9 1.23 Allowed 'General case' 0 C--N 1.343 0.312 0 C-N-CA 123.559 0.744 . . . . 0.0 110.308 -168.511 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.452 ' HB ' ' H ' ' A' ' 15' ' ' ASP . 0.6 OUTLIER 47.25 -98.46 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.303 1.041 . . . . 0.0 113.419 175.368 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.452 ' H ' ' HB ' ' A' ' 14' ' ' THR . 69.1 m-20 -77.42 -18.54 57.14 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 125.347 1.459 . . . . 0.0 112.207 -169.531 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -72.63 -8.27 54.45 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 120.275 1.398 . . . . 0.0 112.491 -176.53 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.43 -12.0 60.92 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-O 117.057 -1.449 . . . . 0.0 110.862 169.389 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 9.2 tp -56.82 -39.72 66.36 Favored 'Isoleucine or valine' 0 C--N 1.341 0.234 0 CA-C-N 121.107 1.776 . . . . 0.0 112.275 -170.117 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -58.73 -46.82 92.86 Favored Glycine 0 C--N 1.339 0.708 0 CA-C-N 119.484 1.038 . . . . 0.0 111.229 176.25 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 62.4 t -62.95 -47.92 90.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-O 118.618 -0.706 . . . . 0.0 109.477 175.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 20.3 mmt180 -63.73 -31.95 73.29 Favored 'General case' 0 C--N 1.346 0.452 0 CA-C-O 117.298 -1.334 . . . . 0.0 111.688 -176.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 18.2 mt -60.6 -48.16 89.78 Favored 'Isoleucine or valine' 0 C--N 1.341 0.233 0 CA-C-N 121.033 1.742 . . . . 0.0 109.62 176.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 18.8 m -74.64 -33.45 31.9 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-N 119.429 1.013 . . . . 0.0 111.368 -173.486 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 62.8 mt-10 -63.29 -44.41 95.12 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 118.383 0.538 . . . . 0.0 109.934 172.206 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -66.33 -37.6 85.74 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 119.427 1.012 . . . . 0.0 110.197 177.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.8 tp -63.79 -39.78 95.07 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 119.08 0.855 . . . . 0.0 109.088 -178.636 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -62.16 -22.5 65.92 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.251 0.62 . . . . 0.0 112.578 179.302 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 90.3 mt-30 -94.32 -45.09 7.64 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.213 1.405 . . . . 0.0 110.201 -178.704 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 80.4 mtt180 -81.69 -25.33 35.6 Favored 'General case' 0 CA--C 1.528 0.109 0 CA-C-O 118.753 -0.641 . . . . 0.0 111.165 -173.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.402 ' HA ' ' H ' ' A' ' 159' ' ' ARG . 56.5 m-85 -125.54 151.33 46.51 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-N 118.611 0.642 . . . . 0.0 111.019 -179.511 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 46.3 mm -104.56 133.64 48.11 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 103.51 -2.774 . . . . 0.0 103.51 168.81 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -113.04 146.76 35.83 Favored Pre-proline 0 C--O 1.237 0.4 0 C-N-CA 123.28 0.632 . . . . 0.0 109.703 -169.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -65.17 157.89 55.06 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 122.458 2.105 . . . . 0.0 109.9 170.564 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -57.49 -34.01 68.61 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 -169.408 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 12.0 p90 -76.26 -10.73 59.63 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 -177.171 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 69.1 t -91.84 119.37 39.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 172.002 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -111.84 114.68 27.78 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 107.343 -1.354 . . . . 0.0 107.343 169.536 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -85.06 102.43 10.97 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 N-CA-C 104.484 -2.413 . . . . 0.0 104.484 168.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 59.5 tp -107.54 128.37 54.46 Favored 'General case' 0 C--O 1.232 0.151 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 -173.244 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -79.3 119.43 22.35 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 169.539 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -78.41 -80.1 0.74 Allowed Glycine 0 C--N 1.338 0.664 0 N-CA-C 106.64 -2.584 . . . . 0.0 106.64 169.527 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 78.28 99.37 0.21 Allowed Glycine 0 C--N 1.342 0.903 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 176.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 13.1 p 53.47 55.62 8.41 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.113 0.965 . . . . 0.0 108.69 -177.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -118.03 -79.89 0.6 Allowed 'General case' 0 C--N 1.348 0.503 0 CA-C-N 114.487 -1.233 . . . . 0.0 111.071 -170.051 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 59.42 -110.2 2.6 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 110.077 -1.209 . . . . 0.0 110.077 -179.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -53.14 -33.03 50.68 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.973 1.309 . . . . 0.0 110.962 -176.387 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -54.43 -22.3 12.18 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 113.784 1.031 . . . . 0.0 113.784 -175.474 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 14.5 mt -95.73 17.89 14.13 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 113.57 0.952 . . . . 0.0 113.57 -169.537 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.705 ' HA ' HG13 ' A' ' 100' ' ' VAL . 4.6 tt -45.78 -60.11 2.41 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 123.239 0.616 . . . . 0.0 112.055 -177.165 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -67.78 -32.52 78.06 Favored Glycine 0 CA--C 1.532 1.146 0 CA-C-N 116.002 -0.545 . . . . 0.0 112.291 -178.076 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -78.47 -32.37 48.33 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 118.836 1.318 . . . . 0.0 112.699 -173.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.534 ' SD ' HG11 ' A' ' 100' ' ' VAL . 53.8 mtp -74.8 -16.98 60.69 Favored 'General case' 0 N--CA 1.454 -0.225 0 O-C-N 121.758 -0.589 . . . . 0.0 110.868 178.261 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -81.13 156.4 25.77 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 123.375 0.67 . . . . 0.0 111.257 -173.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 53.76 36.08 23.01 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 126.588 1.955 . . . . 0.0 113.512 173.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 26.4 mmt180 -100.94 157.29 16.85 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 173.047 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -82.63 -54.68 4.97 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 176.008 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . 0.263 0.0 OUTLIER -116.83 149.95 39.17 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-N 119.522 1.055 . . . . 0.0 108.589 168.551 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 12.6 tp -133.69 115.82 15.06 Favored 'General case' 0 CA--C 1.511 -0.543 0 N-CA-C 104.955 -2.239 . . . . 0.0 104.955 171.782 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 33.8 mt -97.95 111.95 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 N-CA-C 104.885 -2.265 . . . . 0.0 104.885 171.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.552 HD13 HD11 ' A' ' 97' ' ' LEU . 12.2 mt -85.18 134.41 27.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 106.058 -1.83 . . . . 0.0 106.058 171.589 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -117.0 118.41 32.32 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 102.591 -3.114 . . . . 0.0 102.591 168.402 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -156.71 162.12 39.8 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 -175.093 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -85.33 149.66 25.3 Favored 'General case' 0 CA--C 1.534 0.357 0 O-C-N 121.536 -0.727 . . . . 0.0 109.974 170.026 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 11.0 mt -80.46 -30.94 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 C-N-CA 124.7 1.2 . . . . 0.0 110.171 175.678 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . 0.361 2.5 t 60.27 43.77 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.086 0 C-N-CA 126.321 1.848 . . . . 0.0 113.326 -176.402 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 12.8 m 62.04 139.15 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 128.424 2.69 . . . . 0.0 118.172 168.526 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -130.73 -90.04 0.46 Allowed 'General case' 0 N--CA 1.463 0.181 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 169.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 87.9 mttt -139.36 35.41 2.07 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.778 1.231 . . . . 0.0 110.0 -176.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 42.1 t-20 -138.0 161.72 35.98 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.561 1.144 . . . . 0.0 109.844 -171.105 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 2.1 m -62.5 148.3 90.67 Favored Pre-proline 0 CA--C 1.547 0.865 0 C-N-CA 124.666 1.186 . . . . 0.0 113.131 -169.294 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_exo -56.85 157.91 18.52 Favored 'Trans proline' 0 CA--C 1.532 0.419 0 C-N-CA 124.481 3.454 . . . . 0.0 113.038 169.711 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 64.15 16.3 59.82 Favored Glycine 0 CA--C 1.531 1.064 0 CA-C-O 119.491 -0.616 . . . . 0.0 113.809 171.317 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 3.0 m -94.51 146.64 23.96 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 124.672 1.189 . . . . 0.0 109.629 -172.092 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 31.7 ttp -98.04 141.78 30.57 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 171.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 64.3 mtm -133.33 129.73 37.89 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 169.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 38.9 mm -108.21 121.93 61.92 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 -179.528 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.3 mp -121.33 139.01 53.99 Favored 'General case' 0 C--O 1.236 0.367 0 O-C-N 123.833 0.708 . . . . 0.0 109.3 -172.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 52.5 ttp180 -83.95 165.15 18.89 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.922 0.889 . . . . 0.0 110.049 -177.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -30.67 -55.1 0.2 Allowed 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 116.353 1.983 . . . . 0.0 116.353 -175.392 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -87.91 -16.65 33.29 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 -174.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -76.13 -35.09 59.4 Favored 'General case' 0 N--CA 1.461 0.084 0 O-C-N 121.817 -0.552 . . . . 0.0 109.574 -178.254 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.455 ' HB ' ' HD3' ' A' ' 83' ' ' PRO . 88.3 t -59.14 -54.54 55.37 Favored Pre-proline 0 CA--C 1.547 0.848 0 C-N-CA 125.635 1.574 . . . . 0.0 111.787 -175.675 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.455 ' HD3' ' HB ' ' A' ' 82' ' ' VAL . 50.3 Cg_exo -53.86 -42.77 63.83 Favored 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 122.781 2.321 . . . . 0.0 112.41 174.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -71.26 -10.82 60.39 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -91.66 -40.2 11.42 Favored 'General case' 0 C--N 1.343 0.315 0 CA-C-N 120.073 1.306 . . . . 0.0 111.82 -176.539 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.511 ' CE2' HD12 ' A' ' 97' ' ' LEU . 41.4 m-85 -75.52 10.12 1.85 Allowed 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 112.967 0.728 . . . . 0.0 112.967 -171.525 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 75.2 p -60.14 -24.29 64.59 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.154 0.981 . . . . 0.0 111.22 171.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 61.5 t-20 -49.04 118.9 2.87 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.503 1.121 . . . . 0.0 111.235 177.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -74.67 -18.45 60.52 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -174.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 42.1 mt -67.13 -45.59 86.27 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -176.527 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.3 m -73.18 110.54 8.84 Favored Pre-proline 0 CA--C 1.545 0.762 0 C-N-CA 126.291 1.837 . . . . 0.0 112.05 -168.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -76.15 -62.95 0.03 OUTLIER 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 122.254 1.97 . . . . 0.0 112.333 -169.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 6.6 t-80 -56.66 -40.04 74.81 Favored 'General case' 0 N--CA 1.466 0.335 0 O-C-N 121.442 -0.786 . . . . 0.0 110.225 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 22.0 mp0 -62.29 -27.69 69.2 Favored 'General case' 0 N--CA 1.44 -0.955 0 C-N-CA 124.972 1.309 . . . . 0.0 110.082 -172.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 30.9 mt -72.09 -36.72 69.59 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 120.025 1.284 . . . . 0.0 110.447 174.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -66.69 -42.96 92.97 Favored Glycine 0 CA--C 1.528 0.885 0 N-CA-C 110.238 -1.145 . . . . 0.0 110.238 173.387 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.552 HD11 HD13 ' A' ' 60' ' ' ILE . 3.4 tm? -59.79 -41.45 91.2 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.197 0.599 . . . . 0.0 109.791 173.35 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -59.25 -44.65 92.36 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 123.01 0.524 . . . . 0.0 110.542 175.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -66.11 -26.76 67.61 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 118.806 -0.616 . . . . 0.0 111.899 -179.608 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.705 HG13 ' HA ' ' A' ' 49' ' ' LEU . 92.1 t -63.93 -45.84 95.78 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 168.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 87.9 mt -67.07 -33.4 75.43 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 119.266 0.939 . . . . 0.0 110.722 -176.182 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 15.8 m -60.78 -49.25 78.24 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 119.028 0.831 . . . . 0.0 109.957 169.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.402 ' HA ' ' CD2' ' A' ' 106' ' ' PHE . . . -58.1 -41.03 82.63 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 118.185 0.448 . . . . 0.0 111.019 176.737 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -63.48 -32.71 74.24 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 123.741 0.816 . . . . 0.0 110.951 179.74 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 17.6 ptm180 -83.68 -27.86 28.75 Favored 'General case' 0 C--N 1.344 0.369 0 CA-C-N 120.455 1.48 . . . . 0.0 112.19 173.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.402 ' CD2' ' HA ' ' A' ' 103' ' ' ALA . 16.7 m-30 -60.47 -46.58 89.55 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 118.454 0.57 . . . . 0.0 109.843 172.301 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 41.4 p -77.29 -26.8 52.67 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 123.611 0.764 . . . . 0.0 111.54 178.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 75.66 6.35 81.12 Favored Glycine 0 CA--C 1.534 1.232 0 N-CA-C 109.881 -1.288 . . . . 0.0 109.881 -168.497 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -85.24 19.99 2.09 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 119.768 1.784 . . . . 0.0 111.454 179.088 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -56.28 140.03 72.44 Favored Pre-proline 0 CA--C 1.546 0.814 0 C-N-CA 126.034 1.734 . . . . 0.0 110.307 170.058 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 99.6 Cg_exo -57.97 161.37 13.26 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 123.396 2.731 . . . . 0.0 115.531 179.365 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -65.91 -38.63 89.2 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 119.164 -0.446 . . . . 0.0 111.671 176.339 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 4.5 pttm -142.75 89.64 2.15 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 124.259 1.024 . . . . 0.0 108.342 177.7 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 7.4 tt -76.33 142.6 41.19 Favored 'General case' 0 CA--C 1.534 0.356 0 O-C-N 120.961 -1.087 . . . . 0.0 108.592 169.418 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.9 140.81 46.07 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.334 1.454 . . . . 0.0 107.698 174.696 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 14.6 tp -118.59 134.41 55.13 Favored 'General case' 0 N--CA 1.467 0.411 0 O-C-N 120.48 -1.388 . . . . 0.0 108.496 175.291 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 20.4 t -105.92 85.09 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 N-CA-C 104.788 -2.301 . . . . 0.0 104.788 169.154 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -81.31 144.66 24.77 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 110.41 -1.076 . . . . 0.0 110.41 179.732 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 39.2 t -128.43 130.98 69.3 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 CA-C-N 117.405 0.603 . . . . 0.0 109.989 179.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 16.8 mt -85.17 132.92 43.9 Favored Pre-proline 0 CA--C 1.539 0.529 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 176.396 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -77.01 -179.06 5.05 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 123.075 2.517 . . . . 0.0 111.617 -177.569 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.453 ' HB3' HG21 ' A' ' 131' ' ' THR . 6.3 tp10 -110.09 -51.18 2.9 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.994 0.918 . . . . 0.0 109.807 169.753 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 66.4 m -118.65 -54.53 2.25 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 118.201 0.455 . . . . 0.0 111.964 -169.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER 54.54 52.84 11.61 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.652 1.181 . . . . 0.0 112.163 -177.293 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -119.25 165.92 15.87 Favored Pre-proline 0 CA--C 1.537 0.472 0 C-N-CA 123.468 0.707 . . . . 0.0 109.954 -179.372 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -78.32 81.78 2.64 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 121.755 1.636 . . . . 0.0 112.634 -169.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -171.09 141.59 1.68 Allowed 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 102.218 -3.253 . . . . 0.0 102.218 177.293 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -108.21 166.59 4.25 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 N-CA-C 113.596 0.962 . . . . 0.0 113.596 -169.286 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 97.33 141.21 11.94 Favored Glycine 0 C--N 1.338 0.646 0 N-CA-C 105.751 -2.94 . . . . 0.0 105.751 -168.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.61 HD22 ' H ' ' A' ' 130' ' ' LEU . 1.0 OUTLIER -67.41 158.49 31.59 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 117.861 0.83 . . . . 0.0 109.882 176.943 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.453 HG21 ' HB3' ' A' ' 122' ' ' GLU . 63.4 p -69.14 169.75 10.78 Favored Pre-proline 0 CA--C 1.543 0.681 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 168.018 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -58.02 -37.13 97.12 Favored 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 121.57 1.513 . . . . 0.0 111.388 173.305 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 82.8 m -64.33 -33.75 76.55 Favored 'General case' 0 N--CA 1.443 -0.785 0 C-N-CA 124.415 1.086 . . . . 0.0 111.436 -178.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 73.8 t -103.23 -27.59 3.2 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 O-C-N 121.81 -0.556 . . . . 0.0 111.511 -172.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -51.73 -49.37 62.69 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 119.035 0.834 . . . . 0.0 108.88 169.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -61.89 -20.88 64.22 Favored 'General case' 0 N--CA 1.447 -0.575 0 N-CA-C 112.994 0.738 . . . . 0.0 112.994 179.373 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 3.0 mmm -78.04 -7.89 57.48 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 -179.619 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 72.5 mt -55.95 -50.59 68.31 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.295 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 170.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -70.51 -44.89 18.4 Favored Pre-proline 0 CA--C 1.538 0.481 0 CA-C-O 117.284 -1.341 . . . . 0.0 113.756 -168.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -57.66 -41.33 71.75 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 CA-C-N 122.076 1.777 . . . . 0.0 111.152 172.412 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.01 -35.89 74.69 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-O 118.263 -0.875 . . . . 0.0 112.046 179.285 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 39.0 mt -61.09 -48.64 80.75 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-N 120.087 1.312 . . . . 0.0 108.929 172.249 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -54.73 -35.31 63.55 Favored 'General case' 0 CA--C 1.531 0.237 0 O-C-N 123.398 0.436 . . . . 0.0 109.995 175.288 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 2.1 mm100 -78.7 -35.74 44.58 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 45.7 t -59.27 -48.27 87.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 169.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 44.0 mt -60.23 -36.55 77.99 Favored 'General case' 0 C--O 1.226 -0.148 0 C-N-CA 123.413 0.685 . . . . 0.0 110.88 177.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -70.1 -44.23 69.44 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 119.139 0.881 . . . . 0.0 110.856 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -66.53 -30.99 71.43 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 119.676 1.126 . . . . 0.0 111.225 177.433 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 12.9 mt -62.27 -52.99 61.5 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 169.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 93.6 mtt-85 -64.73 -28.65 69.74 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 120.231 1.378 . . . . 0.0 112.432 -178.413 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -69.34 -28.75 66.51 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 119.203 0.91 . . . . 0.0 109.982 176.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 51.0 m -82.51 8.24 12.22 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.392 1.077 . . . . 0.0 111.906 169.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 72.83 10.52 77.09 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-O 117.291 -1.838 . . . . 0.0 113.11 -174.56 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 38.2 t -91.05 119.54 38.39 Favored 'Isoleucine or valine' 0 C--N 1.345 0.378 0 CA-C-N 121.025 2.412 . . . . 0.0 108.48 -176.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -97.57 91.32 5.38 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 172.385 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -55.9 139.11 47.08 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 169.051 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 20.5 mt -83.33 126.87 70.71 Favored Pre-proline 0 CA--C 1.529 0.161 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 -173.263 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -68.47 89.83 0.4 Allowed 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 123.045 2.497 . . . . 0.0 109.029 174.64 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . 0.402 ' H ' ' HA ' ' A' ' 30' ' ' TYR . 29.1 ttp180 52.34 17.13 0.69 Allowed 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 127.628 2.371 . . . . 0.0 114.567 179.489 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 57.7 m 48.24 37.07 7.68 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.057 0.943 . . . . 0.0 111.145 -169.015 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -140.73 45.84 1.79 Allowed 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.14 1.376 . . . . 0.0 108.991 -170.659 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 8.5 m . . . . . 0 C--O 1.258 1.503 0 C-N-CA 124.977 1.311 . . . . 0.0 110.509 -177.816 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.8 ttt . . . . . 0 N--CA 1.499 2.016 0 CA-C-O 119.646 -0.216 . . . . 0.0 110.938 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 38.9 ttm180 -64.42 124.02 20.72 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 120.007 -1.683 . . . . 0.0 109.693 176.617 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 5.5 mt -119.73 132.7 68.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 -174.526 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 43.3 tp -113.61 145.72 40.84 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 105.849 -1.908 . . . . 0.0 105.849 167.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 30.2 t -124.32 131.37 72.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 N-CA-C 105.017 -2.216 . . . . 0.0 105.017 169.213 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 6.6 mt -125.36 117.3 23.43 Favored 'General case' 0 CA--C 1.511 -0.547 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 -173.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -87.88 133.29 11.71 Favored Glycine 0 CA--C 1.521 0.424 0 N-CA-C 107.709 -2.157 . . . . 0.0 107.709 169.652 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.5 m -142.27 133.01 24.76 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 CA-C-N 119.317 1.559 . . . . 0.0 112.507 -170.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 144.79 169.59 13.42 Favored Glycine 0 CA--C 1.525 0.684 0 C-N-CA 125.948 1.737 . . . . 0.0 109.123 169.572 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.548 HD21 HD13 ' A' ' 13' ' ' LEU . 0.2 OUTLIER -76.94 116.77 17.9 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 122.81 1.29 . . . . 0.0 111.45 -176.459 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.1 pt -63.99 36.34 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.861 0 N-CA-C 116.096 1.888 . . . . 0.0 116.096 172.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 5.4 mp -129.52 -9.53 4.59 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 120.545 1.52 . . . . 0.0 110.025 168.525 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.548 HD13 HD21 ' A' ' 10' ' ' ASN . 4.7 mp -106.59 56.47 0.65 Allowed 'General case' 0 C--N 1.343 0.299 0 N-CA-C 114.739 1.385 . . . . 0.0 114.739 -168.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.255 0.2 OUTLIER 54.95 -109.59 0.51 Allowed 'General case' 0 C--O 1.238 0.45 0 C-N-CA 123.428 0.691 . . . . 0.0 110.921 170.428 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -77.9 -7.45 56.75 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.435 0.694 . . . . 0.0 111.831 -175.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 23.0 tp10 -55.85 -32.59 63.76 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 120.012 1.278 . . . . 0.0 111.417 169.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.9 5.0 14.97 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-O 115.888 -2.006 . . . . 0.0 110.082 -179.1 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 6.6 tp -57.07 -42.82 80.13 Favored 'Isoleucine or valine' 0 C--N 1.342 0.242 0 CA-C-N 123.369 2.804 . . . . 0.0 110.92 -179.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -61.23 -43.18 99.71 Favored Glycine 0 CA--C 1.526 0.727 0 CA-C-N 119.564 1.075 . . . . 0.0 111.465 175.428 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 83.2 t -66.93 -51.46 54.62 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 CA-C-N 117.449 0.624 . . . . 0.0 109.559 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 74.4 mmt-85 -57.55 -34.76 69.51 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 117.142 -1.409 . . . . 0.0 112.479 176.578 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 24.2 mt -60.72 -47.73 91.84 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-N 121.839 2.109 . . . . 0.0 110.507 175.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 35.2 m -74.26 -27.2 21.39 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-N 120.25 1.386 . . . . 0.0 111.416 -175.426 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -69.18 -45.69 69.36 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 174.597 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -64.32 -45.11 89.3 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 123.313 0.645 . . . . 0.0 110.509 -179.442 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 8.1 tp -61.78 -41.58 97.9 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-O 118.86 -0.59 . . . . 0.0 110.068 179.672 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -60.05 -38.73 83.67 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 118.209 0.459 . . . . 0.0 110.965 177.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 9.5 mm-40 -75.75 -40.6 55.17 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 118.631 0.651 . . . . 0.0 111.065 -179.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 41.5 mmt180 -87.4 -31.57 20.01 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 117.637 -1.173 . . . . 0.0 113.02 -169.498 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 72.0 m-85 -122.54 137.76 54.78 Favored 'General case' 0 CA--C 1.522 -0.134 0 CA-C-N 120.76 1.618 . . . . 0.0 111.969 -176.05 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 43.7 mm -90.87 137.65 21.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 N-CA-C 105.591 -2.003 . . . . 0.0 105.591 168.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -124.25 154.98 68.83 Favored Pre-proline 0 CA--C 1.541 0.62 0 C-N-CA 124.985 1.314 . . . . 0.0 109.902 -170.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -59.44 157.13 32.61 Favored 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 123.318 2.679 . . . . 0.0 112.041 169.697 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -63.19 -31.38 72.51 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -171.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 18.8 p90 -72.66 -6.19 42.67 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 118.186 -0.911 . . . . 0.0 112.699 178.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 38.2 t -100.9 130.73 49.81 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 CA-C-N 120.054 1.297 . . . . 0.0 108.32 175.391 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -118.55 135.35 54.46 Favored 'General case' 0 CA--C 1.529 0.171 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 170.078 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -106.47 118.12 53.54 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 N-CA-C 104.691 -2.337 . . . . 0.0 104.691 169.368 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 48.7 tp -127.19 126.4 42.75 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-O 120.889 0.376 . . . . 0.0 110.307 -174.735 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -78.0 119.42 21.42 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 168.715 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -57.51 -55.84 28.28 Favored Glycine 0 CA--C 1.53 0.975 0 N-CA-C 109.073 -1.611 . . . . 0.0 109.073 172.411 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 74.74 87.56 0.24 Allowed Glycine 0 C--N 1.341 0.833 0 N-CA-C 111.451 -0.66 . . . . 0.0 111.451 169.699 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 20.3 p 50.81 58.91 5.02 Favored 'General case' 0 CA--C 1.546 0.8 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 -177.532 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -116.65 -86.72 0.62 Allowed 'General case' 0 C--N 1.348 0.508 0 CA-C-N 114.495 -1.23 . . . . 0.0 111.352 -169.334 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 65.76 -94.97 0.22 Allowed Glycine 0 C--N 1.341 0.836 0 N-CA-C 108.947 -1.661 . . . . 0.0 108.947 -169.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 3.5 tpt -62.77 -31.41 72.37 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 125.288 1.435 . . . . 0.0 111.764 179.687 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -66.36 -7.69 20.7 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -169.32 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 70.9 mt -84.26 3.74 34.06 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 113.854 1.057 . . . . 0.0 113.854 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.479 ' HA ' HG13 ' A' ' 100' ' ' VAL . 6.0 tt -41.36 -59.0 1.68 Allowed 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 114.107 1.151 . . . . 0.0 114.107 -170.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -93.34 -26.02 17.12 Favored Glycine 0 CA--C 1.527 0.786 0 C-N-CA 123.698 0.666 . . . . 0.0 111.896 -178.461 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -62.06 -34.7 76.74 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 118.639 1.22 . . . . 0.0 111.335 179.467 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 26.8 mtp -78.28 -3.58 43.6 Favored 'General case' 0 CA--C 1.529 0.137 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 178.378 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.5 157.84 36.84 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 118.817 0.735 . . . . 0.0 110.824 -178.124 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 55.3 39.51 31.31 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.827 1.651 . . . . 0.0 114.66 168.311 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 13.4 mmt180 -107.11 148.86 28.28 Favored 'General case' 0 N--CA 1.473 0.714 0 O-C-N 121.121 -0.987 . . . . 0.0 109.411 176.11 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -82.49 -36.05 26.82 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 171.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 1.7 t-160 -138.45 137.93 37.66 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 -176.002 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 20.8 tp -136.41 131.47 34.19 Favored 'General case' 0 CA--C 1.507 -0.686 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 169.275 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 3.8 mp -112.42 119.81 61.15 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 169.656 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 5.3 mt -96.55 117.71 41.48 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 177.097 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -84.56 113.41 21.22 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 103.2 -2.889 . . . . 0.0 103.2 169.519 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -124.16 155.37 38.59 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 114.358 1.244 . . . . 0.0 114.358 -167.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -113.18 119.4 37.65 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 169.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 92.0 mt -76.71 -26.01 16.22 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.753 0 O-C-N 124.148 0.905 . . . . 0.0 111.558 -171.703 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . 0.286 47.4 t 69.75 -62.58 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 C-N-CA 128.887 2.875 . . . . 0.0 111.572 -170.61 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 5.5 m -151.68 138.84 19.23 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 177.561 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 73.3 tttt -157.3 170.06 23.32 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 127.534 2.334 . . . . 0.0 105.234 168.735 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.01 -22.5 65.89 Favored 'General case' 0 N--CA 1.473 0.675 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 -170.314 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -71.16 164.92 24.66 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 123.087 0.555 . . . . 0.0 110.292 -177.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 18.6 m -61.57 149.57 83.76 Favored Pre-proline 0 CA--C 1.55 0.949 0 C-N-CA 124.257 1.023 . . . . 0.0 112.125 -171.232 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -54.21 152.53 24.77 Favored 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 122.77 2.313 . . . . 0.0 112.255 169.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 69.65 7.36 58.25 Favored Glycine 0 CA--C 1.531 1.036 0 CA-C-O 118.661 -1.077 . . . . 0.0 114.44 175.276 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 20.5 m -89.19 148.14 23.79 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 119.608 1.704 . . . . 0.0 110.043 -173.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 25.5 ttp -90.77 147.6 23.11 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.264 178.316 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 19.9 ttm -141.54 116.48 9.86 Favored 'General case' 0 CA--C 1.528 0.118 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 -177.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.6 mp -96.28 122.96 48.29 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 177.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -115.52 126.81 54.73 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 179.228 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 74.9 mtm180 -91.63 177.26 6.26 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 123.354 0.662 . . . . 0.0 109.68 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -48.19 -47.86 35.08 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 115.341 1.608 . . . . 0.0 115.341 -169.7 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -76.18 -15.89 59.96 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 119.046 0.839 . . . . 0.0 112.198 -178.33 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -96.36 -23.68 16.52 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 123.863 0.865 . . . . 0.0 110.714 -169.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.427 HG12 ' CE2' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -68.57 -37.99 11.41 Favored Pre-proline 0 CA--C 1.535 0.37 0 O-C-N 120.608 -1.308 . . . . 0.0 112.554 178.19 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -62.78 -12.04 26.96 Favored 'Trans proline' 0 CA--C 1.546 1.105 0 C-N-CA 121.55 1.5 . . . . 0.0 112.746 168.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -98.9 4.59 47.44 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.91 0.884 . . . . 0.0 111.742 173.436 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.504 HD13 ' C ' ' A' ' 85' ' ' LEU . 2.1 tm? -111.76 -57.25 2.28 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 124.025 0.93 . . . . 0.0 111.166 -175.701 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.427 ' CE2' HG12 ' A' ' 82' ' ' VAL . 67.4 m-85 -66.14 -15.89 63.5 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 118.764 0.711 . . . . 0.0 111.534 -170.307 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 68.4 p -85.29 -9.94 57.08 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 125.539 1.535 . . . . 0.0 113.139 -168.482 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -59.38 152.04 22.28 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 118.476 0.58 . . . . 0.0 109.926 174.584 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -78.5 -10.05 59.56 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 113.456 0.91 . . . . 0.0 113.456 -169.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 4.8 mp -84.76 -53.46 10.78 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 CA-C-N 119.396 0.998 . . . . 0.0 109.44 -171.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 3.9 m -59.95 109.23 1.81 Allowed Pre-proline 0 CA--C 1.549 0.908 0 C-N-CA 124.1 0.96 . . . . 0.0 111.814 -169.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -71.9 -54.15 0.15 Allowed 'Trans proline' 0 C--N 1.354 0.821 0 CA-C-N 120.817 1.328 . . . . 0.0 112.438 -169.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 18.2 m80 -80.93 -32.25 34.68 Favored 'General case' 0 N--CA 1.467 0.408 0 O-C-N 121.984 -0.447 . . . . 0.0 110.108 -175.126 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 3.9 mm-40 -71.16 -23.12 61.99 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 118.485 -0.769 . . . . 0.0 110.523 -179.112 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 10.4 mt -62.98 -30.52 71.65 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 120.387 1.448 . . . . 0.0 110.974 169.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -64.1 -40.75 98.4 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 109.916 -1.274 . . . . 0.0 109.916 171.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 22.5 tp -67.93 -30.93 70.36 Favored 'General case' 0 CA--C 1.532 0.287 0 O-C-N 122.142 -0.622 . . . . 0.0 110.546 174.658 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -58.87 -44.11 91.0 Favored 'General case' 0 N--CA 1.451 -0.389 0 O-C-N 120.796 -1.19 . . . . 0.0 108.895 171.131 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -70.89 -20.38 62.51 Favored 'General case' 0 N--CA 1.456 -0.13 0 O-C-N 121.789 -0.57 . . . . 0.0 111.494 177.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.479 HG13 ' HA ' ' A' ' 49' ' ' LEU . 55.2 t -70.04 -41.26 79.19 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.871 0 CA-C-O 117.764 -1.113 . . . . 0.0 108.126 169.315 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 6.8 mp -60.69 -38.21 84.23 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 120.602 1.546 . . . . 0.0 109.887 175.312 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 16.4 m -63.46 -45.1 92.38 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 174.546 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -65.65 -41.48 92.53 Favored 'General case' 0 N--CA 1.447 -0.587 0 O-C-N 121.535 -0.728 . . . . 0.0 110.554 -178.448 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.405 HD13 ' CD ' ' A' ' 111' ' ' PRO . 28.3 mt -58.96 -39.6 82.18 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 124.665 1.186 . . . . 0.0 110.306 174.609 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 41.3 ttm180 -67.4 -36.56 81.54 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 118.771 -0.633 . . . . 0.0 109.983 175.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 13.5 m-30 -68.51 -41.11 80.43 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 118.963 0.801 . . . . 0.0 111.051 178.38 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 55.8 p -75.93 -27.1 57.48 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 118.827 0.739 . . . . 0.0 110.994 179.546 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 78.4 10.03 86.54 Favored Glycine 0 CA--C 1.534 1.271 0 CA-C-O 119.278 -0.734 . . . . 0.0 111.465 -169.676 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 -94.07 15.21 17.6 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 118.807 1.303 . . . . 0.0 112.268 -177.392 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 8.1 t80 -53.69 132.24 55.89 Favored Pre-proline 0 CA--C 1.539 0.55 0 C-N-CA 125.349 1.459 . . . . 0.0 110.317 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.405 ' CD ' HD13 ' A' ' 104' ' ' LEU . 60.7 Cg_exo -50.5 136.37 40.61 Favored 'Trans proline' 0 C--N 1.354 0.817 0 C-N-CA 123.461 2.774 . . . . 0.0 112.32 178.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -63.19 -24.1 67.73 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 119.287 -0.387 . . . . 0.0 111.796 -173.64 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 57.2 tttm -141.85 108.31 5.31 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 169.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -85.89 142.01 29.17 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 169.123 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.62 153.25 45.98 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 105.951 -1.87 . . . . 0.0 105.951 171.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -145.29 138.23 26.25 Favored 'General case' 0 C--N 1.33 -0.276 0 O-C-N 120.512 -1.368 . . . . 0.0 108.636 176.259 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 48.8 t -110.12 95.91 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 N-CA-C 103.635 -2.728 . . . . 0.0 103.635 169.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -87.44 151.96 23.84 Favored Glycine 0 C--N 1.332 0.351 0 N-CA-C 110.101 -1.2 . . . . 0.0 110.101 178.059 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 44.9 t -132.77 137.15 54.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 178.691 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 51.0 mt -86.76 129.83 51.08 Favored Pre-proline 0 CA--C 1.542 0.659 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 170.491 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -74.04 171.98 16.87 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 124.03 3.153 . . . . 0.0 112.561 -179.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -109.4 -43.89 4.02 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.461 1.105 . . . . 0.0 108.599 169.443 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 63.8 m -128.73 152.09 48.81 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.473 0.709 . . . . 0.0 111.266 176.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.4 tp -152.54 54.5 0.79 Allowed 'General case' 0 CA--C 1.548 0.893 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 -169.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -127.35 170.14 10.77 Favored Pre-proline 0 N--CA 1.479 1.002 0 CA-C-O 117.756 -1.116 . . . . 0.0 110.595 -178.43 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_exo -63.45 88.56 0.14 Allowed 'Trans proline' 0 CA--C 1.548 1.201 0 C-N-CA 123.806 3.004 . . . . 0.0 114.409 -176.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 179.0 145.72 0.15 Allowed 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 104.415 -2.439 . . . . 0.0 104.415 175.303 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -118.09 167.09 11.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 CA-C-N 120.032 1.287 . . . . 0.0 112.886 -172.798 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 91.56 148.9 22.87 Favored Glycine 0 C--N 1.34 0.796 0 N-CA-C 106.809 -2.516 . . . . 0.0 106.809 -168.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -82.84 162.28 21.68 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-O 121.447 0.642 . . . . 0.0 111.115 -169.396 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 39.8 p -68.92 168.61 14.37 Favored Pre-proline 0 CA--C 1.541 0.619 0 CA-C-N 114.911 -1.041 . . . . 0.0 109.535 168.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -57.1 -32.81 94.42 Favored 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 121.302 1.335 . . . . 0.0 110.906 169.397 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 23.8 m -68.34 -38.69 81.74 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 118.999 -0.524 . . . . 0.0 111.905 179.323 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 20.2 t -108.62 -10.48 11.12 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 CA-C-N 119.471 1.032 . . . . 0.0 112.021 -169.195 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -60.11 -46.87 88.15 Favored 'General case' 0 N--CA 1.465 0.318 0 O-C-N 119.733 -1.854 . . . . 0.0 107.436 169.082 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -71.74 6.55 1.91 Allowed 'General case' 0 N--CA 1.439 -1.015 0 CA-C-O 117.965 -1.017 . . . . 0.0 112.661 176.312 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 26.5 mmm -94.1 -11.54 30.35 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 119.778 1.172 . . . . 0.0 111.083 170.014 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 72.6 mt -61.76 -46.36 96.7 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 179.003 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -69.9 -54.87 9.41 Favored Pre-proline 0 CA--C 1.536 0.405 0 CA-C-O 117.394 -1.289 . . . . 0.0 112.814 -172.331 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -59.82 -34.81 95.53 Favored 'Trans proline' 0 C--N 1.349 0.569 0 CA-C-N 122.301 1.857 . . . . 0.0 111.327 177.031 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -71.11 -45.03 64.45 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-O 118.719 -0.658 . . . . 0.0 110.497 -177.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -63.68 -36.8 85.02 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 119.235 0.925 . . . . 0.0 109.916 177.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -61.88 -39.03 90.51 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 118.007 0.367 . . . . 0.0 111.076 175.585 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 42.4 mm-40 -74.3 -28.37 61.15 Favored 'General case' 0 CA--C 1.535 0.399 0 O-C-N 121.44 -0.787 . . . . 0.0 111.828 176.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 70.4 t -62.93 -46.96 95.0 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 169.502 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 56.8 mt -65.67 -33.63 76.32 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 119.055 0.843 . . . . 0.0 111.143 179.148 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -60.0 -35.59 75.38 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 118.513 0.597 . . . . 0.0 111.275 177.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -61.73 -44.95 95.92 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 118.388 0.54 . . . . 0.0 111.244 175.708 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 7.1 mp -61.41 -40.55 94.8 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 122.726 0.41 . . . . 0.0 110.082 176.454 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 83.5 mtm-85 -65.59 -16.59 63.86 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 117.504 -1.236 . . . . 0.0 112.594 178.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -58.57 -30.7 67.36 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 120.781 1.628 . . . . 0.0 111.351 177.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 6.7 m -113.39 30.37 7.26 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.503 1.121 . . . . 0.0 111.129 177.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 64.31 23.57 68.36 Favored Glycine 0 CA--C 1.529 0.967 0 CA-C-O 118.566 -1.13 . . . . 0.0 113.821 174.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 60.4 t -87.63 131.35 35.57 Favored 'Isoleucine or valine' 0 C--N 1.34 0.194 0 N-CA-C 106.362 -1.718 . . . . 0.0 106.362 174.112 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -120.68 123.29 42.39 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 -177.732 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -82.15 144.36 30.79 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 172.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 6.9 mm -101.53 123.89 42.78 Favored Pre-proline 0 CA--C 1.53 0.207 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 -173.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -60.6 108.97 0.58 Allowed 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.188 1.926 . . . . 0.0 108.182 173.449 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 34.3 ptt180 43.8 15.62 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 128.825 2.85 . . . . 0.0 116.239 -177.397 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 3.8 m 45.83 31.71 1.11 Allowed 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 125.366 1.466 . . . . 0.0 112.732 -168.662 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -156.24 129.33 8.01 Favored 'General case' 0 C--O 1.235 0.342 0 O-C-N 121.135 -0.978 . . . . 0.0 109.449 177.154 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 12.5 m . . . . . 0 C--O 1.253 1.259 0 C-N-CA 124.317 1.047 . . . . 0.0 111.391 -174.473 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.9 tpt . . . . . 0 N--CA 1.496 1.866 0 N-CA-C 110.46 -0.2 . . . . 0.0 110.46 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 6.0 ptp180 -150.46 123.61 8.85 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 177.221 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 66.7 mt -141.54 133.32 27.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-N 119.12 0.873 . . . . 0.0 110.172 -169.975 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -116.39 128.64 55.69 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 105.952 -1.87 . . . . 0.0 105.952 168.419 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.0 t -106.95 98.1 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 103.466 -2.79 . . . . 0.0 103.466 172.844 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.8 mt -99.09 110.42 23.0 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 123.912 0.885 . . . . 0.0 110.17 -169.433 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -89.69 121.42 6.12 Favored Glycine 0 N--CA 1.446 -0.659 0 N-CA-C 107.102 -2.399 . . . . 0.0 107.102 170.313 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 13.0 m -134.21 -171.89 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.016 0 C-N-CA 124.321 1.048 . . . . 0.0 108.258 -178.148 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 110.66 154.63 13.91 Favored Glycine 0 C--N 1.336 0.539 0 N-CA-C 110.453 -1.059 . . . . 0.0 110.453 -173.233 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.446 HD21 ' HB2' ' A' ' 12' ' ' LEU . 3.1 t30 -77.36 96.84 4.73 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 123.788 0.835 . . . . 0.0 109.224 -179.143 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.3 pt -72.47 36.4 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 C-N-CA 124.504 1.122 . . . . 0.0 113.96 -179.077 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.446 ' HB2' HD21 ' A' ' 10' ' ' ASN . 28.0 mt -121.95 -8.75 8.83 Favored 'General case' 0 CA--C 1.531 0.248 0 O-C-N 121.091 -1.005 . . . . 0.0 108.729 171.55 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -127.27 83.95 2.21 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 -169.12 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.443 ' HB ' ' H ' ' A' ' 15' ' ' ASP . 2.1 m 35.74 -104.2 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 113.266 -1.788 . . . . 0.0 114.698 169.65 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.443 ' H ' ' HB ' ' A' ' 14' ' ' THR . 77.2 m-20 -68.08 -19.73 64.89 Favored 'General case' 0 N--CA 1.437 -1.097 0 CA-C-O 117.975 -1.012 . . . . 0.0 112.475 -169.187 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -68.03 -23.69 65.02 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 121.208 1.822 . . . . 0.0 111.818 178.976 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.36 -12.45 52.13 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-O 116.01 -1.948 . . . . 0.0 110.588 172.783 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.401 HG21 HG11 ' A' ' 119' ' ' VAL . 6.7 tp -53.74 -38.3 34.84 Favored 'Isoleucine or valine' 0 C--N 1.342 0.26 0 CA-C-N 122.176 2.262 . . . . 0.0 110.271 -177.742 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -61.47 -43.62 99.08 Favored Glycine 0 C--N 1.337 0.596 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 -178.879 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 57.8 t -70.18 -47.21 68.77 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 176.094 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 20.4 mmt180 -61.19 -31.86 71.61 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 117.016 -1.468 . . . . 0.0 112.505 -177.918 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 19.8 mt -58.93 -48.66 85.74 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 CA-C-N 121.74 2.063 . . . . 0.0 109.756 175.68 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.8 m -76.32 -31.07 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-N 119.432 1.015 . . . . 0.0 110.897 -172.202 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 59.2 mt-10 -64.99 -41.49 95.37 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 119.107 -0.473 . . . . 0.0 110.083 171.545 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -66.09 -37.03 84.76 Favored 'General case' 0 C--N 1.344 0.328 0 CA-C-N 119.42 1.009 . . . . 0.0 110.803 175.55 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 6.5 tp -63.07 -41.2 99.39 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 119.075 0.852 . . . . 0.0 110.036 -177.267 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -59.46 -27.68 66.31 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.516 0.726 . . . . 0.0 112.882 -179.991 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 50.6 mt-30 -95.05 -37.34 11.15 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 125.865 1.666 . . . . 0.0 111.41 -175.875 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 75.4 mtt180 -89.61 -27.28 20.3 Favored 'General case' 0 C--O 1.224 -0.244 0 CA-C-O 118.099 -0.953 . . . . 0.0 112.46 -175.965 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 52.6 m-85 -122.93 145.28 48.61 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 119.796 1.18 . . . . 0.0 112.967 -175.391 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 38.9 mm -95.39 139.07 19.56 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 N-CA-C 103.949 -2.611 . . . . 0.0 103.949 168.871 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 42.9 mt -128.81 147.19 63.48 Favored Pre-proline 0 CA--C 1.532 0.284 0 C-N-CA 123.457 0.703 . . . . 0.0 110.185 -168.835 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -67.77 158.55 56.76 Favored 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 122.76 2.306 . . . . 0.0 110.479 172.126 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -59.17 -33.42 70.91 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 114.436 1.273 . . . . 0.0 114.436 -169.403 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 10.0 p90 -75.05 -13.42 60.49 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 118.927 -0.559 . . . . 0.0 112.49 -177.746 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 75.0 t -88.09 122.47 39.72 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 170.531 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -124.18 129.41 50.77 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 169.67 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -82.81 137.46 20.97 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.809 0 N-CA-C 106.068 -1.827 . . . . 0.0 106.068 167.81 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 52.2 tp -128.36 136.45 50.95 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 169.717 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -93.15 120.94 33.99 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 169.246 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -72.8 -71.73 1.05 Allowed Glycine 0 CA--C 1.526 0.74 0 N-CA-C 108.981 -1.647 . . . . 0.0 108.981 174.159 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 84.98 92.56 0.78 Allowed Glycine 0 C--N 1.342 0.884 0 N-CA-C 107.942 -2.063 . . . . 0.0 107.942 -177.862 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 44.2 p 55.18 30.61 14.83 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 125.009 1.324 . . . . 0.0 111.893 176.879 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -81.61 -65.49 1.01 Allowed 'General case' 0 C--N 1.348 0.507 0 N-CA-C 115.25 1.574 . . . . 0.0 115.25 -168.194 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 60.95 -109.68 2.57 Favored Glycine 0 CA--C 1.528 0.865 0 N-CA-C 110.262 -1.135 . . . . 0.0 110.262 -175.376 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.32 -21.23 66.25 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.315 1.046 . . . . 0.0 112.061 -175.409 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -60.68 -18.85 56.46 Favored 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 113.534 0.938 . . . . 0.0 113.534 -175.158 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 11.4 mt -98.64 15.08 26.27 Favored 'General case' 0 C--N 1.347 0.458 0 N-CA-C 115.155 1.539 . . . . 0.0 115.155 -169.412 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 5.6 tt -48.2 -58.59 4.31 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 119.703 1.138 . . . . 0.0 111.244 -175.477 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -63.15 -31.59 81.23 Favored Glycine 0 CA--C 1.53 1.025 0 CA-C-O 119.419 -0.656 . . . . 0.0 112.368 -176.153 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -81.19 -35.89 30.81 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 118.509 1.155 . . . . 0.0 112.375 -177.556 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 32.6 mtp -74.07 -27.11 60.75 Favored 'General case' 0 N--CA 1.452 -0.361 0 O-C-N 122.102 -0.374 . . . . 0.0 110.045 178.415 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.51 157.59 31.8 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-O 121.677 0.751 . . . . 0.0 111.608 -179.691 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 16.3 m120 63.24 4.07 1.53 Allowed 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 127.27 2.228 . . . . 0.0 115.64 169.769 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 26.9 mmt180 -76.69 158.49 30.96 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 119.97 1.259 . . . . 0.0 109.05 178.759 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -84.38 -54.24 4.91 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 175.392 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . 0.27 0.0 OUTLIER -124.24 147.18 48.26 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-N 119.812 1.187 . . . . 0.0 108.308 169.28 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 19.0 tp -138.48 113.34 9.14 Favored 'General case' 0 CA--C 1.507 -0.678 0 N-CA-C 104.819 -2.289 . . . . 0.0 104.819 -175.272 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 24.5 mt -95.75 112.36 27.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 105.351 -2.092 . . . . 0.0 105.351 176.976 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.479 HG22 HD23 ' A' ' 116' ' ' LEU . 41.5 mt -86.96 137.84 20.16 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 N-CA-C 106.722 -1.584 . . . . 0.0 106.722 171.405 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -122.77 117.2 25.12 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 103.567 -2.753 . . . . 0.0 103.567 168.002 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -153.78 158.26 40.64 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 124.91 1.284 . . . . 0.0 108.208 -178.83 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -88.05 152.96 21.65 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 169.537 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 81.1 mt -87.52 -21.92 7.02 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 C-N-CA 125.114 1.366 . . . . 0.0 110.485 -178.786 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.425 HG13 HD22 ' A' ' 124' ' ' LEU 0.299 96.2 t 69.73 -45.31 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.175 0 C-N-CA 129.448 3.099 . . . . 0.0 113.966 -175.935 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.8 p -165.29 151.29 9.75 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 119.839 1.199 . . . . 0.0 111.939 172.331 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 13.4 tppt? -162.79 176.25 10.45 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 127.477 2.311 . . . . 0.0 105.05 169.449 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 13.7 ptpt -61.26 -26.72 67.95 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 175.946 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 34.2 t-20 -75.74 165.59 24.81 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.815 0.846 . . . . 0.0 110.53 -174.658 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 2.5 m -61.92 152.48 76.61 Favored Pre-proline 0 CA--C 1.547 0.862 0 C-N-CA 124.486 1.114 . . . . 0.0 112.542 -170.186 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -59.37 160.45 19.79 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 124.494 3.463 . . . . 0.0 113.35 169.655 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 61.35 23.89 62.91 Favored Glycine 0 CA--C 1.537 1.461 0 CA-C-O 119.66 -0.522 . . . . 0.0 112.699 170.773 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 3.3 m -105.91 141.36 37.44 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 125.41 1.484 . . . . 0.0 109.314 -170.49 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 41.6 ttp -94.25 142.89 26.89 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 170.372 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 69.6 mtm -132.8 139.91 47.74 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 170.427 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 6.8 mm -93.31 122.46 44.82 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 177.199 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -112.19 123.82 51.1 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 175.726 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 82.1 mtp180 -81.3 170.71 15.71 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 123.004 0.522 . . . . 0.0 110.333 175.842 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -35.59 -55.47 0.68 Allowed 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 116.15 1.908 . . . . 0.0 116.15 -173.827 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -88.61 -9.33 52.57 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -176.001 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -87.64 -40.52 14.11 Favored 'General case' 0 N--CA 1.454 -0.26 0 O-C-N 121.911 -0.493 . . . . 0.0 109.866 -174.868 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 1.4 m -53.5 -47.66 95.58 Favored Pre-proline 0 CA--C 1.54 0.574 0 CA-C-O 117.928 -1.034 . . . . 0.0 112.27 -179.79 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -61.53 -40.09 50.13 Favored 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 122.284 1.99 . . . . 0.0 110.305 179.907 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.48 -4.16 44.14 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.874 0.869 . . . . 0.0 113.103 177.497 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -87.6 -40.78 13.93 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-N 119.338 0.972 . . . . 0.0 110.005 -179.325 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -79.91 24.66 0.39 Allowed 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.538 0.735 . . . . 0.0 112.763 -171.016 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 20.3 p -65.76 -21.99 66.55 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.489 1.116 . . . . 0.0 112.973 179.082 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 51.5 t-20 -61.69 127.49 31.69 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.659 0.783 . . . . 0.0 110.388 -177.257 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 47.8 mmtm -79.12 -19.2 51.7 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 -176.959 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 91.0 mt -64.16 -46.24 94.11 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 C-N-CA 123.786 0.834 . . . . 0.0 108.804 -178.831 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.8 m -67.22 109.07 3.05 Favored Pre-proline 0 CA--C 1.549 0.933 0 C-N-CA 126.589 1.956 . . . . 0.0 110.962 -169.718 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -71.99 -63.0 0.04 OUTLIER 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 122.342 2.028 . . . . 0.0 112.805 -169.063 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 12.4 t-80 -59.32 -40.41 86.21 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 123.61 0.764 . . . . 0.0 110.227 -179.166 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 22.1 mp0 -63.58 -29.98 71.16 Favored 'General case' 0 N--CA 1.441 -0.911 0 C-N-CA 124.924 1.29 . . . . 0.0 110.106 -174.384 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 20.8 mt -67.72 -44.73 76.94 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 120.393 1.451 . . . . 0.0 110.691 172.909 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -61.69 -40.14 98.37 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 110.238 -1.145 . . . . 0.0 110.238 176.554 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 39.1 tp -65.95 -39.53 90.53 Favored 'General case' 0 CA--C 1.534 0.335 0 O-C-N 122.289 -0.536 . . . . 0.0 109.979 176.225 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -62.21 -42.45 99.31 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 119.172 0.896 . . . . 0.0 109.776 176.664 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -67.64 -28.84 68.05 Favored 'General case' 0 N--CA 1.454 -0.257 0 O-C-N 122.007 -0.433 . . . . 0.0 110.755 178.382 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -73.92 -37.39 47.74 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 O-C-N 121.336 -0.853 . . . . 0.0 111.289 173.654 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 31.5 mt -67.83 -37.62 82.17 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 176.762 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 75.7 m -65.39 -37.13 86.05 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-O 118.34 -0.838 . . . . 0.0 110.055 171.532 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.445 ' HA ' ' CD2' ' A' ' 106' ' ' PHE . . . -64.2 -40.52 96.26 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-N 119.953 1.252 . . . . 0.0 110.661 175.705 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 4.0 mt -64.71 -32.82 74.66 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 118.638 0.653 . . . . 0.0 110.562 174.841 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 51.5 ttp180 -72.15 -29.04 63.65 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 118.763 -0.637 . . . . 0.0 110.033 176.36 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.445 ' CD2' ' HA ' ' A' ' 103' ' ' ALA . 13.6 m-30 -72.12 -47.1 53.67 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 119.118 0.872 . . . . 0.0 110.369 175.467 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 41.6 p -72.68 -25.84 61.4 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 118.313 0.506 . . . . 0.0 111.853 -176.761 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 73.43 7.55 73.39 Favored Glycine 0 CA--C 1.535 1.312 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 -168.495 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -87.55 20.22 3.01 Favored 'General case' 0 C--N 1.348 0.522 0 CA-C-N 119.456 1.628 . . . . 0.0 110.689 176.536 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -58.45 138.2 85.45 Favored Pre-proline 0 CA--C 1.547 0.854 0 C-N-CA 125.903 1.681 . . . . 0.0 109.341 169.952 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_exo -58.0 163.81 9.09 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 123.66 2.907 . . . . 0.0 115.386 -179.359 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -67.72 -37.02 81.66 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 119.024 -0.513 . . . . 0.0 112.112 174.628 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 10.6 ttmm -141.58 74.41 1.45 Allowed 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 -175.474 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 5.5 tt -71.47 138.35 48.94 Favored 'General case' 0 CA--C 1.533 0.289 0 O-C-N 119.959 -1.713 . . . . 0.0 107.516 171.831 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -134.38 141.95 47.03 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 175.763 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.479 HD23 HG22 ' A' ' 60' ' ' ILE . 0.3 OUTLIER -129.26 119.93 24.84 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 120.128 1.331 . . . . 0.0 109.228 -179.939 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 6.2 t -86.5 87.81 2.7 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 N-CA-C 105.61 -1.996 . . . . 0.0 105.61 175.84 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -81.38 135.17 14.07 Favored Glycine 0 C--N 1.334 0.447 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -172.901 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.448 HG13 ' SD ' ' A' ' 137' ' ' MET . 54.7 t -121.94 123.56 69.41 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.238 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.988 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 42.5 mt -84.67 133.11 44.62 Favored Pre-proline 0 CA--C 1.538 0.492 0 N-CA-C 105.52 -2.029 . . . . 0.0 105.52 169.775 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -75.04 175.33 11.38 Favored 'Trans proline' 0 N--CA 1.449 -1.09 0 C-N-CA 122.287 1.992 . . . . 0.0 111.589 -176.706 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -94.56 -49.23 5.75 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 114.442 -1.253 . . . . 0.0 108.293 169.236 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 97.3 p -127.91 -52.77 1.32 Allowed 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 113.164 0.802 . . . . 0.0 113.164 -170.203 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.425 HD22 HG13 ' A' ' 65' ' ' VAL . 1.8 tp 52.51 34.75 16.12 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 124.362 1.065 . . . . 0.0 113.229 -169.398 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -76.36 164.02 62.53 Favored Pre-proline 0 CA--C 1.549 0.931 0 O-C-N 120.95 -1.094 . . . . 0.0 110.65 174.053 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -80.03 88.25 1.44 Allowed 'Trans proline' 0 CA--C 1.544 0.999 0 C-N-CA 121.66 1.573 . . . . 0.0 112.577 -172.194 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -176.5 154.96 1.33 Allowed 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 104.413 -2.44 . . . . 0.0 104.413 -179.946 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -110.79 162.64 8.18 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-N 120.447 1.476 . . . . 0.0 113.149 -169.663 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 93.71 143.14 12.86 Favored Glycine 0 CA--C 1.53 0.998 0 N-CA-C 106.374 -2.69 . . . . 0.0 106.374 -169.166 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.658 HD22 ' H ' ' A' ' 130' ' ' LEU . 0.4 OUTLIER -71.92 165.15 24.76 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 119.576 1.688 . . . . 0.0 110.602 -177.701 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 39.5 p -67.92 166.36 24.2 Favored Pre-proline 0 CA--C 1.539 0.533 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 167.826 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -59.73 -30.57 92.42 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 CA-C-N 120.588 1.246 . . . . 0.0 111.514 173.026 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 79.1 m -67.7 -41.85 82.97 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-N 118.903 0.774 . . . . 0.0 110.105 179.904 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 91.0 t -95.32 -26.26 4.34 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.214 0 CA-C-N 118.329 0.513 . . . . 0.0 110.751 -169.973 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -52.4 -46.91 66.5 Favored 'General case' 0 N--CA 1.464 0.243 0 O-C-N 120.567 -1.333 . . . . 0.0 108.418 169.409 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -69.84 -16.28 63.24 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 113.952 1.093 . . . . 0.0 113.952 -177.935 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . 0.448 ' SD ' HG13 ' A' ' 119' ' ' VAL . 84.0 mtp -71.13 -12.09 61.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 117.24 -1.362 . . . . 0.0 112.6 173.679 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 35.3 mt -53.13 -47.33 55.51 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.28 0 CA-C-N 120.451 1.478 . . . . 0.0 109.226 175.307 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -73.38 -47.1 7.65 Favored Pre-proline 0 CA--C 1.544 0.73 0 CA-C-N 120.296 1.407 . . . . 0.0 112.109 -169.875 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -54.39 -44.78 46.3 Favored 'Trans proline' 0 C--N 1.353 0.802 0 C-N-CA 122.452 2.101 . . . . 0.0 112.179 170.174 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -67.81 -39.41 83.95 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 118.518 -0.753 . . . . 0.0 111.195 -179.055 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 29.0 mt -59.88 -45.57 92.08 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-N 119.79 1.177 . . . . 0.0 109.284 173.075 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -58.18 -33.67 69.51 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 118.993 0.815 . . . . 0.0 110.099 175.689 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -69.72 -39.9 76.57 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 118.778 0.717 . . . . 0.0 111.267 175.412 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 81.1 t -59.36 -44.81 93.28 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 172.596 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 14.7 mt -58.91 -42.65 90.13 Favored 'General case' 0 C--N 1.342 0.246 0 CA-C-N 119.017 0.826 . . . . 0.0 109.576 176.909 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -66.9 -43.63 82.91 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 119.146 0.885 . . . . 0.0 110.687 -176.796 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -67.71 -29.4 68.64 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 119.127 0.876 . . . . 0.0 111.131 179.186 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 41.6 mt -64.76 -49.67 69.86 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 170.298 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 14.7 mtp-105 -68.77 -16.8 63.9 Favored 'General case' 0 CA--C 1.527 0.095 0 CA-C-O 118.219 -0.896 . . . . 0.0 111.557 -177.82 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 30.6 mm-40 -65.6 -23.56 66.86 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 120.32 1.418 . . . . 0.0 111.299 170.826 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 58.4 m -100.73 17.2 22.6 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 119.054 0.843 . . . . 0.0 110.221 168.467 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 68.44 18.33 71.54 Favored Glycine 0 C--N 1.336 0.55 0 CA-C-O 117.656 -1.635 . . . . 0.0 111.958 -176.179 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 42.7 t -91.93 119.01 38.59 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 CA-C-N 120.344 2.072 . . . . 0.0 106.149 -177.121 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -111.26 89.23 2.99 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 178.383 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -49.55 138.3 13.99 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 114.833 -1.076 . . . . 0.0 109.72 169.663 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 15.8 mm -84.79 128.99 58.49 Favored Pre-proline 0 C--O 1.232 0.161 0 CA-C-O 117.483 -1.246 . . . . 0.0 107.902 -174.125 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -66.69 92.09 0.3 Allowed 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 122.922 2.414 . . . . 0.0 108.916 171.376 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 10.1 ttt-85 49.21 19.28 0.3 Allowed 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 128.441 2.696 . . . . 0.0 115.804 179.624 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 64.0 m 46.18 38.39 4.89 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.64 1.176 . . . . 0.0 111.886 -169.624 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -85.68 53.64 2.84 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.102 0.961 . . . . 0.0 110.005 179.368 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 13.5 m . . . . . 0 C--O 1.252 1.2 0 C-N-CA 125.311 1.444 . . . . 0.0 110.266 -177.712 . . . . . . . . 0 0 . 1 stop_ save_